Phenotypic	Phenotypic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
trio	BEGIN-trio-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Abl	BEGIN-Abl-INSIDE	NN	I-NP	B
cooperate	cooperate	VBP	B-VP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
axon	axon	NN	B-NP	O
outgrowth	outgrowth	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
embryonic	embryonic	JJ	I-NP	O
central	central	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
(	(	(	O	O
CNS	CNS	NN	B-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
located	locate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
lamina	lamina	NN	B-NP	O
VII	VII	CD	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
lamina	lamina	NN	B-NP	O
VIII	VIII	CD	I-NP	O
,	,	,	O	O
accounting	account	VBG	B-VP	O
for	for	IN	B-PP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
labeled	label	VBN	I-NP	O
neurons	neuron	NNS	I-NP	O

We	We	PRP	B-NP	O
measured	measure	VBD	B-VP	O
electromyograms	electromyogram	NNS	B-NP	O
(	(	(	O	O
EMG	EMG	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alae	alae	JJ	I-NP	O
nasi	nasi	NNS	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
their	their	PRP$	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	I-NP	O
timing	timing	NN	I-NP	O
to	to	TO	B-PP	O
contraction	contraction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rib	rib	NN	I-NP	O
cage	cage	NN	I-NP	O
muscles	muscle	NNS	I-NP	O
and	and	CC	O	O
diaphragm	diaphragm	NN	B-NP	O
during	during	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
in	in	IN	B-PP	O
nine	nine	CD	B-NP	O
patients	patient	NNS	I-NP	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
control	control	NN	I-NP	O
study	study	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
:	:	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
pairs	pair	NNS	I-NP	O
of	of	IN	B-PP	O
Hepatitis	Hepatitis	NN	B-NP	O
A	A	NN	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
in	in	IN	B-PP	O
Weng	Weng	NN	B-NP	O
-	-	HYPH	O	O
ling	le	VBG	B-VP	O
Zhe	Zhe	NN	B-NP	O
-	-	HYPH	B-NP	O
jiang	jiang	NN	I-NP	O
during	during	IN	B-PP	O
April	April	NNP	B-NP	O
1	1	CD	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
shock	shock	NN	B-NP	O
,	,	,	O	O
sepsis	sepsis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
identifiable	identifiable	JJ	I-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
lactic	lactic	JJ	B-NP	O
acidosis	acidosis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
severe	severe	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
(	(	(	O	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	B-NP	B
1	1	CD	I-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
dl	dl	NN	I-NP	O
)	)	)	O	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
etiologic	etiologic	JJ	I-NP	O
factor	factor	NN	I-NP	O

However	However	RB	B-ADVP	O
the	the	DT	B-NP	O
precise	precise	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
DNA	BEGIN-DNA	NN	B-NP	B
-	-	HYPH	B-NP	I
PK	PK-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
strand	strand	NN	I-NP	O
break	break	NN	I-NP	O
repair	repair	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
known	know	VBN	I-VP	O

The	The	DT	B-NP	O
COR	BEGIN-COR-INSIDE	JJ	I-NP	B
biosynthetic	biosynthetic	JJ	I-NP	O
gene	gene	NN	I-NP	O
cluster	cluster	NN	I-NP	O
in	in	IN	B-PP	O
P.	P.	NNP	B-NP	O
syringae	syringae	NNP	I-NP	O
pv.	pv.	NN	I-NP	O
glycinea	glycinea	NN	I-NP	O
PG1	PG1	NN	I-NP	O
is	be	VBZ	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
region	region	NN	I-NP	O
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
structural	structural	JJ	I-NP	O
and	and	CC	I-NP	O
regulatory	regulatory	JJ	I-NP	O
genes	gene	NNS	I-NP	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
COR	BEGIN-COR-INSIDE	NN	B-NP	B
synthesis	synthesis	NN	I-NP	O

Substitution	Substitution	NN	B-NP	O
of	of	IN	B-PP	O
cholinergic	cholinergic	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
Alzheimer	Alzheimer	NNP	B-NP	O
type	type	NN	I-NP	O
dementia	dementia	NN	I-NP	O
(	(	(	O	O
AD	AD	NN	B-NP	O
/	/	SYM	B-NP	O
SDAT	SDAT	NN	I-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
hitherto	hitherto	VBN	I-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
very	very	RB	B-ADJP	O
successful	successful	JJ	I-ADJP	O

FEurea	FEurea	NNP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
measured	measure	VBN	I-VP	O
during	during	IN	B-PP	O
stable	stable	JJ	B-NP	O
graft	graft	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
allograft	allograft	VB	I-VP	O
dysfunction	dysfunction	NN	B-NP	O

The	The	DT	B-NP	O
findings	finding	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
reference	reference	NN	B-NP	O
to	to	TO	B-PP	O
possible	possible	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
parasite	parasite	JJ	B-NP	O
development	development	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
controlled	control	VBN	I-VP	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
basal	basal	JJ	B-NP	O
MAPK	BEGIN-MAPK-INSIDE	NN	I-NP	B
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
Raf	BEGIN-Raf	JJ	B-ADJP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
activity	activity	NN	B-NP	O
was	be	VBD	B-VP	O
constitutively	constitutively	RB	I-VP	O
enhanced	enhance	VBN	I-VP	O
in	in	IN	B-PP	O
Jak1	BEGIN-Jak1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
HeLa	HeLa	NN	I-NP	O
cells	cell	NNS	I-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
hypokalemia	hypokalemia	NN	I-NP	O
,	,	,	O	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
depletion	depletion	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
K	K	NN	I-NP	O
,	,	,	O	O
bringing	bring	VBG	B-VP	O
about	about	IN	B-PP	O
more	more	RBR	B-NP	O
general	general	JJ	I-NP	O
consequences	consequence	NNS	I-NP	O

We	We	PRP	B-NP	O
present	present	VBP	B-VP	O
here	here	RB	B-ADVP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
primary	primary	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
gp1	gp1-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
variant	variant	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
principal	principal	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
autoantigen	autoantigen	NN	I-NP	O
causing	cause	VBG	B-VP	O
Heymann	Heymann	NNP	B-NP	O
membranous	membranous	JJ	I-NP	O
glomerulonephritis	glomerulonephritis	NN	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O

A	A	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
deletion	deletion	NN	B-NP	O
mutants	mutant	NNS	I-NP	O
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
transiently	transiently	RB	B-ADVP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
human	human	JJ	I-NP	O
hepatocytes	hepatocyte	NNS	I-NP	O
,	,	,	O	O
HepG1	HepG1	NN	B-NP	O
and	and	CC	I-NP	O
PLC	PLC	NN	I-NP	O

Biol	Biol	NNP	B-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O

No	No	DT	B-NP	O
patient	patient	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	O
procollagen	BEGIN-procollagen-INSIDE	NN	I-NP	B
(	(	(	O	O
PC	BEGIN-PC	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
)	)	)	O	O
serum	serum	NN	B-NP	O
level	level	NN	I-NP	O
analysis	analysis	NN	I-NP	O

In	In	IN	B-PP	O
four	four	CD	B-NP	O
calves	calf	NNS	I-NP	O
given	give	VBN	B-VP	O
Haemonchus	Haemonchus	NNP	B-NP	O
contortus	contortu	VBZ	B-VP	O
larvae	larvae	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
serum	BEGIN-serum	NN	I-NP	B
pepsinogen	pepsinogen-INSIDE	NN	I-NP	I
concentration	concentration	NN	I-NP	O
rose	rise	VBD	B-VP	O
quickly	quickly	RB	B-ADVP	O
to	to	TO	B-VP	O
reach	reach	VB	I-VP	O
a	a	DT	B-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
iu	iu	NN	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
after	after	IN	B-PP	O
infection	infection	NN	B-NP	O

The	The	DT	B-NP	O
P	BEGIN-P	NN	I-NP	B
-	-	HYPH	B-NP	I
ITIM	ITIM	NN	I-NP	I
-	-	HYPH	O	I
compelled	compel	VBN	B-VP	I
multi	multi	AFX	B-NP	I
-	-	HYPH	I-NP	I
phosphoprotein	phosphoprotein	NN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
and	and	CC	O	O
activates	activate	VBZ	B-VP	O
SHP	BEGIN-SHP	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
dephosphorylates	dephosphorylate	VBZ	B-VP	O
SHIP	BEGIN-SHIP-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Shc	BEGIN-Shc-INSIDE	NN	I-NP	B
and	and	CC	O	O
probably	probably	RB	B-ADVP	O
other	other	JJ	B-NP	O
substrates	substrate	NNS	I-NP	O

Paradoxically	Paradoxically	RB	B-ADVP	O
,	,	,	O	O
loop	loop	NN	B-NP	O
1i	1i	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
M1Ach	BEGIN-M1Ach	NN	I-NP	B
-	-	HYPH	B-NP	I
muscarinic	muscarinic	JJ	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
maximally	maximally	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
GnRH	BEGIN-GnRH-INSIDE	NN	B-NP	B
agonist	agonist	NN	I-NP	O
-	-	HYPH	B-VP	O
stimulated	stimulate	VBN	B-NP	O
cAMP	cAMP	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
and	and	CC	O	O
PRL	BEGIN-PRL-INSIDE	NN	B-NP	B
release	release	NN	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
both	both	DT	B-NP	O
effects	effect	NNS	I-NP	O
mediated	mediate	VBN	B-VP	O
through	through	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Gs	BEGIN-G	NNS	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
)	)	)	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
-	-	HYPH	O	O
shift	shift	NN	B-NP	O
assays	assay	NNS	I-NP	O
with	with	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
COS	COS	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
expression	expression	NN	B-NP	O
vectors	vector	NNS	I-NP	O
for	for	IN	B-PP	O
SMADs	BEGIN-SMAD	NNS	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
SMAD1	BEGIN-SMAD1-INSIDE	NN	B-NP	B
forms	form	VBZ	B-VP	O
a	a	DT	B-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
migration	migration	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	BEGIN-endogenous	JJ	I-NP	B
TGF	TGF	NN	I-NP	I
-	-	HYPH	B-NP	I
beta	beta	SYM	I-NP	I
-	-	HYPH	I-NP	I
specific	specific	JJ	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
fibroblast	fibroblast	NN	B-NP	O
extracts	extract	NNS	I-NP	O

Oligomers	Oligomer	NNS	B-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mlc	BEGIN-mlc	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
/	/	SYM	I-NP	I
1	1	CD	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
encompasses	encompass	VBZ	B-VP	O
this	this	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
,	,	,	O	O
bound	bind	VBD	B-VP	O
MEF	BEGIN-MEF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
competed	compete	VBD	B-VP	O
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mck	BEGIN-mck-INSIDE	NN	I-NP	B
enhancer	enhancer	NN	I-NP	O

cDNA	cDNA	NN	B-NP	O
cloning	cloning	NN	I-NP	O
and	and	CC	O	O
transcriptional	transcriptional	JJ	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
GC	BEGIN-GC	NN	I-NP	B
box	box	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
BTEB1	BEGIN-BTEB1-INSIDE	NN	B-NP	B

N1	N1	NN	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
favorable	favorable	JJ	I-ADJP	O
than	than	IN	B-PP	O
N1	N1	NN	B-NP	O
or	or	CC	I-NP	O
N1	N1	NN	I-NP	O
disease	disease	NN	I-NP	O

Elimination	Elimination	NN	B-NP	O
of	of	IN	B-PP	O
brush	brush	JJ	B-NP	O
border	border	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
of	of	IN	B-PP	O
glomerular	glomerular	JJ	B-NP	O
marker	marker	NN	I-NP	O
proteins	protein	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
after	after	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
osmolar	osmolar	JJ	I-NP	O
CM	CM	NN	I-NP	O
iopamidol	iopamidol	NN	I-NP	O
1	1	CD	I-NP	O
(	(	NN	I-NP	O
1	1	CD	B-NP	O
mOsm	mOsm	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
after	after	IN	B-PP	O
meglumine	meglumine	NN	B-NP	O
diatrizoate	diatrizoate	NN	I-NP	O
1	1	CD	I-NP	O
(	(	NN	I-NP	O
1	1	CD	B-NP	O
mOsm	mOsm	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O

Overall	Overall	JJ	B-NP	O
graft	graft	NN	I-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
survival	survival	NN	I-NP	O
after	after	IN	B-PP	O
HAT	HAT	NN	B-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Of	Of	IN	B-PP	O
1	1	CD	B-NP	O
girls	girl	NNS	I-NP	O
cured	cure	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
bacteriuria	bacteriuria	NN	I-NP	O
1	1	CD	I-NP	O
recurred	recur	VBD	B-VP	O
,	,	,	O	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
pyelonephritis	pyelonephritis	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
cystitis	cystitis	NN	B-NP	O

Partial	Partial	JJ	B-NP	O
hepatectomy	hepatectomy	NN	I-NP	O
in	in	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
Wilms	Wilms	NNP	I-NP	O
'	'	POS	B-NP	O
tumor	tumor	NN	I-NP	O

MRS	MRS	NN	B-NP	O
allowed	allow	VBD	B-VP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
metabolites	metabolite	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
:	:	:	O	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
acetyl	acetyl	NN	I-NP	O
-	-	HYPH	O	O
aspartate	aspartate	NN	B-NP	O
(	(	(	O	O
NAA	NAA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
creatine	creatine	NN	B-NP	O
and	and	CC	I-NP	O
phosphocreatine	phosphocreatine	NN	I-NP	O
,	,	,	I-NP	O
phosphorylcholine	phosphorylcholine	NN	I-NP	O
and	and	CC	I-NP	O
glycerophosphorylcholine	glycerophosphorylcholine	NN	I-NP	O
,	,	,	O	O
beta	beta	SYM	B-NP	O
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
gamma	gamma	SYM	O	O
-	-	HYPH	O	O
glutamate	glutamate	NN	B-NP	O
(	(	(	O	O
GLU	GLU	NN	B-NP	O
)	)	)	O	O

Plasma	Plasma	NN	B-NP	O
prolactin	BEGIN-prolactin-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
colorectal	colorectal	JJ	B-NP	O
cancer	cancer	NN	I-NP	O

Studies	Study	NNS	B-NP	O
of	of	IN	B-PP	O
fetal	fetal	JJ	B-NP	O
maturity	maturity	NN	I-NP	O

A	A	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
recovery	recovery	NN	B-NP	O
and	and	CC	I-NP	O
time	time	NN	I-NP	O
for	for	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
mycobacteria	mycobacterium	NNS	B-NP	O
from	from	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
specimens	specimen	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
newly	newly	RB	I-NP	O
developed	develop	VBN	I-NP	O
Mycobacteria	Mycobacteria	NNP	I-NP	O
Growth	Growth	NNP	I-NP	O
Indicator	Indicator	NNP	I-NP	O
Tube	Tube	NNP	I-NP	O
(	(	(	O	O
MGIT	MGIT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
biphasic	biphasic	JJ	I-NP	O
Septi	Septi	NNP	I-NP	O
-	-	HYPH	I-NP	O
Chek	Chek	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
egg	egg	NN	I-NP	O
-	-	HYPH	B-VP	O
based	base	VBN	B-NP	O
Ogawa	Ogawa	NN	I-NP	O
medium	medium	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O

E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
HLF	BEGIN-HLF-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
mediated	mediate	VBN	I-NP	O
cell	cell	NN	I-NP	O
transformation	transformation	NN	I-NP	O
requires	require	VBZ	B-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
activation	activation	NN	I-NP	O
domains	domain	NNS	I-NP	O
of	of	IN	B-PP	O
E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
leucine	leucine	NN	I-NP	O
zipper	zipper	NN	I-NP	O
dimerization	dimerization	NN	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
HLF	BEGIN-HLF-INSIDE	NN	B-NP	B

In	In	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfections	transfection	NNS	I-NP	O
using	use	VBG	B-VP	O
luciferase	BEGIN-luciferase	NN	B-NP	B
reporter	reporter	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
driven	drive	VBN	B-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
flanking	flank	VBG	I-NP	O
DNA	DNA	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
CALM	BEGIN-CALM	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	BEGIN-endogenous	JJ	I-NP	B
CALM	CALM-INSIDE	NN	I-NP	I
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
only	only	RB	O	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
untranslated	untranslated	JJ	I-NP	O
regions	region	NNS	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
constructs	construct	NNS	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
several	several	JJ	B-NP	O
health	health	NN	I-NP	O
behaviors	behavior	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
maintaining	maintain	VBG	B-VP	O
mobility	mobility	NN	B-NP	O
during	during	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
among	among	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
men	man	NNS	I-NP	O
and	and	CC	I-NP	O
women	woman	NNS	I-NP	O
aged	age	VBN	B-VP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
and	and	CC	O	O
older	old	JJR	B-ADJP	O
with	with	IN	B-PP	O
intact	intact	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
who	who	WP	B-NP	O
lived	live	VBD	B-VP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
communities	community	NNS	I-NP	O
:	:	:	O	O
East	East	NNP	B-NP	O
Boston	Boston	NNP	I-NP	O
,	,	,	O	O
Massachusetts	Massachusetts	NNP	B-NP	O
;	;	:	O	O
Iowa	Iowa	NNP	B-NP	O
and	and	CC	I-NP	O
Washington	Washington	NNP	I-NP	O
counties	county	NNS	I-NP	O
,	,	,	O	O
Iowa	Iowa	NNP	B-NP	O
;	;	:	O	O
and	and	CC	O	O
New	New	NNP	B-NP	O
Haven	Haven	NNP	I-NP	O
,	,	,	O	O
Connecticut	Connecticut	NNP	B-NP	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
ZAP	BEGIN-ZAP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
phospho	phospho	AFX	B-NP	O
-	-	HYPH	I-NP	O
TAMs	TAM	NNS	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
cooperativity	cooperativity	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
individually	individually	RB	B-ADVP	O
demonstrate	demonstrate	VBP	B-VP	O
low	low	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
ligand	ligand	NN	I-NP	O

A	A	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
study	study	NN	I-NP	O

Two	Two	CD	B-NP	O
-	-	HYPH	I-NP	O
dimensional	dimensional	JJ	I-NP	O
echocardiographic	echocardiographic	JJ	I-NP	O
parasternal	parasternal	JJ	I-NP	O
long	long	JJ	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
short	short	JJ	I-NP	O
-	-	HYPH	I-NP	O
axis	axis	NN	I-NP	O
views	view	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
during	during	IN	B-PP	O
graded	grade	VBN	B-NP	O
bleeding	bleeding	NN	I-NP	O
by	by	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
increments	increment	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
each	each	DT	B-NP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
calculated	calculate	VBN	B-NP	O
blood	blood	NN	I-NP	O
volume	volume	NN	I-NP	O

Comparative	Comparative	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
peripheral	peripheral	JJ	I-NP	O
domain	domain	NN	I-NP	O
exhibits	exhibit	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
length	length	NN	I-NP	O
polymorphism	polymorphism	NN	I-NP	O
near	near	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
termination	termination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
H	H	NN	I-NP	O
-	-	HYPH	B-NP	O
strand	strand	NN	I-NP	O
replication	replication	NN	I-NP	O

Thirty	Thirty	CD	B-NP	O
-	-	HYPH	I-NP	O
five	five	CD	I-NP	O
pts	pt	NNS	I-NP	O
were	be	VBD	B-VP	O
transplanted	transplant	VBN	I-VP	O
for	for	IN	B-PP	O
constitutional	constitutional	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
Fanconi	Fanconi	NN	B-NP	O
anemia	anemia	NN	I-NP	O
(	(	(	O	O
FA	FA	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
1	1	CD	B-NP	O
pts	pt	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
Dyskeratosis	Dyskeratosis	NN	B-NP	O
congenita	congenita	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
pts	pt	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
Blackfan	Blackfan	NNP	B-NP	O
-	-	HYPH	I-NP	O
Diamond	Diamond	NNP	I-NP	O
erythroblastopenia	erythroblastopenia	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
pts	pt	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
Glanzmann	Glanzmann	NN	B-NP	O
thrombasthenia	thrombasthenia	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
pt	pt	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
osteopetrosis	osteopetrosis	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
pt	pt	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Gaucher	Gaucher	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
pt	pt	NN	I-NP	O
)	)	)	O	O

One	One	CD	B-NP	O
patient	patient	NN	I-NP	O
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
sense	sense	NN	I-NP	O
mutation	mutation	NN	I-NP	O
(	(	(	O	O
codon	codon	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
changed	change	VBD	B-VP	O
a	a	DT	B-NP	O
glutamine	glutamine	NN	I-NP	O
codon	codon	NN	I-NP	O
(	(	(	O	O
CAG	CAG	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
stop	stop	NN	I-NP	O
codon	codon	NN	I-NP	O
(	(	(	O	O
TAG	TAG	NN	B-NP	O
)	)	)	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
approach	approach	NN	I-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
hFIRE	BEGIN-hFIRE-INSIDE	NN	B-NP	B
binds	bind	VBZ	B-VP	O
the	the	DT	B-NP	O
stimulatory	stimulatory	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
Sp1	BEGIN-Sp1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
Sp1	BEGIN-Sp1-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
CBF	BEGIN-CBF-INSIDE	NN	B-NP	B

Cellular	Cellular	JJ	B-NP	O
fractionation	fractionation	NN	I-NP	O
and	and	CC	I-NP	O
Percoll	Percoll	NN	I-NP	O
gradient	gradient	NN	I-NP	O
centrifugation	centrifugation	NN	I-NP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
immunoblotting	immunoblotting	NN	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
cofractionates	cofractionate	NNS	I-NP	O
with	with	IN	B-PP	O
nuclei	nucleus	NNS	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
enriched	enrich	VBN	I-VP	O
in	in	IN	B-PP	O
resistant	resistant	JJ	B-NP	O
structure	structure	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
insoluble	insoluble	JJ	B-ADJP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
M	M	NN	I-NP	O
NaCl	NaCl	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mM	mM	NN	I-NP	O
lithium	lithium	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
diiodosalicylate	diiodosalicylate	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
Triton	Triton	NN	I-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
soluble	soluble	JJ	B-ADJP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
M	M	NN	I-NP	O
urea	urea	NN	I-NP	O

Gene	Gene	NN	B-NP	O
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
controlled	control	VBN	B-VP	O
by	by	IN	B-PP	O
chromatin	chromatin	NN	B-NP	O
remodeling	remodeling	NN	I-NP	O
factors	factor	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
acetylation	acetylation	NN	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
nucleosomal	BEGIN-nucleosomal	JJ	B-NP	B
histones	histones-INSIDE	NN	I-NP	I

Corticosteroid	Corticosteroid	NN	B-NP	O
treatment	treatment	NN	I-NP	O
before	before	IN	B-ADVP	O
,	,	,	O	O
during	during	IN	B-PP	O
,	,	,	O	O
or	or	CC	O	O
after	after	IN	B-SBAR	O
fludarabine	fludarabine	NN	B-NP	O
treatment	treatment	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
alkylator	alkylator	NN	B-NP	O
-	-	HYPH	B-ADJP	O
resistant	resistant	JJ	B-NP	O
,	,	,	I-NP	O
low	low	JJ	I-NP	O
-	-	HYPH	I-NP	O
grade	grade	NN	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
malignancies	malignancy	NNS	I-NP	O
who	who	WP	B-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
received	receive	VBN	I-VP	O
PCP	PCP	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
opportunistic	opportunistic	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
infections	infection	NNS	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
several	several	JJ	B-NP	O
genes	gene	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
NHEJ	NHEJ	NN	B-NP	O
perform	perform	NN	I-NP	O
essential	essential	JJ	I-NP	O
functions	function	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
endonuclease	endonuclease	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
DSBs	DSB	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

The	The	DT	B-NP	O
primary	primary	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
cholesterol	BEGIN-cholesterol	NN	B-NP	B
esterase	esterase-INSIDE	NN	I-NP	I
displayed	display	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
lipases	BEGIN-lipases-INSIDE	NN	I-NP	B
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
lipid	lipid	NN	I-NP	O
interfacial	interfacial	JJ	I-NP	O
recognition	recognition	NN	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
G	G	NN	B-NP	O
-	-	HYPH	O	O
X	X	SYM	B-NP	O
-	-	HYPH	B-NP	O
S	S	NN	I-NP	O
-	-	HYPH	O	O
X	X	SYM	O	O
-	-	HYPH	O	O
G	G	NN	B-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cholesterol	BEGIN-BEGIN-cholesterol	NN	I-NP	B
esterase	esterase-INSIDE	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I

Subtype	Subtype	NN	B-NP	O
-	-	HYPH	O	O
and	and	CC	O	O
response	response	NN	B-NP	O
element	element	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
transactivation	transactivation	NN	B-NP	O
by	by	IN	B-PP	O
peroxisome	BEGIN-peroxisome	NN	B-NP	B
proliferator	proliferator	NN	I-NP	I
-	-	HYPH	B-NP	I
activated	activate	VBN	I-NP	I
receptors	receptor	NNS	I-NP	I
alpha	alpha	NN	I-NP	I
and	and	CC	I-NP	I
gamma	gamma-INSIDE	NN	I-NP	I

Monoclonal	Monoclonal	JJ	B-NP	O
antibodies	antibody	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hapten	hapten	JJ	I-NP	O
phenyloxazolone	phenyloxazolone	NN	I-NP	O
were	be	VBD	B-VP	O
raised	raise	VBN	I-VP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
immunization	immunization	NN	B-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
of	of	IN	B-PP	O
six	six	CD	B-NP	O
strains	strain	NNS	I-NP	O
(	(	(	O	O
BALB	BALB	NN	B-NP	O
/	/	SYM	I-NP	O
c	c	NN	I-NP	O
,	,	,	O	O
C1BL	C1BL	NN	B-NP	O
-	-	HYPH	I-NP	O
Igha	Igha	NN	I-NP	O
,	,	,	O	O
DBA1	DBA1	NN	B-NP	O
,	,	,	O	O
RF	RF	NN	B-NP	O
,	,	,	O	O
A	A	NN	B-NP	O
/	/	SYM	I-NP	O
J	J	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CE	CE	NN	B-NP	O
)	)	)	O	O

PMA	PMA	NN	B-NP	O
produced	produce	VBD	B-VP	O
similar	similar	JJ	B-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
WT	BEGIN-WT	NN	I-NP	B
AP1	AP1-INSIDE	NN	I-NP	I
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
jun	jun-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O
-	-	HYPH	B-NP	O
CAT	CAT	NN	I-NP	O
plasmid	plasmid	NN	I-NP	O
was	be	VBD	B-VP	O
smaller	small	JJR	B-ADJP	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
QT	QT	NN	I-NP	O
duration	duration	NN	I-NP	O
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
beat	beat	NN	I-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
beat	beat	NN	I-NP	O
variability	variability	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
interval	interval	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
:	:	:	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
domain	domain	NN	I-NP	O
(	(	(	O	O
decreased	decrease	VBN	B-VP	O
standard	standard	JJ	B-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
domain	domain	NN	I-NP	O
(	(	(	O	O
decreased	decrease	VBN	B-VP	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
frequency	frequency	NN	I-NP	O
power	power	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spectra	spectrum	NNS	I-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
chaotic	chaotic	JJ	I-NP	O
domain	domain	NN	I-NP	O
(	(	(	O	O
tighter	tight	JJR	B-NP	O
clustering	clustering	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
points	point	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Poincare	Poincare	NNP	I-NP	O
plots	plot	NNS	I-NP	O
)	)	)	O	O

J	J	NNP	B-NP	O

Student	Student	NN	B-NP	O
health	health	NN	I-NP	O

In	In	IN	B-PP	O
both	both	CC	O	O
study	study	NN	B-NP	O
stages.	stages.	NN	I-NP	O
post	post	AFX	O	O
-	-	HYPH	B-NP	O
exposure	exposure	NN	I-NP	O
treatment	treatment	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
injections	injection	NNS	I-NP	O
of	of	IN	B-PP	O
vaccine	vaccine	NN	B-NP	O
[	[	(	O	O
(	(	(	O	O
D	D	NN	B-NP	O
)	)	)	O	O
ays	ay	NNS	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
]	]	)	O	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
rabies	BEGIN-raby	NNS	B-NP	B
immunoglobulin	immunoglobulin-INSIDE	NN	B-NP	I
(	(	(	O	O
RIG	BEGIN-RIG-INSIDE	NN	B-NP	B
)	)	)	O	O
of	of	IN	B-PP	O
equine	equine	JJ	B-NP	O
or	or	CC	I-NP	O
human	human	JJ	I-NP	O
origin	origin	NN	I-NP	O
on	on	IN	B-PP	O
D1	D1	NN	B-NP	O

Essential	Essential	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acid	acid	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
in	in	IN	B-PP	O
childhood	childhood	NN	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
earlier	earlier	RBR	I-VP	O
proposed	propose	VBN	I-VP	O
that	that	IN	B-SBAR	O
CG	CG	NN	B-NP	O
rich	rich	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
resembling	resemble	VBG	B-VP	O
CpG	CpG	NN	B-NP	O
islands	island	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
many	many	JJ	B-NP	O
imprinted	imprinted	JJ	I-NP	O
genes	gene	NNS	I-NP	O
and	and	CC	O	O
often	often	RB	B-ADVP	O
subject	subject	JJ	B-ADJP	O
to	to	TO	B-PP	O
parental	parental	JJ	B-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
methylation	methylation	NN	I-NP	O
,	,	,	O	O
could	could	MD	B-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
imprinting	imprinting	NN	I-NP	O
element	element	NN	I-NP	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
-	-	HYPH	B-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
that	that	WDT	B-NP	O
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
consensus	BEGIN-consensus	NN	I-NP	B
kappa	kappa	NN	I-NP	I
B	B	NN	I-NP	I
motif	motif-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
thalamic	thalamic	JJ	I-NP	O
SD	SD	NN	I-NP	O
was	be	VBD	B-VP	O
regularly	regularly	RB	I-VP	O
triggered	trigger	VBN	I-VP	O
by	by	IN	B-PP	O
short	short	JJ	B-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
)	)	)	O	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
frequency	frequency	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
Hz	Hz	NN	I-NP	O
)	)	)	O	O
ES	ES	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
parietal	parietal	JJ	I-NP	O
cortical	cortical	JJ	I-NP	O
surface	surface	NN	I-NP	O

As	As	IN	B-PP	O
in	in	IN	B-PP	O
IncP	IncP	NN	B-NP	O
alpha	alpha	NN	I-NP	O
plasmids	plasmid	NNS	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
operons	operon	NNS	I-NP	O
are	be	VBP	B-VP	O
transcribed	transcribe	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
bidirectional	bidirectional	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
trfAp	BEGIN-trfAp-INSIDE	NN	B-NP	B
for	for	IN	B-PP	O
the	the	DT	B-NP	O
trfA	BEGIN-trfA	NN	I-NP	B
operon	operon-INSIDE	NN	I-NP	I
and	and	CC	O	O
trbAp	BEGIN-trbAp-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
trbBp	BEGIN-trbBp-INSIDE	NN	I-NP	B
for	for	IN	B-PP	O
the	the	DT	B-NP	O
trb	BEGIN-trb	NN	I-NP	B
operon	operon-INSIDE	NN	I-NP	I

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
encoded	encode	VBN	I-NP	O
ERCC1Dm	BEGIN-ERCC1Dm	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
the	the	DT	B-NP	O
homologous	homologous	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
man	man	NN	B-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
conservation	conservation	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
postulated	postulate	VBN	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
region	region	NN	I-NP	O
and	and	CC	O	O
seven	seven	CD	B-NP	O
'helicase	BEGIN-'helicase	NN	I-NP	B
'	'	``	O	I
domains	domains-INSIDE	NN	B-NP	I

Genetic	Genetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
places	place	VBZ	B-VP	O
CWH1	BEGIN-CWH1-INSIDE	NN	B-NP	B
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
BCK1	BEGIN-BCK1-INSIDE	NN	I-NP	B
branch	branch	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PKC1	BEGIN-PKC1-INSIDE	NN	I-NP	B
signalling	signalling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
cwh1	BEGIN-cwh1-INSIDE	NN	B-NP	B
mutations	mutation	NNS	I-NP	O
were	be	VBD	B-VP	O
synthetic	synthetic	JJ	B-NP	O
lethal	lethal	NN	I-NP	O
with	with	IN	B-PP	O
pkc1	BEGIN-pkc1-INSIDE	NN	B-NP	B
deletion	deletion	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
cwh1	BEGIN-cwh1-INSIDE	NN	I-NP	B
defects	defect	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
rescued	rescue	VBN	I-VP	O
by	by	IN	B-PP	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
BCK1	BEGIN-BCK1-INSIDE	NN	B-NP	B
and	and	CC	B-PP	O
not	not	RB	B-PP	O
by	by	IN	I-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
copy	copy	NN	I-NP	O
-	-	HYPH	I-NP	O
number	number	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
downstream	downstream	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PKC1	BEGIN-PKC1-INSIDE	NN	I-NP	B
pathway	pathway	NN	I-NP	O
However	However	RB	B-ADVP	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
BCK1	BEGIN-BCK1-INSIDE	NN	B-NP	B
,	,	,	O	O
whose	whose	WP$	B-NP	O
disruption	disruption	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cln1	BEGIN-cln1	NN	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
growth	growth	NN	B-NP	O
arrest	arrest	NN	I-NP	O
in	in	IN	B-PP	O
G	G	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
defect	defect	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
double	double	JJ	I-NP	O
cwh1	BEGIN-cwh1-INSIDE	NN	I-NP	B
cln1	BEGIN-cln1	NN	I-NP	B
mutants	mutant-INSIDE	NNS	I-NP	I

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E1	BEGIN-BEGIN-E1-INSIDE	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
repression	repression	NN	I-NP	O
of	of	IN	B-PP	O
HPV	BEGIN-HPV	NN	B-NP	B
E1	BEGIN-E1-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	O	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
,	,	,	O	O
followed	follow	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
later	later	RB	B-ADVP	O
by	by	IN	B-PP	O
profound	profound	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O

Peak	Peak	JJ	B-NP	O
reactive	reactive	JJ	I-NP	O
hyperemia	hyperemia	NN	I-NP	O
(	(	(	O	O
mL.min	mL.min	NN	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
mL	mL	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
calf	calf	NN	I-NP	O
and	and	CC	I-NP	O
forearm	forearm	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
training	training	NN	B-NP	O

The	The	DT	B-NP	O
hematopoietic	hematopoietic	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
PTPN1	BEGIN-PTPN1	NN	B-NP	B
transcript	transcript-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
initiated	initiate	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
downstream	downstream	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
separated	separate	VBN	B-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O

Reversal	Reversal	NN	B-NP	O
of	of	IN	B-PP	O
biliary	biliary	JJ	B-NP	O
sphincter	sphincter	NN	I-NP	O
spasm	spasm	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
glucagon	BEGIN-glucagon-INSIDE	NN	I-NP	B
during	during	IN	B-PP	O
operative	operative	JJ	B-NP	O
cholangiography	cholangiography	NN	I-NP	O

In	In	IN	B-PP	O
ten	ten	CD	B-NP	O
other	other	JJ	I-NP	O
endotoxin	endotoxin	NN	I-NP	O
-	-	HYPH	B-NP	O
albumin	BEGIN-albumin-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
pigs	pig	NNS	I-NP	O
PGE1	PGE1	NN	I-NP	O
infusion	infusion	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
X	X	SYM	B-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
X	X	SYM	I-NP	O
min	min	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
after	after	IN	B-PP	O
established	establish	VBN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
and	and	CC	I-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
closer	close	JJR	B-NP	O
mimicking	mimicking	NN	I-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
use	use	NN	I-NP	O

In	In	IN	B-PP	O
particular	particular	JJ	B-NP	O
,	,	,	O	O
MF	MF	NN	B-NP	O
males	male	NNS	I-NP	O
receiving	receive	VBG	B-VP	O
either	either	CC	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
CDP	CDP	NN	I-NP	O
dose	dose	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
RO	RO	NN	I-NP	O
dose	dose	NN	I-NP	O
explored	explore	VBD	B-VP	O
the	the	DT	B-NP	O
object	object	NN	I-NP	O
more	more	RBR	B-ADVP	O
often	often	RB	I-ADVP	O
than	than	IN	B-PP	O
MM	MM	NN	B-NP	O
males.	males.	NN	I-NP	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-NP	O
1	1	CD	I-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
single	single	JJ	I-NP	O
HD	HD	NN	I-NP	O
session	session	NN	I-NP	O
using	use	VBG	B-VP	O
cellulose	cellulose	NN	B-NP	O
triacetate	triacetate	NN	I-NP	O
or	or	CC	I-NP	O
polysulfone	polysulfone	NN	I-NP	O
membrane	membrane	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
water	water	NN	B-NP	O
content	content	NN	I-NP	O
both	both	CC	B-PP	O
at	at	IN	B-PP	O
forearm	forearm	NN	B-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
leg	leg	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
hybrid	hybrid	JJ	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
PNRC	BEGIN-PNRC-INSIDE	NN	B-NP	B
interacted	interact	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
orphan	orphan	NN	I-NP	O
receptors	receptor	NNS	I-NP	O
SF1	BEGIN-SF1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
ERRalpha1	BEGIN-ERRalpha1-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
a	a	DT	B-NP	O
ligand	ligand	NN	I-NP	O
-	-	HYPH	B-NP	O
independent	independent	JJ	I-NP	O
manner	manner	NN	I-NP	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
will	will	MD	B-VP	O
review	review	VB	I-VP	O
our	our	PRP$	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
prognostic	prognostic	JJ	B-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O

Kaposi	Kaposi	NNP	B-NP	O
's	's	POS	B-NP	O
eruptive	eruptive	JJ	I-NP	O
disease	disease	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
autopsies	autopsy	NNS	I-NP	O
carried	carry	VBN	B-VP	O
out	out	RP	B-PRT	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
dying	die	VBG	B-VP	O
of	of	IN	B-PP	O
intoxication	intoxication	NN	B-NP	O
with	with	IN	B-PP	O
Amanita	Amanita	NNP	B-NP	O
phalloides	phalloide	NNS	I-NP	O

Microscopic	Microscopic	JJ	B-NP	O
examination	examination	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
colonies	colony	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
histiocytes	histiocyte	NNS	B-NP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O

Diffusion	Diffusion	NN	B-NP	O
epidemic	epidemic	JJ	I-NP	O
models	model	NNS	I-NP	O
with	with	IN	B-PP	O
incubation	incubation	NN	B-NP	O
and	and	CC	I-NP	O
crisscross	crisscross	NN	I-NP	O
dynamics	dynamic	NNS	I-NP	O

Additional	Additional	JJ	B-NP	O
genetic	genetic	JJ	I-NP	O
analyses	analysis	NNS	I-NP	O
described	describe	VBN	B-VP	O
herein	herein	RB	B-ADVP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
Skb1	BEGIN-Skb1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
morphology	morphology	NN	I-NP	O
control	control	NN	I-NP	O
branch	branch	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ras	BEGIN-Ras-INSIDE	NN	I-NP	B
signaling	signaling	NN	I-NP	O
cascade	cascade	NN	I-NP	O
in	in	IN	B-PP	O
S.	S.	FW	B-NP	O
pombe	pombe	FW	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
positively	positively	RB	B-ADVP	O
modulates	modulate	VBZ	B-VP	O
Shk1	BEGIN-Shk1-INSIDE	NN	B-NP	B
function	function	NN	I-NP	O

Transient	Transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
assays	assay	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
(	(	(	O	O
-	-	SYM	O	O
1	1	CD	O	O
)	)	)	O	O
UCP1	BEGIN-UCP1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
CAT	BEGIN-CAT-INSIDE	NN	I-NP	B
construct	construct	NN	I-NP	O
,	,	,	O	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
regulatory	regulatory	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	BEGIN-rat	NN	I-NP	B
ucp	ucp	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
was	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
PPARalpha	BEGIN-PPARalpha-INSIDE	NN	B-NP	B
co	co	AFX	O	O
-	-	HYPH	O	O
transfection	transfection	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
potentiated	potentiate	VBN	I-VP	O
by	by	IN	B-PP	O
Wy	Wy	NNP	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
retinoid	BEGIN-retinoid	JJ	B-NP	B
X	X	NN	I-NP	I
receptor	receptor	NN	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I

CRKL	BEGIN-CRKL-INSIDE	NN	B-NP	B
,	,	,	O	O
an	an	DT	B-NP	O
SH1	BEGIN-SH1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
SH1	BEGIN-SH1-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
SH1	BEGIN-SH1-INSIDE	NN	I-NP	B
adapter	adapter	NN	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
tyrosine	BEGIN-tyrosine	NN	I-NP	B
phosphoproteins	phosphoproteins-INSIDE	NN	I-NP	I
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	O
leukemic	leukemic	JJ	I-NP	O
neutrophils	neutrophil	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
CML	CML	NN	B-NP	O

Idealized	Idealize	VBN	B-VP	O
versus	versus	IN	B-PP	O
realized	realize	VBN	B-NP	O
overall	overall	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
times	time	NNS	I-NP	O

Serum	BEGIN-Serum	NN	B-NP	B
C1	C1-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
school	school	NN	I-NP	O
children	child	NNS	I-NP	O
with	with	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
findings	finding	NNS	I-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O

Tc	Tc	NN	B-NP	O
-	-	HYPH	I-NP	O
1m	1m	NN	I-NP	O
HMPAO	HMPAO	NN	I-NP	O
brain	brain	NN	I-NP	O
SPECT	SPECT	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
CT	CT	NN	B-NP	O
and	and	CC	I-NP	O
EEG	EEG	NN	I-NP	O
after	after	IN	B-PP	O
seizures	seizure	NNS	B-NP	O
in	in	IN	B-PP	O
childhood	childhood	NN	B-NP	O

The	The	DT	B-NP	O
adenovirus	BEGIN-adenovirus	NN	I-NP	B
E1B	E1B	NN	I-NP	I
1	1	CD	I-NP	I
,	,	,	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
molecular	molecular	JJ	I-NP	I
-	-	HYPH	I-NP	I
weight	weight	NN	I-NP	I
(	(	(	O	I
1K	1K	NN	B-NP	I
)	)	)	O	I
protein	protein-INSIDE	NN	B-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
and	and	CC	O	O
cooperates	cooperate	VBZ	B-VP	O
with	with	IN	B-PP	O
E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
to	to	TO	B-VP	O
transform	transform	VB	I-VP	O
primary	primary	JJ	B-NP	O
rodent	rodent	NN	I-NP	O
cells	cell	NNS	I-NP	O

Subclones	Subclone	NNS	B-NP	O
of	of	IN	B-PP	O
R1	R1	NN	B-NP	O
which	which	WDT	B-NP	O
reverted	revert	VBD	B-VP	O
to	to	TO	B-PP	O
kappa	BEGIN-kappa	NN	B-NP	B
light	light	JJ	I-NP	I
chain	chain-INSIDE	NN	I-NP	I
production	production	NN	I-NP	O
contained	contain	VBD	B-VP	O
genomic	genomic	JJ	B-NP	O
deletions	deletion	NNS	I-NP	O
of	of	IN	B-PP	O
R1ns	R1n	NNS	B-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
surrounding	surround	VBG	I-NP	O
intron	intron	NN	I-NP	O

Previous	Previous	JJ	B-NP	O
data	datum	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
a	a	DT	B-NP	O
subtle	subtle	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
P	P	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
hCG	BEGIN-hCG-INSIDE	NN	B-NP	B
injection	injection	NN	I-NP	O
without	without	IN	B-PP	O
LH	BEGIN-LH-INSIDE	NN	B-NP	B
surge	surge	NN	I-NP	O
reduces	reduce	VBZ	B-VP	O
the	the	DT	B-NP	O
PR	PR	NN	I-NP	O
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
having	have	VBG	B-VP	O
oocyte	oocyte	NN	B-NP	O
retrievals	retrieval	NNS	I-NP	O
for	for	IN	B-PP	O
IVF	IVF	NN	B-NP	O
;	;	:	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
compared	compare	VBD	B-VP	O
PRs	PR	NNS	B-NP	O
of	of	IN	B-PP	O
recipients	recipient	NNS	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
shared	shared	JJ	I-NP	O
oocyte	oocyte	NN	I-NP	O
program	program	NN	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
donors	donor	NNS	I-NP	O
'	'	POS	B-NP	O
pre	BEGIN-pre	JJ	I-NP	B
-	-	HYPH	I-NP	I
hCG	BEGIN-hCG-INSIDE-INSIDE	NN	I-NP	I
P	P	NN	I-NP	O
level	level	NN	I-NP	O

Scleraxis	BEGIN-Scleraxis-INSIDE	NN	B-NP	B
overexpression	overexpression	NN	I-NP	O
enhanced	enhance	VBD	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aggrecan	BEGIN-aggrecan	JJ	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
normally	normally	RB	I-VP	O
expressed	express	VBN	I-VP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
osteoblastic	osteoblastic	JJ	I-NP	O
cells	cell	NNS	I-NP	O

Region	Region	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
enhancers	enhancer	NNS	I-NP	O
near	near	IN	B-PP	O
two	two	CD	B-NP	O
mammalian	BEGIN-mammalian	JJ	I-NP	B
homeo	homeo	NN	I-NP	I
box	box	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
define	define	NN	I-NP	O
adjacent	adjacent	JJ	I-NP	O
rostrocaudal	rostrocaudal	JJ	I-NP	O
domains	domain	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O

Cells	Cell	NNS	B-NP	O
were	be	VBD	B-VP	O
cotransfected	cotransfecte	VBN	I-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
responder	responder	NN	I-NP	O
plasmids	plasmid	NNS	I-NP	O
and	and	CC	I-NP	O
clonies	clony	NNS	I-NP	O
were	be	VBD	B-VP	O
selected	select	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
Geneticin	Geneticin	NN	B-NP	O
(	(	(	O	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
neomycin	BEGIN-neomycin	NN	I-NP	B
aminoglycoside	aminoglycoside	NN	I-NP	I
phosphotransferase	phosphotransferase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
)	)	)	O	O

To	To	TO	B-VP	O
clone	clone	VB	I-VP	O
cDNAs	cDNA	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
beta	beta	NN	I-NP	O
subunit	subunit	NN	I-NP	O
of	of	IN	B-PP	O
rabbit	BEGIN-rabbit	NN	B-NP	B
eIF	eIF	NN	I-NP	I
-	-	HYPH	O	I
1B	1B-INSIDE	NN	B-NP	I
,	,	,	O	O
amino	amino	NN	B-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
data	datum	NNS	I-NP	O
was	be	VBD	B-VP	O
first	first	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
design	design	VB	I-VP	O
redundant	redundant	JJ	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
primers	primer	NNS	I-NP	O
for	for	IN	B-PP	O
use	use	NN	B-NP	O
in	in	IN	B-PP	O
PCR	PCR	NN	B-NP	O

Deletion	Deletion	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1kb	1kb	NN	I-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
between	between	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
+1	+1	CD	B-NP	O
,	,	,	O	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
Sp1	BEGIN-Sp1	NN	I-NP	B
binding	binding	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
,	,	,	O	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
embigin	BEGIN-embigin	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

A	A	DT	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
segment	segment	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	O
chromosome	chromosome	NN	I-NP	O
XV	XV	NN	I-NP	O
contains	contain	VBZ	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
twice	twice	RB	I-NP	O
as	as	IN	I-NP	O
many	many	JJ	I-NP	O
unknown	unknown	JJ	I-NP	O
as	as	IN	B-PP	O
known	known	JJ	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frames	frame	NNS	I-NP	O

By	By	IN	B-PP	O
applying	apply	VBG	B-VP	O
a	a	DT	B-NP	O
sufficiently	sufficiently	RB	I-NP	O
strong	strong	JJ	I-NP	O
crusher	crusher	NN	I-NP	O
gradient	gradient	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
EPI	EPI	NN	I-NP	O
pulse	pulse	NN	I-NP	O
sequence	sequence	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
temporal	temporal	JJ	I-NP	O
variation	variation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
SSFP	SSFP	NN	B-NP	O
disturbance	disturbance	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
suppressed	suppress	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
diffusion	diffusion	NN	B-NP	O

The	The	DT	B-NP	O
cdc1W1R	BEGIN-cdc1W1R	NN	I-NP	B
temperature	temperature	NN	I-NP	I
-	-	HYPH	B-NP	I
sensitive	sensitive	JJ	I-NP	I
allele	allele-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
displayed	display	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-NP	O
division	division	NN	I-NP	O
-	-	HYPH	B-NP	O
cycle	cycle	NN	I-NP	O
arrest	arrest	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
(	(	(	O	O
large	large	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
unbudded	unbudded	JJ	I-NP	O
cells	cell	NNS	I-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
cdc1	BEGIN-cdc1	NN	I-NP	B
-	-	HYPH	B-NP	I
1ts	1t	NNS	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I

Wolf	Wolf	NNP	B-NP	O
-	-	HYPH	I-NP	O
Hirschhorn	Hirschhorn	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
(	(	(	O	O
WHS	WHS	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
malformation	malformation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hemizygous	hemizygous	JJ	I-NP	O
deletion	deletion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
short	short	JJ	I-NP	O
arm	arm	NN	I-NP	O
of	of	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1p1	1p1	NN	B-NP	O
)	)	)	O	O

To	To	TO	B-VP	O
address	address	VB	I-VP	O
this	this	DT	B-NP	O
question	question	NN	I-NP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
skeletal	skeletal	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
examined	examine	VBN	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Providence	Providence	NN	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	O
muscle	muscle	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
adoptive	adoptive	JJ	B-NP	O
gene	gene	NN	I-NP	O
transfer	transfer	NN	I-NP	O
to	to	TO	B-PP	O
adult	adult	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
infants	infant	NNS	I-NP	O
homozygous	homozygous	JJ	B-ADJP	O
for	for	IN	B-PP	O
spectrin	BEGIN-spectrin	NN	B-NP	B
Providence	Providence-INSIDE	NN	I-NP	I

Adenovirus	Adenovirus	NN	B-NP	O
-	-	HYPH	B-NP	O
mediated	mediate	VBN	I-NP	O
gene	gene	NN	I-NP	O
transfer	transfer	NN	I-NP	O
of	of	IN	B-PP	O
MMAC1	BEGIN-MMAC1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
PTEN	BEGIN-PTEN-INSIDE	NN	I-NP	B
to	to	TO	B-PP	O
glioblastoma	glioblastoma	NN	B-NP	O
cells	cell	NNS	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
entry	entry	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
recruitment	recruitment	NN	I-NP	O
of	of	IN	B-PP	O
p1Kip1	BEGIN-p1Kip1-INSIDE	NN	B-NP	B
into	into	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
CDK1	BEGIN-CDK1-INSIDE	NN	I-NP	B
complexes	complex	NNS	I-NP	O

Increasing	Increase	VBG	B-VP	O
insulin	BEGIN-insulin-INSIDE	JJ	B-NP	B
sensitivity	sensitivity	NN	I-NP	O
in	in	IN	B-PP	O
type	type	NN	B-NP	O
I	I	CD	I-NP	O
diabetic	diabetic	JJ	I-NP	O
patients	patient	NNS	I-NP	O
should	should	MD	B-VP	O
alert	alert	VB	I-VP	O
clinicians	clinician	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O

Experiment	Experiment	NN	B-NP	O
B	B	NN	I-NP	O
:	:	:	O	O
Clinical	Clinical	JJ	B-NP	O
,	,	,	I-NP	O
biochemical	biochemical	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
histological	histological	JJ	B-NP	O
variables	variable	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
day	day	NN	I-NP	O
period	period	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
zymosan	zymosan	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
given	give	VBN	I-VP	O

Lesions	Lesion	NNS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
kind	kind	NN	I-NP	O
resemble	resemble	VBP	B-VP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
A	A	NN	I-NP	O
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
chickens	chicken	NNS	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
excess	excess	JJ	B-NP	O
vitamin	vitamin	NN	I-NP	O
E	E	NN	I-NP	O

Immunoblotting	Immunoblotting	NN	B-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
phosphospecific	BEGIN-phosphospecific	JJ	I-NP	B
anti	anti	AFX	I-NP	I
-	-	HYPH	I-NP	I
Src	Src	NN	I-NP	I
(	(	(	O	I
1Y	1Y	NN	B-NP	I
)	)	)	O	I
antibody	antibody-INSIDE	NN	B-NP	I
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
ceramide	ceramide	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
pp1	BEGIN-pp1-INSIDE	NN	B-NP	B
(	(	(	O	O
src	BEGIN-src-INSIDE	NN	B-NP	B
)	)	)	O	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O

Spinophilin	BEGIN-Spinophilin-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
protein	BEGIN-protein	NN	I-NP	B
phosphatase	phosphatase	NN	I-NP	I
1	1	CD	I-NP	I
binding	binding	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
localized	localize	VBD	B-VP	O
to	to	TO	B-PP	O
dendritic	dendritic	JJ	B-NP	O
spines	spine	NNS	I-NP	O

The	The	DT	B-NP	O
Htf1	BEGIN-Htf1	NN	I-NP	B
-	-	HYPH	O	I
a	a	DT	B-NP	I
gene	gene-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
RanBP1	BEGIN-RanBP1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
partner	partner	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ran	BEGIN-Ran	NN	I-NP	B
GTPase	GTPase-INSIDE	NN	I-NP	I

Membrane	Membrane	NN	B-NP	O
extraction	extraction	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
interfaced	interface	VBN	I-VP	O
with	with	IN	B-PP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
and	and	CC	I-NP	O
mass	mass	NN	I-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
volatile	volatile	JJ	B-NP	O
organics	organic	NNS	I-NP	O
in	in	IN	B-PP	O
water	water	NN	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
produced	produce	VBN	I-VP	O
the	the	DT	B-NP	O
Ure1	BEGIN-Ure1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
yield	yield	NN	I-NP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
gene	gene	NN	I-NP	O

Triethylene	Triethylene	NN	B-NP	O
glycol	glycol	NN	I-NP	O

The	The	DT	B-NP	O
SM	SM	NN	I-NP	O
-	-	HYPH	O	O
specific	specific	JJ	B-NP	O
selection	selection	NN	I-NP	O
of	of	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
results	result	VBZ	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O

Ultimobranchial	Ultimobranchial	JJ	B-NP	O
body	body	NN	I-NP	O
and	and	CC	O	O
parathyroid	parathyroid	JJ	B-NP	O
glands	gland	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
freshwater	freshwater	NN	I-NP	O
snake	snake	VB	B-VP	O
Natrix	Natrix	NNP	B-NP	O
piscator	piscator	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
vitamin	vitamin	NN	B-NP	O
D1	D1	NN	I-NP	O
administration	administration	NN	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
G1	G1	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
G1	G1	NN	B-NP	O
arrest	arrest	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cdk	BEGIN-cdk-INSIDE	NN	I-NP	B
inhibitors	inhibitor	NNS	I-NP	O
p1Cip1	BEGIN-p1-INSIDECiBEGIN-p1-INSIDE	NN	I-NP	B
or	or	CC	I-NP	O
p1Kip1	BEGIN-p1-INSIDEKiBEGIN-p1-INSIDE	NN	I-NP	B
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
bypassed	bypass	VBN	I-VP	O
either	either	CC	O	O
by	by	IN	B-PP	O
inactivation	inactivation	NN	B-NP	O
of	of	IN	B-PP	O
pRb	BEGIN-pRb-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
overexpression	overexpression	NN	I-NP	O
of	of	IN	B-PP	O
E1F	BEGIN-E1F	NN	B-NP	B
family	family	NN	I-NP	I
members	members-INSIDE	NN	I-NP	I

More	More	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
appropriate	appropriate	JJ	I-NP	O
lever	lever	NN	I-NP	O
responding	responding	NN	I-NP	O
was	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
daily	daily	JJ	I-NP	O
training	training	NN	I-NP	O
sessions	session	NNS	I-NP	O
with	with	IN	B-PP	O
DN	DN	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
diazepam	diazepam	NN	I-NP	O
and	and	CC	I-NP	O
PTZ	PTZ	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
training	training	NN	I-NP	O
drug	drug	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
investigated	investigate	VBN	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
SDZ	SDZ	NN	B-NP	O
ENA	ENA	NN	I-NP	O
1	1	CD	I-NP	O
on	on	IN	B-PP	O
spatial	spatial	JJ	B-NP	O
learning	learning	NN	I-NP	O
deficits	deficit	NNS	I-NP	O
in	in	IN	B-PP	O
aged	aged	JJ	B-NP	O
rats	rat	NNS	I-NP	O

A	A	DT	B-NP	O
retrospective	retrospective	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
data	datum	NNS	B-NP	O
accumulated	accumulate	VBN	B-VP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
month	month	NN	I-NP	O
period	period	NN	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
December	December	NNP	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
September	September	NNP	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
regarding	regard	VBG	B-VP	O
investigational	investigational	JJ	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
nanometer	nanometer	NN	I-NP	O
Xenon	Xenon	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Excimer	Excimer	NNP	I-NP	O
Laser	Laser	NNP	I-NP	O
Coronary	Coronary	NNP	I-NP	O
Angioplasty	Angioplasty	NNP	I-NP	O
(	(	(	O	O
ELCA	ELCA	NNP	O	O
)	)	)	O	O
system	system	NN	B-NP	O
(	(	(	O	O
Advanced	Advanced	NNP	B-NP	O
Interventional	Interventional	NNP	I-NP	O
Systems	Systems	NNP	I-NP	O
,	,	,	I-NP	O
Inc.	Inc.	NNP	I-NP	O
,	,	,	O	O
Irvine	Irvine	NNP	B-NP	O
,	,	,	O	O
CA	CA	NNP	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O

Upon	Upon	IN	B-PP	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
Marangoni	Marangoni	NNP	I-NP	O
number	number	NN	I-NP	O
beyond	beyond	IN	B-PP	O
this	this	DT	B-NP	O
threshold	threshold	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
initially	initially	RB	I-NP	O
stationary	stationary	JJ	I-NP	O
flow	flow	NN	I-NP	O
becomes	become	VBZ	B-VP	O
quickly	quickly	RB	B-ADVP	O
time	time	NN	B-NP	O
dependent	dependent	JJ	B-ADJP	O

Investigation	Investigation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
asymmetrical	asymmetrical	JJ	I-NP	O
induced	induce	VBN	I-NP	O
yields	yield	NNS	I-NP	O
in	in	IN	B-PP	O
1Sr	1Sr	NN	B-NP	O
-	-	HYPH	B-NP	O
1Y	1Y	NN	I-NP	O
-	-	HYPH	O	O
beta	beta	SYM	B-NP	O
-	-	HYPH	B-VP	O
irradiated	irradiated	JJ	B-NP	O
D	D	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
L	L	NN	I-NP	O
-	-	HYPH	I-NP	O
alanines	alanine	NNS	I-NP	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
transcripts	transcript	NNS	I-NP	O
encodes	encode	VBZ	B-VP	O
MEQ	BEGIN-MEQ-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
bZIP	BEGIN-bZIP	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Jun	BEGIN-Jun-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Fos	BEGIN-Fos-INSIDE	NN	I-NP	B
family	family	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O

Given	Give	VBN	B-PP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
Egr	BEGIN-Egr	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
growth	growth	NN	B-NP	O
factors	factor	NNS	I-NP	O
or	or	CC	O	O
injury	injury	NN	B-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
underlying	underlie	VBG	B-VP	O
phenotypic	phenotypic	JJ	B-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
smooth	smooth	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
after	after	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
injury	injury	NN	I-NP	O

An	An	DT	B-NP	O
identical	identical	JJ	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
K1F	K1F	NN	B-NP	O
virions	virion	NNS	I-NP	O

The	The	DT	B-NP	O
predictive	predictive	JJ	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
remotely	remotely	RB	I-NP	O
sensed	sense	VBN	I-NP	O
map	map	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
NDVI	NDVI	NN	B-NP	O
data	datum	NNS	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
better	good	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
from	from	IN	B-PP	O
forecast	forecast	JJ	B-NP	O
indices	index	NNS	I-NP	O
based	base	VBN	B-VP	O
only	only	RB	B-ADVP	O
on	on	IN	B-PP	O
climatic	climatic	JJ	B-NP	O
data	datum	NNS	I-NP	O

The	The	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
B1	B1	NN	I-NP	O
,	,	,	O	O
B1	B1	NN	B-NP	O
and	and	CC	I-NP	O
B1	B1	NN	I-NP	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
capsule	capsule	NN	B-NP	O
powder	powder	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
company	company	NN	I-NP	O
(	(	(	O	O
name	name	NN	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
disclosed	disclose	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
secrecy	secrecy	NN	B-NP	O
purpose	purpose	NN	I-NP	O
)	)	)	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
cell	cell	NN	I-NP	O
MRC	MRC	NN	I-NP	O
closely	closely	RB	B-ADVP	O
resembles	resemble	VBZ	B-VP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
cell	cell	NN	I-NP	O
MRC	MRC	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
both	both	CC	O	O
its	its	PRP$	B-NP	O
protein	protein	NN	I-NP	O
composition	composition	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
fractionation	fractionation	NN	I-NP	O
and	and	CC	I-NP	O
chromatographic	chromatographic	JJ	I-NP	O
profile	profile	NN	I-NP	O

Red	Red	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
1mTc	1mTc	NN	B-NP	O
-	-	HYPH	B-NP	O
EC	EC	NN	I-NP	O
and	and	CC	I-NP	O
1I	1I	NN	I-NP	O
-	-	HYPH	O	O
OIH	OIH	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	B-NP	I
kilodalton	kilodalton	NN	I-NP	I
nuclear	nuclear	JJ	I-NP	I
ATP	ATP	NN	I-NP	I
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
phosphoprotein	phosphoprotein-INSIDE	NN	I-NP	I
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
bovine	bovine	JJ	B-NP	O
papillomavirus	papillomavirus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O

To	To	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
GRK1	BEGIN-GRK1	NN	I-NP	B
homologue	homologue-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
chromsome	chromsome	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
several	several	JJ	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
closely	closely	RB	B-NP	O
-	-	HYPH	I-NP	O
spaced	space	VBN	I-NP	O
primers	primer	NNS	I-NP	O
were	be	VBD	B-VP	O
designed	design	VBN	I-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
GRK1	BEGIN-GRK1	NN	I-NP	B
cDNA	cDNA	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
and	and	CC	O	O
then	then	RB	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
amplify	amplify	VB	I-VP	O
human	human	JJ	B-NP	O
genomic	genomic	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
burst	burst	NN	I-NP	O
period	period	NN	I-NP	O
(	(	(	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
min	min	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
local	local	JJ	B-NP	O
blood	blood	NN	I-NP	O
H1O1	H1O1	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
and	and	CC	O	O
xanthine	BEGIN-xanthine	NN	B-NP	B
oxidase	oxidase-INSIDE	NN	I-NP	I
activities	activity	NNS	I-NP	O
were	be	VBD	B-VP	O
highly	highly	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

This	This	DT	B-NP	O
mutant	mutant	NN	I-NP	O
also	also	RB	B-ADVP	O
functions	function	VBZ	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
acting	act	VBG	I-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
inducibility	inducibility	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV	BEGIN-HIV	NN	I-NP	B
long	long	JJ	I-NP	I
terminal	terminal	JJ	I-NP	I
repeat	repeat-INSIDE	NN	I-NP	I
(	(	(	O	O
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
potential	potential	JJ	I-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B	NN	I-NP	I
binding	binding	NN	I-NP	I
sites	sites-INSIDE	NN	I-NP	I
)	)	)	O	O
by	by	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
inhibited	inhibit	VBN	I-VP	O
when	when	WRB	B-ADVP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
co	co	AFX	B-ADJP	O
-	-	HYPH	O	O
transfected	transfecte	VBN	B-VP	O
into	into	IN	B-PP	O
CD1+	BEGIN-CD1+-INSIDE	NN	B-NP	B
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
delta	delta	NN	I-NP	O
SP	SP	NN	I-NP	O
mutant	mutant	NN	I-NP	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
WRM	BEGIN-BEGIN-WRM	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
LIT	BEGIN-LIT	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
WRM	BEGIN-WRM	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
activate	activate	VB	I-VP	O
the	the	DT	B-NP	O
LIT	BEGIN-BEGIN-LIT	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
protein	protein	NN	I-NP	O
kinase	kinase-INSIDE	NN	I-NP	I
when	when	WRB	B-ADVP	O
coexpressed	coexpresse	VBN	B-VP	O
in	in	IN	B-PP	O
vertebrate	vertebrate	NN	B-NP	O
tissue	tissue	NN	I-NP	O
culture	culture	NN	I-NP	O
cells	cell	NNS	I-NP	O

To	To	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
safety	safety	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
angiotensin	BEGIN-angiotensin	NN	I-NP	B
converting	convert	VBG	B-VP	I
enzyme	enzyme-INSIDE	NN	B-NP	I
inhibitor	inhibitor	NN	I-NP	O
enalapril	enalapril	VBP	B-VP	O
a	a	DT	B-NP	O
multicenter	multicenter	JJ	I-NP	O
,	,	,	I-NP	O
open	open	JJ	I-NP	O
,	,	,	I-NP	O
randomized	randomize	VBN	I-NP	O
,	,	,	I-NP	O
prazosin	prazosin	NN	I-NP	O
-	-	HYPH	I-NP	O
controlled	control	VBN	B-NP	O
trial	trial	NN	I-NP	O
was	be	VBD	B-VP	O
designed	design	VBN	I-VP	O
comparing	compare	VBG	B-VP	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
and	and	CC	I-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
hypotension	hypotension	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O

Mutating	Mutate	VBG	B-VP	O
bases	base	NNS	B-NP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
abolishes	abolish	VBZ	B-VP	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
complex	complex	NN	B-NP	O
VII	VII	CD	I-NP	O
and	and	CC	O	O
partially	partially	RB	B-VP	O
inhibits	inhibit	VBZ	I-VP	O
complex	complex	NN	B-NP	O
IV	IV	CD	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
proteins	protein	NNS	I-NP	O
forming	form	VBG	B-VP	O
these	these	DT	B-NP	O
complexes	complex	NNS	I-NP	O
bind	bind	VBP	B-VP	O
neighboring	neighbor	VBG	B-NP	O
segments	segment	NNS	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
and	and	CC	I-NP	O
sequencing	sequencing	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
overlapping	overlap	VBG	I-NP	O
cDNAs	cDNA	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
homologue	homologue	NN	I-NP	I
of	of	IN	B-PP	I
Wnt	Wnt	NN	B-NP	I
-	-	HYPH	O	I
1A	1A-INSIDE	NN	B-NP	I

We	We	PRP	B-NP	O
provided	provide	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
CaM	BEGIN-CaM	NN	B-NP	B
kinase	kinase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
played	play	VBD	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
neurite	neurite	NN	B-NP	O
outgrowth	outgrowth	NN	I-NP	O
and	and	CC	I-NP	O
growth	growth	NN	I-NP	O
cone	cone	NN	I-NP	O
motility	motility	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
autophosphorylation	autophosphorylation	NN	I-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
kinase	kinase	NN	I-NP	O
to	to	TO	B-VP	O
sufficiently	sufficiently	RB	I-VP	O
exert	exert	VB	I-VP	O
its	its	PRP$	B-NP	O
cellular	cellular	JJ	I-NP	O
function	function	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
[	[	(	O	O
Y	Y	NN	B-NP	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
GCD1	BEGIN-GCD1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
GCD1	BEGIN-GCD1-INSIDE	NN	I-NP	B
play	play	VBP	B-VP	O
important	important	JJ	B-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
eIF	BEGIN-eIF	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
eIF	BEGIN-eIF	NN	I-NP	B
-	-	HYPH	B-NP	I
1B	1-INSIDEB	NN	I-NP	I
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
suppressor	suppressor	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
decrease	decrease	VBP	B-VP	O
the	the	DT	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
of	of	IN	B-PP	O
eIF	BEGIN-eIF	NN	B-NP	B
-	-	HYPH	B-NP	I
1B	1-INSIDEB	NN	I-NP	I
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
phosphorylated	phosphorylate	VBN	B-NP	O
eIF	BEGIN-eIF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
without	without	IN	B-PP	O
impairing	impair	VBG	B-VP	O
the	the	DT	B-NP	O
essential	essential	JJ	I-NP	O
catalytic	catalytic	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
eIF	BEGIN-eIF	NN	B-NP	B
-	-	HYPH	B-NP	I
1B	1-INSIDEB	NN	I-NP	I
in	in	IN	B-PP	O
translation	translation	NN	B-NP	O
initiation	initiation	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
extracts	extract	NNS	I-NP	O
,	,	,	O	O
PU.1	BEGIN-PU.1-INSIDE	NN	B-NP	B
forms	form	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
,	,	,	I-NP	O
specific	specific	JJ	I-NP	O
,	,	,	I-NP	O
more	more	RBR	I-NP	O
slowly	slowly	RB	I-NP	O
migrating	migrate	VBG	I-NP	O
complex	complex	NN	I-NP	O
(	(	(	O	O
PU	BEGIN-PU	NN	B-NP	B
-	-	HYPH	B-NP	I
SF	SF-INSIDE	NN	I-NP	I
)	)	)	O	O
when	when	WRB	B-ADVP	O
binding	bind	VBG	B-VP	O
the	the	DT	B-NP	O
GM	BEGIN-GM	NN	I-NP	B
-	-	HYPH	B-NP	I
CSF	CSF	NN	I-NP	I
receptor	receptor	NN	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O
PU.1	BEGIN-PU.1-INSIDE	NN	I-NP	B
site	site	NN	I-NP	O

The	The	DT	B-NP	O
antiserum	antiserum	NN	I-NP	O
used	use	VBN	B-VP	O
for	for	IN	B-PP	O
immunoblotting	immunoblotting	NN	B-NP	O
specifically	specifically	RB	B-ADVP	O
supershifts	supershift	VBZ	B-VP	O
uteroglobin	BEGIN-uteroglobin	NN	B-NP	B
promoter	promoter	NN	I-NP	I
-	-	HYPH	B-NP	I
protein	protein	NN	I-NP	I
complexes	complexes-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
gel	gel	NN	B-NP	O
shift	shift	NN	I-NP	O
experiments	experiment	NNS	I-NP	O

Plasma	BEGIN-Plasma	NN	B-NP	B
LH	BEGIN-LH-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
progesterone	progesterone	NN	I-NP	O
levels	level	NNS	I-NP	O
after	after	IN	B-PP	O
single	single	JJ	B-NP	O
or	or	CC	I-NP	O
multiple	multiple	JJ	I-NP	O
injections	injection	NNS	I-NP	O
of	of	IN	B-PP	O
synthetic	synthetic	JJ	B-NP	O
LH	BEGIN-LH-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
RH	BEGIN-RH-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
anoestrous	anoestrous	JJ	B-NP	O
ewes	ewe	NNS	I-NP	O
and	and	CC	O	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
levels	level	NNS	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
oestrous	oestrous	JJ	I-NP	O
cycle	cycle	NN	I-NP	O

Soluble	Soluble	JJ	B-NP	O
recombinant	recombinant	JJ	I-NP	O
RI	BEGIN-RI-INSIDE	NN	I-NP	B
and	and	CC	O	O
soluble	soluble	JJ	B-NP	O
recombinant	recombinant	JJ	I-NP	O
C	BEGIN-C	NN	I-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
associate	associate	VB	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
be	be	VB	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
cyclic	cyclic	JJ	B-NP	O
AMP	AMP	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
structurally	structurally	RB	B-VP	O
characterized	characterize	VBN	I-VP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
and	and	CC	I-NP	O
cDNA	cDNA	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
ribulose	BEGIN-ribulose	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
,	,	,	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
bisphosphate	bisphosphate	NN	I-NP	I
carboxylase	carboxylase	NN	I-NP	I
/	/	SYM	B-VP	I
oxygenase	oxygenase	NN	B-NP	I
	BEGIN-	NN	I-NP	B
(	(	(	O	I
Rbu	Rbu	NN	B-NP	I
-	-	HYPH	B-NP	I
P1	P1	NN	I-NP	I
carboxylase	carboxylase	NN	I-NP	I
)	)	)	O	I
activase	activase-INSIDE-INSIDE	NN	B-NP	I
from	from	IN	B-PP	O
barley	barley	NN	B-NP	O
(	(	(	O	O
Hordeum	Hordeum	NNP	B-NP	O
vulgare	vulgare	NNP	I-NP	O
L	L	NNP	I-NP	O
.	.	.	O	O
)	)	)	O	O

Cytokine	Cytokine	NN	B-NP	O
inducibility	inducibility	NN	I-NP	O
of	of	IN	B-PP	O
VCAM1	BEGIN-VCAM1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	O
cells	cell	NNS	I-NP	O
utilizes	utilize	VBZ	B-VP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
heterodimeric	heterodimeric	JJ	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
proteins	protein	NNS	I-NP	O
with	with	IN	B-PP	O
IRF	BEGIN-IRF	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
cases	case	NNS	I-NP	O
with	with	IN	B-PP	O
terminal	terminal	JJ	B-NP	O
forces	force	NNS	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
direction	direction	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
delta	delta	NN	I-NP	O
wave	wave	NN	I-NP	O
,	,	,	O	O
superiorly	superiorly	RB	B-ADVP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	leave	VBN	I-NP	O
at	at	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
degrees	degree	NNS	I-NP	O
or	or	CC	O	O
inferiorly	inferiorly	RB	B-ADVP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
at	at	IN	B-PP	O
+1	+1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
forming	form	VBG	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
deflection	deflection	NN	I-NP	O
of	of	IN	B-PP	O
over	over	IN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
seconds	second	NNS	I-NP	O
'	'	POS	B-NP	O
duration	duration	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
delayed	delay	VBN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
or	or	CC	I-NP	O
posterior	posterior	JJ	I-NP	O
fascicle	fascicle	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
after	after	IN	B-SBAR	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
delay	delay	NN	I-NP	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
chromosomal	chromosomal	JJ	I-NP	O
cosmid	cosmid	NN	I-NP	O
library	library	NN	I-NP	O
of	of	IN	B-PP	O
Streptomyces	Streptomyce	NNS	B-NP	O
argillaceus	argillaceus	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
Mtm	BEGIN-Mtm-INSIDE	NN	I-NP	B
producer	producer	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
clone	clone	NN	I-NP	O
(	(	(	O	O
cosAR1	cosAR1	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
by	by	IN	B-PP	O
homology	homology	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
actI	BEGIN-actI	NN	I-NP	B
/	/	SYM	O	I
III	III	CD	B-NP	I
region	region-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
coelicolor	coelicolor	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
strDEM	BEGIN-strDEM	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
griseus	griseus	NN	I-NP	O

A	A	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
myelofibrosis	myelofibrosis	NN	I-NP	O
initially	initially	RB	B-ADVP	O
received	receive	VBD	B-VP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
Ara	Ara	NNP	I-NP	O
C	C	NNP	I-NP	O

The	The	DT	B-NP	O
factors	factor	NNS	I-NP	O
defective	defective	JJ	B-ADJP	O
in	in	IN	B-PP	O
groups	group	NNS	B-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
CIITA	BEGIN-CIITA-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
C	C	NN	B-NP	O
(	(	(	O	O
RFX1	BEGIN-RFX1-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
D	D	NN	B-NP	O
(	(	(	O	O
RFXAP	BEGIN-RFXAP-INSIDE	NN	B-NP	B
)	)	)	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O

Manifestation	Manifestation	NN	B-NP	O
of	of	IN	B-PP	O
superfluidity	superfluidity	NN	B-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
evolving	evolve	VBG	I-NP	O
bose	bose	NN	I-NP	O
-	-	HYPH	B-NP	O
einstein	einstein	NN	I-NP	O
condensed	condense	VBN	B-VP	O
Gas	Gas	NNP	B-NP	O
We	We	PRP	B-NP	O
study	study	VBP	B-VP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
excitations	excitation	NNS	B-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
``	``	``	I-NP	O
impurity	impurity	NN	I-NP	O
''	''	''	O	O
(	(	(	O	O
static	static	JJ	B-NP	O
perturbation	perturbation	NN	I-NP	O
)	)	)	O	O
placed	place	VBN	B-VP	O
into	into	IN	B-PP	O
an	an	DT	B-NP	O
oscillating	oscillate	VBG	I-NP	O
Bose	Bose	NN	I-NP	O
-	-	HYPH	B-NP	O
Einstein	Einstein	NN	I-NP	O
condensed	condense	VBN	B-VP	O
gas	gas	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
trapping	trapping	NN	I-NP	O
field	field	NN	I-NP	O

By	By	IN	B-PP	O
sequencing	sequencing	NN	B-NP	O
of	of	IN	B-PP	O
exonuclease	BEGIN-exonuclease	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
deletion	deletion	NN	I-NP	O
clones	clone	NNS	I-NP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
nucleotides	nucleotide	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
coding	cod	VBG	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mass	mass	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kDa	kDa	NN	I-NP	O

The	The	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
raf	raf	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
proto	proto	AFX	I-NP	I
-	-	HYPH	I-NP	I
oncogene	oncogene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
cellular	BEGIN-cellular	JJ	I-NP	B
homologue	homologue	NN	I-NP	I
of	of	IN	B-PP	I
v	v	NN	B-NP	I
-	-	HYPH	B-NP	I
raf	raf-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
oncogene	oncogene	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
acutely	acutely	RB	I-NP	O
transforming	transform	VBG	I-NP	O
retrovirus	retrovirus	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
MSV	MSV	NN	I-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
orphan	BEGIN-orphan	NN	I-NP	B
receptor	receptor	NN	I-NP	I
related	related	JJ	B-ADJP	I
to	to	TO	B-PP	I
tyrosine	tyrosine	NN	B-NP	I
kinases	kinases-INSIDE	NN	I-NP	I
(	(	(	O	O
Ryk	BEGIN-Ryk-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
structurally	structurally	RB	I-NP	O
unclassified	unclassified	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
growth	BEGIN-growth	NN	I-NP	B
factor	factor	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
family	family	NN	I-NP	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
-	-	HYPH	B-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
between	between	IN	B-PP	O
viral	viral	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
and	and	CC	I-NP	O
BMV	BEGIN-BMV	NN	I-NP	B
CP	CP	NN	I-NP	I
peptides	peptides-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
either	either	CC	O	O
proline	proline	NN	B-NP	O
or	or	CC	I-NP	O
alanine	alanine	NN	I-NP	O
substitutions	substitution	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
nonspecific	nonspecific	JJ	B-ADJP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
detect	detect	VBP	B-VP	O
hCoch	BEGIN-hCoch	JJ	B-NP	B
-	-	HYPH	I-NP	I
1B1	1B1-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
three	three	CD	B-NP	O
overlapping	overlap	VBG	I-NP	O
YACs	YAC	NNS	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
also	also	RB	B-ADVP	O
contain	contain	VBP	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
markers	marker	NNS	I-NP	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
DFNA1.	BEGIN-DFNA1-INSIDE.	JJ	B-NP	I
mCoch	BEGIN-mCoch	JJ	I-NP	B
-	-	HYPH	I-NP	I
1B1	1B1-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
genetically	genetically	RB	I-VP	O
mapped	map	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
to	to	TO	B-PP	O
chromosome	chromosome	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
homologous	homologous	JJ	B-NP	O
synteny	synteny	NN	I-NP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
1q1	1q1	CD	I-NP	O
-	-	HYPH	I-NP	O
q1	q1	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
asp1	BEGIN-asp1-INSIDE	NN	I-NP	B
(	(	(	O	O
audiogenic	BEGIN-audiogenic	JJ	B-NP	B
seizure	seizure	NN	I-NP	I
prone	prone-INSIDE	NN	I-NP	I
)	)	)	O	O
locus	locus	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O

Reasons	Reason	NNS	B-NP	O
are	be	VBP	B-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
tiapamil	tiapamil	NN	B-NP	O
warrants	warrant	VBZ	B-VP	O
further	far	JJR	B-NP	O
clinical	clinical	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
join	join	VB	I-VP	O
the	the	DT	B-NP	O
more	more	RBR	I-NP	O
established	established	JJ	I-NP	O
calcium	calcium	NN	I-NP	O
antagonists	antagonist	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
valuable	valuable	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
agent	agent	NN	I-NP	O

Histopathologic	Histopathologic	JJ	B-NP	O
studies	study	NNS	I-NP	O
displaying	display	VBG	B-VP	O
spongiform	spongiform	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gray	gray	JJ	I-NP	O
matter	matter	NN	I-NP	O
,	,	,	O	O
neuronal	neuronal	JJ	B-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
atrogliosis	atrogliosis	NN	B-NP	O
confirmed	confirm	VBD	B-VP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
Creutzfeldt	Creutzfeldt	NN	B-NP	O
-	-	HYPH	B-NP	O
Jakob	Jakob	NN	I-NP	O
disease	disease	NN	I-NP	O

Current	Current	JJ	B-NP	O
body	body	NN	I-NP	O
size	size	NN	I-NP	O
(	(	(	O	O
wt	wt	NN	B-NP	O
/	/	SYM	B-NP	O
ht1	ht1	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
life	life	NN	B-NP	O
-	-	HYPH	O	O
time	time	NN	B-NP	O
weight	weight	NN	I-NP	O
dissatisfaction	dissatisfaction	NN	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
sexes	sex	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
TCOF1	BEGIN-TCOF1	NN	B-NP	B
mutations	mutations-INSIDE	NN	I-NP	I
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Treacher	Treacher	NNP	I-NP	O
Collins	Collins	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O

Mannich	Mannich	JJ	B-NP	O
bases	base	NNS	I-NP	O
of	of	IN	B-PP	O
vanillin	vanillin	NN	B-NP	O
oxime	oxime	NN	I-NP	O

Its	Its	PRP$	B-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
twice	twice	RB	B-NP	O
that	that	DT	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
construct	construct	NN	I-NP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
CAT	BEGIN-CAT	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
driven	drive	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
H	BEGIN-H	NN	I-NP	B
-	-	HYPH	B-NP	I
1Kb	1Kb	NN	I-NP	I
1	1	CD	I-NP	I
'	'	SYM	I-NP	I
enhancer	enhancer	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
(	(	(	O	O
H1TF1	BEGIN-H1TF1-INSIDE	NN	B-NP	B
/	/	SYM	O	O
KBF1	BEGIN-KBF1-INSIDE	NN	B-NP	B
site	site	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
pRSVCAT	pRSVCAT	NN	B-NP	O
construct	BEGIN-construct	NN	I-NP	B
carrying	carry	VBG	B-VP	I
the	the	DT	B-NP	I
strong	strong	JJ	I-NP	I
Rous	Rous	NNP	I-NP	I
sarcoma	sarcoma	NN	I-NP	I
virus	virus	NN	I-NP	I
LTR	LTR	NN	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
imply	imply	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
command	command	NN	I-NP	O
-	-	HYPH	O	O
carrying	carry	VBG	B-VP	O
medium	medium	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
limbs	limb	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
implies	imply	VBZ	B-VP	O
that	that	IN	B-SBAR	O
some	some	DT	B-NP	O
computational	computational	JJ	I-NP	O
activities	activity	NNS	I-NP	O
take	take	VBP	B-VP	O
place	place	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O
level	level	NN	I-NP	O

The	The	DT	B-NP	O
dipper	dipper	NN	I-NP	O
(	(	(	O	O
RONF	RONF	NN	B-NP	O
of	of	IN	B-PP	O
BP	BP	NN	B-NP	O
(	(	(	O	O
or	or	CC	O	O
HR	HR	NN	B-NP	O
)	)	)	O	O
>	>	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O

I	I	PRP	B-NP	O

Acute	Acute	JJ	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
subdural	subdural	JJ	I-NP	O
haematoma	haematoma	NN	I-NP	O

Nonsuicidal	Nonsuicidal	JJ	B-NP	O
mortality	mortality	NN	I-NP	O
in	in	IN	B-PP	O
late	late	JJ	B-NP	O
-	-	HYPH	I-NP	O
life	life	NN	I-NP	O
depression	depression	NN	I-NP	O

DSS1	BEGIN-DSS1	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
suppressor	suppressor	NN	I-NP	O
of	of	IN	B-PP	O
sec1	BEGIN-sec1	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
exchange	exchange	NN	I-NP	O
protein	protein	NN	I-NP	O
that	that	WDT	B-NP	O
aids	aid	VBZ	B-VP	O
Sec1p	BEGIN-Sec1p-INSIDE	NN	B-NP	B
function	function	NN	I-NP	O

A	A	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
characteristics	characteristic	NNS	B-NP	O
in	in	IN	B-PP	O
adult	adult	JJ	B-NP	O
asthmatics	asthmatic	NNS	I-NP	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
sensitized	sensitize	VBN	I-VP	O
by	by	IN	B-PP	O
cats	cat	NNS	B-NP	O
and	and	CC	I-NP	O
dogs	dog	NNS	I-NP	O
allergens	allergen	NNS	I-NP	O

The	The	DT	B-NP	O
failure	failure	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
assembly	assembly	NN	I-NP	O
competent	competent	JJ	B-ADJP	O
but	but	CC	O	O
complementation	complementation	NN	B-NP	O
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
alpha	alpha	NN	I-NP	O
mutants	mutant	NNS	I-NP	O
lack	lack	VBP	B-VP	O
an	an	DT	O	O
as	as	IN	B-PP	O
yet	yet	RB	B-NP	O
unidentified	unidentified	JJ	I-NP	O
function	function	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O

Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
and	and	CC	O	O
blister	blister	NN	B-NP	O
fluid	fluid	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dosing	dosing	NN	I-NP	O
interval	interval	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
superior	superior	JJ	B-ADJP	O
or	or	CC	O	O
almost	almost	RB	B-ADJP	O
superior	superior	JJ	I-ADJP	O
to	to	TO	B-PP	O
MICs	MIC	NNS	B-NP	O
for	for	IN	B-PP	O
sensitive	sensitive	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
including	include	VBG	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
both	both	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
bound	bind	VBD	B-VP	O
to	to	TO	I-VP	O
PDE	BEGIN-PDE	VB	I-VP	B
alpha	alpha	NN	B-NP	I
/	/	SYM	B-VP	I
beta	beta-INSIDE	NN	B-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
solid	solid	JJ	I-NP	O
-	-	HYPH	I-NP	O
phase	phase	NN	I-NP	O
binding	binding	NN	I-NP	O
assay	assay	NN	I-NP	O

SETTING	SETTING	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
private	private	JJ	I-NP	O
office	office	NN	I-NP	O
-	-	HYPH	B-NP	O
based	base	VBN	I-NP	O
fertility	fertility	NN	I-NP	O
program	program	NN	I-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
direct	direct	JJ	B-NP	O
enantiomeric	enantiomeric	JJ	I-NP	O
separation	separation	NN	I-NP	O
of	of	IN	B-PP	O
mephenytoin	mephenytoin	NN	B-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
chiral	chiral	JJ	I-NP	O
capillary	capillary	JJ	I-NP	O
column	column	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
retention	retention	NN	I-NP	O
times	time	NNS	I-NP	O
for	for	IN	B-PP	O
S	S	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
R	R	NN	I-NP	O
-	-	HYPH	I-NP	O
mephenytoin	mephenytoin	NN	B-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
min	min	NN	I-NP	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
detection	detection	NN	I-NP	O
limit	limit	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
of	of	IN	B-PP	O
mephenytoin	mephenytoin	NN	B-NP	O

The	The	DT	B-NP	O
consensus	consensus	NN	I-NP	O
mammalian	mammalian	JJ	I-NP	O
ER	ER	NN	I-NP	O
stress	stress	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
ERSE	ERSE	NN	B-NP	O
)	)	)	O	O
conserved	conserve	VBN	B-VP	O
among	among	IN	B-PP	O
grp	BEGIN-grp	JJ	B-NP	B
promoters	promoters-INSIDE	NN	I-NP	I
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
tripartite	tripartite	JJ	I-NP	O
structure	structure	NN	I-NP	O
CCAAT	CCAAT	NN	I-NP	O
(	(	(	O	O
N1	N1	NN	B-NP	O
)	)	)	O	O
CCACG	CCACG	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
N	N	NN	B-NP	O
being	be	VBG	B-VP	O
a	a	DT	B-NP	O
strikingly	strikingly	RB	I-NP	O
GC	GC	NN	I-NP	O
-	-	HYPH	I-NP	O
rich	rich	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
find	find	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
BMI1	BEGIN-BMI1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
also	also	RB	I-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
itself	itself	PRP	B-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
certain	certain	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
protein	protein	NN	I-NP	O
import	import	NN	I-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
NTF1	BEGIN-NTF1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Ran	BEGIN-Ran-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
TC1	BEGIN-TC1-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
closely	closely	RB	I-VP	O
linked	link	VBN	I-VP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
NTF1	BEGIN-NTF1-INSIDE	NN	B-NP	B
may	may	MD	B-VP	O
serve	serve	VB	I-VP	O
to	to	TO	I-VP	O
modulate	modulate	VB	I-VP	O
a	a	DT	B-NP	O
transport	transport	NN	I-NP	O
step	step	NN	I-NP	O
involving	involve	VBG	B-VP	O
Ran	BEGIN-Ran-INSIDE	NN	B-NP	B
/	/	SYM	B-VP	O
TC1	BEGIN-TC1-INSIDE	NN	B-NP	B

Our	Our	PRP$	B-NP	O
analysis	analysis	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
correction	correction	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
operating	operate	VBG	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Hbbs	BEGIN-Hbbs-INSIDE	NN	I-NP	B
chromosome	chromosome	NN	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
beta	BEGIN-beta	NN	B-NP	B
s	s-INSIDE	NN	I-NP	I
and	and	CC	O	O
beta	BEGIN-beta	NN	B-NP	B
t	t-INSIDE	NN	I-NP	I
evolving	evolve	VBG	B-VP	O
in	in	IN	B-PP	O
concert	concert	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Hbbd	BEGIN-Hbbd-INSIDE	NN	I-NP	B
chromosome	chromosome	NN	I-NP	O
,	,	,	O	O
beta	BEGIN-beta	NN	B-NP	B
dmin	dmin-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
diverged	diverge	VBN	I-VP	O
considerably	considerably	RB	B-ADVP	O
from	from	IN	B-PP	O
beta	BEGIN-beta	NN	B-NP	B
dmaj	dmaj-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
prosomal	BEGIN-prosomal	JJ	I-NP	B
RNA	RNA	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein	NN	B-NP	I
p1K	p1K-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
human	human	JJ	I-NP	I
prosomal	prosomal	JJ	I-NP	I
gene	gene	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

Because	Because	IN	B-SBAR	O
controlled	control	VBN	B-NP	O
-	-	HYPH	I-NP	O
release	release	NN	I-NP	O
niacin	niacin	NN	I-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
potent	potent	JJ	I-ADJP	O
than	than	IN	B-PP	O
crystalline	crystalline	NN	B-NP	O
niacin	niacin	NN	I-NP	O
,	,	,	O	O
product	product	NN	B-NP	O
substitution	substitution	NN	I-NP	O
without	without	IN	B-PP	O
dose	dose	NN	B-NP	O
adjustment	adjustment	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
avoided	avoid	VBN	I-VP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
transcription	BEGIN-transcription	NN	B-NP	B
factor	factor	NN	I-NP	I
cyclic	cyclic	JJ	I-NP	I
adenosine	adenosine	NN	I-NP	I
1	1	CD	I-NP	I
'	'	SYM	B-NP	I
,	,	,	O	I
1	1	CD	B-NP	I
'	'	SYM	I-NP	I
-	-	HYPH	I-NP	I
monophosphate	monophosphate	NN	B-NP	I
(	(	(	O	I
cAMP	cAMP	NN	B-NP	I
)	)	)	O	I
response	response	NN	B-NP	I
element	element	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
CREB	BEGIN-CREB-INSIDE	NN	B-NP	B
)	)	)	O	O
:	:	:	O	O
regulation	regulation	NN	B-NP	O
by	by	IN	B-PP	O
follicle	BEGIN-follicle	NN	B-NP	B
-	-	HYPH	O	I
stimulating	stimulate	VBG	B-VP	I
hormone	hormone-INSIDE	NN	B-NP	I
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
cAMP	cAMP	NN	I-NP	O
signaling	signaling	NN	I-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	O
rat	rat	NN	I-NP	O
Sertoli	Sertoli	NNP	I-NP	O
cells	cell	NNS	I-NP	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
membrane	membrane	NN	B-NP	O
and	and	CC	I-NP	O
centrifugation	centrifugation	NN	I-NP	O
plasmapheresis	plasmapheresis	NN	I-NP	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
warm	warm	NN	B-NP	O
-	-	HYPH	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
higher	high	JJR	B-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
firing	firing	NN	B-NP	O
and	and	CC	O	O
greater	great	JJR	B-NP	O
thermal	thermal	JJ	I-NP	O
coefficients	coefficient	NNS	I-NP	O
,	,	,	O	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
warm	warm	JJ	B-NP	O
-	-	HYPH	I-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adult	adult	NN	I-NP	O
,	,	,	O	O
gradually	gradually	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
with	with	IN	B-PP	O
growth	growth	NN	B-NP	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
hyperthyroidism	hyperthyroidism	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
pattern	pattern	NN	I-NP	O
and	and	CC	I-NP	O
time	time	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
O1	O1	NN	B-NP	O
uptake	uptake	NN	I-NP	O
(	(	(	O	O
VO1	VO1	NN	B-NP	O
)	)	)	O	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
rest	rest	NN	B-NP	O
to	to	TO	B-VP	O
exercise	exercise	VB	I-VP	O
,	,	,	O	O
six	six	CD	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
six	six	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
performed	perform	VBD	B-VP	O
cycle	cycle	NN	B-NP	O
exercise	exercise	NN	I-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
average	average	JJ	I-NP	O
work	work	NN	I-NP	O
rate	rate	NN	I-NP	O
(	(	(	O	O
WR	WR	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
W	W	NN	I-NP	O
respectively	respectively	RB	B-ADVP	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
)	)	)	O	O

CHIEF	CHIEF	NNP	B-NP	O
OUTCOME	OUTCOME	NNP	I-NP	O
MEASURES	MEASURES	NNP	I-NP	O
:	:	:	O	O
Endoluminal	Endoluminal	JJ	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
prostacyclin	prostacyclin	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
Keto	Keto	NN	I-NP	O
-	-	HYPH	I-NP	O
PGF1	PGF1	NN	I-NP	O
alpha	alpha	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
thromboxane	thromboxane	NN	B-NP	O
B1	B1	NN	I-NP	O
(	(	(	O	O
TxB1	TxB1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
patency	patency	NN	B-NP	O
,	,	,	O	O
EC	EC	NN	B-NP	O
coverage	coverage	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
identity	identity	NN	I-NP	O

Elevated	Elevated	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
postglucose	postglucose	NN	I-NP	O
serum	BEGIN-serum	NN	I-NP	B
insulin	insulin-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
independent	independent	JJ	I-NP	O
,	,	,	I-NP	O
significant	significant	JJ	I-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
mass	mass	NN	I-NP	O
in	in	IN	B-PP	O
female	female	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
subjects	subject	NNS	I-NP	O

Seasonal	Seasonal	JJ	B-NP	O
variation	variation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cadmium	cadmium	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
Murex	Murex	NNP	B-NP	O
trunculus	trunculus	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
cadmium	cadmium	NN	I-NP	O
polluted	pollute	VBN	I-NP	O
environment	environment	NN	I-NP	O

The	The	DT	B-NP	O
total	total	JJ	I-NP	O
area	area	NN	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
curve	curve	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
value	value	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
altered	alter	VBN	I-VP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
SH	SH	NN	B-NP	O
B	B	NN	I-NP	O
1	1	CD	I-NP	O
AB	AB	NN	I-NP	O
or	or	CC	I-NP	O
Neogynon	Neogynon	NN	I-NP	O

Serum	BEGIN-Serum	NN	B-NP	B
IgM	IgM-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
brain	brain	NN	B-NP	O
tumour	tumour	NN	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
controls	control	NNS	B-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
cDNAs	cDNA	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
two	two	CD	B-NP	O
unusual	unusual	JJ	I-NP	O
E1Fs	BEGIN-E1Fs-INSIDE	NN	I-NP	B
,	,	,	O	O
E1F	BEGIN-E1F	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
E1F	BEGIN-E1F	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
each	each	DT	B-NP	O
identified	identify	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
to	to	TO	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
a	a	DT	B-NP	O
yeast	yeast	NN	I-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
hybrid	hybrid	NN	I-NP	O
system	system	NN	I-NP	O

Ultra	Ultra	AFX	O	O
-	-	HYPH	O	O
energy	energy	NN	B-NP	O
(	(	(	O	O
UHE	UHE	NN	B-NP	O
)	)	)	O	O
imaging	imaging	NN	B-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	I-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
simultaneous	simultaneous	JJ	B-NP	O
F	F	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
FDG	FDG	NN	I-NP	O
/	/	SYM	B-NP	O
Tc	Tc	NN	I-NP	O
-	-	HYPH	B-NP	O
1m	1m	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
studies	study	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
electron	electron	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
sec1	BEGIN-sec1	NN	B-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
cells	cell	NNS	I-NP	O
accumulate	accumulate	VBP	B-VP	O
secretory	secretory	JJ	B-NP	O
vesicles	vesicle	NNS	I-NP	O
,	,	,	O	O
ypt1	BEGIN-ypt1	NN	B-NP	B
/	/	SYM	B-NP	I
1	1	CD	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
cells	cell	NNS	I-NP	O
accumulate	accumulate	VBP	B-VP	O
aberrant	aberrant	JJ	B-NP	O
Golgi	Golgi	NNP	I-NP	O
structures	structure	NNS	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
Grap	BEGIN-Grap-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Ras	BEGIN-Ras	NN	I-NP	B
guanine	guanine	NN	I-NP	I
nucleotide	nucleotide	NN	I-NP	I
exchange	exchange	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
mSos1	BEGIN-mSos1-INSIDE	NN	I-NP	B
,	,	,	O	O
primarily	primarily	RB	B-ADVP	O
through	through	IN	B-PP	O
its	its	PRP$	B-NP	O
N	BEGIN-N	NN	I-NP	B
-	-	HYPH	I-NP	I
terminal	terminal	JJ	I-NP	I
SH1	SH1	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I

Correlation	Correlation	NN	B-NP	O
of	of	IN	B-PP	O
nitrogen	nitrogen	NN	B-NP	O
,	,	,	O	O
carbohydrate	carbohydrate	NN	B-NP	O
and	and	CC	O	O
lipid	lipid	NN	B-NP	O
metabolic	metabolic	JJ	I-NP	O
indices	index	NNS	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
cooled	cool	VBN	B-VP	O
under	under	IN	B-PP	O
conditions	condition	NNS	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
altered	altered	JJ	I-NP	O
gaseous	gaseous	JJ	I-NP	O
environment	environment	NN	I-NP	O

Transfer	Transfer	NN	B-NP	O
of	of	IN	B-PP	O
F	F	NN	B-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
plasmids	plasmid	NNS	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
FinOP	BEGIN-FinOP-INSIDE	NN	I-NP	B
system	system	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
controls	control	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
traJ	BEGIN-traJ-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transfer	transfer	NN	I-NP	O
operon	operon	NN	I-NP	O

This	This	DT	B-NP	O
regimen	regimen	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
front	front	JJ	B-ADJP	O
-	-	HYPH	B-NP	O
line	line	NN	I-NP	O
therapy	therapy	NN	I-NP	O
when	when	WRB	B-ADVP	O
autologous	autologous	JJ	B-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
transplantation	transplantation	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
feasible	feasible	JJ	B-ADJP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
response	response	NN	I-NP	O
is	be	VBZ	B-VP	O
particularly	particularly	RB	B-ADJP	O
important	important	JJ	I-ADJP	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
a	a	DT	B-NP	O
recognition	recognition	NN	I-NP	O
task	task	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
two	two	CD	B-NP	O
strings	string	NNS	I-NP	O
of	of	IN	B-PP	O
letters	letter	NNS	B-NP	O
are	be	VBP	B-VP	O
presented	present	VBN	I-VP	O
sequentially	sequentially	RB	B-ADVP	O

Comparison	Comparison	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
homologues	homologue	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
molecules	molecule	NNS	I-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
conservation	conservation	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
Fc	BEGIN-Fc	NN	B-NP	B
gamma	gamma	NN	I-NP	I
RIIb	RIIb-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
murine	BEGIN-murine	JJ	I-NP	B
beta	beta	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
,	,	,	O	O
splicing	splicing	NN	B-NP	O
pattern	pattern	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
tissue	tissue	NN	B-NP	O
distribution	distribution	NN	I-NP	O

A	A	DT	B-NP	O
rabbit	rabbit	NN	I-NP	O
antiserum	antiserum	NN	I-NP	O
raised	raise	VBN	B-VP	O
against	against	IN	B-PP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
(	(	(	O	O
V1	V1	NN	B-NP	O
domain	domain	NN	I-NP	O
)	)	)	O	O
bacterially	bacterially	RB	B-ADVP	O
expressed	express	VBD	B-VP	O
PKC	BEGIN-PKC	NN	B-NP	B
theta	theta	NN	I-NP	I
fragment	fragment-INSIDE	NN	I-NP	I
immunoprecipitated	immunoprecipitate	VBD	B-VP	O
specifically	specifically	RB	B-ADVP	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
protein	protein	NN	I-NP	O
from	from	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	O
cell	cell	NN	I-NP	O
lysates	lysate	NNS	I-NP	O

These	These	DT	B-NP	O
changes	change	NNS	I-NP	O
persisted	persist	VBD	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
week	week	NN	I-NP	O

Hematological	Hematological	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
(	(	(	O	O
leukocyte	leukocyte	NN	B-NP	O
,	,	,	I-NP	O
neutrophil	neutrophil	NN	I-NP	O
and	and	CC	I-NP	O
platelet	platelet	NN	I-NP	O
counts	count	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
liver	liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
standard	standard	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O

(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
betamethasone	betamethasone	NN	B-NP	O
on	on	IN	B-PP	O
duodenal	duodenal	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
absorption	absorption	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
dihydroxy	dihydroxy	NN	I-NP	O
vitamin	vitamin	NN	I-NP	O
D1	D1	NN	I-NP	O
production	production	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chick	chick	NN	I-NP	O

Phosphate	Phosphate	NN	B-NP	O
compounds	compound	NNS	I-NP	O
in	in	IN	B-PP	O
isolated	isolate	VBN	B-VP	O
,	,	,	O	O
perfused	perfuse	VBN	B-NP	O
hearts	heart	NNS	I-NP	O
during	during	IN	B-PP	O
pH	pH	NN	B-NP	O
variation	variation	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	O
PCO1	PCO1	NN	I-NP	O
and	and	CC	I-NP	O
bicarbonate	bicarbonate	NN	I-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
case	case	NN	I-NP	O
discovered	discover	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
girl	girl	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
anaemia	anaemia	NN	B-NP	O

Although	Although	IN	B-SBAR	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
similarity	similarity	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
protein	protein	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
E.	BEGIN-E.	FW	I-NP	B
coli	coli	FW	I-NP	I
RecA	RecA	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
significant	significant	JJ	I-NP	O
homology	homology	NN	I-NP	O
between	between	IN	B-PP	O
them	them	PRP	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
revealed	reveal	VBD	B-VP	O
their	their	PRP$	B-NP	O
identity	identity	NN	I-NP	O
by	by	IN	B-PP	O
five	five	CD	B-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
epitope	epitope	NN	I-NP	O
that	that	WDT	B-NP	O
recognized	recognize	VBD	B-VP	O
the	the	DT	B-NP	O
paratope	paratope	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RecA	BEGIN-RecA	NN	I-NP	B
protein	protein	NN	I-NP	I
antibody	antibody-INSIDE	NN	I-NP	I
for	for	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
epitope	epitope	NN	I-NP	O
-	-	HYPH	B-NP	O
paratope	paratope	NN	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
proteins	protein	NNS	I-NP	O

It	It	PRP	B-NP	O
would	would	MD	B-VP	O
seem	seem	VB	I-VP	O
that	that	DT	B-NP	O
caution	caution	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
exercised	exercise	VBN	I-VP	O
in	in	IN	B-PP	O
using	use	VBG	B-VP	O
HPL	BEGIN-HPL-INSIDE	NN	B-NP	B
values	value	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
placental	placental	JJ	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
anaemic	anaemic	JJ	B-NP	O
women	woman	NNS	I-NP	O

No	No	DT	B-NP	O
IORT	IORT	NN	I-NP	O
related	related	JJ	I-NP	O
mortality	mortality	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
observed	observe	VBN	I-VP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
tonB	BEGIN-tonB-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
phoA	BEGIN-phoA-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
fusion	fusion	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
of	of	IN	B-PP	O
TonB	BEGIN-TonB-INSIDE	NN	B-NP	B
are	be	VBP	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
export	export	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O
and	and	CC	O	O
presumably	presumably	RB	B-NP	O
TonB	BEGIN-TonB-INSIDE	NN	I-NP	B
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
protein	protein	NN	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
yeast	BEGIN-yeast	JJ	B-NP	B
RNase	RNase	NN	I-NP	I
MRP	MRP-INSIDE	NN	I-NP	I
:	:	:	O	O
an	an	DT	B-NP	O
RNA	RNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
zinc	zinc	NN	I-NP	O
-	-	HYPH	I-NP	O
cluster	cluster	NN	I-NP	O
domain	domain	NN	I-NP	O

This	This	DT	B-NP	O
raises	raise	VBZ	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
recombination	recombination	NN	B-NP	O
occurred	occur	VBD	B-VP	O
between	between	IN	B-PP	O
corresponding	correspond	VBG	B-VP	O
LTR	LTR	NN	B-NP	O
and	and	CC	O	O
vif	BEGIN-vif	JJ	B-NP	B
loci	loci-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
quasi	quasi	AFX	I-NP	O
-	-	HYPH	I-NP	O
species	specie	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
isolates	isolate	NNS	I-NP	O
described	describe	VBN	B-VP	O
here	here	RB	B-ADVP	O

1	1	CD	B-NP	O

The	The	DT	B-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
action	action	NN	I-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
established	establish	VBN	B-NP	O
diuretics	diuretic	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
predicted	predict	VBN	B-NP	O
isoform	isoform	NN	I-NP	O
L	L	NN	I-NP	O
diversity	diversity	NN	I-NP	O
across	across	IN	B-PP	O
human	human	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
and	and	CC	I-NP	O
cells	cell	NNS	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
healing	healing	NN	I-NP	O
tendons	tendon	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
collagen	BEGIN-collagen-INSIDE	NN	B-NP	B
synthesis	synthesis	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
noncollagen	nonBEGIN-collagen-INSIDE	JJ	B-NP	I
protein	protein	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
remained	remain	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O

The	The	DT	B-NP	O
aromatic	BEGIN-aromatic	JJ	I-NP	B
hydrocarbon	hydrocarbon	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
AHR	BEGIN-AHR-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
ligand	ligand	NN	I-NP	O
-	-	HYPH	O	O
activated	activate	VBN	B-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
that	that	WDT	B-NP	O
regulates	regulate	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
drug	drug	NN	I-NP	O
-	-	HYPH	O	O
metabolizing	metabolize	VBG	B-VP	O
enzymes	enzyme	NNS	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
immunosuppression	immunosuppression	NN	B-NP	O
,	,	,	O	O
teratogenesis	teratogenesis	NN	B-NP	O
,	,	,	O	O
cell	cell	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
certain	certain	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
malignancies	malignancy	NNS	B-NP	O
and	and	CC	I-NP	O
toxicities	toxicity	NNS	I-NP	O

Fluctuations	Fluctuation	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
measured	measure	VBN	I-NP	O
ECF	ECF	NN	I-NP	O
energy	energy	NN	I-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
substances	substance	NNS	I-NP	O
corresponded	correspond	VBD	B-VP	O
to	to	TO	B-PP	O
various	various	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
events	event	NNS	I-NP	O
presumably	presumably	RB	B-VP	O
involving	involve	VBG	I-VP	O
hypoxia	hypoxia	NN	B-NP	O
/	/	SYM	B-VP	O
ischemia	ischemia	NN	B-NP	O

After	After	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
intervention	intervention	NN	B-NP	O
,	,	,	O	O
sustained	sustain	VBD	B-VP	O
physical	physical	JJ	B-NP	O
training	training	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
FVII	BEGIN-FVII-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
PAI	BEGIN-PAI	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O

The	The	DT	B-NP	O
metalloproteinase	BEGIN-metalloproteinase-INSIDE	NN	I-NP	B
mediating	mediate	VBG	B-VP	O
Met	BEGIN-Met-INSIDE	NN	B-NP	B
cleavage	cleavage	NN	I-NP	O
was	be	VBD	B-VP	O
specifically	specifically	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
tissue	BEGIN-tissue	NN	I-NP	B
inhibitor	inhibitor	NN	I-NP	I
of	of	IN	B-PP	I
metalloproteinases	BEGIN-metalloproteinase-INSIDE	NNS	B-NP	I
(	(	(	O	O
TIMP	TIMP	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
1	1-INSIDE	NN	I-NP	I
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	I-PP	O
by	by	IN	B-PP	O
TIMP	BEGIN-TIMP	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
or	or	CC	I-NP	O
TIMP	BEGIN-TIMP	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

This	This	DT	B-NP	O
constant	constant	JJ	I-NP	O
expression	expression	NN	I-NP	O
profile	profile	NN	I-NP	O
,	,	,	O	O
coupled	couple	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-SBAR	O
over	over	AFX	B-NP	O
-	-	HYPH	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
mSin1A	BEGIN-mSin1A-INSIDE	NN	B-NP	B
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
augment	augment	VB	I-VP	O
the	the	DT	B-NP	O
anti	BEGIN-anti	AFX	I-NP	B
-	-	HYPH	I-NP	I
Myc	Myc-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
Mxi1	BEGIN-Mxi1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
SR	SR	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
embryo	embryo	NN	I-NP	O
fibroblast	fibroblast	NN	I-NP	O
(	(	(	O	O
REF	REF	NN	B-NP	O
)	)	)	O	O
transformation	transformation	NN	B-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
mSin1A	BEGIN-mSin1A-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
limiting	limit	VBG	I-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
Myc	BEGIN-Myc	NN	B-NP	B
superfamily	superfamily-INSIDE	NN	I-NP	I
function	function	NN	I-NP	O

METHODS	METHODS	NNS	B-NP	O
AND	AND	CC	I-NP	O
RESULTS	RESULTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
nitrate	nitrate	NN	I-NP	O
therapy	therapy	NN	I-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
during	during	IN	B-PP	O
healing	heal	VBG	B-VP	O
after	after	IN	B-PP	O
infarction	infarction	NN	B-NP	O
on	on	IN	B-PP	O
serial	serial	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
remodeling	remodeling	NN	I-NP	O
(	(	(	O	O
scar	scar	NN	B-NP	O
expansion	expansion	NN	I-NP	O
,	,	,	O	O
scar	scar	NN	B-NP	O
thinning	thinning	NN	I-NP	O
,	,	,	O	O
ventricular	ventricular	JJ	B-NP	O
dilation	dilation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypertrophy	hypertrophy	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
function	function	NN	B-NP	O
(	(	(	O	O
asynergy	asynergy	NN	B-NP	O
or	or	CC	O	O
akinesis	akinesis	NN	B-NP	O
plus	plus	CC	O	O
dyskinesis	dyskinesis	NN	B-NP	O
and	and	CC	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
dimensional	dimensional	JJ	I-NP	O
echocardiography	echocardiography	NN	I-NP	O
,	,	,	O	O
hemodynamics	hemodynamic	NNS	B-NP	O
,	,	,	O	O
postmortem	postmortem	NN	B-NP	O
topography	topography	NN	I-NP	O
(	(	(	O	O
computerized	computerized	JJ	B-NP	O
planimetry	planimetry	NN	I-NP	O
,	,	,	O	O
geometric	geometric	JJ	B-NP	O
maps	map	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
radiographs	radiograph	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
collagen	BEGIN-collagen-INSIDE	NN	B-NP	B
content	content	NN	I-NP	O
(	(	(	O	O
hydroxyproline	hydroxyproline	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
instrumented	instrumented	JJ	I-NP	O
dogs	dog	NNS	I-NP	O
randomized	randomize	VBD	B-VP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
left	left	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
ligation	ligation	NN	I-NP	O
to	to	TO	B-PP	O
various	various	JJ	B-NP	O
nitrate	nitrate	NN	I-NP	O
regimens	regimen	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
(	(	(	O	O
subgroup	subgroup	NN	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
transdermal	transdermal	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
AM	AM	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
PM	PM	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
subgroup	subgroup	NN	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
transdermal	transdermal	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
plus	plus	CC	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
sustained	sustained	JJ	B-NP	O
-	-	HYPH	I-NP	O
release	release	NN	I-NP	O
oral	oral	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
PM	PM	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
PM	PM	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
subgroup	subgroup	NN	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
oral	oral	JJ	B-NP	O
isosorbide	isosorbide	NN	I-NP	O
dinitrate	dinitrate	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
AM	AM	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
PM	PM	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
or	or	CC	O	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
(	(	(	O	O
subgroup	subgroup	NN	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
isosorbide	isosorbide	NN	B-NP	O
dinitrate	dinitrate	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
matching	match	VBG	B-VP	O
controls	control	NNS	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
nationwide	nationwide	JJ	I-NP	O
survey	survey	NN	I-NP	O
uncovered	uncover	VBD	B-VP	O
a	a	DT	B-NP	O
tenfold	tenfold	JJ	I-NP	O
variation	variation	NN	I-NP	O
between	between	IN	B-PP	O
counties	county	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prescribing	prescribing	NN	I-NP	O
of	of	IN	B-PP	O
IFNB	BEGIN-IFNB-INSIDE	NN	B-NP	B

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
HOX	BEGIN-HOX	NN	I-NP	B
cofactor	cofactor-INSIDE	NN	I-NP	I
,	,	,	O	O
PBX1A	BEGIN-PBX1A-INSIDE	NN	B-NP	B
,	,	,	O	O
participates	participate	VBZ	B-VP	O
in	in	IN	B-PP	O
cooperative	cooperative	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
with	with	IN	B-PP	O
HOXA	BEGIN-HOXA	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
Deformed	BEGIN-Deformed-INSIDE	NN	I-NP	B
group	group	NN	I-NP	O
protein	protein	NN	I-NP	O
HOXD	BEGIN-HOXD	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

RESULTS	RESULTS	NNS	B-NP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
enrolled	enrol	VBN	I-VP	O
into	into	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
;	;	:	O	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
attended	attend	VBD	B-VP	O
for	for	IN	B-PP	O
repeat	repeat	NN	B-NP	O
colposcopy	colposcopy	NN	I-NP	O
and	and	CC	I-NP	O
cytology	cytology	NN	I-NP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
pro	BEGIN-pro	JJ	B-NP	B
-	-	HYPH	I-NP	I
IGF	IGF	NN	I-NP	I
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
initially	initially	RB	I-VP	O
form	form	VB	I-VP	O
two	two	CD	B-NP	O
disulfide	disulfide	NN	I-NP	O
isomers	isomer	NNS	I-NP	O
that	that	WDT	B-NP	O
undergo	undergo	VBP	B-VP	O
rearrangement	rearrangement	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
conformation	conformation	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
primate	primate	JJ	B-ADJP	O
vs.	vs.	IN	B-PP	O
rodent	rodent	NN	B-NP	O
promoter	promoter	NN	I-NP	O
selectivity	selectivity	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
TBP	BEGIN-TBP-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
TAFI	BEGIN-TAFI-INSIDE	NN	I-NP	B
complex	complex	NN	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
cumulative	cumulative	JJ	B-NP	O
subtle	subtle	JJ	I-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
individual	individual	JJ	B-NP	O
subunits	subunit	NNS	I-NP	O
that	that	WDT	B-NP	O
lead	lead	VBP	B-VP	O
to	to	TO	B-PP	O
species	species	NN	B-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
RNA	BEGIN-RNA	NN	B-NP	B
polymerase	polymerase	NN	I-NP	I
I	I-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O

Anti	BEGIN-Anti	AFX	O	B
-	-	HYPH	O	I
Jo	Jo	NNP	B-NP	I
-	-	HYPH	I-NP	I
1	1	CD	I-NP	I
antibody	antibody-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
not	not	RB	O	O
present	present	JJ	B-ADJP	O

The	The	DT	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
murine	BEGIN-murine	JJ	I-NP	B
gene	gene	NN	I-NP	I
encoding	encode	VBG	B-VP	I
granulocyte	granulocyte	NN	B-NP	I
-	-	HYPH	I-NP	I
macrophage	macrophage	NN	I-NP	I
colony	colony	NN	I-NP	I
stimulating	stimulate	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
utilisation	utilisation	NN	B-NP	O
of	of	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
promoters	promoter	NNS	I-NP	O

Cotransfection	Cotransfection	NN	B-NP	O
of	of	IN	B-PP	O
pINV	pINV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
construct	construct	NN	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
of	of	IN	B-PP	O
hINV	BEGIN-hINV	JJ	B-NP	B
upstream	upstream	JJ	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
luciferase	BEGIN-luciferase-INSIDE	NN	B-NP	B
,	,	,	O	O
with	with	IN	B-PP	O
POU	BEGIN-POU	NN	B-NP	B
homeodomain	homeodomain	NN	I-NP	I
transcription	transcription	NN	I-NP	I
factors	factors-INSIDE	NN	I-NP	I
Oct1	BEGIN-Oct1-INSIDE	NN	I-NP	B
,	,	,	O	O
Oct1	BEGIN-Oct1-INSIDE	NN	B-NP	B
,	,	,	O	O
Brn1	BEGIN-Brn1-INSIDE	NN	B-NP	B
,	,	,	O	O
SCIP	BEGIN-SCIP-INSIDE	NN	B-NP	B
,	,	,	O	O
Skn1a	BEGIN-Skn1a-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
Skn1i	BEGIN-Skn1i-INSIDE	NN	I-NP	B
,	,	,	O	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
basal	basal	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O

Central	Central	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
unit	unit	NN	I-NP	O
saves	save	VBZ	B-VP	O
nurses	nurse	NNS	B-NP	O
,	,	,	O	O
adds	add	VBZ	B-VP	O
income	income	NN	B-NP	O
,	,	,	O	O
improves	improve	VBZ	B-VP	O
care	care	NN	B-NP	O

The	The	DT	B-NP	O
Grb1	BEGIN-Grb1-INSIDE	NN	I-NP	B
SH1	BEGIN-SH1	NN	I-NP	B
(	(	(	O	I
C	C	NN	B-NP	I
)	)	)	O	I
binding	binding	NN	B-NP	I
region	region-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
Gab1	BEGIN-Gab1-INSIDE	NN	B-NP	B
has	have	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
adapter	BEGIN-adapter	NN	I-NP	B
protein	protein	NN	I-NP	I
SLP	SLP	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
QCS	QCS	NNP	I-NP	O
appears	appear	VBZ	B-VP	O
comparable	comparable	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
MMSE	MMSE	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
quicker	quick	JJR	B-ADJP	O
to	to	TO	B-VP	O
administer	administer	VB	I-VP	O

A	A	DT	B-NP	O
positive	positive	JJ	I-NP	O
FTA	BEGIN-FTA	NN	I-NP	B
-	-	HYPH	B-NP	I
ABS	ABS	NN	I-NP	I
-	-	HYPH	B-NP	I
1S	1S	NN	I-NP	I
-	-	HYPH	I-NP	I
IgM	IgM-INSIDE	NN	I-NP	I
test	test	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
the	the	DT	B-NP	O
necessity	necessity	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O

A	A	DT	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
novel	novel	JJ	I-NP	O
target	target	NN	I-NP	O
-	-	HYPH	B-ADVP	O
like	like	JJ	B-PP	O
sequences	sequence	NNS	B-NP	O
:	:	:	O	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
flanking	flanking	NN	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
breakpoint	breakpoint	NN	I-NP	O
junction	junction	NN	I-NP	O
of	of	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
T	T	NN	B-NP	O
-	-	HYPH	B-NP	O
acute	acute	JJ	I-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
ALL	ALL	NN	B-NP	O
)	)	)	O	O
carrying	carry	VBG	B-VP	O
the	the	DT	B-NP	O
t	t	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
q1	q1	NN	B-NP	O
;	;	:	O	O
q1	q1	NN	B-NP	O
)	)	)	O	O
rearrangement	rearrangement	NN	B-NP	O
and	and	CC	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
on	on	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
of	of	IN	I-NP	O
five	five	CD	I-NP	O
T	T	NN	I-NP	O
-	-	HYPH	I-NP	O
ALL	ALL	NN	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
t	t	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
p1	p1	NN	B-NP	O
;	;	:	O	O
q1	q1	NN	B-NP	O
)	)	)	O	O
rearrangement	rearrangement	NN	B-NP	O

1	1	LS	B-LST	O
)	)	)	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
iron	iron	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
toxigenicity	toxigenicity	NN	I-NP	O
of	of	IN	B-PP	O
Vibrio	Vibrio	NNP	B-NP	O
cholerae	cholerae	NNS	I-NP	O

The	The	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
untranslated	untranslated	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
were	be	VBD	B-VP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
both	both	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
clones	clone	NNS	I-NP	O

The	The	DT	B-NP	O
anesthesiologist	anesthesiologist	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
proteins	protein	NNS	I-NP	O
copurified	copurifie	VBN	B-VP	O
through	through	IN	B-PP	O
several	several	JJ	B-NP	O
biochemical	biochemical	JJ	I-NP	O
fractionation	fractionation	NN	I-NP	O
steps	step	NNS	I-NP	O
and	and	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
coimmunoprecipitated	coimmunoprecipitate	VBN	I-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
antibodies	antibody	NNS	B-NP	O
against	against	IN	B-PP	O
GCD1	BEGIN-GCD1-INSIDE	NN	B-NP	B
or	or	CC	O	O
GCD1	BEGIN-GCD1-INSIDE	NN	B-NP	B

From	From	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
community	community	NN	B-NP	O
-	-	HYPH	O	O
acquired	acquire	VBN	B-VP	O
respiratory	respiratory	JJ	B-NP	O
tract	tract	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
pneumoniae	pneumoniae	NNP	I-NP	O
(	(	(	O	O
n=1	n=1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Haemophilus	Haemophilus	NN	B-NP	O
influenzae	influenzae	NNS	I-NP	O
(	(	(	O	O
n=1	n=1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
Moraxella	Moraxella	NN	B-NP	O
catarrhalis	catarrhalis	NN	I-NP	O
(	(	(	O	O
n=1	n=1	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
centres	centre	NNS	I-NP	O
in	in	IN	B-PP	O
Australia	Australia	NNP	B-NP	O
,	,	,	O	O
Hong	Hong	NNP	B-NP	O
Kong	Kong	NNP	I-NP	O
,	,	,	O	O
Japan	Japan	NNP	B-NP	O
,	,	,	O	O
China	China	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Philippines	Philippines	NNP	I-NP	O
,	,	,	O	O
Singapore	Singapore	NNP	B-NP	O
,	,	,	O	O
South	South	NNP	B-NP	O
Africa	Africa	NNP	I-NP	O
and	and	CC	O	O
Taiwan	Taiwan	NNP	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
SENTRY	SENTRY	NNP	I-NP	O
Antimicrobial	Antimicrobial	NNP	I-NP	O
Surveillance	Surveillance	NNP	I-NP	O
Program	Program	NNP	I-NP	O

Rats	Rat	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
multiple	multiple	JJ	I-NP	O
oral	oral	JJ	I-NP	O
dosage	dosage	NN	I-NP	O
regimen	regimen	NN	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
unlabelled	unlabelled	JJ	B-NP	O
HMCF	HMCF	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
drinking	drinking	NN	I-NP	O
water	water	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
bolus	bolus	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
1C	1C	NN	B-NP	O
]	]	)	I-NP	O
HMCF	HMCF	NN	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
search	search	VB	I-VP	O
for	for	IN	B-PP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
multicopy	BEGIN-multicopy	JJ	I-NP	B
RBM	RBM	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
male	male	JJ	B-NP	O
infertility	infertility	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
sequence	sequence	NN	B-NP	O
data	datum	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
reported	report	VBN	I-NP	O
cDNA	cDNA	NN	I-NP	O
clone	clone	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
intron	intron	NN	I-NP	O
exon	exon	NN	I-NP	O
boundaries	boundary	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
YRRM	BEGIN-YRRM	NN	I-NP	B
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Uterine	Uterine	NN	B-NP	O
contractions	contraction	NNS	I-NP	O
began	begin	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
latency	latency	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PGF1	PGF1	NN	I-NP	O
alpha	alpha	NN	I-NP	O
infused	infuse	VBN	B-VP	O
women	woman	NNS	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
controls	control	NNS	B-NP	O
uterine	uterine	JJ	B-NP	O
activity	activity	NN	I-NP	O
remained	remain	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O

The	The	DT	B-NP	O
implication	implication	NN	I-NP	O
of	of	IN	B-PP	O
Rac	BEGIN-Rac-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
using	use	VBG	B-VP	O
either	either	CC	O	O
constitutively	constitutively	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
(	(	(	O	O
V1	V1	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
dominant	dominant	JJ	B-ADJP	O
-	-	HYPH	O	O
interfering	interfere	VBG	B-VP	O
(	(	(	O	O
N1	N1	NN	B-NP	O
)	)	)	O	O
mutants	mutant	NNS	B-NP	O

The	The	DT	B-NP	O
evolutionary	evolutionary	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
similarities	similarity	NNS	I-NP	O
of	of	IN	B-PP	O
intron	intron	NN	B-NP	O
secondary	secondary	JJ	I-NP	O
structures	structure	NNS	I-NP	O
and	and	CC	O	O
open	open	JJ	B-NP	O
reading	reading	NN	I-NP	O
frames	frame	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ND1	BEGIN-ND1	NN	I-NP	B
,	,	,	O	I
1	1	CD	B-NP	I
and	and	CC	O	I
ATPase	ATPase	NN	B-NP	I
1	1	CD	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
separate	separate	JJ	I-NP	O
evolution	evolution	NN	I-NP	O
of	of	IN	B-PP	O
structural	structural	JJ	B-NP	O
and	and	CC	I-NP	O
coding	coding	NN	I-NP	O
sequences	sequence	NNS	I-NP	O

Although	Although	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
cone	cone	NN	B-NP	O
ratios	ratio	NNS	I-NP	O
do	do	VBP	B-VP	O
determine	determine	VB	I-VP	O
colour	colour	NN	B-NP	O
appearance	appearance	NN	I-NP	O
under	under	IN	B-PP	O
many	many	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
or	or	CC	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
computation	computation	NN	I-NP	O
is	be	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O

Procedures	Procedure	NNS	B-NP	O
with	with	IN	B-PP	O
perfected	perfect	VBN	B-NP	O
method	method	NN	I-NP	O

In	In	IN	B-PP	O
an	an	DT	B-NP	O
effort	effort	NN	I-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
factors	factor	NNS	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
important	important	JJ	I-NP	O
erythroid	erythroid	JJ	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
EKLF	EKLF	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
and	and	CC	O	O
systematically	systematically	RB	B-VP	O
analyzed	analyze	VBD	I-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O

Accordingly	Accordingly	RB	B-ADVP	O
,	,	,	O	O
superpeptide	superpeptide	NN	B-NP	O
antigenic	antigenic	JJ	I-NP	O
material	material	NN	I-NP	O
was	be	VBD	B-VP	O
readily	readily	RB	I-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
immunoblotting	immunoblotte	VBG	B-VP	O
cell	cell	NN	B-NP	O
extracts	extract	NNS	I-NP	O
and	and	CC	O	O
enriched	enrich	VBN	B-VP	O
in	in	IN	B-PP	O
vacuolar	vacuolar	JJ	B-NP	O
preparations	preparation	NNS	I-NP	O
of	of	IN	B-PP	O
PrA	BEGIN-PrA-INSIDE	NN	B-NP	B
deficient	deficient	JJ	I-NP	O
mutant	mutant	JJ	I-NP	O
cells	cell	NNS	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
All	All	DT	B-NP	O
primary	primary	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
CAM1	BEGIN-CAM1-INSIDE	NN	B-NP	B

However	However	RB	B-NP	O
massive	massive	JJ	I-NP	O
necrosis	necrosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
tubules	tubule	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
with	with	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1mg	1mg	NN	I-NP	O
of	of	IN	B-PP	O
DSM	DSM	NN	B-NP	O
administration	administration	NN	I-NP	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
functioning	function	VBG	B-VP	O
parathyroid	parathyroid	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
with	with	IN	B-PP	O
hypereninemic	hypereninemic	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O

Together	Together	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
phase	phase	NN	B-NP	O
II	II	CD	I-NP	O
trials	trial	NNS	I-NP	O
,	,	,	O	O
phase	phase	NN	B-NP	O
I	I	CD	I-NP	O
trials	trial	NNS	I-NP	O
utilizing	utilize	VBG	B-VP	O
escalating	escalate	VBG	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
carboplatin	carboplatin	NN	B-NP	O
and	and	CC	I-NP	O
paclitaxel	paclitaxel	NN	I-NP	O
with	with	IN	B-PP	O
growth	growth	NN	B-NP	O
factor	factor	NN	I-NP	O
or	or	CC	O	O
growth	growth	NN	B-NP	O
factor	factor	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
stem	stem	NN	I-NP	O
-	-	HYPH	B-NP	O
cell	cell	NN	I-NP	O
support	support	NN	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
substantial	substantial	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
dose	dose	NN	B-NP	O
intensity	intensity	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
achieved	achieve	VBN	I-VP	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
class	class	NN	I-NP	O
1	1	CD	I-NP	O
laminar	laminar	JJ	I-NP	O
flow	flow	NN	I-NP	O
clean	clean	JJ	I-NP	O
bench	bench	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
minimize	minimize	VB	I-VP	O
particulate	particulate	JJ	B-NP	O
contamination	contamination	NN	I-NP	O
from	from	IN	B-PP	O
extraneous	extraneous	JJ	B-NP	O
sources	source	NNS	I-NP	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
integrated	integrate	VBN	I-NP	O
transforming	transform	VBG	I-NP	O
DNA	DNA	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
altered	alter	VBN	I-VP	O
or	or	CC	O	O
lost	lose	VBN	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RbcS1	BEGIN-RbcS1-INSIDE	NN	I-NP	B
:	:	:	O	O
:	:	:	O	O
aadA	BEGIN-aadA-INSIDE	NN	B-NP	B
:	:	:	O	O
:	:	:	O	O
RbcS1	BEGIN-BEGIN-RbcS1-INSIDE	NN	B-NP	B
gene	gene	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
	-INSIDE	NN	B-NP	I
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
repressed	repress	VBN	I-VP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
holo	BEGIN-holo	JJ	I-NP	B
-	-	HYPH	I-NP	I
dTFIIA	dTFIIA-INSIDE	NN	I-NP	I
(	(	(	O	O
L	L	NN	B-NP	O
/	/	SYM	O	O
S	S	NN	B-NP	O
)	)	)	O	O
binds	bind	VBZ	B-VP	O
TBP	BEGIN-TBP-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O

In	In	IN	B-PP	O
one	one	CD	B-NP	O
trial	trial	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
transfusion	transfusion	NN	B-NP	O
-	-	HYPH	O	O
related	relate	VBN	B-NP	O
chronic	chronic	JJ	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
C	C	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
lymphoblastoid	BEGIN-lymphoblastoid	JJ	B-NP	B
interferon	interferon-INSIDE	NN	I-NP	I
(	(	(	O	O
1	1	CD	B-NP	O
MU	MU	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
mo	mo	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
1	1	CD	B-NP	O
MU	MU	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
1	1	CD	I-NP	O
mo	mo	NN	I-NP	O
)	)	)	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
preferential	preferential	JJ	I-NP	O
endometrial	endometrial	JJ	I-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
BTEB	BEGIN-BTEB-INSIDE	NN	B-NP	B
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
its	its	PRP$	B-NP	O
regulatory	regulatory	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
-	-	HYPH	O	O
associated	associate	VBN	B-VP	O
endometrial	endometrial	JJ	B-NP	O
epithelial	epithelial	JJ	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O

The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
LZ1	BEGIN-LZ1-INSIDE	NN	B-NP	B
matched	match	VBD	B-VP	O
that	that	IN	B-SBAR	O
of	of	IN	B-PP	O
RREB1	BEGIN-BEGIN-RRE-INSIDEB1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
that	that	WDT	B-NP	O
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
Ras	BEGIN-Ras	NN	I-NP	B
responsive	responsive	JJ	I-NP	I
element	element-INSIDE	NN	I-NP	I
(	(	(	O	O
RRE	BEGIN-RRE-INSIDE	NN	B-NP	B
)	)	)	O	O
very	very	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
with	with	IN	B-PP	O
which	which	WDT	B-NP	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
LZ1	BEGIN-LZ1-INSIDE	NN	B-NP	B

Phosphorylation	Phosphorylation	NN	B-NP	O
at	at	IN	B-PP	O
Ser	Ser	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
impairs	impair	VBZ	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
GRK1	BEGIN-GRK1-INSIDE	NN	B-NP	B
to	to	TO	B-VP	O
phosphorylate	phosphorylate	VB	I-VP	O
both	both	CC	O	O
soluble	soluble	JJ	B-NP	O
and	and	CC	I-NP	O
membrane	membrane	NN	I-NP	O
-	-	HYPH	O	O
incorporated	incorporate	VBN	B-NP	O
receptor	receptor	NN	I-NP	O
substrates	substrate	NNS	I-NP	O
and	and	CC	O	O
dramatically	dramatically	RB	B-VP	O
attenuates	attenuate	VBZ	I-VP	O
Gbetagamma	BEGIN-Gbetagamma-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
mediated	mediate	VBN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
mRAR	BEGIN-BEGIN-mRAR	NN	B-NP	B
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
1	1-INSIDE	NN	I-NP	I
region	region	NN	I-NP	O
A	A-INSIDE	NN	I-NP	I
differs	differ	VBZ	B-VP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
mRAR	BEGIN-mRAR	NN	B-NP	B
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
1	1-INSIDE	NN	B-NP	I
by	by	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
1	1	CD	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
encoded	encode	VBN	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
-	-	HYPH	B-NP	O
long	long	JJ	I-NP	O
putative	putative	JJ	I-NP	O
exon	exon	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
spliced	splice	VBN	I-VP	O
in	in	IN	B-ADVP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
exons	exon	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
A	BEGIN-A	NN	I-NP	B
and	and	CC	I-NP	I
B	B	NN	I-NP	I
regions	region	NNS	I-NP	I
of	of	IN	B-PP	I
mRAR	BEGIN-mRAR	NN	B-NP	B
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
1	1-INSIDE-INSIDE	NN	B-NP	I

Rad1	BEGIN-Rad1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	O
repair	repair	NN	I-NP	O
and	and	CC	I-NP	O
checkpoint	checkpoint	NN	I-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
fission	fission	NN	B-NP	O
yeast	yeast	NN	I-NP	O

The	The	DT	B-NP	O
longest	long	JJS	I-NP	O
S1	S1	NN	I-NP	O
-	-	HYPH	I-NP	O
S1	S1	NN	I-NP	O
interval	interval	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
S1	S1	NN	B-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	B-PP	O
capture	capture	NN	B-NP	O
(	(	(	O	O
effective	effective	JJ	B-NP	O
refractory	refractory	JJ	I-NP	O
period	period	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
longer	long	JJR	B-ADJP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
msec	msec	NN	I-NP	O
at	at	IN	B-PP	O
twice	twice	JJ	B-NP	O
threshold	threshold	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
msec	msec	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
times	time	NNS	I-NP	O
threshold	threshold	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
basic	basic	JJ	I-NP	O
drive	drive	NN	I-NP	O
and	and	CC	I-NP	O
extrastimuli	extrastimuli	NNS	I-NP	O
were	be	VBD	B-VP	O
delivered	deliver	VBN	I-VP	O
to	to	TO	B-PP	O
separate	separate	JJ	B-NP	O
sites	site	NNS	I-NP	O

Using	Use	VBG	B-VP	O
lasers	laser	NNS	B-NP	O
,	,	,	O	O
PRK	PRK	NN	B-NP	O
involves	involve	VBZ	B-VP	O
reshaping	reshape	VBG	I-VP	O
the	the	DT	B-NP	O
cornea	cornea	NN	I-NP	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
its	its	PRP$	B-NP	O
refractive	refractive	JJ	I-NP	O
power	power	NN	I-NP	O
is	be	VBZ	B-VP	O
increased	increase	VBN	I-VP	O

Using	Use	VBG	B-VP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
screening	screening	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
first	first	RB	B-ADVP	O
identified	identify	VBD	B-VP	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
that	that	WDT	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
interfere	interfere	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
His	His	NN	I-NP	O
-	-	HYPH	B-NP	O
Asp	Asp	NN	I-NP	O
phosphorelay	phosphorelay	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
HPt	HPt	NN	I-NP	O
domain	domain	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
receiver	receiver	NN	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
OmpR	BEGIN-OmpR-INSIDE	NN	B-NP	B
,	,	,	O	O
provided	provide	VBN	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
multicopy	multicopy	JJ	I-NP	O
plasmid	plasmid	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
six	six	CD	B-NP	O
other	other	JJ	I-NP	O
landmarks	landmark	NNS	I-NP	O
favored	favor	VBD	B-VP	O
the	the	DT	B-NP	O
xeroradiograph	xeroradiograph	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
statistical	statistical	JJ	B-NP	O
significance	significance	NN	I-NP	O

Coronary	Coronary	JJ	B-NP	O
vasoconstriction	vasoconstriction	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
endothelin	BEGIN-endothelin	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
enhanced	enhance	VBN	I-VP	O
by	by	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
-	-	HYPH	B-NP	O
reperfusion	reperfusion	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
norepinephrine	norepinephrine	NN	B-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
concentrations	concentration	NNS	B-NP	O
typically	typically	RB	B-VP	O
observed	observe	VBN	I-VP	O
after	after	IN	B-PP	O
neonatal	neonatal	JJ	B-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
bypass	bypass	NN	I-NP	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
Raf	BEGIN-Raf	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
signaling	signaling	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	O
antibody	antibody	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
interferes	interfere	VBZ	B-VP	O
with	with	IN	B-PP	O
Raf	BEGIN-Raf	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Mek	BEGIN-Mek-INSIDE	NN	B-NP	B
substrate	substrate	NN	I-NP	O
binding	binding	NN	I-NP	O

Laparoscopic	Laparoscopic	JJ	B-NP	O
examination	examination	NN	I-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
after	after	IN	B-PP	O
surgery	surgery	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
enlarged	enlarged	JJ	I-NP	O
,	,	,	I-NP	O
thin	thin	JJ	I-NP	O
-	-	HYPH	I-NP	O
walled	wall	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
fluid	fluid	NN	B-NP	O
-	-	HYPH	O	O
filled	fill	VBN	B-VP	O
uterine	uterine	JJ	B-NP	O
segment	segment	NN	I-NP	O
cranial	cranial	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
midcornus	midcornus	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
animals	animal	NNS	I-NP	O

NBSII	NBSII	NN	B-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
ribosome	ribosome	NN	B-NP	O
-	-	HYPH	O	O
stimulated	stimulate	VBN	B-NP	O
activity	activity	NN	I-NP	O

Gel	Gel	NN	B-NP	O
shift	shift	NN	I-NP	O
and	and	CC	I-NP	O
southwestern	southwestern	JJ	I-NP	O
experiments	experiment	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
nuclear	nuclear	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kDa	kDa	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
kDa	kDa	NN	I-NP	O
in	in	IN	B-PP	O
GC	GC	NN	B-NP	O
and	and	CC	I-NP	O
fish	fish	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
tGH	BEGIN-tGH-INSIDE	NN	I-NP	B
CRE	CRE	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
CRE	BEGIN-CRE	NN	B-NP	B
-	-	HYPH	B-NP	I
binding	binding	NN	I-NP	I
-	-	HYPH	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
activating	BEGIN-activating	JJ	B-NP	B
-	-	HYPH	I-NP	I
transcription	transcription	NN	I-NP	I
-	-	HYPH	B-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	I-NP	I
l	l-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
related	relate	VBN	I-NP	O
peptides	peptide	NNS	I-NP	O
in	in	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
response	response	NN	I-NP	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
such	such	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
lead	lead	VBP	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
transition	transition	NN	I-NP	O
in	in	IN	B-PP	O
chromatin	chromatin	NN	B-NP	O
structure	structure	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
DNase	BEGIN-DNase	NN	I-NP	B
I	I	CD	I-NP	I
hypersensitive	hypersensitive	JJ	I-NP	I
region	region-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
replaced	replace	VBN	I-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
stable	stable	JJ	I-NP	O
,	,	,	I-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	I-NP	O
positioned	position	VBN	I-NP	O
nucleosomes	nucleosome	NNS	I-NP	O

Two	Two	CD	B-NP	O
measures	measure	NNS	I-NP	O
of	of	IN	B-PP	O
sensory	sensory	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
were	be	VBD	B-VP	O
employed	employ	VBN	I-VP	O
,	,	,	O	O
S1	S1	NN	B-NP	O
/	/	SYM	B-VP	O
S1	S1	NN	B-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
amplitude	amplitude	NN	I-NP	O
ratio	ratio	NN	I-NP	O
and	and	CC	O	O
S1	S1	NN	B-NP	O
-	-	HYPH	B-NP	O
S1	S1	NN	I-NP	O
amplitude	amplitude	NN	I-NP	O
difference	difference	NN	I-NP	O

The	The	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
identified	identify	VBN	B-VP	O
by	by	IN	B-PP	O
primer	primer	NN	B-NP	O
extension	extension	NN	I-NP	O
and	and	CC	O	O
S1	BEGIN-S1	NN	B-NP	B
nuclease	nuclease-INSIDE	NN	I-NP	I
assay	assay	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
nt	nt	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
initiation	initiation	NN	I-NP	O
codon	codon	NN	I-NP	O

The	The	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
valproate	valproate	NN	B-NP	O
and	and	CC	I-NP	O
ethosuximide	ethosuximide	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
differential	differential	JJ	I-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
thalamocortical	thalamocortical	JJ	B-NP	O
excitability	excitability	NN	I-NP	O

Central	Central	JJ	B-NP	O
projections	projection	NNS	I-NP	O
of	of	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
afferent	afferent	JJ	I-NP	O
vagal	vagal	JJ	I-NP	O
inputs	input	NNS	I-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
biological	biological	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
Elf	BEGIN-Elf	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
IgH	BEGIN-IgH	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
,	,	,	O	O
attribute	attribute	VBP	B-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
receptor	receptor	NN	B-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
B	B	NN	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
and	and	CC	O	O
provide	provide	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
link	link	NN	I-NP	O
between	between	IN	B-PP	O
IgM	BEGIN-IgM	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
mediated	mediate	VBN	I-NP	O
signalling	signalling	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
enhancer	enhancer	NN	I-NP	O
activation	activation	NN	I-NP	O

Like	Like	IN	B-PP	O
Mdm1	BEGIN-Mdm1-INSIDE	NN	B-NP	B
,	,	,	O	O
MdmX	BEGIN-MdmX-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
and	and	CC	O	O
inhibit	inhibit	VB	B-VP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
transactivation	transactivation	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
MdmX	BEGIN-MdmX-INSIDE	NN	B-NP	B
to	to	TO	B-VP	O
degrade	degrade	VB	I-VP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
has	have	VBZ	B-VP	O
yet	yet	RB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
examined	examine	VBN	I-VP	O

The	The	DT	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mAR	BEGIN-mAR-INSIDE	NN	I-NP	B
ORF	ORF	NN	I-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
sequence	sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
mAR	BEGIN-mAR-INSIDE	NN	B-NP	B
cDNA	cDNA	NN	I-NP	O
fragments	fragment	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	O
testis	testis	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
mAR	BEGIN-mAR-INSIDE	NN	B-NP	B
specific	specific	JJ	I-NP	O
primers	primer	NNS	I-NP	O

Transforming	BEGIN-Transforming	JJ	B-NP	B
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
(	(	(	O	O
TGF	BEGIN-TGF	NN	B-NP	B
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
)	)	)	O	O
inhibits	inhibit	VBZ	B-VP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
through	through	IN	B-PP	O
up	up	RB	B-ADVP	O
-	-	HYPH	O	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
WAF1	BEGIN-WAF1-INSIDE	NN	B-NP	B
/	/	SYM	O	O
Cip1	CiBEGIN-p1-INSIDE	NN	B-NP	I
)	)	)	O	O
(	(	(	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
)	)	)	O	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O

Decreased	Decrease	VBN	B-NP	O
plasma	plasma	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
antithrombin	BEGIN-antithrombin	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
assumed	assume	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
factors	factor	NNS	I-NP	O
underlying	underlie	VBG	B-VP	O
hypercoagulable	hypercoagulable	JJ	B-NP	O
state	state	NN	I-NP	O
in	in	IN	B-PP	O
nephrotic	nephrotic	JJ	B-NP	O
syndrome	syndrome	NN	I-NP	O

In	In	IN	B-PP	O
both	both	DT	B-NP	O
RAW	RAW	NN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
microglia	microglia	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
EOC1	EOC1	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
IFN	BEGIN-IFN	NN	I-NP	B
-	-	HYPH	B-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
activated	activate	VBN	B-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
STAT	BEGIN-STAT	NN	B-NP	B
-	-	HYPH	B-NP	I
1alpha	1alpha-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
IRF	BEGIN-IRF	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
bind	bind	VBP	B-VP	O
the	the	DT	B-NP	O
GAS	BEGIN-GAS-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
IRF	BEGIN-IRF	NN	I-NP	B
elements	elements-INSIDE	NN	I-NP	I
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

All	All	DT	B-NP	O
patients	patient	NNS	I-NP	O
received	receive	VBD	B-VP	O
marrow	marrow	NN	B-NP	O
from	from	IN	B-PP	O
HLA	BEGIN-HLA-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
identical	identical	JJ	I-NP	O
sibling	sibling	NN	I-NP	O
donors	donor	NNS	I-NP	O
,	,	,	O	O
underwent	undergo	VBD	B-VP	O
similar	similar	JJ	B-NP	O
myeloablative	myeloablative	JJ	I-NP	O
regimens	regimen	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
similar	similar	JJ	B-NP	O
pretreatment	pretreatment	NN	I-NP	O
characteristics	characteristic	NNS	I-NP	O

In	In	IN	B-PP	O
Types	Type	NNS	B-NP	O
I	I	CD	B-NP	O
and	and	CC	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
capillary	capillary	JJ	B-NP	O
walls	wall	NNS	I-NP	O
became	become	VBD	B-VP	O
thinner	thinner	RBR	B-ADJP	O
and	and	CC	B-ADVP	O
more	more	RBR	B-NP	O
capillary	capillary	JJ	I-NP	O
lumens	lumen	NNS	I-NP	O
were	be	VBD	B-VP	O
visiable	visiable	JJ	B-ADJP	O

Immunoblot	Immunoblot	NN	B-NP	O
analyses	analysis	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
activator	activator	NN	B-NP	O
function	function	NN	I-NP	O
coincides	coincide	NNS	I-NP	O
with	with	IN	B-PP	O
selective	selective	JJ	B-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C	BEGIN-C	NN	I-NP	B
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
domain	domain	NN	I-NP	I
(	(	(	O	I
CTD	CTD	NN	B-NP	I
)	)	)	O	I
-	-	HYPH	O	I
hyperphosphorylated	hyperphosphorylate	VBN	B-NP	I
RNAP	RNAP	NN	I-NP	I
IIO	IIO-INSIDE	NN	I-NP	I
along	along	IN	B-PP	O
with	with	IN	B-PP	O
NC1	BEGIN-NC1-INSIDE	NN	B-NP	B

In	In	IN	B-PP	O
bell	bell	NN	B-NP	O
pepper	pepper	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
plastid	plastid	NN	I-NP	O
-	-	HYPH	B-NP	O
lipid	lipid	NN	I-NP	O
associated	associate	VBN	I-NP	O
protein	protein	NN	I-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
as	as	IN	B-PP	O
both	both	DT	B-NP	O
partially	partially	RB	B-VP	O
and	and	CC	I-VP	O
totally	totally	RB	B-NP	O
spliced	splice	VBN	I-NP	O
transcripts	transcript	NNS	I-NP	O
(	(	(	O	O
respectively	respectively	RB	B-NP	O
PAP1	BEGIN-PAP1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
PAP1	BEGIN-PAP1-INSIDE	NN	I-NP	B
)	)	)	O	O

Aggregation	Aggregation	NN	B-NP	O
in	in	IN	B-PP	O
washed	wash	VBN	B-NP	O
platelets	platelet	NNS	I-NP	O
from	from	IN	B-PP	O
rats	rat	NNS	B-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
was	be	VBD	B-VP	O
enhanced	enhance	VBN	I-VP	O

Instead	Instead	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
ssDNA	ssDNA	NN	B-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-NP	O
affinities	affinity	NNS	I-NP	O
reflects	reflect	VBZ	B-VP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
hexamerization	hexamerization	NN	B-NP	O
ability	ability	NN	I-NP	O
by	by	IN	B-PP	O
uvsY	BEGIN-uvsY-INSIDE	NN	B-NP	B
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
intrahexamer	intrahexamer	NN	B-NP	O
synergism	synergism	NN	I-NP	O
or	or	CC	I-NP	O
cooperativity	cooperativity	NN	I-NP	O
between	between	IN	B-PP	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
uvsY	BEGIN-BEGIN-uvsY-INSIDE	NN	I-NP	B
hexamer	hexamer-INSIDE	NN	I-NP	I
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
high	high	JJ	I-NP	O
observed	observe	VBN	I-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
ssDNA	ssDNA	NN	B-NP	O

The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
investigate	investigate	VBP	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O
aged	age	VBN	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
incl.	incl.	RB	B-ADVP	O
in	in	IN	B-PP	O
particular	particular	JJ	B-NP	O
a	a	DT	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
ones	one	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	O	O
checked	check	VBD	B-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
at	at	IN	B-PP	O
two	two	CD	B-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
Bratislava	Bratislava	NNP	B-NP	O
-	-	HYPH	B-VP	O
-	-	:	O	O
a	a	DT	B-NP	O
town	town	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
varying	vary	VBG	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
NOX	NOX	NN	B-NP	O
,	,	,	O	O
SO1	SO1	NN	B-NP	O
,	,	,	O	O
dustiness	dustiness	NN	B-NP	O
and	and	CC	O	O
dust	dust	NN	B-NP	O
fallout	fallout	NN	I-NP	O
-	-	HYPH	O	O
-	-	HYPH	O	O
their	their	PRP$	B-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
,	,	,	I-NP	O
type	type	NN	I-NP	O
and	and	CC	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
relapsing	relapse	VBG	B-VP	O
respiratory	respiratory	JJ	B-NP	O
disease	disease	NN	I-NP	O

Such	Such	JJ	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
BMR	BMR	NN	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	O	O
weight	weight	NN	B-NP	O
-	-	HYPH	O	O
matched	match	VBN	B-VP	O
Asian	Asian	JJ	B-NP	O
Indian	Indian	JJ	I-NP	O
males	male	NNS	I-NP	O
,	,	,	O	O
other	other	JJ	B-NP	O
tropical	tropical	JJ	I-NP	O
populations	population	NNS	I-NP	O
and	and	CC	I-NP	O
Americans	American	NNS	I-NP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
DaunoXome	DaunoXome	NNP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
improved	improve	VBN	I-NP	O
pharmacokinetic	pharmacokinetic	JJ	I-NP	O
profile	profile	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
free	free	JJ	B-NP	O
daunorubicin	daunorubicin	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
zincon	zincon	NN	I-NP	O
-	-	HYPH	B-VP	O
loaded	load	VBN	B-NP	O
resin	resin	NN	I-NP	O
was	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
selective	selective	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
trace	trace	NN	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
chalcophile	chalcophile	NN	B-NP	O
elements	element	NNS	I-NP	O
in	in	IN	B-PP	O
natural	natural	JJ	B-NP	O
water	water	NN	I-NP	O
samples	sample	NNS	I-NP	O
prior	prior	RB	B-PP	O
to	to	TO	I-PP	O
neutron	neutron	NN	B-NP	O
activation	activation	NN	I-NP	O
analysis	analysis	NN	I-NP	O

Analyses	Analysis	NNS	B-NP	O
focused	focus	VBD	B-VP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
platyrrhine	platyrrhine	NN	I-NP	O
(	(	(	O	O
New	New	NN	B-NP	O
World	World	NN	I-NP	O
monkey	monkey	NN	I-NP	O
)	)	)	O	O
species	specie	NNS	B-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
common	common	JJ	I-NP	O
marmoset	marmoset	NN	I-NP	O
(	(	(	O	O
Callithrix	Callithrix	FW	B-NP	O
jacchus	jacchus	FW	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
brown	brown	JJ	I-NP	O
capuchin	capuchin	NN	I-NP	O
monkey	monkey	NN	I-NP	O
(	(	(	O	O
Cebus	Cebus	NN	B-NP	O
apella	apella	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
paired	pair	VBN	I-VP	O
,	,	,	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
allelic	allelic	JJ	B-NP	O
gamma	gamma	NN	I-NP	O
loci	locus	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
gamma	gamma	SYM	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
gamma	gamma	SYM	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
)	)	)	O	O

Over	Over	IN	B-PP	O
half	half	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
children	child	NNS	I-NP	O
initially	initially	RB	B-ADJP	O
unresponsive	unresponsive	JJ	I-ADJP	O
to	to	TO	B-PP	O
H.	H.	NN	B-NP	O
influenzae	influenzae	VB	B-VP	O
type	type	NN	B-NP	O
b	b	NN	I-NP	O
meningitis	meningitis	NN	I-NP	O
subsequently	subsequently	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
specific	specific	JJ	B-NP	O
antibodies	antibody	NNS	I-NP	O

The	The	DT	B-NP	O
electron	electron	NN	I-NP	O
spin	spin	NN	I-NP	O
resonance	resonance	NN	I-NP	O
study	study	NN	I-NP	O
also	also	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
superoxide	superoxide	NN	B-NP	O
-	-	HYPH	B-NP	O
DMPO	DMPO	NN	I-NP	O
spin	spin	NN	I-NP	O
adduct	adduct	NN	I-NP	O
was	be	VBD	B-VP	O
strongly	strongly	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
selective	selective	JJ	I-NP	O
cyclooxygenase	BEGIN-cyclooxygenase	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
etodolac	etodolac	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
concentration	concentration	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O

Sox1	BEGIN-Sox1-INSIDE	NN	B-NP	B
maps	map	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
t	BEGIN-t	JJ	I-NP	B
complex	complex-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
mouse	mouse	NN	B-NP	O
chromosome	chromosome	NN	I-NP	O
1	1	CD	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1p1	1p1	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
microphthalmia	microphthalmia	NN	I-NP	O
-	-	HYPH	I-NP	O
cataract	cataract	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
CATM	CATM	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
alpha	alpha	SYM	I-NP	O
-	-	HYPH	I-NP	O
thalassemia	thalassemia	NN	I-NP	O
/	/	SYM	B-NP	O
mental	mental	JJ	I-NP	O
retardation	retardation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
ATR	ATR	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

If	If	IN	B-SBAR	O
vascular	vascular	JJ	B-NP	O
induction	induction	NN	I-NP	O
between	between	IN	B-PP	O
a	a	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
carrier	carrier	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
selected	select	VBN	I-NP	O
jejunal	jejunal	JJ	I-NP	O
segment	segment	NN	I-NP	O
is	be	VBZ	B-VP	O
done	do	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
kind	kind	NN	I-NP	O
of	of	IN	B-PP	O
flap	flap	NN	B-NP	O
prefabrication	prefabrication	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
jejunal	jejunal	JJ	I-NP	O
interposition	interposition	NN	I-NP	O
flap	flap	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
without	without	IN	B-PP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
complex	complex	NN	B-NP	O
microsurgery	microsurgery	NN	I-NP	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cure	cure	NN	I-NP	O
rates	rate	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
QC1	QC1	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
A1	A1	NN	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
regimens	regimen	VBZ	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
both	both	DT	O	O
,	,	,	O	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
parasite	parasite	NN	B-NP	O
genotyping	genotyping	NN	I-NP	O

Acetyl	BEGIN-Acetyl	NN	B-NP	B
-	-	HYPH	I-NP	I
CoA	CoA	NN	I-NP	I
carboxylase	carboxylase-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
yeast	yeast	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
factors	factor	NNS	B-NP	O
that	that	WDT	B-NP	O
control	control	VBP	B-VP	O
phospholipid	phospholipid	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O

The	The	DT	B-NP	O
NH	NH	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
proteins	protein	NNS	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
POZ	POZ	NN	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
motif	motif	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
repression	repression	NN	I-NP	O
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
dimerization	dimerization	NN	I-NP	O

Recognition	Recognition	NN	B-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
by	by	IN	B-PP	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
chain	chain	NN	I-NP	O
derivatives	derivative	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phage	phage	NN	I-NP	O
1	1	CD	I-NP	O
repressor	repressor	NN	I-NP	O
:	:	:	O	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
binding	binding	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
contacted	contact	VBN	I-NP	O
and	and	CC	I-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
contacted	contact	VBN	I-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
Mg1+	Mg1+	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
destabilization	destabilization	NN	B-NP	O
of	of	IN	B-PP	O
tRNAPhe	BEGIN-tRNAPhe-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
but	but	CC	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
confined	confine	VBN	I-VP	O
to	to	TO	B-PP	O
internal	internal	JJ	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
acceptor	acceptor	NN	I-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
psi	psi	NN	I-NP	O
C	C	NN	I-NP	O
helices	helix	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
evidenced	evidence	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
selectively	selectively	RB	I-NP	O
enhanced	enhance	VBN	I-NP	O
exchange	exchange	NN	I-NP	O
rates	rate	NNS	I-NP	O
for	for	IN	B-PP	O
imino	imino	NN	B-NP	O
protons	proton	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O

This	This	DT	B-NP	O
gene	gene	NN	I-NP	O
is	be	VBZ	B-VP	O
named	name	VBN	I-VP	O
PKNOX1	BEGIN-PKNOX1-INSIDE	NN	B-NP	B
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Human	Human	NNP	I-NP	O
Nomenclature	Nomenclature	NNP	I-NP	O
Committee	Committee	NNP	I-NP	O

The	The	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
proteins	protein	NNS	I-NP	O
contain	contain	VBP	B-VP	O
the	the	DT	B-NP	O
bHLH	bHLH	JJ	I-NP	O
motif	motif	NN	I-NP	O
and	and	CC	O	O
differ	differ	VBP	B-VP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
by	by	IN	B-PP	O
only	only	RB	B-NP	O
three	three	CD	I-NP	O
conservative	conservative	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
portions	portion	NNS	I-NP	O
are	be	VBP	B-VP	O
markedly	markedly	RB	B-ADJP	O
divergent	divergent	JJ	I-ADJP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O

A	A	DT	B-NP	O
Drosophila	Drosophila	FW	I-NP	O
subobscura	subobscura	NN	I-NP	O
genomic	genomic	JJ	I-NP	O
fragment	fragment	NN	I-NP	O
containing	contain	VBG	B-VP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
exons	exon	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
late	late	JJ	I-NP	O
and	and	CC	I-NP	O
early	early	JJ	I-NP	O
promotors	promotor	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Sxl	BEGIN-Sxl	NN	I-NP	B
gene	gene	NN	I-NP	I
of	of	IN	B-PP	I
D.	D.	NNP	B-NP	I
melanogaster	melanogaster-INSIDE	NNP	I-NP	I
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
from	from	IN	B-PP	O
animal	animal	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
solid	solid	JJ	B-NP	O
tumors	tumor	NNS	I-NP	O
in	in	IN	B-PP	O
marrow	marrow	NN	B-NP	O
transplant	transplant	NN	I-NP	O
patients	patient	NNS	I-NP	O
may	may	MD	B-VP	O
still	still	RB	I-VP	O
rise	rise	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
coming	come	VBG	I-NP	O
decades	decade	NNS	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transient	transient	JJ	I-NP	O
-	-	HYPH	I-NP	O
transfection	transfection	NN	I-NP	O
assay	assay	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Sp1	BEGIN-Sp1	NN	I-NP	B
binding	binding	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
core	core	NN	I-NP	O
region	region	NN	I-NP	O
(	(	(	O	O
positions	position	NNS	B-NP	O
-	-	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
+1	+1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha1	BEGIN-alpha1	NN	I-NP	B
-	-	HYPH	B-NP	I
integrin	integrin	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
alpha1	BEGIN-alpha1	NN	I-NP	B
-	-	HYPH	B-NP	I
integrin	integrin	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
downregulation	downregulation	NN	I-NP	O
by	by	IN	B-PP	O
Erb	BEGIN-Erb-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
B1	BEGIN-B1-INSIDE	NN	B-NP	B

These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
AF	AF	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
PPARalpha	BEGIN-PPARalpha-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
partially	partially	RB	I-VP	O
silenced	silence	VBN	I-VP	O
by	by	IN	B-PP	O
corepressor	corepressor	NN	B-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
might	might	MD	B-VP	O
interact	interact	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O

Evaluation	Evaluation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
chelation	chelation	NN	B-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
time	time	NN	B-NP	O
following	follow	VBG	B-PP	O
strontium	strontium	NN	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
mice	mouse	NNS	B-NP	O

Insertion	Insertion	NN	B-NP	O
of	of	IN	B-PP	O
alternatively	alternatively	RB	B-NP	O
spliced	splice	VBN	I-NP	O
exon	exon	NN	I-NP	O
W	W	NN	I-NP	O
into	into	IN	B-PP	O
CREB	BEGIN-CREB	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
during	during	IN	B-PP	O
spermatogenesis	spermatogenesis	NN	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
polycistronic	polycistronic	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
two	two	CD	B-NP	O
novel	novel	NN	I-NP	O
internally	internally	RB	B-NP	O
translated	translate	VBN	I-NP	O
CREB	BEGIN-CREB	NN	I-NP	B
repressor	repressor	NN	I-NP	I
isoforms	isoforms-INSIDE	NN	I-NP	I
called	call	VBN	B-VP	O
I	BEGIN-I	NN	B-NP	B
-	-	HYPH	B-NP	I
CREBs	CREBs-INSIDE	NN	I-NP	I
,	,	,	O	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carboxy	carboxy	NN	I-NP	O
-	-	HYPH	O	O
terminal	terminal	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
domain	domain	NN	B-NP	O
devoid	devoid	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transactivation	transactivation	NN	I-NP	O
domains	domain	NNS	I-NP	O

The	The	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
BRCA1	BRCA1	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
E1F	BEGIN-E1F	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I
and	and	CC	O	O
is	be	VBZ	B-VP	O
similarly	similarly	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
E1F1	BEGIN-E1F1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Rb	BEGIN-Rb-INSIDE	NN	I-NP	B

In	In	IN	B-PP	O
the	the	DT	B-NP	O
studies	study	NNS	I-NP	O
described	describe	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
two	two	CD	B-NP	O
potential	potential	JJ	I-NP	O
Ets	BEGIN-Ets-INSIDE	NN	I-NP	B
binding	binding	NN	I-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
EBS1	BEGIN-EBS1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
EBS1	BEGIN-EBS1-INSIDE	NN	I-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
the	the	DT	I-NP	O
human	human	JJ	I-NP	O
and	and	CC	I-NP	O
murine	murine	JJ	I-NP	O
interleukin	BEGIN-interleukin	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
enhancers	enhancer	NNS	I-NP	O

An	An	DT	B-NP	O
enhancement	enhancement	NN	I-NP	O
of	of	IN	B-PP	O
benign	benign	JJ	B-NP	O
liver	liver	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
(	(	(	O	O
tumorigenic	tumorigenic	JJ	B-NP	O
effect	effect	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
CF1	CF1	NN	B-NP	O
male	male	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
only	only	RB	I-NP	O
tested	test	VBN	I-NP	O
dose	dose	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
ppm	ppm	NN	I-NP	O
vs	v	NNS	I-NP	O

Stamps	Stamp	NNS	B-NP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
:	:	:	O	O
de	de	IN	B-NP	O
Musset	Musset	NNP	I-NP	O
sign	sign	NN	I-NP	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
CYT	BEGIN-CYT	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
(	(	(	O	O
P1	BEGIN-P1	NN	B-NP	B
-	-	HYPH	B-NP	I
P1	P1	NN	I-NP	I
RNA	RNA-INSIDE	NN	I-NP	I
)	)	)	O	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
P1	BEGIN-P1	NN	I-NP	B
-	-	HYPH	I-NP	I
P1	P1	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N.	BEGIN-N.	JJ	I-NP	B
crassa	crassa	NN	I-NP	I
mitochondrial	mitochondrial	JJ	I-NP	I
large	large	JJ	I-NP	I
subunit	subunit	NN	I-NP	I
ribosomal	ribosomal	JJ	I-NP	I
RNA	RNA	NN	I-NP	I
intron	intron-INSIDE	NN	I-NP	I

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Polyglutamine	Polyglutamine	NN	B-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
protein	protein	NN	B-NP	O
fragments	fragment	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
accumulate	accumulate	VB	I-VP	O
as	as	IN	B-PP	O
aggregates	aggregate	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
cell	cell	NN	B-NP	O
death	death	NN	I-NP	O
when	when	WRB	B-ADVP	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
proposal	proposal	NN	I-NP	O
that	that	IN	B-SBAR	O
polyglutamine	polyglutamine	NN	B-NP	O
aggregation	aggregation	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
step	step	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activator	activator	NN	I-NP	O
CREM	BEGIN-CREM-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
highly	highly	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
postmeiotic	postmeiotic	JJ	B-NP	O
cells	cell	NNS	I-NP	O

For	For	IN	B-PP	O
more	more	RBR	B-NP	O
detailed	detailed	JJ	I-NP	O
mapping	mapping	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
constructed	construct	VBD	B-VP	O
mouse	mouse	NN	B-NP	O
A1	A1	NN	I-NP	O
cells	cell	NNS	I-NP	O
containing	contain	VBG	B-VP	O
STFs	STF	NNS	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1	1	CD	I-NP	O
tagged	tag	VBN	B-VP	O
with	with	IN	B-PP	O
pSTneo	pSTneo	NN	B-NP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
regions	region	NNS	I-NP	O
in	in	IN	B-PP	O
1q1	1q1	CD	B-NP	O
-	-	HYPH	I-NP	O
qter	qter	NN	I-NP	O

We	We	PRP	B-NP	O
therefore	therefore	RB	B-ADVP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
PRR1	BEGIN-PRR1-INSIDE	NN	B-NP	B
,	,	,	B-NP	O
and	and	CC	I-NP	O
not	not	RB	I-NP	O
PVR	BEGIN-PVR-INSIDE	NN	B-NP	B
,	,	,	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
true	true	JJ	I-NP	O
human	human	JJ	I-NP	O
homolog	homolog	NN	I-NP	O
of	of	IN	B-PP	O
MPH	BEGIN-MPH-INSIDE	NN	B-NP	B

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
herein	herein	RB	B-ADVP	O
the	the	DT	B-NP	O
roles	role	NNS	I-NP	O
that	that	IN	B-SBAR	O
four	four	CD	B-NP	O
different	different	JJ	I-NP	O
PIAS	BEGIN-PIAS	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
(	(	(	O	O
ARIP1	BEGIN-ARIP1-INSIDE	NN	B-NP	B
/	/	SYM	O	O
PIASx	BEGIN-PIASx	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
,	,	,	O	O
Miz1	BEGIN-Miz1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
PIASx	BEGIN-PIASx	NN	I-NP	B
beta	beta-INSIDE	NN	I-NP	I
,	,	,	O	O
GBP	BEGIN-GBP-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
PIAS1	BEGIN-PIAS1-INSIDE	NN	I-NP	B
,	,	,	O	O
and	and	CC	O	O
PIAS1	BEGIN-PIAS1-INSIDE	NN	B-NP	B
)	)	)	O	O
play	play	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
steroid	BEGIN-steroid	JJ	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
or	or	CC	I-NP	O
STAT	BEGIN-STAT-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
mediated	mediate	VBN	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O

Yet	Yet	RB	O	O
testosterone	testosterone	NN	B-NP	O
was	be	VBD	B-VP	O
predominant	predominant	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Type	Type	NN	I-NP	O
II	II	CD	I-NP	O
male	male	JJ	I-NP	O
morph	morph	NN	I-NP	O
which	which	WDT	B-NP	O
neither	neither	CC	O	O
courts	court	VBZ	B-VP	O
females	female	NNS	B-NP	O
nor	nor	CC	I-NP	O
nests	nest	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
instead	instead	RB	B-VP	O
parasitizes	parasitize	VBZ	I-VP	O
Type	Type	NN	B-NP	O
I	I	CD	I-NP	O
males	male	NNS	I-NP	O
with	with	IN	B-PP	O
sneak	sneak	NN	B-NP	O
or	or	CC	I-NP	O
satellite	satellite	NN	I-NP	O
spawning	spawning	NN	I-NP	O
tactics	tactic	NNS	I-NP	O

To	To	TO	B-VP	O
better	well	RBR	I-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
oncogene	oncogene	NN	I-NP	O
and	and	CC	I-NP	O
genetic	genetic	JJ	I-NP	O
instability	instability	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
studied	study	VBN	I-VP	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
expressing	express	VBG	B-VP	O
an	an	DT	B-NP	O
activated	BEGIN-activated	JJ	I-NP	B
human	human	JJ	I-NP	I
Ha	Ha	NN	I-NP	I
-	-	HYPH	I-NP	I
ras	ras-INSIDE	NN	I-NP	I
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	BEGIN-bacterial	JJ	B-NP	B
lactose	lactose	NN	I-NP	I
operon	operon	NN	I-NP	I
regulatory	regulatory	JJ	I-NP	I
elements	elements-INSIDE	NN	I-NP	I
for	for	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
methotrexate	methotrexate	NN	B-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	O	O
dihydrofolate	BEGIN-dihydrofolate	JJ	B-NP	B
reductase	reductase-INSIDE	NN	I-NP	I
(	(	(	O	O
dhfr	BEGIN-dhfr-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O
amplification	amplification	NN	I-NP	O
following	follow	VBG	B-PP	O
mutant	BEGIN-mutant	JJ	B-NP	B
Ha	Ha	NN	I-NP	I
-	-	HYPH	O	I
ras	ras-INSIDE	NN	B-NP	I
induction	induction	NN	I-NP	O

Cbl	BEGIN-Cbl-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
signaling	signal	VBG	I-NP	O
molecule	molecule	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
functional	functional	JJ	I-NP	O
domains	domain	NNS	I-NP	O
:	:	:	O	O
an	an	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
phosphotyrosine	phosphotyrosine	NN	B-NP	O
residues	residue	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
RING	RING	NN	I-NP	O
finger	finger	NN	I-NP	O
domain	domain	NN	I-NP	O
which	which	WDT	B-NP	O
acts	act	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
ubiquitin	BEGIN-ubiquitin	NN	I-NP	B
ligase	ligase-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
proline	proline	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
region	region	NN	I-NP	O
which	which	WDT	B-NP	O
serves	serve	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
docking	docking	NN	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
SH1	BEGIN-SH1	NN	B-NP	B
-	-	HYPH	O	I
containing	contain	VBG	B-VP	I
proteins	proteins-INSIDE	NN	B-NP	I
,	,	,	O	O
phosphotyrosine	phosphotyrosine	NN	B-NP	O
residues	residue	NNS	I-NP	O
which	which	WDT	B-NP	O
serve	serve	VBP	B-VP	O
as	as	IN	B-PP	O
docking	docking	NN	B-NP	O
sites	site	NNS	I-NP	O
for	for	IN	B-PP	O
SH1	BEGIN-SH1	NN	B-NP	B
-	-	HYPH	O	I
containing	contain	VBG	B-VP	I
proteins	proteins-INSIDE	NN	B-NP	I
such	such	PDT	B-NP	O
a	a	DT	I-NP	O
CrkL	BEGIN-CrkL-INSIDE	NN	I-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
subunit	subunit-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
PI	BEGIN-PI	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
localization	localization	NN	I-NP	O
signal	signal	NN	I-NP	O

No	No	DT	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
epidural	epidural	JJ	B-NP	O
anesthesia	anesthesia	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

Region	Region	NN	B-NP	O
I	I	CD	I-NP	O
includes	include	VBZ	B-VP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
cysteine	cysteine	NN	I-NP	O
-	-	HYPH	I-NP	O
cysteine	cysteine	NN	I-NP	O
zinc	zinc	NN	I-NP	O
fingers	finger	NNS	I-NP	O
that	that	WDT	B-NP	O
comprise	comprise	VBP	B-VP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
which	which	WDT	B-NP	O
typifies	typify	VBZ	B-VP	O
all	all	DT	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
superfamily	superfamily	NN	I-NP	O

Leukocytoclasic	Leukocytoclasic	JJ	B-NP	O
vasculitis	vasculitis	NN	I-NP	O
during	during	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	I-NP	O
captopril	captopril	NN	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
Phase	Phase	NN	B-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
study	study	NN	I-NP	O
design	design	NN	I-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
the	the	DT	B-NP	O
controlled	control	VBN	I-NP	O
,	,	,	I-NP	O
randomized	randomize	VBN	I-NP	O
,	,	,	I-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
blind	blind	JJ	I-NP	O
study	study	NN	I-NP	O
-	-	HYPH	B-NP	O
-	-	SYM	I-NP	O
Phase	Phase	NN	B-NP	O
IV	IV	CD	I-NP	O
requires	require	VBZ	B-VP	O
different	different	JJ	B-NP	O
designs	design	NNS	I-NP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
many	many	JJ	I-NP	O
different	different	JJ	I-NP	O
questions	question	NNS	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	B-NP	O
superficial	superficial	JJ	I-NP	O
and	and	CC	I-NP	O
deep	deep	JJ	I-NP	O
cortical	cortical	JJ	I-NP	O
venous	venous	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cat	cat	NN	I-NP	O
kidney	kidney	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
when	when	WRB	B-ADVP	O
measuring	measure	VBG	B-VP	O
renal	BEGIN-renal	JJ	B-NP	B
renin	renin-INSIDE	NN	I-NP	I
release	release	NN	I-NP	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
organize	organize	VB	I-VP	O
chemical	chemical	JJ	B-NP	O
data	datum	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
client	client	NN	I-NP	O
-	-	HYPH	I-NP	O
server	server	NN	I-NP	O
environment	environment	NN	I-NP	O
using	use	VBG	B-VP	O
Database	Database	NNP	B-NP	O
Management	Management	NNP	I-NP	O
System	System	NNP	I-NP	O
and	and	CC	O	O
Web	Web	NNP	B-NP	O
fashion	fashion	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
client	client	NN	I-NP	O
interface	interface	NN	I-NP	O

This	This	DT	B-NP	O
bound	bind	VBN	I-NP	O
[	[	(	I-NP	O
1H	1H	NN	I-NP	O
]	]	)	O	O
iloprost	iloprost	VBP	B-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
and	and	CC	O	O
stimulated	stimulate	VBD	B-VP	O
cAMP	cAMP	NN	B-NP	O
production	production	NN	I-NP	O
when	when	WRB	B-ADVP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
agonist	agonist	NN	B-NP	O

The	The	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
exhibits	exhibit	VBZ	B-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CAD	BEGIN-CAD	NN	I-NP	B
sequences	sequence	NNS	I-NP	I
of	of	IN	B-PP	I
hamster	hamster	NN	B-NP	I
and	and	CC	I-NP	I
Squalus	Squalus	NN	I-NP	I
acanthias	acanthias-INSIDE	NN	I-NP	I

Juvenile	Juvenile	JJ	B-NP	O
idiopathic	idiopathic	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
myopathies	myopathy	NNS	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
magnetic	magnetic	JJ	B-NP	O
resonance	resonance	NN	I-NP	O
imaging	imaging	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
muscle	muscle	NN	B-NP	O
involvement	involvement	NN	I-NP	O

The	The	DT	B-NP	O
methods	method	NNS	I-NP	O
used	use	VBN	B-VP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
AOAC	AOAC	NN	I-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
dilution	dilution	NN	B-NP	O
and	and	CC	I-NP	O
heating	heating	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
mercuric	mercuric	JJ	B-NP	O
chloride	chloride	NN	I-NP	O
,	,	,	O	O
charcoal	charcoal	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Carrez	Carrez	NNP	B-NP	O
reagents	reagent	NNS	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
different	different	JJ	I-NP	O
pH	pH	NN	I-NP	O
values	value	NNS	I-NP	O
;	;	:	O	O
and	and	CC	O	O
direct	direct	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
sample	sample	NN	B-NP	O
supernatants	supernatant	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
treatment	treatment	NN	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
src	BEGIN-src-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
transformed	transform	VBN	I-NP	O
cells	cell	NNS	I-NP	O
GAP	BEGIN-GAP-INSIDE	NN	I-NP	B
forms	form	VBZ	B-VP	O
heteromeric	heteromeric	JJ	B-NP	O
complexes	complex	NNS	I-NP	O
,	,	,	O	O
notably	notably	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylated	phosphorylated	JJ	I-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	I-NP	I
kDa	kDa	NN	I-NP	I
protein	protein	NN	I-NP	I
(	(	(	O	I
p1	p1	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I

Genomic	Genomic	JJ	B-NP	O
Southern	Southern	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
reveals	reveal	NNS	I-NP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
hybridising	hybridising	NN	I-NP	O
fragments	fragment	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
maize	maize	NN	B-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
gene	gene	NN	I-NP	O
family	family	NN	I-NP	O

The	The	DT	B-NP	O
signal	signal	NN	I-NP	O
-	-	HYPH	B-ADVP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
noise	noise	NN	I-NP	O
ratio	ratio	NN	I-NP	O
(	(	(	O	O
SNR	SNR	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T1	T1	NN	I-NP	O
-	-	HYPH	O	O
weighted	weight	VBN	B-VP	O
sequence	sequence	NN	B-NP	O

The	The	DT	B-NP	O
MIC1	MIC1	NN	I-NP	O
of	of	IN	B-PP	O
ABK	ABK	NN	B-NP	O
against	against	IN	B-PP	O
coagulase	BEGIN-coagulase	NN	B-NP	B
type	type	NN	I-NP	I
IV	IV-INSIDE	NN	I-NP	I
strains	strain	NNS	I-NP	O
was	be	VBD	B-VP	O
rather	rather	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
,	,	,	O	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	O	O
ml	ml	NN	B-NP	O

A	A	DT	B-NP	O
review	review	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
younger	young	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
treated	treat	VBN	B-VP	O
at	at	IN	B-PP	O
our	our	PRP$	B-NP	O
Department	Department	NN	I-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
with	with	IN	B-PP	O
transitional	transitional	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bladder	bladder	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
1	1	CD	B-NP	O
had	have	VBD	B-VP	O
superficial	superficial	JJ	B-ADJP	O
(	(	(	O	O
Ta	Ta	NN	B-NP	O
/	/	SYM	B-NP	O
T1	T1	NN	I-NP	O
)	)	)	O	O
disease	disease	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
1	1	CD	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
invasive	invasive	JJ	B-NP	O
disease	disease	NN	I-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Asp	Asp	NN	I-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
Ala	Ala	NNP	I-NP	O
gB	BEGIN-gB-INSIDE	NN	I-NP	B
mutation	mutation	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
steady	steady	JJ	I-NP	O
-	-	HYPH	I-NP	O
state	state	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
gB	BEGIN-gB-INSIDE	NN	B-NP	B
at	at	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
(	(	(	O	O
PM	PM	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
U1	U1	NN	B-NP	O
cells	cell	NNS	I-NP	O

Large	Large	JJ	B-NP	O
volumes	volume	NNS	I-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
certain	certain	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
autologous	autologous	JJ	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
transplants	transplant	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
dauricine	dauricine	NN	B-NP	O
and	and	CC	I-NP	O
verapamil	verapamil	NN	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
salutary	salutary	JJ	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
extracorporeal	extracorporeal	JJ	B-NP	O
circulation	circulation	NN	I-NP	O

Central	Central	JJ	B-NP	O
-	-	HYPH	I-NP	O
venous	venous	JJ	I-NP	O
-	-	HYPH	I-NP	O
catheter	catheter	NN	I-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
infection	infection	NN	I-NP	O
is	be	VBZ	B-VP	O
readily	readily	RB	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
by	by	IN	B-PP	O
comparing	compare	VBG	B-VP	O
simultaneous	simultaneous	JJ	B-NP	O
quantitative	quantitative	JJ	I-NP	O
cultures	culture	NNS	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
samples	sample	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
catheter	catheter	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vein	vein	NN	I-NP	O

For	For	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
model	model	NN	I-NP	O
,	,	,	O	O
simulations	simulation	NNS	B-NP	O
of	of	IN	B-PP	O
physiological	physiological	JJ	B-NP	O
excitation	excitation	NN	I-NP	O
and	and	CC	B-PP	O
of	of	IN	B-PP	O
pathologies	pathology	NNS	B-NP	O
(	(	(	O	O
Wolff	Wolff	NNP	B-NP	O
-	-	HYPH	I-NP	O
Parkinson	Parkinson	NNP	I-NP	O
-	-	HYPH	I-NP	O
White	White	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
complete	complete	JJ	B-NP	O
AV	AV	NN	I-NP	O
-	-	HYPH	B-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
wall	wall	NN	I-NP	O
ischaemia	ischaemia	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O

For	For	IN	B-PP	O
rotating	rotate	VBG	B-VP	O
stimuli	stimulus	NNS	B-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
eye	eye	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
neurons	neuron	NNS	B-NP	O
responded	respond	VBD	B-VP	O
best	well	RBS	B-ADVP	O
to	to	TO	B-PP	O
rotation	rotation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
visual	visual	JJ	I-NP	O
world	world	NN	I-NP	O
about	about	IN	B-PP	O
an	an	DT	B-NP	O
axis	axis	NN	I-NP	O
oriented	orient	VBN	B-VP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
horizontal	horizontal	JJ	I-NP	O
plane	plane	NN	I-NP	O
and	and	CC	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
degrees	degree	NNS	I-NP	O
azimuth	azimuth	JJ	B-ADJP	O

Protein	BEGIN-Protein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
transiently	transiently	RB	B-ADVP	O
activated	activate	VBD	B-VP	O
heteromeric	BEGIN-heteromeric	JJ	B-NP	B
N	N	NN	I-NP	I
-	-	HYPH	B-NP	I
methyl	methyl	NN	I-NP	I
-	-	HYPH	B-NP	I
D	D	NN	I-NP	I
-	-	HYPH	B-NP	I
aspartate	aspartate	NN	I-NP	I
receptor	receptor	NN	I-NP	I
channels	channels-INSIDE	NN	I-NP	I
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phosphorylatable	phosphorylatable	JJ	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
splice	splice	NN	I-NP	O
domain	domain	NN	I-NP	O
and	and	CC	B-PP	O
of	of	IN	B-PP	O
consensus	consensus	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
sites	site	NNS	I-NP	O

The	The	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variability	variability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
free	free	JJ	I-NP	O
PSA	BEGIN-PSA-INSIDE	NN	I-NP	B
/	/	SYM	B-VP	O
total	total	JJ	B-NP	O
PSA	BEGIN-PSA-INSIDE	NN	I-NP	B
ratio	ratio	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
prostate	prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
ectopic	ectopic	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E1A	BEGIN-BEGIN-E1-INSIDEA	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
E1	BEGIN-E1-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
this	this	DT	B-NP	O
macrophage	macrophage	NN	I-NP	O
line	line	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
B	B	NN	I-NP	O
lineage	lineage	NN	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
EBF	BEGIN-EBF-INSIDE	NN	B-NP	B
,	,	,	O	O
IL1Ralpha	BEGIN-IL1Ralpha-INSIDE	NN	B-NP	B
,	,	,	O	O
lambda1	BEGIN-lambda1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
Rag	BEGIN-Rag	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
kappa	BEGIN-kappa	NN	B-NP	B
light	light	JJ	I-NP	I
chain	chain-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
mitogen	mitogen	NN	B-NP	O

A	A	DT	B-NP	O
TAAATA	TAAATA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-NP	O
1	1	CD	I-NP	O
nt	nt	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
CAP	CAP	NN	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
flanking	flank	VBG	I-NP	O
region	region	NN	I-NP	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
several	several	JJ	B-NP	O
putative	putative	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
binding	binding	NN	I-NP	O
sites	site	NNS	I-NP	O

OBJECTIVES	OBJECTIVES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
stimulating	stimulate	VBG	B-VP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
noradrenergic	noradrenergic	JJ	I-NP	O
system	system	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
noradrenaline	noradrenaline	NN	I-NP	O
re	re	AFX	O	O
-	-	HYPH	B-NP	O
uptake	uptake	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
reboxetine	reboxetine	NN	I-NP	O
would	would	MD	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
enhancement	enhancement	NN	I-NP	O
of	of	IN	B-PP	O
memory	memory	NN	B-NP	O
for	for	IN	B-PP	O
emotional	emotional	JJ	B-NP	O
material	material	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O

Iris	Iris	NN	B-NP	O
binding	binding	NN	I-NP	O
and	and	CC	O	O
bioavailability	bioavailability	NN	B-NP	O

The	The	DT	B-NP	O
dopamine	BEGIN-dopamine	NN	I-NP	B
D1	D1	NN	I-NP	I
dopamine	dopamine	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
antagonist	antagonist	NN	I-NP	O
SCH	SCH	NN	I-NP	O
1	1	CD	I-NP	O
dose	dose	NN	I-NP	O
dependently	dependently	RB	B-ADVP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
s.c.	s.c.	NN	I-NP	O
)	)	)	O	O
antagonized	antagonize	VBD	B-VP	O
the	the	DT	B-NP	O
stimulant	stimulant	JJ	I-NP	O
locomotor	locomotor	NN	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
both	both	DT	B-NP	O
drugs	drug	NNS	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
prevent	prevent	VB	I-VP	O
their	their	PRP$	B-NP	O
antiimmobility	antiimmobility	NN	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
behavioral	behavioral	JJ	I-NP	O
despair	despair	NN	I-NP	O
test	test	NN	I-NP	O

Neither	Neither	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
virions	virion	NNS	B-NP	O
,	,	,	O	O
nor	nor	CC	O	O
viral	viral	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
was	be	VBD	B-VP	O
detectable	detectable	JJ	B-ADJP	O
in	in	IN	B-PP	O
plants	plant	NNS	B-NP	O
inoculated	inoculate	VBN	B-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
mutant	mutant	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
mutant	mutant	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
frameshift	frameshift	NN	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
coat	BEGIN-coat	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

Chromaffin	Chromaffin	NN	B-NP	O
cells	cell	NNS	I-NP	O
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
coding	cod	VBG	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Rabphilin1a	Rabphilin1a-INSIDE	NN	I-NP	I
inserted	insert	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
antisense	antisense	JJ	I-NP	O
orientation	orientation	NN	I-NP	O
inhibited	inhibit	VBD	B-VP	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
co	co	AFX	B-NP	O
-	-	HYPH	I-NP	O
expressed	express	VBN	I-NP	O
GH	BEGIN-GH-INSIDE	NN	I-NP	B
by	by	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O

A	A	DT	B-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	B-NP	O
ready	ready	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
Mb	Mb	NN	I-NP	O
PAC	PAC	NN	I-NP	O
contig	contig	NN	I-NP	O
covering	cover	VBG	B-VP	O
1	1	CD	B-NP	O
breakpoints	breakpoint	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Wilms	BEGIN-Wilm	NNS	I-NP	B
tumor	tumor	NN	I-NP	I
/	/	SYM	B-NP	I
anirida	anirida	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1p1	1p1	NN	I-NP	O

Compression	Compression	NN	B-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
outflow	outflow	NN	I-NP	O
tract	tract	NN	I-NP	O
by	by	IN	B-PP	O
aneurysm	aneurysm	NN	B-NP	O
of	of	IN	B-PP	O
ascending	ascend	VBG	B-VP	O
aorta	aorta	NN	B-NP	O

The	The	DT	B-NP	O
sulfur	sulfur	NN	I-NP	O
species	specie	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
separated	separate	VBN	I-VP	O
within	within	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
min	min	NN	I-NP	O
by	by	IN	B-PP	O
CZE	CZE	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pyromellitic	pyromellitic	JJ	I-NP	O
acid	acid	NN	I-NP	O
electrolyte	electrolyte	NN	I-NP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O

High	High	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
p1A	BEGIN-p1A-INSIDE	NN	B-NP	B
(	(	(	O	O
TAp1gamma	BEGIN-TAp1gamma-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
skeletal	skeletal	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
tissue	tissue	NN	I-NP	O
drove	drive	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
a	a	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
myoblastic	myoblastic	JJ	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
increased	increase	VBN	B-NP	O
p1A	BEGIN-p1A-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
after	after	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
induction	induction	NN	I-NP	O

Nosographic	Nosographic	JJ	B-NP	O
problems	problem	NNS	I-NP	O

Since	Since	IN	B-SBAR	O
UmuD	BEGIN-BEGIN-UmuD-INSIDE	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
proteolytically	proteolytically	RB	I-VP	O
processed	process	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
form	form	NN	I-NP	O
(	(	(	O	O
UmuD*	BEGIN-BEGIN-UmuD-INSIDE*-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
RecA*	BEGIN-RecA-INSIDE*	NN	I-NP	I
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
MucA	BEGIN-MucA-INSIDE	NN	B-NP	B
shares	share	NNS	I-NP	O
extensive	extensive	JJ	B-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
UmuD	BEGIN-UmuD-INSIDE	NN	B-NP	B
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
MucA	BEGIN-MucA-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
similarly	similarly	RB	I-VP	O
processed	process	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
antiserum	antiserum	NN	B-NP	O
against	against	IN	B-PP	O
a	a	DT	B-NP	O
LacZ'	BEGIN-LacZ'-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
'MucA	'BEGIN-MucA-INSIDE	NN	I-NP	I
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O

Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
BHR	BHR	NN	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
correlate	correlate	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
with	with	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
mean	mean	JJ	I-NP	O
SO1	SO1	NN	I-NP	O
,	,	,	I-NP	O
NO1	NO1	NN	I-NP	O
and	and	CC	I-NP	O
smoke	smoke	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
mean	mean	JJ	I-NP	O
NO1	NO1	NN	I-NP	O
and	and	CC	I-NP	O
smoke	smoke	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
lag	lag	NN	I-NP	O
NO1	NO1	NN	I-NP	O
;	;	:	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-ADJP	O
small	small	JJ	I-ADJP	O
,	,	,	O	O
accounting	account	VBG	B-VP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variability	variability	NN	I-NP	O
in	in	IN	B-PP	O
within	within	IN	B-PP	O
-	-	HYPH	B-NP	O
subject	subject	NN	I-NP	O
BHR	BHR	NN	I-NP	O
between	between	IN	B-PP	O
visits	visit	NNS	B-NP	O

1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
)	)	)	O	O
intron	intron	NN	B-NP	O
to	to	TO	B-PP	O
AA	AA	NN	B-NP	O

Foamy	Foamy	JJ	B-NP	O
viruses	virus	NNS	I-NP	O
(	(	(	O	O
FVs	FV	NNS	B-NP	O
)	)	)	O	O
express	express	VBP	B-VP	O
the	the	DT	B-NP	O
Gag	BEGIN-Gag	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
a	a	DT	B-NP	O
precursor	precursor	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mass	mass	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kDa	kDa	NN	I-NP	O
(	(	(	O	O
pr1	BEGIN-pr1-INSIDE	NN	B-NP	B
)	)	)	O	O
from	from	IN	B-PP	O
which	which	WDT	B-NP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
protein	protein	NN	I-NP	O
(	(	(	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
cleaved	cleave	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
protease	protease	NN	I-NP	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
domains	domain	NNS	B-NP	O
mediating	mediate	VBG	B-VP	O
transcription	transcription	NN	B-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
repression	repression	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
inhibition	inhibition	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
paired	BEGIN-paired	JJ	I-NP	B
-	-	HYPH	I-NP	I
related	related	JJ	I-NP	I
homeobox	homeobox	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
Prx1	BEGIN-Prx1-INSIDE	NN	B-NP	B
(	(	(	O	O
S1	BEGIN-S1-INSIDE	NN	B-NP	B
)	)	)	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
structural	structural	JJ	I-NP	O
similarities	similarity	NNS	I-NP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
gene	gene	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
termed	term	VBN	I-VP	O
scERV1	BEGIN-scERV1-INSIDE	NN	B-NP	B
from	from	IN	B-PP	O
now	now	RB	B-NP	O
on	on	IN	B-PP	O

Where	Where	WRB	B-ADVP	O
the	the	DT	B-NP	O
resonator	resonator	NN	I-NP	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
holes	hole	NNS	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
terms	term	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
somewhat	somewhat	RB	I-VP	O
modified	modify	VBN	I-VP	O
:	:	:	O	O
A	A	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
combined	combined	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
holes	hole	NNS	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1pi	1pi	NN	I-NP	O
r	r	NN	I-NP	O
(	(	(	O	O
~1r	~1r	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
hole	hole	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
thin	thin	JJ	I-NP	O
-	-	HYPH	I-NP	O
walled	wall	VBN	I-NP	O
vessel	vessel	NN	I-NP	O
and	and	CC	I-NP	O
r	r	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
radius	radius	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
hole	hole	NN	I-NP	O
(	(	(	O	O
Seto	Seto	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
distal	distal	JJ	I-NP	O
active	active	JJ	I-NP	O
site	site	NN	I-NP	O
in	in	IN	B-PP	O
TIGA	BEGIN-TIGA-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
created	create	VBN	I-VP	O
by	by	IN	B-PP	O
excision	excision	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
intron	intron	NN	I-NP	O

GeneCalling	GeneCalle	VBG	B-VP	O
analysis	analysis	NN	B-NP	O
was	be	VBD	B-VP	O
successful	successful	JJ	B-ADJP	O
in	in	IN	B-PP	O
detecting	detect	VBG	B-VP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
complex	complex	JJ	B-NP	O
metabolic	metabolic	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
and	and	CC	O	O
uncovering	uncover	VBG	B-VP	O
novel	novel	JJ	B-NP	O
genes	gene	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
either	either	DT	O	O
coincidentally	coincidentally	RB	B-ADVP	O
regulated	regulate	VBN	B-VP	O
or	or	CC	O	O
directly	directly	RB	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
such	such	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O

Cerebellar	Cerebellar	JJ	B-NP	O
functional	functional	JJ	I-NP	O
compensation	compensation	NN	I-NP	O
after	after	IN	B-PP	O
its	its	PRP$	B-NP	O
complete	complete	JJ	I-NP	O
destruction	destruction	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
neoplasm	neoplasm	NN	I-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
narQ	BEGIN-narQ	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
nitrate	nitrate	NN	I-NP	O
-	-	HYPH	B-NP	O
responsive	responsive	JJ	I-NP	O
sensor	sensor	NN	I-NP	O
-	-	HYPH	I-NP	O
transmitter	transmitter	NN	I-NP	O
protein	protein	NN	I-NP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
(	(	(	O	O
ORF	ORF	NN	B-NP	O
)	)	)	O	O
whose	whose	WP$	B-NP	O
product	product	NN	I-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
similarity	similarity	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
iron	BEGIN-iron	NN	B-NP	B
-	-	HYPH	I-NP	I
sulfur	sulfur	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
beta	beta	NN	I-NP	O
subunit	subunit	NN	I-NP	O
of	of	IN	B-PP	O
glutamate	BEGIN-glutamate	NN	B-NP	B
synthase	synthase-INSIDE	NN	I-NP	I
(	(	(	O	O
gltD	BEGIN-gltD-INSIDE	NN	B-NP	B
)	)	)	O	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
antibody	antibody	NN	I-NP	O
class	class	NN	I-NP	O
switch	switch	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
directed	direct	VBN	I-VP	O
by	by	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
accessibility	accessibility	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
assayed	assay	VBN	B-VP	O
by	by	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
germ	germ	NN	B-NP	O
line	line	NN	I-NP	O
CH	BEGIN-CH-INSIDE	NN	I-NP	B
genes	gene	NNS	I-NP	O

With	With	IN	B-PP	O
repetitive	repetitive	JJ	B-NP	O
intermittent	intermittent	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
,	,	,	O	O
gradual	gradual	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
lactate	lactate	NN	I-NP	O
concentration	concentration	NN	I-NP	O
[	[	(	O	O
(	(	(	O	O
LA	LA	NN	B-NP	O
]	]	)	I-NP	O
b	b	NN	I-NP	O
)	)	)	O	O
occurred	occur	VBD	B-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
its	its	PRP$	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
accumulation	accumulation	NN	B-NP	O
(	(	(	O	O
delta	delta	SYM	B-NP	O
[	[	(	O	O
LA	LA	NN	B-NP	O
]	]	)	I-NP	O
b	b	NN	I-NP	O
)	)	)	O	O
decreased	decrease	VBD	B-VP	O

Wingless	BEGIN-Wingless-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
Wnt	BEGIN-Wnt-INSIDE	NN	I-NP	B
signaling	signaling	NN	I-NP	O
directs	direct	VBZ	B-VP	O
cell	cell	NN	B-NP	O
-	-	HYPH	I-NP	O
fate	fate	NN	I-NP	O
choices	choice	NNS	I-NP	O
during	during	IN	B-PP	O
embryonic	embryonic	JJ	B-NP	O
development	development	NN	I-NP	O

In	In	IN	B-PP	O
CYP1A1	BEGIN-CYP1A1-INSIDE	NN	B-NP	B
transgenic	transgenic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
livers	liver	NNS	B-NP	O
contained	contain	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	I-NP	O
more	more	JJR	I-NP	O
sterol	BEGIN-sterol	NN	I-NP	B
response	response	NN	I-NP	I
element	element	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-NP	I
protein	protein	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
photosensitivity	photosensitivity	NN	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
with	with	IN	B-PP	O
actinic	actinic	JJ	B-NP	O
reticuloid	reticuloid	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
have	have	VBP	B-VP	O
high	high	JJ	B-NP	O
total	total	JJ	I-NP	O
serum	serum	NN	I-NP	O
IgE	BEGIN-IgE-INSIDE	NN	I-NP	B
concentrations	concentration	NNS	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
cognate	cognate	JJ	I-NP	O
binding	binding	NN	I-NP	O
protein	protein	NN	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	CC	O	O
rat	rat	NN	B-NP	O
and	and	CC	O	O
human	human	JJ	O	O
(	(	(	O	O
HeLa	HeLa	NN	B-NP	O
)	)	)	O	O
cell	cell	NN	B-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
entopeduncular	entopeduncular	JJ	I-NP	O
nucleus	nucleus	NN	I-NP	O
(	(	(	O	O
EP	EP	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
jaw	jaw	NN	I-NP	O
-	-	HYPH	O	O
opening	open	VBG	B-VP	O
reflex	reflex	NN	B-NP	O
(	(	(	O	O
JOR	JOR	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cat	cat	NN	I-NP	O
anesthetized	anesthetize	VBN	B-VP	O
with	with	IN	B-PP	O
sodium	sodium	NN	B-NP	O
pentobarbital	pentobarbital	NN	I-NP	O

We	We	PRP	B-NP	O
cloned	clone	VBD	B-VP	O
the	the	DT	B-NP	O
BamHI	BEGIN-BamHI	NN	I-NP	B
-	-	HYPH	B-NP	I
F	F	NN	I-NP	I
fragment	fragment-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
Ad1	Ad1	NN	B-NP	O
in	in	IN	B-PP	O
pUC1	pUC1	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
SalI	BEGIN-SalI-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
BamHI	BEGIN-BamHI	NN	I-NP	B
sites	sites-INSIDE	NN	I-NP	I
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
carry	carry	VB	I-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
structural	structural	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E1A	BEGIN-E1A	NN	I-NP	B
region	region	NN	I-NP	I
of	of	IN	B-PP	I
Ad1	Ad1-INSIDE	NN	B-NP	I

Results	Result	NNS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
when	when	WRB	B-ADVP	O
amniotic	amniotic	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
samples	sample	NNS	I-NP	O
are	be	VBP	B-VP	O
stored	store	VBN	I-VP	O
frozen	frozen	JJ	B-NP	O
and	and	CC	I-NP	O
strict	strict	JJ	I-NP	O
quality	quality	NN	I-NP	O
control	control	NN	I-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
in	in	IN	B-PP	O
analytic	analytic	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
minimal	minimal	JJ	I-NP	O
changes	change	NNS	I-NP	O
occur	occur	VBP	B-VP	O
in	in	IN	B-PP	O
phospholipid	phospholipid	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
over	over	IN	B-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
research	research	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
if	if	IN	B-SBAR	O
ergotamine	ergotamine	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
ergopeptine	ergopeptine	NN	I-NP	O
alkaloid	alkaloid	NN	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
Neotyphodium	Neotyphodium	NN	B-NP	O
-	-	HYPH	B-NP	O
infected	infect	VBN	I-NP	O
grasses	esparto	NNS	I-NP	O
and	and	CC	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
toxicoses	toxicos	NNS	B-NP	O
in	in	IN	B-PP	O
livestock	livestock	NN	B-NP	O
,	,	,	O	O
altered	alter	VBN	B-NP	O
plasma	plasma	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
reproductive	reproductive	JJ	B-NP	O
hormones	hormone	NNS	I-NP	O
in	in	IN	B-PP	O
follicular	follicular	JJ	B-NP	O
phase	phase	NN	I-NP	O
heifers	heifer	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
cows	cow	NNS	B-NP	O
given	give	VBN	B-VP	O
a	a	DT	B-NP	O
progestin	progestin	NN	I-NP	O
implant	implant	NN	I-NP	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
:	:	:	O	O
onset	onset	NN	B-NP	O
time	time	NN	I-NP	O
(	(	(	O	O
time	time	NN	B-NP	O
interval	interval	NN	I-NP	O
from	from	IN	B-PP	O
injection	injection	NN	B-NP	O
to	to	TO	B-PP	O
maximal	maximal	JJ	B-NP	O
or	or	CC	I-NP	O
total	total	JJ	I-NP	O
block	block	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
T1	T1	NN	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
time	time	NN	B-NP	O
for	for	IN	B-PP	O
T1	T1	NN	B-NP	O
to	to	TO	B-VP	O
reach	reach	VB	I-VP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
TOF1	TOF1	NN	B-NP	O
(	(	(	O	O
time	time	NN	B-NP	O
for	for	IN	B-PP	O
TOF	TOF	NN	B-NP	O
ratio	ratio	NN	I-NP	O
to	to	TO	B-VP	O
reach	reach	VB	I-VP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O

Ectopic	Ectopic	JJ	B-NP	O
Xbra	BEGIN-Xbra-INSIDE	NN	I-NP	B
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
Xegr	BEGIN-Xegr	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
indirect	indirect	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
that	that	WDT	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
operate	operate	VB	I-VP	O
via	via	IN	B-PP	O
primary	primary	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
fibroblast	BEGIN-fibroblast	NN	B-NP	B
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
secretion	secretion	NN	I-NP	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
men	man	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
women	woman	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
studied	study	VBN	I-VP	O
,	,	,	O	O
of	of	IN	B-PP	O
whom	whom	WP	B-NP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
traced	trace	VBN	I-VP	O
and	and	CC	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
have	have	VBP	B-VP	O
died	die	VBN	I-VP	O

The	The	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
I	BEGIN-I	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
completely	completely	RB	B-ADJP	O
reversible	reversible	JJ	I-ADJP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
detergent	detergent	NN	I-NP	O
deoxycholate	deoxycholate	NN	I-NP	O
(	(	(	O	O
DOC	DOC	NN	B-NP	O
)	)	)	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
signalling	signalling	NN	I-NP	O
is	be	VBZ	B-VP	O
eliminated	eliminate	VBN	I-VP	O
by	by	IN	B-PP	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
Ste1p	BEGIN-Ste1p-INSIDE	NN	B-NP	B
(	(	(	O	O
or	or	CC	O	O
components	component	NNS	B-NP	O
downstream	downstream	RB	B-ADVP	O
of	of	IN	B-PP	O
Ste1p	BEGIN-Ste1p-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
morphological	morphological	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
lacking	lack	VBG	B-VP	O
Akr1p	BEGIN-Akr1p-INSIDE	NN	B-NP	B
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
rescued	rescue	VBN	I-VP	O
by	by	IN	B-PP	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
known	know	VBN	I-NP	O
pheromone	pheromone	NN	I-NP	O
response	response	NN	I-NP	O
pathway	pathway	NN	I-NP	O
components	component	NNS	I-NP	O

1	1	LS	B-LST	O
)	)	)	O	O
Depending	Depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
certain	certain	JJ	B-NP	O
compounds	compound	NNS	I-NP	O
are	be	VBP	B-VP	O
sequestered	sequester	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cornea	cornea	NN	I-NP	O
(	(	(	O	O
presumably	presumably	RB	B-ADVP	O
the	the	DT	B-NP	O
stroma	stroma	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
form	form	VB	B-VP	O
a	a	DT	B-NP	O
release	release	NN	I-NP	O
system	system	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
aqueous	aqueous	JJ	I-NP	O

To	To	TO	B-VP	O
gain	gain	VB	I-VP	O
further	further	JJ	B-NP	O
insights	insight	NNS	I-NP	O
into	into	IN	B-PP	O
these	these	DT	B-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
porcine	BEGIN-porcine	JJ	I-NP	B
G	G	NN	I-NP	I
alpha	alpha	SYM	B-NP	I
i	i	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene	NN	I-NP	I
minimal	minimal	JJ	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
1	1	CD	B-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
upstream	upstream	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O

Two	Two	CD	B-NP	O
authors	author	NNS	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
journal	journal	NN	I-NP	O
titles	title	NNS	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
drug	drug	NN	I-NP	O
names	name	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
topics	topic	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
general	general	JJ	I-NP	O
medical	medical	JJ	I-NP	O
nature	nature	NN	I-NP	O
were	be	VBD	B-VP	O
retrieved	retrieve	VBN	I-VP	O
under	under	IN	B-PP	O
identical	identical	JJ	B-NP	O
circumstances	circumstance	NNS	I-NP	O
and	and	CC	I-NP	O
conditions	condition	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
hosts	host	NNS	I-NP	O
DATA	DATA	NN	I-NP	O
-	-	HYPH	B-NP	O
STAR	STAR	NN	I-NP	O
,	,	,	O	O
DIALOG	DIALOG	NN	B-NP	O
,	,	,	O	O
DIMDI	DIMDI	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
STN	STN	NN	B-NP	O

For	For	IN	B-PP	O
example	example	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
related	related	JJ	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	I-NP	O
b	BEGIN-b-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
b	BEGIN-b-INSIDE	NN	I-NP	B
'	'	''	O	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cyanobacterium	cyanoBEGIN-b-INSIDEacterium	NN	I-NP	I
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
its	its	PRP$	B-NP	O
ATP	BEGIN-ATP	NN	I-NP	B
synthase	synthase-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
complex	complex	NN	I-NP	O
of	of	IN	B-PP	O
nine	nine	CD	B-NP	O
polypeptides	polypeptide	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
single	single	JJ	B-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
related	related	JJ	B-NP	O
b	BEGIN-b-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
b	BEGIN-BEGIN-b-INSIDE	NN	I-NP	B
'	'	''	I-NP	O
proteins	proteins-INSIDE	NN	I-NP	I
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
two	two	CD	B-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
identical	identical	JJ	B-NP	O
b	BEGIN-BEGIN-b-INSIDE	NN	I-NP	B
subunits	suBEGIN-b-INSIDEunits-INSIDE	NN	I-NP	I
as	as	IN	B-SBAR	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
enzyme.1+off	enzyme.1+off	NN	I-NP	O

DDD	DDD	NN	B-NP	O
(	(	(	O	O
R	R	NN	B-NP	O
)	)	)	O	O
pacing	pacing	NN	B-NP	O
with	with	IN	B-PP	O
automatic	automatic	JJ	B-NP	O
mode	mode	NN	I-NP	O
switch	switch	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
following	follow	VBG	B-PP	O
AV	AV	NN	B-NP	O
nodal	nodal	JJ	I-NP	O
ablation	ablation	NN	I-NP	O

These	These	DT	B-NP	O
events	event	NNS	I-NP	O
were	be	VBD	B-VP	O
only	only	RB	I-VP	O
weakly	weakly	RB	I-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
activated	BEGIN-activated	JJ	I-NP	B
PDGF	PDGF	NN	I-NP	I
alpha	alpha	SYM	O	I
-	-	HYPH	O	I
receptor	receptor-INSIDE	NN	B-NP	I

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
establish	establish	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
gp1	gp1	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
and	and	CC	O	O
that	that	IN	B-SBAR	O
interleukin	BEGIN-interleukin	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
type	type	NN	I-NP	I
cytokines	cytokines-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
promoter	promoter	NN	I-NP	O
via	via	IN	B-PP	O
activated	activate	VBN	B-NP	O
STATs	BEGIN-STATs-INSIDE	NN	I-NP	B

Only	Only	RB	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
injuries	injury	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
serious	serious	JJ	B-NP	O
injuries	injury	NNS	I-NP	O
involved	involve	VBD	B-VP	O
children	child	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
1s	1	NNS	I-NP	O
and	and	CC	O	O
early	early	RB	B-NP	O
1s	1	NNS	I-NP	O
,	,	,	O	O
young	young	JJ	B-NP	O
adults	adult	NNS	I-NP	O
appear	appear	VBP	B-VP	O
at	at	IN	B-PP	O
greatest	great	JJS	B-NP	O
risk	risk	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1s	1	NNS	I-NP	O

Three	Three	CD	B-NP	O
simple	simple	JJ	I-NP	O
methods	method	NNS	I-NP	O
of	of	IN	B-PP	O
detecting	detect	VBG	B-VP	O
malnutrition	malnutrition	NN	B-NP	O
on	on	IN	B-PP	O
medical	medical	JJ	B-NP	O
wards	ward	NNS	I-NP	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
internal	internal	JJ	I-NP	O
fragment	fragment	NN	I-NP	O
of	of	IN	B-PP	O
U1	BEGIN-U1	NN	B-NP	B
methylation	methylation	NN	I-NP	I
guide	guide	NN	I-NP	I
snoRNA	snoRNA-INSIDE	NN	I-NP	I
,	,	,	O	O
encompassing	encompass	VBG	B-VP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
antisense	antisense	JJ	I-NP	O
element	element	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
D	D	NN	I-NP	O
'	'	POS	B-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
'	'	''	I-NP	O
box	box	NN	I-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
support	support	VB	I-VP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
methylation	methylation	NN	I-NP	O
of	of	IN	B-PP	O
rRNA	rRNA	NN	B-NP	O

The	The	DT	B-NP	O
gap	BEGIN-gap-INSIDE	NN	I-NP	B
protein	protein	NN	I-NP	O
knirps	BEGIN-knirps-INSIDE	NN	I-NP	B
mediates	mediate	VBZ	B-VP	O
both	both	CC	O	O
quenching	quench	VBG	B-VP	O
and	and	CC	O	O
direct	direct	JJ	B-NP	O
repression	repression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Drosophila	Drosophila	NN	I-NP	O
embryo	embryo	NN	I-NP	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
is	be	VBZ	B-VP	O
its	its	PRP$	B-NP	O
limited	limited	JJ	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
weak	weak	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
common	common	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	O
cerebral	cerebral	JJ	I-NP	O
cortex	cortex	NN	I-NP	O

An	An	DT	B-NP	O
infant	infant	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
with	with	IN	B-PP	O
congenital	congenital	JJ	B-NP	O
glaucoma	glaucoma	NN	I-NP	O
and	and	CC	I-NP	O
hemophilia	hemophilia	NN	I-NP	O
A	A	NN	I-NP	O
lost	lose	VBD	B-VP	O
one	one	CD	B-NP	O
eye	eye	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
haemorrhages	haemorrhage	NNS	B-NP	O
after	after	IN	B-PP	O
trabeculotomy	trabeculotomy	NN	B-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
eye	eye	NN	I-NP	O
hospital	hospital	NN	I-NP	O

Encapsulation	Encapsulation	NN	B-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
fluorescein	fluorescein	NN	I-NP	O
for	for	IN	B-PP	O
dye	dye	NN	B-NP	O
release	release	NN	I-NP	O
studies	study	NNS	I-NP	O

Ethanol	Ethanol	NN	B-NP	O
preference	preference	NN	I-NP	O
in	in	IN	B-PP	O
strains	strain	NNS	B-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
selectively	selectively	RB	B-VP	O
bred	breed	VBN	I-VP	O
for	for	IN	B-PP	O
behavioral	behavioral	JJ	B-NP	O
characteristics	characteristic	NNS	I-NP	O

VAV	BEGIN-VAV-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
SOCS1	BEGIN-SOCS1-INSIDE	NN	I-NP	B
form	form	VBP	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
complex	complex	NN	I-NP	O
through	through	IN	B-PP	O
interactions	interaction	NNS	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
VAV	BEGIN-BEGIN-VAV-INSIDE	NN	I-NP	B
NH	NH	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
region	region-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
SOCS1	BEGIN-SOCS1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
a	a	DT	B-NP	O
phosphotyrosine	phosphotyrosine	NN	I-NP	O
-	-	HYPH	B-NP	O
independent	independent	JJ	I-NP	O
manner	manner	NN	I-NP	O

Incubation	Incubation	NN	B-NP	O
of	of	IN	B-PP	O
HeLa	HeLa	NN	B-NP	O
cell	cell	NN	I-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
purified	purify	VBN	I-NP	O
recombinant	recombinant	JJ	I-NP	O
glutathione	BEGIN-glutathione	NN	I-NP	B
S	S	NN	I-NP	I
-	-	HYPH	B-NP	I
transferase	transferase-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
raf	BEGIN-raf-INSIDE	NN	I-NP	B
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
ATP	ATP	NN	B-NP	O
released	release	VBD	B-VP	O
active	active	JJ	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
gel	gel	NN	I-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O

Cefminox	Cefminox	NN	B-NP	O
shows	show	VBZ	B-VP	O
greater	great	JJR	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
activity	activity	NN	I-NP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
expected	expect	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
MICs	MIC	NNS	I-NP	O
,	,	,	O	O
excellent	excellent	JJ	B-NP	O
efficacy	efficacy	NN	I-NP	O
and	and	CC	I-NP	O
safety	safety	NN	I-NP	O

Both	Both	CC	O	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O
SB1	SB1	NN	I-NP	O
(	(	(	O	O
SB	SB	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
cotransfection	cotransfection	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
-	-	HYPH	I-NP	O
negative	negative	JJ	I-NP	O
mutant	mutant	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
reduced	reduce	VBD	B-VP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1beta	1beta-INSIDE	NN	I-NP	I
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hBNP	BEGIN-hBNP	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I

Recent	Recent	JJ	B-NP	O
geological	geological	JJ	I-NP	O
studies	study	NNS	I-NP	O
focusing	focus	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Davie	Davie	NNP	I-NP	O
Fracture	Fracture	NNP	I-NP	O
Zone	Zone	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Mozambique	Mozambique	NNP	I-NP	O
Channel	Channel	NNP	I-NP	O
offer	offer	VBP	B-VP	O
a	a	DT	B-NP	O
resolution	resolution	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
situation	situation	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
land	land	NN	I-NP	O
-	-	HYPH	B-NP	O
bridge	bridge	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
-	-	HYPH	I-NP	O
Eocene	Eocene	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
Miocene	Miocene	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
interval	interval	NN	I-NP	O
that	that	WDT	B-NP	O
matches	match	VBZ	B-VP	O
the	the	DT	B-NP	O
ages	age	NNS	I-NP	O
of	of	IN	B-PP	O
Madagascar	Madagascar	NNP	B-NP	O
's	's	POS	B-NP	O
mammalian	mammalian	JJ	I-NP	O
groups	group	NNS	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
pyrene	pyrene	NN	B-NP	O
in	in	IN	B-PP	O
diesel	diesel	NN	B-NP	O
-	-	HYPH	B-NP	O
exhaust	exhaust	NN	I-NP	O
particles	particle	NNS	I-NP	O
(	(	(	O	O
DEP	DEP	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
adjuvant	adjuvant	JJ	I-NP	O
activity	activity	NN	I-NP	O
on	on	IN	B-PP	O
immunoglobulin	BEGIN-immunoglobulin	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
(	(	(	O	O
IgE	BEGIN-IgE-INSIDE	NN	B-NP	B
)	)	)	O	O
antibody	antibody	NN	B-NP	O
production	production	NN	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
immunized	immunize	VBN	B-VP	O
with	with	IN	B-PP	O
Japanese	Japanese	JJ	B-NP	O
cedar	cedar	NN	I-NP	O
pollen	pollen	NN	I-NP	O
allergen	allergen	NN	I-NP	O
(	(	(	O	O
JCPA	JCPA	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
ovalbumin	BEGIN-ovalbumin-INSIDE	NN	B-NP	B
(	(	(	O	O
OA	BEGIN-OA-INSIDE	NN	B-NP	B
)	)	)	O	O
intraperitoneally	intraperitoneally	RB	B-ADVP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
report	report	VBP	B-VP	O
different	different	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
pictures	picture	NNS	I-NP	O
all	all	DT	O	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
toxicity	toxicity	NN	I-NP	O
of	of	IN	B-PP	O
1FU	1FU	NN	B-NP	O

The	The	DT	B-NP	O
immunoprofile	immunoprofile	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
adult	adult	JJ	I-NP	O
patients	patient	NNS	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
and	and	CC	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
normal	normal	JJ	I-NP	O
controls	control	NNS	I-NP	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
long	long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
raloxifene	raloxifene	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
selective	selective	JJ	I-NP	O
estrogen	BEGIN-estrogen	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
modulator	modulator	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
thyroid	thyroid	NN	B-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
profiles	profile	NNS	I-NP	O

Module	Module	NNP	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
RifA	BEGIN-RifA-INSIDE	NN	B-NP	B
lacks	lack	VBZ	B-VP	O
a	a	DT	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
ketoacyl	ketoacyl	NN	I-NP	I
:	:	:	O	I
acyl	acyl	NN	B-NP	I
carrier	carrier	NN	I-NP	I
protein	protein	NN	I-NP	I
reductase	reductase-INSIDE	NN	I-NP	I
(	(	(	O	O
KR	BEGIN-KR-INSIDE	NN	B-NP	B
)	)	)	O	O
domain	domain	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
one	one	NN	I-NP	O
in	in	IN	B-PP	O
module	module	NN	B-NP	O
1	1	CD	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
apparently	apparently	RB	I-NP	O
inactive	inactive	JJ	I-NP	O
NADPH	BEGIN-NADPH	NN	I-NP	B
binding	binding	NN	I-NP	I
motif	motif-INSIDE	NN	I-NP	I
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Er	BEGIN-Er	JJ	I-NP	B
PKS	PKS-INSIDE	NN	I-NP	I
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
eight	eight	CD	I-NP	O
KR	BEGIN-BEGIN-KR-INSIDE	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Rf	BEGIN-Rf	JJ	I-NP	B
PKS	PKS-INSIDE	NN	I-NP	I
should	should	MD	B-VP	O
be	be	VB	I-VP	O
functional	functional	JJ	B-ADJP	O

Synergy	Synergy	NN	B-NP	O
between	between	IN	B-PP	O
interferon	BEGIN-interferon	NN	B-NP	B
-	-	HYPH	I-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
tumor	BEGIN-tumor	NN	I-NP	B
necrosis	necrosis	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	O	I
alpha	alpha-INSIDE	NN	B-NP	I
in	in	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
cooperation	cooperation	NN	B-NP	O
between	between	IN	B-PP	O
signal	BEGIN-signal	JJ	B-NP	B
transducer	transducer	NN	I-NP	I
and	and	CC	I-NP	I
activator	activator	NN	I-NP	I
of	of	IN	B-PP	I
transcription	transcription	NN	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
nuclear	BEGIN-nuclear	JJ	B-NP	B
factor	factor	NN	I-NP	I
kappaB	kappaB-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
tetrapeptide	tetrapeptide	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
SSPD	SSPD	NN	I-NP	O
and	and	CC	I-NP	O
SATD	SATD	NN	I-NP	O
for	for	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
and	and	CC	I-NP	I
mouse	mouse	NN	I-NP	I
PKC	PKC	NN	I-NP	I
-	-	HYPH	B-NP	I
epsilon	epsilon-INSIDE	NN	I-NP	I
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
are	be	VBP	B-VP	O
unusual	unusual	JJ	B-ADJP	O
for	for	IN	B-PP	O
caspase	BEGIN-caspase	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
pneumoperitoneum	pneumoperitoneum	NN	B-NP	O
on	on	IN	B-PP	O
dissemination	dissemination	NN	B-NP	O
and	and	CC	I-NP	O
scar	scar	NN	I-NP	O
implantation	implantation	NN	I-NP	O
of	of	IN	B-PP	O
intra	intra	AFX	B-NP	O
-	-	HYPH	I-NP	O
abdominal	abdominal	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
cells	cell	NNS	I-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
SDB	SDB	NN	B-NP	O
,	,	,	O	O
even	even	RB	B-VP	O
snoring	snore	VBG	I-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
independently	independently	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
men	man	NNS	I-NP	O
and	and	CC	I-NP	O
women	woman	NNS	I-NP	O

A	A	DT	B-NP	O
poly	poly	NN	I-NP	O
(	(	(	O	O
ortho	ortho	JJ	B-NP	O
ester	ester	NN	I-NP	O
)	)	)	O	O
designed	design	VBN	B-VP	O
for	for	IN	B-PP	O
combined	combined	JJ	B-NP	O
ocular	ocular	JJ	I-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
sodium	sodium	NN	I-NP	O
phosphate	phosphate	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
fluorouracil	fluorouracil	NN	I-NP	O
:	:	:	O	O
subconjunctival	subconjunctival	JJ	B-NP	O
tolerance	tolerance	NN	I-NP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
release	release	NN	I-NP	O

Subclones	Subclone	NNS	B-NP	O
stably	stably	RB	B-VP	O
expressing	express	VBG	I-VP	O
alpha1A	BEGIN-alpha1A-INSIDE	NN	B-NP	B
-	-	HYPH	B-ADJP	O
,	,	,	O	O
alpha1B	BEGIN-alpha1B-INSIDE	NN	B-NP	B
-	-	HYPH	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
alpha1D	BEGIN-alpha1D-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
ARs	AR	NNS	I-NP	O
under	under	IN	B-PP	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
and	and	CC	I-NP	O
low	low	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
density	density	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
characterized	characterize	VBN	B-VP	O

Transfection	Transfection	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
Calu	Calu	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
JEG	JEG	NN	I-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PKA	BEGIN-PKA-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
vector	vector	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
renin	renin-INSIDE	NN	I-NP	I
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
constructs	construct	NNS	B-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
native	native	JJ	I-NP	O
or	or	CC	O	O
consensus	consensus	NN	B-NP	O
CRE	CRE	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
construct	construct	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
nonfunctional	nonfunctional	JJ	I-NP	O
CRE	CRE	NN	I-NP	O

In	In	IN	B-PP	O
renal	renal	JJ	B-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
,	,	,	O	O
similar	similar	JJ	B-NP	O
pattern	pattern	NN	I-NP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
tubular	tubular	JJ	I-NP	O
necrosis	necrosis	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
but	but	CC	O	O
RI	RI	NN	B-NP	O
venography	venography	NN	I-NP	O
was	be	VBD	B-VP	O
helpful	helpful	JJ	B-ADJP	O

Restricted	Restrict	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
murine	BEGIN-murine	NN	I-NP	B
atonal	atonal	JJ	I-NP	I
-	-	HYPH	I-NP	I
related	related	JJ	I-NP	I
bHLH	bHLH	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
undifferentiated	undifferentiated	JJ	B-NP	O
neural	neural	JJ	I-NP	O
precursors	precursor	NNS	I-NP	O

Oligo	Oligo	AFX	O	O
-	-	HYPH	O	O
[	[	(	O	O
alpha	alpha	SYM	O	O
]	]	)	O	O
-	-	HYPH	B-NP	O
deoxynucleotides	deoxynucleotide	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
derived	derive	VBN	I-VP	O
by	by	IN	B-PP	O
stabilizing	stabilize	VBG	B-VP	O
(	(	(	O	O
intercalating	intercalating	JJ	O	O
)	)	)	O	O
agents	agent	NNS	B-NP	O
or	or	CC	O	O
reactive	reactive	JJ	B-NP	O
groups	group	NNS	I-NP	O
(	(	(	O	O
cleaving	cleave	VBG	B-VP	O
reagents	reagent	NNS	B-NP	O
,	,	,	O	O
cross	cross	AFX	B-NP	O
-	-	HYPH	I-NP	O
linkers	linker	NNS	B-NP	O
...	...	:	O	O
)	)	)	O	O

Electronic	Electronic	JJ	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
Si	Si	NNP	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
NiSi1	NiSi1	NN	I-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
A	A	NN	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
interfaces	interface	NNS	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	B-VP	O
acting	act	VBG	B-NP	O
elements	element	NNS	I-NP	O
direct	direct	VBP	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
zygotic	zygotic	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Kr	BEGIN-Kr-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
a	a	DT	B-NP	O
striped	striped	JJ	I-NP	O
subpattern	subpattern	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blastoderm	blastoderm	NN	I-NP	O
embryo	embryo	NN	I-NP	O

Embryonal	Embryonal	JJ	B-NP	O
mortality	mortality	NN	I-NP	O

Regardless	Regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
muscle	muscle	NN	B-NP	O
tensioning	tensioning	NN	I-NP	O
or	or	CC	I-NP	O
marination	marination	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
,	,	,	O	O
aging	age	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carcass	carcass	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
(	(	(	O	O
T1	T1	NN	B-NP	O
,	,	,	O	O
T1	T1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
T1	T1	NN	B-NP	O
)	)	)	O	O
produced	produce	VBD	B-VP	O
meats	meat	NNS	B-NP	O
with	with	IN	B-PP	O
lower	low	JJR	B-NP	O
shear	shear	NN	I-NP	O
values	value	NNS	I-NP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
from	from	IN	B-PP	O
hot	hot	JJ	B-NP	O
-	-	HYPH	I-NP	O
boned	bone	VBN	I-NP	O
carcasses	carcass	NNS	I-NP	O
(	(	(	O	O
T1	T1	NN	B-NP	O
and	and	CC	O	O
T1	T1	NN	B-NP	O
)	)	)	O	O

This	This	DT	B-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
stronger	strong	JJR	B-ADJP	O
after	after	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
predoses	predos	NNS	I-NP	O
of	of	IN	B-PP	O
sertraline	sertraline	NN	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
imipramine	imipramine	NN	B-NP	O
Cmax	Cmax	NN	I-NP	O
and	and	CC	O	O
AUC	AUC	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
infinity	infinity	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

For	For	IN	B-PP	O
capsules	capsule	NNS	B-NP	O
containing	contain	VBG	B-VP	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
drug	drug	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
T1	T1	NN	B-NP	O
increased	increase	VBD	B-VP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
particle	particle	NN	I-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
decreased	decrease	VBD	B-VP	O

Its	Its	PRP$	B-NP	O
prognostic	prognostic	JJ	I-NP	O
impact	impact	NN	I-NP	O
is	be	VBZ	B-VP	O
superior	superior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
T1	T1	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
one	one	CD	I-NP	O
(	(	(	O	O
RR	RR	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
fusions	fusion	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
GAL1	BEGIN-GAL1-INSIDE	NN	B-NP	B
,	,	,	O	O
full	full	JJ	B-NP	O
activity	activity	NN	I-NP	O
requires	require	VBZ	B-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
BHV	BEGIN-BHV	NN	I-NP	B
-	-	HYPH	O	I
alpha	alpha	SYM	O	I
TIF	TIF-INSIDE	NN	B-NP	I
,	,	,	O	O
although	although	IN	B-SBAR	O
both	both	CC	O	O
amino	amino	NN	B-NP	O
and	and	CC	I-NP	O
carboxyl	carboxyl	NN	I-NP	O
termini	terminus	NNS	I-NP	O
display	display	VBP	B-VP	O
some	some	DT	B-NP	O
activity	activity	NN	I-NP	O
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
own	own	JJ	I-NP	O

As	As	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
variation	variation	NN	B-NP	O
in	in	IN	B-PP	O
capillary	capillary	JJ	B-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
density	density	NN	I-NP	O
was	be	VBD	B-VP	O
apparent	apparent	JJ	B-ADJP	O
between	between	IN	B-PP	O
ventricles	ventricle	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fetal	fetal	JJ	I-NP	O
and	and	CC	I-NP	O
neonatal	neonatal	JJ	I-NP	O
periods	period	NNS	I-NP	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
repeat	repeat	NN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
control	control	NN	I-NP	O
elements	element	NNS	I-NP	O
enhance	enhance	VBP	B-VP	O
the	the	DT	B-NP	O
efficiency	efficiency	NN	I-NP	O
of	of	IN	B-PP	O
SV1	SV1	NN	B-NP	O
DNA	DNA	NN	I-NP	O
replication	replication	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
provided	provide	VBN	B-PP	O
either	either	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
repeats	repeat	NNS	I-NP	O
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
core	core	NN	I-NP	O
replication	replication	NN	I-NP	O
origin	origin	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
A	A	NN	I-NP	O
+	+	SYM	I-NP	O
T	T	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
sequence	sequence	NN	B-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
pathogenetically	pathogenetically	RB	I-VP	O
proved	prove	VBN	I-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
antithrombin	BEGIN-antithrombin	NN	B-NP	B
III	III-INSIDE	JJ	I-NP	I
concentrate	concentrate	NN	I-NP	O
preparations	preparation	NNS	I-NP	O
with	with	IN	B-PP	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
dysaggregatory	dysaggregatory	JJ	I-NP	O
properties	property	NNS	I-NP	O
,	,	,	O	O
fibronectin	BEGIN-fibronectin-INSIDE	NN	B-NP	B
preparations	preparation	NNS	I-NP	O
,	,	,	O	O
trasylol	trasylol	NN	B-NP	O
or	or	CC	O	O
its	its	PRP$	B-NP	O
analogs	analog	NNS	I-NP	O
during	during	IN	B-PP	O
complex	complex	JJ	B-NP	O
preoperative	preoperative	JJ	I-NP	O
preparation	preparation	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O

ER	ER	NN	B-NP	O
and	and	CC	I-NP	O
DR	DR	NN	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
MIB	BEGIN-MIB	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
LI	LI	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	JJR	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
P	P	NN	I-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
RI	RI	NN	B-NP	O
and	and	CC	I-NP	O
Td	Td	NN	I-NP	O
/	/	SYM	B-NP	O
Te	Te	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O

D.	D.	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Long	Long	NNP	B-NP	O
,	,	,	O	O
C	C	NNP	B-NP	O

A	A	DT	B-NP	O
lead	lead	NN	I-NP	O
phthalocyanin	phthalocyanin	NN	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
demonstration	demonstration	NN	I-NP	O
of	of	IN	B-PP	O
acid	BEGIN-acid	JJ	B-NP	B
hydrolases	hydrolases-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
plant	plant	NN	B-NP	O
and	and	CC	I-NP	O
animal	animal	NN	I-NP	O
tissues	tissue	NNS	I-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
sixth	sixth	JJ	I-NP	O
postirradiation	postirradiation	NN	I-NP	O
day	day	NN	I-NP	O
the	the	DT	B-NP	O
absorption	absorption	NN	I-NP	O
of	of	IN	B-PP	O
phenobarbitone	phenobarbitone	NN	B-NP	O
,	,	,	I-NP	O
sulphafurazole	sulphafurazole	NN	I-NP	O
and	and	CC	I-NP	O
mecamylamine	mecamylamine	NN	I-NP	O
had	have	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
absorption	absorption	NN	I-NP	O
of	of	IN	B-PP	O
quinidine	quinidine	NN	B-NP	O
and	and	CC	I-NP	O
isoniazid	isoniazid	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
retarded	retard	VBN	I-VP	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
-	-	HYPH	I-NP	O
dimensional	dimensional	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
from	from	IN	B-PP	O
Escherichia	Escherichia	NNP	B-NP	O
colidetermined	colidetermine	VBN	B-VP	O
and	and	CC	O	O
refined	refine	VBN	B-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
A	A	NN	I-NP	O
resolution	resolution	NN	I-NP	O

cDNA	cDNA	NN	B-NP	O
cloning	cloning	NN	I-NP	O
,	,	,	O	O
sequencing	sequencing	NN	B-NP	O
and	and	CC	O	O
chromosome	chromosome	NN	B-NP	O
mapping	mapping	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
non	BEGIN-non	NN	I-NP	B
-	-	HYPH	B-NP	I
erythroid	erythroid	JJ	I-NP	I
spectrin	spectrin-INSIDE	NN	I-NP	I
,	,	,	O	O
human	BEGIN-human	JJ	B-ADJP	B
alpha	alpha	SYM	O	I
-	-	HYPH	O	I
fodrin	fodrin-INSIDE	NN	B-NP	I

In	In	IN	B-PP	O
serial	serial	JJ	B-NP	O
recall	recall	NN	I-NP	O
from	from	IN	B-PP	O
short	short	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
memory	memory	NN	I-NP	O
,	,	,	O	O
repeated	repeated	JJ	B-NP	O
items	item	NNS	I-NP	O
are	be	VBP	B-VP	O
recalled	recall	VBN	I-VP	O
well	well	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
close	close	RB	O	O
together	together	RB	O	O
(	(	(	O	O
repetition	repetition	NN	B-NP	O
facilitation	facilitation	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
when	when	WRB	B-ADVP	O
far	far	RB	I-ADVP	O
apart	apart	RB	B-ADVP	O
(	(	(	O	O
repetition	repetition	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
Ranschburg	Ranschburg	NN	I-NP	O
effect	effect	NN	I-NP	O
)	)	)	O	O

Posterior	Posterior	JJ	B-NP	O
osteophytes	osteophyte	NNS	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
edges	edge	NNS	I-NP	O
of	of	IN	B-PP	O
vertebral	vertebral	JJ	B-NP	O
body	body	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
intervertebral	intervertebral	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
corresponded	correspond	VBD	B-VP	O
to	to	TO	B-PP	O
hypertrophic	hypertrophic	JJ	B-NP	O
spur	spur	NN	I-NP	O
in	in	IN	B-PP	O
osteochondrosis	osteochondrosis	NN	B-NP	O

LV	LV	NN	B-NP	O
compliance	compliance	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
slope	slope	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LV	LV	NN	I-NP	O
end	end	NN	I-NP	O
-	-	HYPH	B-NP	O
diastolic	diastolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
(	(	(	O	O
LVEDP	LVEDP	NN	B-NP	O
)	)	)	O	O
vs	v	NNS	B-NP	O

Biol	Biol	NNP	B-NP	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
serum	serum	NN	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
or	or	CC	I-NP	O
desethylamiodarone	desethylamiodarone	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
dosage	dosage	NN	B-NP	O
of	of	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O

Nuclear	Nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
Sertoli	Sertoli	NNP	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
cause	cause	VB	I-VP	O
an	an	DT	B-NP	O
E	E	NN	I-NP	O
-	-	HYPH	I-NP	O
box	box	NN	I-NP	O
gel	gel	NN	I-NP	O
shift	shift	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
to	to	TO	I-VP	O
differentiate	differentiate	VB	I-VP	O
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
under	under	IN	B-PP	O
basal	basal	JJ	B-NP	O
conditions	condition	NNS	I-NP	O

The	The	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
ICP1	BEGIN-ICP1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
US1	BEGIN-US1-INSIDE	NN	I-NP	B
rendered	rendered	JJ	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
surface	BEGIN-surface	NN	B-NP	B
class	BEGIN-class	NN	I-NP	B
I	I	CD	I-NP	I
MHC	MHC-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	O	O
allowed	allow	VBD	B-VP	O
a	a	DT	B-NP	O
class	BEGIN-class	JJ	I-NP	B
I	I	CD	I-NP	I
MHC	MHC-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
low	low	JJ	I-NP	O
population	population	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
cells	cell	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
sorted	sort	VBN	I-VP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O

The	The	DT	B-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
adults	adult	NNS	B-NP	O
schistosomes	schistosome	NNS	I-NP	O
by	by	IN	B-PP	O
extracorporeal	extracorporeal	JJ	B-NP	O
filtration	filtration	NN	I-NP	O

Biochemical	Biochemical	JJ	B-NP	O
studies	study	NNS	I-NP	O
and	and	CC	I-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
expressing	express	VBG	B-VP	O
mutant	mutant	JJ	B-NP	O
IL	BEGIN-BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
tyrosine	BEGIN-tyrosine	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
initiates	initiate	VBZ	B-VP	O
a	a	DT	B-NP	O
complex	complex	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
cascade	cascade	NN	I-NP	O

Serum	Serum	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
angiotensin	BEGIN-angiotensin	NN	B-NP	B
converting	convert	VBG	B-VP	I
enzyme	enzyme-INSIDE	NN	B-NP	I
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
maintained	maintain	VBN	I-VP	O

We	We	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
antifungal	antifungal	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
on	on	IN	B-PP	O
adherence	adherence	NN	B-NP	O
of	of	IN	B-PP	O
Candida	Candida	FW	B-NP	O
albicans	albicans	FW	I-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O

The	The	DT	B-NP	O
sections	section	NNS	I-NP	O
were	be	VBD	B-VP	O
stained	stain	VBN	I-VP	O
with	with	IN	B-PP	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
polymorphonuclear	polymorphonuclear	JJ	I-NP	O
leukocyte	leukocyte	NN	I-NP	O
antibody	antibody	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
endothelial	endothelial	JJ	I-NP	O
marker	marker	NN	I-NP	O
factor	BEGIN-factor	NN	I-NP	B
VIII	VIII	CD	I-NP	I
-	-	HYPH	B-NP	I
related	relate	VBN	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
,	,	,	B-PP	O
and	and	CC	I-PP	O
with	with	IN	B-PP	O
hematoxylin	hematoxylin	NN	B-NP	O
and	and	CC	I-NP	O
eosin	eosin	NN	I-NP	O

Portions	Portion	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
coding	cod	VBG	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
untranslated	untranslated	JJ	I-NP	O
regions	region	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
missing	miss	VBG	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	B-NP	I
and	and	CC	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kb	kb	NN	I-NP	I
topo	topo	NN	I-NP	I
II	II	CD	I-NP	I
alpha	alpha	NN	I-NP	I
mRNAs	mRNAs-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O

The	The	DT	B-NP	O
combined	combine	VBN	I-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
wih	wih	NN	I-NP	O
methaqualone	methaqualone	NN	I-NP	O
,	,	,	O	O
phenobarbital	phenobarbital	NN	B-NP	O
,	,	,	O	O
pyrazole	pyrazole	NN	B-NP	O
or	or	CC	I-NP	O
disulfiram	disulfiram	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
using	use	VBG	B-VP	O
rat	BEGIN-rat	NN	B-NP	B
brain	brain	NN	I-NP	I
microsomal	microsomal	JJ	I-NP	I
NA	NA	NN	I-NP	I
-	-	HYPH	B-NP	I
K	K	NN	I-NP	I
-	-	HYPH	O	I
ATPase	ATPase-INSIDE	NN	B-NP	I

An	An	DT	B-NP	O
analogue	analogue	NN	I-NP	O
of	of	IN	B-PP	O
calcium	calcium	NN	B-NP	O
,	,	,	O	O
strontium	strontium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
Sr	Sr	NN	I-NP	O
1	1	CD	I-NP	O
is	be	VBZ	B-VP	O
rapidly	rapidly	RB	I-VP	O
cleared	clear	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
after	after	IN	B-PP	O
i.v.	i.v.	JJ	B-NP	O
injection	injection	NN	I-NP	O

These	These	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
,	,	,	O	O
assayed	assay	VBN	B-VP	O
by	by	IN	B-PP	O
injection	injection	NN	B-NP	O
into	into	IN	B-PP	O
Xenopus	Xenopus	NN	B-NP	O
oocyte	oocyte	NN	I-NP	O
nuclei	nucleus	NNS	I-NP	O
,	,	,	O	O
delimit	delimit	VBP	B-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
upstream	upstream	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cap	cap	NN	I-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
untranslated	untranslated	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O
leader	leader	NN	I-NP	O

The	The	DT	B-NP	O
ARE	ARE	NN	I-NP	O
is	be	VBZ	B-VP	O
loosely	loosely	RB	I-VP	O
defined	define	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
five	five	CD	I-NP	O
-	-	HYPH	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequence	sequence	NN	I-NP	O
AUUUA	AUUUA	NN	I-NP	O
embedded	embed	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
uracil	uracil	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
region	region	NN	I-NP	O

The	The	DT	B-NP	O
essential	essential	JJ	I-NP	O
oil	oil	NN	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
Zingiberaceae	Zingiberaceae	NNP	I-NP	O
widely	widely	RB	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
medicinal	medicinal	JJ	B-NP	O
aromatic	aromatic	JJ	I-NP	O
plants	plant	NNS	I-NP	O
from	from	IN	B-PP	O
S	S	NN	B-NP	O

(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
With	With	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anteroposterior	anteroposterior	JJ	I-NP	O
direction	direction	NN	I-NP	O
of	of	IN	B-PP	O
layers	layer	NNS	B-NP	O
II	II	CD	B-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
III	III	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
mediolateral	mediolateral	JJ	I-NP	O
direction	direction	NN	I-NP	O
of	of	IN	B-PP	O
layer	layer	NN	B-NP	O
IV	IV	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
vertical	vertical	JJ	I-NP	O
conductivity	conductivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cortex	cortex	NN	I-NP	O
was	be	VBD	B-VP	O
always	always	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
either	either	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
horizontal	horizontal	JJ	I-NP	O
conductivities	conductivity	NNS	I-NP	O

Acad	Acad	NNP	B-NP	O

To	To	TO	B-VP	O
obtain	obtain	VB	I-VP	O
information	information	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Rac1	BEGIN-Rac1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
MAPKAPK	BEGIN-MAPKAPK	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
RA	RA	NN	B-NP	O
signaling	signaling	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
pharmacological	pharmacological	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
gene	gene	NN	I-NP	O
transcription	transcription	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O

A	A	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
empty	BEGIN-empty	JJ	I-NP	B
spiracles	spiracles-INSIDE	NN	I-NP	I
homeobox	homeobox	NN	I-NP	O
gene	gene	NN	I-NP	O
is	be	VBZ	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
conserved	conserve	VBN	I-NP	O
regions	region	NNS	I-NP	O
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
regulatory	regulatory	JJ	B-NP	O
proteins	protein	NNS	I-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
MC	MC	NN	I-NP	O
/	/	SYM	B-VP	O
UA	UA	NN	B-NP	O
ratio	ratio	NN	I-NP	O
improves	improve	VBZ	B-VP	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
prediction	prediction	NN	I-NP	O
of	of	IN	B-PP	O
poor	poor	JJ	B-NP	O
perinatal	perinatal	JJ	I-NP	O
outcome	outcome	NN	I-NP	O
when	when	WRB	B-ADVP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
combined	combine	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
NST	NST	NN	I-NP	O

Together	Together	RB	B-ADVP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
work	work	NN	I-NP	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	B-NP	I
EBP	EBP-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
general	general	JJ	I-NP	O
cooperation	cooperation	NN	I-NP	O
partner	partner	NN	I-NP	O
for	for	IN	B-PP	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	B-NP	I
Myb	Myb-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
myelomonocytic	myelomonocytic	JJ	B-NP	O
cells	cell	NNS	I-NP	O

Evolution	Evolution	NN	B-NP	O
of	of	IN	B-PP	O
cytomegalovirus	cytomegalovirus	NN	B-NP	O
antibodies	antibody	NNS	I-NP	O
of	of	IN	B-PP	O
maternal	maternal	JJ	B-NP	O
origin	origin	NN	I-NP	O
and	and	CC	O	O
acquired	acquire	VBN	B-VP	O
,	,	,	O	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
year	year	NN	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O

IENF	IENF	NN	B-NP	O
density	density	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
calf	calf	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
skin	skin	NN	B-NP	O
at	at	IN	B-PP	O
more	more	RBR	B-NP	O
proximal	proximal	JJ	I-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
length	length	NN	I-NP	O
dependency	dependency	NN	I-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
-	-	HYPH	I-NP	O
fiber	fiber	NN	I-NP	O
loss	loss	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
neuropathies	neuropathy	NNS	I-NP	O

The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
contained	contain	VBD	B-VP	O
five	five	CD	B-NP	O
repeats	repeat	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hypothetical	hypothetical	JJ	I-NP	O
leucine	leucine	NN	I-NP	O
zipper	zipper	NN	I-NP	O
motif	motif	NN	I-NP	O
:	:	:	O	O
one	one	CD	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
globular	globular	JJ	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
four	four	CD	B-NP	O
are	be	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
alpha	alpha	SYM	I-NP	O
-	-	HYPH	I-NP	O
helical	helical	JJ	I-NP	O
stalk	stalk	NN	I-NP	O

This	This	DT	B-NP	O
paper	paper	NN	I-NP	O
reports	report	VBZ	B-VP	O
estimates	estimate	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
mental	mental	JJ	B-NP	O
retardation	retardation	NN	I-NP	O
and	and	CC	O	O
associated	associate	VBN	B-VP	O
factors	factor	NNS	B-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
population	population	NN	I-NP	O
survey	survey	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
children	child	NNS	I-NP	O
in	in	IN	B-PP	O
Greater	Greater	NNP	B-NP	O
Karachi	Karachi	NNP	I-NP	O
,	,	,	O	O
Pakistan	Pakistan	NNP	B-NP	O

Zta	BEGIN-Zta-INSIDE	NN	B-NP	B
stimulated	stimulate	VBD	B-VP	O
the	the	DT	B-NP	O
HAT	BEGIN-HAT-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
CBP	BEGIN-CBP-INSIDE	NN	B-NP	B
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
partially	partially	RB	I-VP	O
purified	purify	VBN	I-VP	O
or	or	CC	I-VP	O
immunoprecipitated	immunoprecipitate	VBN	I-VP	O
from	from	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
cells	cell	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
from	from	IN	B-PP	O
affinity	affinity	NN	B-NP	O
-	-	HYPH	B-NP	O
purified	purify	VBN	B-VP	O
,	,	,	O	O
baculovirus	baculovirus	NN	B-NP	O
expressed	express	VBD	B-VP	O
CBP	BEGIN-CBP-INSIDE	NN	B-NP	B

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
using	use	VBG	B-VP	O
partial	partial	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
have	have	VBP	B-VP	O
suggested	suggest	VBN	I-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
1S	BEGIN-1S-INSIDE	NN	B-NP	B
or	or	CC	O	O
large	BEGIN-large	JJ	B-NP	B
-	-	HYPH	I-NP	I
subunit	subunit-INSIDE	NN	I-NP	I
(	(	(	O	O
LSU	BEGIN-LSU-INSIDE	NN	B-NP	B
)	)	)	O	O
rDNA	rDNA	NN	B-NP	O
for	for	IN	B-PP	O
phylogeny	phylogeny	NN	B-NP	O
retrieval	retrieval	NN	I-NP	O
at	at	IN	B-PP	O
taxonomic	taxonomic	JJ	B-NP	O
levels	level	NNS	I-NP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
investigated	investigate	VBN	B-VP	O
with	with	IN	B-PP	O
1S	BEGIN-BEGIN-1S-INSIDE	NN	B-NP	B
rDNA	rDNA-INSIDE	NN	I-NP	I

P1	BEGIN-P1	NN	B-NP	B
mutations	mutations-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
offer	offer	VBP	B-VP	O
new	new	JJ	B-NP	O
approaches	approach	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
origins	origin	NNS	I-NP	O
of	of	IN	B-PP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
cancer	cancer	NN	I-NP	O

Due	Due	JJ	B-PP	O
to	to	TO	B-PP	O
significant	significant	JJ	B-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Mutator	BEGIN-Mutator	NN	I-NP	B
transposase	transposase-INSIDE	NN	I-NP	I
this	this	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
was	be	VBD	B-VP	O
named	name	VBN	I-VP	O
Trap	BEGIN-Trap-INSIDE	NN	B-NP	B
(	(	(	O	O
transposon	BEGIN-transposon	NN	B-NP	B
-	-	HYPH	O	I
associated	associate	VBN	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
)	)	)	O	O

RT	RT	NN	B-NP	O
-	-	HYPH	I-NP	O
PCR	PCR	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
FGFR	BEGIN-FGFR	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
splice	splice	NN	I-NP	O
variant	variant	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
exons	exon	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
are	be	VBP	B-VP	O
deleted	delete	VBN	I-VP	O

A	A	DT	B-NP	O
novel	novel	JJ	I-NP	O
serine	BEGIN-serine	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activated	activate	VBN	B-VP	O
by	by	IN	B-PP	O
rac1	BEGIN-rac1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
CDC1Hs	BEGIN-CDC1Hs-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
autophosphorylation	autophosphorylation	NN	I-NP	O
is	be	VBZ	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
PAK1	BEGIN-PAK1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
STE1	BEGIN-STE1-INSIDE	NN	I-NP	B

CYP1P1	BEGIN-CYP1P1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
identical	identical	JJ	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
CYP1	CYP1-INSIDE	NN	I-NP	I
coding	coding	NN	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
interrupted	interrupt	VBN	I-VP	O
with	with	IN	B-PP	O
introns	intron	NNS	B-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
six	six	CD	B-NP	O
in	in	IN	B-PP	O
-	-	HYPH	B-NP	O
frame	frame	NN	I-NP	O
stop	stop	NN	I-NP	O
codons	codon	NNS	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
point	point	NN	B-NP	O
mutations	mutation	NNS	I-NP	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
risk	risk	NN	B-NP	O
factors	factor	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
without	without	IN	B-PP	O
risk	risk	NN	B-NP	O
factors	factor	NNS	I-NP	O

Mutations	Mutation	NNS	B-NP	O
in	in	IN	B-PP	O
glnB	BEGIN-glnB-INSIDE	NN	B-NP	B
,	,	,	O	O
nifR1	BEGIN-nifR1-INSIDE	NN	B-NP	B
(	(	(	O	O
ntrC	BEGIN-ntrC-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
NifR1	BEGIN-NifR1-INSIDE	NN	B-NP	B
(	(	(	O	O
ntrA	BEGIN-ntrA-INSIDE	NN	B-NP	B
encoding	encode	VBG	B-VP	O
sigma	BEGIN-sigma	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
put	BEGIN-put	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O

This	This	DT	B-NP	O
bud	bud	NN	I-NP	O
morphology	morphology	NN	I-NP	O
results	result	VBZ	B-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
delay	delay	NN	I-NP	O
imposed	impose	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Cdc1p	BEGIN-Cdc1p-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
kinase	kinase	NN	I-NP	O
Swe1p	BEGIN-Swe1p-INSIDE	NN	I-NP	B

IgE	BEGIN-IgE	NN	B-NP	B
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
Psocoptera	Psocoptera	NN	B-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
immunoblotting	immunoblotting	NN	B-NP	O
experiments	experiment	NNS	I-NP	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Serrate	Serrate	NN	B-NP	O
(	(	(	O	O
Serrate1	Serrate1	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
;	;	:	O	O
Myat	Myat	NNP	B-NP	O
,	,	,	O	O
A.	A.	NNP	B-NP	O
,	,	,	O	O
Henrique	Henrique	NNP	B-NP	O
,	,	,	O	O
D.	D.	NNP	B-NP	O
,	,	,	O	O
Ish	Ish	NNP	B-NP	O
-	-	HYPH	I-NP	O
Horowicz	Horowicz	NNP	I-NP	O
,	,	,	I-NP	O
D.	D.	NNP	I-NP	O
and	and	CC	I-NP	O
Lewis	Lewis	NNP	I-NP	O
,	,	,	O	O
J.	J.	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
technique	technique	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
phases	phase	NNS	B-NP	O
contained	contain	VBN	B-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
polymer	polymer	NN	I-NP	O
blend	blend	NN	I-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
paper	paper	NN	I-NP	O

Nonlethal	Nonlethal	JJ	B-NP	O
sec1	BEGIN-sec1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
sec1	BEGIN-BEGIN-sec1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
mutations	mutations-INSIDE	NN	I-NP	I
eliminate	eliminate	VB	B-VP	O
proteins	protein	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Sec1p	BEGIN-Sec1p-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
BiP	BEGIN-BiP-INSIDE	NN	I-NP	B
complex	complex	NN	I-NP	O
from	from	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O

Our	Our	PRP$	B-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
no	no	DT	B-NP	O
single	single	JJ	I-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
acting	act	VBG	I-NP	O
factor	factor	NN	I-NP	O
is	be	VBZ	B-VP	O
absolutely	absolutely	RB	B-ADJP	O
essential	essential	JJ	I-ADJP	O
for	for	IN	B-PP	O
enhancer	enhancer	NN	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
enhancer	enhancer	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
MerI	BEGIN-MerI-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
combinatorial	combinatorial	JJ	I-NP	O
and	and	CC	I-NP	O
additive	additive	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O

We	We	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
reported	report	VBD	B-VP	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
and	and	CC	I-NP	O
sequencing	sequencing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
1	1	CD	I-NP	I
integrin	integrin	NN	I-NP	I
chain	chain-INSIDE	NN	I-NP	I
and	and	CC	O	O
its	its	PRP$	B-NP	O
regulated	regulate	VBN	I-NP	O
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
skeletal	skeletal	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
(	(	(	O	O
Song	Song	NNP	B-NP	O
et	et	FW	I-NP	O
al	al	FW	I-NP	O

Analytical	Analytical	JJ	B-NP	O
scanning	scanning	NN	I-NP	O
isoelectrofocusing	isoelectrofocuse	VBG	B-VP	O

A	A	DT	B-NP	O
structural	structural	JJ	I-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
Vpu	BEGIN-Vpu-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	O
anchor	anchor	NN	I-NP	O
precedes	precede	VBZ	B-VP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
comprising	comprise	VBG	B-VP	O
two	two	CD	B-NP	O
amphipathic	amphipathic	JJ	I-NP	O
alpha	alpha	SYM	I-NP	O
-	-	HYPH	I-NP	O
helices	helix	NNS	B-NP	O
of	of	IN	B-PP	O
opposed	oppose	VBN	B-NP	O
polarity	polarity	NN	I-NP	O
,	,	,	O	O
joined	join	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
strongly	strongly	RB	I-NP	O
acidic	acidic	JJ	I-NP	O
turn	turn	NN	I-NP	O
that	that	WDT	B-NP	O
protrudes	protrude	VBZ	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
CK	BEGIN-CK	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
phosphorylation	phosphorylation	NN	I-NP	I
sites	sites-INSIDE	NN	I-NP	I

Primer	Primer	NN	B-NP	O
extension	extension	NN	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	I-NP	O
subcloning	subcloning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
virJ	BEGIN-virJ-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
phoA	BEGIN-phoA-INSIDE	NN	I-NP	B
fusion	fusion	NN	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
acetosyringone	acetosyringone	NN	I-NP	O
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
lies	lie	VBZ	B-VP	O
directly	directly	RB	B-ADVP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
virJ	BEGIN-BEGIN-virJ-INSIDE	NN	I-NP	B
structural	structural	JJ	I-NP	O
gene	gene-INSIDE	NN	I-NP	I

This	This	DT	B-NP	O
novel	novel	JJ	I-NP	O
TRPC1	BEGIN-TRPC1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
could	could	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
bipolar	bipolar	JJ	B-NP	O
affective	affective	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
nonsyndromic	nonsyndromic	JJ	B-NP	O
hereditary	hereditary	JJ	I-NP	O
deafness	deafness	NN	I-NP	O
,	,	,	O	O
Knobloch	Knobloch	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
holoprosencephaly	holoprosencephaly	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
future	future	JJ	I-NP	O
,	,	,	I-NP	O
transoesophageal	transoesophageal	JJ	I-NP	O
echocardiography	echocardiography	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
variations	variation	NNS	B-NP	O
in	in	IN	B-PP	O
wall	wall	NN	B-NP	O
thickness	thickness	NN	I-NP	O
which	which	WDT	B-NP	O
change	change	VBP	B-VP	O
the	the	DT	B-NP	O
global	global	JJ	I-NP	O
loading	loading	NN	I-NP	O
conditions	condition	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
midwall	midwall	NN	I-NP	O
compartments	compartment	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
discriminant	discriminant	JJ	I-NP	O
function	function	NN	I-NP	O
predicting	predict	VBG	B-VP	O
surgery	surgery	NN	B-NP	O
outcome	outcome	NN	I-NP	O
(	(	(	O	O
seizure	seizure	NN	B-NP	O
-	-	HYPH	B-ADJP	O
free	free	JJ	I-ADJP	O
vs.	vs.	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	B-NP	O
seizure	seizure	NN	I-NP	O
-	-	HYPH	B-NP	O
free	free	JJ	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
computed	compute	VBN	I-VP	O
separately	separately	RB	B-ADVP	O
for	for	IN	B-PP	O
samples	sample	NNS	B-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
right	right	JJ	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
temporal	temporal	JJ	B-NP	O
lobectomy	lobectomy	NN	I-NP	O
(	(	(	O	O
LATL	LATL	NN	B-NP	O
,	,	,	O	O
RATL	RATL	NN	B-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
porcine	porcine	JJ	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
axonal	axonal	JJ	I-NP	O
injury	injury	NN	I-NP	O
,	,	,	O	O
developed	develop	VBN	B-VP	O
with	with	IN	B-PP	O
information	information	NN	B-NP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
physical	physical	JJ	I-NP	O
models	model	NNS	I-NP	O
and	and	CC	O	O
earlier	early	JJR	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
tissue	tissue	NN	I-NP	O
modeling	modeling	NN	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
correlate	correlate	VB	I-VP	O
histologic	histologic	JJ	B-NP	O
and	and	CC	I-NP	O
radiologic	radiologic	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
axonal	axonal	JJ	B-NP	O
injury	injury	NN	I-NP	O
to	to	TO	B-PP	O
predicted	predict	VBN	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
injury	injury	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
and	and	CC	I-NP	O
theoretical	theoretical	JJ	I-NP	O
analysis	analysis	NN	I-NP	O

Control	Control	NN	B-NP	O
of	of	IN	B-PP	O
ovulation	ovulation	NN	B-NP	O
in	in	IN	B-PP	O
mares	mare	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
breeding	breeding	NN	I-NP	O
season	season	NN	I-NP	O
with	with	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
steroids	steroid	NNS	I-NP	O
and	and	CC	O	O
prostaglandin	prostaglandin	NN	B-NP	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
visual	visual	JJ	I-NP	O
cortex	cortex	NN	I-NP	O
to	to	TO	B-PP	O
chromatic	chromatic	JJ	B-NP	O
stimuli	stimulus	NNS	I-NP	O
using	use	VBG	B-VP	O
magnetoencephalography	magnetoencephalography	NN	B-NP	O
(	(	(	O	O
MEG	MEG	NN	B-NP	O
)	)	)	O	O

By	By	IN	B-PP	O
subtractive	subtractive	JJ	B-NP	O
and	and	CC	I-NP	O
differential	differential	JJ	I-NP	O
screening	screening	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
cloned	clone	VBN	I-VP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
fos	fos-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
krox	BEGIN-krox	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Basal	Basal	JJ	B-NP	O
level	level	NN	I-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
UGA	UGA	NNP	I-NP	O
stop	stop	NN	I-NP	O
codon	codon	NN	I-NP	O
was	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
by	by	IN	B-PP	O
UAG	UAG	NN	B-NP	O
or	or	CC	I-NP	O
UAA	UAA	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
finding	finding	NN	I-NP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
translation	translation	NN	I-NP	O
terminates	terminate	VBZ	B-VP	O
more	more	RBR	B-ADVP	O
efficiently	efficiently	RB	I-ADVP	O
at	at	IN	B-PP	O
UAG	UAG	NNP	B-NP	O
and	and	CC	I-NP	O
UAA	UAA	NNP	I-NP	O
than	than	IN	B-PP	O
at	at	IN	B-PP	O
UGA	UGA	NN	B-NP	O

1	1	CD	B-NP	O

The	The	DT	B-NP	O
root	root	NN	I-NP	O
-	-	HYPH	B-NP	O
mean	mean	JJ	I-NP	O
-	-	HYPH	I-NP	O
square	square	NN	I-NP	O
deviation	deviation	NN	I-NP	O
of	of	IN	B-PP	O
bond	bond	NN	B-NP	O
lengths	length	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ideal	ideal	JJ	I-NP	O
values	value	NNS	I-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
A	A	NN	I-NP	O

Sugar	Sugar	NN	B-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
alpha	BEGIN-alpha	NN	B-NP	B
-	-	HYPH	I-NP	I
TM	TM-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
biosynthetic	biosynthetic	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
part	part	NN	B-NP	O
-	-	HYPH	B-NP	O
time	time	NN	I-NP	O
PGs	PG	NNS	I-NP	O

To	To	TO	B-PP	O
our	our	PRP$	B-NP	O
knowledge	knowledge	NN	I-NP	O
no	no	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
that	that	WDT	B-NP	O
exhibit	exhibit	VBP	B-VP	O
androgen	androgen	NN	B-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epididymis	epididymis	NN	I-NP	O

1	1	CD	B-NP	O

Proceedings	Proceeding	NNS	B-NP	O
:	:	:	O	O
Influence	Influence	NN	B-NP	O
of	of	IN	B-PP	O
halothane	halothane	NN	B-NP	O
on	on	IN	B-PP	O
mortality	mortality	NN	B-NP	O
from	from	IN	B-PP	O
murine	murine	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
MHV1	MHV1	NN	B-NP	O
)	)	)	O	O

Prevalence	Prevalence	NN	B-NP	O
of	of	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
rural	rural	JJ	I-NP	O
population	population	NN	I-NP	O
in	in	IN	B-PP	O
western	western	JJ	B-NP	O
India	India	NNP	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
WHO	WHO	NN	I-NP	O
-	-	HYPH	I-NP	O
ILAR	ILAR	NN	I-NP	O
COPCORD	COPCORD	NN	I-NP	O
Study	Study	NN	I-NP	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
drug	drug	NN	B-NP	O
refractory	refractory	JJ	I-NP	O
ALL	ALL	NN	I-NP	O
,	,	,	O	O
BAC	BAC	NN	B-NP	O
-	-	HYPH	B-NP	O
derived	derive	VBN	I-NP	O
probes	probe	NNS	I-NP	O
applied	apply	VBN	B-VP	O
to	to	TO	B-PP	O
archived	archived	JJ	B-NP	O
marrow	marrow	NN	I-NP	O
cells	cell	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
breakpoint	breakpoint	NN	I-NP	O
occurred	occur	VBD	B-VP	O
between	between	IN	B-PP	O
MDR1	BEGIN-MDR1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
sequences	sequence	NNS	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
KB	KB	NN	I-NP	O
telomeric	telomeric	JJ	B-ADJP	O
to	to	TO	B-PP	O
MDR1	BEGIN-MDR1-INSIDE	NN	B-NP	B
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
random	random	JJ	I-NP	O
chromosomal	chromosomal	JJ	I-NP	O
rearrangement	rearrangement	NN	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
clonidine	clonidine	NN	B-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
produces	produce	VBZ	B-VP	O
sedation	sedation	NN	B-NP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
diazepam	diazepam	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-VP	O
attenuates	attenuate	VBZ	I-VP	O
the	the	DT	B-NP	O
intubation	intubation	NN	I-NP	O
response	response	NN	I-NP	O
without	without	IN	B-PP	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
complications	complication	NNS	B-NP	O

The	The	DT	B-NP	O
other	other	JJ	I-NP	O
regions	region	NNS	I-NP	O
include	include	VBP	B-VP	O
potential	potential	JJ	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
for	for	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
ATF	BEGIN-ATF-INSIDE	NN	B-NP	B
,	,	,	O	O
NF1	BEGIN-NF1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
CCAAT	BEGIN-CCAAT	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
analysis	analysis	NN	I-NP	O
predicted	predict	VBD	B-VP	O
that	that	IN	B-SBAR	O
progressive	progressive	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
or	or	CC	O	O
aspartate	BEGIN-aspartate	NN	B-NP	B
transaminase	transaminase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
will	will	MD	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
1	1	CD	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
clearance	clearance	NN	B-NP	O

1	1	CD	B-NP	O
Intravenous	Intravenous	JJ	I-NP	O
prizidilol	prizidilol	NN	I-NP	O
hydrochloride	hydrochloride	NN	I-NP	O
decreases	decrease	VBZ	B-VP	O
resting	rest	VBG	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
increases	increase	VBZ	B-VP	O
pulse	pulse	NN	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
virtually	virtually	RB	B-NP	O
no	no	DT	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O

The	The	DT	B-NP	O
Saccharomyces	Saccharomyces	NNP	I-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
targets	target	NNS	I-NP	O
of	of	IN	B-PP	O
rapamycin	rapamycin	NN	B-NP	O
,	,	,	I-NP	O
TOR1	BEGIN-TOR1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
TOR1	BEGIN-TOR1-INSIDE	NN	I-NP	B
,	,	,	O	O
signal	signal	NN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
growth	growth	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
nutrient	nutrient	JJ	B-NP	O
availability	availability	NN	I-NP	O

This	This	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
protein	protein	NN	I-NP	O
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
SH1	BEGIN-BEGIN-SH1-INSIDE	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
and	and	CC	O	O
an	an	DT	B-NP	O
inter	BEGIN-inter	JJ	I-NP	B
-	-	HYPH	I-NP	I
SH1	BEGIN-SH1-INSIDE	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
p1alpha	BEGIN-p1alpha-INSIDE	NN	B-NP	B
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
bcr	BEGIN-bcr	NN	I-NP	B
homology	homology	NN	I-NP	I
domains	domains-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
p1alpha	BEGIN-p1alpha-INSIDE	NN	B-NP	B
were	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O

Gene	Gene	NN	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	O	O
precursor	precursor	NN	B-NP	O
processing	processing	NN	I-NP	O

This	This	DT	B-NP	O
effect	effect	NN	I-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Gal1	BEGIN-Gal1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
operates	operate	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
gal1	BEGIN-gal1	NN	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
background	background	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
d	d	NN	B-NP	O
-	-	HYPH	B-NP	O
delta1	delta1	NN	I-NP	O
-	-	HYPH	I-NP	O
carene	carene	NN	I-NP	O
was	be	VBD	B-VP	O
about	about	RB	B-NP	O
four	four	CD	I-NP	O
times	time	NNS	I-NP	O
more	more	RBR	B-ADJP	O
potent	potent	JJ	I-ADJP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
sensory	sensory	JJ	I-NP	O
irritant	irritant	NN	I-NP	O
than	than	IN	B-SBAR	O
I	I	PRP	B-NP	O
-	-	HYPH	O	O
beta	beta	SYM	O	O
-	-	HYPH	O	O
pinene	pinene	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
with	with	IN	B-PP	O
I	I	PRP	B-NP	O
-	-	HYPH	O	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
pinene	pinene	NN	B-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
marked	marked	JJ	I-ADJP	O
;	;	:	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
sensory	sensory	JJ	I-NP	O
irritant	irritant	NN	I-NP	O
,	,	,	O	O
I	I	NN	B-NP	O
-	-	HYPH	O	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
pinene	pinene	NN	B-NP	O
is	be	VBZ	B-VP	O
almost	almost	RB	B-ADJP	O
inactive	inactive	JJ	I-ADJP	O

Blood	Blood	NN	B-NP	O
and	and	CC	I-NP	O
whole	whole	JJ	I-NP	O
-	-	HYPH	I-NP	O
brain	brain	NN	I-NP	O
mercury	mercury	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
pups	pup	NNS	B-NP	O
on	on	IN	B-PP	O
PN	PN	NN	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
birth	birth	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
PN	PN	NN	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
weaning	wean	VBG	B-VP	O
)	)	)	O	O

Multiple	Multiple	JJ	B-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
binding	bind	VBG	I-NP	O
site	site	NN	I-NP	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
genomes	genome	NNS	I-NP	O

Tubular	Tubular	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
in	in	IN	B-PP	O
renal	renal	JJ	B-NP	O
lithiasis	lithiasis	NN	I-NP	O
:	:	:	O	O
cause	cause	VB	B-VP	O
or	or	CC	I-VP	O
consequence	consequence	VB	I-VP	O
?	?	.	O	O
]	]	)	O	O
To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
overall	overall	JJ	B-NP	O
tubular	tubular	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
is	be	VBZ	B-VP	O
encountered	encounter	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
particular	particular	JJ	I-NP	O
subgroup	subgroup	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
urolithiasis	urolithiasis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
tubular	tubular	JJ	I-NP	O
function	function	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
fasting	fast	VBG	B-VP	O
morning	morning	NN	B-NP	O
urine	urine	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
male	male	JJ	I-NP	O
stone	stone	NN	I-NP	O
formers	former	NNS	I-NP	O
:	:	:	O	O
excretion	excretion	NN	B-NP	O
of	of	IN	B-PP	O
lysozyme	BEGIN-lysozyme-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
gamma	BEGIN-gamma	NN	I-NP	B
-	-	HYPH	O	I
glutamyl	glutamyl	NN	B-NP	I
transpeptidase	transpeptidase-INSIDE	NN	I-NP	I
(	(	(	O	O
gamma	BEGIN-gamma	NN	B-NP	B
-	-	HYPH	B-NP	I
GT	GT-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
fractional	fractional	JJ	B-NP	O
excretion	excretion	NN	I-NP	O
(	(	(	O	O
FE	FE	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
glucose	glucose	NN	B-NP	O
,	,	,	O	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
after	after	IN	B-PP	O
an	an	DT	B-NP	O
alkali	alkali	JJ	I-NP	O
load	load	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
theoretical	theoretical	JJ	B-NP	O
phosphate	phosphate	NN	I-NP	O
threshold	threshold	NN	I-NP	O
(	(	(	O	O
TmP	TmP	NN	B-NP	O
/	/	SYM	B-NP	O
GFR	GFR	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
during	during	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
identical	identical	JJ	B-NP	O
weights	weight	NNS	I-NP	O
during	during	IN	B-PP	O
post	post	AFX	B-NP	O
-	-	HYPH	I-NP	O
fast	fast	JJ	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
(	(	(	O	O
Study	Study	NN	B-NP	O
A	A	NN	I-NP	O
)	)	)	O	O

Mol	Mol	NNP	B-NP	O

Arg	Arg	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Gly	Gly	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
Lys	Lys	NNP	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
are	be	VBP	B-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
type	BEGIN-type	JJ	I-NP	B
IB	IB	NN	I-NP	I
topoisomerase	topoisomerase	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
maximal	maximal	JJ	I-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
adrenaline	adrenaline	NN	I-NP	O
was	be	VBD	B-VP	O
of	of	IN	B-PP	O
similar	similar	JJ	B-NP	O
magnitude	magnitude	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
groups	group	NNS	I-NP	O
but	but	CC	O	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
plasma	plasma	NN	I-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
stimulate	stimulate	VB	I-VP	O
this	this	DT	B-NP	O
hormonal	hormonal	JJ	I-NP	O
response	response	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
'unaware	'unaware	NN	I-NP	O
'	'	POS	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
whom	whom	WP	B-NP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
adrenaline	adrenaline	NN	I-NP	O
concentration	concentration	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
reaction	reaction	NN	I-NP	O

PATIENTS	PATIENTS	NNS	B-NP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
women	woman	NNS	I-NP	O
consulting	consult	VBG	B-VP	O
the	the	DT	B-NP	O
general	general	JJ	I-NP	O
practitioner	practitioner	NN	I-NP	O
for	for	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
vaginosis	vaginosis	NN	I-NP	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
ovarian	ovarian	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
,	,	,	O	O
Stage	Stage	NN	B-NP	O
III	III	CD	I-NP	O
or	or	CC	I-NP	O
IV	IV	CD	I-NP	O
(	(	(	O	O
International	International	NNP	B-NP	O
Federation	Federation	NNP	I-NP	O
of	of	IN	B-PP	O
Gynaecology	Gynaecology	NNP	B-NP	O
and	and	CC	I-NP	O
Obstetrics	Obstetrics	NNP	I-NP	O
)	)	)	O	O
,	,	,	O	O
were	be	VBD	B-VP	O
randomized	randomize	VBN	I-VP	O
to	to	TO	B-PP	O
primary	primary	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
with	with	IN	B-PP	O
doxorubicin	doxorubicin	NN	B-NP	O
(	(	(	O	O
Adriamycin	Adriamycin	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
cisplatin	cisplatin	NN	B-NP	O
plus	plus	CC	B-NP	O
or	or	CC	O	O
minus	minus	CC	O	O
hexamethylmelamine	hexamethylmelamine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cyclophosphamide	cyclophosphamide	NN	B-NP	O
(	(	(	O	O
CHAP	CHAP	NN	B-NP	O
)	)	)	O	O

Promoter	Promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proliferating	BEGIN-proliferating	JJ	I-NP	B
-	-	HYPH	I-NP	I
cell	cell	NN	I-NP	I
nuclear	nuclear	JJ	I-NP	I
antigen	antigen	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
inducible	inducible	JJ	B-NP	O
CRE	BEGIN-CRE	NN	I-NP	B
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
interleukin	BEGIN-interleukin	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
stimulated	stimulate	VBN	B-NP	O
T	T	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
1	1	CD	B-NP	O
homology	homology	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
RA	RA	NN	I-NP	O
-	-	HYPH	B-VP	O
derived	derive	VBN	B-NP	O
PTEN	BEGIN-PTEN	NN	I-NP	B
fragments	fragments-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
those	those	DT	B-NP	O
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
SF	SF	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
published	publish	VBN	I-NP	O
GenBank	GenBank	NN	I-NP	O
sequence	sequence	NN	I-NP	O
(	(	(	O	O
accession	accession	NN	B-NP	O
number	number	NN	I-NP	O
U1	BEGIN-U1-INSIDE	NN	I-NP	B
)	)	)	O	O

The	The	DT	B-NP	O
mutation	mutation	NN	I-NP	O
also	also	RB	B-ADVP	O
preferentially	preferentially	RB	B-ADVP	O
limits	limit	NNS	B-NP	O
(	(	(	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
)	)	)	O	O
translation	translation	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
induced	induce	VBN	I-NP	O
gene	gene	NN	I-NP	O
that	that	WDT	B-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
five	five	CD	B-NP	O
AGA	AGA	NN	I-NP	O
codons	codon	NNS	I-NP	O
,	,	,	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
lambda	BEGIN-lambda	NNP	I-NP	B
cI	cI	NN	I-NP	I
repressor	repressor	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
n	n	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
PUFA	PUFA	NN	I-NP	O
intake	intake	NN	I-NP	O
on	on	IN	B-PP	O
measures	measure	NNS	B-NP	O
of	of	IN	B-PP	O
lipid	lipid	NN	B-NP	O
peroxidation	peroxidation	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
equivocal	equivocal	JJ	B-ADJP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
MAPK	BEGIN-BEGIN-MAPK-INSIDE	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O
(	(	(	O	O
PD	PD	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
or	or	CC	O	O
by	by	IN	B-PP	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
kinase	kinase	NN	B-NP	O
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
MAPKs	BEGIN-MAPK-INSIDE	NNS	I-NP	I
activated	activate	VBD	B-VP	O
basal	basal	JJ	B-NP	O
and	and	CC	I-NP	O
GnRH	BEGIN-GnRH	JJ	I-NP	B
-	-	HYPH	I-NP	I
A	A-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
stimulated	stimulate	VBN	B-NP	O
GnRHR	BEGIN-GnRHR-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
Luc	BEGIN-Luc-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
,	,	,	I-NP	O
short	short	JJ	I-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
(	(	(	O	O
concurrent	concurrent	JJ	O	O
)	)	)	O	O
TAL	TAL	NN	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
-	-	HYPH	I-NP	O
flavored	flavor	VBN	I-NP	O
stimuli	stimulus	NNS	I-NP	O
were	be	VBD	B-VP	O
presented	present	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
simultaneous	simultaneous	JJ	B-NP	O
intragastric	intragastric	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
aversive	aversive	JJ	I-NP	O
product	product	NN	I-NP	O
,	,	,	O	O
hypertonic	hypertonic	JJ	B-NP	O
NaCl	NaCl	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
with	with	IN	B-PP	O
saline	saline	NN	B-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
LHB	LHB	NN	B-NP	O
is	be	VBZ	B-VP	O
simple	simple	JJ	B-ADJP	O
,	,	,	I-ADJP	O
easy	easy	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
safe	safe	JJ	I-ADJP	O
to	to	TO	B-VP	O
implement	implement	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
technique	technique	NN	I-NP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
maintaining	maintain	VBG	B-VP	O
independent	independent	JJ	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
body	body	NN	I-NP	O
perfusion	perfusion	NN	I-NP	O
pressure	pressure	NN	I-NP	O

Heterodimerization	BEGIN-Heterodimerization	NN	B-NP	B
mutant	mutant	JJ	I-NP	I
RXR	RXR-INSIDE	NN	I-NP	I
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
alter	alter	VB	I-VP	O
GFP	BEGIN-GFP-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
VDR	BEGIN-VDR-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
nlsGFP	nlsBEGIN-GFP-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
VDR	BEGIN-VDR-INSIDE	NN	I-NP	B
distribution	distribution	NN	I-NP	O
or	or	CC	I-NP	O
activity	activity	NN	I-NP	O

New	New	JJ	B-NP	O
TB	TB	NN	I-NP	O
respirator	respirator	NN	I-NP	O
standards	standard	NNS	I-NP	O
mean	mean	VB	B-VP	O
more	more	JJR	B-NP	O
choices	choice	NNS	I-NP	O
at	at	IN	B-PP	O
less	less	JJR	B-NP	O
cost	cost	NN	I-NP	O

After	After	IN	B-PP	O
first	first	JJ	B-NP	O
strand	strand	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
from	from	IN	B-PP	O
fetal	fetal	JJ	B-NP	O
brain	brain	NN	I-NP	O
mRNAs	mRNA	NNS	I-NP	O
,	,	,	O	O
short	short	JJ	B-NP	O
fragment	fragment	NN	I-NP	O
cDNAs	cDNA	NNS	I-NP	O
(	(	(	O	O
sf	sf	NN	B-NP	O
-	-	HYPH	B-NP	O
cDNAs	cDNA	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
synthesized	synthesize	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
step	step	NN	I-NP	O
amplification	amplification	NN	I-NP	O
system	system	NN	I-NP	O
by	by	IN	B-PP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
modified	modified	JJ	I-NP	O
Degenerate	Degenerate	NNP	I-NP	O
Oligonucleotide	Oligonucleotide	NNP	I-NP	O
Primed	Primed	NNP	I-NP	O
Shuttle	Shuttle	NNP	I-NP	O
Polymerase	Polymerase	NNP	I-NP	O
Chain	Chain	NNP	I-NP	O
Reaction	Reaction	NN	I-NP	O
(	(	(	O	O
DOP	DOP	NN	B-NP	O
-	-	HYPH	B-NP	O
Shuttle	Shuttle	NN	I-NP	O
-	-	HYPH	B-NP	O
PCR	PCR	NN	I-NP	O
)	)	)	O	O
method	method	NN	B-NP	O

Fulminant	Fulminant	JJ	B-NP	O
hepatic	hepatic	JJ	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
cases	case	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
:	:	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
rapid	rapid	JJ	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
serum	BEGIN-serum	NN	B-NP	B
alanine	alanine	NN	I-NP	I
transaminase	transaminase-INSIDE	NN	I-NP	I
(	(	(	O	O
ALT	BEGIN-ALT-INSIDE	NN	B-NP	B
)	)	)	O	O
level	level	NN	B-NP	O
after	after	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
ecarazine	ecarazine	NN	B-NP	O
,	,	,	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
prolonged	prolonged	JJ	B-NP	O
jaundice	jaundice	NN	I-NP	O
despite	despite	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
ecarazine	ecarazine	NN	B-NP	O
,	,	,	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
high	high	JJ	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
nuclear	nuclear	JJ	I-NP	I
antibody	antibody-INSIDE	NN	I-NP	I
(	(	(	O	O
ANA	BEGIN-ANA-INSIDE	NN	B-NP	B
)	)	)	O	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
histological	histological	JJ	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
hepatocellular	hepatocellular	JJ	I-NP	O
necrosis	necrosis	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
bridging	bridge	VBG	B-VP	O
necrosis	necrosis	NN	B-NP	O
to	to	TO	B-PP	O
massive	massive	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O

Smectic	Smectic	JJ	B-ADJP	O
-	-	HYPH	O	O
A	A	DT	B-NP	O
ordering	ordering	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
liquid	liquid	JJ	I-NP	O
-	-	HYPH	I-NP	O
vapor	vapor	NN	I-NP	O
interface	interface	NN	I-NP	O

Simulation	Simulation	NN	B-NP	O
results	result	NNS	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
presented	present	VBN	I-NP	O
model	model	NN	I-NP	O
are	be	VBP	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
data	datum	NNS	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
cMUTs	cMUT	NNS	B-NP	O
reported	report	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
recent	recent	JJ	I-NP	O
literature	literature	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
E1L	BEGIN-E1L	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
pathogenesis	pathogenesis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
model	model	NN	I-NP	O

Parelaphostrongylus	Parelaphostrongylus	NNP	B-NP	O
odocoilei	odocoilei	NNP	I-NP	O
is	be	VBZ	B-VP	O
redescribed	redescribe	VBN	I-VP	O
from	from	IN	B-PP	O
worms	worm	NNS	B-NP	O
collected	collect	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
host	host	NN	I-NP	O
(	(	(	O	O
Odocoileus	Odocoileus	NN	B-NP	O
hemionus	hemionus	NN	I-NP	O
columbianus	columbianus	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
California	California	NNP	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
material	material	NN	B-NP	O
from	from	IN	B-PP	O
experimentally	experimentally	RB	B-NP	O
infected	infected	JJ	I-NP	O
mule	mule	JJ	I-NP	O
deer	deer	NN	I-NP	O
(	(	(	O	O
O.	O.	NN	B-NP	O
h.	h.	NN	I-NP	O
heminus	heminus	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
Alberta	Alberta	NNP	B-NP	O

Sodium	Sodium	NN	B-NP	O
dodecylsulfate	dodecylsulfate	NN	I-NP	O
polyacrylamide	polyacrylamide	NN	I-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
(	(	(	O	O
SDS	SDS	NN	B-NP	O
-	-	HYPH	B-NP	O
PAGE	PAGE	NN	I-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
two	two	CD	B-NP	O
bands	band	NNS	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
the	the	DT	I-NP	O
same	same	JJ	I-NP	O
intensity	intensity	NN	I-NP	O
with	with	IN	B-PP	O
apparent	apparent	JJ	B-NP	O
molecular	molecular	JJ	I-NP	O
masses	mass	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O

Particle	Particle	NN	B-NP	O
bombardment	bombardment	NN	I-NP	O
of	of	IN	B-PP	O
barley	barley	NN	B-NP	O
aleurone	aleurone	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
B1EL1	BEGIN-B1EL1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
GUS	BEGIN-GUS-INSIDE	NN	I-NP	B
(	(	(	O	O
beta	BEGIN-beta	NN	B-NP	B
-	-	HYPH	B-NP	I
glucuronidase	glucuronidase-INSIDE	NN	I-NP	I
)	)	)	O	O
construct	construct	NN	B-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
developing	develop	VBG	B-VP	O
barley	barley	NN	B-NP	O
grains	grain	NNS	I-NP	O

The	The	DT	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
CWH1	BEGIN-CWH1-INSIDE	NN	B-NP	B
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
YCR1c	BEGIN-YCR1c-INSIDE	NN	B-NP	B
and	and	CC	O	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
transmembrane	transmembrane	NN	I-NP	O
segments	segment	NNS	I-NP	O
containing	contain	VBG	B-VP	O
several	several	JJ	B-NP	O
putative	putative	JJ	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
and	and	CC	I-NP	O
glycosylation	glycosylation	NN	I-NP	O
sites	site	NNS	I-NP	O

They	They	PRP	B-NP	O
elicit	elicit	VBP	B-VP	O
similar	similar	JJ	B-NP	O
regional	regional	JJ	I-NP	O
cerebral	cerebral	JJ	I-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
(	(	(	O	O
rCBF	rCBF	NN	B-NP	O
)	)	)	O	O
patterns	pattern	NNS	B-NP	O
,	,	,	O	O
even	even	RB	B-SBAR	O
though	though	IN	I-SBAR	O
sign	sign	NN	B-NP	O
language	language	NN	I-NP	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
spatial	spatial	JJ	B-NP	O
information	information	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
salvage	salvage	NN	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
serum	BEGIN-serum	NN	I-NP	B
PSA	PSA-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-NP	O
mL	mL	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
salvage	salvage	NN	I-NP	O
RP	RP	NN	I-NP	O
and	and	CC	O	O
salvage	salvage	NN	B-NP	O
RT	RT	NN	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

First	First	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
GATA	BEGIN-GATA	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
motif	motif-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
nuclear	nuclear	JJ	B-NP	O
factor	factor	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
presumably	presumably	RB	B-ADVP	O
the	the	DT	B-NP	O
GATA	BEGIN-GATA	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
,	,	,	O	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
K	K	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cell	cell	NN	I-NP	O
extracts	extract	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
living	live	VBG	B-VP	O
K	K	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
proportional	proportional	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
spiral	spiral	JJ	I-NP	O
artery	artery	NN	I-NP	O
flow	flow	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
pressure	pressure	NN	I-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
spiral	spiral	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
amniotic	amniotic	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
pressure	pressure	NN	I-NP	O
difference	difference	NN	I-NP	O
per	per	IN	B-PP	O
flow	flow	NN	B-NP	O
(	(	(	O	O
the	the	DT	B-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cotyledonary	cotyledonary	JJ	I-NP	O
unit	unit	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
.	.	.	B-NP	O
ml	ml	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
.	.	.	I-NP	O
min	min	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
-	-	HYPH	I-NP	O
1kPa	1kPa	NN	I-NP	O
.	.	.	I-NP	O
ml	ml	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
.	.	.	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O

Truncations	Truncation	NNS	B-NP	O
from	from	IN	B-PP	O
Hip	BEGIN-Hip-INSIDE	NN	B-NP	B
's	's	POS	B-NP	O
N	N	NN	I-NP	O
terminus	terminus	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
Hip	BEGIN-Hip-INSIDE	NN	B-NP	B
homo	homo	AFX	O	O
-	-	HYPH	O	O
oligomerization	oligomerization	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
these	these	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
retained	retain	VBD	B-VP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
hsp1	BEGIN-hsp1-INSIDE	NN	B-NP	B
and	and	CC	O	O
were	be	VBD	B-VP	O
recovered	recover	VBN	I-VP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
complexes	complex	NNS	I-NP	O

An	An	DT	B-NP	O
oligomer	oligomer	NN	I-NP	O
synthesized	synthesize	VBN	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
homology	homology	NN	B-NP	O
produced	produce	VBD	B-VP	O
two	two	CD	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
complexes	complex	NNS	I-NP	O
with	with	IN	B-PP	O
oviduct	oviduct	NN	B-NP	O
nuclear	nuclear	JJ	I-NP	O
proteins	protein	NNS	I-NP	O

The	The	DT	B-NP	O
myeloid	BEGIN-myeloid	JJ	I-NP	B
zinc	zinc	NN	I-NP	I
finger	finger	NN	I-NP	I
gene	gene	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
MZF1	BEGIN-MZF1-INSIDE	NN	B-NP	B
)	)	)	O	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
C	BEGIN-C	NN	I-NP	B
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
H	H	NN	B-NP	I
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
zinc	zinc	NN	B-NP	I
finger	finger	NN	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
regulates	regulate	VBZ	B-VP	O
granulopoiesis	granulopoiesis	NN	B-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
proliferation	proliferation	NN	I-NP	O
and	and	CC	I-NP	O
oncogenesis	oncogenesis	NN	I-NP	O

1	1	CD	B-NP	O

The	The	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
collagen	BEGIN-collagen-INSIDE	NN	B-NP	B
synthesis	synthesis	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
scar	scar	NN	I-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-ADJP	O
constant	constant	JJ	I-ADJP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
wounding	wounding	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
hypertrophic	hypertrophic	JJ	I-NP	O
scar	scar	NN	I-NP	O
and	and	CC	O	O
keloid	keloid	VBD	B-VP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
approximately	approximately	RB	B-ADVP	O
twice	twice	RB	I-ADVP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
scar	scar	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
after	after	IN	B-PP	O
wounding	wound	VBG	B-VP	O
it	it	PRP	B-NP	O
fell	fall	VBD	B-VP	O
to	to	TO	B-PP	O
approximately	approximately	RB	B-NP	O
the	the	DT	I-NP	O
same	same	JJ	I-NP	O
level	level	NN	I-NP	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
scar	scar	NN	I-NP	O

When	When	WRB	B-ADVP	O
phentermine	phentermine	NN	B-NP	O
was	be	VBD	B-VP	O
mixed	mix	VBN	B-ADJP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
unlabeled	unlabeled	JJ	I-NP	O
reversible	reversible	JJ	I-NP	O
MAO	BEGIN-MAO-INSIDE	NN	I-NP	B
inhibitors	inhibitor	NNS	I-NP	O
(	(	(	O	O
e.g.	e.g.	FW	B-NP	O
pseudoephedrine	pseudoephedrine	NN	I-NP	O
,	,	,	O	O
ephedrine	ephedrine	NN	B-NP	O
,	,	,	O	O
norephedrine	norephedrine	NN	B-NP	O
;	;	:	O	O
estradiol	estradiol	NN	B-NP	O
benzoate	benzoate	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
MAO	BEGIN-MAO-INSIDE	NN	B-NP	B
inhibition	inhibition	NN	I-NP	O
was	be	VBD	B-VP	O
additive	additive	JJ	B-ADJP	O

W.	W.	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Touster	Touster	NNP	B-NP	O
,	,	,	O	O
O	O	NNP	B-NP	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
IGF	BEGIN-IGF	NN	B-NP	B
IR	IR	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
clone	clone	NN	B-NP	O
CA1	CA1	NN	I-NP	O
after	after	IN	B-PP	O
confluence	confluence	NN	B-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
clone	clone	NN	B-NP	O
ME1	ME1	NN	I-NP	O

Uncoupling	Uncouple	VBG	B-VP	O
gene	gene	NN	B-NP	O
activity	activity	NN	I-NP	O
from	from	IN	B-PP	O
chromatin	chromatin	NN	B-NP	O
structure	structure	NN	I-NP	O
:	:	:	O	O
promoter	promoter	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
can	can	MD	B-VP	O
inactivate	inactivate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
HSP1	HSP1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
without	without	IN	B-PP	O
eliminating	eliminate	VBG	B-VP	O
nucleosome	nucleosome	NN	B-NP	O
-	-	HYPH	B-NP	O
free	free	JJ	I-NP	O
regions	region	NNS	I-NP	O

Heating	Heating	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
upon	upon	IN	B-PP	O
either	either	CC	O	O
force	force	NN	B-NP	O
decline	decline	NN	I-NP	O
or	or	CC	O	O
slowing	slowing	NN	B-NP	O
of	of	IN	B-PP	O
relaxation	relaxation	NN	B-NP	O
during	during	IN	B-PP	O
fatiguing	fatigue	VBG	B-VP	O
contractions	contraction	NNS	B-NP	O

Uncertainty	Uncertainty	NN	B-NP	O
exists	exist	VBZ	B-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
potential	potential	JJ	I-NP	O
isoforms	isoform	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Cbfa1	BEGIN-Cbfa1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
RTI1	BEGIN-RTI1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
spans	span	NNS	I-NP	O
1	1	CD	B-NP	O
kilobase	kilobase	NN	I-NP	O
pairs	pair	NNS	I-NP	O
;	;	:	O	O
it	it	PRP	B-NP	O
contains	contain	VBZ	B-VP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
and	and	CC	O	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
rat	rat	NN	I-NP	O
Identifier	Identifi	JJR	B-NP	O
repetitive	repetitive	JJ	I-NP	O
elements	element	NNS	I-NP	O

The	The	DT	B-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
apparatus	apparatus	NN	I-NP	O
for	for	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
use	use	NN	I-NP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
DEOAEs	DEOAE	NNS	B-NP	O
are	be	VBP	B-VP	O
described	describe	VBN	I-VP	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
typical	typical	JJ	B-NP	O
examples	example	NNS	I-NP	O
of	of	IN	B-PP	O
emissions	emission	NNS	B-NP	O

Anatomical	Anatomical	JJ	B-NP	O
considerations	consideration	NNS	I-NP	O
in	in	IN	B-PP	O
transsphenoidal	transsphenoidal	JJ	B-NP	O
hypophysectomy	hypophysectomy	NN	I-NP	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
confirmed	confirm	VBN	I-VP	O
in	in	IN	B-PP	O
animal	animal	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
microspheres	microsphere	NNS	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
sample	sample	NN	I-NP	O
approximately	approximately	RB	B-ADVP	O
follows	follow	VBZ	B-VP	O
a	a	DT	B-NP	O
Poisson	Poisson	NNP	I-NP	O
distribution	distribution	NN	I-NP	O
,	,	,	O	O
under	under	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
experimental	experimental	JJ	I-NP	O
conditions	condition	NNS	I-NP	O

Maximal	Maximal	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
duration	duration	NN	I-NP	O
and	and	CC	O	O
peak	peak	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
consumption	consumption	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
changed	change	VBN	I-VP	O

Hard	Hard	JJ	B-NP	O
methacrylic	methacrylic	JJ	I-NP	O
polymers	polymer	NNS	I-NP	O

Validity	Validity	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
short	short	JJ	I-NP	O
-	-	HYPH	I-NP	O
form	form	NN	I-NP	O
QIF	QIF	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
correlation	correlation	NN	B-NP	O
with	with	IN	B-PP	O
motor	motor	NN	B-NP	O
scores	score	NNS	I-NP	O
and	and	CC	O	O
using	use	VBG	B-VP	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
variance	variance	NN	B-NP	O
by	by	IN	B-PP	O
motor	motor	NN	B-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
motor	motor	NN	B-NP	O
score	score	NN	I-NP	O
groupings	grouping	NNS	I-NP	O

An	An	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
nt	nt	NN	I-NP	O
tandem	tandem	JJ	I-NP	O
duplication	duplication	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
coding	cod	VBG	I-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
located	locate	VBN	I-VP	O
adjacent	adjacent	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
termination	termination	NN	I-NP	O
codon	codon	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CyIIIb	BEGIN-CyIIIb	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
relic	relic	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
slipped	slipped	JJ	I-NP	O
mispairing	mispairing	NN	I-NP	O
and	and	CC	I-NP	O
replication	replication	NN	I-NP	O
event	event	NN	I-NP	O

During	During	IN	B-PP	O
seed	seed	NN	B-NP	O
maturation	maturation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
napin	BEGIN-napin	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
developmental	developmental	JJ	B-NP	O
signals	signal	NNS	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
transcriptional	BEGIN-transcriptional	JJ	I-NP	B
activator	activator	NN	I-NP	I
ABI1	ABI1-INSIDE	NN	I-NP	I
and	and	CC	O	O
abscisic	abscisic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
ABA	ABA	NN	B-NP	O
)	)	)	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
either	either	CC	O	O
peptide	peptide	NN	B-NP	O
sequencing	sequencing	NN	I-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
sequence	sequence	NN	B-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
cDNAs	cDNA	NNS	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
S.	S.	FW	I-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
genes	gene	NNS	I-NP	O
RFC1	BEGIN-RFC1-INSIDE	NN	I-NP	B
,	,	,	O	O
RFC1	BEGIN-RFC1-INSIDE	NN	B-NP	B
,	,	,	O	O
RFC1	BEGIN-RFC1-INSIDE	NN	B-NP	B
,	,	,	O	O
RFC1	BEGIN-RFC1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
RFC1	BEGIN-RFC1-INSIDE	NN	B-NP	B

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	I-NP	O
V1	V1	NN	I-NP	O
''	''	''	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
tremor	tremor	NN	B-NP	O
,	,	,	O	O
seborrhea	seborrhea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
duration	duration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
illness	illness	NN	I-NP	O

The	The	DT	B-NP	O
isomerization	isomerization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pre	pre	AFX	I-NP	O
-	-	HYPH	I-NP	O
existing	exist	VBG	I-NP	O
closed	close	VBN	I-NP	O
complex	complex	NN	I-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
form	form	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
judged	judge	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
local	local	JJ	I-NP	O
denaturation	denaturation	NN	I-NP	O
of	of	IN	B-PP	O
promoter	promoter	NN	B-NP	O
DNA	DNA	NN	I-NP	O
which	which	WDT	B-NP	O
rendered	render	VBD	B-VP	O
sequences	sequence	NNS	B-NP	O
from	from	IN	B-PP	O
+1	+1	CD	B-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
reactive	reactive	JJ	I-NP	O
towards	towards	IN	B-PP	O
KMnO1	KMnO1	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
fully	fully	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
NifA	BEGIN-NifA-INSIDE	NN	B-NP	B

Mouse	BEGIN-Mouse	NN	B-NP	B
macrophage	macrophage	NN	I-NP	I
beta	beta	NN	I-NP	I
subunit	subunit	NN	I-NP	I
(	(	(	O	I
CD1b	CD1b	NN	B-NP	I
)	)	)	O	I
cDNA	cDNA-INSIDE	NN	B-NP	I
for	for	IN	B-PP	O
the	the	DT	B-NP	O
CR1	BEGIN-CR1	NN	I-NP	B
complement	complement	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
Mac	BEGIN-Mac	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
product	product	NN	I-NP	O
exhibits	exhibit	VBZ	B-VP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
identity	identity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
murine	BEGIN-murine	JJ	I-NP	B
voltage	voltage	NN	I-NP	I
-	-	HYPH	B-VP	I
gated	gate	VBN	B-NP	I
potassium	potassium	NN	I-NP	I
channel	channel	NN	I-NP	I
protein	protein	NN	I-NP	I
Kv1	Kv1-INSIDE	NN	I-NP	I
(	(	(	O	O
Kcna1	BEGIN-Kcna1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
repolarization	repolarization	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
membranes	membrane	NNS	I-NP	O

Elective	Elective	JJ	B-NP	O
replacement	replacement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
root	root	NN	I-NP	O
in	in	IN	B-PP	O
Marfan	Marfan	NNP	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O

Principles	Principle	NNS	B-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	NN	B-NP	O
hormone	hormone	NN	I-NP	O
treatment	treatment	NN	I-NP	O

Their	Their	PRP$	B-NP	O
main	main	JJ	I-NP	O
representatives	representative	NNS	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
American	American	JJ	I-NP	O
diagnostic	diagnostic	JJ	I-NP	O
and	and	CC	I-NP	O
statistical	statistical	JJ	I-NP	O
manual	manual	NN	I-NP	O
of	of	IN	B-PP	O
mental	mental	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
,	,	,	O	O
DSM	DSM	NN	B-NP	O
-	-	HYPH	O	O
III	III	CD	B-NP	O
,	,	,	O	O
its	its	PRP$	B-NP	O
revised	revise	VBN	I-NP	O
version	version	NN	I-NP	O
DSM	DSM	NN	I-NP	O
-	-	HYPH	B-NP	O
III	III	CD	I-NP	O
-	-	HYPH	I-NP	O
R	R	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
international	international	JJ	I-NP	O
classification	classification	NN	I-NP	O
of	of	IN	B-PP	O
mental	mental	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
iCD	iCD	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

Each	Each	DT	B-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
mL	mL	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
test	test	NN	I-NP	O
solutions	solution	NNS	I-NP	O
:	:	:	O	O
levobupivacaine	levobupivacaine	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
levobupivacaine	levobupivacaine	NN	B-NP	O
and	and	CC	O	O
fentanyl	fentanyl	NN	B-NP	O
1	1	CD	I-NP	O
microg	microg	NN	I-NP	O
/	/	SYM	B-NP	O
mL	mL	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
levobupivacaine	levobupivacaine	NN	B-NP	O
and	and	CC	O	O
fentanyl	fentanyl	NN	B-NP	O
1	1	CD	I-NP	O
microg	microg	NN	I-NP	O
/	/	SYM	O	O
mL	mL	NN	B-NP	O

Time	Time	NN	B-NP	O
for	for	IN	B-PP	O
action	action	NN	B-NP	O
on	on	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
immunisation	immunisation	NN	I-NP	O

Kramer	Kramer	NNP	B-NP	O
Hamburg	Hamburg	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
ISBN	ISBN	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O
1	1	CD	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
syndromatic	syndromatic	JJ	I-NP	O
day	day	NN	I-NP	O
-	-	HYPH	B-ADVP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
day	day	NN	I-NP	O
shifting	shifting	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
psychopathological	psychopathological	JJ	I-NP	O
features	feature	NNS	I-NP	O
with	with	IN	B-PP	O
manic	manic	JJ	B-NP	O
,	,	,	I-NP	O
depressive	depressive	JJ	I-NP	O
and	and	CC	I-NP	O
several	several	JJ	I-NP	O
mixed	mixed	JJ	I-NP	O
states	state	NNS	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
well	well	RB	I-NP	O
-	-	HYPH	I-NP	O
defined	define	VBN	I-NP	O
time	time	NN	I-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
studied	study	VBN	B-VP	O
and	and	CC	I-VP	O
reported	report	VBN	I-VP	O
on	on	RP	B-PRT	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
paper	paper	NN	I-NP	O

Internal	Internal	JJ	B-NP	O
controls	control	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
milk	milk	NN	B-NP	O
suckled	suckle	VBN	B-VP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
until	until	IN	B-PP	O
infant	infant	JJ	B-NP	O
rats	rat	NNS	I-NP	O
are	be	VBP	B-VP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	B-NP	O
gastric	gastric	JJ	B-NP	O
distension	distension	NN	I-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
,	,	,	O	O
systemic	systemic	JJ	B-NP	O
dehydration	dehydration	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
intestinal	BEGIN-intestinal	JJ	B-NP	B
hormone	hormone	NN	I-NP	I
cholecystokinin	cholecystokinin-INSIDE	NN	I-NP	I
suppress	suppress	VBP	B-VP	O
milk	milk	NN	B-NP	O
intake	intake	NN	I-NP	O
derived	derive	VBN	B-VP	O
through	through	IN	B-PP	O
suckling	suckling	NN	B-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
HIV	BEGIN-HIV	NN	I-NP	B
LTR	LTR-INSIDE	NN	I-NP	I
,	,	,	O	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
both	both	CC	B-NP	O
positive	positive	JJ	I-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
HIV	HIV	NN	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
rat	rat	NN	B-NP	O
brain	brain	NN	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
,	,	,	O	O
lung	lung	NN	B-NP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
,	,	,	O	O
kidney	kidney	NN	B-NP	O
and	and	CC	I-NP	O
skeletal	skeletal	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
psi	BEGIN-psi	JJ	B-NP	B
PKC	PKC	NN	I-NP	I
zeta	zeta	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
brain	brain	NN	B-NP	O

To	To	TO	B-VP	O
identify	identify	VB	I-VP	O
and	and	CC	I-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
Ino1p	BEGIN-BEGIN-Ino1-INSIDEp-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
raised	raise	VBD	B-VP	O
antibodies	antibody	NNS	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
galactosidase	galactosidase-INSIDE	NN	I-NP	I
/	/	SYM	I-NP	O
Ino1	BEGIN-Ino1-INSIDE	NN	I-NP	B
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
WR	WR	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
WR	WR	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
WR	WR	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
with	with	IN	B-PP	O
per	per	IN	B-PP	O
os	o	NNS	B-NP	O
administration	administration	NN	B-ADJP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
hematopoietic	hematopoietic	JJ	B-NP	O
lethality	lethality	NN	I-NP	O

Isolation	Isolation	NN	B-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
orthologs	ortholog	NNS	I-NP	O
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	O
CCR1	BEGIN-CCR1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
NOT	BEGIN-NOT-INSIDE	NN	I-NP	B
complex	complex	NN	I-NP	O
subunits	subunit	NNS	I-NP	O

Serum	Serum	NN	B-NP	O
AFP	BEGIN-AFP-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
marker	marker	NN	I-NP	O
for	for	IN	B-PP	O
monitoring	monitor	VBG	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O

The	The	DT	B-NP	O
paper	paper	NN	I-NP	O
calls	call	VBZ	B-VP	O
for	for	IN	B-PP	O
standardized	standardized	JJ	B-NP	O
question	question	NN	I-NP	O
formats	format	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
centralized	centralized	JJ	I-NP	O
body	body	NN	I-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
sexual	sexual	JJ	B-NP	O
behaviour	behaviour	NN	I-NP	O

A	A	DT	B-NP	O
heterologous	heterologous	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
construct	construct	NN	I-NP	O
containing	contain	VBG	B-VP	O
three	three	CD	B-NP	O
repeats	repeat	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	O
Sp1	BEGIN-Sp1	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I
,	,	,	O	O
cloned	clone	VBN	B-VP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
copy	copy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ZII	BEGIN-ZII-INSIDE	NN	I-NP	B
(	(	(	O	O
CREB	BEGIN-CREB-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
AP1	BEGIN-AP1-INSIDE	NN	I-NP	B
)	)	)	O	O
element	element	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
BZLF1	BEGIN-BZLF1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
globin	globin-INSIDE	NN	I-NP	I
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
,	,	,	O	O
exhibited	exhibit	VBD	B-VP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
inducibility	inducibility	NN	I-NP	O

A	A	DT	B-NP	O
long	long	JJ	I-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
study	study	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
children	child	NNS	I-NP	O
's	's	POS	B-NP	O
psychiatric	psychiatric	JJ	I-NP	O
day	day	NN	I-NP	O
treatment	treatment	NN	I-NP	O
center	center	NN	I-NP	O

Risk	Risk	NN	B-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
nutrition	nutrition	NN	B-NP	O
are	be	VBP	B-VP	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
hyperglycemia	hyperglycemia	NN	B-NP	O
-	-	HYPH	I-NP	O
diabetes	diabetes	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
salt	salt	NN	I-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
excessive	excessive	JJ	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
recently	recently	RB	I-NP	O
proposed	propose	VBN	I-NP	O
synthetic	synthetic	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
technique	technique	NN	I-NP	O
[	[	(	O	O
J	J	NN	B-NP	O

We	We	PRP	B-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
quantities	quantity	NNS	I-NP	O
collected	collect	VBN	B-VP	O
with	with	IN	B-PP	O
both	both	DT	B-NP	O
pollen	pollen	VBN	I-NP	O
traps	trap	NNS	I-NP	O
during	during	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	I-NP	O
March	March	NNP	I-NP	O
and	and	CC	O	O
April	April	NNP	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
CSF	CSF	NN	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
1	1	CD	B-NP	O
stimulated	stimulate	VBD	B-VP	O
oxygen	oxygen	NN	B-NP	O
consumption	consumption	NN	I-NP	O
above	above	IN	B-PP	O
our	our	PRP$	B-NP	O
cut	cut	VBN	B-VP	O
off	off	RP	B-PRT	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
did	do	VBD	O	O
not	not	RB	O	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mumol	mumol	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
/	/	SYM	B-NP	O
g	g	NN	I-NP	O
dry	dry	JJ	I-NP	O
wt	wt	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
;	;	:	O	O
SD	SD	NN	B-NP	O
n	n	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
minutes	minute	NNS	I-NP	O

These	These	DT	B-NP	O
psoralens	psoralen	NNS	I-NP	O
are	be	VBP	B-VP	O
being	be	VBG	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
research	research	NN	B-NP	O
projects	project	NNS	I-NP	O
sponsored	sponsor	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
National	National	NNP	I-NP	O
Toxicology	Toxicology	NNP	I-NP	O
Program	Program	NNP	I-NP	O

Four	Four	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
R1	BEGIN-R1-INSIDE	NN	B-NP	B
had	have	VBD	B-VP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
four	four	CD	I-NP	O
cases	case	NNS	I-NP	O
the	the	DT	B-NP	O
antibody	antibody	NN	I-NP	O
was	be	VBD	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IgA	BEGIN-IgA-INSIDE	NN	I-NP	B
class	class	NN	I-NP	O

Seventy	Seventy	CD	B-NP	O
-	-	HYPH	I-NP	O
nine	nine	CD	I-NP	O
percent	percent	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
children	child	NNS	I-NP	O
screened	screen	VBD	B-VP	O
and	and	CC	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
children	child	NNS	I-NP	O
with	with	IN	B-PP	O
PbB	PbB	NN	B-NP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
dL	dL	NN	I-NP	O
were	be	VBD	B-VP	O
Hispanic	Hispanic	JJ	B-ADJP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
here	here	RB	B-ADVP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
eight	eight	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	B-NP	O
old	old	JJ	I-NP	O
boy	boy	NN	I-NP	O
who	who	WP	B-NP	O
first	first	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
intravascular	intravascular	JJ	I-NP	O
hemolysis	hemolysis	NN	I-NP	O
following	follow	VBG	B-PP	O
therapy	therapy	NN	B-NP	O
with	with	IN	B-PP	O
amphotericin	amphotericin	NN	B-NP	O
B	B	NN	I-NP	O
(	(	(	O	O
AmB	AmB	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
subsequently	subsequently	RB	B-ADVP	O
a	a	DT	B-NP	O
delayed	delay	VBN	I-NP	O
hemolytic	hemolytic	JJ	I-NP	O
transfusion	transfusion	NN	I-NP	O
reaction	reaction	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
alloantibodies	alloantibody	NNS	B-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
Valsalva	Valsalva	NNP	I-NP	O
ratio	ratio	NN	I-NP	O
or	or	CC	I-NP	O
delta	delta	NN	I-NP	O
SBP	SBP	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O

The	The	DT	B-NP	O
PDSS	PDSS	NN	I-NP	O
identified	identify	VBD	B-VP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
women	woman	NNS	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
with	with	IN	B-PP	O
major	major	JJ	B-NP	O
postpartum	postpartum	NN	I-NP	O
depression	depression	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
EPDS	EPDS	NN	I-NP	O
identified	identify	VBD	B-VP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
women	woman	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
BDI	BDI	NNP	I-NP	O
-	-	HYPH	I-NP	O
II	II	CD	I-NP	O
identified	identify	VBD	B-VP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
women	woman	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

One	One	CD	B-NP	O
ORF	ORF	NN	I-NP	O
extends	extend	VBZ	B-VP	O
from	from	IN	B-PP	O
nucleotides	nucleotide	NNS	B-NP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
encodes	encode	VBZ	B-VP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
preceded	precede	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
ribosome	ribosome	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
site	site	NN	B-NP	O

Blood	BEGIN-Blood	NN	B-NP	B
coagulation	coagulation	NN	I-NP	I
Factor	Factor	NN	I-NP	I
X	X-INSIDE	NN	I-NP	I
and	and	CC	O	O
its	its	PRP$	B-NP	O
activated	activated	JJ	I-NP	O
form	form	NN	I-NP	O
Factor	BEGIN-Factor	NN	I-NP	B
Xa	Xa-INSIDE	NN	I-NP	I
play	play	VBP	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
midphase	midphase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clotting	clotting	NN	I-NP	O
cascade	cascade	NN	I-NP	O

The	The	DT	B-NP	O
Ras	BEGIN-Ras	NN	I-NP	B
GTPase	GTPase	NN	I-NP	I
-	-	HYPH	O	I
activating	activate	VBG	B-VP	I
-	-	HYPH	B-NP	I
protein	protein	NN	I-NP	I
-	-	HYPH	O	I
related	relate	VBN	B-NP	I
human	human	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
IQGAP1	BEGIN-IQGAP1-INSIDE	NN	I-NP	B
harbors	harbor	VBZ	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
actin	BEGIN-actin	NN	I-NP	B
binding	binding	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
and	and	CC	O	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
calmodulin	BEGIN-calmodulin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Rho	BEGIN-Rho	NN	I-NP	B
family	family	NN	I-NP	I
GTPases	GTPases-INSIDE	NN	I-NP	I

On	On	IN	B-PP	O
a	a	DT	B-NP	O
national	national	JJ	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
undiscounted	undiscounted	JJ	B-NP	O
costs	cost	NNS	I-NP	O
are	be	VBP	B-VP	O
expected	expect	VBN	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-PP	O
approximately	approximately	RB	B-NP	O
DF1	DF1	CD	I-NP	O
1	1	CD	I-NP	O
million	million	CD	I-NP	O
annually	annually	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
after	after	IN	B-PP	O
introduction	introduction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
preventative	preventative	JJ	I-NP	O
strategy	strategy	NN	I-NP	O

Reduction	Reduction	NN	B-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
OM	BEGIN-OM-INSIDE	NN	B-NP	B
treatment	treatment	NN	I-NP	O
and	and	CC	O	O
reached	reach	VBD	B-VP	O
maximal	maximal	JJ	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
in	in	IN	B-PP	O
H1	H1	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
in	in	IN	B-PP	O
MCF	MCF	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O

This	This	DT	B-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
place	place	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
compartment	compartment	NN	I-NP	O
as	as	IN	B-PP	O
normal	normal	JJ	B-NP	O
cis	cis	NN	I-NP	O
splicing	splicing	NN	I-NP	O
and	and	CC	O	O
proceeds	proceed	VBZ	B-VP	O
through	through	IN	B-PP	O
Y	Y	NN	B-NP	O
-	-	HYPH	B-NP	O
branched	branch	VBN	I-NP	O
intermediates	intermediate	NNS	I-NP	O
analogous	analogous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lariats	lariat	NNS	I-NP	O
formed	form	VBN	B-VP	O
in	in	IN	B-PP	O
cis	cis	NN	B-NP	O
splicing	splicing	NN	I-NP	O

Production	Production	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
chicken	chicken	NN	I-NP	O
meat	meat	NN	I-NP	O
infusion	infusion	NN	I-NP	O
broth	broth	NN	I-NP	O
suitable	suitable	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
mass	mass	NN	I-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Haemophilus	Haemophilus	NN	I-NP	O
gallinarum	gallinarum	NN	I-NP	O
bacterin	bacterin	NN	I-NP	O

The	The	DT	B-NP	O
maternal	BEGIN-maternal	JJ	I-NP	B
par	par	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
segregation	segregation	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
fate	fate	NN	I-NP	O
specification	specification	NN	I-NP	O
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
Caenorhabditis	Caenorhabditis	NN	I-NP	O
elegans	elegan	NNS	I-NP	O
embryos	embryo	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
may	may	MD	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
value	value	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O

Real	Real	JJ	B-NP	O
-	-	HYPH	I-NP	O
time	time	NN	I-NP	O
two	two	CD	B-NP	O
-	-	HYPH	I-NP	O
dimensional	dimensional	JJ	I-NP	O
echocardiographic	echocardiographic	JJ	I-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
in	in	IN	B-PP	O
short	short	JJ	B-NP	O
-	-	HYPH	I-NP	O
axis	axis	NN	I-NP	O
view	view	NN	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
normal	normal	JJ	I-NP	O
subjects	subject	NNS	I-NP	O

We	We	PRP	B-NP	O
determined	determine	VBD	B-VP	O
their	their	PRP$	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
polypeptides	polypeptide	NNS	I-NP	O
were	be	VBD	B-VP	O
CotT	BEGIN-CotT-INSIDE	NN	B-NP	B
,	,	,	O	O
YeeK	BEGIN-YeeK-INSIDE	NN	B-NP	B
,	,	,	O	O
YxeE	BEGIN-YxeE-INSIDE	NN	B-NP	B
,	,	,	O	O
CotF	BEGIN-CotF-INSIDE	NN	B-NP	B
,	,	,	O	O
YrbA	BEGIN-YrbA-INSIDE	NN	B-NP	B
(	(	(	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
SpoIVA	BEGIN-SpoIVA-INSIDE	NN	B-NP	B
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

The	The	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
diacetyl	diacetyl	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
pentanedione	pentanedione	NN	I-NP	O
and	and	CC	I-NP	O
acetoin	acetoin	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
steps	step	NNS	I-NP	O

The	The	DT	B-NP	O
same	same	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
firing	firing	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
with	with	IN	B-PP	O
saccades	saccade	NNS	B-NP	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
complete	complete	JJ	B-NP	O
darkness	darkness	NN	I-NP	O

The	The	DT	B-NP	O
critical	critical	JJ	I-NP	O
obstacle	obstacle	NN	I-NP	O
in	in	IN	B-PP	O
modeling	model	VBG	B-VP	O
psychiatric	psychiatric	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
limited	limit	VBN	I-VP	O
information	information	NN	B-NP	O
about	about	IN	B-PP	O
their	their	PRP$	B-NP	O
origin	origin	NN	I-NP	O
and	and	CC	O	O
underlying	underlie	VBG	B-VP	O
neural	neural	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
the	the	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
PMLRAR	BEGIN-PMLRAR	NN	B-NP	B
homodimers	homodimers-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
sequestration	sequestration	NN	I-NP	O
of	of	IN	B-PP	O
RXR	BEGIN-RXR-INSIDE	NN	B-NP	B
by	by	IN	B-PP	O
PMLRARs	BEGIN-PMLRARs-INSIDE	NN	B-NP	B
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
which	which	WDT	B-NP	O
underlie	underlie	VBP	B-VP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
APL	APL	NN	B-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Patients	Patient	NNS	B-NP	O
'	'	POS	B-NP	O
attainment	attainment	NN	I-NP	O
of	of	IN	B-PP	O
TGB	TGB	NN	B-NP	O
monotherapy	monotherapy	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
their	their	PRP$	B-NP	O
achievement	achievement	NN	I-NP	O
of	of	IN	B-PP	O
positive	positive	JJ	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
varying	vary	VBG	B-NP	O
degree	degree	NN	I-NP	O
on	on	IN	B-PP	O
psychological	psychological	JJ	B-NP	O
tests	test	NNS	I-NP	O

In	In	IN	B-PP	O
alfalfa	alfalfa	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
insecticides	insecticide	NNS	I-NP	O
caused	cause	VBD	B-VP	O
significant	significant	JJ	B-NP	O
mortality	mortality	NN	I-NP	O
to	to	TO	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
insects	insect	NNS	I-NP	O
evaluated	evaluate	VBD	B-VP	O

Sixtieth	Sixtieth	JJ	B-NP	O
anniversary	anniversary	NN	I-NP	O
of	of	IN	B-PP	O
Angiotensin	BEGIN-Angiotensin-INSIDE	NN	B-NP	B

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
transactivation	transactivation	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
p1c	BEGIN-p1c	NN	I-NP	B
-	-	HYPH	B-NP	I
ets	ets	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
pr	pr-INSIDE	NN	I-NP	I
p1erg	BEGIN-p1erg-INSIDE	NN	I-NP	B
through	through	IN	B-PP	O
the	the	DT	B-NP	O
Polyomavirus	BEGIN-Polyomavirus	NN	I-NP	B
enhancer	enhancer	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
specifically	specifically	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
p1kDaPax	BEGIN-p1kDaPax	NN	I-NP	B
-	-	HYPH	B-NP	I
QNR	QNR-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
assay	assay	NN	I-NP	O

SCAN	BEGIN-SCAN-INSIDE	NN	B-NP	B
boxes	box	NNS	I-NP	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
eight	eight	CD	B-NP	O
other	other	JJ	I-NP	O
genes	gene	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
GenBank	GenBank	NNP	I-NP	O
database	database	NN	I-NP	O
,	,	,	O	O
five	five	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Kruppel	BEGIN-Kruppel	NNP	I-NP	B
family	family-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
zinc	BEGIN-zinc	NN	B-NP	B
finger	finger	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
lacking	lack	VBG	B-VP	O
KRAB	BEGIN-KRAB	NN	B-NP	B
A	A	NN	I-NP	I
and	and	CC	I-NP	I
B	B-INSIDE	NN	I-NP	I
domains	domain	NNS	I-NP	O
and	and	CC	O	O
thereby	thereby	RB	B-VP	O
define	define	VB	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
subclass	subclass	NN	I-NP	O
of	of	IN	B-PP	O
zinc	BEGIN-zinc	NN	B-NP	B
finger	finger	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
in	in	IN	B-PP	O
-	-	HYPH	B-NP	O
plane	plane	NN	I-NP	O
orientational	orientational	JJ	I-NP	O
anisotropy	anisotropy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1CB	1CB	NN	I-NP	O
films	film	NNS	I-NP	O
grown	grow	VBN	B-VP	O
on	on	IN	B-PP	O
unidirectionally	unidirectionally	RB	B-NP	O
photopolymerized	photopolymerized	JJ	I-NP	O
PVCN	PVCN	NN	I-NP	O
substrates	substrate	NNS	I-NP	O
is	be	VBZ	B-VP	O
considerably	considerably	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
intrinsic	intrinsic	JJ	I-NP	O
surface	surface	NN	I-NP	O
orientational	orientational	JJ	I-NP	O
anisotropy	anisotropy	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
substrates	substrate	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
generally	generally	RB	I-NP	O
found	find	VBN	I-NP	O
weak	weak	JJ	I-NP	O
surface	surface	NN	I-NP	O
anchoring	anchoring	NN	I-NP	O
of	of	IN	B-PP	O
liquid	liquid	JJ	B-NP	O
crystals	crystal	NNS	I-NP	O
on	on	IN	B-PP	O
PVCN	PVCN	NN	B-NP	O
alignment	alignment	NN	I-NP	O
layers	layer	NNS	I-NP	O

The	The	DT	B-NP	O
introduction	introduction	NN	I-NP	O
of	of	IN	B-PP	O
FWD1	BEGIN-FWD1-INSIDE	NN	B-NP	B
into	into	IN	B-PP	O
cells	cell	NNS	B-NP	O
significantly	significantly	RB	B-VP	O
promotes	promote	VBZ	I-VP	O
ubiquitination	ubiquitination	NN	B-NP	O
and	and	CC	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
IkappaBalpha	BEGIN-IkappaBalpha-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
concert	concert	NN	B-NP	O
with	with	IN	B-PP	O
IkappaB	BEGIN-IkappaB	NN	B-NP	B
kinases	kinases-INSIDE	NN	I-NP	I
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	O	I
kappaB	kappaB-INSIDE	NN	B-NP	I

Since	Since	IN	B-SBAR	O
blood	blood	NN	B-NP	O
serotonin	serotonin	NN	I-NP	O
is	be	VBZ	B-VP	O
primarily	primarily	RB	I-VP	O
produced	produce	VBN	I-VP	O
peripherally	peripherally	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
some	some	DT	B-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
serotonin	serotonin	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
is	be	VBZ	B-VP	O
abnormal	abnormal	JJ	B-ADJP	O
in	in	IN	B-PP	O
major	major	JJ	B-NP	O
depression	depression	NN	I-NP	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
aplastic	aplastic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
previously	previously	RB	B-ADVP	O
and	and	CC	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
hospitalized	hospitalize	VBN	B-VP	O
,	,	,	O	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
methyl	methyl	NN	B-NP	O
prednisolone	prednisolone	NN	I-NP	O
pulse	pulse	NN	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
successful	successful	JJ	B-ADJP	O

We	We	PRP	B-NP	O
next	next	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
purification	purification	NN	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
bacterial	BEGIN-bacterial	JJ	B-NP	B
recombinant	recombinant	JJ	I-NP	I
MyoD	MyoD	NN	I-NP	I
-	-	HYPH	B-NP	I
bHLH	bHLH	JJ	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
affinity	affinity	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
calmodulin	BEGIN-calmodulin-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
Sepharose	Sepharose	NN	B-NP	O
column	column	NN	I-NP	O
and	and	CC	O	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
peptide	peptide	NN	I-NP	O
by	by	IN	B-PP	O
PKC	BEGIN-PKC-INSIDE	NN	B-NP	B
and	and	CC	O	O
its	its	PRP$	B-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
calmodulin	BEGIN-calmodulin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
S1a	BEGIN-S1a-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
d	d	NN	I-NP	O
orbital	orbital	JJ	I-NP	O
flight	flight	NN	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
onboard	onboard	IN	B-PP	O
the	the	DT	B-NP	O
Cosmos	Cosmos	NNP	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
biosatellite	biosatellite	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
erythroblastosis	erythroblastosis	NN	B-NP	O
,	,	,	O	O
alteration	alteration	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morphology	morphology	NN	I-NP	O
of	of	IN	B-PP	O
megakaryocytes	megakaryocyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
myelopoiesis	myelopoiesis	NN	B-NP	O

Partial	Partial	JJ	B-NP	O
albinism	albinism	NN	I-NP	O
and	and	CC	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
:	:	:	O	O
ultrastructural	ultrastructural	JJ	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
haemophagocytosis	haemophagocytosis	NN	B-NP	O
and	and	CC	I-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
erythroblasts	erythroblast	NNS	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
case	case	NN	I-NP	O

Optical	Optical	JJ	B-NP	O
rotation	rotation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
harmonic	harmonic	JJ	I-NP	O
radiation	radiation	NN	I-NP	O
from	from	IN	B-PP	O
retinal	retinal	NN	B-NP	O
in	in	IN	B-PP	O
bacteriorhodopsin	BEGIN-bacteriorhodopsin	NN	B-NP	B
monomers	monomers-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
Langmuir	Langmuir	NNP	B-NP	O
-	-	HYPH	B-NP	O
Blodgett	Blodgett	NNP	I-NP	O
film	film	NN	I-NP	O
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
nonplanar	nonplanar	JJ	B-NP	O
retinal	retinal	NN	I-NP	O
structure	structure	NN	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Twenty	Twenty	CD	B-NP	O
-	-	HYPH	O	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
ST	ST	NN	B-NP	O
-	-	HYPH	I-NP	O
segment	segment	NN	I-NP	O
depression	depression	NN	I-NP	O
during	during	IN	B-PP	O
AEM	AEM	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
(	(	NN	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
ExT	ExT	NN	B-NP	O

Enhanced	Enhance	VBN	B-NP	O
quantum	quantum	NN	I-NP	O
correlations	correlation	NNS	I-NP	O
in	in	IN	B-PP	O
bound	bind	VBN	B-NP	O
higher	high	JJR	I-NP	O
-	-	HYPH	I-NP	O
order	order	NN	I-NP	O
solitons	soliton	NNS	I-NP	O
Quantum	Quantum	NNP	I-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
bound	bind	VBN	I-NP	O
solitons	soliton	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
drastically	drastically	RB	I-VP	O
enhanced	enhance	VBN	I-VP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
fundamental	fundamental	JJ	I-NP	O
soliton	soliton	NN	I-NP	O

Acute	Acute	JJ	B-NP	O
intoxication	intoxication	NN	I-NP	O
with	with	IN	B-PP	O
cypermethrin	cypermethrin	NN	B-NP	O
(	(	(	O	O
NRDC	NRDC	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Anesthesia	Anesthesia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
radical	radical	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
of	of	IN	B-PP	O
arteriosclerotic	arteriosclerotic	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
disease	disease	NN	I-NP	O

Whereas	Whereas	IN	B-SBAR	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
alpha	BEGIN-alpha	NN	B-NP	B
-	-	HYPH	B-NP	I
actinin	actinin-INSIDE	NN	I-NP	I
(	(	(	O	O
Noegel	Noegel	NNP	B-NP	O
,	,	,	O	O
A.	A.	NNP	B-NP	O
,	,	,	O	O
W	W	NNP	B-NP	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
prenatal	prenatal	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
androgen	androgen	NN	B-NP	O
-	-	HYPH	O	O
based	base	VBN	B-VP	O
synthetic	synthetic	JJ	B-NP	O
progestin	progestin	NN	I-NP	O
exerted	exert	VBD	B-VP	O
a	a	DT	B-NP	O
masculinizing	masculinizing	NN	I-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
defeminizing	defeminize	VBG	B-VP	O
influence	influence	NN	B-NP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	O
behavioral	behavioral	JJ	I-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
prenatal	prenatal	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
natural	natural	JJ	B-NP	O
progesterone	progesterone	NN	I-NP	O
and	and	CC	I-NP	O
progesterone	progesterone	NN	I-NP	O
-	-	HYPH	O	O
based	base	VBN	B-VP	O
synthetic	synthetic	JJ	B-NP	O
progestin	progestin	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
feminizing	feminizing	NN	I-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
demasculinizing	demasculinize	VBG	B-VP	O
influence	influence	NN	B-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
among	among	IN	B-PP	O
female	female	JJ	B-NP	O
subjects	subject	NNS	I-NP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
canine	canine	JJ	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
LCX	LCX	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
CFR	CFR	NN	B-NP	O
was	be	VBD	B-VP	O
impaired	impaired	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
ischemic	ischemic	JJ	I-NP	O
and	and	CC	I-NP	O
remote	remote	JJ	I-NP	O
nonischemic	nonischemic	JJ	I-NP	O
regions	region	NNS	I-NP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-VP	O
moderate	moderate	VB	I-VP	O
ischemic	ischemic	JJ	B-NP	O
-	-	HYPH	I-NP	O
induced	induce	VBN	I-NP	O
regional	regional	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O

Parathyroid	BEGIN-Parathyroid	JJ	B-NP	B
hormone	hormone-INSIDE	NN	I-NP	I
responses	response	NNS	I-NP	O
of	of	IN	B-PP	O
cyclic	cyclic	JJ	B-NP	O
AMP	AMP	NN	I-NP	O
-	-	HYPH	B-ADJP	O
,	,	,	O	O
serum	serum	NN	B-NP	O
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
-	-	HYPH	B-NP	O
responsive	responsive	JJ	I-NP	O
reporter	reporter	NN	I-NP	O
genes	gene	NNS	I-NP	O
in	in	IN	B-PP	O
osteoblast	osteoblast	NN	B-NP	O
-	-	HYPH	O	O
like	like	JJ	B-NP	O
UMR	UMR	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O

Genome	Genome	NN	B-NP	O
timeline	timeline	NN	I-NP	O

The	The	DT	B-NP	O
``	``	``	I-NP	O
Ulm	Ulm	NNP	I-NP	O
Zucker	Zucker	NNP	I-NP	O
Uhr	Uhr	NNP	I-NP	O
System	System	NNP	I-NP	O
''	''	''	O	O
comprises	comprise	VBZ	B-VP	O
a	a	DT	B-NP	O
microdialysis	microdialysis	NN	I-NP	O
probe	probe	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
biosensor	biosensor	NN	I-NP	O
(	(	(	O	O
Glucosensor	Glucosensor	NNP	B-NP	O
Unitec	Unitec	NNP	I-NP	O
Ulm	Ulm	NNP	I-NP	O
s.c.	s.c.	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
sender	sender	NN	I-NP	O
transferring	transfer	VBG	B-VP	O
telemetrically	telemetrically	RB	B-ADVP	O
the	the	DT	B-NP	O
glucose	glucose	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
receiving	receiving	NN	I-NP	O
indicator	indicator	NN	I-NP	O

Previous	Previous	JJ	B-NP	O
work	work	NN	I-NP	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
glucose	glucose	NN	B-NP	O
repression	repression	NN	I-NP	O
of	of	IN	B-PP	O
PRB1	BEGIN-PRB1-INSIDE	NN	B-NP	B
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
HXK1	BEGIN-HXK1-INSIDE	NN	B-NP	B
or	or	CC	B-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
SNF1	BEGIN-SNF1-INSIDE	NN	I-NP	B
,	,	,	O	O
SNF1	BEGIN-SNF1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
SNF1	BEGIN-BEGIN-SNF1-INSIDE	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
(	(	(	O	O
C	C	NN	B-NP	O

The	The	DT	B-NP	O
cumulative	cumulative	JJ	I-NP	O
experience	experience	NN	I-NP	O
in	in	IN	B-PP	O
liver	liver	NN	B-NP	O
transplantation	transplantation	NN	I-NP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
introduction	introduction	NN	I-NP	O
of	of	IN	B-PP	O
cyclosporine	cyclosporine	NN	B-NP	O
A	A	NN	I-NP	O
has	have	VBZ	B-VP	O
confirmed	confirm	VBN	I-VP	O
its	its	PRP$	B-NP	O
efficacy	efficacy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
diverse	diverse	JJ	B-NP	O
liver	liver	NN	I-NP	O
diseases	disease	NNS	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
and	and	CC	I-NP	O
adults	adult	NNS	I-NP	O

Our	Our	PRP$	B-NP	O
objective	objective	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
find	find	VB	I-VP	O
possible	possible	JJ	B-NP	O
predictors	predictor	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
and	and	CC	I-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
LJM	LJM	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
LJM	LJM	NN	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
long	long	JJ	I-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
complications	complication	NNS	I-NP	O
of	of	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O

To	To	TO	B-VP	O
test	test	VB	I-VP	O
this	this	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
system	system	NN	I-NP	O
of	of	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
of	of	IN	B-PP	O
rat	rat	NN	B-NP	O
adipocytes	adipocyte	NNS	I-NP	O
with	with	IN	B-PP	O
constructs	construct	NNS	B-NP	O
containing	contain	VBG	B-VP	O
glyceraldehyde	BEGIN-glyceraldehyde	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
phosphate	phosphate	NN	I-NP	I
dehydrogenase	dehydrogenase-INSIDE	NN	I-NP	I
(	(	(	O	O
GAPDH	BEGIN-GAPDH-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
fatty	BEGIN-fatty	JJ	B-NP	B
acid	acid	NN	I-NP	I
synthetase	synthetase-INSIDE	NN	I-NP	I
(	(	(	O	O
FAS	BEGIN-FAS-INSIDE	NN	B-NP	B
)	)	)	O	O
promoters	promoter	NNS	B-NP	O
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
gene	BEGIN-gene	JJ	B-NP	B
reporter	reporter	NN	I-NP	I
CAT	CAT-INSIDE	NN	I-NP	I

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
available	available	JJ	I-NP	O
databases	database	NNS	I-NP	O
reveals	reveal	VBZ	B-VP	O
very	very	RB	B-NP	O
significant	significant	JJ	I-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ETS	BEGIN-ETS	JJ	I-NP	B
factor	factor-INSIDE	NN	I-NP	I
PE	BEGIN-PE	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
probable	probable	JJ	B-NP	O
near	near	JJ	I-NP	O
-	-	HYPH	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
recently	recently	RB	I-NP	O
cloned	clone	VBN	I-NP	O
factor	factor	NN	I-NP	O
ERF	BEGIN-ERF-INSIDE	NN	I-NP	B

Eight	Eight	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
suppressors	suppressor	NNS	I-NP	O
for	for	IN	B-PP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
complementation	complementation	NN	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
designated	designate	VBN	B-NP	O
KCS1	BEGIN-KCS1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
KCS1	BEGIN-KCS1-INSIDE	NN	I-NP	B

Also	Also	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
PdNi	PdNi	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
segments	segment	NNS	I-NP	O
reduces	reduce	VBZ	B-VP	O
the	the	DT	B-NP	O
heat	heat	NN	I-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
seed	seed	NN	I-NP	O

Further	Further	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CAP1	BEGIN-CAP1	NN	I-NP	B
locus	locus	NN	I-NP	I
of	of	IN	B-PP	I
Cryptococcus	Cryptococcus	NNP	B-NP	I
neoformans	neoformans-INSIDE	NN	I-NP	I
:	:	:	O	O
structure	structure	NN	B-NP	O
defined	define	VBN	B-VP	O
by	by	IN	B-PP	O
forced	force	VBN	B-NP	O
expression	expression	NN	I-NP	O
and	and	CC	I-NP	O
description	description	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
ribosomal	BEGIN-ribosomal	JJ	I-NP	B
protein	protein	NN	I-NP	I
-	-	HYPH	O	I
encoding	encode	VBG	B-VP	I
gene	gene-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
group	group	NN	I-NP	O
effect	effect	NN	I-NP	O
only	only	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
task	task	NN	I-NP	O

Localization	Localization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
porcine	porcine	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
endoplasmic	endoplasmic	JJ	I-NP	O
reticulum	reticulum	NN	I-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
immuno	immuno	AFX	B-NP	O
-	-	HYPH	I-NP	O
electron	electron	NN	I-NP	O
-	-	HYPH	O	O
microscopic	microscopic	JJ	B-NP	O
studies	study	NNS	I-NP	O
using	use	VBG	B-VP	O
pig	pig	NN	B-NP	O
hepatocytes	hepatocyte	NNS	I-NP	O

These	These	DT	B-NP	O
larger	large	JJR	I-NP	O
sizes	size	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
predictions	prediction	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pol	BEGIN-pol	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

More	More	RBR	B-ADJP	O
important	important	JJ	I-ADJP	O
,	,	,	O	O
ligand	ligand	NN	B-NP	O
-	-	HYPH	B-NP	O
activated	activate	VBN	I-NP	O
insulin	BEGIN-insulin-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
IGF	BEGIN-IGF	NN	I-NP	B
-	-	HYPH	B-NP	I
I	I	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
phosphorylate	phosphorylate	NN	I-NP	O
SHC	BEGIN-SHC	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
SHC	BEGIN-SHC	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
could	could	MD	B-VP	O
be	be	VB	I-VP	O
direct	direct	JJ	B-NP	O
substrates	substrate	NNS	I-NP	O
for	for	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
IGF	BEGIN-IGF	NN	I-NP	B
-	-	HYPH	B-NP	I
I	I	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I

International	International	JJ	B-NP	O
efforts	effort	NNS	I-NP	O
are	be	VBP	B-VP	O
now	now	RB	I-VP	O
being	be	VBG	I-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
standardize	standardize	VB	I-VP	O
haemolytic	haemolytic	JJ	B-NP	O
test	test	NN	I-NP	O
conditions	condition	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
is	be	VBZ	B-VP	O
meant	mean	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
contribution	contribution	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O

The	The	DT	B-NP	O
DFA	DFA	NN	I-NP	O
slide	slide	NN	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ThinPrep	ThinPrep	NN	I-NP	O
Test	Test	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
DFA	DFA	NN	I-NP	O
sample	sample	NN	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
endocervical	endocervical	JJ	I-NP	O
swab	swab	NN	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
independently	independently	RB	B-ADVP	O

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
types	BEGIN-type	NNS	B-NP	B
I	I	CD	B-NP	I
and	and	CC	I-NP	I
II	II	CD	I-NP	I
collagen	collagen-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
cross	cross	AFX	I-NP	O
-	-	HYPH	I-NP	O
reaction	reaction	NN	I-NP	O
with	with	IN	B-PP	O
type	BEGIN-type	NN	B-NP	B
III	III	CD	I-NP	I
collagen	collagen-INSIDE	NN	I-NP	I
peptides	peptide	NNS	I-NP	O

The	The	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
estrogen	BEGIN-estrogen	NN	I-NP	B
receptor	receptor	NN	I-NP	I
gene	gene	NN	I-NP	I
of	of	IN	B-PP	I
Oreochromis	Oreochromis	NNP	B-NP	I
aureus	aureus-INSIDE	NNP	I-NP	I
(	(	(	O	O
OaER	BEGIN-OaER-INSIDE	NN	B-NP	B
)	)	)	O	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
hormone	hormone	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
E	E	NN	B-NP	O
domain	domain	NN	I-NP	O
is	be	VBZ	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
interspersed	intersperse	VBN	B-VP	O
by	by	IN	B-PP	O
short	short	JJ	B-NP	O
introns	intron	NNS	I-NP	O
of	of	IN	B-PP	O
only	only	RB	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
each	each	DT	B-NP	O

To	To	TO	B-VP	O
test	test	VB	I-VP	O
for	for	IN	B-PP	O
progesterone	BEGIN-progesterone	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O
,	,	,	O	O
reporter	reporter	NN	B-NP	O
plasmids	plasmid	NNS	I-NP	O
were	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
to	to	TO	B-VP	O
transform	transform	VB	I-VP	O
yeast	yeast	NN	B-NP	O
cells	cell	NNS	I-NP	O
expressing	express	VBG	B-VP	O
PRB	BEGIN-PRB-INSIDE	NN	B-NP	B
or	or	CC	O	O
C1C1	BEGIN-C1C1	NN	B-NP	B
receptors	receptors-INSIDE	NN	I-NP	I

Beyond	Beyond	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
year	year	NN	I-NP	O
post	post	AFX	O	O
-	-	HYPH	B-NP	O
renal	renal	JJ	I-NP	O
transplantation	transplantation	NN	I-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
C	C	NN	B-NP	O
(	(	(	O	O
IO	IO	NN	B-NP	O
)	)	)	O	O
between	between	IN	B-PP	O
LRD	LRD	NN	B-NP	O
and	and	CC	I-NP	O
CAD	CAD	NN	I-NP	O
allografts	allograft	NNS	I-NP	O

TAF	BEGIN-TAF	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
activates	activate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
constitutively	constitutively	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
A	A	NN	I-NP	O
-	-	HYPH	I-NP	O
region	region	NN	I-NP	O

The	The	DT	B-NP	O
ventricular	ventricular	JJ	I-NP	O
demand	demand	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
(	(	(	O	O
VVI	VVI	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
implanted	implant	VBN	I-VP	O
three	three	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
because	because	RB	B-PP	O
of	of	IN	I-PP	O
further	further	JJ	B-NP	O
impairment	impairment	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
performance	performance	NN	I-NP	O
an	an	DT	B-NP	O
av	av	NN	I-NP	O
-	-	HYPH	B-NP	O
sequential	sequential	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
(	(	(	O	O
DDD	DDD	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
restore	restore	VB	I-VP	O
atrio	atrio	AFX	B-NP	O
-	-	HYPH	I-NP	O
ventricular	ventricular	JJ	B-NP	O
synchronisation	synchronisation	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
downregulation	downregulation	NN	I-NP	O
during	during	IN	B-PP	O
hematopoiesis	hematopoiesis	NN	B-NP	O
occured	occur	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
initiation	initiation	NN	I-NP	O

Following	Follow	VBG	B-PP	O
replicate	replicate	NN	B-NP	O
control	control	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
,	,	,	O	O
test	test	NN	B-NP	O
ramps	ramp	NNS	I-NP	O
were	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
nitroprusside	nitroprusside	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
phentolamine	phentolamine	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
eliminate	eliminate	VB	I-VP	O
potential	potential	JJ	B-NP	O
smooth	smooth	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
and	and	CC	O	O
alpha	BEGIN-alpha	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
adrenoceptor	adrenoceptor-INSIDE	JJ	I-NP	I
effects	effect	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Individual	Individual	JJ	B-NP	O
and	and	CC	I-NP	O
combined	combined	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
fumonisin	BEGIN-fumonisin	NN	B-NP	B
B1	B1-INSIDE	NN	I-NP	I
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
Fusarium	Fusarium	NNP	B-NP	O
moniliforme	moniliforme	NNP	I-NP	O
culture	culture	NN	I-NP	O
material	material	NN	I-NP	O
and	and	CC	O	O
diacetoxyscirpenol	diacetoxyscirpenol	NN	B-NP	O
or	or	CC	I-NP	O
ochratoxin	ochratoxin	NN	I-NP	O
A	A	NN	I-NP	O
in	in	IN	B-PP	O
turkey	turkey	NN	B-NP	O
poults	poult	NNS	I-NP	O

This	This	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
domain	domain	NN	I-NP	O
contains	contain	VBZ	B-VP	O
several	several	JJ	B-NP	O
YxxI	YxxI	NN	I-NP	O
/	/	SYM	I-NP	O
L	L	NN	I-NP	O
motifs	motif	NNS	I-NP	O
reminiscent	reminiscent	JJ	B-ADJP	O
of	of	IN	B-PP	O
LMP1A	BEGIN-BEGIN-LMP1-INSIDEA-INSIDE	NN	B-NP	B
and	and	CC	O	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
TRAF	BEGIN-TRAF	NN	I-NP	B
binding	binding	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
in	in	IN	B-PP	O
LMP1	BEGIN-LMP1-INSIDE	NN	B-NP	B

Possibilities	Possibility	NNS	B-NP	O
and	and	CC	I-NP	O
limints	limint	NNS	I-NP	O
of	of	IN	B-PP	O
immunofluorescence	immunofluorescence	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
laboratory	laboratory	NN	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
rabies	raby	NNS	B-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
nt	nt	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rotavirus	rotavirus	NN	I-NP	O
1	1	CD	I-NP	O
'	'	''	I-NP	O
TE	TE	NN	I-NP	O
represents	represent	VBZ	B-VP	O
by	by	IN	B-PP	O
far	far	RB	B-ADVP	O
the	the	DT	B-NP	O
shortest	short	JJS	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
enhancers	enhancer	NNS	I-NP	O
known	know	VBN	B-VP	O
to	to	TO	B-VP	O
stimulate	stimulate	VB	I-VP	O
translation	translation	NN	B-NP	O

Muscle	Muscle	NN	B-NP	O
and	and	CC	I-NP	O
liver	liver	NN	I-NP	O
biopsies	biopsy	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
anomalies	anomaly	NNS	I-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
without	without	IN	B-PP	O
branching	BEGIN-branching	JJ	B-NP	B
enzyme	enzyme-INSIDE	NN	I-NP	I
deficiency	deficiency	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O

The	The	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	I-NP	I
bp	bp	NN	I-NP	I
wild	wild	JJ	I-NP	I
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
HIT1	HIT1	NN	I-NP	I
DNA	DNA-INSIDE	NN	I-NP	I
which	which	WDT	B-NP	O
contained	contain	VBD	B-VP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
AGG	BEGIN-AGG	NN	I-NP	B
arginine	arginine	NN	I-NP	I
tRNA	tRNA	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
complemented	complement	VBD	B-VP	O
all	all	DT	B-NP	O
hit1	BEGIN-hit1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mutant	mutant	JJ	I-NP	I
phenotypes	phenotypes-INSIDE	NN	I-NP	I
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
phenotypes	phenotype	NNS	I-NP	O
were	be	VBD	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
deletion	deletion	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O

The	The	DT	B-NP	O
chicken	chicken	NN	I-NP	O
genome	genome	NN	I-NP	O
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
functional	functional	JJ	I-NP	O
nonallelic	nonallelic	JJ	I-NP	O
beta1	BEGIN-beta1	NN	I-NP	B
,	,	,	O	I
1	1	CD	B-NP	I
-	-	HYPH	I-NP	I
galactosyltransferase	galactosyltransferase	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I

Human	BEGIN-Human	JJ	B-NP	B
CR1	CR1-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
restricted	restricted	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
expressed	express	VBN	I-VP	O
on	on	IN	B-PP	O
B	B	NN	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
,	,	,	O	O
dendritic	dendritic	JJ	B-NP	O
cells	cell	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
,	,	,	O	O
pharyngeal	pharyngeal	JJ	B-NP	O
epithelial	epithelial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
levels	level	NNS	I-NP	O
on	on	IN	B-PP	O
some	some	DT	B-NP	O
T	T	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O

Heterotrimeric	Heterotrimeric	JJ	B-NP	O
guanine	BEGIN-guanine	NN	I-NP	B
nucleotide	nucleotide	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
proteins	proteins-INSIDE	NN	B-NP	I
(	(	(	O	O
G	BEGIN-G	NN	B-NP	B
-	-	HYPH	B-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
)	)	)	O	O
function	function	NN	B-NP	O
as	as	IN	B-PP	O
signal	signal	NN	B-NP	O
transducers	transducer	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
hormone	hormone	NN	B-NP	O
-	-	HYPH	B-NP	O
coupled	couple	VBN	I-NP	O
enzyme	enzyme	NN	I-NP	O
and	and	CC	I-NP	O
ion	ion	NN	I-NP	O
transport	transport	NN	I-NP	O
systems	system	NNS	I-NP	O
in	in	IN	B-PP	O
eukaryotic	eukaryotic	JJ	B-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
enzyme	BEGIN-enzyme	NN	I-NP	B
ACC	ACC	NN	I-NP	I
oxidase	oxidase-INSIDE	NN	I-NP	I
catalyses	catalyse	VBZ	B-VP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
step	step	NN	I-NP	O
of	of	IN	B-PP	O
ethylene	ethylene	NN	B-NP	O
biosynthesis	biosynthesis	NN	I-NP	O
in	in	IN	B-PP	O
plants	plant	NNS	B-NP	O
,	,	,	O	O
converting	convert	VBG	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
aminocyclopropane	aminocyclopropane	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
carboxylic	carboxylic	JJ	I-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
ACC	ACC	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
ethylene	ethylene	NN	B-NP	O

Virol	Virol	NNP	B-NP	O

Mibefradil	Mibefradil	NN	B-NP	O
(	(	(	O	O
Ro	Ro	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
nondihydropyridine	nondihydropyridine	NN	I-NP	O
calcium	calcium	NN	I-NP	O
antagonist	antagonist	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
the	the	DT	B-NP	O
chloramphenicol	BEGIN-chloramphenicol	NN	I-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
(	(	(	O	O
CAT	BEGIN-CABEGIN-T-INSIDE-INSIDE	NN	B-NP	B
)	)	)	O	O
reporter	reporter	NN	B-NP	O
gene	gene	NN	I-NP	O
system	system	NN	I-NP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
T	BEGIN-T-INSIDE	NN	B-NP	B
on	on	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	O
terminal	terminal	JJ	I-NP	O
repeats	repeat	NNS	I-NP	O
(	(	(	O	O
LTRs	LBEGIN-T-INSIDER	NNS	B-NP	I
)	)	)	O	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
endogenous	endogenous	JJ	I-NP	O
retrovirus	retrovirus	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
,	,	,	O	O
RTVL	RBEGIN-T-INSIDEVL	NN	B-NP	I
-	-	HYPH	O	O
H	H	NN	B-NP	O

They	They	PRP	B-NP	O
contain	contain	VBP	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
X	X	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
base	base	NN	B-NP	O
-	-	HYPH	B-NP	O
pairs	pair	NNS	I-NP	O
)	)	)	O	O
intron	intron	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
further	further	RBR	I-VP	O
interrupted	interrupt	VBN	I-VP	O
close	close	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O

The	The	DT	B-NP	O
recombinant	recombinant	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	O
-	-	HYPH	I-NP	O
length	length	NN	I-NP	O
polyhedrin	BEGIN-polyhedrin-INSIDE	NN	I-NP	B
leader	leader	NN	I-NP	O
sequence	sequence	NN	I-NP	O
gave	give	VBD	B-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
N	BEGIN-N	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
AcNPV	BEGIN-AcNPV	NN	B-NP	B
polyhedrin	BEGIN-polyhedrin-INSIDE	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I

Long	Long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
results	result	NNS	I-NP	O
and	and	CC	O	O
curative	curative	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
vesicoureteral	vesicoureteral	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
by	by	IN	B-PP	O
endoscopic	endoscopic	JJ	B-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O

Primer	Primer	NN	B-NP	O
extension	extension	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
using	use	VBG	B-VP	O
dbcAMP	dbcAMP	NN	B-NP	O
-	-	HYPH	O	O
differentiated	differentiate	VBN	B-NP	O
U1	U1	NN	I-NP	O
RNA	RNA	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
initiation	initiation	NN	I-NP	O
site	site	NN	I-NP	O

Sequences	Sequence	NNS	B-NP	O
within	within	IN	B-PP	O
and	and	CC	O	O
flanking	flank	VBG	B-VP	O
hypersensitive	hypersensitive	JJ	B-NP	O
sites	site	NNS	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
globin	globin-INSIDE	NN	I-NP	I
locus	locus	NN	I-NP	O
control	control	NN	I-NP	O
region	region	NN	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
synergistic	synergistic	JJ	B-NP	O
versus	versus	IN	B-PP	O
additive	additive	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
epsilon	BEGIN-epsilon	NN	I-NP	B
-	-	HYPH	B-NP	I
globin	globin	NN	I-NP	I
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

Four	Four	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
as	as	IN	B-PP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
benign	benign	JJ	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
false	false	JJ	B-NP	O
-	-	HYPH	I-NP	O
negatives	negative	NNS	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
mean	mean	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
cells	cell	NNS	I-NP	O
/	/	SYM	O	O
mm1	mm1	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
laser	laser	NN	I-NP	O
group	group	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
cells	cell	NNS	I-NP	O
/	/	SYM	O	O
mm1	mm1	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O

Using	Use	VBG	B-VP	O
reporter	reporter	NN	B-NP	O
gene	gene	NN	I-NP	O
constructs	construct	NNS	I-NP	O
driven	drive	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
CD1	BEGIN-CD1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
HHV	HHV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
can	can	MD	B-VP	O
efficiently	efficiently	RB	I-VP	O
transactivate	transactivate	VB	I-VP	O
such	such	JJ	B-NP	O
genetic	genetic	JJ	I-NP	O
elements	element	NNS	I-NP	O

Through	Through	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
library	library	NN	I-NP	O
screening	screening	NN	I-NP	O
and	and	CC	I-NP	O
PCR	PCR	NN	I-NP	O
-	-	HYPH	O	O
based	base	VBN	B-VP	O
genomic	genomic	JJ	B-ADJP	O
walking	walk	VBG	B-VP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
now	now	RB	I-VP	O
cloned	clone	VBN	I-VP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
E	E	NN	I-NP	I
-	-	HYPH	B-NP	I
Tmod	Tmod	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
whose	whose	WP$	B-NP	O
coding	cod	VBG	B-VP	O
region	region	NN	B-NP	O
spans	span	NNS	I-NP	O
approximately	approximately	RB	B-ADVP	O
1kb	1kb	VBP	B-VP	O
containing	contain	VBG	I-VP	O
nine	nine	CD	B-NP	O
exons	exon	NNS	I-NP	O
and	and	CC	O	O
eight	eight	CD	B-NP	O
introns	intron	NNS	I-NP	O

On	On	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
fronts	front	NNS	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
infection	infection	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
significantly	significantly	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
complications	complication	NNS	I-NP	O
of	of	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
stroke	stroke	VBD	B-VP	O

Cost	Cost	NN	B-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
HSA	HSA	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
framework	framework	NN	I-NP	O

Removal	Removal	NN	B-NP	O
of	of	IN	B-PP	O
ink1a	BEGIN-ink1a-INSIDE	NN	B-NP	B
dramatically	dramatically	RB	B-ADVP	O
reduces	reduce	VBZ	B-VP	O
the	the	DT	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
and	and	CC	I-NP	O
neurological	neurological	JJ	I-NP	O
defects	defect	NNS	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
bmi	BEGIN-bmi	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
deficient	deficient	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
ink1a	BEGIN-ink1a-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
Bmi	BEGIN-Bmi	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

In	In	IN	B-PP	O
fifty	fifty	CD	B-NP	O
non	non	JJ	I-NP	O
selected	select	VBN	I-NP	O
ductal	ductal	JJ	I-NP	O
carcinomas	carcinoma	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
breast	breast	NN	I-NP	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
tumoral	tumoral	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
perinodal	perinodal	JJ	B-NP	O
tumoral	tumoral	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
catarrh	catarrh	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
follicular	follicular	JJ	B-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
mixed	mixed	JJ	B-NP	O
pattern	pattern	NN	I-NP	O
in	in	IN	B-PP	O
lymph	lymph	NN	B-NP	O
nodes	node	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
or	or	CC	O	O
younger	young	JJR	B-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
correlated	correlate	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
with	with	IN	B-PP	O
lymph	lymph	NN	B-NP	O
node	node	NN	I-NP	O
metastases	metastasis	NNS	I-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
high	high	JJ	B-NP	O
histologic	histologic	JJ	I-NP	O
grade	grade	NN	I-NP	O

The	The	DT	B-NP	O
herpesvirus	BEGIN-herpesvirus	NN	I-NP	B
entry	entry	NN	I-NP	I
mediator	mediator	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
(	(	(	O	O
HveC	BEGIN-HveC-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
previously	previously	RB	B-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
poliovirus	BEGIN-poliovirus	NN	B-NP	B
receptor	receptor	NN	I-NP	I
-	-	HYPH	B-NP	I
related	relate	VBN	I-NP	I
protein	protein	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
PRR1	BEGIN-PRR1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
herpesvirus	BEGIN-herpesvirus	NN	I-NP	B
Ig	Ig	NN	I-NP	I
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
HIgR	BEGIN-HIgR-INSIDE	NN	B-NP	B
)	)	)	O	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
bona	bona	NN	I-NP	O
fide	fide	NN	I-NP	O
receptors	receptor	NNS	I-NP	O
employed	employ	VBN	B-VP	O
by	by	IN	B-PP	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
virus	virus	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HSV	HSV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
entry	entry	NN	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
most	most	RBS	B-VP	O
frequently	frequently	RB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
HSV	HSV	NN	B-NP	O
studies	study	NNS	I-NP	O

Spinal	Spinal	JJ	B-NP	O
injuries	injury	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
multiple	multiple	JJ	I-NP	O
trauma	trauma	NN	I-NP	O
patient	patient	NN	I-NP	O

Creatinine	Creatinine	NN	B-NP	O
and	and	CC	I-NP	O
creatine	BEGIN-creatine	NN	I-NP	B
phosphokinase	phosphokinase-INSIDE	NN	I-NP	I
(	(	(	O	O
CPK	BEGIN-CPK-INSIDE	NN	B-NP	B
)	)	)	O	O

The	The	DT	B-NP	O
glyoxysomal	glyoxysomal	JJ	I-NP	O
and	and	CC	I-NP	O
plastid	plastid	NN	I-NP	O
molecular	molecular	JJ	I-NP	O
chaperones	chaperone	NNS	I-NP	O
(	(	(	O	O
1	BEGIN-1	NN	B-NP	B
-	-	HYPH	I-NP	I
kDa	kDa	NN	I-NP	I
heat	heat	NN	I-NP	I
shock	shock	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
)	)	)	O	O
of	of	IN	B-PP	O
watermelon	watermelon	NN	B-NP	O
cotyledons	cotyledon	NNS	I-NP	O
are	be	VBP	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
gene	gene	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
cross	cross	AFX	B-NP	O
-	-	HYPH	I-NP	O
resistance	resistance	NN	I-NP	O
between	between	IN	B-PP	O
fluoroquinolones	fluoroquinolone	NNS	B-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
enterococci	enterococci	NNS	I-NP	O
and	and	CC	I-NP	O
MRSA	MRSA	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
we	we	PRP	B-NP	O
elucidate	elucidate	VBP	B-VP	O
the	the	DT	B-NP	O
subtle	subtle	NN	I-NP	O
highly	highly	RB	B-NP	O
anisotropic	anisotropic	JJ	I-NP	O
interchain	interchain	NN	I-NP	O
correlations	correlation	NNS	I-NP	O
and	and	CC	O	O
reveal	reveal	VB	B-VP	O
the	the	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
atomic	atomic	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
-	-	HYPH	I-NP	O
temperature	temperature	NN	I-NP	O
(	(	(	O	O
1x1	1x1	CD	B-NP	O
)	)	)	O	O
phase	phase	NN	B-NP	O

1	1	LS	B-LST	O
)	)	)	O	O

With	With	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
beyond	beyond	IN	B-PP	O
the	the	DT	B-NP	O
theta	theta	SYM	I-NP	O
-	-	HYPH	I-NP	O
range	range	NN	I-NP	O
three	three	CD	B-NP	O
phenomena	phenomenon	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
:	:	:	O	O
shift	shift	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
burst	burst	NN	I-NP	O
frequencies	frequency	NNS	I-NP	O
to	to	TO	B-PP	O
higher	high	JJR	B-NP	O
or	or	CC	I-NP	O
lower	low	JJR	I-NP	O
harmonics	harmonic	NNS	I-NP	O
of	of	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
frequencies	frequency	NNS	I-NP	O
;	;	:	O	O
complex	complex	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
of	of	IN	B-PP	O
basic	basic	JJ	B-NP	O
background	background	NN	I-NP	O
frequency	frequency	NN	I-NP	O
with	with	IN	B-PP	O
rhythm	rhythm	NN	B-NP	O
of	of	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
(	(	(	O	O
``	``	``	B-VP	O
beating	beat	VBG	I-VP	O
''	''	''	O	O
)	)	)	O	O
;	;	:	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
background	background	NN	B-NP	O
theta	theta	SYM	B-NP	O
-	-	HYPH	B-NP	O
burst	burst	NN	I-NP	O
frequency	frequency	NN	I-NP	O
in	in	IN	B-PP	O
spite	spite	NN	B-NP	O
of	of	IN	B-PP	O
continuing	continue	VBG	B-NP	O
stimulation	stimulation	NN	I-NP	O
(	(	(	O	O
``	``	``	O	O
escape	escape	NN	B-NP	O
''	''	''	O	O
)	)	)	O	O

Incorporation	Incorporation	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
information	information	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
brought	bring	VBD	B-VP	O
about	about	RP	B-PRT	O
a	a	DT	B-NP	O
revised	revise	VBN	I-NP	O
five	five	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
survival	survival	NN	I-NP	O
estimate	estimate	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
percent	percent	NN	I-NP	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
and	and	CC	O	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
assays	assay	NNS	I-NP	O
in	in	IN	B-PP	O
Schneider	Schneider	NNP	B-NP	O
SL	SL	NNP	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
insect	insect	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
that	that	IN	B-SBAR	O
ERalpha	BEGIN-ERalpha-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
interactions	interaction	NNS	I-NP	O
define	define	VBP	B-VP	O
a	a	DT	B-NP	O
pathway	pathway	NN	I-NP	O
for	for	IN	B-PP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
mediated	mediate	VBN	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B

While	While	IN	B-SBAR	O
these	these	DT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
unusual	unusual	JJ	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
A	A	NN	I-NP	O
,	,	,	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
B	B	NN	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
only	only	JJ	B-NP	O
speculation	speculation	NN	I-NP	O
until	until	IN	B-SBAR	O
a	a	DT	B-NP	O
serologic	serologic	JJ	I-NP	O
test	test	NN	I-NP	O
for	for	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
A	A	NN	I-NP	O
,	,	,	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
B	B	NN	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
becomes	become	VBZ	B-VP	O
available	available	JJ	B-ADJP	O

Our	Our	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
studies	study	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
promyelocytic	promyelocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
PML	BEGIN-PML-INSIDE	NN	B-NP	B
which	which	WDT	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
translocation	translocation	NN	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
promyelocytic	promyelocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
APL	APL	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	I-NP	O
transformation	transformation	NN	I-NP	O
suppressor	suppressor	NN	I-NP	O

These	These	DT	B-NP	O
characteristics	characteristic	NNS	I-NP	O
add	add	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
suitability	suitability	NN	I-NP	O
of	of	IN	B-PP	O
NM1	NM1	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
prodrug	prodrug	NN	I-NP	O
of	of	IN	B-PP	O
NM1	NM1	NN	B-NP	O

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	O
clones	clone	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
human	human	JJ	B-NP	O
gamma	gamma	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
predicting	predict	VBG	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
(	(	(	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
half	half	PDT	B-NP	O
the	the	DT	I-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bovine	bovine	JJ	I-NP	O
gamma	gamma	NN	I-NP	O
subunit	subunit	NN	I-NP	O

DISCUSSION	DISCUSSION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
higher	high	JJR	I-NP	O
absolute	absolute	JJ	I-NP	O
knee	knee	NN	I-NP	O
extension	extension	NN	I-NP	O
strength	strength	NN	I-NP	O
measures	measure	NNS	I-NP	O
of	of	IN	B-PP	O
leg	leg	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
similar	similar	JJ	I-NP	O
extension	extension	NN	I-NP	O
strength	strength	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
trunk	trunk	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
obese	obese	JJ	I-NP	O
sample	sample	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lean	lean	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
training	training	NN	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
weight	weight	NN	B-NP	O
bearing	bearing	NN	I-NP	O
and	and	CC	O	O
support	support	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
larger	large	JJR	I-NP	O
body	body	NN	I-NP	O
mass	mass	NN	I-NP	O

Measuring	Measure	VBG	B-VP	O
the	the	DT	B-NP	O
dim	dim	NN	I-NP	O
light	light	NN	I-NP	O
melatonin	melatonin	NN	I-NP	O
onset	onset	NN	I-NP	O
(	(	(	O	O
DLMO	DLMO	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
and	and	CC	I-NP	O
practical	practical	JJ	I-NP	O
way	way	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
circadian	circadian	JJ	B-NP	O
phase	phase	NN	I-NP	O
position	position	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
energy	energy	NN	I-NP	O
-	-	HYPH	B-VP	O
based	base	VBN	B-NP	O
DFT	DFT	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
isoproterenol	isoproterenol	NN	B-NP	O
(	(	(	O	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
J	J	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
J	J	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
stage	stage	NN	I-NP	O
by	by	IN	B-PP	O
infusion	infusion	NN	B-NP	O
of	of	IN	B-PP	O
E1	E1	NN	B-NP	O
and	and	CC	O	O
isoproterenol	isoproterenol	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
vs.	vs.	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	B-PP	O
vs.	vs.	IN	B-PP	O
isoproterenol	isoproterenol	NN	B-NP	O
)	)	)	O	O

This	This	DT	B-NP	O
communication	communication	NN	I-NP	O
presents	present	VBZ	B-VP	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
clinically	clinically	RB	B-NP	O
massive	massive	JJ	I-NP	O
PE	PE	NN	I-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
onset	onset	NN	I-NP	O
(	(	(	O	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
lung	lung	NN	B-NP	O
perfusion	perfusion	NN	I-NP	O
scans	scan	NNS	I-NP	O
)	)	)	O	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
successfully	successfully	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
i.v.	i.v.	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
anisoylated	BEGIN-anisoylated	JJ	B-NP	B
lys	ly	NNS	I-NP	I
-	-	HYPH	B-NP	I
plasminogen	plasminogen	NN	I-NP	I
streptokinase	BEGIN-streptokinase-INSIDE	NN	I-NP	I
activator	activator	NN	I-NP	O
complex	complex-INSIDE	NN	I-NP	I
(	(	(	O	O
APSAC	BEGIN-APSAC-INSIDE	NN	B-NP	B
,	,	,	O	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
U	U	NN	I-NP	O
of	of	IN	B-PP	O
streptokinase	BEGIN-streptokinase-INSIDE	NN	B-NP	B
)	)	)	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
heparinization	heparinization	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O

Capillary	Capillary	JJ	B-NP	O
tortuosity	tortuosity	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
sarcomere	sarcomere	JJ	B-NP	O
length	length	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
animals	animal	NNS	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
relationship	relationship	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
changed	change	VBN	I-VP	O
by	by	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O

A	A	DT	B-NP	O
survey	survey	NN	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
HBsAg	BEGIN-HBsAg	NN	B-NP	B
markers	markers-INSIDE	NN	I-NP	I
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
parents	parent	NNS	I-NP	O
HBV	HBV	NN	I-NP	O
markers	marker	NNS	I-NP	O

In	In	IN	B-PP	O
cases	case	NNS	B-NP	O
of	of	IN	B-PP	O
intracapsular	intracapsular	JJ	B-NP	O
prostatic	prostatic	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
prostatic	BEGIN-prostatic	JJ	B-NP	B
acid	acid	NN	I-NP	I
phosphatase	phosphatase-INSIDE	NN	I-NP	I
(	(	(	O	O
PAP	BEGIN-PAP-INSIDE	NN	B-NP	B
)	)	)	O	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
radioimmunoassay	radioimmunoassay	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	O	O
l	l	NN	B-NP	O

Rv	Rv	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mmHg.ml	mmHg.ml	NN	I-NP	O
-	-	HYPH	O	O
1.min.1	1.min.1	CD	B-NP	O
g	g	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
Cv	Cv	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
tau	tau	SYM	B-NP	O
v	v	NN	I-NP	O
calculated	calculate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
Rv	Rv	NN	B-NP	O
and	and	CC	I-NP	O
Cv	Cv	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
delta	delta	SYM	B-NP	O
V	V	NN	I-NP	O
to	to	TO	B-PP	O
delta	delta	SYM	B-NP	O
Q	Q	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
NS	NS	NN	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
Pel	Pel	NNP	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
mmHg.	mmHg.	NN	I-NP	O
delta	delta	NN	I-NP	O
V	V	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
changing	change	VBG	B-VP	O
Pv	Pv	NN	B-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
average	average	NN	I-NP	O
tau	tau	SYM	O	O
v	v	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	B-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
was	be	VBD	B-VP	O
shorter	short	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
with	with	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
flow	flow	NN	B-NP	O

Peripheral	Peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cherry	cherry	NN	I-NP	O
-	-	HYPH	O	O
red	red	JJ	B-NP	O
spot	spot	NN	I-NP	O
-	-	HYPH	B-NP	O
myoclonus	myoclonus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
(	(	(	O	O
sialidosis	sialidosis	NN	B-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
meaning	meaning	NN	I-NP	O
of	of	IN	B-PP	O
hope	hope	NN	B-NP	O
in	in	IN	B-PP	O
health	health	NN	B-NP	O
and	and	CC	I-NP	O
illness	illness	NN	I-NP	O

For	For	IN	B-PP	O
O1	O1	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
personal	personal	JJ	B-NP	O
exposures	exposure	NNS	I-NP	O
and	and	CC	O	O
ambient	ambient	JJ	B-NP	O
levels	level	NNS	I-NP	O
was	be	VBD	B-VP	O
weakest	weak	JJS	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
winter	winter	NN	I-NP	O
for	for	IN	B-PP	O
residential	residential	JJ	B-NP	O
microenvironments	microenvironment	NNS	I-NP	O
(	(	(	O	O
rs	r	NNS	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
strongest	strong	JJS	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
summer	summer	NN	I-NP	O
for	for	IN	B-PP	O
outdoor	outdoor	JJ	B-NP	O
near	near	JJ	I-NP	O
-	-	HYPH	I-NP	O
roadway	roadway	NN	I-NP	O
microenvironments	microenvironment	NNS	I-NP	O
(	(	(	O	O
rs	r	NNS	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
myb	BEGIN-myb	NN	I-NP	B
proto	proto	NN	I-NP	I
oncogene	oncogene	NN	I-NP	I
product	product-INSIDE	NN	I-NP	I
(	(	(	O	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Myb	Myb-INSIDE	NN	I-NP	I
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
expression	expression	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
are	be	VBP	B-VP	O
tightly	tightly	RB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
entry	entry	NN	I-NP	O
into	into	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
MMP	BEGIN-MMP	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
no	no	DT	B-NP	O
significative	significative	JJ	I-NP	O
synergistic	synergistic	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
PEA	BEGIN-PEA	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
elements	elements-INSIDE	NN	I-NP	I
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
collagenase	BEGIN-collagenase	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
Spanish	Spanish	JJ	B-NP	O
articles	article	NNS	I-NP	O
published	publish	VBN	B-VP	O
in	in	IN	B-PP	O
Anesthesiology	Anesthesiology	NNP	B-NP	O
,	,	,	O	O
BJA	BJA	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Anesth	Anesth	NNP	B-NP	O
Analg	Analg	NNP	I-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
productivity	productivity	NN	I-NP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
EU	EU	NN	I-NP	O
countries	country	NNS	I-NP	O
in	in	IN	B-PP	O
function	function	NN	B-NP	O
of	of	IN	B-PP	O
GNPpc	GNPpc	NNP	B-NP	O
places	place	VBZ	B-VP	O
us	us	PRP	B-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
intermediate	intermediate	JJ	I-NP	O
position	position	NN	I-NP	O

This	This	DT	B-NP	O
fragment	fragment	NN	I-NP	O
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
complete	complete	JJ	I-NP	O
endo	BEGIN-endo	NN	I-NP	B
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
-	-	HYPH	I-NP	I
1	1	CD	I-NP	I
,	,	,	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
glucanase	glucanase	NN	I-NP	I
-	-	HYPH	O	I
encoding	encode	VBG	B-VP	I
genes	genes-INSIDE	NN	B-NP	I
,	,	,	O	O
designated	designate	VBN	B-NP	O
celCCC	BEGIN-celCCC-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
celCCG	BEGIN-celCCG-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
``	``	``	I-NP	O
Gregg	Gregg	NN	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
''	''	''	O	O
implies	imply	VBZ	B-VP	O
that	that	IN	B-SBAR	O
myocardial	myocardial	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
consumption	consumption	NN	I-NP	O
(	(	(	O	O
MVO1	MVO1	NN	B-NP	O
)	)	)	O	O
increase	increase	VBP	B-VP	O
when	when	WRB	B-ADVP	O
coronary	coronary	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
is	be	VBZ	B-VP	O
enhanced	enhance	VBN	I-VP	O
within	within	IN	B-PP	O
or	or	CC	I-PP	O
above	above	IN	I-PP	O
the	the	DT	B-NP	O
autoregulatory	autoregulatory	JJ	I-NP	O
range	range	NN	I-NP	O

Pollinosis	Pollinosis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
U.A.R	U.A.R	NN	I-NP	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
sigma	BEGIN-sigma	NN	B-NP	B
1	1	CD	I-NP	I
promoters	promoters-INSIDE	NN	I-NP	I
,	,	,	O	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
require	require	VB	I-VP	O
cognate	cognate	JJ	B-NP	O
binding	binding	NN	I-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
could	could	MD	B-VP	O
allow	allow	VB	I-VP	O
the	the	DT	B-NP	O
fine	fine	JJ	I-NP	O
-	-	HYPH	I-NP	O
tuning	tuning	NN	I-NP	O
that	that	WDT	B-NP	O
provides	provide	VBZ	B-VP	O
the	the	DT	B-NP	O
temporal	temporal	JJ	I-NP	O
ordering	ordering	NN	I-NP	O
of	of	IN	B-PP	O
flagellar	flagellar	JJ	B-NP	O
gene	gene	NN	I-NP	O
transcription	transcription	NN	I-NP	O

Over	Over	IN	B-PP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
training	training	NN	I-NP	O
sessions	session	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
animals	animal	NNS	I-NP	O
learned	learn	VBD	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
breathe	breathe	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
stimuli	stimulus	NNS	B-NP	O
received	receive	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fifth	fifth	JJ	I-NP	O
session	session	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
session	session	NN	I-NP	O

The	The	DT	B-NP	O
genes	gene	NNS	I-NP	O
on	on	IN	B-PP	O
each	each	DT	B-NP	O
chromosome	chromosome	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
translocation	translocation	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
-	-	HYPH	O	O
encoding	encode	VBG	B-VP	O
genes	gene	NNS	B-NP	O
PAX1	BEGIN-PAX1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
FKHR	BEGIN-FKHR-INSIDE	NN	I-NP	B

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
PRP1	BEGIN-PRP1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
SRM1	SRM1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
Clark	Clark	NNP	B-NP	O
and	and	CC	O	O
Sprague	Sprague	NNP	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Transcriptional	Transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proopiomelanocortin	BEGIN-proopiomelanocortin	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
cyclic	BEGIN-cyclic	JJ	B-NP	B
AMP	AMP	NN	I-NP	I
-	-	HYPH	B-NP	I
responsive	responsive	JJ	I-NP	I
element	element	NN	I-NP	I
binding	binding	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I

Recombinant	BEGIN-Recombinant	JJ	B-NP	B
Human	Human	JJ	I-NP	I
Erythropoietin	Erythropoietin-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Platinum	Platinum	NN	I-NP	O
-	-	HYPH	O	O
Based	Base	VBN	B-VP	O
Chemotherapy	Chemotherapy	NNP	B-NP	O
In	In	IN	B-PP	O
Advanced	Advanced	NNP	B-NP	O
Ovarian	Ovarian	NNP	I-NP	O
Cancer	Cancer	NNP	I-NP	O

After	After	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
finally	finally	RB	I-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
PCH	PCH	NN	B-NP	O
because	because	IN	B-SBAR	O
a	a	DT	B-NP	O
Donath	Donath	NNP	I-NP	O
-	-	HYPH	I-NP	O
Landsteiner	Landsteiner	NNP	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O

Human	Human	JJ	B-NP	O
forearm	forearm	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
dummy	dummy	JJ	I-NP	O
ear	ear	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
electrode	electrode	NN	I-NP	O
HN	HN	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
fixed	fix	VBN	I-VP	O
thereon	thereon	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
sound	sound	JJ	I-NP	O
stimulus	stimulus	NN	I-NP	O
of	of	IN	B-PP	O
1dBnHL	1dBnHL	NN	B-NP	O
was	be	VBD	B-VP	O
delivered	deliver	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
earphone	earphone	NN	I-NP	O
(	(	(	O	O
NC	NC	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Neonatal	Neonatal	JJ	B-NP	O
hyperthyroidism	hyperthyroidism	NN	I-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
spectrum	spectrum	NN	I-NP	O
of	of	IN	B-PP	O
physiologic	physiologic	JJ	B-NP	O
chest	chest	NN	I-NP	O
sounds	sound	NNS	I-NP	O
is	be	VBZ	B-VP	O
contained	contain	VBN	I-VP	O
entirely	entirely	RB	B-ADVP	O
within	within	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
jet	jet	NN	B-NP	O
rotocraft	rotocraft	NN	I-NP	O
noise	noise	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
their	their	PRP$	B-NP	O
stability	stability	NN	I-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
as	as	IN	B-SBAR	O
already	already	RB	B-ADVP	O
reported	report	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
ARS	ARS	NNP	I-NP	O
in	in	IN	B-PP	O
S.	S.	NNP	B-NP	O
occidentalis	occidentalis	.	O	O

When	When	WRB	B-ADVP	O
gene	gene	NN	B-NP	O
conversion	conversion	NN	I-NP	O
is	be	VBZ	B-VP	O
initiated	initiate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
strand	strand	NN	I-NP	O
break	break	NN	I-NP	O
(	(	(	O	O
DSB	DSB	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
any	any	DT	B-NP	O
nonhomologous	nonhomologous	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
ends	end	NNS	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
before	before	IN	B-PP	O
new	new	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
initiated	initiate	VBN	I-VP	O

MRI	MRI	NN	B-NP	O
visualization	visualization	NN	I-NP	O
of	of	IN	B-PP	O
proteoglycan	proteoglycan	NN	B-NP	O
depletion	depletion	NN	I-NP	O
in	in	IN	B-PP	O
articular	articular	JJ	B-NP	O
cartilage	cartilage	NN	I-NP	O
via	via	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
Gd	Gd	NN	B-NP	O
-	-	HYPH	O	O
DTPA	DTPA	NN	B-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
GC	GC	NN	I-NP	O
-	-	HYPH	O	O
rich	rich	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
could	could	MD	B-VP	O
confer	confer	VB	I-VP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
transactivation	transactivation	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
heterologous	heterologous	JJ	I-NP	O
prolactin	BEGIN-prolactin	NN	I-NP	B
minimal	minimal	JJ	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

Neuronal	Neuronal	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
dopaminergic	dopaminergic	JJ	I-NP	O
(	(	(	O	O
DA	DA	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
non	non	AFX	B-ADJP	O
-	-	HYPH	I-ADJP	O
dopaminergic	dopaminergic	JJ	I-ADJP	O
(	(	(	O	O
non	non	AFX	O	O
-	-	HYPH	O	O
DA	DA	NN	B-NP	O
)	)	)	O	O
neurons	neuron	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ventral	ventral	JJ	I-NP	O
tegmental	tegmental	JJ	I-NP	O
area	area	NN	I-NP	O
(	(	(	O	O
VTA	VTA	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
female	female	JJ	B-NP	O
monkeys	monkey	NNS	I-NP	O
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
correlation	correlation	NN	B-NP	O
to	to	TO	B-PP	O
bar	bar	NN	B-NP	O
press	press	NN	I-NP	O
feeding	feeding	NN	I-NP	O
,	,	,	O	O
sensory	sensory	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
and	and	CC	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
motivation	motivation	NN	B-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O

Serum	Serum	NN	B-NP	O
prolactin	BEGIN-prolactin-INSIDE	NN	I-NP	B
rapidly	rapidly	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
after	after	IN	B-PP	O
institution	institution	NN	B-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
actual	actual	JJ	B-NP	O
normalization	normalization	NN	I-NP	O
(	(	(	O	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
1rd	1rd	NN	I-NP	O
month	month	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
correct	correct	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
genes	gene	NNS	I-NP	O

Cloning	Clone	VBG	B-VP	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
human	BEGIN-human	JJ	I-NP	B
zinc	zinc	NN	I-NP	I
finger	finger	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
defines	define	VBZ	B-VP	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
closely	closely	RB	B-NP	O
related	related	JJ	I-NP	O
Kruppel	BEGIN-Kruppel	NNP	I-NP	B
-	-	HYPH	I-NP	I
like	like	JJ	I-NP	I
transcription	transcription	NN	I-NP	I
factors	factors-INSIDE	NN	I-NP	I

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
laboratories	laboratory	NNS	I-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
caveolin	BEGIN-BEGIN-caveolin-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
proteins	proteins-INSIDE	NN	I-NP	I
;	;	:	O	O
caveolin	BEGIN-caveolin-INSIDE	NN	B-NP	B
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
re	re	AFX	B-ADJP	O
-	-	HYPH	O	O
termed	term	VBN	B-NP	O
caveolin	BEGIN-BEGIN-caveolin-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
1	1-INSIDE	NN	B-NP	I

Six	Six	CD	B-NP	O
cDNAs	cDNA	NNS	I-NP	O
represent	represent	VBP	B-VP	O
human	human	JJ	B-NP	O
homologs	homolog	NNS	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
known	know	VBN	B-VP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
namely	namely	RB	B-ADVP	O
,	,	,	O	O
mouse	BEGIN-mouse	NN	B-NP	B
HSPE1	HSPE1-INSIDE	NN	I-NP	I
,	,	,	O	O
Rat	BEGIN-Rat	NN	B-NP	B
RhoGAP	RhoGAP	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
S	BEGIN-S	NN	B-NP	B
cerevisiae	cerevisiae	NN	I-NP	I
leucyl	leucyl	NN	I-NP	I
tRNA	tRNA	NN	I-NP	I
synthetase	synthetase-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
S	BEGIN-S	NN	I-NP	B
cerevisiae	cerevisiae	VBP	B-VP	I
chromosome	chromosome	NN	B-NP	I
II	II	CD	I-NP	I
ORF	ORF	NN	I-NP	I
YBLO1W	YBLO1W-INSIDE	NN	I-NP	I

Three	Three	CD	B-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
amylose	amylose	NN	I-NP	O
rice	rice	NN	I-NP	O
varieties	variety	NNS	I-NP	O
,	,	,	O	O
IR1	IR1	NN	B-NP	O
,	,	,	O	O
IR1	IR1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
IR1	IR1	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
chemical	chemical	JJ	I-NP	O
composition	composition	NN	I-NP	O
including	include	VBG	B-PP	O
amylose	amylose	NN	B-NP	O
content	content	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
were	be	VBD	B-VP	O
cooked	cook	VBN	I-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
and	and	CC	O	O
tested	test	VBN	B-VP	O
for	for	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
digestibility	digestibility	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
and	and	CC	I-NP	O
insulin	BEGIN-insulin-INSIDE	NN	I-NP	B
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
human	human	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O

The	The	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	O
isoform	isoform	NN	I-NP	O
of	of	IN	B-PP	O
1	BEGIN-1	NN	B-NP	B
-	-	HYPH	O	I
phosphofructo	phosphofructo	AFX	O	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
fructose	BEGIN-fructose	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
,	,	,	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
bisphosphatase	bisphosphatase-INSIDE	NN	I-NP	I
(	(	(	O	O
PF1K	BEGIN-PF1K-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
Fru	BEGIN-Fru	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1	CD	I-NP	I
,	,	,	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
BPase	BPase-INSIDE	NN	I-NP	I
)	)	)	O	O
is	be	VBZ	B-VP	O
transcriptionally	transcriptionally	RB	I-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
blocks	block	VBZ	B-VP	O
this	this	DT	B-NP	O
stimulatory	stimulatory	JJ	I-NP	O
effect	effect	NN	I-NP	O

I	I	PRP	B-NP	O

Such	Such	JJ	B-NP	O
simple	simple	JJ	I-NP	O
injuries	injury	NNS	I-NP	O
may	may	MD	B-VP	O
however	however	RB	I-VP	O
be	be	VB	I-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
far	far	RB	B-ADVP	O
reaching	reach	VBG	B-VP	O
consequences	consequence	NNS	B-NP	O

The	The	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	I-NP	I
bp	bp	NN	I-NP	I
PHO1p	PHO1p	NN	I-NP	I
fragment	fragment-INSIDE	NN	I-NP	I
,	,	,	O	O
connected	connect	VBN	B-VP	O
at	at	IN	B-PP	O
position	position	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
upstream	upstream	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
HIS1'	BEGIN-HIS1'-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
'lacZ	BEGIN-'lacZ-INSIDE	NN	I-NP	B
fused	fuse	VBN	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
could	could	MD	B-VP	O
sense	sense	VB	I-VP	O
Pi	Pi	NNP	B-NP	O
signals	signal	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
synthetic	synthetic	JJ	I-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
having	have	VBG	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
from	from	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PHO1p	BEGIN-PHO1p	NN	I-NP	B
DNA	DNA-INSIDE	NN	I-NP	I
could	could	MD	B-VP	O
not	not	RB	O	O

Antibiotic	Antibiotic	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
setting	setting	NN	I-NP	O

In	In	IN	B-PP	O
resume	resume	NN	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
usual	usual	JJ	B-NP	O
regimens	regimen	NNS	I-NP	O
,	,	,	O	O
doxycycline	doxycycline	NN	B-NP	O
plus	plus	CC	O	O
streptomycin	streptomycin	NN	B-NP	O
of	of	IN	B-PP	O
doxycycline	doxycycline	NN	B-NP	O
rifampicin	rifampicin	NN	I-NP	O
is	be	VBZ	B-VP	O
good	good	JJ	B-ADJP	O
,	,	,	O	O
being	be	VBG	B-VP	O
however	however	RB	B-NP	O
time	time	NN	I-NP	O
elapsed	elapse	VBD	B-VP	O
until	until	IN	B-SBAR	O
pain	pain	NN	B-NP	O
ceases	cease	NNS	I-NP	O
of	of	IN	B-PP	O
mean	mean	JJ	B-NP	O
length	length	NN	I-NP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
shorter	short	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
receiving	receive	VBG	B-VP	O
doxycycline	doxycycline	NN	B-NP	O
plus	plus	CC	I-NP	O
streptomycin	streptomycin	NN	I-NP	O

This	This	DT	B-NP	O
indicates	indicate	VBZ	B-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
postvaccination	postvaccination	NN	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
BCG	BCG	NN	B-NP	O

Having	Have	VBG	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
proper	proper	JJ	B-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
GFP	BEGIN-GFP-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
calmodulin	BEGIN-calmodulin-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
budding	bud	VBG	B-VP	O
yeast	yeast	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
fusion	fusion	NN	I-NP	O
between	between	IN	B-PP	O
GFP	BEGIN-GFP-INSIDE	NN	B-NP	B
and	and	CC	O	O
calmodulin	BEGIN-calmodulin-INSIDE	NN	B-NP	B
(	(	(	O	O
GFP	BEGIN-BEGIN-GFP-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
Camlp	Camlp-INSIDE	NN	I-NP	I
)	)	)	O	O
in	in	IN	B-PP	O
fission	fission	NN	B-NP	O
yeast	yeast	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
calmodulin	BEGIN-calmodulin-INSIDE	NN	B-NP	B
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
localized	localize	VBN	I-VP	O
by	by	IN	B-PP	O
any	any	DT	B-NP	O
method	method	NN	I-NP	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
hosts	host	NNS	I-NP	O
were	be	VBD	B-VP	O
equines	equine	NNS	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
bovines	bovine	NNS	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
raccoons	raccoon	NNS	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

Between	Between	IN	B-PP	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
initiation	initiation	NN	I-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
coding	coding	NN	I-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
GC	GC	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
hairpin	hairpin	NN	I-NP	O
structure	structure	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
T	T	NN	I-NP	O
residues	residue	NNS	I-NP	O
that	that	WDT	B-NP	O
looks	look	VBZ	B-VP	O
like	like	IN	B-PP	O
a	a	DT	B-NP	O
rho	BEGIN-rho	JJ	I-NP	B
-	-	HYPH	I-NP	I
independent	independent	JJ	I-NP	I
transcription	transcription	NN	I-NP	I
terminator	terminator-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
the	the	DT	B-NP	O
conscious	conscious	JJ	I-NP	O
animals	animal	NNS	I-NP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
reached	reach	VBD	B-VP	O
statistical	statistical	JJ	B-NP	O
significance	significance	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
animals	animal	NNS	I-NP	O
were	be	VBD	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
oxygen	oxygen	NN	I-NP	O
in	in	IN	B-PP	O
nitrogen	nitrogen	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
arterial	arterial	JJ	B-NP	O
PaO1	PaO1	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O

Fourteen	Fourteen	CD	B-NP	O
eyes	eye	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
developed	develop	VBD	B-VP	O
DLK	DLK	NN	B-NP	O
after	after	IN	B-PP	O
an	an	DT	B-NP	O
epithelial	epithelial	JJ	I-NP	O
defect	defect	NN	I-NP	O
,	,	,	O	O
representing	represent	VBG	B-VP	O
an	an	DT	B-NP	O
odds	odd	NNS	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
times	time	NNS	I-NP	O

Each	Each	DT	B-NP	O
subject	subject	NN	I-NP	O
was	be	VBD	B-VP	O
injected	inject	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
antecubital	antecubital	JJ	I-NP	O
vein	vein	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
fluorescein	fluorescein	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
solution	solution	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
measurements	measurement	NNS	B-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
postinjection	postinjection	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
retina	retina	NN	I-NP	O

Such	Such	JJ	B-NP	O
tetranucleotides	tetranucleotide	NNS	I-NP	O
are	be	VBP	B-VP	O
common	common	JJ	B-ADJP	O
in	in	IN	B-PP	O
promoter	promoter	NN	B-NP	O
regions	region	NNS	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
activating	BEGIN-activating	JJ	B-NP	B
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
cyclic	BEGIN-cyclic	JJ	I-NP	B
AMP	AMP	NN	I-NP	I
response	response	NN	I-NP	I
element	element	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
ATF	BEGIN-ATF-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
CREB	BEGIN-CREB-INSIDE	NN	I-NP	B
)	)	)	O	O
and	and	CC	O	O
E	E	NN	B-NP	O
-	-	HYPH	I-NP	O
box	box	NN	I-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
PIF	BEGIN-PIF-INSIDE	NN	B-NP	B
may	may	MD	B-VP	O
modulate	modulate	VB	I-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
genes	gene	NNS	I-NP	O

The	The	DT	B-NP	O
long	long	JJ	I-NP	O
terminal	terminal	JJ	I-NP	O
repeat	repeat	NN	I-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
in	in	IN	B-PP	O
length	length	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
U1	U1	NN	I-NP	O
region	region	NN	I-NP	O
containing	contain	VBG	B-VP	O
consensus	consensus	NN	B-NP	O
sequences	sequence	NNS	I-NP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
viral	viral	JJ	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O

A	A	DT	B-NP	O
pathogenetic	pathogenetic	JJ	I-NP	O
relation	relation	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Eisenmenger	Eisenmenger	NNP	I-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O

Twenty	Twenty	CD	B-NP	O
-	-	HYPH	I-NP	O
six	six	CD	I-NP	O
calves	calf	NNS	I-NP	O
were	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
technique	technique	NN	I-NP	O
of	of	IN	B-PP	O
cryoablation	cryoablation	NN	B-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
establish	establish	VB	I-VP	O
an	an	DT	B-NP	O
animal	animal	NN	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
complete	complete	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
denervation	denervation	NN	I-NP	O

The	The	DT	B-NP	O
PHO1	BEGIN-BEGIN-PHO1-INSIDE	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Pho1p	BEGIN-Pho1p	NN	I-NP	B
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
itself	itself	PRP	B-NP	O
is	be	VBZ	B-VP	O
negatively	negatively	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
through	through	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
PHO1	BEGIN-PHO1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
PHO1	BEGIN-PHO1-INSIDE	NN	I-NP	B

CNS	CNS	NN	B-NP	O
preventive	preventive	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
without	without	IN	B-PP	O
cranial	cranial	JJ	B-NP	O
irradiation	irradiation	NN	I-NP	O
was	be	VBD	B-VP	O
effective	effective	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
ALL	ALL	NN	B-NP	O
patients	patient	NNS	I-NP	O

This	This	DT	B-NP	O
deletion	deletion	NN	I-NP	O
disrupts	disrupt	VBZ	B-VP	O
the	the	DT	B-NP	O
PU.1	BEGIN-PU.1-INSIDE	NN	I-NP	B
Ets	BEGIN-Et	NNS	I-NP	B
domain	domain-INSIDE	NN	I-NP	I

Basal	Basal	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
hydroxycorticoid	hydroxycorticoid	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
OHCS	OHCS	NN	I-NP	O
)	)	)	O	O
values	value	NNS	B-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
suppression	suppression	NN	I-NP	O
test	test	NN	I-NP	O
favoured	favour	VBD	B-VP	O
Cushing	Cushing	NN	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
cross	cross	AFX	O	O
-	-	HYPH	O	O
over	over	IN	B-PP	O
controlled	control	VBN	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
five	five	CD	B-NP	O
male	male	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
donated	donate	VBD	B-VP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
red	red	JJ	B-NP	O
cells	cell	NNS	I-NP	O
by	by	IN	B-PP	O
MCS	MCS	NN	B-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
whole	whole	JJ	B-NP	O
blood	blood	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
manual	manual	JJ	I-NP	O
method	method	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
apart	apart	RB	B-ADVP	O

The	The	DT	B-NP	O
derepressed	derepresse	VBN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
fixN	BEGIN-fixN-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
purH	BEGIN-purH	NN	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
protein	protein	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
secretory	BEGIN-secretory	JJ	I-NP	B
class	class	NN	I-NP	I
1	1	CD	I-NP	I
acute	acute	JJ	I-NP	I
-	-	HYPH	I-NP	I
phase	phase	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
whose	whose	WP$	B-NP	O
gene	gene	NN	I-NP	O
is	be	VBZ	B-VP	O
transcriptionally	transcriptionally	RB	I-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
APRF	BEGIN-APRF-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
STAT	BEGIN-STAT	NN	I-NP	B
/	/	SYM	B-NP	I
1	1-INSIDE	NN	B-NP	I
and	and	CC	O	O
other	other	JJ	B-NP	O
cytokine	cytokine	NN	I-NP	O
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
proteins	protein	NNS	I-NP	O

D	D	NN	B-NP	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
in	in	IN	B-PP	O
renal	renal	JJ	B-NP	O
allografts	allograft	NNS	I-NP	O
:	:	:	O	O
detection	detection	NN	B-NP	O
with	with	IN	B-PP	O
duplex	duplex	NN	B-NP	O
Doppler	Doppler	NNP	I-NP	O
US	US	NNP	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
Shp1	BEGIN-Shp1-INSIDE	NN	B-NP	B
regulates	regulate	VBZ	B-VP	O
phosphotyrosine	phosphotyrosine	NN	B-NP	O
-	-	HYPH	I-NP	O
signalling	signalling	NN	I-NP	O
events	event	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	JJ	I-NP	O
ectodermal	ectodermal	JJ	I-NP	O
-	-	HYPH	I-NP	O
mesenchymal	mesenchymal	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
mammalian	mammalian	JJ	B-NP	O
budding	budding	NN	I-NP	O
morphogenesis	morphogenesis	NN	I-NP	O

1	1	CD	B-NP	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
exercise	exercise	NN	B-NP	O
-	-	HYPH	I-NP	O
redistribution	redistribution	NN	I-NP	O
1Thallium	1Thallium	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
with	with	IN	B-PP	O
reinjection	reinjection	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
can	can	MD	B-VP	O
identify	identify	VB	I-VP	O
severely	severely	RB	B-ADJP	O
ischemic	ischemic	JJ	I-ADJP	O
but	but	CC	O	O
still	still	RB	B-NP	O
viable	viable	JJ	I-NP	O
myocardium	myocardium	NN	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
particularly	particularly	RB	B-ADJP	O
useful	useful	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prognosis	prognosis	NN	I-NP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
patients	patient	NNS	I-NP	O

To	To	TO	B-PP	O
this	this	DT	B-NP	O
effect	effect	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
survey	survey	NN	I-NP	O
puts	put	NNS	I-NP	O
in	in	IN	B-PP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
delay	delay	NN	I-NP	O
of	of	IN	B-PP	O
stream	stream	NN	B-NP	O
that	that	WDT	B-NP	O
guarantees	guarantee	VBZ	B-VP	O
the	the	DT	B-NP	O
good	good	JJ	I-NP	O
dimensional	dimensional	JJ	I-NP	O
stability	stability	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
class	class	NN	I-NP	O
A	A	NN	I-NP	O
alginates	alginate	VBZ	B-VP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
minutes	minute	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hot	hot	JJ	I-NP	O
and	and	CC	I-NP	O
humid	humid	JJ	I-NP	O
climatic	climatic	JJ	I-NP	O
tropical	tropical	JJ	I-NP	O
country	country	NN	I-NP	O
conditions	condition	NNS	I-NP	O

1	1	CD	B-NP	O

The	The	DT	B-NP	O
term	term	NN	I-NP	O
Kartagener	Kartagener	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
applies	apply	VBZ	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
when	when	WRB	B-ADVP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
infertility	infertility	NN	B-NP	O
and	and	CC	I-NP	O
dextrocardia	dextrocardia	NN	I-NP	O
or	or	CC	I-NP	O
situs	situs	NN	I-NP	O
inversus	inversus	NN	I-NP	O

Although	Although	IN	B-SBAR	O
immunoglobulin	BEGIN-immunoglobulin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
CRP	BEGIN-CRP-INSIDE	NN	I-NP	B
concentration	concentration	NN	I-NP	O
increased	increase	VBD	B-VP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
obviously	obviously	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	B-NP	B
levels	level	NNS	I-NP	O
increasing	increase	VBG	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
dl	dl	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
dl	dl	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
side	side	NN	I-NP	O
effects	effect	NNS	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
also	also	RB	B-ADVP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
TPA	TPA	NN	I-NP	O
activate	activate	VBP	B-VP	O
MBP	BEGIN-MBP-INSIDE	NN	B-NP	B
/	/	SYM	B-VP	O
MAP1	BEGIN-MAP1-INSIDE	NN	B-NP	B
kinase	kinase	NN	I-NP	O
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
de	de	FW	B-NP	O
novo	novo	FW	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
threonine	threonine	NN	B-NP	O
and	and	CC	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
residues	residue	NNS	I-NP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
similar	similar	JJ	I-NP	O
pathway	pathway	NN	I-NP	O

1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
p	p	NN	I-NP	O

As	As	IN	B-SBAR	O
regards	regard	VBZ	B-VP	O
the	the	DT	B-NP	O
short	short	JJ	I-NP	O
stature	stature	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
have	have	VBP	B-VP	O
proved	prove	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
is	be	VBZ	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
somatomedin	BEGIN-somatomedin	NN	B-NP	B
C	C-INSIDE	NN	I-NP	I
(	(	(	O	O
SmC	BEGIN-SmC-INSIDE	NN	B-NP	B
)	)	)	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
	BEGIN-	NN	B-NP	B
[	[	(	I-NP	I
F1	F1	NN	I-NP	I
]	]	)	I-NP	I
R1	R1-INSIDE	NN	I-NP	I
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
structural	structural	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
E.	BEGIN-E.	FW	B-NP	B
coli	coli	FW	I-NP	I
R1	R1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
vicinity	vicinity	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
helix	helix	NN	I-NP	O
distortion	distortion	NN	I-NP	O
can	can	MD	B-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
holoenzyme	holoenzyme	NN	I-NP	O

This	This	DT	B-NP	O
result	result	NN	I-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-NP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hsp1	BEGIN-hsp1	NN	I-NP	B
genes	gene	NNS	I-NP	I
in	in	IN	B-PP	I
T.	T.	NNP	B-NP	I
brucei	brucei-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
mainly	mainly	RB	I-VP	O
controlled	control	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
posttranscriptional	posttranscriptional	JJ	I-NP	O
level	level	NN	I-NP	O

The	The	DT	B-NP	O
cloned	clone	VBN	I-NP	O
rRNA	rRNA	NN	I-NP	O
operon	operon	NN	I-NP	O
was	be	VBD	B-VP	O
transcribed	transcribe	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
purified	BEGIN-purified	JJ	B-NP	B
RNA	RNA	NN	I-NP	I
polymerase	polymerase	NN	I-NP	I
of	of	IN	B-PP	I
Escherichia	Escherichia	NN	B-NP	I
coli	coli-INSIDE	NN	I-NP	I

To	To	TO	B-VP	O
test	test	VB	I-VP	O
whether	whether	IN	B-SBAR	O
Cd	Cd	NN	B-NP	O
exposure	exposure	NN	I-NP	O
would	would	MD	B-VP	O
increase	increase	VB	I-VP	O
Ca	Ca	NN	B-NP	O
release	release	NN	I-NP	O
from	from	IN	B-PP	O
bone	bone	NN	B-NP	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
and	and	CC	I-NP	O
lactation	lactation	NN	I-NP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
etiological	etiological	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
Itai	Itai	NNP	B-NP	O
-	-	HYPH	I-NP	O
Itai	Itai	NNP	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
virgin	virgin	NN	B-NP	O
female	female	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
with	with	IN	B-PP	O
1Ca	1Ca	NN	B-NP	O
prelabeled	prelabele	VBN	I-NP	O
skeletons	skeleton	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
microCi	microCi	NN	I-NP	O
/	/	SYM	B-NP	O
mouse	mouse	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
round	round	NN	I-NP	O
of	of	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
/	/	SYM	O	O
lactation	lactation	NN	B-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
Ca	Ca	NN	I-NP	O
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
diet	diet	NN	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
1	1	CD	B-NP	O
ppm	ppm	NN	I-NP	O
Cd	Cd	NN	I-NP	O
or	or	CC	O	O
1	1	CD	B-NP	O
ppm	ppm	NN	I-NP	O
Pb	Pb	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
conception	conception	NN	B-NP	O
until	until	IN	B-PP	O
Lactation	Lactation	NN	B-NP	O
Day	Day	NN	I-NP	O
1	1	CD	I-NP	O

G	BEGIN-G	NN	B-NP	B
-	-	HYPH	I-NP	I
box	box	NN	I-NP	I
binding	binding	NN	I-NP	I
factors	factors-INSIDE	NN	I-NP	I
(	(	(	O	O
GBFs	BEGIN-GBFs-INSIDE	NN	B-NP	B
)	)	)	O	O
constitute	constitute	VBP	B-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
plant	plant	NN	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
proteins	protein	NNS	B-NP	O
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
G	G	NN	I-NP	O
-	-	HYPH	I-NP	O
box	box	NN	I-NP	O
motif	motif	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
cis	cis	NN	I-NP	O
element	element	NN	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
plant	plant	NN	I-NP	O
genes	gene	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
palindromic	palindromic	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
motif	motif	NN	I-NP	O
of	of	IN	B-PP	O
CACGTG	CACGTG	NN	B-NP	O

The	The	DT	B-NP	O
ferric	BEGIN-ferric	JJ	I-NP	B
uptake	uptake	NN	I-NP	I
regulation	regulation-INSIDE	NN	I-NP	I
(	(	(	O	O
fur	BEGIN-fur-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O
product	product	NN	I-NP	O
participates	participate	VBZ	B-VP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
manganese	manganese	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
iron	iron	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
superoxide	BEGIN-superoxide	NN	B-NP	B
dismutase	dismutase	NN	I-NP	I
genes	gene	NNS	I-NP	I
of	of	IN	B-PP	I
Escherichia	Escherichia	NN	B-NP	I
coli	coli-INSIDE	NN	I-NP	I

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
further	further	RB	I-VP	O
suggested	suggest	VBN	I-VP	O
by	by	IN	B-PP	O
transactivation	transactivation	NN	B-NP	O
assays	assay	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
mouse	mouse	NN	B-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
were	be	VBD	B-VP	O
transiently	transiently	RB	I-VP	O
transfected	transfecte	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
beta	beta	SYM	I-NP	I
-	-	HYPH	I-NP	I
globin	globin	NN	I-NP	I
reporter	reporter	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
and	and	CC	I-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
LKLF	BEGIN-LKLF	NN	I-NP	B
cDNA	cDNA	NN	I-NP	I
construct	construct-INSIDE	NN	I-NP	I

On	On	IN	B-PP	O
average	average	NN	B-NP	O
these	these	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
potency	potency	NN	I-NP	O
estimates	estimate	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
order	order	NN	I-NP	O
of	of	IN	B-PP	O
magnitude	magnitude	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inverse	inverse	JJ	I-NP	O
maximum	maximum	JJ	I-NP	O
dose	dose	NN	I-NP	O
tested	test	VBN	B-VP	O

Anovulatory	Anovulatory	JJ	B-NP	O
cycles	cycle	NNS	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
apparently	apparently	RB	I-NP	O
normal	normal	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
prolactin	BEGIN-prolactin-INSIDE	NN	I-NP	B

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
CL1	BEGIN-CL1-INSIDE	NN	B-NP	B
suppresses	suppress	VBZ	B-VP	O
the	the	DT	B-NP	O
[	[	(	I-NP	O
val1	val1	NN	I-NP	O
]	]	)	I-NP	O
ras	BEGIN-ras-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
MAP	BEGIN-MAP	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-NP	O
free	free	JJ	I-NP	O
system	system	NN	I-NP	O
from	from	IN	B-PP	O
Xenopus	Xenopus	NN	B-NP	O
oocytes	oocyte	NNS	I-NP	O

The	The	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
reporter	reporter	NN	B-NP	O
proteins	protein	NNS	I-NP	O
attained	attain	VBN	B-VP	O
in	in	IN	B-PP	O
transformed	transform	VBN	B-NP	O
cells	cell	NNS	I-NP	O
after	after	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
induction	induction	NN	I-NP	O
represented	represent	VBN	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
protein	protein	NN	I-NP	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
and	and	CC	O	O
hospitalizations	hospitalization	NNS	B-NP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O

The	The	DT	B-NP	O
PK	PK	NN	I-NP	O
domain	domain	NN	I-NP	O
showed	show	VBD	B-VP	O
pairwise	pairwise	RB	B-ADVP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
binding	binding	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
pseudokinase	pseudokinase	NN	I-NP	O
,	,	,	O	O
HisRS	BEGIN-HisRS-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
C	C	NN	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
domains	domain	NNS	I-NP	O
;	;	:	O	O
additionally	additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
HisRS	BEGIN-BEGIN-HisRS-INSIDE	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
interacted	interact	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
region	region	NN	I-NP	O

Renal	Renal	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
induced	induce	VBD	B-VP	O
Coombs	Coombs	NNP	B-NP	O
negative	negative	JJ	I-NP	O
autoimmune	autoimmune	JJ	I-NP	O
hemolytic	hemolytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
nephrectomy	nephrectomy	NN	B-NP	O

The	The	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
Jun	Jun	NN	I-NP	I
delta	delta	SYM	O	I
-	-	HYPH	O	I
domain	domain-INSIDE	NN	B-NP	I
inhibits	inhibit	VBZ	B-VP	O
neuroendocrine	neuroendocrine	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
pituitary	pituitary	JJ	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
manner	manner	NN	I-NP	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
antisense	antisense	JJ	B-NP	O
mediated	mediate	VBN	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
Elk	BEGIN-Elk	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
GH1	GH1	NN	B-NP	O
cells	cell	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
increased	increase	VBN	B-NP	O
prolactin	BEGIN-prolactin	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
and	and	CC	O	O
confirmed	confirm	VBD	B-VP	O
the	the	DT	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
Elk	BEGIN-Elk	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
for	for	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
increased	increase	VBN	B-NP	O
prolactin	BEGIN-prolactin	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O

Smooth	Smooth	JJ	B-NP	O
pursuit	pursuit	NN	I-NP	O
gain	gain	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
eye	eye	NN	I-NP	O
movement	movement	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
various	various	JJ	B-NP	O
saccadic	saccadic	JJ	I-NP	O
subtypes	subtype	NNS	I-NP	O
were	be	VBD	B-VP	O
computed	compute	VBN	I-VP	O
using	use	VBG	B-VP	O
infrared	infrare	VBN	B-NP	O
oculography	oculography	NN	I-NP	O
and	and	CC	O	O
computerized	computerize	VBD	B-VP	O
pattern	pattern	NN	B-NP	O
recognition	recognition	NN	I-NP	O
software	software	NN	I-NP	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
previous	previous	JJ	B-NP	O
reports	report	NNS	I-NP	O
of	of	IN	B-PP	O
muscle	BEGIN-muscle	NN	B-NP	B
creatine	creatine	NN	I-NP	I
phosphokinase	phosphokinase-INSIDE	NN	I-NP	I
release	release	NN	I-NP	O
in	in	IN	B-PP	O
psychiatric	psychiatric	JJ	B-NP	O
patients	patient	NNS	I-NP	O

The	The	DT	B-NP	O
TaqI	BEGIN-TaqI-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
HaeIII	BEGIN-HaeIII-INSIDE	NN	I-NP	B
RFLPs	RFLP	NNS	I-NP	O
will	will	MD	B-VP	O
provide	provide	VB	I-VP	O
tools	tool	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
CR1	BEGIN-CR1-INSIDE	NN	B-NP	B

A	A	DT	B-NP	O
transient	transient	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
fos	fos-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	I-NP	I
jun	jun	NN	I-NP	I
mRNAs	mRNAs-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
TPA	TPA	NN	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
cell	cell	NN	I-NP	O
populations	population	NNS	I-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
associated	associate	VBN	I-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
BSP	BEGIN-BSP	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fetal	fetal	JJ	I-NP	O
rat	rat	NN	I-NP	O
calvarial	calvarial	JJ	I-NP	O
cells	cell	NNS	I-NP	O

Mitoxantrone	Mitoxantrone	NNP	B-NP	O
plus	plus	CC	O	O
ara	ara	AFX	O	O
-	-	HYPH	O	O
C	C	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
combination	combination	NN	I-NP	O
with	with	IN	B-PP	O
great	great	JJ	B-NP	O
promise	promise	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
therapy	therapy	NN	I-NP	O
of	of	IN	B-PP	O
previously	previously	RB	B-NP	O
untreated	untreated	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
AML	AML	NN	B-NP	O

During	During	IN	B-PP	O
an	an	DT	B-NP	O
observation	observation	NN	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
halving	halve	VBG	B-VP	O
atenolol	atenolol	NN	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
and	and	CC	I-NP	O
diastolic	diastolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
rate	rate	NN	I-NP	O
(	(	(	O	O
defined	define	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
diastolic	diastolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
or	or	CC	I-NP	O
less	less	JJR	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

Diet	Diet	JJ	B-NP	O
imbalances	imbalance	NNS	I-NP	O
and	and	CC	O	O
aflatoxicosis	aflatoxicosis	NN	B-NP	O

WBC	WBC	NN	B-NP	O
differential	differential	JJ	I-NP	O
(	(	(	O	O
SEG	SEG	NN	B-NP	O
,	,	,	O	O
BAND	BAND	NN	B-NP	O
,	,	,	O	O
LYMPH	LYMPH	NN	B-NP	O
,	,	,	O	O
MONO	MONO	NN	B-NP	O
,	,	,	O	O
EOSINO	EOSINO	NN	B-NP	O
,	,	,	O	O
BASO	BASO	NN	B-NP	O
)	)	)	O	O
usually	usually	RB	B-ADVP	O
showed	show	VBD	B-VP	O
log	log	NN	B-NP	O
-	-	HYPH	B-NP	O
normal	normal	JJ	I-NP	O
distribution	distribution	NN	I-NP	O

The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
respondents	respondent	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
considered	consider	VBN	B-VP	O
that	that	IN	B-SBAR	O
coitus	coitus	NN	B-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
stopped	stop	VBN	I-VP	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O

Genetic	Genetic	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
mutants	mutant	NNS	I-NP	O
are	be	VBP	B-VP	O
cis	cis	NN	B-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
recessive	recessive	JJ	I-NP	O
mutants	mutant	NNS	I-NP	O
define	define	VBP	B-VP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
complementation	complementation	NN	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
defects	defect	NNS	B-NP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
different	different	JJ	I-NP	O
genes	gene	NNS	I-NP	O
can	can	MD	B-VP	O
restore	restore	VB	I-VP	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
HIS1C	BEGIN-HIS1C-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O

During	During	IN	B-PP	O
normoxic	normoxic	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
O1	O1	NN	I-NP	O
uptake	uptake	NN	I-NP	O
(	(	(	O	O
VO1	VO1	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
l	l	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
,	,	,	O	O
almitrine	almitrine	NN	B-NP	O
increased	increase	VBD	B-VP	O
arterial	arterial	JJ	B-NP	O
PO1	PO1	NN	I-NP	O
(	(	(	O	O
PaO1	PaO1	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
SaO1	SaO1	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
VE	VE	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
arterial	arterial	JJ	B-NP	O
PCO1	PCO1	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
without	without	IN	B-PP	O
affecting	affect	VBG	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
hemodynamics	hemodynamic	NNS	I-NP	O
or	or	CC	I-NP	O
ventilation	ventilation	NN	I-NP	O
-	-	HYPH	B-NP	O
perfusion	perfusion	NN	I-NP	O
distributions	distribution	NNS	I-NP	O

Recombinant	Recombinant	JJ	B-NP	O
protein	protein	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
ESX	BEGIN-ESX-INSIDE	NN	B-NP	B
(	(	(	O	O
for	for	IN	B-PP	O
epithelial	BEGIN-epithelial	JJ	B-NP	B
-	-	HYPH	I-NP	I
restricted	restricted	JJ	B-ADJP	I
with	with	IN	B-PP	I
serine	serine	NN	B-NP	I
box	box-INSIDE	NN	I-NP	I
)	)	)	O	O
exhibits	exhibit	VBZ	B-VP	O
Ets	BEGIN-Ets	NN	B-NP	B
-	-	HYPH	I-NP	I
like	like-INSIDE	NN	I-NP	I
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
specificity	specificity	NN	I-NP	O
in	in	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
and	and	CC	O	O
,	,	,	O	O
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
transactivates	transactivate	VBZ	B-VP	O
Ets	BEGIN-Ets	NN	B-NP	B
-	-	HYPH	I-NP	I
responsive	responsive	JJ	I-NP	I
promoter	promoter	NN	I-NP	I
elements	elements-INSIDE	NN	I-NP	I
including	include	VBG	B-PP	O
that	that	IN	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HER1	BEGIN-HER1-INSIDE	NN	I-NP	B
/	/	SYM	B-VP	O
neu	BEGIN-neu-INSIDE	NN	B-NP	B
oncogene	oncogene	NN	I-NP	O

Static	Static	JJ	B-NP	O
and	and	CC	I-NP	O
dynamic	dynamic	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
and	and	CC	I-NP	O
pathological	pathological	JJ	I-NP	O
female	female	JJ	I-NP	O
pelvic	pelvic	JJ	I-NP	O
floor	floor	NN	I-NP	O

Crystals	Crystal	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
triple	triple	JJ	I-NP	O
mutant	mutant	JJ	I-NP	O
A1D	BEGIN-A1D-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
D1P	BEGIN-D1P-INSIDE	NN	I-NP	B
/	/	SYM	I-NP	O
A1L	BEGIN-A1L-INSIDE	NN	I-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
days	day	NNS	B-NP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
oxidized	oxidize	VBN	I-NP	O
form	form	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
grown	grow	VBN	I-VP	O
from	from	IN	B-PP	O
ammonium	ammonium	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
constants	constant	NNS	I-NP	O
a	a	DT	B-NP	O
=	=	SYM	I-NP	O
b	b	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
A	A	NN	I-NP	O
and	and	CC	I-NP	O
c	c	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
A	A	NN	I-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
space	space	NN	B-NP	O
group	group	NN	I-NP	O
P1	P1	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
1	1	CD	B-NP	O

Two	Two	CD	B-NP	O
adjacent	adjacent	JJ	I-NP	O
,	,	,	I-NP	O
highly	highly	RB	I-NP	O
homologous	BEGIN-homologous	JJ	I-NP	B
endoglucanase	endoglucanase	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
celD	BEGIN-celD-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
celE	BEGIN-celE-INSIDE	NN	I-NP	B
from	from	IN	B-PP	O
Fibrobacter	Fibrobacter	NNP	B-NP	O
succinogenes	succinogene	NNS	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
separated	separate	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
AT	AT	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
intergenic	intergenic	JJ	I-NP	O
region	region	NN	I-NP	O
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
showed	show	VBD	B-VP	O
it	it	PRP	B-NP	O
contained	contain	VBD	B-VP	O
five	five	CD	B-NP	O
potential	potential	JJ	I-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sterol	sterol	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
SRE	SRE	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
(	(	(	O	O
Smith	Smith	NNP	B-NP	O
,	,	,	O	O
J.R.	J.R.	NNP	B-NP	O
,	,	,	O	O
Osborne	Osborne	NNP	B-NP	O
,	,	,	O	O
T.F.	T.F.	NNP	B-NP	O
,	,	,	O	O
Brown	Brown	NNP	B-NP	O
,	,	,	O	O
M.S.	M.S.	NNP	B-NP	O
,	,	,	O	O
Goldstein	Goldstein	NNP	B-NP	O
,	,	,	O	O
J.L.	J.L.	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Gil	Gil	NNP	B-NP	O
,	,	,	O	O
G	G	NNP	B-NP	O

Toxicity	Toxicity	NN	B-NP	O
of	of	IN	B-PP	O
benzoyl	benzoyl	NN	B-NP	O
chloride	chloride	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
trichlorophenyl	trichlorophenyl	NN	I-NP	O
)	)	)	O	O
hydrazone	hydrazone	NN	B-NP	O
(	(	(	O	O
Banamite	Banamite	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
potential	potential	JJ	B-NP	O
metabolites	metabolite	NNS	I-NP	O
to	to	TO	B-PP	O
twospotted	twospotted	JJ	B-NP	O
spider	spider	NN	I-NP	O
mites	mite	NNS	I-NP	O
and	and	CC	I-NP	O
potency	potency	NN	I-NP	O
as	as	IN	B-PP	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
rat	BEGIN-rat	NN	B-NP	B
liver	liver	NN	I-NP	I
monoamine	monoamine	NN	I-NP	I
oxidase	oxidase-INSIDE	NN	I-NP	I

Fetal	Fetal	JJ	B-NP	O
PaO1	PaO1	NN	I-NP	O
fell	fall	VBD	B-VP	O
somewhat	somewhat	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
recovery	recovery	NN	I-NP	O
stages	stage	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
NIT	NIT	NN	B-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
groups	group	NNS	I-NP	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
which	which	WDT	B-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
would	would	MD	B-VP	O
contact	contact	VB	I-VP	O
an	an	DT	B-NP	O
extended	extend	VBN	I-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
B	BEGIN-B	NN	I-NP	B
recognition	recognition	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
evolutionary	evolutionary	JJ	B-NP	O
conservation	conservation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TBP	BEGIN-TBP-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
TFB	BEGIN-TFB-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
DNA	DNA	NN	I-NP	O
complex	complex	NN	I-NP	O
orientation	orientation	NN	I-NP	O
between	between	IN	B-PP	O
two	two	CD	B-NP	O
archaeal	archaeal	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
with	with	IN	B-PP	O
widely	widely	RB	B-NP	O
different	different	JJ	I-NP	O
optimal	optimal	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
for	for	IN	B-PP	O
growth	growth	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
)	)	)	O	O

The	The	DT	B-NP	O
average	average	JJ	I-NP	O
progression	progression	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
(	(	(	O	O
SD	SD	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

1	1	CD	B-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
L	L	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
CCI	CCI	NN	B-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
bedside	bedside	NN	I-NP	O
filtered	filtered	JJ	I-NP	O
PC	PC	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
vs	v	NNS	I-NP	O

Result	Result	NN	B-NP	O
were	be	VBD	B-VP	O
as	as	RB	I-VP	O
followed	follow	VBN	I-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
Early	Early	RB	B-NP	O
cancer	cancer	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
advanced	advance	VBN	I-NP	O
cancers	cancer	NNS	I-NP	O
were	be	VBD	B-VP	O
consisted	consist	VBN	I-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
1	1	CD	B-NP	O
lesions	lesion	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
peptic	peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
in	in	IN	B-PP	O
cancerous	cancerous	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
active	active	JJ	B-NP	O
stage	stage	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
scarring	scar	VBG	I-VP	O
stage	stage	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
median	median	JJ	I-NP	O
cumulative	cumulative	JJ	I-NP	O
incidence	incidence	NN	I-NP	O
rates	rate	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
1	1	CD	B-NP	O
per	per	IN	B-PP	O
million	million	CD	B-NP	O
for	for	IN	B-PP	O
males	male	NNS	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
per	per	IN	I-NP	O
million	million	CD	I-NP	O
for	for	IN	B-PP	O
females	female	NNS	B-NP	O

The	The	DT	B-NP	O
unexpected	unexpected	JJ	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
myc	myc-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
-	-	HYPH	B-NP	I
tubulin	tubulin-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
S	S	NN	I-NP	O
-	-	HYPH	B-NP	O
phase	phase	NN	I-NP	O
library	library	NN	I-NP	O
is	be	VBZ	B-VP	O
supported	support	VBN	I-VP	O
by	by	IN	B-PP	O
Northern	Northern	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
RNA	RNA	NN	B-NP	O
from	from	IN	B-PP	O
phase	phase	NN	B-NP	O
-	-	HYPH	B-NP	O
synchronous	synchronous	JJ	I-NP	O
cells	cell	NNS	I-NP	O

A	A	DT	B-NP	O
spectrophotometric	spectrophotometric	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
microdetermination	microdetermination	NN	I-NP	O
of	of	IN	B-PP	O
periodate	periodate	NN	B-NP	O

Satisfactory	Satisfactory	JJ	B-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
results	result	NNS	I-NP	O

Eleven	Eleven	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
exons	exon	NNS	I-NP	O
have	have	VBP	B-VP	O
complete	complete	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
RBM	BEGIN-RBM	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I

Polyoma	Polyoma	NN	B-NP	O
virus	virus	NN	I-NP	O
in	in	IN	B-PP	O
urine	urine	NN	B-NP	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O

Using	Use	VBG	B-VP	O
probes	probe	NNS	B-NP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
regions	region	NNS	I-NP	O
,	,	,	O	O
rearrangements	rearrangement	NNS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
nine	nine	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
t	t	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
;	;	:	O	O
1	1	CD	O	O
)	)	)	O	O
AML	AML	NN	B-NP	O
examined	examine	VBN	B-VP	O

The	The	DT	B-NP	O
delta	delta	NN	I-NP	O
G	G	NN	I-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
regions	region	NNS	I-NP	O
were	be	VBD	B-VP	O
higher	high	JJR	B-NP	O
,	,	,	I-NP	O
i.e.	i.e.	FW	I-NP	O
potential	potential	JJ	I-NP	O
secondary	secondary	JJ	I-NP	O
structural	structural	JJ	I-NP	O
elements	element	NNS	I-NP	O
were	be	VBD	B-VP	O
fewer	few	JJR	B-ADJP	O
,	,	,	O	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
TIR	TIR	NN	B-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
from	from	IN	B-PP	O
E.	E.	NNP	B-NP	O
coli	coli	NNS	I-NP	O

In	In	IN	B-PP	O
each	each	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
MBF	MBF	NN	B-NP	O
was	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
major	major	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
territories	territory	NNS	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
circumflex	circumflex	NN	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
territories	territory	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
region	region	NN	I-NP	O
)	)	)	O	O
territory	territory	NN	B-NP	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
shosaikoto	shosaikoto	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
oriental	oriental	JJ	I-NP	O
herbal	herbal	JJ	I-NP	O
medicinal	medicinal	JJ	I-NP	O
mixture	mixture	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
restraint	restraint	NN	B-NP	O
-	-	HYPH	B-NP	O
stressed	stress	VBN	I-NP	O
mice	mouse	NNS	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
1mTc	1mTc	NN	B-NP	O
-	-	HYPH	B-NP	O
HL1	HL1	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
marker	marker	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
viability	viability	NN	I-NP	O
when	when	WRB	B-ADVP	O
used	use	VBN	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
acute	acute	JJ	I-NP	O
phase	phase	NN	I-NP	O
after	after	IN	B-PP	O
reperfusion	reperfusion	NN	B-NP	O

Glucose	Glucose	NN	B-NP	O
may	may	MD	B-VP	O
reduce	reduce	VB	I-VP	O
slightly	slightly	RB	B-ADVP	O
the	the	DT	B-NP	O
pool	pool	NN	I-NP	O
of	of	IN	B-PP	O
amino	amino	NN	B-NP	O
nitrogen	nitrogen	NN	I-NP	O
available	available	JJ	B-ADJP	O
for	for	IN	B-PP	O
albumin	BEGIN-albumin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
urea	urea	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
by	by	IN	B-PP	O
diverting	divert	VBG	B-VP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infused	infuse	VBN	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
from	from	IN	B-PP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
to	to	TO	B-PP	O
muscle	muscle	NN	B-NP	O

The	The	DT	B-NP	O
community	community	NN	I-NP	O
-	-	HYPH	B-VP	O
acquired	acquire	VBN	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
was	be	VBD	B-VP	O
mainly	mainly	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
E.	E.	NNP	B-NP	O
coli	coli	NNS	I-NP	O

The	The	DT	B-NP	O
benzo	benzo	AFX	I-NP	O
-	-	HYPH	I-NP	O
pyrone	pyrone	NN	I-NP	O
drug	drug	NN	I-NP	O
Venalot	Venalot	NNP	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
considerable	considerable	JJ	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
air	air	NN	I-NP	O
spaces	space	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
interstitial	interstitial	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oedema	oedema	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O

The	The	DT	B-NP	O
brains	brain	NNS	I-NP	O
were	be	VBD	B-VP	O
bisected	bisect	VBN	I-VP	O
and	and	CC	O	O
T1	T1	NN	B-NP	O
and	and	CC	I-NP	O
T1	T1	NN	I-NP	O
relaxation	relaxation	NN	I-NP	O
times	time	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
and	and	CC	I-NP	O
left	left	JJ	I-NP	O
hemispheres	hemisphere	NNS	I-NP	O
by	by	IN	B-PP	O
MR	MR	NN	B-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
after	after	IN	B-PP	O
dissection	dissection	NN	B-NP	O

The	The	DT	B-NP	O
exact	exact	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
IP	BEGIN-IP	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
yet	yet	RB	I-VP	O
known	know	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
gamma	BEGIN-gamma	NN	B-NP	B
-	-	HYPH	B-NP	I
interferon	interferon-INSIDE	NN	I-NP	I
mediated	mediate	VBN	B-VP	O
immune	immune	JJ	B-NP	O
reactions	reaction	NNS	I-NP	O

Indeed	Indeed	RB	B-ADVP	O
,	,	,	O	O
ectopic	ectopic	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
MOX1	BEGIN-MOX1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
aerobic	aerobic	JJ	B-NP	O
cells	cell	NNS	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
partially	partially	RB	B-NP	O
constitutive	constitutive	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
DAN1	BEGIN-DAN1-INSIDE	NN	B-NP	B

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
gel	gel	NN	B-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
ORF1	ORF1	NN	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
promoter	promoter	NN	B-NP	O
fragment	fragment	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
K1	K1	NN	B-NP	O
in	in	IN	B-PP	O
H1	BEGIN-H1-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
serves	serve	VBZ	B-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
target	target	NN	I-NP	O
of	of	IN	B-PP	O
recombinant	BEGIN-recombinant	JJ	B-NP	B
Gcn1p	Gcn1p-INSIDE	NN	I-NP	I
acetylation	acetylation	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
confers	confer	VBZ	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
,	,	,	I-NP	O
synthetic	synthetic	JJ	I-NP	O
growth	growth	NN	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
gcn1	BEGIN-gcn1-INSIDE	NN	B-NP	B
cells	cell	NNS	I-NP	O

Histological	Histological	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
variable	variable	JJ	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
motor	motor	NN	B-NP	O
neurons	neuron	NNS	I-NP	O
limited	limit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
injection	injection	NN	I-NP	O
site	site	NN	I-NP	O

In	In	IN	B-PP	O
normal	normal	JJ	B-NP	O
B	B	NN	I-NP	O
cells	cell	NNS	I-NP	O
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
LPS	LPS	NN	B-NP	O
or	or	CC	I-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
new	new	JJ	B-NP	O
complexes	complex	NNS	I-NP	O
appear	appear	VBP	B-VP	O
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	I-NP	I
EBP	EBP-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
elements	elements-INSIDE	NN	I-NP	I
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	B-NP	O
region	region	NN	I-NP	O

Phylogenetic	Phylogenetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
neighbor	neighbor	NN	I-NP	O
-	-	HYPH	O	O
joining	join	VBG	B-VP	O
algorithm	algorithm	NN	B-NP	O
showed	show	VBD	B-VP	O
closest	close	JJS	B-NP	O
similarity	similarity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
horse	BEGIN-horse	JJ	I-NP	B
mu	mu	NN	I-NP	I
chain	chain	NN	I-NP	I
-	-	HYPH	O	I
encoding	encode	VBG	B-VP	I
constant	constant	JJ	B-NP	I
region	region	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
human	human	JJ	B-NP	O
and	and	CC	I-NP	O
dog	dog	NN	I-NP	O
sequences	sequence	NNS	I-NP	O

Progressive	Progressive	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
IgA	BEGIN-IgA-INSIDE	NN	B-NP	B
deficiency	deficiency	NN	I-NP	O

Mouse	Mouse	NN	B-NP	O
embryo	embryo	NN	I-NP	O
cells	cell	NNS	I-NP	O
(	(	(	O	O
C1BL	C1BL	NN	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
H	H	NN	B-NP	O
-	-	HYPH	I-NP	O
1b	1b	NN	I-NP	O
)	)	)	O	O
transformed	transform	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
E1A	BEGIN-E1A-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
E1B	BEGIN-E1B-INSIDE	NN	I-NP	B
genes	gene	NNS	I-NP	O
of	of	IN	B-PP	O
adenovirus	adenovirus	NN	B-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
Ad1E1	Ad1E1	NN	B-NP	O
MEC	MEC	NN	I-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
highly	highly	RB	B-ADJP	O
immunogenic	immunogenic	JJ	I-ADJP	O

We	We	PRP	B-NP	O
hypothesized	hypothesize	VBD	B-VP	O
that	that	IN	B-SBAR	O
subjects	subject	NNS	B-NP	O
would	would	MD	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
PKAR	PKAR	NN	B-NP	O
during	during	IN	B-PP	O
both	both	CC	O	O
hopping	hop	VBG	B-VP	O
and	and	CC	I-VP	O
stepping	step	VBG	I-VP	O
,	,	,	O	O
adding	add	VBG	B-VP	O
support	support	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
PKAR	PKAR	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
centrally	centrally	RB	I-NP	O
mediated	mediate	VBN	I-NP	O
adaptation	adaptation	NN	I-NP	O
of	of	IN	B-PP	O
general	general	JJ	B-NP	O
locomotor	locomotor	NN	I-NP	O
trajectory	trajectory	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
specific	specific	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
locomotion	locomotion	NN	B-NP	O
used	use	VBN	B-VP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
rotating	rotating	NN	I-NP	O
disk	disk	NN	I-NP	O

The	The	DT	B-NP	O
major	major	JJ	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
predicts	predict	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kD	kD	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
leucine	leucine	NN	I-NP	O
zipper	zipper	NN	I-NP	O
situated	situate	VBN	B-VP	O
adjacent	adjacent	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
myc	BEGIN-myc	NN	I-NP	B
-	-	HYPH	B-NP	I
related	relate	VBN	I-NP	I
motif	motif-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
proposed	propose	VBN	I-VP	O
to	to	TO	I-VP	O
assume	assume	VB	I-VP	O
a	a	DT	B-NP	O
helix	helix	NN	I-NP	O
-	-	HYPH	B-NP	O
loop	loop	NN	I-NP	O
-	-	HYPH	I-NP	O
helix	helix	NN	I-NP	O
structure	structure	NN	I-NP	O

Medical	Medical	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
-	-	HYPH	I-NP	O
stage	stage	NN	I-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O

Other	Other	JJ	B-NP	O
Fischer	Fischer	NNP	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
rats	rat	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
exposed	expose	VBN	I-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
or	or	CC	B-PP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
ppm	ppm	NN	I-NP	O
O1	O1	NN	I-NP	O

Evidence	Evidence	NN	B-NP	O
from	from	IN	B-PP	O
four	four	CD	B-NP	O
areas	area	NNS	I-NP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
sensory	sensory	JJ	I-NP	O
deprivation	deprivation	NN	I-NP	O
,	,	,	O	O
enriched	enriched	JJ	B-NP	O
environments	environment	NNS	I-NP	O
,	,	,	O	O
nervous	nervous	JJ	B-NP	O
system	system	NN	I-NP	O
plasticity	plasticity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sensitive	sensitive	JJ	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
neurodevelopment	neurodevelopment	NN	B-NP	O
-	-	HYPH	O	O
-	-	HYPH	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
sensory	sensory	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
programs	program	NNS	I-NP	O
are	be	VBP	B-VP	O
potentially	potentially	RB	B-ADJP	O
beneficial	beneficial	JJ	I-ADJP	O
for	for	IN	B-PP	O
STR	STR	NN	B-NP	O
patients	patient	NNS	I-NP	O

The	The	DT	B-NP	O
limb	limb	NN	I-NP	O
defects	defect	NNS	I-NP	O
,	,	,	O	O
oligodactyly	oligodactyly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
syndactyly	syndactyly	RB	I-ADVP	O
,	,	,	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
traced	trace	VBN	I-VP	O
to	to	TO	B-PP	O
improper	improper	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
apical	apical	JJ	I-NP	O
ectodermal	ectodermal	JJ	I-NP	O
ridge	ridge	NN	I-NP	O
(	(	(	O	O
AER	AER	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
shortening	shortening	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anteroposterior	anteroposterior	JJ	I-NP	O
limb	limb	NN	I-NP	O
axis	axis	NN	I-NP	O

Action	Action	NN	B-NP	O
against	against	IN	B-PP	O
Vibrio	Vibrio	NNP	B-NP	O
cholerae	cholerae	NNP	I-NP	O
O1	O1	NN	I-NP	O
Tox+	BEGIN-Tox+-INSIDE	NN	I-NP	B
of	of	IN	B-PP	O
chemical	chemical	JJ	B-NP	O
products	product	NNS	I-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lemon	lemon	NN	I-NP	O
production	production	NN	I-NP	O

Sera	Sera	NN	B-NP	O
collected	collect	VBN	B-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
residents	resident	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
selected	select	VBN	I-NP	O
Alaskan	Alaskan	JJ	I-NP	O
Eskimo	Eskimo	NNP	I-NP	O
villages	village	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
virus	virus	NN	I-NP	O
infection	infection	NN	I-NP	O

Donehower	Donehower	NN	B-NP	O
and	and	CC	I-NP	O
H	H	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
studied	study	VBN	I-VP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
parameters	parameter	NNS	I-NP	O
governing	govern	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
foreign	foreign	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
-	-	HYPH	B-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
construct	construct	NN	I-NP	O
incorporated	incorporate	VBN	B-VP	O
into	into	IN	B-PP	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HSV	HSV	NN	B-NP	O
)	)	)	O	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O

cDNA	cDNA	NN	B-NP	O
cloning	cloning	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
two	two	CD	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
beta1	beta1	NN	I-NP	I
integrin	integrin	NN	I-NP	I
transcripts	transcripts-INSIDE	NN	I-NP	I
distinct	distinct	JJ	B-ADJP	O
in	in	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
domains	domain	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O

Children	Children	NN	B-NP	O
with	with	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
proteinuria	proteinuria	NN	I-NP	O
during	during	IN	B-PP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
tend	tend	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
pathologic	pathologic	JJ	B-NP	O
findings	finding	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
i.v.	i.v.	JJ	I-NP	O
-	-	HYPH	I-NP	O
pyelogram	pyelogram	NN	I-NP	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
Centers	Center	NNPS	I-NP	O
for	for	IN	B-PP	O
Disease	Disease	NN	B-NP	O
Control	Control	NN	I-NP	O
and	and	CC	O	O
Prevention	Prevention	NN	B-NP	O

The	The	DT	B-NP	O
translated	translate	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
FLI	BEGIN-FLI	NN	I-NP	B
LRR	LRR	NN	I-NP	I
associated	associate	VBN	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
FLAP	BEGIN-FLAP-INSIDE	NN	B-NP	B
)	)	)	O	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
protein	protein	NN	I-NP	O
not	not	RB	B-VP	O
represented	represent	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
data	data	NN	I-NP	O
base	base	NN	I-NP	O

The	The	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
eight	eight	CD	B-NP	O
signaling	signal	VBG	I-NP	O
molecules	molecule	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
TGFbeta	BEGIN-TGFbeta-INSIDE	NN	I-NP	B
,	,	,	O	O
FGF	BEGIN-FGF-INSIDE	NN	B-NP	B
,	,	,	O	O
Hh	BEGIN-Hh-INSIDE	NN	B-NP	B
,	,	,	O	O
Wnt	BEGIN-Wnt-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
EGF	BEGIN-EGF	NN	B-NP	B
families	families-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
tooth	tooth	JJ	B-NP	O
explant	explant	NN	I-NP	O
cultures	culture	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
edar	BEGIN-edar-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
activinbetaA	BEGIN-activinbetaA-INSIDE	NN	B-NP	B
,	,	,	O	O
whereas	whereas	IN	O	O
Wnt1	BEGIN-Wnt-INSIDE1	NN	B-NP	I
induced	induce	VBD	B-VP	O
ectodysplasin	BEGIN-ectodysplasin-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O

In	In	IN	B-PP	O
two	two	CD	B-NP	O
separate	separate	JJ	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
specimens	specimen	NNS	B-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
individuals	individual	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
(	(	(	O	O
mean	mean	JJ	B-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
persons	person	NNS	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
(	(	(	O	O
mean	mean	JJ	B-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
concentrations	concentration	NNS	B-NP	O
of	of	IN	B-PP	O
IgA	BEGIN-IgA-INSIDE	NN	B-NP	B
as	as	IN	B-PP	O
functions	function	NNS	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
electrolyte	electrolyte	NN	B-NP	O
conductivity	conductivity	NN	I-NP	O
;	;	:	O	O
some	some	DT	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
IgG	BEGIN-IgG-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
IgM	BEGIN-IgM-INSIDE	NN	I-NP	B
content	content	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
plant	BEGIN-plant	NN	I-NP	B
malate	malate	NN	I-NP	I
synthases	synthases-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
extension	extension	NN	I-NP	O
is	be	VBZ	B-VP	O
probably	probably	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
routing	rout	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
microbodies	microbody	NNS	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
it	it	PRP	B-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
peroxisomal	peroxisomal	JJ	I-NP	O
targeting	targeting	NN	I-NP	O
signal	signal	NN	I-NP	O
,	,	,	O	O
Ser	Ser	NN	B-NP	O
-	-	HYPH	B-NP	O
Arg	Arg	NN	I-NP	O
/	/	SYM	B-NP	O
Lys	Lys	NN	I-NP	O
-	-	HYPH	B-NP	O
Leu	Leu	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
carboxy	carboxy	NN	I-NP	O
terminus	terminus	NN	I-NP	O

These	These	DT	B-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
cognate	cognate	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
act	act	VB	I-VP	O
in	in	IN	B-PP	O
concert	concert	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
partial	partial	JJ	B-NP	O
redundancy	redundancy	NN	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
discrete	discrete	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
were	be	VBD	B-VP	O
only	only	RB	B-ADJP	O
partially	partially	RB	I-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
activity	activity	NN	I-NP	O

Upon	Upon	IN	B-PP	O
incubation	incubation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
highly	highly	RB	I-NP	O
purified	purify	VBN	I-NP	O
fractions	fraction	NNS	I-NP	O
with	with	IN	B-PP	O
Mn	Mn	NN	B-NP	O
-	-	HYPH	B-NP	O
ATP	ATP	NN	I-NP	O
or	or	CC	I-NP	O
Mg	Mg	NN	I-NP	O
-	-	HYPH	O	O
ATP	ATP	NN	B-NP	O
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
protein	protein	NN	I-NP	O
phosphorylated	phosphorylate	VBN	B-VP	O
on	on	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O

CLINICAL	CLINICAL	JJ	B-NP	O
FEATURES	FEATURES	NNS	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
yr	yr	NN	I-NP	O
-	-	HYPH	I-NP	O
old	old	JJ	I-NP	O
gravida	gravida	NN	I-NP	O
V	V	NN	I-NP	O
para	para	NN	I-NP	O
1	1	CD	I-NP	O
woman	woman	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
anaesthesia	anaesthesia	NN	I-NP	O
consultation	consultation	NN	I-NP	O
clinic	clinic	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
wk	wk	NN	I-NP	O
gestation	gestation	NN	I-NP	O
to	to	TO	B-VP	O
discuss	discuss	VB	I-VP	O
pain	pain	NN	B-NP	O
relief	relief	NN	I-NP	O
options	option	NNS	I-NP	O
for	for	IN	B-PP	O
labour	labour	NN	B-NP	O
and	and	CC	I-NP	O
delivery	delivery	NN	I-NP	O

Judge	Judge	NNP	B-NP	O
Christian	Christian	NNP	I-NP	O
Byk	Byk	NNP	I-NP	O
renders	render	VBZ	B-VP	O
service	service	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Steering	Steering	NNP	I-NP	O
Committee	Committee	NNP	I-NP	O
on	on	IN	B-PP	O
Bioethics	Bioethics	NNP	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Council	Council	NNP	I-NP	O
of	of	IN	B-PP	O
Europe	Europe	NNP	B-NP	O
(	(	(	O	O
CDBI	CDBI	NNP	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
proposing	propose	VBG	B-VP	O
a	a	DT	B-NP	O
draft	draft	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
protocol	protocol	NN	I-NP	O
destined	destine	VBN	B-VP	O
to	to	TO	I-VP	O
fill	fill	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
gap	gap	NN	I-NP	O
in	in	IN	B-PP	O
international	international	JJ	B-NP	O
law	law	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
embryo	embryo	NN	I-NP	O

In	In	IN	B-PP	O
agreement	agreement	NN	I-PP	O
with	with	IN	I-PP	O
this	this	DT	B-NP	O
model	model	NN	I-NP	O
,	,	,	O	O
elimination	elimination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ADAM1	BEGIN-BEGIN-ADAM1-INSIDE	NN	I-NP	B
cytoplasmic	cytoplasmic	JJ	I-NP	O
domain	domain-INSIDE	NN	I-NP	I
increased	increase	VBD	B-VP	O
developmental	developmental	JJ	B-NP	O
alterations	alteration	NNS	I-NP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
ADAM1	BEGIN-ADAM1-INSIDE	NN	B-NP	B
proteolytic	proteolytic	JJ	I-NP	O
activity	activity	NN	I-NP	O

Studies	Study	NNS	B-NP	O
in	in	IN	B-PP	O
B.	B.	NNP	B-NP	O
glabrata	glabrata	NNP	I-NP	O
,	,	,	O	O
B.	B.	NNP	B-NP	O
straminea	straminea	NNP	I-NP	O
and	and	CC	O	O
B.	B.	NNP	B-NP	O
tenagophila	tenagophila	NN	I-NP	O
under	under	IN	B-PP	O
outdoor	outdoor	JJ	B-NP	O
conditions	condition	NNS	I-NP	O

E.R.C.P.	E.R.C.P.	NNP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
advance	advance	NN	I-NP	O
in	in	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
laboratory	laboratory	NN	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
prerenal	prerenal	JJ	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
RFT	RFT	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
treatment	treatment	NN	B-NP	O
is	be	VBZ	B-VP	O
unpredictable	unpredictable	JJ	B-ADJP	O
and	and	CC	O	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
worse	worse	JJR	I-NP	O
prognosis	prognosis	NN	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
RFI	RFI	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
/	/	SYM	O	O
1	1	CD	B-NP	O
deaths	death	NNS	I-NP	O
vs	vs	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
deaths	death	NNS	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
strangulated	strangulated	JJ	I-NP	O
intestinal	intestinal	JJ	I-NP	O
pathologies	pathology	NNS	I-NP	O
of	of	IN	B-PP	O
horses	horse	NNS	B-NP	O
are	be	VBP	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
local	local	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
neutrophils	neutrophil	NNS	I-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
revealed	reveal	VBN	I-VP	O
by	by	IN	B-PP	O
measuring	measure	VBG	B-VP	O
the	the	DT	B-NP	O
tissular	tissular	JJ	I-NP	O
enzymatic	enzymatic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
granulocytic	granulocytic	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
myeloperoxidase	BEGIN-myeloperoxidase-INSIDE	NN	I-NP	B
(	(	(	O	O
MPO	BEGIN-MPO-INSIDE	NN	B-NP	B
)	)	)	O	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	O
protein	protein	NN	I-NP	O
is	be	VBZ	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
base	base	NN	I-NP	O
pair	pair	NN	I-NP	O
-	-	HYPH	B-NP	O
long	long	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
glandular	glandular	JJ	I-NP	O
epithelial	epithelial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endometrium	endometrium	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cyclic	cyclic	JJ	I-NP	O
manner	manner	NN	I-NP	O
;	;	:	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
epithelial	epithelial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fallopian	fallopian	JJ	I-NP	O
tubes	tube	NNS	I-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
preceding	precede	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
site	site	NN	I-NP	O
has	have	VBZ	B-VP	O
few	few	JJ	O	O
,	,	,	O	O
if	if	IN	B-SBAR	O
any	any	DT	B-NP	O
,	,	,	O	O
functional	functional	JJ	B-NP	O
ORFs	ORF	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
contains	contain	VBZ	B-VP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
repeats	repeat	NNS	I-NP	O
,	,	,	O	O
INGI	BEGIN-INGI	NN	B-NP	B
retrotransposon	retrotransposon	NN	I-NP	I
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
elements	elements-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
novel	novel	JJ	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
repeats	repeat	NNS	I-NP	O
found	find	VBN	B-VP	O
near	near	IN	B-PP	O
other	other	JJ	B-NP	O
telomeres	telomere	NNS	I-NP	O

Rather	Rather	RB	B-PP	O
than	than	IN	I-PP	O
seeking	seek	VBG	B-VP	O
a	a	DT	B-NP	O
blanket	blanket	NN	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
essentially	essentially	RB	I-NP	O
heterogeneous	heterogeneous	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
useful	useful	JJ	I-ADJP	O
to	to	TO	B-VP	O
consider	consider	VB	I-VP	O
idiom	idiom	NN	B-NP	O
comprehension	comprehension	NN	I-NP	O
a	a	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
manifestation	manifestation	NN	I-NP	O
of	of	IN	B-PP	O
semantic	semantic	JJ	B-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
pragmatic	pragmatic	JJ	B-NP	O
difficulties	difficulty	NNS	I-NP	O

The	The	DT	B-NP	O
two	two	CD	I-NP	O
redox	redox	NN	I-NP	O
centers	center	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
FAD	FAD	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
[	[	(	I-NP	O
1Fe1S	1Fe1S	NN	I-NP	O
]	]	)	O	O
+1	+1	CD	B-NP	O
,	,	,	O	O
+1	+1	CD	B-NP	O
cluster	cluster	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
monomer	monomer	NN	I-NP	O

The	The	DT	B-NP	O
BDU	BDU	NN	I-NP	O
neurons	neuron	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ALM	ALM	NN	I-NP	O
touch	touch	NN	I-NP	O
neurons	neuron	NNS	I-NP	O
are	be	VBP	B-VP	O
lineal	lineal	JJ	B-NP	O
sister	sister	NN	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AB.a	AB.a	NNP	I-NP	O
lineage	lineage	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
VA	VA	NN	I-NP	O
and	and	CC	I-NP	O
VB	VB	NN	I-NP	O
motor	motor	NN	I-NP	O
neurons	neuron	NNS	I-NP	O
are	be	VBP	B-VP	O
lineal	lineal	JJ	B-NP	O
sister	sister	NN	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AB.p	AB.p	NN	I-NP	O
lineage	lineage	NN	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
triazolam	triazolam	NN	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
effectively	effectively	RB	I-VP	O
counteract	counteract	VB	I-VP	O
a	a	DT	B-NP	O
posture	posture	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
sleep	sleep	NN	I-NP	O
disturbance	disturbance	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
induces	induce	VBZ	B-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
EEG	EEG	NN	I-NP	O
spectra	spectrum	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
typical	typical	JJ	B-ADJP	O
for	for	IN	B-PP	O
benzodiazepine	BEGIN-benzodiazepine	JJ	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
agonists	agonist	NNS	I-NP	O

The	The	DT	B-NP	O
biological	biological	JJ	I-NP	O
actions	action	NNS	I-NP	O
of	of	IN	B-PP	O
VHR	BEGIN-VHR-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
oocytes	oocyte	NNS	B-NP	O
clearly	clearly	RB	B-ADVP	O
distinguish	distinguish	VBP	B-VP	O
it	it	PRP	B-NP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
dual	dual	JJ	I-NP	O
specificity	specificity	NN	I-NP	O
phosphatases	phosphatas	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
inhibitory	inhibitory	JJ	B-NP	O
effects	effect	NNS	I-NP	O
when	when	WRB	B-ADVP	O
tested	test	VBN	B-VP	O
in	in	IN	B-PP	O
oocytes	oocyte	NNS	B-NP	O

Discriminant	Discriminant	JJ	B-NP	O
function	function	NN	I-NP	O
analysis	analysis	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
AUDIT	AUDIT	NN	B-NP	O
scores	score	NNS	I-NP	O
can	can	MD	B-VP	O
successfully	successfully	RB	I-VP	O
identify	identify	VB	I-VP	O
SAT	SAT	NN	B-NP	O
-	-	HYPH	B-NP	O
positive	positive	JJ	I-NP	O
and	and	CC	I-NP	O
SAT	SAT	NN	I-NP	O
-	-	HYPH	O	O
negative	negative	JJ	B-NP	O
patients	patient	NNS	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
analysis	analysis	NN	I-NP	O
accounted	account	VBD	B-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variance	variance	NN	I-NP	O
and	and	CC	O	O
correctly	correctly	RB	B-VP	O
classified	classify	VBD	I-VP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sample	sample	NN	I-NP	O

Failure	Failure	NN	B-NP	O
to	to	TO	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
anti	anti	AFX	I-NP	O
-	-	HYPH	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
effect	effect	NN	I-NP	O
with	with	IN	B-PP	O
alpha	alpha	NN	B-NP	O
tocopherol	tocopherol	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O

The	The	DT	B-NP	O
flanking	flank	VBG	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frames	frame	NNS	I-NP	O
in	in	IN	B-PP	O
pARGC1	pARGC1	NN	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
homologies	homology	NNS	I-NP	O
to	to	TO	B-VP	O
arginine	arginine	VB	I-VP	O
biosynthetic	biosynthetic	JJ	B-NP	O
genes	gene	NNS	I-NP	O

Estrogen	Estrogen	NN	B-NP	O
pretreated	pretreate	VBN	B-VP	O
castrated	castrate	VBD	B-VP	O
males	male	NNS	B-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
estradiol	estradiol	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
coronary	coronary	JJ	B-NP	O
flow	flow	NN	I-NP	O
velocity	velocity	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	O	O
kg	kg	NN	B-NP	O
dose	dose	NN	I-NP	O
(	(	(	O	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
kHz	kHz	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
diastolic	diastolic	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
control	control	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
/	/	SYM	B-NP	O
mkHz	mkHz	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
studies	study	NNS	I-NP	O
permit	permit	VBP	B-VP	O
considering	consider	VBG	I-VP	O
the	the	DT	B-NP	O
detected	detect	VBN	I-NP	O
shifts	shift	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immunity	immunity	NN	I-NP	O
system	system	NN	I-NP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
nontumorous	nontumorous	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
parotid	parotid	NN	I-NP	O
glands	gland	NNS	I-NP	O

The	The	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
protein	protein	NN	I-NP	O
systems	system	NNS	I-NP	O
with	with	IN	B-PP	O
microtubules	microtubule	NNS	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
step	step	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
organelles	organelle	NNS	I-NP	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
liver	liver	NN	B-NP	O
,	,	,	O	O
muscle	muscle	NN	B-NP	O
,	,	,	O	O
fat	fat	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pituitary	pituitary	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
(	(	(	O	O
DwDw	DwDw	NN	B-NP	O
)	)	)	O	O
chickens	chicken	NNS	B-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
transcript	transcript	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kilobases	kilobas	NNS	I-NP	O
(	(	(	O	O
kb	kb	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
three	three	CD	B-NP	O
minor	minor	JJ	I-NP	O
transcripts	transcript	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
correspond	correspond	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cGHR	BEGIN-cGHR-INSIDE	NN	I-NP	B

SHBG	BEGIN-SHBG-INSIDE	NN	B-NP	B
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
at	at	IN	B-PP	O
T	T	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
T	T	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
values	value	NNS	I-NP	O

Chromosome	Chromosome	NN	B-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
STSs	STS	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
telomeres	telomere	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
TYACs	TYAC	NNS	I-NP	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
groups	group	NNS	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
hypertrophic	hypertrophic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
angina	angina	NN	B-NP	O
pectoris	pectoris	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
valvular	valvular	JJ	I-NP	O
disease	disease	NN	I-NP	O

The	The	DT	B-NP	O
two	two	CD	I-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
pheromone	pheromone	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
a	BEGIN-a	NN	I-NP	B
and	and	CC	O	I
alpha	alpha	SYM	B-NP	I
-	-	HYPH	I-NP	I
factor	factor	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
,	,	,	O	O
share	share	VBP	B-VP	O
many	many	JJ	B-NP	O
functional	functional	JJ	I-NP	O
similarities	similarity	NNS	I-NP	O
:	:	:	O	O
both	both	DT	B-NP	O
G	BEGIN-G	NN	B-NP	B
protein	protein	NN	I-NP	I
-	-	HYPH	B-NP	I
coupled	couple	VBN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
couple	couple	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
downstream	downstream	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathway	pathway	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
both	both	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
undergo	undergo	VBP	B-VP	O
feedback	feedback	NN	B-NP	O
regulation	regulation	NN	I-NP	O
involving	involve	VBG	B-VP	O
increased	increase	VBN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
domains	domain	NNS	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
ligand	ligand	NN	B-NP	O
challenge	challenge	NN	I-NP	O

Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
consumption	consumption	NN	I-NP	O
increased	increase	VBD	B-VP	O
1+	1+	SYM	B-NP	O
/	/	SYM	B-NP	O
-	-	SYM	B-VP	O
1	1	CD	B-NP	O
bpm	bpm	NN	I-NP	O
and	and	CC	O	O
1+	1+	SYM	B-NP	O
/	/	SYM	B-NP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
O1	O1	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
x	x	SYM	B-NP	O
min	min	NN	I-NP	O
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
supine	supine	NN	B-NP	O
resting	rest	VBG	B-VP	O
values	value	NNS	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
produces	produce	VBZ	B-VP	O
an	an	DT	B-NP	O
NH1	NH1	NN	I-NP	O
terminus	terminus	NN	I-NP	O
that	that	WDT	B-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
equivalent	equivalent	JJ	I-NP	O
NH1	NH1	NN	I-NP	O
terminus	terminus	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
processed	process	VBN	I-NP	O
matrix	matrix	NN	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
similar	similar	JJ	I-NP	O
alpha1	BEGIN-alpha1	NN	I-NP	B
(	(	(	O	I
XI	XI	NN	B-NP	I
)	)	)	O	I
chain	chain-INSIDE	NN	B-NP	I
,	,	,	O	O
thus	thus	RB	B-ADVP	O
suggesting	suggest	VBG	B-VP	O
physiological	physiological	JJ	B-NP	O
significance	significance	NN	I-NP	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
transactivation	transactivation	NN	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
four	four	CD	I-NP	O
Ahr	BEGIN-Ahr-INSIDE	NN	I-NP	B
Sp1	BEGIN-BEGIN-Sp1-INSIDE	NN	I-NP	B
sites	sites-INSIDE	NN	I-NP	I
,	,	,	O	O
we	we	PRP	B-NP	O
fused	fuse	VBD	B-VP	O
the	the	DT	B-NP	O
Ahr	BEGIN-BEGIN-Ahr-INSIDE	JJ	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
a	a	DT	B-NP	O
luciferase	BEGIN-luciferase-INSIDE	NN	I-NP	B
(	(	(	O	O
LUC	BEGIN-LUC-INSIDE	NN	B-NP	B
)	)	)	O	O
reporter	reporter	NN	B-NP	O
gene	gene	NN	I-NP	O
and	and	CC	O	O
transfected	transfecte	VBD	B-VP	O
the	the	DT	B-NP	O
construct	construct	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
Drosophila	Drosophila	FW	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
Schneider	Schneider	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
no	no	DT	B-NP	O
Sp1	BEGIN-Sp1-INSIDE	NN	I-NP	B
or	or	CC	I-NP	O
Sp1	BEGIN-BEGIN-Sp1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
factors	factors-INSIDE	NN	I-NP	I

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
also	also	RB	B-ADVP	O
predict	predict	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
budding	BEGIN-budding	JJ	I-NP	B
yeast	yeast	NN	I-NP	I
arsenate	arsenate	NN	I-NP	I
resistance	resistance	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
Acr1	BEGIN-Acr1-INSIDE	NN	I-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
ORF	BEGIN-ORF	NN	I-NP	B
Ygr1w	Ygr1w-INSIDE	NN	I-NP	I
encode	encode	VBP	B-VP	O
protein	protein	NN	B-NP	O
phosphatases	phosphatas	NNS	I-NP	O
with	with	IN	B-PP	O
catalytic	catalytic	JJ	B-NP	O
properties	property	NNS	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Cdc1	BEGIN-Cdc1	NN	I-NP	B
family	family-INSIDE	NN	I-NP	I

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
CT	CT	NN	I-NP	O
results	result	VBZ	B-VP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
method	method	NN	I-NP	O
showed	show	VBD	B-VP	O
areas	area	NNS	B-NP	O
of	of	IN	B-PP	O
cerebral	cerebral	JJ	B-NP	O
activity	activity	NN	I-NP	O
anatomically	anatomically	RB	B-ADVP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
neurological	neurological	JJ	B-NP	O
signs	sign	NNS	I-NP	O
or	or	CC	O	O
vascular	vascular	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O

Signal	Signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
in	in	IN	B-PP	O
fibroblasts	fibroblast	NNS	B-NP	O
stably	stably	RB	B-VP	O
transformed	transform	VBN	I-VP	O
by	by	IN	B-PP	O
[	[	(	B-NP	O
Val1	Val1	NN	I-NP	O
]	]	)	I-NP	O
Ras	Ras	NN	I-NP	O
-	-	HYPH	O	O
-	-	HYPH	O	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
extracellular	BEGIN-extracellular	JJ	B-NP	B
-	-	HYPH	I-NP	I
signal	signal	NN	I-NP	I
-	-	HYPH	O	I
regulated	regulate	VBN	B-VP	I
kinase	kinase-INSIDE	NN	B-NP	I
and	and	CC	O	O
Jun	BEGIN-Jun	NN	B-NP	B
N	N	NN	I-NP	I
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
only	only	RB	I-VP	O
moderately	moderately	RB	I-VP	O
increased	increase	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
delta	delta	SYM	I-NP	O
-	-	HYPH	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
Jun	Jun-INSIDE	NN	B-NP	I
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
alleviated	alleviate	VBN	I-VP	O

Avian	BEGIN-Avian	JJ	B-NP	B
EMILIN	EMILIN-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
extracted	extract	VBN	I-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
day	day	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
embryonic	embryonic	JJ	I-NP	O
chick	chick	NN	I-NP	O
aortas	aorta	NNS	I-NP	O
and	and	CC	O	O
associated	associate	VBN	B-NP	O
blood	blood	NN	I-NP	O
vessels	vessel	NNS	I-NP	O
and	and	CC	O	O
purified	purify	VBN	B-VP	O
by	by	IN	B-PP	O
ion	ion	NN	B-NP	O
-	-	HYPH	B-NP	O
exchange	exchange	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
and	and	CC	I-NP	O
gel	gel	NN	I-NP	O
filtration	filtration	NN	I-NP	O

Asymptomatic	Asymptomatic	JJ	B-NP	O
ischaemia	ischaemia	NN	I-NP	O
during	during	IN	B-PP	O
daily	daily	JJ	B-NP	O
life	life	NN	I-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
relevant	relevant	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
redundant	redundant	JJ	I-ADJP	O

Individual	Individual	JJ	B-NP	O
intolerance	intolerance	NN	I-NP	O
to	to	TO	B-PP	O
betaxolol	betaxolol	NN	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
occur	occur	VB	I-VP	O
and	and	CC	I-VP	O
care	care	VB	I-VP	O
is	be	VBZ	B-VP	O
always	always	RB	I-VP	O
required	require	VBN	I-VP	O
when	when	WRB	B-ADVP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
or	or	CC	I-NP	O
respiratory	respiratory	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
are	be	VBP	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
antagonist	antagonist	NN	I-NP	O

DESIGN	DESIGN	NN	B-NP	O
:	:	:	O	O
Prospective	Prospective	JJ	B-NP	O
case	case	NN	I-NP	O
study	study	NN	I-NP	O
(	(	(	O	O
Canadian	Canadian	JJ	B-NP	O
Task	Task	NNP	I-NP	O
Force	Force	NNP	I-NP	O
classification	classification	NN	I-NP	O
II	II	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
highest	high	JJS	I-NP	O
incidence	incidence	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
for	for	IN	B-PP	O
V.	V.	NNP	B-NP	O
alginolyticus	alginolyticus	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
V.	V.	NN	B-NP	O
parahaemolyticus	parahaemolyticus	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
V.	V.	NN	B-NP	O
fluvialis	fluvialis	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
V.	V.	NN	B-NP	O
vulnificus	vulnificus	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
V.	V.	NNP	B-NP	O
furnissii	furnissii	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
V.	V.	NN	B-NP	O
mimicus	mimicus	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
V.	V.	NNP	B-NP	O
cholerae	cholerae	VBP	B-VP	O
non	non	AFX	O	O
-	-	HYPH	O	O
O1	O1	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Self	Self	NN	B-NP	O
-	-	HYPH	I-NP	O
consistent	consistent	JJ	I-NP	O
calculation	calculation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
electronic	electronic	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
(	(	(	I-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
reconstructed	reconstruct	VBN	B-NP	O
Au	Au	NN	I-NP	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
surface	surface	NN	B-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
polypropylene	polypropylene	NN	B-NP	O
glycol	glycol	NN	I-NP	O
,	,	,	O	O
PG	PG	NN	B-NP	O
-	-	HYPH	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
corn	corn	NN	B-NP	O
oil	oil	NN	I-NP	O
all	all	DT	O	O
removed	remove	VBD	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MDI	MDI	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O

Peak	Peak	JJ	B-NP	O
insulin	BEGIN-insulin-INSIDE	NN	I-NP	B
response	response	NN	I-NP	O
to	to	TO	B-PP	O
glucose	glucose	NN	B-NP	O
infusion	infusion	NN	I-NP	O
declined	decline	VBD	B-VP	O
from	from	IN	B-PP	O
Groups	Group	NNS	B-NP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
microU	microU	NN	I-NP	O
/	/	SYM	B-PP	O
ml	ml	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
with	with	IN	B-PP	O
Group	Group	NN	B-NP	O
1	1	CD	I-NP	O
exhibiting	exhibit	VBG	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
decreased	decrease	VBN	I-NP	O
mean	mean	JJ	I-NP	O
peak	peak	JJ	I-NP	O
level	level	NN	I-NP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
groups	group	NNS	I-NP	O

Chemical	Chemical	JJ	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
SF	SF	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

Reexamination	Reexamination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cdc1	BEGIN-cdc1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
being	be	VBG	B-VP	O
defective	defective	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
defective	defective	JJ	B-ADJP	O
in	in	IN	B-PP	O
G	G	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
M	M	NN	I-NP	O
transition	transition	NN	I-NP	O
when	when	WRB	B-ADVP	O
released	release	VBN	B-VP	O
from	from	IN	B-PP	O
hydroxyurea	hydroxyurea	NN	B-NP	O
-	-	HYPH	B-PP	O
induced	induce	VBN	B-NP	O
S	S	NN	I-NP	O
-	-	HYPH	O	O
phase	phase	NN	B-NP	O
arrest	arrest	NN	I-NP	O

Structure	Structure	NN	B-NP	O
and	and	CC	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
luteinizing	BEGIN-luteinizing	JJ	I-NP	B
hormone	hormone	NN	I-NP	I
receptor	receptor	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
procedure	procedure	NN	I-NP	O
was	be	VBD	B-VP	O
technically	technically	RB	B-ADJP	O
successful	successful	JJ	I-ADJP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
stenoses	stenose	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fibromuscular	fibromuscular	JJ	I-NP	O
dysplasia	dysplasia	NN	I-NP	O
subgroup	subgroup	NN	I-NP	O
but	but	CC	B-PP	O
in	in	IN	B-PP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
lesions	lesion	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
neurofibromatosis	neurofibromatosis	NN	I-NP	O
subgroup	subgroup	NN	I-NP	O

Amplitude	Amplitude	NN	B-NP	O
of	of	IN	B-PP	O
late	late	JJ	B-NP	O
surface	surface	NN	I-NP	O
(	(	(	O	O
P1	P1	NN	B-NP	O
and	and	CC	O	O
N1	N1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
depth	depth	NN	B-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
and	and	CC	O	O
C	C	NN	B-NP	O
)	)	)	O	O
components	component	NNS	B-NP	O
significantly	significantly	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
when	when	WRB	B-ADVP	O
patients	patient	NNS	B-NP	O
shifted	shift	VBD	B-VP	O
from	from	IN	B-PP	O
SWS	SWS	NN	B-NP	O
IV	IV	CD	I-NP	O
to	to	TO	B-PP	O
PS	PS	NNP	B-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
PS	PS	NNP	B-NP	O
to	to	TO	B-PP	O
W1	W1	NN	B-NP	O

Unconventional	Unconventional	JJ	B-NP	O
mRNA	mRNA	NN	I-NP	O
processing	processing	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
calcineurin	BEGIN-calcineurin	NN	I-NP	B
B	B	NN	I-NP	I
isoforms	isoforms-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
Dictyostelium	Dictyostelium	NN	B-NP	O

T1	T1	NN	B-NP	O
and	and	CC	I-NP	O
T1	T1	NN	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
from	from	IN	B-PP	O
guinea	guinea	NN	B-NP	O
pig	pig	NN	I-NP	O
brain	brain	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
T	T	NN	I-NP	O

A	A	DT	B-NP	O
chest	chest	NN	I-NP	O
-	-	HYPH	I-NP	O
X	X	NN	I-NP	O
ray	ray	NN	I-NP	O
film	film	NN	I-NP	O
showed	show	VBD	B-VP	O
infiltrative	infiltrative	JJ	B-NP	O
shadows	shadow	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	NN	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
lung	lung	NN	I-NP	O
density	density	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O

Transcription	Transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inserted	insert	VBN	I-NP	O
gene	gene	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
subgenomic	subgenomic	JJ	I-NP	O
polyadenylated	polyadenylate	VBN	I-NP	O
mRNA	mRNA	NN	I-NP	O
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
by	by	IN	B-PP	O
Northern	Northern	NN	B-NP	O
(	(	(	O	O
RNA	RNA	NN	B-NP	O
)	)	)	O	O
blot	blot	NN	B-NP	O
hybridization	hybridization	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
encoded	encode	VBN	I-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
enzyme	enzyme	NN	B-NP	O
assay	assay	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
radioimmunoprecipitation	radioimmunoprecipitation	NN	B-NP	O

We	We	PRP	B-NP	O
then	then	RB	B-ADVP	O
supplemented	supplement	VBD	B-VP	O
these	these	DT	B-NP	O
spliceosomes	spliceosome	NNS	I-NP	O
with	with	IN	B-PP	O
purified	purify	VBN	B-NP	O
proteins	protein	NNS	I-NP	O
or	or	CC	O	O
yeast	yeast	NN	B-NP	O
extract	extract	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
assay	assay	NN	I-NP	O
for	for	IN	B-PP	O
second	second	JJ	B-NP	O
-	-	HYPH	I-NP	O
step	step	NN	I-NP	O
splicing	splicing	NN	I-NP	O
factors	factor	NNS	I-NP	O

The	The	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
psychomotor	psychomotor	NN	I-NP	O
retardation	retardation	NN	I-NP	O
varied	vary	VBD	B-VP	O
from	from	IN	B-PP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-VP	O
severe	severe	VB	I-VP	O

Plasma	BEGIN-Plasma	NN	B-NP	B
insulin	insulin-INSIDE	NN	I-NP	I
responses	response	NNS	I-NP	O
to	to	TO	B-VP	O
glucose	glucose	VB	I-VP	O
in	in	IN	B-PP	O
femoral	femoral	JJ	B-NP	O
,	,	,	I-NP	O
hepatic	hepatic	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pancreatic	pancreatic	JJ	B-NP	O
veins	vein	NNS	I-NP	O
in	in	IN	B-PP	O
dogs	dog	NNS	B-NP	O

The	The	DT	B-NP	O
reading	reading	NN	I-NP	O
achievement	achievement	NN	I-NP	O
of	of	IN	B-PP	O
students	student	NNS	B-NP	O
with	with	IN	B-PP	O
learning	learn	VBG	B-NP	O
disabilities	disability	NNS	I-NP	O
who	who	WP	B-NP	O
received	receive	VBD	B-VP	O
reading	read	VBG	I-VP	O
instruction	instruction	NN	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
DISTAR	DISTAR	NN	I-NP	O
program	program	NN	I-NP	O
was	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
similar	similar	JJ	B-NP	O
students	student	NNS	I-NP	O
using	use	VBG	B-VP	O
basal	basal	JJ	B-NP	O
reader	reader	NN	I-NP	O
materials	material	NNS	I-NP	O

We	We	PRP	B-NP	O
discuss	discuss	VBP	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
DNA	DNA	NN	B-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
at	at	IN	B-PP	O
homologous	homologous	JJ	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
like	like	IN	B-PP	O
those	those	DT	B-NP	O
identified	identify	VBN	B-VP	O
in	in	IN	B-PP	O
PII	PII	NN	B-NP	O
are	be	VBP	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
gene	gene	NN	I-NP	O
cascade	cascade	NN	I-NP	O
that	that	WDT	B-NP	O
participates	participate	VBZ	B-VP	O
in	in	IN	B-PP	O
timing	time	VBG	B-VP	O
fla	BEGIN-fla	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
C.	C.	NNP	I-NP	O
crescentus	crescentus	NN	I-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
homology	homology	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
type	type	NN	I-NP	O
A	A	NN	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
binding	binding	NN	I-NP	O
site	site	NN	I-NP	O
consensus	consensus	NN	I-NP	O
sequence	sequence	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
ATPase	BEGIN-ATPase-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
DNA	DNA	NN	B-NP	O
containing	contain	VBG	B-VP	O
specific	specific	JJ	B-NP	O
mismatched	mismatched	JJ	I-NP	O
residues	residue	NNS	I-NP	O

The	The	DT	B-NP	O
detergent	detergent	NN	I-NP	O
-	-	HYPH	B-NP	O
solubilized	solubilize	VBN	I-NP	O
complex	complex	NN	I-NP	O
oxidizes	oxidize	VBZ	B-VP	O
caldariella	caldariella	NN	B-NP	O
quinol	quinol	NN	I-NP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
rates	rate	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
completely	completely	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
cyanide	cyanide	NN	B-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
quinolone	quinolone	NN	B-NP	O
analogs	analog	NNS	I-NP	O
,	,	,	O	O
potent	potent	JJ	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
of	of	IN	B-PP	O
quinol	BEGIN-quinol	NN	B-NP	B
oxidases	oxidases-INSIDE	NN	I-NP	I

Significantly	Significantly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
murine	BEGIN-murine	JJ	I-NP	B
P	P	NN	I-NP	I
-	-	HYPH	B-NP	I
selectin	selectin	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
features	feature	NNS	I-NP	O
not	not	RB	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gene	gene	NN	I-NP	O

Consistently	Consistently	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
phosphorylation	phosphorylation	NN	B-NP	O
by	by	IN	B-PP	O
protein	BEGIN-protein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
A	A-INSIDE	NN	I-NP	I
inhibits	inhibit	VBZ	B-VP	O
Sfl1	BEGIN-Sfl1-INSIDE	NN	B-NP	B
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
tpk1Delta	BEGIN-tpk1Delta-INSIDE	NN	I-NP	B
mutation	mutation	NN	I-NP	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Sfl1	BEGIN-BEGIN-Sfl1-INSIDE	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
elements	element	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

This	This	DT	B-NP	O
region	region	NN	I-NP	O
was	be	VBD	B-VP	O
unfavourable	unfavourable	JJ	B-ADJP	O
,	,	,	O	O
due	due	JJ	B-PP	O
to	to	TO	I-PP	O
malaria	malaria	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O

SM	BEGIN-SM-INSIDE	NN	B-NP	B
binds	bind	VBZ	B-VP	O
RNA	RNA	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
sequence	sequence	NN	B-NP	O
-	-	HYPH	B-VP	O
or	or	CC	O	O
structure	structure	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
might	might	MD	B-VP	O
mediate	mediate	VB	I-VP	O
SM	BEGIN-SM-INSIDE	NN	B-NP	B
specificity	specificity	NN	I-NP	O

Stress	Stress	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prolactin	BEGIN-prolactin-INSIDE	NN	I-NP	B
afternoon	afternoon	NN	I-NP	O
surge	surge	NN	I-NP	O
in	in	IN	B-PP	O
ovariectomized	ovariectomize	VBN	B-NP	O
,	,	,	I-NP	O
estrogen	estrogen	NN	I-NP	O
-	-	HYPH	I-NP	O
treated	treat	VBN	B-NP	O
rats	rat	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
surge	surge	NN	I-NP	O
in	in	IN	B-PP	O
pseudopregnant	pseudopregnant	JJ	B-NP	O
rats	rat	NNS	I-NP	O
are	be	VBP	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
median	median	NN	B-NP	O
eminence	eminence	NN	I-NP	O
dihydroxyphenylacetic	dihydroxyphenylacetic	JJ	I-NP	O
acid	acid	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
kinase	kinase	NN	I-NP	O
assays	assay	NNS	I-NP	O
on	on	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
microvilli	microvilli	NNS	I-NP	O
and	and	CC	O	O
microvillar	microvillar	JJ	B-NP	O
fractions	fraction	NNS	I-NP	O
enriched	enrich	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
particle	particle	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
specific	specific	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
tyrosine	BEGIN-tyrosine	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
membranes	membrane	NNS	B-NP	O
from	from	IN	B-PP	O
EGF	BEGIN-BEGIN-EGF-INSIDE	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
overexpressing	overexpresse	VBG	B-VP	O
A1	A1	NN	B-NP	O
cells	cell	NNS	I-NP	O
maximally	maximally	RB	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
EGF	BEGIN-EGF-INSIDE	NN	B-NP	B

Among	Among	IN	B-PP	O
these	these	DT	B-NP	O
,	,	,	O	O
four	four	CD	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
AIDS	AIDS	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
1	1	CD	B-NP	O
individuals	individual	NNS	I-NP	O
were	be	VBD	B-VP	O
HIV	HIV	NN	B-NP	O
carriers	carrier	NNS	I-NP	O

Carcinogenic	Carcinogenic	JJ	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
groundnut	groundnut	NN	B-NP	O
meal	meal	NN	I-NP	O
containing	contain	VBG	B-VP	O
aflatoxin	aflatoxin	NN	B-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O

The	The	DT	B-NP	O
UASB	UASB	NNP	I-NP	O
reactors	reactor	NNS	I-NP	O
treated	treat	VBD	B-VP	O
a	a	DT	B-NP	O
VFA	VFA	NN	I-NP	O
mixture	mixture	NN	I-NP	O
(	(	(	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
acetate	acetate	NN	I-NP	O
:	:	:	O	O
propionate	propionate	NN	B-NP	O
:	:	:	O	O
butyrate	butyrate	VB	B-VP	O
ratio	ratio	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
1	1	CD	I-NP	O
:	:	SYM	I-NP	O
1	1	CD	I-NP	O
on	on	IN	B-PP	O
COD	COD	NN	B-NP	O
basis	basis	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
acetate	acetate	NN	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
sole	sole	JJ	I-NP	O
substrate	substrate	NN	I-NP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
COD	COD	NN	I-NP	O
:	:	:	O	O
sulfate	sulfate	NN	B-NP	O
ratios	ratio	NNS	I-NP	O

Lack	Lack	NN	B-NP	O
of	of	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
milk	milk	NN	B-NP	O
production	production	NN	I-NP	O
and	and	CC	O	O
milk	milk	NN	B-NP	O
composition	composition	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
acute	acute	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
somatotropin	BEGIN-somatotropin-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
concomitant	concomitant	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
are	be	VBP	B-VP	O
not	not	RB	O	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
stimulate	stimulate	VB	I-VP	O
synthesis	synthesis	NN	B-NP	O
of	of	IN	B-PP	O
milk	milk	NN	B-NP	O
and	and	CC	I-NP	O
milk	milk	NN	I-NP	O
components	component	NNS	I-NP	O
by	by	IN	B-PP	O
cows	cow	NNS	B-NP	O
during	during	IN	B-PP	O
established	established	JJ	B-NP	O
lactation	lactation	NN	I-NP	O

The	The	DT	B-NP	O
initial	initial	JJ	I-NP	O
oral	oral	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-VP	O
kg	kg	NN	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
enoximone	enoximone	NN	B-NP	O
improved	improve	VBD	B-VP	O
central	central	JJ	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
with	with	IN	B-PP	O
apparent	apparent	JJ	B-NP	O
preferential	preferential	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
limb	limb	NN	B-NP	O
vascular	vascular	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	I-NP	O
augmentation	augmentation	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
flow	flow	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
limb	limb	NN	I-NP	O
region	region	NN	I-NP	O
(	(	(	O	O
peripheral	peripheral	JJ	B-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	O
system	system	NN	I-NP	O
)	)	)	O	O

Genomic	Genomic	JJ	B-NP	O
clones	clone	NNS	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
C.	C.	NNP	I-NP	O
briggsae	briggsae	NN	I-NP	O
gene	gene	NN	I-NP	O
are	be	VBP	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
completely	completely	RB	I-VP	O
rescue	rescue	VB	I-VP	O
the	the	DT	B-NP	O
unc	BEGIN-unc	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
phenotype	phenotype-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
transgenic	transgenic	JJ	B-NP	O
C.	C.	NNP	I-NP	O
elegans	elegan	NNS	I-NP	O
mutants	mutant	NNS	I-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
on	on	IN	B-PP	O
receptor	receptor	NN	B-NP	O
desensitization	desensitization	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
using	use	VBG	B-VP	O
receptor	receptor	NN	B-NP	O
mutants	mutant	NNS	I-NP	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
COS	COS	NN	B-NP	O
cells	cell	NNS	I-NP	O
or	or	CC	O	O
Chinese	Chinese	JJ	B-NP	O
hamster	hamster	NN	I-NP	O
lung	lung	NN	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O

For	For	IN	B-PP	O
il1ra	BEGIN-il1ra-INSIDE	NN	B-NP	B
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
formed	form	VBN	I-VP	O
from	from	IN	B-PP	O
two	two	CD	B-NP	O
exons	exon	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
for	for	IN	B-PP	O
il1rb	BEGIN-il1rb-INSIDE	NN	B-NP	B
,	,	,	O	O
seven	seven	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
neutrophil	neutrophil	NN	I-NP	O
mRNAs	mRNA	NNS	I-NP	O
are	be	VBP	B-VP	O
formed	form	VBN	I-VP	O
by	by	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O

The	The	DT	B-NP	O
coding	cod	VBG	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
rat	BEGIN-rat	NN	B-NP	B
MEK	MEK	NN	I-NP	I
kinase	kinase	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
MEKK1	BEGIN-MEKK1-INSIDE	NN	B-NP	B
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
determined	determine	VBN	I-VP	O
from	from	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
,	,	,	I-NP	O
independent	independent	JJ	I-NP	O
cDNA	cDNA	NN	I-NP	O
clones	clone	NNS	I-NP	O

By	By	IN	B-PP	O
deletion	deletion	NN	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
identified	identify	VBD	B-VP	O
the	the	DT	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
Jun	Jun-INSIDE	NN	B-NP	I
encoding	encode	VBG	B-VP	O
transformation	transformation	NN	B-NP	O
and	and	CC	I-NP	O
transactivation	transactivation	NN	I-NP	O
functions	function	NNS	I-NP	O

Several	Several	JJ	B-NP	O
waveforms	waveform	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
somatosensory	somatosensory	JJ	I-NP	O
(	(	(	O	O
N1	N1	NN	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
/	/	SYM	B-VP	O
N	N	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
P1	P1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
brainstem	brainstem	NN	I-NP	O
auditory	auditory	NN	I-NP	O
-	-	HYPH	B-VP	O
evoked	evoke	VBN	B-NP	O
response	response	NN	I-NP	O
(	(	(	O	O
I	I	NN	B-NP	O
,	,	,	O	O
III	III	CD	B-NP	O
,	,	,	I-NP	O
IV	IV	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
V	V	NN	B-NP	O
)	)	)	O	O
demonstrated	demonstrate	VBD	B-VP	O
shorter	short	JJR	B-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
latencies	latency	NNS	B-NP	O
in	in	IN	B-PP	O
growth	growth	NN	B-NP	O
-	-	HYPH	O	O
retarded	retard	VBN	B-NP	O
fetuses	fetus	NNS	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
-	-	HYPH	I-NP	O
sized	size	VBN	I-NP	O
fetuses	fetus	NNS	I-NP	O

The	The	DT	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
initial	initial	JJ	B-NP	O
reperfusion	reperfusion	NN	I-NP	O
pressure	pressure	NN	I-NP	O

Interactions	Interaction	NNS	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
detected	detect	VBN	I-VP	O
between	between	IN	B-PP	O
full	full	JJ	B-NP	O
-	-	HYPH	I-NP	O
length	length	NN	I-NP	O
HSF1	BEGIN-HSF1-INSIDE	NN	I-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
subunit	subunit	NN	I-NP	O
(	(	(	O	O
gamma	gamma	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
TFIIA	BEGIN-TFIIA-INSIDE	NN	B-NP	B

Pyknotic	Pyknotic	JJ	B-NP	O
osteocytes	osteocyte	NNS	I-NP	O
increased	increase	VBD	B-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	B-NP	O
human	human	JJ	I-NP	O
and	and	CC	I-NP	O
murine	murine	JJ	I-NP	O
genes	gene	NNS	I-NP	O
encode	encode	VBP	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
transcripts	transcript	NNS	I-NP	O

ALT	BEGIN-ALT-INSIDE	NN	B-NP	B
(	(	(	O	O
alanine	BEGIN-alanine	NN	B-NP	B
aminotransferase	aminotransferase-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
Hb	BEGIN-Hb-INSIDE	NN	B-NP	B
(	(	(	O	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	B-NP	B
)	)	)	O	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
predictive	predictive	JJ	B-ADJP	O
for	for	IN	B-PP	O
efficacy	efficacy	NN	B-NP	O

Maternal	Maternal	JJ	B-NP	O
behavior	behavior	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
using	use	VBG	B-VP	O
observational	observational	JJ	B-NP	O
techniques	technique	NNS	I-NP	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
timepidium	timepidium	NN	B-NP	O
bromide	bromide	NN	I-NP	O
(	(	(	O	O
TB	TB	NN	B-NP	O
;	;	:	O	O
anticholinergic	anticholinergic	JJ	B-NP	O
agent	agent	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
acetylcholine	acetylcholine	NN	B-NP	O
(	(	(	O	O
ACh	ACh	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
neostigmine	neostigmine	NN	B-NP	O
(	(	(	O	O
Neost	Neost	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
and	and	CC	I-NP	O
duodenal	duodenal	JJ	I-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
distribution	distribution	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
1I	1I	NN	B-NP	O
-	-	HYPH	O	O
labeled	label	VBN	B-VP	O
macroaggregated	macroaggregate	VBN	B-VP	O
human	human	JJ	B-NP	O
serum	serum	NN	I-NP	O
albumin	albumin	NN	I-NP	O
(	(	(	O	O
MAA	BEGIN-MAA-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O

Nucleotide	Nucleotide	NN	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gag	BEGIN-BEGIN-gag-INSIDE	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
gag	BEGIN-gag-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
pol	BEGIN-pol-INSIDE	NN	I-NP	B
junction	junction	NN	I-NP	O
of	of	IN	B-PP	O
feline	feline	NN	B-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O

When	When	WRB	B-ADVP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
impedance	impedance	NN	I-NP	O
testing	testing	NN	I-NP	O
device	device	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
post	post	NN	I-NP	O
shock	shock	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
displayed	display	VBN	I-VP	O
as	as	IN	B-PP	O
'no	'no	``	O	O
signal	signal	NN	B-NP	O
'	'	''	O	O
(	(	(	O	O
Hewlett	Hewlett	NNP	B-NP	O
Packard	Packard	NNP	I-NP	O
XL	XL	NNP	I-NP	O
)	)	)	O	O
or	or	CC	O	O
'asystole	'asystole	NN	B-NP	O
'	'	''	O	O
(	(	(	O	O
Physio	Physio	NNP	B-NP	O
-	-	HYPH	I-NP	O
Control	Control	NNP	I-NP	O
LIFEPAK	LIFEPAK	NN	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
plasma	plasma	NN	I-NP	O
steroid	steroid	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CAPD	CAPD	NN	I-NP	O
patients	patient	NNS	I-NP	O
after	after	IN	B-PP	O
each	each	DT	B-NP	O
infusion	infusion	NN	I-NP	O
rate	rate	NN	I-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
or	or	CC	O	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O

Nramp1	BEGIN-Nramp1-INSIDE	NN	B-NP	B
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
classical	classical	JJ	I-NP	O
iron	iron	NN	I-NP	O
responsive	responsive	JJ	I-NP	O
element	element	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
untranslated	untranslated	JJ	I-NP	O
region	region	NN	I-NP	O
that	that	WDT	B-NP	O
confers	confer	VBZ	B-VP	O
iron	iron	NN	B-NP	O
dependent	dependent	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O
stabilization	stabilization	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
reduced	reduce	VBD	B-VP	O
metabolism	metabolism	NN	B-NP	O
to	to	TO	B-PP	O
cotinine	cotinine	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
proliposomes	proliposome	NNS	I-NP	O
and	and	CC	I-NP	O
MP	MP	NN	I-NP	O
was	be	VBD	B-VP	O
apparently	apparently	RB	B-ADJP	O
responsible	responsible	JJ	I-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
sustained	sustain	VBN	I-NP	O
plasma	plasma	NN	I-NP	O
nicotine	nicotine	NN	I-NP	O
levels	level	NNS	I-NP	O

D	D	NN	B-NP	O

BCR	BEGIN-BCR-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
ABL	BEGIN-ABL-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
confers	confer	VBZ	B-VP	O
cross	cross	AFX	O	O
-	-	HYPH	O	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
multiple	multiple	JJ	B-NP	O
genotoxic	genotoxic	JJ	I-NP	O
anticancer	anticancer	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
by	by	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
apoptotic	apoptotic	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	O
damage	damage	NN	I-NP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
arrest	arrest	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
G1	G1	NN	I-NP	O
-	-	HYPH	B-NP	O
M	M	NN	I-NP	O
restriction	restriction	NN	I-NP	O
point	point	NN	I-NP	O

When	When	WRB	B-ADVP	O
a	a	DT	B-NP	O
longer	long	JJR	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
+1	+1	CD	I-NP	O
fragment	fragment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PBGD	BEGIN-PBGD	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
used	use	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
GATA	GATA	NN	I-NP	O
mutant	mutant	NN	I-NP	O
still	still	RB	B-ADVP	O
displays	display	VBZ	B-VP	O
erythroid	erythroid	JJ	B-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
cis	cis	NN	B-NP	O
-	-	HYPH	O	O
activated	activate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
1'HS	BEGIN-1'HS	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
CCACC	CCACC	NN	I-NP	O
mutant	mutant	NN	I-NP	O
is	be	VBZ	B-VP	O
completely	completely	RB	B-ADJP	O
inactive	inactive	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1'HS	BEGIN-1'HS	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I

Deletion	Deletion	NN	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
TM	TM	NN	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
Golgi	Golgi	NNP	B-NP	O
targeting	target	VBG	B-VP	O

In	In	IN	B-PP	O
area	area	NN	B-NP	O
CA1	CA1	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hippocampus	hippocampus	NN	I-NP	O
,	,	,	O	O
numbers	number	NNS	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
neurons	neuron	NNS	I-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
fold	fold	RB	B-ADVP	O
by	by	IN	B-PP	O
MK	MK	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
treatment	treatment	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Considering	Consider	VBG	B-VP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
facts	fact	NNS	I-NP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
vasectomy	vasectomy	NN	B-NP	O
may	may	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
prostatic	prostatic	JJ	B-NP	O
tumors	tumor	NNS	I-NP	O
-	-	:	O	O
a	a	DT	B-NP	O
disease	disease	NN	I-NP	O
that	that	WDT	B-NP	O
claims	claim	VBZ	B-VP	O
nearly	nearly	RB	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
lives	life	NNS	I-NP	O
each	each	DT	B-NP	O
year	year	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
United	United	NNP	I-NP	O
States	State	NNPS	I-NP	O
alone	alone	RB	B-ADVP	O

Further	Further	JJ	B-NP	O
studies	study	NNS	I-NP	O
aim	aim	VBP	B-VP	O
at	at	IN	B-PP	O
characterizing	characterize	VBG	B-VP	O
the	the	DT	B-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
acting	act	VBG	B-VP	O
factors	factor	NNS	B-NP	O
that	that	WDT	B-NP	O
mediate	mediate	VBP	B-VP	O
the	the	DT	B-NP	O
spatial	spatial	JJ	I-NP	O
and	and	CC	I-NP	O
temporal	temporal	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Hox	BEGIN-Hox	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
developing	develop	VBG	I-NP	O
embryo	embryo	NN	I-NP	O

The	The	DT	B-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
overexpressed	overexpresse	VBN	I-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
and	and	CC	O	O
purified	purify	VBN	B-VP	O
to	to	TO	B-PP	O
homogeneity	homogeneity	NN	B-NP	O

At	At	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
such	such	JJ	I-NP	O
complex	complex	NN	I-NP	O
is	be	VBZ	B-VP	O
eliminated	eliminate	VBN	I-VP	O
by	by	IN	B-PP	O
preincubating	preincubate	VBG	B-VP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
extract	extract	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
antibody	antibody	NN	I-NP	O
with	with	IN	B-PP	O
broad	broad	JJ	B-NP	O
cross	cross	AFX	I-NP	O
-	-	HYPH	I-NP	O
reactivity	reactivity	NN	I-NP	O
with	with	IN	B-PP	O
Ets	BEGIN-Ets	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Ets	BEGIN-BEGIN-Ets	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
,	,	,	O	O
thus	thus	RB	B-ADVP	O
confirming	confirm	VBG	B-VP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
ETS	BEGIN-ETS	JJ	I-NP	B
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
(	(	(	B-NP	I
s	s	NNS	I-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
recognizes	recognize	VBZ	B-VP	O
the	the	DT	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
motif	motif	NN	I-NP	O

Paraplegia	Paraplegia	NN	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
intraaortic	intraaortic	JJ	B-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
counterpulsation	counterpulsation	NN	I-NP	O

Gas	Gas	NN	B-NP	O
exchange	exchange	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
breath	breath	NN	B-NP	O
by	by	IN	B-PP	O
breath	breath	NN	B-NP	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Peripheral	Peripheral	JJ	B-NP	O
kappa	BEGIN-kappa	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
agonists	agonist	NNS	I-NP	O
may	may	MD	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
approach	approach	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
functional	functional	JJ	B-NP	O
dyspepsia	dyspepsia	NNS	I-NP	O

Checking	Check	VBG	B-VP	O
for	for	IN	B-PP	O
patient	patient	NN	B-NP	O
compliance	compliance	NN	I-NP	O
,	,	,	O	O
samples	sample	NNS	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
FK	FK	NN	I-NP	O
I	I	CD	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-NP	O
mL	mL	NN	I-NP	O
were	be	VBD	B-VP	O
re	re	AFX	B-ADJP	O
-	-	HYPH	B-NP	O
analyzed	analyze	VBN	B-VP	O

The	The	DT	B-NP	O
Robert	Robert	NNP	I-NP	O
Wood	Wood	NNP	I-NP	O
Johnson	Johnson	NNP	I-NP	O
Foundation	Foundation	NNP	I-NP	O
:	:	:	O	O
billion	billion	CD	B-NP	O
dollar	dollar	NN	I-NP	O
force	force	NN	I-NP	O
for	for	IN	B-PP	O
health	health	NN	B-NP	O
-	-	HYPH	I-NP	O
care	care	NN	I-NP	O
change	change	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
support	support	VBP	B-VP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
Nck	BEGIN-Nck-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
CKI	BEGIN-CKI	NN	I-NP	B
-	-	HYPH	B-NP	I
gamma1	gamma1-INSIDE	NN	I-NP	I
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
CKI	BEGIN-CKI	NN	B-NP	B
-	-	HYPH	B-NP	I
gamma1	gamma1-INSIDE	NN	I-NP	I
could	could	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
signaling	signaling	NN	B-NP	O
pathways	pathway	NNS	I-NP	O
downstream	downstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
RTKs	BEGIN-RTKs-INSIDE	NN	B-NP	B

1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
Hydroxyproline	Hydroxyproline	NN	I-NP	O
assays	assay	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
collagen	BEGIN-collagen-INSIDE	NN	B-NP	B
content	content	NN	I-NP	O

The	The	DT	B-NP	O
biological	biological	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
CNAPs	CNAP	NNS	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
CS1	CS1	NN	B-NP	O
is	be	VBZ	B-VP	O
under	under	IN	B-PP	O
investigation	investigation	NN	B-NP	O

Non	Non	AFX	O	O
-	-	HYPH	O	O
suppressed	suppress	VBN	B-VP	O
thyroidal	thyroidal	JJ	B-NP	O
radioactive	radioactive	JJ	I-NP	O
iodine	iodine	NN	I-NP	O
uptake	uptake	NN	I-NP	O
(	(	(	O	O
RAIU	RAIU	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
thyrotoxic	thyrotoxic	JJ	B-NP	O
phase	phase	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
subacute	subacute	JJ	B-NP	O
thyroiditis	thyroiditis	NN	I-NP	O
with	with	IN	B-PP	O
thyroid	thyroid	NN	B-NP	O
-	-	HYPH	O	O
stimulating	stimulate	VBG	B-VP	O
antibodies	antibody	NNS	B-NP	O
(	(	(	O	O
TSAb	TSAb	NN	B-NP	O
)	)	)	O	O

Blotting	Blot	VBG	B-VP	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
intestinal	intestinal	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
and	and	CC	I-NP	O
hybridization	hybridization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blots	blot	NNS	I-NP	O
with	with	IN	B-PP	O
carboxy	carboxy	NN	B-NP	O
apoB	BEGIN-apoB-INSIDE	NN	I-NP	B
cDNA	cDNA	NN	I-NP	O
probes	probe	NNS	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O
band	band	NN	I-NP	O
whereas	whereas	IN	B-PP	O
hybridization	hybridization	NN	B-NP	O
with	with	IN	B-PP	O
amino	amino	JJ	B-NP	O
terminal	terminal	JJ	I-NP	O
probes	probe	NNS	I-NP	O
produced	produce	VBD	B-VP	O
two	two	CD	B-NP	O
hybridization	hybridization	NN	I-NP	O
bands	band	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O

The	The	DT	B-NP	O
temporal	temporal	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
CRAlBP	BEGIN-CRAlBP-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
IRBP	BEGIN-IRBP-INSIDE	NN	B-NP	B
while	while	IN	B-SBAR	O
bFGF	BEGIN-bFGF-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
expressed	express	VBN	I-VP	O
until	until	IN	B-PP	O
after	after	IN	B-PP	O
photoreceptor	photoreceptor	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
is	be	VBZ	B-VP	O
complete	complete	JJ	B-ADJP	O

Several	Several	JJ	B-NP	O
components	component	NNS	I-NP	O
in	in	IN	B-PP	O
cytokine	cytokine	NN	B-NP	O
signaling	signaling	NN	I-NP	O
remain	remain	VBP	B-VP	O
unidentified	unidentified	JJ	B-ADJP	O

Virgin	Virgin	NN	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
report	report	NN	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
element	element	NN	B-NP	O
between	between	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
thyroid	BEGIN-thyroid	JJ	B-NP	B
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
TTF	BEGIN-TTF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
activities	activity	NNS	I-NP	O

No	No	DT	B-NP	O
universally	universally	RB	I-NP	O
accepted	accept	VBN	I-NP	O
standardized	standardized	JJ	I-NP	O
classification	classification	NN	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
acne	acne	NN	B-NP	O
vulgaris	vulgaris	NN	I-NP	O
exists	exist	VBZ	B-VP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
it	it	PRP	B-NP	O

Constant	Constant	JJ	B-NP	O
slowing	slowing	NN	I-NP	O
of	of	IN	B-PP	O
median	median	JJ	B-NP	O
MNCV	MNCV	NN	I-NP	O
and	and	CC	I-NP	O
SNCV	SNCV	NN	I-NP	O
and	and	CC	O	O
ulnar	ulnar	JJ	B-NP	O
SNCV	SNCV	NN	I-NP	O
without	without	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
morphology	morphology	NN	B-NP	O
,	,	,	I-NP	O
amplitude	amplitude	NN	I-NP	O
and	and	CC	I-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
MAP	MAP	NN	B-NP	O
and	and	CC	I-NP	O
SAP	SAP	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
after	after	IN	B-PP	O
six	six	CD	B-NP	O
months	month	NNS	I-NP	O

Kudzu	Kudzu	NN	B-NP	O
extract	extract	NN	I-NP	O
shows	show	VBZ	B-VP	O
potential	potential	NN	B-NP	O
for	for	IN	B-PP	O
moderating	moderate	VBG	B-VP	O
alcohol	alcohol	NN	B-NP	O
abuse	abuse	NN	I-NP	O

Serum	Serum	NN	B-NP	O
IgG	BEGIN-IgG-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
IgA	BEGIN-IgA-INSIDE	NN	I-NP	B
level	level	NN	I-NP	O
were	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O

A	A	DT	B-NP	O
novel	novel	JJ	I-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
RNA	RNA	NN	B-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
protein	protein	NN	I-NP	O
conserved	conserve	VBN	B-VP	O
from	from	IN	B-PP	O
fruitflies	fruitfly	NNS	B-NP	O
to	to	TO	B-PP	O
humans	human	NNS	B-NP	O

High	High	JJ	B-NP	O
-	-	HYPH	I-NP	O
affinity	affinity	NN	I-NP	O
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
recombinant	BEGIN-recombinant	JJ	B-NP	B
SH1	SH1	NN	I-NP	I
domains	domains-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	B-NP	I
src	src-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	B-NP	I
fps	fps-INSIDE	NN	I-NP	I
,	,	,	O	O
raising	raise	VBG	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
between	between	IN	B-PP	O
various	various	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasmic	BEGIN-cytoplasmic	JJ	I-NP	B
PTK	PTK	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
M	M	NN	I-NP	O
-	-	HYPH	I-NP	O
phase	phase	NN	I-NP	O
induction	induction	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
Wee1	BEGIN-Wee1	NN	B-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
phosphorylates	phosphorylate	VBZ	B-VP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	B-NP	B
on	on	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

Youssoufian	Youssoufian	JJ	B-ADJP	O
,	,	,	O	O
A	A	DT	O	O

Since	Since	IN	B-SBAR	O
1	1	CD	B-NP	O
Modulit	Modulit	NN	I-NP	O
-	-	HYPH	B-NP	O
SZ	SZ	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
localization	localization	NN	B-NP	O
of	of	IN	B-PP	O
nephroliths	nephrolith	NNS	B-NP	O
and	and	CC	I-NP	O
ureteroliths	ureterolith	NNS	I-NP	O

Lactate	Lactate	NN	B-NP	O
,	,	,	I-NP	O
pyruvate	pyruvate	NN	I-NP	O
and	and	CC	I-NP	O
actual	actual	JJ	I-NP	O
pH	pH	NN	I-NP	O
values	value	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
venous	venous	JJ	I-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
newborn	newborn	JJ	B-NP	O
calves	calf	NNS	I-NP	O

The	The	DT	B-NP	O
steady	steady	JJ	I-NP	O
-	-	HYPH	I-NP	O
state	state	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Cdk1	BEGIN-Cdk1-INSIDE	NN	B-NP	B
,	,	,	O	O
Cdk1	BEGIN-Cdk1-INSIDE	NN	B-NP	B
and	and	CC	O	O
Cyclin	BEGIN-Cyclin	NN	B-NP	B
A	A	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
unaffected	unaffected	JJ	B-ADJP	O
by	by	IN	B-PP	O
HPR	HPR	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
Cyclin	BEGIN-Cyclin	NN	B-NP	B
D1	D1-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

The	The	DT	B-NP	O
dermatoglyphic	dermatoglyphic	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
demostrates	demostrate	VBZ	B-VP	O
a	a	DT	B-NP	O
distal	distal	JJ	I-NP	O
triradius	triradius	NN	I-NP	O
and	and	CC	O	O
small	small	JJ	B-NP	O
whorl	whorl	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O

The	The	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
equilibrium	equilibrium	NN	B-NP	O
complex	complex	NN	I-NP	O
formation	formation	NN	I-NP	O
between	between	IN	B-PP	O
OTC	OTC	NNP	B-NP	O
and	and	CC	O	O
PVP	PVP	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
being	be	VBG	B-VP	O
mainly	mainly	RB	B-ADVP	O
the	the	DT	B-NP	O
complex	complex	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
i.v.	i.v.	RB	I-VP	O
injected	inject	VBN	I-VP	O
when	when	WRB	B-ADVP	O
both	both	DT	B-NP	O
products	product	NNS	I-NP	O
are	be	VBP	B-VP	O
combined	combine	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
injection	injection	NN	I-NP	O
formulation	formulation	NN	I-NP	O

The	The	DT	B-NP	O
MI	MI	NN	I-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
predictive	predictive	JJ	B-ADJP	O
of	of	IN	B-PP	O
hemodynamic	hemodynamic	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
both	both	CC	B-PP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
during	during	IN	B-PP	O
exercise	exercise	NN	B-NP	O
:	:	:	O	O
anterior	anterior	JJ	B-NP	O
MIs	MI	NNS	I-NP	O
are	be	VBP	B-VP	O
more	more	RBR	B-ADJP	O
impaired	impaired	JJ	I-ADJP	O
than	than	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
MIs	MI	NNS	I-NP	O

The	The	DT	B-NP	O
median	median	JJ	I-NP	O
survival	survival	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O

Studies	Study	NNS	B-NP	O
with	with	IN	B-PP	O
and	and	CC	B-PP	O
without	without	IN	B-PP	O
attenuating	attenuate	VBG	B-NP	O
media	medium	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
myocardium	myocardium	NN	B-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
defect	defect	NN	I-NP	O
count	count	NN	I-NP	O
ratios	ratio	NNS	I-NP	O
and	and	CC	O	O
defect	defect	NN	B-NP	O
sizes	size	NNS	I-NP	O
from	from	IN	B-PP	O
dual	dual	JJ	B-NP	O
-	-	HYPH	I-NP	O
isotope	isotope	NN	I-NP	O
SPECT	SPECT	NN	I-NP	O
images	image	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
myocardium	myocardium	NN	B-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
defect	defect	NN	I-NP	O
count	count	NN	I-NP	O
ratios	ratio	NNS	I-NP	O
and	and	CC	O	O
defect	defect	NN	B-NP	O
sizes	size	NNS	I-NP	O
from	from	IN	B-PP	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
isotope	isotope	NN	I-NP	O
(	(	(	O	O
1Tl	1Tl	NN	B-NP	O
and	and	CC	O	O
1mTc	1mTc	NN	B-NP	O
)	)	)	O	O
SPECT	SPECT	NN	B-NP	O
images	image	NNS	I-NP	O

Biology	Biology	NNP	B-NP	O
of	of	IN	B-PP	O
Anopheles	Anopheles	NNP	B-NP	O
quadrimaculatus	quadrimaculatus	NN	I-NP	O
under	under	IN	B-PP	O
field	field	NN	B-NP	O
conditions	condition	NNS	I-NP	O
in	in	IN	B-PP	O
central	central	JJ	B-NP	O
Florida	Florida	NNP	I-NP	O

This	This	DT	B-NP	O
transformation	transformation	NN	I-NP	O
suppression	suppression	NN	I-NP	O
by	by	IN	B-PP	O
Rb	BEGIN-Rb-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
further	further	RB	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
repression	repression	NN	I-NP	O
of	of	IN	B-PP	O
neu	BEGIN-neu-INSIDE	NN	B-NP	B
using	use	VBG	B-VP	O
Rb	BEGIN-Rb-INSIDE	NN	B-NP	B
expressing	express	VBG	B-VP	O
effector	effector	NN	B-NP	O
plasmid	plasmid	NN	I-NP	O
and	and	CC	O	O
neu	BEGIN-neu-INSIDE	NN	B-NP	B
promoter	promoter	NN	I-NP	O
-	-	HYPH	B-NP	O
chloramphenicol	BEGIN-chloramphenicol	NN	I-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
involving	involve	VBG	B-VP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	O	I
ATp	ATp-INSIDE	NN	B-NP	I
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
regulate	regulate	VB	I-VP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
type	type	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
-	-	HYPH	O	O
dependent	dependent	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SCM	BEGIN-SCM	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
genes	genes-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
seven	seven	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
new	new	JJ	B-NP	O
Q	Q	NN	I-NP	O
-	-	HYPH	B-NP	O
waves	wave	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pathologic	pathologic	JJ	I-NP	O
CK	BEGIN-CK	NN	I-NP	B
-	-	HYPH	O	I
MB	MB-INSIDE	NN	B-NP	I
profile	profile	NN	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
II	II	CD	I-NP	O
)	)	)	O	O
troponin	BEGIN-troponin	NN	B-NP	B
T	T-INSIDE	NN	I-NP	I
reached	reach	VBD	B-VP	O
median	median	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	O	O
l	l	NN	B-NP	O
(	(	(	O	O
quartile	quartile	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
I	I	CD	I-NP	O
vs	vs	IN	B-PP	O
II	II	CD	B-NP	O
)	)	)	O	O

EMG	EMG	NN	B-NP	O
-	-	HYPH	B-NP	O
based	base	VBN	I-NP	O
measures	measure	NNS	I-NP	O
of	of	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
repetitive	repetitive	JJ	I-NP	O
squat	squat	NN	I-NP	O
exercise	exercise	NN	I-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
intranasal	intranasal	JJ	B-NP	O
challenge	challenge	NN	I-NP	O
with	with	IN	B-PP	O
FLU	FLU	NN	B-NP	O
induces	induce	VBZ	B-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
leukocyte	leukocyte	NN	B-NP	O
histamine	histamine	NN	I-NP	O
release	release	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
other	other	JJ	B-NP	O
systemic	systemic	JJ	I-NP	O
immune	immune	JJ	I-NP	O
and	and	CC	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
responses	response	NNS	I-NP	O

Southern	Southern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
CCaMK	BEGIN-CCaMK-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
gene	gene	NN	I-NP	O

The	The	DT	B-NP	O
gamma	BEGIN-gamma	NN	I-NP	B
-	-	HYPH	I-NP	I
GCS	GCS	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
ubiquitously	ubiquitously	RB	B-ADVP	O
and	and	CC	O	O
induced	induce	VBN	B-VP	O
coordinately	coordinately	RB	B-ADVP	O
with	with	IN	B-PP	O
NAD	BEGIN-NAD	NN	B-NP	B
(	(	(	O	I
P	P	NN	B-NP	I
)	)	)	O	I
H	H	NN	B-NP	I
:	:	:	O	I
quinone	quinone	NN	B-NP	I
oxidoreductase	oxidoreductase	NN	I-NP	I
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
(	(	(	O	O
NQO1	BEGIN-NQO1-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
glutathione	BEGIN-glutathione	NN	B-NP	B
S	S	NN	I-NP	I
-	-	HYPH	B-NP	I
transferase	transferase	NN	I-NP	I
Ya	Ya-INSIDE	NN	I-NP	I
(	(	(	O	O
GST	BEGIN-GST	NN	B-NP	B
Ya	Ya-INSIDE	NN	I-NP	I
)	)	)	O	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
xenobiotics	xenobiotic	NNS	B-NP	O
and	and	CC	I-NP	O
antioxidants	antioxidant	NNS	I-NP	O

A	A	DT	B-NP	O
fine	fine	JJ	I-NP	O
-	-	HYPH	I-NP	O
structure	structure	NN	I-NP	O
radiation	radiation	NN	I-NP	O
hybrid	hybrid	NN	I-NP	O
map	map	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
that	that	WDT	B-NP	O
extends	extend	VBZ	B-VP	O
from	from	IN	B-PP	O
D1S1	BEGIN-D1S1-INSIDE	NN	B-NP	B
(	(	(	O	O
distal	distal	JJ	B-ADJP	O
)	)	)	O	O
to	to	TO	B-PP	O
D1S1	BEGIN-D1S1-INSIDE	NN	B-NP	B
(	(	(	O	O
proximal	proximal	JJ	B-ADJP	O
)	)	)	O	O
was	be	VBD	B-VP	O
prepared	prepare	VBN	I-VP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
construction	construction	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
,	,	,	I-NP	O
integrated	integrate	VBN	I-NP	O
YAC	YAC	NN	I-NP	O
/	/	SYM	I-NP	O
BAC	BAC	NN	I-NP	O
contig	contig	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
interval	interval	NN	I-NP	O

The	The	DT	B-NP	O
N1	N1	NN	I-NP	O
-	-	HYPH	I-NP	O
P1	P1	NN	I-NP	O
amplitudes	amplitude	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AEP	AEP	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
strength	strength	NN	I-NP	O
of	of	IN	B-PP	O
muscular	muscular	JJ	B-NP	O
innervation	innervation	NN	I-NP	O

Measurements	Measurement	NNS	B-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
given	give	VBN	B-VP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
propranolol	propranolol	NN	B-NP	O
that	that	WDT	B-NP	O
partially	partially	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
NA	NA	NN	I-NP	O
-	-	HYPH	B-VP	O
induced	induce	VBN	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
Q	Q	NN	B-NP	O
to	to	TO	B-PP	O
IBAT	IBAT	NN	B-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
decline	decline	NN	I-NP	O
in	in	IN	B-PP	O
ENAIBAT	ENAIBAT	NN	B-NP	O
was	be	VBD	B-VP	O
attributable	attributable	JJ	B-ADJP	O
primarily	primarily	RB	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
Q	Q	NN	B-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
to	to	TO	B-PP	O
increasing	increase	VBG	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
uptake	uptake	NN	B-NP	O
mechanisms	mechanism	NNS	I-NP	O

Messenger	Messenger	NN	B-NP	O
RNA	RNA	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Ad1	BEGIN-Ad1	NN	I-NP	B
DNA	DNA	NN	I-NP	I
binding	binding	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
:	:	:	O	O
DNA	DNA	NN	B-NP	O
sequences	sequence	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
leader	leader	NN	I-NP	O
and	and	CC	I-NP	O
heterogenity	heterogenity	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	O
1	1	CD	I-NP	O
'	'	``	I-NP	O
end	end	NN	I-NP	O

All	All	DT	B-NP	O
rights	right	NNS	I-NP	O
reserved	reserve	VBD	B-VP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
using	use	VBG	I-VP	O
either	either	CC	O	O
preimmune	preimmune	JJ	B-NP	O
sera	serum	NNS	I-NP	O
or	or	CC	O	O
antiserum	antiserum	NN	B-NP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
luminal	luminal	JJ	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glycoprotein	glycoprotein	NN	I-NP	O
precursor	precursor	NN	I-NP	O

The	The	DT	B-NP	O
yeast	yeast	NN	I-NP	O
genome	genome	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
ORD1	BEGIN-ORD1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
resides	reside	VBZ	B-VP	O
on	on	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
XI	XI	NN	I-NP	O

HNF1alpha1	BEGIN-HNF1alpha1	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
totipotent	totipotent	JJ	B-NP	O
embryonic	embryonic	JJ	I-NP	O
stem	stem	NN	I-NP	O
cells	cell	NNS	I-NP	O

Northern	Northern	NN	B-NP	O
(	(	(	O	O
RNA	RNA	NN	B-NP	O
)	)	)	O	O
blot	blot	NN	B-NP	O
hybridization	hybridization	NN	I-NP	O
analysis	analysis	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
p1c	BEGIN-p1c	NN	I-NP	B
-	-	HYPH	B-NP	I
ets	ets	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	I-NP	O
RNase	BEGIN-RNase-INSIDE	NN	I-NP	B
protection	protection	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
mRNA	mRNA	NN	I-NP	O
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
chicken	chicken	NN	I-NP	O
spleen	spleen	NN	I-NP	O
and	and	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
normal	normal	JJ	B-NP	O
chicken	chicken	NN	I-NP	O
thymus	thymus	NN	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
T	T	NN	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

The	The	DT	B-NP	O
fz	BEGIN-fz	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
fz	BEGIN-BEGIN-fz	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
widely	widely	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
rat	rat	NN	B-NP	O
tissues	tissue	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
steady	steady	JJ	I-NP	O
-	-	HYPH	I-NP	O
state	state	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	O
in	in	IN	B-PP	O
kidney	kidney	NN	B-NP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
,	,	,	O	O
uterus	uterus	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ovary.	ovary.	NN	B-NP	O
fz	BEGIN-BEGIN-fz	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
mRNA	mRNA-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
in	in	IN	B-PP	O
neonatal	neonatal	JJ	B-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
corresponding	correspond	VBG	B-VP	O
adult	adult	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O

We	We	PRP	B-NP	O
carried	carry	VBD	B-VP	O
out	out	RP	B-PRT	O
two	two	CD	B-NP	O
experiments	experiment	NNS	I-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
this	this	DT	B-NP	O
problem	problem	NN	I-NP	O

Mean	Mean	JJ	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
maternal	maternal	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
across	across	IN	B-PP	O
all	all	DT	B-NP	O
sampling	sample	VBG	I-NP	O
times	time	NNS	I-NP	O
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
in	in	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
treated	treat	VBN	I-NP	O
animals	animal	NNS	I-NP	O

Steady	Steady	JJ	B-NP	O
-	-	HYPH	I-NP	O
state	state	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
murine	BEGIN-murine	JJ	B-NP	B
MMR	MMR	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
macrophage	macrophage	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
J1E	J1E	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
express	express	VB	I-VP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
Xenopus	Xenopus	NN	B-NP	O
oocyte	oocyte	NN	I-NP	O
maturation	maturation	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
read	read	VB	I-NP	O
-	-	HYPH	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
examining	examine	VBG	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
neu	BEGIN-neu-INSIDE	NN	I-NP	B
tyrosine	BEGIN-tyrosine	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
p1neu	p1BEGIN-neu-INSIDE	NN	B-NP	I
)	)	)	O	O
to	to	TO	B-VP	O
participate	participate	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
epidermal	BEGIN-epidermal	JJ	I-NP	B
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
(	(	(	O	I
EGF	EGF	NN	B-NP	I
)	)	)	O	I
receptor	receptor-INSIDE	NN	B-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathway	pathway	NN	I-NP	O

Triaxiality	Triaxiality	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proton	proton	NN	I-NP	O
-	-	HYPH	O	O
neutron	neutron	NN	B-NP	O
interacting	interact	VBG	B-VP	O
boson	boson	NN	B-NP	O
model	model	NN	I-NP	O
:	:	:	O	O
Perturbed	Perturb	VBN	B-NP	O
O	O	NN	I-NP	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
symmetry	symmetry	NN	B-NP	O
with	with	IN	B-PP	O
application	application	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mass	mass	NN	I-NP	O
A	A	NN	I-NP	O

Role	Role	NN	B-NP	O
of	of	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
mitogen	BEGIN-mitogen	NN	I-NP	B
-	-	HYPH	B-VP	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
pathways	pathway	NNS	I-NP	O
and	and	CC	O	O
cooperation	cooperation	NN	B-NP	O
between	between	IN	B-PP	O
Ets	BEGIN-Ets	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
ATF	BEGIN-ATF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
Jun	BEGIN-Jun	NN	B-NP	B
family	family	NN	I-NP	I
members	members-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
urokinase	urokinase	NN	I-NP	I
-	-	HYPH	B-NP	I
type	type	NN	I-NP	I
plasminogen	plasminogen	NN	I-NP	I
activator	activator	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
induction	induction	NN	I-NP	O
by	by	IN	B-PP	O
interleukin	BEGIN-interleukin	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
tetradecanoyl	tetradecanoyl	NN	I-NP	O
phorbol	phorbol	NN	I-NP	O
acetate	acetate	NN	I-NP	O

Comparative	Comparative	JJ	B-NP	O
volumetric	volumetric	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
is	be	VBZ	B-VP	O
defined	define	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
mean	mean	JJ	B-NP	O
corpuscular	corpuscular	JJ	I-NP	O
erythrocyte	erythrocyte	NN	I-NP	O
volume	volume	NN	I-NP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
blood	blood	NN	I-NP	O
(	(	(	O	O
MCVB	MCVB	NN	B-NP	O
)	)	)	O	O
diluted	dilute	VBN	B-VP	O
in	in	IN	B-PP	O
urine	urine	NN	B-NP	O
supernatant	supernatant	NN	I-NP	O
after	after	IN	B-PP	O
centrifugation	centrifugation	NN	B-NP	O
and	and	CC	O	O
mean	mean	JJ	B-NP	O
corpuscular	corpuscular	JJ	I-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
erythrocytes	erythrocyte	NNS	I-NP	O
(	(	(	O	O
MCVU	MCVU	NN	B-NP	O
)	)	)	O	O

To	To	TO	B-VP	O
assess	assess	VB	I-VP	O
whether	whether	IN	B-SBAR	O
thallium	thallium	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
thallous	thallous	JJ	I-NP	O
chloride	chloride	NN	I-NP	O
(	(	(	O	O
Tl	Tl	NN	B-NP	O
)	)	)	O	O
can	can	MD	B-VP	O
detect	detect	VB	I-VP	O
childhood	childhood	NN	B-NP	O
tumors	tumor	NNS	I-NP	O
and	and	CC	O	O
whether	whether	IN	B-SBAR	O
diagnostic	diagnostic	JJ	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
improves	improve	VBZ	B-VP	O
with	with	IN	B-PP	O
combined	combine	VBN	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
imaging	imaging	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
using	use	VBG	B-VP	O
single	single	JJ	B-NP	O
photon	photon	NN	I-NP	O
emission	emission	NN	I-NP	O
computed	compute	VBN	B-VP	O
tomography	tomography	NN	B-NP	O
(	(	(	O	O
SPECT	SPECT	NN	B-NP	O
)	)	)	O	O
:	:	:	O	O
Tl	Tl	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
mCi	mCi	NN	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
by	by	IN	B-PP	O
technetium	technetium	NN	B-NP	O
-	-	HYPH	B-NP	O
1m	1m	NN	I-NP	O
-	-	HYPH	O	O
hexamethylpropyleneamine	hexamethylpropyleneamine	NN	B-NP	O
oxime	oxime	NN	I-NP	O
(	(	(	O	O
1mTc	1mTc	NN	B-NP	O
-	-	HYPH	B-NP	O
HMPAO	HMPAO	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
mCi	mCi	NN	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
)	)	)	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
NUT1	BEGIN-NUT1-INSIDE	NN	B-NP	B
and	and	CC	O	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
nitrogen	nitrogen	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
process	process	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
pathogenicity	pathogenicity	NN	B-NP	O
assays	assay	NNS	I-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
mRNA	mRNA	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
ACBF	BEGIN-ACBF	NN	I-NP	B
cDNA	cDNA-INSIDE	NN	I-NP	I
as	as	IN	B-SBAR	O
probe	probe	NN	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
ACBF	BEGIN-ACBF	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
tissues	tissue	NNS	I-NP	O
examined	examine	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
transcript	transcript	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
stem	stem	NN	B-NP	O
tissues	tissue	NNS	I-NP	O

When	When	WRB	B-ADVP	O
PCR	PCR	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
amplify	amplify	VB	I-VP	O
agar	agar	NN	B-NP	O
cultures	culture	NNS	I-NP	O
which	which	WDT	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
express	express	VB	I-VP	O
the	the	DT	B-NP	O
fimbriae	fimbria	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
switch	switch	NN	I-NP	O
region	region	NN	I-NP	O
was	be	VBD	B-VP	O
OFF	OFF	NN	B-NP	O
only	only	RB	B-ADVP	O

We	We	PRP	B-NP	O
therefore	therefore	RB	B-ADVP	O
investigated	investigate	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
TRH	TRH	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
directly	directly	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
RA	RA	NN	B-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
transient	transient	JJ	I-NP	O
transfection	transfection	NN	I-NP	O
assay	assay	NN	I-NP	O
into	into	IN	B-PP	O
CV	CV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
tests	test	VBZ	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
O1	O1	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
component	component	NN	I-NP	O
in	in	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
protection	protection	NN	I-NP	O
afforded	afford	VBN	B-VP	O
by	by	IN	B-PP	O
BCP	BCP	NN	B-NP	O

Sin1	BEGIN-Sin1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Srb1	BEGIN-Srb1-INSIDE	NN	I-NP	B
,	,	,	O	O
components	component	NNS	B-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
RNA	BEGIN-RNA	NN	I-NP	B
polymerase	polymerase	NN	I-NP	I
II	II	CD	I-NP	I
sub	sub	AFX	B-NP	I
-	-	HYPH	I-NP	I
complexes	complexes-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
Ssn1	BEGIN-Ssn1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
Tup1	BEGIN-Tup1-INSIDE	NN	I-NP	B
repression	repression	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
Sfl1	BEGIN-Sfl1-INSIDE	NN	B-NP	B
repression	repression	NN	I-NP	O
function	function	NN	I-NP	O

Functional	Functional	JJ	B-NP	O
PET	PET	NN	I-NP	O
scanning	scanning	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
preoperative	preoperative	JJ	I-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
cerebral	cerebral	JJ	B-NP	O
arteriovenous	arteriovenous	JJ	I-NP	O
malformations	malformation	NNS	I-NP	O

The	The	DT	B-NP	O
MEE	MEE	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
BEE	BEE	NN	I-NP	O
and	and	CC	O	O
significantly	significantly	RB	B-ADJP	O
less	less	JJR	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
calculated	calculate	VBN	I-NP	O
energy	energy	NN	I-NP	O
expenditure	expenditure	NN	I-NP	O

Differences	Difference	NNS	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
colons	colon	NNS	B-NP	O
by	by	IN	B-PP	O
SEM	SEM	NN	B-NP	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
rh1	BEGIN-rh1-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
R1	BEGIN-R1-INSIDE	NN	B-NP	B
disappears	disappear	VBZ	B-VP	O
when	when	WRB	B-ADVP	O
R1	BEGIN-R1-INSIDE	NN	B-NP	B
cells	cell	NNS	I-NP	O
are	be	VBP	B-VP	O
absent	absent	JJ	B-ADJP	O
(	(	(	O	O
in	in	IN	B-PP	O
sevenless	BEGIN-sevenless	JJ	B-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
)	)	)	O	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	O
RIL	BEGIN-RIL	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
:	:	:	O	O
mapping	map	VBG	B-VP	O
to	to	TO	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1q1	1q1	CD	I-NP	O
,	,	,	O	O
genomic	genomic	JJ	B-NP	O
organization	organization	NN	I-NP	O
and	and	CC	O	O
alternative	alternative	JJ	B-NP	O
transcripts	transcript	NNS	I-NP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
dominant	dominant	JJ	I-NP	O
factor	factor	NN	I-NP	O
that	that	WDT	B-NP	O
facilitates	facilitate	VBZ	B-VP	O
AcMNPV	AcMNPV	NN	B-NP	O
growth	growth	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
manner	manner	NN	I-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
remarkable	remarkable	JJ	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
MTB	BEGIN-MTB	NN	B-NP	B
-	-	HYPH	B-NP	I
Zf	Zf	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
and	and	CC	O	O
two	two	CD	B-NP	O
other	other	JJ	I-NP	O
hybridizable	hybridizable	JJ	I-NP	O
mRNAs	mRNA	NNS	I-NP	O
of	of	IN	B-PP	O
1kb	1kb	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
when	when	WRB	B-ADVP	O
human	human	JJ	B-NP	O
brain	brain	NN	I-NP	O
and	and	CC	O	O
primary	primary	JJ	B-NP	O
brain	brain	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
recently	recently	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
induced	induce	VBN	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
CDK	BEGIN-CDK-INSIDE	NN	I-NP	B
target	target	NN	I-NP	O
site	site	NN	I-NP	O
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
mutant	mutant	NN	I-NP	O
,	,	,	O	O
Op1	BEGIN-Op1-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
S1A	S1A	NN	B-NP	O
,	,	,	O	O
S1A	S1A	NN	B-NP	O
,	,	,	O	O
blocks	block	VBZ	B-VP	O
human	human	JJ	B-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
during	during	IN	B-PP	O
G1	G1	NN	B-NP	O
/	/	SYM	O	O
M	M	NN	B-NP	O
transition	transition	NN	I-NP	O

ATF1	BEGIN-ATF1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
basic	BEGIN-basic	JJ	I-NP	B
-	-	HYPH	I-NP	I
leucine	leucine	NN	I-NP	I
zipper	zipper	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
by	by	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
SRF	BEGIN-SRF-INSIDE	NN	B-NP	B
and	and	CC	O	O
in	in	IN	B-PP	O
particular	particular	JJ	B-ADJP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
domain	domain	NN	I-NP	O

An	An	DT	B-NP	O
ICU	ICU	NN	I-NP	O
length	length	NN	I-NP	O
of	of	IN	B-PP	O
stay	stay	NN	B-NP	O
shorter	short	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
group	group	NN	B-NP	O
C	C	NN	I-NP	O
errors	error	NNS	I-NP	O

Primers	Primer	NNS	B-NP	O
were	be	VBD	B-VP	O
developed	develop	VBN	I-VP	O
for	for	IN	B-PP	O
specific	specific	JJ	B-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
1	BEGIN-1	NN	B-NP	B
gene	gene	NN	I-NP	I
fragments	fragments-INSIDE	NN	I-NP	I

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
GGTase	BEGIN-GGTase	NN	B-NP	B
-	-	HYPH	B-NP	I
I	I-INSIDE	NN	I-NP	I
inhibitors	inhibitor	NNS	I-NP	O
arrest	arrest	VBP	B-VP	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
G1	G1	NN	B-NP	O
/	/	SYM	B-NP	O
G1	G1	NN	I-NP	O
and	and	CC	O	O
induce	induce	VB	B-VP	O
accumulation	accumulation	NN	B-NP	O
of	of	IN	B-PP	O
p1WAF	BEGIN-BEGIN-p1-INSIDEWAF-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
a	a	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
independent	independent	JJ	I-NP	O
manner	manner	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
FTase	BEGIN-FTase-INSIDE	NN	B-NP	B
inhibitors	inhibitor	NNS	I-NP	O
can	can	MD	B-VP	O
interfere	interfere	VB	I-VP	O
with	with	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
events	event	NNS	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
that	that	WDT	B-NP	O
involves	involve	VBZ	B-VP	O
neither	neither	CC	O	O
p1WAF	BEGIN-BEGIN-p1-INSIDEWAF-INSIDE	NN	B-NP	B
nor	nor	CC	I-NP	O
p1KIP	BEGIN-p1-INSIDEKIP	NN	I-NP	I

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
provide	provide	VBP	B-VP	O
strong	strong	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
conserved	conserve	VBN	B-NP	O
interhelical	interhelical	JJ	I-NP	O
packing	packing	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gp1	BEGIN-gp1	NN	I-NP	B
core	core-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
important	important	JJ	B-NP	O
determinants	determinant	NNS	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
entry	entry	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
inhibition	inhibition	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
CR1	BEGIN-CR1-INSIDE	NN	B-NP	B
possesses	possess	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
function	function	NN	I-NP	O
besides	besides	IN	B-PP	O
pRb	BEGIN-pRb-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
binding	bind	VBG	B-VP	O

Injection	Injection	NN	B-NP	O
of	of	IN	B-PP	O
horseradish	BEGIN-horseradish	JJ	B-NP	B
peroxidase	peroxidase-INSIDE	NN	I-NP	I
(	(	(	O	O
HRP	BEGIN-HRP-INSIDE	NN	B-NP	B
)	)	)	O	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
cerebellar	cerebellar	JJ	I-NP	O
flocculus	flocculus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
was	be	VBD	B-VP	O
employed	employ	VBN	I-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
neurons	neuron	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
abducens	abducens	NN	I-NP	O
nucleus	nucleus	NN	I-NP	O
that	that	WDT	B-NP	O
project	project	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
flocculus	flocculus	NN	I-NP	O

Natl	Natl	NN	B-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	I-NP	I
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
after	after	IN	B-PP	O
PMA	PMA	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O

From	From	IN	B-PP	O
our	our	PRP$	B-NP	O
own	own	JJ	I-NP	O
investigations	investigation	NNS	I-NP	O
on	on	IN	B-PP	O
phantoms	phantom	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
smallest	small	JJS	I-NP	O
signal	signal	NN	I-NP	O
-	-	HYPH	B-ADVP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
noise	noise	NN	I-NP	O
ratio	ratio	NN	I-NP	O
(	(	(	O	O
delta	delta	SYM	B-NP	O
S	S	NN	I-NP	O
min	min	NN	I-NP	O
/	/	SYM	B-NP	O
delta	delta	SYM	I-NP	O
R	R	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
determines	determine	VBZ	B-VP	O
the	the	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
film	film	NN	I-NP	O
properties	property	NNS	I-NP	O
(	(	(	O	O
film	film	NN	B-NP	O
response	response	NN	I-NP	O
S	S	NN	I-NP	O
,	,	,	O	O
film	film	NN	B-NP	O
gradient	gradient	NN	I-NP	O
gamma	gamma	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
scatter	scatter	NN	B-NP	O

It	It	PRP	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
that	that	WDT	B-NP	O
controls	control	VBZ	B-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
concert	concert	NN	B-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
gene	gene	NN	I-NP	O
products	product	NNS	I-NP	O
,	,	,	O	O
differentiative	differentiative	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
of	of	IN	B-PP	O
tissues	tissue	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
Scr	BEGIN-Scr-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O

We	We	PRP	B-NP	O
functionally	functionally	RB	B-ADVP	O
characterised	characterise	VBD	B-VP	O
AtXPO1	BEGIN-AtXPO1-INSIDE	NN	B-NP	B
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
NESs	NES	NNS	B-NP	O
of	of	IN	B-PP	O
animal	animal	NN	B-NP	O
and	and	CC	I-NP	O
plant	plant	NN	I-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cytotoxin	cytotoxin	NN	I-NP	O
leptomycin	leptomycin	NN	I-NP	O
B	B	NN	I-NP	O
(	(	(	O	O
LMB	LMB	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
small	BEGIN-small	JJ	I-NP	B
GTPase	GTPase-INSIDE	NN	I-NP	I
Ran1	BEGIN-Ran1-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
hybrid	hybrid	NN	I-NP	O
system	system	NN	I-NP	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
self	self	NN	B-NP	O
-	-	HYPH	B-NP	O
measured	measure	VBN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
determinations	determination	NNS	I-NP	O
in	in	IN	B-PP	O
assessing	assess	VBG	B-VP	O
dynamics	dynamic	NNS	B-NP	O
of	of	IN	B-PP	O
drug	drug	NN	B-NP	O
compliance	compliance	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
study	study	NN	I-NP	O
with	with	IN	B-PP	O
amlodipine	amlodipine	NN	B-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
morning	morning	NN	B-NP	O
versus	versus	IN	B-PP	O
evening	evening	NN	B-NP	O

The	The	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cloned	clone	VBN	I-NP	O
fragment	fragment	NN	I-NP	O
is	be	VBZ	B-VP	O
equally	equally	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
on	on	IN	B-PP	O
pyruvate	pyruvate	NN	B-NP	O
and	and	CC	I-NP	O
hydroxypyruvate	hydroxypyruvate	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
has	have	VBZ	B-VP	O
both	both	CC	O	O
D	BEGIN-D	NN	B-NP	B
-	-	HYPH	B-NP	I
lactate	lactate	NN	I-NP	I
and	and	CC	I-NP	I
D	D	NN	I-NP	I
-	-	HYPH	B-NP	I
glycerate	glycerate	NN	I-NP	I
dehydrogenase	dehydrogenase-INSIDE	NN	I-NP	I
activities	activity	NNS	I-NP	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
unc	BEGIN-unc	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
unc	BEGIN-unc	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
gag	BEGIN-gag-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
myc	BEGIN-myc-INSIDE	NN	I-NP	B
proteins	protein	NNS	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
these	these	DT	B-NP	O
variants	variant	NNS	I-NP	O
efficiently	efficiently	RB	B-VP	O
localized	localize	VBD	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
nucleus	nucleus	NN	I-NP	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
supposition	supposition	NN	I-NP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
exists	exist	VBZ	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
connection	connection	NN	I-NP	O
between	between	IN	B-PP	O
certain	certain	JJ	B-NP	O
psychopathological	psychopathological	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
syndromes	syndrome	NNS	B-NP	O
(	(	(	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	O	O
hallucinations	hallucination	NNS	B-NP	O
)	)	)	O	O
and	and	CC	O	O
regional	regional	JJ	B-NP	O
cerebral	cerebral	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
auditory	auditory	JJ	B-NP	O
and	and	CC	I-NP	O
tactile	tactile	JJ	I-NP	O
hallucinations	hallucination	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
symptom	symptom	NN	I-NP	O
-	-	HYPH	O	O
oriented	orient	VBN	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
technetium	technetium	NN	B-NP	O
-	-	HYPH	B-NP	O
1m	1m	NN	I-NP	O
-	-	HYPH	B-NP	O
Hexamethyl	Hexamethyl	NN	I-NP	O
-	-	HYPH	O	O
propylenamine	propylenamine	NN	B-NP	O
Oxime	Oxime	NN	I-NP	O
(	(	(	O	O
1m	1m	NN	B-NP	O
-	-	HYPH	B-NP	O
Tc	Tc	NN	I-NP	O
-	-	HYPH	B-NP	O
HMPAO	HMPAO	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	O	O
Single	Single	NNP	B-NP	O
Photon	Photon	NNP	I-NP	O
Emission	Emission	NNP	I-NP	O
Computed	Computed	NNP	I-NP	O
Tomography	Tomography	NNP	I-NP	O
(	(	(	O	O
SPECT	SPECT	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
controls	control	NNS	I-NP	O

The	The	DT	B-NP	O
encoded	encode	VBN	I-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	O	I
amino	amino	JJ	O	I
-	-	HYPH	O	I
acid	acid	NN	B-NP	I
(	(	(	O	I
aa	aa	NN	B-NP	I
)	)	)	O	I
(	(	(	O	I
H1	H1	NN	B-NP	I
-	-	HYPH	B-NP	I
I	I	NN	I-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
and	and	CC	I-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	O	I
aa	aa	NN	B-NP	I
(	(	(	O	I
H1	H1	NN	B-NP	I
-	-	HYPH	O	I
II	II	CD	O	I
)	)	)	O	I
polypeptides	polypeptides-INSIDE	NN	B-NP	I
possess	possess	VBP	B-VP	O
the	the	DT	B-NP	O
typical	typical	JJ	I-NP	O
tripartite	tripartite	JJ	I-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
animal	BEGIN-animal	JJ	B-NP	B
H1	H1	NN	I-NP	I
histones	histones-INSIDE	NN	I-NP	I
,	,	,	O	O
with	with	IN	B-PP	O
variable	variable	JJ	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	O	O
terminal	terminal	JJ	B-NP	O
domains	domain	NNS	I-NP	O
flanking	flank	VBG	B-VP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
'globular	'globular	JJ	I-NP	O
'	'	``	I-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	I-NP	O
binding	bind	VBG	B-VP	O
domain	domain	NN	B-NP	O

The	The	DT	B-NP	O
best	good	JJS	I-NP	O
-	-	HYPH	I-NP	O
studied	study	VBN	I-NP	O
neurotrophin	neurotrophin	NN	I-NP	O
,	,	,	O	O
nerve	BEGIN-nerve	NN	B-NP	B
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
NGF	BEGIN-NGF-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
survival	survival	NN	I-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
sympathetic	sympathetic	JJ	B-NP	O
and	and	CC	I-NP	O
sensory	sensory	JJ	I-NP	O
neurons	neuron	NNS	I-NP	O
and	and	CC	O	O
promotes	promote	VBZ	B-VP	O
differentiation	differentiation	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
well	well	RB	I-NP	O
-	-	HYPH	I-NP	O
studied	study	VBN	I-NP	O
model	model	NN	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
PC1	PC1	NN	B-NP	O
cells	cell	NNS	I-NP	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
phase	phase	NN	I-NP	O
-	-	HYPH	B-NP	O
II	II	CD	I-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
safety	safety	NN	I-NP	O
and	and	CC	I-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
transrectal	transrectal	JJ	B-NP	O
HIFU	HIFU	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
minimally	minimally	RB	I-NP	O
invasive	invasive	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
modality	modality	NN	I-NP	O
for	for	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
benign	benign	JJ	I-NP	O
prostatic	prostatic	JJ	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
(	(	(	O	O
BPH	BPH	NN	B-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O

A	A	DT	B-NP	O
novel	novel	JJ	I-NP	O
alternative	alternative	NN	I-NP	O
spliced	splice	VBN	B-VP	O
variant	variant	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
AP1alpha	BEGIN-AP1alpha-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
ocular	ocular	JJ	I-NP	O
lens	len	NNS	I-NP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
high	high	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
MF	MF	NN	I-NP	O
-	-	HYPH	B-NP	O
ERG	ERG	NN	I-NP	O
seems	seem	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
than	than	IN	B-PP	O
low	low	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
MF	MF	NN	I-NP	O
-	-	HYPH	O	O
ERG	ERG	NN	B-NP	O

The	The	DT	B-NP	O
residual	residual	JJ	I-NP	O
small	small	JJ	I-NP	O
rRNAs	rRNA	NNS	I-NP	O
in	in	IN	B-PP	O
[	[	(	O	O
poky	poky	JJ	O	O
]	]	)	O	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
synthesized	synthesize	VBN	I-VP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
are	be	VBP	B-VP	O
missing	miss	VBG	I-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O
from	from	IN	B-PP	O
their	their	PRP$	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
ends	end	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
either	either	CC	O	O
that	that	IN	B-SBAR	O
pre	pre	AFX	B-NP	O
-	-	HYPH	I-NP	O
rRNAs	rRNA	NNS	B-NP	O
are	be	VBP	B-VP	O
processed	process	VBN	I-VP	O
abnormally	abnormally	RB	B-ADVP	O
or	or	CC	O	O
that	that	IN	B-SBAR	O
abnormal	abnormal	JJ	B-NP	O
1	1	CD	I-NP	O
'	'	''	I-NP	O
RNA	RNA	NN	I-NP	O
ends	end	NNS	I-NP	O
are	be	VBP	B-VP	O
unstable	unstable	JJ	B-ADJP	O

Homology	Homology	NN	B-NP	O
is	be	VBZ	B-VP	O
much	much	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
protein	protein	NN	I-NP	O
and	and	CC	I-NP	O
regions	region	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
strongly	strongly	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
serine	BEGIN-serine	NN	I-NP	B
protease	protease	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
inactivation	inactivation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Sir1p	BEGIN-BEGIN-Sir1p-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
interacting	interact	VBG	B-VP	O
protein	protein	NN	B-NP	O
Rap1p	Rap1p-INSIDE	NN	I-NP	I
reduces	reduce	VBZ	B-VP	O
partitioning	partitioning	NN	B-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
LexA	BEGIN-LexA-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
Sir1p	BEGIN-Sir1p-INSIDE	NN	I-NP	B
fusion	fusion	NN	I-NP	O

Childbirth	Childbirth	NNP	B-NP	O
and	and	CC	O	O
authoritative	authoritative	JJ	B-NP	O
knowledge	knowledge	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
linearized	linearize	VBN	I-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
can	can	MD	B-VP	O
initiate	initiate	VB	I-VP	O
new	new	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
by	by	IN	B-PP	O
BIR	BIR	NN	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
newly	newly	RB	I-NP	O
synthesized	synthesize	VBN	I-NP	O
DNA	DNA	NN	I-NP	O
is	be	VBZ	B-VP	O
displaced	displace	VBN	I-VP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
forms	form	VBZ	I-VP	O
circles	circle	NNS	B-NP	O
by	by	IN	B-PP	O
NHEJ	NHEJ	NN	B-NP	O

The	The	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
polymorphonuclear	polymorphonuclear	JJ	B-NP	O
granulocytes	granulocyte	NNS	I-NP	O
and	and	CC	O	O
cartilage	cartilage	NN	B-NP	O
destruction	destruction	NN	I-NP	O
in	in	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
ADH	BEGIN-ADH	NN	I-NP	B
subunit	subunit-INSIDE	NN	I-NP	I

Nine	Nine	CD	B-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vaccination	vaccination	NN	I-NP	O
anti	BEGIN-anti	AFX	O	B
-	-	HYPH	O	I
HBsAg	HBsAg-INSIDE	NN	B-NP	I
levels	level	NNS	I-NP	O
had	have	VBD	B-VP	O
dropped	drop	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
M	M	NN	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	HYPH	O	O
SE	SE	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
geometric	geometric	JJ	I-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nine	nine	CD	I-NP	O
remaining	remain	VBG	I-NP	O
evaluable	evaluable	JJ	I-NP	O
patients	patient	NNS	I-NP	O

The	The	DT	B-NP	O
point	point	NN	I-NP	O
mutation	mutation	NN	I-NP	O
Asp	Asp	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
-	-	HYPH	I-NP	O
>	>	SYM	I-NP	O
Asn	Asn	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
analogous	analogous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ERK1	BEGIN-ERK1-INSIDE	NN	I-NP	B
(	(	(	O	O
extracellular	BEGIN-extracellular	JJ	B-NP	B
-	-	HYPH	I-NP	I
signal	signal	NN	I-NP	I
-	-	HYPH	B-NP	I
regulated	regulate	VBN	I-NP	I
kinase	kinase	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
sevenmaker	BEGIN-sevenmaker-INSIDE	NN	B-NP	B
mutation	mutation	NN	I-NP	O
,	,	,	O	O
dramatically	dramatically	RB	B-VP	O
decreases	decrease	VBZ	I-VP	O
its	its	PRP$	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
MKP	BEGIN-MKP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
substantially	substantially	RB	B-VP	O
compromises	compromise	VBZ	I-VP	O
its	its	PRP$	B-NP	O
stimulatory	stimulatory	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
phosphatase	phosphatase	NN	I-NP	O

Cortical	Cortical	JJ	B-NP	O
somatosensory	somatosensory	JJ	I-NP	O
evoked	evoked	JJ	I-NP	O
potentials	potential	NNS	I-NP	O
to	to	TO	B-PP	O
median	median	JJ	B-NP	O
nerve	nerve	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
delayed	delay	VBN	I-NP	O
peak	peak	NN	I-NP	O
latencies	latency	NNS	I-NP	O
of	of	IN	B-PP	O
N1	N1	NN	B-NP	O
,	,	,	O	O
P1	P1	NN	B-NP	O
,	,	,	O	O
P1	P1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
N1	N1	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
N1	N1	NN	B-NP	O
latency	latency	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O

Catalase	BEGIN-Catalase-INSIDE	NN	B-NP	B
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
antioxidant	antioxidant	NN	I-NP	O
,	,	,	O	O
protecting	protect	VBG	B-VP	O
aerobic	aerobic	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
toxic	toxic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
hydrogen	hydrogen	NN	B-NP	O
peroxide	peroxide	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
cases	case	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
postulated	postulate	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
virulence	virulence	NN	I-NP	O
factor	factor	NN	I-NP	O

Prazosin	Prazosin	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
proenzyme	proenzyme	NN	B-NP	O
processing	processing	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
PC1	BEGIN-PC1-INSIDE	NN	B-NP	B
,	,	,	O	O
but	but	CC	O	O
peptides	peptide	NNS	B-NP	O
containing	contain	VBG	B-VP	O
mutations	mutation	NNS	B-NP	O
that	that	WDT	B-NP	O
affect	affect	VBP	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
propeptide	propeptide	NN	I-NP	O
(	(	(	O	O
and	and	CC	O	O
cleavage	cleavage	NN	B-NP	O
sites	site	NNS	I-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
fold	fold	VB	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
pocket	pocket	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
beyond	beyond	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
secretory	secretory	NN	I-NP	O
pathway	pathway	NN	I-NP	O

Cloning	Cloning	NN	B-NP	O
,	,	,	O	O
sequence	sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	BEGIN-gene	JJ	I-NP	B
encoding	encode	VBG	I-NP	I
formaldehyde	formaldehyde	NN	I-NP	I
dismutase	dismutase	NN	I-NP	I
from	from	IN	B-PP	I
Pseudomonas	Pseudomonas	NNP	B-NP	I
putida	putida	NN	I-NP	I
F1	F1-INSIDE	NN	I-NP	I

Taking	Take	VBG	B-VP	O
into	into	IN	B-PP	O
account	account	NN	B-NP	O
certain	certain	JJ	I-NP	O
well	well	RB	I-NP	O
defined	define	VBN	I-NP	O
conditions	condition	NNS	I-NP	O
(	(	(	O	O
frequent	frequent	JJ	B-NP	O
feedings	feeding	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
supplementary	supplementary	JJ	I-NP	O
feeding	feeding	NN	I-NP	O
before	before	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
method	method	NN	B-NP	O
only	only	RB	B-ADVP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
menstruation	menstruation	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
LAM	LAM	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
relied	rely	VBN	I-VP	O
on	on	RP	B-PRT	O
for	for	IN	B-PP	O
contraceptive	contraceptive	JJ	B-NP	O
protection	protection	NN	I-NP	O
for	for	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
post	post	IN	B-PP	O
partum	partum	NN	B-NP	O

The	The	DT	B-NP	O
bioconversion	bioconversion	NN	I-NP	O
of	of	IN	B-PP	O
penicillin	penicillin	NN	B-NP	O
G	G	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
inexpensive	inexpensive	JJ	I-NP	O
substrate	substrate	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
valuable	valuable	JJ	I-NP	O
intermediate	intermediate	NN	I-NP	O
for	for	IN	B-PP	O
semisynthetic	semisynthetic	JJ	B-NP	O
cephalosporin	cephalosporin	NN	I-NP	O
production	production	NN	I-NP	O
,	,	,	O	O
deacetoxycephalosporin	deacetoxycephalosporin	NN	B-NP	O
G	G	NN	I-NP	O
(	(	(	O	O
DAOG	DAOG	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
recently	recently	RB	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
eliminating	eliminate	VBG	B-VP	O
agitation	agitation	NN	B-NP	O
and	and	CC	O	O
adding	add	VBG	B-VP	O
decane	decane	NN	B-NP	O

Doctors	Doctor	NNS	B-NP	O
given	give	VBN	B-PP	O
intrathecal	intrathecal	JJ	B-NP	O
methotrexate	methotrexate	NN	I-NP	O
had	have	VBD	B-VP	O
headache	headache	NN	B-NP	O
when	when	WRB	B-ADVP	O
1	1	CD	B-NP	O
gauge	gauge	NN	I-NP	O
standard	standard	JJ	I-NP	O
needle	needle	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O

The	The	DT	B-NP	O
IGFBP	BEGIN-IGFBP	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
IRS	BEGIN-IRS-INSIDE	NN	I-NP	B
and	and	CC	O	O
PEPCK	BEGIN-PEPCK-INSIDE	NN	B-NP	B
IRS	BEGIN-IRS-INSIDE	NN	I-NP	B
both	both	DT	B-NP	O
bind	bind	VBP	B-VP	O
the	the	DT	B-NP	O
alpha	alpha	NN	I-NP	O
and	and	CC	I-NP	O
beta	beta	NN	I-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
hepatic	BEGIN-hepatic	JJ	B-NP	B
nuclear	nuclear	JJ	I-NP	I
factor	factor	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
HNF	BEGIN-HNF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
does	do	VBZ	B-VP	O
so	so	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sixfold	sixfold	RB	I-NP	O
-	-	HYPH	I-NP	O
lower	low	JJR	I-NP	O
relative	relative	JJ	I-NP	O
affinity	affinity	NN	I-NP	O

Free	Free	JJ	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
S	S-INSIDE	NN	I-NP	I
deficiency	deficiency	NN	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
stroke	stroke	NN	I-NP	O

Low	Low	JJ	B-NP	O
-	-	HYPH	I-NP	O
affinity	affinity	NN	I-NP	O
E1	BEGIN-BEGIN-E1-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
binding	bind	VBG	B-NP	O
site	site-INSIDE	NN	I-NP	I
mediates	mediate	VBZ	B-VP	O
downmodulation	downmodulation	NN	B-NP	O
of	of	IN	B-PP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
transactivation	transactivation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
papillomavirus	papillomavirus	NN	I-NP	I
type	type	NN	I-NP	I
1	1	CD	I-NP	I
late	late	JJ	B-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

This	This	DT	B-NP	O
domain	domain	NN	I-NP	O
encompasses	encompass	VBZ	B-VP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
ARP	BEGIN-ARP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
COUP	BEGIN-COUP	NN	I-NP	B
-	-	HYPH	B-NP	I
TFII	TFII-INSIDE	NN	I-NP	I
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
helices	helix	NNS	B-NP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
recently	recently	RB	I-NP	O
published	publish	VBN	I-NP	O
crystal	crystal	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	BEGIN-nuclear	JJ	I-NP	B
receptor	receptor	NN	I-NP	I
superfamily	superfamily-INSIDE	NN	I-NP	I

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ZF	BEGIN-ZF	NN	I-NP	B
-	-	HYPH	B-NP	I
HD	HD-INSIDE	NN	I-NP	I
class	class	NN	I-NP	O
of	of	IN	B-PP	O
homeodomain	BEGIN-homeodomain	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
characteristic	characteristic	JJ	I-NP	O
expression	expression	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C1	BEGIN-C1	NN	I-NP	B
PEPCase	PEPCase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

When	When	WRB	B-ADVP	O
medical	medical	JJ	B-NP	O
aid	aid	NN	I-NP	O
was	be	VBD	B-VP	O
sought	seek	VBN	I-VP	O
a	a	DT	B-NP	O
false	false	JJ	I-NP	O
history	history	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
true	true	JJ	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
child	child	NN	I-NP	O
's	's	POS	B-NP	O
illness	illness	NN	I-NP	O
,	,	,	O	O
heat	heat	NN	B-NP	O
stroke	stroke	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
determined	determine	VBN	I-VP	O
until	until	IN	B-PP	O
after	after	IN	B-PP	O
death	death	NN	B-NP	O

BACKGROUND	BACKGROUND	NN	B-NP	O

To	To	TO	B-VP	O
test	test	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
myb	BEGIN-BEGIN-myb-INSIDE	NN	B-NP	B
family	family	NN	I-NP	O
members	members-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
progression	progression	NN	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
comicroinjected	comicroinjecte	VBD	B-VP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
myc	myc-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
myb	BEGIN-myb-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
vectors	vector	NNS	I-NP	O
into	into	IN	B-PP	O
serum	serum	NN	B-NP	O
-	-	HYPH	B-VP	O
deprived	deprive	VBN	B-NP	O
quiescent	quiescent	JJ	I-NP	O
SMCs	SMC	NNS	I-NP	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
IME1	BEGIN-IME1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
sporulation	sporulation	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
meiosis	meiosis	NN	B-NP	O
specific	specific	JJ	I-NP	O
genes	gene	NNS	I-NP	O
in	in	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O

Cytogenetic	Cytogenetic	JJ	B-NP	O
structures	structure	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
mixte	mixte	JJ	I-NP	O
karyotype	karyotype	NN	I-NP	O
:	:	:	O	O
mosaicim	mosaicim	NN	B-NP	O
1	1	CD	I-NP	O
XX	XX	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
XY	XY	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Ultrasound	Ultrasound	NN	B-NP	O
biomicroscopy	biomicroscopy	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
tool	tool	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
APVR	APVR	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
difficult	difficult	JJ	B-ADJP	O
by	by	IN	B-PP	O
ordinary	ordinary	JJ	B-NP	O
methods	method	NNS	I-NP	O

Morphological	Morphological	JJ	B-NP	O
-	-	HYPH	I-NP	O
functional	functional	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
edentulous	edentulous	JJ	I-NP	O
mandible	mandible	NN	I-NP	O
and	and	CC	I-NP	O
selection	selection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
effective	effective	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
functional	functional	JJ	B-NP	O
impression	impression	NN	I-NP	O
-	-	HYPH	O	O
taking	take	VBG	B-VP	O

Eight	Eight	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
seropositive	seropositive	JJ	I-NP	O
patients	patient	NNS	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
detectable	detectable	JJ	B-NP	O
hepatitis	BEGIN-hepatitis	NN	I-NP	B
B	B	NN	I-NP	I
surface	surface	NN	I-NP	I
antibody	antibody-INSIDE	NN	I-NP	I
within	within	IN	B-PP	O
three	three	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
injection	injection	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
seronegative	seronegative	JJ	I-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

Like	Like	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Drosophila	Drosophila	NN	I-NP	O
gene	gene	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
three	three	CD	I-NP	O
isoforms	isoform	NNS	I-NP	O
of	of	IN	B-PP	O
full	BEGIN-full	JJ	B-NP	B
length	length	NN	I-NP	I
dystrophin	dystrophin	NN	I-NP	I
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
(	(	(	O	O
dmDLP1	BEGIN-dmDLP1-INSIDE	NN	B-NP	B
,	,	,	I-NP	O
dmDLP1	BEGIN-dmDLP1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
dmDLP1	BEGIN-dmDLP1-INSIDE	NN	I-NP	B
,	,	,	O	O
)	)	)	O	O
,	,	,	O	O
regulated	regulate	VBN	B-VP	O
by	by	IN	B-PP	O
different	different	JJ	B-NP	O
promoters	promoter	NNS	I-NP	O
located	locate	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
smaller	small	JJR	I-NP	O
product	product	NN	I-NP	O
regulated	regulate	VBN	B-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
internal	internal	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
(	(	(	O	O
dmDp1	BEGIN-dmDp1-INSIDE	NN	B-NP	B
)	)	)	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
presenting	present	VBG	B-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
hepatocellular	hepatocellular	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
after	after	IN	B-PP	O
resection	resection	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
first	first	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
type	type	NN	I-NP	O
is	be	VBZ	B-VP	O
reported	report	VBN	I-VP	O

The	The	DT	B-NP	O
equation	equation	NN	I-NP	O
for	for	IN	B-PP	O
mean	mean	JJ	B-NP	O
trabecular	trabecular	JJ	I-NP	O
number	number	NN	I-NP	O
passed	pass	VBD	B-VP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
validity	validity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
equations	equation	NNS	I-NP	O
for	for	IN	B-PP	O
mean	mean	JJ	B-NP	O
trabecular	trabecular	JJ	I-NP	O
separation	separation	NN	I-NP	O
and	and	CC	I-NP	O
Tb.Wi	Tb.Wi	NN	I-NP	O
appeared	appear	VBD	B-VP	O
limited	limited	JJ	B-ADJP	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
authoritative	authoritative	JJ	I-NP	O
way	way	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
diet	diet	NN	B-NP	O
on	on	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
pH	pH	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
feeding	feeding	NN	I-NP	O
trial	trial	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
universally	universally	RB	I-NP	O
accepted	accept	VBN	I-NP	O
protocol	protocol	NN	I-NP	O
for	for	IN	B-PP	O
measuring	measure	VBG	B-VP	O
urinary	urinary	JJ	B-NP	O
pH	pH	NN	I-NP	O

The	The	DT	B-NP	O
performances	performance	NNS	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
ProstAsure	ProstAsure	NNP	I-NP	O
index	index	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
percent	percent	NN	I-NP	O
free	free	JJ	I-NP	O
PSA	BEGIN-PSA-INSIDE	NN	I-NP	B
test	test	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
detecting	detect	VBG	B-VP	O
cancer	cancer	NN	B-NP	O

But	But	CC	O	O
if	if	IN	B-SBAR	O
one	one	CD	B-NP	O
equalizes	equalize	VBZ	B-VP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
limits	limit	NNS	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
markers	marker	NNS	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
1	1	CD	I-NP	O
specificity	specificity	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	O
-	-	HYPH	O	O
indicating	indicate	VBG	B-VP	O
sensitivity	sensitivity	NN	B-NP	O
of	of	IN	B-PP	O
CA	BEGIN-BEGIN-CA	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
1	1-INSIDE	NN	I-NP	I
clearly	clearly	RB	B-ADVP	O
surpasses	surpass	VBZ	B-VP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
CA	BEGIN-CA	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I

For	For	IN	B-PP	O
economical	economical	JJ	B-NP	O
reasons	reason	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
send	send	VB	I-VP	O
a	a	DT	B-NP	O
questionnaire	questionnaire	NN	I-NP	O
to	to	TO	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
individuals	individual	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
based	base	VBD	B-VP	O
the	the	DT	B-NP	O
investigation	investigation	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
SRS	SRS	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
men	man	NNS	I-NP	O
,	,	,	O	O
post	post	AFX	O	O
-	-	HYPH	B-NP	O
stratified	stratify	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
risk	risk	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
-	-	HYPH	I-NP	O
risk	risk	NN	I-NP	O
group	group	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
arterial	arterial	JJ	B-NP	O
dimensions	dimension	NNS	I-NP	O
,	,	,	O	O
results	result	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
caliper	caliper	NN	B-NP	O
estimates	estimate	NNS	I-NP	O
of	of	IN	B-PP	O
luminal	luminal	JJ	B-NP	O
area	area	NN	I-NP	O
and	and	CC	I-NP	O
diameter	diameter	NN	I-NP	O
are	be	VBP	B-VP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
videodensitometry	videodensitometry	NN	B-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
XR	XR	NN	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
system	system	NN	I-NP	O

Oncogenic	Oncogenic	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
RET	BEGIN-RET-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
papillary	papillary	JJ	I-NP	O
thyroid	thyroid	JJ	I-NP	O
tumours	tumour	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
endocrine	endocrine	JJ	I-NP	O
neoplasia	neoplasia	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
syndromes	syndrome	NNS	I-NP	O

Evasion	Evasion	NN	B-NP	O
of	of	IN	B-PP	O
host	host	NN	B-NP	O
immunity	immunity	NN	I-NP	O
by	by	IN	B-PP	O
Toxocara	Toxocara	NNP	B-NP	O
canis	canis	MD	B-VP	O
infective	infective	JJ	B-NP	O
larvae	larva	NNS	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
nematode	nematode	NN	I-NP	O
surface	surface	NN	I-NP	O
coat	coat	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
shed	shed	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
binding	binding	NN	B-NP	O
by	by	IN	B-PP	O
host	host	NN	B-NP	O
antibody	antibody	NN	I-NP	O
molecules	molecule	NNS	I-NP	O
or	or	CC	O	O
effector	effector	NN	B-NP	O
cells	cell	NNS	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
processing	processing	NN	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
target	target	NN	I-NP	O
transcripts	transcript	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
P	BEGIN-P	NN	I-NP	B
-	-	HYPH	B-NP	I
element	element	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
,	,	,	O	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
PSI	BEGIN-PSI-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
U1	BEGIN-U1-INSIDE	NN	I-NP	B
snRNP	snRNP	NN	I-NP	O
interaction	interaction	NN	I-NP	O
in	in	IN	B-PP	O
Drosophila	Drosophila	NN	B-NP	O

The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
proteins	protein	NNS	I-NP	O
show	show	VBP	B-VP	O
strong	strong	JJ	B-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
ABA	BEGIN-ABA	NN	I-NP	B
-	-	HYPH	O	I
inducible	inducible	JJ	B-NP	I
glycine	glycine	NN	I-NP	I
-	-	HYPH	B-NP	I
rich	rich	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
maize	maize	NN	B-NP	O
embryos	embryo	NNS	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mammalian	BEGIN-mammalian	JJ	I-NP	B
RNA	RNA	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein	NN	B-NP	I
A1	A1-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heterogeneous	heterogeneous	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
ribonucleoprotein	ribonucleoprotein	NN	I-NP	O
complex	complex	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
pre	pre	AFX	B-NP	O
-	-	HYPH	I-NP	O
mRNA	mRNA	NN	I-NP	O
splicing	splicing	NN	I-NP	O

Ptx1	BEGIN-Ptx1-INSIDE	NN	B-NP	B
belongs	belong	VBZ	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
expanding	expand	VBG	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
bicoid	BEGIN-bicoid	JJ	B-NP	B
-	-	HYPH	I-NP	I
related	related-INSIDE	NN	I-NP	I
vertebrate	vertebrate	NN	I-NP	O
homeobox	homeobox	NN	I-NP	O
genes	gene	NNS	I-NP	O

Reactive	Reactive	JJ	B-NP	O
mesothelial	mesothelial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
usually	usually	RB	B-VP	O
seen	see	VBN	I-VP	O
as	as	IN	B-PP	O
exfoliated	exfoliate	VBN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
consistently	consistently	RB	B-ADVP	O
strongly	strongly	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
for	for	IN	B-PP	O
alpha	BEGIN-alpha	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
antichymotrypsin	antichymotrypsin-INSIDE	NN	I-NP	I
and	and	CC	O	O
more	more	RBR	B-ADVP	O
variably	variably	RB	I-ADVP	O
for	for	IN	B-PP	O
alpha	BEGIN-alpha	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
antitrypsin	antitrypsin-INSIDE	JJ	I-NP	I
and	and	CC	I-NP	O
lysozyme	BEGIN-lysozyme-INSIDE	JJ	I-NP	B

However	However	RB	B-ADVP	O
,	,	,	O	O
all	all	DT	B-NP	O
pathophysiologic	pathophysiologic	JJ	I-NP	O
assessments	assessment	NNS	I-NP	O
reported	report	VBN	B-VP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
during	during	IN	B-PP	O
or	or	CC	O	O
immediately	immediately	RB	B-ADVP	O
after	after	IN	B-PP	O
IVOX	IVOX	NN	B-NP	O
utilization	utilization	NN	I-NP	O

The	The	DT	B-NP	O
wet	wet	JJ	I-NP	O
and	and	CC	I-NP	O
dry	dry	JJ	I-NP	O
methods	method	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HA	HA	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
are	be	VBP	B-VP	O
considered	consider	VBN	I-VP	O

In	In	IN	B-PP	O
agreement	agreement	NN	I-PP	O
with	with	IN	I-PP	O
other	other	JJ	B-NP	O
authors	author	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
recommend	recommend	VBP	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
safe	safe	JJ	I-NP	O
one	one	NN	I-NP	O
,	,	,	O	O
providing	provide	VBG	B-VP	O
satisfactory	satisfactory	JJ	B-NP	O
results	result	NNS	I-NP	O

In	In	IN	B-PP	O
several	several	JJ	B-NP	O
steps	step	NNS	I-NP	O
we	we	PRP	B-NP	O
converted	convert	VBD	B-VP	O
the	the	DT	B-NP	O
retinoid	retinoid	NN	I-NP	O
specific	specific	JJ	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
retinoic	retinoic	JJ	I-NP	I
acid	acid	NN	I-NP	I
receptor	receptor	NN	I-NP	I
beta	beta	SYM	B-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
into	into	IN	B-PP	O
the	the	DT	B-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
/	/	SYM	B-VP	O
retinoic	retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
osteocalcin	osteocalcin	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
define	define	VBP	B-VP	O
Ile	Ile	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
Val	Val	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
Val	Val	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Ile	Ile	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
crucial	crucial	JJ	B-ADJP	O
for	for	IN	B-PP	O
protein	BEGIN-protein	NN	B-NP	B
S	S-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
secondary	secondary	JJ	B-NP	O
effects	effect	NNS	I-NP	O
from	from	IN	B-PP	O
Leu	Leu	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
Val	Val	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

Synthesis	Synthesis	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
oxavitamin	oxavitamin	NN	I-NP	O
D1	D1	NN	I-NP	O
analogues	analogue	NNS	I-NP	O

The	The	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
confer	confer	VB	I-VP	O
drug	drug	NN	B-NP	O
resistance	resistance	NN	I-NP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-PP	O
LMB	LMB	NN	B-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
some	some	DT	B-NP	O
chloroplast	BEGIN-chloroplast	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
tRNA	tRNA	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
wheat	wheat	NN	B-NP	O
mtDNA	mtDNA	NN	I-NP	O
are	be	VBP	B-VP	O
transcribed	transcribe	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
transcripts	transcript	NNS	B-NP	O
undergoing	undergo	VBG	B-VP	O
processing	processing	NN	B-NP	O
,	,	,	O	O
post	post	AFX	B-NP	O
-	-	HYPH	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
modification	modification	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
CCA	CCA	NN	I-NP	O
addition	addition	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
mature	mature	JJ	B-NP	O
tRNAs	tRNA	NNS	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
mitochondrial	mitochondrial	JJ	B-NP	O
protein	protein	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O

Previously	Previously	RB	B-NP	O
identified	identify	VBN	I-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
variant	variant	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
within	within	IN	B-PP	O
or	or	CC	O	O
close	close	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
coding	cod	VBG	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HMBS	BEGIN-HMBS	NNP	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
exon	exon	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
solely	solely	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ubiquitous	ubiquitous	JJ	I-NP	O
isoform	isoform	NN	I-NP	O

Immunologic	Immunologic	JJ	B-NP	O
tolerance	tolerance	NN	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
during	during	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
inhalation	inhalation	NN	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
trimellitic	trimellitic	JJ	B-NP	O
anhydride	anhydride	NN	I-NP	O

In	In	IN	B-PP	O
stage	stage	NN	B-NP	O
I	I	CD	I-NP	O
,	,	,	O	O
histochemistry	histochemistry	NN	B-NP	O
for	for	IN	B-PP	O
copper	copper	NN	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
1	1	CD	I-NP	O
cases	case	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
were	be	VBD	B-VP	O
T+	T+	JJ	B-ADJP	O
;	;	:	O	O
1	1	CD	B-NP	O
case	case	NN	I-NP	O
R+	R+	JJ	B-ADJP	O
and	and	CC	O	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
O+	O+	JJ	B-ADJP	O
;	;	:	O	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
were	be	VBD	B-VP	O
T+	T+	NNP	B-NP	O
,	,	,	O	O
R+	R+	NNP	B-NP	O
,	,	,	O	O
O+	O+	NNP	B-NP	O

Rat	BEGIN-Rat	NN	B-NP	B
cholesterol	cholesterol	NN	I-NP	I
side	side	NN	I-NP	I
-	-	HYPH	B-NP	I
chain	chain	NN	I-NP	I
cleavage	cleavage	NN	I-NP	I
cytochrome	cytochrome	NN	I-NP	I
P	P	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
P	BEGIN-P	NN	B-NP	B
-	-	HYPH	B-NP	I
1scc	1scc-INSIDE	NN	I-NP	I
)	)	)	O	O
gene	gene	NN	B-NP	O

Almost	Almost	RB	B-NP	O
every	every	DT	I-NP	O
image	image	NN	I-NP	O
that	that	WDT	B-NP	O
appears	appear	VBZ	B-VP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
therapy	therapy	NN	I-NP	O
session	session	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
symbolic	symbolic	JJ	I-NP	O
nature	nature	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
very	very	JJ	I-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
symbol	symbol	NN	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
free	free	JJ	B-ADJP	O
from	from	IN	B-PP	O
ambiguity	ambiguity	NN	B-NP	O
some	some	DT	B-NP	O
positions	position	NNS	I-NP	O
originated	originate	VBN	B-VP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
investigation	investigation	NN	B-NP	O
are	be	VBP	B-VP	O
mentioned	mention	VBN	I-VP	O
,	,	,	O	O
ending	end	VBG	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
description	description	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
traits	trait	NNS	I-NP	O
that	that	WDT	B-NP	O
,	,	,	O	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
writer	writer	NN	I-NP	O
,	,	,	O	O
bestow	bestow	VBP	B-VP	O
a	a	DT	B-NP	O
symbolic	symbolic	JJ	I-NP	O
character	character	NN	I-NP	O
to	to	TO	B-PP	O
images	image	NNS	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
mapped	map	VBN	I-VP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
domains	domain	NNS	I-NP	O
within	within	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteins	protein	NNS	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
interaction	interaction	NN	I-NP	O

A	A	DT	B-NP	O
trend	trend	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
toward	toward	IN	B-PP	O
increased	increase	VBN	B-NP	O
graft	graft	NN	I-NP	O
half	half	NN	I-NP	O
-	-	HYPH	I-NP	O
life	life	NN	I-NP	O
in	in	IN	B-PP	O
era	era	NN	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
NS	NS	NN	B-NP	O
)	)	)	O	O

After	After	IN	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
of	of	IN	B-PP	O
hemorrhage	hemorrhage	NN	B-NP	O
the	the	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
in	in	IN	B-PP	O
fed	feed	VBN	B-NP	O
and	and	CC	I-NP	O
starved	starve	VBN	I-NP	O
animals	animal	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
striking	striking	JJ	I-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

A	A	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
pregnant	pregnant	JJ	I-NP	O
woman	woman	NN	I-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
hyperemesis	hyperemesis	NN	B-NP	O
gravidarum	gravidarum	NN	I-NP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O

The	The	DT	B-NP	O
nucleoporin	BEGIN-nucleoporin	NN	I-NP	B
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
NUP1	BEGIN-NUP1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
rearranged	rearrange	VBN	I-VP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
acute	acute	JJ	I-NP	O
myeloid	myeloid	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
translocations	translocation	NNS	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O

Human	BEGIN-Human	JJ	B-NP	B
CD1	CD1-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
leukocyte	leukocyte	NN	I-NP	O
receptor	receptor	NN	I-NP	O
and	and	CC	I-NP	O
ectoenzyme	ectoenzyme	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
eukaryotic	eukaryotic	JJ	I-NP	O
gene	gene	NN	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
nicotinamide	BEGIN-nicotinamide	NN	B-NP	B
adenine	adenine	NN	I-NP	I
dinucleotide+	dinucleotide+	SYM	O	I
-	-	HYPH	O	I
converting	convert	VBG	B-VP	I
enzymes	enzymes-INSIDE	NN	B-NP	I
:	:	:	O	O
extensive	extensive	JJ	B-NP	O
structural	structural	JJ	I-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
for	for	IN	B-PP	O
murine	BEGIN-murine	JJ	B-NP	B
bone	bone	NN	I-NP	I
marrow	marrow	NN	I-NP	I
stromal	stromal	JJ	I-NP	I
cell	cell	NN	I-NP	I
antigen	antigen	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
aplysian	BEGIN-aplysian	JJ	B-NP	B
ADP	ADP	NN	I-NP	I
-	-	HYPH	B-NP	I
ribosyl	ribosyl	NN	I-NP	I
cyclase	cyclase-INSIDE	NN	I-NP	I

Juvenile	Juvenile	JJ	B-NP	O
angiofibromas	angiofibroma	NNS	I-NP	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HNF1	BEGIN-HNF1	NN	I-NP	B
element	element-INSIDE	NN	I-NP	I
significantly	significantly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
HepG1	HepG1	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
this	this	DT	B-NP	O
element	element	NN	I-NP	O
in	in	IN	B-PP	O
isolation	isolation	NN	B-NP	O
conferred	confer	VBD	B-VP	O
HNF1beta	BEGIN-HNF1beta-INSIDE	NN	B-NP	B
responsiveness	responsiveness	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
heterologous	heterologous	JJ	I-NP	O
promoter	promoter	NN	I-NP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Detection	Detection	NN	B-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
head	head	NN	I-NP	O
and	and	CC	O	O
neck	neck	NN	B-NP	O
cancer	cancer	NN	I-NP	O
is	be	VBZ	B-VP	O
feasible	feasible	JJ	B-ADJP	O
with	with	IN	B-PP	O
FDG	FDG	NN	B-NP	O
PET	PET	NN	I-NP	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
haptoglobin	BEGIN-haptoglobin-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
asphyxia	asphyxia	NN	B-NP	O
mechanism	mechanism	NN	I-NP	O
(	(	(	O	O
II	II	CD	B-NP	O
)	)	)	O	O
-	-	HYPH	O	O
-	-	HYPH	B-NP	O
Acute	Acute	JJ	I-NP	O
drowning	drowning	NN	I-NP	O
and	and	CC	O	O
hanging	hang	VBG	B-VP	O

Patients	Patient	NNS	B-NP	O
adopt	adopt	VBP	B-VP	O
new	new	JJ	B-NP	O
sets	set	NNS	I-NP	O
based	base	VBN	B-VP	O
partly	partly	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
original	original	JJ	I-NP	O
topic	topic	NN	I-NP	O
and	and	CC	O	O
partly	partly	RB	B-ADVP	O
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
own	own	JJ	I-NP	O
personal	personal	JJ	I-NP	O
idiosyncratic	idiosyncratic	JJ	I-NP	O
concerns	concern	NNS	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
PET	PET	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
wide	wide	JJ	B-NP	O
variations	variation	NNS	I-NP	O
in	in	IN	B-PP	O
CBF	CBF	NN	B-NP	O
between	between	IN	B-PP	O
regions	region	NNS	B-NP	O
during	during	IN	B-PP	O
isoflurane	isoflurane	NN	B-NP	O
anaesthesia	anaesthesia	NN	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
propofol	propofol	NN	B-NP	O
anaesthesia	anaesthesia	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
rCMRO1	rCMRO1	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
globally	globally	RB	B-ADVP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
during	during	IN	B-PP	O
both	both	CC	O	O
isoflurane	isoflurane	NN	B-NP	O
and	and	CC	O	O
propofol	propofol	NN	B-NP	O
anaesthesia	anaesthesia	NN	I-NP	O

Long	Long	JJ	B-NP	O
chain	chain	NN	I-NP	O
acyl	acyl	NN	I-NP	O
-	-	HYPH	B-NP	O
CoA	CoA	NN	I-NP	O
esters	ester	NNS	I-NP	O
are	be	VBP	B-VP	O
important	important	JJ	B-NP	O
intermediates	intermediate	NNS	I-NP	O
in	in	IN	B-PP	O
degradation	degradation	NN	B-NP	O
and	and	CC	I-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
fatty	fatty	JJ	B-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
having	have	VBG	B-VP	O
important	important	JJ	B-NP	O
functions	function	NNS	I-NP	O
in	in	IN	B-PP	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
intermediary	intermediary	JJ	B-NP	O
metabolism	metabolism	NN	I-NP	O
and	and	CC	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Improved	Improved	NNP	I-NP	O
Crest	Crest	NNP	I-NP	O
Complete	Complete	NNP	I-NP	O
with	with	IN	B-PP	O
longer	long	JJR	B-NP	O
rippled	rippled	JJ	I-NP	O
outer	outer	JJ	I-NP	O
bristles	bristle	NNS	I-NP	O
provided	provide	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
superior	superior	JJ	I-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
interproximal	interproximal	JJ	B-NP	O
penetration	penetration	NN	I-NP	O
overall	overall	JJ	B-ADVP	O
and	and	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
gumline	gumline	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
Colgate	Colgate	NNP	I-NP	O
Total	Total	NNP	I-NP	O
and	and	CC	I-NP	O
Oral	Oral	NNP	I-NP	O
-	-	HYPH	I-NP	O
B	B	NN	I-NP	O
Advantage	Advantage	NN	I-NP	O
brushes	brush	NNS	I-NP	O

Buchstein	Buchstein	NNP	B-NP	O
,	,	,	O	O
L.	L.	NNP	B-NP	O
-	-	HYPH	B-NP	O
L	L	NN	I-NP	O

The	The	DT	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	NN	I-NP	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
rationale	rationale	NN	I-NP	O
for	for	IN	B-PP	O
conserved	conserve	VBN	B-NP	O
ITAM	BEGIN-ITAM-INSIDE	NN	I-NP	B
residues	residue	NNS	I-NP	O
,	,	,	O	O
substrate	substrate	NN	B-NP	O
specificity	specificity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
substrate	substrate	NN	B-NP	O
binds	bind	VBZ	B-VP	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
active	active	JJ	I-NP	O
conformation	conformation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Src	BEGIN-Src	NN	I-NP	B
family	family	NN	I-NP	I
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
unlike	unlike	IN	B-PP	O
the	the	DT	B-NP	O
ATP	ATP	NN	I-NP	O
cofactor	cofactor	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
bind	bind	VB	I-VP	O
the	the	DT	B-NP	O
inactive	inactive	JJ	I-NP	O
form	form	NN	I-NP	O

Sucrose	Sucrose	NN	B-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
signalling	signalling	NN	I-NP	O
represses	repress	VBZ	B-VP	O
translation	translation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Arabidopsis	BEGIN-Arabidopsis	NN	I-NP	B
ATB1	ATB1	NN	I-NP	I
bZIP	bZIP	NN	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
probably	probably	RB	B-ADVP	O
because	because	IN	B-SBAR	O
,	,	,	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
some	some	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
perhaps	perhaps	RB	B-NP	O
dormant	dormant	JJ	I-NP	O
forms	form	NNS	I-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
not	not	RB	O	O
entirely	entirely	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
upon	upon	IN	B-PP	O
urease	BEGIN-urease-INSIDE	NN	B-NP	B
for	for	IN	B-PP	O
survival	survival	NN	B-NP	O

Our	Our	PRP$	B-NP	O
aim	aim	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
this	this	DT	B-NP	O
technique	technique	NN	I-NP	O
by	by	IN	B-PP	O
cross	cross	AFX	B-NP	O
-	-	HYPH	I-NP	O
calibrating	calibrate	VBG	B-VP	O
the	the	DT	B-NP	O
DXA	DXA	NN	I-NP	O
method	method	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
carcass	carcass	NN	I-NP	O
chemical	chemical	NN	I-NP	O
analysis	analysis	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
heterogeneous	heterogeneous	JJ	I-NP	O
population	population	NN	I-NP	O
of	of	IN	B-PP	O
nondiabetic	nondiabetic	JJ	B-NP	O
Wistar	Wistar	NNP	I-NP	O
and	and	CC	O	O
diabetic	diabetic	JJ	B-NP	O
GK	GK	NN	I-NP	O
rats	rat	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
animals	animal	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
precision	precision	NN	B-NP	O
error	error	NN	I-NP	O
and	and	CC	I-NP	O
reproducibility	reproducibility	NN	I-NP	O
determinations	determination	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
accuracy	accuracy	NN	B-NP	O
studies	study	NNS	I-NP	O
)	)	)	O	O

Biopsy	Biopsy	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lesion	lesion	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
granulomatous	granulomatous	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	O	O
numerous	numerous	JJ	B-NP	O
septate	septate	NN	I-NP	O
hyphae	hypha	NNS	I-NP	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
serum	BEGIN-serum	NN	B-NP	B
eosinophil	eosinophil	NN	I-NP	I
cationic	cationic	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
AGA	BEGIN-AGA-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
prototype	prototype	NN	I-NP	O
now	now	RB	B-ADVP	O
structures	structure	VBZ	B-VP	O
oncology	oncology	NN	B-NP	O
-	-	HYPH	I-NP	O
related	relate	VBN	I-NP	O
information	information	NN	I-NP	O
available	available	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Internet	Internet	NNP	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
places	place	VBZ	B-VP	O
resources	resource	NNS	B-NP	O
maintained	maintain	VBD	B-VP	O
locally	locally	RB	B-ADVP	O
at	at	IN	B-PP	O
users	user	NNS	B-NP	O
'	'	POS	B-NP	O
disposal	disposal	NN	I-NP	O

Ischaemia	Ischaemia	NN	B-NP	O
and	and	CC	I-NP	O
reperfusion	reperfusion	NN	I-NP	O
injury	injury	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
kidney	kidney	NN	I-NP	O
:	:	:	O	O
current	current	JJ	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
future	future	JJ	B-NP	O
direction	direction	NN	I-NP	O

No	No	DT	B-NP	O
viral	viral	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
replication	replication	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
mutant	mutant	JJ	B-NP	O
RNAs	RNA	NNS	I-NP	O

As	As	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
side	side	NN	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
SISO	SISO	NN	B-NP	O
,	,	,	O	O
cylindruria	cylindruria	NN	B-NP	O
with	with	IN	B-PP	O
aggravation	aggravation	NN	B-NP	O
of	of	IN	B-PP	O
microscopic	microscopic	JJ	B-NP	O
hematuria	hematuria	NN	I-NP	O
and	and	CC	O	O
elevations	elevation	NNS	B-NP	O
of	of	IN	B-PP	O
GOT	BEGIN-GOT-INSIDE	NN	B-NP	B
,	,	,	I-NP	O
GPT	BEGIN-GPT-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
A1	BEGIN-A1	NN	I-NP	B
-	-	HYPH	B-NP	I
P	P-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
each	each	DT	B-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
viable	viable	JJ	I-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
-	-	HYPH	B-NP	O
generated	generate	VBN	I-NP	O
deletion	deletion	NN	I-NP	O
mutant	mutant	NN	I-NP	O
of	of	IN	B-PP	O
PSTVd	PSTVd	NNP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O

Reduced	Reduce	VBN	B-NP	O
cell	cell	NN	I-NP	O
numbers	number	NNS	I-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
insonation	insonation	NN	B-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
insonated	insonate	VBN	I-VP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
antinode	antinode	NN	I-NP	O
but	but	CC	O	O
not	not	RB	O	O
when	when	WRB	B-ADVP	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
node	node	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
now	now	RB	I-VP	O
isolated	isolate	VBN	I-VP	O
cDNA	cDNA	NN	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
invertebrate	BEGIN-invertebrate	JJ	I-NP	B
Pax	Pax	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
protein	protein	NN	I-NP	I
from	from	IN	B-PP	I
sea	sea	NN	B-NP	I
urchin	urchin	NN	I-NP	I
embryos	embryos-INSIDE	NN	I-NP	I

Mating	Mat	VBG	B-VP	O
response	response	NN	B-NP	O
,	,	,	O	O
ovulation	ovulation	NN	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
follicle	follicle	NN	B-NP	O
and	and	CC	I-NP	O
corpus	corpus	NN	I-NP	O
luteum	luteum	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
gestation	gestation	NN	B-NP	O
length	length	NN	I-NP	O
,	,	,	O	O
pregnancy	pregnancy	NN	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
lambing	lamb	VBG	B-VP	O
rate	rate	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lamb	lamb	NN	B-NP	O
birth	birth	NN	I-NP	O
weight	weight	NN	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O

From	From	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
locally	locally	RB	B-NP	O
or	or	CC	I-NP	O
regionally	regionally	RB	I-NP	O
advanced	advanced	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
uterine	uterine	JJ	I-NP	O
cervix	cervix	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
(	(	(	O	O
RT	RT	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
pelvic	pelvic	JJ	B-NP	O
regional	regional	JJ	I-NP	O
hyperthermia	hyperthermia	NN	I-NP	O
(	(	(	O	O
HT	HT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Divisions	Divisions	NNP	I-NP	O
of	of	IN	B-PP	O
Radiation	Radiation	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
University	University	NNP	I-NP	O
of	of	IN	B-PP	O
Utah	Utah	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
(	(	(	O	O
UU	UU	NNP	B-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Kenneth	Kenneth	NNP	I-NP	O
Norris	Norris	NNP	I-NP	O
Jr	Jr	NNP	I-NP	O
Cancer	Cancer	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
University	University	NNP	I-NP	O
of	of	IN	B-PP	O
Southern	Southern	NNP	B-NP	O
California	California	NNP	I-NP	O
(	(	(	O	O
USC	USC	NNP	B-NP	O
)	)	)	O	O

These	These	DT	B-NP	O
proteins	protein	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
antibody	antibody	NN	I-NP	O
which	which	WDT	B-NP	O
recognizes	recognize	VBZ	B-VP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	O	O
terminus	terminus	NN	B-NP	O
of	of	IN	B-PP	O
SRK1	BEGIN-SRK1-INSIDE	NN	B-NP	B
and	and	CC	O	O
,	,	,	O	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
F1	F1	NN	I-NP	O
progeny	progeny	NN	I-NP	O
segregating	segregate	VBG	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
S1	BEGIN-S1	NN	I-NP	B
haplotype	haplotype-INSIDE	NN	I-NP	I
,	,	,	O	O
were	be	VBD	B-VP	O
only	only	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
plants	plant	NNS	B-NP	O
possessing	possess	VBG	B-VP	O
the	the	DT	B-NP	O
S1	BEGIN-S1	NN	I-NP	B
haplotype	haplotype-INSIDE	NN	I-NP	I

For	For	IN	B-PP	O
all	all	DT	B-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blast	blast	NN	I-NP	O
flag	flag	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
CD1	CD1	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
STKS	STKS	NN	B-NP	O
:	:	:	O	O
sensitivity	sensitivity	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
;	;	:	O	O
specificity	specificity	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD1	CD1	NN	I-NP	O
IG	IG	NN	I-NP	O
flag	flag	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
STKS	STKS	NN	B-NP	O
:	:	:	O	O
sensitivity	sensitivity	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
:	:	:	O	O
specificity	specificity	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NRBC	NRBC	NNP	I-NP	O
flag	flag	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
STKS	STKS	NN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
;	;	:	O	O
specificity	specificity	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O

Like	Like	IN	B-PP	O
other	other	JJ	B-NP	O
IAPs	BEGIN-IAPs-INSIDE	NN	I-NP	B
,	,	,	O	O
ch	BEGIN-ch	NN	B-NP	B
-	-	HYPH	B-NP	I
IAP1	IAP1-INSIDE	NN	I-NP	I
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
N	BEGIN-N	NN	I-NP	B
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
baculovirus	baculovirus	NN	I-NP	I
IAP	IAP	NN	I-NP	I
repeats	repeats-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
RING	RING	NN	I-NP	O
finger	finger	NN	I-NP	O
motifs	motif	NNS	I-NP	O

As	As	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chicken	chicken	NN	I-NP	O
homologue	homologue	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
two	two	CD	B-NP	O
hPR	BEGIN-hPR-INSIDE	JJ	I-NP	B
forms	form	NNS	I-NP	O
,	,	,	I-NP	O
A	A	NN	I-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
originate	originate	VBP	B-VP	O
from	from	IN	B-PP	O
translational	translational	JJ	B-NP	O
initiation	initiation	NN	I-NP	O
at	at	IN	B-PP	O
AUG1	AUG1	NN	B-NP	O
(	(	(	O	O
codon	codon	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
AUG1	AUG1	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

A	A	DT	B-NP	O
biopsy	biopsy	NN	I-NP	O
specimen	specimen	NN	I-NP	O
taken	take	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
frontal	frontal	JJ	I-NP	O
branch	branch	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
superficial	superficial	JJ	I-NP	O
artery	artery	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
segmental	segmental	JJ	B-NP	O
intimal	intimal	JJ	I-NP	O
thickening	thickening	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
intimal	intimal	JJ	B-NP	O
fibroplasia	fibroplasia	NN	I-NP	O
type	type	NN	I-NP	O
FMD	FMD	NN	I-NP	O
upon	upon	IN	B-PP	O
histological	histological	JJ	B-NP	O
examination	examination	NN	I-NP	O

Serum	BEGIN-Serum	NN	B-NP	B
alkaline	alkaline	NN	I-NP	I
phosphatase	phosphatase-INSIDE	NN	I-NP	I
and	and	CC	O	O
creatine	BEGIN-creatine	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activities	activity	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
A	A	NN	I-NP	O
praelongus	praelongus	NN	I-NP	O
-	-	HYPH	O	O
fed	feed	VBN	B-NP	O
pigs	pig	NNS	I-NP	O
and	and	CC	O	O
significantly	significantly	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
in	in	IN	B-PP	O
Na1SeO1	Na1SeO1	NN	B-NP	O
-	-	HYPH	B-NP	O
fed	feed	VBN	I-NP	O
pigs	pig	NNS	I-NP	O

The	The	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
gamma	BEGIN-gamma	NN	B-NP	B
-	-	HYPH	B-NP	I
glutamyl	glutamyl	NN	I-NP	I
transpeptidase	transpeptidase-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
of	of	IN	B-PP	O
problem	problem	NN	B-NP	O
drinkers	drinker	NNS	I-NP	O

The	The	DT	B-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
monoamine	monoamine	NN	B-NP	O
metabolites	metabolite	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
hydroxyindoleacetic	hydroxyindoleacetic	JJ	I-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
HIAA	HIAA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
homovanillic	homovanillic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
HVA	HVA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
-	-	SYM	O	O
-	-	HYPH	O	O
tryptophan	tryptophan	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cerebrospinal	cerebrospinal	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O

Reduced	Reduce	VBN	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
upper	upper	JJ	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
complications	complication	NNS	I-NP	O
with	with	IN	B-PP	O
celecoxib	celecoxib	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
COX	BEGIN-COX	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O

Mutations	Mutation	NNS	B-NP	O
in	in	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
that	that	WDT	B-NP	O
block	block	VBP	B-VP	O
meiotic	meiotic	JJ	B-NP	O
prophase	prophase	NN	I-NP	O
chromosome	chromosome	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
and	and	CC	O	O
confer	confer	VB	B-VP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
arrest	arrest	NN	I-NP	O
at	at	IN	B-PP	O
pachytene	pachytene	NN	B-NP	O
identify	identify	VBP	B-VP	O
two	two	CD	B-NP	O
new	new	JJ	I-NP	O
meiosis	BEGIN-meiosis	NN	I-NP	B
-	-	HYPH	B-NP	I
specific	specific	JJ	I-NP	I
genes	gene	NNS	I-NP	I
SAE1	BEGIN-SAE1-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	O	O
SAE1	BEGIN-SAE1-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
transfer	transfer	NN	I-NP	O
by	by	IN	B-PP	O
conjugation	conjugation	NN	B-NP	O
to	to	TO	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
K1	K1	NN	I-NP	O
of	of	IN	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
and	and	CC	I-NP	O
carbenicillin	carbenicillin	NN	I-NP	O
resistance	resistance	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
strains	strain	NNS	I-NP	O
:	:	:	O	O
(	(	(	O	O
E.	E.	FW	B-ADVP	O
coli	coli	FW	I-ADVP	O
:	:	:	O	O
1	1	CD	B-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
freundii	freundii	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
,	,	,	O	O
K.	K.	NNP	B-NP	O
pneumoniae	pneumoniae	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
,	,	,	O	O
E.	E.	NNP	B-NP	O
cloacae	cloaca	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
stuartii	stuartii	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
)	)	)	O	O

Over	Over	IN	B-PP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
clone	clone	NN	I-NP	O
(	(	(	O	O
A1	A1	NN	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
IGS	IGS	NN	I-NP	O
length	length	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O

Following	Follow	VBG	B-PP	O
EGF	BEGIN-EGF-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
NGF	BEGIN-NGF-INSIDE	NN	I-NP	B
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	I-NP	I
CrkPC1	Crk-INSIDEPC1	NN	I-NP	I
cells	cell	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	B-NP	I
Crk	Crk-INSIDE	NN	I-NP	I
protein	protein	NN	I-NP	O
itself	itself	PRP	B-NP	O
became	become	VBD	B-VP	O
tyrosine	tyrosine	NN	B-ADJP	O
phosphorylated	phosphorylated	JJ	I-ADJP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O

After	After	IN	B-PP	O
nine	nine	CD	B-NP	O
months	month	NNS	I-NP	O
GFR	GFR	NN	I-NP	O
improved	improve	VBD	B-VP	O
spontaneously	spontaneously	RB	B-ADVP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
/	/	SYM	O	O
1	1	CD	B-NP	O
m1	m1	NN	I-NP	O
despite	despite	IN	B-PP	O
no	no	DT	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O

Insulin	BEGIN-Insulin-INSIDE	NN	B-NP	B
-	-	HYPH	B-PP	O
stimulated	stimulate	VBN	B-NP	O
autophosphorylation	autophosphorylation	NN	I-NP	O
at	at	IN	B-PP	O
specific	specific	JJ	B-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tyrosine	BEGIN-tyrosine	NN	I-NP	B
kinase	kinase	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
's	's	POS	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
subunit	subunit	NN	I-NP	O
is	be	VBZ	B-VP	O
correlated	correlate	VBN	I-VP	O
kinetically	kinetically	RB	B-ADVP	O
with	with	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
kinase	kinase	NN	B-NP	O
-	-	HYPH	O	O
catalyzed	catalyze	VBN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
substrate	substrate	NN	I-NP	O
(	(	(	O	O
reduced	reduce	VBN	B-VP	O
and	and	CC	O	O
carboxyamidomethylated	carboxyamidomethylate	VBN	B-NP	O
lysozyme	BEGIN-lysozyme-INSIDE	NN	I-NP	B
;	;	:	O	O
RCAM	BEGIN-RCAM	NN	B-NP	B
-	-	HYPH	I-NP	I
lysozyme	BEGIN-lysozyme-INSIDE-INSIDE	NN	I-NP	I
)	)	)	O	O

Likewise	Likewise	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	O
signal	signal	NN	I-NP	O
believed	believe	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
terminating	terminate	VBG	B-VP	O
VV	BEGIN-VV	NN	B-NP	B
early	early	JJ	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
,	,	,	O	O
TTTTTNT	TTTTTNT	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
boundary	boundary	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
N1	N1	NN	I-NP	O
and	and	CC	I-NP	O
M1	M1	NN	I-NP	O
ORFs	ORF	NNS	I-NP	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
VV	BEGIN-VV	JJ	B-NP	B
early	early	JJ	I-NP	I
genes	gene-INSIDE	NNS	I-NP	I

Enzymatic	Enzymatic	JJ	B-NP	O
and	and	CC	I-NP	O
chemical	chemical	JJ	I-NP	O
structure	structure	NN	I-NP	O
probing	probing	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
mainly	mainly	RB	B-ADVP	O
the	the	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
terminal	terminal	JJ	I-NP	O
part	part	NN	I-NP	O
(	(	(	O	O
termed	term	VBN	B-VP	O
1'C	1'C	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DI1c	DI1c	NN	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
UTR	UTR	NN	I-NP	O
containing	contain	VBG	B-VP	O
distinctive	distinctive	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
stem	stem	NN	I-NP	O
-	-	HYPH	O	O
loop	loop	NN	B-NP	O
,	,	,	O	O
SL	SL	NN	B-NP	O
I	I	NN	I-NP	O
,	,	,	O	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
terminus	terminus	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
considerably	considerably	RB	I-NP	O
less	less	RBR	I-NP	O
stable	stable	JJ	I-NP	O
stem	stem	NN	I-NP	O
-	-	HYPH	O	O
loop	loop	NN	B-NP	O
,	,	,	O	O
SL	SL	NN	B-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
forms	form	VBZ	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
1'C	1'C	NN	B-NP	O

Attention	Attention	NN	B-NP	O
is	be	VBZ	B-VP	O
devoted	devote	VBN	I-VP	O
in	in	IN	B-PP	O
particular	particular	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
thermoregulating	thermoregulate	VBG	B-VP	O
nervous	nervous	JJ	B-NP	O
and	and	CC	I-NP	O
hormonal	hormonal	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O

ES	ES	NN	B-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
erythroid	erythroid	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
GATA	BEGIN-GATA	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
disrupted	disrupt	VBN	I-VP	O
fail	fail	VBP	B-VP	O
to	to	TO	I-VP	O
produce	produce	VB	I-VP	O
mature	mature	JJ	B-NP	O
erythroid	erythroid	JJ	I-NP	O
cells	cell	NNS	I-NP	O
either	either	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
or	or	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

Acidic	Acidic	JJ	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
gene	BEGIN-gene	JJ	B-NP	B
1	1	CD	I-NP	I
protein	protein	NN	I-NP	I
of	of	IN	B-PP	I
bacteriophage	bacteriophage	NN	B-NP	I
T1	T1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
protein	protein	NN	B-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
interactions	interaction	NNS	I-NP	O

They	They	PRP	B-NP	O
encode	encode	VBP	B-VP	O
proteins	protein	NNS	B-NP	O
whose	whose	WP$	B-NP	O
core	core	NN	I-NP	O
regions	region	NNS	I-NP	O
display	display	VBP	B-VP	O
great	great	JJ	B-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
Aspergillus	BEGIN-Aspergillus	JJ	B-NP	B
HAPB	HAPB-INSIDE	NN	I-NP	I
,	,	,	O	O
HAPC	BEGIN-HAPC-INSIDE	NN	B-NP	B
and	and	CC	O	O
HAPE	BEGIN-HAPE-INSIDE	NN	B-NP	B
and	and	CC	B-PP	O
to	to	TO	B-PP	O
known	know	VBN	B-NP	O
HAP	BEGIN-HAP	NN	I-NP	B
homologs	homologs-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
organisms	organism	NNS	I-NP	O

Three	Three	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
positions	position	NNS	I-NP	O
are	be	VBP	B-VP	O
novel	novel	JJ	B-ADJP	O
in	in	IN	B-SBAR	O
that	that	IN	I-SBAR	O
they	they	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
binding	bind	VBG	B-VP	O
PC	PC	NN	B-NP	O
by	by	IN	B-PP	O
previous	previous	JJ	B-NP	O
crystallographic	crystallographic	JJ	I-NP	O
analysis	analysis	NN	I-NP	O

Three	Three	CD	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
control	control	NN	I-NP	O
elements	element	NNS	I-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
flanking	flank	VBG	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	BEGIN-rat	NN	I-NP	B
glucagon	BEGIN-glucagon-INSIDE	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
regulatory	regulatory	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
and	and	CC	O	O
direct	direct	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
glucagon	BEGIN-glucagon-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
producing	produce	VBG	B-VP	O
islet	islet	NN	B-NP	O
cells	cell	NNS	I-NP	O

Fusion	Fusion	NN	B-NP	O
proteins	protein	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
by	by	IN	B-PP	O
affinity	affinity	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
on	on	IN	B-PP	O
APTG	APTG	NN	B-NP	O
-	-	HYPH	O	O
Sepharose	Sepharose	NN	B-NP	O

(	(	(	B-LST	O
1m	1m	LS	I-LST	O
)	)	)	O	O
Tc	Tc	NN	B-NP	O
Ethyl	Ethyl	NN	I-NP	O
Cysteinate	Cysteinate	NN	I-NP	O
Dimer	Dimer	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
during	during	IN	B-PP	O
1h	1h	NN	B-NP	O
has	have	VBZ	B-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
ictal	ictal	JJ	B-NP	O
studies	study	NNS	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
location	location	NN	I-NP	O
of	of	IN	B-PP	O
partial	partial	JJ	B-NP	O
seizure	seizure	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
propolis	propolis	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
mouthrinse	mouthrinse	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
de	de	FW	B-NP	O
novo	novo	FW	I-NP	O
plaque	plaque	NN	I-NP	O
formation	formation	NN	I-NP	O
are	be	VBP	B-VP	O
presented	present	VBN	I-VP	O

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
Myc	BEGIN-Myc-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
action	action	NN	I-NP	O
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
CDK1	BEGIN-CDK1-INSIDE	NN	I-NP	B
,	,	,	O	O
and	and	CC	O	O
occurs	occur	VBZ	B-VP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
neutralization	neutralization	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
(	(	(	O	O
Kip1	KiBEGIN-p1-INSIDE	NN	B-NP	I
)	)	)	O	O
family	family	NN	B-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
Cdc1A	BEGIN-Cdc1A-INSIDE	NN	B-NP	B

A	A	DT	B-NP	O
less	less	RBR	I-NP	O
common	common	JJ	I-NP	O
and	and	CC	O	O
much	much	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
perplexing	perplexing	JJ	B-NP	O
circumstance	circumstance	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
when	when	WRB	B-ADVP	O
evaluating	evaluate	VBG	B-VP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
sarcoidosis	sarcoidosis	NN	B-NP	O
established	establish	VBN	B-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
years	year	NNS	I-NP	O
present	present	JJ	B-ADJP	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
or	or	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O

The	The	DT	B-NP	O
training	training	NN	I-NP	O
programs	program	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
/	/	SYM	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
motor	motor	NN	I-NP	O
-	-	HYPH	O	O
driven	drive	VBN	B-VP	O
treadmill	treadmill	NN	B-NP	O

(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
J	J	.	O	O

The	The	DT	B-NP	O
avian	avian	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
virus	virus	NN	I-NP	O
MH1	MH1	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
hybrid	hybrid	NN	I-NP	O
gene	gene	NN	I-NP	O
delta	BEGIN-delta	NN	I-NP	B
gag	gag-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
mht	BEGIN-mht-INSIDE	NN	I-NP	B
with	with	IN	B-PP	O
a	a	DT	B-NP	O
contiguous	contiguous	JJ	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	I-NP	I
myc	myc-INSIDE	NN	I-NP	I
and	and	CC	O	O
avian	avian	JJ	B-NP	O
helper	helper	NN	I-NP	O
virus	virus	NN	I-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
sequences.	sequences.	NN	I-NP	O
delta	BEGIN-delta	NN	I-NP	B
gag	gag-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
partial	partial	JJ	I-NP	O
retroviral	BEGIN-retroviral	JJ	I-NP	B
core	core	NN	I-NP	I
protein	protein	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
while	while	IN	B-SBAR	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	B-NP	I
mht	BEGIN-mht-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	O	I
myc	myc-INSIDE	NN	B-NP	I
are	be	VBP	B-VP	O
cell	cell	NN	B-NP	O
-	-	HYPH	O	O
drived	drive	VBN	B-VP	O
sequences	sequence	NNS	B-NP	O

The	The	DT	B-NP	O
DW	DW	NNP	I-NP	O
directions	direction	NNS	I-NP	O
uniformly	uniformly	RB	B-ADVP	O
sampled	sample	VBD	B-VP	O
the	the	DT	B-NP	O
diffusion	diffusion	NN	I-NP	O
ellipsoid	ellipsoid	NN	I-NP	O
surface	surface	NN	I-NP	O

The	The	DT	B-NP	O
recent	recent	JJ	I-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
bioartificial	bioartificial	JJ	I-NP	O
organ	organ	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
such	such	JJ	B-NP	O
disadvantages	disadvantage	NNS	I-NP	O

The	The	DT	B-NP	O
pressure	pressure	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
under	under	IN	B-PP	O
steady	steady	JJ	B-NP	O
flow	flow	NN	I-NP	O
conditions	condition	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
performance	performance	NN	I-NP	O
(	(	(	O	O
including	include	VBG	B-PP	O
pressure	pressure	NN	B-NP	O
gradient	gradient	NN	I-NP	O
and	and	CC	O	O
effective	effective	JJ	B-NP	O
orifice	orifice	NN	I-NP	O
area	area	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
SPAB	SPAB	NN	B-NP	O
is	be	VBZ	B-VP	O
superior	superior	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
stented	stented	JJ	I-NP	O
counterpart	counterpart	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
smaller	small	JJR	I-NP	O
sizes	size	NNS	I-NP	O

Recent	Recent	JJ	B-NP	O
,	,	,	I-NP	O
highly	highly	RB	I-NP	O
visible	visible	JJ	I-NP	O
reviews	review	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
subject	subject	NN	I-NP	O
have	have	VBP	B-VP	O
clearly	clearly	RB	I-VP	O
pointed	point	VBN	I-VP	O
out	out	RP	B-PRT	O
that	that	IN	B-SBAR	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
through	through	IN	B-PP	O
which	which	WDT	B-NP	O
inhaled	inhale	VBD	B-VP	O
asbestos	asbestos	NN	B-NP	O
fibers	fiber	NNS	I-NP	O
cause	cause	VBP	B-VP	O
the	the	DT	B-NP	O
well	well	RB	I-NP	O
known	know	VBN	I-NP	O
,	,	,	O	O
debilitating	debilitate	VBG	B-VP	O
lung	lung	NN	B-NP	O
disease	disease	NN	I-NP	O
-	-	HYPH	O	O
asbestosis	asbestosis	NN	B-NP	O
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
interstitial	interstitial	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
)	)	)	O	O

During	During	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
salmon	BEGIN-salmon	JJ	B-NP	B
calcitonin	calcitonin-INSIDE	NN	I-NP	I
,	,	,	O	O
alkaline	BEGIN-alkaline	NN	B-NP	B
phosphatase	phosphatase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
and	and	CC	O	O
urinary	urinary	JJ	B-NP	O
hydroxyproline	hydroxyproline	NN	I-NP	O
excretion	excretion	NN	I-NP	O
decrease	decrease	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
average	average	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Paget	Paget	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O

Cerebral	Cerebral	JJ	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
iv	iv	JJ	I-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
Xe	Xe	NN	I-NP	O
CBF	CBF	NN	I-NP	O
determination	determination	NN	I-NP	O
and	and	CC	I-NP	O
AVDO1	AVDO1	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
using	use	VBG	B-VP	O
systemic	systemic	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
-	-	HYPH	I-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
content	content	NN	I-NP	O
differences	difference	NNS	I-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
FNCAT	BEGIN-FNCAT-INSIDE	NN	B-NP	B
increased	increase	VBD	B-VP	O
on	on	IN	B-PP	O
serum	serum	NN	B-NP	O
treatment	treatment	NN	I-NP	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
FN	BEGIN-FN	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
between	between	IN	B-PP	O
positions	position	NNS	B-NP	O
+1	+1	CD	B-NP	O
and	and	CC	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
mediated	mediate	VBD	B-VP	O
serum	serum	NN	B-NP	O
responsiveness	responsiveness	NN	I-NP	O

Gallstone	Gallstone	NN	B-NP	O
-	-	HYPH	I-NP	O
formation	formation	NN	I-NP	O
has	have	VBZ	B-VP	O
traditionally	traditionally	RB	I-VP	O
been	be	VBN	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
supersaturation	supersaturation	NN	B-NP	O
of	of	IN	B-PP	O
bile	bile	NN	B-NP	O
with	with	IN	B-PP	O
cholesterol	cholesterol	NN	B-NP	O

Possible	Possible	JJ	B-NP	O
consequences	consequence	NNS	I-NP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
binder	binder	NN	I-NP	O
distribution	distribution	NN	I-NP	O
through	through	IN	B-PP	O
powder	powder	NN	B-NP	O
aggregates	aggregate	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O

Bile	Bile	NN	B-NP	O
salts	salt	NNS	I-NP	O
,	,	,	O	O
hormonal	hormonal	JJ	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
male	male	NN	I-NP	O
disadvantage	disadvantage	NN	I-NP	O

The	The	DT	B-NP	O
fusion	fusion	NN	I-NP	O
gene	gene	NN	I-NP	O
cassette	cassette	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
vaccinia	BEGIN-vaccinia	NNP	I-NP	B
virus	virus	NN	I-NP	I
early	early	JJ	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
and	and	CC	O	O
cloned	clone	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
host	host	NN	I-NP	O
-	-	HYPH	B-NP	O
restricted	restrict	VBN	I-NP	O
fowlpox	fowlpox	NN	I-NP	O
viral	viral	JJ	I-NP	O
vector	vector	NN	I-NP	O

We	We	PRP	B-NP	O
describe	describe	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
stat	BEGIN-stat	NN	I-NP	B
-	-	HYPH	B-NP	I
related	relate	VBN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
EGF	BEGIN-EGF-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
A1	A1	NN	I-NP	O
cell	cell	NN	I-NP	O
extracts	extract	NNS	I-NP	O
but	but	CC	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
absent	absent	JJ	B-ADJP	O
in	in	IN	B-PP	O
bovine	BEGIN-bovine	JJ	B-NP	B
fibroblast	fibroblast	NN	I-NP	I
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
bFGF	BEGIN-bFGF-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
IFN	BEGIN-IFN	NN	B-NP	B
-	-	HYPH	O	I
gamma	gamma-INSIDE	NN	B-NP	I
,	,	,	O	O
tumor	BEGIN-tumor	NN	B-NP	B
necrosis	necrosis	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	O	I
alpha	alpha-INSIDE	NN	B-NP	I
(	(	(	O	O
TNF	BEGIN-TNF	NN	B-NP	B
-	-	HYPH	B-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
untreated	untreated	JJ	B-NP	O
cells.	cells.	NNS	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
antigenically	antigenically	RB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
stat1.	BEGIN-stat1-INSIDE.	NN	B-NP	I
p1c	BEGIN-p1-INSIDEc	NN	I-NP	I
-	-	HYPH	B-VP	O
neu+	BEGIN-neu-INSIDE+	JJ	B-ADJP	I
,	,	,	O	O
EGFr+	BEGIN-EGF-INSIDEr+	JJ	B-ADJP	I
(	(	(	O	O
M1	BEGIN-M1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
p1c	BEGIN-p1-INSIDEc	NN	B-NP	I
-	-	HYPH	B-NP	O
neu	BEGIN-neu-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
kinase	kinase	NN	I-NP	O
inactive	inactive	JJ	B-ADJP	O
,	,	,	O	O
EGFr+	BEGIN-EGF-INSIDEr+	JJ	B-ADJP	I
(	(	(	O	O
NEN1	BEGIN-NEN1-INSIDE	NN	B-NP	B
)	)	)	O	O
expressing	expressing	NN	B-NP	O
cells	cell	NNS	I-NP	O
undergo	undergo	VBP	B-VP	O
different	different	JJ	B-NP	O
mitotic	mitotic	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-VP	O
EGF	BEGIN-EGF-INSIDE	VB	I-VP	B

MRI	MRI	NN	B-NP	O
measurements	measurement	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O

Phosphorylation	Phosphorylation	NN	B-NP	O
by	by	IN	B-PP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	B-NP	B
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anaphase	anaphase	NN	I-NP	O
-	-	HYPH	O	O
promoting	promote	VBG	B-VP	O
complex	complex	NN	B-NP	O

Phosphorylated	Phosphorylate	VBN	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
residues	residue	NNS	I-NP	O
were	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
sequencing	sequence	VBG	B-VP	O
the	the	DT	B-NP	O
separated	separate	VBN	I-NP	O
phosphopeptides	phosphopeptide	NNS	I-NP	O
by	by	IN	B-PP	O
matrix	matrix	NN	B-NP	O
assisted	assisted	JJ	I-NP	O
laser	laser	NN	I-NP	O
desorption	desorption	NN	I-NP	O
ionization	ionization	NN	I-NP	O
mass	mass	NN	I-NP	O
spectrometry	spectrometry	NN	I-NP	O
(	(	(	O	O
MALDI	MALDI	NN	B-NP	O
-	-	HYPH	B-NP	O
MS	MS	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Edman	Edman	NN	B-NP	O
degradation	degradation	NN	I-NP	O

Superovulation	Superovulation	NN	B-NP	O
with	with	IN	B-PP	O
intrauterine	intrauterine	JJ	B-NP	O
insemination	insemination	NN	I-NP	O
(	(	(	O	O
SO	SO	NN	B-NP	O
-	-	HYPH	B-NP	O
IUI	IUI	NN	I-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
alternative	alternative	NN	I-NP	O
to	to	TO	B-VP	O
gamete	gamete	VB	I-VP	O
intrafallopian	intrafallopian	JJ	B-NP	O
transfer	transfer	NN	I-NP	O
(	(	(	O	O
GIFT	GIFT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
controlled	controlled	JJ	B-NP	O
or	or	CC	I-NP	O
comparative	comparative	JJ	I-NP	O
trials	trial	NNS	I-NP	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
elements	element	NNS	I-NP	O
resembles	resemble	VBZ	B-VP	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
identified	identify	VBN	I-NP	O
cellular	cellular	JJ	I-NP	O
``	``	``	I-NP	O
transcription	transcription	NN	I-NP	O
''	''	''	I-NP	O
factor	factor	NN	I-NP	O

The	The	DT	B-NP	O
Rep1	BEGIN-Rep1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
adeno	adeno	AFX	B-NP	O
-	-	HYPH	I-NP	O
associated	associate	VBN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
AAV	AAV	NN	B-NP	O
)	)	)	O	O
contains	contain	VBZ	B-VP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
motifs	motif	NNS	I-NP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
rolling	BEGIN-rolling	JJ	B-NP	B
-	-	HYPH	I-NP	I
circle	circle	NN	I-NP	I
replication	replication	NN	I-NP	I
(	(	(	O	I
RCR	RCR	NN	B-NP	I
)	)	)	O	I
initiator	initiator	NN	B-NP	I
proteins	proteins-INSIDE	NN	I-NP	I

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
cell	cell	NN	I-NP	O
counts	count	NNS	I-NP	O
and	and	CC	O	O
interview	interview	NN	B-NP	O
data	datum	NNS	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
survey	survey	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
adult	adult	JJ	I-NP	O
patients	patient	NNS	I-NP	O
attending	attend	VBG	B-VP	O
a	a	DT	B-NP	O
community	community	NN	I-NP	O
hospital	hospital	NN	I-NP	O
-	-	HYPH	B-NP	O
based	base	VBN	I-NP	O
HIV	HIV	NN	I-NP	O
outpatient	outpatient	NN	I-NP	O
clinic	clinic	NN	I-NP	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
1	1	CD	B-NP	O
determinations	determination	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glucose	glucose	NN	I-NP	O
from	from	IN	B-PP	O
sinigrin	sinigrin	NN	B-NP	O
,	,	,	O	O
analyzed	analyze	VBN	B-VP	O
under	under	IN	B-PP	O
different	different	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
accuracy	accuracy	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
glucosinolate	glucosinolate	NN	I-NP	O
determination	determination	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O

Transcriptional	Transcriptional	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
cluster	cluster	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
by	by	IN	B-PP	O
detecting	detect	VBG	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
mRNAs	mRNA	NNS	B-NP	O
spanning	span	VBG	B-VP	O
adjacent	adjacent	JJ	B-NP	O
genes	gene	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
promoterless	promoterless	JJ	I-NP	O
lacZ	BEGIN-lacZ	NN	I-NP	B
reporter	reporter	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
seven	seven	CD	I-NP	O
genes	gene	NNS	I-NP	O
contained	contain	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tol	BEGIN-tol-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
oprL	BEGIN-oprL-INSIDE	NN	I-NP	B
locus	locus	NN	I-NP	O

The	The	DT	B-NP	O
regions	region	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
mature	mature	JJ	I-NP	O
proteinases	proteinas	NNS	I-NP	O
were	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
into	into	IN	B-PP	O
an	an	DT	B-NP	O
expression	expression	NN	I-NP	O
vector	vector	NN	I-NP	O
and	and	CC	O	O
recombinant	recombinant	JJ	B-NP	O
protein	protein	NN	I-NP	O
produced	produce	VBN	B-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O

H	H	NN	B-NP	O

Rhinovirus	BEGIN-Rhinovirus	NN	B-NP	B
1A	1A	NN	I-NP	I
protease	protease-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
foot	BEGIN-foot	NN	I-NP	B
-	-	HYPH	B-NP	I
and	and	CC	I-NP	I
-	-	HYPH	I-NP	I
mouth	mouth	NN	I-NP	I
-	-	HYPH	I-NP	I
disease	disease	NN	I-NP	I
virus	virus	NN	I-NP	I
L	L	NN	I-NP	I
protease	protease-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
eIF1G	BEGIN-BEGIN-eIF1-INSIDEG-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
eIF1A	BEGIN-BEGIN-eIF1-INSIDEA-INSIDE	NN	B-NP	B
,	,	,	O	O
eIF1E	BEGIN-BEGIN-eIF1-INSIDEE-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
eIF1	BEGIN-eIF1-INSIDE	NN	B-NP	B

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Two	Two	CD	B-NP	O
patients	patient	NNS	I-NP	O
developed	develop	VBD	B-VP	O
cervical	cervical	JJ	B-NP	O
myelopathy	myelopathy	NN	I-NP	O
or	or	CC	I-NP	O
radiculopathy	radiculopathy	NN	I-NP	O
after	after	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
manipulation	manipulation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
magnetic	magnetic	JJ	B-NP	O
resonance	resonance	NN	I-NP	O
imaging	imaging	NN	I-NP	O
showed	show	VBD	B-VP	O
herniated	herniate	VBN	I-VP	O
cervical	cervical	JJ	B-NP	O
discs	disc	NNS	I-NP	O
at	at	IN	B-PP	O
C1	C1	NN	B-NP	O
-	-	HYPH	B-NP	O
C1	C1	NN	I-NP	O
and	and	CC	I-NP	O
C1	C1	NN	I-NP	O
-	-	HYPH	O	O
C1	C1	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

This	This	DT	B-NP	O
increased	increase	VBN	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
significant	significant	JJ	B-NP	O
excess	excess	JJ	I-NP	O
mortality	mortality	NN	I-NP	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
repeating	repeat	VBG	I-NP	O
domains	domain	NNS	I-NP	O
(	(	(	O	O
Yheb1	BEGIN-Yheb1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
chromosome	chromosome	NN	I-NP	O
and	and	CC	O	O
purified	purify	VBN	B-VP	O
by	by	IN	B-PP	O
metal	metal	NN	B-NP	O
chelating	chelate	VBG	B-VP	O
chromatography	chromatography	NN	B-NP	O

Assessment	Assessment	NN	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
anion	anion	NN	I-NP	O
-	-	HYPH	B-NP	O
exchange	exchange	NN	I-NP	O
resins	resin	NNS	I-NP	O
for	for	IN	B-PP	O
direct	direct	JJ	B-NP	O
use	use	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
screening	screening	NN	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
porphobilinogen	porphobilinogen	NN	I-NP	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
define	define	VBP	B-VP	O
a	a	DT	B-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
elements	element	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mode	mode	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
heretofore	heretofore	RB	I-VP	O
described	describe	VBN	I-VP	O

Using	Use	VBG	B-VP	O
lacZ	BEGIN-lacZ-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
probe	probe	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
screened	screen	VBD	B-VP	O
a	a	DT	B-NP	O
splenic	splenic	JJ	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
in	in	IN	B-PP	O
transiently	transiently	RB	B-NP	O
transfected	transfecte	VBN	I-NP	O
antigen	antigen	NN	I-NP	O
-	-	HYPH	O	O
presenting	present	VBG	B-VP	O
cells	cell	NNS	B-NP	O
(	(	(	O	O
APCs	APC	NNS	B-NP	O
)	)	)	O	O
and	and	CC	O	O
isolated	isolate	VBN	B-VP	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
clone	clone	NN	I-NP	O
that	that	WDT	B-NP	O
allowed	allow	VBD	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
peptide	BEGIN-peptide	NN	I-NP	B
/	/	SYM	B-NP	I
Kb	Kb	NN	I-NP	I
MHC	MHC	NN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
APC	APC	NN	B-NP	O

This	This	DT	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	BEGIN-immunoglobulin	NN	B-NP	B
A	A-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
,	,	,	O	O
consequently	consequently	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
resistance	resistance	NN	I-NP	O
against	against	IN	B-PP	O
infections	infection	NNS	B-NP	O

A	A	DT	B-NP	O
previously	previously	RB	I-NP	O
developed	develop	VBN	I-NP	O
kinetic	kinetic	JJ	I-NP	O
model	model	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
major	major	JJ	B-NP	O
chemical	chemical	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
involving	involve	VBG	B-VP	O
PAH	PAH	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afterburner	afterburner	NN	I-NP	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
-	-	HYPH	O	I
activated	activate	VBN	B-VP	I
kinase	kinase-INSIDE	NN	B-NP	I
(	(	(	O	O
PAK	BEGIN-PAK-INSIDE	NN	B-NP	B
)	)	)	O	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
Gbeta	Gbeta	NN	I-NP	I
-	-	HYPH	B-NP	I
like	like-INSIDE	NN	I-NP	I
WD	WD	JJ	I-NP	O
-	-	HYPH	I-NP	O
repeat	repeat	NN	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
hPIP1	BEGIN-hPIP1-INSIDE	NN	B-NP	B

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
requires	require	VBZ	B-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
host	host	NN	B-NP	O
cell	cell	NN	I-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
to	to	TO	B-PP	O
cis	cis	JJ	B-NP	O
elements	element	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proviral	proviral	JJ	I-NP	O
long	long	JJ	I-NP	O
terminal	terminal	JJ	I-NP	O
repeat	repeat	NN	I-NP	O
(	(	(	O	O
LTR	LTR	NN	B-NP	O
)	)	)	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
ratios	ratio	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
areas	area	NNS	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
concentration	concentration	NN	I-NP	O
-	-	HYPH	O	O
time	time	NN	B-NP	O
curves	curve	NNS	I-NP	O
in	in	IN	B-PP	O
CSF	CSF	NN	B-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
penetration	penetration	NN	I-NP	O
of	of	IN	B-PP	O
rifampicin	rifampicin	NN	B-NP	O
into	into	IN	B-PP	O
CSF	CSF	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
median	median	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

Adaptability	Adaptability	NN	B-NP	O
of	of	IN	B-PP	O
Nippostrongylus	Nippostrongylus	NN	B-NP	O
brasiliensis	brasiliensis	NN	I-NP	O
(	(	(	O	O
Travassos	Travassos	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
lead	lead	VB	I-VP	O
contamination	contamination	NN	B-NP	O

In	In	IN	B-PP	O
early	early	JJ	B-NP	O
midgestation	midgestation	NN	I-NP	O
embryos	embryo	NNS	I-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
telencephalic	telencephalic	JJ	B-NP	O
,	,	,	I-NP	O
diencephalic	diencephalic	JJ	I-NP	O
and	and	CC	I-NP	O
mesencephalic	mesencephalic	JJ	I-NP	O
regions	region	NNS	I-NP	O
but	but	CC	B-PP	O
from	from	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
gestation	gestation	NN	B-NP	O
its	its	PRP$	B-NP	O
expression	expression	NN	I-NP	O
disappears	disappear	VBZ	B-VP	O
from	from	IN	B-PP	O
dorsal	dorsal	JJ	B-NP	O
telencephalon	telencephalon	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
confined	confine	VBN	I-VP	O
to	to	TO	B-PP	O
diencephalic	diencephalic	JJ	B-NP	O
and	and	CC	I-NP	O
mesencephalic	mesencephalic	JJ	I-NP	O
regions	region	NNS	I-NP	O

A	A	DT	B-NP	O
child	child	NN	I-NP	O
presumed	presume	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	I-NP	I
hydroxylase	hydroxylase-INSIDE	NN	I-NP	I
deficiency	deficiency	NN	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
congenital	congenital	JJ	B-NP	O
adrenal	adrenal	JJ	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
extensively	extensively	RB	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
infant	infant	NN	I-NP	O

The	The	DT	B-NP	O
size	size	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
protein	protein	NN	I-NP	O
were	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
experimentally	experimentally	RB	B-ADVP	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
Nopp1	BEGIN-Nopp1-INSIDE	NN	B-NP	B
binds	bind	VBZ	B-VP	O
primarily	primarily	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CK1	BEGIN-CK1	NN	I-NP	B
regulatory	regulatory	JJ	I-NP	I
subunit	subunit	NN	I-NP	I
,	,	,	O	I
beta	beta-INSIDE	NN	B-NP	I

Further	Further	RB	B-ADVP	O
,	,	,	O	O
more	more	RBR	B-NP	O
recent	recent	JJ	I-NP	O
communications	communication	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
liver	liver	NN	B-NP	O
disease	disease	NN	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
differential	differential	JJ	I-NP	O
alteration	alteration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytochrome	BEGIN-cytochrome	NN	I-NP	B
P	P	NN	I-NP	I
-	-	HYPH	B-NP	I
1s	1s-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
protein	protein	NN	B-NP	O
content	content	NN	I-NP	O
and	and	CC	O	O
activity	activity	NN	B-NP	O

A	A	DT	B-NP	O
constructed	construct	VBN	I-NP	O
phylogenetic	phylogenetic	JJ	I-NP	O
tree	tree	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
UbcP1	BEGIN-UbcP1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
subfamily	subfamily	NN	I-NP	O
of	of	IN	B-PP	O
E1s	BEGIN-E1s-INSIDE	NN	B-NP	B

Isolates	Isolate	NNS	B-NP	O
of	of	IN	B-PP	O
B.	B.	NNP	B-NP	O
burgdorferi	burgdorferi	NNP	I-NP	O
from	from	IN	B-PP	O
humans	human	NNS	B-NP	O
,	,	,	O	O
rodents	rodent	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
I.	I.	NNP	B-NP	O
dammini	dammini	NNS	I-NP	O
are	be	VBP	B-VP	O
usually	usually	RB	B-ADVP	O
indistinguishable	indistinguishable	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
strains	strain	NNS	B-NP	O
of	of	IN	B-PP	O
B.	B.	FW	B-NP	O
burgdorferi	burgdorferi	FW	I-NP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
major	major	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O

Alignment	Alignment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	BEGIN-rat	NNP	I-NP	B
and	and	CC	O	I
human	human	JJ	B-NP	I
WIN	WIN	NN	I-NP	I
cDNAs	cDNAs-INSIDE	NN	I-NP	I
and	and	CC	O	O
their	their	PRP$	B-NP	O
comparison	comparison	NN	I-NP	O
with	with	IN	B-PP	O
mouse	mouse	NN	B-NP	O
genomic	genomic	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
WIN	BEGIN-WIN	NN	I-NP	B
DNA	DNA	NN	I-NP	I
binding	binding	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
four	four	CD	B-NP	O
exons	exon	NNS	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
(	(	(	O	O
exons	exon	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
alternatively	alternatively	RB	I-VP	O
spliced	splice	VBN	I-VP	O
to	to	TO	I-VP	O
generate	generate	VB	I-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
three	three	CD	I-NP	O
classes	class	NNS	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	O
transcripts	transcript	NNS	I-NP	O

1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
mgs	mg	NNS	I-NP	O
of	of	IN	B-PP	O
hyoscine	hyoscine	NN	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
butyl	butyl	NN	I-NP	O
bromide	bromide	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
1	1	CD	I-NP	O
mgs	mg	NNS	I-NP	O
propinoxate	propinoxate	NN	I-NP	O
,	,	,	O	O
i.v.	i.v.	JJ	B-ADJP	O
plus	plus	CC	O	O
diazepam	diazepam	NN	B-NP	O

The	The	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
plasminogen	BEGIN-plasminogen	NN	B-NP	B
activator	activator-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
tissue	tissue	NN	B-NP	O
sections	section	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
aid	aid	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
Todd	Todd	NN	I-NP	O
technique	technique	NN	I-NP	O

These	These	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
were	be	VBD	B-VP	O
further	further	RB	I-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
enhancer	enhancer	NN	I-NP	O
element	element	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
a	a	DT	B-NP	O
fusion	fusion	NN	I-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CAT	BEGIN-CAT	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
gamma	BEGIN-gamma	NN	I-NP	B
-	-	HYPH	B-NP	I
globin	globin	NN	I-NP	I
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
in	in	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	O
(	(	(	O	O
K1	K1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
non	non	AFX	O	O
-	-	HYPH	O	O
erythroid	erythroid	JJ	O	O
(	(	(	O	O
HeLa	HeLa	NN	B-NP	O
)	)	)	I-NP	O
cells	cell	NNS	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
IgM	BEGIN-IgM	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
B	B	NN	I-NP	O
cells	cell	NNS	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
transactivation	transactivation	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
enhancer	enhancer	NN	I-NP	O

DESIGN	DESIGN	NN	B-NP	O
,	,	,	I-NP	O
SETTING	SETTING	NN	I-NP	O
AND	AND	CC	I-NP	O
SUBJECTS	SUBJECTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
analysis	analysis	NN	I-NP	O
is	be	VBZ	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
data	datum	NNS	B-NP	O
collected	collect	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
two	two	CD	I-NP	O
rounds	round	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nationally	nationally	RB	I-NP	O
representative	representative	JJ	I-NP	O
Ghana	Ghana	NNP	I-NP	O
Living	Living	NNP	I-NP	O
Standards	Standards	NNP	I-NP	O
Survey	Survey	NNP	I-NP	O
,	,	,	O	O
held	hold	VBN	B-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
GLSS	GLSS	NN	B-NP	O
-	-	HYPH	B-NP	O
I	I	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
GLSS	GLSS	NN	B-NP	O
-	-	HYPH	O	O
II	II	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
both	both	DT	B-NP	O
surveys	survey	NNS	I-NP	O
covering	cover	VBG	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
households	household	NNS	I-NP	O

Genetic	Genetic	JJ	B-NP	O
and	and	CC	I-NP	O
physiological	physiological	JJ	I-NP	O
experiments	experiment	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
close	close	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
cdc1+	BEGIN-cdc1+-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
cdc1+	BEGIN-BEGIN-cdc1+-INSIDE	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
mitosis	mitosis	NN	B-NP	O
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
higher	high	JJR	B-NP	O
eukaryotic	eukaryotic	JJ	I-NP	O
cells	cell	NNS	I-NP	O

Association	Association	NN	B-NP	O
of	of	IN	B-PP	O
Syk	BEGIN-Syk-INSIDE	NN	B-NP	B
protein	BEGIN-protein	NN	I-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
PTK	BEGIN-PTK-INSIDE	NN	B-NP	B
)	)	)	O	O
with	with	IN	B-PP	O
LMP1A	BEGIN-LMP1A-INSIDE	NN	B-NP	B
occurs	occur	VBZ	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
tyrosines	tyrosine	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LMP1A	BEGIN-BEGIN-LMP1A-INSIDE	NN	I-NP	B
immunoreceptor	immunoreceptor-INSIDE	NN	I-NP	I
tyrosine	tyrosine	NN	I-NP	O
-	-	HYPH	B-VP	O
based	base	VBN	B-NP	O
activation	activation	NN	I-NP	O
motif	motif	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
hypothesized	hypothesize	VBN	I-VP	O
that	that	IN	B-SBAR	O
Lyn	BEGIN-Lyn-INSIDE	NN	B-NP	B
PTK	BEGIN-PTK-INSIDE	NN	I-NP	B
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
YEEA	YEEA	NN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
motif	motif	NN	I-NP	O
at	at	IN	B-PP	O
LMP1A	BEGIN-LMP1A-INSIDE	NN	B-NP	B
tyrosine	tyrosine	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
Y1	Y1	NN	B-NP	O
)	)	)	O	O

Theoretical	Theoretical	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
hyperuricemia	hyperuricemia	NN	B-NP	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
relative	relative	JJ	B-NP	O
biological	biological	JJ	I-NP	O
effects	effect	NNS	I-NP	O
(	(	(	O	O
RBE	RBE	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
straight	straight	JJ	I-NP	O
line	line	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
by	by	IN	B-PP	O
modifying	modify	VBG	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
least	least	JJS	B-NP	O
squares	square	VBZ	B-VP	O
the	the	DT	B-NP	O
curves	curve	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
anomalous	anomalous	JJ	B-NP	O
fetuses	fetus	NNS	I-NP	O
in	in	IN	B-PP	O
total	total	JJ	B-NP	O
implants	implant	NNS	I-NP	O
and	and	CC	O	O
survived	survive	VBD	B-VP	O
embryos	embryo	NNS	B-NP	O
irradiated	irradiate	VBN	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
rad	rad	NN	I-NP	O
by	by	IN	B-PP	O
Cf	Cf	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
rad	rad	NN	I-NP	O
by	by	IN	B-PP	O
Co	Co	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O

Moclobemide	Moclobemide	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
well	well	RB	I-NP	O
-	-	HYPH	I-NP	O
tolerated	tolerate	VBN	I-NP	O
alternative	alternative	JJ	I-NP	O
antidepressant	antidepressant	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
prospective	prospective	JJ	B-NP	O
controlled	controlled	JJ	I-NP	O
trials	trial	NNS	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
its	its	PRP$	B-NP	O
long	long	JJ	I-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
efficacy	efficacy	NN	I-NP	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
pilot	pilot	NN	I-NP	O
study	study	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
two	two	CD	B-NP	O
dogs	dog	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
parenteral	parenteral	JJ	B-NP	O
rifampin	rifampin	NN	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
operation	operation	NN	B-NP	O
and	and	CC	I-NP	O
grafts	graft	NNS	I-NP	O
were	be	VBD	B-VP	O
preclotted	preclotte	VBN	I-VP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
that	that	WDT	B-NP	O
contained	contain	VBD	B-VP	O
rifampin	rifampin	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
hours	hour	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
regulated	regulate	VBN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cys	BEGIN-cy	NNS	I-NP	B
-	-	HYPH	B-NP	I
1+	1+	JJ	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
tapasin	tapasin	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
kilobases	kilobas	NNS	I-NP	O
from	from	IN	B-PP	O
H1	BEGIN-H1	NN	B-NP	B
-	-	HYPH	B-NP	I
K	K-INSIDE	NN	I-NP	I
at	at	IN	B-PP	O
the	the	DT	B-NP	O
centromeric	centromeric	JJ	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
MHC	MHC-INSIDE	NN	I-NP	I

Conversion	Conversion	NN	B-NP	O
of	of	IN	B-PP	O
glucose	glucose	NN	B-NP	O
phosphate	phosphate	NN	I-NP	O
-	-	HYPH	B-NP	O
1C	1C	NN	I-NP	O
to	to	TO	B-PP	O
glucose	glucose	NN	B-NP	O
-	-	HYPH	B-NP	O
1C	1C	NN	I-NP	O
in	in	IN	B-PP	O
passage	passage	NN	B-NP	O
through	through	IN	B-PP	O
human	human	JJ	B-NP	O
brain	brain	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

New	New	JJ	B-NP	O
,	,	,	I-NP	O
selective	selective	JJ	I-NP	O
catechol	BEGIN-catechol	NN	I-NP	B
-	-	HYPH	B-NP	I
O	O	NN	I-NP	I
-	-	HYPH	I-NP	I
methyltransferase	methyltransferase-INSIDE	NN	I-NP	I
inhibitors	inhibitor	NNS	I-NP	O
as	as	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
in	in	IN	B-PP	O
Parkinson	Parkinson	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O

The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
upstream	upstream	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cap	cap	NN	I-NP	O
site	site	NN	I-NP	O
contains	contain	VBZ	B-VP	O
characteristic	characteristic	JJ	B-NP	O
RNA	BEGIN-RNA	NN	I-NP	B
polymerase	polymerase	NN	I-NP	I
II	II	CD	I-NP	I
promoter	promoter	NN	I-NP	I
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
sites	sites-INSIDE	NN	I-NP	I
:	:	:	O	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
at	at	IN	B-PP	O
position	position	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
Sp	BEGIN-Sp	NN	I-NP	B
1	1	CD	I-NP	I
binding	binding	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
(	(	(	O	O
GGGGCGGAGA	GGGGCGGAGA	NN	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
position	position	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
while	while	IN	B-SBAR	O
Y.	Y.	NNP	B-NP	O
lipolytica	lipolytica	NN	I-NP	O
CEN	CEN	NN	I-NP	O
DNA	DNA	NN	I-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
plasmid	plasmid	NN	B-NP	O
maintenance	maintenance	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
function	function	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
supplied	supply	VBN	I-VP	O
by	by	IN	B-PP	O
several	several	JJ	B-NP	O
sub	sub	AFX	I-NP	O
-	-	HYPH	I-NP	O
fragments	fragment	NNS	I-NP	O
which	which	WDT	B-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
,	,	,	O	O
form	form	VBP	B-VP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
chromosomal	chromosomal	JJ	I-NP	O
centromere	centromere	NN	I-NP	O

These	These	DT	B-NP	O
three	three	CD	I-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
further	further	RB	I-VP	O
examined	examine	VBN	I-VP	O
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
rate	rate	NN	I-NP	O
i	i	NN	I-NP	O
)	)	)	O	O
during	during	IN	B-PP	O
motor	motor	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
W	W	NNP	B-NP	O
,	,	,	O	O
ii	ii	LS	B-LST	O
)	)	)	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
transitional	transitional	JJ	I-NP	O
phase	phase	NN	I-NP	O
from	from	IN	B-PP	O
SS	SS	NN	B-NP	O
to	to	TO	B-PP	O
paradoxical	paradoxical	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
(	(	(	O	O
PS	PS	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
iii	iii	LS	B-LST	O
)	)	)	O	O
during	during	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
eye	eye	NN	I-NP	O
movements	movement	NNS	I-NP	O
(	(	(	O	O
REMs	REM	NNS	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
PS	PS	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
iv	iv	NN	B-NP	O
)	)	)	O	O
following	follow	VBG	B-PP	O
electrical	electrical	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
midbrain	midbrain	NN	I-NP	O
reticular	reticular	JJ	I-NP	O
formation	formation	NN	I-NP	O
(	(	(	O	O
MRF	MRF	NN	B-NP	O
)	)	)	O	O

Benzyl	Benzyl	NN	B-NP	O
alcohol	alcohol	NN	I-NP	O
administration	administration	NN	I-NP	O
in	in	IN	B-PP	O
neonates	neonate	NNS	B-NP	O

Id	BEGIN-BEGIN-Id	JJ	B-NP	B
-	-	HYPH	I-NP	I
1H	1-INSIDEH-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Id	BEGIN-BEGIN-Id	NN	I-NP	B
-	-	HYPH	O	I
1H	1-INSIDEH-INSIDE	NN	B-NP	I
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
human	human	JJ	B-NP	O
homologues	homologue	NNS	I-NP	O
of	of	IN	B-PP	O
mouse	BEGIN-mouse	NN	B-NP	B
Id	BEGIN-Id	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Id	BEGIN-Id	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
have	have	VBP	B-VP	O
potential	potential	NN	B-NP	O
to	to	TO	B-VP	O
encode	encode	VB	I-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
proteins	protein	NNS	I-NP	O

Normal	Normal	JJ	B-NP	O
dogs	dog	NNS	I-NP	O
were	be	VBD	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
either	either	CC	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
1	1	CD	B-NP	O
Gy	Gy	NN	I-NP	O
of	of	IN	B-PP	O
X	X	NN	B-NP	O
rays	ray	NNS	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
hemisphere	hemisphere	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
gross	gross	JJ	I-NP	O
and	and	CC	I-NP	O
histopathologic	histopathologic	JJ	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
qualitatively	qualitatively	RB	B-ADVP	O

The	The	DT	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
fly	fly	NN	B-NP	O
receptors	receptor	NNS	I-NP	O
with	with	IN	B-PP	O
features	feature	NNS	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
mammalian	BEGIN-mammalian	JJ	B-NP	B
glycoprotein	glycoprotein	NN	I-NP	I
hormone	hormone	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
allows	allow	VBZ	B-VP	O
a	a	DT	B-NP	O
better	good	JJR	I-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
evolution	evolution	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
unique	unique	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
GPCRs	BEGIN-GPCRs-INSIDE	NN	B-NP	B
and	and	CC	O	O
future	future	JJ	B-NP	O
elucidation	elucidation	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
ligand	ligand	NN	I-NP	O
signaling	signaling	NN	I-NP	O
mechanisms	mechanism	NNS	I-NP	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
involved	involve	VBN	B-VP	O
,	,	,	O	O
IGF	BEGIN-IGF	NN	B-NP	B
-	-	HYPH	I-NP	I
1R	1R	NN	I-NP	I
promoter	promoter	NN	I-NP	I
reporter	reporter	NN	I-NP	I
constructs	constructs-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
transiently	transiently	RB	I-VP	O
transfected	transfecte	VBN	I-VP	O
in	in	IN	B-PP	O
CHO	CHO	NN	B-NP	O
-	-	HYPH	B-NP	O
AT1	AT1	NN	I-NP	O
cells	cell	NNS	I-NP	O
that	that	WDT	B-NP	O
overexpress	overexpres	VBP	B-VP	O
angiotensin	BEGIN-angiotensin	NN	B-NP	B
AT1	AT1	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I

Importin	BEGIN-Importin	NN	B-NP	B
beta	beta-INSIDE	NN	I-NP	I
mediates	mediate	VBZ	B-VP	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
Smad	BEGIN-Smad	JJ	B-NP	B
1	1-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
effect	effect	NN	I-NP	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
hydrocarbon	hydrocarbon	NN	B-NP	O
nephropathy	nephropathy	NN	I-NP	O
in	in	IN	B-PP	O
male	male	JJ	B-NP	O
rats	rat	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
considered	consider	VBN	I-VP	O
relevant	relevant	JJ	B-ADJP	O
for	for	IN	B-PP	O
human	human	JJ	B-NP	O
health	health	NN	I-NP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
unusual	unusual	JJ	I-NP	O
tRNA	tRNA	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
found	find	VBD	B-VP	O
inserted	insert	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Neurospora	Neurospora	NNP	I-NP	O
retroplasmid	retroplasmid	NN	I-NP	O

Gel	Gel	NN	B-NP	O
shift	shift	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
binding	binding	NN	I-NP	O
from	from	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
caveolin	BEGIN-caveolin	NN	I-NP	B
promoter	promoter	NN	I-NP	I
DNA	DNA	NN	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
DNase	BEGIN-DNase	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
footprinting	footprinting	NN	I-NP	O
,	,	,	O	O
confirmed	confirm	VBD	B-VP	O
nucleoprotein	nucleoprotein	NN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SRE	SRE	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
elements	element	NNS	I-NP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
LDL	BEGIN-LDL	NN	B-NP	B
-	-	HYPH	O	I
FC	FC-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
Ca1+	Ca1+	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
serum	serum	NN	I-NP	O
after	after	IN	B-PP	O
intragastrically	intragastrically	RB	B-NP	O
fenarimol	fenarimol	NN	I-NP	O
administration	administration	NN	I-NP	O
(	(	(	O	O
doses	dose	NNS	B-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
LD1	LD1	NN	I-NP	O
)	)	)	O	O
during	during	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
potential	potential	JJ	I-NP	O
Ste1	BEGIN-Ste1	NN	I-NP	B
recognition	recognition	NN	I-NP	I
sites	sites-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fus1	BEGIN-fus1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
region	region	NN	I-NP	O
abolished	abolish	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
expression	expression	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
restored	restore	VBN	I-VP	O
when	when	WRB	B-ADVP	O
we	we	PRP	B-NP	O
inserted	insert	VBD	B-VP	O
a	a	DT	B-NP	O
different	different	JJ	I-NP	O
Ste1	BEGIN-Ste1	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mat1	BEGIN-mat1	NN	I-NP	B
-	-	HYPH	B-NP	I
P	P	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

J.	J.	NNP	B-NP	O
,	,	,	O	O
&	&	CC	O	O
Olefsky	Olefsky	NNP	B-NP	O
,	,	,	O	O
J	J	NNP	B-NP	O

Early	Early	JJ	B-NP	O
attempts	attempt	NNS	I-NP	O
for	for	IN	B-PP	O
modifying	modify	VBG	B-VP	O
growth	growth	NN	B-NP	O
functions	function	NNS	I-NP	O
to	to	TO	B-PP	O
annual	annual	JJ	B-NP	O
variations	variation	NNS	I-NP	O
dating	date	VBG	B-VP	O
back	back	RB	B-ADVP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
decades	decade	NNS	I-NP	O
are	be	VBP	B-VP	O
recalled	recall	VBN	I-VP	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
examples	example	NNS	B-NP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
application	application	NN	I-NP	O
showing	show	VBG	B-VP	O
rather	rather	RB	B-NP	O
different	different	JJ	I-NP	O
degrees	degree	NNS	I-NP	O
of	of	IN	B-PP	O
approximation	approximation	NN	B-NP	O

PRIP	BEGIN-PRIP-INSIDE	NN	B-NP	B
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
LXXLL	LXXLL	NN	I-NP	O
signature	signature	NN	I-NP	O
motifs	motif	NNS	I-NP	O

BPN	BPN	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
experimentally	experimentally	RB	I-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
intratracheal	intratracheal	JJ	B-NP	O
inoculation	inoculation	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
and	and	CC	O	O
ventilator	ventilator	NN	B-NP	O
-	-	HYPH	O	O
associated	associate	VBN	B-NP	O
BPN	BPN	NN	I-NP	O
by	by	IN	B-PP	O
ventilating	ventilate	VBG	B-VP	O
baboons	baboon	NNS	B-NP	O
with	with	IN	B-PP	O
oleic	oleic	JJ	B-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
lung	lung	NN	I-NP	O
injury	injury	NN	I-NP	O

Coexpression	Coexpression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
dominant	BEGIN-dominant	JJ	I-NP	B
negative	negative	JJ	I-NP	I
c	c	NN	I-NP	I
-	-	HYPH	B-NP	I
jun	jun-INSIDE	NN	I-NP	I
antagonized	antagonize	VBD	B-VP	O
the	the	DT	B-NP	O
ras	BEGIN-ras-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	I-NP	I
kDa	kDa	NN	I-NP	I
gelatinase	gelatinase	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O
-	-	HYPH	B-VP	O
driven	drive	VBN	B-NP	O
CAT	BEGIN-CAT	NN	I-NP	B
reporter	reporter-INSIDE	NN	I-NP	I

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
safety	safety	NN	I-NP	O
of	of	IN	B-PP	O
design	design	NN	B-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
assured	assure	VBN	I-VP	O
as	as	RB	B-ADVP	O
long	long	RB	I-ADVP	O
as	as	IN	B-SBAR	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
received	receive	VBD	B-VP	O
three	three	CD	B-NP	O
courses	course	NNS	I-NP	O
of	of	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
unusual	unusual	JJ	B-ADJP	O
in	in	IN	B-PP	O
phase	phase	NN	B-NP	O
I	I	CD	B-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
Japan	Japan	NNP	B-NP	O

The	The	DT	B-NP	O
plants	plant	NNS	I-NP	O
were	be	VBD	B-VP	O
then	then	RB	I-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
our	our	PRP$	B-NP	O
Houston	Houston	NNP	I-NP	O
laboratory	laboratory	NN	I-NP	O
where	where	WRB	B-ADVP	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
and	and	CC	O	O
analyzed	analyze	VBN	B-VP	O
for	for	IN	B-PP	O
lignin	lignin	NN	B-NP	O
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
content	content	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
phenylalanine	BEGIN-phenylalanine	NN	B-NP	B
ammonia	ammonia	NN	I-NP	I
-	-	HYPH	O	I
lyase	lyase-INSIDE	NN	B-NP	I
(	(	(	O	O
PAL	BEGIN-PAL-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
peroxidase	BEGIN-peroxidase-INSIDE	NN	B-NP	B
activities	activity	NNS	I-NP	O

The	The	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
PCR	PCR	NN	I-NP	O
-	-	HYPH	B-NP	O
amplified	amplify	VBN	I-NP	O
SMT1A	BEGIN-SMT1A-INSIDE	NN	I-NP	B
genomic	genomic	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
SMT1A	BEGIN-BEGIN-SMT1A-INSIDE	NN	B-NP	B
cDNA	cDNA-INSIDE	NN	I-NP	I
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
intron	intron	NN	B-NP	O
(	(	(	O	O
s	s	NNS	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
protein	protein	NN	I-NP	O
coding	cod	VBG	B-VP	O
region	region	NN	B-NP	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
tyrosine	BEGIN-tyrosine	NN	B-NP	B
kinase	kinase	NN	I-NP	I
-	-	HYPH	O	I
containing	contain	VBG	B-VP	I
receptors	receptors-INSIDE	NN	B-NP	I
,	,	,	O	O
heterotrimeric	BEGIN-heterotrimeric	JJ	B-NP	B
G	G	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
protein	BEGIN-protein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
enhanced	enhance	VBD	B-VP	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
MEK	BEGIN-MEK	JJ	I-NP	B
isoforms	isoforms-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	O	O
PC1	PC1	NN	B-NP	O
cells	cell	NNS	I-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Transpulmonary	Transpulmonary	JJ	B-NP	O
stable	stable	JJ	I-NP	O
air	air	NN	I-NP	O
microbubbles	microbubble	NNS	I-NP	O
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
galactose	galactose	NN	I-NP	O
carrier	carrier	NN	I-NP	O
represent	represent	VBP	B-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
and	and	CC	I-NP	O
safe	safe	JJ	I-NP	O
contrast	contrast	NN	I-NP	O
agent	agent	NN	I-NP	O
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
insufficient	insufficient	JJ	I-NP	O
native	native	JJ	I-NP	O
signal	signal	NN	I-NP	O
in	in	IN	B-PP	O
transcranial	transcranial	JJ	B-NP	O
Doppler	Doppler	NNP	I-NP	O
investigation	investigation	NN	I-NP	O

DP	BEGIN-DP	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
DP	BEGIN-DP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
encode	encode	VBP	B-VP	O
maternally	maternally	RB	I-VP	O
stored	store	VBN	I-VP	O
transcripts	transcript	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
during	during	IN	B-PP	O
early	early	JJ	B-NP	O
development	development	NN	I-NP	O

Human	BEGIN-Human	JJ	B-NP	B
recombinant	recombinant	JJ	I-NP	I
erythropoietin	erythropoietin-INSIDE	NN	I-NP	I
(	(	(	O	O
r	BEGIN-r	NN	B-NP	B
-	-	HYPH	B-NP	I
HuEPO	HuEPO-INSIDE	NN	I-NP	I
,	,	,	O	O
EprexR	BEGIN-EprexR-INSIDE	NN	B-NP	B
)	)	)	O	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
transfusion	transfusion	NN	I-NP	O
requirement	requirement	NN	I-NP	O

Specifically	Specifically	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
engineered	engineer	VBD	B-VP	O
two	two	CD	B-NP	O
chimeras	chimera	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Abl	Abl-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
swapped	swap	VBN	I-VP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	O	I
Src	Src-INSIDE	NN	B-NP	I

Indications	Indication	NNS	B-NP	O
for	for	IN	B-PP	O
therapy	therapy	NN	B-NP	O
using	use	VBG	B-VP	O
MAO	BEGIN-MAO-INSIDE	NN	B-NP	B
inhibitors	inhibitor	NNS	I-NP	O

Although	Although	IN	B-SBAR	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
activate	activate	VB	I-VP	O
ERK	BEGIN-ERK	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
HepG1	HepG1	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
STAT1	BEGIN-STAT1-INSIDE	NN	B-NP	B
transactivation	transactivation	NN	I-NP	O
and	and	CC	O	O
Ser	Ser	NN	B-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
phosphorylation	phosphorylation	NN	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
MAP	BEGIN-MAP	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
/	/	SYM	B-VP	O
ERK	BEGIN-ERK	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
MEK	BEGIN-MEK-INSIDE	NN	B-NP	B
)	)	)	O	O
inhibitor	inhibitor	NN	B-NP	O
PD1	PD1	NN	I-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
dominant	dominant	JJ	B-NP	O
-	-	HYPH	I-NP	O
negative	negative	JJ	I-NP	O
Raf	BEGIN-Raf-INSIDE	NN	I-NP	B

Mean	Mean	JJ	B-NP	O
disposition	disposition	NN	I-NP	O
constants	constant	NNS	I-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
/	/	SYM	O	O
-	-	HYPH	B-NP	O
SD	SD	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
individualized	individualize	VBN	B-NP	O
fits	fit	NNS	I-NP	O
(	(	(	O	O
V1	V1	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
LITER	LITER	NN	I-NP	O
/	/	SYM	B-NP	O
KG	KG	NN	I-NP	O
,	,	,	O	O
Vdarea	Vdarea	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
liter	liter	NN	I-NP	O
/	/	SYM	B-PP	O
kg	kg	NN	B-NP	O
,	,	,	O	O
alpha	alpha	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
beta	beta	SYM	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
k1	k1	CD	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Clinical	Clinical	JJ	B-NP	O
trials	trial	NNS	I-NP	O
bring	bring	VBP	B-VP	O
informations	information	NNS	B-NP	O
for	for	IN	B-PP	O
pharmacology	pharmacology	NN	B-NP	O
and	and	CC	I-NP	O
epidemiology	epidemiology	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
compared	compare	VBN	I-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
GST	BEGIN-GST-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
Bem1	BEGIN-Bem1-INSIDE	NN	I-NP	B
to	to	TO	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
GAP	BEGIN-GAP-INSIDE	NN	I-NP	B
for	for	IN	B-PP	O
Cdc1Hs	BEGIN-Cdc1Hs-INSIDE	NN	B-NP	B
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rho	BEGIN-rho-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
GAP	BEGIN-GAP-INSIDE	NN	I-NP	B
subfamily	subfamily	NN	I-NP	O
and	and	CC	O	O
found	find	VBD	B-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
order	order	NN	I-NP	O
of	of	IN	B-PP	O
potency	potency	NN	B-NP	O
:	:	:	O	O
human	BEGIN-human	JJ	B-NP	B
platelet	platelet	NN	I-NP	I
Cdc1Hs	BEGIN-Cdc1Hs-INSIDE	NN	I-NP	I
GAP	BEGIN-GAP-INSIDE-INSIDE	NN	I-NP	B
>	>	SYM	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
>	>	SYM	I-NP	O
Bem1	BEGIN-Bem1-INSIDE	NN	I-NP	B
>	>	SYM	I-NP	O
break	BEGIN-break	JJ	I-NP	B
point	point	NN	I-NP	I
cluster	cluster	NN	I-NP	I
region	region	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
whereas	whereas	IN	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
like	like	IN	B-PP	O
Bem1	BEGIN-Bem1-INSIDE	NN	B-NP	B
,	,	,	O	O
shows	show	VBZ	B-VP	O
no	no	DT	B-NP	O
GAP	BEGIN-GAP-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
GTP	GTP	NN	I-NP	O
-	-	HYPH	B-VP	O
bound	bind	VBN	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
Cdc1Hs	BEGIN-Cdc1Hs-INSIDE	NN	B-NP	B

Through	Through	IN	B-PP	O
effective	effective	JJ	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
laboratory	laboratory	NN	B-NP	O
testing	testing	NN	I-NP	O
database	database	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
possible	possible	JJ	B-ADJP	O
to	to	TO	B-VP	O
shift	shift	VB	I-VP	O
away	away	RP	B-PRT	O
our	our	PRP$	B-NP	O
vague	vague	JJ	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
pre	pre	AFX	B-NP	O
-	-	HYPH	I-NP	O
analytic	analytic	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
quality	quality	NN	B-NP	O
control	control	NN	I-NP	O
so	so	RB	B-ADVP	O
far	far	RB	I-ADVP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
established	established	JJ	I-NP	O
system	system	NN	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
objective	objective	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O

Nonlinearities	Nonlinearity	NNS	B-NP	O
in	in	IN	B-PP	O
cochlear	cochlear	JJ	B-NP	O
hydrodynamics	hydrodynamic	NNS	I-NP	O

The	The	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
are	be	VBP	B-VP	O
generated	generate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-VP	O
translocated	translocate	VBN	I-VP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endoplasmic	endoplasmic	JJ	I-NP	O
reticulum	reticulum	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
transporter	BEGIN-transporter	NN	I-NP	B
associated	associate	VBN	B-VP	I
with	with	IN	B-PP	I
antigen	antigen	NN	B-NP	I
processing	processing-INSIDE	NN	I-NP	I
(	(	(	O	O
TAP	BEGIN-TAP-INSIDE	NN	B-NP	B
)	)	)	O	O

An	An	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
'glass	'glass	NN	I-NP	O
stomach	stomach	NN	I-NP	O
'	'	''	O	O
(	(	(	O	O
containing	contain	VBG	B-VP	O
various	various	JJ	B-NP	O
volumes	volume	NNS	I-NP	O
of	of	IN	B-PP	O
hydrochloric	hydrochloric	JJ	B-NP	O
acid	acid	NN	I-NP	O
[	[	(	O	O
HCl	HCl	NN	B-NP	O
]	]	)	O	O
and	and	CC	O	O
ammonium	ammonium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
[	[	(	O	O
NH1Cl	NH1Cl	NN	B-NP	O
]	]	)	O	O
)	)	)	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
means	mean	NNS	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-NP	O
'gastric	'gastric	JJ	I-NP	O
'	'	''	I-NP	O
pH	pH	NN	I-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NH1+	NH1+	NN	I-NP	O
-	-	SYM	B-VP	O
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
NH1	NH1	NN	I-NP	O
transition	transition	NN	I-NP	O
that	that	WDT	B-NP	O
occurs	occur	VBZ	B-VP	O
significantly	significantly	RB	B-ADVP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
1	1	CD	I-NP	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
hybrid	hybrid	NN	I-NP	O
protein	protein	NN	I-NP	O
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
PvALF	BEGIN-PvALF	NN	I-NP	B
activation	activation	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
and	and	CC	I-NP	O
dimerization	dimerization	NN	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
ROM1	BEGIN-ROM1-INSIDE	NN	B-NP	B
activated	activated	JJ	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
ROM1	BEGIN-ROM1-INSIDE	NN	B-NP	B
recognizes	recognize	VBZ	B-VP	O
the	the	DT	B-NP	O
DLEC1	BEGIN-DLEC1	NN	I-NP	B
enhancer	enhancer-INSIDE	NN	I-NP	I
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
;	;	:	O	O
consequently	consequently	RB	B-ADVP	O
,	,	,	O	O
ROM1	BEGIN-ROM1-INSIDE	NN	B-NP	B
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
site	site	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
repressor	repressor	NN	I-NP	O

Northern	Northern	NN	B-NP	O
analyses	analysis	NNS	I-NP	O
further	further	RB	B-ADVP	O
confirm	confirm	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
-	-	HYPH	B-NP	I
ENaC	ENaC	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
Pa	Pa	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
is	be	VBZ	B-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
ectopic	ectopic	JJ	I-NP	O
HMGI	BEGIN-HMGI	NN	I-NP	B
-	-	HYPH	B-NP	I
C	C-INSIDE	NN	I-NP	I
overexpression	overexpression	NN	I-NP	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
myb	myb-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
shift	shift	NN	I-NP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
after	after	IN	B-PP	O
PMA	PMA	NN	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
phosphorylation	phosphorylation	NN	B-NP	O
by	by	IN	B-PP	O
casein	BEGIN-casein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
mitogen	BEGIN-mitogen	NN	I-NP	B
-	-	HYPH	O	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
at	at	IN	B-PP	O
positions	position	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
or	or	CC	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
myb	myb-INSIDE	NN	B-NP	I
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
are	be	VBP	B-VP	O
not	not	RB	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
RXR	BEGIN-RXR-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
VDR	BEGIN-VDR-INSIDE	NN	I-NP	B
transactivated	transactivate	VBN	B-VP	O
selectively	selectively	RB	B-ADVP	O
from	from	IN	B-PP	O
VDRE	BEGIN-VDR-INSIDEE	NN	B-NP	I
-	-	HYPH	B-NP	O
linked	link	VBN	I-NP	O
templates	template	NNS	I-NP	O
exclusively	exclusively	RB	B-ADVP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
heterodimeric	heterodimeric	JJ	I-NP	O
complex	complex	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
neither	neither	DT	B-NP	O
receptor	receptor	NN	I-NP	O
alone	alone	RB	B-ADVP	O
enhanced	enhance	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
in	in	FW	B-PP	O
vitro	vitro	FW	B-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
thromboxane	thromboxane	NN	B-NP	O
as	as	IN	B-SBAR	O
evidenced	evidence	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
dinorthromboxane	dinorthromboxane	NN	I-NP	O
B1	B1	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oestrogen	oestrogen	NN	I-NP	O
group	group	NN	I-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
orchidectomy	orchidectomy	NN	I-NP	O
group	group	NN	I-NP	O

Assays	Assay	NNS	B-NP	O
of	of	IN	B-PP	O
APRE	APRE	NN	B-NP	O
-	-	HYPH	B-NP	O
luciferase	BEGIN-luciferase-INSIDE	NN	I-NP	B
reporter	reporter	NN	I-NP	O
plasmids	plasmid	NNS	I-NP	O
transfected	transfecte	VBN	B-VP	O
into	into	IN	B-PP	O
HepG1	HepG1	NN	B-NP	O
cells	cell	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
mutated	mutate	VBN	I-NP	O
APRE	APRE	NN	I-NP	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
only	only	RB	B-NP	O
BPi	BEGIN-BPi-INSIDE	JJ	I-NP	B
functions	function	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
inducible	inducible	JJ	I-NP	O
enhancer	enhancer	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
a	a	DT	B-NP	O
mutated	mutate	VBN	I-NP	O
APRE	APRE	NN	I-NP	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
only	only	RB	B-NP	O
BPc	BEGIN-BPc-INSIDE	NN	I-NP	B
does	do	VBZ	B-VP	O
not	not	RB	O	O

Compared	Compare	VBN	B-PP	O
with	with	IN	B-PP	O
controls	control	NNS	B-NP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
unmedicated	unmedicated	JJ	I-NP	O
state	state	NN	I-NP	O
had	have	VBD	B-VP	O
low	low	JJ	B-NP	O
smooth	smooth	JJ	I-NP	O
pursuit	pursuit	NN	I-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
corrective	corrective	JJ	B-NP	O
catch	catch	VB	B-VP	O
-	-	HYPH	B-PRT	O
up	up	RP	B-PRT	O
saccades	saccade	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
spend	spend	VB	I-VP	O
less	less	JJR	B-NP	O
time	time	NN	I-NP	O
engaged	engage	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tracking	tracking	NN	I-NP	O
task	task	NN	I-NP	O

Epstein	BEGIN-Epstein	NNP	B-NP	B
-	-	HYPH	I-NP	I
Barr	Barr	NNP	I-NP	I
virus	virus	NN	I-NP	I
nuclear	nuclear	JJ	I-NP	I
antigen	antigen	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
exerts	exert	VBZ	B-VP	O
its	its	PRP$	B-NP	O
transactivating	transactivating	NN	I-NP	O
function	function	NN	I-NP	O
through	through	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
recombination	BEGIN-recombination	NN	B-NP	B
signal	signal	NN	I-NP	I
binding	binding	NN	I-NP	I
protein	protein	NN	I-NP	I
RBP	RBP	NN	I-NP	I
-	-	HYPH	B-NP	I
J	J	NN	I-NP	I
kappa	kappa-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
homologue	homologue	NN	I-NP	O
of	of	IN	B-PP	O
Drosophila	BEGIN-Drosophila	NN	B-NP	B
Suppressor	Suppressor	NN	I-NP	I
of	of	IN	B-PP	I
Hairless	Hairless-INSIDE	NN	B-NP	I

A.	BEGIN-A.	JJ	B-ADJP	B
thaliana	thaliana	IN	B-PP	I
cystathionine	cystathionine	NN	B-NP	I
beta	beta	SYM	B-NP	I
-	-	HYPH	B-NP	I
lyase	lyase-INSIDE	NN	I-NP	I
exhibits	exhibit	VBZ	B-VP	O
1	1	CD	B-NP	O
sequence	sequence	NN	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
corresponding	correspond	VBG	B-VP	O
enzyme	enzyme	NN	B-NP	O
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
additional	additional	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
protein	protein	NN	I-NP	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
-	-	HYPH	I-NP	O
dimensional	dimensional	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
CR	CR	NN	I-NP	O
domain	domain	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
sequence	sequence	NN	I-NP	O
conservation	conservation	NN	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
structural	structural	JJ	I-NP	O
motif	motif	NN	I-NP	O

Co	Co	AFX	B-NP	O
-	-	HYPH	I-NP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
PLD1	BEGIN-PLD1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
COS	COS	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
recombinant	BEGIN-recombinant	JJ	I-NP	B
CK1	CK1	NN	I-NP	I
subunits	subunits-INSIDE	NN	I-NP	I
,	,	,	O	O
alpha	alpha	NN	B-NP	O
or	or	CC	O	O
beta	beta	NN	B-NP	O
,	,	,	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
PLD1	BEGIN-PLD1-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
the	the	DT	B-NP	O
kinase	kinase	NN	I-NP	O
is	be	VBZ	B-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
beta	beta	NN	I-NP	O
subunit	subunit	NN	I-NP	O

Despite	Despite	IN	B-PP	O
this	this	DT	B-NP	O
dependency	dependency	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
B.	BEGIN-B.	NNP	I-NP	B
japonicum	japonicum	NN	I-NP	I
fixK	BEGIN-fixK	NN	I-NP	B
mutant	mutant-INSIDE-INSIDE	NN	I-NP	I
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
phenotypic	phenotypic	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
B.	BEGIN-B.	JJ	B-NP	B
japonicum	japonicum	NN	I-NP	I
fixL	fixL-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
fixJ	BEGIN-fixJ	NN	I-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
:	:	:	O	O
the	the	DT	B-NP	O
fixK	BEGIN-fixK	NN	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
neither	neither	CC	O	O
Fix	Fix	NN	B-NP	O
-	-	HYPH	B-ADJP	O
in	in	IN	B-PP	O
symbiosis	symbiosis	NN	B-NP	O
with	with	IN	B-PP	O
soybean	soybean	NN	B-NP	O
plants	plant	NNS	I-NP	O
nor	nor	CC	O	O
defective	defective	JJ	B-ADJP	O
in	in	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
respiration	respiration	NN	I-NP	O
with	with	IN	B-PP	O
nitrate	nitrate	NN	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
terminal	terminal	JJ	I-NP	O
electron	electron	NN	I-NP	O
acceptor	acceptor	NN	I-NP	O

The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
Pst1p	BEGIN-Pst1p-INSIDE	NN	B-NP	B
possessed	possess	VBD	B-VP	O
high	high	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Sin1	BEGIN-Sin1	NN	I-NP	B
family	family-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
,	,	,	O	O
known	know	VBN	B-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
histone	BEGIN-histone	NN	B-NP	B
deacetylases	deacetylases-INSIDE	NN	I-NP	I

This	This	DT	B-NP	O
selective	selective	JJ	I-NP	O
squelching	squelching	NN	I-NP	O
activity	activity	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
GRIM	BEGIN-GRIM-INSIDE	NN	B-NP	B
can	can	MD	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RNA	BEGIN-RNA	NN	I-NP	B
polymerase	polymerase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
machinery	machinery	NN	I-NP	O

A	A	DT	B-NP	O
third	third	JJ	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	I-VP	O
receive	receive	VB	I-VP	O
the	the	DT	B-NP	O
canalith	canalith	NN	I-NP	O
repositioning	reposition	VBG	B-VP	O
maneuver	maneuver	NN	B-NP	O
without	without	IN	B-PP	O
mastoid	mastoid	JJ	B-NP	O
vibration	vibration	NN	I-NP	O

With	With	IN	B-PP	O
the	the	DT	B-NP	O
help	help	NN	I-NP	O
of	of	IN	B-PP	O
partially	partially	RB	B-VP	O
overlapping	overlap	VBG	I-VP	O
parenchymatous	parenchymatous	JJ	B-NP	O
sutures	suture	NNS	I-NP	O
,	,	,	O	O
different	different	JJ	B-NP	O
renal	renal	JJ	I-NP	O
segments	segment	NNS	I-NP	O
were	be	VBD	B-VP	O
devitalized	devitalize	VBN	I-VP	O

The	The	DT	B-NP	O
S.	BEGIN-S.	NNP	I-NP	B
typhimurium	typhimurium	NNP	I-NP	I
aspartyl	aspartyl	NN	I-NP	I
/	/	SYM	O	I
asparaginyl	asparaginyl	NN	O	I
beta	beta	SYM	O	I
-	-	HYPH	O	I
hydroxylase	hydroxylase	NN	B-NP	I
homologue	homologue-INSIDE	NN	I-NP	I
(	(	(	O	O
designated	designate	VBN	B-NP	O
lpxO	BEGIN-lpxO-INSIDE	NN	I-NP	B
)	)	)	O	O
was	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
into	into	IN	B-PP	O
pBluescriptSK	pBluescriptSK	NN	B-NP	O
and	and	CC	O	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
K	K	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
contain	contain	VB	I-VP	O
lpxO	BEGIN-lpxO-INSIDE	NN	B-NP	B

Cardiac	Cardiac	JJ	B-NP	O
NE	NE	NN	I-NP	O
spillover	spillover	NN	I-NP	O
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
.1	.1	NN	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
group	group	NN	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
renal	renal	JJ	B-NP	O
and	and	CC	I-NP	O
whole	whole	JJ	I-NP	O
-	-	HYPH	I-NP	O
body	body	NN	I-NP	O
NE	NE	NN	I-NP	O
spillovers	spillover	NNS	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
groups	group	NNS	I-NP	O

Translation	Translation	NN	B-NP	O
of	of	IN	B-PP	O
mok	BEGIN-mok-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
tightly	tightly	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
Sok	BEGIN-Sok	JJ	B-NP	B
RNA	RNA-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
Sok	BEGIN-Sok	JJ	B-NP	B
RNA	RNA-INSIDE	NN	I-NP	I
thus	thus	RB	B-ADVP	O
regulates	regulate	VBZ	B-VP	O
hok	BEGIN-hok-INSIDE	NN	B-NP	B
translation	translation	NN	I-NP	O
indirectly	indirectly	RB	B-ADVP	O
through	through	IN	B-PP	O
mok	BEGIN-mok-INSIDE	NN	B-NP	B

In	In	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
determined	determine	VBD	B-VP	O
the	the	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
eight	eight	CD	B-NP	O
VirF	BEGIN-VirF	NN	I-NP	B
-	-	HYPH	B-NP	I
binding	bind	VBG	B-NP	I
sites	sites-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
four	four	CD	B-NP	O
different	different	JJ	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
DNase	BEGIN-DNase	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
or	or	CC	O	O
hydroxyl	hydroxyl	NN	B-NP	O
radical	radical	NN	I-NP	O
footprinting	footprinting	NN	I-NP	O

Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
ACE	BEGIN-ACE-INSIDE	NN	B-NP	B
inhibitors	inhibitor	NNS	I-NP	O
after	after	IN	B-PP	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O

One	One	CD	B-NP	O
-	-	HYPH	I-NP	O
hour	hour	NN	I-NP	O
O1	O1	NN	I-NP	O
,	,	,	O	O
NO1	NO1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
SO1	SO1	NN	B-NP	O
personal	personal	JJ	I-NP	O
exposures	exposure	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
using	use	VBG	B-VP	O
samplers	sampler	NNS	B-NP	O
developed	develop	VBN	B-VP	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
laboratory	laboratory	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
short	short	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
PM1	PM1	NN	I-NP	O
,	,	,	O	O
CO	CO	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
VOCs	VOC	NNS	B-NP	O
exposures	exposure	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
using	use	VBG	B-VP	O
currently	currently	RB	B-NP	O
available	available	JJ	I-NP	O
monitors	monitor	NNS	I-NP	O

Recombinant	BEGIN-Recombinant	JJ	B-NP	B
MsERK1	MsERK1-INSIDE	NN	I-NP	I
(	(	(	O	O
rMsERK1	BEGIN-rMsERK1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
overexpressed	overexpresse	VBN	B-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
recognized	recognize	VBN	I-VP	O
by	by	IN	B-PP	O
antibodies	antibody	NNS	B-NP	O
raised	raise	VBN	B-VP	O
against	against	IN	B-PP	O
MAP	BEGIN-MAP	NN	B-NP	B
kinases	kinase	NNS	I-NP	I
from	from	IN	B-PP	I
rat	rat	NN	B-NP	I
,	,	,	O	I
Xenopus	Xenopus	NN	B-NP	I
,	,	,	O	I
and	and	CC	O	I
sea	sea	NN	B-NP	I
star	star-INSIDE	NN	I-NP	I
and	and	CC	B-PP	O
by	by	IN	B-PP	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
phosphotyrosine	phosphotyrosine	NN	I-NP	I
antibodies	antibodies-INSIDE	NN	I-NP	I

However	However	RB	B-ADVP	O
,	,	,	O	O
UV	UV	NN	B-NP	O
resistance	resistance	NN	I-NP	O
is	be	VBZ	B-VP	O
only	only	RB	B-VP	O
minimally	minimally	RB	I-VP	O
restored	restore	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
mutant	mutant	JJ	B-NP	O
cells	cell	NNS	I-NP	O
remain	remain	VBP	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
gamma	gamma	NN	B-NP	O
radiation	radiation	NN	I-NP	O

The	The	DT	B-NP	O
melanoma	BEGIN-melanoma	NN	I-NP	B
growth	growth	NN	I-NP	I
stimulatory	stimulatory	JJ	I-NP	I
activity	activity	NN	I-NP	I
/	/	SYM	B-NP	I
growth	growth	NN	I-NP	I
-	-	HYPH	O	I
regulated	regulate	VBN	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
,	,	,	O	O
CXCL1	BEGIN-CXCL1-INSIDE	NN	B-NP	B
,	,	,	O	O
is	be	VBZ	B-VP	O
constitutively	constitutively	RB	I-VP	O
expressed	express	VBN	I-VP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
during	during	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
and	and	CC	I-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
melanocytes	melanocyte	NNS	B-NP	O
into	into	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
melanoma	melanoma	NN	I-NP	O

The	The	DT	B-NP	O
activated	activate	VBN	I-NP	O
glucocorticoid	BEGIN-glucocorticoid	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
forms	form	VBZ	B-VP	O
a	a	DT	B-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
Stat1	BEGIN-Stat1-INSIDE	NN	B-NP	B
and	and	CC	O	O
enhances	enhance	VBZ	B-VP	O
Stat1	BEGIN-Stat1-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
mediated	mediate	VBN	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
induction	induction	NN	I-NP	O

A	A	DT	B-NP	O
simple	simple	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
for	for	IN	B-PP	O
accurate	accurate	JJ	B-NP	O
quantitation	quantitation	NN	I-NP	O
of	of	IN	B-PP	O
factor	BEGIN-factor	NN	B-NP	B
VIII	VIII-INSIDE	NN	I-NP	I
inhibitors	inhibitor	NNS	I-NP	O

Diagnostic	Diagnostic	JJ	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
determining	determine	VBG	B-VP	O
leucine	BEGIN-leucine	NN	B-NP	B
aminotransferase	aminotransferase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
T1E	BEGIN-T1E	NN	B-NP	B
-	-	HYPH	B-NP	I
p1s1k	p1s1k-INSIDE	NN	I-NP	I
migrated	migrate	VBD	B-VP	O
more	more	RBR	B-ADVP	O
slowly	slowly	RB	I-ADVP	O
in	in	IN	B-PP	O
SDS	SDS	NN	B-NP	O
-	-	HYPH	B-NP	O
polyacrylamide	polyacrylamide	NN	I-NP	O
gels	gel	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
demonstrated	demonstrate	VBD	B-VP	O
partial	partial	JJ	B-NP	O
kinase	kinase	NN	I-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
type	type	NN	I-NP	O
)	)	)	O	O

Transcription	BEGIN-Transcription	NN	B-NP	B
factor	factor	NN	I-NP	I
IIIC	IIIC-INSIDE	NN	I-NP	I
(	(	(	O	O
TFIIIC	BEGIN-TFIIIC-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
assembly	assembly	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
preinitiation	preinitiation	NN	I-NP	O
complex	complex	NN	I-NP	O
on	on	IN	B-PP	O
1S	BEGIN-1S	NN	B-NP	B
RNA	RNA-INSIDE	NN	I-NP	I
,	,	,	O	O
tRNA	tRNA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
adenovirus	BEGIN-adenovirus	NN	B-NP	B
VA	VA-INSIDE	NN	I-NP	I
RNA	RNA	NN	I-NP	O
genes	gene	NNS	I-NP	O
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
separable	separable	JJ	I-NP	O
components	component	NNS	I-NP	O
,	,	,	O	O
TFIIIC1	BEGIN-TFIIIC-INSIDE1	NN	B-NP	I
and	and	CC	I-NP	O
TFIIIC1	BEGIN-TFIIIC-INSIDE1	NN	I-NP	I

Synchronous	Synchronous	JJ	B-NP	O
multicentric	multicentric	JJ	I-NP	O
giant	giant	JJ	I-NP	O
cell	cell	NN	I-NP	O
tumour	tumour	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
case	case	NN	I-NP	O
report	report	NN	I-NP	O
with	with	IN	B-PP	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
literature	literature	NN	B-NP	O

Lysates	Lysate	NNS	B-NP	O
of	of	IN	B-PP	O
COS	COS	NN	B-NP	O
cells	cell	NNS	I-NP	O
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
modified	BEGIN-modified	JJ	B-NP	B
hGrzB	hGrzB	NN	I-NP	I
cDNA	cDNA-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
hydrolyze	hydrolyze	VB	I-VP	O
tert	tert	NN	B-NP	O
-	-	HYPH	B-NP	O
butyloxycarbonyl	butyloxycarbonyl	NN	I-NP	O
-	-	HYPH	B-NP	O
Ala	Ala	NN	I-NP	O
-	-	HYPH	B-NP	O
Ala	Ala	NN	I-NP	O
-	-	HYPH	B-NP	O
Asp	Asp	NN	I-NP	O
-	-	HYPH	O	O
thiobenzyl	thiobenzyl	NN	B-NP	O
ester	ester	NN	I-NP	O
(	(	(	O	O
Boc	Boc	NN	B-NP	O
-	-	HYPH	B-NP	O
Ala	Ala	NN	I-NP	O
-	-	HYPH	B-NP	O
Ala	Ala	NN	I-NP	O
-	-	HYPH	B-NP	O
Asp	Asp	NN	I-NP	O
-	-	HYPH	B-NP	O
SBzl	SBzl	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
lysates	lysate	NNS	B-NP	O
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
unmodified	unBEGIN-modified	JJ	B-NP	O
hGrzB	hGrzB	NN	I-NP	O
cDNA	cDNA-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
inactive	inactive	JJ	B-ADJP	O

Mutant	BEGIN-Mutant	JJ	B-NP	B
M	M	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
complement	complement	VB	I-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
temperature	temperature	NN	I-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
M	BEGIN-M	NN	I-NP	B
protein	protein	NN	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
virus	virus	NN	I-NP	O
tsO1	tsO1	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
nonpermissive	nonpermissive	JJ	I-NP	O
temperature	temperature	NN	I-NP	O

The	The	DT	B-NP	O
POU	BEGIN-POU-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
Pit	BEGIN-Pit	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
sequence	sequence	NN	B-NP	O
-	-	HYPH	B-ADJP	O
specific	specific	JJ	B-NP	O
,	,	,	I-NP	O
high	high	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
dependent	dependent	JJ	B-NP	O
Pit	BEGIN-Pit	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
Pit	BEGIN-Pit	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
interactions	interaction	NNS	I-NP	O

It	It	PRP	B-NP	O
competes	compete	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
calcium	calcium	NN	I-NP	O
ion	ion	NN	I-NP	O
which	which	WDT	B-NP	O
brings	bring	VBZ	B-VP	O
about	about	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
myosine	BEGIN-myosine	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
a	a	DT	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
phosphorylated	phosphorylate	VBN	B-NP	O
myosine	myosine	NN	I-NP	O

It	It	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
untreated	untreated	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
stage	stage	NN	B-NP	O
I	I	CD	I-NP	O
or	or	CC	I-NP	O
II	II	CD	I-NP	O
NHL	NHL	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
definite	definite	JJ	I-NP	O
radiographic	radiographic	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
with	with	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
radiographs	radiograph	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
extrathoracic	extrathoracic	JJ	I-NP	O
spread	spread	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
treated	treat	VBN	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
questionable	questionable	JJ	B-NP	O
radiographs	radiograph	NNS	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
LGCS	LGCS	NN	B-NP	O
is	be	VBZ	B-VP	O
successful	successful	JJ	B-ADJP	O
in	in	IN	B-PP	O
treating	treat	VBG	B-VP	O
esophageal	esophageal	JJ	B-NP	O
varices	varix	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hyperdynamic	hyperdynamic	JJ	B-NP	O
portal	portal	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
with	with	IN	B-PP	O
acceptable	acceptable	JJ	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O

1	1	LS	B-LST	O
)	)	)	O	O
The	The	DT	B-NP	O
progress	progress	NN	I-NP	O
of	of	IN	B-PP	O
fibrinolysis	BEGIN-fibrin-INSIDEolysis	NN	B-NP	I
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	O
collection	collection	NN	I-NP	O
of	of	IN	B-PP	O
middle	middle	JJ	B-NP	O
ear	ear	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
side	side	NN	I-NP	O
ear	ear	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
having	have	VBG	B-VP	O
much	much	JJ	B-NP	O
activity	activity	NN	I-NP	O
for	for	IN	B-PP	O
fibrin	BEGIN-fibrin-INSIDE	NN	B-NP	B
degradation	degradation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lowering	lowering	NN	B-NP	O
of	of	IN	B-PP	O
fibrinolytic	BEGIN-fibrin-INSIDEolytic	JJ	B-NP	I
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
revealed	reveal	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
1	1	CD	I-NP	O
cases	case	NNS	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O

In	In	IN	B-PP	O
lyzozyme	BEGIN-lyzozyme-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
periodicity	periodicity	NN	B-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
groups	group	NNS	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
youngest	young	JJS	I-NP	O
foals	foal	NNS	I-NP	O

Alternative	Alternative	JJ	B-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
DNA	DNA	NN	I-NP	O
motifs	motif	NNS	I-NP	O
as	as	IN	B-PP	O
activators	activator	NNS	B-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
mRNA	mRNA	NN	I-NP	O
transcription	transcription	NN	I-NP	O
and	and	CC	B-PP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
initiator	initiator	NN	I-NP	O
element	element	NN	I-NP	O
for	for	IN	B-PP	O
late	late	JJ	B-NP	O
mRNA	mRNA	NN	I-NP	O
transcription	transcription	NN	I-NP	O
help	help	NN	I-NP	O
explain	explain	VB	B-VP	O
how	how	WRB	B-ADVP	O
polyomavirus	polyomavirus	NN	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
during	during	IN	B-PP	O
lytic	lytic	JJ	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
during	during	IN	B-PP	O
development	development	NN	B-NP	O

The	The	DT	B-NP	O
median	median	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
t	BEGIN-t	NN	B-NP	B
-	-	HYPH	B-NP	I
PA	PA	NN	I-NP	I
Ag	Ag-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
PAI	BEGIN-PAI-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
were	be	VBD	B-VP	O
respectively	respectively	RB	B-NP	O
1	1	CD	I-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
(	(	(	O	O
interquartile	interquartile	JJ	B-NP	O
range	range	NN	I-NP	O
1	1	CD	I-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
(	(	(	O	O
interquartile	interquartile	JJ	B-NP	O
range	range	NN	I-NP	O
1	1	CD	I-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
Mer1	BEGIN-BEGIN-Mer1-INSIDE	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
KH	KH	NN	I-NP	O
motif	motif	NN	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
RNA	RNA	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
RNA	RNA	NN	B-NP	O
gel	gel	NN	I-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Mer1	BEGIN-Mer1-INSIDE	NN	B-NP	B
binds	bind	VBZ	B-VP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-PP	O
MER1	BEGIN-MER1	NN	B-NP	B
RNA	RNA-INSIDE	NN	I-NP	I

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
EGF	BEGIN-EGF-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
stimulated	stimulate	VBN	B-NP	O
mitotic	mitotic	JJ	I-NP	O
growth	growth	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
absolutely	absolutely	RB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
stat1	BEGIN-stat1-INSIDE	NN	I-NP	B
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
such	such	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
complexes	complex	NNS	I-NP	O
are	be	VBP	B-VP	O
more	more	RBR	B-ADJP	O
complex	complex	JJ	I-ADJP	O
than	than	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
reported	report	VBN	B-VP	O

A	A	DT	B-NP	O
procaryotic	procaryotic	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
factor	factor	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
histone	BEGIN-histone	NN	I-NP	B
H1	H1	NN	I-NP	I
-	-	HYPH	B-VP	I
like	like	JJ	B-NP	I
carboxy	carboxy	AFX	I-NP	I
-	-	HYPH	I-NP	I
terminal	terminal	JJ	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
:	:	:	O	O
clonal	clonal	JJ	B-NP	O
variation	variation	NN	I-NP	O
of	of	IN	B-PP	O
repeats	repeat	NNS	B-NP	O
within	within	IN	B-PP	O
algP	BEGIN-algP-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
mucoidy	mucoidy	NN	B-NP	O
in	in	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O

Innervation	Innervation	NN	B-NP	O
of	of	IN	B-PP	O
reticular	reticular	JJ	B-NP	O
papillae	papilla	NNS	I-NP	O
in	in	IN	B-PP	O
sheep	sheep	NNS	B-NP	O
and	and	CC	I-NP	O
goats	goat	NNS	I-NP	O

The	The	DT	B-NP	O
monkeys	monkey	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
administered	administer	VBN	I-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
lead	lead	NN	I-NP	O
isotope	isotope	NN	I-NP	O
``	``	``	I-NP	O
mix	mix	NN	I-NP	O
''	''	''	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
Pb	Pb	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
body	body	NN	I-NP	O
wt	wt	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
from	from	IN	B-PP	O
age	age	NN	B-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
start	start	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
palindromic	palindromic	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
located	locate	VBN	B-VP	O
at	at	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
cutinase	BEGIN-cutinase	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
Fusarium	Fusarium	NNP	B-NP	O
solani	solani	NNP	I-NP	O
f.	f.	NN	I-NP	O
sp.	sp.	NN	I-NP	O
pisi	pisi	NN	I-NP	O
(	(	(	O	O
Nectria	Nectria	NN	B-NP	O
haematococca	haematococca	NN	I-NP	O
mating	mat	VBG	B-VP	O
type	type	NN	B-NP	O
VI	VI	CD	I-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
hydroxy	hydroxy	NN	I-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
from	from	IN	B-PP	O
plant	plant	NN	B-NP	O
cutin	cutin	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
protein	protein	NN	I-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
promoter	promoter	NN	I-NP	O
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
this	this	DT	B-NP	O
element	element	NN	I-NP	O

In	In	IN	B-PP	O
cells	cell	NNS	B-NP	O
co	co	AFX	O	O
-	-	HYPH	O	O
expressing	express	VBG	B-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B
)	)	)	O	O
kinase	kinase	NN	B-NP	O
(	(	(	O	O
MKK1	BEGIN-MKK1-INSIDE	NN	B-NP	B
)	)	)	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
mitogen	mitogen	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
cyclin	BEGIN-cyclin	NN	I-NP	B
D1	D1-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

ANL	ANL	NN	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

Pig	Pig	NNP	B-NP	O
uPA	BEGIN-uPA-INSIDE	NN	I-NP	B
promoter	promoter	NN	I-NP	O
-	-	HYPH	B-NP	O
CAT	BEGIN-CAT-INSIDE	NN	I-NP	B
constructs	construct	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
active	active	JJ	I-ADJP	O
than	than	IN	B-PP	O
mouse	mouse	NN	B-NP	O
constructs	construct	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
assay	assay	NN	I-NP	O

Thermal	Thermal	JJ	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bovine	bovine	JJ	I-NP	O
uterus	uterus	NN	I-NP	O
following	follow	VBG	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
estradiol	estradiol	NN	B-NP	O
-	-	HYPH	O	O
1beta	1beta	NN	B-NP	O

Elements	Element	NNS	B-NP	O
regulating	regulate	VBG	B-VP	O
cell	cell	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
stage	stage	NN	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C.	C.	NNP	I-NP	O
elegans	elegans	NNP	I-NP	O
MyoD	BEGIN-MyoD-INSIDE	NNP	I-NP	B
family	family	NN	I-NP	O
homolog	homolog	NN	I-NP	O
hlh	BEGIN-hlh	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Restriction	Restriction	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
genomic	genomic	JJ	I-NP	O
clones	clone	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
endogenous	endogenous	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
abutting	abut	VBG	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
ends	end	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
A	A	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
K	K	NN	I-NP	O
transgenes	transgene	NNS	I-NP	O
are	be	VBP	B-VP	O
separated	separate	VBN	I-VP	O
by	by	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
,	,	,	O	O
providing	provide	VBG	B-VP	O
strong	strong	JJ	B-NP	O
support	support	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
single	single	JJ	I-NP	O
integration	integration	NN	I-NP	O
model	model	NN	I-NP	O

The	The	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
for	for	IN	B-PP	O
ergometry	ergometry	NN	B-NP	O
and	and	CC	I-NP	O
treadmill	treadmill	NN	I-NP	O
testing	testing	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
respectively	respectively	RB	B-ADVP	O

All	All	PDT	B-NP	O
these	these	DT	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
after	after	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O

The	The	DT	B-NP	O
STS	BEGIN-STS	JJ	I-NP	B
sequence	sequence	NN	I-NP	I
WI	WI	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
untranslated	untranslated	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
PUNC	PUNC	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Four	Four	CD	B-NP	O
antifungal	antifungal	JJ	I-NP	O
agents	agent	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
:	:	:	O	O
amphotericin	amphotericin	NN	B-NP	O
B	B	NN	I-NP	O
,	,	,	O	O
flucytosine	flucytosine	NN	B-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ketoconazole	ketoconazole	NN	B-NP	O

Phylogenetic	Phylogenetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	O
,	,	,	O	O
invertebrate	invertebrate	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
mammalian	mammalian	JJ	I-NP	O
isoforms	isoform	NNS	I-NP	O
of	of	IN	B-PP	O
SNF1	BEGIN-SNF1-INSIDE	NN	B-NP	B
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
duplication	duplication	NN	I-NP	O
likely	likely	RB	B-VP	O
occurred	occur	VBD	I-VP	O
early	early	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
metazoan	metazoan	NN	I-NP	O
lineage	lineage	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
loci	locus	NNS	I-NP	O
are	be	VBP	B-VP	O
relatively	relatively	RB	B-ADJP	O
divergent	divergent	JJ	I-ADJP	O

Blood	Blood	NN	B-NP	O
samples	sample	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
via	via	IN	B-PP	O
an	an	DT	B-NP	O
indwelling	indwell	VBG	I-NP	O
arm	arm	NN	I-NP	O
catheter	catheter	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
at	at	IN	B-PP	O
minutes	minute	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
exercise	exercise	NN	B-NP	O
for	for	IN	B-PP	O
determinations	determination	NNS	B-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	O
EPI	EPI	NN	I-NP	O
,	,	,	O	O
serum	serum	NN	B-NP	O
free	free	JJ	I-NP	O
fatty	fatty	JJ	I-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
FFA	FFA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
serum	serum	NN	B-NP	O
glycerol	glycerol	NN	I-NP	O
(	(	(	O	O
GLY	GLY	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
(	(	(	O	O
GLU	GLU	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
lactate	lactate	NN	I-NP	O
(	(	(	O	O
LA	LA	NN	B-NP	O
)	)	)	O	O
concentrations	concentration	NNS	B-NP	O

The	The	DT	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	I-NP	I
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
precursor	precursor	NN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
lyt	BEGIN-lyt	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
,	,	,	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
)	)	)	O	O
generates	generate	VBZ	B-VP	O
after	after	IN	B-PP	O
proteolytic	proteolytic	JJ	B-NP	O
processing	processing	NN	I-NP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
subunit	subunit	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
kappa	BEGIN-kappa	NN	B-NP	B
B	B	NN	I-NP	I
-	-	HYPH	O	I
motifs	motifs-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
delta	delta	NN	I-NP	O
mean	mean	NN	I-NP	O
VAF	VAF	NNP	I-NP	O
and	and	CC	O	O
delta	delta	SYM	B-NP	O
mean	mean	NN	I-NP	O
SABP	SABP	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
varied	vary	VBD	B-VP	O
mean	mean	JJ	B-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
VAF	VAF	NN	B-NP	O
and	and	CC	I-NP	O
SABP	SABP	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Gel	Gel	NN	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
reveal	reveal	VBP	B-VP	O
that	that	IN	B-SBAR	O
FRTL	FRTL	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
thyroid	thyroid	NN	I-NP	O
cell	cell	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
form	form	VBP	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
protein	protein	NN	I-NP	O
/	/	SYM	B-NP	O
DNA	DNA	NN	I-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
prevented	prevent	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
TTF	BEGIN-BEGIN-TTF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
element	element-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
the	the	DT	B-NP	O
TG	BEGIN-TG	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
;	;	:	O	O
FRT	FRT	NN	B-NP	O
and	and	CC	I-NP	O
BRL	BRL	NN	I-NP	O
cell	cell	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
TTF	BEGIN-TTF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
form	form	VB	I-VP	O
this	this	DT	B-NP	O
complex	complex	NN	I-NP	O

The	The	DT	B-NP	O
rice	rice	NN	I-NP	O
gene	gene	NN	I-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
exons	exon	NNS	I-NP	O

Thallium	Thallium	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
scintigraphy	scintigraphy	NN	I-NP	O
after	after	IN	B-PP	O
dipyridamole	dipyridamole	NN	B-NP	O
infusion	infusion	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
level	level	NN	I-NP	O
exercise	exercise	NN	I-NP	O

Dominant	Dominant	JJ	B-NP	O
-	-	HYPH	I-NP	O
negative	negative	JJ	I-NP	O
upf1	BEGIN-upf1-INSIDE	NN	I-NP	B
mutations	mutation	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
following	follow	VBG	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
UPF1	BEGIN-UPF1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ORFs	ORF	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Methanococcus	Methanococcus	NNP	I-NP	O
jannaschii	jannaschii	NN	I-NP	O
genome	genome	NN	I-NP	O
possesses	possess	VBZ	B-VP	O
high	high	JJ	B-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
M.	BEGIN-M.	JJ	I-NP	B
aeolicus	aeolicus	NN	I-NP	I
ilvB	ilvB-INSIDE	NN	I-NP	I
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
authentic	authentic	JJ	I-NP	O
AHAS	BEGIN-AHAS-INSIDE	NN	I-NP	B

It	It	PRP	B-NP	O
differed	differ	VBD	B-VP	O
from	from	IN	B-PP	O
cued	cue	VBN	B-NP	O
recall	recall	NN	I-NP	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
instructions	instruction	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
directed	direct	VBD	B-VP	O
subjects	subject	NNS	B-NP	O
away	away	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
memory	memory	NN	I-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
asked	ask	VBD	B-VP	O
them	them	PRP	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
each	each	DT	B-NP	O
three	three	CD	I-NP	O
-	-	HYPH	I-NP	O
letter	letter	NN	I-NP	O
cue	cue	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
word	word	NN	I-NP	O
that	that	WDT	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-VP	O
mind	mind	VB	I-VP	O

Such	Such	JJ	B-NP	O
saturation	saturation	NN	I-NP	O
often	often	RB	B-ADVP	O
occurs	occur	VBZ	B-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
recording	record	VBG	I-NP	O
sweeps	sweep	NNS	I-NP	O
after	after	IN	B-PP	O
large	large	JJ	B-NP	O
amplitude	amplitude	NN	I-NP	O
signals	signal	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
eye	eye	NN	B-NP	O
blinks	blink	NNS	I-NP	O
are	be	VBP	B-VP	O
rejected	reject	VBN	I-VP	O

To	To	TO	B-VP	O
define	define	VB	I-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
regulating	regulate	VBG	B-VP	O
FGFR	BEGIN-FGFR	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
proliferating	proliferate	VBG	B-VP	O
myoblasts	myoblast	NNS	B-NP	O
and	and	CC	O	O
post	post	AFX	B-NP	O
-	-	HYPH	I-NP	O
mitotic	mitotic	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
fibers	fiber	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
partially	partially	RB	B-VP	O
characterized	characterize	VBD	I-VP	O
the	the	DT	B-NP	O
avian	avian	JJ	I-NP	O
FGFR	BEGIN-FGFR	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O

Samarium	Samarium	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
intravascular	intravascular	JJ	B-NP	O
irradiation	irradiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
liquid	liquid	NN	B-NP	O
-	-	HYPH	B-NP	O
filled	fill	VBN	I-NP	O
balloons	balloon	NNS	I-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
restenosis	restenosis	NN	B-NP	O
:	:	:	O	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
long	long	JJ	I-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
hypercholesterolemic	hypercholesterolemic	JJ	I-NP	O
rabbit	rabbit	NN	I-NP	O
restenosis	restenosis	NN	I-NP	O
model	model	NN	I-NP	O

This	This	DT	B-NP	O
element	element	NN	I-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
both	both	CC	O	O
basal	basal	JJ	B-NP	O
and	and	CC	O	O
activated	activate	VBN	B-VP	O
expression	expression	NN	B-NP	O
and	and	CC	O	O
almost	almost	RB	B-ADVP	O
certainly	certainly	RB	I-ADVP	O
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
TATA	BEGIN-TATA	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	JJ	B-NP	I
interaction	interaction	NN	I-NP	O
site	site	NN	I-NP	O

This	This	DT	B-NP	O
report	report	NN	I-NP	O
establishes	establish	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
homozygous	homozygous	JJ	B-NP	O
sickle	sickle	JJ	I-NP	O
cell	cell	NN	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
growth	growth	NN	B-NP	O
patterns	pattern	NNS	I-NP	O
in	in	IN	B-PP	O
childhood	childhood	NN	B-NP	O
is	be	VBZ	B-VP	O
apparent	apparent	JJ	B-ADJP	O
before	before	IN	B-SBAR	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O

But	But	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
hemispheres	hemisphere	NNS	I-NP	O
differ	differ	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
manner	manner	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
they	they	PRP	B-NP	O
make	make	VBP	B-VP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
semantic	semantic	JJ	B-NP	O
structures	structure	NNS	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
hemisphere	hemisphere	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
selective	selective	JJ	I-NP	O
manner	manner	NN	I-NP	O
,	,	,	O	O
appropriate	appropriate	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
solution	solution	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
task	task	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hemisphere	hemisphere	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
diffuse	diffuse	JJ	I-NP	O
and	and	CC	I-NP	O
global	global	JJ	I-NP	O
manner	manner	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
reveal	reveal	VBP	B-VP	O
preferences	preference	NNS	B-NP	O
for	for	IN	B-PP	O
particular	particular	JJ	B-NP	O
initiating	initiate	VBG	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O
(	(	(	O	O
ATP	ATP	NN	B-NP	O
>	>	SYM	B-VP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
GTP	GTP	NN	B-NP	O
>	>	SYM	B-NP	O
UTP	UTP	NN	I-NP	O
>	>	SYM	B-NP	O
>	>	SYM	B-NP	O
CTP	CTP	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
for	for	IN	B-PP	O
starting	start	VBG	B-VP	O
positions	position	NNS	B-NP	O
downstream	downstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Pribnow	Pribnow	NN	I-NP	O
box	box	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
>	>	SYM	O	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
>	>	SYM	I-NP	O
1	1	CD	I-NP	O
>	>	SYM	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

We	We	PRP	B-NP	O
determined	determine	VBD	B-VP	O
that	that	IN	B-SBAR	O
Hop	BEGIN-Hop	NN	B-NP	B
(	(	(	O	I
T1	T1	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
glutamic	glutamic	JJ	I-NP	O
acid	acid	NN	I-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
lysine	lysine	NN	I-NP	O
substitution	substitution	NN	I-NP	O
at	at	IN	B-PP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
residue	residue	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
E1K	E1K	NN	B-NP	O
)	)	)	O	O

Androgen	Androgen	NN	B-NP	O
ablation	ablation	NN	I-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
later	later	RB	B-ADVP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
of	of	IN	B-PP	O
tail	tail	NN	B-NP	O
tip	tip	NN	I-NP	O
necrosis	necrosis	NN	I-NP	O
in	in	IN	B-PP	O
kittens	kitten	NNS	B-NP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
neonatal	neonatal	JJ	B-NP	O
isoerythrolysis	isoerythrolysis	NN	I-NP	O
or	or	CC	I-NP	O
isoagglutination	isoagglutination	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O

Men	Men	NN	B-NP	O
and	and	CC	I-NP	O
women	woman	NNS	I-NP	O
entering	enter	VBG	B-VP	O
psychotherapy	psychotherapy	NN	B-NP	O
more	more	RBR	B-ADVP	O
often	often	RB	I-ADVP	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
Wish	Wish	NNP	I-NP	O
elements	element	NNS	I-NP	O
than	than	IN	B-PP	O
others	other	NNS	B-NP	O

This	This	DT	B-NP	O
clone	clone	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
identifying	identify	VBG	B-VP	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
determinants	determinant	NNS	I-NP	O
of	of	IN	B-PP	O
FIV	FIV	CD	B-NP	O
-	-	HYPH	O	O
Oma	Oma	NNP	B-NP	O
's	's	POS	B-NP	O
biological	biological	JJ	I-NP	O
activities	activity	NNS	I-NP	O

Serum	BEGIN-Serum	NN	B-NP	B
prolactin	prolactin-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
oestradiol	oestradiol	NN	I-NP	O
levels	level	NNS	I-NP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
puberty	puberty	NN	B-NP	O

The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
revealed	reveal	VBD	B-VP	O
pure	pure	JJ	B-NP	O
CAG	CAG	NN	I-NP	O
stretches	stretch	NNS	I-NP	O

Total	Total	JJ	B-NP	O
body	body	NN	I-NP	O
BMD	BMD	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
femoral	femoral	JJ	B-NP	O
neck	neck	NN	I-NP	O
BMD	BMD	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
positively	positively	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
weight	weight	NN	B-NP	O
-	-	HYPH	O	O
bearing	bear	VBG	B-VP	O
activity	activity	NN	B-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
with	with	IN	I-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
weight	weight	NN	I-NP	O
-	-	HYPH	O	O
bearing	bear	VBG	B-VP	O
activity	activity	NN	B-NP	O

PCC	PCC	NN	B-NP	O
1	1	CD	I-NP	O
mutant	mutant	NN	I-NP	O
impaired	impaired	JJ	B-ADJP	O
in	in	IN	B-PP	O
cytochrome	BEGIN-cytochrome	NN	B-NP	B
c	c-INSIDE	NN	I-NP	I
maturation	maturation	NN	I-NP	O

Ureases	BEGIN-Ureases-INSIDE	NN	B-NP	B
were	be	VBD	B-VP	O
purified	purify	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
shown	show	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
enzyme	enzyme	NN	B-NP	O
when	when	WRB	B-ADVP	O
analyzed	analyze	VBN	B-VP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
filtration	filtration	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
and	and	CC	O	O
sodium	sodium	NN	B-NP	O
dodecyl	dodecyl	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
-	-	HYPH	B-NP	O
polyacrylamide	polyacrylamide	NN	I-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
every	every	DT	B-NP	O
case	case	NN	I-NP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
levels	level	NNS	I-NP	O
correlated	correlate	VBD	B-VP	O
to	to	TO	I-VP	O
nickel	nickel	VB	I-VP	O
contents	content	NNS	B-NP	O
as	as	IN	B-SBAR	O
analyzed	analyze	VBN	B-VP	O
by	by	IN	B-PP	O
atomic	atomic	JJ	B-NP	O
absorption	absorption	NN	I-NP	O
analysis	analysis	NN	I-NP	O

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
catfish	catfish	NN	I-NP	O
JH	BEGIN-JH-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
CH	BEGIN-CH-INSIDE	NN	I-NP	B
intron	intron	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
several	several	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
which	which	WDT	B-NP	O
appear	appear	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
important	important	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
elements	element	NNS	I-NP	O
found	find	VBN	B-VP	O
within	within	IN	B-PP	O
JH	BEGIN-JH-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
CH	BEGIN-CH-INSIDE	NN	I-NP	B
introns	intron	NNS	I-NP	O
of	of	IN	B-PP	O
higher	high	JJR	B-NP	O
vertebrates	vertebrate	NNS	I-NP	O

Seroconversion	Seroconversion	NN	B-NP	O
after	after	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
vaccination	vaccination	NN	I-NP	O

On	On	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
m	m	NN	I-NP	O
,	,	,	O	O
RI	RI	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
body	body	NN	B-NP	O
weight	weight	NN	I-NP	O
(	(	(	O	O
BW	BW	NN	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
SL	SL	NN	B-NP	O
but	but	CC	O	O
AI	AI	NN	B-NP	O
maintained	maintain	VBD	B-VP	O
it	it	PRP	B-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
CBP	BEGIN-CBP-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
potentiated	potentiate	VBD	B-VP	O
HS1	HS1	NN	B-NP	O
-	-	HYPH	O	O
mediated	mediate	VBN	B-NP	O
transactivation	transactivation	NN	I-NP	O

The	The	DT	B-NP	O
perforated	perforate	VBN	I-NP	O
splint	splint	NN	I-NP	O
gives	give	VBZ	B-VP	O
superior	superior	JJ	B-NP	O
results	result	NNS	I-NP	O
by	by	IN	B-PP	O
virtue	virtue	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
for	for	IN	B-PP	O
purposes	purpose	NNS	B-NP	O
of	of	IN	B-PP	O
hygiene	hygiene	NN	B-NP	O
and	and	CC	O	O
can	can	MD	B-VP	O
thus	thus	RB	I-VP	O
produce	produce	VB	I-VP	O
a	a	DT	B-NP	O
satisfactory	satisfactory	JJ	I-NP	O
result	result	NN	I-NP	O
even	even	RB	B-ADVP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
fail	fail	VBP	B-VP	O
to	to	TO	I-VP	O
grasp	grasp	VB	I-VP	O
the	the	DT	B-NP	O
technique	technique	NN	I-NP	O
of	of	IN	B-PP	O
removal	removal	NN	B-NP	O
and	and	CC	I-NP	O
replacement	replacement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
splint	splint	NN	I-NP	O

Using	Use	VBG	B-VP	O
lasers	laser	NNS	B-NP	O
in	in	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
wound	wound	NN	I-NP	O
healing	healing	NN	I-NP	O

Protein	Protein	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
disorders	disorder	NNS	I-NP	O
in	in	IN	B-PP	O
burns	burn	NNS	B-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Gq	BEGIN-Gq-INSIDE	NN	I-NP	B
-	-	HYPH	B-VP	O
coupled	couple	VBN	B-NP	O
alpha	alpha	NN	I-NP	O
1B	1B	NN	I-NP	O
AR	AR	NN	I-NP	O
or	or	CC	O	O
M1	BEGIN-M1-INSIDE	NN	B-NP	B
muscarinic	BEGIN-muscarinic	JJ	I-NP	B
cholinergic	cholinergic	JJ	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
unaffected	unaffected	JJ	B-ADJP	O
by	by	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
beta	BEGIN-beta	NN	B-NP	B
ARKct	ARKct-INSIDE	NN	I-NP	I
or	or	CC	O	O
RasN1	BEGIN-RasN1-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
PTK	BEGIN-PTK-INSIDE	NN	B-NP	B
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
N	BEGIN-N	NN	B-NP	B
delta	delta	NN	I-NP	I
Raf	Raf-INSIDE	NN	I-NP	I
or	or	CC	B-PP	O
by	by	IN	B-PP	O
PKC	BEGIN-PKC-INSIDE	NN	B-NP	B
depletion	depletion	NN	I-NP	O

RNA	RNA	NN	B-NP	O
unwinding	unwinding	NN	I-NP	O
in	in	IN	B-PP	O
U1	BEGIN-U1-INSIDE	NN	B-NP	B
/	/	SYM	O	O
U1	BEGIN-U1-INSIDE	NN	B-NP	B
snRNPs	snRNP	NNS	I-NP	O
requires	require	VBZ	B-VP	O
ATP	ATP	NN	B-NP	O
hydrolysis	hydrolysis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
DEIH	DEIH	NN	I-NP	O
-	-	HYPH	I-NP	O
box	box	NN	I-NP	O
splicing	splicing	NN	I-NP	O
factor	factor	NN	I-NP	O
Brr1	BEGIN-Brr1-INSIDE	NN	I-NP	B

Extra	Extra	NNP	B-NP	O
dose	dose	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
extravehicular	extravehicular	JJ	B-NP	O
activity	activity	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
NASA1	NASA1	NN	I-NP	O
mission	mission	NN	I-NP	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
on	on	IN	B-PP	O
-	-	HYPH	B-NP	O
board	board	NN	I-NP	O
TLD	TLD	NN	I-NP	O
system	system	NN	I-NP	O

Preface	Preface	NN	B-NP	O
and	and	CC	I-NP	O
acknowledgements	acknowledgement	NNS	I-NP	O

G	BEGIN-G	NN	B-NP	B
-	-	HYPH	O	I
CSF	CSF-INSIDE	NN	B-NP	I
(	(	(	O	O
1	1	CD	B-NP	O
microg	microg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
+1	+1	CD	I-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
engrafted	engraft	VBN	B-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
median	median	JJ	I-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
range	range	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
until	until	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
median	median	JJ	I-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
range	range	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
until	until	IN	B-PP	O
platelets	platelet	NNS	B-NP	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
/	/	SYM	O	O
l	l	NN	B-NP	O
(	(	(	O	O
ie	ie	NN	B-NP	O
platelet	platelet	NN	I-NP	O
transfusion	transfusion	NN	I-NP	O
independence	independence	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fluorouracil	fluorouracil	NN	I-NP	O
regimen	regimen	NN	I-NP	O
shows	show	VBZ	B-VP	O
weak	weak	JJ	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
advanced	advance	VBN	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
which	which	WDT	B-NP	O
seems	seem	VBZ	B-VP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-VP	O
gemcitabine	gemcitabine	VB	I-VP	O

At	At	IN	B-PP	O
D1	D1	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
automatic	automatic	JJ	B-NP	O
mode	mode	NN	I-NP	O
switch	switch	NN	I-NP	O
prompted	prompt	VBN	B-VP	O
by	by	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
a	BEGIN-a	NN	B-NP	B
-	-	HYPH	B-NP	I
factor	factor	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
endocytosis	endocytosis	NN	I-NP	O
and	and	CC	O	O
consequent	consequent	JJ	B-NP	O
vacuolar	vacuolar	JJ	I-NP	O
turnover	turnover	NN	I-NP	O
depend	depend	VBP	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
available	available	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
ubiquitin	BEGIN-ubiquitin-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O

Early	Early	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
and	and	CC	O	O
early	early	JJ	B-NP	O
surgical	surgical	JJ	I-NP	O
division	division	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
biliary	biliary	JJ	I-NP	O
tract	tract	NN	I-NP	O
and	and	CC	O	O
pancreatic	pancreatic	JJ	B-NP	O
duct	duct	NN	I-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
for	for	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
AAPBD	AAPBD	NN	B-NP	O

This	This	DT	B-NP	O
approach	approach	NN	I-NP	O
allowed	allow	VBD	B-VP	O
examination	examination	NN	B-NP	O
of	of	IN	B-PP	O
baseline	baseline	NN	B-NP	O
factors	factor	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
mileage	mileage	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	O
problem	problem	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
another	another	DT	B-NP	O
health	health	NN	I-NP	O
problem	problem	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
dropout	dropout	NN	B-NP	O

Increased	Increase	VBN	B-NP	O
gliadin	BEGIN-gliadin	NN	I-NP	B
antibody	antibody-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
more	more	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
subtotal	subtotal	JJ	B-NP	O
villous	villous	JJ	I-NP	O
atrophy	atrophy	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
1	1	CD	B-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
partial	partial	JJ	B-NP	O
villous	villous	JJ	I-NP	O
atrophy	atrophy	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
1	1	CD	B-NP	O
)	)	)	O	O
or	or	CC	O	O
normal	normal	JJ	B-NP	O
villous	villous	JJ	I-NP	O
appearance	appearance	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
1	1	CD	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
cefazolin	cefazolin	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
III	III	CD	I-NP	O
cerebral	cerebral	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
doses	dose	NNS	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
on	on	IN	B-PP	O
GABA	GABA	NN	B-NP	O
content	content	NN	I-NP	O
,	,	,	O	O
GAD	GAD	NN	B-NP	O
and	and	CC	I-NP	O
GABA	GABA	NN	I-NP	O
-	-	HYPH	O	O
T	T	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
-	-	HYPH	B-NP	O
stem	stem	NN	I-NP	O
of	of	IN	B-PP	O
young	young	JJ	B-NP	O
chickens	chicken	NNS	I-NP	O
(	(	(	O	O
Gallus	Gallus	NN	B-NP	O
domesticus	domesticus	NN	I-NP	O
)	)	)	O	O

This	This	DT	B-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
confer	confer	VB	I-VP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
activation	activation	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
heterologous	heterologous	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
and	and	CC	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
sequence	sequence	NN	I-NP	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
shift	shift	NN	I-NP	O
analysis	analysis	NN	I-NP	O

CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
assays	assay	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
RXRalpha	BEGIN-RXRalpha-INSIDE	NN	B-NP	B
conferred	confer	VBD	B-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
RA	RA	NN	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
our	our	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-SBAR	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	O	O
RA	RA	NN	B-NP	O
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
potent	potent	JJ	I-ADJP	O
than	than	IN	B-PP	O
all	all	DT	B-NP	O
-	-	HYPH	B-VP	O
trans	trans	AFX	O	O
-	-	HYPH	O	O
RA	RA	NN	B-NP	O
for	for	IN	B-PP	O
inducing	induce	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AFP	BEGIN-AFP	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
N	N	NN	B-NP	O
region	region	NN	I-NP	O
diversity	diversity	NN	I-NP	O
at	at	IN	B-PP	O
V-INSIDE	BEGIN-V-INSIBEGIN-D-INSIDEE	NN	B-NP	I
(	(	(	O	O
D	BEGIN-D-INSIDE	NN	B-NP	B
)	)	)	O	O
J	BEGIN-J-INSIDE	NN	B-NP	B
junctions	junction	NNS	I-NP	O
within	within	IN	B-PP	O
rearranged	rearrange	VBN	B-NP	O
immunoglobulin	BEGIN-immunoglobulin-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
T	BEGIN-T	NN	I-NP	B
cell	cell	NN	I-NP	I
receptor	receptor	NN	I-NP	I
gene	gene	NN	I-NP	I
loci-INSIDE	loci-INSIBEGIN-D-INSIDEE	NN	I-NP	I
can	can	MD	B-VP	O
only	only	RB	I-VP	O
be	be	VB	I-VP	O
introduced	introduce	VBN	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
RAG	BEGIN-RAG-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
catalyzed	catalyze	VBN	I-NP	O
DNA	BEGIN-D-INSIDENA	NN	I-NP	I
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
strand	strand	NN	I-NP	O
breaks	break	NNS	I-NP	O
,	,	,	O	O
i.e.	i.e.	FW	B-PP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
DNA	BEGIN-D-INSIDENA	NN	I-NP	I
end	end	NN	I-NP	O
joining	join	VBG	B-VP	O
phase	phase	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
V-INSIDE	BEGIN-V-INSIBEGIN-D-INSIDEE	NN	I-NP	I
(	(	(	O	O
D	BEGIN-D-INSIDE	NN	B-NP	B
)	)	)	O	O
J	BEGIN-J-INSIDE	NN	B-NP	B
recombination	recombination	NN	I-NP	O
reaction	reaction	NN	I-NP	O

The	The	DT	B-NP	O
pra1	BEGIN-pra1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
pea	BEGIN-pea	NNP	I-NP	B
(	(	(	O	I
Pisum	Pisum	NNP	B-NP	I
sativum	sativum	NNP	I-NP	I
)	)	)	O	I
small	small	JJ	B-NP	I
GTPase	GTPase-INSIDE	NN	I-NP	I
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
YPT	BEGIN-YPT-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
rab	BEGIN-rab-INSIDE	NN	I-NP	B
family	family	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
down	down	RB	B-ADVP	O
-	-	HYPH	B-NP	O
regulated	regulate	VBN	B-VP	O
by	by	IN	B-PP	O
light	light	NN	B-NP	O
,	,	,	O	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
phytochrome	BEGIN-phytochrome-INSIDE	NN	B-NP	B

To	To	TO	B-VP	O
directly	directly	RB	I-VP	O
address	address	VB	I-VP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
a	a	DT	B-NP	O
tetracycline	tetracycline	NN	I-NP	O
-	-	HYPH	O	O
regulated	regulate	VBN	B-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
U1OS	U1OS	NN	I-NP	O
osteosarcoma	osteosarcoma	NN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
found	find	VBD	I-VP	O
that	that	IN	B-SBAR	O
BCL1	BEGIN-BCL1-INSIDE	NN	B-NP	B
mediates	mediate	VBZ	B-VP	O
growth	growth	NN	B-NP	O
suppression	suppression	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
S	S	NN	I-NP	O
phase	phase	NN	I-NP	O
progression	progression	NN	I-NP	O
and	and	CC	O	O
apoptosis	apoptosis	NN	B-NP	O

Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
water	water	NN	B-NP	O
and	and	CC	I-NP	O
electrolyte	electrolyte	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
and	and	CC	I-NP	O
edema	edema	NN	I-NP	O
formation	formation	NN	I-NP	O
after	after	IN	B-PP	O
acute	acute	JJ	B-NP	O
,	,	,	I-NP	O
drug	drug	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
hypertension	hypertension	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
albino	albino	NN	B-NP	O
rabbits	rabbit	NNS	I-NP	O

The	The	DT	B-NP	O
amino	BEGIN-amino	NN	I-NP	B
-	-	HYPH	O	I
terminal	terminal	JJ	B-NP	I
gag	BEGIN-gag-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
encoded	encode	VBN	B-NP	O
region	region-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
P1gag	BEGIN-P1BEGIN-gag-INSIDE-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
fps	BEGIN-fps-INSIDE	NN	I-NP	B
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
phosphotyrosine	phosphotyrosine	NN	I-NP	O
residue	residue	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
gag	BEGIN-gag-INSIDE	NN	I-NP	B
phosphorylation	phosphorylation	NN	I-NP	O
sites	site	NNS	I-NP	O

To	To	TO	B-VP	O
explore	explore	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
on	on	IN	B-PP	O
cardiovascular	cardiovascular	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
groups	group	NNS	B-NP	O
of	of	IN	B-PP	O
newborn	newborn	JJ	B-NP	O
rats	rat	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
ppm	ppm	NN	I-NP	O
CO	CO	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
development	development	NN	B-NP	O
continued	continue	VBN	B-VP	O
in	in	IN	B-PP	O
ambient	ambient	JJ	B-NP	O
air	air	NN	I-NP	O

The	The	DT	B-NP	O
subjects	subject	NNS	I-NP	O
'	'	POS	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
ventilated	ventilate	VBN	I-VP	O
with	with	IN	B-PP	O
N1O	N1O	NN	B-NP	O
in	in	IN	B-PP	O
O1	O1	NN	B-NP	O
(	(	(	O	O
FIO1	FIO1	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
-	-	HYPH	B-NP	O
tidal	tidal	JJ	I-NP	O
CO1	CO1	NN	I-NP	O
present	present	JJ	B-ADJP	O
before	before	IN	B-PP	O
anesthesia	anesthesia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
CBF	CBF	NN	B-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
using	use	VBG	B-VP	O
intravenous	intravenous	JJ	B-NP	O
1Xe	1Xe	NN	I-NP	O
and	and	CC	O	O
ten	ten	CD	B-NP	O
scintillation	scintillation	NN	I-NP	O
counters	counter	NNS	I-NP	O
,	,	,	O	O
five	five	CD	B-NP	O
over	over	IN	B-PP	O
each	each	DT	B-NP	O
cerebral	cerebral	JJ	I-NP	O
hemisphere	hemisphere	NN	I-NP	O

Cutaneous	Cutaneous	JJ	B-NP	O
melanoma	melanoma	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
retinoblastoma	retinoblastoma	NN	I-NP	O

This	This	DT	B-NP	O
complex	complex	NN	I-NP	O
was	be	VBD	B-VP	O
eliminated	eliminate	VBN	I-VP	O
by	by	IN	B-PP	O
mutation	mutation	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	B-NP	O
half	half	JJ	I-NP	O
-	-	HYPH	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
supershifted	supershifte	VBN	I-VP	O
by	by	IN	B-PP	O
antibodies	antibody	NNS	B-NP	O
against	against	IN	B-PP	O
chicken	BEGIN-chicken	JJ	B-NP	B
ovalbumin	ovalbumin	NN	I-NP	I
upstream	upstream	JJ	I-NP	I
promoter	promoter	NN	I-NP	I
-	-	HYPH	O	I
transcription	transcription	NN	B-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
COUP	BEGIN-COUP	NN	B-NP	B
-	-	HYPH	B-NP	I
TF	TF-INSIDE	NN	I-NP	I
)	)	)	O	O

Polymorphisms	Polymorphism	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CCR1	BEGIN-CCR1	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
African	African	JJ	B-NP	O
green	green	JJ	I-NP	O
monkeys	monkey	NNS	I-NP	O
and	and	CC	I-NP	O
mice	mouse	NNS	I-NP	O
implicate	implicate	VBP	B-VP	O
specific	specific	JJ	B-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
in	in	IN	B-PP	O
infections	infection	NNS	B-NP	O
by	by	IN	B-PP	O
simian	simian	JJ	B-NP	O
and	and	CC	I-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
viruses	virus	NNS	I-NP	O

The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
was	be	VBD	B-VP	O
localized	localize	VBN	I-VP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
the	the	DT	B-NP	O
ATG	ATG	NN	I-NP	O
codon	codon	NN	I-NP	O
by	by	IN	B-PP	O
RNase	BEGIN-RNase-INSIDE	NN	B-NP	B
protection	protection	NN	I-NP	O
and	and	CC	O	O
primer	primer	NN	B-NP	O
extension	extension	NN	I-NP	O
mapping	mapping	NN	I-NP	O

Statistical	Statistical	JJ	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
relation	relation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
radioprotective	radioprotective	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
mercaptoethylamine	mercaptoethylamine	NN	B-NP	O
derivatives	derivative	NNS	I-NP	O
and	and	CC	I-NP	O
analogs	analog	NNS	I-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
electron	electron	NN	I-NP	O
parameters	parameter	NNS	I-NP	O

Six	Six	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
developed	develop	VBD	B-VP	O
sepsis	sepsis	NN	B-NP	O
and	and	CC	O	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
survived	survive	VBD	B-VP	O

The	The	DT	B-NP	O
material	material	NN	I-NP	O
then	then	RB	B-ADVP	O
was	be	VBD	B-VP	O
cut	cut	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diamond	diamond	NN	I-NP	O
saw	see	VBD	B-VP	O
into	into	IN	B-PP	O
sheets	sheet	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
surface	surface	NN	I-NP	O
was	be	VBD	B-VP	O
polished	polish	VBN	I-VP	O
by	by	IN	B-PP	O
colloidal	colloidal	JJ	B-NP	O
SiO1	SiO1	NN	I-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
covered	cover	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
carbon	carbon	NN	I-NP	O
-	-	HYPH	O	O
titanium	titanium	NN	B-NP	O
(	(	(	O	O
C	C	NN	B-NP	O
:	:	:	O	O
Ti	Ti	NN	B-NP	O
)	)	)	O	O
layer	layer	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
microm	microm	NN	I-NP	O
)	)	)	O	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
-	-	HYPH	O	O
enhanced	enhance	VBN	B-VP	O
physical	physical	JJ	B-NP	O
vapor	vapor	NN	I-NP	O
deposition	deposition	NN	I-NP	O
method	method	NN	I-NP	O

We	We	PRP	B-NP	O
present	present	VBP	B-VP	O
here	here	RB	B-ADVP	O
a	a	DT	B-NP	O
statistical	statistical	JJ	I-NP	O
technique	technique	NN	I-NP	O
we	we	PRP	B-NP	O
developed	develop	VBD	B-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
elements	element	NNS	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
regulation	regulation	NN	I-NP	O

Diabetic	Diabetic	JJ	B-NP	O
osteopenia	osteopenia	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
chronic	chronic	JJ	I-NP	O
complication	complication	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
with	with	IN	B-PP	O
alterations	alteration	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
calcium	calcium	NN	I-NP	O
-	-	HYPH	B-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
endocrine	endocrine	NN	I-NP	O
system	system	NN	I-NP	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nod	BEGIN-BEGIN-nod	JJ	I-NP	B
box	box-INSIDE	NN	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
(	(	(	O	O
brady	brady	JJ	O	O
)	)	)	O	O
rhizobia	rhizobia	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
divergent	divergent	JJ	I-NP	O
nod	BEGIN-nod	NN	I-NP	B
box	box-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
Azorhizobium	Azorhizobium	NN	B-NP	O
caulinodans	caulinodan	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
now	now	RB	B-ADVP	O
propose	propose	VBP	B-VP	O
a	a	DT	B-NP	O
modular	modular	JJ	I-NP	O
build	build	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nod	BEGIN-nod	JJ	I-NP	B
box	box-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
A	A	NN	I-NP	O
-	-	HYPH	I-NP	O
T	T	NN	I-NP	O
-	-	HYPH	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
N1	N1	NN	I-NP	O
-	-	HYPH	B-NP	O
G	G	NN	I-NP	O
-	-	HYPH	B-NP	O
A	A	NN	I-NP	O
-	-	HYPH	I-NP	O
T	T	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
target	target	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NodD	BEGIN-NodD	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
the	the	DT	B-NP	O
NodD	BEGIN-NodD	NN	I-NP	B
box	box-INSIDE	NN	I-NP	I
)	)	)	O	O

This	This	DT	B-NP	O
dip	dip	NN	I-NP	O
also	also	RB	B-ADVP	O
occurred	occur	VBD	B-VP	O
during	during	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	I-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
occur	occur	VB	I-VP	O
when	when	WRB	B-ADVP	O
calcium	calcium	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
baseline	baseline	NN	I-NP	O
value	value	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
start	start	NN	I-NP	O
of	of	IN	B-PP	O
combined	combined	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O

Highly	Highly	RB	B-NP	O
conserved	conserve	VBN	I-NP	O
regions	region	NNS	I-NP	O
called	call	VBN	B-VP	O
src	BEGIN-src	NN	B-NP	B
homology	homology	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
1	1	CD	B-NP	O
(	(	(	O	O
SH1	BEGIN-SH1-INSIDE	NN	B-NP	B
and	and	CC	O	O
SH1	BEGIN-SH1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
comprising	comprise	VBG	B-VP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
modulate	modulate	VB	I-VP	O
the	the	DT	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
-	-	HYPH	B-NP	I
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
carboxy	carboxy	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
halves	half	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
src	BEGIN-src	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
novel	novel	JJ	B-NP	O
techniques	technique	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
histopathologic	histopathologic	JJ	B-NP	O
ultrastaging	ultrastaging	NN	I-NP	O
,	,	,	O	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
staining	staining	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
reverse	BEGIN-reverse	JJ	B-NP	B
transcriptase	transcriptase-INSIDE	NN	I-NP	I
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
help	help	VB	I-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
accuracy	accuracy	NN	I-NP	O
and	and	CC	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O

Acanthamoeba	BEGIN-Acanthamoeba	NN	B-NP	B
myosin	myosin	NN	I-NP	I
I	I	CD	I-NP	I
heavy	heavy	JJ	I-NP	I
chain	chain	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
MIHCK	BEGIN-MIHCK-INSIDE	NN	B-NP	B
)	)	)	O	O
phosphorylates	phosphorylate	VBZ	B-VP	O
the	the	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
chains	chain	NNS	I-NP	O
of	of	IN	B-PP	O
amoeba	BEGIN-amoeba	NN	B-NP	B
myosins	myosin	NNS	I-NP	I
I	I-INSIDE	NN	I-NP	I
,	,	,	O	O
increasing	increase	VBG	B-VP	O
their	their	PRP$	B-NP	O
actin	BEGIN-actin-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
activated	activate	VBN	B-NP	O
ATPase	BEGIN-ATPase-INSIDE	NN	I-NP	B
activities	activity	NNS	I-NP	O

Two	Two	CD	B-NP	O
different	different	JJ	I-NP	O
genes	gene	NNS	I-NP	O
(	(	(	O	O
polA	BEGIN-polA-INSIDE	NN	B-NP	B
and	and	CC	O	O
polB	BEGIN-polB-INSIDE	NN	B-NP	B
)	)	)	O	O
encoding	encode	VBG	B-VP	O
family	BEGIN-family	NN	B-NP	B
B	B	NN	I-NP	I
DNA	DNA	NN	I-NP	I
polymerases	polymerases-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
organism	organism	NN	I-NP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
using	use	VBG	B-VP	O
degenerated	degenerate	VBN	B-NP	O
primers	primer	NNS	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
conserved	conserve	VBN	I-NP	O
motifs	motif	NNS	I-NP	O
(	(	(	O	O
motif	motif	NN	B-NP	O
A	A	NN	I-NP	O
and	and	CC	O	O
B	B	NN	B-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
reconstituted	reconstitute	VBN	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
RNAP	BEGIN-RNAP	NN	B-NP	B
IIA	IIA-INSIDE	NN	I-NP	I
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
RNAP	BEGIN-RNAP	NN	B-NP	B
IIB	IIB-INSIDE	NN	I-NP	I
,	,	,	O	O
can	can	MD	B-VP	O
transcribe	transcribe	VB	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
DHFR	BEGIN-DHFR	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
an	an	DT	B-NP	O
immunological	immunological	JJ	I-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
responsiveness	responsiveness	NN	I-NP	O
to	to	TO	B-PP	O
enterotoxin	BEGIN-enterotoxin	NN	B-NP	B
A	A-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
considerable	considerable	JJ	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O

The	The	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
contained	contain	VBD	B-VP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
calculated	calculate	VBN	I-NP	O
M	M	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
and	and	CC	I-NP	O
mouse	BEGIN-mouse	JJ	I-NP	B
CAD	CAD-INSIDE	NN	I-NP	I
(	(	(	O	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
)	)	)	O	O

Focal	Focal	JJ	B-NP	O
or	or	CC	I-NP	O
regional	regional	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
Hz	Hz	NN	I-NP	O
low	low	JJ	I-NP	O
-	-	HYPH	I-NP	O
voltage	voltage	NN	I-NP	O
epileptiform	epileptiform	NN	I-NP	O
paroxysms	paroxysm	NNS	I-NP	O
in	in	IN	B-PP	O
either	either	CC	O	O
hippocampus	hippocampus	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
amygdala	amygdala	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
patient	patient	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
both	both	DT	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
patient	patient	NN	I-NP	O
)	)	)	O	O
preceded	precede	VBD	B-VP	O
initial	initial	JJ	B-ADJP	O
motionless	motionless	IN	B-PP	O
staring	star	VBG	B-VP	O

Cytokine	Cytokine	NN	B-NP	O
-	-	HYPH	B-PP	O
mediated	mediate	VBN	B-NP	O
I	BEGIN-I	NN	I-NP	B
kappa	kappa	NN	I-NP	I
B	B	NN	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
reappearance	reappearance	NN	I-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	I-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
cycloheximide	cycloheximide	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
found	find	VBD	B-VP	O
one	one	CD	B-NP	O
an1	BEGIN-an1	NN	I-NP	B
allele	allele-INSIDE	NN	I-NP	I
(	(	(	O	O
an1	BEGIN-an1	NN	B-NP	B
-	-	HYPH	B-NP	I
W1A	W1A-INSIDE	NN	I-NP	I
)	)	)	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
a	a	DT	B-NP	O
dTph1	BEGIN-dTph1	NN	I-NP	B
element	element-INSIDE	NN	I-NP	I
had	have	VBD	B-VP	O
inserted	insert	VBN	I-VP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
start	start	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
inactivating	inactivate	VBG	B-VP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
cornea	cornea	NN	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
was	be	VBD	B-VP	O
cauterized	cauterize	VBN	I-VP	O
by	by	IN	B-PP	O
drops	drop	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
N	N	NN	I-NP	O
HC1	HC1	NN	I-NP	O
over	over	IN	B-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
one	one	CD	I-NP	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O

The	The	DT	B-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
dose	dose	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Z	Z	NN	B-NP	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
presentation	presentation	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
review	review	VB	I-VP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
knowledge	knowledge	NN	B-NP	O
regarding	regard	VBG	B-VP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
eicosatetraynoic	eicosatetraynoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
ETYA	ETYA	NN	B-NP	O
,	,	,	O	O
Ro	Ro	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
lipid	lipid	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O

Pathophysiologic	Pathophysiologic	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
underlying	underlie	VBG	B-VP	O
spatial	spatial	JJ	B-NP	O
disorientation	disorientation	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Alzheimer	Alzheimer	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O

Secretion	Secretion	NN	B-NP	O
of	of	IN	B-PP	O
cuticle	cuticle	NN	B-NP	O
over	over	IN	B-PP	O
and	and	CC	I-PP	O
between	between	IN	I-PP	O
the	the	DT	B-NP	O
domed	domed	JJ	I-NP	O
apical	apical	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
honeycomb	honeycomb	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
structure	structure	NN	I-NP	O
and	and	CC	O	O
gives	give	VBZ	B-VP	O
the	the	DT	B-NP	O
superficial	superficial	JJ	I-NP	O
wart	wart	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
of	of	IN	B-PP	O
mitotic	mitotic	JJ	B-NP	O
clones	clone	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
adult	adult	JJ	I-NP	O

The	The	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
previously	previously	RB	I-NP	O
known	know	VBN	I-NP	O
tail	BEGIN-tail	JJ	I-NP	B
genes-INSIDE	genes-INBEGIN-S-INSIDEIDE	NN	I-NP	I
,	,	,	I-NP	O
R-INSIDE	BEGIN-R-INBEGIN-S-INSIDEIDE	NN	I-NP	I
and	and	CC	I-NP	O
S	BEGIN-S-INSIDE	NN	I-NP	B
,	,	,	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
temperate	temperate	JJ	I-NP	O
bacteriophage	bacteriophage	NN	I-NP	O
P1	P1	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
(	(	(	O	O
orf	orf	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
located	located	JJ	B-ADJP	O
between	between	IN	B-PP	O
S	BEGIN-S-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
V	BEGIN-V-INSIDE	NN	I-NP	B
,	,	,	O	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O

NGF	BEGIN-NGF-INSIDE	NN	B-NP	B
also	also	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
with	with	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
Sp1	BEGIN-Sp1	NN	I-NP	B
sites	sites-INSIDE	NN	I-NP	I
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
core	core	NN	I-NP	O
promoter	promoter	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
regulated	regulate	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
chimeric	chimeric	JJ	I-NP	O
transactivator	transactivator	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
Gal1	BEGIN-Gal1	NN	I-NP	B
DNA	DNA	NN	I-NP	I
binding	binding	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
fused	fuse	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Sp1	BEGIN-Sp1	NN	I-NP	B
transactivation	transactivation	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
transactivation	transactivation	NN	I-NP	O
domain	domain	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
NGF	BEGIN-NGF-INSIDE	NN	B-NP	B

Nuclear	Nuclear	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
assays	assay	NNS	I-NP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
cys	BEGIN-cys	JJ	B-NP	B
-	-	HYPH	I-NP	I
1+	1+-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
under	under	IN	B-PP	O
sulfur	sulfur	NN	B-NP	O
-	-	HYPH	O	O
regulated	regulate	VBN	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
cys	BEGIN-cys	JJ	B-NP	B
-	-	HYPH	I-NP	I
1+	1+-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
was	be	VBD	B-VP	O
constitutive	constitutive	JJ	B-ADJP	O
in	in	IN	B-PP	O
sulfur	BEGIN-sulfur	NN	B-NP	B
controller	controller-INSIDE	NN	I-NP	I
(	(	(	O	O
scon	BEGIN-scon-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
mutants	mutant	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
UvrA	BEGIN-UvrA-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
triplet	triplet	JJ	B-NP	O
repeat	repeat	NN	I-NP	O
instability	instability	NN	I-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
,	,	,	O	O
E1orf1	BEGIN-E1orf1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
by	by	IN	B-SBAR	O
itself	itself	PRP	B-NP	O
to	to	TO	B-VP	O
trigger	trigger	VB	I-VP	O
a	a	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
independent	independent	JJ	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
pathway	pathway	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
operate	operate	VB	I-VP	O
independently	independently	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
known	know	VBN	I-NP	O
zVAD	zVAD	NN	I-NP	O
-	-	HYPH	I-NP	O
inhibitable	inhibitable	JJ	I-NP	O
caspases	BEGIN-caspases-INSIDE	NN	I-NP	B
,	,	,	O	O
and	and	CC	O	O
that	that	DT	B-NP	O
may	may	MD	B-VP	O
involve	involve	VB	I-VP	O
an	an	DT	B-NP	O
as	as	IN	B-PP	O
yet	yet	RB	B-NP	O
uncharacterized	uncharacterized	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
system	system	NN	I-NP	O
developed	develop	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
method	method	NN	I-NP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
air	air	NN	B-NP	O
-	-	HYPH	O	O
trapping	trap	VBG	B-VP	O
during	during	IN	B-PP	O
TGI	TGI	NN	B-NP	O

The	The	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
this	this	DT	B-NP	O
product	product	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
deduced	deduce	VBN	B-VP	O

After	After	IN	B-PP	O
a	a	DT	B-NP	O
shift	shift	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
Rat1	BEGIN-Rat1	NN	I-NP	B
-	-	HYPH	B-NP	I
1p	1p-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
Nup1	BEGIN-Nup1	NN	I-NP	B
-	-	HYPH	B-NP	I
1p	1p-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
lost	lose	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
rim	rim	NN	I-NP	O
of	of	IN	B-PP	O
rat1	rat1	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	I-NP	O
NPCs	NPC	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
clustered	cluster	VBN	I-VP	O
together	together	RB	B-ADVP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
grown	grow	VBN	B-VP	O
under	under	IN	B-PP	O
permissive	permissive	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
become	become	VBP	B-VP	O
substantially	substantially	RB	B-ADJP	O
less	less	RBR	B-VP	O
clustered	cluster	VBN	I-VP	O

Evidence	Evidence	NN	B-NP	O
for	for	IN	B-PP	O
Gcr1p	BEGIN-Gcr1p-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
Gcr1p	BEGIN-Gcr1p-INSIDE	NN	I-NP	B
interaction	interaction	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
presented	present	VBN	I-VP	O
earlier	earlier	RBR	B-ADVP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
supported	support	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
Gcr1p	BEGIN-Gcr1p-INSIDE	NN	B-NP	B
suppressing	suppress	VBG	B-VP	O
gcr1	BEGIN-gcr1-INSIDE	NN	B-NP	B
,	,	,	O	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
growth	growth	NN	B-NP	O
and	and	CC	I-NP	O
enzyme	enzyme	NN	I-NP	O
assay	assay	NN	I-NP	O

Renal	Renal	JJ	B-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
men	man	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
women	woman	NNS	I-NP	O
,	,	,	O	O
mean	mean	JJ	B-NP	O
age	age	NN	I-NP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
survived	survive	VBN	I-VP	O
the	the	DT	B-NP	O
malignant	malignant	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

Mammalian	Mammalian	JJ	B-NP	O
ribonucleotide	BEGIN-ribonucleotide	NN	I-NP	B
reductase	reductase-INSIDE	NN	I-NP	I
shows	show	VBZ	B-VP	O
S	S	NN	B-NP	O
-	-	HYPH	I-NP	O
phase	phase	NN	I-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
identical	identical	JJ	I-NP	O
subunits	subunit	NNS	I-NP	O
,	,	,	O	O
proteins	BEGIN-protein	NNS	B-NP	B
R1	BEGIN-R1-INSIDE-INSIDE	NN	I-NP	I
(	(	(	O	O
large	large	JJ	B-NP	O
subunit	subunit	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
R1	BEGIN-R1-INSIDE	NN	B-NP	B
(	(	(	O	O
small	small	JJ	B-NP	O
subunit	subunit	NN	I-NP	O
)	)	)	O	O

Azoospermia	Azoospermia	NN	B-NP	O
was	be	VBD	B-VP	O
graded	grade	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
way	way	NN	I-NP	O
:	:	:	O	O
adequate	adequate	JJ	B-NP	O
spermatozoa	spermatozoa	NN	I-NP	O
(	(	(	O	O
A1	A1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
low	low	JJ	B-NP	O
,	,	,	I-NP	O
scanty	scanty	JJ	I-NP	O
or	or	CC	I-NP	O
rare	rare	JJ	I-NP	O
spermatozoa	spermatozoa	NN	I-NP	O
(	(	(	O	O
A1	A1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
spermatid	spermatid	NN	B-NP	O
arrest	arrest	NN	I-NP	O
(	(	(	O	O
B1	B1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
spermatocyte	spermatocyte	NN	B-NP	O
arrest	arrest	NN	I-NP	O
(	(	(	O	O
B1	B1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Sertoli	Sertoli	NNP	B-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-VP	O
only	only	RB	B-NP	O
pattern	pattern	NN	I-NP	O
(	(	(	O	O
C	C	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
sclerosis	sclerosis	NN	B-NP	O
(	(	(	O	O
D	D	NN	B-NP	O
)	)	)	O	O

This	This	DT	B-NP	O
paper	paper	NN	I-NP	O
describes	describe	VBZ	B-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
agoraphobic	agoraphobic	JJ	I-NP	O
female	female	JJ	I-NP	O
patient	patient	NN	I-NP	O

Plasmids	Plasmid	NNS	B-NP	O
bearing	bear	VBG	B-VP	O
the	the	DT	B-NP	O
P.	BEGIN-P.	JJ	I-NP	B
stipitis	stipitis	NN	I-NP	I
URA1	URA1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
and	and	CC	O	O
ARS1	ARS1	NN	B-NP	O
element	element	NN	I-NP	O
produced	produce	VBD	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
transformants	transformant	NNS	I-NP	O
per	per	IN	B-PP	O
micrograms	microgram	NNS	B-NP	O
of	of	IN	B-PP	O
plasmid	plasmid	NN	B-NP	O
DNA	DNA	NN	I-NP	O

The	The	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
kappaB	kappaB-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
transcription	transcription	NN	I-NP	O
by	by	IN	B-PP	O
E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
potently	potently	RB	I-VP	O
suppressed	suppress	VBN	I-VP	O
upon	upon	IN	B-PP	O
coexpression	coexpression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E1B	BEGIN-E1B	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kDa	kDa	NN	I-NP	I
protein	protein	NN	I-NP	I
(	(	(	O	I
1K	1K	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I

We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
light	light	NN	B-NP	O
on	on	IN	B-PP	O
tubulin	BEGIN-tubulin	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
abundance	abundance	NN	I-NP	O
in	in	IN	B-PP	O
Arabidopsis	Arabidopsis	NN	B-NP	O
seedlings	seedling	NNS	I-NP	O
using	use	VBG	B-VP	O
RNA	RNA	NN	B-NP	O
gel	gel	NN	I-NP	O
blot	blot	NN	I-NP	O
hybridizations	hybridization	NNS	I-NP	O
and	and	CC	I-NP	O
gene	gene	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
probes	probe	NNS	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
SCD1	BEGIN-SCD1-INSIDE	NN	B-NP	B
and	and	CC	O	O
SCD1	BEGIN-BEGIN-SCD1-INSIDE	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
cellular	cellular	JJ	B-NP	O
sterol	sterol	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
SREBP	BEGIN-SREBP-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
ADD1	BEGIN-ADD1-INSIDE	NN	I-NP	B
and	and	CC	O	O
that	that	IN	B-SBAR	O
transcriptional	transcriptional	JJ	B-NP	O
induction	induction	NN	I-NP	O
requires	require	VBZ	B-VP	O
three	three	CD	B-NP	O
spatially	spatially	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
cis	cis	NN	I-NP	O
elements	element	NNS	I-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
SREBP	BEGIN-SREBP-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	O	I
Y	Y-INSIDE	NN	B-NP	I

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Recent	Recent	JJ	B-NP	O
iterative	iterative	JJ	I-NP	O
methods	method	NNS	I-NP	O
for	for	IN	B-PP	O
sequence	sequence	NN	B-NP	O
alignment	alignment	NN	I-NP	O
have	have	VBP	B-VP	O
indicated	indicate	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
motor	motor	NN	I-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
dynein	BEGIN-dynein-INSIDE	NN	B-NP	B
belongs	belong	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
AAA	BEGIN-AAA	NN	I-NP	B
class	class-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
chaperone	BEGIN-chaperone	NN	B-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
ATPases	ATPases-INSIDE	NN	I-NP	I

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
death	death	NN	B-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mansoni	mansoni	NNP	I-NP	O
cercariae	cercariae	NNS	I-NP	O
during	during	IN	B-PP	O
penetration	penetration	NN	B-NP	O
of	of	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
host	host	NN	I-NP	O
skin	skin	NN	I-NP	O
is	be	VBZ	B-VP	O
probably	probably	RB	B-ADVP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
exhaustion	exhaustion	NN	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
energy	energy	NN	I-NP	O
reserves	reserve	NNS	I-NP	O

In	In	IN	B-PP	O
particular	particular	JJ	B-NP	O
,	,	,	I-NP	O
lacZ	BEGIN-lacZ	NN	I-NP	B
transcripts	transcripts-INSIDE	NN	I-NP	I
synthesised	synthesise	VBD	B-VP	O
this	this	DT	B-NP	O
way	way	NN	I-NP	O
are	be	VBP	B-VP	O
highly	highly	RB	B-ADJP	O
unstable	unstable	JJ	I-ADJP	O
and	and	CC	O	O
yield	yield	NN	B-VP	O
little	little	JJ	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	O	I
galactosidase	galactosidase-INSIDE	NN	B-NP	I

Recent	Recent	JJ	B-NP	O
research	research	NN	I-NP	O
on	on	IN	B-PP	O
lipolysis	lipolysis	NN	B-NP	O

Instead	Instead	RB	B-ADVP	O
,	,	,	O	O
HBx	BEGIN-HBx-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
activate	activate	VB	I-VP	O
the	the	DT	B-NP	O
cyclin	BEGIN-BEGIN-cyclin	NN	I-NP	B
A	A-INSIDE	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
induce	induce	VBP	B-VP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
A	A-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
cyclin	BEGIN-cyclin	NN	I-NP	B
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
kinase	kinase	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
complexes	complex	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
promote	promote	VB	B-VP	O
cycling	cycling	NN	B-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
-	-	HYPH	O	O
arrested	arrest	VBN	B-NP	O
cells	cell	NNS	I-NP	O
into	into	IN	B-PP	O
G1	G1	NN	B-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
pathway	pathway	NN	I-NP	O
involving	involve	VBG	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
Src	BEGIN-Src	NN	B-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinases	kinases-INSIDE	NN	I-NP	I

Fifty	Fifty	CD	B-NP	O
-	-	HYPH	I-NP	O
seven	seven	CD	I-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
patients	patient	NNS	I-NP	O
reporting	report	VBG	B-VP	O
mild	mild	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
had	have	VBD	B-VP	O
abnormal	abnormal	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
leucocytes	leucocyte	NNS	B-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
CSF	CSF	NN	I-NP	O

The	The	DT	B-NP	O
vertebrate	BEGIN-vertebrate	JJ	I-NP	B
transcription	transcription	NN	I-NP	I
factors	factor	NNS	I-NP	I
TCF	TCF-INSIDE	NN	B-NP	I
(	(	(	O	O
T	BEGIN-T	NN	B-NP	B
cell	cell	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
LEF	BEGIN-LEF-INSIDE	NN	B-NP	B
(	(	(	O	O
lymphocyte	BEGIN-lymphocyte	NN	B-NP	B
enhancer	enhancer	NN	I-NP	I
binding	binding	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
)	)	)	O	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
beta	BEGIN-beta	NN	B-NP	B
-	-	HYPH	B-NP	I
catenin	catenin-INSIDE	NN	I-NP	I
and	and	CC	O	O
are	be	VBP	B-VP	O
hypothesized	hypothesize	VBN	I-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
Wingless	BEGIN-Wingless-INSIDE	NN	B-NP	B
/	/	SYM	O	O
Wnt	BEGIN-Wnt-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O

DESIGN	DESIGN	NN	B-NP	O
:	:	:	O	O
Activating	BEGIN-Activating	JJ	B-NP	B
protein	protein	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
AP	BEGIN-AP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
Tat	BEGIN-Tat-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
transcription	transcription	NN	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
using	use	VBG	B-VP	O
Jun	BEGIN-Jun-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
hybrid	hybrid	NN	I-NP	O
Tat	BEGIN-Tat-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Jun	BEGIN-Jun-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
expression	expression	NN	B-NP	O
plasmids	plasmid	NNS	I-NP	O
and	and	CC	O	O
reporter	reporter	NN	B-NP	O
gene	gene	NN	I-NP	O
constructs	construct	NNS	I-NP	O
which	which	WDT	B-NP	O
contained	contain	VBD	B-VP	O
AP	BEGIN-BEGIN-AP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
sites	sites-INSIDE	NN	I-NP	I
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	BEGIN-rat	NN	I-NP	B
prolactin	prolactin	NN	I-NP	I
TATAA	TATAA	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I
or	or	CC	O	O
an	an	DT	B-NP	O
HIV	BEGIN-HIV	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
LTR	LTR	NN	I-NP	I
construct	construct-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
AP	BEGIN-BEGIN-AP	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
sites	sites-INSIDE	NN	I-NP	I
replaced	replace	VBD	B-VP	O
the	the	DT	B-NP	O
TAR	TAR	NN	I-NP	O
element	element	NN	I-NP	O

The	The	DT	B-NP	O
PRP1	BEGIN-PRP1	NN	I-NP	B
protein	protein	NN	I-NP	I
of	of	IN	B-PP	I
Saccharomyces	Saccharomyce	NNS	B-NP	I
cerevisiae	cerevisiae-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
U1	BEGIN-U1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
U1	BEGIN-U1-INSIDE	NN	I-NP	B
snRNP	snRNP	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	O
splicing	splicing	NN	I-NP	O
apparatus	apparatus	NN	I-NP	O

According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
penetration	penetration	NN	I-NP	O
of	of	IN	B-PP	O
Ca	Ca	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
microleakage	microleakage	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
scored	score	VBN	I-VP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
section	section	NN	I-NP	O

Endothelial	Endothelial	JJ	B-NP	O
purine	purine	NN	I-NP	O
content	content	NN	I-NP	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
transformed	transform	VBN	B-NP	O
Ah	BEGIN-Ah	NN	I-NP	B
receptor	receptor	NN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dioxin	dioxin	NN	I-NP	O
responsive	responsive	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
enhancer	enhancer	NN	I-NP	O
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
heteromeric	heteromeric	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
forms	form	NNS	I-NP	O

KatA	BEGIN-KatA-INSIDE	NN	B-NP	B
,	,	,	O	O
AhpCF	BEGIN-AhpCF-INSIDE	NN	B-NP	B
,	,	,	O	O
heme	heme	NN	B-NP	O
biosynthesis	biosynthesis	NN	I-NP	O
enzymes	enzyme	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
MrgA	BEGIN-MrgA-INSIDE	NN	B-NP	B
are	be	VBP	B-VP	O
also	also	RB	I-VP	O
induced	induce	VBN	I-VP	O
upon	upon	IN	B-PP	O
entry	entry	NN	B-NP	O
into	into	IN	B-PP	O
stationary	stationary	JJ	B-NP	O
phase	phase	NN	I-NP	O
under	under	IN	B-PP	O
conditions	condition	NNS	B-NP	O
of	of	IN	B-PP	O
iron	iron	NN	B-NP	O
and	and	CC	I-NP	O
manganese	manganese	NN	I-NP	O
limitation	limitation	NN	I-NP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chromosome	chromosome	NN	I-NP	O
1	1	CD	I-NP	O
breakpoint	breakpoint	NN	I-NP	O
region	region	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
transcription	BEGIN-transcription	NN	I-NP	B
factor	factor	NN	I-NP	I
-	-	HYPH	O	I
encoding	encode	VBG	B-VP	I
USF1	USF1	NN	B-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
affected	affect	VBN	I-VP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
pseudo	BEGIN-pseudo	JJ	B-NP	B
VH	VH	NN	I-NP	I
gene	gene	NN	I-NP	I
segment	segment	NN	I-NP	I
recombination	recombination	NN	I-NP	I
products	products-INSIDE	NN	I-NP	I
reveals	reveal	VBZ	B-VP	O
no	no	DT	B-NP	O
bias	bias	NN	I-NP	O
in	in	IN	B-PP	O
D	BEGIN-D	NN	B-NP	B
gene	gene	NN	I-NP	I
segment	segment-INSIDE	NN	I-NP	I
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
utilization	utilization	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
dangerous	dangerous	JJ	B-ADJP	O
to	to	TO	B-VP	O
label	label	VB	I-VP	O
such	such	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
as	as	IN	B-PP	O
'inappropriate	'inappropriate	JJ	B-NP	O
'	'	''	I-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
ADH	BEGIN-ADH-INSIDE	NN	B-NP	B
since	since	IN	B-PP	O
the	the	DT	B-NP	O
maintenance	maintenance	NN	I-NP	O
of	of	IN	B-PP	O
circulating	circulate	VBG	B-VP	O
volume	volume	NN	B-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
as	as	IN	B-PP	O
important	important	JJ	B-ADJP	O
a	a	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
requirement	requirement	NN	I-NP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
defence	defence	NN	I-NP	O
of	of	IN	B-PP	O
tonicity	tonicity	NN	B-NP	O

The	The	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
KP	KP	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
triazole	triazole	NN	I-NP	O
derivative	derivative	NN	I-NP	O
,	,	,	O	O
against	against	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
fungi	fungus	NNS	I-NP	O
that	that	WDT	B-NP	O
cause	cause	VBP	B-VP	O
dermatomycoses	dermatomycos	NNS	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
efficacy	efficacy	NN	I-NP	O
against	against	IN	B-PP	O
plantar	plantar	NN	B-NP	O
tinea	tinea	NN	I-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
cutaneous	cutaneous	JJ	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
in	in	IN	B-PP	O
guinea	guinea	NN	B-NP	O
pigs	pig	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
simulated	simulated	JJ	I-NP	O
cough	cough	NN	I-NP	O
machine	machine	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
adding	add	VBG	B-VP	O
tensio	tensio	AFX	B-NP	O
-	-	HYPH	I-NP	O
active	active	JJ	I-NP	O
liquids	liquid	NNS	I-NP	O
as	as	IN	B-PP	O
sol	sol	NN	B-NP	O
phase	phase	NN	I-NP	O
simulant	simulant	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
clearance	clearance	NN	I-NP	O
of	of	IN	B-PP	O
gel	gel	NN	B-NP	O
mucus	mucus	NN	I-NP	O
simulant	simulant	NN	I-NP	O
by	by	IN	B-PP	O
cough	cough	NN	B-NP	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
cyclosporin	cyclosporin	NN	B-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
CyA	CyA	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
vascularized	vascularize	VBN	B-NP	O
osteochondral	osteochondral	JJ	I-NP	O
grafts	graft	NNS	I-NP	O
between	between	IN	B-PP	O
rat	rat	NN	B-NP	O
strains	strain	NNS	I-NP	O
[	[	(	O	O
DA	DA	NN	B-NP	O
(	(	(	O	O
donor	donor	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
Lewis	Lewis	NNP	B-NP	O
(	(	(	O	O
recipient	recipient	NN	B-NP	O
)	)	)	O	O
]	]	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
host	host	NN	B-NP	O
immune	immune	JJ	I-NP	O
tolerance	tolerance	NN	I-NP	O
and	and	CC	I-NP	O
graft	graft	NN	I-NP	O
antigen	antigen	NN	I-NP	O
modulation	modulation	NN	I-NP	O
after	after	IN	B-PP	O
cessation	cessation	NN	B-NP	O
of	of	IN	B-PP	O
immunosuppression	immunosuppression	NN	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
examined	examine	VBN	I-VP	O

Insulin	BEGIN-Insulin-INSIDE	NN	B-NP	B
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
alpha	alpha	SYM	I-NP	O
-	-	HYPH	I-NP	O
subunit	subunit	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
receptor	receptor	NN	I-NP	O
stimulates	stimulate	VBZ	B-VP	O
the	the	DT	B-NP	O
receptor	BEGIN-receptor	NN	I-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
phosphorylate	phosphorylate	VB	I-VP	O
the	the	DT	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
subunit	subunit	NN	I-NP	O
and	and	CC	O	O
several	several	JJ	B-NP	O
endogenous	endogenous	JJ	I-NP	O
protein	protein	NN	I-NP	O
substrates	substrate	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
pp1	BEGIN-pp1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
HA1	BEGIN-HA1-INSIDE	NN	I-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
liver	liver	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
glycoprotein	glycoprotein	NN	I-NP	O
of	of	IN	B-PP	O
M	M	NN	B-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
)	)	)	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O

The	The	DT	B-NP	O
second	second	JJ	I-NP	O
intron	intron	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
smallest	small	JJS	I-NP	O
of	of	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
introns	intron	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
)	)	)	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
findings	finding	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Tc1	BEGIN-Tc1	NN	I-NP	B
encoding	encode	VBG	B-VP	I
gene	gene-INSIDE	NN	B-NP	I
underline	underline	NN	I-NP	O
the	the	DT	B-NP	O
interest	interest	NN	I-NP	O
of	of	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
manipulation	manipulation	NN	I-NP	O
of	of	IN	B-PP	O
T.	T.	NNP	B-NP	O
cruzi	cruzi	NNS	I-NP	O
,	,	,	O	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
making	make	VBG	B-VP	O
it	it	PRP	B-NP	O
possible	possible	JJ	B-ADJP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
more	more	RBR	B-ADVP	O
closely	closely	RB	I-ADVP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-VP	O
find	find	VB	I-VP	O
out	out	RP	B-PRT	O
how	how	WRB	B-ADVP	O
genes	gene	NNS	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
'attenuated	'attenuate	VBN	I-VP	O
'	'	POS	B-NP	O
strains	strain	NNS	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
vaccinal	vaccinal	JJ	B-NP	O
strategies	strategy	NNS	I-NP	O

Pretreatment	Pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
dose	dose	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
CCl1	CCl1	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
prolongation	prolongation	NN	I-NP	O
of	of	IN	B-PP	O
TMO	TMO	NN	B-NP	O
half	half	NN	I-NP	O
-	-	HYPH	I-NP	O
life	life	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
increase	increase	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
curve	curve	NN	I-NP	O
(	(	(	O	O
AUC	AUC	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
clearance	clearance	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
distribution	distribution	NN	B-NP	O
(	(	(	O	O
Vd	Vd	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
not	not	RB	O	O
significantly	significantly	RB	B-VP	O
decreased	decrease	VBD	I-VP	O

Healthy	Healthy	JJ	B-NP	O
preterm	preterm	JJ	I-NP	O
infants	infant	NNS	I-NP	O
of	of	IN	B-PP	O
gestational	gestational	JJ	B-NP	O
age	age	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
'mature	'mature	NN	I-NP	O
'	'	POS	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
permeability	permeability	NN	B-NP	O
at	at	IN	B-PP	O
birth	birth	NN	B-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
temporary	temporary	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
permeability	permeability	NN	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O

The	The	DT	B-NP	O
promoter	promoter	NN	I-NP	O
for	for	IN	B-PP	O
HMG	BEGIN-HMG	NN	B-NP	B
-	-	HYPH	I-NP	I
CoA	CoA	NN	I-NP	I
synthase	synthase-INSIDE	NN	I-NP	I
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
sterol	BEGIN-sterol	NN	I-NP	B
regulatory	regulatory	JJ	I-NP	I
element	element	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
proteins	proteins-INSIDE	NN	B-NP	I
(	(	(	O	O
SREBPs	BEGIN-SREBPs-INSIDE	NN	B-NP	B
)	)	)	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
electrical	electrical	JJ	I-NP	O
analog	analog	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
present	present	VBP	B-VP	O
an	an	DT	B-NP	O
analysis	analysis	NN	I-NP	O
that	that	WDT	B-NP	O
allows	allow	VBZ	B-VP	O
calculation	calculation	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
parameters	parameter	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
corner	corner	NN	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
network	network	NN	I-NP	O
(	(	(	O	O
f1	f1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
without	without	IN	B-PP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
similar	similar	JJ	B-NP	O
assumptions	assumption	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
transcription	transcription	NN	B-NP	O
influences	influence	VBZ	B-VP	O
aspects	aspect	NNS	B-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
conversion	conversion	NN	I-NP	O
after	after	IN	B-PP	O
initiation	initiation	NN	B-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
strand	strand	NN	B-NP	O
invasion	invasion	NN	I-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
mismatch	mismatch	NN	B-NP	O
repair	repair	NN	I-NP	O
(	(	(	O	O
MMR	MMR	NN	B-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O
(	(	(	O	O
hGH	BEGIN-hGH-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
LDLR	BEGIN-LDLR-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
DAF1	BEGIN-DAF1-INSIDE	NN	I-NP	B
,	,	,	O	O
abbreviated	abbreviate	VBD	B-VP	O
HLD	BEGIN-HLD-INSIDE	NN	B-NP	B
)	)	)	O	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
fragment	fragment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
serine	serine	NN	I-NP	O
/	/	SYM	B-NP	O
threonine	threonine	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LDL	BEGIN-LDL	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
LDLR	BEGIN-LDLR-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DAF	BEGIN-DAF	NN	I-NP	B
-	-	HYPH	B-VP	I
derived	derive	VBN	B-NP	I
serine	serine	NN	I-NP	I
/	/	SYM	B-NP	I
threonine	threonine	NN	I-NP	I
-	-	HYPH	I-NP	I
rich	rich	JJ	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
,	,	,	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
become	become	VB	I-VP	O
GPI	GPI	NN	B-NP	O
anchored	anchor	VBN	B-VP	O

Ocular	Ocular	JJ	B-NP	O
injuries	injury	NNS	I-NP	O
during	during	IN	B-PP	O
general	general	JJ	B-NP	O
anesthesia	anesthesia	NN	I-NP	O

Of	Of	IN	B-PP	O
concern	concern	NN	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
,	,	,	I-NP	O
unexplained	unexplained	JJ	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
BV	BV	NN	B-NP	O
among	among	IN	B-PP	O
African	African	JJ	B-NP	O
-	-	HYPH	I-NP	O
American	American	JJ	I-NP	O
women	woman	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
at	at	IN	B-PP	O
extremely	extremely	RB	B-NP	O
high	high	JJ	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
preterm	preterm	JJ	B-NP	O
birth	birth	NN	I-NP	O

The	The	DT	B-NP	O
RAG	BEGIN-RAG	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
V	BEGIN-V	NN	I-NP	B
(	(	(	O	I
D	D	NN	B-NP	I
)	)	)	O	I
J	J	NN	B-NP	I
recombinase	recombinase-INSIDE	NN	I-NP	I
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
assembly	assembly	NN	I-NP	O
of	of	IN	B-PP	O
antigen	antigen	NN	B-NP	O
receptor	receptor	NN	I-NP	O
genes	gene	NNS	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	O
and	and	CC	O	O
T	T	NN	B-NP	O
lymphocytes	lymphocyte	NNS	B-NP	O

The	The	DT	B-NP	O
LAB	LAB	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cecum	cecum	NN	I-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
1	1	CD	I-NP	O
log	log	NN	I-NP	O
CFU	CFU	NN	I-NP	O
/	/	SYM	B-NP	O
g	g	NN	I-NP	O
)	)	)	O	O
increased	increase	VBD	B-VP	O
slightly	slightly	RB	B-ADVP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
abattoir	abattoir	NN	I-NP	O
holding	holding	NN	I-NP	O
time	time	NN	I-NP	O

Reproduction	Reproduction	NN	B-NP	O
and	and	CC	O	O
maternal	maternal	JJ	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
when	when	WRB	B-ADVP	O
thiamine	thiamine	NN	B-NP	O
intake	intake	NN	I-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	I-VP	O

Activated	BEGIN-Activated	JJ	B-NP	B
Ki	Ki	NN	I-NP	I
-	-	HYPH	B-NP	I
Ras	Ras-INSIDE	NN	I-NP	I
suppresses	suppress	VBZ	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
O	O	NN	I-NP	O
-	-	HYPH	B-NP	O
tetradecanoylphorbol	tetradecanoylphorbol	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
acetate	acetate	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	O	I
Jun	Jun	NN	B-NP	I
NH1	NH1	NN	I-NP	I
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
kinase	kinase	NN	I-NP	I
pathway	pathway-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
colon	colon	NN	I-NP	O
cancer	cancer	NN	I-NP	O
cells	cell	NNS	I-NP	O

1	1	CD	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
present	present	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Vps1	BEGIN-Vps1-INSIDE	NN	I-NP	B
/	/	SYM	B-VP	O
Pep1	BEGIN-Pep1-INSIDE	NN	B-NP	B
protein	protein	NN	I-NP	O
colocalizes	colocalize	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Vps1	BEGIN-Vps1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Pep1	BEGIN-Pep1-INSIDE	NN	I-NP	B
protein	protein	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytosolic	cytosolic	JJ	I-NP	O
face	face	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vacuolar	vacuolar	JJ	I-NP	O
membrane	membrane	NN	I-NP	O

Cell	Cell	NN	B-NP	O
-	-	HYPH	O	O
free	free	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
(	(	(	O	O
fpg	BEGIN-fpg-INSIDE	NN	B-NP	B
mutY	BEGIN-mutY-INSIDE	NN	I-NP	B
)	)	)	O	O
harboring	harbor	VBG	B-VP	O
pYSB1	pYSB1	NN	B-NP	O
possess	possess	VBP	B-VP	O
an	an	DT	B-NP	O
enzymatic	enzymatic	JJ	I-NP	O
activity	activity	NN	I-NP	O
that	that	WDT	B-NP	O
cleaves	cleave	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
mer	mer	NN	I-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
oxoG	oxoG	NN	I-NP	O
opposite	opposite	VBP	B-VP	O
a	a	DT	B-NP	O
cytosine	cytosine	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
OxoG	OxoG	NN	I-NP	O
/	/	SYM	I-NP	O
C	C	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
discussed	discuss	VBD	B-VP	O
their	their	PRP$	B-NP	O
experience	experience	NN	I-NP	O
in	in	IN	B-PP	O
investigating	investigate	VBG	B-VP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
maxillary	maxillary	JJ	B-NP	O
malignant	malignant	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
using	use	VBG	B-VP	O
routine	routine	JJ	B-NP	O
x	x	SYM	I-NP	O
-	-	HYPH	I-NP	O
ray	ray	NN	I-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
MR	MR	NN	B-NP	O
-	-	HYPH	I-NP	O
tomography	tomography	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
investigated	investigate	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
way	way	NN	I-NP	O
plus	plus	CC	O	O
CT	CT	NN	B-NP	O

Magnification	Magnification	NN	B-NP	O
-	-	HYPH	B-PP	O
corrected	correct	VBN	B-NP	O
planimetry	planimetry	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
parapapillary	parapapillary	JJ	I-NP	O
region	region	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
Littmann	Littmann	NNP	B-NP	O
's	's	POS	B-NP	O
method	method	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
unselected	unselected	JJ	I-NP	O
eyes	eye	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
primary	primary	JJ	I-NP	O
open	open	JJ	I-NP	O
-	-	HYPH	I-NP	O
angle	angle	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
normal	normal	JJ	I-NP	O
eyes	eye	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
age	age	NN	I-NP	O
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
refraction	refraction	NN	B-NP	O
-	-	HYPH	O	O
matched	match	VBN	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
using	use	VBG	B-VP	O
optic	optic	JJ	B-NP	O
disk	disk	NN	I-NP	O
photographs	photograph	NNS	I-NP	O

Both	Both	CC	O	O
merR	BEGIN-merR	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
consist	consist	VBP	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
ORF	ORF	NN	I-NP	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
DNA	DNA	NN	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
placed	place	VBN	B-VP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chloramphenicol	BEGIN-chloramphenicol	JJ	I-NP	B
acetyltransferase	acetyltransferase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
functionally	functionally	RB	B-ADJP	O
active	active	JJ	I-ADJP	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
Fos	BEGIN-Fos-INSIDE	NN	B-NP	B
down	down	RB	B-ADVP	O
regulates	regulate	VBZ	B-VP	O
several	several	JJ	B-NP	O
immediate	BEGIN-immediate	JJ	I-NP	B
-	-	HYPH	I-NP	I
early	early	JJ	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
(	(	(	O	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
fos	fos-INSIDE	NN	I-NP	I
,	,	,	O	O
Egr	BEGIN-Egr	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
Egr	BEGIN-Egr	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
after	after	IN	B-PP	O
mitogenic	mitogenic	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O

Polar	Polar	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
transposon	transposon	NN	B-NP	O
insertions	insertion	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
mRNAs	mRNA	NNS	I-NP	O
arose	arise	VBD	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
transcription	transcription	NN	B-NP	O
initiated	initiate	VBD	B-VP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
to	to	TO	B-PP	O
nifH	BEGIN-nifH-INSIDE	NN	B-NP	B

Heart	Heart	NN	B-NP	O
disease	disease	NN	I-NP	O

A	A	DT	B-NP	O
definitive	definitive	JJ	I-NP	O
answer	answer	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
must	must	MD	B-VP	O
come	come	VB	I-VP	O
from	from	IN	B-PP	O
large	large	JJ	B-NP	O
scale	scale	NN	I-NP	O
mortality	mortality	NN	I-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
in	in	IN	B-PP	O
whom	whom	WP	B-NP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
/	/	SYM	B-NP	O
benefit	benefit	NN	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
thrombolysis	thrombolysis	NN	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
unacceptably	unacceptably	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
whom	whom	WP	B-NP	O
electrocardiographic	electrocardiographic	JJ	B-NP	O
criteria	criterion	NNS	I-NP	O
of	of	IN	B-PP	O
infarction	infarction	NN	B-NP	O
are	be	VBP	B-VP	O
unequivocal	unequivocal	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
whom	whom	WP	B-NP	O
treatment	treatment	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
initiated	initiate	VBN	I-VP	O
early	early	RB	B-ADVP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
with	with	IN	B-PP	O
regimens	regimen	NNS	B-NP	O
that	that	WDT	B-NP	O
will	will	MD	B-VP	O
induce	induce	VB	I-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
early	early	JJ	B-NP	O
recanalization	recanalization	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
also	also	RB	B-ADVP	O
sustained	sustain	VBD	B-VP	O
patency	patency	NN	B-NP	O
in	in	IN	B-PP	O
infarct	infarct	NN	B-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
arteries	artery	NNS	I-NP	O

Sonography	Sonography	NN	B-NP	O
depicted	depict	VBD	B-VP	O
the	the	DT	B-NP	O
true	true	JJ	I-NP	O
morphology	morphology	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cystic	cystic	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
more	more	RBR	B-ADVP	O
clearly	clearly	RB	I-ADVP	O
than	than	IN	B-PP	O
CT	CT	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
sonographic	sonographic	JJ	I-NP	O
findings	finding	NNS	I-NP	O
virtually	virtually	RB	B-ADVP	O
excluded	exclude	VBD	B-VP	O
uncomplicated	uncomplicated	JJ	B-NP	O
hepatic	hepatic	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O

The	The	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
tumorlike	tumorlike	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cockroach	cockroach	NN	I-NP	O
leucophaea	leucophaea	NN	I-NP	O
maderae	maderae	NNS	I-NP	O
after	after	IN	B-PP	O
anal	anal	JJ	B-NP	O
blockage	blockage	NN	I-NP	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
identify	identify	VBP	B-VP	O
the	the	DT	B-NP	O
analytical	analytical	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PDF	PDF	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
such	such	JJ	I-NP	O
measure	measure	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
order	order	NN	I-NP	O
parameter	parameter	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1D	1D	NN	I-NP	O
XY	XY	NN	I-NP	O
model	model	NN	I-NP	O

The	The	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
antithrombin	BEGIN-antithrombin	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
(	(	(	O	O
AT	BEGIN-AT	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
significance	significance	NN	I-NP	O

In	In	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
studied	study	VBN	I-NP	O
HPV	HPV	NN	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
CDP	BEGIN-CDP-INSIDE	NN	I-NP	B
/	/	SYM	I-NP	O
Cut	BEGIN-Cut-INSIDE	NN	I-NP	B
binding	binding	NN	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
PSM	BEGIN-PSM-INSIDE	NN	B-NP	B
overlap	overlap	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
known	know	VBN	I-NP	O
or	or	CC	I-NP	O
presumed	presume	VBN	I-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
replication	BEGIN-replication	NN	I-NP	B
initiator	initiator	NN	I-NP	I
protein	protein	NN	I-NP	I
E1	E1-INSIDE	NN	I-NP	I

With	With	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
operators	operator	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
glp	BEGIN-glp	NN	I-NP	B
regulon	regulon-INSIDE	NN	I-NP	I
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
characterized	characterize	VBN	I-VP	O

Located	Locate	VBN	B-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
spliced	splice	VBN	I-NP	O
leader	leader	NN	I-NP	O
acceptor	acceptor	NN	I-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
translational	translational	JJ	I-NP	O
initiation	initiation	NN	I-NP	O
codon	codon	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GP1	BEGIN-GP1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
conserved	conserve	VBN	B-NP	O
hexanucleotide	hexanucleotide	NN	I-NP	O
direct	direct	JJ	I-NP	O
repeats	repeat	NNS	I-NP	O
(	(	(	O	O
CTCGCC	CTCGCC	NN	B-NP	O
)	)	)	O	O
which	which	WDT	B-NP	O
vary	vary	VBP	B-VP	O
in	in	IN	B-PP	O
number	number	NN	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
species	specie	NNS	B-NP	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
impact	impact	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ESRD	ESRD	NN	I-NP	O
treatment	treatment	NN	I-NP	O
modality	modality	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
quality	quality	NN	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Type	Type	NN	B-NP	O
I	I	CD	I-NP	O
(	(	(	O	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
dependent	dependent	JJ	O	O
)	)	)	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O

MDA	MDA	NN	B-NP	O
-	-	HYPH	I-NP	O
MB	MB	NN	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
stably	stably	RB	I-VP	O
transfected	transfecte	VBN	I-VP	O
with	with	IN	B-PP	O
either	either	CC	O	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
CMV	BEGIN-CMV	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
driven	drive	VBN	B-NP	O
rabbit	BEGIN-BEGIN-rabbit	NN	I-NP	B
beta	beta	SYM	O	I
-	-	HYPH	O	I
globin	globin-INSIDE	NN	B-NP	I
gene	gene-INSIDE	NN	I-NP	I
or	or	CC	O	O
plasmids	plasmid	NNS	B-NP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
CMV	BEGIN-CMV	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
driven	drive	VBN	B-NP	O
chimeric	chimeric	JJ	I-NP	O
gadd1	BEGIN-gadd1-INSIDE	NN	I-NP	B
1	1	CD	I-NP	O
''	''	''	O	O
-	-	HYPH	B-NP	O
UTR	UTR	NN	I-NP	O
-	-	HYPH	I-NP	O
rabbit	BEGIN-BEGIN-rabbit	NN	I-NP	B
beta	beta	SYM	B-NP	I
-	-	HYPH	B-NP	I
globin	globin-INSIDE	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
entire	BEGIN-entire	JJ	I-NP	B
gadd1	BEGIN-BEGIN-gadd1-INSIDE	NN	I-NP	I
1	1	CD	I-NP	O
''	''	''	O	O
-	-	HYPH	B-NP	O
UTR	UTR	NN	I-NP	O
(	(	(	O	O
from	from	IN	B-PP	O
+1	+1	CD	B-NP	O
to	to	TO	B-PP	O
+1	+1	CD	B-NP	O
)	)	)	O	O
	-INSIDE-INSIDE	NN	B-NP	I
or	or	CC	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
subfragment	subfragment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gadd1	BEGIN-BEGIN-gadd1-INSIDE	NN	I-NP	B
1	1	CD	I-NP	O
''	''	''	O	O
-	-	HYPH	B-NP	O
UTR	UTR	NN	I-NP	O
(	(	(	O	O
from	from	IN	B-PP	O
+1	+1	CD	B-NP	O
to	to	TO	B-PP	O
+1	+1	CD	B-NP	O
)	)	)	O	O
	-INSIDE	NN	B-NP	I
was	be	VBD	B-VP	O
positioned	position	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
''	''	''	O	O
-	-	HYPH	O	O
end	end	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rabbit	BEGIN-BEGIN-rabbit	NN	I-NP	B
beta	beta	SYM	O	I
-	-	HYPH	O	I
globin	globin-INSIDE	NN	B-NP	I
gene	gene-INSIDE	NN	I-NP	I

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
BMK	BEGIN-BMK	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
and	and	CC	O	O
other	other	JJ	B-NP	O
1	1	CD	I-NP	O
contents	content	NNS	I-NP	O
significantly	significantly	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
depolarization	depolarization	NN	B-NP	O
parameters	parameter	NNS	I-NP	O
Vmax	Vmax	NN	I-NP	O
,	,	,	O	O
APA	APA	NN	B-NP	O
,	,	,	O	O
OS	OS	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
MDP	MDP	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
TTX	BEGIN-TTX-INSIDE	NN	B-NP	B
and	and	CC	O	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Nim	Nim	NN	B-NP	O
and	and	CC	I-NP	O
BaCl1	BaCl1	NN	I-NP	O

Fourteen	Fourteen	CD	B-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
seven	seven	CD	B-NP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
IR1	IR1	NN	B-NP	O
and	and	CC	I-NP	O
IR1	IR1	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
moisture	moisture	NN	B-NP	O
content	content	NN	I-NP	O
,	,	,	O	O
germination	germination	NN	B-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
abnormal	abnormal	JJ	B-NP	O
seedlings	seedling	NNS	I-NP	O
,	,	,	O	O
speed	speed	NN	B-NP	O
of	of	IN	B-PP	O
germination	germination	NN	B-NP	O
,	,	,	O	O
conductance	conductance	NN	B-NP	O
of	of	IN	B-PP	O
leachates	leachate	NNS	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
dehydrogenase	dehydrogenase	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
free	free	JJ	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
soluble	soluble	JJ	I-NP	O
sugar	sugar	NN	I-NP	O
,	,	,	O	O
fat	fat	JJ	B-NP	O
acidity	acidity	NN	I-NP	O
,	,	,	O	O
gelatinization	gelatinization	NN	B-NP	O
temperature	temperature	NN	I-NP	O
,	,	,	O	O
gel	gel	NN	B-NP	O
consistency	consistency	NN	I-NP	O
,	,	,	O	O
amylose	amylose	NN	B-NP	O
content	content	NN	I-NP	O
,	,	,	O	O
translucency	translucency	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
whiteness	whiteness	NN	I-NP	O

Southern	Southern	JJ	B-NP	O
zoo	zoo	NN	I-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
ZNF1	BEGIN-ZNF1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
genomes	genome	NNS	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	O
species	specie	NNS	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
yeast	yeast	NN	B-NP	O

1	1	CD	B-NP	O

This	This	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
splice	splice	NN	I-NP	O
acceptor	acceptor	NN	I-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
used	use	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
biologically	biologically	RB	I-NP	O
active	active	JJ	I-NP	O
provirus	provirus	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
efficiency	efficiency	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
site	site	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
digit	digit	NN	B-NP	O
identity	identity	NN	I-NP	O
and	and	CC	O	O
varying	vary	VBG	B-NP	O
degrees	degree	NNS	I-NP	O
of	of	IN	B-PP	O
polydactyly	polydactyly	RB	B-NP	O
,	,	,	O	O
proximal	proximal	JJ	B-NP	O
skeletal	skeletal	JJ	I-NP	O
elements	element	NNS	I-NP	O
are	be	VBP	B-VP	O
severely	severely	RB	I-VP	O
shortened	shorten	VBN	I-VP	O
in	in	IN	B-PP	O
Xt	BEGIN-Xt-INSIDE	NN	B-NP	B
;	;	:	O	O
ld	BEGIN-ld-INSIDE	NN	B-NP	B
double	double	JJ	I-NP	O
homozygous	homozygous	JJ	I-NP	O
limbs	limb	NNS	I-NP	O

In	In	IN	B-PP	O
turn	turn	NN	B-NP	O
,	,	,	O	O
production	production	NN	B-NP	O
of	of	IN	B-PP	O
sufficient	sufficient	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
TraR	BEGIN-TraR-INSIDE	NN	B-NP	B
apparently	apparently	RB	B-ADVP	O
is	be	VBZ	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
function	function	NN	I-NP	O
requiring	require	VBG	B-VP	O
RNase	BEGIN-RNase	NN	B-NP	B
D	D-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
lasalocid	lasalocid	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
rumen	rumen	NN	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
fungus	fungus	NN	I-NP	O
Neocallimastix	Neocallimastix	NNP	I-NP	O
frontalis	frontalis	DT	B-NP	O
RK	RK	NNP	I-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O

1	1	CD	B-NP	O
1	1	CD	I-NP	O
new	new	JJ	I-NP	O
mothers	mother	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
retrospectively	retrospectively	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
-	-	HYPH	B-VP	O
linked	link	VBN	B-NP	O
immunosorbent	immunosorbent	NN	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
ELISA	ELISA	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
IgG	BEGIN-IgG-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
cytomegalovirus	cytomegalovirus	NN	B-NP	O
(	(	(	O	O
CMV	CMV	NN	B-NP	O
)	)	)	O	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O

Promoter	Promoter	NN	B-NP	O
,	,	,	O	O
spliced	splice	VBN	B-VP	O
leader	leader	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
coding	cod	VBG	B-VP	O
sequence	sequence	NN	B-NP	O
for	for	IN	B-PP	O
BICP1	BEGIN-BICP1-INSIDE	NN	B-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
largest	large	JJS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immediate	BEGIN-immediate	JJ	I-NP	B
-	-	HYPH	I-NP	I
early	early	JJ	I-NP	I
proteins	protein	NNS	I-NP	I
of	of	IN	B-PP	I
bovine	bovine	JJ	B-NP	I
herpesvirus	herpesvirus	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I

ER	BEGIN-ER	NN	B-NP	B
beta	beta-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
potent	potent	JJ	I-ADJP	O
than	than	IN	B-PP	O
ER	BEGIN-ER	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
activating	activate	VBG	B-VP	O
E1	E1	NN	B-NP	O
-	-	HYPH	O	O
stimulated	stimulate	VBN	B-NP	O
ERELuc	BEGIN-ERELuc-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
vs	v	NNS	I-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
lysine	BEGIN-lysine	NN	B-NP	B
vasopressin	vasopressin-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
the	the	DT	B-NP	O
EEG	EEG	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
animal	animal	NN	B-NP	O
and	and	CC	I-NP	O
man	man	NN	I-NP	O
after	after	IN	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
nicotine	nicotine	NN	B-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
elimination	elimination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kinase	kinase	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
DCAMKL1	BEGIN-DCAMKL1-INSIDE	NN	B-NP	B
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
detectable	detectable	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
microtubule	microtubule	NN	I-NP	O
polymerization	polymerization	NN	I-NP	O
activity	activity	NN	I-NP	O

Sequencing	Sequencing	NN	B-NP	O
and	and	CC	I-NP	O
restriction	restriction	NN	I-NP	O
enzyme	enzyme	NN	I-NP	O
analysis	analysis	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
copy	copy	NN	I-NP	O
gene	gene	NN	I-NP	O
contains	contain	VBZ	B-VP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
and	and	CC	I-NP	O
spans	span	NNS	I-NP	O
1	1	CD	I-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
labour	labour	NN	B-NP	O
pains	pain	NNS	I-NP	O
with	with	IN	B-PP	O
Th	Th	NN	B-NP	O
1a	1a	NN	I-NP	O
and	and	CC	I-NP	O
Isoptin	Isoptin	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
circulation	circulation	NN	B-NP	O
,	,	,	O	O
organ	organ	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
metabolic	metabolic	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mother	mother	NN	I-NP	O

The	The	DT	B-NP	O
anaesthetic	anaesthetic	JJ	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
period	period	NN	I-NP	O
at	at	IN	B-PP	O
Clinica	Clinica	NNP	B-NP	O
Puerta	Puerta	NNP	I-NP	O
de	de	IN	I-NP	O
Hierro	Hierro	NNP	I-NP	O
is	be	VBZ	B-VP	O
reviewed	review	VBN	I-VP	O

In	In	IN	B-PP	O
uraemic	uraemic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
similar	similar	JJ	B-NP	O
maximum	maximum	JJ	I-NP	O
serum	serum	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
iv	iv	NN	I-NP	O
dose	dose	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
unit	unit	NN	I-NP	O
housing	housing	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
compact	compact	JJ	I-NP	O
cyclotron	cyclotron	NN	I-NP	O
and	and	CC	I-NP	O
positron	positron	NN	I-NP	O
emission	emission	NN	I-NP	O
CT	CT	NN	I-NP	O
(	(	(	O	O
PET	PET	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
positron	positron	NN	B-NP	O
emitting	emit	VBG	B-VP	O
gas	gas	NN	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
1O	1O	NN	B-NP	O
,	,	,	O	O
1C	1C	NN	B-NP	O
,	,	,	O	O
C1O1	C1O1	NN	B-NP	O
,	,	,	O	O
C1O	C1O	NN	B-NP	O
etc.	etc.	FW	I-NP	O
is	be	VBZ	B-VP	O
supplied	supply	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cyclotron	cyclotron	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
PET	PET	NN	I-NP	O
room	room	NN	I-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
transportation	transportation	NN	I-NP	O
pipe	pipe	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
shield	shield	NN	I-NP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
positron	positron	NN	B-NP	O
annihilation	annihilation	NN	I-NP	O
radiation	radiation	NN	I-NP	O

Although	Although	IN	B-SBAR	O
CB	CB	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
chlorine	chlorine	NN	B-NP	O
than	than	IN	B-PP	O
CB	CB	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
isolates	isolate	NNS	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
of	of	IN	B-PP	O
contact	contact	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
input	input	NN	I-NP	O
virus	virus	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
infectious	infectious	JJ	B-ADJP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
and	and	CC	O	O
initial	initial	JJ	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
IPP	BEGIN-IPP-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
human	human	JJ	I-NP	O
gene	gene	NN	I-NP	O
that	that	WDT	B-NP	O
predicts	predict	VBZ	B-VP	O
a	a	DT	B-NP	O
kelch	BEGIN-kelch	JJ	I-NP	B
family	family	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
Ipp	Ipp	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
described	describe	VBN	I-NP	O
kelch	BEGIN-kelch	JJ	I-NP	B
family	family	NN	I-NP	I
member	member-INSIDE	NN	I-NP	I

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
identifies	identify	VBZ	B-VP	O
a	a	DT	B-NP	O
ras	BEGIN-ras	NN	I-NP	B
-	-	HYPH	O	I
associating	associating-INSIDE	NN	B-NP	I
(	(	(	O	O
RA	BEGIN-RA-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
domain	domain	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	O	O
termini	terminus	NNS	B-NP	O
of	of	IN	B-PP	O
band	BEGIN-band	NN	B-NP	B
1	1	CD	I-NP	I
/	/	SYM	I-NP	I
JEF	JEF	NN	I-NP	I
domains	domains-INSIDE	NN	I-NP	I
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Grb1	BEGIN-Grb1	NN	I-NP	B
/	/	SYM	B-NP	I
1	1	CD	I-NP	I
/	/	SYM	I-NP	I
1	1	CD	I-NP	I
adapter	adapter	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

Sleeping	Sleep	VBG	B-VP	O
position	position	NN	B-NP	O
and	and	CC	O	O
sudden	sudden	JJ	B-NP	O
infant	infant	NN	I-NP	O
death	death	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
(	(	(	O	O
SIDS	SIDS	NN	B-NP	O
)	)	)	O	O
:	:	:	O	O
effect	effect	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
intervention	intervention	NN	I-NP	O
programme	programme	NN	I-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
prone	prone	JJ	B-NP	O
sleeping	sleeping	NN	I-NP	O

Statistical	Statistical	JJ	B-NP	O
conservation	conservation	NN	I-NP	O
laws	law	NNS	I-NP	O
in	in	IN	B-PP	O
turbulent	turbulent	JJ	B-NP	O
transport	transport	NN	I-NP	O

Characterization	Characterization	NN	B-NP	O
and	and	CC	O	O
targeted	target	VBN	B-NP	O
disruption	disruption	NN	I-NP	O
of	of	IN	B-PP	O
murine	BEGIN-murine	JJ	B-NP	B
Nup1	NuBEGIN-p1-INSIDE-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
Kip1	KiBEGIN-p1-INSIDE	NN	B-NP	I
)	)	)	O	O
-	-	HYPH	O	O
interacting	interact	VBG	B-VP	O
component	component	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
pore	pore	NN	I-NP	O
complex.	complex.	NN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
Kip1	KiBEGIN-p1-INSIDE	NN	B-NP	I
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Cip	BEGIN-Cip-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
Kip	BEGIN-Kip-INSIDE	NN	I-NP	B
family	family	NN	I-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-BEGIN-cyclin-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
Cdk	BEGIN-Cdk-INSIDE	NN	B-NP	B
)	)	)	O	O
inhibitors	inhibitor	NNS	B-NP	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
cyclin	BEGIN-cyclin-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
Cdk	BEGIN-Cdk-INSIDE	NN	I-NP	B
complexes	complex	NNS	I-NP	O
and	and	CC	O	O
inhibits	inhibit	VBZ	B-VP	O
their	their	PRP$	B-NP	O
catalytic	catalytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
antiproliferative	antiproliferative	JJ	B-NP	O
stimuli.	stimuli.	NN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
Kip1	KiBEGIN-p1-INSIDE	NN	B-NP	I
)	)	)	O	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
several	several	JJ	B-NP	O
posttranscriptional	posttranscriptional	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
subcellular	subcellular	JJ	B-NP	O
localization	localization	NN	I-NP	O

Further	Further	JJ	B-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
warranted	warrant	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
are	be	VBP	B-VP	O
idiosyncratic	idiosyncratic	JJ	B-ADJP	O
,	,	,	O	O
coincidental	coincidental	JJ	B-ADJP	O
,	,	,	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
general	general	JJ	I-NP	O
phenomenon	phenomenon	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
sigma	BEGIN-sigma	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
screen	screen	NN	I-NP	O
designed	design	VBN	B-VP	O
to	to	TO	I-VP	O
isolate	isolate	VB	I-VP	O
trans	trans	AFX	O	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
mutations	mutation	NNS	B-NP	O
that	that	WDT	B-NP	O
abolish	abolish	VBP	B-VP	O
expression	expression	NN	B-NP	O
from	from	IN	B-PP	O
either	either	CC	O	O
htrA	BEGIN-htrA-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
rpoHP1	BEGIN-rpoHP1-INSIDE	NN	I-NP	B
,	,	,	O	O
two	two	CD	B-NP	O
promoters	promoter	NNS	I-NP	O
recognized	recognize	VBN	B-VP	O
uniquely	uniquely	RB	B-ADVP	O
by	by	IN	B-PP	O
sigma	BEGIN-sigma	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
RNA	BEGIN-RNA	NN	B-NP	B
polymerase	polymerase-INSIDE	NN	I-NP	I

METHODOLOGY	METHODOLOGY	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
case	case	NN	I-NP	O
control	control	NN	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
survivors	survivor	NNS	B-NP	O
with	with	IN	B-PP	O
gestational	gestational	JJ	B-NP	O
age	age	NN	I-NP	O
(	(	(	O	O
GA	GA	NN	B-NP	O
)	)	)	O	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
or	or	CC	O	O
birthweight	birthweight	NN	B-NP	O
(	(	(	O	O
BW	BW	NN	B-NP	O
)	)	)	O	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
using	use	VBG	B-VP	O
data	datum	NNS	B-NP	O
collected	collect	VBN	B-VP	O
prospectively	prospectively	RB	B-ADVP	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
Neonatal	Neonatal	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
database	database	NN	I-NP	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
IPFSA	IPFSA	NN	I-NP	O
can	can	MD	B-VP	O
promote	promote	VB	I-VP	O
the	the	DT	B-NP	O
healing	healing	JJ	I-NP	O
process	process	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
avascular	avascular	JJ	I-NP	O
zone	zone	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
torn	torn	JJ	I-NP	O
meniscus	meniscus	NN	I-NP	O
in	in	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
systemic	systemic	JJ	B-NP	O
vascularity	vascularity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
synovium	synovium	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
meniscus	meniscus	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
healing	heal	VBG	B-VP	O
to	to	TO	I-VP	O
occur	occur	VB	I-VP	O

Biomass	Biomass	NN	B-NP	O
growth	growth	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
using	use	VBG	B-VP	O
pressure	pressure	NN	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cocurrent	cocurrent	JJ	I-NP	O
biofilter	biofilter	NN	I-NP	O

Mutant	Mutant	JJ	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
DNA	DNA-INSIDE	NN	I-NP	I
clones	clone	NNS	I-NP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
colon	colon	NN	I-NP	O
carcinomas	carcinoma	NNS	I-NP	O
cooperate	cooperate	VBP	B-VP	O
with	with	IN	B-PP	O
ras	BEGIN-ras-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
transforming	transform	VBG	B-VP	O
primary	primary	JJ	B-NP	O
rat	rat	NN	I-NP	O
cells	cell	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
``	``	``	I-NP	O
hot	hot	JJ	I-NP	O
spot	spot	NN	I-NP	O
''	''	''	I-NP	O
mutant	mutant	JJ	I-NP	O
phenotypes	phenotype	NNS	I-NP	O

The	The	DT	B-NP	O
RHO1	BEGIN-RHO1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
homolog	homolog	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	O
RhoA	BEGIN-RhoA	NN	I-NP	B
small	small	JJ	I-NP	I
GTP	GTP	NN	I-NP	I
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
Saccharomyces	Saccharomyces	NNP	I-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O

Inspection	Inspection	NN	B-NP	O
of	of	IN	B-PP	O
X.	BEGIN-X.	NNP	B-NP	B
tropicalis	tropicalis	NN	I-NP	I
,	,	,	O	I
mouse	mouse	NN	B-NP	I
and	and	CC	O	I
human	human	JJ	B-NP	I
U1	U1	NN	I-NP	I
DNA	DNA	NN	I-NP	I
upstream	upstream	JJ	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
and	and	CC	I-NP	O
enhancer	enhancer	NN	I-NP	O
(	(	(	O	O
octamer	octamer	NN	B-NP	O
motif	motif	NN	I-NP	O
)	)	)	O	O
elements	element	NNS	B-NP	O
contained	contain	VBN	B-VP	O
in	in	IN	B-PP	O
snRNA	snRNA	NN	B-NP	O
genes	gene	NNS	I-NP	O
transcribed	transcribe	VBN	B-VP	O
by	by	IN	B-PP	O
RNA	BEGIN-RNA	NN	B-NP	B
polymerase	polymerase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
men	man	NNS	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
/	/	SYM	I-NP	O
height1	height1	NN	I-NP	O
met	meet	VBD	B-VP	O
the	the	DT	B-NP	O
criteria	criterion	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
satisfactory	satisfactory	JJ	I-NP	O
index	index	NN	I-NP	O
in	in	IN	B-PP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
strong	strong	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
triceps	tricep	NNS	B-NP	O
skinfold	skinfold	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
negligible	negligible	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
height	height	NN	B-NP	O

When	When	WRB	B-ADVP	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
thymidine	BEGIN-thymidine	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
L	L	NN	I-NP	O
cells	cell	NNS	I-NP	O
or	or	CC	O	O
1T1	1T1	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	B-NP	I
EBPalpha	EBPalpha-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
complex	complex	NN	I-NP	O
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
E1F	BEGIN-E1F	NN	I-NP	B
binding	binding	NN	I-NP	I
sites	sites-INSIDE	NN	I-NP	I
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoters	promoter	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
for	for	IN	B-PP	O
E1F	BEGIN-E1F	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
dihydrofolate	BEGIN-dihydrofolate	JJ	B-NP	B
reductase	reductase-INSIDE	NN	I-NP	I
(	(	(	O	O
DHFR	BEGIN-DHFR-INSIDE	NN	B-NP	B
)	)	)	O	O

Phenylalanine	Phenylalanine	NN	B-NP	O
and	and	CC	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
who	who	WP	B-NP	O
received	receive	VBD	B-VP	O
Vamin	Vamin	NNP	B-NP	O
1	1	CD	I-NP	O
glucose	glucose	NN	I-NP	O
but	but	CC	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
infants	infant	NNS	B-NP	O
given	give	VBN	B-PP	O
Vamin	Vamin	NNP	B-NP	O
Infant	Infant	NNP	I-NP	O
had	have	VBD	B-VP	O
tyrosine	tyrosine	NN	B-NP	O
levels	level	NNS	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
limit	limit	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
range	range	NN	I-NP	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
osteocalcin	BEGIN-osteocalcin	NN	I-NP	B
gene	gene	NN	I-NP	I
promoter	promoter	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
AP1	BEGIN-AP1-INSIDE	NN	B-NP	B

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Neurodevelopmental	Neurodevelopmental	JJ	B-NP	O
assessment	assessment	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
year	year	NN	I-NP	O
is	be	VBZ	B-VP	O
predictive	predictive	JJ	B-ADJP	O
of	of	IN	B-PP	O
school	school	NN	B-NP	O
performance	performance	NN	I-NP	O
and	and	CC	I-NP	O
outcome	outcome	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adolescent	adolescent	JJ	I-NP	O
period	period	NN	I-NP	O

Phenotypic	Phenotypic	JJ	B-NP	O
responses	response	NNS	I-NP	O
of	of	IN	B-PP	O
additional	additional	JJ	B-NP	O
mutants	mutant	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
exo1	BEGIN-exo1-INSIDE	NN	B-NP	B
,	,	,	O	O
srs1	BEGIN-srs1-INSIDE	NN	B-NP	B
,	,	,	O	O
rad1	BEGIN-rad1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
rdh1	BEGIN-rdh1-INSIDE	NN	B-NP	B
strains	strain	NNS	I-NP	O
,	,	,	O	O
suggest	suggest	VBP	B-VP	O
roles	role	NNS	B-NP	O
in	in	IN	B-PP	O
recombinational	recombinational	JJ	B-NP	O
repair	repair	NN	I-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
NHEJ	NHEJ	NN	B-NP	O

Although	Although	IN	B-SBAR	O
hSSTR1	BEGIN-hBEGIN-SST-INSIDER1-INSIDE	NN	B-NP	B
displays	display	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
sequence	sequence	NN	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
rat	BEGIN-rat	NN	B-NP	B
SSTR1	BEGIN-SST-INSIDER1-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
receptors	receptor	NNS	I-NP	O
display	display	VBP	B-VP	O
significantly	significantly	RB	B-NP	O
different	different	JJ	I-NP	O
pharmacological	pharmacological	JJ	I-NP	O
profiles	profile	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
binding	binding	NN	I-NP	O
affinities	affinity	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
SST	BEGIN-SST-INSIDE	NN	I-NP	B
analogue	analogue	NN	I-NP	O
SMS	SMS	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
stimulated	stimulate	VBN	I-NP	O
,	,	,	I-NP	O
Rho	BEGIN-Rho-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
cytoskeletal	cytoskeletal	JJ	I-NP	O
reorganization	reorganization	NN	I-NP	O
may	may	MD	B-VP	O
cluster	cluster	VB	I-VP	O
signaling	signal	VBG	I-VP	O
molecules	molecule	NNS	B-NP	O
in	in	IN	B-PP	O
specific	specific	JJ	B-NP	O
architectures	architecture	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
disease	disease	NN	I-NP	O

Deletion	Deletion	NN	B-NP	O
mutants	mutant	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
CHOP	CHOP	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
identify	identify	VBP	B-VP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
comprising	comprise	VBG	B-VP	O
nucleotides	nucleotide	NNS	B-NP	O
-	-	SYM	O	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
both	both	CC	B-NP	O
constitutive	constitutive	JJ	I-NP	O
and	and	CC	I-NP	O
ER	ER	NN	I-NP	O
-	-	HYPH	B-NP	O
stress	stress	NN	I-NP	O
-	-	HYPH	O	O
inducible	inducible	JJ	B-NP	O
expression	expression	NN	I-NP	O

Anderson	Anderson	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
and	and	CC	O	O
Tumor	Tumor	NNP	B-NP	O
Institute	Institute	NNP	I-NP	O
at	at	IN	B-PP	O
Houston	Houston	NNP	B-NP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
interval	interval	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
to	to	TO	O	O
1	1	CD	O	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
ten	ten	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
,	,	,	O	O
we	we	PRP	B-NP	O
determined	determine	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
prognostic	prognostic	JJ	I-NP	O
factor	factor	NN	I-NP	O
of	of	IN	B-PP	O
survival	survival	NN	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
positive	positive	JJ	B-NP	O
nodes	node	NNS	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
atherogenic	atherogenic	JJ	I-NP	O
process	process	NN	I-NP	O
includes	include	VBZ	B-VP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
collagen	BEGIN-collagen-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
elastin	BEGIN-elastin-INSIDE	NN	I-NP	B
synthesis	synthesis	NN	I-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
nine	nine	CD	B-NP	O
consecutive	consecutive	JJ	I-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
ACB	ACB	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
five	five	CD	B-NP	O
males	male	NNS	I-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
females	female	NNS	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
routine	routine	JJ	I-NP	O
spiral	spiral	JJ	I-NP	O
CT	CT	NN	I-NP	O
examinations	examination	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
,	,	,	O	O
performed	perform	VBN	B-VP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O

The	The	DT	B-NP	O
absolute	absolute	JJ	I-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
count	count	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
de	de	FW	B-NP	O
novo	novo	FW	I-NP	O
IBD	IBD	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
/	/	SYM	O	O
ml	ml	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
IBD	IBD	NN	B-NP	O

Four	Four	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
fibroblast	fibroblast	NN	I-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
retrovirus	retrovirus	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
cDNA	BEGIN-cDNA	NN	I-NP	B
encoding	encode	VBG	B-VP	I
myoD	myoD-INSIDE	NN	B-NP	I
and	and	CC	O	O
a	a	DT	B-NP	O
puromycin	puromycin	NN	I-NP	O
selection	selection	NN	I-NP	O
marker	marker	NN	I-NP	O

Sexual	Sexual	JJ	B-NP	O
adventurism	adventurism	NN	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
risk	risk	NN	I-NP	O
behavior	behavior	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
seroconversion	seroconversion	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
Chicago	Chicago	NNP	I-NP	O
MACS	MACS	NN	I-NP	O
-	-	HYPH	I-NP	O
CCS	CCS	NN	I-NP	O
cohort	cohort	JJ	B-ADJP	O
,	,	,	O	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O

As	As	IN	B-SBAR	O
already	already	RB	B-ADVP	O
available	available	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
known	known	JJ	I-NP	O
mammalian	mammalian	JJ	I-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
family	family	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
here	here	RB	B-ADVP	O
define	define	VBP	B-VP	O
structural	structural	JJ	B-NP	O
and	and	CC	I-NP	O
functional	functional	JJ	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
lymphoma	lymphoma	NN	I-NP	I
proprotein	proprotein	NN	I-NP	I
convertase	convertase-INSIDE	NN	I-NP	I
(	(	(	O	O
LPC	BEGIN-LPC-INSIDE	NN	B-NP	B
)	)	)	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
the	the	DT	B-NP	O
feasibility	feasibility	NN	I-NP	O
and	and	CC	I-NP	O
potential	potential	JJ	I-NP	O
usefulness	usefulness	NN	I-NP	O
of	of	IN	B-PP	O
syngeneic	syngeneic	JJ	B-NP	O
BM	BM	NN	I-NP	O
Txp	Txp	NN	I-NP	O
in	in	IN	B-PP	O
myeloma	myeloma	NN	B-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
to	to	TO	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
HITT	HITT	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
its	its	PRP$	B-NP	O
devastating	devastate	VBG	I-NP	O
clinical	clinical	JJ	I-NP	O
consequences	consequence	NNS	I-NP	O

Results	Result	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
tritium	tritium	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
direct	direct	JJ	B-NP	O
chemical	chemical	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O

Relation	Relation	NN	B-NP	O
between	between	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
roentgenological	roentgenological	JJ	I-NP	O
scores	score	NNS	I-NP	O
and	and	CC	I-NP	O
measures	measure	NNS	I-NP	O
of	of	IN	B-PP	O
lung	lung	NN	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
cystic	cystic	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
special	special	JJ	B-NP	O
reference	reference	NN	I-NP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
Xenon1	Xenon1	NN	I-NP	O
elimination	elimination	NN	I-NP	O

Phytohemagglutinin	BEGIN-Phytohemagglutinin-INSIDE	NN	B-NP	B
(	(	(	O	O
PHA	BEGIN-PHA-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
seed	BEGIN-seed	JJ	I-NP	B
lectin	lectin-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
common	common	JJ	I-NP	O
bean	bean	NN	I-NP	O
,	,	,	O	O
accumulates	accumulate	VBZ	B-VP	O
in	in	IN	B-PP	O
protein	protein	NN	B-NP	O
storage	storage	NN	I-NP	O
vacuoles	vacuole	NNS	I-NP	O
of	of	IN	B-PP	O
storage	storage	NN	B-NP	O
parenchyma	parenchyma	NN	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
cotyledons	cotyledon	NNS	B-NP	O

New	New	JJ	B-NP	O
concepts	concept	NNS	I-NP	O
of	of	IN	B-PP	O
condyloma	condyloma	NN	B-NP	O
acuminata	acuminata	NNS	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O

When	When	WRB	B-ADVP	O
recombinant	BEGIN-recombinant	JJ	B-NP	B
gE	gE-INSIDE	NN	I-NP	I
produced	produce	VBN	B-VP	O
in	in	IN	B-PP	O
HeLa	HeLa	NN	B-NP	O
cells	cell	NNS	I-NP	O
was	be	VBD	B-VP	O
probed	probe	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
antiphosphotyrosine	antiphosphotyrosine	JJ	I-NP	O
antibody	antibody	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
dimeric	BEGIN-dimeric	JJ	I-NP	B
gE	gE-INSIDE	NN	I-NP	I
form	form	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
kDa	kDa	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O

The	The	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
soluble	soluble	JJ	B-NP	O
L	BEGIN-L	NN	I-NP	B
-	-	HYPH	B-NP	I
selectin	selectin-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
ICAM	BEGIN-ICAM	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ELISA	ELISA	NN	I-NP	O
method	method	NN	I-NP	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
lung	lung	NN	B-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
vasoactivity	vasoactivity	NN	I-NP	O
of	of	IN	B-PP	O
furosemide	furosemide	NN	B-NP	O

Within	Within	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
few	few	JJ	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
WWW	WWW	NNP	I-NP	O
has	have	VBZ	B-VP	O
grown	grow	VBN	I-VP	O
enormously	enormously	RB	B-ADVP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
insertion	insertion	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Saccharomyces	BEGIN-Saccharomyces	FW	I-NP	B
cerevisiae	cerevisiae	FW	I-NP	I
MSH1	MSH1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
MSH1	BEGIN-MSH1	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
separate	separate	JJ	B-NP	O
mitochondrial	mitochondrial	JJ	I-NP	O
and	and	CC	I-NP	O
nuclear	nuclear	JJ	I-NP	O
functions	function	NNS	I-NP	O

These	These	DT	B-NP	O
cells	cell	NNS	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
A	A-INSIDE	NN	I-NP	I
and	and	CC	O	O
cyclin	BEGIN-BEGIN-cyclin	NN	B-NP	B
A	A-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
E	E	NN	I-NP	O
-	-	HYPH	O	O
associated	associate	VBN	B-NP	O
kinase	kinase-INSIDE	NN	I-NP	I
activities	activity	NNS	I-NP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
induction	induction	NN	I-NP	O

Anisotropy	Anisotropy	NN	B-NP	O
of	of	IN	B-PP	O
Hc1	Hc1	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
breadth	breadth	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
resistive	resistive	JJ	I-NP	O
transition	transition	NN	I-NP	O
of	of	IN	B-PP	O
polycrystalline	polycrystalline	NN	B-NP	O
YBa1Cu	YBa1Cu	NN	I-NP	O

TGF	BEGIN-TGF	NN	B-NP	B
-	-	HYPH	I-NP	I
beta1	beta1-INSIDE	NN	I-NP	I
induced	induce	VBD	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
Smad1	BEGIN-Smad1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Smad1	BEGIN-Smad1-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
Mv1Lu	Mv1Lu	NN	B-NP	O
mink	mink	NN	I-NP	O
lung	lung	NN	I-NP	O
epithelial	epithelial	JJ	I-NP	O
cells	cell	NNS	I-NP	O

Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
X	X	NN	B-NP	O
-	-	HYPH	B-NP	O
chromatin	chromatin	NN	I-NP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
under	under	IN	B-PP	O
Prednisone	Prednisone	NN	B-NP	O
therapy	therapy	NN	I-NP	O

Obtaining	Obtain	VBG	B-VP	O
kidney	kidney	NN	B-NP	O
cells	cell	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
beagle	beagle	NN	I-NP	O
puppy	puppy	NN	I-NP	O
(	(	(	O	O
RPB	RPB	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cryopreservation	cryopreservation	NN	I-NP	O
bank	bank	NN	I-NP	O

Microscopically	Microscopically	RB	B-ADVP	O
,	,	,	O	O
cartilage	cartilage	NN	B-NP	O
showed	show	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
stunted	stunt	VBN	I-VP	O
and	and	CC	O	O
disorganized	disorganize	VBN	B-VP	O
endochondral	endochondral	JJ	B-NP	O
ossification	ossification	NN	I-NP	O

When	When	WRB	B-ADVP	O
incubated	incubate	VBN	B-VP	O
with	with	IN	B-PP	O
infective	infective	JJ	B-NP	O
larvae	larva	NNS	I-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
penetrated	penetrate	VBN	I-VP	O
mouse	mouse	NN	B-NP	O
skin	skin	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
normal	normal	JJ	I-NP	O
and	and	CC	I-NP	O
immune	immune	JJ	I-NP	O
cells	cell	NNS	I-NP	O
attached	attach	VBN	B-VP	O
to	to	TO	B-VP	O
larvae	larvae	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O

During	During	IN	B-PP	O
each	each	DT	B-NP	O
step	step	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pulse	pulse	NN	I-NP	O
infusion	infusion	NN	I-NP	O
the	the	DT	B-NP	O
osteocalcin	BEGIN-osteocalcin-INSIDE	JJ	I-NP	B
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
CaI	CaI	NN	B-NP	O
in	in	IN	B-PP	O
general	general	JJ	B-ADJP	O
were	be	VBD	B-VP	O
parallel	parallel	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
PTH	BEGIN-PTH-INSIDE	NN	B-NP	B
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
were	be	VBD	B-VP	O
inversely	inversely	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
to	to	TO	B-PP	O
CaI	CaI	NN	B-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

GH	BEGIN-GH-INSIDE	NN	B-NP	B
signals	signal	NNS	I-NP	O
by	by	IN	B-PP	O
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
GH	BEGIN-BEGIN-GH-INSIDE	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
GHR	BEGIN-GH-INSIDER	NN	B-NP	I
)	)	)	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
MT	BEGIN-MT-INSIDE	NN	B-NP	B
potentiates	potentiate	VBZ	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
MCF1	MCF1	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
downregulation	downregulation	NN	B-NP	O
of	of	IN	B-PP	O
MT	BEGIN-MT-INSIDE	NN	B-NP	B
elicits	elicit	VBZ	B-VP	O
antiproliferative	antiproliferative	JJ	B-NP	O
effects	effect	NNS	I-NP	O

The	The	DT	B-NP	O
induction	induction	NN	I-NP	O
by	by	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
of	of	IN	B-PP	O
rat	BEGIN-rat	NN	B-NP	B
liver	liver	NN	I-NP	I
CYP1A1	BEGIN-CYP1A1-INSIDE-INSIDE	NN	I-NP	I
differs	differ	VBZ	B-VP	O
from	from	IN	B-PP	O
classical	classical	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
gene	gene	NN	I-NP	O
regulation	regulation	NN	I-NP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
because	because	IN	B-SBAR	O
both	both	CC	O	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
and	and	CC	I-NP	O
antiglucocorticoids	antiglucocorticoid	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
pregnenolone	pregnenolone	NN	B-NP	O
1	1	CD	I-NP	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
carbonitrile	carbonitrile	NN	B-NP	O
(	(	(	O	O
PCN	PCN	NN	B-NP	O
)	)	)	O	O
induce	induce	VBP	B-VP	O
CYP1A1	BEGIN-CYP1A1-INSIDE	NN	B-NP	B
through	through	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
gene	gene	NN	I-NP	O
activation	activation	NN	I-NP	O

A	A	DT	B-NP	O
pharmacokinetic	pharmacokinetic	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
LY1	LY1	NN	B-NP	O
and	and	CC	I-NP	O
diazepam	diazepam	NN	I-NP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lowering	lowering	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
diazepam	diazepam	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
MYD	MYD	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
arterial	arterial	JJ	B-NP	O
PO1	PO1	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
seated	seat	VBN	I-NP	O
posture	posture	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
supine	supine	NN	I-NP	O
posture	posture	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
PCO1	PCO1	NN	I-NP	O

The	The	DT	B-NP	O
animals	animal	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
h	h	NN	I-NP	O
posttraumatic	posttraumatic	JJ	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
processed	process	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
LM	LM	NN	I-NP	O
and	and	CC	I-NP	O
TEM	TEM	NN	I-NP	O
visualization	visualization	NN	I-NP	O
of	of	IN	B-PP	O
HRP	BEGIN-HRP-INSIDE	NN	B-NP	B

Glucose	Glucose	NN	B-NP	O
consumption	consumption	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
brain	brain	NN	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
infusions	infusion	NNS	I-NP	O
of	of	IN	B-PP	O
glucose	glucose	NN	B-NP	O
,	,	,	I-NP	O
glucagon	BEGIN-glucagon-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
glucose	glucose	NN	I-NP	O
-	-	HYPH	O	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
enterocolitis	enterocolitis	NN	B-NP	O
,	,	,	O	O
pathological	pathological	JJ	B-NP	O
microbial	microbial	JJ	I-NP	O
flora	flora	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stool	stool	NN	I-NP	O
and	and	CC	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
colon	colon	NN	I-NP	O
mucosa	mucosa	NN	I-NP	O
were	be	VBD	B-VP	O
absent	absent	JJ	B-ADJP	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
and	and	CC	I-NP	O
biological	biological	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
nebulized	nebulize	VBN	B-NP	O
interleukin	BEGIN-interleukin	NN	I-NP	B
1	1-INSIDE	NN	I-NP	I
liposomes	liposome	NNS	I-NP	O

Although	Although	IN	B-SBAR	O
mutant	BEGIN-mutant	JJ	B-NP	B
pex1delta	pex1delta-INSIDE	NN	I-NP	I
cells	cell	NNS	I-NP	O
expressing	express	VBG	B-VP	O
a	a	DT	B-NP	O
yeast	BEGIN-yeast	NN	I-NP	B
/	/	SYM	B-NP	I
tobacco	tobacco	NN	I-NP	I
Pex1p	Pex1p	NN	I-NP	I
chimaera	chimaera-INSIDE	NN	I-NP	I
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
import	import	VB	I-VP	O
a	a	DT	B-NP	O
GFP	BEGIN-GFP-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
Eci1p	BEGIN-Eci1p-INSIDE	NN	I-NP	B
reporter	reporter	NN	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
grow	grow	VB	I-VP	O
on	on	IN	B-PP	O
oleic	oleic	JJ	B-NP	O
acid	acid	NN	I-NP	O

Two	Two	CD	B-NP	O
human	BEGIN-human	JJ	I-NP	B
beta	beta	SYM	I-NP	I
-	-	HYPH	I-NP	I
1	1	CD	I-NP	I
,	,	,	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
N	N	NN	I-NP	I
-	-	HYPH	I-NP	I
acetylglucosaminyltransferases	acetylglucosaminyltransferases-INSIDE	NN	I-NP	I
forming	form	VBG	B-VP	O
the	the	DT	B-NP	O
core	core	NN	I-NP	O
1	1	CD	I-NP	O
O	O	NN	I-NP	O
-	-	HYPH	B-NP	O
glycan	glycan	NN	I-NP	O
branch	branch	NN	I-NP	O
,	,	,	O	O
C1GnT	C1GnT	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
I	BEGIN-I	NN	I-NP	B
antigen	antigen-INSIDE	NN	I-NP	I
,	,	,	O	O
IGnT	BEGIN-IGnT-INSIDE	NN	B-NP	B
,	,	,	O	O
are	be	VBP	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
domain	domain	NN	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
,	,	,	I-NP	O
B	B	NN	I-NP	O
,	,	,	I-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
genes	gene	NNS	I-NP	O
reside	reside	VBP	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
locus	locus	NN	I-NP	O
,	,	,	O	O
chromosome	chromosome	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
band	band	NN	B-NP	O
q1	q1	NN	I-NP	O
(	(	(	O	O
Bierhuizen	Bierhuizen	NNP	B-NP	O
,	,	,	O	O
M.F.A.	M.F.A.	NNP	B-NP	O
,	,	,	O	O
Mattei	Mattei	NNP	B-NP	O
,	,	,	O	O
M.	M.	NNP	B-NP	O
-	-	HYPH	I-NP	O
G.	G.	NNP	I-NP	O
and	and	CC	I-NP	O
Fukuda	Fukuda	NNP	I-NP	O
,	,	,	O	O
M.	M.	NNP	B-NP	O
,	,	,	O	O
Genes	Genes	NNP	B-NP	O
Dev.	Dev.	NNP	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Previously	Previously	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
had	have	VBD	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
interleukin	BEGIN-interleukin	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
is	be	VBZ	B-VP	O
constitutively	constitutively	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
HTLV	HTLV	NN	B-NP	O
-	-	HYPH	B-NP	O
I	I	NN	I-NP	O
-	-	HYPH	B-NP	O
infected	infect	VBN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
transiently	transiently	RB	B-VP	O
expressing	express	VBG	I-VP	O
Tax	BEGIN-Tax-INSIDE	NN	B-NP	B

We	We	PRP	B-NP	O
undertook	undertake	VBD	B-VP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
delivery	delivery	NN	I-NP	O
(	(	(	O	O
DO1	DO1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
tissue	tissue	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
tension	tension	NN	I-NP	O
(	(	(	O	O
TPO1	TPO1	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
hypovolemic	hypovolemic	JJ	B-NP	O
shock	shock	NN	I-NP	O

The	The	DT	B-NP	O
lowest	low	JJS	I-NP	O
PaCO1	PaCO1	NN	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
in	in	IN	B-PP	O
MCE	MCE	NN	B-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
F	F	NNP	I-NP	O
,	,	,	O	O
W	W	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
D	D	NN	B-NP	O
(	(	(	O	O
F	F	NN	B-NP	O
+	+	SYM	B-NP	O
W	W	NN	I-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
)	)	)	I-NP	O
group	group	NN	I-NP	O
or	or	CC	I-NP	O
controls	control	NNS	I-NP	O

The	The	DT	B-NP	O
psychosomatic	psychosomatic	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-PP	O
temporomandibular	temporomandibular	JJ	B-NP	O
arthrosis	arthrosis	NN	I-NP	O

Detection	Detection	NN	B-NP	O
of	of	IN	B-PP	O
sinusoidal	sinusoidal	JJ	B-NP	O
gratings	grating	NNS	I-NP	O
by	by	IN	B-PP	O
pattern	pattern	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
detectors	detector	NNS	I-NP	O
:	:	:	O	O
further	further	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
correlation	correlation	NN	I-NP	O
principle	principle	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
vision	vision	NN	I-NP	O

The	The	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IA	BEGIN-IA	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
rapid	rapid	JJ	I-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	O
ends	end	VBZ	B-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
translational	translational	JJ	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O

Function	Function	NN	B-NP	O
was	be	VBD	B-VP	O
retained	retain	VBN	I-VP	O
when	when	WRB	B-ADVP	O
one	one	CD	B-NP	O
copy	copy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
sequence	sequence	NN	I-NP	O
represents	represent	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
element	element	NN	I-NP	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
also	also	RB	B-ADVP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
gamma	BEGIN-gamma	NN	B-NP	B
CACCC	CACCC	NN	I-NP	I
box	box	NN	I-NP	I
binding	binding	NN	I-NP	I
factors	factors-INSIDE	NN	I-NP	I
mediate	mediate	VBP	B-VP	O
LCR	BEGIN-LCR	NN	B-NP	B
-	-	HYPH	O	I
gamma	gamma-INSIDE	NN	B-NP	I
interactions	interaction	NNS	I-NP	O
which	which	WDT	B-NP	O
normally	normally	RB	B-ADVP	O
enhance	enhance	VBP	B-VP	O
gamma	BEGIN-gamma	NN	B-NP	B
-	-	HYPH	I-NP	I
globin	globin-INSIDE	NN	I-NP	I
and	and	CC	O	O
suppress	suppress	VBP	B-VP	O
beta	BEGIN-beta	NN	B-NP	B
-	-	HYPH	B-NP	I
globin	globin	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
fetal	fetal	JJ	B-NP	O
erythroid	erythroid	JJ	I-NP	O
cells	cell	NNS	I-NP	O

Left	Left	JJ	B-NP	O
ventricle	ventricle	NN	I-NP	O
to	to	TO	B-PP	O
coronary	coronary	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
fistula	fistula	NN	I-NP	O

No	No	DT	B-NP	O
other	other	JJ	I-NP	O
transcripts	transcript	NNS	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
length	length	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
after	after	IN	B-PP	O
prolonged	prolong	VBN	B-NP	O
exposure	exposure	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	I-VP	O
sequenced	sequence	VBN	I-VP	O
cDNA	cDNA	NN	B-NP	O
sequences	sequence	NNS	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
novel	novel	JJ	I-NP	O
genes	gene	NNS	I-NP	O
that	that	WDT	B-NP	O
map	map	VBP	B-VP	O
to	to	TO	B-PP	O
Xq1	Xq1	NN	B-NP	O

The	The	DT	B-NP	O
vaccinia	vaccinia	NN	I-NP	O
virus	virus	NN	I-NP	O
D1R	BEGIN-D1R-INSIDE	NN	I-NP	B
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
subunit	subunit	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heterodimeric	heterodimeric	JJ	I-NP	O
vaccinia	BEGIN-vaccinia	NNP	I-NP	B
virus	virus	NN	I-NP	I
early	early	JJ	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
VETF	BEGIN-VETF-INSIDE	NN	B-NP	B
)	)	)	O	O
that	that	WDT	B-NP	O
activates	activate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
early	BEGIN-early	JJ	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
nuclear	nuclear	JJ	B-NP	O
magnetic	magnetic	JJ	I-NP	O
resonance	resonance	NN	I-NP	O
(	(	(	O	O
NMR	NMR	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
the	the	DT	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
RNA	RNA	NN	I-NP	O
``	``	``	I-NP	O
kissing	kissing	NN	I-NP	O
''	''	''	I-NP	O
hairpin	hairpin	NN	I-NP	O
complex	complex	NN	I-NP	O
formed	form	VBN	B-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
HIV	HIV	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAR	TAR	NN	I-NP	O
hairpin	hairpin	NN	I-NP	O
loop	loop	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
hairpin	hairpin	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
complementary	complementary	JJ	I-NP	O
loop	loop	NN	I-NP	O
sequence	sequence	NN	I-NP	O

Xnr1	BEGIN-Xnr1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
transcriptionally	transcriptionally	RB	I-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
wnt	BEGIN-wnt-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O
during	during	IN	B-PP	O
gastrulation	gastrulation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Xenopus	Xenopus	NN	I-NP	O
embryo	embryo	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
identify	identify	VBP	B-VP	O
Tyr1	Tyr1	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
functionally	functionally	RB	I-NP	O
important	important	JJ	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
site	site	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ZAP	BEGIN-ZAP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
interdomain	interdomain	NN	I-NP	I
B	B	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I

Renal	Renal	JJ	B-NP	O
dysplasia	dysplasia	NN	I-NP	O
with	with	IN	B-PP	O
multisystem	multisystem	JJ	B-NP	O
malformation	malformation	NN	I-NP	O
-	-	HYPH	B-NP	O
-	-	:	O	O
a	a	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O

Brome	BEGIN-Brome	NN	B-NP	B
mosaic	mosaic	JJ	I-NP	I
virus	virus	NN	I-NP	I
polymerase	polymerase-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
protein	BEGIN-protein	NN	I-NP	B
1a	1a-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
directed	direct	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
endoplasmic	endoplasmic	JJ	I-NP	O
reticulum	reticulum	NN	I-NP	O
by	by	IN	B-PP	O
helicase	BEGIN-helicase-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
like	like	JJ	B-NP	O
viral	BEGIN-viral	JJ	I-NP	B
protein	BEGIN-protein	NN	I-NP	B
1a	1a-INSIDE-INSIDE	NN	I-NP	I

Mutations	Mutation	NNS	B-NP	O
abolishing	abolish	VBG	B-VP	O
MalK	BEGIN-MalK-INSIDE	NN	B-NP	B
function	function	NN	I-NP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
transport	transport	VB	I-VP	O
maltose	maltose	NN	B-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
cause	cause	VBP	B-VP	O
constitutive	constitutive	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
maltose	BEGIN-maltose	NN	I-NP	B
regulon	regulon-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
D.	D.	NNP	I-NP	O
discoideum	discoideum	NN	I-NP	O
proteins	protein	NNS	I-NP	O
were	be	VBD	B-VP	O
entirely	entirely	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
four	four	CD	I-NP	O
regions	region	NNS	I-NP	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
GTP	GTP	NN	B-NP	O
binding	binding	NN	I-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
contained	contain	VBD	B-VP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
CAAX	CAAX	NN	I-NP	O
aa	aa	NN	I-NP	O
motifs	motif	NNS	I-NP	O
shared	share	VBN	B-VP	O
by	by	IN	B-PP	O
other	other	JJ	B-NP	O
Rho	BEGIN-Rho	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
chronically	chronically	RB	B-NP	O
depressed	depressed	JJ	I-NP	O
LCBF	LCBF	NN	I-NP	O
(	(	(	O	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
)	)	)	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
quick	quick	JJ	I-NP	O
structural	structural	JJ	I-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
endothelium	endothelium	NN	B-NP	O

Functional	Functional	JJ	B-NP	O
uncoupling	uncoupling	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Janus	BEGIN-Janus	NN	I-NP	B
kinase	kinase	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
Stat1	BEGIN-Stat1-INSIDE	NN	I-NP	B
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-VP	O
transformed	transform	VBN	B-NP	O
human	human	JJ	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O

An	An	DT	B-NP	O
environmental	environmental	JJ	I-NP	O
investigation	investigation	NN	I-NP	O
found	find	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
suboptimal	suboptimal	JJ	B-NP	O
food	food	NN	I-NP	O
storage	storage	NN	I-NP	O
and	and	CC	I-NP	O
cooking	cooking	NN	I-NP	O
temperatures	temperature	NNS	I-NP	O
at	at	IN	B-PP	O
Restaurant	Restaurant	NN	B-NP	O
A	A	NN	I-NP	O
;	;	:	O	O
cross	cross	VB	B-VP	O
contamination	contamination	NN	B-NP	O
of	of	IN	B-PP	O
foods	food	NNS	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
attributable	attributable	JJ	I-NP	O
risk	risk	NN	I-NP	O
identified	identify	VBN	B-VP	O
for	for	IN	B-PP	O
chile	chile	NN	B-NP	O
rellenos	relleno	NNS	I-NP	O

We	We	PRP	B-NP	O
used	use	VBD	B-VP	O
event	event	NN	B-NP	O
-	-	HYPH	O	O
related	relate	VBN	B-NP	O
functional	functional	JJ	I-NP	O
magnetic	magnetic	JJ	I-NP	O
resonance	resonance	NN	I-NP	O
imaging	imaging	NN	I-NP	O
(	(	(	O	O
fMRI	fMRI	NN	B-NP	O
)	)	)	O	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
cued	cue	VBN	I-NP	O
spatial	spatial	JJ	I-NP	O
-	-	HYPH	I-NP	O
attention	attention	NN	I-NP	O
task	task	NN	I-NP	O
to	to	TO	B-VP	O
dissociate	dissociate	VB	I-VP	O
brain	brain	NN	B-NP	O
activity	activity	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
attentional	attentional	JJ	B-NP	O
control	control	NN	I-NP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
related	related	JJ	I-NP	O
to	to	TO	I-NP	O
selective	selective	JJ	I-NP	O
processing	processing	NN	I-NP	O
of	of	IN	B-PP	O
target	target	NN	B-NP	O
stimuli	stimulus	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
microinjection	microinjection	NN	B-NP	O
of	of	IN	B-PP	O
reconstituted	reconstitute	VBN	B-NP	O
mRNPs	mRNP	NNS	I-NP	O
into	into	IN	B-PP	O
Xenopus	Xenopus	NNP	B-NP	O
oocytes	oocyte	NNS	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
although	although	IN	B-SBAR	O
translational	translational	JJ	B-NP	O
repression	repression	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
consensus	consensus	NN	B-NP	O
RNA	RNA	NN	I-NP	O
binding	binding	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
for	for	IN	B-PP	O
FRGY1	BEGIN-FRGY1-INSIDE	NN	B-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
FRGY1	BEGIN-BEGIN-FRGY1-INSIDE	NN	B-NP	B
recognition	recognition	NN	I-NP	O
elements	elements-INSIDE	NN	I-NP	I
within	within	IN	B-PP	O
mRNA	mRNA	NN	B-NP	O
potentiates	potentiate	VBZ	B-VP	O
translational	translational	JJ	B-NP	O
repression	repression	NN	I-NP	O

Results	Result	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
Chinese	Chinese	JJ	B-NP	O
medicine	medicine	NN	I-NP	O
use	use	NN	I-NP	O
among	among	IN	B-PP	O
this	this	DT	B-NP	O
population	population	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
health	health	NN	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
care	care	NN	B-NP	O
for	for	IN	B-PP	O
Chinese	Chinese	JJ	B-NP	O
medicine	medicine	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
preference	preference	NN	I-NP	O
for	for	IN	B-PP	O
Chinese	Chinese	JJ	B-NP	O
medicine	medicine	NN	I-NP	O
are	be	VBP	B-VP	O
two	two	CD	B-NP	O
predictors	predictor	NNS	I-NP	O
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
use	use	NN	I-NP	O

A	A	DT	B-NP	O
V1	BEGIN-V1	NN	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
generated	generate	VBN	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
altered	alter	VBN	B-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
viable	viable	JJ	B-NP	O
and	and	CC	I-NP	O
produced	produce	VBN	I-NP	O
symptoms	symptom	NNS	I-NP	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
infection	infection	NN	I-NP	O

These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
clr1+	BEGIN-clr1+-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
rik1+	BEGIN-rik1+-INSIDE	NN	I-NP	B
must	must	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
assembly	assembly	NN	I-NP	O
of	of	IN	B-PP	O
Swi1p	BEGIN-Swi1p-INSIDE	NN	B-NP	B
into	into	IN	B-PP	O
a	a	DT	B-NP	O
transcriptionally	transcriptionally	RB	I-NP	O
silent	silent	JJ	I-NP	O
,	,	,	I-NP	O
inaccessible	inaccessible	JJ	I-NP	O
chromatin	chromatin	NN	I-NP	O
structure	structure	NN	I-NP	O
at	at	IN	B-PP	O
fission	fission	NN	B-NP	O
yeast	yeast	NN	I-NP	O
centromeres	centromere	NNS	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
facilitate	facilitate	VB	I-VP	O
interactions	interaction	NNS	B-NP	O
with	with	IN	B-PP	O
spindle	spindle	NN	B-NP	O
microtubules	microtubule	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
normal	normal	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
segregation	segregation	NN	I-NP	O

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
sequence	sequence	NN	I-NP	O
predicts	predict	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
mol	mol	NN	I-NP	O
wt	wt	NN	I-NP	O
apoprotein	apoprotein	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
having	have	VBG	B-VP	O
an	an	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
hydrophobic	hydrophobic	JJ	I-NP	O
signal	signal	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
potential	potential	JJ	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-VP	O
linked	link	VBN	B-NP	O
glycosylation	glycosylation	NN	I-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
hydrophobic	hydrophobic	JJ	I-NP	O
anchor	anchor	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
terminus	terminus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
hydrophilic	hydrophilic	JJ	I-NP	O
cysteine	cysteine	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
C	C	NN	I-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O

Likewise	Likewise	RB	B-ADVP	O
,	,	,	O	O
epidural	epidural	JJ	B-NP	O
morphine	morphine	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
modify	modify	VB	I-VP	O
the	the	DT	B-NP	O
intraoperative	intraoperative	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
and	and	CC	I-NP	O
hormonal	hormonal	JJ	I-NP	O
responses	response	NNS	I-NP	O

Only	Only	RB	B-NP	O
the	the	DT	I-NP	O
native	native	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
phosphorylated	phosphorylate	VBN	B-NP	O
ERK	BEGIN-ERK-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
recognized	recognize	VBN	I-VP	O
by	by	IN	B-PP	O
VHR	BEGIN-VHR-INSIDE	NN	B-NP	B
and	and	CC	O	O
was	be	VBD	B-VP	O
inactivated	inactivate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
-	-	HYPH	I-NP	O
order	order	NN	I-NP	O
rate	rate	NN	I-NP	O
constant	constant	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
M	M	NN	I-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
s	s	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

Omitting	Omit	VBG	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
NOE	NOE	NN	I-NP	O
-	-	HYPH	B-NP	O
derived	derive	VBN	I-NP	O
distances	distance	NNS	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
restraint	restraint	NN	I-NP	O
violations	violation	NNS	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
R	R	NN	I-NP	O
factors	factor	NNS	I-NP	O
but	but	CC	O	O
impairs	impair	VBZ	B-VP	O
structural	structural	JJ	B-NP	O
convergence	convergence	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rMD	rMD	NN	I-NP	O
refinement	refinement	NN	I-NP	O

The	The	DT	B-NP	O
region	region	NN	I-NP	O
immediately	immediately	RB	B-VP	O
following	follow	VBG	I-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	B-NP	O
to	to	TO	B-PP	O
ORF1	ORF1	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
terminator	terminator	NN	I-NP	O
sequence	sequence	NN	I-NP	O

Cell	Cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
components	component	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
largely	largely	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
eukaryotes	eukaryote	NNS	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
orthologs	ortholog	NNS	B-NP	O
of	of	IN	B-PP	O
neither	neither	CC	O	O
CAK1	BEGIN-CAK1-INSIDE	NN	B-NP	B
nor	nor	CC	I-NP	O
csk1	BEGIN-csk1-INSIDE	NN	I-NP	B
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
species	specie	NNS	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O

Within	Within	IN	B-PP	O
any	any	DT	B-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
several	several	JJ	B-NP	O
Tcfs	BEGIN-Tcfs-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
TLEs	BEGIN-TLEs-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
co	co	AFX	O	O
-	-	HYPH	O	O
expressed	express	VBN	B-VP	O

In	In	IN	B-PP	O
marked	marked	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
published	publish	VBN	I-NP	O
human	BEGIN-human	JJ	I-NP	B
CD1	CD1	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
sequence	sequence	NN	I-NP	O
predicts	predict	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
tail	tail	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
closely	closely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
and	and	CC	O	O
possesses	possess	VBZ	B-VP	O
two	two	CD	B-NP	O
proline	proline	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
motifs	motif	NNS	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
-	-	HYPH	B-NP	I
domain	domain	NN	I-NP	I
binding	binding	NN	I-NP	I
consensus	consensus	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
,	,	,	O	O
three	three	CD	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
C	C	NN	I-NP	I
phosphorylation	phosphorylation	NN	I-NP	I
site	site	NN	I-NP	I
motifs	motifs-INSIDE	NN	I-NP	I
,	,	,	O	O
nine	nine	CD	B-NP	O
casein	BEGIN-casein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
phosphorylation	phosphorylation	NN	I-NP	I
site	site	NN	I-NP	I
motifs	motifs-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
serine	serine	NN	I-NP	O
-	-	HYPH	B-NP	O
threonine	threonine	NN	I-NP	O
-	-	HYPH	I-NP	O
rich	rich	JJ	I-NP	O
motif	motif	NN	I-NP	O
repeated	repeat	VBD	B-VP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O

The	The	DT	B-NP	O
Xenopus	BEGIN-Xenopus	NNP	I-NP	B
homeobox	homeobox	NN	I-NP	I
gene	gene	NN	I-NP	I
twin	twin-INSIDE	NN	I-NP	I
mediates	mediate	VBZ	B-VP	O
Wnt	BEGIN-Wnt-INSIDE	NN	B-NP	B
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
goosecoid	BEGIN-goosecoid-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
establishment	establishment	NN	B-NP	O
of	of	IN	B-PP	O
Spemann	Spemann	NNP	B-NP	O
's	's	POS	B-NP	O
organizer	organizer	NN	I-NP	O

Quinethazone	Quinethazone	NNP	B-NP	O

Divergent	Divergent	JJ	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
left	left	JJ	I-NP	O
hemisphere	hemisphere	NN	I-NP	O
used	use	VBN	B-VP	O
for	for	IN	B-PP	O
decoding	decode	VBG	B-NP	O
and	and	CC	I-NP	O
storage	storage	NN	I-NP	O
of	of	IN	B-PP	O
information	information	NN	B-NP	O
emerged	emerge	VBD	B-VP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
working	work	VBG	I-NP	O
memory	memory	NN	I-NP	O
versus	versus	IN	B-PP	O
control	control	NN	B-NP	O
task	task	NN	I-NP	O
comparison	comparison	NN	I-NP	O

Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
epithelial	epithelial	JJ	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
only	only	RB	B-NP	O
RTS1b	RTS1b	NN	I-NP	O
cells	cell	NNS	I-NP	O
allowed	allow	VBD	B-VP	O
an	an	DT	B-NP	O
expression	expression	NN	I-NP	O
pattern	pattern	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
naturally	naturally	RB	B-NP	O
infected	infected	JJ	I-NP	O
benign	benign	JJ	I-NP	O
condylomas	condyloma	NNS	I-NP	O

These	These	DT	B-NP	O
involve	involve	VBP	B-VP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
subcloning	subclone	VBG	B-VP	O
a	a	DT	B-NP	O
promoterless	promoterless	JJ	I-NP	O
sucCD	BEGIN-sucCD	NN	I-NP	B
fragment	fragment-INSIDE	NN	I-NP	I
downstream	downstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lac	BEGIN-lac	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
M1mp1	M1mp1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
precise	precise	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
suc	BEGIN-suc	NN	I-NP	B
coding	cod	VBG	B-VP	I
regions	regions-INSIDE	NN	B-NP	I
with	with	IN	B-PP	O
the	the	DT	B-NP	O
efficient	efficient	JJ	I-NP	O
atpE	BEGIN-atpE	NN	I-NP	B
ribosome	ribosome	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
site	site-INSIDE	NN	B-NP	I
and	and	CC	I-NP	O
expression	expression	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
thermoinducible	thermoinducible	JJ	I-NP	O
lambda	lambda	NN	I-NP	O
promoters	promoter	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pJLA1	pJLA1	NN	I-NP	O
vector	vector	NN	I-NP	O

Increase	Increase	NN	B-NP	O
in	in	IN	B-PP	O
[	[	(	O	O
Ca++	Ca++	NN	B-NP	O
]	]	)	O	O
counteracted	counteract	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
verapamil	verapamil	NN	B-NP	O
on	on	IN	B-PP	O
RAD	RAD	NN	B-NP	O

Evidence	Evidence	NN	B-NP	O
for	for	IN	B-PP	O
involvement	involvement	NN	B-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
HU	BEGIN-HU-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
RpoS	BEGIN-RpoS-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
osmoresponsive	osmoresponsive	JJ	I-NP	O
proU	BEGIN-proU	NN	I-NP	B
operon	operon-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O

In	In	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
silent	silent	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
,	,	,	O	O
CBF	CBF	NN	B-NP	O
increases	increase	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
auditory	auditory	JJ	B-NP	O
cortex	cortex	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
superior	superior	JJ	I-NP	O
parietal	parietal	JJ	I-NP	O
,	,	,	I-NP	O
right	right	JJ	I-NP	O
dorsolateral	dorsolateral	JJ	I-NP	O
frontal	frontal	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
right	right	JJ	B-NP	O
premotor	premotor	NN	I-NP	O
regions	region	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
modulation	modulation	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
attentional	attentional	JJ	B-NP	O
condition	condition	NN	I-NP	O

Detonation	Detonation	NN	B-NP	O
-	-	HYPH	I-NP	O
traumatic	traumatic	JJ	I-NP	O
load	load	NN	I-NP	O
during	during	IN	B-PP	O
military	military	JJ	B-NP	O
service	service	NN	I-NP	O

Deletion	Deletion	NN	B-NP	O
of	of	IN	B-PP	O
CDC1	BEGIN-CDC1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
lethal	lethal	JJ	B-ADJP	O
and	and	CC	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dumbbell	dumbbell	NN	I-NP	O
-	-	HYPH	O	O
shaped	shape	VBN	B-VP	O
terminal	terminal	JJ	B-NP	O
morphology	morphology	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
nuclei	nucleus	NNS	I-NP	O
almost	almost	RB	B-VP	O
divided	divide	VBN	I-VP	O
but	but	CC	O	O
still	still	RB	B-VP	O
connected	connect	VBN	I-VP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
pathway	pathway	NN	I-NP	O
to	to	TO	B-PP	O
Fc	BEGIN-Fc	NN	B-NP	B
epsilonRI	epsilonRI-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
MEK	BEGIN-MEK-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
ERK	BEGIN-ERK-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
ERK	BEGIN-ERK-INSIDE	NN	I-NP	B
activation	activation	NN	I-NP	O
can	can	MD	B-VP	O
apparently	apparently	RB	I-VP	O
bypass	bypass	VB	I-VP	O
Ras	BEGIN-Ras-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Raf	BEGIN-Raf	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Bovine	Bovine	JJ	B-NP	O
anaplasmosis	anaplasmosis	NN	I-NP	O
:	:	:	O	O
susceptibility	susceptibility	NN	B-NP	O
of	of	IN	B-PP	O
seronegative	seronegative	JJ	B-NP	O
cows	cow	NNS	I-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
infected	infected	JJ	I-NP	O
herd	herd	NN	I-NP	O
to	to	TO	B-PP	O
experimental	experimental	JJ	B-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
Anaplasma	Anaplasma	NN	B-NP	O
marginale	marginale	NN	I-NP	O

The	The	DT	B-NP	O
starting	start	VBG	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
administered	administer	VBN	B-VP	O
intravenously	intravenously	RB	B-ADVP	O
(	(	(	O	O
IV	IV	CD	B-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
infusion	infusion	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
repeated	repeat	VBD	B-VP	O
every	every	DT	B-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
with	with	IN	B-PP	O
dose	dose	NN	B-NP	O
adjustments	adjustment	NNS	I-NP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
patient	patient	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O

The	The	DT	B-NP	O
related	related	JJ	I-NP	O
adhesion	BEGIN-adhesion	NN	I-NP	B
focal	focal	JJ	I-NP	I
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
tyrosine	tyrosine	NN	B-NP	O
-	-	HYPH	O	O
phosphorylated	phosphorylate	VBN	B-VP	O
after	after	IN	B-PP	O
beta1	BEGIN-beta1	NN	B-NP	B
-	-	HYPH	B-NP	I
integrin	integrin-INSIDE	NN	I-NP	I
stimulation	stimulation	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
p1cas	BEGIN-p1cas-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
cerebellar	cerebellar	JJ	I-NP	O
cortical	cortical	JJ	I-NP	O
vessels	vessel	NNS	I-NP	O
:	:	:	O	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cerebral	cerebral	JJ	I-NP	O
vessels	vessel	NNS	I-NP	O

Plasma	BEGIN-Plasma	NN	B-NP	B
prolactin	prolactin-INSIDE	NN	I-NP	I
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
pinealectomized	pinealectomize	VBN	B-NP	O
ewes	ewe	NNS	I-NP	O
receiving	receive	VBG	B-VP	O
melatonin	melatonin	NN	B-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
pineal	pineal	JJ	B-NP	O
intact	intact	JJ	I-NP	O
ewes	ewe	NNS	I-NP	O
maintained	maintain	VBN	B-VP	O
under	under	IN	B-PP	O
a	a	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
hour	hour	NN	I-NP	O
photoperiod	photoperiod	NN	I-NP	O

After	After	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
stimulation	stimulation	NN	I-NP	O
with	with	IN	B-PP	O
G	BEGIN-G	NN	B-NP	B
-	-	HYPH	B-NP	I
CSF	CSF-INSIDE	NN	I-NP	I
(	(	(	O	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
1l	1l	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
was	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
,	,	,	O	O
kept	keep	VBD	B-VP	O
unprocessed	unprocessed	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
reinfused	reinfuse	VBD	B-VP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
completion	completion	NN	B-NP	O
of	of	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O

The	The	DT	B-NP	O
species	specie	NNS	I-NP	O
composition	composition	NN	I-NP	O
and	and	CC	I-NP	O
abundance	abundance	NN	I-NP	O
upon	upon	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
manure	manure	NN	B-NP	O
with	with	IN	B-PP	O
polyethylene	polyethylene	NN	B-NP	O
,	,	,	I-NP	O
polystyrene	polystyrene	NN	I-NP	O
and	and	CC	I-NP	O
glass	glass	NN	I-NP	O
particles	particle	NNS	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
i.e.	i.e.	FW	B-NP	O
natural	natural	JJ	I-NP	O
and	and	CC	I-NP	O
inert	inert	JJ	I-NP	O
sand	sand	NN	I-NP	O

We	We	PRP	B-NP	O
present	present	VBP	B-VP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
an	an	DT	B-NP	O
unusually	unusually	RB	I-NP	O
large	large	JJ	I-NP	O
mucoid	mucoid	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
measuring	measure	VBG	B-VP	O
1	1	CD	B-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
uncommon	uncommon	JJ	I-NP	O
localization	localization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
maxillary	maxillary	NN	I-NP	O

Twenty	Twenty	CD	B-NP	O
male	male	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
during	during	IN	B-PP	O
almokalant	almokalant	JJ	B-NP	O
infusion	infusion	NN	I-NP	O
aiming	aim	VBG	B-VP	O
at	at	IN	B-PP	O
plasma	plasma	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
(	(	(	O	O
Cpl	Cpl	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
nmol	nmol	NN	I-NP	O
/	/	SYM	O	O
l	l	NN	B-NP	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
TGFbeta1	BEGIN-TGFbeta1-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
upregulated	upregulate	VBN	I-VP	O
in	in	IN	B-PP	O
mouse	mouse	NN	B-NP	O
keratinocytes	keratinocyte	NNS	I-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	I-NP	I
rasHa	rasHa-INSIDE	NN	I-NP	I
retrovirus	retrovirus	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
clear	clear	JJ	B-ADJP	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	O
to	to	TO	B-PP	O
thyroglobulin	BEGIN-thyroglobulin-INSIDE	NN	B-NP	B
and	and	CC	O	O
thyroid	BEGIN-thyroid	JJ	B-NP	B
peroxidase	peroxidase-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
subgroup	subgroup	NN	B-NP	O
1	1	CD	I-NP	O

Protein	BEGIN-Protein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
(	(	(	O	O
PKC	BEGIN-PKC-INSIDE	NN	B-NP	B
)	)	)	O	O
activation	activation	NN	B-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
neuroblastoma	neuroblastoma	NN	I-NP	O
SK	SK	NN	I-NP	O
-	-	HYPH	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
BE	BE	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
C	C	NN	B-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
myristate	myristate	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
enhance	enhance	VB	I-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
dopamine	BEGIN-dopamine	NN	I-NP	B
beta	beta	SYM	O	I
-	-	HYPH	O	I
hydroxylase	hydroxylase-INSIDE	NN	B-NP	I
(	(	(	O	O
DBH	BEGIN-DBH-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
cells	cell	NNS	I-NP	O

Radiographic	Radiographic	JJ	B-NP	O
spatial	spatial	JJ	I-NP	O
frequencies	frequency	NNS	I-NP	O
essential	essential	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
incipient	incipient	JJ	B-NP	O
interproximal	interproximal	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O

The	The	DT	B-NP	O
originally	originally	RB	I-NP	O
embryonic	BEGIN-embryonic	JJ	I-NP	B
gamma	gamma	SYM	I-NP	I
-	-	HYPH	I-NP	I
globin	globin	NN	I-NP	I
locus	locus-INSIDE	NN	I-NP	I
duplicated	duplicate	VBD	B-VP	O
and	and	CC	I-VP	O
acquired	acquire	VBD	I-VP	O
a	a	DT	O	O
novel	novel	JJ	O	O
(	(	(	O	O
fetal	fetal	JJ	B-ADJP	O
)	)	)	O	O
pattern	pattern	NN	B-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
defined	define	VBN	I-NP	O
time	time	NN	I-NP	O
period	period	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
million	million	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
)	)	)	O	O
during	during	IN	B-PP	O
primate	primate	NN	B-NP	O
phylogeny	phylogeny	NN	I-NP	O

The	The	DT	B-NP	O
pcaR	BEGIN-pcaR	NN	I-NP	B
regulatory	regulatory	JJ	I-NP	I
locus	locus-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
pca	BEGIN-pca	NNP	I-NP	B
regulon	regulon-INSIDE	NN	I-NP	I
(	(	(	O	O
pcaBDC	BEGIN-pcaBDC-INSIDE	NN	B-NP	B
,	,	,	O	O
pcaIJ	BEGIN-pcaIJ-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
pcaF	BEGIN-pcaF-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
chemotactic	chemotactic	JJ	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
to	to	TO	B-PP	O
aromatic	aromatic	JJ	B-NP	O
compounds	compound	NNS	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
i	BEGIN-i	NN	I-NP	B
-	-	HYPH	B-NP	I
leader	leader	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
viral	viral	JJ	I-NP	O
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
stability	stability	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
made	make	VBN	I-VP	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
quantities	quantity	NNS	I-NP	O
at	at	IN	B-PP	O
intermediate	intermediate	JJ	B-NP	O
times	time	NNS	I-NP	O
of	of	IN	B-PP	O
productive	productive	JJ	B-NP	O
infection.	infection.	NN	I-NP	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-NP	O
1	1	CD	I-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

Consequently	Consequently	RB	B-ADVP	O
,	,	,	O	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
evolution	evolution	NN	I-NP	O
of	of	IN	B-PP	O
mammals	mammal	NNS	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
CKbeta1GT	BEGIN-CKbeta1GT	NN	I-NP	B
-	-	HYPH	B-NP	I
I	I	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
lineage	lineage	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
recruited	recruit	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
biosynthesis	biosynthesis	NN	I-NP	O
of	of	IN	B-PP	O
lactose	lactose	NN	B-NP	O

The	The	DT	B-NP	O
Pi	Pi	NNP	I-NP	O
signals	signal	NNS	I-NP	O
are	be	VBP	B-VP	O
conveyed	convey	VBN	I-VP	O
to	to	TO	B-PP	O
PHO1	BEGIN-BEGIN-PHO-INSIDE1-INSIDE	NN	B-NP	B
by	by	IN	B-PP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
PHO1	BEGIN-BEGIN-BEGIN-PHO-INSIDE1-INSIDE	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
factor	factor	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
PHO1	BEGIN-BEGIN-PHO-INSIDE1-INSIDE	NN	B-NP	B
(	(	(	O	O
PHO1p	BEGIN-BEGIN-PHO-INSIDE1-INSIDEp	NN	B-NP	I
)	)	)	O	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PHO	BEGIN-PHO-INSIDE	NN	I-NP	B
regulatory	regulatory	JJ	I-NP	O
circuit	circuit	NN	I-NP	O

Direct	Direct	JJ	B-NP	O
saturation	saturation	NN	I-NP	O
analysis	analysis	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
neural	neural	JJ	I-NP	O
network	network	NN	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
density	density	NN	I-NP	O
mask	mask	NN	I-NP	O
(	(	(	O	O
thresholds	threshold	NNS	B-NP	O
,	,	,	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
H	H	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
radiologist	radiologist	NN	I-NP	O
serving	serve	VBG	B-VP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
gold	gold	NN	I-NP	O
standard	standard	NN	I-NP	O

Mutational	Mutational	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IME1	BEGIN-IME1	NN	I-NP	B
UAS	UAS-INSIDE	NN	I-NP	I
reveals	reveal	VBZ	B-VP	O
two	two	CD	B-NP	O
critical	critical	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
elements	element	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
G+C	G+C	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
(	(	(	O	O
called	call	VBN	B-VP	O
URS1	URS1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
previously	previously	RB	B-VP	O
identified	identify	VBN	I-VP	O
at	at	IN	B-PP	O
many	many	JJ	B-NP	O
meiotic	meiotic	JJ	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
newly	newly	RB	I-NP	O
described	describe	VBN	I-NP	O
element	element	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
T1C	T1C	NN	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
meiotic	meiotic	JJ	B-NP	O
genes	gene	NNS	I-NP	O

We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
1Tl	1Tl	NN	I-NP	O
uptake	uptake	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
1Tl	1Tl	NN	B-NP	O
uptake	uptake	NN	I-NP	O
and	and	CC	O	O
systolic	systolic	JJ	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
being	be	VBG	I-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
heart	heart	NN	B-NP	O
-	-	HYPH	I-NP	O
lung	lung	NN	I-NP	O
transplantation	transplantation	NN	I-NP	O

Clinical	Clinical	JJ	B-NP	O
findings	finding	NNS	I-NP	O
plaque	plaque	VBP	B-VP	O
index	index	NN	B-NP	O
,	,	,	O	O
PI	PI	NN	B-NP	O
;	;	:	O	O
gingival	gingival	JJ	B-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
GI	GI	NN	B-NP	O
;	;	:	O	O
bleeding	bleed	VBG	B-VP	O
on	on	IN	B-PP	O
probing	probing	NN	B-NP	O
,	,	,	O	O
BOP	BOP	NN	B-NP	O
;	;	:	O	O
pus	pus	NN	B-NP	O
discharge	discharge	NN	I-NP	O
,	,	,	O	O
pus	pus	NN	B-NP	O
;	;	:	O	O
and	and	CC	O	O
probing	probe	VBG	B-VP	O
depth	depth	NN	B-NP	O
,	,	,	O	O
PD	PD	NN	B-NP	O
at	at	IN	B-PP	O
both	both	CC	O	O
PT	PT	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
control	control	NN	B-NP	O
sites	site	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
at	at	IN	B-PP	O
every	every	DT	B-NP	O
visit	visit	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O

Therefore	Therefore	RB	B-ADVP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
GAL1	BEGIN-GAL1-INSIDE	NN	B-NP	B
on	on	IN	B-PP	O
PGK	BEGIN-PGK-INSIDE	NN	B-NP	B
transcription	transcription	NN	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
mediated	mediate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
PGK	BEGIN-BEGIN-PGK-INSIDE	NNP	I-NP	B
UAS	UAS-INSIDE	NNP	I-NP	I
,	,	,	O	O
presumably	presumably	RB	B-ADVP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
complex	complex	NN	I-NP	O

The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
recommend	recommend	VBP	B-VP	O
in	in	IN	B-PP	O
cases	case	NNS	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
transaminase	transaminase	NN	I-NP	O
serum	serum	NN	I-NP	O
activity	activity	NN	I-NP	O
more	more	RBR	B-ADJP	O
frequent	frequent	JJ	I-ADJP	O
check	check	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
examinations	examination	NNS	B-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
missing	missing	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
relapse	relapse	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
repeatedly	repeatedly	RB	B-NP	O
IgM	BEGIN-IgM-INSIDE	JJ	I-NP	B
anti	BEGIN-anti	AFX	I-NP	B
-	-	HYPH	I-NP	I
HAV	HAV-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
in	in	IN	B-PP	O
protracted	protracted	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
IgM	BEGIN-IgM-INSIDE	NN	I-NP	B
anti	BEGIN-anti	AFX	O	B
-	-	HYPH	B-NP	I
HAV	HAV-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
persist	persist	VB	I-VP	O
even	even	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
the	the	DT	B-NP	O
transaminase	transaminase	NN	I-NP	O
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O

Effects	Effect	NNS	B-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
of	of	IN	B-PP	O
extremely	extremely	RB	B-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
frequency	frequency	NN	I-NP	O
electromagnetic	electromagnetic	JJ	I-NP	O
radiation	radiation	NN	I-NP	O
(	(	(	O	O
EHF	EHF	NN	B-NP	O
EMR	EMR	NN	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
indices	index	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
and	and	CC	I-NP	O
endocrine	endocrine	JJ	I-NP	O
systems	system	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
hyperplastic	hyperplastic	JJ	B-NP	O
processes	process	NNS	I-NP	O
in	in	IN	B-PP	O
endometrium	endometrium	NN	B-NP	O

Management	Management	NN	B-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Ewing	Ewing	NNP	B-NP	O
's	's	POS	B-NP	O
sarcoma	sarcoma	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
reference	reference	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
to	to	TO	B-VP	O
achieve	achieve	VB	I-VP	O
an	an	DT	B-NP	O
excellent	excellent	JJ	I-NP	O
local	local	JJ	I-NP	O
result	result	NN	I-NP	O
from	from	IN	B-PP	O
radiation	radiation	NN	B-NP	O
therapy	therapy	NN	I-NP	O
now	now	RB	B-ADVP	O
that	that	IN	B-SBAR	O
patients	patient	NNS	B-NP	O
are	be	VBP	B-VP	O
experiencing	experience	VBG	I-VP	O
long	long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
survival	survival	NN	I-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
hyperaemia	hyperaemia	NN	B-NP	O
on	on	IN	B-PP	O
thallium	thallium	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
redistribution	redistribution	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
canine	canine	JJ	I-NP	O
myocardium	myocardium	NN	I-NP	O

After	After	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
online	online	NN	I-NP	O
,	,	,	O	O
lactate	lactate	NN	B-NP	O
was	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
lactate	BEGIN-lactate	NN	B-NP	B
oxidase	oxidase-INSIDE	NN	I-NP	I
immobilized	immobilize	VBN	B-VP	O
to	to	TO	B-PP	O
porous	porous	JJ	B-NP	O
glass	glass	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
depletion	depletion	NN	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
was	be	VBD	B-VP	O
registered	register	VBN	I-VP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Clark	Clark	NNP	I-NP	O
electrode	electrode	NN	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
and	and	CC	O	O
Sp1	BEGIN-BEGIN-Sp1-INSIDE	NN	B-NP	B
transcription	transcription	NN	I-NP	O
factors	factors-INSIDE	NN	I-NP	I
upregulate	upregulate	VBP	B-VP	O
HGF	BEGIN-HGF	NN	B-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Sp1	BEGIN-BEGIN-Sp1-INSIDE	NN	I-NP	B
binding	binding	NN	I-NP	O
site	site-INSIDE	NN	I-NP	I
at	at	IN	B-PP	O
position	position	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HGF	BEGIN-HGF	NN	I-NP	B
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

As	As	IN	B-PP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
uncoupling	BEGIN-uncoupling	JJ	I-NP	B
protein	protein	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I
,	,	,	O	O
UCP1	BEGIN-UCP1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
ubiquitously	ubiquitously	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
rodents	rodent	NNS	B-NP	O
and	and	CC	I-NP	O
humans	human	NNS	I-NP	O
,	,	,	O	O
implicating	implicate	VBG	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
thermogenesis	thermogenesis	NN	B-NP	O

1Tcm	1Tcm	NN	B-NP	O
-	-	HYPH	B-PP	O
labelled	label	VBN	B-NP	O
albumin	BEGIN-albumin-INSIDE	NN	I-NP	B
colloid	colloid	NN	I-NP	O
,	,	,	O	O
albures	albure	NNS	B-NP	O
(	(	(	O	O
radius	radius	NN	B-NP	O
1	1	CD	I-NP	O
nm	nm	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
nanocoll	nanocoll	NN	B-NP	O
(	(	(	O	O
radius	radius	NN	B-NP	O
1	1	CD	I-NP	O
nm	nm	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
both	both	DT	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
test	test	NN	B-NP	O
substances	substance	NNS	I-NP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
clearance	clearance	NN	I-NP	O
after	after	IN	B-PP	O
RES	RES	NNS	B-NP	O
stimulation	stimulation	NN	I-NP	O

Hepatitis	Hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
markers	marker	NNS	I-NP	O
in	in	IN	B-PP	O
Lancashire	Lancashire	NNP	B-NP	O
police	police	NN	I-NP	O
officers	officer	NNS	I-NP	O

Xa1	BEGIN-Xa1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
dominantly	dominantly	RB	I-NP	O
inherited	inherit	VBN	I-NP	O
rice	rice	NN	I-NP	O
gene	gene	NN	I-NP	O
that	that	WDT	B-NP	O
confers	confer	VBZ	B-VP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
Philippine	Philippine	JJ	B-NP	O
race	race	NN	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
blight	blight	NN	I-NP	O
pathogen	pathogen	NN	I-NP	O
Xanthomonas	Xanthomonas	NN	I-NP	O
oryzae	oryzae	VBP	B-VP	O
pv.	pv.	NN	B-NP	O
oryzae	oryzae	NNS	I-NP	O
in	in	IN	B-PP	O
rice	rice	NN	B-NP	O

Screening	Screening	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
cDNA	cDNA	NN	I-NP	O
libraries	library	NNS	I-NP	O
has	have	VBZ	B-VP	O
identified	identify	VBN	I-VP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
termini	terminus	NNS	I-NP	O
and	and	CC	O	O
alternatively	alternatively	RB	B-NP	O
spliced	splice	VBN	I-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
Fli	Fli	NNP	I-NP	I
-	-	HYPH	I-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
Fli	BEGIN-Fli	JJ	B-NP	B
-	-	HYPH	I-NP	I
1b	1b-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
independent	independent	JJ	I-NP	O
promoters	promoter	NNS	I-NP	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
construct	construct	VB	I-VP	O
chvI	BEGIN-chvI-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
chvG	BEGIN-chvG	NN	I-NP	B
insertion	insertion	NN	I-NP	I
mutants	mutants-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
R.	R.	NNP	B-NP	O
meliloti	meliloti	NNP	I-NP	O
,	,	,	O	O
whereas	whereas	IN	B-PP	O
mutants	mutant	NNS	B-NP	O
carrying	carry	VBG	B-VP	O
insertions	insertion	NNS	B-NP	O
outside	outside	JJ	B-ADJP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
were	be	VBD	B-VP	O
readily	readily	RB	I-VP	O
obtained	obtain	VBN	I-VP	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
transcription	transcription	NN	B-NP	O
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
localized	localize	VBN	I-VP	O
in	in	IN	B-PP	O
nuclei	nucleus	NNS	B-NP	O
of	of	IN	B-PP	O
transfected	transfecte	VBN	B-NP	O
cells	cell	NNS	I-NP	O

When	When	WRB	B-ADVP	O
yeast	yeast	NN	B-NP	O
cells	cell	NNS	I-NP	O
reach	reach	VBP	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
size	size	NN	I-NP	O
in	in	IN	B-PP	O
late	late	JJ	B-NP	O
G1	G1	NN	I-NP	O
they	they	PRP	B-NP	O
simultaneously	simultaneously	RB	B-ADVP	O
start	start	VBP	B-VP	O
budding	bud	VBG	I-VP	O
,	,	,	O	O
initiate	initiate	VB	B-VP	O
DNA	DNA	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
activate	activate	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
that	that	WDT	B-NP	O
includes	include	VBZ	B-VP	O
G1	BEGIN-G1	NN	B-NP	B
cyclins	cyclins-INSIDE	NN	I-NP	I
CLN1	BEGIN-CLN1-INSIDE	NN	I-NP	B
,	,	,	O	O
CLN1	BEGIN-CLN1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
many	many	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
genes	gene	NNS	I-NP	O

After	After	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
h	h	NN	I-NP	O
rest	rest	NN	I-NP	O
(	(	(	O	O
for	for	IN	B-PP	O
T1	T1	NN	B-NP	O
return	return	NN	I-NP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
subjects	subject	NNS	B-NP	O
repeated	repeat	VBD	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
min	min	NN	I-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
final	final	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
/	/	SYM	O	O
MRS	MRS	NN	B-NP	O

Use	Use	NN	B-NP	O
of	of	IN	B-PP	O
ELISAs	ELISA	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
canine	canine	JJ	B-NP	O
atopy	atopy	NN	I-NP	O

In	In	FW	B-NP	O
situ	situ	FW	I-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
PCP	BEGIN-PCP	NN	B-NP	B
-	-	HYPH	B-NP	I
A1	A1	NN	I-NP	I
transcripts	transcripts-INSIDE	NN	I-NP	I
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
accumulate	accumulate	VBP	B-VP	O
specifically	specifically	RB	B-ADVP	O
in	in	IN	B-PP	O
pollen	pollen	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
late	late	JJ	I-NP	O
binucleate	binucleate	NN	I-NP	O
/	/	SYM	B-NP	O
trinucleate	trinucleate	NN	I-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
development	development	NN	B-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tapetum	tapetum	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
previously	previously	RB	B-ADVP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
principal	principal	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pollen	pollen	NN	I-NP	O
coat	coat	NN	I-NP	O

A	A	DT	B-NP	O
single	single	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Cef	Cef	NN	B-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
intravenously	intravenously	RB	B-ADVP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
autoimmune	autoimmune	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
and	and	CC	O	O
varying	vary	VBG	B-NP	O
degrees	degree	NNS	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
impairment	impairment	NN	I-NP	O
(	(	(	O	O
Group	Group	NN	B-NP	O
I	I	CD	I-NP	O
CLCR	CLCR	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-PP	O
min	min	NN	B-NP	O
,	,	,	O	O
Group	Group	NN	B-NP	O
II	II	CD	I-NP	O
CLCR	CLCR	NN	I-NP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
)	)	)	O	O

Postheparin	Postheparin	NN	B-NP	O
lipoprotein	BEGIN-lipoprotein	NN	I-NP	B
lipase	lipase-INSIDE	NN	I-NP	I
,	,	,	O	O
measured	measure	VBN	B-VP	O
using	use	VBG	B-VP	O
fat	fat	JJ	B-NP	O
emulsion	emulsion	NN	I-NP	O
as	as	IN	B-PP	O
substrate	substrate	NN	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
in	in	IN	B-PP	O
female	female	JJ	B-NP	O
rats	rat	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
males	male	NNS	B-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
major	major	JJ	I-NP	O
and	and	CC	I-NP	O
novel	novel	JJ	I-NP	O
Shc	BEGIN-Shc-INSIDE	NN	I-NP	B
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
Y1	Y1	NN	B-NP	O
and	and	CC	I-NP	O
Y1	Y1	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
applicability	applicability	NN	I-NP	O
of	of	IN	B-PP	O
countercurrent	countercurrent	JJ	B-NP	O
chromatography	chromatography	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
ultratrace	ultratrace	NN	B-NP	O
elements	element	NNS	I-NP	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
our	our	PRP$	B-NP	O
sequence	sequence	NN	I-NP	O
data	datum	NNS	I-NP	O
,	,	,	O	O
ORF1	ORF1	NN	B-NP	O
from	from	IN	B-PP	O
most	most	JJS	B-NP	O
isolates	isolate	NNS	I-NP	O
excluding	exclude	VBG	B-PP	O
G1	G1	NN	B-NP	O
encode	encode	NN	I-NP	O
truncated	truncate	VBD	B-VP	O
1	1	CD	B-NP	O
aa	aa	NN	I-NP	O
(	(	(	O	O
pORF1a	pORF1a	NN	B-NP	O
)	)	)	O	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
an	an	DT	B-NP	O
in	in	IN	B-PP	O
-	-	HYPH	B-NP	O
frame	frame	NN	I-NP	O
stop	stop	NN	I-NP	O
codon	codon	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
ORF1s	ORF1	NNS	B-NP	O
from	from	IN	B-PP	O
most	most	JJS	B-NP	O
G1	G1	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
encode	encode	VBP	B-VP	O
1	1	CD	B-NP	O
aa	aa	NN	I-NP	O
(	(	(	O	O
pORF1ab	pORF1ab	NN	B-NP	O
)	)	)	O	O

Fusions	Fusion	NNS	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
GAL	BEGIN-GAL	JJ	I-NP	B
DNA	DNA	NN	I-NP	I
binding	binding	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
and	and	CC	O	O
full	BEGIN-full	JJ	B-NP	B
-	-	HYPH	I-NP	I
length	length	NN	I-NP	I
mSin1	mSin1-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
repression	repression	NN	B-NP	O

Clinical	Clinical	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
provides	provide	VBZ	B-VP	O
tentative	tentative	JJ	B-NP	O
suggestions	suggestion	NNS	I-NP	O
on	on	IN	B-PP	O
(	(	(	O	O
a	a	DT	O	O
)	)	)	O	O
possible	possible	JJ	B-NP	O
additional	additional	JJ	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
cigarette	cigarette	NN	B-NP	O
smoking	smoking	NN	I-NP	O
(	(	(	O	O
b	b	NN	B-NP	O
)	)	)	O	O
avoidance	avoidance	NN	B-NP	O
of	of	IN	B-PP	O
venography	venography	NN	B-NP	O
(	(	(	O	O
c	c	NN	B-NP	O
)	)	)	O	O
avoidance	avoidance	NN	B-NP	O
of	of	IN	B-PP	O
varicose	varicose	NN	B-NP	O
vein	vein	NN	I-NP	O
surgery	surgery	NN	I-NP	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cryptic	cryptic	JJ	I-NP	O
plasmid	plasmid	NN	I-NP	O
,	,	,	O	O
pRmeGR1b	pRmeGR1b	NN	B-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nodulation	nodulation	NN	I-NP	O
of	of	IN	B-PP	O
Medicago	Medicago	NNP	B-NP	O
sativa	sativa	NN	I-NP	O
by	by	IN	B-PP	O
strain	strain	NN	B-NP	O
GR1	GR1	NN	I-NP	O
of	of	IN	B-PP	O
Rhizobium	Rhizobium	NN	B-NP	O
meliloti	meliloti	NNS	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
LSD	LSD	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
female	female	JJ	I-NP	O
copulatory	copulatory	JJ	I-NP	O
response	response	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
increased	increase	VBN	B-NP	O
dopamine	BEGIN-dopamine	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
but	but	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
LSD	LSD	NN	I-NP	O
effect	effect	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
modulated	modulate	VBN	I-VP	O
by	by	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
dopaminergic	dopaminergic	JJ	I-NP	O
activity	activity	NN	I-NP	O

The	The	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
(	(	(	O	O
Killip	Killip	NN	B-NP	O
class	class	NN	I-NP	O
III	III	CD	B-NP	O
or	or	CC	I-NP	O
IV	IV	CD	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
early	early	JJ	B-NP	O
presentation	presentation	NN	I-NP	O
,	,	,	O	O
than	than	IN	B-PP	O
with	with	IN	B-PP	O
late	late	JJ	B-NP	O
presentation	presentation	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
vs	vs	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
also	also	RB	B-ADVP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
unless	unless	IN	B-SBAR	O
excluded	exclude	VBN	B-VP	O
by	by	IN	B-PP	O
other	other	JJ	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
C	BEGIN-C	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
located	locate	VBN	I-VP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
length	length	NN	I-NP	O
of	of	IN	B-PP	O
nascent	nascent	JJ	B-NP	O
transcripts	transcript	NNS	I-NP	O

ADR1	BEGIN-ADR1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
extracts	extract	NNS	B-NP	O
made	make	VBN	B-VP	O
from	from	IN	B-PP	O
glucose	glucose	NN	B-NP	O
-	-	HYPH	B-NP	O
repressed	repress	VBN	B-VP	O
and	and	CC	O	O
-	-	HYPH	B-NP	O
derepressed	derepresse	VBN	I-NP	O
cells	cell	NNS	I-NP	O
bound	bind	VBD	B-VP	O
UAS1	UAS1	NN	B-NP	O
DNA	DNA	NN	I-NP	O
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
affinities	affinity	NNS	I-NP	O
despite	despite	IN	B-PP	O
having	have	VBG	B-VP	O
greatly	greatly	RB	B-NP	O
different	different	JJ	I-NP	O
abilities	ability	NNS	I-NP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
ADH1	BEGIN-ADH1	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Comparing	Compare	VBG	B-VP	O
the	the	DT	B-NP	O
outcome	outcome	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
having	have	VBG	B-VP	O
histologically	histologically	RB	B-NP	O
normal	normal	JJ	I-NP	O
biopsies	biopsy	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
having	have	VBG	B-VP	O
nonspecifically	nonspecifically	RB	B-NP	O
abnormal	abnormal	JJ	I-NP	O
ones	one	NNS	I-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
frontal	frontal	JJ	B-NP	O
biopsy	biopsy	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
high	high	JJ	I-NP	O
prognostic	prognostic	JJ	I-NP	O
value	value	NN	I-NP	O
as	as	IN	B-SBAR	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
claimed	claim	VBN	I-VP	O
in	in	IN	B-PP	O
previous	previous	JJ	B-NP	O
reports	report	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
using	use	VBG	B-VP	O
wet	wet	JJ	B-NP	O
weight	weight	NN	I-NP	O
/	/	SYM	I-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
methodology	methodology	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
U1F	U1F	NN	B-NP	O
significantly	significantly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
water	water	NN	B-NP	O
content	content	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hippocampus	hippocampus	NN	I-NP	O
(	(	(	O	O
contralateral	contralateral	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
injury	injury	NN	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
saline	saline	NN	B-NP	O
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
animals	animal	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
ready	ready	JJ	I-NP	O
-	-	HYPH	I-NP	O
made	make	VBN	I-NP	O
prosthesis	prosthesis	NN	I-NP	O
is	be	VBZ	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
external	external	JJ	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ribs	rib	NNS	I-NP	O
vertically	vertically	RB	B-VP	O
bridging	bridge	VBG	I-VP	O
the	the	DT	B-NP	O
flailed	flailed	JJ	I-NP	O
chest	chest	NN	I-NP	O
segment	segment	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
fixed	fix	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
first	first	RB	I-NP	O
lower	low	JJR	I-NP	O
intact	intact	JJ	I-NP	O
rib	rib	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mobile	mobile	JJ	I-NP	O
segments	segment	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
affected	affect	VBN	I-NP	O
ribs	rib	NNS	I-NP	O

The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
alprazolam	alprazolam	NN	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
enhanced	enhance	VBN	I-VP	O
specificity	specificity	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
subpopulation	subpopulation	NN	I-NP	O
of	of	IN	B-PP	O
benzodiazepine	BEGIN-benzodiazepine	NN	B-NP	B
receptors	receptors-INSIDE	NN	I-NP	I

They	They	PRP	B-NP	O
showed	show	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
antifungal	antifungal	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
fungi	fungus	NNS	B-NP	O
and	and	CC	I-NP	O
yeasts	yeast	NNS	I-NP	O
including	include	VBG	B-PP	O
clinically	clinically	RB	B-NP	O
important	important	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
were	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
albicans	albican	NNS	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
after	after	IN	B-PP	O
iv	iv	NN	B-NP	O
and	and	CC	I-NP	O
im	im	NN	I-NP	O
administrations	administration	NNS	I-NP	O

Central	Central	JJ	O	O
(	(	(	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
VE	VE	NN	B-NP	O
,	,	,	O	O
VO1	VO1	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
local	local	JJ	B-NP	O
(	(	(	O	O
muscle	muscle	NN	B-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
lactate	lactate	NN	I-NP	O
,	,	,	O	O
adenosine	adenosine	NN	B-NP	O
triphosphate	triphosphate	NN	I-NP	O
,	,	,	O	O
creatine	BEGIN-creatine	NN	B-NP	B
phosphokinase	phosphokinase-INSIDE	NN	I-NP	I
,	,	,	O	O
glycogen	glycogen	NN	B-NP	O
)	)	)	O	O
cues	cue	NNS	B-NP	O
highlighted	highlight	VBN	B-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
complexity	complexity	NN	I-NP	O
of	of	IN	B-PP	O
effort	effort	NN	B-NP	O
perception	perception	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
components	component	NNS	I-NP	O
upon	upon	IN	B-PP	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
based	base	VBN	I-VP	O

The	The	DT	B-NP	O
method	method	NN	I-NP	O
was	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
on	on	IN	B-PP	O
1	1	CD	B-NP	O
rats	rat	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
hr	hr	NN	I-NP	O
-	-	HYPH	I-NP	O
old	old	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
sham	sham	NN	I-NP	O
-	-	HYPH	B-NP	O
operated	operate	VBN	I-NP	O
controls	control	NNS	I-NP	O

Disruption	Disruption	NN	B-NP	O
and	and	CC	I-NP	O
reconstruction	reconstruction	NN	I-NP	O
:	:	:	O	O
narrative	narrative	JJ	B-NP	O
insights	insight	NNS	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
experience	experience	NN	I-NP	O
of	of	IN	B-PP	O
family	family	NN	B-NP	O
members	member	NNS	I-NP	O
caring	care	VBG	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
relative	relative	JJ	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
with	with	IN	B-PP	O
serious	serious	JJ	B-NP	O
mental	mental	JJ	I-NP	O
illness	illness	NN	I-NP	O

Transcription	Transcription	NN	B-NP	O
start	start	NN	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
sal	BEGIN-sal-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
salR	BEGIN-BEGIN-sal-INSIDER	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
lie	lie	VB	I-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
respective	respective	JJ	I-NP	O
initiation	initiation	NN	I-NP	O
codons	codon	NNS	I-NP	O
and	and	CC	O	O
separated	separate	VBN	B-VP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
nucleotides	nucleotide	NNS	I-NP	O

Co	Co	AFX	B-NP	O
-	-	HYPH	I-NP	O
operativity	operativity	NN	I-NP	O
of	of	IN	B-PP	O
functional	functional	JJ	B-NP	O
domains	domain	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
muscle	BEGIN-muscle	NN	I-NP	B
-	-	HYPH	B-NP	I
specific	specific	JJ	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
Myf	Myf	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Henry	Henry	NNP	B-NP	O
Quastler	Quastler	NNP	I-NP	O
brought	bring	VBD	B-VP	O
experience	experience	NN	B-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
actual	actual	JJ	I-NP	O
x	x	NN	I-NP	O
-	-	HYPH	B-NP	O
ray	ray	NN	I-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Dr	Dr	NN	B-NP	O

Hybridization	Hybridization	NN	B-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
between	between	IN	B-PP	O
polyadenylated	BEGIN-polyadenylated	JJ	B-NP	B
H	H	NN	I-NP	I
chain	chain	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
,	,	,	O	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hybridomas	hybridoma	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
VH	BEGIN-VH-INSIDE	NN	I-NP	B
probe	probe	NN	I-NP	O

The	The	DT	B-NP	O
general	general	JJ	I-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
RARE	BEGIN-RARE-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
cleavage	cleavage	NN	I-NP	O
mapping	mapping	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
its	its	PRP$	B-NP	O
applications	application	NNS	I-NP	O
and	and	CC	I-NP	O
limitations	limitation	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O

(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
Expression	Expression	NN	B-NP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
is	be	VBZ	B-VP	O
driven	drive	VBN	I-VP	O
by	by	IN	B-PP	O
separable	separable	JJ	B-NP	O
elements	element	NNS	I-NP	O
widely	widely	RB	B-ADVP	O
dispersed	disperse	VBD	B-VP	O
throughout	throughout	IN	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
1	1	CD	I-NP	O
'	'	''	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
lactate	lactate	NN	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
magnitude	magnitude	NN	I-NP	O
observed	observe	VBN	B-VP	O
during	during	IN	B-PP	O
alkali	alkali	NN	B-NP	O
therapy	therapy	NN	I-NP	O
need	need	MD	B-VP	O
not	not	RB	I-VP	O
indicate	indicate	VB	I-VP	O
a	a	DT	B-NP	O
worsening	worsening	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
picture	picture	NN	I-NP	O
in	in	IN	B-PP	O
lactic	lactic	JJ	B-NP	O
acidosis	acidosis	NN	I-NP	O

The	The	DT	B-NP	O
virus	virus	NN	I-NP	O
must	must	MD	B-VP	O
progress	progress	VB	I-VP	O
past	past	IN	B-PP	O
the	the	DT	B-NP	O
immediate	immediate	JJ	I-NP	O
-	-	HYPH	I-NP	O
early	early	JJ	I-NP	O
phase	phase	NN	I-NP	O
and	and	CC	O	O
express	express	VBP	B-VP	O
an	an	DT	B-NP	O
early	BEGIN-early	JJ	I-NP	B
gene	gene	NN	I-NP	I
product	product	NN	I-NP	I
(	(	(	I-NP	I
s	s	NNS	I-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O

The	The	DT	B-NP	O
software	software	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
BASIC	BASIC	NN	B-NP	O
adapted	adapt	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Hewlett	Hewlett	NNP	I-NP	O
-	-	HYPH	I-NP	O
Packard	Packard	NNP	I-NP	O
calculators	calculator	NNS	I-NP	O
HP	HP	NN	I-NP	O
-	-	HYPH	B-NP	O
1B	1B	NN	I-NP	O
and	and	CC	I-NP	O
HP	HP	NN	I-NP	O
-	-	HYPH	O	O
1A	1A	NN	B-NP	O

Genealogical	Genealogical	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
mainly	mainly	RB	B-ADVP	O
a	a	DT	B-NP	O
mother	mother	NN	I-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
offspring	offspre	VBG	I-NP	O
transmission	transmission	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
STLV	STLV	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

The	The	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mature	mature	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
showed	show	VBD	B-VP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
homology	homology	NN	I-NP	O
(	(	(	O	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
identity	identity	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
known	known	JJ	B-NP	O
pectinolytic	pectinolytic	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
pectate	BEGIN-pectate	NN	I-NP	B
lyase	lyase	NN	I-NP	I
superfamily	superfamily-INSIDE	NN	I-NP	I
(	(	(	O	O
the	the	DT	B-NP	O
polysaccharide	BEGIN-polysaccharide	NN	I-NP	B
lyase	lyase	NN	I-NP	I
family	family	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O

The	The	DT	B-NP	O
pineal	pineal	JJ	I-NP	O
hormone	hormone	NN	I-NP	O
melatonin	melatonin	NN	I-NP	O
(	(	(	O	O
MLT	MLT	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
exert	exert	VB	I-VP	O
an	an	DT	B-NP	O
oncostatic	oncostatic	JJ	I-NP	O
action	action	NN	I-NP	O

Patients	Patient	NNS	B-NP	O
commonly	commonly	RB	B-VP	O
considered	consider	VBN	I-VP	O
the	the	DT	B-NP	O
external	external	JJ	I-NP	O
frame	frame	NN	I-NP	O
cumbersome	cumbersome	NN	I-NP	O

A	A	DT	B-NP	O
wound	wound	NN	I-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
decubitus	decubitus	NN	B-NP	O
and	and	CC	I-NP	O
leg	leg	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
dermal	dermal	JJ	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
in	in	IN	B-PP	O
type	BEGIN-type	JJ	B-NP	B
I	I	NN	I-NP	I
collagen	collagen-INSIDE	NN	I-NP	I
dermal	dermal	JJ	I-NP	O
``	``	``	I-NP	O
equivalent	equivalent	JJ	I-NP	O
''	''	''	I-NP	O
matrix	matrix	NN	I-NP	O
(	(	(	O	O
DEM	DEM	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
exposed	expose	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
to	to	TO	B-PP	O
electric	electric	JJ	B-NP	O
fields	field	NNS	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
postulated	postulate	VBN	B-NP	O
endogenous	endogenous	JJ	I-NP	O
fields	field	NNS	I-NP	O
in	in	IN	B-PP	O
wounds	wound	NNS	B-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
DNA	DNA	NN	B-NP	O
replication	replication	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
L1V	L1V	NN	I-NP	O
substitution	substitution	NN	I-NP	O
in	in	IN	B-PP	O
large	BEGIN-large	JJ	B-NP	B
T	T	NN	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
prevent	prevent	VB	I-VP	O
complex	complex	NN	B-NP	O
formation	formation	NN	I-NP	O
with	with	IN	B-PP	O
Hsc1	BEGIN-Hsc1-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
Rb	BEGIN-Rb	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
tail	tail	NN	I-NP	O
deviated	deviate	VBN	B-VP	O
ipsilaterally	ipsilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
cats	cat	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hemisection	hemisection	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
tail	tail	NN	I-NP	O
was	be	VBD	B-VP	O
ventroflexed	ventroflexe	VBN	I-VP	O
in	in	IN	B-PP	O
cats	cat	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
transection	transection	NN	I-NP	O

Lastly	Lastly	RB	B-ADVP	O
,	,	,	O	O
several	several	JJ	B-NP	O
restriction	restriction	NN	I-NP	O
length	length	NN	I-NP	O
polymorphisms	polymorphism	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
and	and	CC	O	O
mapped	map	VBN	B-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
region	region	NN	I-NP	O
located	located	JJ	B-ADJP	O
immediately	immediately	RB	B-ADJP	O
upstream	upstream	JJ	I-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
JH	BEGIN-JH	NN	I-NP	B
cluster	cluster-INSIDE	NN	I-NP	I

Peak	Peak	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
ACTH	BEGIN-ACTH-INSIDE	NN	I-NP	B
responses	response	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	B-ADJP	O
significantly	significantly	RB	I-ADJP	O
different	different	JJ	I-ADJP	O
between	between	IN	B-PP	O
control	control	NN	B-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
groups	group	NNS	I-NP	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
deoxyglucose	deoxyglucose	NN	I-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
primary	primary	JJ	I-NP	O
rat	rat	NN	I-NP	O
adipocytes	adipocyte	NNS	I-NP	O
and	and	CC	O	O
1T1	1T1	NN	B-NP	O
-	-	HYPH	I-NP	O
L1	L1	NN	I-NP	O
adipocytes	adipocyte	NNS	I-NP	O
pretreated	pretreate	VBN	B-VP	O
with	with	IN	B-PP	O
U1	U1	NN	B-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
recordings	recording	NNS	I-NP	O
are	be	VBP	B-VP	O
incomplete	incomplete	JJ	B-ADJP	O
;	;	:	O	O
the	the	DT	B-NP	O
actual	actual	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	O
neurons	neuron	NNS	I-NP	O
is	be	VBZ	B-VP	O
estimated	estimate	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
acutely	acutely	RB	I-NP	O
sensitized	sensitize	VBN	I-NP	O
preparation	preparation	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
control	control	NN	I-NP	O
regions	region	NNS	I-NP	O
from	from	IN	B-PP	O
both	both	CC	B-NP	O
human	BEGIN-human	JJ	I-NP	B
and	and	CC	I-NP	I
Wistar	Wistar	NNP	I-NP	I
-	-	HYPH	I-NP	I
rat	rat	NN	I-NP	I
single	single	JJ	I-NP	I
copy	copy	NN	I-NP	I
EGF	EGF	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
and	and	CC	O	O
their	their	PRP$	B-NP	O
functional	functional	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
in	in	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	O
cell	cell	NN	I-NP	O
cultures	culture	NNS	I-NP	O

Along	Along	IN	B-PP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
graminearum	graminearum	NN	I-NP	O
group	group	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
ZON	ZON	NN	B-NP	O
,	,	,	O	O
DON	DON	NN	B-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
1AcDON	1AcDON	NN	B-NP	O
or	or	CC	O	O
1AcDON	1AcDON	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
F.	F.	NN	B-NP	O
chlamydosporum	chlamydosporum	NN	I-NP	O
;	;	:	O	O
F.	F.	NN	B-NP	O
acuminatum	acuminatum	NN	I-NP	O
(	(	(	O	O
type	type	NN	B-NP	O
-	-	HYPH	I-NP	O
A	A	NN	I-NP	O
trichothecene	trichothecene	NN	I-NP	O
derivatives	derivative	NNS	I-NP	O
)	)	)	O	O
;	;	:	O	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
semitectum	semitectum	NN	I-NP	O
were	be	VBD	B-VP	O
often	often	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O

C.	C.	NNP	B-NP	O
glabrata	glabrata	NNP	I-NP	O
cells	cell	NNS	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
CBF1	BEGIN-CBF1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
under	under	IN	B-PP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
shutdown	shutdown	NN	I-NP	O
promoter	promoter	NN	I-NP	O
(	(	(	O	O
tetO	tetO	NN	B-NP	O
-	-	HYPH	B-NP	O
ScHOP	ScHOP	NN	I-NP	O
)	)	)	O	O
arrested	arrest	VBD	B-VP	O
their	their	PRP$	B-NP	O
growth	growth	NN	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
of	of	IN	B-PP	O
cultivation	cultivation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
reactive	reactive	JJ	I-NP	O
drug	drug	NN	I-NP	O
doxycycline	doxycycline	NN	I-NP	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
that	that	IN	B-SBAR	O
muscle	muscle	NN	B-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IPC	IPC	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
preischemic	preischemic	JJ	B-NP	O
LMK	LMK	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	O	O
)	)	)	O	O
groups	group	NNS	B-NP	O
were	be	VBD	B-VP	O
smaller	small	JJR	B-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
characteristic	characteristic	JJ	I-NP	O
feature	feature	NN	I-NP	O
is	be	VBZ	B-VP	O
their	their	PRP$	B-NP	O
tendency	tendency	NN	I-NP	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
homo	homo	AFX	B-NP	O
-	-	HYPH	I-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
heterodimeric	heterodimeric	JJ	B-NP	O
complexes	complex	NNS	I-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O

A	A	DT	B-NP	O
female	female	JJ	I-NP	O
infant	infant	NN	I-NP	O
with	with	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
noncompaction	noncompaction	NN	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
myocardium	myocardium	NN	I-NP	O
who	who	WP	B-NP	O
developed	develop	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
tachyarrhythmia	tachyarrhythmia	NN	I-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O

Methodological	Methodological	JJ	B-NP	O
considerations	consideration	NNS	I-NP	O
limiting	limit	VBG	B-VP	O
causal	causal	JJ	B-NP	O
assertions	assertion	NNS	I-NP	O
permissible	permissible	JJ	B-ADJP	O
with	with	IN	B-PP	O
nonexperimental	nonexperimental	JJ	B-NP	O
data	datum	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O

Skytthe	Skytthe	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
K	K	NN	B-NP	O

Y1	BEGIN-Y1-INSIDE	NN	B-NP	B
,	,	,	O	O
Y1	BEGIN-Y1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
Y1	BEGIN-Y1-INSIDE	NN	B-NP	B
/	/	SYM	O	O
PP1	BEGIN-PP1-INSIDE	NN	B-NP	B

S	S	NN	B-NP	O
-	-	HYPH	B-NP	O
phase	phase	NN	I-NP	O
-	-	HYPH	O	O
promoting	promote	VBG	B-VP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
kinases	kinases-INSIDE	NN	I-NP	I
(	(	(	O	O
Cdks	BEGIN-Cdks-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
kinase	kinase	NN	I-NP	O
Dbf1	BEGIN-Dbf1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	I-NP	B
then	then	RB	B-ADVP	O
act	act	VBP	B-VP	O
to	to	TO	I-VP	O
initiate	initiate	VB	I-VP	O
replication	replication	NN	B-NP	O

The	The	DT	B-NP	O
cleft	cleft	NN	I-NP	O
walls	wall	NNS	I-NP	O
are	be	VBP	B-VP	O
lined	line	VBN	I-VP	O
with	with	IN	B-PP	O
highly	highly	RB	B-NP	O
conserved	conserved	JJ	I-NP	O
residues	residue	NNS	I-NP	O
and	and	CC	O	O
NADP	NADP	NN	B-NP	O
is	be	VBZ	B-VP	O
bound	bind	VBN	I-VP	O
along	along	IN	B-PP	O
one	one	CD	B-NP	O
wall	wall	NN	I-NP	O

The	The	DT	B-NP	O
primary	primary	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
for	for	IN	B-PP	O
acceptable	acceptable	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
use	use	NN	I-NP	O
were	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
exhaled	exhale	VBN	B-NP	O
-	-	HYPH	I-NP	O
volume	volume	NN	I-NP	O
monitoring	monitor	VBG	B-VP	O
be	be	VB	I-VP	O
performed	perform	VBN	I-VP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
O1	O1	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
be	be	VB	B-VP	O
performed	perform	VBN	I-VP	O
both	both	DT	B-NP	O
when	when	WRB	B-ADVP	O
setting	set	VBG	B-VP	O
FIO1	FIO1	NN	B-NP	O
and	and	CC	O	O
continuously	continuously	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
FIO1	FIO1	NN	B-NP	O
levels	level	NNS	I-NP	O
are	be	VBP	B-VP	O
critical	critical	JJ	B-ADJP	O

Genetic	Genetic	JJ	B-NP	O
mutation	mutation	NN	I-NP	O
or	or	CC	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
activin	BEGIN-activin-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
transforming	BEGIN-transforming	JJ	I-NP	B
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
(	(	(	O	I
TGFbeta	TGFbeta	NN	B-NP	I
)	)	)	O	I
receptor	receptor-INSIDE	NN	B-NP	I
function	function	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
,	,	,	I-NP	O
breast	breast	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
colorectal	colorectal	JJ	B-NP	O
tumors	tumor	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Hep1B	Hep1B	NN	B-NP	O
and	and	CC	I-NP	O
Mv1Lu	Mv1Lu	NN	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

Non	Non	AFX	B-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	B-NP	O
immunological	immunological	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O
in	in	IN	B-PP	O
whom	whom	WP	B-NP	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
looked	look	VBN	I-VP	O
for	for	IN	B-SBAR	O

No	No	DT	B-NP	O
cleavage	cleavage	NN	I-NP	O
of	of	IN	B-PP	O
gp	BEGIN-gp	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
analogous	analogous	JJ	B-NP	O
pulse	pulse	NN	I-NP	O
-	-	HYPH	B-NP	O
chase	chase	NN	I-NP	O
radiolabelling	radiolabelling	NN	I-NP	O
of	of	IN	B-PP	O
Ad	Ad	NN	B-NP	O
-	-	HYPH	B-NP	O
gB	BEGIN-gB-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
infected	infect	VBN	B-NP	O
human	human	JJ	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
,	,	,	O	O
even	even	RB	B-SBAR	O
though	though	IN	I-SBAR	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
are	be	VBP	B-VP	O
permissive	permissive	JJ	B-ADJP	O
for	for	IN	B-PP	O
HCMV	HCMV	NN	B-NP	O
replication	replication	NN	I-NP	O
and	and	CC	O	O
can	can	MD	B-VP	O
process	process	VB	I-VP	O
the	the	DT	B-NP	O
native	BEGIN-native	JJ	I-NP	B
gB	BEGIN-gB-INSIDE	NN	I-NP	I
molecule	molecule-INSIDE	NN	I-NP	I

Because	Because	IN	B-SBAR	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
Vo1DIR	Vo1DIR	NN	B-NP	O
and	and	CC	I-NP	O
Vo1INDIR	Vo1INDIR	NN	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
pooled	pool	VBD	B-VP	O
data	datum	NNS	B-NP	O
from	from	IN	B-PP	O
septic	septic	JJ	B-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
animals	animal	NNS	I-NP	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
acquired	acquire	VBN	B-NP	O
immune	immune	JJ	I-NP	O
deficiency	deficiency	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
(	(	(	O	O
AIDS	AIDS	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
homosexual	homosexual	JJ	B-NP	O
males	male	NNS	I-NP	O
with	with	IN	B-PP	O
spindle	spindle	NN	B-NP	O
-	-	HYPH	B-NP	O
endothelial	endothelial	JJ	I-NP	O
cell	cell	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
recrudescent	recrudescent	JJ	B-NP	O
melioidosis	melioidosis	NN	I-NP	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
assess	assess	VB	I-VP	O
laboratory	laboratory	NN	B-NP	O
practice	practice	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
examination	examination	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
films	film	NNS	I-NP	O
for	for	IN	B-PP	O
malarial	malarial	JJ	B-NP	O
parasites	parasite	NNS	I-NP	O

Little	Little	JJ	B-NP	O
honoured	honour	VBN	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
country	country	NN	I-NP	O
:	:	:	O	O
statues	statue	NNS	B-NP	O
in	in	IN	B-PP	O
recognition	recognition	NN	B-NP	O
of	of	IN	B-PP	O
Edward	Edward	NNP	B-NP	O
Jenner	Jenner	NNP	I-NP	O
MD	MD	NNP	I-NP	O
FRS	FRS	NNP	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
GRF1	BEGIN-GRF1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
GRF1	BEGIN-GRF1-INSIDE	NN	I-NP	B
can	can	MD	B-VP	O
form	form	VB	I-VP	O
homo	homo	AFX	B-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
hetero	hetero	AFX	I-NP	O
-	-	HYPH	I-NP	O
oligomers	oligomer	NNS	I-NP	O
via	via	IN	B-PP	O
their	their	PRP$	B-NP	O
DH	BEGIN-DH	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
,	,	,	O	O
that	that	IN	B-SBAR	O
mutational	mutational	JJ	B-NP	O
inactivation	inactivation	NN	I-NP	O
of	of	IN	B-PP	O
oligomer	oligomer	NN	B-NP	O
formation	formation	NN	I-NP	O
by	by	IN	B-PP	O
GRF1	BEGIN-GRF1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
biological	biological	JJ	I-NP	O
and	and	CC	I-NP	O
signaling	signaling	NN	I-NP	O
activities	activity	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
1T	1T	NN	B-NP	O
cells	cell	NNS	I-NP	O
GRF1	BEGIN-GRF1-INSIDE	NN	B-NP	B
mediates	mediate	VBZ	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
pathways	pathway	NNS	I-NP	O
for	for	IN	B-PP	O
Raf	BEGIN-Raf-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
:	:	:	O	O
one	one	CD	B-NP	O
a	a	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
signal	signal	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
mainly	mainly	RB	B-ADVP	O
Ras	BEGIN-Ras-INSIDE	NN	B-NP	B
-	-	HYPH	B-VP	O
dependent	dependent	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
one	one	CD	B-NP	O
an	an	DT	B-NP	O
ionomycin	ionomycin	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
signal	signal	NN	I-NP	O
that	that	WDT	B-NP	O
cooperates	cooperate	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
signal	signal	NN	I-NP	O
without	without	IN	B-PP	O
further	further	RB	B-VP	O
augmenting	augment	VBG	I-VP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
GTP	BEGIN-GTP	NN	B-NP	B
-	-	HYPH	O	I
Ras	BEGIN-Ras-INSIDE-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
phosphorus	phosphorus	NN	B-NP	O
balance	balance	NN	I-NP	O
in	in	IN	B-PP	O
ruminants	ruminant	NNS	B-NP	O
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
extend	extend	VBP	B-VP	O
our	our	PRP$	B-NP	O
knowledge	knowledge	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
SNF1	BEGIN-SNF1	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
family	family	NN	I-NP	I
member	member-INSIDE	NN	I-NP	I
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
PASG	BEGIN-PASG-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
leukemogenesis	leukemogenesis	NN	B-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
fos	fos	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
,	,	,	O	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Fos	Fos	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
replaced	replace	VBN	I-VP	O
by	by	IN	B-PP	O
proteins	protein	NNS	B-NP	O
of	of	IN	B-PP	O
Fos	BEGIN-Fos	NN	B-NP	B
family	family-INSIDE	NN	I-NP	I
(	(	(	O	O
Fra	BEGIN-Fra	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
ATF	BEGIN-ATF	NN	B-NP	B
family	family-INSIDE	NN	I-NP	I
(	(	(	O	O
ATF	BEGIN-ATF	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
and	and	CC	O	O
ATFa	BEGIN-ATFa-INSIDE	NN	B-NP	B
)	)	)	O	O

The	The	DT	B-NP	O
interaction	interaction	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
DBM	DBM	NN	B-NP	O
scores	score	NNS	I-NP	O
was	be	VBD	B-VP	O
further	further	RBR	I-VP	O
qualified	qualify	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
three	three	CD	I-NP	O
-	-	HYPH	I-NP	O
way	way	NN	I-NP	O
interaction	interaction	NN	I-NP	O
that	that	WDT	B-NP	O
limited	limit	VBD	B-VP	O
this	this	DT	B-NP	O
pattern	pattern	NN	I-NP	O
to	to	TO	B-PP	O
participants	participant	NNS	B-NP	O
scoring	score	VBG	B-VP	O
higher	higher	RBR	B-ADVP	O
on	on	IN	B-PP	O
self	self	AFX	B-NP	O
-	-	HYPH	I-NP	O
deception	deception	NN	I-NP	O

To	To	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
Ras	BEGIN-Ras-INSIDE	NN	I-NP	B
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
activates	activate	VBZ	B-VP	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
the	the	DT	B-NP	O
pituitary	BEGIN-pituitary	JJ	I-NP	B
-	-	HYPH	I-NP	I
specific	specific	JJ	I-NP	I
rat	rat	NN	I-NP	I
prolactin	prolactin-INSIDE	NN	I-NP	I
(	(	(	O	O
rPRL	BEGIN-rPRL-INSIDE	NN	B-NP	B
)	)	)	O	O
promoter	promoter	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
of	of	IN	B-PP	O
oncogenic	BEGIN-oncogenic	JJ	B-NP	B
Ras	BEGIN-Ras-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Raf	BEGIN-Raf-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
GH1	GH1	NN	B-NP	O
rat	rat	NN	I-NP	O
pituitary	pituitary	JJ	I-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
proU	BEGIN-proU-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
is	be	VBZ	B-VP	O
directed	direct	VBN	I-VP	O
from	from	IN	B-PP	O
two	two	CD	B-NP	O
promoters	promoter	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
(	(	(	O	O
P1	P1	NN	B-NP	O
)	)	)	O	O
characterized	characterize	VBN	B-VP	O
earlier	earlier	RBR	B-ADVP	O
by	by	IN	B-PP	O
other	other	JJ	B-NP	O
workers	worker	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
1	1	CD	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
initiation	initiation	NN	I-NP	O
codon	codon	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
structural	structural	JJ	I-NP	O
gene	gene	NN	I-NP	O
(	(	(	O	O
proV	BEGIN-proV-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
(	(	(	O	O
P1	P1	NN	B-NP	O
)	)	)	O	O
situated	situate	VBD	B-VP	O
1	1	CD	B-NP	O
nucleotides	nucleotide	NNS	I-NP	O
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
proV	BEGIN-proV-INSIDE	NN	B-NP	B

Coexpression	Coexpression	NN	B-NP	O
of	of	IN	B-PP	O
CREB	BEGIN-CREB	NN	B-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
CBP	BEGIN-CBP-INSIDE	NN	B-NP	B
)	)	)	O	O
/	/	SYM	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
with	with	IN	B-PP	O
TReP	BEGIN-TReP	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
additive	additive	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
proteins	protein	NNS	I-NP	O
were	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
to	to	TO	I-VP	O
interact	interact	VB	I-VP	O
physically	physically	RB	B-ADVP	O

Thirty	Thirty	CD	B-NP	O
minutes	minute	NNS	I-NP	O
after	after	IN	B-PP	O
reperfusion	reperfusion	NN	B-NP	O
,	,	,	O	O
lung	lung	NN	B-NP	O
lymph	lymph	NN	I-NP	O
flow	flow	NN	I-NP	O
(	(	(	O	O
QL	QL	NN	B-NP	O
)	)	)	O	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
minutes	minute	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
lymph	lymph	NN	B-NP	O
/	/	SYM	B-VP	O
plasma	plasma	NN	B-NP	O
protein	protein	NN	I-NP	O
ratio	ratio	NN	I-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
lymph	lymph	NN	I-NP	O
protein	protein	NN	I-NP	O
clearance	clearance	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
minutes	minute	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
data	datum	NNS	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
microvascular	microvascular	JJ	I-NP	O
permeability	permeability	NN	I-NP	O

The	The	DT	B-NP	O
shift	shift	NN	I-NP	O
from	from	IN	B-PP	O
complex	complex	NN	B-NP	O
I	I	CD	I-NP	O
to	to	TO	B-PP	O
complex	complex	NN	B-NP	O
II	II	CD	I-NP	O
seen	see	VBN	B-VP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
SCM	BEGIN-SCM	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
producer	producer	NN	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
upon	upon	IN	B-PP	O
activation	activation	NN	B-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	I-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
cyclosporin	cyclosporin	NN	B-NP	O
A	A	NN	I-NP	O

Database	Database	NN	B-NP	O
searches	search	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
similarity	similarity	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
families	family	NNS	I-NP	O
of	of	IN	B-PP	O
serine	BEGIN-serine	NN	B-NP	B
proteases	proteases-INSIDE	NN	I-NP	I
,	,	,	O	O
in	in	IN	B-PP	O
particular	particular	JJ	B-ADJP	O
the	the	DT	B-NP	O
trypsin	BEGIN-trypsin	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
proteases	proteases-INSIDE	NN	I-NP	I
,	,	,	O	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glandular	BEGIN-glandular	JJ	I-NP	B
kallikrein	kallikrein	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I
(	(	(	O	O
including	include	VBG	B-PP	O
prostate	BEGIN-prostate	NN	B-NP	B
-	-	HYPH	B-NP	I
specific	specific	JJ	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
,	,	,	O	O
nerve	BEGIN-nerve	NN	B-NP	B
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
epidermal	BEGIN-epidermal	JJ	B-NP	B
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
activators	activator	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
kringle	BEGIN-kringle	JJ	I-NP	B
family	family	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
(	(	(	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
tissue	tissue	NN	I-NP	I
plasminogen	plasminogen	NN	I-NP	I
activator	activator-INSIDE	NN	I-NP	I
and	and	CC	O	O
human	BEGIN-human	JJ	B-NP	B
hepatocyte	hepatocyte	NN	I-NP	I
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
activator	activator-INSIDE	NN	I-NP	I
)	)	)	O	O

UPR	UPR	NN	B-NP	O
elements	element	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
ER	ER	NN	I-NP	O
chaperone	chaperone	NN	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
yeast	BEGIN-yeast	JJ	B-NP	B
KAR1	KAR1-INSIDE	NN	I-NP	I
(	(	(	O	O
BiP	BEGIN-BiP-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
mammalian	BEGIN-mammalian	JJ	B-NP	B
GRP1	BEGIN-GRP1-INSIDE-INSIDE	NN	I-NP	I
(	(	(	O	O
BiP	BEGIN-BiP-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
GRP1	BEGIN-GRP1-INSIDE	NN	B-NP	B
,	,	,	O	O
function	function	NN	B-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
analogous	analogous	JJ	I-NP	O
manner	manner	NN	I-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
FKB1	BEGIN-FKB1-INSIDE	NN	B-NP	B

No	No	DT	B-NP	O
bafilomycin	bafilomycin	NN	I-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
ATPase	BEGIN-ATPase-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
vacuolar	vacuolar	JJ	I-NP	O
fraction	fraction	NN	I-NP	O

The	The	DT	B-NP	O
kinase	kinase	NN	I-NP	O
domains	domain	NNS	I-NP	O
encoded	encode	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
COOH	COOH	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
moiety	moiety	NN	I-NP	O
are	be	VBP	B-VP	O
1	1	CD	B-NP	O
conserved	conserve	VBN	B-VP	O
;	;	:	O	O
the	the	DT	B-NP	O
NH1	NH1	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
moieties	moiety	NNS	I-NP	O
are	be	VBP	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
homologous	homologous	JJ	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
may	may	MD	B-VP	O
encode	encode	VB	I-VP	O
sequences	sequence	NNS	B-NP	O
conferring	confer	VBG	B-VP	O
differential	differential	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
kinases	kinase	NNS	I-NP	O

From	From	IN	B-PP	O
this	this	DT	B-NP	O
asymmetry	asymmetry	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
suggested	suggest	VBD	B-VP	O
previously	previously	RB	B-ADVP	O
that	that	IN	B-SBAR	O
GCN1	BEGIN-GCN1-INSIDE	NN	B-NP	B
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
nonequivalent	nonequivalent	JJ	B-ADJP	O
and	and	CC	O	O
possibly	possibly	RB	B-VP	O
overlapping	overlap	VBG	I-VP	O
half	half	RB	B-NP	O
-	-	HYPH	I-NP	O
sites	site	NNS	I-NP	O
(	(	(	O	O
ATGAC	ATGAC	NN	B-NP	O
and	and	CC	O	O
ATGAG	ATGAG	NN	B-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
different	different	JJ	B-NP	O
affinities	affinity	NNS	I-NP	O

The	The	DT	B-NP	O
essential	essential	JJ	I-NP	O
questions	question	NNS	I-NP	O
about	about	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O

DRAP1	BEGIN-DRAP1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
recognized	recognize	VBN	I-VP	O
by	by	IN	B-PP	O
CD1	BEGIN-CD1	NN	B-NP	B
antibodies	antibodies-INSIDE	NN	I-NP	I

YACs	YAC	NNS	B-NP	O
selected	select	VBN	B-VP	O
from	from	IN	B-PP	O
our	our	PRP$	B-NP	O
contig	contig	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
starting	start	VBG	I-NP	O
point	point	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LGMD1B	BEGIN-LGMD1B	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
and	and	CC	O	O
thereby	thereby	RB	B-VP	O
establish	establish	VB	I-VP	O
the	the	DT	B-NP	O
biological	biological	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
muscular	muscular	JJ	B-NP	O
dystrophy	dystrophy	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
limb	limb	NN	I-NP	O
-	-	HYPH	B-NP	O
girdle	girdle	NN	I-NP	O
muscular	muscular	JJ	I-NP	O
dystrophies	dystrophy	NNS	I-NP	O

Acceptability	Acceptability	NN	B-NP	O
of	of	IN	B-PP	O
home	home	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
aid	aid	NN	I-NP	O
to	to	TO	B-PP	O
conception	conception	NN	B-NP	O

Starches	Starch	NNS	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O

The	The	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
biological	biological	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
terminus	terminus	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
impair	impair	VB	I-VP	O
EGF	BEGIN-EGF-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
GTP	BEGIN-GTP	NN	B-NP	B
-	-	HYPH	B-NP	I
Ras	Ras-INSIDE	NN	I-NP	I
and	and	CC	B-PP	O
of	of	IN	B-PP	O
MAP	BEGIN-MAP	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
Sos	BEGIN-Sos-INSIDE	NN	I-NP	B
to	to	TO	B-VP	O
form	form	VB	I-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
activated	activate	VBN	B-NP	O
EGF	BEGIN-BEGIN-EGF-INSIDE	NN	I-NP	B
receptors	receptors-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
tensile	tensile	NN	I-NP	O
strengths	strength	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
adhesive	adhesive	JJ	I-NP	O
luting	lute	VBG	I-NP	O
resin	resin	NN	I-NP	O
'Panavia	'Panavia	NNP	I-NP	O
EX	EX	NNP	I-NP	O
'	'	POS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bovine	bovine	JJ	I-NP	O
dentin	dentin	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
zinc	zinc	NN	I-NP	O
iontophoresis	iontophoresis	NN	I-NP	O

The	The	DT	B-NP	O
Giessener	Giessener	NNP	I-NP	O
Tumordokumentationssystem	Tumordokumentationssystem	NN	I-NP	O
(	(	(	O	O
GTDS	GTDS	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
such	such	PDT	B-NP	O
a	a	DT	I-NP	O
disease	disease	NN	I-NP	O
specific	specific	JJ	I-NP	O
system	system	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
sympathetic	sympathetic	JJ	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
separate	separate	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O

A	A	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
Nlk	BEGIN-Nlk	NN	I-NP	B
message	message-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
during	during	IN	B-PP	O
embryogenesis	embryogenesis	NN	B-NP	O
,	,	,	O	O
detectable	detectable	JJ	B-ADJP	O
at	at	IN	B-PP	O
day	day	NN	B-NP	O
E1	E1	NN	I-NP	O

The	The	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	I-NP	I
HT1	HT1-INSIDE	NN	I-NP	I
antagonist	antagonist	NN	I-NP	O
ondansetron	ondansetron	NN	I-NP	O
reduced	reduce	VBD	B-VP	O
alcohol	alcohol	NN	B-NP	O
intake	intake	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
medium	medium	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
preferring	prefer	VBG	B-VP	O
rats	rat	NNS	B-NP	O
at	at	IN	B-PP	O
doses	dose	NNS	B-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	O	O
kg	kg	NN	B-NP	O

In	In	IN	B-PP	O
humans	human	NNS	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
TEWL	TEWL	NN	B-NP	O
on	on	IN	B-PP	O
both	both	CC	O	O
forearm	forearm	NN	B-NP	O
and	and	CC	I-NP	O
thigh	thigh	NN	I-NP	O
in	in	IN	B-PP	O
CS	CS	NN	B-NP	O
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
patients	patient	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	B-NP	O
CS	CS	NN	I-NP	O
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

Southern	Southern	NN	B-NP	O
hybridization	hybridization	NN	I-NP	O
of	of	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
from	from	IN	B-PP	O
WT	WT	NN	B-NP	O
and	and	CC	I-NP	O
Lp	BEGIN-Lp-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Lp	BEGIN-Lp-INSIDE	NN	B-NP	B
embryos	embryo	NNS	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
specific	specific	JJ	B-NP	O
rearrangements	rearrangement	NNS	I-NP	O
at	at	IN	B-PP	O
or	or	CC	I-PP	O
near	near	IN	I-PP	O
the	the	DT	B-NP	O
Nhlh1	BEGIN-Nhlh1	NN	I-NP	B
locus	locus-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
Northern	Northern	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
blotting	blotting	NN	I-NP	O
and	and	CC	I-NP	O
RT	RT	NN	I-NP	O
-	-	HYPH	B-NP	O
PCR	PCR	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
Nhlh1	BEGIN-Nhlh1	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
and	and	CC	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
Nhlh1	BEGIN-Nhlh1	NN	B-NP	B
mRNAs	mRNA-INSIDE	NNS	I-NP	I
produced	produce	VBN	B-VP	O
in	in	IN	B-PP	O
WT	WT	NN	B-NP	O
and	and	CC	I-NP	O
Lp	BEGIN-Lp-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Lp	BEGIN-Lp-INSIDE	NN	B-NP	B
embryos	embryo	NNS	I-NP	O
were	be	VBD	B-VP	O
indistinguishable	indistinguishable	JJ	B-ADJP	O

Mutations	Mutation	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
PTEN	PTEN	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
behavioral	behavioral	JJ	I-NP	O
avoidance	avoidance	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
as	as	RB	B-ADJP	O
susceptible	susceptible	JJ	I-ADJP	O
to	to	TO	B-PP	O
experimental	experimental	JJ	B-NP	O
demand	demand	NN	I-NP	O
as	as	IN	B-SBAR	O
other	other	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
approach	approach	NN	B-NP	O
behaviors	behavior	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
influenced	influence	VBN	I-VP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
mapped	map	VBD	B-VP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
hnRNP	BEGIN-BEGIN-hnRNP	NN	I-NP	B
A1	A1-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
site	site-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
U1	BEGIN-U1	NN	B-NP	B
RNA	RNA-INSIDE	NN	I-NP	I
and	and	CC	O	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
p1CRS	BEGIN-p1BEGIN-CRS-INSIDE-INSIDE	NN	B-NP	B
(	(	(	O	O
hnRNP	BEGIN-hnRNP	NN	B-NP	B
A1	A1-INSIDE	NN	I-NP	I
)	)	)	O	O
binding	binding	NN	B-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
site	site	NN	I-NP	O
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
CRS	BEGIN-CRS-INSIDE	NN	B-NP	B
function	function	NN	I-NP	O

Biochemical	Biochemical	JJ	B-NP	O
experiments	experiment	NNS	I-NP	O
and	and	CC	O	O
genome	genome	NN	B-NP	O
sequencing	sequencing	NN	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
prokaryotic	prokaryotic	JJ	I-NP	O
cell	cell	NN	I-NP	O
and	and	CC	I-NP	O
genome	genome	NN	I-NP	O
organization	organization	NN	I-NP	O
,	,	,	O	O
basal	basal	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
elements	element	NNS	I-NP	O
of	of	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
domain	domain	NN	I-NP	O
Archaea	Archaea	NN	I-NP	O
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
TATA	TATA	NN	B-NP	O
box	box	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
,	,	,	O	O
RNA	BEGIN-RNA	NN	B-NP	B
polymerase	polymerase-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
TBP	BEGIN-TBP-INSIDE	NN	B-NP	B
,	,	,	O	O
TFIIB	BEGIN-TFIIB-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
TFIIS	BEGIN-TFIIS-INSIDE	NN	B-NP	B
)	)	)	O	O
are	be	VBP	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
eukaryotic	eukaryotic	JJ	I-NP	O
type	type	NN	I-NP	O

MGF	BEGIN-MGF-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytokine	BEGIN-cytokine	NN	I-NP	B
-	-	HYPH	B-VP	I
regulated	regulate	VBN	B-NP	I
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
gene	gene	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

One	One	CD	B-NP	O
month	month	NN	I-NP	O
after	after	IN	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
1I	1I	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
cats	cat	NNS	I-NP	O
evaluated	evaluate	VBN	B-VP	O
were	be	VBD	B-VP	O
clinically	clinically	RB	I-VP	O
improved	improve	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
(	(	NN	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
cats	cat	NNS	I-NP	O
evaluated	evaluate	VBN	B-VP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
serum	serum	NN	I-NP	O
T1	T1	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
cats	cat	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
remained	remain	VBD	B-VP	O
hyperthyroxinemic	hyperthyroxinemic	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
cats	cat	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
hypothyroxinemic	hypothyroxinemic	JJ	B-ADJP	O

Csk	BEGIN-Csk-INSIDE	NN	B-NP	B
(	(	(	O	O
C	BEGIN-C	NN	B-NP	B
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
Src	BEGIN-Src-INSIDE	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	BEGIN-protein	JJ	I-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
phosphorylates	phosphorylate	VBZ	B-VP	O
Src	BEGIN-BEGIN-Src-INSIDE	NN	B-NP	B
family	family	NN	I-NP	O
member	member	NN	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
tails	tails-INSIDE	NN	I-NP	I
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
downregulation	downregulation	NN	B-NP	O
of	of	IN	B-PP	O
Src	BEGIN-Src-INSIDE	NN	B-NP	B
family	family	NN	I-NP	O
members	member	NNS	I-NP	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
enoyl	BEGIN-enoyl	NN	B-NP	B
-	-	HYPH	B-NP	I
ACP	ACP	NN	I-NP	I
reductase	reductase	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
steady	steady	JJ	I-NP	O
-	-	HYPH	I-NP	O
state	state	NN	I-NP	O
levels	level	NNS	I-NP	O
during	during	IN	B-PP	O
seed	seed	NN	B-NP	O
development	development	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
enzyme	enzyme	NN	B-NP	O
activity	activity	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
storage	storage	NN	B-NP	O
lipid	lipid	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O

Lung	Lung	NN	B-NP	O
transplantation	transplantation	NN	I-NP	O
is	be	VBZ	B-VP	O
warranted	warrant	VBN	I-VP	O
for	for	IN	B-PP	O
stable	stable	JJ	B-NP	O
,	,	,	I-NP	O
ventilator	ventilator	NN	I-NP	O
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
recipients	recipient	NNS	I-NP	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
myocyte	BEGIN-myocyte	NN	I-NP	B
-	-	HYPH	B-NP	I
specific	specific	JJ	I-NP	I
enhancer	enhancer	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
that	that	WDT	B-NP	O
recognizes	recognize	VBZ	B-VP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
element	element	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
genes	gene	NNS	I-NP	O

The	The	DT	B-NP	O
magnesium	magnesium	NN	I-NP	O
content	content	NN	I-NP	O
in	in	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
estimated	estimate	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
interaction	interaction	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
ion	ion	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Percoll	Percoll	NN	I-NP	O
(	(	(	O	O
R	R	NN	B-NP	O
)	)	)	O	O
media	medium	NNS	B-NP	O

The	The	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
such	such	JJ	B-NP	O
guidelines	guideline	NNS	I-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
on	on	IN	B-PP	O
both	both	CC	O	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
scientific	scientific	JJ	I-NP	O
grounds	ground	NNS	I-NP	O

This	This	DT	B-NP	O
activity	activity	NN	I-NP	O
creates	create	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
staggered	stagger	VBD	B-VP	O
cut	cut	VBN	I-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
OH	OH	NN	I-NP	O
overhangs	overhang	NNS	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1S	BEGIN-1S	NN	I-NP	B
rRNA	rRNA	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
omega	omega	SYM	B-NP	O
-	-	HYPH	O	O
strains	strain	NNS	B-NP	O

Herewith	Herewith	IN	B-PP	O
C.	C.	NNP	B-NP	O
psittaci	psittaci	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
positive	positive	JJ	I-NP	O
samples	sample	NNS	I-NP	O

Chem	Chem	NNP	B-NP	O

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
endocrine	endocrine	JJ	I-NP	O
neoplasia	neoplasia	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
MEN1	BEGIN-MEN1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
heritable	heritable	JJ	I-NP	O
predisposition	predisposition	NN	I-NP	O
to	to	TO	B-PP	O
endocrine	endocrine	JJ	B-NP	O
tumours	tumour	NNS	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O

Is	Be	VBZ	O	O
it	it	PRP	B-NP	O
time	time	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
wine	wine	NN	I-NP	O
trial	trial	NN	I-NP	O

We	We	PRP	B-NP	O
previously	previously	RB	B-ADVP	O
identified	identify	VBD	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
L	L	NN	I-NP	O
-	-	HYPH	O	O
X	X	SYM	O	O
-	-	HYPH	O	O
X	X	SYM	B-NP	O
-	-	HYPH	B-NP	O
L	L	NN	I-NP	O
-	-	HYPH	I-NP	O
F	F	NN	I-NP	O
sequence	sequence	NN	I-NP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Gag	BEGIN-Gag	NN	I-NP	B
precursor	precursor-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
virion	virion	NN	I-NP	O
association	association	NN	I-NP	O
motif	motif	NN	I-NP	O
for	for	IN	B-PP	O
HIV	BEGIN-HIV	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
Vpr	Vpr-INSIDE	NN	I-NP	I

Three	Three	CD	B-NP	O
patients	patient	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
amphotericin	amphotericin	NN	B-NP	O
B	B	NN	I-NP	O
,	,	,	O	O
single	single	JJ	B-NP	O
course	course	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
multiple	multiple	JJ	B-NP	O
courses	course	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
other	other	JJ	B-NP	O
antifungal	antifungal	JJ	I-NP	O
agents	agent	NNS	I-NP	O
(	(	(	O	O
hydroxystilbamidine	hydroxystilbamidine	NN	B-NP	O
and	and	CC	O	O
miconazole	miconazole	NN	B-NP	O
)	)	)	O	O
have	have	VBP	B-VP	O
all	all	DT	O	O
relapsed	relapse	VBN	B-VP	O

The	The	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
acetylation	acetylation	NN	B-NP	O
of	of	IN	B-PP	O
Tat	BEGIN-Tat-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
lysine	lysine	NN	I-NP	O
motif	motif	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
RKKRRQ	RKKRRQ	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
basic	basic	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
motif	motif	NN	I-NP	O
of	of	IN	B-PP	O
Tat	BEGIN-Tat-INSIDE	NN	B-NP	B

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
Torpedo	Torpedo	NNP	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
single	single	JJ	I-NP	O
transcript	transcript	NN	I-NP	O
is	be	VBZ	B-VP	O
seen	see	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
expresses	express	VBZ	B-VP	O
several	several	JJ	B-NP	O
mRNAs	mRNA	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
different	different	JJ	B-NP	O
isoforms	isoform	NNS	I-NP	O

trans	trans	AFX	B-NP	O
-	-	HYPH	I-NP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV	BEGIN-HIV	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
LTR	LTR-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
the	the	DT	B-NP	O
HIV	BEGIN-HIV	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
Tat	Tat-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
HTLV	BEGIN-HTLV	NN	I-NP	B
-	-	HYPH	B-NP	I
I	I	NN	I-NP	I
Tax	Tax	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
different	different	JJ	B-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O

NSD1	BEGIN-NSD1-INSIDE	NN	B-NP	B
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
SET	BEGIN-SET	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
PHD	PHD	NN	I-NP	O
fingers	finger	NNS	I-NP	O

After	After	IN	B-PP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
labeled	label	VBN	I-NP	O
erythrocytes	erythrocyte	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O

Latex	Latex	JJ	B-NP	O
products	product	NNS	I-NP	O
(	(	(	O	O
gloves	glove	NNS	B-NP	O
,	,	,	O	O
balloons	balloon	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
condoms	condom	NNS	B-NP	O
)	)	)	O	O
directly	directly	RB	B-ADVP	O
bound	bind	VBD	B-VP	O
IgE	BEGIN-IgE-INSIDE	NN	B-NP	B
from	from	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
patients	patient	NNS	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
in	in	IN	B-PP	O
T1	BEGIN-T1	NN	B-NP	B
RNA	RNA	NN	I-NP	I
polymerase	polymerase-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
not	not	RB	O	O
free	free	JJ	B-ADJP	O
of	of	IN	B-PP	O
steric	steric	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ternary	ternary	JJ	I-NP	O
complex	complex	NN	I-NP	O
and	and	CC	O	O
not	not	RB	B-ADJP	O
available	available	JJ	I-ADJP	O
for	for	IN	B-PP	O
structure	structure	NN	B-NP	O
formation	formation	NN	I-NP	O
until	until	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
bases	base	NNS	I-NP	O
away	away	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
polymerization	polymerization	NN	B-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
infantile	infantile	JJ	B-NP	O
undernutrition	undernutrition	NN	I-NP	O
on	on	IN	B-PP	O
adult	adult	JJ	B-NP	O
sucrose	sucrose	NN	I-NP	O
solution	solution	NN	I-NP	O
consumption	consumption	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O

The	The	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
P	BEGIN-P	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
(	(	(	O	I
1	1	CD	B-NP	I
beta	beta	NN	I-NP	I
)	)	)	O	I
gene	gene-INSIDE	NN	B-NP	I
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
transcription	transcription	NN	I-NP	O
system	system	NN	I-NP	O
using	use	VBG	B-VP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
bovine	bovine	JJ	B-NP	O
adrenal	adrenal	JJ	I-NP	O
cortex	cortex	NN	I-NP	O

The	The	DT	B-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
active	active	JJ	B-ADJP	O
(	(	(	O	O
MA	MA	JJ	B-ADJP	O
)	)	)	O	O
individuals	individual	NNS	B-NP	O
rose	rise	VBD	B-VP	O
earlier	earlier	RBR	B-ADVP	O
and	and	CC	O	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
bed	bed	NN	B-NP	O
earlier	earlier	RBR	B-ADVP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
active	active	JJ	B-ADJP	O
(	(	(	O	O
EA	EA	NN	B-NP	O
)	)	)	O	O
individuals	individual	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
former	former	JJ	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
longer	long	JJR	I-NP	O
sleep	sleep	JJ	I-NP	O
length	length	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
during	during	IN	B-PP	O
days	day	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
morning	morning	NN	I-NP	O
shift	shift	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
opposite	opposite	NN	I-NP	O
was	be	VBD	B-VP	O
true	true	JJ	B-ADJP	O
for	for	IN	B-PP	O
afternoon	afternoon	NN	B-NP	O
and	and	CC	I-NP	O
night	night	NN	I-NP	O
shifts	shift	NNS	I-NP	O

Appl	Appl	NNP	B-NP	O

The	The	DT	B-NP	O
CHED	BEGIN-CHED	JJ	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
includes	include	VBZ	B-VP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	O
ATP	ATP	NN	I-NP	O
binding	binding	NN	I-NP	O
and	and	CC	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
domains	domain	NNS	I-NP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
kinases	kinase	NNS	B-NP	O
,	,	,	O	O
displays	display	VBZ	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
identically	identically	RB	I-NP	O
aligned	align	VBN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
cdc1	BEGIN-cdc1	NN	I-NP	B
-	-	HYPH	B-VP	I
related	relate	VBN	B-NP	I
kinases	kinases-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
considerably	considerably	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
at	at	IN	B-PP	O
its	its	PRP$	B-NP	O
amino	amino	NN	I-NP	O
and	and	CC	I-NP	O
carboxyl	carboxyl	NN	I-NP	O
termini	terminus	NNS	I-NP	O

These	These	DT	B-NP	O
include	include	VBP	B-VP	O
urinalysis	urinalysis	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
X	X	NN	I-NP	O
-	-	HYPH	B-NP	O
P	P	NN	I-NP	O
,	,	,	O	O
ECG	ECG	NN	B-NP	O
,	,	,	O	O
hematological	hematological	JJ	B-NP	O
examinations	examination	NNS	I-NP	O
(	(	(	O	O
RBC	RBC	NNP	B-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
,	,	,	O	O
Ht	Ht	NNP	B-NP	O
,	,	,	O	O
Hb	BEGIN-Hb-INSIDE	NNP	B-NP	B
,	,	,	O	O
PLT	PLT	NNP	B-NP	O
and	and	CC	O	O
ESR	ESR	NNP	B-NP	O
)	)	)	O	O
and	and	CC	O	O
biochemical	biochemical	JJ	B-NP	O
tests	test	NNS	I-NP	O
(	(	(	O	O
AST	BEGIN-AST-INSIDE	NN	B-NP	B
,	,	,	O	O
ALT	BEGIN-ALT-INSIDE	NN	B-NP	B
,	,	,	O	O
ALP	BEGIN-ALP-INSIDE	NN	B-NP	B
,	,	,	O	O
gamma	BEGIN-gamma	NN	B-NP	B
GTP	GTP-INSIDE	NN	I-NP	I
,	,	,	O	O
LDH	BEGIN-LDH-INSIDE	NN	B-NP	B
,	,	,	O	O
CPK	BEGIN-CPK-INSIDE	NN	B-NP	B
,	,	,	O	O
Chol	Chol	NN	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
-	-	HYPH	I-NP	O
Bil	Bil	NN	I-NP	O
,	,	,	O	O
TP	TP	NN	B-NP	O
,	,	,	O	O
Alb	BEGIN-Alb-INSIDE	NN	B-NP	B
,	,	,	O	O
TG	TG	NN	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
,	,	,	O	O
Cr	Cr	NN	B-NP	O
,	,	,	O	O
Glu	Glu	NN	B-NP	O
,	,	,	O	O
Na	Na	NN	B-NP	O
,	,	,	O	O
K	K	NN	B-NP	O
,	,	,	O	O
Ca	Ca	NN	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
and	and	CC	O	O
CRP	BEGIN-CRP-INSIDE	NN	B-NP	B
)	)	)	O	O

We	We	PRP	B-NP	O
challenge	challenge	VBP	B-VP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
consecutive	consecutive	JJ	I-NP	O
ragweed	ragweed	NN	I-NP	O
(	(	(	O	O
RW	RW	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	O	O
allergic	allergic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
hay	hay	NN	B-NP	O
fever	fever	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
graded	grade	VBN	B-NP	O
increasing	increase	VBG	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
ragweed	ragweed	NN	B-NP	O
extract	extract	NN	I-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
and	and	CC	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
(	(	(	O	O
ER	ER	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
late	late	JJ	B-NP	O
(	(	(	I-NP	O
LPR	LPR	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
rechallenge	rechallenge	NN	B-NP	O
reactions	reaction	NNS	I-NP	O
(	(	(	O	O
RCRs	RCR	NNS	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
nasal	nasal	JJ	B-NP	O
challenge	challenge	NN	I-NP	O

Vasodilator	Vasodilator	NN	B-NP	O
and	and	CC	I-NP	O
hypotensive	hypotensive	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
optical	optical	JJ	I-NP	O
isomers	isomer	NNS	I-NP	O
of	of	IN	B-PP	O
nicardipine	nicardipine	NN	B-NP	O
(	(	(	O	O
YC	YC	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
Ca1+	Ca1+	NN	I-NP	O
-	-	HYPH	O	O
antagonist	antagonist	NN	B-NP	O

The	The	DT	B-NP	O
encoded	encode	VBN	I-NP	O
protein	protein	NN	I-NP	O
contains	contain	VBZ	B-VP	O
an	an	DT	B-NP	O
amino	amino	JJ	I-NP	O
terminal	terminal	JJ	I-NP	O
PDZ	BEGIN-PDZ-INSIDE	NN	I-NP	B
domain	domain	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
predicted	predict	VBN	I-NP	O
coiled	coil	VBN	I-NP	O
-	-	HYPH	I-NP	O
coil	coil	NN	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PEST	PEST	NN	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
carboxy	carboxy	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
SAM	SAM	NN	I-NP	O
domain	domain	NN	I-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
ends	end	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
P	BEGIN-P-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
O	BEGIN-O	NN	I-NP	B
gene	gene	NN	I-NP	I
mRNAs	mRNAs-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
separated	separate	VBN	I-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
pairs	pair	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
template	template	NN	I-NP	O

Those	Those	DT	B-NP	O
diagnosed	diagnose	VBN	B-VP	O
as	as	IN	B-PP	O
having	have	VBG	B-VP	O
affective	affective	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
DSM	DSM	NN	B-NP	O
-	-	HYPH	I-NP	O
IIIR	IIIR	NN	I-NP	O
criteria	criterion	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
affective	affective	JJ	I-NP	O
suicide	suicide	NN	I-NP	O
attempters	attempter	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
leukotriene	BEGIN-leukotriene	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
antagonist	antagonist	NN	I-NP	O
zafirlukast	zafirlukast	NN	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
sulfur	sulfur	NN	B-NP	O
dioxide	dioxide	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
bronchoconstriction	bronchoconstriction	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
asthma	asthma	NN	B-NP	O

The	The	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
sequence	sequence-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
features	feature	VBZ	B-VP	O
an	an	DT	B-NP	O
acidic	acidic	JJ	I-NP	O
domain	domain	NN	I-NP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
sequence	sequence	NN	B-NP	O
blocks	block	NNS	I-NP	O
displaying	display	VBG	B-VP	O
limited	limited	JJ	B-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
positionally	positionally	RB	B-NP	O
equivalent	equivalent	JJ	I-NP	O
regions	region	NNS	I-NP	O
in	in	IN	B-PP	O
sigma	BEGIN-sigma	NN	B-NP	B
factors	factors-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
eubacteria	eubacteria	NNS	B-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
mitochondria	mitochondrion	NNS	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
thus	thus	RB	I-VP	O
cloned	clone	VBN	I-VP	O
two	two	CD	B-NP	O
yeast	yeast	NN	I-NP	O
homologs	homolog	NNS	I-NP	O
of	of	IN	B-PP	O
mammalian	BEGIN-mammalian	JJ	B-NP	B
p1	p1-INSIDE	NN	I-NP	I

A	A	DT	B-NP	O
phase	phase	NN	I-NP	O
II	II	CD	I-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
on	on	IN	B-PP	O
MDS	MDS	NN	B-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cooperative	cooperative	JJ	I-NP	O
study	study	NN	I-NP	O
with	with	IN	B-PP	O
orally	orally	RB	B-NP	O
administrable	administrable	JJ	I-NP	O
ara	ara	AFX	I-NP	O
-	-	HYPH	I-NP	O
C	C	NN	I-NP	O
analogue	analogue	NN	I-NP	O
,	,	,	O	O
PLAC	PLAC	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
cytidine	BEGIN-cytidine	NN	B-NP	B
deaminase	deaminase-INSIDE	NN	I-NP	I
and	and	CC	O	O
had	have	VBD	B-VP	O
shown	show	VBN	I-VP	O
an	an	DT	B-NP	O
anti	anti	AFX	I-NP	O
-	-	HYPH	I-NP	O
tumor	tumor	NN	I-NP	O
activity	activity	NN	I-NP	O
on	on	IN	B-PP	O
various	various	JJ	B-NP	O
experimental	experimental	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
route	route	NN	I-NP	O

The	The	DT	B-NP	O
arrangement	arrangement	NN	I-NP	O
of	of	IN	B-PP	O
amino	amino	JJ	B-NP	O
acids	acid	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
helix	helix	NN	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
helix	helix	NN	I-NP	O
1	1	CD	B-NP	O
regions	region	NNS	I-NP	O
is	be	VBZ	B-VP	O
quite	quite	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
Mxi	BEGIN-Mxi-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Mad	BEGIN-Mad-INSIDE	NN	I-NP	B
,	,	,	O	O
but	but	CC	O	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
E1F	BEGIN-E1F	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
DP	BEGIN-DP	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Platelets	Platelet	NNS	B-NP	O
and	and	CC	I-NP	O
RBCs	RBC	NNS	I-NP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
animal	animal	NN	I-NP	O
were	be	VBD	B-VP	O
labeled	label	VBN	I-VP	O
with	with	IN	B-PP	O
1Cr	1Cr	NN	B-NP	O
and	and	CC	I-NP	O
1mTc	1mTc	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
were	be	VBD	B-VP	O
rapidly	rapidly	RB	I-VP	O
injected	inject	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
while	while	IN	B-SBAR	O
blood	blood	NN	B-NP	O
was	be	VBD	B-VP	O
sampled	sample	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ascending	ascending	NN	I-NP	O
aorta	aorta	NN	I-NP	O

PDGF	BEGIN-PDGF-INSIDE	NN	B-NP	B
stimulated	stimulate	VBD	B-VP	O
CDK1	BEGIN-CDK1-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
mesangial	mesangial	JJ	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
(	(	(	O	O
kip1	kiBEGIN-p1-INSIDE	NN	B-NP	I
)	)	)	O	O
cyclin	cyclin	NN	B-NP	O
kinase	kinase	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
protein	protein	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
cytochrome	BEGIN-cytochrome	NN	B-NP	B
P	P	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
1A1	1A1-INSIDE	NN	I-NP	I
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cormorant	cormorant	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Ah	BEGIN-Ah	JJ	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
process	process	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
TCDD	TCDD	NN	B-NP	O
and	and	CC	I-NP	O
related	related	JJ	I-NP	O
chemicals	chemical	NNS	I-NP	O
exert	exert	VBP	B-VP	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
toxicities	toxicity	NNS	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
activated	activate	VBN	I-VP	O

In	In	IN	B-PP	O
gel	gel	NN	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
binding	binding	NN	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
ATPC	BEGIN-ATPC	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
low	low	JJ	B-NP	O
binding	binding	NN	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
CBF	BEGIN-CBF-INSIDE	NN	B-NP	B
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
tissue	tissue	NN	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
AtpC	BEGIN-AtpC-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
opposite	opposite	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
extracts	extract	NNS	B-NP	O
from	from	IN	B-PP	O
tissues	tissue	NNS	B-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
AtpC	BEGIN-AtpC-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
levels	level	NNS	I-NP	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
testicular	testicular	JJ	I-NP	O
germ	germ	NN	I-NP	O
cell	cell	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
male	male	NN	I-NP	O
is	be	VBZ	B-VP	O
reported	report	VBN	I-VP	O

Using	Use	VBG	B-VP	O
green	BEGIN-green	JJ	B-NP	B
fluorescent	fluorescent	JJ	I-NP	I
protein	protein-INSIDE	JJ	I-NP	I
fusions	fusion	NNS	I-NP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
SYT	BEGIN-SYT-INSIDE	NN	I-NP	B
,	,	,	O	O
SSX	BEGIN-SSX-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
SYT	BEGIN-SYT-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
SSX	BEGIN-SSX-INSIDE	NN	I-NP	B
proteins	protein	NNS	I-NP	O
are	be	VBP	B-VP	O
nuclear	nuclear	JJ	B-NP	O
proteins	protein	NNS	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
are	be	VBP	B-VP	O
deficient	deficient	JJ	B-ADJP	O
in	in	IN	B-PP	O
production	production	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
O	BEGIN-O	NN	I-NP	B
-	-	HYPH	I-NP	I
antigen	antigen	NN	I-NP	I
polymerase	polymerase-INSIDE	NN	I-NP	I
and	and	CC	O	O
were	be	VBD	B-VP	O
termed	term	VBN	I-VP	O
rfc	BEGIN-rfc	NN	B-NP	B
mutants	mutants-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
program	program	NN	I-NP	O
for	for	IN	B-PP	O
myogenic	myogenic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
is	be	VBZ	B-VP	O
subject	subject	JJ	B-ADJP	O
to	to	TO	B-PP	O
negative	negative	JJ	B-NP	O
control	control	NN	I-NP	O
by	by	IN	B-PP	O
several	several	JJ	B-NP	O
peptide	peptide	NN	I-NP	O
growth	growth	NN	I-NP	O
factors	factor	NNS	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
mutationally	mutationally	RB	B-NP	O
activated	activate	VBN	I-NP	O
ras	BEGIN-ras	NN	I-NP	B
oncogenes	oncogenes-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
persistently	persistently	RB	B-ADVP	O
activate	activate	VBP	B-VP	O
intracellular	intracellular	JJ	B-NP	O
cascades	cascade	NNS	I-NP	O
normally	normally	RB	B-VP	O
triggered	trigger	VBN	I-VP	O
by	by	IN	B-PP	O
specific	specific	JJ	B-NP	O
growth	growth	NN	I-NP	O
factors	factor	NNS	I-NP	O

The	The	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
PITSLRE	BEGIN-PITSLRE	NN	B-NP	B
beta	beta	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
protein	protein	NN	B-NP	O
kinase	kinase	NN	I-NP	O
(	(	(	O	O
PK	PK	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
supergene	supergene	NN	I-NP	O
family	family	NN	I-NP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
master	BEGIN-master	JJ	I-NP	B
mitotic	mitotic	JJ	I-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
p1cdc1	BEGIN-p1-INSIDEcdc1	NN	B-NP	I

By	By	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
usage	usage	NN	I-NP	O
and	and	CC	O	O
exon	exon	NN	B-NP	O
splicing	splicing	NN	I-NP	O
,	,	,	O	O
each	each	DT	B-NP	O
ROR	BEGIN-ROR	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
generates	generate	VBZ	B-VP	O
several	several	JJ	B-NP	O
isoforms	isoform	NNS	I-NP	O
that	that	WDT	B-NP	O
differ	differ	VBP	B-VP	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
their	their	PRP$	B-NP	O
amino	amino	NN	I-NP	O
terminus	terminus	NN	I-NP	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
LjEmx	BEGIN-LjEmx-INSIDE	NN	B-NP	B
changed	change	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
during	during	IN	B-PP	O
embryogenesis	embryogenesis	NN	B-NP	O
;	;	:	O	O
expression	expression	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
neural	neural	JJ	I-NP	O
tube	tube	NN	I-NP	O
and	and	CC	I-NP	O
mesoderm	mesoderm	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
secondarily	secondarily	RB	I-VP	O
downregulated	downregulate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
secondarily	secondarily	RB	B-ADVP	O
in	in	IN	B-PP	O
cranial	cranial	JJ	B-NP	O
nerve	nerve	NN	I-NP	O
ganglia	ganglia	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
craniofacial	craniofacial	JJ	I-NP	O
mesenchyme	mesenchyme	NN	I-NP	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
antisense	BEGIN-antisense	JJ	B-NP	B
TGF	TGF	NN	I-NP	I
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
type	type	NN	I-NP	I
II	II	CD	I-NP	I
receptor	receptor	NN	I-NP	I
oligodeoxynucleotides	oligodeoxynucleotide	NNS	I-NP	I
(	(	(	O	I
1	1	CD	B-NP	I
microM	microM	NN	I-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
branching	branching	NN	B-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
scrambled	scramble	VBN	B-NP	O
and	and	CC	I-NP	O
mismatched	mismatch	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
controls	control	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
TGF	BEGIN-TGF	NN	B-NP	B
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
,	,	,	O	I
type	type	NN	B-NP	I
II	II	CD	I-NP	I
receptor	receptor	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
and	and	CC	O	O
its	its	PRP$	B-NP	O
protein	protein	NN	I-NP	O
expression	expression	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Despite	Despite	IN	B-PP	O
this	this	DT	B-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
YEpFAS1	BEGIN-YEpFAS1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
complement	complement	VB	I-VP	O
a	a	DT	B-NP	O
fas1	BEGIN-fas1-INSIDE	NN	I-NP	B
mutation	mutation	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
enoyl	BEGIN-enoyl	NN	I-NP	B
reductase	reductase-INSIDE	NN	I-NP	I
domain	domain	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
PDGF	BEGIN-PDGF-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
was	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
to	to	TO	B-PP	O
Tyr	Tyr	NN	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
;	;	:	O	O
Tyr	Tyr	NN	B-NP	O
1	1	CD	I-NP	O
is	be	VBZ	B-VP	O
exposed	expose	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
peptide	peptide	NN	I-NP	I
binding	binding	NN	I-NP	I
surface	surface-INSIDE	NN	I-NP	I

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
hydroxytryptamine	hydroxytryptamine	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
HT	HT	NN	I-NP	O
)	)	)	O	O
content	content	NN	B-NP	O
in	in	IN	B-PP	O
platelets	platelet	NNS	B-NP	O
was	be	VBD	B-VP	O
:	:	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
increased	increase	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subgroup	subgroup	NN	I-NP	O
of	of	IN	B-PP	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
social	social	JJ	I-NP	O
alcoholics	alcoholic	NNS	I-NP	O
;	;	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
transiently	transiently	RB	B-ADVP	O
and	and	CC	I-ADVP	O
differently	differently	RB	B-VP	O
altered	alter	VBN	I-VP	O
in	in	IN	B-PP	O
alcoholics	alcoholic	NNS	B-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-VP	O
opiate	opiate	VB	I-VP	O
addicts	addict	NNS	B-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
lowered	lower	VBN	B-VP	O
in	in	IN	B-PP	O
drinking	drink	VBG	B-VP	O
alcoholics	alcoholic	NNS	B-NP	O
and	and	CC	O	O
normal	normal	JJ	B-ADJP	O
in	in	IN	B-PP	O
alcoholics	alcoholic	NNS	B-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
drinking	drink	VBG	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
smoking	smoking	NN	B-NP	O
(	(	(	O	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
occur	occur	VB	I-VP	O
via	via	IN	B-PP	O
MAO	BEGIN-MAO	NN	B-NP	B
-	-	HYPH	B-NP	I
B	B-INSIDE	NN	I-NP	I
inhibition	inhibition	NN	I-NP	O
by	by	IN	B-PP	O
smoke	smoke	NN	B-NP	O
)	)	)	O	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
SMRT	BEGIN-SMRT-INSIDE	NN	B-NP	B
also	also	RB	B-ADVP	O
directly	directly	RB	B-ADVP	O
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
LAZ1	BEGIN-LAZ1-INSIDE	NN	B-NP	B
(	(	(	O	O
BCL	BEGIN-BCL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
POZ	POZ	NN	I-NP	O
/	/	SYM	O	O
Zn	Zn	NN	B-NP	O
finger	finger	NN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
repressor	repressor	NN	I-NP	O
involvedin	involvedin	NN	I-NP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
activating	BEGIN-activating	JJ	B-NP	B
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
cAMP	BEGIN-cAMP	NN	I-NP	B
response	response	NN	I-NP	I
element	element	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
Ca1+	BEGIN-Ca1+	JJ	B-NP	B
/	/	SYM	I-NP	I
calmodulin	calmodulin	NN	I-NP	I
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
protein	protein	NN	I-NP	I
kinases	kinase	NNS	I-NP	I
type	type	NN	I-NP	I
I	I	CD	I-NP	I
,	,	,	I-NP	I
II	II	CD	I-NP	I
,	,	,	O	I
and	and	CC	O	I
IV	IV-INSIDE	NN	B-NP	I

Accordingly	Accordingly	RB	B-ADVP	O
,	,	,	O	O
constitutive	constitutive	JJ	B-NP	O
downregulation	downregulation	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
accessory	accessory	JJ	B-NP	O
molecules	molecule	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MHC	BEGIN-MHC	NN	I-NP	B
class	class	NN	I-NP	I
I	I	CD	I-NP	I
pathway	pathway-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
reveal	reveal	VB	I-VP	O
differences	difference	NNS	B-NP	O
between	between	IN	B-PP	O
H1	BEGIN-H1	NN	B-NP	B
class	class	NN	I-NP	I
I	I	CD	I-NP	I
alleles	alleles-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
antigen	antigen	NN	B-NP	O
presentation	presentation	NN	I-NP	O
not	not	RB	B-VP	O
encountered	encounter	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
levels	level	NNS	I-NP	O
are	be	VBP	B-VP	O
augmented	augmented	JJ	B-ADJP	O

Cross	Cross	NN	B-NP	O
-	-	HYPH	I-NP	O
sectional	sectional	JJ	I-NP	O
studies	study	NNS	I-NP	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
dominate	dominate	VB	I-VP	O

G1	BEGIN-G1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MOL1	BEGIN-MOL1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
stress	stress	NN	B-NP	O
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
from	from	IN	B-PP	O
Fusarium	Fusarium	NNP	B-NP	O
;	;	:	O	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
NAT1	BEGIN-NAT1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
which	which	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
methionine	BEGIN-methionine	NN	I-NP	B
N	N	NN	I-NP	I
-	-	HYPH	B-NP	I
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
;	;	:	O	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
RPL1B	BEGIN-RPL1B	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
ribosomal	BEGIN-ribosomal	JJ	I-NP	B
protein	protein	NN	I-NP	I
L1	L1-INSIDE	NN	I-NP	I
;	;	:	O	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
RSR1	BEGIN-RSR1-INSIDE	NN	B-NP	B
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
ras	BEGIN-ras	NN	I-NP	B
-	-	HYPH	O	I
related	relate	VBN	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
;	;	:	O	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
CYS1	BEGIN-CYS1-INSIDE	NN	B-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
cystathionine	BEGIN-cystathionine	NN	B-NP	B
beta	beta	SYM	O	I
-	-	HYPH	O	I
synthase	synthase-INSIDE	NN	B-NP	I
;	;	:	O	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
ORF1	ORF1	NN	B-NP	O
located	located	JJ	B-ADJP	O
close	close	RB	I-ADJP	O
to	to	TO	B-PP	O
CYS1	BEGIN-CYS1-INSIDE	NN	B-NP	B
;	;	:	O	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
PEM1	BEGIN-PEM1-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
CHO1	BEGIN-CHO1-INSIDE	NN	I-NP	B
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
phosphatidylethanolamine	BEGIN-phosphatidylethanolamine	NN	I-NP	B
methyltransferase	methyltransferase-INSIDE	NN	I-NP	I
;	;	:	O	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
NSR1	BEGIN-NSR1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
signal	signal	NN	I-NP	O
recognition	recognition	NN	I-NP	O
protein	protein	NN	I-NP	O

The	The	DT	B-NP	O
tau	tau	SYM	I-NP	O
v	v	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
Hz	Hz	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
Hz	Hz	NN	I-NP	O

This	This	DT	B-NP	O
action	action	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
antagonized	antagonize	VBN	I-VP	O
by	by	IN	B-PP	O
aminophylline	aminophylline	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
competitive	competitive	JJ	I-NP	O
antagonist	antagonist	NN	I-NP	O
on	on	IN	B-PP	O
P1	BEGIN-P1	NN	B-NP	B
purinoceptors	purinoceptors-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
NPS1	BEGIN-NPS1-INSIDE	NN	B-NP	B
,	,	,	O	O
sequences	sequence	NNS	B-NP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
kinases	kinase	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O

The	The	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
protein	protein	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
lacks	lack	VBZ	B-VP	O
the	the	DT	B-NP	O
UGA	UGA	NNP	I-NP	O
codons	codon	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
MCS	MCS	NN	I-NP	I
cDNA	cDNA-INSIDE	NN	I-NP	I
and	and	CC	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
presumed	presume	VBN	I-VP	O
to	to	TO	I-VP	O
encode	encode	VB	I-VP	O
the	the	DT	B-NP	O
selenocysteine	selenocysteine	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
terminal	terminal	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
mouse	mouse	NN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O

It	It	PRP	B-NP	O
differed	differ	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
by	by	IN	B-PP	O
country	country	NN	B-NP	O
(	(	(	O	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
United	United	NNP	I-NP	O
Kingdom	Kingdom	NNP	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
Portugal	Portugal	NNP	B-NP	O
)	)	)	O	O
and	and	CC	O	O
by	by	IN	B-PP	O
transmission	transmission	NN	B-NP	O
category	category	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
among	among	IN	B-PP	O
homo	homo	NN	B-NP	O
/	/	SYM	I-NP	O
bisexuals	bisexual	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
among	among	IN	B-PP	O
injecting	inject	VBG	B-VP	O
drug	drug	NN	B-NP	O
users	user	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
among	among	IN	B-PP	O
heterosexual	heterosexual	JJ	B-NP	O
subgroup	subgroup	NN	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
definition	definition	NN	I-NP	O
of	of	IN	B-PP	O
bias	bias	NN	B-NP	O
founded	found	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
base	base	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
differential	differential	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
parahippocampal	parahippocampal	JJ	I-NP	O
region	region	NN	I-NP	O
during	during	IN	B-PP	O
verbal	verbal	JJ	B-NP	O
memory	memory	NN	I-NP	O
tasks	task	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
side	side	NN	I-NP	O
activated	activate	VBN	B-VP	O
shifted	shift	VBD	B-VP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
task	task	NN	I-NP	O
employed	employ	VBN	B-VP	O
;	;	:	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
rCBF	rCBF	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
parahippocampal	parahippocampal	JJ	I-NP	O
gyrus	gyrus	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
retrieval	retrieval	NN	B-NP	O
strategy	strategy	NN	I-NP	O
of	of	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
matching	match	VBG	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
rCBF	rCBF	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
parahippocampal	parahippocampal	JJ	I-NP	O
gyrus	gyrus	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
retrieval	retrieval	NN	B-NP	O
strategy	strategy	NN	I-NP	O
of	of	IN	B-PP	O
matching	matching	NN	B-NP	O

Cells	Cell	NNS	B-NP	O
were	be	VBD	B-VP	O
co	co	AFX	O	O
-	-	HYPH	O	O
infected	infect	VBN	B-VP	O
simultaneously	simultaneously	RB	B-ADVP	O
with	with	IN	B-PP	O
IBV	IBV	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	O
FPV	FPV	NN	I-NP	O
(	(	(	O	O
rFPV	rFPV	NN	B-NP	O
)	)	)	O	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
D	D	NN	I-NP	O
-	-	HYPH	B-NP	O
RNA	RNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
rFPV	rFPV	NN	I-NP	O
expressing	express	VBG	B-VP	O
T1	BEGIN-T1	NN	B-NP	B
RNA	RNA	NN	I-NP	I
polymerase	polymerase-INSIDE	NN	I-NP	I
for	for	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
D	D	NN	I-NP	O
-	-	HYPH	B-NP	O
RNA	RNA	NN	I-NP	O
transcript	transcript	NN	I-NP	O
,	,	,	O	O
subsequently	subsequently	RB	B-VP	O
rescued	rescue	VBN	I-VP	O
by	by	IN	B-PP	O
helper	helper	NN	B-NP	O
IBV	IBV	NN	I-NP	O

Antigen	Antigen	NN	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
response	response	NN	I-NP	O
curves	curve	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
cumulative	cumulative	JJ	I-NP	O
dose	dose	NN	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
specific	specific	JJ	B-NP	O
airway	airway	NN	I-NP	O
conductance	conductance	NN	I-NP	O
was	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
and	and	CC	O	O
designated	designate	VBN	B-VP	O
Provocation	Provocation	NN	B-NP	O
Dose	Dose	NN	I-NP	O
(	(	(	O	O
PD1	PD1	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
pharmacokinetic	pharmacokinetic	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
,	,	,	O	O
t1	t1	NN	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
Cltp	Cltp	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
indices	index	NNS	B-NP	O
of	of	IN	B-PP	O
drug	drug	NN	B-NP	O
elimination	elimination	NN	I-NP	O
ability	ability	NN	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O

The	The	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	O
potassium	potassium	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
two	two	CD	I-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
standard	standard	JJ	B-NP	O
HD	HD	NN	I-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
membrane	membrane	NN	I-NP	O
hyperpolarization	hyperpolarization	NN	I-NP	O

The	The	DT	B-NP	O
more	more	RBR	I-NP	O
sustained	sustained	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
cyclofenil	cyclofenil	NN	B-NP	O
on	on	IN	B-PP	O
prolactin	BEGIN-prolactin-INSIDE	NN	B-NP	B
secretion	secretion	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
relapse	relapse	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
oestradiol	oestradiol	NN	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
might	might	MD	B-VP	O
indicate	indicate	VB	I-VP	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
thromboembolism	thromboembolism	NN	B-NP	O
,	,	,	O	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
drug	drug	NN	I-NP	O
has	have	VBZ	B-VP	O
some	some	DT	B-NP	O
advantage	advantage	NN	I-NP	O
over	over	IN	B-PP	O
bromocriptine	bromocriptine	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
postpartum	postpartum	NN	B-NP	O
lactation	lactation	NN	I-NP	O

Therefore	Therefore	RB	B-NP	O
prostaglandin	prostaglandin	NN	I-NP	O
E1	E1	NN	I-NP	O
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	O
F1	F1	NN	I-NP	O
-	-	HYPH	O	O
alpha	alpha	SYM	O	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
stronger	strong	JJR	I-NP	O
uterine	uterine	JJ	I-NP	O
effectiveness	effectiveness	NN	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
a	a	DT	B-NP	O
pronounced	pronounced	JJ	I-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
system	system	NN	I-NP	O

Epithelial	Epithelial	JJ	B-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
activation	activation	NN	I-NP	O
is	be	VBZ	B-VP	O
achieved	achieve	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cooperative	cooperative	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
apparently	apparently	RB	B-NP	O
ubiquitous	ubiquitous	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
factors	factor	NNS	I-NP	O

This	This	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
and	and	CC	I-NP	O
physical	physical	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
suggests	suggest	VBZ	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
yeast	yeast	NN	B-NP	O
RNA	RNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
proteins	protein	NNS	B-NP	O
in	in	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O

In	In	IN	B-PP	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
mean	mean	JJ	B-NP	O
z	z	NN	I-NP	O
-	-	HYPH	B-NP	O
score	score	NN	I-NP	O
for	for	IN	B-PP	O
GFR	GFR	NN	B-NP	O
was	be	VBD	B-VP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
mean	mean	NN	I-NP	O
z	z	NN	I-NP	O
-	-	HYPH	B-NP	O
score	score	NN	I-NP	O
was	be	VBD	B-VP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
kidneys	kidney	NNS	I-NP	O
)	)	)	O	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
Mann	Mann	NNP	B-NP	O
-	-	HYPH	I-NP	O
Whitney	Whitney	NNP	I-NP	O
U	U	NN	I-NP	O
-	-	HYPH	I-NP	O
test	test	NN	I-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
B	B	NN	I-NP	O
-	-	HYPH	B-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
enhancer	enhancer	NN	I-NP	O
element	element	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
1	1	CD	B-NP	O
'	'	SYM	B-NP	O
of	of	IN	B-PP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
octamerlike	octamerlike	JJ	I-NP	O
motifs	motif	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
immunoglobulin	immunoglobulin	NN	I-NP	I
heavy	heavy	JJ	I-NP	I
-	-	HYPH	I-NP	I
chain	chain	NN	I-NP	I
gene	gene	NN	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
retained	retain	VBD	B-VP	O
the	the	DT	B-NP	O
parental	parental	JJ	I-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
intergeneric	intergeneric	JJ	B-NP	O
coaggregation	coaggregation	NN	I-NP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
oral	oral	JJ	I-NP	O
actinomyces	actinomyce	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
altering	alter	VBG	B-VP	O
intrageneric	intrageneric	JJ	B-NP	O
coaggregations	coaggregation	NNS	I-NP	O

Electrically	Electrically	RB	B-NP	O
induced	induce	VBN	I-NP	O
undulations	undulation	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
competition	competition	NN	I-NP	O
with	with	IN	B-PP	O
electrically	electrically	RB	B-NP	O
induced	induce	VBN	I-NP	O
convection	convection	NN	I-NP	O
in	in	IN	B-PP	O
cholesteric	cholesteric	JJ	B-NP	O
liquid	liquid	NN	I-NP	O
crystals	crystal	NNS	I-NP	O

Critical	Critical	JJ	B-NP	O
review	review	NN	I-NP	O
of	of	IN	B-PP	O
general	general	JJ	B-NP	O
results	result	NNS	I-NP	O

A	A	DT	B-NP	O
visibly	visibly	RB	I-NP	O
distinct	distinct	JJ	I-NP	O
muscular	muscular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
(	(	(	O	O
mh	mh	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
commonly	commonly	RB	B-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
double	double	JJ	B-NP	O
muscling	muscling	NN	I-NP	O
,	,	,	O	O
occurs	occur	VBZ	B-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Belgian	Belgian	JJ	I-NP	O
Blue	Blue	NN	I-NP	O
and	and	CC	O	O
Piedmontese	Piedmontese	JJ	B-NP	O
cattle	cattle	NNS	I-NP	O
breeds	breed	NNS	I-NP	O

The	The	DT	B-NP	O
LS	BEGIN-LS	NN	I-NP	B
gene	gene	NN	I-NP	I
promoter	promoter	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
homology	homology	NN	B-NP	O
with	with	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
promoter	promoter	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
;	;	:	O	O
its	its	PRP$	B-NP	O
terminator	terminator	NN	I-NP	O
sequence	sequence	NN	I-NP	O
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
forming	form	VBG	B-VP	O
a	a	DT	B-NP	O
stem	stem	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
-	-	HYPH	I-NP	O
loop	loop	NN	I-NP	O
structure	structure	NN	I-NP	O

The	The	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
binding	binding	NN	I-NP	O
constant	constant	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
calf	calf	NN	B-NP	O
thymus	thymus	NN	I-NP	O
DNA	DNA	NN	I-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
X	X	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
M	M	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
whereas	whereas	IN	B-PP	O
netropsin	BEGIN-netropsin-INSIDE	NN	B-NP	B
under	under	IN	B-PP	O
similar	similar	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
gives	give	VBZ	B-VP	O
a	a	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
X	X	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
M	M	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

Computed	Compute	VBN	B-VP	O
tomographic	tomographic	JJ	B-ADJP	O
(	(	(	O	O
CT	CT	NN	B-NP	O
)	)	)	O	O
findings	finding	NNS	B-NP	O
of	of	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
ductal	ductal	JJ	I-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
combined	combined	JJ	I-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
enhancement	enhancement	NN	I-NP	O
CT	CT	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
dose	dose	NN	I-NP	O
enhancement	enhancement	NN	I-NP	O
CT	CT	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
carcinomas	carcinoma	NNS	I-NP	O

Southern	Southern	NN	B-NP	O
hybridization	hybridization	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
BenR	BEGIN-BenR-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
BenS	BEGIN-BenS	NN	I-NP	B
transformants	transformants-INSIDE	NN	I-NP	I
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
plasmid	plasmid	NN	B-NP	O
integration	integration	NN	I-NP	O
occurred	occur	VBD	B-VP	O
most	most	RBS	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
chromosomal	chromosomal	JJ	I-NP	O
bens	BEGIN-bens	NNP	I-NP	B
locus	locus-INSIDE	NN	I-NP	I
,	,	,	O	O
however	however	RB	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
gene	gene	NN	B-NP	O
conversion	conversion	NN	I-NP	O
and	and	CC	O	O
heterologous	heterologous	JJ	B-NP	O
recombination	recombination	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
observed	observe	VBN	I-VP	O

Recombinant	BEGIN-Recombinant	JJ	B-NP	B
mouse	mouse	NN	I-NP	I
GSTT1	GSTT1	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
catalytically	catalytically	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
towards	towards	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
epoxy	epoxy	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
(	(	(	O	O
p	p	NN	B-NP	O
-	-	HYPH	B-NP	O
nitrophenoxy	nitrophenoxy	NN	I-NP	O
)	)	)	O	O
propane	propane	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
nitrobenzyl	nitrobenzyl	NN	I-NP	O
chloride	chloride	NN	I-NP	O
and	and	CC	O	O
dichloromethane	dichloromethane	NN	B-NP	O

The	The	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
overlap	overlap	NN	B-NP	O
in	in	IN	B-PP	O
VFI	VFI	NN	B-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
RVF	RVF	NN	B-NP	O
values	value	NNS	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
groups	group	NNS	I-NP	O
was	be	VBD	B-VP	O
considerable	considerable	JJ	B-ADJP	O

In	In	IN	B-PP	O
pituitary	pituitary	JJ	B-NP	O
GH1	GH1	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
PRL	BEGIN-PRL	NN	B-NP	B
transcripts	transcripts-INSIDE	NN	I-NP	I
and	and	CC	O	O
stimulates	stimulate	VBZ	B-VP	O
the	the	DT	B-NP	O
PRL	BEGIN-PRL	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I

Neonatal	Neonatal	JJ	B-NP	O
masculinization	masculinization	NN	I-NP	O
affects	affect	VBZ	B-VP	O
maternal	maternal	JJ	B-NP	O
behavior	behavior	NN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
in	in	IN	B-PP	O
female	female	JJ	B-NP	O
rats	rat	NNS	I-NP	O

The	The	DT	B-NP	O
Thrombolysis	Thrombolysis	NN	I-NP	O
in	in	IN	B-PP	O
Myocardial	Myocardial	JJ	B-NP	O
Infarction	Infarction	NN	I-NP	O
(	(	(	O	O
TIMI	TIMI	NN	B-NP	O
)	)	)	O	O
Phase	Phase	NN	B-NP	O
II	II	CD	I-NP	O
Trial	Trial	NNP	I-NP	O
randomized	randomize	VBD	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
to	to	TO	B-PP	O
either	either	CC	O	O
an	an	DT	B-NP	O
invasive	invasive	JJ	I-NP	O
(	(	(	O	O
INV	INV	NN	B-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
conservative	conservative	JJ	I-NP	O
(	(	(	O	O
CON	CON	NN	B-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	O	O
)	)	)	O	O
strategy	strategy	NN	B-NP	O
after	after	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
recombinant	BEGIN-recombinant	JJ	I-NP	B
tissue	tissue	NN	I-NP	I
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
plasminogen	plasminogen	NN	I-NP	I
activator	activator-INSIDE	NN	I-NP	I
(	(	(	O	O
rt	BEGIN-rt	NN	B-NP	B
-	-	HYPH	B-NP	I
PA	PA-INSIDE	NN	I-NP	I
)	)	)	O	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O

Present	Present	JJ	B-NP	O
investigation	investigation	NN	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
to	to	TO	I-VP	O
elucidate	elucidate	VB	I-VP	O
what	what	WP	B-NP	O
pharmacokinetic	pharmacokinetic	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
in	in	IN	B-PP	O
animal	animal	NN	B-NP	O
experiment	experiment	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
more	more	RBR	B-ADJP	O
predictable	predictable	JJ	I-ADJP	O
for	for	IN	B-PP	O
human	human	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	O
-	-	HYPH	O	O
blocking	block	VBG	B-VP	O
agents	agent	NNS	B-NP	O

Association	Association	NN	B-NP	O
of	of	IN	B-PP	O
Smads	BEGIN-Smads-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
lymphoid	BEGIN-lymphoid	JJ	B-NP	B
enhancer	enhancer	NN	I-NP	I
binding	binding	NN	I-NP	I
factor	factor	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	O	O
T	BEGIN-T	NN	B-NP	B
cell	cell	NN	I-NP	I
-	-	HYPH	B-NP	I
specific	specific	JJ	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
mediates	mediate	VBZ	B-VP	O
cooperative	cooperative	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
transforming	BEGIN-transforming	JJ	I-NP	B
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
wnt	BEGIN-wnt-INSIDE	NN	I-NP	B
pathways	pathway	NNS	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
univariate	univariate	JJ	I-NP	O
models	model	NNS	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
fixed	fix	VBN	B-VP	O
or	or	CC	O	O
time	time	NN	B-NP	O
dependent	dependent	JJ	B-NP	O
covariates	covariate	NNS	I-NP	O
,	,	,	O	O
many	many	JJ	B-NP	O
variables	variable	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
risk	risk	NN	B-NP	O
of	of	IN	B-PP	O
progression	progression	NN	B-NP	O
to	to	TO	B-PP	O
AIDS	AIDS	NN	B-NP	O
(	(	(	O	O
T1	T1	NN	B-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
,	,	,	O	O
T1	T1	NN	B-NP	O
/	/	SYM	B-NP	O
T1	T1	NN	I-NP	O
ratio	ratio	NN	I-NP	O
,	,	,	O	O
blastogenic	blastogenic	JJ	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
phytohemagglutinin	BEGIN-phytohemagglutinin-INSIDE	NN	B-NP	B
,	,	,	O	O
concanavalin	BEGIN-concanavalin	NN	B-NP	B
A	A-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
pokeweed	BEGIN-pokeweed	JJ	B-NP	B
mitogen	mitogen-INSIDE	NN	I-NP	I
,	,	,	O	O
serum	BEGIN-serum	NN	B-NP	B
IgA	IgA-INSIDE	NN	I-NP	I
,	,	,	O	O
appearance	appearance	NN	B-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1	NN	B-NP	B
antigen	antigen-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
hairy	hairy	JJ	I-NP	O
leukoplakia	leukoplakia	NN	I-NP	O
,	,	,	O	O
thrush	thrush	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
herpes	herpes	NN	B-NP	O
zoster	zoster	NN	I-NP	O
)	)	)	O	O

But	But	CC	O	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
mated	mat	VBN	B-NP	O
males	male	NNS	I-NP	O
built	build	VBD	B-VP	O
nests	nest	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
young	young	JJ	B-NP	O
,	,	,	I-NP	O
T	T	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
only	only	RB	B-ADVP	O
for	for	IN	B-PP	O
early	early	JJ	B-NP	O
broods	brood	NNS	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
short	short	JJ	B-NP	O
dwell	dwell	NN	I-NP	O
times	time	NNS	I-NP	O
,	,	,	O	O
uncorrected	uncorrected	JJ	O	O
(	(	(	O	O
whole	whole	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
/	/	SYM	B-NP	O
P	P	NN	I-NP	O
and	and	CC	I-NP	O
Cp	Cp	NN	I-NP	O
of	of	IN	B-PP	O
urea	urea	NN	B-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
corrected	corrected	JJ	I-NP	O
(	(	(	O	O
plasma	plasma	NN	B-NP	O
water	water	NN	I-NP	O
)	)	)	O	O
values	value	NNS	B-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
some	some	DT	B-NP	O
cows	cow	NNS	I-NP	O
that	that	WDT	B-NP	O
fail	fail	VBP	B-VP	O
to	to	TO	I-VP	O
produce	produce	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
dihydroxyvitamin	dihydroxyvitamin	NN	I-NP	O
D	D	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
lactation	lactation	NN	B-NP	O

The	The	DT	B-NP	O
AmyI	BEGIN-AmyI-INSIDE	NN	I-NP	B
specific	specific	JJ	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
UTR	UTR	NN	I-NP	O
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
IR	IR	NN	B-NP	O
sequences	sequence	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
'AATAAA	'AATAAA	NN	I-NP	O
'	'	POS	B-NP	O
polyadenylation	polyadenylation	NN	I-NP	O
signal	signal	NN	I-NP	O

Off	Off	AFX	B-NP	O
-	-	HYPH	I-NP	O
shell	shell	NN	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
Rydberg	Rydberg	NN	B-NP	O
-	-	HYPH	B-NP	O
atom	atom	NN	I-NP	O
-	-	HYPH	B-NP	O
alkali	alkali	AFX	I-NP	O
-	-	HYPH	I-NP	O
metal	metal	NN	I-NP	O
-	-	HYPH	I-NP	O
atom	atom	NN	I-NP	O
scattering	scattering	NN	I-NP	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
photonic	photonic	JJ	B-NP	O
radiation	radiation	NN	I-NP	O
,	,	,	O	O
short	short	JJ	B-NP	O
wavelength	wavelength	NN	I-NP	O
UV	UV	NN	I-NP	O
(	(	(	O	O
UV	UV	NN	B-NP	O
-	-	HYPH	B-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
gamma	gamma	NN	B-NP	O
radiation	radiation	NN	I-NP	O
,	,	,	O	O
activate	activate	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
factor	factor	NN	I-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	O	I
kappaB	kappaB-INSIDE	NN	B-NP	I

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
biochemical	biochemical	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
Tax1	BEGIN-Tax1-INSIDE	NN	B-NP	B
transactivation	transactivation	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
developed	develop	VBN	I-VP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
transactivation	transactivation	NN	I-NP	O
assay	assay	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
wild	wild	JJ	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
Tax1	BEGIN-Tax1-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
specifically	specifically	RB	I-VP	O
transactivate	transactivate	VB	I-VP	O
a	a	DT	B-NP	O
polymerase	BEGIN-polymerase	NN	I-NP	B
II	II-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O
through	through	IN	B-PP	O
upstream	upstream	JJ	B-NP	O
Tax1	BEGIN-BEGIN-Tax1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
responsive	responsive	JJ	I-NP	O
elements	elements-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
atf1+	BEGIN-atf1+	JJ	I-NP	B
gene	gene	NN	I-NP	I
of	of	IN	B-PP	I
Schizosaccharomyces	Schizosaccharomyces	NNP	B-NP	I
pombe	pombe-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
bZIP	BEGIN-bZIP	NN	I-NP	B
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
strong	strong	JJ	B-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mammalian	BEGIN-mammalian	JJ	I-NP	B
factor	factor	NN	I-NP	I
ATF	ATF	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Cotransfection	Cotransfection	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
hGATA	BEGIN-hGATA	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
PMA	PMA	NN	I-NP	O
/	/	SYM	O	O
A1	A1	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
are	be	VBP	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O

(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

Prenatal	Prenatal	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
diseases	disease	NNS	I-NP	O

1	1	CD	B-NP	O

Mortality	Mortality	NN	B-NP	O
rates	rate	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
different	different	JJ	B-ADJP	O
(	(	(	O	O
chi1	chi1	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

M.	M.	NNP	B-NP	O
,	,	,	O	O
Apps	Apps	NNP	B-NP	O
,	,	,	O	O
D	D	NNP	B-NP	O

Cox	Cox	NNP	B-NP	O
proportional	proportional	JJ	I-NP	O
hazard	hazard	NN	I-NP	O
analysis	analysis	NN	I-NP	O
identified	identify	VBD	B-VP	O
dialysis	dialysis	NN	B-NP	O
modality	modality	NN	I-NP	O
and	and	CC	O	O
pre	pre	AFX	B-NP	O
-	-	HYPH	I-NP	O
dialysis	dialysis	NN	I-NP	O
UV	UV	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
per	per	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
significant	significant	JJ	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
UV	UV	NN	B-NP	O
survival	survival	NN	I-NP	O

The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
chain	chain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha	alpha	NN	I-NP	O
subunit	subunit	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
clone	clone	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
deduced	deduce	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
establishes	establish	VBZ	B-VP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
chain	chain	NN	I-NP	O

The	The	DT	B-NP	O
Gastrointestinal	Gastrointestinal	NNP	I-NP	O
Tumor	Tumor	NNP	I-NP	O
Study	Study	NNP	I-NP	O
Group	Group	NNP	I-NP	O
(	(	(	O	O
GITSG	GITSG	NN	B-NP	O
)	)	)	O	O
protocol	protocol	NN	B-NP	O
GI	GI	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
randomized	randomize	VBD	B-VP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
following	follow	VBG	B-PP	O
complete	complete	JJ	B-NP	O
surgical	surgical	JJ	I-NP	O
resection	resection	NN	I-NP	O
of	of	IN	B-PP	O
stages	stage	NNS	B-NP	O
B1	B1	NN	I-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
rectal	rectal	JJ	I-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
to	to	TO	B-PP	O
four	four	CD	B-NP	O
treatment	treatment	NN	I-NP	O
arms	arm	NNS	I-NP	O
:	:	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
no	no	DT	B-NP	O
adjuvant	adjuvant	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
chemotherapy	chemotherapy	NN	B-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
radiotherapy	radiotherapy	NN	B-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
radiotherapy	radiotherapy	NN	B-NP	O
and	and	CC	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
(	(	(	O	O
combined	combine	VBN	B-NP	O
modality	modality	NN	I-NP	O
)	)	)	O	O

Samples	Sample	NNS	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
extracted	extract	VBN	I-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
potassium	potassium	NN	I-NP	O
chloride	chloride	NN	I-NP	O
(	(	(	O	O
KCl	KCl	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
methanol	methanol	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
diluted	dilute	VBD	B-VP	O
subsequently	subsequently	RB	B-ADVP	O
to	to	TO	B-VP	O
give	give	VB	I-VP	O
two	two	CD	B-NP	O
-	-	HYPH	O	O
fold	fold	RB	B-ADVP	O
to	to	TO	B-PP	O
ten	ten	CD	B-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
step	step	NN	I-NP	O
-	-	HYPH	B-NP	O
wise	wise	JJ	I-NP	O
dilutions	dilution	NNS	I-NP	O
in	in	IN	B-PP	O
phosphate	phosphate	NN	B-NP	O
-	-	HYPH	O	O
buffered	buffer	VBN	B-NP	O
saline	saline	NN	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
Tween	Tween	CD	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
bovine	BEGIN-bovine	JJ	I-NP	B
serum	serum	NN	I-NP	I
albumin	albumin-INSIDE	NN	I-NP	I
(	(	(	O	O
PBS	PBS	NN	B-NP	O
-	-	HYPH	I-NP	O
T	T	NN	I-NP	O
BSA	BEGIN-BSA-INSIDE	NN	I-NP	B
)	)	)	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
children	child	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
questionnaire	questionnaire	NN	I-NP	O
satisfactorily	satisfactorily	RB	B-VP	O
completed	complete	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
relative	relative	JJ	I-NP	O
or	or	CC	I-NP	O
guardian	guardian	JJ	I-NP	O
(	(	(	O	O
usually	usually	RB	B-ADVP	O
the	the	DT	B-NP	O
mother	mother	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O

Using	Use	VBG	B-VP	O
community	community	NN	B-NP	O
development	development	NN	I-NP	O
approaches	approach	NNS	I-NP	O

Cell	Cell	NN	B-NP	O
lines	line	NNS	I-NP	O
expressing	express	VBG	B-VP	O
single	single	JJ	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
substitutions	substitution	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
asparagine	asparagine	NN	I-NP	O
of	of	IN	B-PP	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
are	be	VBP	B-VP	O
incapable	incapable	JJ	B-ADJP	O
of	of	IN	B-PP	O
avidity	avidity	NN	B-NP	O
regulation	regulation	NN	I-NP	O
by	by	IN	B-PP	O
TCR	BEGIN-TCR-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O
,	,	,	O	O
PMA	PMA	NN	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
elevation	elevation	NN	B-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
cAMP	cAMP	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
demonstrating	demonstrate	VBG	B-VP	O
that	that	IN	B-SBAR	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
stimuli	stimulus	NNS	I-NP	O
utilizes	utilize	VBZ	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
structural	structural	JJ	I-NP	O
element	element	NN	I-NP	O
for	for	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
avidity	avidity	NN	I-NP	O

Iomazenil	Iomazenil	NN	B-NP	O
-	-	HYPH	I-NP	O
SPECT	SPECT	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
benzodiazepine	BEGIN-benzodiazepine	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
studied	study	VBN	I-NP	O
cortical	cortical	JJ	I-NP	O
regions	region	NNS	I-NP	O
except	except	IN	B-PP	O
temporal	temporal	JJ	B-NP	O
cortices	cortex	NNS	I-NP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
PGE1	PGE1	NN	B-NP	O
is	be	VBZ	B-VP	O
effective	effective	JJ	B-ADJP	O
in	in	IN	B-PP	O
increasing	increase	VBG	B-VP	O
PVF	PVF	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
transplanted	transplant	VBN	I-NP	O
condition	condition	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	O
circulatory	circulatory	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
attributed	attribute	VBN	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
agent	agent	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
limited	limit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
following	follow	VBG	B-PP	O
transplantation	transplantation	NN	B-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
variation	variation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
assay	assay	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
protease	protease	NN	I-NP	O
is	be	VBZ	B-VP	O
omitted	omit	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
exhibited	exhibit	VBD	B-VP	O
substantial	substantial	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
prolyl	BEGIN-prolyl	JJ	B-NP	B
isomerase	isomerase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
wild	wild	JJ	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
revealing	reveal	VBG	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
mutations	mutation	NNS	I-NP	O
confer	confer	VBP	B-VP	O
sensitivity	sensitivity	NN	B-NP	O
to	to	TO	B-PP	O
protease	protease	NN	B-NP	O
digestion	digestion	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
classic	classic	JJ	I-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
assay	assay	NN	I-NP	O
for	for	IN	B-PP	O
prolyl	BEGIN-prolyl	JJ	B-NP	B
isomerase	isomerase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
misleading	mislead	VBG	I-VP	O

The	The	DT	B-NP	O
WEB1	BEGIN-WEB1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
homology	homology	NN	B-NP	O
to	to	TO	B-PP	O
nucleic	BEGIN-nucleic	JJ	B-NP	B
acid	acid	NN	I-NP	I
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
ATPases	ATPases-INSIDE	NN	I-NP	I

V	BEGIN-V	NN	B-NP	B
-	-	HYPH	B-NP	I
ErbB	ErbB	NN	I-NP	I
-	-	HYPH	B-NP	I
mediated	mediate	VBN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
formation	formation	NN	I-NP	O
and	and	CC	I-NP	O
transformation	transformation	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
occur	occur	VB	I-VP	O
independently	independently	RB	B-ADVP	O
of	of	IN	B-PP	O
Ras	BEGIN-Ras-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
OAS	BEGIN-OAS	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
flanked	flank	VBN	I-VP	O
by	by	IN	B-PP	O
markers	BEGIN-marker	NNS	B-NP	B
WI	WI	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
cen	BEGIN-cen-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
D1S1	BEGIN-D1S1-INSIDE	NN	B-NP	B
(	(	(	O	O
tel	BEGIN-tel-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
are	be	VBP	B-VP	O
contained	contain	VBN	I-VP	O
within	within	IN	B-PP	O
three	three	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
overlapping	overlap	VBG	B-VP	O
cosmid	cosmid	NN	B-NP	O
clones	clone	NNS	I-NP	O

1	1	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
Deletion	Deletion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Stat	BEGIN-Stat	NN	I-NP	B
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
sites	sites-INSIDE	NN	I-NP	I
abolished	abolish	VBD	B-VP	O
all	all	DT	B-NP	O
promoter	promoter	NN	I-NP	O
-	-	HYPH	B-NP	O
reporter	reporter	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
PRL	BEGIN-PRL-INSIDE	NN	B-NP	B

Increasing	Increase	VBG	B-VP	O
the	the	DT	B-NP	O
height	height	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
agar	agar	NN	I-NP	O
column	column	NN	I-NP	O
overlying	overlie	VBG	B-VP	O
the	the	DT	B-NP	O
SN	SN	NN	I-NP	O
fabric	fabric	NN	I-NP	O
diminished	diminish	VBD	B-VP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
SN	SN	NN	B-NP	O
on	on	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
growth	growth	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
differential	differential	JJ	B-NP	O
utilization	utilization	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
determinants	determinant	NNS	I-NP	O
mediate	mediate	VBP	B-VP	O
RAR	BEGIN-RAR-INSIDE	JJ	B-NP	B
-	-	HYPH	I-NP	O
RXR	BEGIN-RXR-INSIDE	NN	I-NP	B
heterodimer	heterodimer	NN	I-NP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
DR	DR	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
DR	DR	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
RAREs	BEGIN-RAR-INSIDEE	NNS	I-NP	I

Biochem	Biochem	NNP	B-NP	O

Conversely	Conversely	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
GAL	BEGIN-GAL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
chimera	chimera-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
LAZ1	BEGIN-LAZ1-INSIDE	NN	I-NP	B
/	/	SYM	O	O
BCL1	BEGIN-BCL1-INSIDE	NN	B-NP	B
BTB	BEGIN-BTB-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
POZ	POZ	NN	I-NP	O
domain	domain	NN	I-NP	O
appears	appear	VBZ	B-VP	O
nearly	nearly	RB	B-ADJP	O
as	as	RB	I-ADJP	O
efficient	efficient	JJ	I-ADJP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
protein	protein	NN	I-NP	O
at	at	IN	B-PP	O
inducing	induce	VBG	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
repression	repression	NN	I-NP	O

When	When	WRB	B-ADVP	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
,	,	,	O	O
SH	BEGIN-SH	NN	B-NP	B
-	-	HYPH	O	I
PTP1	PTP1-INSIDE	NN	B-NP	I
displays	display	VBZ	B-VP	O
tyrosine	BEGIN-tyrosine	NN	B-NP	B
-	-	HYPH	I-NP	I
specific	specific	JJ	I-NP	I
phosphatase	phosphatase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
hypothesized	hypothesize	VBN	I-VP	O
this	this	DT	B-NP	O
occurs	occur	VBZ	B-VP	O
through	through	IN	B-PP	O
antagonism	antagonism	NN	B-NP	O
of	of	IN	B-PP	O
PML	BEGIN-PML-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
RAR	BEGIN-RAR	NN	I-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
actions	action	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
leukemic	leukemic	JJ	I-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
main	main	JJ	I-NP	O
new	new	JJ	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
version	version	NN	I-NP	O
are	be	VBP	B-VP	O
that	that	IN	B-SBAR	O
end	end	NN	B-NP	O
-	-	HYPH	I-NP	O
tidal	tidal	JJ	I-NP	O
PO1	PO1	NN	I-NP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
inspiratory	inspiratory	JJ	B-NP	O
PO1	PO1	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
kept	keep	VBN	I-VP	O
constant	constant	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
correcting	correct	VBG	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
controllers	controller	NNS	I-NP	O
(	(	(	O	O
capnostat	capnostat	NN	B-NP	O
and	and	CC	O	O
oxystat	oxystat	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
proportional	proportional	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
magnitude	magnitude	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
actual	actual	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
adjusted	adjust	VBN	I-NP	O
end	end	NN	I-NP	O
-	-	HYPH	B-NP	O
tidal	tidal	JJ	I-NP	O
PCO1	PCO1	NN	I-NP	O
or	or	CC	I-NP	O
PO1	PO1	NN	I-NP	O

Fli	BEGIN-Fli	AFX	O	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
proto	proto	AFX	I-NP	O
-	-	HYPH	I-NP	O
oncogene	oncogene	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
rearranged	rearrange	VBN	I-VP	O
in	in	IN	B-PP	O
tumors	tumor	NNS	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
three	three	CD	B-NP	O
different	different	JJ	I-NP	O
retroviruses	retrovirus	NNS	I-NP	O
,	,	,	O	O
Cas	Cas	NNP	B-NP	O
-	-	HYPH	I-NP	O
Br	Br	NNP	I-NP	O
-	-	HYPH	I-NP	O
E	E	NN	I-NP	O
,	,	,	O	O
F	F	NN	B-NP	O
-	-	HYPH	I-NP	O
MuLV	MuLV	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1A1	1A1	NN	B-NP	O

Routine	Routine	NN	B-NP	O
imaging	imaging	NN	I-NP	O
modalities	modality	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
metastases	metastasis	NNS	I-NP	O

Cervical	Cervical	JJ	B-NP	O
CT	CT	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
irregular	irregular	JJ	I-NP	O
low	low	JJ	I-NP	O
density	density	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
periphery	periphery	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
vertebra	vertebra	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
C1	C1	NN	I-NP	O
to	to	TO	B-PP	O
C1	C1	NN	B-NP	O
level	level	NN	I-NP	O

Human	BEGIN-Human	JJ	B-NP	B
myotonic	myotonic	JJ	I-NP	I
dystrophy	dystrophy	NN	I-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
DMPK	BEGIN-DMPK-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
multidomain	multidomain	JJ	B-NP	O
protein	protein	NN	I-NP	O
kinases	kinase	NNS	I-NP	O
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
cell	cell	NN	B-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
shape	shape	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
organisms	organism	NNS	B-NP	O

The	The	DT	B-NP	O
MAP	BEGIN-MAP	NN	I-NP	B
kinase	kinase	NN	I-NP	I
kinase	kinase	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
MLK1	BEGIN-MLK1-INSIDE	NN	I-NP	B
co	co	AFX	O	O
-	-	HYPH	B-NP	O
localizes	localize	VBZ	B-VP	O
with	with	IN	B-PP	O
activated	activate	VBN	B-NP	O
JNK	BEGIN-JNK-INSIDE	NN	I-NP	B
along	along	IN	B-PP	O
microtubules	microtubule	NNS	B-NP	O
and	and	CC	O	O
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
kinesin	BEGIN-kinesin	NN	B-NP	B
superfamily	superfamily-INSIDE	NN	I-NP	I
motor	motor	NN	I-NP	O
KIF1	BEGIN-KIF1-INSIDE	NN	I-NP	B

Sequential	Sequential	JJ	B-NP	O
immunoprecipitation	immunoprecipitation	NN	I-NP	O
showed	show	VBD	B-VP	O
all	all	DT	B-NP	O
detectable	detectable	JJ	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
to	to	TO	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PAb1+	BEGIN-PAb1+-INSIDE	NN	I-NP	B
class	class	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
LPV	LPV	NN	I-NP	O
-	-	HYPH	B-NP	O
transformed	transform	VBN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
stable	stable	JJ	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
indeed	indeed	RB	B-ADVP	O
wild	wild	JJ	B-NP	O
type	type	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
transcriptional	transcriptional	JJ	B-NP	O
fusions	fusion	NNS	I-NP	O
were	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
xcpP	BEGIN-xcpP-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
xcpR	BEGIN-xcpR	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
lacZ	BEGIN-lacZ	NN	I-NP	B
reporter	reporter-INSIDE	NN	I-NP	I

Increased	Increase	VBN	B-NP	O
platelet	BEGIN-platelet	NN	I-NP	B
-	-	HYPH	O	I
derived	derive	VBN	B-NP	I
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
production	production	NN	I-NP	O
and	and	CC	O	O
intimal	intimal	JJ	B-NP	O
thickening	thickening	NN	I-NP	O
during	during	IN	B-PP	O
healing	healing	NN	B-NP	O
of	of	IN	B-PP	O
Dacron	Dacron	NNP	B-NP	O
grafts	graft	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
canine	canine	NN	I-NP	O
model	model	NN	I-NP	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
NES	BEGIN-NES	NN	I-NP	B
mutant	mutant	JJ	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
altered	alter	VBN	I-VP	O
interactions	interaction	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
splicing	splicing	NN	I-NP	O
complex	complex	NN	I-NP	O
,	,	,	O	O
binding	bind	VBG	B-VP	O
more	more	RBR	B-ADVP	O
tightly	tightly	RB	I-ADVP	O
to	to	TO	B-PP	O
SC1	BEGIN-SC1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
co	co	AFX	B-NP	O
-	-	HYPH	I-NP	O
immunoprecipitation	immunoprecipitation	NN	I-NP	O
assays	assay	NNS	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
EHV	BEGIN-EHV	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gp1	gp1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
structural	structural	JJ	I-NP	O
homolog	homolog	NN	I-NP	O
of	of	IN	B-PP	O
herpes	BEGIN-herpes	NN	B-NP	B
simplex	simplex	NN	I-NP	I
virus	virus	NN	I-NP	I
glycoprotein	glycoprotein	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
and	and	CC	O	O
further	further	RB	B-VP	O
suggest	suggest	VBP	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
epitope	epitope	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
herpesvirus	BEGIN-herpesvirus	NN	I-NP	B
gC	gC	NN	I-NP	I
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
glycoproteins	glycoproteins-INSIDE	NN	I-NP	I
have	have	VBP	B-VP	O
undergone	undergo	VBN	I-VP	O
more	more	RBR	B-NP	O
extensive	extensive	JJ	I-NP	O
evolutionary	evolutionary	JJ	I-NP	O
divergence	divergence	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O

Previously	Previously	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
(	(	(	O	O
GT1	BEGIN-GT1-INSIDE	NN	B-NP	B
)	)	)	O	O
encoding	encode	VBG	B-VP	O
this	this	DT	B-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
mouse	mouse	NN	I-NP	O
1T1	1T1	NN	I-NP	O
-	-	HYPH	B-NP	O
L1	L1	NN	I-NP	O
adipocyte	adipocyte	NN	I-NP	O
library	library	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sequenced	sequence	VBN	I-VP	O

By	By	IN	B-PP	O
RT	RT	NN	B-NP	O
-	-	HYPH	B-NP	O
PCR	PCR	NN	I-NP	O
,	,	,	O	O
different	different	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epidermis	epidermis	NN	I-NP	O
,	,	,	O	O
nerve	nerve	NN	B-NP	O
cord	cord	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
eyestalk	eyestalk	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
pre	pre	AFX	I-NP	O
-	-	HYPH	I-NP	O
molt	molt	NN	I-NP	O
shrimp	shrimp	NN	I-NP	O

PATIENTS	PATIENTS	NNS	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
HIV	HIV	NN	I-NP	O
-	-	HYPH	O	O
infected	infect	VBN	B-VP	O
,	,	,	O	O
zidovudine	zidovudine	NN	B-NP	O
-	-	HYPH	B-NP	O
experienced	experience	VBN	B-VP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
serum	serum	NN	B-NP	O
HIV	HIV	NN	I-NP	O
RNA	RNA	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
copies	copy	NNS	I-NP	O
/	/	SYM	B-NP	O
mL	mL	NN	I-NP	O
and	and	CC	I-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
counts	count	NNS	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
/	/	SYM	O	O
mm1	mm1	NN	B-NP	O

The	The	DT	B-NP	O
potential	potential	JJ	I-NP	O
biological	biological	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
identified	identify	VBN	I-NP	O
structural	structural	JJ	I-NP	O
motif	motif	NN	I-NP	O
shared	share	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
CCR1	BEGIN-CCR1-INSIDE-INSIDE	NN	I-NP	I
,	,	,	O	O
CCR1	BEGIN-CCR1-INSIDE	NN	B-NP	B
,	,	,	O	O
CCR1B	BEGIN-CCR1-INSIDEB	NN	B-NP	I
and	and	CC	O	O
other	other	JJ	B-NP	O
GPCRs	BEGIN-GPCRs-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O

Materials	Material	NNS	B-NP	O
are	be	VBP	B-VP	O
presented	present	VBN	I-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
comparative	comparative	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
morphological	morphological	JJ	B-NP	O
and	and	CC	I-NP	O
cultural	cultural	JJ	I-NP	O
properties	property	NNS	I-NP	O
and	and	CC	O	O
virulence	virulence	NN	B-NP	O
of	of	IN	B-PP	O
liophylized	liophylize	VBN	B-NP	O
cultures	culture	NNS	I-NP	O
of	of	IN	B-PP	O
Leishmania	Leishmania	NNP	B-NP	O
tropica	tropica	NN	I-NP	O
major	major	JJ	B-ADJP	O
after	after	IN	B-PP	O
their	their	PRP$	B-NP	O
rehydration	rehydration	NN	I-NP	O
or	or	CC	B-PP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
passage	passage	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
NNN	NNN	NN	I-NP	O
medium	medium	NN	I-NP	O

The	The	DT	B-NP	O
chromosomal	chromosomal	JJ	I-NP	O
location	location	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
YACs	YAC	NNS	I-NP	O
was	be	VBD	B-VP	O
verified	verify	VBN	I-VP	O
using	use	VBG	B-VP	O
FISH	FISH	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
also	also	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
their	their	PRP$	B-NP	O
nonchimeric	nonchimeric	JJ	I-NP	O
nature	nature	NN	I-NP	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
indication	indication	NN	I-NP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
experiments	experiment	NNS	I-NP	O
that	that	IN	B-NP	O
linker	BEGIN-linker	NN	B-NP	B
histones	histones-INSIDE	NN	I-NP	I
bind	bind	VBP	B-VP	O
fundamentally	fundamentally	RB	B-ADVP	O
differently	differently	RB	B-ADVP	O
to	to	TO	B-PP	O
1	BEGIN-1	NN	B-NP	B
S	S-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
bulk	bulk	NN	I-NP	O
nucleosomes	nucleosome	NNS	I-NP	O

Gas	Gas	NN	B-NP	O
chromatographic	chromatographic	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
headspace	headspace	NN	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
alkalinized	alkalinize	VBN	B-NP	O
vaginal	vaginal	JJ	I-NP	O
discharges	discharge	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
trimethylamine	trimethylamine	NN	B-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
1	1	CD	I-NP	O
samples	sample	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
fishy	fishy	JJ	I-NP	O
odor	odor	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
samples	sample	NNS	I-NP	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
step	step	NN	I-NP	O
of	of	IN	B-PP	O
spliceosome	spliceosome	NN	B-NP	O
assembly	assembly	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
Snu1p	BEGIN-Snu1p-INSIDE	NN	B-NP	B
acts	act	VBZ	B-VP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
nondenaturing	nondenaturing	JJ	B-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O

The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
primer	primer	NN	B-NP	O
extension	extension	NN	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
over	over	IN	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
flanking	flanking	NN	I-NP	O
DNA	DNA	NN	I-NP	O
was	be	VBD	B-VP	O
sequenced	sequence	VBN	I-VP	O

PURPOSE	PURPOSE	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
adding	add	VBG	B-VP	O
a	a	DT	B-NP	O
pulsating	pulsate	VBG	I-NP	O
bristle	bristle	JJ	I-NP	O
action	action	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
established	establish	VBN	I-NP	O
oscillating	oscillating	NN	I-NP	O
/	/	SYM	O	O
rotating	rotating	NN	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Braun	Braun	NNP	I-NP	O
Oral	Oral	NNP	I-NP	O
-	-	:	O	O
B	B	NN	B-NP	O
Ultra	Ultra	NNP	I-NP	O
Plaque	Plaque	NNP	I-NP	O
Remover	Remover	NNP	I-NP	O
(	(	(	O	O
D1	D1	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
plaque	plaque	NN	B-NP	O
removal	removal	NN	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
postmitotic	postmitotic	JJ	B-NP	O
neurons	neuron	NNS	I-NP	O
possessed	possess	VBD	B-VP	O
extremely	extremely	RB	B-NP	O
low	low	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
E1F1	BEGIN-E1F1	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
electrophoretic	electrophoretic	JJ	I-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
and	and	CC	O	O
Western	Western	NN	B-NP	O
blotting	blotting	NN	I-NP	O

The	The	DT	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
sequence	sequence	NN	B-NP	O
conservation	conservation	NN	I-NP	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
direct	direct	VB	I-VP	O
nucleolar	nucleolar	JJ	B-NP	O
protein	protein	NN	I-NP	O
transport	transport	NN	I-NP	O
supports	support	VBZ	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
MAK1	BEGIN-MAK1	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
biogenesis	biogenesis	NN	I-NP	O
of	of	IN	B-PP	O
1S	BEGIN-1S	NN	B-NP	B
subunits	subunits-INSIDE	NN	I-NP	I

NO1	NO1	NN	B-NP	O
pollution	pollution	NN	I-NP	O
on	on	IN	B-PP	O
major	major	JJ	B-NP	O
trunk	trunk	NN	I-NP	O
roads	road	NNS	I-NP	O
frequently	frequently	RB	B-ADVP	O
exceeded	exceed	VBD	B-VP	O
British	British	NNP	B-NP	O
and	and	CC	I-NP	O
European	European	NNP	I-NP	O
Union	Union	NNP	I-NP	O
air	air	NN	I-NP	O
quality	quality	NN	I-NP	O
standards	standard	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
particle	particle	NN	B-NP	O
pollution	pollution	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	O
RFC	BEGIN-RFC	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
differs	differ	VBZ	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
and	and	CC	I-NP	O
hamster	hamster	NN	I-NP	O
genes	gene	NNS	I-NP	O
both	both	CC	B-PP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
exons	exon	NNS	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
alternatives	alternative	NNS	B-NP	O
of	of	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
which	which	WDT	B-NP	O
encode	encode	VBP	B-VP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
end	end	NN	I-NP	O
heterogeneity	heterogeneity	NN	I-NP	O

Computer	Computer	NN	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
simple	simple	JJ	B-NP	O
correlation	correlation	NN	I-NP	O
hypothesis	hypothesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
distribution	distribution	NN	B-NP	O
method	method	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
freedom	freedom	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
significant	significant	JJ	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
vertical	vertical	JJ	B-NP	O
root	root	NN	I-NP	O
fracture	fracture	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
technique	technique	NN	I-NP	O
of	of	IN	B-PP	O
instrumentation	instrumentation	NN	B-NP	O
and	and	CC	I-NP	O
obturation	obturation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
canal	canal	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
length	length	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
post	post	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
post	post	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

CrkII	BEGIN-CrkII-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
CrkL	BEGIN-CrkL-INSIDE	NN	I-NP	B
constitutively	constitutively	RB	B-ADVP	O
formed	form	VBD	B-VP	O
complex	complex	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
guanine	BEGIN-guanine	NN	I-NP	B
nucleotide	nucleotide	NN	I-NP	I
exchange	exchange	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
C1G	BEGIN-C1G-INSIDE	NN	I-NP	B
,	,	,	O	O
in	in	IN	B-PP	O
unstimulated	unstimulated	JJ	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
PDGF	BEGIN-PDGF-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
stimulated	stimulate	VBN	I-NP	O
cells	cell	NNS	I-NP	O

Plasmid	Plasmid	NN	B-NP	O
subclones	subclone	NNS	I-NP	O
of	of	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	O
phage	phage	NN	I-NP	O
lambda	lambda	NN	I-NP	O
Asm1	Asm1	NN	I-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
complement	complement	VB	I-VP	O
both	both	DT	B-NP	O
Escherichia	BEGIN-Escherichia	FW	I-NP	B
coli	coli	FW	I-NP	I
gltB	gltB-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
A.	A.	NN	I-NP	O
sesbaniae	sesbaniae	VBP	B-VP	O
Asm	Asm	NNP	B-NP	O
-	-	HYPH	I-NP	O
Vi	Vi	NNP	I-NP	O
mutants	mutant	NNS	I-NP	O
;	;	:	O	O
NADPH	BEGIN-NADPH	NN	B-NP	B
-	-	HYPH	I-NP	I
glutamate	glutamate	NN	I-NP	I
synthase	synthase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
such	such	JJ	I-NP	O
strains	strain	NNS	I-NP	O
complemented	complement	VBN	B-VP	O
to	to	TO	B-PP	O
Asm+	Asm+	JJ	B-NP	O

Any	Any	DT	B-NP	O
respectative	respectative	JJ	I-NP	O
material	material	NN	I-NP	O
(	(	(	O	O
class	class	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
class	class	NN	B-NP	O
I	I	CD	I-NP	O
-	-	HYPH	B-NP	O
II	II	CD	I-NP	O
findings	finding	NNS	I-NP	O
belonged	belong	VBD	B-VP	O
to	to	TO	B-PP	O
1m1	1m1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
classified	classify	VBN	I-VP	O
as	as	IN	B-PP	O
class	class	NN	B-NP	O
HII	HII	NN	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
class	class	NN	B-NP	O
V	V	NN	I-NP	O

DSIP	DSIP	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
significantly	significantly	RB	I-VP	O
increase	increase	VB	I-VP	O
slow	slow	JJ	B-NP	O
-	-	HYPH	I-NP	O
waves	wave	NNS	I-NP	O
(	(	(	O	O
delta	delta	SYM	B-NP	O
sleep	sleep	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sleep	sleep	NN	I-NP	O
EEG	EEG	NN	I-NP	O

YDL1w	BEGIN-YDL1w-INSIDE	NN	B-NP	B
(	(	(	O	O
also	also	RB	B-ADVP	O
termed	term	VBN	B-NP	O
MCD1	BEGIN-MCD1-INSIDE	NN	I-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
homologue	homologue	NN	I-NP	O
of	of	IN	B-PP	O
Schizosaccharomyces	BEGIN-Schizosaccharomyces	FW	B-NP	B
pombe	pombe	FW	I-NP	I
rad1	rad1-INSIDE	NN	I-NP	I
,	,	,	O	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
gene	gene	NN	I-NP	O
implicated	implicate	VBN	B-VP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
strand	strand	NN	I-NP	O
break	break	NN	I-NP	O
repair	repair	NN	I-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
organization	organization	NN	I-NP	O
in	in	IN	B-PP	O
fission	fission	NN	B-NP	O
yeast	yeast	NN	I-NP	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
movements	movement	NNS	I-NP	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
occur	occur	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HAL	HAL	NN	I-NP	O
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
rats	rat	NNS	I-NP	O
were	be	VBD	B-VP	O
slower	slow	JJR	B-ADJP	O
than	than	IN	B-PP	O
normal	normal	JJ	B-ADJP	O

The	The	DT	B-NP	O
recombinant	BEGIN-recombinant	JJ	I-NP	B
L	L	NN	I-NP	I
/	/	SYM	B-NP	I
F	F	NN	I-NP	I
-	-	HYPH	B-NP	I
transferase	transferase-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
as	as	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
purified	purify	VBN	I-NP	O
wild	wild	JJ	I-NP	O
type	type	NN	I-NP	O
enzyme	enzyme	NN	I-NP	O
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
no	no	DT	B-NP	O
detectable	detectable	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
component	component	NN	I-NP	O

AST	BEGIN-AST-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
PMNs	PMN	NNS	B-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
HPLFs	HPLF	NNS	B-NP	O

Two	Two	CD	B-NP	O
courses	course	NNS	I-NP	O
of	of	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
(	(	(	O	O
CBCDA	CBCDA	NN	B-NP	O
+	+	SYM	B-NP	O
VDS	VDS	NN	I-NP	O
)	)	)	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
gain	gain	VB	I-VP	O
any	any	DT	B-NP	O
improvement	improvement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
bone	bone	NN	I-NP	O
metastases	metastasis	NNS	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
mainly	mainly	RB	B-ADVP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
supportive	supportive	JJ	I-NP	O
care	care	NN	I-NP	O

Intraspinal	Intraspinal	JJ	B-NP	O
and	and	CC	I-NP	O
mediastinal	mediastinal	JJ	I-NP	O
foregut	foregut	NN	I-NP	O
cyst	cyst	NN	I-NP	O
compressing	compress	VBG	B-VP	O
the	the	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O

The	The	DT	B-NP	O
H1	BEGIN-H1	NN	I-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
:	:	:	O	O
DH1	BEGIN-DH1-INSIDE	NN	B-NP	B
(	(	(	O	O
all	all	DT	B-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
in	in	IN	B-PP	O
D	D	NN	B-NP	O
configuration	configuration	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
H1F	BEGIN-H1F-INSIDE	NN	B-NP	B
(	(	(	O	O
where	where	WRB	B-ADVP	O
all	all	DT	O	O
His	His	PRP$	B-NP	O
are	be	VBP	B-VP	O
replaced	replace	VBN	I-VP	O
by	by	IN	B-PP	O
Phe	Phe	NN	B-NP	O
at	at	IN	B-PP	O
positions	position	NNS	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Accordingly	Accordingly	RB	B-ADVP	O
,	,	,	O	O
infection	infection	NN	B-NP	O
of	of	IN	B-PP	O
IFN	BEGIN-IFN-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
pretreated	pretreate	VBN	I-NP	O
HeLa	HeLa	NN	I-NP	O
S1	S1	NN	I-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
E1L	E1L	NN	I-NP	O
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
VV	VV	NN	I-NP	O
(	(	(	O	O
VVDeltaE1L	VVDeltaE1L	NN	B-NP	O
)	)	)	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
increased	increase	VBN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
PKR	BEGIN-PKR-INSIDE	NN	B-NP	B
and	and	CC	O	O
eIF1alpha	BEGIN-eIF1alpha-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
human	human	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
element	element	NN	I-NP	O
TGACTCT	TGACTCT	NN	I-NP	O
that	that	WDT	B-NP	O
also	also	RB	B-ADVP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
murine	BEGIN-murine	JJ	I-NP	B
ras	ras	NN	I-NP	I
-	-	HYPH	B-NP	I
responsive	responsive	JJ	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I

GAGA	BEGIN-GAGA	NN	B-NP	B
factor	factor-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
remodel	remodel	VB	I-VP	O
the	the	DT	B-NP	O
chromatin	chromatin	NN	I-NP	O
structure	structure	NN	I-NP	O
in	in	IN	B-PP	O
concert	concert	NN	B-NP	O
with	with	IN	B-PP	O
nucleosome	BEGIN-nucleosome	NN	B-NP	B
-	-	HYPH	O	I
remodeling	remodel	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
NURF	BEGIN-NURF-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Drosophila	Drosophila	FW	I-NP	O
embryonic	embryonic	JJ	I-NP	O
S1	S1	NN	I-NP	O
extract	extract	NN	I-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
camC	BEGIN-camC	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
along	along	IN	B-PP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
flanking	flanking	NN	I-NP	O
sequence	sequence	NN	I-NP	O

After	After	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
amifostine	amifostine	NN	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
morphology	morphology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MDS	MDS	NN	I-NP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
myelomonocytic	myelomonocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
CMML	CMML	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
appearance	appearance	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
continuously	continuously	RB	B-ADVP	O
increasing	increase	VBG	B-VP	O
leukocytes	leukocyte	NNS	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
we	we	PRP	B-NP	O
discontinued	discontinue	VBD	B-VP	O
amifostine	amifostine	NN	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
to	to	TO	B-VP	O
exclude	exclude	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
side	side	NN	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
amifostine	amifostine	NN	B-NP	O

A	A	DT	B-NP	O
gene	gene	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
sequence	sequence	NN	B-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
mammalian	BEGIN-mammalian	JJ	B-NP	B
ADP	ADP	NN	I-NP	I
-	-	HYPH	O	I
ribosylation	ribosylation	NN	B-NP	I
factors	factors-INSIDE	NN	I-NP	I
(	(	(	O	O
ARFs	BEGIN-ARFs-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
believed	believe	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
vesicular	vesicular	JJ	B-NP	O
transport	transport	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O

Theophylline	Theophylline	NNP	B-NP	O
QID	QID	NNP	I-NP	O
,	,	,	O	O
TID	TID	NNP	B-NP	O
,	,	,	O	O
BID	BID	NNP	B-NP	O
and	and	CC	O	O
now	now	RB	B-ADVP	O
QD	QD	VBN	B-VP	O
?	?	.	O	O
A	A	DT	B-NP	O
report	report	NN	I-NP	O
on	on	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
hour	hour	NN	I-NP	O
dosing	dosing	NN	I-NP	O
with	with	IN	B-PP	O
slow	slow	JJ	B-NP	O
-	-	HYPH	I-NP	O
release	release	NN	I-NP	O
theophylline	theophylline	NN	I-NP	O
formulations	formulation	NNS	I-NP	O
with	with	IN	B-PP	O
emphasis	emphasis	NN	B-NP	O
on	on	IN	B-PP	O
analyses	analysis	NNS	B-NP	O
of	of	IN	B-PP	O
data	datum	NNS	B-NP	O
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
Food	Food	NNP	B-NP	O
and	and	CC	I-NP	O
Drug	Drug	NNP	I-NP	O
Administration	Administration	NNP	I-NP	O
approval	approval	NN	I-NP	O
for	for	IN	B-PP	O
Theo	Theo	AFX	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

We	We	PRP	B-NP	O
anticipated	anticipate	VBD	B-VP	O
SNS	SNS	NN	B-NP	O
function	function	NN	I-NP	O
after	after	IN	B-PP	O
CVA	CVA	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
asymmetric	asymmetric	JJ	B-ADJP	O
and	and	CC	O	O
selected	select	VBN	B-VP	O
null	null	JJ	B-NP	O
hypotheses	hypothesis	NNS	I-NP	O
of	of	IN	B-PP	O
bilaterally	bilaterally	RB	B-NP	O
symmetric	symmetric	JJ	I-NP	O
SSR	SSR	NN	I-NP	O
latencies	latency	NNS	I-NP	O
and	and	CC	I-NP	O
amplitudes	amplitude	NNS	I-NP	O
irrespective	irrespective	JJ	B-ADJP	O
of	of	IN	B-PP	O
side	side	NN	B-NP	O
of	of	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
recording	record	VBG	B-VP	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
BSMV	BEGIN-BSMV	NN	I-NP	B
coat	coat	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
sole	sole	JJ	I-NP	O
translation	translation	NN	I-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genomic	BEGIN-genomic	JJ	I-NP	B
RNA	RNA	NN	I-NP	I
beta	beta-INSIDE	NN	I-NP	I
,	,	,	O	O
whereas	whereas	IN	O	O
sgRNA	BEGIN-sgRNA	NN	B-NP	B
beta	beta	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
serves	serve	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
messenger	messenger	NN	I-NP	O
for	for	IN	B-PP	O
translation	translation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
b	b	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
sgRNA	BEGIN-sgRNA	NN	B-NP	B
beta	beta	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
messenger	messenger	NN	I-NP	O
for	for	IN	B-PP	O
translation	translation	NN	B-NP	O
of	of	IN	B-PP	O
beta	BEGIN-beta	NN	B-NP	B
c	c-INSIDE	NN	I-NP	I
and	and	CC	O	O
beta	BEGIN-beta	NN	B-NP	B
d	d-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
newly	newly	RB	I-NP	O
discovered	discover	VBN	I-NP	O
beta	BEGIN-BEGIN-beta	NN	I-NP	B
d	d-INSIDE	NN	I-NP	I
'	'	''	I-NP	O
protein	protein-INSIDE	NN	I-NP	I

Without	Without	IN	B-PP	O
a	a	DT	B-NP	O
team	team	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
little	little	JJ	B-NP	O
hope	hope	NN	I-NP	O
for	for	IN	B-PP	O
fetal	fetal	JJ	B-NP	O
survival	survival	NN	I-NP	O
;	;	:	O	O
mortality	mortality	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
search	search	NN	I-NP	O
for	for	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
and	and	CC	I-NP	O
acquired	acquire	VBN	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
to	to	TO	B-PP	O
nontuberculous	nontuberculous	JJ	B-NP	O
mycobacteria	mycobacterium	NNS	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
search	search	NN	I-NP	O
for	for	IN	B-PP	O
susceptibility	susceptibility	NN	B-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
MTB	MTB	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
an	an	DT	B-NP	O
opportunity	opportunity	NN	I-NP	O
to	to	TO	B-VP	O
recognize	recognize	VB	I-VP	O
endogenous	endogenous	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
exploited	exploit	VBN	I-VP	O
therapeutically	therapeutically	RB	B-ADVP	O

This	This	DT	B-NP	O
gene	gene	NN	I-NP	O
is	be	VBZ	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
six	six	CD	B-NP	O
exons	exon	NNS	I-NP	O
spanning	span	VBG	B-VP	O
about	about	IN	B-PP	O
1kb	1kb	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
five	five	CD	I-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
Reg	Reg-INSIDE	NN	I-NP	I
(	(	(	O	O
regenerating	BEGIN-regenerating	JJ	B-NP	B
gene	gene	NN	I-NP	I
product	product-INSIDE	NN	I-NP	I
)	)	)	O	O
proteins	protein	NNS	B-NP	O

The	The	DT	B-NP	O
RNA	RNA	NN	I-NP	O
,	,	,	O	O
whether	whether	IN	B-SBAR	O
antisense	antisense	JJ	B-NP	O
,	,	,	I-NP	O
ribozyme	ribozyme	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
RNA	RNA	NN	B-NP	O
aptamer	aptamer	NN	I-NP	O
,	,	,	O	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
efficiently	efficiently	RB	I-VP	O
transcribed	transcribe	VBN	I-VP	O
,	,	,	O	O
stabilized	stabilize	VBN	B-VP	O
against	against	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
degradation	degradation	NN	I-NP	O
,	,	,	O	O
folded	fold	VBD	B-VP	O
correctly	correctly	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
directed	direct	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
most	most	RBS	B-ADJP	O
effective	effective	JJ	I-ADJP	O

Interconversions	Interconversion	NNS	B-NP	O
between	between	IN	B-PP	O
haloperidol	haloperidol	NN	B-NP	O
and	and	CC	O	O
reduced	reduce	VBN	B-NP	O
haloperidol	haloperidol	NN	I-NP	O
in	in	IN	B-PP	O
schizophrenic	schizophrenic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
guinea	guinea	NN	B-NP	O
pigs	pig	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
steady	steady	JJ	I-NP	O
-	-	HYPH	I-NP	O
state	state	NN	I-NP	O
study	study	NN	I-NP	O

PEAP	PEAP	NN	B-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
IDC	IDC	NN	B-NP	O
patients	patient	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
controls	control	NNS	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
vs	v	NNS	I-NP	O

Recurrent	Recurrent	JJ	B-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
episodic	episodic	JJ	B-NP	O
lymphopenia	lymphopenia	NN	I-NP	O
and	and	CC	O	O
impaired	impaired	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
immunity	immunity	NN	I-NP	O

Bilirubin	Bilirubin	NN	B-NP	O
and	and	CC	I-NP	O
red	red	JJ	I-NP	O
cell	cell	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
neonatal	neonatal	JJ	B-NP	O
jaundice	jaundice	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
renal	renal	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
who	who	WP	B-NP	O
experienced	experience	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
while	while	IN	B-SBAR	O
undergoing	undergo	VBG	B-VP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	I-NP	O
bolus	bolus	NN	I-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ade1	BEGIN-ade1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
a	a	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
kb	kb	NN	I-NP	I
Sau1A	Sau1A	NN	I-NP	I
insert	insert-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
shuttle	shuttle	NN	I-NP	O
vector	vector	NN	I-NP	O
pWH1	pWH1	NN	I-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
chitinolytic	chitinolytic	JJ	B-NP	O
enzymes	enzyme	NNS	I-NP	O
by	by	IN	B-PP	O
cultured	culture	VBN	B-NP	O
L.	L.	NN	I-NP	O
major	major	JJ	I-NP	O
parasites	parasite	NNS	I-NP	O
is	be	VBZ	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
blood	blood	NN	B-NP	O
or	or	CC	I-NP	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	I-NP	B
,	,	,	O	O
and	and	CC	O	O
hence	hence	RB	B-ADVP	O
these	these	DT	B-NP	O
enzymes	enzyme	NNS	I-NP	O
are	be	VBP	B-VP	O
apparently	apparently	RB	B-ADJP	O
absent	absent	JJ	I-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
-	-	HYPH	O	O
fed	feed	VBN	B-VP	O
infected	infected	JJ	B-NP	O
flies	fly	NNS	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
valve	valve	NN	I-NP	O
appears	appear	VBZ	B-VP	O
undamaged	undamaged	JJ	B-ADJP	O

Oral	Oral	JJ	B-NP	O
hypoglycemic	hypoglycemic	JJ	I-NP	O
agents	agent	NNS	I-NP	O

Identification	Identification	NN	B-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
yeast	yeast	NN	I-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
U1	BEGIN-U1	NN	I-NP	B
small	small	JJ	I-NP	I
nuclear	nuclear	JJ	I-NP	I
ribonucleoprotein	ribonucleoprotein	NN	I-NP	I
particle	particle	NN	I-NP	I
B	B	NN	I-NP	I
''	''	''	I-NP	I
protein	protein-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
false	false	JJ	I-NP	O
positive	positive	JJ	I-NP	O
fraction	fraction	NN	I-NP	O
(	(	(	O	O
FPF	FPF	NN	B-NP	O
)	)	)	O	O
decreased	decrease	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
count	count	NN	I-NP	O
density	density	NN	I-NP	O
increased	increase	VBD	B-VP	O
;	;	:	O	O
no	no	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
FPF	FPF	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
lesion	lesion	NN	B-NP	O
tracer	tracer	NN	I-NP	O
concentration	concentration	NN	I-NP	O

Members	Member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CRE	BEGIN-CRE	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
CREB	BEGIN-CREB-INSIDE	NN	B-NP	B
)	)	)	O	O
/	/	SYM	B-NP	O
activating	BEGIN-activating	JJ	I-NP	B
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
family	family	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Jun	BEGIN-Jun-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Fos	BEGIN-Fos-INSIDE	NN	I-NP	B
family	family	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
sequence	sequence	NN	I-NP	O

Nature	Nature	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
thermopower	thermopower	NN	I-NP	O
in	in	IN	B-PP	O
bipolar	bipolar	JJ	B-NP	O
semiconductors	semiconductor	NNS	I-NP	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
SNURF	BEGIN-SNURF-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	O
mammalian	mammalian	JJ	I-NP	O
cells	cell	NNS	I-NP	O
enhanced	enhance	VBD	B-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
androgen	androgen	NN	B-NP	O
,	,	,	O	O
glucocorticoid	glucocorticoid	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
progesterone	BEGIN-progesterone	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
transactivation	transactivation	NN	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
basal	basal	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
from	from	IN	B-PP	O
steroid	steroid	NN	B-NP	O
-	-	HYPH	B-NP	O
regulated	regulate	VBN	I-NP	O
promoters	promoter	NNS	I-NP	O

Long	Long	JJ	B-NP	O
-	-	HYPH	I-NP	O
range	range	NN	I-NP	O
mapping	mapping	NN	I-NP	O
by	by	IN	B-PP	O
pulse	pulse	NN	B-NP	O
-	-	HYPH	I-NP	O
field	field	NN	I-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
mdr	BEGIN-mdr	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
closely	closely	RB	I-VP	O
linked	link	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
segment	segment	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
kilobases	kilobas	NNS	I-NP	O

Oral	Oral	JJ	B-NP	O
basal	basal	JJ	I-NP	O
body	body	NN	I-NP	O
temperature	temperature	NN	I-NP	O
(	(	(	O	O
BBT	BBT	NN	B-NP	O
)	)	)	O	O
recordings	recording	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
women	woman	NNS	I-NP	O
that	that	WDT	B-NP	O
conceived	conceive	VBD	B-VP	O
by	by	IN	B-PP	O
donor	donor	NN	B-NP	O
insemination	insemination	NN	I-NP	O
and	and	CC	O	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
midcycle	midcycle	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
luteinising	BEGIN-luteinising	JJ	B-NP	B
hormone	hormone-INSIDE	NN	I-NP	I
(	(	(	O	O
LH	BEGIN-LH-INSIDE	NN	B-NP	B
)	)	)	O	O
were	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
to	to	TO	I-VP	O
establish	establish	VB	I-VP	O
features	feature	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
optimal	optimal	JJ	I-NP	O
cycle	cycle	NN	I-NP	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
start	start	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
performance	performance	NN	I-NP	O
ride	ride	NN	I-NP	O
,	,	,	O	O
plasma	plasma	NN	B-NP	O
glucose	glucose	NN	I-NP	O
averaged	average	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mmol.l	mmol.l	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
CON	CON	NN	B-NP	O
,	,	,	O	O
CHO	CHO	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CHO	CHO	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
(	(	(	O	O
all	all	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Adhesion	Adhesion	NN	B-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
mAbs	mAb	NNS	B-NP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
COOH	COOH	NN	I-NP	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
and	and	CC	I-NP	O
central	central	JJ	I-NP	O
cell	cell	NN	I-NP	O
binding	binding	NN	I-NP	O
domains	domain	NNS	I-NP	O
of	of	IN	B-PP	O
fibronectin	BEGIN-fibronectin-INSIDE	NN	B-NP	B
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
CS1	BEGIN-CS1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
RGD	BEGIN-RGD	NN	I-NP	B
peptides	peptides-INSIDE	NN	I-NP	I

Usher	Usher	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
1C	1C	NN	I-NP	O
(	(	(	O	O
USH1C	USH1C	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
congenital	congenital	JJ	I-NP	O
condition	condition	NN	I-NP	O
manifesting	manifest	VBG	B-VP	O
profound	profound	JJ	B-NP	O
hearing	hearing	NN	I-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
vestibular	vestibular	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
eventual	eventual	JJ	B-NP	O
retinal	retinal	NN	I-NP	O
degeneration	degeneration	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
determined	determine	VBN	I-VP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
cDNA	cDNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
rat	BEGIN-rat	NN	B-NP	B
plectin	plectin-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
well	well	RB	B-NP	O
-	-	HYPH	I-NP	O
characterized	characterize	VBN	B-VP	O
overlapping	overlap	VBG	B-VP	O
lambda	lambda	NN	B-NP	O
gt1	gt1	NN	I-NP	O
clones	clone	NNS	I-NP	O

Minute	BEGIN-Minute	JJ	B-NP	B
virus	virus	NN	I-NP	I
of	of	IN	B-PP	I
mice	mouse	NNS	B-NP	I
NS1	NS1-INSIDE	NN	I-NP	I
,	,	,	O	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
mainly	mainly	RB	B-NP	O
nuclear	nuclear	JJ	I-NP	O
phosphoprotein	phosphoprotein	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
only	only	RB	I-NP	O
viral	viral	JJ	I-NP	O
nonstructural	nonstructural	JJ	I-NP	O
protein	protein	NN	I-NP	O
required	require	VBN	B-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
processes	process	NNS	I-NP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
virus	virus	NN	B-NP	O
propagation	propagation	NN	I-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
we	we	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
acceptor	acceptor	NN	I-NP	O
peptide	peptide	NN	I-NP	O
binds	bind	VBZ	B-VP	O
the	the	DT	B-NP	O
transferase	transferase	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
like	like	JJ	I-NP	O
conformation	conformation	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
penultimate	penultimate	JJ	B-NP	O
residue	residue	NN	I-NP	O
side	side	NN	I-NP	O
chain	chain	NN	I-NP	O
steric	steric	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
determining	determine	VBG	B-VP	O
extent	extent	NN	B-NP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
given	give	VBN	I-NP	O
Ser	Ser	NN	I-NP	O
or	or	CC	I-NP	O
Thr	Thr	NN	I-NP	O
is	be	VBZ	B-VP	O
glycosylated	glycosylate	VBN	I-VP	O

A	A	DT	B-NP	O
higher	high	JJR	I-NP	O
median	median	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
spirochaetes	spirochaete	NNS	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
sites	site	NNS	B-NP	O
after	after	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O
of	of	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
attachment	attachment	NN	B-NP	O

Conventional	Conventional	JJ	B-NP	O
and	and	CC	I-NP	O
digital	digital	JJ	I-NP	O
radiography	radiography	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
aorta	aorta	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
vascularity	vascularity	NN	I-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O

Although	Although	IN	B-SBAR	O
cDNA	cDNA	NN	B-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
phagocyte	phagocyte	NN	I-NP	I
formyl	formyl	NN	I-NP	I
peptide	peptide	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
recently	recently	RB	B-ADVP	O
(	(	(	O	O
Boulay	Boulay	NNP	B-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
,	,	,	O	O
Tardif	Tardif	NNP	B-NP	O
,	,	,	O	O
M.	M.	NNP	B-NP	O
,	,	,	O	O
Brouchon	Brouchon	NNP	B-NP	O
,	,	,	O	O
L.	L.	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Vignais	Vignais	NNP	B-NP	O
,	,	,	O	O
P	P	NNP	B-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
PVB	PVB	NN	I-NP	O
therapy	therapy	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
cure	cure	VB	I-VP	O
the	the	DT	B-NP	O
cases	case	NNS	I-NP	O
with	with	IN	B-PP	O
choriocarcinoma	choriocarcinoma	NN	B-NP	O
element	element	NN	I-NP	O
or	or	CC	O	O
bulky	bulky	JJ	B-NP	O
metastasis	metastasis	NN	I-NP	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
spatial	spatial	JJ	I-NP	O
counting	counting	NN	I-NP	O
approach	approach	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
location	location	NN	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
and	and	CC	I-NP	O
every	every	DT	I-NP	O
PN	PN	NN	I-NP	O
and	and	CC	I-NP	O
NP	NP	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stratum	stratum	NN	I-NP	O
pyramidale	pyramidale	NN	I-NP	O
of	of	IN	B-PP	O
sectors	sector	NNS	B-NP	O
CA1	CA1	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
normal	normal	JJ	I-NP	O
control	control	NN	I-NP	O
(	(	(	O	O
CONs	CON	NNS	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
SZs	SZ	NNS	I-NP	O
matched	match	VBN	B-VP	O
for	for	IN	B-PP	O
age	age	NN	B-NP	O
and	and	CC	I-NP	O
postmortem	postmortem	NN	I-NP	O
interval	interval	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
1	1	CD	B-NP	O
manic	manic	JJ	I-NP	O
depressive	depressive	JJ	I-NP	O
(	(	(	O	O
MD	MD	NN	B-NP	O
)	)	)	O	O
subjects	subject	NNS	B-NP	O
matched	match	VBN	B-VP	O
for	for	IN	B-PP	O
age	age	NN	B-NP	O

No	No	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
phorbol	phorbol	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
myristate	myristate	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
acetate	acetate	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
hnRNP	BEGIN-hnRNP	NN	B-NP	B
H	H-INSIDE	NN	I-NP	I

For	For	IN	B-PP	O
large	large	JJ	B-NP	O
breasts	breast	NNS	I-NP	O
(	(	(	O	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
)	)	)	O	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
X	X	NN	B-NP	O
-	-	HYPH	I-NP	O
ray	ray	NN	I-NP	O
sets	set	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
IGE	IGE	NN	I-NP	O
DMR	DMR	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
automatically	automatically	RB	B-ADVP	O
select	select	VBP	B-VP	O
the	the	DT	B-NP	O
beam	beam	NN	I-NP	O
quality	quality	NN	I-NP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
breast	breast	NN	I-NP	O
,	,	,	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
doses	dose	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
sets	set	NNS	B-NP	O
using	use	VBG	B-VP	O
manual	manual	JJ	B-NP	O
tube	tube	NN	I-NP	O
potential	potential	NN	I-NP	O
selection	selection	NN	I-NP	O

First	First	RB	B-ADVP	O
,	,	,	O	O
ste1Delta	BEGIN-ste1Delta-INSIDE	NN	B-NP	B
cells	cell	NNS	I-NP	O
differ	differ	VBP	B-VP	O
from	from	IN	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
disruptions	disruption	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
elements	element	NNS	I-NP	O
(	(	(	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	O	O
ste1Delta	BEGIN-ste1Delta-INSIDE	NN	B-NP	B
,	,	,	O	O
ste1Delta	BEGIN-ste1Delta-INSIDE	NN	B-NP	B
,	,	,	O	O
ste1Delta	BEGIN-ste1Delta-INSIDE	NN	B-NP	B
,	,	,	O	O
ste1Delta	BEGIN-ste1Delta-INSIDE	NN	B-NP	B
,	,	,	O	O
ste1Delta	BEGIN-ste1Delta-INSIDE	NN	B-NP	B
,	,	,	O	O
or	or	CC	O	O
fus1Delta	BEGIN-fus1Delta-INSIDE	NN	B-NP	B
kss1Delta	BEGIN-kss1Delta-INSIDE	NN	I-NP	B
cells	cell	NNS	I-NP	O
)	)	)	O	O
in	in	IN	B-SBAR	O
that	that	IN	I-SBAR	O
they	they	PRP	B-NP	O
clearly	clearly	RB	B-ADVP	O
retain	retain	VBP	B-VP	O
some	some	DT	B-NP	O
capacity	capacity	NN	I-NP	O
for	for	IN	B-PP	O
inducing	induce	VBG	B-VP	O
Ste1p	BEGIN-Ste1p-INSIDE	NN	B-NP	B
phosphorylation	phosphorylation	NN	I-NP	O

The	The	DT	B-NP	O
Valpha	BEGIN-Valpha-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
Vbeta	BEGIN-Vbeta	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
have	have	VBP	B-VP	O
the	the	DT	B-NP	O
canonical	canonical	JJ	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
known	known	JJ	B-NP	O
teleost	BEGIN-teleost	JJ	I-NP	B
and	and	CC	I-NP	I
mammalian	mammalian	JJ	I-NP	I
TCR	TCR	NN	I-NP	I
V	V	NN	I-NP	I
domains	domains-INSIDE	NN	I-NP	I
,	,	,	O	O
including	include	VBG	B-PP	O
conserved	conserve	VBN	B-NP	O
residues	residue	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
of	of	IN	B-PP	O
FR1	BEGIN-FR1-INSIDE	NN	B-NP	B
and	and	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
FR1	BEGIN-FR1-INSIDE	NN	B-NP	B

Asthma	Asthma	NN	B-NP	O
diagnoses	diagnosis	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
recommended	recommend	VBN	B-NP	O
National	National	NNP	I-NP	O
Asthma	Asthma	NNP	I-NP	O
Expert	Expert	NNP	I-NP	O
Panel	Panel	NNP	I-NP	O
Guidelines	Guidelines	NNP	I-NP	O

The	The	DT	B-NP	O
atpA	BEGIN-atpA-INSIDE	NN	I-NP	B
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
ends	end	VBZ	B-VP	O
with	with	IN	B-PP	O
four	four	CD	B-NP	O
tandem	tandem	JJ	I-NP	O
UGA	UGA	NN	I-NP	O
codons	codon	NNS	I-NP	O
which	which	WDT	B-NP	O
overlap	overlap	VBP	B-VP	O
four	four	CD	B-NP	O
tandem	tandem	JJ	I-NP	O
AUG	AUG	NN	I-NP	O
codons	codon	NNS	I-NP	O
initiating	initiate	VBG	B-VP	O
an	an	DT	B-NP	O
unidentified	unidentified	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
,	,	,	O	O
orf1	orf1	NN	B-NP	O

Deletion	Deletion	NN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
PRE	PRE	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
exist	exist	VB	I-VP	O
downstream	downstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
UL1	BEGIN-UL1	NN	I-NP	B
mRNA	mRNA	NN	I-NP	I
start	start	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
,	,	,	O	O
while	while	IN	B-SBAR	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
NRE	NRE	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O

An	An	DT	B-NP	O
ERp1	BEGIN-ERp1	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
the	the	DT	B-NP	O
filarial	filarial	JJ	I-NP	O
parasite	parasite	NN	I-NP	O
Dirofilaria	Dirofilaria	NN	I-NP	O
immitis	immitis	NN	I-NP	O
has	have	VBZ	B-VP	O
both	both	CC	O	O
transglutaminase	transglutaminase	NN	B-NP	O
and	and	CC	O	O
protein	protein	NN	B-NP	O
disulfide	disulfide	NN	I-NP	O
isomerase	isomerase	NN	I-NP	O
activity	activity	NN	I-NP	O

Fos	BEGIN-Fos-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
Jun	BEGIN-Jun-INSIDE	NN	I-NP	B
bound	bind	VBN	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
unacetylated	unacetylated	JJ	I-NP	O
nucleosome	nucleosome	NN	I-NP	O
with	with	IN	B-PP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
affinity	affinity	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
naked	naked	JJ	B-NP	O
DNA	DNA	NN	I-NP	O

Pediatric	Pediatric	JJ	B-NP	O
patients	patient	NNS	I-NP	O
-	-	HYPH	O	O
-	-	HYPH	O	O
handle	handle	NN	B-NP	O
with	with	IN	B-PP	O
care	care	NN	B-NP	O

K	K	NN	B-NP	O

The	The	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
diameters	diameter	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
and	and	CC	I-NP	O
middle	middle	JJ	I-NP	O
segments	segment	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ramus	Ramus	NNP	I-NP	O
interventricularis	interventriculari	VBZ	B-VP	O
anterior	anterior	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
middle	middle	JJ	I-NP	O
segment	segment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ramus	Ramus	NN	I-NP	O
circumflexus	circumflexus	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

S1	BEGIN-S1	NN	B-NP	B
nuclease	nuclease-INSIDE	NN	I-NP	I
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
QT1	QT1	NN	B-NP	O
-	-	HYPH	O	O
LD	LD	NN	B-NP	O
clones	clone	NNS	I-NP	O
gave	give	VBD	B-VP	O
similar	similar	JJ	B-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
LD	LD	NNP	I-NP	O
population	population	NN	I-NP	O
was	be	VBD	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
viruses	virus	NNS	B-NP	O
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
identical	identical	JJ	I-NP	O
deletion	deletion	NN	I-NP	O
endpoints	endpoint	NNS	I-NP	O

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
ocular	ocular	JJ	B-NP	O
/	/	SYM	I-NP	O
adnexal	adnexal	JJ	I-NP	O
SCC	SCC	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
hair	hair	NN	I-NP	O
colors	color	NNS	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
bay	bay	NN	B-NP	O
,	,	,	O	O
brown	brown	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
black	black	JJ	O	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

ZNS	ZNS	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mmolar	mmolar	JJ	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
scavenged	scavenge	VBD	B-VP	O
hydroxyl	hydroxyl	NN	B-NP	O
and	and	CC	O	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
radicals	radical	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O

Murine	BEGIN-Murine	JJ	B-NP	B
ELAM	ELAM	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
copy	copy	NN	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
spanning	span	VBG	B-VP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
structurally	structurally	RB	I-VP	O
organized	organize	VBN	I-VP	O
into	into	IN	B-PP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
introns	intron	NNS	I-NP	O
;	;	:	O	O
very	very	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
human	human	JJ	I-NP	O
counterpart	counterpart	NN	I-NP	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
more	more	JJR	I-NP	O
slower	slow	JJR	I-NP	O
migrating	migrate	VBG	I-NP	O
Stat1B	BEGIN-Stat1B-INSIDE	NN	I-NP	B
bands	band	NNS	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
GH	BEGIN-GH-INSIDE	NN	B-NP	B
contain	contain	VB	B-VP	O
phosphorylated	phosphorylate	VBN	B-NP	O
tyrosyl	tyrosyl	NN	I-NP	O
residues	residue	NNS	I-NP	O

Protection	Protection	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
were	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
in	in	IN	B-PP	O
groups	group	NNS	B-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
krad	krad	NN	I-NP	O
cercariae	cercariae	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
krad	krad	NN	I-NP	O
cercariae	cercariae	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
krad	krad	NN	I-NP	O
cercariae	cercariae	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
krad	krad	NN	I-NP	O
cercariae	cercariae	NNS	I-NP	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
1st	1st	JJ	I-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
all	all	DT	B-NP	O
subjects	subject	NNS	I-NP	O
received	receive	VBD	B-VP	O
either	either	CC	O	O
mianserin	mianserin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
or	or	CC	O	O
clomipramine	clomipramine	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O

EMBO	EMBO	NN	B-NP	O
(	(	(	O	O
Eur	Eur	NNP	B-NP	O

When	When	WRB	B-ADVP	O
stratifying	stratify	VBG	B-VP	O
FLM	FLM	NN	B-NP	O
values	value	NNS	I-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
>	>	JJR	I-NP	O
1	1	CD	I-NP	O
wks	wk	NNS	I-NP	O
'	'	POS	B-NP	O
gestation	gestation	NN	I-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
no	no	DT	B-NP	O
difference	difference	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
mean	mean	JJ	B-NP	O
difference	difference	NN	I-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	O
/	/	SYM	B-NP	O
S	S	NN	I-NP	O
and	and	CC	I-NP	O
LB	LB	NN	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
1	1	CD	B-NP	O
wks	wk	NNS	I-NP	O

Are	Be	VBP	O	O
there	there	EX	B-NP	O
any	any	DT	B-NP	O
lessons	lesson	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
learnt	learnt	NN	B-NP	O

The	The	DT	B-NP	O
other	other	JJ	I-NP	O
five	five	CD	I-NP	O
from	from	IN	B-PP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
SRO	SRO	NN	I-NP	O
may	may	MD	B-VP	O
provide	provide	VB	I-VP	O
an	an	DT	B-NP	O
entrance	entrance	NN	I-NP	O
point	point	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
candidate	candidate	NN	B-NP	O
genes	gene	NNS	I-NP	O
for	for	IN	B-PP	O
neuroblastoma	neuroblastoma	NN	B-NP	O

Three	Three	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
human	BEGIN-human	JJ	I-NP	B
HDACs	HDACs-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
RPD1	BEGIN-RPD1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
yeast	yeast	NN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulator	regulator	NN	I-NP	O

The	The	DT	B-NP	O
longest	long	JJS	I-NP	O
cDNA	cDNA	NN	I-NP	O
insert	insert	NN	I-NP	O
identified	identify	VBD	B-VP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
and	and	CC	O	O
encoded	encode	VBD	B-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
of	of	IN	B-PP	O
rat	BEGIN-rat	NN	B-NP	B
CgA	CgA-INSIDE	NN	I-NP	I
including	include	VBG	B-PP	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
hydrophobic	hydrophobic	JJ	I-NP	O
signal	signal	NN	I-NP	O
peptide	peptide	NN	I-NP	O

The	The	DT	B-NP	O
vaccine	vaccine	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
efficacious	efficacious	JJ	I-NP	O
against	against	IN	B-PP	O
Chlamydia	Chlamydia	NNP	B-NP	O
and	and	CC	I-NP	O
Campylobacter	Campylobacter	NNP	I-NP	O
spp	spp	NN	I-NP	O
and	and	CC	O	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
protective	protective	JJ	B-ADJP	O

The	The	DT	B-NP	O
RPC1	BEGIN-RPC1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
C1	BEGIN-C1	NN	I-NP	B
subunit	subunit	NN	I-NP	I
of	of	IN	B-PP	I
Saccharomyces	Saccharomyces	NNP	B-NP	I
cerevisiae	cerevisiae	NNP	I-NP	I
RNA	RNA	NN	I-NP	I
polymerase	polymerase	NN	I-NP	I
C	C	NN	I-NP	I
(	(	(	O	I
III	III	CD	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
isolated	isolate	VBN	I-VP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
fragment	fragment	NN	I-NP	O
cloned	clone	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
lambda	lambda	SYM	I-NP	O
gt1	gt1	NN	I-NP	O
library	library	NN	I-NP	O

Slowly	Slowly	RB	B-ADVP	O
adapting	adapt	VBG	B-VP	O
type	type	NN	B-NP	O
I	I	CD	I-NP	O
mechanoreceptor	mechanoreceptor	NN	I-NP	O
discharge	discharge	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
dynamic	dynamic	JJ	B-NP	O
force	force	NN	I-NP	O
versus	versus	IN	B-PP	O
dynamic	dynamic	JJ	B-NP	O
displacement	displacement	NN	I-NP	O
of	of	IN	B-PP	O
glabrous	glabrous	JJ	B-NP	O
skin	skin	NN	I-NP	O
of	of	IN	B-PP	O
raccoon	raccoon	NN	B-NP	O
and	and	CC	I-NP	O
squirrel	squirrel	NN	I-NP	O
monkey	monkey	NN	I-NP	O
hand	hand	NN	I-NP	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
investigation	investigation	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
BMIPP	BMIPP	NN	B-NP	O
uptake	uptake	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
differentiate	differentiate	VB	I-VP	O
viable	viable	JJ	B-NP	O
myocardium	myocardium	NN	I-NP	O
from	from	IN	B-PP	O
scar	scar	NN	B-NP	O
tissue	tissue	NN	I-NP	O
soon	soon	RB	B-ADVP	O
after	after	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
thrombolysis	thrombolysis	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O

The	The	DT	B-NP	O
same	same	JJ	I-NP	O
slice	slice	NN	I-NP	O
was	be	VBD	B-VP	O
imaged	image	VBN	I-VP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
each	each	DT	B-NP	O
with	with	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
using	use	VBG	B-VP	O
spatial	spatial	JJ	B-NP	O
presaturation	presaturation	NN	I-NP	O
or	or	CC	O	O
not	not	RB	O	O

IRIS	BEGIN-IRIS-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
GAS	BEGIN-GAS-INSIDE	NN	I-NP	B
DNA	DNA	NN	I-NP	O
also	also	RB	B-ADVP	O
formed	form	VBD	B-VP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
complexes	complex	NNS	I-NP	O
with	with	IN	B-PP	O
constitutively	constitutively	RB	B-NP	O
expressed	express	VBN	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
Abs	Ab	NNS	I-NP	O

Making	Make	VBG	B-VP	O
sense	sense	NN	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
sensor	sensor	NN	I-NP	O

Recovery	Recovery	NN	B-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
energy	energy	NN	B-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
intracellular	intracellular	JJ	B-NP	O
pH	pH	NN	I-NP	O
during	during	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
at	at	IN	B-PP	O
1Hz	1Hz	NN	B-NP	O
were	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
observed	observe	VBN	B-VP	O
during	during	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
at	at	IN	B-PP	O
1Hz	1Hz	NN	B-NP	O

The	The	DT	B-NP	O
Zn	BEGIN-Zn	NN	I-NP	B
-	-	HYPH	O	I
1	1	CD	B-NP	I
DNA	DNA	NN	I-NP	I
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
domain	domain-INSIDE	NN	I-NP	I
comprises	comprise	VBZ	B-VP	O
three	three	CD	B-NP	O
zinc	zinc	NN	I-NP	O
fingers	finger	NNS	I-NP	O
separated	separate	VBN	B-VP	O
by	by	IN	B-PP	O
unusually	unusually	RB	B-NP	O
long	long	JJ	I-NP	O
linker	linker	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
that	that	WDT	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
expected	expect	VBN	I-VP	O
to	to	TO	I-VP	O
interrupt	interrupt	VB	I-VP	O
specific	specific	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
site	site	NN	I-NP	O
recognition	recognition	NN	I-NP	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
included	include	VBD	B-VP	O
1	1	LS	B-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
teased	tease	VBN	I-NP	O
myelinated	myelinated	JJ	I-NP	O
fibers	fiber	NNS	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
upper	upper	JJ	I-NP	O
limit	limit	NN	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
confidence	confidence	NN	I-NP	O
interval	interval	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	LS	B-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
densities	density	NNS	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
,	,	,	I-NP	O
large	large	JJ	I-NP	O
and	and	CC	I-NP	O
small	small	JJ	I-NP	O
myelinated	myelinated	JJ	I-NP	O
fibers	fiber	NNS	I-NP	O
and	and	CC	B-PP	O
of	of	IN	B-PP	O
unmyelinated	unmyelinated	JJ	B-NP	O
fibers	fiber	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
lower	low	JJR	I-NP	O
limit	limit	NN	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
confidence	confidence	NN	I-NP	O
interval	interval	NN	I-NP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
decade	decade	NN	I-NP	O

The	The	DT	B-NP	O
yield	yield	NN	I-NP	O
of	of	IN	B-PP	O
endocervical	endocervical	JJ	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
dysplasia	dysplasia	NN	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
for	for	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
prenatal	prenatal	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
postpartum	postpartum	NN	I-NP	O
Pap	Pap	NN	I-NP	O
smears	smear	NNS	I-NP	O
performed	perform	VBN	B-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O

Others	Other	NNS	B-NP	O
as	as	IN	B-PP	O
for	for	IN	B-PP	O
example	example	NN	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
labeled	label	VBN	I-NP	O
short	short	JJ	I-NP	O
chain	chain	NN	I-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
are	be	VBP	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
horizon	horizon	NN	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
BR	BEGIN-BR	NN	I-NP	B
-	-	HYPH	B-NP	I
C	C	NN	I-NP	I
early	early	JJ	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
directly	directly	RB	B-ADVP	O
activates	activate	VBZ	B-VP	O
late	BEGIN-late	JJ	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
by	by	IN	B-PP	O
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
late	BEGIN-late	JJ	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
cis	cis	NN	I-NP	O
-	-	HYPH	B-PP	O
acting	act	VBG	B-NP	O
regulatory	regulatory	JJ	I-NP	O
elements	element	NNS	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
temporal	temporal	JJ	I-NP	O
linkage	linkage	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
and	and	CC	I-NP	O
late	late	JJ	I-NP	O
ecdysone	ecdysone	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O

Exogenous	Exogenous	JJ	B-NP	O
heart	heart	NN	I-NP	O
stress	stress	NN	I-NP	O
raised	raise	VBD	B-VP	O
log	log	NN	B-NP	O
circulating	circulate	VBG	B-VP	O
NE	NE	NN	B-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
proportion	proportion	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
given	give	VBN	I-NP	O
work	work	NN	I-NP	O
load	load	NN	I-NP	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
the	the	DT	B-NP	O
usual	usual	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
these	these	DT	B-NP	O
variables	variable	NNS	I-NP	O
,	,	,	O	O
previously	previously	RB	B-VP	O
observed	observe	VBN	I-VP	O
during	during	IN	B-PP	O
other	other	JJ	B-NP	O
stresses	stress	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
preserved	preserve	VBN	I-VP	O

We	We	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
PEH	PEH	NN	B-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
reductions	reduction	NNS	B-NP	O
in	in	IN	B-PP	O
TPR	TPR	NN	B-NP	O
and	and	CC	O	O
sympathetic	sympathetic	JJ	B-NP	O
nerve	nerve	NN	I-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
SNA	SNA	NN	B-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
short	short	JJ	I-NP	O
conserved	conserve	VBN	I-NP	O
motif	motif	NN	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
repressor	repressor	NN	B-NP	O
domain	domain	NN	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
myeloid	myeloid	JJ	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
CCAAT	BEGIN-CCAAT	NN	I-NP	B
/	/	SYM	B-NP	I
enhancer	enhancer	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein	NN	B-NP	I
epsilon	epsilon-INSIDE	NN	I-NP	I

Purified	Purify	VBN	B-NP	O
fER	BEGIN-fER-INSIDE	NN	I-NP	B
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
distribution	distribution	NN	I-NP	O
constant	constant	NN	I-NP	O
(	(	(	O	O
KD	KD	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
estradiol	estradiol	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
nM	nM	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
strains	strain	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
most	most	RBS	I-NP	O
highly	highly	RB	I-NP	O
related	related	JJ	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
DdPIK1	BEGIN-DdPIK1-INSIDE	NN	B-NP	B
and	and	CC	O	O
DdPIK1	BEGIN-DdPIK1-INSIDE	NN	B-NP	B
,	,	,	O	O
were	be	VBD	B-VP	O
disrupted	disrupt	VBN	I-VP	O
showed	show	VBD	B-VP	O
both	both	CC	O	O
growth	growth	NN	B-NP	O
and	and	CC	O	O
developmental	developmental	JJ	B-NP	O
defects	defect	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
double	double	JJ	B-NP	O
knockouts	knockout	NNS	I-NP	O
of	of	IN	B-PP	O
DdPIK1	BEGIN-DdPIK1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
DdPIK1	BEGIN-DdPIK1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
DdPIK1	BEGIN-DdPIK1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
DdPIK1	BEGIN-DdPIK1-INSIDE	NN	I-NP	B
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
lethal	lethal	JJ	B-ADJP	O

The	The	DT	B-NP	O
exon	exon	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
determined	determine	VBN	B-VP	O
from	from	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
differences	difference	NNS	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
published	publish	VBN	I-NP	O
rat	BEGIN-rat	NN	I-NP	B
GLUT1	GLUT1	NN	I-NP	I
cDNA	cDNA-INSIDE	NN	I-NP	I

1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
in	in	IN	B-PP	O
R1	R1	NN	B-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AUC	AUC	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
PR	PR	NN	B-NP	O
vs	v	NNS	I-NP	O

This	This	DT	B-NP	O
integration	integration	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
MMTV	BEGIN-MMTV	NN	B-NP	B
/	/	SYM	I-NP	I
mdr1	mdr1	NN	I-NP	I
fusion	fusion	NN	I-NP	I
transcripts	transcripts-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
originate	originate	VBP	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
antisense	antisense	JJ	I-NP	O
1'LTR	BEGIN-1'LTR-INSIDE	NN	I-NP	B
of	of	IN	B-PP	O
the	the	DT	B-NP	O
provirus	provirus	NN	I-NP	O

This	This	DT	B-NP	O
surface	surface	NN	I-NP	O
in	in	IN	B-PP	O
specimens	specimen	NNS	B-NP	O
from	from	IN	B-PP	O
unfertilized	unfertilized	JJ	B-NP	O
eggs	egg	NNS	I-NP	O
is	be	VBZ	B-VP	O
almost	almost	RB	B-ADJP	O
flat	flat	JJ	I-ADJP	O

Following	Follow	VBG	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
``	``	``	I-NP	O
ischemia	ischemia	NN	I-NP	O
''	''	''	O	O
,	,	,	O	O
preparations	preparation	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
PC	PC	NN	B-NP	O
recovered	recover	VBN	B-VP	O
from	from	IN	B-PP	O
transmural	transmural	JJ	B-NP	O
conduction	conduction	NN	I-NP	O
block	block	NN	I-NP	O
more	more	RBR	B-ADVP	O
rapidly	rapidly	RB	I-ADVP	O
(	(	(	B-NP	O
PC1	PC1	NN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
;	;	:	O	O
PC1	PC1	NN	B-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
,	,	,	O	O
ns	n	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
compared	compare	VBN	B-VP	O
to	to	TO	I-VP	O
control.	control.	VB	I-VP	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-NP	O
1	1	CD	I-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
myogenic	myogenic	JJ	I-NP	O
lineage	lineage	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
desmin	BEGIN-desmin-INSIDE	NN	B-NP	B

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
DEAD	BEGIN-DEAD	NN	I-NP	B
box	box	NN	I-NP	I
ATPase	ATPase-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
RNA	BEGIN-RNA	NN	I-NP	B
helicase	helicase-INSIDE	NN	I-NP	I
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
Arabidopsis	Arabidopsis	NNP	B-NP	O
thaliana	thaliana	NNP	I-NP	O

The	The	DT	B-NP	O
host	host	NN	I-NP	O
range	range	NN	I-NP	O
(	(	(	O	O
HR	HR	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
poliovirus	poliovirus	NN	B-NP	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
primarily	primarily	RB	I-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
molecule	molecule	NN	I-NP	O
that	that	WDT	B-NP	O
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
poliovirus	BEGIN-poliovirus	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
PVR	BEGIN-PVR-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
since	since	IN	B-SBAR	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
are	be	VBP	B-VP	O
made	make	VBN	I-VP	O
poliovirus	poliovirus	NN	B-NP	O
sensitive	sensitive	JJ	B-ADJP	O
by	by	IN	B-PP	O
introducing	introduce	VBG	B-VP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
PVR	BEGIN-PVR-INSIDE	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
into	into	IN	B-PP	O
the	the	DT	B-NP	O
genome	genome	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
paper	paper	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
used	use	VBD	B-VP	O
measured	measure	VBN	B-NP	O
weight	weight	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
white	white	JJ	I-NP	O
women	woman	NNS	I-NP	O
aged	age	VBN	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Epidemiologic	Epidemiologic	JJ	I-NP	O
Follow	Follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
Study	Study	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
First	First	NNP	I-NP	O
National	National	NNP	I-NP	O
Health	Health	NNP	I-NP	O
and	and	CC	O	O
Nutrition	Nutrition	NNP	B-NP	O
Examination	Examination	NNP	I-NP	O
Survey	Survey	NNP	I-NP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
overweight	overweight	NN	B-NP	O
on	on	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
incidence	incidence	NN	I-NP	O
(	(	(	O	O
mean	mean	JJ	B-NP	O
length	length	NN	I-NP	O
of	of	IN	B-PP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
,	,	,	O	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
reciprocal	reciprocal	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
Gab1	BEGIN-Gab1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Gab1	BEGIN-Gab1-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
mediating	mediate	VBG	B-VP	O
Elk	BEGIN-Elk	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
induction	induction	NN	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
molecules	molecule	NNS	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
extracellular	BEGIN-extracellular	JJ	B-NP	B
signal	signal	NN	I-NP	I
-	-	HYPH	B-NP	I
regulated	regulate	VBN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
either	either	CC	B-NP	O
oncogenic	oncogenic	JJ	I-NP	O
Ras	BEGIN-Ras-INSIDE	NN	I-NP	B
or	or	CC	I-NP	O
growth	growth	NN	I-NP	O
factor	factor	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
statistical	statistical	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
effect	effect	NN	I-NP	O
between	between	IN	B-PP	O
gender	gender	NN	B-NP	O
and	and	CC	I-NP	O
globulin	BEGIN-globulin	NN	I-NP	B
protein	protein-INSIDE	JJ	I-NP	I
concentration	concentration	NN	I-NP	O
on	on	IN	B-PP	O
Vu	Vu	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
NS	BEGIN-NS	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
isoforms	isoforms-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
pI	pI	NN	I-NP	O
value	value	NN	I-NP	O
close	close	RB	B-ADVP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
as	as	IN	B-PP	O
three	three	CD	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
unevenly	unevenly	JJ	B-NP	O
phosphorylated	phosphorylate	VBN	I-NP	O
polypeptides	polypeptide	NNS	I-NP	O
,	,	,	O	O
each	each	DT	B-NP	O
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
protein	protein	NN	I-NP	O
species	specie	NNS	I-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
isobarin	isobarin	NN	B-NP	O
on	on	IN	B-PP	O
electrocardiographic	electrocardiographic	JJ	B-NP	O
indices	index	NNS	I-NP	O
in	in	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
disease	disease	NN	I-NP	O

The	The	DT	B-NP	O
column	column	NN	I-NP	O
densities	density	NNS	I-NP	O
of	of	IN	B-PP	O
frozen	frozen	JJ	B-NP	O
molecular	molecular	JJ	I-NP	O
hydrogen	hydrogen	NN	I-NP	O
and	and	CC	I-NP	O
methanol	methanol	NN	I-NP	O
are	be	VBP	B-VP	O
inferred	infer	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

TAAG	TAAG	NN	B-NP	O
sites	site	NNS	I-NP	O
that	that	WDT	B-NP	O
serve	serve	VBP	B-VP	O
as	as	IN	B-PP	O
functional	functional	JJ	B-NP	O
late	late	JJ	I-NP	O
promoters	promoter	NNS	I-NP	O
in	in	IN	B-PP	O
OpMNPV	OpMNPV	NN	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
initiation	initiation	NN	I-NP	O
at	at	IN	B-PP	O
only	only	JJ	B-NP	O
basal	basal	JJ	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AcMNPV	AcMNPV	NN	I-NP	O
genome	genome	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
late	late	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
activation	activation	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
virus	virus	NN	B-NP	O
specific	specific	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
Baculoviridae	Baculoviridae	NNP	B-NP	O

The	The	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
globular	globular	JJ	I-NP	O
domain	domain	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
six	six	CD	B-NP	O
exons	exon	NNS	I-NP	O
which	which	WDT	B-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
delineate	delineate	VB	I-VP	O
its	its	PRP$	B-NP	O
structural	structural	JJ	I-NP	O
subdomains	subdomain	NNS	I-NP	O

In	In	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
AVNRT	AVNRT	NN	B-NP	O
and	and	CC	I-NP	O
AJR	AJR	NN	I-NP	O
,	,	,	O	O
junctional	junctional	JJ	B-NP	O
beats	beat	NNS	I-NP	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
trigger	trigger	NN	I-NP	O
for	for	IN	B-PP	O
reentry	reentry	NN	B-NP	O

Fus1p	BEGIN-Fus1p-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Kss1p	BEGIN-Kss1p-INSIDE	NN	I-NP	B
together	together	RB	B-ADVP	O
increase	increase	VBP	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
CLN1	BEGIN-CLN1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
PCL1	BEGIN-PCL1	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
promote	promote	VBP	B-VP	O
budding	bud	VBG	I-VP	O
,	,	,	O	O
and	and	CC	O	O
Kss1p	BEGIN-Kss1p-INSIDE	NN	B-NP	B
inhibits	inhibit	VBZ	B-VP	O
the	the	DT	B-NP	O
MAP	BEGIN-MAP	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
cascade	cascade	NN	I-NP	O

Measurement	Measurement	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spectral	spectral	JJ	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ERG	ERG	NN	I-NP	O
can	can	MD	B-VP	O
thus	thus	RB	I-VP	O
help	help	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
three	three	CD	I-NP	O
hereditary	hereditary	JJ	I-NP	O
diseases	disease	NNS	I-NP	O

On	On	IN	B-PP	O
both	both	CC	O	O
indocyanine	indocyanine	NN	B-NP	O
green	green	JJ	I-NP	O
video	video	NN	I-NP	O
and	and	CC	I-NP	O
fluorescein	fluorescein	NN	I-NP	O
angiography	angiography	NN	I-NP	O
,	,	,	O	O
hypofluorescent	hypofluorescent	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
almost	almost	RB	B-NP	O
the	the	DT	I-NP	O
same	same	JJ	I-NP	O
size	size	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
light	light	JJ	I-NP	O
yellow	yellow	JJ	I-NP	O
area	area	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
dark	dark	JJ	I-NP	O
yellow	yellow	JJ	I-NP	O
center	center	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
placoid	placoid	NN	I-NP	O
lesion	lesion	NN	I-NP	O

Other	Other	JJ	B-NP	O
similar	similar	JJ	I-NP	O
patients	patient	NNS	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
found	find	VBN	I-VP	O
before	before	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
established	establish	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
colloid	colloid	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
is	be	VBZ	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nevoid	nevoid	JJ	I-NP	O
basal	basal	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O

Coexpression	Coexpression	NN	B-NP	O
of	of	IN	B-PP	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	B-NP	I
EBP	EBP	NN	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
altered	alter	VBD	B-VP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
specificity	specificity	NN	I-NP	O

Dominant	Dominant	JJ	B-NP	O
-	-	HYPH	I-NP	O
negative	negative	JJ	I-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
G	BEGIN-G	NN	I-NP	B
-	-	HYPH	B-NP	I
protein	protein	NN	I-NP	I
-	-	HYPH	O	I
coupled	couple	VBN	B-VP	I
alpha	alpha	SYM	B-NP	I
-	-	HYPH	B-NP	I
factor	factor	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
map	map	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	O
ends	end	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transmembrane	transmembrane	NN	I-NP	O
segments	segment	NNS	I-NP	O

Possibility	Possibility	NN	B-NP	O
of	of	IN	B-PP	O
using	use	VBG	B-VP	O
gynecologic	gynecologic	JJ	B-NP	O
nurses	nurse	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
independently	independently	RB	I-NP	O
administered	administer	VBN	I-NP	O
health	health	NN	I-NP	O
centers	center	NNS	I-NP	O

Platelet	Platelet	NN	B-NP	O
count	count	NN	I-NP	O
and	and	CC	O	O
plasma	plasma	NN	B-NP	O
volume	volume	NN	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
group	group	NN	B-NP	O
A	A	NN	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
group	group	NN	B-NP	O
B	B	NN	I-NP	O
throughout	throughout	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O

The	The	DT	B-NP	O
complexity	complexity	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
reports	report	NNS	I-NP	O
of	of	IN	B-PP	O
VACURG	VACURG	NN	B-NP	O
studies	study	NNS	I-NP	O
has	have	VBZ	B-VP	O
led	lead	VBN	I-VP	O
some	some	DT	B-NP	O
to	to	TO	B-VP	O
believe	believe	VB	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
opposed	oppose	VBN	I-VP	O
to	to	TO	B-PP	O
estrogens	estrogen	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
that	that	DT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
true	true	JJ	B-ADJP	O

This	This	DT	B-NP	O
increase	increase	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
alterations	alteration	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
deposition	deposition	NN	I-NP	O
of	of	IN	B-PP	O
inhaled	inhale	VBN	B-NP	O
particles	particle	NNS	I-NP	O
of	of	IN	B-PP	O
capsaicin	capsaicin	NN	B-NP	O
brought	bring	VBD	B-VP	O
about	about	RP	B-PRT	O
by	by	IN	B-PP	O
volume	volume	NN	B-NP	O
restriction	restriction	NN	I-NP	O

Mycobacterium	Mycobacterium	NN	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
IFN	BEGIN-IFN	NN	B-NP	B
-	-	HYPH	I-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
transcriptional	transcriptional	JJ	I-NP	O
responses	response	NNS	I-NP	O
without	without	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
STAT1	BEGIN-STAT1-INSIDE	NN	B-NP	B

Pituitary	Pituitary	JJ	B-NP	O
thyrotropic	thyrotropic	JJ	I-NP	O
adenoma	adenoma	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
congenital	congenital	JJ	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O

Upstream	Upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
afa	BEGIN-afa	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene	NN	I-NP	I
cluster	cluster-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
region	region	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
1	1	CD	B-NP	O
identical	identical	JJ	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RepFIB	BEGIN-RepFIB	NN	I-NP	B
sequence	sequence-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enterotoxigenic	enterotoxigenic	JJ	I-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
plasmids	plasmid	NNS	I-NP	O
(	(	(	O	O
P1	P1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
ancestor	ancestor	NN	I-NP	O
plasmid	plasmid	NN	I-NP	O

Maintenance	Maintenance	NN	B-NP	O
metabolizable	metabolizable	JJ	I-NP	O
-	-	HYPH	I-NP	O
energy	energy	NN	B-NP	O
(	(	(	O	O
ME	ME	NN	B-NP	O
)	)	)	O	O
requirement	requirement	NN	B-NP	O
averaged	average	VBD	B-VP	O
1	1	CD	B-NP	O
kcal	kcal	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
body	body	NN	I-NP	O
wt	wt	NN	I-NP	O

Interferon	BEGIN-Interferon	NN	B-NP	B
-	-	HYPH	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
inducibility	inducibility	NN	I-NP	O
of	of	IN	B-PP	O
IFI1	BEGIN-IFI1-INSIDE	NN	B-NP	B
may	may	MD	B-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
interferon	BEGIN-interferon	NN	I-NP	B
-	-	HYPH	O	I
alpha	alpha	SYM	B-NP	I
/	/	SYM	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
stimulated	stimulate	VBN	I-NP	O
response	response	NN	I-NP	O
consensus	consensus	NN	I-NP	O
element	element	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
UT	UT	NN	I-NP	O
exon	exon	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
motif	motif	NN	I-NP	O
is	be	VBZ	B-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
position	position	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
related	related	JJ	I-NP	O
myeloid	BEGIN-myeloid	JJ	I-NP	B
cell	cell	NN	I-NP	I
nuclear	nuclear	JJ	I-NP	I
differentiation	differentiation	NN	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
gene.	gene.	NN	I-NP	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-NP	O
1	1	CD	I-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
end	end	NN	I-NP	O
points	point	NNS	I-NP	O
included	include	VBD	B-VP	O
creatine	BEGIN-creatine	JJ	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
peak	peak	NN	I-NP	O
,	,	,	O	O
ventricular	ventricular	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
/	/	SYM	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
death	death	NN	B-NP	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
day	day	NN	I-NP	O
follow	follow	VB	B-VP	O
-	-	HYPH	B-NP	O
up	up	RP	B-PRT	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
day	day	NN	I-NP	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
population	population	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
melanoma	melanoma	NN	B-NP	O
levels	level	NNS	I-NP	O
III	III	CD	B-NP	O
and	and	CC	I-NP	O
IV	IV	CD	I-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
survival	survival	NN	B-NP	O
rate	rate	NN	I-NP	O
were	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
thickness	thickness	NN	B-NP	O
(	(	(	O	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
or	or	CC	O	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
though	though	IN	B-SBAR	O
not	not	RB	O	O
with	with	IN	B-PP	O
level	level	NN	B-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
sck1	BEGIN-sck1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
cloned	clone	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
copy	copy	NN	I-NP	O
number	number	NN	I-NP	O
suppressor	suppressor	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
git1	BEGIN-git1-INSIDE	NN	B-NP	B
,	,	,	O	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
suppress	suppress	VB	I-VP	O
the	the	DT	B-NP	O
defects	defect	NNS	I-NP	O
conferred	confer	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
git	BEGIN-git	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
reviewers	reviewer	NNS	B-NP	O
and	and	CC	I-NP	O
editors	editor	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
scientific	scientific	JJ	I-NP	O
work	work	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O

Comparisons	Comparison	NNS	B-NP	O
of	of	IN	B-PP	O
defective	defective	JJ	B-NP	O
HTLV	HTLV	NN	I-NP	O
-	-	HYPH	B-NP	O
I	I	NN	I-NP	O
proviruses	provirus	NNS	I-NP	O
predict	predict	VBP	B-VP	O
the	the	DT	B-NP	O
mode	mode	NN	I-NP	O
of	of	IN	B-PP	O
origin	origin	NN	B-NP	O
and	and	CC	O	O
coding	cod	VBG	B-VP	O
potential	potential	NN	B-NP	O
of	of	IN	B-PP	O
internally	internally	RB	B-NP	O
deleted	delete	VBN	I-NP	O
genomes	genome	NNS	I-NP	O

When	When	WRB	B-ADVP	O
proper	proper	JJ	B-NP	O
controls	control	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
psychophysical	psychophysical	JJ	I-NP	O
data	datum	NNS	I-NP	O
and	and	CC	O	O
computer	computer	NN	B-NP	O
simulation	simulation	NN	I-NP	O
gave	give	VBD	B-VP	O
remarkably	remarkably	RB	B-NP	O
comparable	comparable	JJ	I-NP	O
results	result	NNS	I-NP	O

Results	Result	NNS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
studies	study	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
relevant	relevant	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
alveolitis	alveolitis	NN	B-NP	O
in	in	IN	B-PP	O
organic	organic	JJ	B-NP	O
dust	dust	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
lung	lung	NN	I-NP	O
diseases	disease	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
attachment	attachment	NN	I-NP	O
strength	strength	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CSTi	CSTi	NNP	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
coating	coating	NN	I-NP	O
was	be	VBD	B-VP	O
comparable	comparable	JJ	B-ADJP	O
both	both	CC	B-PP	O
to	to	TO	B-PP	O
CSTi	CSTi	NNP	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
HA	HA	NN	I-NP	O
-	-	HYPH	B-VP	O
coated	coat	VBN	B-NP	O
control	control	NN	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O

The	The	DT	B-NP	O
phosphoprotein	BEGIN-phosphoprotein	NN	I-NP	B
pUL1	pUL1-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
cytomegalovirus	cytomegalovirus	NN	I-NP	O
(	(	(	O	O
HCMV	HCMV	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
herpesvirus	herpesvirus	NN	I-NP	O
of	of	IN	B-PP	O
considerable	considerable	JJ	B-NP	O
medical	medical	JJ	I-NP	O
importance	importance	NN	I-NP	O
in	in	IN	B-PP	O
immunosuppressed	immunosuppressed	JJ	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	I-NP	O
newborns	newborn	NNS	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
early	BEGIN-early	JJ	I-NP	B
-	-	HYPH	I-NP	I
late	late	JJ	I-NP	I
viral	viral	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
stimulate	stimulate	VB	I-VP	O
several	several	JJ	B-NP	O
viral	viral	JJ	I-NP	O
and	and	CC	I-NP	O
cellular	cellular	JJ	I-NP	O
promoters	promoter	NNS	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
exerts	exert	VBZ	I-VP	O
a	a	DT	B-NP	O
rather	rather	RB	I-NP	O
broad	broad	JJ	I-NP	O
activation	activation	NN	I-NP	O
pattern	pattern	NN	I-NP	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-VP	O
cold	cold	VB	I-VP	O
on	on	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
awake	awake	JJ	B-NP	O
rats	rat	NNS	I-NP	O

RNase	BEGIN-RNase-INSIDE	NN	B-NP	B
protection	protection	NN	I-NP	O
analysis	analysis	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
SCD1	BEGIN-SCD1	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
during	during	IN	B-PP	O
1T1	1T1	NN	B-NP	O
-	-	HYPH	B-NP	O
L1	L1	NN	I-NP	O
preadipocyte	preadipocyte	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O

Spontaneous	Spontaneous	JJ	B-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tarsal	tarsal	JJ	I-NP	O
bone	bone	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
leprosy	leprosy	NN	B-NP	O

CERIP	BEGIN-CERIP-INSIDE	NN	B-NP	B
interaction	interaction	NN	I-NP	O

The	The	DT	B-NP	O
response	response	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
were	be	VBD	B-VP	O
localized	localize	VBN	I-VP	O
between	between	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
+1	+1	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
simian	simian	JJ	I-NP	O
cytomegalovirus	cytomegalovirus	NN	I-NP	O
IE1	BEGIN-IE1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
and	and	CC	O	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
position	position	NN	B-NP	O
+1	+1	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HCMV	BEGIN-HCMV	NN	I-NP	B
IE1	BEGIN-IE1	NN	I-NP	B
promoter	promoter-INSIDE-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Scmh1	BEGIN-Scmh1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
rae1	BEGIN-rae1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
mph1	BEGIN-mph1-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
tissues	tissue	NNS	I-NP	O
of	of	IN	B-PP	O
embryos	embryo	NNS	B-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
possible	possible	JJ	B-ADJP	O
to	to	TO	B-VP	O
augment	augment	VB	I-VP	O
IN	BEGIN-IN-INSIDE	NN	B-NP	B
function	function	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
heterologous	heterologous	JJ	I-NP	O
domain	domain	NN	I-NP	O

Retinoic	Retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
the	the	DT	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
certain	certain	JJ	B-NP	O
cancers	cancer	NNS	I-NP	O
,	,	,	O	O
repressed	repress	VBD	B-VP	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	B-NP	I
src	src-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
MMP	BEGIN-MMP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O

Untransformed	Untransformed	JJ	B-NP	O
1T1	1T1	NN	I-NP	O
cells	cell	NNS	I-NP	O
carry	carry	VBP	B-VP	O
abundant	abundant	JJ	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
Hox	BEGIN-Hox	NN	I-NP	B
1	1-INSIDE	NN	I-NP	I
RNA	RNA	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
methylcholanthrene	methylcholanthrene	NN	I-NP	O
-	-	HYPH	B-NP	O
transformed	transform	VBN	I-NP	O
MB1	MB1	NN	I-NP	O
and	and	CC	I-NP	O
LTK	LTK	NN	I-NP	O
-	-	HYPH	B-NP	O
cells	cell	NNS	B-NP	O
or	or	CC	O	O
1T1	1T1	NN	B-NP	O
cells	cell	NNS	I-NP	O
transformed	transform	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
oncogenes	oncogene	NNS	I-NP	O
src	BEGIN-src-INSIDE	NN	I-NP	B
,	,	,	O	O
fos	BEGIN-fos-INSIDE	NN	B-NP	B
or	or	CC	O	O
SV1	BEGIN-SV1	NN	B-NP	B
T	T	NN	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
express	express	VBP	B-VP	O
only	only	RB	B-NP	O
low	low	JJ	I-NP	O
levels	level	NNS	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
established	establish	VBN	I-VP	O
that	that	IN	B-SBAR	O
serine	serine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
STAT1a	BEGIN-STAT1a-INSIDE	NN	B-NP	B
transactivation	transactivation	NN	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
MAPK	BEGIN-MAPK-INSIDE	NN	I-NP	B
pathway	pathway	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
means	means	NN	I-NP	O
of	of	IN	B-PP	O
modifying	modify	VBG	B-VP	O
GH	BEGIN-GH-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O

Prevention	Prevention	NN	B-NP	O
of	of	IN	B-PP	O
gravid	gravid	NN	B-NP	O
Rhesus	Rhesus	NN	I-NP	O
isoimmunization	isoimmunization	NN	I-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
efficiency	efficiency	NN	I-NP	O
by	by	IN	B-PP	O
integration	integration	NN	B-NP	O
indicators	indicator	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
rational	rational	JJ	I-NP	O
utilization	utilization	NN	I-NP	O
of	of	IN	B-PP	O
budgeted	budget	VBN	B-NP	O
funds	fund	NNS	I-NP	O

We	We	PRP	B-NP	O
infer	infer	VBP	B-VP	O
that	that	IN	B-SBAR	O
RecA	BEGIN-RecA-INSIDE	NN	B-NP	B
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
cleavage	cleavage	NN	I-NP	O
of	of	IN	B-PP	O
UmuD	BEGIN-UmuD-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
another	another	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
RecA	BEGIN-RecA-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
SOS	SOS	NN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
,	,	,	O	O
probably	probably	RB	B-ADVP	O
activating	activate	VBG	B-VP	O
UmuD	BEGIN-UmuD-INSIDE	NN	B-NP	B
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
mutagenic	mutagenic	JJ	I-NP	O
function	function	NN	I-NP	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
long	long	JJ	B-NP	O
term	term	NN	I-NP	O
(	(	(	O	O
with	with	IN	B-PP	O
/	/	SYM	B-NP	O
without	without	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
/	/	SYM	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
adrenoreceptor	adrenoreceptor-INSIDE	NN	I-NP	I
blocking	block	VBG	B-VP	O
drugs	drug	NNS	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
sixteen	sixteen	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
nineteen	nineteen	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
-	-	HYPH	I-NP	O
moderate	moderate	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Autocapture	Autocapture	NN	B-NP	O
devices	device	NNS	I-NP	O
(	(	(	O	O
Pacesetter	Pacesetter	NNP	B-NP	O
Microny	Microny	NNP	I-NP	O
SR+	SR+	NNP	I-NP	O
/	/	SYM	B-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
Regency	Regency	NN	I-NP	O
SR+	SR+	NN	I-NP	O
/	/	SYM	B-VP	O
-	-	HYPH	B-NP	O
;	;	:	O	O
Pacesetter	Pacesetter	NNP	B-NP	O
,	,	,	O	O
Solna	Solna	NNP	B-NP	O
,	,	,	O	O
Sweden	Sweden	NNP	B-NP	O
)	)	)	O	O
and	and	CC	O	O
steroid	steroid	NN	B-NP	O
-	-	HYPH	O	O
eluting	elute	VBG	B-VP	O
epicardial	epicardial	JJ	B-NP	O
pacing	pacing	NN	I-NP	O
leads	lead	VBZ	B-VP	O
(	(	(	O	O
Medtronic	Medtronic	NNP	B-NP	O
CapSure	CapSure	NNP	I-NP	O
Epi	Epi	NNP	I-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
Medtronic	Medtronic	NNP	B-NP	O
,	,	,	O	O
Inc	Inc	NNP	B-NP	O
,	,	,	O	O
Minneapolis	Minneapolis	NNP	B-NP	O
,	,	,	O	O
MN	MN	NNP	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
implanted	implant	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
another	another	DT	B-NP	O
example	example	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
principle	principle	NN	I-NP	O
-	-	HYPH	B-VP	O
-	-	SYM	B-NP	O
less	less	JJR	B-NP	O
is	be	VBZ	B-VP	O
more	more	JJR	B-NP	O

The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
includes	include	VBZ	B-VP	O
an	an	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
signal	signal	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
pro	pro	AFX	O	O
-	-	HYPH	O	O
region	region	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
catalytic	catalytic	JJ	I-NP	O
domain	domain	NN	I-NP	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
serine	BEGIN-serine	JJ	I-NP	B
protease	protease-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
trypsin	BEGIN-trypsin-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
specificity	specificity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
hydrophobic	hydrophobic	JJ	I-NP	O
extension	extension	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
predicted	predict	VBN	I-VP	O
to	to	TO	I-VP	O
function	function	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
membrane	membrane	NN	I-NP	O
anchor	anchor	NN	I-NP	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	O
pi	pi	NN	I-NP	O
mesons	meson	NNS	I-NP	O
on	on	IN	B-PP	O
mouse	mouse	NN	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
cells	cell	NNS	I-NP	O

Phenotypic	Phenotypic	JJ	B-NP	O
and	and	CC	I-NP	O
molecular	molecular	JJ	I-NP	O
analyses	analysis	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
partial	partial	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1	1	CD	I-NP	O
monosomy	monosomy	NN	I-NP	O
enabled	enable	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
define	define	VB	I-VP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
spanning	span	VBG	B-VP	O
1	1	CD	B-NP	O
Mb	Mb	NN	I-NP	O
between	between	IN	B-PP	O
D1S1	BEGIN-D1S1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
D1S1	BEGIN-D1S1-INSIDE	NN	I-NP	B
,	,	,	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
arthrogryposis	arthrogryposis	NN	B-NP	O
,	,	,	O	O
mental	mental	JJ	B-NP	O
retardation	retardation	NN	I-NP	O
,	,	,	O	O
hypertonia	hypertonia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
several	several	JJ	B-NP	O
facial	facial	JJ	I-NP	O
anomalies	anomaly	NNS	I-NP	O

Relation	Relation	NN	B-NP	O
between	between	IN	B-PP	O
circulating	circulate	VBG	B-VP	O
immune	immune	JJ	B-NP	O
complexes	complex	NNS	I-NP	O
and	and	CC	O	O
serum	BEGIN-serum	NN	B-NP	B
ferritin	ferritin-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
hemosiderosis	hemosiderosis	NN	B-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
etiologies	etiology	NNS	I-NP	O

The	The	DT	B-NP	O
zinc	BEGIN-zinc	NN	I-NP	B
finger	finger	NN	I-NP	I
protein	protein	NN	I-NP	I
A1	A1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
tumor	BEGIN-tumor	NN	I-NP	B
necrosis	necrosis	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
TNF	BEGIN-TNF-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	O	O
and	and	CC	O	O
interleukin	BEGIN-interleukin	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
protein	protein	NN	I-NP	O
that	that	WDT	B-NP	O
negatively	negatively	RB	B-VP	O
regulates	regulate	VBZ	I-VP	O
nuclear	BEGIN-nuclear	JJ	B-NP	B
factor	factor	NN	I-NP	I
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
(	(	(	O	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
kappaB	kappaB-INSIDE	NN	I-NP	I
)	)	)	O	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O

The	The	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
antithrombin	BEGIN-antithrombin	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
(	(	(	O	O
AT	BEGIN-AT	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
significance	significance	NN	I-NP	O

Treatments	Treatment	NNS	B-NP	O
were	be	VBD	B-VP	O
two	two	CD	B-NP	O
adrenocorticotrophin	BEGIN-adrenocorticotrophin-INSIDE	NN	I-NP	B
(	(	(	O	O
ACTH	BEGIN-ACTH-INSIDE	NN	B-NP	B
)	)	)	O	O
preparations	preparation	NNS	B-NP	O
given	give	VBN	B-VP	O
intramuscularly	intramuscularly	RB	B-ADVP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
U	U	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ACTH	BEGIN-ACTH-INSIDE	NN	I-NP	B
preparations	preparation	NNS	I-NP	O
given	give	VBN	B-VP	O
intramuscularly	intramuscularly	RB	B-ADVP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
U	U	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
with	with	IN	B-PP	O
ACTH	BEGIN-BEGIN-ACTH-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
like	like-INSIDE	NN	B-NP	I
activity	activity	NN	I-NP	O
(	(	(	O	O
tetracosactrin	tetracosactrin	NN	B-NP	O
,	,	,	O	O
cosyntropin	cosyntropin	NN	B-NP	O
)	)	)	O	O
given	give	VBN	B-VP	O
intravenously	intravenously	RB	B-ADVP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	O	O
kg	kg	NN	B-NP	O

The	The	DT	B-NP	O
deviation	deviation	NN	I-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
equivalent	equivalent	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
exon	exon	NN	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	B-VP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
splice	splice	NN	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	O	O
subunit	subunit	NN	B-NP	O

The	The	DT	B-NP	O
liver	liver	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
contains	contain	VBZ	B-VP	O
unique	unique	JJ	B-NP	O
consensus	consensus	NN	I-NP	O
sites	site	NNS	I-NP	O
for	for	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
by	by	IN	B-PP	O
cyclic	BEGIN-cyclic	JJ	B-NP	B
AMP	AMP	NN	I-NP	I
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
and	and	CC	B-PP	O
by	by	IN	B-PP	O
protein	BEGIN-protein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I

Seizure	Seizure	NN	B-NP	O
recurrence	recurrence	NN	I-NP	O
(	(	(	O	O
HR	HR	NN	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
CI	CI	NN	I-NP	O
=	=	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
antiepileptic	antiepileptic	JJ	B-NP	O
drug	drug	NN	I-NP	O
treatment	treatment	NN	I-NP	O
(	(	(	O	O
HR	HR	NN	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
CI	CI	NN	I-NP	O
=	=	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
influence	influence	VB	I-VP	O
mortality	mortality	NN	B-NP	O
rate	rate	NN	I-NP	O

All	All	DT	B-NP	O
patients	patient	NNS	I-NP	O
whose	whose	WP$	B-NP	O
PSA	BEGIN-PSA-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
reached	reach	VBD	B-VP	O
1	1	CD	B-NP	O
ng.	ng.	NN	I-NP	O
/	/	SYM	O	O
ml	ml	NN	B-NP	O

The	The	DT	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
diffraction	diffraction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
synthesized	synthesize	VBN	I-NP	O
HAp	HAp	NN	I-NP	O
crystals	crystal	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Col	Col	NN	I-NP	O
fiber	fiber	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
around	around	IN	I-NP	O
1	1	CD	I-NP	O
arching	arching	JJ	I-NP	O
angle	angle	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
that	that	DT	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
ChS	ChS	NN	I-NP	O
fiber	fiber	NN	I-NP	O
showed	show	VBD	B-VP	O
just	just	RB	B-NP	O
around	around	IN	I-NP	O
1	1	CD	I-NP	O
degrees	degree	NNS	I-NP	O

Fas	BEGIN-Fas-INSIDE	NN	B-NP	B
(	(	(	O	O
APO	BEGIN-APO	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	I-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	BEGIN-tumor	NN	I-NP	B
necrosis	necrosis	NN	I-NP	I
factor	factor	NN	I-NP	I
receptor	receptor	NN	I-NP	I
superfamily	superfamily-INSIDE	NN	I-NP	I
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
receptor	receptor	NN	I-NP	O
that	that	WDT	B-NP	O
induces	induce	VBZ	B-VP	O
apoptosis	apoptosis	NN	B-NP	O

Soft	Soft	JJ	B-NP	O
independent	independent	JJ	I-NP	O
modelling	modelling	NN	I-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
analogy	analogy	NN	I-NP	O
(	(	(	O	O
SIMCA	SIMCA	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
near	near	RB	B-ADVP	O
-	-	HYPH	O	O
infrared	infrare	VBN	B-VP	O
(	(	(	O	O
NIR	NIR	NN	B-NP	O
)	)	)	O	O
spectra	spectrum	NNS	B-NP	O
of	of	IN	B-PP	O
ten	ten	CD	B-NP	O
excipients	excipient	NNS	I-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pharmaceutical	pharmaceutical	JJ	I-NP	O
industry	industry	NN	I-NP	O

Mutations	Mutation	NNS	B-NP	O
of	of	IN	B-PP	O
SIN1	BEGIN-SIN1-INSIDE	NN	B-NP	B
,	,	,	O	O
ROX1	BEGIN-ROX1-INSIDE	NN	B-NP	B
,	,	,	O	O
SRB1	BEGIN-SRB1-INSIDE	NN	B-NP	B
,	,	,	O	O
SRB1	BEGIN-SRB1-INSIDE	NN	B-NP	B
,	,	,	O	O
SRB1	BEGIN-SRB1-INSIDE	NN	B-NP	B
,	,	,	O	O
SRB1	BEGIN-SRB1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
novel	novel	JJ	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
NUT1	BEGIN-NUT1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
NUT1	BEGIN-NUT1-INSIDE	NN	I-NP	B
,	,	,	O	O
relieve	relieve	VB	B-VP	O
the	the	DT	B-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
Swi1p	BEGIN-Swi1p-INSIDE	NN	B-NP	B
for	for	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
reporter	reporter	NN	I-NP	O

The	The	DT	B-NP	O
IB1	BEGIN-IB1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
HGMW	HGMW	NN	B-NP	O
-	-	HYPH	B-NP	O
approved	approve	VBN	I-NP	O
symbol	symbol	NN	I-NP	O
MAPK1IP1	BEGIN-MAPK1IP1-INSIDE	NN	I-NP	B
)	)	)	O	O
maps	map	VBZ	B-VP	O
to	to	TO	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1q1	1q1	NN	I-NP	O
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
1	1	CD	B-NP	O
coding	coding	NN	I-NP	O
exons	exon	NNS	I-NP	O

Implantation	Implantation	NN	B-NP	O
is	be	VBZ	B-VP	O
contraindicated	contraindicate	VBN	I-VP	O
for	for	IN	B-PP	O
severe	severe	JJ	B-NP	O
dysplasia	dysplasia	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cochlea	cochlea	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
recently	recently	RB	I-NP	O
described	describe	VBN	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
x	x	NN	B-NP	O
-	-	HYPH	O	O
linked	link	VBN	B-NP	O
deafness	deafness	NN	I-NP	O
with	with	IN	B-PP	O
deficient	deficient	JJ	B-NP	O
bone	bone	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
fundus	fundus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
internal	internal	JJ	I-NP	O
auditory	auditory	JJ	I-NP	O
meatus	meatus	NN	I-NP	O

The	The	DT	B-NP	O
RsmA	BEGIN-RsmA	NN	I-NP	B
-	-	HYPH	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
,	,	,	O	O
like	like	IN	B-PP	O
its	its	PRP$	B-NP	O
parent	parent	NN	I-NP	O
,	,	,	O	O
produces	produce	VBZ	B-VP	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
(	(	(	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
oxohexanoyl	oxohexanoyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
L	L	NN	I-NP	O
-	-	HYPH	O	O
homoserine	homoserine	NN	B-NP	O
lactone	lactone	NN	I-NP	O
(	(	(	O	O
HSL	HSL	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
starvation	starvation	NN	I-NP	O
/	/	SYM	O	O
cell	cell	NN	B-NP	O
density	density	NN	I-NP	O
-	-	HYPH	O	O
sensing	sense	VBG	B-VP	O
signal	signal	NN	B-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	O
enzyme	enzyme	NN	I-NP	O
production	production	NN	I-NP	O

The	The	DT	B-NP	O
1st	1st	JJ	I-NP	O
annual	annual	JJ	I-NP	O
meeting	meeting	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Japanese	Japanese	NNP	I-NP	O
Ophthalmological	Ophthalmological	NNP	I-NP	O
Society	Society	NNP	I-NP	O

The	The	DT	B-NP	O
other	other	JJ	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
cluster	cluster	NN	I-NP	O
contained	contain	VBD	B-VP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
type	type	NN	I-NP	I
I	I	CD	I-NP	I
cytokeratin	cytokeratin-INSIDE	NN	I-NP	I
K1	BEGIN-K1-INSIDE	NN	I-NP	B
and	and	CC	O	O
K1	BEGIN-BEGIN-K1-INSIDE	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
loci	locus	NNS	I-NP	O

In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
these	these	DT	B-NP	O
criteria	criterion	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
met	meet	VBN	I-VP	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
reproducibility	reproducibility	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
VO1	VO1	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
P	P	NN	I-NP	O
-	-	HYPH	B-NP	O
MET	MET	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
MET	MET	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
maximal	maximal	JJ	I-NP	O
VO1	VO1	NN	I-NP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
reached	reach	VBN	I-VP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pT1	pT1	NN	I-NP	O
plasmid	plasmid	NN	I-NP	O
,	,	,	O	O
inactivation	inactivation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
initiator	BEGIN-initiator	NN	I-NP	B
RepC	RepC	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
occurs	occur	VBZ	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
attachment	attachment	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
active	active	JJ	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
residue	residue	NN	I-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
start	start	NN	I-NP	O
sites	site	NNS	I-NP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
base	base	NN	I-NP	O
pair	pair	NN	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
start	start	NN	I-NP	O
codon	codon	NN	I-NP	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
or	or	CC	O	O
phosphorylated	BEGIN-phosphorylated	JJ	B-NP	B
CREB	CREB-INSIDE	NN	I-NP	I
transactivated	transactivate	VBD	B-VP	O
the	the	DT	B-NP	O
mCgA	BEGIN-BEGIN-mCgA-INSIDE	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
dose	dose	NN	I-NP	O
dependently	dependently	RB	B-ADVP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
coexpression	coexpression	NN	B-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
additive	additive	JJ	I-NP	O
mCgA	BEGIN-BEGIN-mCgA-INSIDE	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
response.	response.	NN	I-NP	O
mCgA	BEGIN-mCgA-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
,	,	,	O	O
comprising	comprise	VBG	B-VP	O
the	the	DT	B-NP	O
Sp1	BEGIN-Sp1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Egr	BEGIN-Egr	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
site	site	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
CRE	CRE	NN	I-NP	O
motif	motif	NN	I-NP	O
,	,	,	O	O
conferred	confer	VBD	B-VP	O
gastrin	BEGIN-gastrin-INSIDE	NN	B-NP	B
responsiveness	responsiveness	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
heterologous	BEGIN-heterologous	JJ	I-NP	B
thymidine	thymidine	NN	I-NP	I
kinase	kinase	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
system	system	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
true	true	JJ	I-NP	O
''	''	''	I-NP	O
enhancer	enhancer	NN	I-NP	O
element	element	NN	I-NP	O

Alfalfa	Alfalfa	NN	B-NP	O
phosphorus	phosphorus	NN	I-NP	O
release	release	NN	I-NP	O
kinetics	kinetic	NNS	I-NP	O
showed	show	VBD	B-VP	O
high	high	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
phosphorus	phosphorus	NN	I-NP	O
contamination	contamination	NN	I-NP	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
ORCA1	BEGIN-ORCA1-INSIDE	NN	B-NP	B
regulates	regulate	VBZ	B-VP	O
jasmonate	jasmonate	NN	B-NP	O
-	-	HYPH	B-NP	O
responsive	responsive	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Str	BEGIN-Str	JJ	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
via	via	IN	B-PP	O
direct	direct	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
JERE	JERE	NN	I-NP	O

PC1	PC1	NN	B-NP	O
cultures	culture	NNS	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
``	``	``	I-VP	O
primed	prim	VBN	I-VP	O
''	''	''	O	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
way	way	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
accelerated	accelerate	VBN	I-NP	O
and	and	CC	O	O
augmented	augment	VBD	B-VP	O
differentiation	differentiation	NN	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-VP	O
nerve	BEGIN-nerve	VB	I-VP	B
growth	growth	NN	B-NP	I
factor	factor-INSIDE	NN	I-NP	I

Pseudotumor	Pseudotumor	NN	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
nocardia	nocardia	NN	I-NP	O
infection	infection	NN	I-NP	O
(	(	(	O	O
Nocardia	Nocardia	NNP	B-NP	O
nova	nova	NNP	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
patient	patient	NN	I-NP	O

Deoxyuridine	Deoxyuridine	NN	B-NP	O
-	-	HYPH	I-NP	O
suppression	suppression	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
culture	culture	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
macrocytic	macrocytic	JJ	B-NP	O
refractory	refractory	JJ	I-NP	O
anaemias	anaemia	NNS	I-NP	O

A	A	DT	B-NP	O
computerized	computerized	JJ	I-NP	O
database	database	NN	I-NP	O
of	of	IN	B-PP	O
veterans	veteran	NNS	B-NP	O
discharged	discharge	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
military	military	NN	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
was	be	VBD	B-VP	O
selected	select	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
contains	contain	VBZ	B-VP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
Vietnam	Vietnam	NNP	I-NP	O
era	era	NN	I-NP	O
veteran	veteran	NN	I-NP	O
population	population	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
reasonably	reasonably	RB	B-ADJP	O
unbiased	unbiased	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
feasible	feasible	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
identifying	identify	VBG	B-VP	O
twins	twin	NNS	B-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
Nim1	BEGIN-Nim1-INSIDE	NN	B-NP	B
possesses	possess	VBZ	B-VP	O
intrinsic	intrinsic	JJ	B-NP	O
serine	BEGIN-serine	NN	I-NP	B
-	-	HYPH	B-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
threonine	BEGIN-threonine	NN	B-NP	B
-	-	HYPH	B-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
tyrosine	BEGIN-tyrosine	NN	I-NP	B
-	-	HYPH	B-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
activities	activity	NNS	I-NP	O

This	This	DT	B-NP	O
mutation	mutation	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
or	or	CC	I-NP	O
absent	absent	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
TGF	BEGIN-TGF	NN	B-NP	B
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
RI	RI	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
and	and	CC	O	O
p1	BEGIN-p1	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
tumor	tumor	NN	B-NP	O
tissues	tissue	NNS	I-NP	O

Keys	Key	NNS	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
identifying	identify	VBG	B-VP	O
species	specie	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
European	European	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
USSR	USSR	NNP	I-NP	O
and	and	CC	O	O
north	north	RB	B-NP	O
-	-	HYPH	I-NP	O
eastern	eastern	JJ	I-NP	O
Kazakhstan	Kazakhstan	NNP	I-NP	O

Time	Time	NN	B-NP	O
between	between	IN	B-PP	O
tests	test	NNS	B-NP	O
(	(	(	O	O
usually	usually	RB	B-ADVP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
one	one	CD	I-NP	O
year	year	NN	I-NP	O
)	)	)	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
correlations	correlation	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
MMPI	MMPI	NN	B-NP	O
response	response	NN	I-NP	O
-	-	HYPH	B-NP	O
set	set	VBN	I-NP	O
variables	variable	NNS	I-NP	O
(	(	(	O	O
L	L	NN	B-NP	O
,	,	,	O	O
F	F	NN	B-NP	O
,	,	,	O	O
K	K	NN	B-NP	O
,	,	,	O	O
F	F	NN	B-NP	O
-	-	HYPH	B-NP	O
K	K	NN	I-NP	O
)	)	)	O	O
did	do	VBD	B-VP	O

Cloning	Cloning	NN	B-NP	O
and	and	CC	I-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
chymotrypsinlike	BEGIN-chymotrypsinlike	JJ	I-NP	B
protease	protease	NN	I-NP	I
from	from	IN	B-PP	I
Treponema	Treponema-INSIDE	NN	B-NP	I
denticola	denticola	NN	I-NP	O

To	To	TO	B-VP	O
initiate	initiate	VB	I-VP	O
our	our	PRP$	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
factors	factor	NNS	B-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
eIF	BEGIN-eIF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
,	,	,	O	O
selected	select	VBD	B-VP	O
a	a	DT	B-NP	O
CAP	CAP	NN	I-NP	O
-	-	HYPH	B-NP	O
proximal	proximal	JJ	I-NP	O
element	element	NN	I-NP	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
methylation	methylation	NN	I-NP	O
protection	protection	NN	I-NP	O
analysis	analysis	NN	I-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
factor	factor	NN	I-NP	O

The	The	DT	B-NP	O
isoproterenol	isoproterenol	NN	I-NP	O
infusion	infusion	NN	I-NP	O
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
so	so	RB	B-SBAR	O
that	that	IN	I-SBAR	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
(	(	(	O	O
HR	HR	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
beats	beat	NNS	I-NP	O
/	/	SYM	O	O
min	min	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
baseline	baseline	NN	B-NP	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
monaural	monaural	JJ	B-NP	O
middle	middle	JJ	I-NP	O
ear	ear	JJ	I-NP	O
destruction	destruction	NN	I-NP	O
on	on	IN	B-PP	O
postnatal	postnatal	JJ	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	O
inferior	inferior	JJ	I-NP	O
colliculus	colliculus	NN	I-NP	O

The	The	DT	B-NP	O
specificity	specificity	NN	I-NP	O
and	and	CC	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
method	method	NN	I-NP	O
(	(	(	O	O
limit	limit	NN	B-NP	O
of	of	IN	B-PP	O
detection	detection	NN	B-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
mL	mL	NN	I-NP	O
and	and	CC	O	O
<	<	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
mL	mL	NN	I-NP	O
for	for	IN	B-PP	O
febantel	febantel	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
metabolites	metabolite	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
were	be	VBD	B-VP	O
sufficiently	sufficiently	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
to	to	TO	B-VP	O
enable	enable	VB	I-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
after	after	IN	B-SBAR	O
oral	oral	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
doses	dose	NNS	I-NP	O
to	to	TO	B-VP	O
sheep	sheep	VB	I-VP	O

MATERIALS	MATERIALS	NNS	B-NP	O
AND	AND	CC	I-NP	O
METHODS	METHODS	NNS	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
seven	seven	CD	I-NP	O
-	-	HYPH	I-NP	O
wavelength	wavelength	NN	I-NP	O
frequency	frequency	NN	I-NP	O
-	-	HYPH	B-NP	O
domain	domain	NN	I-NP	O
photon	photon	NN	I-NP	O
migration	migration	NN	I-NP	O
probe	probe	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
noninvasive	noninvasive	JJ	B-NP	O
NIR	NIR	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
breasts	breast	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
women	woman	NNS	I-NP	O
,	,	,	O	O
both	both	CC	O	O
pre	pre	AFX	B-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
postmenopausal	postmenopausal	JJ	I-NP	O
,	,	,	I-NP	O
aged	aged	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O

Drug	Drug	NN	B-NP	O
therapy	therapy	NN	I-NP	O
of	of	IN	B-PP	O
AAPMC	AAPMC	NN	B-NP	O
is	be	VBZ	B-VP	O
directed	direct	VBN	I-VP	O
at	at	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
Cl.	Cl.	NNP	B-NP	O
difficile	difficile	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
colon	colon	NN	I-NP	O
and	and	CC	O	O
promoting	promote	VBG	B-VP	O
normalization	normalization	NN	B-NP	O
of	of	IN	B-PP	O
intestinal	intestinal	JJ	B-NP	O
flora	flora	NNS	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
release	release	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
pulley	pulley	NN	I-NP	O
after	after	IN	B-PP	O
repair	repair	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tendons	tendon	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
area	area	NN	I-NP	O
improved	improve	VBD	B-VP	O
gliding	glide	VBG	I-VP	O
excursions	excursion	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tendons	tendon	NNS	I-NP	O
and	and	CC	O	O
reduced	reduce	VBN	B-VP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
motion	motion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
repaired	repair	VBN	I-NP	O
tendons	tendon	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
provide	provide	VBP	B-VP	O
support	support	NN	B-NP	O
for	for	IN	B-PP	O
partial	partial	JJ	B-NP	O
A1	A1	NN	I-NP	O
pulley	pulley	NN	I-NP	O
incision	incision	NN	I-NP	O
after	after	IN	B-PP	O
repair	repair	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tendons	tendon	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pulley	pulley	NN	I-NP	O

The	The	DT	B-NP	O
Ick	BEGIN-Ick-INSIDE	NN	I-NP	B
protein	BEGIN-protein	NN	I-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
antibody	antibody	NN	B-NP	O
-	-	HYPH	B-NP	O
mediated	mediate	VBN	I-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
(	(	(	O	O
CDR1	BEGIN-CDR1	NN	B-NP	B
-	-	HYPH	B-NP	I
loop	loop-INSIDE	NN	I-NP	I
)	)	)	O	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
that	that	WDT	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
transcription	transcription	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
targeted	target	VBN	I-VP	O
to	to	TO	B-PP	O
peroxisomes	peroxisome	NNS	B-NP	O
when	when	WRB	B-ADVP	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
yeast	yeast	NN	B-NP	O

Whether	Whether	RB	B-ADVP	O
or	or	CC	O	O
not	not	RB	O	O
these	these	DT	B-NP	O
novel	novel	JJ	I-NP	O
repeated	repeated	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
SMA	BEGIN-SMA	NN	I-NP	B
region	region-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
remains	remain	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O

All	All	DT	B-NP	O
except	except	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
interventions	intervention	NNS	I-NP	O
are	be	VBP	B-VP	O
physical	physical	JJ	B-NP	O
treatments	treatment	NNS	I-NP	O
that	that	WDT	B-NP	O
create	create	VBP	B-VP	O
a	a	DT	B-NP	O
wound	wound	NN	I-NP	O
-	-	HYPH	I-NP	O
tissue	tissue	NN	I-NP	O
environment	environment	NN	I-NP	O
conducive	conducive	VBP	B-VP	O
to	to	TO	B-PP	O
healing	heal	VBG	B-VP	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
our	our	PRP$	B-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-SBAR	O
AP	BEGIN-AP	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
binding	binding	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	I-NP	I
Jun	Jun-INSIDE	NN	I-NP	I
coactivation	coactivation	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
PU.1	BEGIN-PU.1-INSIDE	NN	B-NP	B
by	by	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Jun	Jun-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
Fos	Fos-INSIDE	NN	B-NP	I

In	In	IN	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
papers	paper	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
staging	staging	NN	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
melanoma	melanoma	NN	B-NP	O
was	be	VBD	B-VP	O
critically	critically	RB	I-VP	O
analyzed	analyze	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
many	many	JJ	B-NP	O
shortcomings	shortcoming	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O

The	The	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
initiation	initiation	NN	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
RAG1	BEGIN-RAG1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
localized	localize	VBN	I-VP	O
at	at	IN	B-PP	O
A	A	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
translational	translational	JJ	I-NP	O
initiation	initiation	NN	I-NP	O
codon	codon	NN	I-NP	O
,	,	,	O	O
ATG	ATG	NN	B-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
primer	primer	NN	I-NP	O
extension	extension	NN	I-NP	O
assay	assay	NN	I-NP	O

The	The	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
products	product	NNS	B-NP	O
expressed	express	VBN	B-VP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
chimeric	chimeric	JJ	I-NP	O
cDNAs	cDNA	NNS	I-NP	O
in	in	IN	B-PP	O
COS	COS	NN	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
activity	activity	NN	B-NP	O
assay	assay	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
metabolic	metabolic	JJ	B-NP	O
labeling	labeling	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteins	protein	NNS	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
immunoprecipitation	immunoprecipitation	NN	B-NP	O
and	and	CC	I-NP	O
SDS	SDS	NN	I-NP	O
-	-	HYPH	O	O
PAGE	PAGE	NN	B-NP	O

The	The	DT	B-NP	O
leucine	leucine	NN	I-NP	O
zipper	zipper	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
ATF	BEGIN-BEGIN-ATF-INSIDE	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
jun	jun-INSIDE	NN	I-NP	I
family	family	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
whose	whose	WP$	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
site	site	NN	I-NP	O
differs	differ	VBZ	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ATF	BEGIN-ATF-INSIDE	NN	I-NP	B
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
site	site	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
position	position	NN	I-NP	O

Immunoblotting	Immunoblotting	NN	B-NP	O
with	with	IN	B-PP	O
antiphosphotyrosine	antiphosphotyrosine	NN	B-NP	O
antibody	antibody	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
many	many	JJ	B-NP	O
yeast	yeast	NN	I-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
p1CDC1	BEGIN-p1CDC1	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
became	become	VBD	B-VP	O
phosphorylated	phosphorylate	VBN	I-VP	O
at	at	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
expressing	express	VBG	B-VP	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	O	I
src	src-INSIDE	NN	B-NP	I

1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
Veneto	Veneto	NNP	I-NP	O
Region	Region	NNP	I-NP	O
)	)	)	O	O

Differential	Differential	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
plastome	plastome	NN	B-NP	O
-	-	HYPH	O	O
encoded	encode	VBN	B-VP	O
genes	gene	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mesophyll	mesophyll	NN	I-NP	O
and	and	CC	I-NP	O
bundle	bundle	NN	I-NP	O
-	-	HYPH	B-NP	O
sheath	sheath	NN	I-NP	O
chloroplasts	chloroplast	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
monocotyledonous	monocotyledonous	JJ	I-NP	O
NADP	NADP	NN	I-NP	O
-	-	HYPH	O	O
malic	BEGIN-malic	JJ	B-NP	B
enzyme	enzyme-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
type	type	NN	I-NP	O
C1	C1	NN	I-NP	O
plants	plant	NNS	I-NP	O
maize	maize	VBP	B-VP	O
and	and	CC	O	O
Sorghum	Sorghum	NNP	B-NP	O

AIMS	AIMS	NNS	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
postulated	postulate	VBD	B-VP	O
that	that	IN	B-SBAR	O
perhexiline	perhexiline	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
anti	anti	AFX	I-NP	O
-	-	HYPH	I-NP	O
ischaemic	ischaemic	JJ	I-NP	O
agent	agent	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
-	-	HYPH	O	O
sparing	spar	VBG	B-VP	O
metabolic	metabolic	JJ	B-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
myocardium	myocardium	NN	I-NP	O
(	(	(	O	O
via	via	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
carnitine	BEGIN-carnitine	NN	B-NP	B
palmitoyltransferase	palmitoyltransferase	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
adverse	adverse	JJ	I-NP	O
haemodynamic	haemodynamic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
improve	improve	VB	I-VP	O
symptomatic	symptomatic	JJ	B-NP	O
status	status	NN	I-NP	O
in	in	IN	B-PP	O
elderly	elderly	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O

Developmentally	Developmentally	RB	B-ADVP	O
-	-	HYPH	B-PP	O
regulated	regulate	VBN	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
complex	complex	NN	I-NP	O
containing	contain	VBG	B-VP	O
CDP	BEGIN-CDP-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
cut	BEGIN-cut-INSIDE	NN	I-NP	B
with	with	IN	B-PP	O
the	the	DT	B-NP	O
early	BEGIN-early	JJ	I-NP	B
histone	histone	NN	I-NP	I
H1	H1	NN	I-NP	I
gene	gene	NN	I-NP	I
promoter	promoter	NN	I-NP	I
of	of	IN	B-PP	I
the	the	DT	B-NP	I
sea	sea	NN	I-NP	I
urchin	urchin	NN	I-NP	I
Tetrapygus	Tetrapygus	NN	I-NP	I
niger	niger-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
chromatin	chromatin	NN	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	O	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
LH	BEGIN-LH-INSIDE	NN	I-NP	B
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
sex	BEGIN-sex	NN	B-NP	B
-	-	HYPH	B-NP	I
hormone	hormone	NN	I-NP	I
binding	binding	NN	I-NP	I
globulin	globulin-INSIDE	NN	I-NP	I
(	(	(	O	O
SHBG	BEGIN-SHBG-INSIDE	NN	B-NP	B
)	)	)	O	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
nmol	nmol	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
)	)	)	O	O
concentrations	concentration	NNS	B-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
normal	normal	JJ	I-NP	O
control	control	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
nmol	nmol	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O

IRA1	BEGIN-IRA1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
gene	gene	NN	I-NP	O
of	of	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
domain	domain	NN	I-NP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
mammalian	mammalian	JJ	B-NP	O
ras	BEGIN-ras	NN	I-NP	B
GTPase	GTPase	NN	I-NP	I
-	-	HYPH	O	I
activating	activate	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I

Gastrin	BEGIN-Gastrin-INSIDE	NN	B-NP	B
stimulates	stimulate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
histidine	histidine	NN	I-NP	I
decarboxylase	decarboxylase-INSIDE	NN	I-NP	I
(	(	(	O	O
HDC	BEGIN-HDC-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O
through	through	IN	B-PP	O
binding	binding	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
G	BEGIN-G	NN	I-NP	B
-	-	HYPH	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
coupled	couple	VBN	B-NP	O
cholecystokinin	BEGIN-cholecystokinin	NN	I-NP	B
-	-	HYPH	B-NP	I
B	B-INSIDE	NN	I-NP	I
/	/	SYM	I-NP	O
gastrin	BEGIN-gastrin	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I

RESULTS	RESULTS	NNS	B-NP	O
-	-	SYM	O	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
maximal	maximal	JJ	I-NP	O
early	early	JJ	I-NP	O
asthmatic	asthmatic	JJ	I-NP	O
response	response	NN	I-NP	O
after	after	IN	B-PP	O
allergen	allergen	NN	B-NP	O
with	with	IN	B-PP	O
placebo	placebo	NN	B-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
(	(	(	O	O
SE	SE	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
WEB	WEB	NN	B-NP	O
1	1	CD	I-NP	O
1	1	CD	I-NP	O
(	(	NN	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcript	transcript	NN	I-NP	O
contained	contain	VBD	B-VP	O
a	a	DT	B-NP	O
fully	fully	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
,	,	,	O	O
correctly	correctly	RB	B-NP	O
spliced	splice	VBN	I-NP	O
TCR	BEGIN-TCR	NN	I-NP	B
alpha	alpha	NN	I-NP	I
C	C	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
polyadenylated	polyadenylate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
end	end	NN	I-NP	O

Structural	Structural	JJ	B-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
Elk1	Elk1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
and	and	CC	O	O
its	its	PRP$	B-NP	O
processed	process	VBN	I-NP	O
pseudogene	BEGIN-pseudogene	NN	I-NP	B
Elk1	Elk1-INSIDE	NN	I-NP	I

Results	Result	NNS	B-NP	O
:	:	:	O	O
hepatic	hepatic	JJ	B-NP	O
hydatidosis	hydatidosis	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O

Prematurely	Prematurely	RB	B-ADVP	O
inactivating	inactivate	VBG	B-VP	O
p1	BEGIN-p1	NN	B-NP	B
MAPK	MAPK-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
egg	egg	NN	B-NP	O
extracts	extract	NNS	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
hastening	hastening	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
mitosis	mitosis	NN	I-NP	O

Anxiogenic	Anxiogenic	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
pentagastrin	pentagastrin	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
social	social	JJ	B-NP	O
phobia	phobia	NN	I-NP	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O

Dynamic	Dynamic	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
broad	BEGIN-broad	JJ	B-NP	B
-	-	HYPH	I-NP	I
complex	complex	NN	I-NP	I
isoforms	isoforms-INSIDE	NN	I-NP	I
mediates	mediate	VBZ	B-VP	O
temporal	temporal	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ecdysteroid	ecdysteroid	NN	I-NP	O
target	target	NN	I-NP	O
gene	gene	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
metamorphosis	metamorphosis	NN	I-NP	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
chromosomal	chromosomal	JJ	I-NP	O
replication	replication	NN	I-NP	O
origin	origin	NN	I-NP	O
from	from	IN	B-PP	O
Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
initiator	BEGIN-initiator	NN	I-NP	B
protein	protein	NN	I-NP	I
DnaA	DnaA-INSIDE	NN	I-NP	I

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
concordance	concordance	NN	I-NP	O
between	between	IN	B-PP	O
ST	ST	NN	B-NP	O
-	-	HYPH	I-NP	O
RD	RD	NN	I-NP	O
/	/	SYM	B-NP	O
RI	RI	NN	I-NP	O
/	/	SYM	I-NP	O
LRD	LRD	NN	I-NP	O
1Tl	1Tl	NN	I-NP	O
and	and	CC	I-NP	O
R	R	NN	I-NP	O
-	-	HYPH	B-NP	O
ST	ST	NN	I-NP	O
/	/	SYM	I-NP	O
N	N	NN	I-NP	O
+	+	SYM	O	O
Inf	Inf	NN	B-NP	O
1Tcm	1Tcm	NN	I-NP	O
-	-	HYPH	B-NP	O
tetrofosmin	tetrofosmin	NN	I-NP	O
imaging	imaging	NN	I-NP	O
regarding	regard	VBG	B-VP	O
reversibility	reversibility	NN	B-NP	O

Sub	Sub	NN	B-NP	O
-	-	HYPH	O	O
inhibitory	inhibitory	JJ	B-ADJP	O
and	and	CC	O	O
post	post	AFX	B-NP	O
-	-	HYPH	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
spiramycin	spiramycin	NN	B-NP	O
and	and	CC	I-NP	O
erythromycin	erythromycin	NN	I-NP	O
on	on	IN	B-PP	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NN	I-NP	O

There	There	EX	B-NP	O
remains	remain	VBZ	B-VP	O
the	the	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
problem	problem	NN	I-NP	O
-	-	HYPH	B-VP	O
-	-	SYM	B-NP	O
one	one	CD	B-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
always	always	RB	I-VP	O
been	be	VBN	I-VP	O
foremost	foremost	RB	B-ADVP	O
in	in	IN	B-PP	O
Moruzzi	Moruzzi	NNP	B-NP	O
's	's	POS	B-NP	O
thinking	thinking	NN	I-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
intrinsic	intrinsic	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
brain	brain	NN	B-NP	O
activity	activity	NN	I-NP	O
-	-	HYPH	B-VP	O
-	-	SYM	B-NP	O
of	of	IN	B-PP	O
how	how	WRB	B-ADVP	O
the	the	DT	B-NP	O
separate	separate	JJ	I-NP	O
actions	action	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
arousal	arousal	JJ	I-NP	O
systems	system	NNS	I-NP	O
are	be	VBP	B-VP	O
brought	bring	VBN	I-VP	O
together	together	RB	B-ADVP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
whole	whole	NN	I-NP	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
variation	variation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
milk	milk	NN	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
small	small	JJ	I-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
simple	simple	JJ	I-NP	O
alternative	alternative	JJ	I-NP	O
approach	approach	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
to	to	TO	B-VP	O
include	include	VB	I-VP	O
only	only	RB	B-NP	O
an	an	DT	I-NP	O
average	average	JJ	I-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
value	value	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
estimate	estimate	NN	I-NP	O
of	of	IN	B-PP	O
energy	energy	NN	B-NP	O
content	content	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
biliary	biliary	JJ	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
TBZ	TBZ	NN	B-NP	O
and	and	CC	I-NP	O
FBZ	FBZ	NN	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
metabolites	metabolite	NNS	I-NP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
recycling	recycling	NN	I-NP	O

Hyperlipemia	Hyperlipemia	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
recently	recently	RB	I-VP	O
described	describe	VBN	I-VP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
migraine	migraine	NN	B-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
suggested	suggest	VBD	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
alteration	alteration	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
thorough	thorough	JJ	I-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
fibrous	fibrous	JJ	I-NP	O
histiocytoma	histiocytoma	NN	I-NP	O
(	(	(	O	O
MFH	MFH	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
subtype	subtype	NN	I-NP	O
of	of	IN	B-PP	O
soft	soft	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
sarcoma	sarcoma	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
improved	improve	VBN	B-NP	O
histologic	histologic	JJ	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
protocols	protocol	NNS	I-NP	O

The	The	DT	B-NP	O
proteins	protein	NNS	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
called	call	VBN	B-VP	O
GF1	BEGIN-GF1	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
,	,	,	O	O
participate	participate	VBP	B-VP	O
in	in	IN	B-PP	O
protein	protein	NN	B-NP	O
/	/	SYM	B-NP	O
DNA	DNA	NN	I-NP	O
complexes	complex	NNS	I-NP	O
and	and	CC	O	O
show	show	VBP	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
,	,	,	O	O
widely	widely	RB	B-NP	O
distributed	distribute	VBN	I-NP	O
protein	protein	NN	I-NP	O
family	family	NN	I-NP	O
,	,	,	O	O
collectively	collectively	RB	B-VP	O
referred	refer	VBN	I-VP	O
to	to	TO	B-PP	O
as	as	IN	B-PP	O
1	BEGIN-1	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
proteins	protein	NNS	I-NP	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
uncomplicated	uncomplicated	JJ	I-NP	O
Type	Type	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
diabetic	diabetic	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
of	of	IN	B-PP	O
higher	high	JJR	B-NP	O
middle	middle	JJ	I-NP	O
class	class	NN	I-NP	O
to	to	TO	B-PP	O
rich	rich	JJ	B-NP	O
socio	socio	AFX	I-NP	O
-	-	HYPH	I-NP	O
economic	economic	JJ	I-NP	O
status	status	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O

Using	Use	VBG	B-VP	O
yeast	yeast	NN	B-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
hybrid	hybrid	NN	I-NP	O
screening	screening	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
histone	BEGIN-histone	NN	B-NP	B
H1	H1-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
an	an	DT	B-NP	O
interacting	interact	VBG	I-NP	O
factor	factor	NN	I-NP	O
of	of	IN	B-PP	O
CIA	BEGIN-CIA-INSIDE	NN	B-NP	B

Elevated	Elevated	JJ	B-NP	O
total	total	JJ	I-NP	O
serum	serum	NN	I-NP	O
calcium	calcium	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	O	O
dl	dl	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
group	group	NN	B-NP	O
)	)	)	O	O
developed	develop	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gentamicin	gentamicin	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
1	1	CD	B-NP	O
vitamin	vitamin	NN	I-NP	O
D1	D1	NN	I-NP	O
group	group	NN	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
pronounced	pronounced	JJ	B-NP	O
structural	structural	JJ	I-NP	O
damage	damage	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
through	through	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
domain	domain	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SIV	BEGIN-SIV	NN	I-NP	B
Env	Env-INSIDE	NN	I-NP	I
into	into	IN	B-PP	O
virions	virion	NNS	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
generated	generate	VBD	B-VP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
SIV	BEGIN-BEGIN-SIV	NN	B-NP	B
Env	Env-INSIDE	NN	I-NP	I
mutants	mutants-INSIDE	NN	I-NP	I
carrying	carry	VBG	B-VP	O
small	small	JJ	B-ADJP	O
in	in	IN	B-PP	O
-	-	HYPH	B-NP	O
frame	frame	NN	I-NP	O
deletions	deletion	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
domain	domain	NN	I-NP	O

Ozone	Ozone	NN	B-NP	O
uptake	uptake	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
in	in	IN	B-PP	O
awake	awake	NN	B-NP	O
,	,	,	O	O
spontaneously	spontaneously	RB	B-NP	O
breathing	breathing	JJ	I-NP	O
Fischer	Fischer	NNP	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
Sprague	Sprague	NNP	I-NP	O
-	-	HYPH	I-NP	O
Dawley	Dawley	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Long	Long	NNP	B-NP	O
-	-	HYPH	I-NP	O
Evans	Evans	NNP	I-NP	O
rats	rat	NNS	I-NP	O
and	and	CC	O	O
Hartley	Hartley	NNP	B-NP	O
guinea	guinea	NNP	I-NP	O
pigs	pig	NNS	I-NP	O
to	to	TO	B-VP	O
provide	provide	VB	I-VP	O
data	datum	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
dosimetry	dosimetry	NN	I-NP	O
of	of	IN	B-PP	O
O1	O1	NN	B-NP	O
in	in	IN	B-PP	O
small	small	JJ	B-NP	O
laboratory	laboratory	NN	I-NP	O
animals	animal	NNS	I-NP	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
resistant	resistant	JJ	I-NP	O
rejection	rejection	NN	I-NP	O
following	follow	VBG	B-PP	O
renal	renal	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
:	:	:	O	O
benefits	benefit	NNS	B-NP	O
and	and	CC	I-NP	O
risks	risk	NNS	I-NP	O
of	of	IN	B-PP	O
OKT1	BEGIN-OKT1-INSIDE	NN	B-NP	B
therapy	therapy	NN	I-NP	O

SETTING	SETTING	NN	B-NP	O
:	:	:	O	O
University	University	NN	B-NP	O
research	research	NN	I-NP	O
laboratory	laboratory	NN	I-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
1rd	1rd	NN	I-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
remained	remained	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
,	,	,	O	O
structural	structural	JJ	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
walls	wall	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glomerular	glomerular	JJ	I-NP	O
arterioles	arteriole	NNS	I-NP	O
and	and	CC	O	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
filtration	filtration	NN	I-NP	O
-	-	HYPH	B-NP	O
reabsorption	reabsorption	NN	I-NP	O
barrier	barrier	NN	I-NP	O
undergo	undergo	VBP	B-VP	O
certain	certain	JJ	B-NP	O
ultrastructural	ultrastructural	JJ	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
that	that	IN	B-NP	O
with	with	IN	B-PP	O
time	time	NN	B-NP	O
elapsed	elapse	VBD	B-VP	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
)	)	)	O	O
gradually	gradually	RB	B-ADVP	O
pass	pass	VBP	B-VP	O
away	away	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
amount	amount	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
hypertrophic	hypertrophic	JJ	B-NP	O
processes	process	NNS	I-NP	O
increases	increase	VBZ	B-VP	O

Non	Non	AFX	O	O
-	-	HYPH	B-NP	O
finger	finger	NN	I-NP	O
-	-	HYPH	O	O
coding	cod	VBG	B-VP	O
modules	module	NNS	B-NP	O
conserved	conserve	VBN	B-VP	O
among	among	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
subfamilies	subfamily	NNS	B-NP	O
of	of	IN	B-PP	O
zinc	BEGIN-zinc	NN	B-NP	B
finger	finger	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
described	describe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
genome	genome	NN	I-NP	O
(	(	(	O	O
finger	finger	NN	B-NP	O
-	-	HYPH	B-NP	O
associated	associate	VBN	I-NP	O
boxes	box	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
FAX	FAX	NN	B-NP	O
domain	domain	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
genome	genome	NN	I-NP	O
(	(	(	O	O
Kruppel	BEGIN-Kruppel	NN	B-NP	B
-	-	HYPH	O	I
associated	associate	VBN	B-NP	I
boxes	boxes-INSIDE	NN	I-NP	I
,	,	,	O	O
or	or	CC	O	O
KRAB	BEGIN-KRAB	NN	B-NP	B
domain	domain-INSIDE	NN	I-NP	I
)	)	)	O	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	B-NP	I
EBPs	EBPs-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
spi	BEGIN-spi	NNP	I-NP	B
1	1	CD	I-NP	I
1	1	CD	I-NP	I
'	'	SYM	I-NP	I
UTR	UTR	NN	I-NP	I
repressor	repressor	NN	I-NP	I
sites	sites-INSIDE	NN	I-NP	I
,	,	,	O	O
although	although	IN	B-SBAR	O
rather	rather	RB	B-ADJP	O
weak	weak	JJ	I-ADJP	O
,	,	,	O	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
that	that	WDT	B-NP	O
otherwise	otherwise	RB	B-ADVP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
reveal	reveal	VB	I-VP	O
specific	specific	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
liver	liver	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

The	The	DT	B-NP	O
newly	newly	RB	I-NP	O
identified	identify	VBN	I-NP	O
NF	BEGIN-NF	NN	I-NP	B
kappa	kappa	NN	I-NP	I
B	B	NN	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I
(	(	(	O	O
TGGAAATTCC	TGGAAATTCC	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
bound	bind	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
TNF	BEGIN-TNF	NN	I-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
nuclear	nuclear	JJ	I-NP	O
protein	protein	NN	I-NP	O
and	and	CC	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
key	key	JJ	I-NP	O
element	element	NN	I-NP	O
in	in	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
induction	induction	NN	I-NP	O
by	by	IN	B-PP	O
TNF	BEGIN-TNF	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
(	(	(	O	O
and	and	CC	O	O
TPA	TPA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
transactivation	transactivation	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
element	element	NN	I-NP	O
is	be	VBZ	B-VP	O
repressed	repress	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ligand	ligand	NN	I-NP	O
-	-	HYPH	B-VP	O
bound	bind	VBN	B-NP	O
glucocorticoid	BEGIN-glucocorticoid	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
biochemical	biochemical	JJ	B-NP	O
estimates	estimate	NNS	I-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
turnover	turnover	NN	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
(	(	(	O	O
short	short	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
)	)	)	O	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
rhGH	BEGIN-rhGH-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
IGF	BEGIN-IGF	NN	I-NP	B
-	-	HYPH	B-NP	I
I	I-INSIDE	NN	I-NP	I
stimulates	stimulate	VBZ	B-VP	O
bone	bone	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
osteoporotic	osteoporotic	JJ	I-NP	O
older	old	JJR	I-NP	O
people	people	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
bone	bone	NN	B-NP	O
mineral	mineral	NN	I-NP	O
density	density	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
femur	femur	NN	I-NP	O

Parental	Parental	JJ	B-NP	O
and	and	CC	I-NP	O
vector	vector	NN	I-NP	O
-	-	HYPH	B-NP	O
transfected	transfecte	VBN	I-NP	O
MCF1	MCF1	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
-	-	HYPH	O	O
inhibitory	inhibitory	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
atRA	atRA	NN	B-NP	O
,	,	,	O	O
exhibited	exhibit	VBD	B-VP	O
atRA	atRA	NN	B-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
retinoic	BEGIN-retinoic	JJ	I-NP	B
acid	acid	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
RAR	BEGIN-RAR-INSIDE	NN	B-NP	B
)	)	)	O	O
transactivation	transactivation	NN	B-NP	O
and	and	CC	I-NP	O
transrepression	transrepression	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
O	O	NN	I-NP	O
-	-	HYPH	B-NP	O
tetradecanoylphorbol	tetradecanoylphorbol	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
acetate	acetate	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O

Chemiluminescence	Chemiluminescence	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
opsonized	opsonize	VBN	B-NP	O
zymosan	zymosan	NN	I-NP	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fMLP	fMLP	NN	I-NP	O
-	-	HYPH	B-NP	O
stimulated	stimulate	VBN	I-NP	O
PMNs	PMN	NNS	I-NP	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
hybrid	hybrid	NN	I-NP	O
screening	screening	NN	I-NP	O
method	method	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CCAAT	BEGIN-CCAAT	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I

Our	Our	PRP$	B-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
helicase	BEGIN-helicase-INSIDE	NN	I-NP	B
assembly	assembly	NN	I-NP	O
protein	protein	NN	I-NP	O
is	be	VBZ	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
loading	load	VBG	B-VP	O
T1	BEGIN-T1	NN	B-NP	B
gene	gene	NN	I-NP	I
1	1	CD	I-NP	I
helicase	BEGIN-helicase-INSIDE-INSIDE	NN	I-NP	I
specifically	specifically	RB	B-ADVP	O
at	at	IN	B-PP	O
replication	replication	NN	B-NP	O
forks	fork	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
its	its	PRP$	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
arm	arm	NN	I-NP	O
must	must	MD	B-VP	O
hold	hold	VB	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
six	six	CD	I-NP	O
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
strongly	strongly	RB	B-VP	O
suggest	suggest	VBP	I-VP	O
that	that	IN	B-SBAR	O
HSV	HSV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
infection	infection	NN	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
host	host	NN	B-NP	O
cell	cell	NN	I-NP	O
splicing	splicing	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
ICP1	BEGIN-ICP1-INSIDE	NN	B-NP	B

Sci	Sci	NNS	B-NP	O

In	In	IN	B-PP	O
our	our	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
treated	treat	VBD	B-VP	O
MCF	MCF	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
paclitaxel	paclitaxel	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
arrest	arrest	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
G1	G1	NN	B-NP	O
with	with	IN	B-PP	O
1n	1n	NN	B-NP	O
DNA	DNA	NN	I-NP	O
content	content	NN	I-NP	O
(	(	(	O	O
pseudo	pseudo	NN	B-NP	O
G1	G1	NN	I-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
GTP	GTP	NN	I-NP	O
/	/	SYM	I-NP	O
GDP	GDP	NN	I-NP	O
exchange	exchange	NN	I-NP	O
assay	assay	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Ras	BEGIN-Ras-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathway	pathway	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
ERK	BEGIN-ERK-INSIDE	NN	B-NP	B
phosphorylation	phosphorylation	NN	I-NP	O
;	;	:	O	O
DADLE	DADLE	NN	B-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
stimulate	stimulate	VB	I-VP	O
GTP	GTP	NN	B-NP	O
/	/	SYM	I-NP	O
GDP	GDP	NN	I-NP	O
exchange	exchange	NN	I-NP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
PMA	PMA	NN	B-NP	O

The	The	DT	B-NP	O
primary	primary	JJ	I-NP	O
structures	structure	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
KB	KB	NN	I-NP	I
cell	cell	NN	I-NP	I
(	(	(	O	I
FR	BEGIN-FR-INSIDE	NN	B-NP	I
-	-	HYPH	B-NP	O
KB1	KB1	NN	I-NP	O
)	)	)	O	O
folate	folate	NN	B-NP	O
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
FR	BEGIN-FR-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
placental	placental	NN	I-NP	I
(	(	(	O	I
FR	BEGIN-FR-INSIDE	NN	B-NP	I
-	-	HYPH	B-NP	O
P1	P1	NN	I-NP	O
)	)	)	O	O
FR	BEGIN-FR-INSIDE-INSIDE	NN	B-NP	B
,	,	,	O	O
proteins	protein	NNS	B-NP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
folates	folate	NNS	B-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
deduced	deduce	VBN	I-VP	O
from	from	IN	B-PP	O
cDNA	cDNA	NN	B-NP	O
sequences	sequence	NNS	I-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O

Possible	Possible	JJ	B-NP	O
or	or	CC	I-NP	O
definite	definite	JJ	I-NP	O
neglect	neglect	NN	I-NP	O
or	or	CC	I-NP	O
abuse	abuse	NN	I-NP	O
before	before	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
was	be	VBD	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
DBH	BEGIN-DBH-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O

The	The	DT	B-NP	O
remaining	remain	VBG	I-NP	O
1	1	CD	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
domain	domain	NN	B-NP	O
II	II	CD	I-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
domains	domain	NNS	B-NP	O
III	III	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
nucleotides	nucleotide	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
nucleotides	nucleotide	NNS	I-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
not	not	RB	O	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
DIssE	BEGIN-DIssE	NN	B-NP	B
RNA	RNA-INSIDE	NN	I-NP	I

Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
tension	tension	NN	B-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
isometrically	isometrically	RB	B-ADVP	O
on	on	IN	B-PP	O
spiral	spiral	JJ	B-NP	O
strips	strip	NNS	I-NP	O
of	of	IN	B-PP	O
freshly	freshly	RB	B-NP	O
obtained	obtain	VBN	I-NP	O
bovine	bovine	JJ	I-NP	O
basilar	basilar	JJ	I-NP	O
arteries	artery	NNS	I-NP	O

The	The	DT	B-NP	O
preparative	preparative	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
fractionated	fractionate	VBN	B-NP	O
total	total	JJ	I-NP	O
body	body	NN	I-NP	O
irradiation	irradiation	NN	I-NP	O
(	(	(	O	O
TBI	TBI	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
cyclophosphamide	cyclophosphamide	NN	B-NP	O
(	(	(	O	O
CY	CY	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
dynamics	dynamic	NNS	I-NP	O
of	of	IN	B-PP	O
protozoa	protozoa	NN	B-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
rumen	rumen	NN	B-NP	O
-	-	HYPH	B-NP	O
fistulated	fistulate	VBN	I-NP	O
cattle	cattle	NNS	I-NP	O
fed	feed	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
basal	basal	JJ	I-NP	O
diet	diet	NN	I-NP	O
of	of	IN	B-PP	O
molasses	molass	NNS	B-NP	O
ad	ad	NN	I-NP	O
lib.	lib.	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
oaten	oaten	NN	B-NP	O
chaff	chaff	NN	I-NP	O
given	give	VBN	B-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
live	live	JJ	I-NP	O
weight	weight	NN	I-NP	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
pocket	pocket	NN	I-NP	O
of	of	IN	B-PP	O
Rb	BEGIN-Rb-INSIDE	NN	B-NP	B
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
TAF	BEGIN-TAF	NN	B-NP	B
(	(	(	O	I
II	II	CD	B-NP	I
)	)	)	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
pocket	pocket	NN	I-NP	O
domains	domain	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
TAF	BEGIN-TAF	NN	B-NP	B
(	(	(	O	I
II	II	CD	B-NP	I
)	)	)	O	I
1	1-INSIDE	NN	B-NP	I
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
Eales	Eale	NNS	B-NP	O
'	'	POS	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
chorioretinitis	chorioretinitis	NN	B-NP	O
,	,	,	O	O
central	central	JJ	B-NP	O
serous	serous	JJ	I-NP	O
retinopathy	retinopathy	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
malignant	malignant	JJ	B-NP	O
choroidal	choroidal	JJ	I-NP	O
melanoma	melanoma	NN	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
HLA	BEGIN-HLA-INSIDE	NN	B-NP	B
antigen	antigen	NN	I-NP	O
deviation	deviation	NN	I-NP	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
derived	derive	VBN	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HCMV	BEGIN-HCMV	NN	I-NP	B
UL1	UL1	NN	I-NP	I
gene	gene	NN	I-NP	I
product	product-INSIDE	NN	I-NP	I
reveals	reveal	VBZ	B-VP	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
overlap	overlap	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O

White	White	JJ	B-NP	O
female	female	JJ	I-NP	O
cases	case	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
worked	work	VBN	I-VP	O
as	as	IN	B-PP	O
registered	register	VBN	B-NP	O
nurses	nurse	NNS	I-NP	O
than	than	IN	B-SBAR	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
controls	control	NNS	I-NP	O
(	(	(	O	O
OR	OR	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
CI	CI	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Fentanyl	Fentanyl	NN	B-NP	O
citrate	citrate	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mL	mL	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1H1	1H1	NN	B-NP	O
-	-	HYPH	O	O
fentanyl	fentanyl	NN	B-NP	O
(	(	(	O	O
internal	internal	JJ	B-NP	O
standard	standard	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mL	mL	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
L	L	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
extracted	extract	VBN	I-VP	O
with	with	IN	B-PP	O
Toxi	Toxi	AFX	B-NP	O
-	-	HYPH	I-NP	O
A	A	NN	I-NP	O
tubes	tube	NNS	I-NP	O
(	(	(	O	O
Toxi	Toxi	NNP	B-NP	O
-	-	HYPH	I-NP	O
Lab	Lab	NNP	I-NP	O
,	,	,	I-NP	O
Irvine	Irvine	NNP	I-NP	O
,	,	,	I-NP	O
CA	CA	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
analyzed	analyze	VBN	B-VP	O
by	by	IN	B-PP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
-	-	HYPH	O	O
mass	mass	NN	B-NP	O
spectrometry	spectrometry	NN	I-NP	O

O1	BEGIN-O1-INSIDE	NN	B-NP	B
shows	show	VBZ	B-VP	O
homology	homology	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
SAS1	BEGIN-SAS1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
and	and	CC	O	O
another	another	DT	B-NP	O
hypothetical	hypothetical	JJ	I-NP	O
protein	protein	NN	I-NP	O
from	from	IN	B-PP	O
yeast	yeast	NN	B-NP	O

Cotransfection	Cotransfection	NN	B-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
plasmids	plasmid	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
A	A-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
an	an	DT	B-NP	O
inactive	inactive	JJ	I-NP	O
protein	BEGIN-protein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
A	A-INSIDE	NN	I-NP	I
(	(	(	O	O
PKA	BEGIN-PKA-INSIDE	NN	B-NP	B
)	)	)	O	O
catalytic	catalytic	JJ	B-NP	O
beta	beta	NN	I-NP	O
subunit	subunit	NN	I-NP	O
,	,	,	O	O
inhibited	inhibit	VBD	B-VP	O
both	both	CC	O	O
forskolin	forskolin	NN	B-NP	O
and	and	CC	O	O
PACAP	BEGIN-PACAP-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
chromogranin	BEGIN-chromogranin	NN	B-NP	B
A	A-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
,	,	,	O	O
revealing	reveal	VBG	B-VP	O
that	that	IN	B-SBAR	O
PACAP	BEGIN-PACAP-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
induced	induce	VBN	B-VP	O
trans	trans	AFX	O	O
-	-	HYPH	O	O
activation	activation	NN	B-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
PKA	BEGIN-PKA-INSIDE	NN	B-NP	B

Of	Of	IN	B-PP	O
all	all	DT	B-NP	O
YASR	YASR	NN	I-NP	O
syndromes	syndrome	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
stability	stability	NN	I-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Anxious	Anxious	JJ	I-NP	O
/	/	SYM	I-NP	O
Depressed	Depressed	JJ	I-NP	O
scale	scale	NN	I-NP	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
serum	BEGIN-serum	NN	B-NP	B
albumin	albumin-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
transferrin	BEGIN-transferrin-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
serum	BEGIN-serum	NN	B-NP	B
prealbumin	prealbumin-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
fed	feed	VBN	B-VP	O
early	early	RB	B-ADVP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
desirable	desirable	JJ	I-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
dl	dl	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-VP	O
dl	dl	NN	B-NP	O
vs	v	NNS	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
dl	dl	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
dl	dl	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
introduction	introduction	NN	I-NP	O
gives	give	VBZ	B-VP	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
Research	Research	NNP	B-NP	O
Programme	Programme	NNP	I-NP	O
MZ	MZ	NNP	I-NP	O
-	-	HYPH	B-NP	O
XVII	XVII	NNP	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
implementation	implementation	NN	I-NP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
Poland	Poland	NNP	B-NP	O

The	The	DT	B-NP	O
uap1	BEGIN-uap1-INSIDE	NN	I-NP	B
cis	cis	NN	I-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
,	,	,	O	O
up	up	RB	B-ADVP	O
-	-	HYPH	B-NP	O
promoter	promoter	NN	I-NP	O
,	,	,	O	O
constitutive	constitutive	JJ	B-NP	O
mutation	mutation	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
duplication	duplication	NN	I-NP	O
that	that	WDT	B-NP	O
comprises	comprise	VBZ	B-VP	O
two	two	CD	B-NP	O
GATA	GATA	NN	I-NP	O
sites	site	NNS	I-NP	O
and	and	CC	O	O
suppresses	suppress	VBZ	B-VP	O
weakly	weakly	RB	B-ADVP	O
the	the	DT	B-NP	O
AREA	BEGIN-AREA	NN	I-NP	B
zinc	zinc	NN	I-NP	I
finger	finger	NN	I-NP	I
mutation	mutation-INSIDE	NN	I-NP	I
but	but	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
alleviate	alleviate	VB	I-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
functional	functional	JJ	B-NP	O
UAY	BEGIN-UAY-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
AREA	BEGIN-AREA	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I

Significant	Significant	JJ	B-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
cis	cis	NN	B-NP	O
-	-	HYPH	I-NP	O
elements	element	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
LDH	BEGIN-LDH	NN	I-NP	B
/	/	SYM	B-NP	I
C	C	NN	I-NP	I
proximal	proximal	JJ	I-NP	I
promoter	promoter	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
somatic	somatic	JJ	B-NP	O
versus	versus	IN	B-PP	O
germ	germ	NN	B-NP	O
cells	cell	NNS	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
G1	G1	NN	I-NP	O
sequence	sequence	NN	I-NP	O
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
protein	protein	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
G1	G1	NN	I-NP	O
enhancer	enhancer	NN	I-NP	O
-	-	HYPH	B-VP	O
like	like	JJ	B-NP	O
element	element	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
bipartite	bipartite	JJ	B-ADJP	O

With	With	IN	B-PP	O
BCPP	BCPP	NN	B-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
achieved	achieve	VBD	B-VP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
evidenced	evidence	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
displayed	display	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
response	response	NN	I-NP	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
tilmicosin	tilmicosin	NN	B-NP	O
administration	administration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
feed	feed	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
injection	injection	NN	I-NP	O
therapy	therapy	NN	I-NP	O
of	of	IN	B-PP	O
clinically	clinically	RB	B-NP	O
diseased	disease	VBN	I-NP	O
pigs	pig	NNS	I-NP	O
with	with	IN	B-PP	O
long	long	RB	B-ADVP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
oxytetracycline	oxytetracycline	NN	B-NP	O
(	(	(	O	O
Terramycine	Terramycine	NN	B-NP	O
LA	LA	NN	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
bodyweight	bodyweight	NN	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O

In	In	IN	B-PP	O
1	1	CD	B-NP	O
men	man	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
suddenly	suddenly	RB	B-ADVP	O
the	the	DT	B-NP	O
functionally	functionally	RB	I-NP	O
important	important	JJ	I-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
myocardium	myocardium	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sino	sino	AFX	I-NP	O
-	-	HYPH	I-NP	O
auricular	auricular	JJ	I-NP	O
area	area	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
subendocardial	subendocardial	JJ	I-NP	O
layers	layer	NNS	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
ventricle	ventricle	NN	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
necropsy	necropsy	NN	B-NP	O
no	no	RB	B-NP	O
more	more	JJR	I-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
death	death	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
prepared	prepare	VBN	B-VP	O
for	for	IN	B-PP	O
study	study	NN	B-NP	O
by	by	IN	B-PP	O
electron	electron	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O

Importantly	Importantly	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
base	base	NN	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fifth	fifth	JJ	I-NP	O
position	position	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	O	I
fos	fos	NN	B-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
(	(	(	O	O
GGTCTnnnAGACC	GGTCTnnnAGACC	NN	B-NP	O
to	to	TO	B-PP	O
GGTCA	GGTCA	NN	B-NP	O
/	/	SYM	B-NP	O
GnnnAGACC	GnnnAGACC	NN	I-NP	O
)	)	)	O	O
produced	produce	VBD	B-VP	O
an	an	DT	B-NP	O
element	element	NN	I-NP	O
that	that	WDT	B-NP	O
bound	bind	VBD	B-VP	O
the	the	DT	B-NP	O
estrogen	BEGIN-estrogen	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
and	and	CC	O	O
conferred	confer	VBD	B-VP	O
estrogen	estrogen	NN	B-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O

A	A	DT	B-NP	O
preterm	preterm	JJ	I-NP	O
formula	formula	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
traditional	traditional	JJ	I-NP	O
corn	corn	NN	I-NP	O
oil	oil	NN	I-NP	O
/	/	SYM	I-NP	O
MCT	MCT	NN	I-NP	O
blend	blend	NN	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
MCTs	MCT	NNS	I-NP	O
(	(	(	O	O
MCT	MCT	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
fat	fat	JJ	I-NP	O
blend	blend	NN	I-NP	O
,	,	,	O	O
designed	design	VBN	B-VP	O
to	to	TO	I-VP	O
resemble	resemble	VB	I-VP	O
human	human	JJ	B-NP	O
milk	milk	NN	I-NP	O
more	more	JJR	I-NP	O
,	,	,	O	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
MCTs	MCT	NNS	I-NP	O
(	(	(	O	O
LCT	LCT	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
TFIIIB	BEGIN-TFIIIB-INSIDE	NN	I-NP	B
assembly	assembly	NN	I-NP	O
pathway	pathway	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
faithful	faithful	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
natural	natural	JJ	B-NP	O
eukaryotic	eukaryotic	JJ	I-NP	O
tRNA	tRNA	NN	I-NP	O
genes	gene	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
TFIIIC	BEGIN-TFIIIC-INSIDE	NN	B-NP	B
provides	provide	VBZ	B-VP	O
novel	novel	JJ	B-NP	O
insights	insight	NNS	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
flexibility	flexibility	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
eukaryotic	eukaryotic	JJ	I-NP	O
tRNA	tRNA	NN	I-NP	O
gene	gene	NN	I-NP	O
transcription	transcription	NN	I-NP	O
machinery	machinery	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
evolution	evolution	NN	I-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
ancestral	ancestral	JJ	I-NP	O
RNA	BEGIN-RNA	NN	I-NP	B
polymerase	polymerase	NN	I-NP	I
III	III-INSIDE	JJ|NN	B-NP	I
system	system	NN	I-NP	O
relying	rely	VBG	B-VP	O
on	on	IN	B-PP	O
upstream	upstream	JJ	B-NP	O
,	,	,	I-NP	O
TATA	TATA	NN	I-NP	O
-	-	HYPH	I-NP	O
centered	center	VBN	B-NP	O
control	control	NN	I-NP	O
elements	element	NNS	I-NP	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
mutations	mutation	NNS	I-NP	O
disturbs	disturb	NNS	I-NP	O
mitosis	mitosis	NN	I-NP	O
and	and	CC	O	O
produces	produce	VBZ	B-VP	O
elongated	elongate	VBN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
PCR	PCR	NN	I-NP	O
approach	approach	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
homologue	homologue	NN	I-NP	O
of	of	IN	B-PP	O
Prp1	BEGIN-Prp1-INSIDE	NN	B-NP	B
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
and	and	CC	I-NP	O
mouse	mouse	NN	I-NP	O
cells	cell	NNS	I-NP	O

Successive	Successive	JJ	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
deletions	deletion	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
[	[	(	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
+1	+1	CD	B-NP	O
]	]	)	I-NP	O
type	BEGIN-type	JJ	I-NP	B
II	II	CD	I-NP	I
sPLA1	sPLA1	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
position	position	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
activity	activity	NN	I-NP	O
sixfold	sixfold	RB	B-ADVP	O
in	in	IN	B-PP	O
HepG1	HepG1	NN	B-NP	O
cells	cell	NNS	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
HeLa	HeLa	NN	B-NP	O
cells	cell	NNS	I-NP	O

Pyridostigmine	Pyridostigmine	NN	B-NP	O
pretreatment	pretreatment	NN	I-NP	O
was	be	VBD	B-VP	O
supplemented	supplement	VBN	I-VP	O
by	by	IN	B-PP	O
therapy	therapy	NN	B-NP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antidotal	antidotal	JJ	I-NP	O
combination	combination	NN	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
,	,	,	O	O
TM	TM	NN	B-NP	O
,	,	,	O	O
B	B	NN	B-NP	O
)	)	)	O	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
atropine	atropine	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	O	O
kg	kg	NN	B-NP	O
TMB	TMB	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
benactyzine	benactyzine	NN	I-NP	O
which	which	WDT	B-NP	O
assured	assure	VBD	B-VP	O
survival	survival	NN	B-NP	O
in	in	IN	B-PP	O
five	five	CD	B-NP	O
of	of	IN	I-NP	O
six	six	CD	I-NP	O
animals	animal	NNS	I-NP	O
following	follow	VBG	B-PP	O
three	three	CD	B-NP	O
separate	separate	JJ	I-NP	O
exposures	exposure	NNS	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
LD1	LD1	NN	I-NP	O
soman	soman	NN	I-NP	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
and	and	CC	O	O
DNase	BEGIN-DNase	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
protection	protection	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
FP	BEGIN-FP	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
bound	bind	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
PU.1	BEGIN-PU.1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Spi	BEGIN-Spi	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
noncoordinate	noncoordinate	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
FSK	BEGIN-FSK-INSIDE	NN	B-NP	B
on	on	IN	B-PP	O
PMA	PMA	NN	B-NP	O
-	-	HYPH	B-NP	O
stimulated	stimulate	VBN	I-NP	O
MKK	BEGIN-MKK-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
MAPK	BEGIN-MAPK-INSIDE	NN	I-NP	B
activities	activity	NNS	I-NP	O
indicates	indicate	VBZ	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
additional	additional	JJ	I-NP	O
distal	distal	JJ	I-NP	O
cAMP	cAMP	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O

Motilin	BEGIN-Motilin-INSIDE	NN	B-NP	B
serum	serum	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
hour	hour	NN	I-NP	O

Parameters	Parameter	NNS	B-NP	O
of	of	IN	B-PP	O
sperm	sperm	NN	B-NP	O
quality	quality	NN	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
freezing	freeze	VBG	B-VP	O
/	/	SYM	B-NP	O
thawing	thawing	NN	I-NP	O

Comment	Comment	NN	B-NP	O
on	on	IN	B-PP	O
``	``	``	O	O
Critical	Critical	JJ	B-NP	O
behavior	behavior	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
binary	binary	JJ	I-NP	O
mixture	mixture	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
and	and	CC	I-NP	O
salt	salt	NN	I-NP	O
water	water	NN	I-NP	O
''	''	''	O	O

Site	Site	NN	B-NP	O
-	-	HYPH	B-PP	O
directed	direct	VBN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
to	to	TO	I-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
element	element	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
minus	minus	NN	I-NP	O
-	-	HYPH	B-NP	O
strand	strand	NN	I-NP	O
terminal	terminal	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
``	``	``	O	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
OH	OH	NN	I-NP	O
-	-	HYPH	I-NP	O
CCCUAU	CCCUAU	NN	I-NP	O
,	,	,	O	O
''	''	''	O	O
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
minus	minus	AFX	I-NP	O
-	-	HYPH	I-NP	O
strand	strand	NN	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
end	end	NN	I-NP	O
sequence	sequence	NN	I-NP	O
``	``	``	O	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
OH	OH	NN	I-NP	O
-	-	HYPH	O	O
CC	CC	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
(	(	(	O	O
A	A	NN	B-NP	O
/	/	SYM	I-NP	O
U	U	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
A	A	NN	B-NP	O
/	/	SYM	I-NP	O
U	U	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
A	A	NN	B-NP	O
/	/	SYM	I-NP	O
U	U	NN	I-NP	O
)	)	)	O	O
''	''	''	O	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
carmovirus	carmovirus	NN	I-NP	O
RNAs	RNA	NNS	I-NP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
nuclear	BEGIN-nuclear	JJ	I-NP	B
deformed	deform	VBN	I-NP	I
epidermal	epidermal	JJ	I-NP	I
autoregulatory	autoregulatory	JJ	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
DEAF	BEGIN-DEAF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
-	-	HYPH	O	O
related	relate	VBN	B-ADJP	O
(	(	(	O	O
NUDR	BEGIN-NUDR-INSIDE	NN	B-NP	B
)	)	)	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
protein	protein	NN	I-NP	O

Cardiac	Cardiac	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
exotoxic	exotoxic	JJ	B-NP	O
shock	shock	NN	I-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
family	family	NN	B-NP	O
visits	visit	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
-	-	HYPH	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O

Prospects	Prospect	NNS	B-NP	O
of	of	IN	B-PP	O
chemosterilant	chemosterilant	JJ	B-NP	O
and	and	CC	I-NP	O
genetic	genetic	JJ	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
rodents	rodent	NNS	B-NP	O

Neurological	Neurological	JJ	B-NP	O
toxicity	toxicity	NN	I-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
fludarabine	fludarabine	NN	B-NP	O
(	(	(	O	O
FAMP	FAMP	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
and	and	CC	O	O
cytosine	cytosine	NN	B-NP	O
arabinoside	arabinoside	NN	I-NP	O
(	(	(	O	O
Ara	Ara	NN	B-NP	O
-	-	HYPH	B-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
new	new	JJ	B-ADJP	O
or	or	CC	O	O
relapsed	relapse	VBD	B-VP	O
acute	acute	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
or	or	CC	I-NP	O
myelodysplasia	myelodysplasia	NN	I-NP	O

Ondansetron	Ondansetron	NN	B-NP	O
is	be	VBZ	B-VP	O
thus	thus	RB	B-ADVP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
first	first	JJ	I-NP	O
-	-	HYPH	I-NP	O
line	line	NN	I-NP	O
antiemetic	antiemetic	JJ	B-ADJP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
undergoing	undergo	VBG	B-VP	O
chemotherapy	chemotherapy	NN	B-NP	O
,	,	,	I-NP	O
radiotherapy	radiotherapy	NN	I-NP	O
and	and	CC	I-NP	O
surgery	surgery	NN	I-NP	O

Paclitaxel	Paclitaxel	NN	B-NP	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
and	and	CC	I-NP	O
transient	transient	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
Jun	Jun	NN	B-NP	I
NH1	NH1	NN	I-NP	I
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B
)	)	)	O	O
activity	activity	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
proposed	propose	VBN	I-NP	O
mediator	mediator	NN	I-NP	O
of	of	IN	B-PP	O
stress	stress	NN	B-NP	O
activation	activation	NN	I-NP	O
pathways	pathway	NNS	I-NP	O

Aspirin	Aspirin	NN	B-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rheumatic	rheumatic	JJ	I-NP	O
diseases	disease	NNS	I-NP	O

High	High	JJ	B-NP	O
-	-	HYPH	I-NP	O
level	level	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
sccypB	BEGIN-sccypB-INSIDE	NN	B-NP	B
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
of	of	IN	B-PP	O
sccypA	BEGIN-sccypA-INSIDE	NN	B-NP	B
cloned	clone	VBN	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
vector	vector	NN	I-NP	O
pIJ1	pIJ1	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
produce	produce	VB	I-VP	O
detectable	detectable	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
growth	growth	NN	B-NP	O
and	and	CC	I-NP	O
morphology	morphology	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
chrysomallus	chrysomallus	NN	I-NP	O
and	and	CC	I-NP	O
S.	S.	NN	I-NP	O
lividans	lividan	NNS	I-NP	O

Reasons	Reason	NNS	B-NP	O
are	be	VBP	B-VP	O
presented	present	VBN	I-VP	O
to	to	TO	I-VP	O
support	support	VB	I-VP	O
the	the	DT	B-NP	O
contention	contention	NN	I-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
increase	increase	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
real	real	JJ	B-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Hox	BEGIN-Hox	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
egl	BEGIN-egl	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
mab	BEGIN-mab	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
lin	BEGIN-lin	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
lin	BEGIN-BEGIN-lin	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
mutants	mutants-INSIDE	NN	I-NP	I
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
lin	BEGIN-lin	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
lin	BEGIN-lin	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
regulate	regulate	VBP	B-VP	O
HOM	BEGIN-HOM	NN	B-NP	B
-	-	HYPH	I-NP	I
C	C	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
C.	C.	NNP	B-NP	O
elegans	elegans	NNP	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
trx	BEGIN-trx	NN	I-NP	B
-	-	HYPH	B-NP	I
G	G	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
do	do	VBP	B-VP	O
in	in	IN	B-PP	O
Drosophila.	Drosophila.	FW	B-NP	O
lin	BEGIN-lin	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
lin	BEGIN-BEGIN-lin	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
transgenes	transgenes-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
widely	widely	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
C.	C.	NNP	B-NP	O
elegans	elegans	NNP	I-NP	O
animals	animal	NNS	I-NP	O

In	In	IN	B-PP	O
cotransfection	cotransfection	NN	B-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
fragment	fragment	NN	I-NP	O
of	of	IN	B-PP	O
Sin	BEGIN-Sin-INSIDE	NN	B-NP	B
retaining	retain	VBG	B-VP	O
the	the	DT	B-NP	O
Src	BEGIN-Src-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
SH1	BEGIN-SH1-INSIDE	NN	I-NP	B
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
motif	motif	NN	B-NP	O
induced	induce	VBD	B-VP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Src	BEGIN-Src-INSIDE-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
reporter	reporter	NN	I-NP	O

TFIIB	BEGIN-TFIIB-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
VDR	BEGIN-VDR-INSIDE	NN	I-NP	B
can	can	MD	B-VP	O
also	also	RB	I-VP	O
interact	interact	VB	I-VP	O
directly	directly	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
synergize	synergize	VBP	B-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
transactivation	transactivation	NN	B-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mice	mouse	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
(	(	(	I-NP	O
Mus	Mus	NN	I-NP	O
spretus	spretus	NN	I-NP	O
x	x	SYM	B-NP	O
C1BL	C1BL	NN	I-NP	O
/	/	SYM	B-NP	O
1J	1J	NN	I-NP	O
)	)	)	O	O
F1	F1	NN	B-NP	O
x	x	SYM	B-NP	O
C1BL	C1BL	NN	I-NP	O
/	/	SYM	B-NP	O
1J	1J	NN	I-NP	O
interspecific	interspecific	JJ	I-NP	O
backcross	backcross	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-PP	O
order	order	NN	B-NP	O
marker	marker	NN	I-NP	O
loci	locus	NNS	I-NP	O
and	and	CC	O	O
calculate	calculate	VBP	B-VP	O
intergene	intergene	NN	B-NP	O
distances	distance	NNS	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
AIF	AIF	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
morphologic	morphologic	JJ	I-NP	O
correlate	correlate	NN	I-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	O
regression	regression	NN	I-NP	O
following	follow	VBG	B-PP	O
preoperative	preoperative	JJ	B-NP	O
cytotoxic	cytotoxic	JJ	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O

Hypocalcemia	Hypocalcemia	NN	B-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	B-ADVP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
either	either	CC	O	O
a	a	DT	B-NP	O
disturbance	disturbance	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
parathyroid	BEGIN-parathyroid	JJ	I-NP	B
hormone	hormone-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
adenylate	BEGIN-adenylate	NN	I-NP	B
cyclase	cyclase-INSIDE	NN	I-NP	I
system	system	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
disturbance	disturbance	NN	I-NP	O
in	in	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O

The	The	DT	B-NP	O
system	system	NN	I-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
TV	TV	NN	I-NP	O
unit	unit	NN	I-NP	O
compatible	compatible	JJ	B-ADJP	O
to	to	TO	B-PP	O
IBM	IBM	NNP	B-NP	O
PC	PC	NN	I-NP	O
/	/	SYM	B-NP	O
AT	AT	NN	I-NP	O
and	and	CC	I-NP	O
software	software	NN	I-NP	O

Newly	Newly	RB	B-NP	O
hatched	hatch	VBN	I-NP	O
F1	F1	NN	I-NP	O
nymphs	nymph	NNS	I-NP	O
of	of	IN	B-PP	O
Aiolopus	Aiolopus	NNP	B-NP	O
thalassinus	thalassinus	NNP	I-NP	O
(	(	(	O	O
Fabr.	Fabr.	NNP	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
fed	feed	VBN	I-VP	O
on	on	IN	B-PP	O
food	food	NN	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
HgCl1	HgCl1	NN	B-NP	O
,	,	,	O	O
CdCl1	CdCl1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
PbCl1	PbCl1	NN	B-NP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
adult	adult	JJ	B-NP	O
life	life	NN	I-NP	O

Reduced	Reduce	VBN	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
antithrombin	BEGIN-antithrombin	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
,	,	,	O	O
plasminogen	BEGIN-plasminogen-INSIDE	NN	B-NP	B
,	,	,	O	O
(	(	(	O	O
free	free	JJ	O	O
)	)	)	O	O
protein	BEGIN-protein	NN	B-NP	B
S	S-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
protein	BEGIN-protein	NN	B-NP	B
C	C-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
patients	patient	NNS	I-NP	O
but	but	CC	O	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
either	either	CC	O	O
thrombosis	thrombosis	NN	B-NP	O
or	or	CC	O	O
lupus	lupus	NN	B-NP	O
anticoagulant	anticoagulant	NN	I-NP	O

UICC	UICC	NN	B-NP	O
criteria	criterion	NNS	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
VM	VM	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
for	for	IN	B-PP	O
VE	VE	NN	B-NP	O
(	(	(	O	O
not	not	RB	O	O
significant	significant	JJ	B-ADJP	O
)	)	)	O	O

Simvastatin	Simvastatin	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
LDL	BEGIN-LDL	NN	B-NP	B
cholesterol	cholesterol-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
triglycerides	triglyceride	NNS	B-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
apolipoprotein	BEGIN-apolipoprotein	NN	B-NP	B
B	B-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
tocopherol	tocopherol	NN	B-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
beta	beta	SYM	O	O
-	-	HYPH	O	O
carotene	carotene	NN	B-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ubiquinol	ubiquinol	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	JJR	B-NP	O
.1	.1	NN	I-NP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
)	)	)	O	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
HDL	BEGIN-HDL	NN	B-NP	B
cholesterol	cholesterol-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
.1	.1	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
serum	BEGIN-serum	NN	B-NP	B
insulin	insulin-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=.1	=.1	CD	I-NP	O
)	)	)	O	O

Ultrasonography	Ultrasonography	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
alternative	alternative	NN	I-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
replace	replace	VB	I-VP	O
arthrography	arthrography	NN	B-NP	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
with	with	IN	B-PP	O
GPR1	BEGIN-GPR1-INSIDE	NN	B-NP	B
probes	probe	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
main	main	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
mRNA	mRNA	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
less	less	RBR	I-NP	O
abundant	abundant	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
mRNA	mRNA	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
brain	brain	NN	I-NP	O
tissues	tissue	NNS	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
corpus	corpus	NN	B-NP	O
callosum	callosum	NN	I-NP	O
,	,	,	O	O
medulla	medulla	NN	B-NP	O
,	,	,	O	O
putamen	putaman	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
caudate	caudate	VBP	B-VP	O
nucleus	nucleus	NN	B-NP	O

TNF	BEGIN-TNF	NN	B-NP	B
-	-	HYPH	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
eliminated	eliminate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
substitution	substitution	NN	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B1	B1	NN	I-NP	I
binding	binding	NN	I-NP	I
half	half	JJ	I-NP	I
site	site-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B	NN	I-NP	I
cis	cis	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I

Three	Three	CD	B-NP	O
RasV1	BEGIN-RasV1	NN	I-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
(	(	(	O	O
S1	BEGIN-S1-INSIDE	NN	B-NP	B
,	,	,	O	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
C1	BEGIN-C1-INSIDE	NN	B-NP	B
)	)	)	O	O
which	which	WDT	B-NP	O
differ	differ	VBP	B-VP	O
by	by	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
Ras	BEGIN-Ras	NN	B-NP	B
effectors	effectors-INSIDE	NN	I-NP	I
(	(	(	O	O
Raf	BEGIN-Raf-INSIDE	NN	B-NP	B
,	,	,	O	O
Ral	BEGIN-Ral	JJ	B-NP	B
-	-	HYPH	I-NP	I
GEFs	GEFs-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
subunit	subunit	NN	I-NP	I
of	of	IN	B-PP	I
PI	PI	NN	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
sustained	sustained	JJ	B-NP	O
NR	NR	NN	I-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
was	be	VBD	B-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
transform	transform	VB	I-VP	O
NIH	NIH	NNP	B-NP	O
1T1	1T1	NN	I-NP	O
cells	cell	NNS	I-NP	O

A	A	DT	B-NP	O
possible	possible	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
mandibular	mandibular	JJ	B-NP	O
growth	growth	NN	I-NP	O
retardation	retardation	NN	I-NP	O
and	and	CC	O	O
palatal	palatal	JJ	B-NP	O
clefting	clefting	NN	I-NP	O
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O

Total	Total	JJ	B-NP	O
cross	cross	NN	I-NP	O
sections	section	NNS	I-NP	O
for	for	IN	B-PP	O
electron	electron	NN	B-NP	O
scattering	scattering	NN	I-NP	O
by	by	IN	B-PP	O
CO1	CO1	NN	B-NP	O
molecules	molecule	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
energy	energy	NN	I-NP	O
range	range	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
eV	eV	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
depending	depend	VBG	B-VP	O
upon	upon	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
context	context	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
cooperative	cooperative	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
domains	domain	NNS	I-NP	O
to	to	TO	B-VP	O
confer	confer	VB	I-VP	O
high	high	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	binding	NN	B-NP	O
affinity	affinity	NN	I-NP	O
and	and	CC	O	O
specificity	specificity	NN	B-NP	O

RESEARCH	RESEARCH	NN	B-NP	O
DESIGN	DESIGN	NN	I-NP	O
AND	AND	CC	B-NP	O
METHODS	METHODS	NNS	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
IDDM	IDDM	NN	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
normoalbuminuria	normoalbuminuria	NNS	B-NP	O
were	be	VBD	B-VP	O
randomized	randomize	VBN	I-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
group	group	NN	I-NP	O
receiving	receive	VBG	B-VP	O
placebo	placebo	NN	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
BMI	BMI	NN	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
kg	kg	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
group	group	NN	I-NP	O
receiving	receive	VBG	B-VP	O
an	an	DT	B-NP	O
average	average	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
daily	daily	JJ	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
BMI	BMI	NN	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
kg	kg	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
)	)	)	O	O

This	This	DT	B-NP	O
experience	experience	NN	I-NP	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
home	home	NN	B-NP	O
nutritional	nutritional	JJ	I-NP	O
support	support	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
scleroderma	scleroderma	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
relatively	relatively	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
and	and	CC	O	O
no	no	DT	B-NP	O
major	major	JJ	I-NP	O
organ	organ	NN	I-NP	O
failure	failure	NN	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O

Adult	Adult	JJ	B-NP	O
-	-	HYPH	I-NP	O
onset	onset	NN	I-NP	O
parkinsonism	parkinsonism	NN	I-NP	O
has	have	VBZ	B-VP	O
appeared	appear	VBN	I-VP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
previously	previously	RB	I-NP	O
unaffected	unaffected	JJ	I-NP	O
members	member	NNS	I-NP	O
in	in	IN	B-PP	O
families	family	NNS	B-NP	O
with	with	IN	B-PP	O
DRD	DRD	NN	B-NP	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
phenotypical	phenotypical	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O

Production	Production	NN	B-NP	O
of	of	IN	B-PP	O
VT	VT	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
examined	examine	VBN	I-VP	O
retrospectively	retrospectively	RB	B-ADVP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
serotype	serotype	NN	B-NP	O
O1	O1	NN	I-NP	O
:	:	:	O	O
H1	H1	NN	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
diarrhoea	diarrhoea	NN	B-NP	O
;	;	:	O	O
eight	eight	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
produced	produce	VBD	B-VP	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
verotoxin	BEGIN-verotoxin	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
despite	despite	IN	B-PP	O
several	several	JJ	B-NP	O
years	year	NNS	I-NP	O
storage	storage	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
deals	deal	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
screening	screening	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
plants	plant	NNS	I-NP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
opportunistic	opportunistic	JJ	I-NP	O
pathogen	pathogen	NN	I-NP	O
fungus	fungu	VBZ	B-VP	O
Candida	Candida	NNP	B-NP	O
albicans	albican	NNS	I-NP	O

The	The	DT	B-NP	O
tam	BEGIN-tam	NN	I-NP	B
A	A	NN	I-NP	I
gene	gene	NN	I-NP	I
of	of	IN	B-PP	I
Aspergillus	Aspergillus	NN	B-NP	I
nidulans	nidulans-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
similarity	similarity	NN	B-NP	O
to	to	TO	B-PP	O
Uga1p	BEGIN-Uga1p-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
Dal1p	BEGIN-Dal1p-INSIDE	NN	I-NP	B
/	/	SYM	I-NP	O
DurLp	BEGIN-DurLp-INSIDE	NN	I-NP	B
of	of	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
flanking	flank	VBG	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
kbp	kbp	NN	I-NP	O
long	long	RB	B-ADVP	O
,	,	,	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
elements	element	NNS	I-NP	O
for	for	IN	B-PP	O
transcription	transcription	NN	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
TATA	TATA	NN	B-NP	O
,	,	,	O	O
GC	GC	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
CCAAT	CCAAT	NN	B-NP	O
boxes	box	NNS	I-NP	O

The	The	DT	B-NP	O
Molteno	Molteno	NNP	I-NP	O
implant	implant	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
complicated	complicate	VBN	B-NP	O
and	and	CC	I-NP	O
refractory	refractory	JJ	I-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
glaucoma	glaucoma	NN	B-NP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
risk	risk	NN	I-NP	O
eyes	eye	NNS	I-NP	O

Two	Two	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
submitted	submit	VBN	I-VP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
(	(	(	O	O
FiO1	FiO1	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
group	group	NN	B-NP	O
F1	F1	NN	I-NP	O
and	and	CC	I-NP	O
FiO1	FiO1	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
group	group	NN	B-NP	O
F1	F1	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
to	to	TO	B-PP	O
normoxia	normoxia	NN	B-NP	O
(	(	(	O	O
FiO1	FiO1	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
group	group	NN	B-NP	O
F1	F1	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
thermoneutral	thermoneutral	JJ	I-NP	O
and	and	CC	I-NP	O
controlled	control	VBN	I-NP	O
environment	environment	NN	I-NP	O

Glutathione	BEGIN-Glutathione	NN	B-NP	B
reductase	reductase-INSIDE	NN	I-NP	I
(	(	(	O	O
GR	BEGIN-GR-INSIDE	NN	B-NP	B
)	)	)	O	O
was	be	VBD	B-VP	O
purified	purify	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cyanobacterium	cyanobacterium	NN	I-NP	O
Anabaena	Anabaena	NNP	I-NP	O
PCC	PCC	NNP	I-NP	O
1	1	CD	I-NP	O

Genotype	Genotype	NN	B-NP	O
-	-	HYPH	I-NP	O
phenotype	phenotype	NN	I-NP	O
correlations	correlation	NNS	I-NP	O
in	in	IN	B-PP	O
male	male	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
partial	partial	JJ	I-NP	O
nullisomy	nullisomy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
X	X	NN	I-NP	O
chromosome	chromosome	NN	I-NP	O
have	have	VBP	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
locus	locus	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
MRX	MRX	NN	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Xp1	Xp1	NN	B-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
NE	NE	NN	B-NP	O
transport	transport	NN	I-NP	O
and	and	CC	O	O
antagonist	antagonist	NN	B-NP	O
(	(	(	O	O
[	[	(	O	O
1I	1I	NN	B-NP	O
]	]	)	I-NP	O
RTI	RTI	NN	I-NP	O
-	-	HYPH	O	O
1	1	CD	O	O
)	)	)	O	O
binding	binding	NN	B-NP	O
assays	assay	NNS	I-NP	O
on	on	IN	B-PP	O
whole	whole	JJ	B-NP	O
LLC	LLC	NN	I-NP	O
-	-	HYPH	I-NP	O
NET	NET	NN	I-NP	O
cells	cell	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
tunicamycin	tunicamycin	NN	B-NP	O
reveal	reveal	VBP	B-VP	O
a	a	DT	B-NP	O
pronounced	pronounced	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
NE	NE	NN	B-NP	O
transport	transport	NN	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
hNET	BEGIN-hNET-INSIDE	NN	B-NP	B
membrane	membrane	NN	I-NP	O
density	density	NN	I-NP	O
paralleled	parallel	VBN	B-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
inability	inability	NN	I-NP	O
of	of	IN	B-PP	O
NET	BEGIN-NET	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
replenish	replenish	VB	I-VP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
M	M	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
)	)	)	O	O
hNET	BEGIN-hNET-INSIDE	NN	B-NP	B
pool	pool	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
now	now	RB	I-VP	O
completed	complete	VBN	I-VP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
fibrillin	BEGIN-fibrillin-INSIDE	NN	B-NP	B
,	,	,	O	O
elucidated	elucidate	VBD	B-VP	O
the	the	DT	B-NP	O
exon	exon	NN	I-NP	O
/	/	SYM	B-NP	O
intron	intron	NN	I-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
and	and	CC	O	O
derived	derive	VBD	B-VP	O
a	a	DT	B-NP	O
physical	physical	JJ	I-NP	O
map	map	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
locus	locus	NN	I-NP	O

The	The	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
PutR	BEGIN-PutR-INSIDE	NN	B-NP	B
(	(	(	O	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
homology	homology	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
Lrp	BEGIN-Lrp-INSIDE	NN	I-NP	B
,	,	,	O	O
BkdR	BEGIN-BkdR-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
AsnC	BEGIN-AsnC-INSIDE	NN	B-NP	B

NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	I-NP	I
kappaB	kappaB-INSIDE	NN	I-NP	I
only	only	RB	B-ADVP	O
partially	partially	RB	I-ADVP	O
mediates	mediate	VBZ	B-VP	O
Epstein	BEGIN-Epstein	NN	B-NP	B
-	-	HYPH	I-NP	I
Barr	Barr	NN	I-NP	I
virus	virus	NN	I-NP	I
latent	latent	JJ	I-NP	I
membrane	membrane	NN	I-NP	I
protein	protein	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
cells	cell	NNS	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
stem	stem	NN	B-NP	O
-	-	HYPH	B-NP	O
loop	loop	NN	I-NP	O
structures	structure	NNS	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
domain	domain	NN	I-NP	O
showed	show	VBD	B-VP	O
great	great	JJ	B-NP	O
variations	variation	NNS	I-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
,	,	,	O	O
sequence	sequence	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
structure	structure	NN	B-NP	O

Whereas	Whereas	IN	B-PP	O
Sprague	Sprague	NNP	B-NP	O
-	-	HYPH	O	O
Dawleys	Dawleys	NNP	B-NP	O
displayed	display	VBD	B-VP	O
lights	light	NNS	B-NP	O
-	-	HYPH	B-ADJP	O
off	off	RP	B-PRT	O
and	and	CC	O	O
lights	light	NNS	B-NP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
peaks	peak	NNS	B-NP	O
of	of	IN	B-PP	O
ingestive	ingestive	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
minority	minority	NN	I-NP	O
of	of	IN	B-PP	O
Fisher	Fisher	NNP	B-NP	O
-	-	HYPH	I-NP	O
1s	1	NNS	I-NP	O
displayed	display	VBD	B-VP	O
a	a	DT	B-NP	O
consistent	consistent	JJ	I-NP	O
lights	light	NNS	I-NP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
peak	peak	NN	B-NP	O
of	of	IN	B-PP	O
ingestive	ingestive	JJ	B-NP	O
activity	activity	NN	I-NP	O

The	The	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	O
UPR	UPR	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	B-VP	O
acting	act	VBG	B-NP	O
ER	ER	NN	I-NP	O
stress	stress	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
nt	nt	NN	I-NP	O
(	(	(	O	O
CCAATN	CCAATN	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
CCACG	CCACG	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
CCACG	CCACG	NN	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
provide	provide	VB	I-VP	O
specificity	specificity	NN	B-NP	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
lipids	lipid	NNS	I-NP	O
on	on	IN	B-PP	O
whole	whole	JJ	B-NP	O
-	-	HYPH	I-NP	O
body	body	NN	I-NP	O
retention	retention	NN	I-NP	O
and	and	CC	I-NP	O
organ	organ	NN	I-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
organic	organic	JJ	B-NP	O
and	and	CC	I-NP	O
inorganic	inorganic	JJ	I-NP	O
mercury	mercury	NN	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O

This	This	DT	B-NP	O
region	region	NN	I-NP	O
shows	show	VBZ	B-VP	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
calmodulin	BEGIN-calmodulin	NN	I-NP	B
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
region	region-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
rat	BEGIN-rat	NN	B-NP	B
brain	brain	NN	I-NP	I
Ca1+	Ca1+	NN	I-NP	I
/	/	SYM	B-NP	I
calmodulin	calmodulin	NN	I-NP	I
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
protein	protein	NN	I-NP	I
kinase	kinase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
and	and	CC	O	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
equivalent	equivalent	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
chicken	BEGIN-chicken	JJ	B-NP	B
smooth	smooth	JJ	I-NP	I
muscle	muscle	NN	I-NP	I
myosin	myosin	NN	I-NP	I
light	light	JJ	I-NP	I
chain	chain	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I

1H	1H	NN	B-NP	O
and	and	CC	I-NP	O
1N	1N	NN	I-NP	O
magnetic	magnetic	JJ	I-NP	O
resonance	resonance	NN	I-NP	O
assignments	assignment	NNS	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
tertiary	tertiary	JJ	B-NP	O
fold	fold	NN	I-NP	O
of	of	IN	B-PP	O
Escherichia	BEGIN-Escherichia	FW	B-NP	B
coli	coli	FW	I-NP	I
DnaJ	DnaJ	NN	I-NP	I
(	(	(	O	I
1	1	CD	B-NP	I
-	-	HYPH	O	I
1	1	CD	O	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
inoculum	inoculum	NN	B-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
medium	medium	NN	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
duration	duration	NN	B-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
testing	testing	NN	I-NP	O
of	of	IN	B-PP	O
Aspergillus	Aspergillus	NN	B-NP	O
fumigatus	fumigatus	NN	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
using	use	VBG	B-VP	O
broth	broth	NN	B-NP	O
micro	micro	AFX	B-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
macro	macro	AFX	I-NP	O
-	-	HYPH	I-NP	O
dilution	dilution	NN	I-NP	O
techniques	technique	NNS	I-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O

This	This	DT	B-NP	O
dynamic	dynamic	JJ	I-NP	O
nature	nature	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
relevant	relevant	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
both	both	CC	O	O
to	to	TO	B-VP	O
homodimerize	homodimerize	VB	I-VP	O
and	and	CC	O	O
to	to	TO	B-VP	O
heterodimerize	heterodimerize	VB	I-VP	O
with	with	IN	B-PP	O
MyoD	BEGIN-MyoD-INSIDE	NN	B-NP	B
,	,	,	O	O
Id	BEGIN-Id-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
Tal1	BEGIN-Tal1-INSIDE	NN	B-NP	B

We	We	PRP	B-NP	O
identified	identify	VBD	B-VP	O
clones	clone	NNS	B-NP	O
of	of	IN	B-PP	O
Chlamydomonas	Chlamydomonas	NNP	B-NP	O
genomic	genomic	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
that	that	WDT	B-NP	O
rescued	rescue	VBD	B-VP	O
the	the	DT	B-NP	O
Ca	Ca	NN	I-NP	O
(	(	(	O	O
1+	1+	CD	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
axonemal	axonemal	JJ	I-NP	O
microtubule	microtubule	NN	I-NP	O
severing	sever	VBG	B-VP	O
defect	defect	NN	B-NP	O
of	of	IN	B-PP	O
fa1	BEGIN-fa1	NN	B-NP	B
mutants	mutants-INSIDE	NN	I-NP	I

STUDY	STUDY	NN	B-NP	O
SELECTION	SELECTION	NN	I-NP	O
:	:	:	O	O
Not	Not	RB	B-ADJP	O
applicable	applicable	JJ	I-ADJP	O

Sequence	Sequence	NN	B-NP	O
and	and	CC	I-NP	O
deletion	deletion	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
recombination	BEGIN-recombination	NN	I-NP	B
enhancement	enhancement	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
ref	BEGIN-ref-INSIDE	NN	B-NP	B
)	)	)	O	O
of	of	IN	B-PP	O
bacteriophage	bacteriophage	NN	B-NP	O
P1	P1	NN	I-NP	O
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
promoter	promoter	NN	B-NP	O
-	-	HYPH	I-NP	O
operator	operator	NN	I-NP	O
and	and	CC	I-NP	O
attenuator	attenuator	NN	I-NP	O
-	-	HYPH	O	O
antiterminator	antiterminator	NN	B-NP	O
control	control	NN	I-NP	O

Viral	BEGIN-Viral	JJ	B-NP	B
protein	protein	NN	I-NP	I
U	U-INSIDE	NN	I-NP	I
(	(	(	O	O
Vpu	BEGIN-Vpu-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
promotes	promote	VBZ	B-VP	O
the	the	DT	B-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
virus	virus	NN	I-NP	O
receptor	receptor	NN	I-NP	O
,	,	,	O	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
enhances	enhance	VBZ	B-VP	O
the	the	DT	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
virus	virus	NN	B-NP	O
particles	particle	NNS	I-NP	O
from	from	IN	B-PP	O
cells	cell	NNS	B-NP	O

There	There	EX	B-NP	O
also	also	RB	B-ADVP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
osmotic	osmotic	JJ	B-NP	O
challenges	challenge	NNS	I-NP	O
to	to	TO	B-PP	O
mucosal	mucosal	JJ	B-NP	O
cell	cell	NN	I-NP	O
function	function	NN	I-NP	O
as	as	IN	B-SBAR	O
evidenced	evidence	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
rates	rate	NNS	I-NP	O
with	with	IN	B-PP	O
hyper	hyper	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
hypotonic	hypotonic	JJ	I-NP	O
saline	saline	NN	I-NP	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
objective	objective	JJ	I-NP	O
response	response	NN	I-NP	O
rate	rate	NN	I-NP	O
(	(	(	O	O
RR	RR	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
[	[	(	O	O
1	1	CD	B-NP	O
confidence	confidence	NN	I-NP	O
interval	interval	NN	I-NP	O
(	(	(	O	O
CI	CI	NN	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
]	]	)	O	O
including	include	VBG	B-PP	O
four	four	CD	B-NP	O
complete	complete	JJ	I-NP	O
responses	response	NNS	I-NP	O
and	and	CC	O	O
eight	eight	CD	B-NP	O
partial	partial	JJ	I-NP	O
responses	response	NNS	I-NP	O

In	In	IN	B-PP	O
spite	spite	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variability	variability	NN	I-NP	O
of	of	IN	B-PP	O
DD1	DD1	NN	B-NP	O
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
neuromuscular	neuromuscular	JJ	B-NP	O
transmission	transmission	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
groups	group	NNS	I-NP	O
is	be	VBZ	B-VP	O
comparable	comparable	JJ	B-ADJP	O

SH1A	BEGIN-SH1A-INSIDE	NN	B-NP	B
competes	compete	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
Grb1	BEGIN-Grb1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
binding	binding	NN	B-NP	O
to	to	TO	B-PP	O
mSos1	BEGIN-mSos1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
intersectin	BEGIN-intersectin-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
mSos1	BEGIN-mSos1-INSIDE	NN	I-NP	B
complex	complex	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
separated	separate	VBN	I-VP	O
from	from	IN	B-PP	O
Grb1	BEGIN-Grb1-INSIDE	NN	B-NP	B
by	by	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
gradient	gradient	NN	I-NP	O
centrifugation	centrifugation	NN	I-NP	O

Both	Both	DT	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
cross	cross	AFX	B-NP	O
-	-	HYPH	I-NP	O
competition	competition	NN	I-NP	O
and	and	CC	I-NP	O
antibody	antibody	NN	I-NP	O
supershift	supershift	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
established	establish	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
strand	strand	NN	I-NP	O
binding	binding	NN	I-NP	O
protein	protein	NN	I-NP	O
is	be	VBZ	B-VP	O
equivalent	equivalent	JJ	B-ADJP	O
to	to	TO	B-PP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
major	major	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
designated	designate	VBN	B-VP	O
as	as	IN	B-PP	O
+1	+1	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
RACE	RACE	NN	B-NP	O
(	(	(	O	O
rapid	rapid	JJ	B-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	O
ends	end	VBZ	B-VP	O
)	)	)	O	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
liver	liver	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
located	locate	VBN	I-VP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O

Kerstin	Kerstin	NNP	B-NP	O
takes	take	VBZ	B-VP	O
the	the	DT	B-NP	O
abbreviated	abbreviated	JJ	I-NP	O
medical	medical	JJ	I-NP	O
education	education	NN	I-NP	O

Epithelial	Epithelial	JJ	B-NP	O
cells	cell	NNS	I-NP	O
had	have	VBD	B-VP	O
abnormal	abnormal	JJ	B-NP	O
and	and	CC	I-NP	O
accelerated	accelerate	VBN	I-NP	O
exfoliation	exfoliation	NN	I-NP	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
multifocal	multifocal	JJ	B-NP	O
epithelial	epithelial	JJ	I-NP	O
defects	defect	NNS	I-NP	O

Influenza	Influenza	NN	B-NP	O
virus	virus	NN	I-NP	O
-	-	HYPH	B-VP	O
induced	induce	VBN	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
kappaB	kappaB	NN	I-NP	I
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
and	and	CC	O	O
involves	involve	VBZ	B-VP	O
oxidative	oxidative	JJ	B-NP	O
radicals	radical	NNS	I-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
IkappaB	BEGIN-IkappaB	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
Xenopus	BEGIN-Xenopus	NNP	I-NP	B
annexin	annexin	NN	I-NP	I
II	II	CD	I-NP	I
heavy	heavy	JJ	I-NP	I
chain	chain-INSIDE	NN	I-NP	I
lacks	lack	VBZ	B-VP	O
the	the	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
at	at	IN	B-PP	O
position	position	NN	B-NP	O
1	1	CD	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
src	BEGIN-src	NN	B-NP	B
oncogene	oncogene-INSIDE	NN	I-NP	I
tyrosine	BEGIN-tyrosine	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
phosphorylation	phosphorylation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	NN	I-NP	O
protein	protein	NN	I-NP	O

This	This	DT	B-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
a	a	DT	B-NP	O
relative	relative	JJ	I-NP	O
independence	independence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
given	give	VBN	I-NP	O
synchronizer	synchronizer	NN	I-NP	O
of	of	IN	B-PP	O
rhythmicity	rhythmicity	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
tissue	tissue	NN	I-NP	O
level	level	NN	I-NP	O
from	from	IN	B-PP	O
any	any	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
regulatory	regulatory	JJ	I-NP	O
center	center	NN	I-NP	O

Two	Two	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteins	protein	NNS	I-NP	O
UPRF	BEGIN-UPRF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
UPRF	BEGIN-UPRF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
apparently	apparently	RB	B-ADVP	O
a	a	DT	B-NP	O
proteolytic	proteolytic	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
UPRF	BEGIN-UPRF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
bind	bind	VBP	B-VP	O
inefficiently	inefficiently	RB	B-ADVP	O
to	to	TO	B-PP	O
mutant	mutant	JJ	B-NP	O
versions	version	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
UPR	UPR	NN	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
confer	confer	VB	I-VP	O
responsiveness	responsiveness	NN	B-NP	O
to	to	TO	B-PP	O
unfolded	unfolded	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
(	(	(	O	O
CYC1	BEGIN-CYC1-INSIDE	NN	O	B
)	)	)	O	O
promoter	promoter	NN	B-NP	O

Since	Since	IN	B-PP	O
nearly	nearly	RB	B-NP	O
all	all	DT	I-NP	O
transformants	transformant	NNS	I-NP	O
involving	involve	VBG	B-VP	O
homeologous	homeologous	JJ	B-NP	O
DNAs	DNA	NNS	I-NP	O
carried	carry	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
recombinant	recombinant	JJ	I-NP	O
plasmid	plasmid	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
Pms+	BEGIN-Pms+-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Pms	BEGIN-Pm	NNS	I-NP	B
-	-	HYPH	B-NP	I
	-INSIDE	NN	I-NP	I
strains	strain	NNS	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
heteroduplex	heteroduplex	NN	I-NP	O
DNA	DNA	NN	I-NP	O
appears	appear	VBZ	B-VP	O
less	less	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
than	than	IN	B-PP	O
for	for	IN	B-PP	O
homologous	homologous	JJ	B-NP	O
DNAs	DNA	NNS	I-NP	O

Western	Western	JJ	B-NP	O
and	and	CC	I-NP	O
immunocytochemical	immunocytochemical	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
implied	imply	VBD	B-VP	O
that	that	IN	B-SBAR	O
PREB	BEGIN-PREB-INSIDE	NN	B-NP	B
accumulates	accumulate	VBZ	B-VP	O
specifically	specifically	RB	B-ADVP	O
in	in	IN	B-PP	O
GH1	GH1	NN	B-NP	O
cell	cell	NN	I-NP	O
nuclei	nucleus	NNS	I-NP	O

Coronary	Coronary	JJ	B-NP	O
arteries	artery	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
biopsy	biopsy	NN	I-NP	O
tissue	tissue	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
formed	form	VBD	B-VP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
group	group	NN	I-NP	O

Cotransfection	Cotransfection	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
junB	BEGIN-junB-INSIDE	NN	I-NP	B
stimulated	stimulate	VBD	B-VP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
1	1	CD	I-NP	I
(	(	(	O	I
I	I	NN	B-NP	I
)	)	)	O	I
collagen	collagen	NN	B-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
1	1	CD	I-NP	O
-	-	HYPH	B-VP	O
fold	fold	RB	B-ADVP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

The	The	DT	B-NP	O
extraordinary	extraordinary	JJ	I-NP	O
high	high	JJ	I-NP	O
substrate	substrate	NN	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
rPulA	BEGIN-rPulA-INSIDE	NN	B-NP	B
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
thermal	thermal	JJ	I-NP	O
stability	stability	NN	I-NP	O
makes	make	VBZ	B-VP	O
this	this	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
biotechnological	biotechnological	JJ	B-NP	O
applications	application	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
starch	starch	NN	I-NP	O
-	-	HYPH	O	O
processing	process	VBG	B-VP	O
industry	industry	NN	B-NP	O

An	An	DT	B-NP	O
atypical	atypical	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
juvenile	juvenile	JJ	B-NP	O
myasthenia	myasthenia	NN	I-NP	O
gravis	gravis	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
emaciation	emaciation	NN	I-NP	O
,	,	,	O	O
muscle	muscle	NN	B-NP	O
atrophy	atrophy	NN	I-NP	O
,	,	,	O	O
ophthalmoplegia	ophthalmoplegia	NN	B-NP	O
,	,	,	O	O
bulbar	bulbar	NN	B-NP	O
signs	sign	NNS	I-NP	O
and	and	CC	O	O
joint	joint	NN	B-NP	O
contracture	contracture	NN	I-NP	O

Anesthesia	Anesthesia	NNP	B-NP	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
droperidol	droperidol	NN	B-NP	O
1	1	CD	I-NP	O
mg.kg	mg.kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
fentanyl	fentanyl	NN	B-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
,	,	,	O	O
thiamylal	thiamylal	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
succinylcholine	succinylcholine	NN	B-NP	O
1	1	CD	I-NP	O
mg.kg	mg.kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
maintained	maintain	VBN	B-VP	O
with	with	IN	B-PP	O
nitrous	nitrous	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
and	and	CC	O	O
O1	O1	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
:	:	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
supplemented	supplement	VBN	B-VP	O
with	with	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
i.v.	i.v.	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
fentanyl	fentanyl	NN	B-NP	O
(	(	(	O	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
micrograms.kg	micrograms.kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
enhancers	enhancer	NNS	B-NP	O
act	act	VBP	B-VP	O
primarily	primarily	RB	B-ADVP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
probability	probability	NN	I-NP	O
of	of	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
and	and	CC	I-NP	O
efficient	efficient	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
complex	complex	NN	I-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
initiation	initiation	NN	B-NP	O

(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
bound	bind	VBD	B-VP	O
fast	fast	RB	B-ADVP	O
-	-	HYPH	O	O
migrating	migrate	VBG	B-VP	O
,	,	,	O	O
underprocessed	underprocesse	VBN	B-VP	O
wild	BEGIN-wild	JJ	B-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
ICP1	BEGIN-ICP1-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
ICP1	BEGIN-ICP1-INSIDE	NN	I-NP	B
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
ICP1	BEGIN-ICP1-INSIDE	NN	B-NP	B
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
identified	identify	VBN	I-NP	O
cellular	BEGIN-cellular	JJ	I-NP	B
protein	protein	NN	I-NP	I
p1	BEGIN-p1-INSIDE-INSIDE	NN	I-NP	I
(	(	(	O	O
R	R	NN	B-NP	O

Hetero	Hetero	AFX	B-NP	O
-	-	HYPH	I-NP	O
oligomerization	oligomerization	NN	B-NP	O
of	of	IN	B-PP	O
Smad1	BEGIN-Smad1-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
the	the	DT	B-NP	O
pathway	pathway	NN	I-NP	O
-	-	HYPH	B-VP	O
restricted	restrict	VBN	B-NP	O
SMAD	BEGIN-SMAD	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
Smad1	BEGIN-Smad1-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
mediated	mediate	VBN	B-VP	O
transcription	transcription	NN	B-NP	O

This	This	DT	B-NP	O
group	group	NN	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
infiltrated	infiltrate	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
dentinal	dentinal	JJ	I-NP	O
tubules	tubule	NNS	I-NP	O
coronally	coronally	RB	B-ADVP	O
and	and	CC	O	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
canals	canal	NNS	I-NP	O

Hydroxyl	Hydroxyl	NN	B-NP	O
radical	radical	NN	I-NP	O
footprinting	footprinting	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
complexes	complex	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ets	BEGIN-ets	JJ	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
PU.1	BEGIN-PU.1-INSIDE	NN	B-NP	B
and	and	CC	O	O
its	its	PRP$	B-NP	O
comparison	comparison	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
crystal	crystal	NN	I-NP	O
structure	structure	NN	I-NP	O

Autophosphorylation	Autophosphorylation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
site	site	NN	I-NP	O
Y1	Y1	NN	I-NP	O
upregulates	upregulate	VBZ	B-VP	O
the	the	DT	B-NP	O
kinase	kinase	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
,	,	,	O	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
Vmax	Vmax	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phosphotransfer	phosphotransfer	NN	I-NP	O
reaction	reaction	NN	I-NP	O

The	The	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
dorso	dorso	AFX	B-NP	O
-	-	HYPH	I-NP	O
ventral	ventral	JJ	I-NP	O
polarity	polarity	NN	I-NP	O
during	during	IN	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
embryogenesis	embryogenesis	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
maternally	maternally	RB	I-NP	O
expressed	express	VBN	I-NP	O
gene	gene	NN	I-NP	O
products	product	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
dorsal	BEGIN-dorsal	JJ	I-NP	B
group	group-INSIDE	NN	I-NP	I

Immunoblot	Immunoblot	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
purified	purify	VBN	B-NP	O
and	and	CC	I-NP	O
protease	protease	NN	I-NP	O
-	-	HYPH	O	O
digested	digest	VBN	B-VP	O
intracellular	intracellular	JJ	B-NP	O
mature	mature	JJ	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
IMV	IMV	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
extracellular	extracellular	JJ	B-NP	O
enveloped	envelop	VBN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
EEV	EEV	NN	B-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
A1R	BEGIN-A1R	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
EEV	EEV	NN	B-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
membrane	membrane	NN	I-NP	O
topology	topology	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
were	be	VBD	B-VP	O
absent	absent	JJ	B-ADJP	O
from	from	IN	B-PP	O
IMV	IMV	NN	B-NP	O

To	To	TO	B-VP	O
prevent	prevent	VB	I-VP	O
section	section	NN	B-NP	O
wrinkles	wrinkle	NNS	I-NP	O
usually	usually	RB	B-VP	O
encountered	encounter	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
coated	coat	VBN	B-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
hole	hole	NN	I-NP	O
grids	grid	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
method	method	NN	I-NP	O
was	be	VBD	B-VP	O
developed	develop	VBN	I-VP	O

An	An	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-VP	O
random	random	VB	I-VP	O
integration	integration	NN	B-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
fragments	fragment	NNS	I-NP	O
into	into	IN	B-PP	O
plants	plant	NNS	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
utilize	utilize	VB	I-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
site	site	NN	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
recombination	recombination	NN	I-NP	O
(	(	(	O	O
SSR	SSR	NN	B-NP	O
)	)	)	O	O
systems	system	NNS	B-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Cre	BEGIN-Cre-INSIDE	NN	B-NP	B
/	/	SYM	B-VP	O
lox	BEGIN-lox-INSIDE	NN	B-NP	B

Both	Both	CC	O	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	B-NP	I
Myb	Myb-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
Myb	Myb-INSIDE	NN	I-NP	I
bind	bind	VBP	B-VP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-PP	O
delta	BEGIN-delta	NN	B-NP	B
E1	E1-INSIDE	NN	I-NP	I

After	After	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
year	year	NN	I-NP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
,	,	,	O	O
argon	argon	NN	B-NP	O
laser	laser	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
effect	effect	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
Kolmogorow	Kolmogorow	NNP	B-NP	O
-	-	HYPH	I-NP	O
Smirnov	Smirnov	NNP	I-NP	O
test	test	NN	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
stabilization	stabilization	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
amelioration	amelioration	NN	I-NP	O
of	of	IN	B-PP	O
visual	visual	JJ	B-NP	O
acuity	acuity	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
non	non	JJ	I-NP	O
treated	treat	VBN	I-NP	O
group	group	NN	I-NP	O

As	As	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
Dutch	Dutch	JJ	I-NP	O
prospective	prospective	JJ	I-NP	O
multicenter	multicenter	JJ	I-NP	O
study	study	NN	I-NP	O
(	(	(	O	O
Netherlands	Netherlands	NNP	B-NP	O
Cooperative	Cooperative	NNP	I-NP	O
Study	Study	NNP	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Adequacy	Adequacy	NN	I-NP	O
of	of	IN	B-PP	O
Dialysis	Dialysis	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
we	we	PRP	B-NP	O
consecutively	consecutively	RB	B-VP	O
included	include	VBD	I-VP	O
all	all	DT	B-NP	O
new	new	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
end	end	NN	B-NP	O
-	-	HYPH	B-NP	O
stage	stage	NN	I-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
for	for	IN	B-PP	O
whom	whom	WP	B-NP	O
residual	residual	JJ	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
obtained	obtain	VBN	I-VP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
start	start	NN	I-NP	O
of	of	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
therapy	therapy	NN	I-NP	O

Relationship	Relationship	NN	B-NP	O
between	between	IN	B-PP	O
age	age	NN	B-NP	O
-	-	HYPH	O	O
associated	associate	VBN	B-VP	O
endocrine	endocrine	JJ	B-NP	O
deficiencies	deficiency	NNS	I-NP	O
and	and	CC	O	O
muscle	muscle	NN	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
elderly	elderly	JJ	B-NP	O
women	woman	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
cross	cross	AFX	I-NP	O
-	-	HYPH	I-NP	O
sectional	sectional	JJ	I-NP	O
study	study	NN	I-NP	O

Intensity	Intensity	NN	B-NP	O
variations	variation	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
variable	variable	JJ	I-NP	O
TR	TR	NN	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
correlation	correlation	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
lateralized	lateralized	JJ	I-NP	O
stimulus	stimulus	NN	I-NP	O

Improvement	Improvement	NN	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
pharmaceutical	pharmaceutical	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
clofibrate	clofibrate	NN	B-NP	O
by	by	IN	B-PP	O
cyclodextrin	cyclodextrin	NN	B-NP	O
complexation	complexation	NN	I-NP	O

We	We	PRP	B-NP	O
assessed	assess	VBD	B-VP	O
cardiovascular	cardiovascular	JJ	B-NP	O
variables	variable	NNS	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
O1	O1	NN	I-NP	O
contents	content	NNS	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
O1	O1	NN	B-NP	O
transport	transport	NN	I-NP	O
in	in	IN	B-PP	O
ponies	pony	NNS	B-NP	O
during	during	IN	B-PP	O
treadmill	treadmill	NN	B-NP	O
exercise	exercise	NN	I-NP	O

Somatic	Somatic	JJ	B-NP	O
and	and	CC	I-NP	O
visceral	visceral	JJ	I-NP	O
inputs	input	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
thoracic	thoracic	JJ	I-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cat	cat	NN	I-NP	O
:	:	:	O	O
effects	effect	NNS	B-NP	O
of	of	IN	B-PP	O
noxious	noxious	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
biliary	biliary	JJ	I-NP	O
system	system	NN	I-NP	O

Some	Some	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
DNA	DNA	NN	I-NP	O
:	:	:	O	O
protein	protein	NN	B-NP	O
complexes	complex	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
at	at	IN	B-PP	O
lower	low	JJR	B-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
untransformed	untransformed	JJ	B-NP	O
rat	rat	NN	I-NP	O
cells	cell	NNS	I-NP	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
factors	factor	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
down	down	RB	B-NP	O
-	-	HYPH	I-NP	O
regulation	regulation	NN	B-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
Ad1	BEGIN-Ad1	NN	B-NP	B
E1A	E1A-INSIDE	NN	I-NP	I

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
IFNA	BEGIN-IFNA	NN	B-NP	B
promoter	promoter	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
requires	require	VBZ	B-VP	O
cooperation	cooperation	NN	B-NP	O
between	between	IN	B-PP	O
alpha	BEGIN-alpha	NN	B-NP	B
F1	F1	NN	I-NP	I
binding	binding	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
IRF	BEGIN-IRF	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Two	Two	CD	B-NP	O
pharmacokinetic	pharmacokinetic	JJ	I-NP	O
models	model	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O

Morphine	Morphine	NN	B-NP	O
administration	administration	NN	I-NP	O
acutely	acutely	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
plasma	plasma	NN	B-NP	O
clearance	clearance	NN	I-NP	O
of	of	IN	B-PP	O
sulfobromophthalein	sulfobromophthalein	NN	B-NP	O
(	(	(	O	O
BSP	BSP	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
hepatic	hepatic	JJ	I-NP	O
retention	retention	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dye	dye	NN	I-NP	O

A	A	DT	B-NP	O
Buddhist	Buddhist	NN	I-NP	O
view	view	NN	I-NP	O
of	of	IN	B-PP	O
abortion	abortion	NN	B-NP	O

Cryoglobulinaemia	Cryoglobulinaemia	NN	B-NP	O
among	among	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
haemodialysis	haemodialysis	NN	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
relation	relation	NN	I-NP	O
to	to	TO	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
infection	infection	NN	I-NP	O

In	In	IN	B-PP	O
HepG1	HepG1	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
SREBP	BEGIN-SREBP	NN	B-NP	B
-	-	HYPH	I-NP	I
1c	1c	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
precursor	precursor	NN	I-NP	O
protein	protein	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
R	R	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
hydroxycholesterol	hydroxycholesterol	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	B-NP	O
retinoic	retinoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
confirming	confirm	VBG	B-VP	O
that	that	IN	B-SBAR	O
endogenous	endogenous	JJ	B-NP	O
LXR	BEGIN-LXR-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
RXR	BEGIN-RXR-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
endogenous	BEGIN-endogenous	JJ	B-NP	B
SREBP	SREBP	NN	I-NP	I
-	-	HYPH	O	I
1c	1c-INSIDE	NN	B-NP	I
expression	expression	NN	I-NP	O

The	The	DT	B-NP	O
T	T	NN	I-NP	O
(	(	(	O	O
CCO1	CCO1	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PCO1	PCO1	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
Pearson	Pearson	NNP	I-NP	O
product	product	NN	I-NP	O
coefficient	coefficient	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
.1	.1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
difference	difference	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
(	(	(	O	O
CCO1	CCO1	NN	B-NP	O
)	)	)	O	O
>	>	SYM	O	O
P	P	NN	B-NP	O
(	(	(	O	O
CO1	CO1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
confidence	confidence	NN	I-NP	O
interval	interval	NN	I-NP	O
of	of	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
footprint	footprint	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
and	and	CC	O	I
human	human	JJ	B-NP	I
HPRT	HPRT	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
regulatory	regulatory	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
between	between	IN	B-PP	O
these	these	DT	B-NP	O
species	specie	NNS	I-NP	O
is	be	VBZ	B-VP	O
generally	generally	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
but	but	CC	O	O
not	not	RB	O	O
identical	identical	JJ	B-ADJP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
sought	seek	VBD	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
HIV	BEGIN-HIV	NN	B-NP	B
protease	protease-INSIDE	NN	I-NP	I
inhibitors	inhibitor	NNS	I-NP	O
on	on	IN	B-PP	O
patient	patient	NN	B-NP	O
weight	weight	NN	I-NP	O

The	The	DT	B-NP	O
cats	cat	NNS	I-NP	O
with	with	IN	B-PP	O
stage	stage	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
FeLV	FeLV	NN	B-NP	O
-	-	HYPH	B-NP	O
test	test	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
treatment	treatment	NN	B-NP	O

E1	BEGIN-E1-INSIDE	NN	B-NP	B
recognition	recognition	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bovine	bovine	JJ	I-NP	O
papillomavirus	papillomavirus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
replication	replication	NN	I-NP	O
:	:	:	O	O
interaction	interaction	NN	B-NP	O
between	between	IN	B-PP	O
half	half	JJ	B-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inverted	invert	VBN	I-NP	O
repeats	repeat	NNS	I-NP	O

Phase	Phase	NN	B-NP	O
I	I	CD	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
fluorouracil	fluorouracil	NN	I-NP	O
and	and	CC	I-NP	O
leucovorin	leucovorin	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
day	day	NN	I-NP	O
circadian	circadian	JJ	I-NP	O
infusion	infusion	NN	I-NP	O
in	in	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
patients	patient	NNS	I-NP	O

Although	Although	IN	B-SBAR	O
polyubiquitin	BEGIN-polyBEGIN-ubiquitin-INSIDE	JJ	B-NP	B
chains	chains-INSIDE	NN	I-NP	I
linked	link	VBN	B-VP	O
through	through	IN	B-PP	O
Lys	Ly	NNS	B-NP	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
of	of	IN	B-PP	O
ubiquitin	BEGIN-ubiquitin-INSIDE	NN	B-NP	B
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
targeting	targeting	NN	I-NP	O
of	of	IN	B-PP	O
certain	certain	JJ	B-NP	O
substrates	substrate	NNS	I-NP	O
to	to	TO	B-PP	O
proteasomes	proteasome	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
signaling	signaling	NN	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
chains	chain	NNS	I-NP	O
are	be	VBP	B-VP	O
poorly	poorly	RB	I-VP	O
understood	understand	VBN	I-VP	O

B	BEGIN-B-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
BEGIN-C1	BEGIN-B-INSIDEEGIN-C1	NN	I-NP	I
fusions	fusions-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
BEGIN-yeast	BEGIN-B-INSIDEEGIN-yeast	JJ	B-NP	I
GAL1	GAL1	NN	I-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	I-VP	O
and	and	CC	O	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
domains	domains-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
interact	interact	VB	I-VP	O
when	when	WRB	B-ADVP	O
synthesized	synthesize	VBN	B-VP	O
and	and	CC	O	O
assayed	assay	VBN	B-VP	O
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O

Deletion	Deletion	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	O	I
kb	kb	NN	B-NP	I
GATA	BEGIN-GATA	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O
region	region-INSIDE	NN	I-NP	I
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
is	be	VBZ	B-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
GATA	BEGIN-GATA	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
neurons	neuron	NNS	B-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
verified	verify	VBD	B-VP	O
that	that	IN	B-SBAR	O
PI	BEGIN-PI	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
:	:	:	O	O
p1lck	BEGIN-p1lck	NN	B-NP	B
complex	complex-INSIDE	NN	I-NP	I
as	as	IN	B-SBAR	O
judged	judge	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
PI	PI	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
phosphate	phosphate	NN	I-NP	O
generated	generate	VBN	B-VP	O
from	from	IN	B-PP	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
CD1	BEGIN-CD1-INSIDE-INSIDE	NN	I-NP	I
immunoprecipitates	immunoprecipitate	NNS	I-NP	O
and	and	CC	O	O
detected	detect	VBN	B-VP	O
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
pressure	pressure	NN	I-NP	O
liquid	liquid	JJ	I-NP	O
chromatographic	chromatographic	JJ	I-NP	O
analysis	analysis	NN	I-NP	O

Reality	Reality	NN	B-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	BEGIN-immunoglobulin-INSIDE	NN	B-NP	B
preparations	preparation	NNS	I-NP	O

This	This	DT	B-NP	O
evidence	evidence	NN	I-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
coding	cod	VBG	I-NP	O
sequence	sequence	NN	I-NP	O
starting	start	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
BamHI	BEGIN-BamHI	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
complement	complement	VB	I-VP	O
a	a	DT	B-NP	O
shy1	BEGIN-shy1	NN	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
,	,	,	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Shy1p	BEGIN-Shy1p-INSIDE	NN	I-NP	B
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
domains	domain	NNS	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
separately	separately	RB	I-VP	O
expressed	express	VBN	I-VP	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
protein	protein	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
UNC	BEGIN-UNC	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
VA	VA	NN	I-NP	O
motor	motor	NN	I-NP	O
neurons	neuron	NNS	I-NP	O
specifies	specify	VBZ	B-VP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
presynaptic	presynaptic	JJ	B-NP	O
input	input	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
technical	technical	JJ	B-NP	O
advances	advance	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
the	the	DT	B-NP	O
limitations	limitation	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
tests	test	NNS	I-NP	O
as	as	IN	B-PP	O
tests	test	NNS	B-NP	O
for	for	IN	B-PP	O
IgM	BEGIN-IgM-INSIDE	NN	B-NP	B
can	can	MD	B-VP	O
be	be	VB	I-VP	O
positive	positive	JJ	B-ADJP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
residual	residual	JJ	B-NP	O
specific	specific	JJ	I-NP	O
IgM	BEGIN-IgM-INSIDE	NN	I-NP	B
or	or	CC	O	O
even	even	RB	B-ADVP	O
in	in	IN	B-PP	O
subjects	subject	NNS	B-NP	O
free	free	JJ	B-ADJP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
infection	infection	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
natural	natural	JJ	B-NP	O
interfering	interfere	VBG	I-NP	O
IgM	BEGIN-IgM-INSIDE	NN	I-NP	B

Transesophageal	Transesophageal	JJ	B-NP	O
echocardiography	echocardiography	NN	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
stroke	stroke	NN	B-NP	O
in	in	IN	B-PP	O
nonvalvular	nonvalvular	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
VDR	BEGIN-VDR-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
mediated	mediate	VBN	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
1D1	1D1	NN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
VDR	BEGIN-VDR-INSIDE	NN	B-NP	B
alters	alter	VBZ	B-VP	O
the	the	DT	B-NP	O
conformation	conformation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ligand	ligand	NN	I-NP	O
binding	binding	NN	I-NP	O
domain	domain	NN	I-NP	O
such	such	IN	B-PP	O
that	that	IN	I-PP	O
it	it	PRP	B-NP	O
:	:	:	O	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
engages	engage	NNS	B-NP	O
in	in	IN	B-PP	O
strong	strong	JJ	B-NP	O
heterodimerization	heterodimerization	NN	I-NP	O
with	with	IN	B-PP	O
RXR	BEGIN-RXR-INSIDE	NN	B-NP	B
to	to	TO	B-VP	O
facilitate	facilitate	VB	I-VP	O
VDRE	BEGIN-VDR-INSIDEE	NN	B-NP	I
binding	binding	NN	I-NP	O
,	,	,	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
influences	influence	VBZ	B-VP	O
the	the	DT	B-NP	O
RXR	BEGIN-BEGIN-RXR-INSIDE	JJ	I-NP	B
ligand	ligand	NN	I-NP	O
binding	binding	NN	I-NP	O
domain	domain-INSIDE	NN	I-NP	I
such	such	IN	B-PP	O
that	that	IN	I-PP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
cis	cis	NN	I-NP	O
RA	RA	NN	I-NP	O
but	but	CC	O	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
recruiting	recruit	VBG	B-VP	O
coactivator	coactivator	NN	B-NP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
AF	AF	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
(	(	(	B-LST	O
iii	iii	LS	I-LST	O
)	)	)	O	O
presents	present	VBZ	B-VP	O
the	the	DT	B-NP	O
AF	AF	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
region	region	NN	I-NP	O
in	in	IN	B-PP	O
VDR	BEGIN-VDR-INSIDE	NN	B-NP	B
for	for	IN	B-PP	O
coactivator	coactivator	NN	B-NP	O
association	association	NN	I-NP	O

Our	Our	PRP$	B-NP	O
case	case	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
histologic	histologic	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
serum	BEGIN-serum	NN	I-NP	B
alpha	alpha	NN	I-NP	I
fetoprotein	fetoprotein-INSIDE	NN	I-NP	I
at	at	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O

Second	Second	RB	B-ADVP	O
,	,	,	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
RIM1	BEGIN-RIM1-INSIDE	NN	B-NP	B
can	can	MD	B-VP	O
suppress	suppress	VB	I-VP	O
an	an	DT	B-NP	O
ime1	BEGIN-ime1-INSIDE	NN	I-NP	B
missense	missense	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
(	(	(	O	O
ime1	BEGIN-BEGIN-ime1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
L1F	L1F-INSIDE	NN	I-NP	I
)	)	)	O	O
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
an	an	DT	B-NP	O
ime1	BEGIN-ime1-INSIDE	NN	I-NP	B
deletion	deletion	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
always	always	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
origin	origin	NN	I-NP	O
and	and	CC	I-NP	O
insertion	insertion	NN	I-NP	O

We	We	PRP	B-NP	O
evaluated	evaluate	VBD	B-VP	O
1mTc	1mTc	NN	B-NP	O
-	-	HYPH	B-NP	O
ECD	ECD	NN	I-NP	O
SPECT	SPECT	NN	I-NP	O
comparing	compare	VBG	B-VP	O
with	with	IN	B-PP	O
rCBF	rCBF	NN	B-NP	O
images	image	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
by	by	IN	B-PP	O
PET	PET	NN	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
spinocerebellar	spinocerebellar	JJ	B-NP	O
degeneration	degeneration	NN	I-NP	O
(	(	(	O	O
SCD	SCD	NN	B-NP	O
)	)	)	O	O

Nimodipine	Nimodipine	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
infusion	infusion	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
microgram	microgram	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
lowered	lower	VBD	B-VP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
normotensive	normotensive	JJ	I-NP	O
and	and	CC	I-NP	O
hypertensive	hypertensive	JJ	I-NP	O
rats	rat	NNS	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
dose	dose	NN	I-NP	O
schedule	schedule	NN	I-NP	O
of	of	IN	B-PP	O
nifedipine	nifedipine	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	O	O
lower	low	JJR	B-NP	O
MAP	MAP	NN	I-NP	O

When	When	WRB	B-ADVP	O
severe	severe	JJ	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
was	be	VBD	B-VP	O
acutely	acutely	RB	I-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
ventilation	ventilation	NN	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
oxygen	oxygen	NN	I-NP	O
mixtures	mixture	NNS	I-NP	O
in	in	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
(	(	(	O	O
PaO1	PaO1	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
torr	torr	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
control	control	NN	B-NP	O
animals	animal	NNS	I-NP	O
(	(	(	O	O
PaO1	PaO1	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
torr	torr	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
plasma	BEGIN-plasma	NN	B-NP	B
insulin	insulin-INSIDE	NN	I-NP	I
responses	response	NNS	I-NP	O
were	be	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
raised	raise	VBN	I-VP	O
antibodies	antibody	NNS	B-NP	O
against	against	IN	B-PP	O
a	a	DT	B-NP	O
peptide	peptide	NN	I-NP	O
specific	specific	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
protein	protein	NN	I-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
second	second	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O

Using	Use	VBG	B-VP	O
unidirectional	unidirectional	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
and	and	CC	O	O
delineated	delineate	VBD	B-VP	O
the	the	DT	B-NP	O
intronic	intronic	JJ	I-NP	O
/	/	SYM	I-NP	O
exonic	exonic	JJ	I-NP	O
boundaries	boundary	NNS	I-NP	O
which	which	WDT	B-NP	O
include	include	VBP	B-VP	O
a	a	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
coding	cod	VBG	B-VP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
intron	intron	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
coding	cod	VBG	I-NP	O
exon	exon	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
structure	structure	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RNase	BEGIN-RNase	NN	I-NP	B
A	A	NN	I-NP	I
superfamily	superfamily-INSIDE	NN	I-NP	I

Results	Result	NNS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
biotin	biotin	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
protection	protection	NN	B-NP	O
of	of	IN	B-PP	O
regions	region	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
domain	domain	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
vicinity	vicinity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
domain	domain	NN	I-NP	O
from	from	IN	B-PP	O
chemical	chemical	JJ	B-NP	O
cleavage	cleavage	NN	I-NP	O

The	The	DT	B-NP	O
family	family	NN	I-NP	O
histories	history	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
parents	parent	NNS	I-NP	O

Absence	Absence	NN	B-NP	O
of	of	IN	B-PP	O
nitroso	nitroso	NN	B-NP	O
formation	formation	NN	I-NP	O
from	from	IN	B-PP	O
(	(	(	O	O
1C	1C	NN	B-NP	O
)	)	)	O	O
methomyl	methomyl	NN	B-NP	O
and	and	CC	I-NP	O
sodium	sodium	NN	I-NP	O
nitrite	nitrite	NN	I-NP	O
under	under	IN	B-PP	O
simulated	simulated	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
conditions	condition	NNS	I-NP	O

The	The	DT	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
murine	BEGIN-murine	JJ	I-NP	B
Dtk	Dtk	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
determined	determine	VBN	I-VP	O

Outlook	Outlook	NN	B-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
cutaneous	cutaneous	JJ	I-NP	O
Kaposi	Kaposi	NNP	I-NP	O
's	's	POS	B-NP	O
sarcoma	sarcoma	NN	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
oleosin	BEGIN-oleosin	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
tissue	tissue	NN	I-NP	O
-	-	HYPH	O	O
specific	specific	JJ	B-NP	O
and	and	CC	I-NP	O
temporally	temporally	RB	I-NP	O
regulated	regulate	VBN	I-NP	O
manner	manner	NN	I-NP	O
and	and	CC	O	O
clearly	clearly	RB	B-VP	O
indicate	indicate	VBP	I-VP	O
that	that	IN	B-SBAR	O
oleosin	BEGIN-oleosin	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
co	co	AFX	B-ADJP	O
-	-	HYPH	O	O
ordinated	ordinate	VBN	B-VP	O
primarily	primarily	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
level	level	NN	I-NP	O

Allergic	Allergic	JJ	B-NP	O
field	field	NN	I-NP	O
:	:	:	O	O
how	how	WRB	B-ADVP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
it	it	PRP	B-NP	O

The	The	DT	B-NP	O
actual	actual	JJ	I-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
after	after	IN	B-PP	O
mapping	mapping	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GPi	GPi	NNP	I-NP	O
by	by	IN	B-PP	O
microrecording	microrecorde	VBG	B-VP	O
,	,	,	O	O
using	use	VBG	B-VP	O
stimulation	stimulation	NN	B-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
sensorimotor	sensorimotor	NN	I-NP	O
region	region	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
somatotopic	somatotopic	JJ	I-NP	O
organization	organization	NN	I-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
inch	inch	JJ	I-NP	O
FloWire	FloWire	NNP	I-NP	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
fidelity	fidelity	NN	I-NP	O
continuous	continuous	JJ	I-NP	O
Doppler	Doppler	NNP	I-NP	O
signal	signal	NN	I-NP	O

Other	Other	JJ	B-NP	O
recommendations	recommendation	NNS	I-NP	O
for	for	IN	B-PP	O
enhancing	enhance	VBG	B-VP	O
the	the	DT	B-NP	O
safety	safety	NN	I-NP	O
of	of	IN	B-PP	O
potent	potent	JJ	B-NP	O
antiplatelet	antiplatelet	JJ	I-NP	O
agents	agent	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
situations	situation	NNS	I-NP	O
are	be	VBP	B-VP	O
provided	provide	VBN	I-VP	O

The	The	DT	B-NP	O
concepts	concept	NNS	I-NP	O
were	be	VBD	B-VP	O
developed	develop	VBN	I-VP	O
by	by	IN	B-PP	O
Mines	Mines	NNP	B-NP	O
and	and	CC	I-NP	O
Garrey	Garrey	NNP	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
simple	simple	JJ	I-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
rheumatoid	BEGIN-rheumatoid	JJ	B-NP	B
factor	factor-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
nitrocellulose	nitrocellulose	NN	B-NP	O
was	be	VBD	B-VP	O
developed	develop	VBN	I-VP	O
that	that	WDT	B-NP	O
allows	allow	VBZ	B-VP	O
quantitative	quantitative	JJ	B-NP	O
detection	detection	NN	I-NP	O

Maximum	Maximum	JJ	B-NP	O
overexpression	overexpression	NN	I-NP	O
of	of	IN	B-PP	O
holoenzyme	holoenzyme	NN	B-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
inclusion	inclusion	NN	I-NP	O
in	in	IN	B-PP	O
such	such	JJ	B-NP	O
plasmids	plasmid	NNS	I-NP	O
of	of	IN	B-PP	O
Salmonella	Salmonella	NNP	B-NP	O
typhimurium	typhimurium	NNP	I-NP	O
cysG	cysG	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
uroporphyrinogen	BEGIN-uroporphyrinogen	NN	I-NP	B
III	III	CD	I-NP	I
methyltransferase	methyltransferase-INSIDE	NN	I-NP	I
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
siroheme	siroheme	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
cofactor	cofactor	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
hemoprotein	hemoprotein	NN	I-NP	O

Determination	Determination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LD	LD	NN	I-NP	O
1	1	CD	I-NP	O
(	(	NN	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
during	during	IN	B-PP	O
infant	infant	NN	B-NP	O
period	period	NN	I-NP	O
and	and	CC	I-NP	O
growth	growth	NN	I-NP	O
period	period	NN	I-NP	O

Mutational	Mutational	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
yeast	BEGIN-yeast	JJ	B-NP	B
CEG1	CEG1-INSIDE	NN	I-NP	I
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
four	four	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
five	five	CD	I-NP	O
conserved	conserve	VBN	I-NP	O
motifs	motif	NNS	I-NP	O
are	be	VBP	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
capping	BEGIN-capping	JJ	B-NP	B
enzyme	enzyme-INSIDE	NN	I-NP	I
function	function	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Purified	Purify	VBN	B-NP	O
phosphorylated	phosphorylate	VBN	I-NP	O
PhoP	BEGIN-PhoP-INSIDE	NN	B-NP	B
(	(	(	O	O
PhoPP	BEGIN-PhoP-INSIDEP	NN	B-NP	I
)	)	)	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
half	half	JJ	I-NP	O
-	-	HYPH	I-NP	O
life	life	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
min	min	NN	I-NP	O
by	by	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
molar	molar	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
*PhoR	BEGIN-*BEGIN-PhoR-INSIDE-INSIDE	NN	B-NP	B
(	(	(	O	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
PhoR	BEGIN-PhoR-INSIDE	NN	B-NP	B
)	)	)	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
exercise	exercise	NN	B-NP	O
-	-	HYPH	B-VP	O
induced	induce	VBN	B-NP	O
ST	ST	NN	I-NP	O
-	-	HYPH	I-NP	O
segment	segment	NN	I-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
or	or	CC	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
aneurysm	aneurysm	NN	I-NP	O
is	be	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
spasm	spasm	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
vessel	vessel	NN	I-NP	O

It	It	PRP	B-NP	O
spans	span	VBZ	B-VP	O
1	1	CD	B-NP	O
kilobases	kilobas	NNS	I-NP	O
,	,	,	O	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
introns	intron	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
TATA	TATA	NN	I-NP	O
motif	motif	NN	I-NP	O
1	1	CD	B-NP	O
nucleotides	nucleotide	NNS	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O

Metastatic	Metastatic	JJ	B-NP	O
tumours	tumour	NNS	I-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
in	in	IN	B-PP	O
Nigerians	Nigerian	NNS	B-NP	O

A	A	DT	B-NP	O
survey	survey	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
late	late	JJ	I-NP	O
detected	detect	VBN	I-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
CDH	CDH	NN	B-NP	O
born	bear	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
years	year	NNS	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
is	be	VBZ	B-VP	O
presented	present	VBN	I-VP	O

This	This	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
biochemical	biochemical	JJ	I-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
STAT1A	BEGIN-STAT1A-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
STAT1B	BEGIN-STAT1B-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
with	with	IN	B-PP	O
purified	purify	VBN	B-NP	O
activated	activate	VBN	I-NP	O
STAT1	BEGIN-STAT1	NN	I-NP	B
recombinant	recombinant	JJ	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I

Enoxacin	Enoxacin	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
well	well	RB	I-NP	O
tolerated	tolerate	VBN	I-NP	O
and	and	CC	I-NP	O
convenient	convenient	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
gonorrhoea	gonorrhoea	NN	B-NP	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Precision	Precision	NN	B-NP	O
and	and	CC	I-NP	O
accuracy	accuracy	NN	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
using	use	VBG	B-VP	O
controls	control	NNS	B-NP	O
and	and	CC	O	O
method	method	NN	B-NP	O
comparison	comparison	NN	I-NP	O
studies	study	NNS	I-NP	O

Important	Important	JJ	B-NP	O
prognostic	prognostic	JJ	I-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
physiotherapeutic	physiotherapeutic	JJ	B-NP	O
exercises	exercise	NNS	I-NP	O
in	in	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	O
claudication	claudication	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
Tax1	BEGIN-Tax1-INSIDE	NN	B-NP	B
activates	activate	VBZ	B-VP	O
CArG	CArG	NN	B-NP	O
-	-	HYPH	O	O
mediated	mediate	VBN	B-NP	O
transcription	transcription	NN	I-NP	O
without	without	IN	B-PP	O
mitogenic	mitogenic	JJ	B-NP	O
signals	signal	NNS	I-NP	O
through	through	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
CArG	BEGIN-CArG	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-NP	I
factor	factor-INSIDE	NN	I-NP	I
,	,	,	O	O
p1SRF	BEGIN-p1SRF-INSIDE	NN	B-NP	B

In	In	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
combined	combine	VBN	B-NP	O
sensitization	sensitization	NN	I-NP	O
to	to	TO	B-PP	O
mercury	mercury	NN	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
metal	metal	NN	I-NP	O
salts	salt	NNS	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-NP	O
gold	gold	NN	I-NP	O
sodium	sodium	NN	I-NP	O
thiosulfate	thiosulfate	NN	I-NP	O
(	(	(	O	O
GST	GST	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
palladium	palladium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
(	(	(	O	O
PDC	PDC	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

Amongst	Amongst	IN	B-PP	O
1	1	CD	B-NP	O
``	``	``	I-NP	O
inoperable	inoperable	JJ	I-NP	O
''	''	''	O	O
(	(	(	O	O
T1	T1	NN	B-NP	O
,	,	,	O	O
N1	N1	NN	B-NP	O
,	,	,	O	O
N1	N1	NN	B-NP	O
,	,	,	O	O
T.	T.	NN	B-NP	O
,	,	,	O	O
N1	N1	NN	B-NP	O
,	,	,	O	O
N1	N1	NN	B-NP	O
)	)	)	O	O
cases	case	NNS	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
scan	scan	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
a	a	DT	B-NP	O
doubtful	doubtful	JJ	I-NP	O
scan	scan	NN	I-NP	O

Acyclovir	Acyclovir	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
ointment	ointment	NN	I-NP	O
)	)	)	O	O
used	use	VBD	B-VP	O
topically	topically	RB	B-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
five	five	CD	I-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
acute	acute	JJ	B-NP	O
ocular	ocular	JJ	I-NP	O
HSV	HSV	NN	I-NP	O
infection	infection	NN	I-NP	O
gave	give	VBD	B-VP	O
beneficial	beneficial	JJ	B-NP	O
results	result	NNS	I-NP	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
corneal	corneal	JJ	B-NP	O
involvement	involvement	NN	I-NP	O
,	,	,	O	O
conjunctivitis	conjunctivitis	NN	B-NP	O
,	,	,	O	O
iritis	iritis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
corneal	corneal	NN	B-NP	O
clouding	cloud	VBG	B-VP	O

The	The	DT	B-NP	O
efficiency	efficiency	NN	I-NP	O
of	of	IN	B-PP	O
transfections	transfection	NNS	B-NP	O
was	be	VBD	B-VP	O
normalized	normalize	VBN	I-VP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
net	net	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
plasmid	plasmid	NN	I-NP	O
actually	actually	RB	B-VP	O
transfected	transfecte	VBN	I-VP	O
into	into	IN	B-PP	O
recipient	recipient	JJ	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
Southern	Southern	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O
procedure	procedure	NN	I-NP	O

Initial	Initial	JJ	B-NP	O
computer	computer	NN	I-NP	O
based	based	JJ	I-NP	O
similarity	similarity	NN	I-NP	O
searches	search	NNS	I-NP	O
identified	identify	VBD	B-VP	O
human	BEGIN-human	JJ	B-NP	B
retinoblastoma	retinoblastoma	NN	I-NP	I
binding	binding	NN	I-NP	I
protein	protein	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
RBP	BEGIN-RBP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
Drosophila	BEGIN-Drosophila	NN	B-NP	B
melanogaster	melanogaster	NN	I-NP	I
male	male	NN	I-NP	I
specific	specific	JJ	I-NP	I
lethal	lethal	JJ	I-NP	I
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
Msl	BEGIN-Msl	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
S.	BEGIN-S.	NNP	B-NP	B
pombe	pombe	NN	I-NP	I
altered	alter	VBD	B-VP	I
polarity	polarity	NN	B-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
Alp1	BEGIN-Alp1-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
S.	BEGIN-S.	FW	B-NP	B
cerevisiae	cerevisiae	FW	I-NP	I
Eaf1p	Eaf1p-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
NuA1	NuA1-INSIDE	NN	I-NP	I
HAT	BEGIN-HAT-INSIDE	NN	I-NP	B
complex	complex	NN	I-NP	O
(	(	(	O	O
Galarneau	Galarneau	NNP	B-NP	O
et	et	FW	I-NP	O
al.	al.	FW	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O

These	These	DT	B-NP	O
aa	aa	JJ	I-NP	O
residues	residue	NNS	I-NP	O
correspond	correspond	VBP	B-VP	O
to	to	TO	B-PP	O
codons	codon	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
P.	BEGIN-P.	JJ	I-NP	B
falciparum	falciparum	NN	I-NP	I
DHFR	DHFR	NN	I-NP	I
active	active	JJ	I-NP	I
site	site-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
similar	similar	JJ	B-NP	O
aa	aa	NN	I-NP	O
substitutions	substitution	NNS	I-NP	O
(	(	(	O	O
Cys	Cys	NN	B-NP	O
Arg	Arg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
Ser	Ser	NN	B-NP	O
Asn	Asn	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
pyrimethamine	pyrimethamine	NN	B-NP	O
resistance	resistance	NN	I-NP	O

Efficacy	Efficacy	NN	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
whom	whom	WP	B-NP	O
eight	eight	CD	B-NP	O
received	receive	VBD	B-VP	O
RD	RD	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
SD	SD	NN	I-NP	O

Short	Short	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
growth	growth	NN	I-NP	O
:	:	:	O	O
rhythms	rhythm	NNS	B-NP	O
,	,	,	O	O
chaos	chaos	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
noise	noise	NN	B-NP	O

Sequences	Sequence	NNS	B-NP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	O
TUF	BEGIN-TUF	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
UAS	UAS	NN	B-NP	I
boxes	boxes-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
flanking	flanking	NN	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
genes	gene	NNS	I-NP	O

Residues	Residue	NNS	B-NP	O
crucial	crucial	JJ	B-ADJP	O
for	for	IN	B-PP	O
Ras	BEGIN-Ras-INSIDE	JJ	B-NP	B
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
GDP	BEGIN-GDP	NN	B-NP	B
-	-	HYPH	I-NP	I
GTP	GTP	NN	I-NP	I
exchangers	exchangers-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
gene	BEGIN-gene	JJ	I-NP	B
atp1	BEGIN-atp1-INSIDE-INSIDE	NN	I-NP	I
,	,	,	O	O
encoding	encode	VBG	B-VP	O
subunit	subunit	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitochondrial	mitochondrial	JJ	I-NP	O
F1	BEGIN-F1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
ATPase	BEGIN-ATPase-INSIDE	NN	I-NP	B
complex	complex	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
characterized	characterize	VBN	I-VP	O
from	from	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
(	(	(	O	O
fertile	fertile	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
Ogura	Ogura	NNP	B-NP	O
(	(	(	O	O
male	male	JJ	B-NP	O
-	-	HYPH	I-NP	O
sterile	sterile	JJ	I-NP	O
)	)	)	O	O
radish	radish	JJ	B-NP	O
cytoplasms	cytoplasm	NNS	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
if	if	IN	B-SBAR	O
previously	previously	RB	B-NP	O
identified	identify	VBN	I-NP	O
atp1	BEGIN-atp1-INSIDE	NN	I-NP	B
transcriptional	transcriptional	JJ	I-NP	O
differences	difference	NNS	I-NP	O
could	could	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
male	male	JJ	I-NP	O
sterility	sterility	NN	I-NP	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
transcript	transcript	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
transient	transient	JJ	I-NP	O
embryonic	embryonic	JJ	I-NP	O
excision	excision	NN	I-NP	O
assay	assay	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
zebrafish	zebrafish	VBP	B-VP	O
fertilized	fertilize	VBN	B-NP	O
eggs	egg	NNS	I-NP	O
were	be	VBD	B-VP	O
co	co	AFX	B-ADJP	O
-	-	HYPH	O	O
injected	inject	VBN	B-VP	O
with	with	IN	B-PP	O
RNA	RNA	NN	B-NP	O
transcribed	transcribe	VBN	B-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
Tol1	BEGIN-Tol1	NN	I-NP	B
cDNA	cDNA-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
a	a	DT	B-NP	O
template	template	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
DNA	DNA	NN	I-NP	O
harboring	harbor	VBG	B-VP	O
a	a	DT	B-NP	O
nonautonomous	nonautonomous	JJ	I-NP	O
Tol1	BEGIN-Tol1	NN	I-NP	B
element	element-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
deletion	deletion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
transposase	BEGIN-transposase	NN	I-NP	B
coding	coding	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
CAPL	BEGIN-CAPL-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
protein	protein	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
calcium	calcium	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
only	only	RB	B-ADJP	O
moderately	moderately	RB	I-ADJP	O
elevated	elevated	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
doxorubicin	doxorubicin	NN	I-NP	O
-	-	HYPH	B-NP	O
resistant	resistant	JJ	I-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
reconstituted	reconstitute	VBN	I-NP	O
enzyme	enzyme	NN	I-NP	O
binds	bind	VBZ	B-VP	O
DNA	DNA	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
affinity	affinity	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intact	intact	JJ	I-NP	O
topo1	BEGIN-topo1-INSIDE	NN	I-NP	B

In	In	IN	B-PP	O
late	late	JJ	B-NP	O
October	October	NNP	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
postoperative	postoperative	JJ	I-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
nonhuman	nonhuman	JJ	I-NP	O
primate	primate	NN	I-NP	O
(	(	(	O	O
Macaca	Macaca	NNP	B-NP	O
mulatta	mulatta	NNP	I-NP	O
)	)	)	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
undergone	undergo	VBN	I-VP	O
surgical	surgical	JJ	B-NP	O
operation	operation	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
Gle1p	BEGIN-Gle1p-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
strictly	strictly	RB	I-VP	O
coupled	couple	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
short	short	JJ	I-NP	O
GLEBS	BEGIN-GLEBS-INSIDE	NN	I-NP	B
within	within	IN	B-PP	O
Nup1p	BEGIN-Nup1p-INSIDE	NN	B-NP	B
which	which	WDT	B-NP	O
links	link	VBZ	B-VP	O
this	this	DT	B-NP	O
putative	putative	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O
transport	transport	NN	I-NP	O
factor	factor	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
pores	pore	NNS	I-NP	O

Seminal	Seminal	JJ	B-NP	O
prolactin	BEGIN-prolactin-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
infertile	infertile	JJ	I-NP	O
males	male	NNS	I-NP	O

The	The	DT	B-NP	O
recruitment	recruitment	NN	I-NP	O
of	of	IN	B-PP	O
constitutively	constitutively	RB	B-NP	O
phosphorylated	phosphorylate	VBN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
neu	BEGIN-neu-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
activated	activate	VBN	I-NP	O
mitogenic	mitogenic	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
proteins	protein	NNS	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
membrane	membrane	NN	I-NP	O
-	-	HYPH	B-NP	O
microfilament	microfilament	NN	I-NP	O
interaction	interaction	NN	I-NP	O
site	site	NN	I-NP	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
physical	physical	JJ	I-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
integrating	integrate	VBG	B-VP	O
the	the	DT	B-NP	O
assembly	assembly	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitogenic	mitogenic	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
transmission	transmission	NN	I-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
factor	factor	NN	I-NP	O
signal	signal	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytoskeleton	cytoskeleton	NN	I-NP	O

The	The	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
net	BEGIN-net	NN	B-NP	B
RNA	RNA-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
adult	adult	JJ	B-NP	O
mouse	mouse	NN	I-NP	O
tissues	tissue	NNS	I-NP	O
is	be	VBZ	B-VP	O
different	different	JJ	B-ADJP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
capsaicin	capsaicin	NN	B-NP	O
on	on	IN	B-PP	O
hexobarbital	hexobarbital	NN	B-NP	O
-	-	HYPH	B-NP	O
anesthetized	anesthetize	VBN	I-NP	O
rats	rat	NNS	I-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
complement	complement	NN	I-NP	I
receptor	receptor	NN	I-NP	I
type	type	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
CR1	BEGIN-CR1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
primarily	primarily	RB	B-ADJP	O
restricted	restricted	JJ	I-ADJP	O
to	to	TO	B-PP	O
mature	mature	JJ	B-NP	O
B	B	NN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
follicular	follicular	JJ	B-NP	O
dendritic	dendritic	JJ	I-NP	O
cells	cell	NNS	I-NP	O

A	A	DT	B-NP	O
physical	physical	JJ	I-NP	O
and	and	CC	I-NP	O
genetic	genetic	JJ	I-NP	O
map	map	NN	I-NP	O
covering	cover	VBG	B-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
RP1	BEGIN-RP1	NN	I-NP	B
candidate	candidate	NN	I-NP	I
gene	gene	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
premature	premature	JJ	B-NP	O
infants	infant	NNS	I-NP	O
plasminogen	BEGIN-plasminogen-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
are	be	VBP	B-VP	O
low	low	JJ	B-ADJP	O
;	;	:	O	O
thus	thus	RB	B-ADVP	O
,	,	,	O	O
defense	defense	NN	B-NP	O
against	against	IN	B-PP	O
intra	intra	AFX	B-NP	O
-	-	HYPH	I-NP	O
alveolar	alveolar	JJ	I-NP	O
fibrin	BEGIN-fibrin-INSIDE	NN	I-NP	B
deposition	deposition	NN	I-NP	O
during	during	IN	B-PP	O
birth	birth	NN	B-NP	O
trauma	trauma	NN	I-NP	O
is	be	VBZ	B-VP	O
reduced	reduce	VBN	I-VP	O

Progestins	Progestin	NNS	B-NP	O
:	:	:	O	O
present	present	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
future	future	JJ	I-ADJP	O

Indeed	Indeed	RB	B-ADVP	O
,	,	,	O	O
DEX	DEX	NN	B-NP	O
also	also	RB	B-ADVP	O
enhanced	enhance	VBD	B-VP	O
the	the	DT	B-NP	O
RA	RA	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
RARbeta	BEGIN-RARbeta	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cycloheximide	cycloheximide	NN	I-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
manner	manner	NN	I-NP	O

In	In	IN	B-PP	O
both	both	CC	O	O
immortalized	immortalize	VBN	B-NP	O
and	and	CC	I-NP	O
normal	normal	JJ	I-NP	O
diploid	diploid	JJ	I-NP	O
human	human	JJ	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
wt	wt	NN	B-NP	O
AAV	AAV	NN	I-NP	O
targeted	target	VBD	B-VP	O
integration	integration	NN	B-NP	O
to	to	TO	B-PP	O
ch	ch	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
both	both	DT	B-NP	O
versions	version	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brief	brief	JJ	I-NP	O
SL	SL	NNP	I-NP	O
&	&	CC	I-NP	O
amp	amp	NN	I-NP	O
;	;	:	O	O
shy	shy	NN	B-NP	O
;	;	:	O	O
ASIA	ASIA	NN	B-NP	O
had	have	VBD	B-VP	O
similar	similar	JJ	B-NP	O
correlations	correlation	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
variables	variable	NNS	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	O
scale	scale	NN	I-NP	O
SL	SL	NNP	I-NP	O
&	&	CC	I-NP	O
amp	amp	NN	I-NP	O
;	;	:	O	O
shy	shy	NN	B-NP	O
;	;	:	O	O
ASIA	ASIA	NN	B-NP	O

These	These	DT	B-NP	O
operons	operon	NNS	I-NP	O
encode	encode	VBP	B-VP	O
subunits	subunit	NNS	B-NP	O
of	of	IN	B-PP	O
photosystems	BEGIN-photosystem	NNS	B-NP	B
I	I-INSIDE	NN	I-NP	I
(	(	(	O	O
psa	BEGIN-psa-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
II	II	CD	B-NP	O
(	(	(	O	O
psb	BEGIN-psb-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
cytochrome	BEGIN-cytochrome	NN	I-NP	B
bGf	bGf	NN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
(	(	(	O	O
pet	BEGIN-pet-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
plastid	plastid	NN	I-NP	O
NAD	BEGIN-NAD	NN	I-NP	B
(	(	(	O	I
P	P	NN	B-NP	I
)	)	)	O	I
H	H	NN	B-NP	I
dehydrogenase	dehydrogenase-INSIDE	NN	I-NP	I
(	(	(	O	O
ndh	BEGIN-ndh-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
unidentified	unidentified	JJ	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
ycf1	BEGIN-ycf1-INSIDE	NN	I-NP	B

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
dominant	BEGIN-dominant	JJ	B-NP	B
negative	negative	JJ	I-NP	I
Rac	Rac-INSIDE	NN	I-NP	I
(	(	(	O	O
N1Rac1	BEGIN-N1Rac1-INSIDE	NN	B-NP	B
)	)	)	O	O
inhibited	inhibit	VBD	B-VP	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
Galpha1	BEGIN-Galpha1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
HEK1	HEK1	NN	B-NP	O
cells	cell	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
three	three	CD	B-NP	O
other	other	JJ	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

A	A	DT	B-NP	O
major	major	JJ	I-NP	O
feature	feature	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
first	first	JJ	I-NP	O
intron	intron	NN	I-NP	O
(	(	(	O	O
Il	Il	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
long	long	RB	B-ADVP	O
,	,	,	O	O
located	located	JJ	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
downstream	downstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
start	start	NN	I-NP	O
ATG	ATG	NN	I-NP	O
codon	codon	NN	I-NP	O

We	We	PRP	B-NP	O
reviewed	review	VBD	B-VP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
published	publish	VBN	I-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
high	high	JJ	I-NP	O
dose	dose	NN	I-NP	O
methotrexate	methotrexate	NN	I-NP	O
neurotoxicity	neurotoxicity	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
underlying	underlie	VBG	I-NP	O
mechanisms	mechanism	NNS	I-NP	O

The	The	DT	B-NP	O
expected	expected	JJ	I-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cloned	clone	VBN	I-NP	O
bph	BEGIN-bph	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
except	except	IN	B-PP	O
bphA1	BEGIN-bphA1-INSIDE	NN	B-NP	B
,	,	,	O	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
transcription	transcription	NN	I-NP	O
-	-	HYPH	B-NP	O
translation	translation	NN	I-NP	O
system	system	NN	I-NP	O

The	The	DT	B-NP	O
immunoreactive	immunoreactive	JJ	I-NP	O
antithrombin	BEGIN-antithrombin	NN	I-NP	B
III	III-INSIDE	NN	I-NP	I
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
antithrombin	BEGIN-antithrombin	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
insignificant	insignificant	JJ	B-ADJP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
male	male	JJ	I-NP	O
Caucasian	Caucasian	JJ	I-NP	O
Danes	Dane	NNS	I-NP	O
upon	upon	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
supplementation	supplementation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
daily	daily	RB	B-ADVP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cod	cod	NN	I-NP	O
liver	liver	NN	I-NP	O
oil	oil	NN	I-NP	O
concentrate	concentrate	NN	I-NP	O

Only	Only	RB	B-NP	O
the	the	DT	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
after	after	IN	B-PP	O
N	BEGIN-N	NN	B-NP	B
-	-	HYPH	B-NP	I
glycosidase	glycosidase-INSIDE	NN	I-NP	I
treatment	treatment	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
PLP	BEGIN-PLP	NN	B-NP	B
-	-	HYPH	O	I
H	H-INSIDE	NN	B-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
glycoprotein	glycoprotein	NN	I-NP	O

These	These	DT	B-NP	O
observed	observe	VBN	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
when	when	WRB	B-ADVP	O
assessing	assess	VBG	B-VP	O
NPY	BEGIN-NPY-INSIDE	NN	B-NP	B
level	level	NN	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
fluid	fluid	NN	I-NP	O

In	In	IN	B-PP	O
three	three	CD	B-NP	O
other	other	JJ	I-NP	O
patients	patient	NNS	I-NP	O
the	the	DT	B-NP	O
electrophysiologic	electrophysiologic	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
atrioventricular	atrioventricular	JJ	B-NP	O
conduction	conduction	NN	I-NP	O
prevented	prevent	VBD	B-VP	O
a	a	DT	B-NP	O
demonstration	demonstration	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
differences	difference	NNS	I-NP	O

These	These	DT	B-NP	O
sequence	sequence	NN	I-NP	O
differences	difference	NNS	I-NP	O
are	be	VBP	B-VP	O
reflected	reflect	VBN	I-VP	O
in	in	IN	B-PP	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
eyes	eye	NNS	I-NP	O
injected	inject	VBN	B-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
RPE	RPE	NN	I-NP	O
cells	cell	NNS	I-NP	O
showed	show	VBD	B-VP	O
STAGE	STAGE	NN	B-NP	O
1	1	CD	I-NP	O
or	or	CC	I-NP	O
less	less	JJR	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O

The	The	DT	B-NP	O
cumulative	cumulative	JJ	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
nursing	nurse	VBG	B-VP	O
staff	staff	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-SBAR	O
treatment	treatment	NN	B-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
patient	patient	NN	B-NP	O
mobility	mobility	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
mSv	mSv	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
self	self	NN	I-NP	O
-	-	HYPH	O	O
caring	care	VBG	B-VP	O
patient	patient	NN	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
mSv	mSv	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
totally	totally	RB	I-NP	O
helpless	helpless	JJ	I-NP	O
patient	patient	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
MBq	MBq	NN	I-NP	O
/	/	SYM	B-NP	O
group	group	NN	I-NP	O
A	A	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
analysis	analysis	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
1	1	LS	O	O
)	)	)	O	O
fitting	fitting	JJ	B-NP	O
first	first	JJ	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
second	second	JJ	I-NP	O
-	-	HYPH	I-NP	O
order	order	NN	I-NP	O
autoregressive	autoregressive	JJ	I-NP	O
models	model	NNS	I-NP	O
(	(	(	O	O
AR1	AR1	NN	B-NP	O
and	and	CC	O	O
AR1	AR1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	LS	B-LST	O
)	)	)	O	O
obtaining	obtain	VBG	B-VP	O
the	the	DT	B-NP	O
power	power	NN	I-NP	O
spectra	spectrum	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
by	by	IN	B-PP	O
fast	fast	JJ	B-NP	O
-	-	HYPH	I-NP	O
Fourier	Fourier	NNP	I-NP	O
transform	transform	NN	I-NP	O

Of	Of	IN	B-PP	O
1	1	CD	B-NP	O
specimens	specimen	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
yielded	yield	VBD	B-VP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
albicans	albican	NNS	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
mainly	mainly	RB	B-ADVP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
lymphocyte	lymphocyte	NN	I-NP	O
counts	count	NNS	I-NP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
previous	previous	JJ	I-NP	O
azole	azole	NN	I-NP	O
exposure	exposure	NN	I-NP	O

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
GnSE	BEGIN-GnSE	NN	B-NP	B
response	response	NN	I-NP	I
elements	elements-INSIDE	NN	I-NP	I
interact	interact	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
regions	region	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
GATA	BEGIN-GATA	NN	B-NP	B
-	-	HYPH	B-NP	I
and	and	CC	I-NP	I
LIM	LIM	NN	I-NP	I
-	-	HYPH	O	I
related	relate	VBN	B-NP	I
factors	factors-INSIDE	NN	I-NP	I
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

The	The	DT	B-NP	O
NrfC	BEGIN-NrfC	NN	I-NP	B
polypeptide	polypeptide-INSIDE	NN	I-NP	I
,	,	,	O	O
M	BEGIN-M	NN	B-NP	B
(	(	(	O	I
r	r	NN	B-NP	I
)	)	)	O	I
1	1	CD	B-NP	I
,	,	,	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
contains	contain	VBZ	B-VP	O
1	1	CD	B-NP	O
cysteine	cysteine	NN	I-NP	O
residues	residue	NNS	I-NP	O
arranged	arrange	VBN	B-VP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
clusters	cluster	NNS	I-NP	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CooF	BEGIN-CooF	NN	I-NP	B
super	super	NN	I-NP	I
-	-	HYPH	B-NP	I
family	family-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
haem	haem	NN	B-NP	O
iron	iron	NN	I-NP	O
-	-	HYPH	B-NP	O
sulphur	sulphur	NN	I-NP	O
proteins	protein	NNS	I-NP	O

Hamdija	Hamdija	NNP	B-NP	O
Karamehmedovic	Karamehmedovic	NNP	I-NP	O
;	;	:	O	O
Ibn	Ibn	NNP	B-NP	O
al	al	NNP	I-NP	O
-	-	HYPH	O	O
Nefis	Nefis	NNP	B-NP	O
,	,	,	O	O
``	``	``	O	O
Mudzez	Mudzez	JJ	B-NP	O
al	al	JJ	I-NP	O
-	-	HYPH	I-NP	O
Kanum	Kanum	NNP	I-NP	O
''	''	''	O	O
,	,	,	O	O
Republicki	Republicki	NNP	B-NP	O
zavod	zavod	NN	I-NP	O
za	za	FW	I-NP	O
zdravstvenu	zdravstvenu	FW	I-NP	O
zastitu	zastitu	FW	I-NP	O
Sarajevo	Sarajevo	NNP	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
Mr	Mr	NNP	B-NP	O
ph	ph	NN	I-NP	O
Samuel	Samuel	NNP	I-NP	O
Elazar	Elazar	NNP	I-NP	O
,	,	,	O	O
Ajnija	Ajnija	NNP	B-NP	O
Omanic	Omanic	NNP	I-NP	O
:	:	:	O	O
``	``	``	O	O
Bibliografija	Bibliografija	NN	B-NP	O
medicinskih	medicinskih	NN	I-NP	O
djela	djela	NN	I-NP	O
u	u	NN	I-NP	O
SR	SR	NN	I-NP	O
BiH	BiH	NN	I-NP	O
do	do	VBP	B-VP	O
1.	1.	CD	B-NP	O
''	''	''	O	O
Medicinska	Medicinska	NNP	B-NP	O
knjiga	knjiga	NNP	I-NP	O
Beograd	Beograd	NNP	I-NP	O
-	-	HYPH	O	O
Zagreb	Zagreb	NNP	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
Besides	Besides	IN	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
great	great	JJ	I-NP	O
contribution	contribution	NN	I-NP	O
in	in	IN	B-PP	O
bibliography	bibliography	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
by	by	IN	B-PP	O
dr	dr	NN	B-NP	O
Lujo	Lujo	NNP	I-NP	O
Taler	Taler	NNP	I-NP	O
,	,	,	O	O
prof.	prof.	NN	B-NP	O
dr	dr	NN	I-NP	O

Patients	Patient	NNS	B-NP	O
randomized	randomize	VBN	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
groups	group	NNS	I-NP	O
A1	A1	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
A1	A1	NN	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
received	receive	VBD	B-VP	O
topical	topical	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
diclofenac	diclofenac	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
hyaluronan	hyaluronan	NN	I-NP	O
gel	gel	NN	I-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Southern	Southern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
altered	alter	VBN	B-NP	O
CpG	CpG	NN	I-NP	O
methylation	methylation	NN	I-NP	O
within	within	IN	B-PP	O
intron	intron	NN	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
from	from	IN	B-PP	O
all	all	DT	B-NP	O
BCC	BCC	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
,	,	,	I-NP	O
mortal	mortal	JJ	I-NP	O
human	human	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
epithelial	epithelial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
(	(	(	O	O
HMEC	HMEC	NNS	B-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
blocked	block	VBD	B-VP	O
phosphatidylcholine	phosphatidylcholine	NN	B-NP	O
hydrolysis	hydrolysis	NN	I-NP	O
and	and	CC	O	O
protein	BEGIN-protein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
translocation	translocation	NN	I-NP	O

Human	BEGIN-Human	JJ	B-NP	B
PDNP1	PDNP1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
glioma	glioma	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
prostate	prostate	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
uterus	uterus	NN	B-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
alimentary	alimentary	JJ	I-NP	O
tract	tract	NN	I-NP	O

1	1	CD	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
T	BEGIN-T	NN	B-NP	B
antigen	antigen-INSIDE	NN	I-NP	I
could	could	MD	B-VP	O
mediate	mediate	VB	I-VP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
through	through	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
TATA	BEGIN-TATA	NN	I-NP	B
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
upstream	upstream	JJ	B-NP	O
bound	bind	VBN	I-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
infC	BEGIN-infC-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
rpmI	BEGIN-rpmI-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
rplT	BEGIN-rplT-INSIDE	NN	I-NP	B
operon	operon	NN	I-NP	O
flanked	flank	VBN	B-VP	O
by	by	IN	B-PP	O
long	long	JJ	B-NP	O
inverted	inverted	JJ	I-NP	O
repeats	repeat	NNS	I-NP	O
in	in	IN	B-PP	O
Mycoplasma	Mycoplasma	NN	B-NP	O
fermentans	fermentan	NNS	I-NP	O
(	(	(	O	O
incognitus	incognitus	NN	B-NP	O
strain	strain	NN	I-NP	O
)	)	)	O	O

IgE	BEGIN-IgE	NN	B-NP	B
antibody	antibody-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
twelve	twelve	VB	I-VP	O
common	common	JJ	B-NP	O
food	food	NN	I-NP	O
and	and	CC	I-NP	O
inhalant	inhalant	JJ	I-NP	O
allergens	allergen	NNS	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
enzyme	enzyme	NN	B-NP	O
-	-	HYPH	O	O
linked	link	VBN	B-NP	O
immunosorbent	immunosorbent	NN	I-NP	O
assay	assay	NN	I-NP	O
(	(	(	O	O
ELISA	ELISA	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sera	serum	NNS	I-NP	O
of	of	IN	B-PP	O
thirteen	thirteen	CD	B-NP	O
atopic	atopic	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
allergic	allergic	JJ	I-NP	O
disorders	disorder	NNS	I-NP	O
(	(	(	O	O
asthma	asthma	NN	B-NP	O
occurring	occur	VBG	B-VP	O
in	in	IN	B-PP	O
eleven	eleven	CD	B-NP	O
;	;	:	O	O
rhinitis	rhinitis	NN	B-NP	O
in	in	IN	B-PP	O
ten	ten	CD	B-NP	O
;	;	:	O	O
eczema	eczema	NN	B-NP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
;	;	:	O	O
urticaria	urticaria	NN	B-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
;	;	:	O	O
mouth	mouth	NN	B-NP	O
and	and	CC	O	O
gastro	gastro	AFX	B-NP	O
-	-	HYPH	I-NP	O
intestinal	intestinal	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
of	of	IN	B-PP	O
twelve	twelve	CD	B-NP	O
non	non	AFX	O	O
-	-	HYPH	B-NP	O
atopic	atopic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
(	(	(	O	O
asthma	asthma	NN	B-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
;	;	:	O	O
rhinitis	rhinitis	NN	B-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
;	;	:	O	O
eczema	eczema	NN	B-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
;	;	:	O	O
urticaria	urticaria	NN	B-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
;	;	:	O	O
mouth	mouth	NN	B-NP	O
and	and	CC	O	O
gastro	gastro	AFX	B-NP	O
-	-	HYPH	I-NP	O
intestinal	intestinal	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
sixteen	sixteen	CD	B-NP	O
cord	cord	NN	I-NP	O
blood	blood	NN	I-NP	O
sera	serum	NNS	I-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
Mb	Mb	NN	I-NP	O
of	of	IN	B-PP	O
published	publish	VBN	B-NP	O
sequence	sequence	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
conserved	conserve	VBN	B-NP	O
synteny	synteny	NN	I-NP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1q1	1q1	NN	I-NP	O
-	-	HYPH	B-NP	O
q1	q1	NN	I-NP	O
identified	identify	VBN	B-VP	O
1	1	CD	B-NP	O
gene	gene	NN	I-NP	O
candidates	candidate	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
1	1	CD	B-NP	O
expressed	express	VBN	B-VP	O
genes	gene	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
IL	IL	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
cytokine	cytokine	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
cluster	cluster	NN	I-NP	O

These	These	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
E1F	BEGIN-E1F-INSIDE	NN	I-NP	B
complexes	complex	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
young	young	JJ	B-NP	O
G1	G1	NN	I-NP	O
cells	cell	NNS	I-NP	O
at	at	IN	B-PP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
in	in	IN	B-PP	O
senescent	senescent	JJ	B-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
delta	delta	NN	I-NP	O
Mo	Mo	NN	I-NP	O
+	+	SYM	B-NP	O
SV	SV	NN	I-NP	O
tumor	tumor	NN	I-NP	O
DNAs	DNA	NNS	I-NP	O
from	from	IN	B-PP	O
B	B	NN	B-NP	O
-	-	HYPH	B-NP	O
lineage	lineage	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
were	be	VBD	B-VP	O
typically	typically	RB	I-VP	O
rearranged	rearrange	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	BEGIN-immunoglobulin	NN	I-NP	B
gene	gene	NN	I-NP	I
loci	loci-INSIDE	NN	I-NP	I
and	and	CC	O	O
contained	contain	VBD	B-VP	O
germ	germ	NN	B-NP	O
line	line	NN	I-NP	O
configurations	configuration	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	BEGIN-T	NN	I-NP	B
-	-	HYPH	B-NP	I
cell	cell	NN	I-NP	I
receptor	receptor	NN	I-NP	I
beta	beta	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

An	An	DT	B-NP	O
increased	increase	VBN	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
ATN	ATN	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
introduction	introduction	NN	I-NP	O
of	of	IN	B-PP	O
cyclosporin	cyclosporin	NN	B-NP	O
A	A	NN	I-NP	O

Earlier	Early	JJR	B-NP	O
reports	report	NNS	I-NP	O
have	have	VBP	B-VP	O
localized	localize	VBN	I-VP	O
mutations	mutation	NNS	B-NP	O
which	which	WDT	B-NP	O
affect	affect	VBP	B-VP	O
the	the	DT	B-NP	O
processing	processing	NN	I-NP	O
and	and	CC	I-NP	O
transport	transport	NN	I-NP	O
of	of	IN	B-PP	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
virus	virus	NN	I-NP	O
1	1	CD	B-NP	O
glycoproteins	glycoprotein	NNS	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
located	located	JJ	B-ADJP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
specifying	specify	VBG	B-VP	O
glycoprotein	BEGIN-glycoprotein	NN	B-NP	B
B	B-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
viral	viral	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
protein	protein	NN	B-NP	O
(	(	(	O	O
beta	BEGIN-beta	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O

Magnetic	Magnetic	JJ	B-NP	O
force	force	NN	I-NP	O
and	and	CC	I-NP	O
torque	torque	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
T	T	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
dislodge	dislodge	VB	I-VP	O
the	the	DT	B-NP	O
GF	GF	NN	I-NP	O
or	or	CC	O	O
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
perforation	perforation	NN	B-NP	O
of	of	IN	B-PP	O
canine	canine	JJ	B-NP	O
IVC	IVC	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
GF	GF	NN	I-NP	O

The	The	DT	B-NP	O
rec1	BEGIN-rec1	NN	I-NP	B
(	(	(	O	I
+	+	SYM	O	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
,	,	,	O	O
rec1	BEGIN-rec1	NN	B-NP	B
(	(	(	O	I
+	+	SYM	O	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
,	,	,	O	O
and	and	CC	O	O
rec1	BEGIN-BEGIN-rec1	NN	B-NP	B
(	(	(	O	I
+	+	SYM	O	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
genes	gene	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fission	fission	NN	I-NP	O
yeast	yeast	NN	I-NP	O
Schizosaccharomyces	Schizosaccharomyces	NNP	I-NP	O
pombe	pombe-INSIDE	NN	I-NP	I
exhibit	exhibit	VBP	B-VP	O
similar	similar	JJ	B-NP	O
specificities	specificity	NNS	I-NP	O
for	for	IN	B-PP	O
meiotic	meiotic	JJ	B-NP	O
recombination	recombination	NN	I-NP	O
and	and	CC	O	O
rec1	BEGIN-rec1	NN	B-NP	B
(	(	(	O	I
+	+	SYM	O	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
sister	sister	NN	B-NP	O
chromatid	chromatid	NN	I-NP	O
cohesion	cohesion	NN	I-NP	O
and	and	CC	O	O
homolog	homolog	NN	B-NP	O
pairing	pairing	NN	I-NP	O

Synergistic	Synergistic	JJ	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
cells	cell	NNS	I-NP	O
(	(	(	O	O
U1	U1	NN	B-NP	O
)	)	)	O	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
bryostatin	bryostatin	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
proteasome	proteasome	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
lactacystin	lactacystin	NN	I-NP	O
involves	involve	VBZ	B-VP	O
dysregulation	dysregulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PKC	BEGIN-PKC-INSIDE	NN	I-NP	B
/	/	SYM	B-VP	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B
cascade	cascade	NN	I-NP	O

The	The	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
D	D	NN	I-NP	O
-	-	HYPH	O	O
loop	loop	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
step	step	NN	I-NP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
strand	strand	NN	I-NP	O
break	break	NN	I-NP	O
repair	repair	NN	I-NP	O
through	through	IN	B-PP	O
recombination	recombination	NN	B-NP	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
sera	sera	NN	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
full	full	JJ	B-NP	O
chlamydial	chlamydial	JJ	I-NP	O
micro	micro	AFX	I-NP	O
-	-	HYPH	I-NP	O
immunofluorescence	immunofluorescence	NN	I-NP	O
results	result	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
a	a	DT	B-NP	O
clear	clear	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
evaluated	evaluate	VBN	I-VP	O
the	the	DT	B-NP	O
Chlamydia	Chlamydia	NNP	I-NP	O
Spot	Spot	NN	I-NP	O
-	-	HYPH	O	O
IF	IF	NN	B-NP	O
test	test	NN	I-NP	O
(	(	(	O	O
bioMerieux	bioMerieux	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
allows	allow	VBZ	B-VP	O
a	a	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
titres	titre	NNS	B-NP	O
to	to	TO	B-PP	O
Chlamydia	BEGIN-Chlamydia	NN	B-NP	B
trachomatis	trachomatis	NN	I-NP	I
and	and	CC	O	I
C.	C.	FW	B-NP	I
psittaci	psittaci	FW	I-NP	I
antigens	antigens-INSIDE	NN	I-NP	I

ET	BEGIN-ET	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
limited	limit	VBD	B-VP	O
the	the	DT	B-NP	O
electrocardiographic	electrocardiographic	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
subendocardial	subendocardial	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
and	and	CC	O	O
attenuated	attenuate	VBD	B-VP	O
contractile	contractile	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
flows	flow	NNS	I-NP	O
,	,	,	O	O
even	even	RB	B-SBAR	O
though	though	IN	I-SBAR	O
lactate	lactate	NN	B-NP	O
flux	flux	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O

The	The	DT	B-NP	O
AtNMT1	BEGIN-AtNMT1-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
profile	profile	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
ubiquity	ubiquity	NN	B-NP	O
in	in	IN	B-PP	O
roots	root	NNS	B-NP	O
,	,	,	O	O
stem	stem	NN	B-NP	O
,	,	,	O	O
leaves	leaf	NNS	B-NP	O
,	,	,	O	O
flowers	flower	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
siliques	silique	NNS	B-NP	O
(	(	(	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
transcript	transcript	NN	I-NP	O
and	and	CC	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
immunoreactive	immunoreactive	JJ	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
)	)	)	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
greater	great	JJR	I-NP	O
level	level	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
younger	young	JJR	I-NP	O
tissue	tissue	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
developmentally	developmentally	RB	B-ADVP	O
very	very	RB	B-ADJP	O
active	active	JJ	I-ADJP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
DMIPP	DMIPP	NN	B-NP	O
detects	detect	VBZ	B-VP	O
regionally	regionally	RB	I-VP	O
hypoperfused	hypoperfuse	VBN	I-VP	O
myocardium	myocardium	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
agreement	agreement	NN	B-VP	O
between	between	IN	B-PP	O
MBF	MBF	NN	B-NP	O
and	and	CC	O	O
fatty	fatty	JJ	B-NP	O
acid	acid	NN	I-NP	O
uptake	uptake	NN	I-NP	O
deteriorates	deteriorate	NNS	I-NP	O

The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
putative	putative	JJ	B-NP	O
TSC1	BEGIN-BEGIN-TSC1-INSIDE	NN	I-NP	B
mutations	mutations-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
sporadic	sporadic	JJ	O	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
TSC1	BEGIN-TSC1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
linked	link	VBN	I-NP	O
families	family	NNS	I-NP	O

Thirty	Thirty	CD	B-NP	O
-	-	HYPH	I-NP	O
three	three	CD	I-NP	O
small	small	JJ	I-NP	O
glottic	glottic	JJ	I-NP	O
carcinomas	carcinoma	NNS	I-NP	O
(	(	(	O	O
T1	T1	NN	B-NP	O
and	and	CC	O	O
small	small	JJ	B-NP	O
T1	T1	NN	I-NP	O
;	;	:	O	O
UICC	UICC	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
by	by	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
grading	grading	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
factor	factor	NN	I-NP	O
system	system	NN	I-NP	O
proposed	propose	VBN	B-VP	O
by	by	IN	B-PP	O
Jakobsson	Jakobsson	NNP	B-NP	O
et	et	FW	I-NP	O
al	al	FW	I-NP	O

None	None	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
sequences	sequence	NNS	I-NP	O
has	have	VBZ	B-VP	O
hitherto	hitherto	RB	I-VP	O
been	be	VBN	I-VP	O
recognized	recognize	VBN	I-VP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O

Studies	Study	NNS	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O

Transfection	Transfection	NN	B-NP	O
of	of	IN	B-PP	O
H	BEGIN-H	NN	B-NP	B
chain	chain	NN	I-NP	I
loss	loss	NN	I-NP	I
variant	variant-INSIDE	NN	I-NP	I
myeloma	myeloma	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
construct	construct	NN	I-NP	O
,	,	,	O	O
termed	term	VBN	B-NP	O
1H	BEGIN-1H	NN	I-NP	B
-	-	HYPH	B-NP	I
Cmicro	Cmicro-INSIDE	NN	I-NP	I
,	,	,	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
intact	intact	JJ	B-NP	O
Ig	Ig	NN	I-NP	O
pairing	pairing	NN	I-NP	O
1H	BEGIN-1H	NN	I-NP	B
-	-	HYPH	B-NP	I
Cmicro	Cmicro-INSIDE	NN	I-NP	I
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lambda	BEGIN-lambda	NNP	I-NP	B
L	L	NN	I-NP	I
chain	chain-INSIDE	NN	I-NP	I
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
transfectant	BEGIN-transfectant	JJ	B-NP	B
Ig	Ig-INSIDE	NN	I-NP	I
lacked	lack	VBD	B-VP	O
autoreactivity	autoreactivity	NN	B-NP	O
and	and	CC	I-NP	O
pathogenicity	pathogenicity	NN	I-NP	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
human	human	JJ	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
annexin	BEGIN-BEGIN-annexin	NN	B-NP	B
II	I-INSIDEI-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
mouse	mouse	NN	B-NP	O
,	,	,	O	O
rat	rat	NN	B-NP	O
and	and	CC	O	O
human	human	JJ	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
annexin	BEGIN-annexin	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
pigeon	pigeon	NN	B-NP	O
cp1	cBEGIN-p1-INSIDE	NN	I-NP	I
(	(	(	O	O
an	an	DT	B-NP	O
annexin	BEGIN-BEGIN-annexin	NN	I-NP	B
I	I-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
related	relate	VBN	B-NP	O
protein	protein-INSIDE	NN	I-NP	I
)	)	)	O	O
shows	show	VBZ	B-VP	O
strong	strong	JJ	B-NP	O
genomic	genomic	JJ	I-NP	O
structural	structural	JJ	I-NP	O
conservation	conservation	NN	I-NP	O
supporting	support	VBG	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
ancestor	ancestor	NN	I-NP	O

Now	Now	RB	B-ADVP	O
:	:	:	O	O
pleasure	pleasure	VB	B-VP	O
in	in	IN	B-PP	O
work	work	NN	B-NP	O

Cerumen	Cerumen	NN	B-NP	O
management	management	NN	I-NP	O
in	in	IN	B-PP	O
hearing	hear	VBG	B-VP	O
conservation	conservation	NN	B-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
Dallas	Dallas	NNP	I-NP	O
(	(	(	O	O
Texas	Texas	NNP	B-NP	O
)	)	)	O	O
Independent	Independent	NNP	B-NP	O
School	School	NNP	I-NP	O
District	District	NNP	I-NP	O
program	program	NN	I-NP	O

Mammalian	Mammalian	JJ	B-NP	O
homologues	homologue	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Polycomb	BEGIN-Polycomb	NN	I-NP	B
-	-	HYPH	I-NP	I
group	group	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
Enhancer	BEGIN-Enhancer	NN	I-NP	B
of	of	IN	B-PP	I
zeste	zeste-INSIDE	NN	B-NP	I
mediate	mediate	VBP	B-VP	O
gene	gene	NN	B-NP	O
silencing	silencing	NN	I-NP	O
in	in	IN	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
heterochromatin	heterochromatin	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
telomeres	telomere	VBZ	B-VP	O

Xanthoepocin	Xanthoepocin	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
antibiotic	antibiotic	NN	I-NP	O
from	from	IN	B-PP	O
Penicillium	Penicillium	NNP	B-NP	O
simplicissimum	simplicissimum	JJ	I-NP	O
IFO1	IFO1	NN	I-NP	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
VAHS	VAHS	NN	B-NP	O
is	be	VBZ	B-VP	O
often	often	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
fatal	fatal	JJ	B-NP	O
infectious	infectious	JJ	I-NP	O
mononucleosis	mononucleosis	NN	I-NP	O
(	(	(	O	O
IM	IM	NN	B-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
mutations	mutation	NNS	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
Ubx	BEGIN-Ubx	NN	I-NP	B
unit	unit	NN	I-NP	I
exons	exons-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
and	and	CC	O	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
behave	behave	NN	I-NP	O
as	as	IN	B-PP	O
null	null	JJ	B-NP	O
alleles	allele	NNS	I-NP	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
peroxisome	peroxisome	NN	I-NP	O
proliferator	proliferator	NN	I-NP	O
-	-	HYPH	B-NP	O
activated	activate	VBN	I-NP	O
receptor	receptor	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
PPRE	PPRE	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
from	from	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O

In	In	IN	B-PP	O
T	T	NN	B-NP	O
cells	cell	NNS	I-NP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
signal	signal	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
are	be	VBP	B-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
interleukin	BEGIN-interleukin	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
production	production	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
induce	induce	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
and	and	CC	O	O
initiator	initiator	NN	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
vitronectin	BEGIN-vitronectin	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
lacks	lack	VBZ	B-VP	O
the	the	DT	B-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
,	,	,	O	O
initiator	initiator	NN	B-NP	O
and	and	CC	I-NP	O
GC	GC	NN	I-NP	O
box	box	NN	I-NP	O

Both	Both	DT	B-NP	O
residues	residue	NNS	I-NP	O
are	be	VBP	B-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
phosphorylated	phosphorylate	VBN	I-NP	O
paralogs	paralog	NNS	I-NP	O
but	but	CC	O	O
are	be	VBP	B-VP	O
absent	absent	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ones	one	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
substrates	substrate	NNS	B-NP	O
of	of	IN	B-PP	O
RsbT	BEGIN-RsbT-INSIDE	NN	B-NP	B
:	:	:	O	O
YetI	BEGIN-YetI-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
YezB	BEGIN-YezB-INSIDE	NN	I-NP	B
,	,	,	O	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
bears	bear	VBZ	B-VP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
residues	residue	NNS	I-NP	O
;	;	:	O	O
and	and	CC	O	O
YtvA	BEGIN-YtvA-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
lacks	lack	VBZ	B-VP	O
both	both	DT	B-NP	O
residues	residue	NNS	B-NP	O
and	and	CC	O	O
instead	instead	RB	B-VP	O
possesses	possess	VBZ	I-VP	O
an	an	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
PAS	BEGIN-PAS-INSIDE	NN	I-NP	B
domain	domain	NN	I-NP	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
PORT	PORT	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
N1	N1	NN	B-NP	O
tumours	tumour	NNS	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
and	and	CC	O	O
may	may	MD	B-VP	O
justify	justify	VB	I-VP	O
further	far	JJR	B-NP	O
research	research	NN	I-NP	O

The	The	DT	B-NP	O
TDx	TDx	NN	I-NP	O
assay	assay	NN	I-NP	O
for	for	IN	B-PP	O
cyclosporine	cyclosporine	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
metabolites	metabolite	NNS	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
samples	sample	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
HPLC	HPLC	NN	B-NP	O
and	and	CC	I-NP	O
RIA	RIA	NN	I-NP	O
methods	method	NNS	I-NP	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
retinoid	BEGIN-retinoid	JJ	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
function	function	NN	I-NP	O
in	in	IN	B-PP	O
RA	RA	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
ERK1	BEGIN-ERK1-INSIDE	NN	I-NP	B
activation	activation	NN	I-NP	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
Vi	BEGIN-Vi	JJ	B-NP	B
antigen	antigen-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
system	system	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
rcs	BEGIN-rcs-INSIDE	NN	I-NP	B
regulatory	regulatory	JJ	I-NP	O
system	system	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
colanic	colanic	JJ	B-NP	O
acid	acid	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
specific	specific	JJ	B-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
trans	trans	AFX	O	O
-	-	HYPH	O	O
acting	act	VBG	B-NP	O
factors	factor	NNS	I-NP	O
control	control	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prodynorphin	BEGIN-prodynorphin	JJ	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
not	not	RB	O	O
as	as	RB	B-VP	O
clearly	clearly	RB	I-VP	O
defined	define	VBN	I-VP	O

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
set	set	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
mitochondrial	mitochondrial	JJ	I-NP	O
genome	genome	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Reclinomonas	Reclinomonas	NNP	B-NP	O
americana	americana	NNS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
amoeboid	amoeboid	JJ	I-NP	O
protozoan	protozoan	NN	I-NP	O

The	The	DT	B-NP	O
library	library	NN	I-NP	O
will	will	MD	B-VP	O
thus	thus	RB	I-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
selection	selection	NN	I-NP	O
of	of	IN	B-PP	O
cosmid	cosmid	NN	B-NP	O
clones	clone	NNS	I-NP	O
which	which	WDT	B-NP	O
carry	carry	VBP	B-VP	O
CDC	BEGIN-CDC	NN	B-NP	B
genes	gene	NNS	I-NP	I
from	from	IN	B-PP	I
yeast	yeast-INSIDE	NN	B-NP	I
by	by	IN	B-PP	O
complementing	complement	VBG	B-VP	O
first	first	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
vectorial	vectorial	JJ	I-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
gene	gene	NN	I-NP	I
URA1	URA1-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
pyrimidine	pyrimidine	NN	I-NP	O
auxotrophy	auxotrophy	NN	I-NP	O
of	of	IN	B-PP	O
most	most	JJS	B-NP	O
cdc	BEGIN-cdc-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
strains	strain	NNS	B-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
respective	respective	JJ	I-NP	O
CDC	BEGIN-CDC	NN	I-NP	B
wild	wild	JJ	I-NP	I
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
temperature	temperature	NN	I-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
mutant	mutant	JJ	I-NP	O
alleles	allele	NNS	I-NP	O

A	A	DT	B-NP	O
plasma	plasma	NN	I-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
connective	connective	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
cores	core	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
papillae	papilla	NNS	I-NP	O

Peptide	Peptide	NN	B-NP	O
competition	competition	NN	I-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
localized	localize	VBN	I-VP	O
a	a	DT	B-NP	O
cyclin	BEGIN-cyclin	NN	I-NP	B
A	A	NN	I-NP	I
interaction	interaction	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
a	a	DT	B-NP	O
Lys1Lys1Leu1Met1Phe1	Lys1Lys1Leu1Met1Phe1	NN	I-NP	O
sequence	sequence	NN	I-NP	O
within	within	IN	B-PP	O
C	C	NN	B-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
negative	negative	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
p1	p1-INSIDE	NN	I-NP	I

A	A	DT	B-NP	O
phase	phase	NN	I-NP	O
II	II	CD	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pure	pure	JJ	I-NP	O
L	L	NN	I-NP	O
-	-	HYPH	O	O
isomer	isomer	NN	B-NP	O
of	of	IN	B-PP	O
LV	LV	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
FU	FU	NN	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
epirubicin	epirubicin	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
cancer	cancer	NN	I-NP	O

Attenuated	Attenuate	VBN	B-NP	O
serum	serum	NN	I-NP	O
cortisol	cortisol	NN	I-NP	O
responses	response	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
despite	despite	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
ACTH	BEGIN-ACTH-INSIDE	NN	I-NP	B
test	test	NN	I-NP	O

While	While	IN	B-SBAR	O
some	some	DT	B-NP	O
still	still	RB	B-VP	O
automatically	automatically	RB	I-VP	O
refuse	refuse	VB	I-VP	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
mediastinoscopy	mediastinoscopy	NN	I-NP	O
,	,	,	O	O
most	most	JJS	B-NP	O
authors	author	NNS	I-NP	O
still	still	RB	B-ADVP	O
remain	remain	VBP	B-VP	O
very	very	RB	B-ADJP	O
interventionistic	interventionistic	JJ	I-ADJP	O
for	for	IN	B-PP	O
N1	N1	NN	B-NP	O
patients	patient	NNS	I-NP	O
selected	select	VBN	B-VP	O
on	on	IN	B-PP	O
very	very	RB	B-NP	O
accurate	accurate	JJ	I-NP	O
criteria	criterion	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
above	above	IN	B-PP	O

Inability	Inability	NN	B-NP	O
of	of	IN	B-PP	O
niacin	niacin	NN	B-NP	O
to	to	TO	B-VP	O
protect	protect	VB	I-VP	O
from	from	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
hyperoxia	hyperoxia	NN	I-NP	O
or	or	CC	O	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
microsomal	microsomal	JJ	I-NP	O
lipid	lipid	NN	I-NP	O
peroxidation	peroxidation	NN	I-NP	O

Sesame	Sesame	NN	B-NP	O
seed	seed	NN	I-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
a	a	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
allergic	allergic	JJ	B-NP	O
reactions	reaction	NNS	I-NP	O
to	to	TO	B-PP	O
drug	drug	NN	B-NP	O
products	product	NNS	I-NP	O
and	and	CC	I-NP	O
cosmetics	cosmetic	NNS	I-NP	O

In	In	IN	B-PP	O
absence	absence	NN	B-NP	O
of	of	IN	B-PP	O
i.m.	i.m.	JJ	B-NP	O
medication	medication	NN	I-NP	O
,	,	,	O	O
levels	level	NNS	B-NP	O
over	over	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
U	U	NN	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
carefully	carefully	RB	I-VP	O
screened	screen	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
SNM	SNM	NN	B-NP	O
or	or	CC	O	O
organic	organic	JJ	B-NP	O
pathology	pathology	NN	I-NP	O
associated	associate	VBN	B-VP	O

A	A	DT	B-NP	O
yeast	yeast	NN	I-NP	O
mitochondrial	mitochondrial	JJ	I-NP	O
translation	translation	NN	I-NP	O
initiation	initiation	NN	I-NP	O
codon	codon	NN	I-NP	O
mutation	mutation	NN	I-NP	O
affecting	affect	VBG	B-VP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
cytochrome	BEGIN-cytochrome	NN	B-NP	B
oxidase	oxidase	NN	I-NP	I
subunit	subunit	NN	I-NP	I
III	III-INSIDE	NN	I-NP	I
(	(	(	O	O
COX1	BEGIN-COX1-INSIDE	NN	B-NP	B
)	)	)	O	O
was	be	VBD	B-VP	O
partially	partially	RB	I-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
mutation	mutation	NN	I-NP	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
or	or	CC	O	O
vascular	vascular	JJ	B-NP	O
infection	infection	NN	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-VP	O
frequently	frequently	RB	I-VP	O
immunocompromised	immunocompromise	VBN	I-VP	O
and	and	CC	O	O
older	old	JJR	B-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
Q	Q	NN	I-NP	O
fever	fever	NN	I-NP	O

This	This	DT	B-NP	O
latter	latter	JJ	I-NP	O
complex	complex	NN	I-NP	O
reacts	react	VBZ	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
antibody	antibody	NN	I-NP	O
to	to	TO	B-PP	O
serum	BEGIN-serum	NN	B-NP	B
response	response	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
SRF	BEGIN-SRF-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
exhibits	exhibit	VBZ	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
binding	binding	NN	I-NP	O
characteristics	characteristic	NNS	I-NP	O
as	as	IN	B-PP	O
purified	purify	VBN	B-NP	O
SRF	BEGIN-SRF-INSIDE	NN	I-NP	B

MEASURES	MEASURES	NNS	B-NP	O
:	:	:	O	O
SF	SF	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
questionnaires	questionnaire	NNS	I-NP	O
were	be	VBD	B-VP	O
completed	complete	VBN	I-VP	O
by	by	IN	B-PP	O
patients	patient	NNS	B-NP	O
at	at	IN	B-PP	O
both	both	CC	B-NP	O
initial	initial	JJ	I-NP	O
and	and	CC	I-NP	O
discharge	discharge	NN	I-NP	O
examinations	examination	NNS	I-NP	O

Hormonal	Hormonal	JJ	B-NP	O
replacement	replacement	NN	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
personal	personal	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O

The	The	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
SHBG	SHBG	NN	I-NP	I
proximal	proximal	JJ	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
DNase	BEGIN-DNase	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
footprinting	footprinting	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
footprinted	footprinte	VBN	I-NP	O
regions	region	NNS	I-NP	O
(	(	(	O	O
FP1	FP1	NN	B-NP	O
-	-	HYPH	B-NP	O
FP1	FP1	NN	I-NP	O
)	)	)	O	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
HepG1	HepG1	NN	I-NP	O
hepatoblastoma	hepatoblastoma	NN	I-NP	O
cells	cell	NNS	I-NP	O

Endodontic	Endodontic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
deciduous	deciduous	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
formocresol	formocresol	NN	I-NP	O
amputation	amputation	NN	I-NP	O
method	method	NN	I-NP	O

The	The	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
results	result	NNS	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
seroprevalence	seroprevalence	NN	B-NP	O
of	of	IN	B-PP	O
Lyme	Lyme	NN	B-NP	O
borreliosis	borreliosis	NN	I-NP	O
in	in	IN	B-PP	O
dogs	dog	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Kosice	Kosice	NNP	I-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
negligible	negligible	JJ	B-ADJP	O

Mutant	Mutant	JJ	B-NP	O
beta1	BEGIN-beta1	NN	I-NP	B
-	-	HYPH	B-NP	I
adrenergic	adrenergic	JJ	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Tyr	Tyr	NN	I-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
Phe	Phe	NN	I-NP	O
substitution	substitution	NN	I-NP	O
at	at	IN	B-PP	O
Tyr	Tyr	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
display	display	VB	I-VP	O
agonist	agonist	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
desensitization	desensitization	NN	I-NP	O
,	,	,	O	O
Src	BEGIN-Src-INSIDE	NN	B-NP	B
recruitment	recruitment	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
Src	BEGIN-Src-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O

The	The	DT	B-NP	O
feasibility	feasibility	NN	I-NP	O
of	of	IN	B-PP	O
creating	create	VBG	B-VP	O
CR1	BEGIN-CR1-INSIDE	NN	B-NP	B
/	/	SYM	B-VP	O
Ig	BEGIN-Ig-INSIDE	NN	B-NP	B
chimeras	chimera	NNS	I-NP	O
makes	make	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
strategy	strategy	NN	I-NP	O
of	of	IN	B-PP	O
targeting	target	VBG	B-VP	O
complement	complement	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
Ig	BEGIN-BEGIN-Ig-INSIDE	NN	B-NP	B
fusion	fusion	NN	I-NP	O
partners	partners-INSIDE	NN	I-NP	I
having	have	VBG	B-VP	O
particular	particular	JJ	B-NP	O
antigenic	antigenic	JJ	I-NP	O
specificities	specificity	NNS	I-NP	O

Otosclerosis	Otosclerosis	NN	B-NP	O
in	in	IN	B-PP	O
monozygotic	monozygotic	JJ	B-NP	O
twins	twin	NNS	I-NP	O
:	:	:	O	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
genetical	genetical	JJ	I-NP	O
analysis	analysis	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
uninfected	uninfected	JJ	B-NP	O
NIH	NIH	NN	I-NP	O
-	-	HYPH	B-NP	O
1T1	1T1	NN	I-NP	O
cells	cell	NNS	I-NP	O
Avarol	Avarol	NN	B-NP	O
(	(	(	O	O
i	i	NN	B-NP	O
)	)	)	O	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
rate	rate	NN	I-NP	O
only	only	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
microM	microM	NN	I-NP	O
and	and	CC	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
is	be	VBZ	B-VP	O
accumulated	accumulate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
close	close	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
disruption	disruption	NN	B-NP	O
of	of	IN	B-PP	O
pcr1	BEGIN-pcr1-INSIDE	NN	B-NP	B
reduced	reduce	VBD	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
fbp1	BEGIN-fbp1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
-	-	HYPH	B-NP	O
repressible	repressible	JJ	I-NP	O
gene	gene	NN	I-NP	O
negatively	negatively	RB	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
PKA	BEGIN-PKA-INSIDE	NN	B-NP	B

This	This	DT	B-NP	O
B	B	NN	I-NP	O
-	-	HYPH	O	O
box	box	NN	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
ETS1	BEGIN-ETS1-INSIDE	NN	B-NP	B
,	,	,	O	O
ETS1	BEGIN-ETS1-INSIDE	NN	B-NP	B
,	,	,	O	O
PEA1	BEGIN-PEA1-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
PU.1	BEGIN-PU.1-INSIDE	NN	I-NP	B
and	and	CC	O	O
these	these	DT	B-NP	O
proteins	protein	NNS	I-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
ternary	ternary	JJ	B-NP	O
complexes	complex	NNS	I-NP	O
with	with	IN	B-PP	O
SRF	BEGIN-SRF-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Egrl	BEGIN-Egrl-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
SREs	SRE	NNS	I-NP	O
or	or	CC	O	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
fos	fos-INSIDE	NN	B-NP	I
SRE	SRE	NN	I-NP	O

Excretion	Excretion	NN	B-NP	O
of	of	IN	B-PP	O
radiopharmaceuticals	radiopharmaceutical	NNS	B-NP	O
into	into	IN	B-PP	O
breast	breast	NN	B-NP	O
milk	milk	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
drinking	drinking	NN	I-NP	O
ampules	ampule	NNS	I-NP	O
of	of	IN	B-PP	O
VP	VP	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
replaced	replace	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
oral	oral	JJ	I-NP	O
capsules	capsule	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recommended	recommended	JJ	I-NP	O
initial	initial	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
given	give	VBN	B-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
day	day	NN	I-NP	O
courses	course	VBZ	B-VP	O
every	every	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O

Deletion	Deletion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
from	from	IN	B-PP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
postulated	postulate	VBN	I-VP	O
to	to	TO	I-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
CBP	BEGIN-CBP-INSIDE	NN	I-NP	B
,	,	,	O	O
also	also	RB	B-ADVP	O
abolished	abolish	VBD	B-VP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
,	,	,	O	O
whereas	whereas	IN	O	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
from	from	IN	B-PP	O
residues	residue	NNS	B-NP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
1th	1th	NN	I-NP	O
and	and	CC	I-NP	O
1st	1st	JJ	I-NP	O
day	day	NN	I-NP	O
after	after	IN	B-SBAR	O
cimetidine	cimetidine	NN	B-NP	O
administration	administration	NN	I-NP	O
serum	BEGIN-serum	NN	I-NP	B
gastrin	gastrin-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O

Both	Both	CC	O	O
PMP1	BEGIN-PMP1	NN	B-NP	B
gene	gene	NN	I-NP	I
products	products-INSIDE	NN	I-NP	I
contain	contain	VBP	B-VP	O
the	the	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
AKL	AKL	NN	I-NP	O
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
SKL	SKL	NN	I-NP	O
peroxisomal	peroxisomal	JJ	I-NP	O
sorting	sorting	NN	I-NP	O
sequence	sequence	NN	I-NP	O
(	(	(	O	O
Gould	Gould	NNP	B-NP	O
,	,	,	O	O
S	S	NNP	B-NP	O

After	After	IN	B-PP	O
cumulative	cumulative	JJ	B-NP	O
occlusions	occlusion	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
,	,	,	O	O
transmural	transmural	JJ	B-NP	O
needle	needle	NN	I-NP	O
biopsies	biopsy	NNS	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
area	area	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
analyzed	analyze	VBN	I-VP	O
for	for	IN	B-PP	O
adenine	adenine	NN	B-NP	O
nucleotides	nucleotide	NNS	I-NP	O
,	,	,	O	O
nucleosides	nucleoside	NNS	B-NP	O
,	,	,	O	O
creatine	creatine	NN	B-NP	O
phosphate	phosphate	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ultrastructural	ultrastructural	JJ	B-NP	O
changes	change	NNS	I-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	B-NP	I
Ras	Ras-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
PC	BEGIN-PC	NN	I-NP	B
-	-	HYPH	I-NP	I
PLC	PLC-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
transformed	transform	VBN	I-NP	O
cells	cell	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
insensitive	insensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
platelet	BEGIN-platelet	NN	B-NP	B
-	-	HYPH	B-NP	I
derived	derive	VBN	I-NP	I
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
PDGF	BEGIN-PDGF-INSIDE	NN	B-NP	B
)	)	)	O	O

Although	Although	IN	B-SBAR	O
indomethacin	indomethacin	NN	B-NP	O
is	be	VBZ	B-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
examining	examine	VBG	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
cyclooxygenase	BEGIN-cyclooxygenase	NN	B-NP	B
products	products-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
asthmatic	asthmatic	JJ	B-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Shb	BEGIN-Shb-INSIDE	NN	I-NP	B
-	-	HYPH	B-VP	O
overexpressing	overexpresse	VBG	B-NP	O
cells	cell	NNS	I-NP	O
extended	extend	VBD	B-VP	O
neurites	neurite	NNS	B-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
epidermal	BEGIN-epidermal	JJ	B-NP	B
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I

Tre	Tre	NN	B-NP	O
during	during	IN	B-PP	O
exercise	exercise	NN	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
W	W	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-NP	O
correlated	correlate	VBN	I-NP	O
r	r	NN	I-NP	O
=	=	SYM	B-VP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
with	with	IN	B-PP	O
Vo1max	Vo1max	NN	B-NP	O
and	and	CC	I-NP	O
r	r	NN	I-NP	O
=	=	SYM	B-NP	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
Tre	Tre	NN	B-NP	O
during	during	IN	B-PP	O
exercise	exercise	NN	B-NP	O
in	in	IN	B-PP	O
heat	heat	NN	B-NP	O

Therapeutic	Therapeutic	JJ	B-NP	O
iodine	iodine	NN	I-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
hyperthyroidism	hyperthyroidism	NN	B-NP	O
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
special	special	JJ	I-NP	O
radiobiological	radiobiological	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
follicular	follicular	JJ	I-NP	O
cell	cell	NN	I-NP	O

The	The	DT	B-NP	O
biological	biological	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
was	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
by	by	IN	B-PP	O
determining	determine	VBG	B-VP	O
their	their	PRP$	B-NP	O
capacity	capacity	NN	I-NP	O
to	to	TO	B-PP	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
reconstitute	reconstitute	VB	B-VP	O
RNA	BEGIN-RNA	NN	B-NP	B
polymerase	polymerase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
by	by	IN	B-PP	O
cotransfection	cotransfection	NN	B-NP	O
with	with	IN	B-PP	O
proteins	protein	NNS	B-NP	O
NP	BEGIN-NP-INSIDE	NN	I-NP	B
,	,	,	O	O
PB1	BEGIN-PB1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
PA	BEGIN-PA-INSIDE	NN	B-NP	B
and	and	CC	O	O
a	a	DT	B-NP	O
virion	virion	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
cat	BEGIN-cat-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
into	into	IN	B-PP	O
vaccinia	vaccinia	NN	B-NP	O
virus	virus	NN	I-NP	O
T1	T1	NN	I-NP	O
-	-	HYPH	B-VP	O
infected	infect	VBN	B-NP	O
COS	COS	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
complete	complete	VB	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
wild	BEGIN-wild	JJ	I-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
PB1	BEGIN-PB1-INSIDE-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O

Should	Should	MD	O	O
we	we	PRP	B-NP	O
use	use	VB	B-VP	O
thiazide	thiazide	NN	B-NP	O
diuretics	diuretic	NNS	I-NP	O
in	in	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
insulin	BEGIN-insulin-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O

It	It	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
K	K	NN	I-NP	O
-	-	HYPH	B-NP	O
ABC	ABC	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
nonbiased	nonbiased	JJ	I-NP	O
test	test	NN	I-NP	O
suitable	suitable	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
gifted	gift	VBN	B-NP	O
and	and	CC	I-NP	O
nongifted	nongifted	JJ	I-NP	O
children	child	NNS	I-NP	O
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
race	race	NN	B-NP	O
or	or	CC	I-NP	O
gender	gender	NN	I-NP	O

The	The	DT	B-NP	O
University	University	NNP	I-NP	O
of	of	IN	B-PP	O
North	North	NNP	B-NP	O
Carolina	Carolina	NNP	I-NP	O
caries	cary	NNS	I-NP	O
risk	risk	NN	I-NP	O
assessment	assessment	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O
initially	initially	RB	B-ADVP	O
in	in	IN	B-PP	O
grades	grade	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
from	from	IN	B-PP	O
low	low	JJ	B-NP	O
fluoride	fluoride	NN	I-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
South	South	NNP	B-NP	O
Carolina	Carolina	NNP	I-NP	O
and	and	CC	O	O
Maine	Maine	NNP	B-NP	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
with	with	IN	B-PP	O
TNF	BEGIN-TNF	NN	B-NP	B
-	-	HYPH	B-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
p1	BEGIN-BEGIN-p1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
1	1-INSIDE	NN	I-NP	I
MAPK	MAPK	NN	I-NP	O
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
coding	cod	VBG	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
nifA	BEGIN-nifA-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
translational	translational	JJ	I-NP	O
lacZ	BEGIN-lacZ	NN	I-NP	B
fusion	fusion-INSIDE	NN	I-NP	I
and	and	CC	B-PP	O
by	by	IN	B-PP	O
site	site	NN	B-NP	O
-	-	HYPH	O	O
directed	direct	VBN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
which	which	WDT	B-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
in	in	IN	B-PP	O
frame	frame	NN	B-NP	O
AUG	AUG	NN	I-NP	O
codons	codon	NNS	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O

In	In	IN	B-PP	O
phase	phase	NN	B-NP	O
II	II	CD	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
MDL	MDL	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
1A	1A	NN	B-NP	O
is	be	VBZ	B-VP	O
proving	prove	VBG	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
adjunct	adjunct	NN	I-NP	O
to	to	TO	B-PP	O
conventional	conventional	JJ	B-NP	O
therapy	therapy	NN	I-NP	O

A	A	DT	B-NP	O
derived	derive	VBN	I-NP	O
RA	RA	NN	I-NP	O
-	-	HYPH	I-NP	O
resistant	resistant	JJ	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
NT1	NT1	NN	B-NP	O
/	/	SYM	B-NP	O
D1	D1	NN	I-NP	O
-	-	HYPH	B-NP	O
R1	R1	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
deficient	deficient	JJ	B-ADJP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
co	co	AFX	O	O
-	-	HYPH	O	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
cisplatin	cisplatin	NN	B-NP	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
reveal	reveal	VBP	B-VP	O
that	that	IN	B-SBAR	O
CREM	BEGIN-CREM-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
tissue	tissue	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
factor	factor	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
and	and	CC	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
gonadotropins	BEGIN-gonadotropins-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ovary	ovary	NN	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
CREM	BEGIN-CREM-INSIDE	NN	I-NP	B
transcripts	transcript	NNS	I-NP	O
encode	encode	VBP	B-VP	O
the	the	DT	B-NP	O
repressor	BEGIN-repressor	NN	I-NP	B
protein	protein	NN	I-NP	I
ICER	BEGIN-ICER-INSIDE-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
ICER	BEGIN-ICER-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
cAMP	cAMP	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inhibin	BEGIN-inhibin	NN	I-NP	B
alpha	alpha	SYM	O	I
-	-	HYPH	O	I
subunit	subunit	NN	B-NP	I
gene	gene-INSIDE	NN	I-NP	I

A	A	DT	B-NP	O
small	small	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
ILK	BEGIN-ILK-INSIDE	NN	I-NP	B
inhibitor	inhibitor	NN	I-NP	O
suppresses	suppress	VBZ	B-VP	O
the	the	DT	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
PKB	BEGIN-PKB-INSIDE	NN	B-NP	B
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Ser	Ser	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
Thr	Thr	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
site	site	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PTEN	BEGIN-PTEN-INSIDE	NN	I-NP	B
mutant	mutant	JJ	I-NP	O
cells	cell	NNS	I-NP	O

Menstrual	Menstrual	JJ	B-NP	O
and	and	CC	I-NP	O
lunar	lunar	JJ	I-NP	O
cycles	cycle	NNS	I-NP	O

Phenacetin	Phenacetin	NN	B-NP	O
nephritis	nephritis	NN	I-NP	O

Both	Both	CC	O	O
claR	BEGIN-claR-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
car	BEGIN-car-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
as	as	IN	B-PP	O
monocistronic	monocistronic	JJ	B-NP	O
transcripts	transcript	NNS	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
transcript	transcript	NN	B-NP	O
declined	decline	VBD	B-VP	O
rapidly	rapidly	RB	B-ADVP	O
after	after	IN	B-PP	O
1h	1h	NN	B-NP	O
in	in	IN	B-PP	O
complex	complex	JJ	B-NP	O
media	medium	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
low	low	JJ	B-NP	O
sustained	sustained	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
defined	define	VBN	B-NP	O
GSPG	GSPG	NN	I-NP	O
medium	medium	NN	I-NP	O
until	until	IN	B-PP	O
1h.	1h.	CD	B-NP	O
claR	BEGIN-claR-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
car	BEGIN-car-INSIDE	NN	I-NP	B
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
mutants	mutant	NNS	B-NP	O
disrupted	disrupt	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ccaR	BEGIN-ccaR	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
gene	gene	NN	I-NP	O
that	that	WDT	B-NP	O
controls	control	VBZ	B-VP	O
positively	positively	RB	B-NP	O
clavulanic	clavulanic	JJ	I-NP	O
acid	acid	NN	I-NP	O
and	and	CC	I-NP	O
cephamycin	cephamycin	NN	I-NP	O
biosynthesis	biosynthesis	NN	I-NP	O

Viral	Viral	JJ	B-NP	O
complementary	complementary	JJ	I-NP	O
1	BEGIN-1	NN	I-NP	B
S	S	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
directs	direct	VBZ	B-VP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
N	BEGIN-N	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
and	and	CC	O	O
hybridizes	hybridize	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
N	BEGIN-N	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
DNA	DNA	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
infected	infect	VBN	B-NP	O
cell	cell	NN	I-NP	O
extracts	extract	NNS	I-NP	O

Experiments	Experiment	NNS	B-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
without	without	IN	B-PP	O
polarization	polarization	NN	B-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
cathodic	cathodic	JJ	B-NP	O
and	and	CC	I-NP	O
anodic	anodic	JJ	I-NP	O
polarization	polarization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
adsorbent	adsorbent	NN	I-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
Sp1	BEGIN-BEGIN-Sp1-INSIDE	NN	B-NP	B
binding	binding	NN	I-NP	O
site	site-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
function	function	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
TGF	BEGIN-BEGIN-TGF	NN	I-NP	B
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
responsive	responsive	JJ	I-NP	O
element	element-INSIDE	NN	I-NP	I
for	for	IN	B-PP	O
TGF	BEGIN-TGF	NN	B-NP	B
-	-	HYPH	I-NP	I
beta	beta-INSIDE	NN	I-NP	I
mediated	mediate	VBN	I-NP	O
promoter	promoter	NN	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
per	per	FW	B-ADVP	O
se	se	FW	I-ADVP	O
can	can	MD	B-VP	O
mediate	mediate	VB	I-VP	O
this	this	DT	B-NP	O
response	response	NN	I-NP	O

A	A	DT	B-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
established	establish	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
FP1C	BEGIN-FP1C-INSIDE	NN	B-NP	B
binding	binding	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

In	In	IN	B-PP	O
another	another	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
IRPF	IRPF	NN	B-NP	O
recurred	recur	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ureter	ureter	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
living	live	VBG	I-NP	O
related	related	JJ	I-NP	O
renal	renal	JJ	I-NP	O
graft	graft	NN	I-NP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
transplantation	transplantation	NN	B-NP	O

Similar	Similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
BEGIN-D	BEGIN-B-INSIDEEGIN-D-INSIDE	NN	I-NP	B
,	,	,	O	O
B	BEGIN-B-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
B	BEGIN-B-INSIDE	NN	I-NP	B
'	'	SYM	B-NP	O
and	and	CC	O	O
BEGIN-E	BEGIN-B-INSIDEEGIN-E	NN	B-NP	I
proteins-INSIBEGIN-DE	proteins-INSIBEGIN-B-INSIDEEGIN-D-INSIDEE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
F	BEGIN-F-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
BEGIN-G	BEGIN-B-INSIDEEGIN-G	NN	I-NP	I
proteins-INSIBEGIN-DE	proteins-INSIBEGIN-B-INSIDEEGIN-D-INSIDEE	NN	I-NP	I
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
possess	possess	VB	I-VP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
known	known	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
binding	binding	NN	I-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
other	other	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
RNA	RNA	NN	B-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
occur	occur	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
snRNP	snRNP	NN	I-NP	O
core	core	NN	I-NP	O

Ultrasound	Ultrasound	NN	B-NP	O
-	-	HYPH	O	O
guided	guide	VBN	B-NP	O
fine	fine	JJ	I-NP	O
-	-	HYPH	I-NP	O
needle	needle	NN	I-NP	O
aspiration	aspiration	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
(	(	(	O	O
US	US	NN	B-NP	O
-	-	HYPH	B-NP	O
FNAB	FNAB	NN	I-NP	O
)	)	)	O	O
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
-	-	HYPH	O	O
looking	look	VBG	B-VP	O
squamous	squamous	JJ	B-NP	O
cells	cell	NNS	I-NP	O

HC	BEGIN-HC	NN	B-NP	B
-	-	HYPH	I-NP	I
toxin	toxin-INSIDE	NN	I-NP	I
exerts	exert	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
cytostatic	cytostatic	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
plant	plant	NN	B-NP	O
and	and	CC	I-NP	O
animal	animal	NN	I-NP	O
cells	cell	NNS	I-NP	O
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
histone	BEGIN-histone	NN	B-NP	B
deacetylase	deacetylase-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
EGF	BEGIN-EGF	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
signaling	signaling	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
PKB	PKB-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
Akt	BEGIN-Akt-INSIDE	NN	I-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
mitogen	BEGIN-mitogen	NN	I-NP	B
-	-	HYPH	B-VP	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase	NN	I-NP	I
c	c	NN	I-NP	I
-	-	HYPH	B-NP	I
Jun	Jun	NN	I-NP	I
N	N	NN	I-NP	I
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
extracellular	BEGIN-extracellular	JJ	B-NP	B
signal	signal	NN	I-NP	I
-	-	HYPH	B-NP	I
regulated	regulate	VBN	I-NP	I
kinase	kinase	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
function	function	NN	B-NP	O
downstream	downstream	RB	B-ADVP	O
of	of	IN	B-PP	O
phosphatidylinositol	BEGIN-phosphatidylinositol	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
PI	BEGIN-PI	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
)	)	)	O	O

Blockade	Blockade	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
surface	surface	NN	I-NP	O
-	-	HYPH	B-VP	O
linked	link	VBN	B-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
chain	chain	NN	I-NP	O
antibody	antibody	NN	I-NP	O
to	to	TO	B-PP	O
CTLA	BEGIN-CTLA	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
)	)	)	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
homology	homology	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Rel	Rel-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
controlling	control	VBG	B-VP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	I-NP	I
1R	1R	NN	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O

Site	Site	NN	B-NP	O
-	-	HYPH	B-PP	O
directed	direct	VBN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
sites	site	NNS	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
IRE	BEGIN-IRE-INSIDE	NN	I-NP	B
alter	alter	VBP	B-VP	O
negative	negative	JJ	B-NP	O
control	control	NN	I-NP	O
and	and	CC	I-NP	O
IRE	BEGIN-BEGIN-IRE-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
BP	BP-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
reflecting	reflect	VBG	B-VP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
footprint	footprint	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IRE	BEGIN-BEGIN-IRE-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
BP	BP-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
IRE	BEGIN-IRE-INSIDE	NN	I-NP	B

However	However	RB	B-ADVP	O
,	,	,	O	O
LXRalpha	BEGIN-LXRalpha-INSIDE	NN	B-NP	B
inhibited	inhibit	VBD	B-VP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
PPARalpha	BEGIN-PPARalpha-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
RXRalpha	BEGIN-RXRalpha-INSIDE	NN	I-NP	B
heterodimers	heterodimer	NNS	I-NP	O
to	to	TO	B-PP	O
PPREs	PPRE	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
coexpression	coexpression	NN	B-NP	O
of	of	IN	B-PP	O
LXRalpha	BEGIN-LXRalpha-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
cells	cell	NNS	I-NP	O
antagonized	antagonize	VBD	B-VP	O
peroxisome	peroxisome	NN	B-NP	O
proliferator	proliferator	NN	I-NP	O
signaling	signaling	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
PPARalpha	BEGIN-PPARalpha-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
RXRalpha	BEGIN-RXRalpha-INSIDE	NN	I-NP	B
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

In	In	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
are	be	VBP	B-VP	O
frequently	frequently	RB	I-VP	O
neglected	neglect	VBN	I-VP	O
although	although	IN	B-SBAR	O
they	they	PRP	B-NP	O
occur	occur	VBP	B-VP	O
more	more	RBR	B-ADVP	O
often	often	RB	I-ADVP	O
than	than	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
generally	generally	RB	I-VP	O
assumed	assume	VBN	I-VP	O

Complementary	Complementary	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
libraries	library	NNS	I-NP	O
from	from	IN	B-PP	O
liver	liver	NN	B-NP	O
and	and	CC	I-NP	O
ovary	ovary	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
immature	immature	JJ	I-NP	O
female	female	JJ	I-NP	O
channel	channel	NN	I-NP	O
catfish	catfish	NN	I-NP	O
were	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
homologous	BEGIN-homologous	JJ	I-NP	B
ERalpha	ERalpha	NN	I-NP	I
cDNA	cDNA-INSIDE	NN	I-NP	I
probe	probe	NN	I-NP	O

Examination	Examination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Coomassie	Coomassie	NNP	I-NP	O
-	-	HYPH	I-NP	O
stained	stain	VBN	I-NP	O
gels	gel	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
capsid	capsid	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
particles	particle	NNS	I-NP	O
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N1	BEGIN-N1	NN	I-NP	B
-	-	HYPH	B-NP	I
VP1	VP1-INSIDE	NN	I-NP	I
protein	protein	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
contain	contain	VB	I-VP	O
any	any	DT	B-NP	O
host	host	NN	I-NP	O
-	-	HYPH	O	O
derived	derive	VBN	B-VP	O
histones	BEGIN-histones-INSIDE	NN	B-NP	B

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
one	one	CD	B-NP	O
nudF	BEGIN-BEGIN-nudF-INSIDE	NN	I-NP	B
suppressor	suppressor-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
suppresses	suppress	VBZ	B-VP	O
hs	h	NNS	B-NP	O
-	-	HYPH	B-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
nudA	BEGIN-nudA-INSIDE	NN	B-NP	B
,	,	,	O	O
nudC	BEGIN-nudC-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
nudG	BEGIN-nudG-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
deletions	deletion	NNS	I-NP	O
in	in	IN	B-PP	O
nudA	BEGIN-nudA-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
nudF	BEGIN-nudF-INSIDE	NN	I-NP	B

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
rearrangement	rearrangement	NN	I-NP	O
by	by	IN	B-PP	O
E1A	BEGIN-E1A	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
therapy	therapy	NN	I-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
clinically	clinically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
advanced	advance	VBN	B-NP	O
malignant	malignant	JJ	I-NP	O
disease	disease	NN	I-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
Bry1	BEGIN-Bry1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
Skn1	BEGIN-Skn1-INSIDE	NN	I-NP	B
can	can	MD	B-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
MCB	MCB	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
SCB	SCB	NN	I-NP	O
-	-	HYPH	I-NP	O
driven	drive	VBN	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
budding	bud	VBG	B-VP	O
yeast	yeast	NN	B-NP	O
,	,	,	O	O
perhaps	perhaps	RB	B-ADVP	O
including	include	VBG	B-PP	O
genes	gene	NNS	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
wall	wall	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
,	,	,	O	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
component	component	NN	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathway	pathway	NN	I-NP	O
which	which	WDT	B-NP	O
activates	activate	VBZ	B-VP	O
Bry1	BEGIN-Bry1-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
Skn1	BEGIN-Skn1-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
unidentified	unidentified	JJ	I-NP	O
signal	signal	NN	I-NP	O

Buspirone	Buspirone	NN	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
Type	Type	NN	B-NP	O
A	A	NN	I-NP	O
behavior	behavior	NN	I-NP	O
,	,	,	O	O
hostility	hostility	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
perceived	perceive	VBN	B-VP	O
stress	stress	NN	B-NP	O
in	in	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
patients	patient	NNS	I-NP	O

When	When	WRB	B-ADVP	O
furA	BEGIN-furA-INSIDE	NN	B-NP	B
alone	alone	RB	B-ADVP	O
was	be	VBD	B-VP	O
introduced	introduce	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
Delta	Delta	NN	I-NP	O
(	(	(	O	O
furA	BEGIN-furA-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
katG	BEGIN-katG-INSIDE	NN	I-NP	B
)	)	)	O	O
mutant	mutant	NN	B-NP	O
,	,	,	O	O
survival	survival	NN	B-NP	O
in	in	IN	B-PP	O
mouse	mouse	NN	B-NP	O
lungs	lung	NNS	I-NP	O
was	be	VBD	B-VP	O
moderately	moderately	RB	I-VP	O
increased	increase	VBN	I-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
FurA	BEGIN-FurA-INSIDE	NN	B-NP	B
could	could	MD	B-VP	O
regulate	regulate	VB	I-VP	O
genes	gene	NNS	B-NP	O
,	,	,	O	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
katG	BEGIN-katG-INSIDE	NN	B-NP	B
,	,	,	O	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
pathogenesis	pathogenesis	NN	B-NP	O

The	The	DT	B-NP	O
resulting	result	VBG	I-NP	O
threshold	threshold	NN	I-NP	O
elevation	elevation	NN	I-NP	O
curves	curve	NNS	I-NP	O
fell	fall	VBD	B-VP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
discrete	discrete	JJ	B-NP	O
spatial	spatial	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
central	central	JJ	I-NP	O
vision	vision	NN	I-NP	O

Through	Through	IN	B-PP	O
interactions	interaction	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
pre	pre	AFX	I-NP	O
-	-	HYPH	I-NP	O
mRNA	mRNA	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
CTD	CTD	NN	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Polymerase	BEGIN-Polymerase	NN	I-NP	B
II	II-INSIDE	NN	I-NP	I
,	,	,	O	O
SR	BEGIN-SR	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
regulate	regulate	VB	I-VP	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O

The	The	DT	B-NP	O
screen	screen	NN	I-NP	O
identifies	identify	VBZ	B-VP	O
mutants	mutant	NNS	B-NP	O
whose	whose	WP$	B-NP	O
growth	growth	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
gene	gene	NN	I-NP	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
-	-	HYPH	B-NP	O
DNA	DNA	NN	I-NP	O
complexes	complex	NNS	I-NP	O
formed	form	VBN	B-VP	O
with	with	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
I1C	I1C	NN	B-NP	O
-	-	HYPH	B-ADVP	O
treated	treat	VBN	B-NP	O
and	and	CC	I-NP	O
-	-	HYPH	I-NP	O
untreated	untreated	JJ	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
supershift	supershift	NN	B-NP	O
assays	assay	NNS	I-NP	O
using	use	VBG	B-VP	O
Sp1	BEGIN-Sp1	NN	B-NP	B
antibodies	antibodies-INSIDE	NN	I-NP	I
,	,	,	O	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Sp1	BEGIN-Sp1	NN	I-NP	B
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
site	site-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CDK1	BEGIN-CDK1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
forms	form	VBZ	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
I1C	I1C	NN	I-NP	O
-	-	HYPH	O	O
responsive	responsive	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
complex	complex	NN	I-NP	O
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
Sp1	BEGIN-Sp1	NN	I-NP	B
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
intestinal	intestinal	JJ	B-NP	O
absorption	absorption	NN	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
hydroxy	hydroxy	NN	I-NP	O
-	-	HYPH	I-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
may	may	MD	B-VP	O
differ	differ	VB	I-VP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
absorption	absorption	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
hydroxy	hydroxy	NN	I-NP	O
-	-	HYPH	I-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
possibly	possibly	RB	B-VP	O
being	be	VBG	I-VP	O
less	less	RBR	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
bile	bile	NN	B-NP	O
acids	acid	NNS	I-NP	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
study	study	NN	I-NP	O
in	in	IN	B-PP	O
Singapore	Singapore	NNP	B-NP	O
,	,	,	O	O
Chinese	Chinese	NNP	B-NP	O
,	,	,	O	O
Malay	Malay	NNP	B-NP	O
and	and	CC	O	O
Indian	Indian	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
daily	daily	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
streptomycin	streptomycin	NN	B-NP	O
,	,	,	O	O
isoniazid	isoniazid	NN	B-NP	O
,	,	,	O	O
rifampicin	rifampicin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pyrazinamide	pyrazinamide	NN	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
daily	daily	JJ	B-NP	O
isoniazid	isoniazid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
rifampicin	rifampicin	NN	B-NP	O
either	either	CC	B-PP	O
with	with	IN	I-PP	O
pyrazinamide	pyrazinamide	NN	B-NP	O
(	(	(	O	O
SHRZ	SHRZ	NN	B-NP	O
/	/	SYM	B-NP	O
HRZ	HRZ	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
without	without	IN	B-PP	O
it	it	PRP	B-NP	O
(	(	(	O	O
SHRZ	SHRZ	NN	B-NP	O
/	/	SYM	O	O
HR	HR	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
allocated	allocate	VBN	B-VP	O
at	at	IN	B-PP	O
random	random	NN	B-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	I-NP	I
EBP	EBP	NN	I-NP	I
beta	beta-INSIDE	NN	I-NP	I
stimulated	stimulate	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
primarily	primarily	RB	B-ADVP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
cAMP	cAMP	NN	I-NP	O
-	-	HYPH	O	O
responsive	responsive	JJ	B-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
CRE	CRE	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
maps	map	VBZ	B-VP	O
between	between	IN	B-PP	O
positions	position	NNS	B-NP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
more	more	JJR	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O

Helenalin	Helenalin	NN	B-NP	O
triggers	trigger	VBZ	B-VP	O
a	a	DT	B-NP	O
CD1	BEGIN-CD1	NN	I-NP	B
death	death	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
independent	independent	JJ	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
Bcl	BEGIN-Bcl	NN	B-NP	B
-	-	HYPH	O	I
x	x	SYM	B-NP	I
(	(	(	O	I
L	L	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
or	or	CC	I-NP	O
Bcl	BEGIN-Bcl	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
observed	observe	VBN	I-NP	O
alterations	alteration	NNS	I-NP	O
in	in	IN	B-PP	O
lung	lung	NN	B-NP	O
functions	function	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
subjects	subject	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
individuals	individual	NNS	B-NP	O
performing	perform	VBG	B-VP	O
heavy	heavy	JJ	B-NP	O
continuous	continuous	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
are	be	VBP	B-VP	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
lower	low	JJR	B-NP	O
O1	O1	NN	I-NP	O
levels	level	NNS	I-NP	O

Shields	Shield	NNS	B-NP	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pacemakers	pacemaker	NNS	B-NP	O

A	A	DT	B-NP	O
nationwide	nationwide	JJ	I-NP	O
record	record	NN	I-NP	O
linkage	linkage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Finnish	Finnish	NNP	I-NP	O
Twin	Twin	NNP	I-NP	O
Cohort	Cohort	NNP	I-NP	O
Study	Study	NNP	I-NP	O
(	(	(	O	O
FTCS	FTCS	NNP	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Discharge	Discharge	NNP	I-NP	O
Registry	Registry	NNP	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Registry	Registry	NN	I-NP	O
of	of	IN	B-PP	O
Rights	Right	NNS	B-NP	O
for	for	IN	B-PP	O
Free	Free	JJ	B-NP	O
medication	medication	NN	I-NP	O
is	be	VBZ	B-VP	O
presented	present	VBN	I-VP	O

Results	Result	NNS	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
S.	S.	NNP	I-NP	O
europaea	europaea	NN	I-NP	O
and	and	CC	I-NP	O
A.	A.	NN	I-NP	O
prostrata	prostrata	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
seeds	seed	NNS	B-NP	O
that	that	WDT	B-NP	O
germinated	germinate	VBN	B-VP	O
decreased	decrease	VBD	B-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
growing	grow	VBG	I-NP	O
season	season	NN	I-NP	O

A	A	DT	B-NP	O
personal	personal	JJ	I-NP	O
view	view	NN	I-NP	O
of	of	IN	B-PP	O
future	future	JJ	B-NP	O
trends	trend	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
field	field	NN	I-NP	O
of	of	IN	B-PP	O
immunoassay	immunoassay	NN	B-NP	O
concludes	conclude	VBZ	B-VP	O
this	this	DT	B-NP	O
review	review	NN	I-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
admit	admit	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
ribosome	ribosome	NN	I-NP	O
scanning	scanning	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MP	BEGIN-MP	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
from	from	IN	B-PP	O
I	I	PRP	B-NP	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
sgRNA	sgRNA	NN	B-NP	O
operates	operate	VBZ	B-VP	O
concurrently	concurrently	RB	B-ADVP	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
Fluosol	Fluosol	NN	B-NP	O
significantly	significantly	RB	B-VP	O
attenuates	attenuate	VBZ	I-VP	O
neutrophil	neutrophil	NN	B-NP	O
adherence	adherence	NN	I-NP	O
,	,	,	O	O
cytotoxicity	cytotoxicity	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
enzyme	enzyme	NN	B-NP	O
release	release	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
microvascular	microvascular	JJ	B-NP	O
injury	injury	NN	I-NP	O

1	1	CD	B-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
positive	positive	JJ	B-ADJP	O
at	at	IN	B-PP	O
histology	histology	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
corpus	corpus	NN	I-NP	O
mucosa	mucosa	NN	I-NP	O
;	;	:	O	O
all	all	DT	B-NP	O
but	but	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
circulating	circulate	VBG	I-VP	O
IgG	BEGIN-IgG-INSIDE	NN	B-NP	B
to	to	TO	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
(	(	(	O	O
Group	Group	NN	B-NP	O
C	C	NN	I-NP	O
)	)	)	O	O

Concerning	Concern	VBG	B-VP	O
the	the	DT	B-NP	O
practical	practical	JJ	I-NP	O
approach	approach	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
setting	setting	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
pointed	point	VBN	I-VP	O
out	out	RP	B-PRT	O
that	that	IN	B-SBAR	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
diseases	disease	NNS	I-NP	O
a	a	DT	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
C	C	NN	I-NP	O
infection	infection	NN	I-NP	O
has	have	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
and	and	CC	O	O
testing	testing	NN	B-NP	O
for	for	IN	B-PP	O
hepatitis	BEGIN-hepatitis	NN	B-NP	B
C	C	NN	I-NP	I
antibodies	antibodies-INSIDE	NN	I-NP	I
and	and	CC	O	O
,	,	,	O	O
if	if	IN	B-SBAR	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
hepatitis	BEGIN-hepatitis	NN	B-NP	B
C	C	NN	I-NP	I
-	-	HYPH	B-NP	I
RNA	RNA-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
indicated	indicate	VBN	I-VP	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
local	local	JJ	I-NP	O
direct	direct	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
danazol	danazol	NN	B-NP	O
upon	upon	IN	B-PP	O
endometriosis	endometriosis	NN	B-NP	O
,	,	,	O	O
intravaginal	intravaginal	JJ	B-NP	O
and	and	CC	I-NP	O
intrauterine	intrauterine	JJ	I-NP	O
application	application	NN	I-NP	O
were	be	VBD	B-VP	O
tried	try	VBN	I-VP	O

Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
detected	detect	VBD	B-VP	O
SMBP	BEGIN-SMBP-INSIDE	NN	B-NP	B
as	as	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
protein	protein	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
further	further	RBR	B-ADJP	O
cleaved	cleave	VBN	I-ADJP	O
into	into	IN	B-PP	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
polypeptide	polypeptide	NN	I-NP	O

1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
)	)	)	O	O
surrounding	surround	VBG	B-VP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
initiation	initiation	NN	I-NP	O

A	A	DT	B-NP	O
backward	backward	JJ	I-NP	O
look	look	NN	I-NP	O
at	at	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infections	infection	NNS	I-NP	O

All	All	PDT	B-NP	O
the	the	DT	I-NP	O
cognate	cognate	JJ	I-NP	O
gene	gene	NN	I-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
,	,	,	O	O
using	use	VBG	B-VP	O
either	either	CC	O	O
PCR	PCR	NN	B-NP	O
products	product	NNS	I-NP	O
amplified	amplify	VBN	B-VP	O
from	from	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
gap	gap	NN	B-NP	O
-	-	HYPH	O	O
repair	repair	NN	B-NP	O

On	On	IN	B-PP	O
Western	Western	JJ	B-NP	O
blots	blot	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
antibodies	antibody	NNS	I-NP	O
recognized	recognize	VBD	B-VP	O
the	the	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	O
protein	protein	NN	I-NP	O
migrating	migrate	VBG	B-VP	O
slightly	slightly	RB	B-ADJP	O
slower	slow	JJR	I-ADJP	O
on	on	IN	B-PP	O
SDS	SDS	NN	B-NP	O
/	/	SYM	B-NP	O
PAGE	PAGE	NN	I-NP	O
than	than	IN	B-PP	O
chicken	BEGIN-chicken	JJ	B-NP	B
axonin	axonin	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

BCR	BEGIN-BCR-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
ABL	BEGIN-ABL-INSIDE	NN	I-NP	B
elicits	elicit	VBZ	B-VP	O
transformation	transformation	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
fibroblast	fibroblast	NN	B-NP	O
and	and	CC	O	O
hematopoietic	hematopoietic	JJ	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
blocks	block	VBZ	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
following	follow	VBG	B-PP	O
cytokine	cytokine	NN	B-NP	O
deprivation	deprivation	NN	I-NP	O
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
factor	factor	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
transcriptional	BEGIN-transcriptional	JJ	I-NP	B
transactivator	transactivator-INSIDE	NN	I-NP	I
(	(	(	O	O
Tas	BEGIN-Tas-INSIDE	NN	B-NP	B
)	)	)	O	O
of	of	IN	B-PP	O
simian	simian	JJ	B-NP	O
foamy	foamy	JJ	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
strongly	strongly	RB	B-VP	O
augments	augment	VBZ	I-VP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
long	long	JJ	I-NP	O
terminal	terminal	JJ	I-NP	O
repeat	repeat	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
newly	newly	RB	I-NP	O
discovered	discover	VBN	I-NP	O
internal	internal	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
env	BEGIN-env	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
nt	nt	NN	B-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
more	more	JJR	I-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
regions	region	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
genome	genome	NN	I-NP	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
site	site	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
integration	integration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ITR	ITR	NN	I-NP	O
-	-	HYPH	B-VP	O
flanked	flank	VBN	B-NP	O
DNA	DNA	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ITR	BEGIN-ITR	NN	I-NP	B
-	-	HYPH	B-NP	I
aavs1	aavs1	NN	I-NP	I
junction	junction-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
transduced	transduce	VBN	B-NP	O
human	human	JJ	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
animals	animal	NNS	B-NP	O
carrying	carry	VBG	B-VP	O
a	a	DT	B-NP	O
snf	BEGIN-snf-INSIDE	NN	I-NP	B
mutation	mutation	NN	I-NP	O
that	that	WDT	B-NP	O
converts	convert	VBZ	B-VP	O
SNF	BEGIN-SNF-INSIDE	NN	B-NP	B
from	from	IN	B-PP	O
a	a	DT	B-NP	O
bifunctional	bifunctional	JJ	I-NP	O
protein	protein	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
U1	BEGIN-U1	NN	I-NP	B
snRNP	snRNP	NN	I-NP	I
-	-	HYPH	B-NP	I
specific	specific	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
viable	viable	JJ	B-ADJP	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
interaction	interaction	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
E1F1	BEGIN-E1F1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
domain	domain	NN	I-NP	O
also	also	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
E1F1	BEGIN-E1F1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
E1F1	BEGIN-E1F1-INSIDE	NN	I-NP	B
but	but	CC	O	O
absent	absent	JJ	B-ADJP	O
in	in	IN	B-PP	O
E1F1	BEGIN-E1F1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
E1F1	BEGIN-E1F1-INSIDE	NN	I-NP	B
,	,	,	O	O
were	be	VBD	B-VP	O
essential	essential	JJ	B-ADJP	O

To	To	TO	B-VP	O
gain	gain	VB	I-VP	O
additional	additional	JJ	B-NP	O
insights	insight	NNS	I-NP	O
into	into	IN	B-PP	O
this	this	DT	B-NP	O
novel	novel	JJ	I-NP	O
apoptotic	apoptotic	JJ	I-NP	O
checkpoint	checkpoint	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
now	now	RB	I-VP	O
characterized	characterize	VBN	I-VP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
survivin	survivin	NN	I-NP	I
locus	locus-INSIDE	NN	I-NP	I

Since	Since	IN	B-SBAR	O
RIP1	BEGIN-RIP1-INSIDE	NN	B-NP	B
generally	generally	RB	B-ADVP	O
down	down	RB	I-ADVP	O
-	-	HYPH	B-NP	O
regulates	regulate	VBZ	B-VP	O
receptor	receptor	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
specifically	specifically	RB	B-ADVP	O
down	down	RB	I-ADVP	O
-	-	HYPH	B-NP	O
regulates	regulate	VBZ	B-VP	O
coactivation	coactivation	NN	B-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
SRC	BEGIN-SRC	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
we	we	PRP	B-NP	O
propose	propose	VBP	B-VP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
RIP1	BEGIN-RIP1-INSIDE	NN	B-NP	B
indirectly	indirectly	RB	B-ADVP	O
regulates	regulate	VBZ	B-VP	O
nuclear	BEGIN-nuclear	JJ	B-NP	B
receptor	receptor	NN	I-NP	I
AF	AF	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
competition	competition	NN	B-NP	O
for	for	IN	B-PP	O
coactivators	coactivator	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
SRC	BEGIN-SRC	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

We	We	PRP	B-NP	O
constructed	construct	VBD	B-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
,	,	,	I-NP	O
doubly	doubly	RB	I-NP	O
transfected	transfecte	VBN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
(	(	(	O	O
TIS	TIS	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
carrying	carry	VBG	B-VP	O
a	a	DT	B-NP	O
chromosomally	chromosomally	RB	I-NP	O
integrated	integrate	VBN	I-NP	O
ptetO1	BEGIN-ptetO1	NN	I-NP	B
-	-	HYPH	I-NP	I
CMV	CMV	NN	I-NP	I
-	-	HYPH	I-NP	I
L	L-INSIDE	NN	I-NP	I
reporter	reporter	NN	I-NP	O
construct	construct	NN	I-NP	O
and	and	CC	O	O
expressing	express	VBG	B-VP	O
the	the	DT	B-NP	O
TetR	BEGIN-TetR-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
KRAB	BEGIN-KRAB-INSIDE	NN	I-NP	B
protein	protein	NN	I-NP	O

Value	Value	NN	B-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
scintigraphy	scintigraphy	NN	I-NP	O
with	with	IN	B-PP	O
Tc1MDP	Tc1MDP	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
mobilization	mobilization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
prosthesis	prosthesis	NN	I-NP	O

Coimmunoprecipitation	Coimmunoprecipitation	NN	B-NP	O
analysis	analysis	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
residues	residue	NNS	I-NP	O
likely	likely	RB	B-ADVP	O
contribute	contribute	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
multimerization	multimerization	JJ	I-NP	O
function	function	NN	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
homomeric	homomeric	JJ	B-NP	O
complex	complex	NN	I-NP	O
formation	formation	NN	I-NP	O
or	or	CC	O	O
heteromeric	heteromeric	JJ	B-NP	O
complex	complex	NN	I-NP	O
formation	formation	NN	I-NP	O
with	with	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
that	that	IN	B-SBAR	O
no	no	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-BEGIN-p1-INSIDE	NN	B-NP	B
delta	delta-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
itself	itself	PRP	B-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O

The	The	DT	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
crt1	BEGIN-crt1	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
cdc	BEGIN-cdc	NN	I-NP	B
allele	allele-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
POL1	BEGIN-POL1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
CDC1	BEGIN-CDC1-INSIDE	NN	I-NP	B
,	,	,	O	O
suggests	suggest	VBZ	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
time	time	NN	I-NP	O
that	that	IN	B-ADVP	O
directly	directly	RB	B-VP	O
blocking	block	VBG	I-VP	O
DNA	DNA	NN	B-NP	O
replication	replication	NN	I-NP	O
can	can	MD	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
signal	signal	NN	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
damage	damage	NN	I-NP	O
response.	response.	NN	I-NP	O
crt1	BEGIN-crt1	NN	I-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
show	show	VBP	B-VP	O
a	a	DT	B-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
basal	basal	JJ	B-NP	O
level	level	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
RNR1	BEGIN-RNR1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
lacZ	BEGIN-lacZ-INSIDE	NN	I-NP	B
reporter	reporter	NN	I-NP	O
constructs	construct	NNS	I-NP	O

Denaturing	Denature	VBG	B-VP	O
gradient	gradient	NN	B-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
(	(	(	O	O
DGGE	DGGE	NN	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
sequence	sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
PGCL1	BEGIN-PGCL1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
member	member	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
female	female	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
gland	gland	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
submaxillary	submaxillary	JJ	I-NP	O
and	and	CC	I-NP	O
lachrymal	lachrymal	JJ	I-NP	O
glands	gland	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
sexes	sex	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
counterpart	counterpart	NN	I-NP	O
in	in	IN	B-PP	O
male	male	JJ	B-NP	O
liver	liver	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
coagulate	coagulate	NN	I-NP	O
glands	gland	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
PGCL1	BEGIN-PGCL1-INSIDE	NN	B-NP	B

Five	Five	CD	B-NP	O
sequence	sequence	NN	I-NP	O
variants	variant	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O

If	If	IN	B-SBAR	O
failure	failure	NN	B-NP	O
to	to	TO	B-VP	O
solve	solve	VB	I-VP	O
invisible	invisible	JJ	B-NP	O
displacements	displacement	NNS	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
memory	memory	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
the	the	DT	B-NP	O
primates	primate	NNS	I-NP	O
should	should	MD	B-VP	O
perform	perform	VB	I-VP	O
at	at	IN	B-PP	O
chance	chance	NN	B-NP	O
level	level	NN	I-NP	O
on	on	IN	B-PP	O
all	all	DT	B-NP	O
1	1	CD	I-NP	O
problems	problem	NNS	I-NP	O

Mouse	BEGIN-Mouse	NN	B-NP	B
GRK1	GRK1	NN	I-NP	I
-	-	HYPH	B-NP	I
C	C-INSIDE	NN	I-NP	I
displays	display	VBZ	B-VP	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
motifs	motif	NNS	I-NP	O

The	The	DT	B-NP	O
cumulative	cumulative	JJ	I-NP	O
length	length	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RGSV	RGSV	NN	I-NP	O
genome	genome	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
RNAs	RNA	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
nt	nt	NN	I-NP	O

CTDK1	BEGIN-CTDK1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
CTDK1	BEGIN-CTDK1-INSIDE	NN	I-NP	B
also	also	RB	B-ADVP	O
differ	differ	VBP	B-VP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
protein	protein	NN	I-NP	O
substrate	substrate	NN	I-NP	O
specificity	specificity	NN	I-NP	O

ATF	ATF	NN	B-NP	O
is	be	VBZ	B-VP	O
formulated	formulate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
prothrombin	BEGIN-proBEGIN-thrombin-INSIDE-INSIDE	NN	I-NP	B
time	time	NN	I-NP	O
(	(	(	O	O
PT	PT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
fibrinogen	BEGIN-fibrinogen-INSIDE	NN	B-NP	B
transformation	transformation	NN	I-NP	O
rate	rate	NN	I-NP	O
(	(	(	O	O
FTR	FTR	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
a	a	DT	B-NP	O
representation	representation	NN	I-NP	O
of	of	IN	B-PP	O
thrombin	BEGIN-thrombin-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
consideration	consideration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fibrinogen	BEGIN-fibrinogen-INSIDE	NN	I-NP	B
(	(	(	O	O
FBG	BEGIN-FBG-INSIDE	NN	B-NP	B
)	)	)	O	O
content	content	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
plasma	plasma	NN	I-NP	O

Protease	Protease	NN	B-NP	O
digestion	digestion	NN	I-NP	O
and	and	CC	I-NP	O
alkaline	alkaline	NN	I-NP	O
extraction	extraction	NN	I-NP	O
of	of	IN	B-PP	O
microsomes	microsome	NNS	B-NP	O
containing	contain	VBG	B-VP	O
labeled	label	VBN	B-VP	O
mutant	mutant	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
further	further	RB	B-ADVP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
segment	segment	NN	B-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
stable	stable	JJ	B-NP	O
membrane	membrane	NN	I-NP	O
anchoring	anchoring	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glycoproteins	glycoprotein	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
segment	segment	NN	I-NP	O
may	may	MD	B-VP	O
specify	specify	VB	I-VP	O
the	the	DT	B-NP	O
transmembrane	transmembrane	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gB	BEGIN-gB	NN	I-NP	B
glycoprotein	glycoprotein-INSIDE	NN	I-NP	I

Peripheral	Peripheral	JJ	B-NP	O
visual	visual	JJ	I-NP	O
acuity	acuity	NN	I-NP	O
with	with	IN	B-PP	O
monovision	monovision	NN	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
contact	contact	NN	I-NP	O
lens	lens	NN	I-NP	O
corrections	correction	NNS	I-NP	O
for	for	IN	B-PP	O
presbyopia	presbyopia	NN	B-NP	O

ORF1	ORF1	NN	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
encode	encode	VB	I-VP	O
the	the	DT	B-NP	O
homologue	homologue	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
well	well	RB	I-NP	O
-	-	HYPH	I-NP	O
conserved	conserve	VBN	I-NP	O
proteasomal	BEGIN-proteasomal	JJ	I-NP	B
1S	1S	NN	I-NP	I
regulatory	regulatory	JJ	I-NP	I
subunit	subunit-INSIDE	NN	I-NP	I

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Protein	Protein	NN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
UAS1MLS1	BEGIN-UAS1MLS1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
extracts	extract	NNS	B-NP	O
from	from	IN	B-PP	O
derepressed	derepresse	VBN	B-VP	O
but	but	CC	B-PP	O
not	not	RB	B-NP	O
from	from	IN	B-PP	O
repressed	repress	VBN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
competed	compete	VBN	I-VP	O
for	for	IN	B-PP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
excess	excess	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
unlabelled	unlabelled	JJ	I-NP	O
CSRE	CSRE	NN	I-NP	O
(	(	(	O	O
ICL1	BEGIN-ICL1-INSIDE	NN	B-NP	B
)	)	)	O	O
sequence	sequence	NN	B-NP	O

This	This	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
competition	competition	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
EMC	EMC	NN	I-NP	O
virus	virus	NN	I-NP	O
IRES	IRES	NN	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
pEP	BEGIN-pEP	NN	B-NP	B
-	-	HYPH	B-NP	I
1A	1A	NN	I-NP	I
transcripts	transcripts-INSIDE	NN	I-NP	I
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
proteolytically	proteolytically	RB	B-NP	O
active	active	JJ	I-NP	O
1Apro	BEGIN-1Apro-INSIDE	NN	I-NP	B

These	These	DT	B-NP	O
properties	property	NNS	I-NP	O
prompted	prompt	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
Ets	BEGIN-Ets	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
human	human	JJ	I-NP	O
astroglial	astroglial	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
of	of	IN	B-PP	O
WHO	WHO	NN	B-NP	O
grades	grade	NNS	I-NP	O
I	I	CD	I-NP	O
-	-	HYPH	I-NP	O
IV	IV	CD	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
correlate	correlate	VB	I-VP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
VEGF	BEGIN-VEGF-INSIDE	NN	B-NP	B
,	,	,	O	O
Flt	BEGIN-Flt	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
KDR	BEGIN-KDR-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
CydDC	BEGIN-CydDC	NN	I-NP	B
system	system-INSIDE	NN	I-NP	I
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
prokaryotic	prokaryotic	JJ	I-NP	O
example	example	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
heterodimeric	BEGIN-heterodimeric	JJ	I-NP	B
ABC	ABC	NNP	I-NP	I
transport	transport	NN	I-NP	I
system	system-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
each	each	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
contains	contain	VBZ	B-VP	O
both	both	CC	O	O
hydrophobic	hydrophobic	JJ	B-NP	O
and	and	CC	I-NP	O
ATP	ATP	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
domains	domain	NNS	B-NP	O

Ionic	Ionic	JJ	B-NP	O
composition	composition	NN	I-NP	O
(	(	(	O	O
Na+	Na+	NN	B-NP	O
,	,	,	O	O
K+	K+	NN	B-NP	O
,	,	,	O	O
Ca+1	Ca+1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Mg1+	Mg1+	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
cerebrospinal	cerebrospinal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
and	and	CC	I-NP	O
feeding	feeding	NN	I-NP	O
behavior	behavior	NN	I-NP	O
in	in	IN	B-PP	O
sheep	sheep	NN	B-NP	O

Recently	Recently	RB	B-ADVP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
performed	perform	VBN	I-VP	O
a	a	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
neuronal	neuronal	JJ	I-NP	O
populations	population	NNS	I-NP	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
mutation	mutation	NN	I-NP	O
which	which	WDT	B-NP	O
shed	shed	VBD	B-VP	O
new	new	JJ	B-NP	O
light	light	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Krox	BEGIN-Krox	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
segmentation	segmentation	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
consequences	consequence	NNS	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
inactivation	inactivation	NN	I-NP	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
DNA	BEGIN-DNA	NN	I-NP	B
polymerases	polymerases-INSIDE-INSIDE	NN	I-NP	I
including	include	VBG	B-PP	O
E.	BEGIN-E.	FW	B-NP	B
coli	coli	FW	I-NP	I
DNA	DNA	NN	I-NP	I
polymerase	polymerase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
nine	nine	CD	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserved	JJ	I-NP	O
regions	region	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
constructed	construct	VBD	B-VP	O
an	an	DT	B-NP	O
unrooted	unrooted	JJ	I-NP	O
phylogenetic	phylogenetic	JJ	I-NP	O
tree	tree	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA	BEGIN-DNA	JJ	I-NP	B
polymerases	polymerases-INSIDE	NN	I-NP	I
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
regions	region	NNS	I-NP	O

Guanylyl	BEGIN-Guanylyl	JJ	B-NP	B
cyclase	cyclase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
guanylin	BEGIN-guanylin	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
abundant	abundant	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intestine	intestine	NN	I-NP	O
by	by	IN	B-PP	O
Northern	Northern	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
or	or	CC	I-NP	O
cDNA	cDNA	NN	I-NP	O
cloning	cloning	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
adrenal	adrenal	JJ	B-NP	O
gland	gland	NN	I-NP	O
,	,	,	O	O
airway	airway	NN	B-NP	O
epithelial	epithelial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
brain	brain	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
olfactory	olfactory	JJ	B-NP	O
and	and	CC	I-NP	O
tracheal	tracheal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O

Older	Old	JJR	B-NP	O
females	female	NNS	I-NP	O
had	have	VBD	B-VP	O
lumbar	lumbar	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
TB	TB	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	O	O
)	)	)	O	O
BMD	BMD	NN	B-NP	O
Z	Z	NN	I-NP	O
scores	score	NNS	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
both	both	CC	O	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
E1F	BEGIN-BEGIN-E1-INSIDEF	NN	I-NP	I
binding	binding	NN	I-NP	O
site	site-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cdc1A	BEGIN-cdc1A	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
abolished	abolish	VBD	B-VP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
repression	repression	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
mutation	mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
E1F	BEGIN-BEGIN-E1-INSIDEF	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
or	or	CC	O	O
the	the	DT	B-NP	O
E1	BEGIN-BEGIN-E1-INSIDE	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O

Psychopathological	Psychopathological	JJ	B-NP	O
,	,	,	I-NP	O
vegetative	vegetative	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
vital	vital	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
every	every	DT	B-NP	O
hour	hour	NN	I-NP	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
rate	rate	NN	B-NP	O
-	-	HYPH	B-NP	O
adaptive	adaptive	JJ	I-NP	O
pacemakers	pacemaker	NNS	I-NP	O
accomplishes	accomplish	VBZ	B-VP	O
this	this	DT	B-NP	O
circadian	circadian	JJ	I-NP	O
rate	rate	NN	I-NP	O
variation	variation	NN	I-NP	O
by	by	IN	B-PP	O
modeling	model	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
sleep	sleep	NN	I-NP	O
-	-	HYPH	B-NP	O
wake	wake	NN	I-NP	O
cycle	cycle	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
-	-	HYPH	B-NP	O
of	of	IN	B-PP	O
-	-	HYPH	B-NP	O
day	day	NN	I-NP	O
clock	clock	NN	I-NP	O
inside	inside	IN	B-PP	O
the	the	DT	B-NP	O
device	device	NN	I-NP	O

New	New	JJ	B-NP	O
strategies	strategy	NNS	I-NP	O
are	be	VBP	B-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
coronary	coronary	JJ	B-NP	O
rethrombosis	rethrombosis	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
atherosclerosis	atherosclerosis	NN	I-NP	O
after	after	IN	B-PP	O
thrombolytic	thrombolytic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O

METHODS	METHODS	NNS	B-NP	O
AND	AND	CC	I-NP	O
RESULTS	RESULTS	NNS	I-NP	O
:	:	:	O	O
With	With	IN	B-PP	O
an	an	DT	B-NP	O
array	array	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
unipole	unipole	NN	I-NP	O
,	,	,	O	O
epicardial	epicardial	JJ	B-NP	O
maps	map	NNS	I-NP	O
of	of	IN	B-PP	O
electrically	electrically	RB	B-NP	O
induced	induce	VBN	I-NP	O
AF	AF	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
dogs	dog	NNS	I-NP	O
(	(	(	O	O
acute	acute	JJ	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
self	self	NN	B-NP	O
-	-	HYPH	B-VP	O
sustained	sustain	VBN	B-NP	O
AF	AF	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
dogs	dog	NNS	I-NP	O
(	(	(	O	O
chronic	chronic	JJ	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
pacing	pacing	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
dogs	dog	NNS	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
creating	create	VBG	B-VP	O
linear	linear	JJ	B-NP	O
radiofrequency	radiofrequency	NN	I-NP	O
ablation	ablation	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
atria	atrium	NNS	I-NP	O
that	that	WDT	B-NP	O
eliminated	eliminate	VBD	B-VP	O
the	the	DT	B-NP	O
AF	AF	NN	I-NP	O

The	The	DT	B-NP	O
mitochondrial	BEGIN-mitochondrial	JJ	I-NP	B
tyrosyl	tyrosyl	NN	I-NP	I
-	-	HYPH	B-NP	I
tRNA	tRNA	NN	I-NP	I
synthetase	synthetase-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
Podospora	Podospora	NNP	B-NP	O
anserina	anserina	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
bifunctional	bifunctional	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
and	and	CC	O	O
RNA	RNA	NN	B-NP	O
splicing	splicing	NN	I-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
nonconserved	nonconserved	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
subunit	subunit	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
function	function	NN	B-NP	O
and	and	CC	O	O
likely	likely	RB	B-VP	O
acts	act	VBZ	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
spacer	spacer	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
regions	region	NNS	I-NP	O

Further	Further	JJ	B-NP	O
comparative	comparative	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
identified	identify	VBD	B-VP	O
an	an	DT	B-NP	O
ADNP	BEGIN-ADNP-INSIDE	NN	I-NP	B
paralog	paralog	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
similarity	similarity	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
belong	belong	VBP	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
protein	protein	NN	I-NP	O
family	family	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nine	nine	CD	I-NP	O
-	-	HYPH	I-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
motif	motif	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
homeobox	homeobox	NN	I-NP	O
domain	domain	NN	I-NP	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
apo	BEGIN-apo	AFX	O	B
-	-	HYPH	O	I
iso	iso	AFX	O	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
cytochrome	cytochrome	NN	I-NP	I
c	c-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
absent	absent	JJ	B-ADJP	O
in	in	IN	B-PP	O
cyc1	BEGIN-cyc1	NN	B-NP	B
-	-	HYPH	B-NP	I
	-INSIDE	NN	I-NP	I
strains	strain	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
apo	BEGIN-apo	AFX	O	B
-	-	HYPH	O	I
iso	iso	AFX	O	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
cytochrome	cytochrome	NN	I-NP	I
c	c-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
the	the	DT	I-NP	O
same	same	JJ	I-NP	O
level	level	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
holo	BEGIN-holo	JJ	B-ADJP	B
-	-	HYPH	O	I
iso	iso	AFX	O	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
cytochrome	cytochrome	NN	I-NP	I
c	c-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
CYC1+	BEGIN-CYC1+-INSIDE	NN	B-NP	B
strains	strain	NNS	I-NP	O

A	A	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
phosphatidylinositol	BEGIN-phosphatidylinositol	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
beta	BEGIN-beta	NN	B-NP	B
1	1	CD	I-NP	I
integrin	integrin-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
antigen	antigen	NN	I-NP	O

The	The	DT	B-NP	O
cluster	cluster	NN	I-NP	O
was	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
to	to	TO	B-PP	O
nucleotides	nucleotide	NNS	B-NP	O
-	-	SYM	O	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
relative	relative	JJ	B-ADJP	O
to	to	TO	B-PP	O
nucleotide	nucleotide	NN	B-NP	O
A	A	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
initiation	initiation	NN	I-NP	O
codon	codon	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O

All	All	PDT	B-NP	O
the	the	DT	I-NP	O
previously	previously	RB	I-NP	O
mapped	map	VBN	I-NP	O
structural	structural	JJ	I-NP	O
protein	protein	NN	I-NP	O
-	-	HYPH	O	O
encoding	encode	VBG	B-VP	O
genes	gene	NNS	B-NP	O
of	of	IN	B-PP	O
phage	phage	NN	B-NP	O
LL	LL	NN	I-NP	O
-	-	HYPH	B-NP	O
H	H	NN	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O

An	An	DT	B-NP	O
exception	exception	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
Bcl	BEGIN-Bcl	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mutated	mutate	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
human	human	JJ	I-NP	O
memory	memory	NN	I-NP	O
B	B	NN	I-NP	O
cells	cell	NNS	I-NP	O

Nature	Nature	NN	B-NP	O
and	and	CC	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
conditioned	condition	VBN	B-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
methadone	methadone	NN	I-NP	O
population	population	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
laboratory	laboratory	NN	B-NP	O
,	,	,	O	O
clinic	clinic	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
naturalistic	naturalistic	JJ	B-NP	O
settings	setting	NNS	I-NP	O

Serum	Serum	NN	B-NP	O
PRL	BEGIN-PRL-INSIDE	NN	I-NP	B
concentrations	concentration	NNS	I-NP	O
significantly	significantly	RB	B-VP	O
increased	increase	VBD	I-VP	O
after	after	IN	B-PP	O
MCP	MCP	NN	B-NP	O
administration	administration	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
women	woman	NNS	I-NP	O
,	,	,	O	O
hyperprolactinemic	hyperprolactinemic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
sella	sella	NN	I-NP	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
microadenoma	microadenoma	NN	B-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
macroadenoma	macroadenoma	NN	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
and	and	CC	I-PP	O
without	without	IN	I-PP	O
suprasellar	suprasellar	JJ	B-NP	O
expansion	expansion	NN	I-NP	O
(	(	(	O	O
SSE	SSE	NN	B-NP	O
)	)	)	O	O

Fourteen	Fourteen	CD	B-NP	O
Centers	Center	NNS	I-NP	O
participated	participate	VBD	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
trial	trial	NN	I-NP	O

In	In	IN	B-PP	O
cells	cell	NNS	B-NP	O
stably	stably	RB	B-VP	O
transfected	transfecte	VBN	I-VP	O
with	with	IN	B-PP	O
G	BEGIN-G	NN	B-NP	B
alpha	alpha	SYM	B-VP	I
i	i	AFX	B-NP	I
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
or	or	CC	I-NP	O
G	BEGIN-BEGIN-G	NN	I-NP	B
alpha	alpha	SYM	B-NP	I
i	i	AFX	B-VP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
1	1	CD	I-NP	O
'	'	SYM	O	O
-	-	HYPH	O	O
flanking	flank	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O
fused	fuse	VBN	B-VP	O
to	to	TO	B-VP	O
firefly	firefly	VB	I-VP	O
luciferase	BEGIN-luciferase-INSIDE	NN	B-NP	B
cDNA	cDNA	NN	I-NP	O
reporter	reporter	NN	I-NP	O
,	,	,	O	O
temporal	temporal	JJ	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
genes	gene	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
before	before	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
polarization	polarization	NN	I-NP	O

A	A	DT	B-NP	O
gene	gene	NN	I-NP	O
(	(	(	O	O
FMR	BEGIN-FMR	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
four	four	CD	I-NP	O
cosmid	cosmid	NN	I-NP	O
contig	contig	NN	I-NP	O
of	of	IN	B-PP	O
YAC	YAC	NN	B-NP	O
DNA	DNA	NN	I-NP	O
that	that	WDT	B-NP	O
expresses	express	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
message	message	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
brain	brain	NN	I-NP	O

These	These	DT	B-NP	O
include	include	VBP	B-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
antioxidants	antioxidant	NNS	B-NP	O
,	,	,	O	O
N	BEGIN-N	NN	B-NP	B
-	-	HYPH	B-NP	I
methyl	methyl	NN	I-NP	I
-	-	HYPH	B-NP	I
D	D	NN	I-NP	I
-	-	HYPH	I-NP	I
aspartate	aspartate	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
antagonists	antagonist	NNS	I-NP	O
,	,	,	O	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
glutamate	glutamate	NN	B-NP	O
release	release	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
,	,	,	O	O
polyamine	polyamine	NN	B-NP	O
antagonists	antagonist	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nitric	BEGIN-nitric	JJ	B-NP	B
oxide	oxide	NN	I-NP	I
synthase	synthase-INSIDE	NN	I-NP	I
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
cannabinoids	cannabinoid	NNS	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
melatonin	melatonin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
vitamin	vitamin	NN	B-NP	O
B	B	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
ANH	ANH	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
negative	negative	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
endocrine	endocrine	JJ	I-NP	O
stress	stress	NN	I-NP	O
response	response	NN	I-NP	O
during	during	IN	B-PP	O
orthopedic	orthopedic	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
under	under	IN	B-PP	O
epidural	epidural	JJ	B-NP	O
anesthesia	anesthesia	NN	I-NP	O

Both	Both	DT	B-NP	O
genes	BEGIN-gene	NNS	I-NP	B
ARO1	BEGIN-ARO1-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
ARO1	BEGIN-ARO1-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
strongly	strongly	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
general	general	JJ	I-NP	O
control	control	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
system	system	NN	I-NP	O

Calculation	Calculation	NN	B-NP	O
of	of	IN	B-PP	O
energy	energy	NN	B-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
E1	E1	NN	B-NP	O
transition	transition	NN	I-NP	O
amplitudes	amplitude	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
parity	parity	NN	B-NP	O
violation	violation	NN	I-NP	O
in	in	IN	B-PP	O
francium	francium	NN	B-NP	O

A	A	DT	B-NP	O
homologue	homologue	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MAP	BEGIN-MAP-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
ERK	BEGIN-ERK-INSIDE	NN	I-NP	B
family	family	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
kinase	kinase	NN	I-NP	O
genes	gene	NNS	I-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
vegetative	vegetative	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
female	female	JJ	B-NP	O
reproductive	reproductive	JJ	I-NP	O
organs	organ	NNS	I-NP	O
of	of	IN	B-PP	O
Petunia	Petunia	NNP	B-NP	O
hybrida	hybrida	NN	I-NP	O

Significance	Significance	NN	B-NP	O
of	of	IN	B-PP	O
esophagocardiac	esophagocardiac	JJ	B-NP	O
reflexes	reflex	NNS	I-NP	O
for	for	IN	B-PP	O
inducing	induce	VBG	B-VP	O
thoracic	thoracic	JJ	B-NP	O
pain	pain	NN	I-NP	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
ADAMTS	BEGIN-ADAMTS	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
up	up	RB	B-ADVP	O
-	-	HYPH	B-NP	O
regulated	regulate	VBN	B-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
metaphyseal	metaphyseal	JJ	O	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
fold	fold	RB	B-ADVP	O
)	)	)	O	O
and	and	CC	O	O
diaphyseal	diaphyseal	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
fold	fold	RB	O	O
)	)	)	O	O
bone	bone	NN	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
PTH	BEGIN-PTH	NN	B-NP	B
-	-	HYPH	O	I
(	(	(	O	I
1	1	CD	O	I
-	-	HYPH	O	I
1	1	CD	O	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
injection	injection	NN	I-NP	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
levels	level	NNS	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O

The	The	DT	B-NP	O
findings	finding	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
multiple	multiple	JJ	I-NP	O
myeloma	myeloma	NN	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
represent	represent	VBP	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
examples	example	NNS	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
downregulated	downregulate	VBN	B-NP	O
PU.1	BEGIN-PU.1-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
and	and	CC	O	O
apparently	apparently	RB	B-VP	O
contradict	contradict	VBP	I-VP	O
observations	observation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
PU.1	BEGIN-PU.1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
and	and	CC	O	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
plasmacytoma	plasmacytoma	NN	B-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
identified	identify	VBD	B-VP	O
retina	retina	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
transcripts	transcript	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
for	for	IN	B-PP	O
rod	BEGIN-rod	NN	B-NP	B
G	G	NN	I-NP	I
alpha	alpha	SYM	B-NP	I
t	t-INSIDE	NN	I-NP	I
and	and	CC	O	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
for	for	IN	B-PP	O
cone	BEGIN-cone	NN	B-NP	B
G	G	NN	I-NP	I
alpha	alpha	SYM	B-VP	I
t	t-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
STP1	BEGIN-STP1	NN	I-NP	B
locus	locus-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
on	on	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
IV	IV	CD	I-NP	O
close	close	NN	I-NP	O
to	to	TO	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
other	other	JJ	I-NP	O
genes	gene	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
RNA	RNA	NN	B-NP	O
splicing	splicing	NN	I-NP	O
:	:	:	O	O
PRP1	BEGIN-PRP1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
SPP1	BEGIN-SPP1-INSIDE	NN	I-NP	B

Both	Both	CC	O	O
sequence	sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
restriction	restriction	NN	B-NP	O
fragment	fragment	NN	I-NP	O
length	length	NN	I-NP	O
polymorphism	polymorphism	NN	I-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
sequence	sequence	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
homology	homology	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
structural	structural	JJ	B-NP	O
similarity	similarity	NN	I-NP	O
among	among	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ART	BEGIN-ART-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
CH	BEGIN-CH-INSIDE	NN	I-NP	B
family	family	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
their	their	PRP$	B-NP	O
common	common	JJ	I-NP	O
origin	origin	NN	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
penetration	penetration	NN	I-NP	O
into	into	IN	B-PP	O
chicken	chicken	NN	B-NP	O
DNA	DNA	NN	I-NP	O

This	This	DT	B-NP	O
interesting	interesting	JJ	I-NP	O
exon	exon	NN	I-NP	O
junction	junction	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
novel	novel	JJ	B-NP	O
deduced	deduce	VBN	I-NP	O
amino	amino	JJ	I-NP	O
terminal	terminal	JJ	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frames	frame	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
completely	completely	RB	B-ADVP	O
in	in	IN	B-PP	O
-	-	HYPH	B-NP	O
frame	frame	NN	I-NP	O
with	with	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
located	located	JJ	B-VP	O
further	further	RB	B-ADVP	O
downstream	downstream	RB	B-ADVP	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
evolution	evolution	NN	B-NP	O
of	of	IN	B-PP	O
bronchial	bronchial	JJ	B-NP	O
albumin	BEGIN-albumin-INSIDE	NN	I-NP	B
,	,	,	O	O
IgA	BEGIN-IgA-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
IgG	BEGIN-IgG-INSIDE	NN	B-NP	B
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
ventilated	ventilate	VBN	B-NP	O
ICU	ICU	NN	I-NP	O
patients	patient	NNS	I-NP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
nosocomial	nosocomial	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
highly	highly	RB	B-NP	O
correlated	correlate	VBN	I-NP	O
frequencies	frequency	NNS	I-NP	O
provided	provide	VBD	B-VP	O
strong	strong	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
medium	medium	JJ	I-NP	O
-	-	HYPH	I-NP	O
frequency	frequency	NN	I-NP	O
pattern	pattern	NN	I-NP	O
generator	generator	NN	I-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
remain	remain	VB	I-VP	O
operative	operative	JJ	B-ADJP	O
beyond	beyond	IN	B-PP	O
the	the	DT	B-NP	O
neonatal	neonatal	JJ	I-NP	O
period	period	NN	I-NP	O

Pancreatic	Pancreatic	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glucagon	BEGIN-glucagon	NNP	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
three	three	CD	I-NP	O
DNA	DNA	NN	I-NP	O
control	control	NN	I-NP	O
elements	element	NNS	I-NP	O
:	:	:	O	O
G1	G1	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
element	element	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
G1	G1	NN	B-NP	O
and	and	CC	I-NP	O
G1	G1	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
enhancer	enhancer	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O

Before	Before	IN	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
eradication	eradication	NN	I-NP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
fasting	fast	VBG	B-VP	O
gastrinemia	gastrinemia	NN	B-NP	O
and	and	CC	I-NP	O
pepsinogen	BEGIN-pepsinogen	NN	I-NP	B
I	I-INSIDE	NN	I-NP	I
,	,	,	O	O
basal	basal	JJ	B-NP	O
and	and	CC	I-NP	O
peak	peak	JJ	I-NP	O
acid	acid	NN	I-NP	O
output	output	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
detailed	detail	VBD	B-VP	O
histological	histological	JJ	B-NP	O
assessment	assessment	NN	I-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
ECL	ECL	NN	I-NP	O
cell	cell	NN	I-NP	O
proliferative	proliferative	JJ	I-NP	O
patterns	pattern	NNS	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
CARP	BEGIN-CARP-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
YB	BEGIN-YB	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
associated	associate	VBN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
and	and	CC	O	O
represents	represent	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
identified	identify	VBN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
-	-	HYPH	I-NP	O
restricted	restricted	JJ	I-NP	O
downstream	downstream	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
gene	gene	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
homeobox	homeobox	NN	I-NP	O
gene	gene	NN	I-NP	O
Nkx1	BEGIN-Nkx1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
pathway	pathway	NN	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
HF	BEGIN-HF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
for	for	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O

Barium	Barium	NN	B-NP	O
mucosal	mucosal	JJ	I-NP	O
coating	coating	NN	I-NP	O
was	be	VBD	B-VP	O
judged	judge	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
better	good	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
members	member	NNS	I-NP	O
to	to	TO	B-PP	O
whom	whom	WP	B-NP	O
magnesium	magnesium	NN	B-NP	O
sulphate	sulphate	NN	I-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

Structure	Structure	NN	B-NP	O
and	and	CC	I-NP	O
chromosomal	chromosomal	JJ	I-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gene	gene	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phosphotyrosyl	BEGIN-phosphotyrosyl	NN	I-NP	B
phosphatase	phosphatase	NN	I-NP	I
activator	activator-INSIDE	NN	I-NP	I
(	(	(	O	O
PTPA	BEGIN-PTPA-INSIDE	NN	B-NP	B
)	)	)	O	O
of	of	IN	B-PP	O
protein	BEGIN-protein	NN	B-NP	B
phosphatase	phosphatase	NN	I-NP	I
1A	1A-INSIDE	NN	I-NP	I

This	This	DT	B-NP	O
article	article	NN	I-NP	O
expands	expand	VBZ	B-VP	O
the	the	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
numeric	numeric	JJ	I-NP	O
example	example	NN	I-NP	O
included	include	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
SAS	SAS	NN	I-NP	O
GLM	GLM	NN	I-NP	O
procedure	procedure	NN	I-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
several	several	JJ	B-NP	O
crucial	crucial	JJ	I-NP	O
statistical	statistical	JJ	I-NP	O
aspects	aspect	NNS	I-NP	O
relevant	relevant	JJ	B-ADJP	O
to	to	TO	B-PP	O
ANCOVA	ANCOVA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
highlight	highlight	VB	I-VP	O
the	the	DT	B-NP	O
meaning	meaning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
statistical	statistical	JJ	I-NP	O
results	result	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O

The	The	DT	B-NP	O
PEP1	BEGIN-PEP1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
library	library	NN	I-NP	O
by	by	IN	B-PP	O
complementation	complementation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pep1	BEGIN-pep1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
mutation	mutation	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
panretinal	panretinal	JJ	B-NP	O
photocoagulation	photocoagulation	NN	I-NP	O
offers	offer	VBZ	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
effective	effective	JJ	I-NP	O
means	mean	NNS	I-NP	O
of	of	IN	B-PP	O
dealing	deal	VBG	B-VP	O
with	with	IN	B-PP	O
early	early	JJ	B-NP	O
and	and	CC	I-NP	O
moderately	moderately	RB	I-NP	O
advanced	advance	VBN	I-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
angle	angle	NN	B-NP	O
neovascularization	neovascularization	NN	I-NP	O

Bilateral	Bilateral	JJ	B-NP	O
renal	renal	JJ	I-NP	O
oncocytoma	oncocytoma	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Greyhound	Greyhound	NN	I-NP	O
dog	dog	NN	I-NP	O

Membrane	Membrane	NN	B-NP	O
depolarization	depolarization	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
neuronal	neuronal	JJ	B-NP	O
signaling	signaling	NN	I-NP	O

The	The	DT	B-NP	O
E.	E.	NNP	I-NP	O
multilocularis	multilocularis	JJ	I-NP	O
/	/	SYM	I-NP	O
Mongolian	Mongolian	JJ	I-NP	O
gerbil	gerbil	NN	I-NP	O
system	system	NN	I-NP	O
can	can	MD	B-VP	O
replace	replace	VB	I-VP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
canid	canid	JJ	I-NP	O
hosts	host	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
way	way	NN	I-NP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
infective	infective	JJ	B-NP	O
eggs	egg	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
host	host	NN	B-NP	O
-	-	HYPH	B-NP	O
parasite	parasite	NN	I-NP	O
interactions	interaction	NNS	I-NP	O

The	The	DT	B-NP	O
Fugu	Fugu	NN	I-NP	O
rubripes	rubripe	NNS	I-NP	O
(	(	(	O	O
Fugu	Fugu	NN	B-NP	O
)	)	)	O	O
gene	gene	NN	B-NP	O
fragment	fragment	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
isolate	isolate	VB	I-VP	O
the	the	DT	B-NP	O
GH	BEGIN-GH	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
a	a	DT	B-NP	O
Fugu	Fugu	NNP	I-NP	O
genomic	genomic	JJ	I-NP	O
library	library	NN	I-NP	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
time	time	NN	I-NP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
red	BEGIN-red	JJ	I-NP	B
algal	algal	JJ	I-NP	I
lhc	lhc	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
presented	present	VBN	I-VP	O

All	All	DT	B-NP	O
such	such	JJ	I-NP	O
polypeptides	polypeptide	NNS	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
residues	residue	NNS	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
P1gag	BEGIN-P1gag-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
fps	BEGIN-fps-INSIDE	NN	B-NP	B
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
residues	residue	NNS	I-NP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
enzymatically	enzymatically	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
as	as	IN	B-PP	O
tyrosine	BEGIN-tyrosine	NN	B-NP	B
kinases	kinases-INSIDE	NN	I-NP	I

Were	Were	WRB	B-ADVP	O
this	this	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
correct	correct	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
elF1A	BEGIN-elF1A-INSIDE	NN	B-NP	B
should	should	MD	B-VP	O
correlate	correlate	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	O
secondary	secondary	JJ	I-NP	O
structure	structure	NN	I-NP	O

Comparison	Comparison	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
hemodynamic	hemodynamic	JJ	B-NP	O
results	result	NNS	I-NP	O

Localized	Localize	VBN	B-NP	O
Bicaudal	BEGIN-Bicaudal	JJ	I-NP	B
-	-	HYPH	I-NP	I
C	C	NN	I-NP	I
RNA	RNA-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
KH	KH	NN	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
binding	binding	NN	I-NP	O
motif	motif	NN	I-NP	O
of	of	IN	B-PP	O
FMR1	BEGIN-FMR1-INSIDE	NN	B-NP	B

Despite	Despite	IN	B-PP	O
a	a	DT	B-NP	O
lowering	lowering	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
plasma	plasma	NN	I-NP	O
ACTH	BEGIN-ACTH-INSIDE	NN	I-NP	B
concentration	concentration	NN	I-NP	O
during	during	IN	B-PP	O
therapy	therapy	NN	B-NP	O
with	with	IN	B-PP	O
valproic	valproic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
tumour	tumour	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
regression	regression	NN	B-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
report	report	NN	I-NP	O
which	which	WDT	B-NP	O
clearly	clearly	RB	B-ADVP	O
proved	prove	VBD	B-VP	O
CEA	BEGIN-CEA-INSIDE	NN	B-NP	B
synthesis	synthesis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
of	of	IN	B-PP	O
HCC	HCC	NN	B-NP	O

NASA	NASA	NNP	B-NP	O
CR	CR	NNP	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

1	1	CD	B-NP	O

The	The	DT	B-NP	O
classic	classic	JJ	I-NP	O
sterol	sterol	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
cis	cis	NN	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
sre	sre	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
LDL	BEGIN-LDL	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O
mediates	mediate	VBZ	B-VP	O
sterol	BEGIN-sterol	NN	B-NP	B
regulatory	regulatory	JJ	I-NP	I
element	element	NN	I-NP	I
binding	binding	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
SREBP	BEGIN-SREBP-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	B-NP	O
binding	bind	VBG	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
platelet	BEGIN-platelet	NN	I-NP	B
derived	derive	VBN	I-NP	I
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
PDGF	BEGIN-PDGF-INSIDE	NN	B-NP	B
)	)	)	O	O

The	The	DT	B-NP	O
D1N	BEGIN-D1N	NN	I-NP	B
substitution	substitution-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
activating	activate	VBG	I-NP	O
mutation	mutation	NN	I-NP	O
that	that	WDT	B-NP	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
SCAP	BEGIN-SCAP-INSIDE	NN	B-NP	B
and	and	CC	O	O
renders	render	VBZ	B-VP	O
it	it	PRP	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
inhibition	inhibition	NN	B-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
hydroxycholesterol	hydroxycholesterol	NN	I-NP	O

Transcriptional	Transcriptional	JJ	B-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anti	BEGIN-anti	AFX	I-NP	B
-	-	HYPH	I-NP	I
apoptotic	apoptotic	JJ	I-NP	I
protein	protein	NN	I-NP	I
BCL	BCL	NN	I-NP	I
-	-	HYPH	B-NP	I
XL	XL-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
the	the	DT	B-NP	O
paired	BEGIN-paired	JJ	I-NP	B
box	box	NN	I-NP	I
transcription	transcription	NN	I-NP	I
factors	factors-INSIDE	NN	I-NP	I
PAX1	BEGIN-PAX1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
PAX1	BEGIN-PAX1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
FKHR	BEGIN-FKHR-INSIDE	NN	B-NP	B

1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
risperidone	risperidone	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
study	study	NN	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
annual	annual	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
de	de	FW	B-NP	O
novo	novo	FW	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
formation	formation	NN	I-NP	O
is	be	VBZ	B-VP	O
relatively	relatively	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
cumulative	cumulative	JJ	I-NP	O
risk	risk	NN	I-NP	O
becomes	become	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
case	case	NN	I-NP	O
myogenic	myogenic	JJ	B-NP	O
factors	factor	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
initially	initially	RB	B-VP	O
expressed	express	VBN	I-VP	O
and	and	CC	O	O
these	these	DT	B-NP	O
migratory	migratory	JJ	I-NP	O
cells	cell	NNS	I-NP	O
are	be	VBP	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
paired	BEGIN-paired-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
box	box	NN	I-NP	O
gene	gene	NN	I-NP	O
Pax1	BEGIN-Pax1-INSIDE	NN	I-NP	B

In	In	IN	B-PP	O
those	those	DT	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
before	before	IN	B-PP	O
transplantation	transplantation	NN	B-NP	O
were	be	VBD	B-VP	O
serological	serological	JJ	B-ADJP	O
negative	negative	JJ	I-ADJP	O
for	for	IN	B-PP	O
CMV	CMV	NN	B-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
organs	organ	NNS	B-NP	O
from	from	IN	B-PP	O
CMV	BEGIN-CMV	NN	B-NP	B
-	-	HYPH	I-NP	I
IgG	IgG-INSIDE	NN	I-NP	I
positive	positive	JJ	I-NP	O
donors	donor	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
highest	high	JJS	B-ADJP	O

The	The	DT	B-NP	O
fecal	fecal	JJ	I-NP	O
excretion	excretion	NN	I-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
third	third	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
measured	measure	VBN	B-VP	O
in	in	IN	B-PP	O
urine	urine	NN	B-NP	O

This	This	DT	B-NP	O
ERD	ERD	NN	I-NP	O
is	be	VBZ	B-VP	O
recorded	record	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
contralateral	contralateral	JJ	I-NP	O
central	central	JJ	I-NP	O
region	region	NN	I-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
of	of	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
VII	VII	CD	I-NP	O
of	of	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
four	four	CD	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frames	frame	NNS	I-NP	O
(	(	(	O	O
ORFs	ORF	NNS	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O

Tax	BEGIN-Tax-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
to	to	TO	I-VP	O
interact	interact	VB	I-VP	O
directly	directly	RB	B-ADVP	O
with	with	IN	B-PP	O
CREB1	BEGIN-CREB1-INSIDE	NN	B-NP	B
but	but	CC	B-PP	O
not	not	RB	B-PP	O
with	with	IN	I-PP	O
other	other	JJ	B-NP	O
bZIP	BEGIN-bZIP	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
,	,	,	O	O
including	include	VBG	B-PP	O
CREB1	BEGIN-CREB1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Jun	BEGIN-Jun-INSIDE	NN	I-NP	B

Forty	Forty	CD	B-NP	O
-	-	HYPH	I-NP	O
five	five	CD	I-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
excreted	excrete	VBN	I-VP	O
as	as	IN	B-PP	O
methyldopa	methyldopa	NN	B-NP	O
as	as	IN	B-SBAR	O
opposed	oppose	VBN	B-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
normally	normally	RB	B-VP	O
seen	see	VBN	I-VP	O
after	after	IN	B-PP	O
oral	oral	JJ	B-NP	O
methyldopa	methyldopa	NN	I-NP	O
dosages	dosage	NNS	I-NP	O

Standing	Standing	JJ	B-NP	O
values	value	NNS	I-NP	O
:	:	:	O	O
placebo	placebo	NN	B-NP	O
1	1	CD	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
BHT	BHT	NN	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O

Zoonotic	Zoonotic	JJ	B-NP	O
areas	area	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
HIV	HIV	NN	B-NP	O
co	co	AFX	I-NP	O
-	-	HYPH	B-NP	O
infection	infection	NN	I-NP	O
is	be	VBZ	B-VP	O
common	common	JJ	B-ADJP	O
could	could	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
risk	risk	NN	B-NP	O
as	as	IN	B-SBAR	O
sandflies	sandfly	NNS	B-NP	O
can	can	MD	B-VP	O
become	become	VB	I-VP	O
infected	infect	VBN	I-VP	O
from	from	IN	B-PP	O
co	co	AFX	B-NP	O
-	-	HYPH	I-NP	O
infected	infect	VBN	I-NP	O
individuals	individual	NNS	I-NP	O

In	In	IN	B-PP	O
cases	case	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
insulitis	insulitis	NN	B-NP	O
affected	affect	VBD	B-VP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
islets	islet	NNS	B-NP	O
containing	contain	VBG	B-VP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
,	,	,	O	O
but	but	CC	O	O
affected	affect	VBD	B-VP	O
only	only	RB	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
islets	islet	NNS	B-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
insulin	BEGIN-insulin-INSIDE	NN	B-ADJP	B
deficient	deficient	JJ	I-ADJP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
supporting	support	VBG	B-VP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
that	that	IN	B-SBAR	O
insulitis	insulitis	NN	B-NP	O
represents	represent	VBZ	B-VP	O
an	an	DT	B-NP	O
immunologically	immunologically	RB	I-NP	O
mediated	mediate	VBN	I-NP	O
destruction	destruction	NN	I-NP	O
of	of	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
secreting	secreting	NN	I-NP	O
B	B	NN	I-NP	O
cells	cell	NNS	I-NP	O

Each	Each	DT	B-NP	O
fusion	fusion	NN	I-NP	O
leads	lead	VBZ	B-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
principle	principle	NN	B-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
effect	effect	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
ret	BEGIN-ret	NN	I-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
uncoupled	uncoupled	JJ	B-ADJP	O
from	from	IN	B-PP	O
its	its	PRP$	B-NP	O
stringent	stringent	JJ	I-NP	O
physiological	physiological	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
by	by	IN	B-PP	O
replacement	replacement	NN	B-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
end	end	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
aberrantly	aberrantly	RB	I-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
parts	part	NNS	I-NP	O
of	of	IN	B-PP	O
fused	fuse	VBN	B-NP	O
genes	gene	NNS	I-NP	O
in	in	IN	B-PP	O
thyrocytes	thyrocyte	NNS	B-NP	O
that	that	WDT	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
normally	normally	RB	I-VP	O
express	express	VB	I-VP	O
ret	BEGIN-ret	NN	B-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I

Proteins	Protein	NNS	B-NP	O
PBP	BEGIN-PBP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
PBP	BEGIN-PBP	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
promoter	promoter	NN	I-NP	O
elements	element	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
trypanosomatid	trypanosomatid	JJ	I-NP	O
Leptomonas	Leptomonas	NNP	I-NP	O
seymouri	seymouri	NNS	I-NP	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
interferon	BEGIN-interferon	NN	B-NP	B
-	-	HYPH	B-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
(	(	(	O	O
IFNalpha	BEGIN-IFNalpha-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
virus	virus	NN	B-NP	O
-	-	HYPH	B-NP	O
infected	infect	VBN	I-NP	O
cells	cell	NNS	I-NP	O
requires	require	VBZ	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
IRF1	BEGIN-IRF1-INSIDE	NN	B-NP	B
and	and	CC	O	O
IRF1	BEGIN-IRF1-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
differences	difference	NNS	I-NP	O
of	of	IN	B-PP	O
percentages	percentage	NNS	B-NP	O
for	for	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
drug	drug	NN	I-NP	O
users	user	NNS	I-NP	O
(	(	(	O	O
IVDU	IVDU	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
non	non	JJ	B-NP	O
IVDU	IVDU	NN	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
statistical	statistical	JJ	I-NP	O
difference	difference	NN	I-NP	O
(	(	(	O	O
chi	chi	NN	B-NP	O
1	1	CD	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Humoral	Humoral	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
is	be	VBZ	B-VP	O
altered	alter	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
IgG	BEGIN-IgG-INSIDE	NN	B-NP	B
levels	level	NNS	I-NP	O

The	The	DT	B-NP	O
vicinity	vicinity	NN	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
industrial	industrial	JJ	I-NP	O
emissions	emission	NNS	I-NP	O
of	of	IN	B-PP	O
lead	lead	NN	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
mean	mean	JJ	B-NP	O
Pb	Pb	NN	I-NP	O
-	-	HYPH	B-NP	O
B	B	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
were	be	VBD	B-VP	O
usually	usually	RB	B-ADVP	O
twice	twice	RB	B-ADJP	O
as	as	RB	I-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
rural	rural	JJ	B-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Katowice	Katowice	NNP	I-NP	O
voivodship	voivodship	NN	I-NP	O

(	(	(	O	O
control	control	NN	B-NP	O
hearts	heart	NNS	I-NP	O
)	)	)	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
BCR	BEGIN-BCR-INSIDE	NN	B-NP	B
ligation	ligation	NN	I-NP	O
initiates	initiate	VBZ	B-VP	O
a	a	DT	B-NP	O
PI	BEGIN-PI	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
Akt	BEGIN-Akt-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
GSK	BEGIN-GSK	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
positive	positive	JJ	I-NP	O
inotropic	inotropic	JJ	I-NP	O
agent	agent	NN	I-NP	O
(	(	(	O	O
OPC	OPC	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
canine	canine	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
papillary	papillary	JJ	I-NP	O
muscle	muscle	NN	I-NP	O

Although	Although	IN	B-SBAR	O
several	several	JJ	B-NP	O
other	other	JJ	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
molecules	molecule	NNS	I-NP	O
also	also	RB	B-ADVP	O
contain	contain	VBP	B-VP	O
tandemly	tandemly	RB	I-VP	O
occurring	occur	VBG	I-VP	O
SH1	BEGIN-SH1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
SH1	BEGIN-BEGIN-SH1-INSIDE	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
closely	closely	RB	I-NP	O
spaced	spaced	JJ	I-NP	O
domains	domain	NNS	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
well	well	RB	B-VP	O
understood	understand	VBN	I-VP	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
acoustic	acoustic	JJ	I-NP	O
power	power	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
chloride	chloride	NN	B-NP	O
formation	formation	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
kHz	kHz	NN	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
when	when	WRB	B-ADVP	O
a	a	DT	B-NP	O
probe	probe	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
larger	large	JJR	I-NP	O
tip	tip	NN	I-NP	O
area	area	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
significantly	significantly	RB	B-ADJP	O
less	less	JJR	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
kHz	kHz	NN	I-NP	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
report	report	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
specificity	specificity	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
energy	energy	NN	I-NP	O
coupling	coupling	NN	I-NP	O
proteins	protein	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PTS	PTS	NNS	I-NP	O

The	The	DT	B-NP	O
R1A	R1A	NN	I-NP	O
mutant	mutant	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
expected	expect	VBN	B-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
support	support	VB	I-VP	O
mRNA	mRNA	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	O
reconstitution	reconstitution	NN	I-NP	O
reaction	reaction	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
transcription	transcription	NN	B-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
minigenome	minigenome	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
reverse	reverse	JJ	I-NP	O
genetic	genetic	JJ	I-NP	O
approach	approach	NN	I-NP	O

As	As	IN	B-SBAR	O
expected	expect	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
QOLS	QOLS	NN	I-NP	O
-	-	HYPH	O	O
N	N	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
health	health	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
self	self	NN	B-NP	O
-	-	HYPH	B-NP	O
reported	report	VBN	I-NP	O
symptoms	symptom	NNS	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
mental	mental	JJ	B-NP	O
health	health	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Human	BEGIN-Human	JJ	B-NP	B
epidermal	epidermal	JJ	I-NP	I
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
EGF	BEGIN-EGF-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
naturally	naturally	RB	I-NP	O
occurring	occur	VBG	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
protection	protection	NN	I-NP	O
of	of	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
integrity	integrity	NN	I-NP	O

Elevated	Elevated	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
GAL	BEGIN-GAL	JJ	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
completely	completely	RB	I-VP	O
blocked	block	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
pituitary	pituitary	JJ	B-NP	O
adenylyl	BEGIN-adenylyl	JJ	I-NP	B
cyclase	cyclase	NN	I-NP	I
-	-	HYPH	O	I
activating	activate	VBG	B-VP	I
polypeptide	polypeptide-INSIDE	NN	B-NP	I
and	and	CC	I-NP	O
histamine	histamine	NN	I-NP	O
stimulations	stimulation	NNS	I-NP	O
were	be	VBD	B-VP	O
only	only	RB	I-VP	O
partially	partially	RB	I-VP	O
blocked	block	VBN	I-VP	O
,	,	,	O	O
by	by	IN	B-PP	O
cycloheximide	cycloheximide	NN	B-NP	O

DNA	DNA	NN	B-NP	O
elements	element	NNS	I-NP	O
recognizing	recognize	VBG	B-VP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
Y	Y-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Sp1	BEGIN-Sp1-INSIDE	NN	I-NP	B
regulate	regulate	VBP	B-VP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
multidrug	multidrug	JJ	I-NP	I
-	-	HYPH	I-NP	I
resistance	resistance	NN	I-NP	I
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

We	We	PRP	B-NP	O
constructed	construct	VBD	B-VP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
chimeric	chimeric	JJ	B-NP	O
genes	gene	NNS	I-NP	O
containing	contain	VBG	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
exon	exon	NN	I-NP	O
and	and	CC	O	O
increasingly	increasingly	RB	B-NP	O
longer	long	JJR	I-NP	O
1	1	CD	I-NP	O
'	'	''	I-NP	O
flanking	flanking	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ODC	BEGIN-ODC	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
either	either	CC	O	O
bacterial	BEGIN-bacterial	JJ	B-NP	B
chloramphenicol	chloramphenicol	NN	I-NP	I
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
(	(	(	O	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
)	)	)	O	O
or	or	CC	O	O
luciferase	BEGIN-luciferase	NN	B-NP	B
reporter	reporter	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
this	this	DT	B-NP	O
possibility	possibility	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
conducted	conduct	VBD	B-VP	O
split	split	NN	B-NP	O
-	-	HYPH	B-NP	O
visual	visual	JJ	I-NP	O
-	-	HYPH	I-NP	O
field	field	NN	I-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
we	we	PRP	B-NP	O
manipulated	manipulate	VBD	B-VP	O
stimulus	stimulus	NN	B-NP	O
sets	set	NNS	I-NP	O
,	,	,	O	O
recognition	recognition	NN	B-NP	O
task	task	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
exposure	exposure	NN	B-NP	O
duration	duration	NN	I-NP	O

Like	Like	IN	B-PP	O
pimethixene	pimethixene	NN	B-NP	O
and	and	CC	I-NP	O
cyproheptadine	cyproheptadine	NN	I-NP	O
,	,	,	O	O
WA	WA	NNP	B-NP	O
1	1	CD	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
antagonistic	antagonistic	JJ	I-NP	O
qualities	quality	NNS	I-NP	O
against	against	IN	B-PP	O
bradykinin	BEGIN-bradykinin-INSIDE	NN	B-NP	B

To	To	TO	B-VP	O
explore	explore	VB	I-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
insulin	BEGIN-insulin	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
phosphorylation	phosphorylation	NN	I-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
NIH1T1	NIH1T1	NN	B-NP	O
cells	cell	NNS	I-NP	O
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
receptor	receptor	NN	I-NP	O
constructs	construct	NNS	I-NP	O
:	:	:	O	O
one	one	CD	B-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
chimeric	chimeric	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
EGF	EGF	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
cytosolic	cytosolic	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-BEGIN-human	JJ	I-NP	B
insulin	BEGIN-insulin	NN	I-NP	B
receptor	receptor-INSIDE-INSIDE	NN	I-NP	I
beta	beta	SYM	O	O
-	-	HYPH	O	O
subunit	subunit-INSIDE	NN	B-NP	I
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
construct	construct	NN	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
kinase	kinase	NN	I-NP	O
-	-	HYPH	B-NP	O
defiecient	defiecient	JJ	I-NP	O
human	BEGIN-human	JJ	I-NP	B
insulin	BEGIN-insulin	NN	I-NP	B
receptor	receptor-INSIDE-INSIDE	NN	I-NP	I

Additional	Additional	JJ	B-NP	O
simulations	simulation	NNS	I-NP	O
account	account	VBP	B-VP	O
for	for	IN	B-PP	O
interactions	interaction	NNS	B-NP	O
of	of	IN	B-PP	O
spatial	spatial	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
with	with	IN	B-PP	O
stimulus	stimulus	NN	B-NP	O
duration	duration	NN	I-NP	O
,	,	,	O	O
effects	effect	NNS	B-NP	O
of	of	IN	B-PP	O
adaptation	adaptation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
properties	property	NNS	B-NP	O
of	of	IN	B-PP	O
residual	residual	JJ	B-NP	O
traces	trace	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
opposed	oppose	VBN	B-VP	O
to	to	TO	B-PP	O
visual	visual	JJ	B-NP	O
persistence	persistence	NN	I-NP	O

A	A	DT	B-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
that	that	WDT	B-NP	O
complements	complement	VBZ	B-VP	O
the	the	DT	B-NP	O
uvs	BEGIN-uv	NNS	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
mutation	mutation	NN	I-NP	O
was	be	VBD	B-VP	O
subcloned	subclone	VBN	I-VP	O
by	by	IN	B-PP	O
monitoring	monitor	VBG	B-VP	O
its	its	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
transform	transform	VB	I-VP	O
the	the	DT	B-NP	O
uvs	BEGIN-BEGIN-uv	NNS	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
MMS	MMS	NN	B-NP	O
resistance	resistance	NN	I-NP	O

This	This	DT	B-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
expresses	express	VBZ	B-VP	O
productively	productively	RB	B-NP	O
rearranged	rearrange	VBN	I-NP	O
immunoglobulin	BEGIN-immunoglobulin	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
Oct	BEGIN-Oct	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	O
murine	murine	JJ	I-NP	O
splenic	splenic	JJ	I-NP	O
B	B	NN	I-NP	O
cells	cell	NNS	I-NP	O

Back	Back	RB	B-ADVP	O
-	-	HYPH	O	O
ground	ground	NN	B-NP	O
factors	factor	NNS	I-NP	O
which	which	WDT	B-NP	O
affect	affect	VBP	B-VP	O
the	the	DT	B-NP	O
outcome	outcome	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
type	type	NN	I-NP	O
B	B	NN	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
-	-	HYPH	B-VP	O
-	-	HYPH	B-NP	O
statistical	statistical	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mode	mode	NN	I-NP	O
of	of	IN	B-PP	O
HBV	HBV	NN	B-NP	O
transmission	transmission	NN	I-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
food	food	NN	B-NP	O
on	on	IN	B-PP	O
hemodynamics	hemodynamic	NNS	B-NP	O

PTP1	BEGIN-PTP1-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
lacZ	BEGIN-lacZ-INSIDE	NN	I-NP	B
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
PTP1	BEGIN-PTP1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
spatially	spatially	RB	B-ADJP	O
localized	localized	JJ	I-ADJP	O
to	to	TO	B-VP	O
prestalk	prestalk	VB	I-VP	O
and	and	CC	O	O
anterior	anterior	JJ	B-NP	O
-	-	HYPH	I-NP	O
like	like	JJ	I-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O

Morphologic	Morphologic	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
rhe	rhe	NN	B-NP	O
renal	renal	JJ	I-NP	O
calyx	calyx	NN	I-NP	O
and	and	CC	I-NP	O
pelvis	pelvis	NN	I-NP	O
control	control	NN	I-NP	O
ureteric	ureteric	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rabbit	rabbit	NN	I-NP	O

Human	BEGIN-Human	JJ	B-NP	B
alcohol	alcohol	NN	I-NP	I
dehydrogenase	dehydrogenase-INSIDE	NN	I-NP	I
(	(	(	O	O
ADH	BEGIN-ADH-INSIDE	NN	B-NP	B
)	)	)	O	O
exists	exist	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
heterogeneous	heterogeneous	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
isozymes	isozyme	NNS	B-NP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
oxidizing	oxidize	VBG	B-VP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
aliphatic	aliphatic	JJ	B-NP	O
and	and	CC	I-NP	O
aromatic	aromatic	JJ	I-NP	O
alcohols	alcohol	NNS	I-NP	O

We	We	PRP	B-NP	O
reviewed	review	VBD	B-VP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
dementia	dementia	NN	B-NP	O
and	and	CC	I-NP	O
autopsy	autopsy	NN	I-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
Alzheimer	Alzheimer	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
AD	AD	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
seizures	seizure	NNS	B-NP	O
or	or	CC	O	O
myoclonus	myoclonus	NN	B-NP	O
after	after	IN	B-PP	O
onset	onset	NN	B-NP	O
of	of	IN	B-PP	O
dementia	dementia	NN	B-NP	O

The	The	DT	B-NP	O
second	second	JJ	I-NP	O
system	system	NN	I-NP	O
(	(	(	O	O
VacFix	VacFix	NN	B-NP	O
)	)	)	O	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
thick	thick	JJ	I-NP	O
plastic	plastic	NN	I-NP	O
bag	bag	NN	I-NP	O
loosely	loosely	RB	B-VP	O
filled	fill	VBN	I-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
polysterol	polysterol	NN	I-NP	O
spheres	sphere	VBZ	B-VP	O

Expression	Expression	NN	B-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
lines	line	NNS	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
inclusion	inclusion	NN	I-NP	O
of	of	IN	B-PP	O
regions	region	NNS	B-NP	O
further	further	RBR	B-ADVP	O
upstream	upstream	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
extinguished	extinguish	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
inclusion	inclusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
intron	intron	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
thyroid	thyroid	JJ	I-NP	O
scan	scan	NN	I-NP	O
and	and	CC	I-NP	O
RAIU	RAIU	NN	I-NP	O
were	be	VBD	B-VP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
TSAb	TSAb	NN	B-NP	O

U	U	NN	B-NP	O

A	A	DT	B-NP	O
Laboratory	Laboratory	NNP	I-NP	O
Manual	Manual	NNP	I-NP	O
,	,	,	O	O
1nd	1nd	NN	B-NP	O
ed	ed	VBD	B-VP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
buccal	buccal	JJ	I-NP	O
Class	Class	NN	I-NP	O
II	II	CD	I-NP	O
tendency	tendency	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
molars	molar	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Class	Class	NN	I-NP	O
I	I	CD	I-NP	O
relationship	relationship	NN	I-NP	O
when	when	WRB	B-ADVP	O
evaluated	evaluate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
lingual	lingual	JJ	I-NP	O
side	side	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
1	1	CD	B-NP	O
belonged	belong	VBD	B-VP	O
to	to	TO	B-PP	O
mild	mild	JJ	B-NP	O
(	(	(	O	O
1st	1st	CD	B-NP	O
degrees	degree	NNS	I-NP	O
)	)	)	O	O
Class	Class	NN	B-NP	O
II	II	CD	I-NP	O
with	with	IN	B-PP	O
molar	molar	JJ	B-NP	O
rotations	rotation	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cases	case	NNS	I-NP	O

The	The	DT	B-NP	O
resulting	result	VBG	I-NP	O
score	score	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
allowed	allow	VBD	B-VP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
expressed	express	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
continuous	continuous	JJ	I-NP	O
variable	variable	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
effectively	effectively	RB	I-VP	O
utilized	utilize	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
correlations	correlation	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
CAD	CAD	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
individual	individual	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
/	/	SYM	B-NP	O
risk	risk	NN	B-NP	O
markers	marker	NNS	I-NP	O

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
cellulase	BEGIN-cellulase-INSIDE	NN	I-NP	B
(	(	(	O	O
Avicelase	BEGIN-Avicelase-INSIDE	NN	B-NP	B
)	)	)	O	O
Cel1	BEGIN-Cel1-INSIDE	NN	B-NP	B
from	from	IN	B-PP	O
Streptomyces	Streptomyces	NNP	B-NP	O
reticuli	reticuli	NNS	I-NP	O
and	and	CC	O	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
domains	domain	NNS	I-NP	O

A	A	DT	B-NP	O
protein	protein	NN	I-NP	O
which	which	WDT	B-NP	O
promotes	promote	VBZ	B-VP	O
DNA	DNA	NN	B-NP	O
strand	strand	NN	I-NP	O
transfer	transfer	NN	I-NP	O
between	between	IN	B-PP	O
linear	linear	JJ	B-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
stranded	stranded	JJ	I-NP	O
M1mp1	M1mp1	NN	I-NP	O
DNA	DNA	NN	I-NP	O
and	and	CC	O	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
stranded	stranded	JJ	I-NP	O
viral	viral	JJ	I-NP	O
M1mp1	M1mp1	NN	I-NP	O
DNA	DNA	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
recA	BEGIN-recA	NN	B-NP	B
-	-	HYPH	B-NP	I
	-INSIDE	JJ	I-NP	I
E.coli	E.coli	NNP	I-NP	O

We	We	PRP	B-NP	O
speculate	speculate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
enhancing	enhance	VBG	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
glucose	glucose	NN	B-NP	O
and	and	CC	I-NP	O
galactose	galactose	NN	I-NP	O
on	on	IN	B-PP	O
fructose	fructose	NN	B-NP	O
absorption	absorption	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fructose	BEGIN-fructose	NN	I-NP	B
carrier	carrier-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
nutraceuticals	nutraceutical	NNS	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
vitamins	vitamin	NNS	I-NP	O
,	,	,	O	O
minerals	mineral	NNS	B-NP	O
,	,	,	O	O
phytoestrogens	phytoestrogen	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
essential	essential	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acid	acid	NN	I-NP	O
supplementations	supplementation	NNS	I-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
vital	vital	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
reduction	reduction	NN	I-NP	O
health	health	NN	I-NP	O
program	program	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
V.	V.	NNP	B-NP	O
furnissii	furnissii	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
E.	BEGIN-E.	FW	I-NP	B
coli	coli	FW	I-NP	I
manX	manX	NN	I-NP	I
equivalent	equivalent-INSIDE	NN	I-NP	I
comprises	comprise	VBZ	B-VP	O
two	two	CD	B-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
separated	separate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
genome	genome	NN	I-NP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
other	other	JJ	I-NP	O
genes	gene	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ptsM	BEGIN-ptsM	NN	I-NP	B
complex	complex-INSIDE	NN	I-NP	I

An	An	DT	B-NP	O
scrR	BEGIN-scrR	NN	I-NP	B
promoter	promoter	NN	I-NP	I
fragment	fragment-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
dose	dose	VBP	B-VP	O
not	not	RB	I-VP	O
contain	contain	VB	I-VP	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
resembling	resemble	VBG	B-VP	O
OB	BEGIN-OB-INSIDE	NN	B-NP	B
,	,	,	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
shifted	shift	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O

Ectopic	Ectopic	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
D1	D1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
progestin	progestin	NN	B-NP	O
-	-	HYPH	B-NP	O
inhibited	inhibit	VBN	I-NP	O
cells	cell	NNS	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
reappearance	reappearance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
active	active	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
Cdk1	BEGIN-Cdk1-INSIDE	NN	I-NP	B
preceding	precede	VBG	B-VP	O
the	the	DT	B-NP	O
resumption	resumption	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O

We	We	PRP	B-NP	O
screened	screen	VBD	B-VP	O
an	an	DT	B-NP	O
A.	A.	NN	I-NP	O
thaliana	thaliana	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
,	,	,	O	O
whose	whose	WP$	B-NP	O
inserts	insert	NNS	I-NP	O
are	be	VBP	B-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
galactose	galactose	NN	I-NP	O
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
GAL1	BEGIN-GAL1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
for	for	IN	B-PP	O
cDNAs	cDNA	NNS	B-NP	O
which	which	WDT	B-NP	O
enabled	enable	VBD	B-VP	O
YDH1	YDH1	NN	B-NP	O
cells	cell	NNS	I-NP	O
to	to	TO	B-VP	O
grow	grow	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
restrictive	restrictive	JJ	I-NP	O
temperature	temperature	NN	I-NP	O

The	The	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
alpha	alpha	NN	I-NP	I
A	A	NN	I-NP	I
-	-	HYPH	I-NP	I
CRYBP1	CRYBP1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
specifies	specify	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
identity	identity	NN	I-NP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
human	human	JJ	I-NP	O
homologue	homologue	NN	I-NP	O
,	,	,	O	O
PRDII	BEGIN-PRDII	NN	B-NP	B
-	-	HYPH	O	I
BF1	BF1-INSIDE	NN	B-NP	I

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
Hv	BEGIN-Hv	NN	B-NP	B
-	-	HYPH	B-NP	I
p1	p1-INSIDE	NN	I-NP	I
belongs	belong	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
FAD	BEGIN-FAD	NN	B-NP	B
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
glucose	glucose	NN	I-NP	I
methanol	methanol	NN	I-NP	I
choline	choline	NN	I-NP	I
oxidoreductases	oxidoreductases-INSIDE	NN	I-NP	I
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
shares	share	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
identity	identity	NN	I-NP	O
(	(	(	O	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
alcohol	BEGIN-alcohol	NN	I-NP	B
oxidases	oxidases-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
methylotrophic	methylotrophic	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
reevaluated	reevaluate	VBN	I-VP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
serum	BEGIN-serum	NN	B-NP	B
leptin	leptin-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
adiposity	adiposity	NN	B-NP	O
and	and	CC	I-NP	O
androgen	androgen	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
community	community	NN	B-NP	O
dwelling	dwelling	NN	I-NP	O
men	man	NNS	I-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
survival	survival	NN	I-NP	O
rates	rate	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
N1	N1	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
significantly	significantly	RB	B-VP	O
exceeded	exceed	VBD	I-VP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
N1	N1	NN	B-NP	O
patients	patient	NNS	I-NP	O

While	While	IN	B-SBAR	O
reviewing	review	VBG	B-VP	O
gastric	gastric	JJ	B-NP	O
specimens	specimen	NNS	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
baboons	baboon	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
giant	giant	JJ	I-NP	O
mucosal	mucosal	JJ	I-NP	O
folds	fold	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
specimens	specimen	NNS	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
giant	giant	JJ	I-NP	O
mucosal	mucosal	JJ	I-NP	O
nodules	nodule	NNS	I-NP	O
in	in	IN	B-PP	O
another	another	DT	B-NP	O
1	1	CD	I-NP	O

Morphologically	Morphologically	RB	B-ADVP	O
,	,	,	O	O
corrugation	corrugation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
internal	internal	JJ	I-NP	O
elastic	elastic	JJ	I-NP	O
lamina	lamina	NN	I-NP	O
of	of	IN	B-PP	O
vessels	vessel	NNS	B-NP	O
was	be	VBD	B-VP	O
often	often	RB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
vehicle	vehicle	NN	I-NP	O
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
not	not	RB	O	O
prominent	prominent	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
GLNVA	GLNVA	NN	I-NP	O
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
groups	group	NNS	I-NP	O
or	or	CC	O	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O

Transcripts	Transcript	NNS	B-NP	O
initiating	initiate	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
CAGT	CAGT	NN	I-NP	O
motif	motif	NN	I-NP	O
(	(	(	O	O
proximal	proximal	JJ	B-NP	O
transcripts	transcript	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
abolished	abolish	VBN	I-VP	O
by	by	IN	B-PP	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
CAGT	CAGT	NN	B-NP	O

The	The	DT	B-NP	O
phenomena	phenomena	NN	I-NP	O
of	of	IN	B-PP	O
nursing	nursing	NN	B-NP	O
are	be	VBP	B-VP	O
deeply	deeply	RB	I-VP	O
rooted	root	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
condition	condition	NN	I-NP	O

Coronatine	BEGIN-Coronatine-INSIDE	NN	B-NP	B
(	(	(	O	O
COR	BEGIN-COR-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
-	-	HYPH	O	O
encoded	encode	VBN	B-NP	O
phytotoxin	phytotoxin	NN	I-NP	O
synthesized	synthesize	VBN	B-VP	O
by	by	IN	B-PP	O
several	several	JJ	B-NP	O
pathovars	pathovar	NNS	I-NP	O
of	of	IN	B-PP	O
phytopathogenic	phytopathogenic	JJ	B-NP	O
Pseudomonas	Pseudomonas	NN	I-NP	O
syringae	syringae	NNS	I-NP	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
one	one	CD	B-NP	O
mediator	mediator	NN	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
ALI	ALI	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
rather	rather	RB	B-NP	O
a	a	DT	I-NP	O
complex	complex	JJ	I-NP	O
interplay	interplay	NN	I-NP	O
exists	exist	VBZ	B-VP	O
between	between	IN	B-PP	O
diverse	diverse	JJ	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	O
(	(	(	O	O
e.g.	e.g.	FW	O	O
,	,	,	O	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
,	,	,	O	O
complement	complement	NN	B-NP	O
products	product	NNS	I-NP	O
,	,	,	O	O
cytocains	cytocain	NNS	B-NP	O
,	,	,	O	O
chemocains	chemocain	NNS	B-NP	O
,	,	,	O	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
and	and	CC	O	O
arachidonic	arachidonic	JJ	B-NP	O
acid	acid	NN	I-NP	O
products	product	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
anti	anti	AFX	O	O
-	-	HYPH	O	O
inflammatory	inflammatory	JJ	O	O
(	(	(	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
IL	BEGIN-BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
RA	RA-INSIDE	NN	I-NP	I
,	,	,	I-NP	O
PGI1	PGI1	NN	I-NP	O
)	)	)	O	O
mediators	mediator	NNS	B-NP	O

Not	Not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
will	will	MD	O	O
it	it	PRP	B-NP	O
substantially	substantially	RB	B-VP	O
reduce	reduce	VBP	I-VP	O
incident	incident	JJ	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
decade	decade	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
framework	framework	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
successful	successful	JJ	I-NP	O
introduction	introduction	NN	I-NP	O
of	of	IN	B-PP	O
future	future	JJ	B-NP	O
adolescent	adolescent	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
initiatives	initiative	NNS	I-NP	O
in	in	IN	B-PP	O
Australia	Australia	NNP	B-NP	O

Radioactively	Radioactively	RB	B-NP	O
labeled	label	VBN	I-NP	O
microspheres	microsphere	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
and	and	CC	I-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
nitroprusside	nitroprusside	NN	I-NP	O
(	(	(	O	O
SNP	SNP	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
(	(	(	O	O
NTG	NTG	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
deep	deep	JJ	B-NP	O
enflurane	enflurane	NN	I-NP	O
anesthesia	anesthesia	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
during	during	IN	B-PP	O
controlled	control	VBN	B-NP	O
hypotension	hypotension	NN	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
controls	control	NNS	B-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
MMF	MMF	NN	I-NP	O
lesion	lesion	NN	I-NP	O
is	be	VBZ	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
intramuscular	intramuscular	JJ	B-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
aluminium	aluminium	NN	B-NP	O
hydroxide	hydroxide	NN	I-NP	O
-	-	HYPH	B-VP	O
containing	contain	VBG	B-NP	O
vaccines	vaccine	NNS	I-NP	O
,	,	,	O	O
shows	show	VBZ	B-VP	O
both	both	CC	O	O
long	long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
persistence	persistence	NN	I-NP	O
of	of	IN	B-PP	O
aluminium	aluminium	NN	B-NP	O
hydroxide	hydroxide	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ongoing	ongoing	JJ	I-NP	O
local	local	JJ	I-NP	O
immune	immune	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
which	which	WDT	B-NP	O
appeared	appear	VBD	B-VP	O
subsequently	subsequently	RB	B-ADVP	O
to	to	TO	B-PP	O
vaccination	vaccination	NN	B-NP	O

Advisory	Advisory	NNP	B-NP	O
Committee	Committee	NNP	I-NP	O
report	report	NN	I-NP	O
recommends	recommend	VBZ	B-VP	O
that	that	IN	B-SBAR	O
US	US	NNP	B-NP	O
make	make	VBP	B-VP	O
amends	amend	NNS	B-NP	O
for	for	IN	B-PP	O
human	human	JJ	B-NP	O
radiation	radiation	NN	I-NP	O
experiments	experiment	NNS	I-NP	O

An	An	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
control	control	NN	I-NP	O
for	for	IN	B-PP	O
platelet	platelet	NN	B-NP	O
neutralization	neutralization	NN	I-NP	O
procedure	procedure	NN	I-NP	O
testing	testing	NN	I-NP	O
with	with	IN	B-PP	O
seven	seven	CD	B-NP	O
commercial	commercial	JJ	I-NP	O
activated	activate	VBN	I-NP	O
partial	partial	JJ	I-NP	O
thromboplastin	BEGIN-thromboplastin-INSIDE	NN	I-NP	B
time	time	NN	I-NP	O
reagents	reagent	NNS	I-NP	O

Transmission	Transmission	NN	B-NP	O
of	of	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
to	to	TO	B-PP	O
infants	infant	NNS	B-NP	O
following	follow	VBG	B-PP	O
short	short	JJ	B-NP	O
term	term	NN	I-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
iodine	iodine	NN	I-NP	O
-	-	HYPH	I-NP	O
NaF	NaF	NN	I-NP	O
solution	solution	NN	I-NP	O
to	to	TO	B-PP	O
mothers	mother	NNS	B-NP	O
'	'	POS	B-NP	O
dentition	dentition	NN	I-NP	O

Glycoprotein	Glycoprotein	NN	B-NP	O
biosynthesis	biosynthesis	NN	I-NP	O
in	in	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
:	:	:	O	O
ngd1	BEGIN-ngd1-INSIDE	NN	B-NP	B
,	,	,	O	O
an	an	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	I-NP	O
glycosylation	glycosylation	NN	I-NP	O
mutant	mutant	NN	I-NP	O
allelic	allelic	JJ	B-ADJP	O
to	to	TO	B-PP	O
och1	BEGIN-och1-INSIDE	NN	B-NP	B
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
initiation	initiation	NN	I-NP	O
of	of	IN	B-PP	O
outer	outer	JJ	B-NP	O
chain	chain	NN	I-NP	O
formation	formation	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
consensus	consensus	NN	I-NP	O
on	on	IN	B-PP	O
indications	indication	NNS	B-NP	O
exists	exist	VBZ	B-VP	O
and	and	CC	O	O
,	,	,	O	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
,	,	,	O	O
results	result	NNS	B-NP	O
are	be	VBP	B-VP	O
contradictory	contradictory	JJ	B-ADJP	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
erythrosine	erythrosine	NN	B-NP	O
(	(	(	O	O
Red	Red	VBN	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
rose	rise	VBD	B-VP	O
bengal	bengal	JJ	B-NP	O
B	B	NN	I-NP	O
(	(	(	O	O
Red	Red	VBN	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
thyroidectomy	thyroidectomy	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
tumor	tumor	NN	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
male	male	JJ	B-NP	O
Wistar	Wistar	NNP	I-NP	O
rats	rat	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
N	N	NN	B-NP	O
-	-	HYPH	O	O
bis	bis	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
hydroxypropyl	hydroxypropyl	NN	I-NP	O
)	)	)	O	O
nitrosamine	nitrosamine	NN	B-NP	O
(	(	(	O	O
DHPN	DHPN	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
region	region	NN	I-NP	O
surrounding	surround	VBG	B-VP	O
the	the	DT	B-NP	O
ZNF1	BEGIN-ZNF1	NN	I-NP	B
zinc	zinc	NN	I-NP	I
finger	finger	NN	I-NP	I
protein	protein	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
1p1	1p1	NN	B-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
particular	particular	JJ	B-NP	O
interest	interest	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
1	1	CD	I-NP	O
is	be	VBZ	B-VP	O
frequently	frequently	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
rearrangements	rearrangement	NNS	B-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
deletions	deletion	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
human	human	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
including	include	VBG	B-PP	O
lung	lung	NN	B-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
or	or	CC	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
mdm1	BEGIN-mdm1	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
hamster	hamster	NN	B-NP	O
UV1	UV1	NN	I-NP	O
cells	cell	NNS	I-NP	O
after	after	IN	B-PP	O
UV	UV	NN	B-NP	O
exposure	exposure	NN	I-NP	O

Complete	Complete	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
signal	BEGIN-signal	JJ	B-NP	B
transducer	transducer	NN	I-NP	I
and	and	CC	I-NP	I
activator	activator	NN	I-NP	I
of	of	IN	B-PP	I
transcription	transcription	NN	B-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
STAT1	BEGIN-STAT1-INSIDE	NN	B-NP	B
)	)	)	O	O
requires	require	VBZ	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
at	at	IN	B-PP	O
both	both	CC	O	O
Y1	Y1	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
PMS	PMS	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
P	P	NN	B-NP	O
sequence	sequence	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
believed	believe	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
operation	operation	NN	I-NP	O
is	be	VBZ	B-VP	O
effective	effective	JJ	B-ADJP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
cuts	cut	VBZ	B-VP	O
the	the	DT	B-NP	O
spinothalamic	spinothalamic	JJ	I-NP	O
tract	tract	NN	I-NP	O
(	(	(	O	O
STT	STT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
primary	primary	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
carrying	carry	VBG	B-VP	O
nociceptive	nociceptive	JJ	B-NP	O
information	information	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
experiments	experiment	NNS	B-NP	O
with	with	IN	B-PP	O
mutant	mutant	JJ	B-NP	O
virus	virus	NN	I-NP	O
and	and	CC	O	O
transfection	transfection	NN	B-NP	O
with	with	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
herpes	BEGIN-herpes	NN	I-NP	B
simplex	simplex	NN	I-NP	I
virus	virus	NN	I-NP	I
immediate	immediate	JJ	B-ADJP	I
-	-	HYPH	B-NP	I
early	early	JJ	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
product	product	NN	I-NP	O
ICP1	BEGIN-ICP1-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	B-VP	O
positively	positively	RB	I-VP	O
regulate	regulate	VB	I-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
viral	BEGIN-viral	JJ	B-NP	B
early	early	JJ	I-NP	I
and	and	CC	I-NP	I
late	late	JJ	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
and	and	CC	O	O
negatively	negatively	RB	B-VP	O
regulate	regulate	VBP	I-VP	O
expression	expression	NN	B-NP	O
from	from	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
promoter	promoter	NN	I-NP	O

Alcohol	Alcohol	NN	B-NP	O
abuse	abuse	NN	I-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
skin	skin	NN	B-NP	O
disease	disease	NN	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
reduction	reduction	NN	B-NP	O
in	in	IN	B-PP	O
PRA	PRA	NN	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
peak	BEGIN-peak	NN	I-NP	B
III	III	CD	I-NP	I
PDE	PDE-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
studies	study	NNS	B-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
A1	BEGIN-A1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
LMP1	BEGIN-LMP1-INSIDE	NN	B-NP	B
transcriptionally	transcriptionally	RB	B-ADVP	O
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
A1	BEGIN-A1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
through	through	IN	B-PP	O
cis	cis	NN	B-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-NP	O
kappa	BEGIN-kappa	NN	I-NP	B
B	B	NN	I-NP	I
sites	sites-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
were	be	VBD	B-VP	O
sequenced	sequence	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
a	a	DT	B-NP	O
CATAA	CATAA	NN	I-NP	O
box	box	NN	I-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
a	a	DT	B-NP	O
TATAA	TATAA	NN	I-NP	O
box	box	NN	I-NP	O
and	and	CC	O	O
several	several	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
motifs	motif	NNS	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
activation	activation	NN	B-NP	O
genes	gene	NNS	I-NP	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
investigated	investigate	VBN	B-VP	O
if	if	IN	B-SBAR	O
signal	signal	NN	B-NP	O
-	-	HYPH	O	O
averaged	average	VBN	B-NP	O
low	low	JJ	I-NP	O
amplitude	amplitude	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
potentials	potential	NNS	I-NP	O
predict	predict	VBP	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
or	or	CC	O	O
flutter	flutter	NN	B-NP	O
(	(	(	O	O
AFF	AFF	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
expression	expression	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
multimerization	multimerization	NN	B-NP	O
of	of	IN	B-PP	O
UAS1	UAS1	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
native	native	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
ADR1	BEGIN-ADR1-INSIDE	NN	B-NP	B

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
tested	test	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
activation	activation	NN	B-NP	O
by	by	IN	B-PP	O
either	either	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
components	component	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SAGA	BEGIN-SAGA	NN	I-NP	B
complex	complex-INSIDE	NN	I-NP	I

One	One	CD	B-NP	O
child	child	NN	I-NP	O
,	,	,	O	O
recently	recently	RB	B-VP	O
fed	feed	VBN	I-VP	O
,	,	,	O	O
vomited	vomit	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
milk	milk	NN	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
crying	cry	VBG	B-VP	O
and	and	CC	O	O
apparently	apparently	RB	B-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
laryngospasm	laryngospasm	NN	I-NP	O
,	,	,	O	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
sudden	sudden	JJ	I-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PtcO1	PtcO1	NN	I-NP	O
level	level	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
discomfort	discomfort	NN	B-NP	O

The	The	DT	B-NP	O
central	central	JJ	I-NP	O
venous	venous	JJ	I-NP	O
O1	O1	NN	I-NP	O
saturation	saturation	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
fat	fat	NN	I-NP	O
embolism	embolism	NN	I-NP	O

Such	Such	JJ	B-NP	O
unique	unique	JJ	I-NP	O
recognition	recognition	NN	I-NP	O
capabilities	capability	NNS	I-NP	O
are	be	VBP	B-VP	O
generated	generate	VBN	I-VP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
alterations	alteration	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CDR1	BEGIN-CDR1-INSIDE	NN	I-NP	B
loops	loop	VBZ	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TCR	BEGIN-TCR-INSIDE	NN	I-NP	B

Sequence	Sequence	NN	B-NP	O
comparisons	comparison	NNS	I-NP	O
reveal	reveal	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
P.	BEGIN-P.	NNP	I-NP	B
woesei	woesei	NNP	I-NP	I
GTP	GTP	NN	I-NP	I
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
strikingly	strikingly	RB	I-VP	O
related	relate	VBN	I-VP	O
in	in	IN	B-PP	O
sequence	sequence	NN	B-NP	O
to	to	TO	B-PP	O
eubacterial	BEGIN-eubacterial	JJ	B-NP	B
FtsZ	FtsZ-INSIDE	NN	I-NP	I
and	and	CC	O	O
is	be	VBZ	B-VP	O
marginally	marginally	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
eukaryotic	BEGIN-eukaryotic	JJ	B-NP	B
tubulins	tubulins-INSIDE	NN	I-NP	I
than	than	IN	B-SBAR	O
are	be	VBP	B-VP	O
bacterial	BEGIN-bacterial	JJ	B-NP	B
FtsZ	FtsZ	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I

Additional	Additional	JJ	B-NP	O
transection	transection	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
ADN	ADN	NN	I-NP	O
eliminated	eliminate	VBD	B-VP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
sigmoidal	sigmoidal	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
MAP	MAP	NN	B-NP	O
and	and	CC	I-NP	O
RSNA	RSNA	NN	I-NP	O
with	with	IN	B-PP	O
further	further	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
resting	rest	VBG	B-NP	O
MAP	MAP	NN	I-NP	O
and	and	CC	I-NP	O
RSNA	RSNA	NN	I-NP	O

Cross	Cross	AFX	B-NP	O
-	-	HYPH	I-NP	O
talk	talk	NN	B-NP	O
between	between	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	I-NP	I
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
C	BEGIN-C	NN	I-NP	B
/	/	SYM	B-NP	I
EBP	EBP-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O

FDP	FDP	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	NN	I-NP	O
1	1	CD	B-NP	O
micrograms.kg	micrograms.kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
intracoronary	intracoronary	JJ	B-NP	O
injection	injection	NN	I-NP	O
increased	increase	VBD	B-VP	O
collateral	collateral	NN	B-NP	O
flow	flow	NN	I-NP	O
,	,	,	O	O
reduced	reduce	VBD	B-VP	O
systemic	systemic	JJ	B-NP	O
artery	artery	NN	I-NP	O
resistance	resistance	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
infarcted	infarcte	VBN	B-NP	O
region	region	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
infarction	infarction	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	JJR	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
experiments	experiment	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
charcoal	charcoal	NN	B-NP	O
,	,	,	O	O
imbiber	imbiber	NN	B-NP	O
beads	bead	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
anion	anion	NN	I-NP	O
exchanges	exchange	NNS	I-NP	O
resins	resin	NNS	I-NP	O
,	,	,	O	O
Dowex	Dowex	NNP	B-NP	O
XFS	XFS	NNP	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
Dowex	Dowex	NNP	B-NP	O
SBR	SBR	NN	I-NP	O
-	-	HYPH	B-NP	O
C1	C1	NN	I-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-NP	O
agents	agent	NNS	I-NP	O
for	for	IN	B-PP	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
dieldrin	dieldrin	NN	B-NP	O
eliminated	eliminate	VBN	B-VP	O
via	via	IN	B-PP	O
feces	fece	NNS	B-NP	O
(	(	(	O	O
droppings	dropping	NNS	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
chickens	chicken	NNS	B-NP	O

Neither	Neither	CC	O	O
raw	raw	JJ	B-NP	O
nor	nor	CC	I-NP	O
retrograded	retrograded	JJ	I-NP	O
resistant	resistant	JJ	I-NP	O
starch	starch	NN	I-NP	O
lowers	lower	NNS	I-NP	O
fasting	fast	VBG	B-VP	O
serum	serum	NN	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
normolipidemic	normolipidemic	JJ	I-NP	O
subjects	subject	NNS	I-NP	O

A	A	DT	B-NP	O
regression	regression	NN	I-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variance	variance	NN	I-NP	O
in	in	IN	B-PP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
was	be	VBD	B-VP	O
predicted	predict	VBN	I-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
leading	leading	JJ	I-NP	O
indicators	indicator	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O

Heterologous	Heterologous	JJ	B-NP	O
hybridization	hybridization	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rps1	BEGIN-rps1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
specific	specific	JJ	I-NP	O
probe	probe	NN	I-NP	O
from	from	IN	B-PP	O
Euglena	Euglena	NNP	B-NP	O
has	have	VBZ	B-VP	O
revealed	reveal	VBN	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
rps1	BEGIN-rps1	NN	B-NP	B
homologous	homologous	JJ	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
within	within	IN	B-PP	O
the	the	DT	B-NP	O
inverted	invert	VBN	I-NP	O
repeat	repeat	NN	I-NP	O
of	of	IN	B-PP	O
Spirodela	Spirodela	NN	B-NP	O
chloroplast	chloroplast	NN	I-NP	O
DNA	DNA	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
fragment	BEGIN-fragment	NN	I-NP	B
BamHI	BamHI	NN	I-NP	I
-	-	HYPH	O	I
V	V-INSIDE	NN	B-NP	I

In	In	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
kidneys	kidney	NNS	I-NP	O
)	)	)	O	O
irrigation	irrigation	NN	B-NP	O
with	with	IN	B-PP	O
Solution	Solution	NNP	B-NP	O
G	G	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
pelvis	pelvis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
dissolution	dissolution	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
infectious	infectious	JJ	I-NP	O
stones	stone	NNS	I-NP	O

Derepression	Derepression	NN	B-NP	O
of	of	IN	B-PP	O
RAR	BEGIN-RAR-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O
by	by	IN	B-PP	O
expressing	express	VBG	B-VP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
-	-	HYPH	I-NP	O
negative	negative	JJ	I-NP	O
corepressor	corepressor	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
embryos	embryo	NNS	B-NP	O
that	that	WDT	B-NP	O
exhibited	exhibit	VBD	B-VP	O
phenotypes	phenotype	NNS	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
treated	treat	VBN	B-VP	O
by	by	IN	B-PP	O
RA	RA	NN	B-NP	O

Flux	Flux	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
paramyxovirus	paramyxovirus	NN	I-NP	O
hemagglutinin	BEGIN-hemagglutinin-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
neuraminidase	BEGIN-neuraminidase-INSIDE	NN	I-NP	B
glycoprotein	glycoprotein	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
endoplasmic	endoplasmic	JJ	I-NP	O
reticulum	reticulum	NN	I-NP	O
activates	activate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GRP1	BEGIN-GRP1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
BiP	BEGIN-BiP-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O

Within	Within	IN	B-PP	O
the	the	DT	B-NP	O
final	final	JJ	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
1	1	CD	B-NP	O
aromatic	aromatic	JJ	I-NP	O
,	,	,	I-ADJP	O
1	1	CD	I-ADJP	O
basic	basic	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
acidic	acidic	JJ	I-NP	O
residues	residue	NNS	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
proposed	propose	VBN	I-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
residues	residue	NNS	I-NP	O
stack	stack	VBP	B-VP	O
with	with	IN	B-PP	O
and	and	CC	O	O
electrostatically	electrostatically	RB	B-VP	O
interact	interact	VBP	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
kinked	kink	VBN	I-NP	O
DNA	DNA	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pyrimidine	pyrimidine	NN	I-NP	O
dimer	dimer	NN	I-NP	O

The	The	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
temperatures	temperature	NNS	I-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
and	and	CC	O	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
on	on	IN	B-PP	O
coagulation	coagulation	NN	B-NP	O
factors	factor	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
measuring	measure	VBG	B-VP	O
clotting	clotting	NN	B-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
recalcification	recalcification	NN	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
partial	partial	JJ	B-NP	O
thromboplastin	BEGIN-thromboplastin-INSIDE	NN	I-NP	B
time	time	NN	I-NP	O
(	(	(	O	O
PTT	PTT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
thromboplastin	BEGIN-thromboplastin-INSIDE	NN	B-NP	B
time	time	NN	I-NP	O
test	test	NN	I-NP	O

Recombinant	Recombinant	JJ	B-NP	O
propeptides	propeptide	NNS	I-NP	O
containing	contain	VBG	B-VP	O
mutations	mutation	NNS	B-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
tryptophan	tryptophan	NN	I-NP	O
residues	residue	NNS	I-NP	O
were	be	VBD	B-VP	O
three	three	CD	B-NP	O
orders	order	NNS	I-NP	O
of	of	IN	B-PP	O
magnitude	magnitude	NN	B-NP	O
less	less	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
as	as	IN	B-PP	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
mature	BEGIN-mature	JJ	B-NP	B
cathepsin	cathepsin	NN	I-NP	I
S	S-INSIDE	NN	I-NP	I
than	than	IN	B-PP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
propeptide	propeptide	NN	I-NP	O

Molecular	Molecular	JJ	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
cDNAs	cDNA	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
alpha	alpha	SYM	B-NP	O
-	-	HYPH	B-VP	O
subunits	subunit	NNS	B-NP	O
of	of	IN	B-PP	O
guanine	BEGIN-guanine	NN	B-NP	B
nucleotide	nucleotide	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
regulatory	regulatory	JJ	B-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
(	(	(	O	O
G	BEGIN-G	NN	B-NP	B
-	-	HYPH	B-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
)	)	)	O	O
has	have	VBZ	B-VP	O
revealed	reveal	VBN	I-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
nine	nine	CD	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
alpha	alpha	SYM	B-NP	O
-	-	HYPH	I-NP	O
subunits	subunit	NNS	I-NP	O

In	In	IN	B-PP	O
all	all	DT	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
soluble	soluble	JJ	B-NP	O
Al	Al	NNP	I-NP	O
became	become	VBD	B-VP	O
insoluble	insoluble	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
after	after	IN	B-PP	O
ingestion	ingestion	NN	B-NP	O

The	The	DT	B-NP	O
free	free	JJ	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
amitriptyline	amitriptyline	NN	B-NP	O
(	(	(	O	O
AT	AT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
equilibrium	equilibrium	NN	B-NP	O
dialysis	dialysis	NN	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
AT	AT	NN	I-NP	O
-	-	HYPH	O	O
treated	treat	VBN	B-VP	O
depressed	depressed	JJ	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
values	value	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
controls	control	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
mean	mean	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
prominent	prominent	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
older	old	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
(	(	(	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
osteoporosis	osteoporosis	NN	I-NP	O
)	)	)	O	O

AU	AU	NN	B-NP	O
-	-	HYPH	I-NP	O
rich	rich	JJ	I-NP	O
elements	element	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
untranslated	untranslated	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
mucin	BEGIN-mucin	NN	I-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
family	family	NN	I-NP	O
of	of	IN	B-PP	O
Trypanosoma	Trypanosoma	NN	B-NP	O
cruzi	cruzi	NN	I-NP	O
confers	confer	VBZ	B-VP	O
mRNA	mRNA	NN	B-NP	O
instability	instability	NN	I-NP	O
and	and	CC	O	O
modulates	modulate	VBZ	B-VP	O
translation	translation	NN	B-NP	O
efficiency	efficiency	NN	I-NP	O

Under	Under	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
(	(	(	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
day	day	NN	I-NP	O
experiment	experiment	NN	I-NP	O
)	)	)	O	O
these	these	DT	B-NP	O
organisms	organism	NNS	I-NP	O
degraded	degrade	VBD	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TEM	TEM	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
alkanes	alkane	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
selected	select	VBN	B-NP	O
polycyclic	polycyclic	JJ	I-NP	O
aromatic	aromatic	JJ	I-NP	O
hydrocarbons	hydrocarbon	NNS	I-NP	O

They	They	PRP	B-NP	O
cause	cause	VBP	B-VP	O
temporary	temporary	JJ	B-NP	O
disability	disability	NN	I-NP	O
,	,	,	O	O
invalidity	invalidity	NN	B-NP	O
and	and	CC	I-NP	O
mortality	mortality	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
productive	productive	JJ	I-NP	O
population	population	NN	I-NP	O
,	,	,	O	O
significantly	significantly	RB	B-VP	O
damaging	damage	VBG	I-VP	O
the	the	DT	B-NP	O
economic	economic	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
country	country	NN	I-NP	O

We	We	PRP	B-NP	O
then	then	RB	B-ADVP	O
isolated	isolate	VBD	B-VP	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	O
-	-	HYPH	I-NP	O
length	length	NN	I-NP	O
coding	coding	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
BACH1	BACH1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
using	use	VBG	B-VP	O
expressed	express	VBN	B-NP	O
sequence	sequence	NN	I-NP	O
tags	tag	NNS	I-NP	O
,	,	,	O	O
reverse	reverse	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
-	-	HYPH	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
and	and	CC	O	O
rapid	rapid	JJ	B-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	O
ends	end	NNS	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
wild	wild	JJ	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
and	and	CC	O	O
mutated	mutate	VBN	B-NP	O
DNA	DNA	NN	I-NP	O
templates	template	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
probes	probe	NNS	B-NP	O
in	in	IN	B-PP	O
DNase	BEGIN-DNase	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
protection	protection	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
sites	site	NNS	B-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
-	-	HYPH	B-NP	O
DNA	DNA	NN	I-NP	O
interaction	interaction	NN	I-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
-	-	:	O	O
-	-	HYPH	B-NP	O
Postlumbar	Postlumbar	NNP	I-NP	O
puncture	puncture	NN	I-NP	O
headache	headache	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
substance	BEGIN-substance	NN	B-NP	B
P	P-INSIDE	NN	I-NP	I
triggered	trigger	VBN	B-VP	O
by	by	IN	B-PP	O
lumbar	lumbar	NN	B-NP	O
puncture	puncture	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
predisposed	predispose	VBD	B-VP	O
to	to	TO	I-VP	O
headache	headache	VB	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
hypersensitivity	hypersensitivity	NN	I-NP	O
to	to	TO	B-PP	O
substance	BEGIN-substance	NN	B-NP	B
P	P-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
repeats	repeat	NNS	I-NP	O
are	be	VBP	B-VP	O
highly	highly	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
both	both	CC	B-PP	O
within	within	IN	I-PP	O
a	a	DT	B-NP	O
given	give	VBN	I-NP	O
element	element	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
between	between	IN	B-PP	O
different	different	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
(	(	(	O	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
divergence	divergence	NN	I-NP	O
)	)	)	O	O

They	They	PRP	B-NP	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
several	several	JJ	B-NP	O
advantages	advantage	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
indices	index	NNS	I-NP	O
of	of	IN	B-PP	O
skewness	skewness	NN	B-NP	O
and	and	CC	O	O
kurtosis	kurtosis	NN	B-NP	O
(	(	(	O	O
square	square	NN	B-NP	O
root	root	NN	I-NP	O
of	of	IN	B-PP	O
b1	b1	NN	B-NP	O
and	and	CC	O	O
b1	b1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
serious	serious	JJ	I-NP	O
drawbacks	drawback	NNS	I-NP	O

Second	Second	RB	B-ADVP	O
,	,	,	O	O
CGGA	CGGA	NN	B-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O
placed	place	VBN	B-VP	O
at	at	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
delta	BEGIN-delta	NN	I-NP	B
MTV	MTV	NN	I-NP	I
-	-	HYPH	B-NP	I
CAT	CAT	NN	I-NP	I
reporter	reporter-INSIDE	NN	I-NP	I
plasmid	plasmid	NN	I-NP	O
conferred	confer	VBD	B-VP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
responsiveness	responsiveness	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mammary	BEGIN-mammary	JJ	I-NP	B
tumor	tumor	NN	I-NP	I
virus	virus	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

Hemorrheological	Hemorrheological	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	O	O
proposed	propose	VBD	B-VP	O
pharmacological	pharmacological	JJ	B-NP	O
uses	use	NNS	I-NP	O

Stimulation	Stimulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endosteal	endosteal	JJ	I-NP	O
bone	bone	NN	I-NP	O
formation	formation	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
mainly	mainly	RB	B-ADJP	O
impaired	impaired	JJ	I-ADJP	O
in	in	IN	B-PP	O
D	D	NN	B-NP	O
-	-	HYPH	B-NP	O
depleted	deplete	VBN	I-NP	O
rats	rat	NNS	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
trabecular	trabecular	JJ	B-NP	O
bone	bone	NN	I-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
,	,	,	O	O
in	in	FW	B-PP	O
-	-	HYPH	B-NP	O
D	D	NN	I-NP	O
mother	mother	NN	I-NP	O
rats	rat	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
bone	bone	NN	I-NP	O
ash	ash	NN	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
bone	bone	NN	I-NP	O
calcium	calcium	NN	I-NP	O

Biochemical	Biochemical	JJ	B-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
using	use	VBG	B-VP	O
erythrocyte	erythrocyte	NN	B-NP	O
enzyme	enzyme	NN	I-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
vitamin	vitamin	NN	I-NP	O
levels	level	NNS	I-NP	O

The	The	DT	B-NP	O
Polycomb	BEGIN-Polycomb	NN	I-NP	B
group	group	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
silenced	silenced	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
developmentally	developmentally	RB	I-NP	O
regulated	regulate	VBN	I-NP	O
genes	gene	NNS	I-NP	O

Repeated	Repeat	VBN	B-NP	O
interferon	BEGIN-interferon	NN	I-NP	B
-	-	HYPH	O	I
beta	beta-INSIDE	NN	B-NP	I
(	(	(	O	O
IFN	BEGIN-IFN	NN	B-NP	B
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
)	)	)	O	O
silencer	silencer	NN	B-NP	O
B	B	NN	I-NP	O
motifs	motif	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
lysozyme	BEGIN-lysozyme	NN	I-NP	B
silencer	silencer	NN	I-NP	I
1	1	CD	I-NP	I
motif	motif-INSIDE	NN	I-NP	I
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CD1	BEGIN-CD1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

We	We	PRP	B-NP	O
find	find	VBP	B-VP	O
that	that	IN	B-SBAR	O
Fus1p	BEGIN-Fus1p-INSIDE	NN	B-NP	B
and	and	CC	O	O
Kss1p	BEGIN-Kss1p-INSIDE	NN	B-NP	B
both	both	CC	O	O
control	control	NN	B-NP	O
G1	G1	NN	I-NP	O
arrest	arrest	NN	I-NP	O
through	through	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
functions	function	NNS	I-NP	O
that	that	WDT	B-NP	O
operate	operate	VBP	B-VP	O
in	in	IN	B-PP	O
parallel	parallel	NN	B-NP	O
with	with	IN	B-PP	O
Far1p	BEGIN-Far1p-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
Id1	BEGIN-Id1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
HLH	HLH	JJ	I-NP	O
domain	domain	NN	I-NP	O
highly	highly	RB	B-VP	O
conserved	conserve	VBN	I-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
dnHLH	BEGIN-dnHLH	JJ	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
drosophila	drosophila	NN	B-NP	O

The	The	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pilocytic	pilocytic	JJ	I-NP	O
astrocytoma	astrocytoma	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
relation	relation	NN	I-NP	O
between	between	IN	B-PP	O
MIB	BEGIN-MIB	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
labeling	labeling	NN	I-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-ADJP	O
and	and	CC	O	O
neuro	neuro	AFX	B-ADJP	O
-	-	HYPH	I-ADJP	O
radiological	radiological	JJ	I-ADJP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O

Desensitization	Desensitization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
growth	BEGIN-growth	NN	I-NP	B
hormone	hormone-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
Janus	BEGIN-Janus	NN	I-NP	B
kinase	kinase	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
Jak	BEGIN-Jak	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
/	/	SYM	O	O
signal	BEGIN-signal	NN	B-NP	B
transducer	transducer	NN	I-NP	I
and	and	CC	O	I
activator	activator	NN	B-NP	I
of	of	IN	B-PP	I
transcription	transcription	NN	B-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
Stat1	BEGIN-Stat1-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	B-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
requires	require	VBZ	B-VP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
and	and	CC	O	O
phospholipase	BEGIN-phospholipase	NN	B-NP	B
C	C-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
exercise	exercise	NN	B-NP	O
training	training	NN	I-NP	O
can	can	MD	B-VP	O
augment	augment	VB	I-VP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
diastolic	diastolic	JJ	I-NP	O
filling	filling	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
during	during	IN	B-PP	O
exercise	exercise	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	O	O
whether	whether	IN	B-SBAR	O
any	any	DT	B-NP	O
correlation	correlation	NN	I-NP	O
exists	exist	VBZ	B-VP	O
between	between	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
filling	filling	NN	I-NP	O
and	and	CC	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O

Alterations	Alteration	NNS	B-NP	O
in	in	IN	B-PP	O
TCR	BEGIN-TCR-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
MHC	BEGIN-MHC-INSIDE	NN	I-NP	B
contacts	contact	VBZ	B-VP	O
subsequent	subsequent	JJ	B-ADJP	O
to	to	TO	B-PP	O
cross	cross	AFX	B-NP	O
-	-	HYPH	I-NP	O
recognition	recognition	NN	I-NP	O
of	of	IN	B-PP	O
class	BEGIN-class	NN	B-NP	B
I	I	CD	I-NP	I
MHC	BEGIN-MHC-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	O	O
singly	singly	RB	B-NP	O
substituted	substitute	VBN	I-NP	O
peptide	peptide	NN	I-NP	O
variants	variant	NNS	I-NP	O

Scalp	Scalp	NN	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
laser	laser	NN	I-NP	O
Doppler	Doppler	NN	I-NP	O
flow	flow	NN	I-NP	O
sensor	sensor	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
incorporated	incorporate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
transcutaneous	transcutaneous	JJ	I-NP	O
PO1	PO1	NN	I-NP	O
electrode	electrode	NN	I-NP	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
overall	overall	JJ	I-NP	O
functional	functional	JJ	I-NP	O
similarity	similarity	NN	I-NP	O
between	between	IN	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
fos	fos	NN	I-NP	I
promoters	promoters-INSIDE	NN	I-NP	I
,	,	,	O	O
since	since	IN	B-SBAR	O
transfection	transfection	NN	B-NP	O
of	of	IN	B-PP	O
excess	excess	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
promoter	promoter	NN	B-NP	O
DNA	DNA	NN	I-NP	O
into	into	IN	B-PP	O
intact	intact	JJ	B-NP	O
HeLa	HeLa	NN	I-NP	O
cells	cell	NNS	I-NP	O
modulates	modulate	VBZ	B-VP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heterologous	heterologous	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
construct	construct	NN	I-NP	O

Detailed	Detailed	JJ	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
cp1	BEGIN-cp1-INSIDE	NN	B-NP	B
and	and	CC	O	O
human	BEGIN-human	JJ	B-NP	B
calpactin	calpactin	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
substantial	substantial	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
dissimilarity	dissimilarity	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
domain	domain	NN	I-NP	O
encoding	encode	VBG	B-VP	O
amino	amino	JJ	B-NP	O
acids	acid	NNS	I-NP	O
between	between	IN	B-PP	O
residues	residue	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
which	which	WDT	B-NP	O
includes	include	VBZ	B-VP	O
a	a	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
site	site	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
,	,	,	O	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
residues	residue	NNS	I-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
physiological	physiological	JJ	I-NP	O
significance	significance	NN	I-NP	O

Power	Power	NN	B-NP	O
deposition	deposition	NN	I-NP	O
by	by	IN	B-PP	O
inverse	inverse	JJ	B-NP	O
-	-	HYPH	I-NP	O
bremsstrahlung	bremsstrahlung	NN	I-NP	O
is	be	VBZ	B-VP	O
modeled	model	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
scheme	scheme	NN	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
Gaussian	Gaussian	JJ	B-NP	O
quadrature	quadrature	NN	I-NP	O
to	to	TO	B-VP	O
accommodate	accommodate	VB	I-VP	O
a	a	DT	B-NP	O
deposition	deposition	NN	I-NP	O
rate	rate	NN	I-NP	O
whose	whose	WP$	B-NP	O
spatial	spatial	JJ	I-NP	O
variation	variation	NN	I-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
nonuniform	nonuniform	JJ	I-ADJP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
malaria	malaria	NN	I-NP	O
vectors	vector	NNS	I-NP	O
Anopheles	Anophele	VBZ	B-VP	O
funestus	funestus	NN	B-NP	O
and	and	CC	I-NP	O
An.	An.	NNP	I-NP	O
gambiae	gambiae	NNS	I-NP	O
have	have	VBP	B-VP	O
both	both	DT	B-NP	O
become	become	VBP	B-VP	O
more	more	RBR	B-ADJP	O
abundant	abundant	JJ	I-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
1s	1	NNS	I-NP	O
and	and	CC	I-NP	O
1s	1	NNS	I-NP	O
and	and	CC	I-NP	O
sporozoite	sporozoite	NN	I-NP	O
-	-	HYPH	B-NP	O
positive	positive	JJ	I-NP	O
specimens	specimen	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O

Greer	Greer	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
L.A	L.A	NN	B-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
Msx	BEGIN-Msx	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Msx	BEGIN-Msx	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
studied	study	VBN	I-VP	O
during	during	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
osteoblast	osteoblast	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Dlx	BEGIN-Dlx-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
this	this	DT	B-NP	O
context	context	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
-	-	HYPH	B-NP	O
expressed	express	VBN	I-NP	O
genes	gene	NNS	I-NP	O
is	be	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O

The	The	DT	B-NP	O
salt	salt	NN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
two	two	CD	B-NP	O
ion	ion	NN	I-NP	O
pairs	pair	NNS	I-NP	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
Zn1+	Zn1+	NN	B-NP	O
(	(	(	O	O
NC	NC	NN	B-NP	O
-	-	HYPH	B-NP	O
F1	F1	NN	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
polynucleotide	polynucleotide	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
one	one	CD	B-NP	O
ion	ion	NN	I-NP	O
pair	pair	NN	I-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
metal	metal	NN	I-NP	O
-	-	HYPH	O	O
free	free	JJ	B-NP	O
peptide	peptide	NN	I-NP	O
-	-	HYPH	B-NP	O
nucleic	nucleic	JJ	I-NP	O
acid	acid	NN	I-NP	O
complex	complex	NN	I-NP	O

Histopathologically	Histopathologically	RB	B-ADVP	O
,	,	,	O	O
(	(	(	O	O
mice	mouse	NNS	B-NP	O
killed	kill	VBN	B-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
GMC	GMC	NN	B-NP	O
-	-	HYPH	B-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
given	give	VBN	B-VP	O
orally	orally	RB	B-ADVP	O
)	)	)	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
hyperemia	hyperemia	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
parenchymal	parenchymal	JJ	B-NP	O
degeneration	degeneration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kidney	kidney	NN	I-NP	O
tubuli	tubuli	NN	I-NP	O
epithelium	epithelium	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
edema	edema	NN	B-NP	O
and	and	CC	I-NP	O
emphysema	emphysema	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O

Cytochemical	Cytochemical	JJ	B-NP	O
and	and	CC	I-NP	O
ultrastructural	ultrastructural	JJ	I-NP	O
observations	observation	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tegument	tegument	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
trematode	trematode	NN	I-NP	O
Megalodiscus	Megalodiscus	NN	I-NP	O
temperatus	temperatus	NN	I-NP	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
biohydrogenation	biohydrogenation	NN	B-NP	O
of	of	IN	B-PP	O
C1	C1	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
declined	decline	VBD	B-VP	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
h	h	NN	I-NP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
percentage	percentage	NN	I-NP	O
unit	unit	NN	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
C1	C1	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
added	add	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
substrate	substrate	NN	I-NP	O

Transient	Transient	JJ	B-NP	O
thyrotoxicosis	thyrotoxicosis	NN	I-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	O
anti	anti	AFX	I-NP	O
-	-	HYPH	I-NP	O
phospholipid	phospholipid	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O

The	The	DT	B-NP	O
highest	high	JJS	I-NP	O
TTX	BEGIN-TTX-INSIDE	NN	I-NP	B
content	content	NN	I-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
microg	microg	NN	I-NP	O
/	/	SYM	B-NP	O
g	g	NN	I-NP	O
in	in	IN	B-PP	O
N.	N.	NNP	B-NP	O
livescens	livescen	NNS	I-NP	O

The	The	DT	B-NP	O
BUR	BUR	NN	I-NP	O
was	be	VBD	B-VP	O
set	set	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
min	min	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
IT	IT	NN	I-NP	O
at	at	IN	B-PP	O
.1	.1	CD	B-NP	O
seconds	second	NNS	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
of	of	IN	B-PP	O
EM	EM	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
neutrophil	neutrophil	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
molecules	molecule	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
L	BEGIN-L	NN	B-NP	B
-	-	HYPH	B-NP	I
selectin	selectin-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Mac	BEGIN-Mac	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

It	It	PRP	B-NP	O
contains	contain	VBZ	B-VP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
1	1	CD	I-NP	O
introns	intron	NNS	I-NP	O
,	,	,	O	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
significant	significant	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
variant	variant	JJ	B-NP	O
transcripts	transcript	NNS	I-NP	O
that	that	WDT	B-NP	O
maintain	maintain	VBP	B-VP	O
the	the	DT	B-NP	O
original	original	JJ	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
of	of	IN	B-PP	O
MRP	BEGIN-MRP	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I

This	This	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
/	/	SYM	I-NP	O
organellar	organellar	JJ	I-NP	O
gene	gene	NN	I-NP	O
transfer	transfer	NN	I-NP	O
event	event	NN	I-NP	O
is	be	VBZ	B-VP	O
strikingly	strikingly	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
experimentally	experimentally	RB	I-NP	O
accessible	accessible	JJ	I-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
integration	integration	NN	I-NP	O
of	of	IN	B-PP	O
introduced	introduce	VBN	B-NP	O
heterologous	heterologous	JJ	I-NP	O
DNA	DNA	NN	I-NP	O

Under	Under	IN	B-PP	O
control	control	NN	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
pretreatment	pretreatment	NN	B-NP	O
with	with	IN	B-PP	O
lithium	lithium	NN	B-NP	O
during	during	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
modify	modify	VB	I-VP	O
the	the	DT	B-NP	O
hyperlocomotion	hyperlocomotion	NN	I-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
d	d	NN	B-NP	O
-	-	HYPH	O	O
amphetamine	amphetamine	NN	B-NP	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
GIY	BEGIN-GIY	NN	I-NP	B
-	-	HYPH	B-NP	I
YIG	YIG-INSIDE	NN	I-NP	I
ORF	ORF	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
canonical	canonical	JJ	I-NP	O
LAGLI	BEGIN-LAGLI	NN	I-NP	B
-	-	HYPH	B-NP	I
DADG	DADG	NN	I-NP	I
-	-	HYPH	B-NP	I
GIY	BEGIN-GIY	NN	I-NP	B
-	-	HYPH	I-NP	I
YIG	YIG-INSIDE-INSIDE	NN	I-NP	I
ORF	ORF	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
generated	generate	VBN	I-VP	O
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
integration	integration	NN	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
endonuclease	endonuclease	NN	B-NP	O
activities	activity	NNS	I-NP	O
which	which	WDT	B-NP	O
recognize	recognize	VBP	B-VP	O
and	and	CC	I-VP	O
cut	cut	VBP	I-VP	O
the	the	DT	B-NP	O
insertion	insertion	NN	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
optional	optional	JJ	I-NP	O
sequence	sequence	NN	I-NP	O

This	This	DT	B-NP	O
article	article	NN	I-NP	O
describes	describe	VBZ	B-VP	O
a	a	DT	B-NP	O
program	program	NN	I-NP	O
that	that	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
percent	percent	NN	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
inventory	inventory	NN	B-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
five	five	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
interval	interval	NN	I-NP	O

Risk	Risk	NN	B-NP	O
ratios	ratio	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
age	age	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
with	with	IN	B-PP	O
number	number	NN	B-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
biopsies	biopsy	NNS	I-NP	O
,	,	,	O	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
estrogen	estrogen	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
time	time	NN	B-NP	O
between	between	IN	B-PP	O
screenings	screening	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
comparison	comparison	NN	I-NP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
mammograms	mammogram	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
radiologist	radiologist	NN	I-NP	O
's	's	POS	B-NP	O
tendency	tendency	NN	I-NP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
mammograms	mammogram	NNS	B-NP	O
abnormal	abnormal	JJ	B-ADJP	O

The	The	DT	B-NP	O
pharmacokinetics	pharmacokinetic	NNS	I-NP	O
were	be	VBD	B-VP	O
best	well	RBS	I-VP	O
described	describe	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
compartment	compartment	NN	I-NP	O
open	open	JJ	I-NP	O
model	model	NN	I-NP	O
giving	give	VBG	B-VP	O
distribution	distribution	NN	B-NP	O
half	half	NN	I-NP	O
-	-	HYPH	B-NP	O
lives	life	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
elimination	elimination	NN	B-NP	O
half	half	NN	I-NP	O
-	-	HYPH	B-NP	O
lives	life	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
for	for	IN	B-PP	O
oxolinic	oxolinic	JJ	B-NP	O
acid	acid	NN	I-NP	O
and	and	CC	O	O
oxytetracycline	oxytetracycline	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
substrate	substrate	NN	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
RSK1	BEGIN-RSK1-INSIDE	NN	B-NP	B
differed	differ	VBD	B-VP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
reported	report	VBN	B-VP	O
for	for	IN	B-PP	O
other	other	JJ	B-NP	O
isoforms	isoform	NNS	I-NP	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
link	link	NN	I-NP	O
between	between	IN	B-PP	O
alterations	alteration	NNS	B-NP	O
in	in	IN	B-PP	O
platelet	BEGIN-platelet	NN	B-NP	B
-	-	HYPH	B-NP	I
derived	derive	VBN	I-NP	I
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
PDGF	BEGIN-PDGF-INSIDE	NN	B-NP	B
)	)	)	O	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
ornithine	BEGIN-ornithine	NN	B-NP	B
decarboxylase	decarboxylase-INSIDE	NN	I-NP	I
(	(	(	O	O
ODC	BEGIN-ODC-INSIDE	NN	B-NP	B
)	)	)	O	O
expression	expression	NN	B-NP	O
during	during	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
conversion	conversion	NN	I-NP	O

Fosinopril	Fosinopril	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
ISH	ISH	NN	B-NP	O

1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

Loss	Loss	NN	B-NP	O
of	of	IN	B-PP	O
pRb	BEGIN-pRb-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
binding	binding	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
transforming	transform	VBG	B-VP	O
activity	activity	NN	B-NP	O

Influence	Influence	NN	B-NP	O
of	of	IN	B-PP	O
huanglian	huanglian	JJ	B-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
huangqin	huangqin	NN	B-NP	O
and	and	CC	I-NP	O
gancao	gancao	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
erythrocytic	erythrocytic	JJ	I-NP	O
osmotic	osmotic	JJ	I-NP	O
fragilitas	fragilita	NNS	I-NP	O
of	of	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
glucose	BEGIN-glucose	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
phosphate	phosphate	NN	I-NP	I
dehydrogenase	dehydrogenase-INSIDE	NN	I-NP	I
deficiency	deficiency	NN	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
]	]	)	O	O
OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
common	common	JJ	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
Huanglian	Huanglian	JJ	B-NP	O
(	(	(	O	O
Coptis	Coptis	NN	B-NP	O
chinensis	chinensis	NN	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
erythrocytic	erythrocytic	JJ	I-NP	O
osmotic	osmotic	JJ	I-NP	O
fragilitas	fragilita	NNS	I-NP	O
of	of	IN	B-PP	O
glucose	BEGIN-glucose	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
phosphate	phosphate	NN	I-NP	I
dehydrogenase	dehydrogenase-INSIDE	NN	I-NP	I
(	(	(	O	O
G1PD	BEGIN-G1PD-INSIDE	NN	B-NP	B
)	)	)	O	O
deficiency	deficiency	NN	B-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O

Inhibitory	Inhibitory	JJ	B-NP	O
receptors	receptor	NNS	I-NP	O
are	be	VBP	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
characteristic	characteristic	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
known	know	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
immunoreceptor	immunoreceptor	NN	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
-	-	HYPH	O	O
based	base	VBN	B-VP	O
inhibitory	inhibitory	JJ	B-NP	O
motif	motif	NN	I-NP	O
(	(	(	O	O
ITIM	ITIM	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
tail	tail	NN	I-NP	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
Healon	Healon	NNP	B-NP	O
and	and	CC	I-NP	O
Amvisc	Amvisc	NNP	I-NP	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
toluenediamine	toluenediamine	NN	I-NP	O
in	in	IN	B-PP	O
hydrolysed	hydrolyse	VBN	B-NP	O
plasma	plasma	NN	I-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	O
after	after	IN	B-PP	O
test	test	NN	B-NP	O
-	-	HYPH	B-NP	O
chamber	chamber	NN	I-NP	O
exposure	exposure	NN	I-NP	O
of	of	IN	B-PP	O
humans	human	NNS	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
toluene	toluene	NN	I-NP	O
diisocyanate	diisocyanate	NN	I-NP	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
facilities	facility	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prognosis	prognosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
tetanus	tetanus	NN	B-NP	O
specially	specially	RB	B-ADVP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
considering	consider	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
therapy	therapy	NN	I-NP	O
deserve	deserve	VBP	B-VP	O
further	further	JJ	B-NP	O
study	study	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
assistance	assistance	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
tetanus	tetanus	NN	B-NP	O

Interaction	Interaction	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
activity	activity	NN	B-NP	O
CBF	BEGIN-CBF-INSIDE	NN	I-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
cyt	BEGIN-BEGIN-cyt	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O
element	element-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Agrobacterium	Agrobacterium	NN	I-NP	O
tumefaciens	tumefacien	VBZ	B-VP	O
T	T	NN	B-NP	O
-	-	HYPH	I-NP	O
DNA	DNA	NN	I-NP	O
gene	gene	NN	I-NP	O
T	BEGIN-T	NN	I-NP	B
-	-	HYPH	B-NP	I
CYT	CYT-INSIDE	NN	I-NP	I
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
cyt	BEGIN-cyt	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
directed	direct	VBN	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
tissue	tissue	NN	I-NP	O
types	type	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
repetitive	repetitive	JJ	B-NP	O
GAA	GAA	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
enhance	enhance	VBP	B-VP	O
splicing	splicing	NN	B-NP	O
by	by	IN	B-PP	O
binding	bind	VBG	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
complex	complex	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
binding	binding	NN	I-NP	O
protein	protein	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
general	general	JJ	I-NP	O
splicing	splicing	NN	I-NP	O
activator	activator	NN	I-NP	O
that	that	IN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
,	,	,	O	O
recruit	recruit	VBP	B-VP	O
additional	additional	JJ	B-NP	O
SR	BEGIN-SR	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I

Organization	Organization	NN	B-NP	O
of	of	IN	B-PP	O
exons	exon	NNS	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
VEGF	VEGF	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
generates	generate	VBZ	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
isoforms	isoform	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
predict	predict	VB	I-VP	O
a	a	DT	B-NP	O
fourth	fourth	JJ	I-NP	O
VEGF	BEGIN-VEGF	NN	I-NP	B
isoform	isoform-INSIDE	NN	I-NP	I
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
human	BEGIN-human	JJ	B-NP	B
VEGF1	VEGF1-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
papers	paper	NNS	I-NP	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
broad	broad	JJ	I-NP	O
perspective	perspective	NN	I-NP	O
of	of	IN	B-PP	O
MPAs	MPA	NNS	B-NP	O
and	and	CC	O	O
include	include	VBP	B-VP	O
social	social	JJ	B-NP	O
,	,	,	I-NP	O
economic	economic	JJ	I-NP	O
,	,	,	I-NP	O
cultural	cultural	JJ	I-NP	O
,	,	,	I-NP	O
biological	biological	JJ	I-NP	O
and	and	CC	I-NP	O
statistical	statistical	JJ	I-NP	O
components	component	NNS	I-NP	O

The	The	DT	B-NP	O
great	great	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
vein	vein	NN	I-NP	O
flow	flow	NN	I-NP	O
became	become	VBD	B-VP	O
zero	zero	CD	B-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
at	at	IN	B-PP	O
zero	zero	CD	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
moment	moment	NN	I-NP	O
(	(	(	O	O
dead	dead	JJ	B-NP	O
time	time	NN	I-NP	O
)	)	)	O	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
initiation	initiation	NN	I-NP	O
of	of	IN	B-PP	O
reperfusion	reperfusion	NN	B-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
histamine	BEGIN-histamine	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
synthesis	synthesis	NN	I-NP	O

Issues	Issue	NNS	B-NP	O
discussed	discuss	VBN	B-VP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
validity	validity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MMPI	MMPI	NN	I-NP	O
Mf	Mf	NN	I-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
questions	question	NNS	B-NP	O
of	of	IN	B-PP	O
sample	sample	NN	B-NP	O
representativeness	representativeness	NN	I-NP	O
,	,	,	O	O
whether	whether	IN	B-SBAR	O
``	``	``	O	O
straights	straight	NNS	B-NP	O
''	''	''	O	O
can	can	MD	B-VP	O
do	do	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
research	research	NN	I-NP	O
on	on	IN	B-PP	O
homosexuality	homosexuality	NN	B-NP	O
,	,	,	O	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
heterosexual	heterosexual	JJ	B-NP	O
and	and	CC	I-NP	O
homosexual	homosexual	JJ	I-NP	O
sexuality	sexuality	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
subculture	subculture	NN	B-NP	O
acculturation	acculturation	NN	I-NP	O
in	in	IN	B-PP	O
homosexual	homosexual	JJ	B-NP	O
psychological	psychological	JJ	I-NP	O
adjustment	adjustment	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
cluster	cluster	NN	B-NP	O
-	-	HYPH	B-NP	O
analysis	analysis	NN	I-NP	O
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
typologies	typology	NNS	B-NP	O
of	of	IN	B-PP	O
homosexualities	homosexuality	NNS	B-NP	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
some	some	DT	B-NP	O
defects	defect	NNS	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
BS	BS	NNP	B-NP	O
,	,	,	I-NP	O
WS	WS	NNP	I-NP	O
or	or	CC	I-NP	O
RTS	RTS	NNP	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
unrestrained	unrestrained	JJ	B-NP	O
recombination	recombination	NN	I-NP	O

LAC1	BEGIN-LAC1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-NP	O
protein	protein	NN	I-NP	O
that	that	WDT	B-NP	O
regulates	regulate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lactose	BEGIN-lactose	JJ	I-NP	B
-	-	HYPH	I-NP	I
galactose	galactose	NN	I-NP	I
regulon	regulon-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
Kluyveromyces	Kluyveromyce	NNS	B-NP	O
lactis	lactis	NN	I-NP	O

Some	Some	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
excited	excite	VBN	I-VP	O
,	,	,	O	O
others	other	NNS	B-NP	O
inhibited	inhibit	VBN	B-VP	O
by	by	IN	B-PP	O
,	,	,	O	O
and	and	CC	O	O
only	only	RB	B-NP	O
some	some	DT	I-NP	O
were	be	VBD	B-VP	O
directionally	directionally	RB	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
optomotor	optomotor	NN	I-NP	O
stimulus	stimulus	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
cloned	clone	VBN	I-VP	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
SLBP	BEGIN-SLBP-INSIDE	NN	I-NP	B
from	from	IN	B-PP	O
humans	human	NNS	B-NP	O
,	,	,	O	O
mice	mouse	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
frogs	frog	NNS	B-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
recently	recently	RB	I-NP	O
developed	develop	VBN	I-NP	O
yeast	yeast	NN	I-NP	O
three	three	CD	I-NP	O
-	-	HYPH	I-NP	O
hybrid	hybrid	NN	I-NP	O
system	system	NN	I-NP	O

The	The	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
event	event	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
underlying	underlie	VBG	B-VP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
specificities	specificity	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
(	(	(	O	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
native	native	JJ	I-NP	O
target	target	NN	I-NP	O
genes	gene	NNS	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
important	important	JJ	I-NP	O
issue	issue	NN	I-NP	O
that	that	WDT	B-NP	O
remains	remain	VBZ	B-VP	O
poorly	poorly	RB	B-VP	O
understood	understand	VBN	I-VP	O

Alternative	Alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
serotonin	serotonin	NN	I-NP	I
transporter	transporter	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Nuclear	Nuclear	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
bound	bind	VBD	B-VP	O
the	the	DT	B-NP	O
cad	BEGIN-cad	JJ	I-NP	B
+1	+1	NN	I-NP	I
/	/	SYM	B-NP	I
+1	+1	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
in	in	IN	B-PP	O
electromobility	electromobility	NN	B-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
;	;	:	O	O
antibodies	antibody	NNS	B-NP	O
specific	specific	JJ	B-ADJP	O
to	to	TO	B-PP	O
USF	BEGIN-USF-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Max	BEGIN-Max-INSIDE	NN	I-NP	B
blocked	block	VBD	B-VP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
growth	growth	NN	I-NP	O
-	-	HYPH	B-VP	O
regulated	regulate	VBN	B-NP	O
protein	protein	NN	I-NP	O
-	-	HYPH	B-NP	O
DNA	DNA	NN	I-NP	O
complexes	complex	NNS	I-NP	O

For	For	IN	B-PP	O
Thermus	Thermus	NNP	B-NP	O
strain	strain	NN	I-NP	O
ZO1	BEGIN-ZO1	NN	I-NP	B
dihydroorotase	dihydroorotase-INSIDE	NN	I-NP	I
(	(	(	O	O
DHOase	BEGIN-DHOase-INSIDE	NN	B-NP	B
;	;	:	O	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
pyrC	BEGIN-pyrC-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
similarity	similarity	NN	I-NP	O
scores	score	NNS	I-NP	O
(	(	(	O	O
about	about	RB	B-NP	O
1	1	CD	I-NP	O
identity	identity	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
with	with	IN	B-PP	O
DHOases	BEGIN-DHOase-INSIDE	NNS	B-NP	I
from	from	IN	B-PP	O
B.	B.	NNP	B-NP	O
caldolyticus	caldolyticus	NN	I-NP	O
and	and	CC	I-NP	O
Bacillus	Bacillus	NN	I-NP	O
subtilis	subtili	NNS	I-NP	O

This	This	DT	B-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
SP	BEGIN-SP	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
SP	BEGIN-BEGIN-BEGIN-SP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
peptides	peptide-INSIDEs-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
not	not	RB	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
differential	differential	JJ	I-NP	O
uptake	uptake	NN	I-NP	O
by	by	IN	B-PP	O
cell	cell	NN	B-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
times	time	NNS	I-NP	O
more	more	JJR	I-NP	O
SP	BEGIN-BEGIN-SP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
peptide	peptide-INSIDE	NN	I-NP	I
could	could	MD	B-VP	O
be	be	VB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
than	than	IN	B-PP	O
SP	BEGIN-BEGIN-SP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
peptide	peptide-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
experiments	experiment	NNS	B-NP	O
using	use	VBG	B-VP	O
radiolabeled	radiolabele	VBN	B-NP	O
peptides	peptide	NNS	I-NP	O

The	The	DT	B-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
Bv1	BEGIN-Bv1-INSIDE	NN	B-NP	B
,	,	,	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
divergent	divergent	JJ	I-NP	O
copy	copy	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
(	(	(	O	O
approx	approx	NN	B-NP	O

The	The	DT	B-NP	O
carboxy	carboxy	NN	I-NP	O
-	-	HYPH	B-NP	O
proximal	proximal	JJ	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
VP1	BEGIN-VP1-INSIDE	NN	I-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
contain	contain	VBP	B-VP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
homology	homology	NN	I-NP	O
,	,	,	O	O
displayed	display	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
conservation	conservation	NN	B-NP	O
in	in	IN	B-PP	O
structural	structural	JJ	B-NP	O
features	feature	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
a	a	DT	B-NP	O
hydrophilic	hydrophilic	JJ	I-NP	O
,	,	,	I-NP	O
highly	highly	RB	I-NP	O
basic	basic	JJ	I-NP	O
domain	domain	NN	I-NP	O

The	The	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
at	at	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
starting	start	VBG	I-NP	O
site	site	NN	I-NP	O
showed	show	VBD	B-VP	O
1	1	CD	B-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Escherichia	BEGIN-Escherichia	FW	I-NP	B
coli	coli	FW	I-NP	I
sigma	sigma	SYM	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
two	two	CD	I-NP	O
ORFs	ORF	NNS	I-NP	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
similarity	similarity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
replication	replication	NN	I-NP	O
protein	protein	NN	I-NP	O
from	from	IN	B-PP	O
plasmid	plasmid	NN	B-NP	O
pTiK1	pTiK1	NN	I-NP	O
of	of	IN	B-PP	O
Thiobacillus	Thiobacillus	NN	B-NP	O
intermedius	intermedius	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
CoIE1	CoIE1	NN	I-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
plasmids	plasmid	NNS	I-NP	O

A	A	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
blind	blind	JJ	I-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
topical	topical	JJ	B-NP	O
miconazole	miconazole	NN	I-NP	O
and	and	CC	I-NP	O
clotrimazole	clotrimazole	NN	I-NP	O
against	against	IN	B-PP	O
superficial	superficial	JJ	B-NP	O
fungal	fungal	JJ	I-NP	O
infections	infection	NNS	I-NP	O
and	and	CC	O	O
erythrasma	erythrasma	NN	B-NP	O

Lumbar	Lumbar	NN	B-NP	O
spine	spine	NN	I-NP	O
bone	bone	NN	I-NP	O
mineral	mineral	NN	I-NP	O
density	density	NN	I-NP	O
(	(	(	O	O
BMD	BMD	NN	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
dual	dual	JJ	B-NP	O
-	-	HYPH	I-NP	O
energy	energy	NN	I-NP	O
X	X	NN	I-NP	O
-	-	HYPH	O	O
ray	ray	NN	B-NP	O
absorptiometry	absorptiometry	NN	I-NP	O
(	(	(	O	O
DXA	DXA	NN	B-NP	O
)	)	)	O	O
increased	increase	VBD	B-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
in	in	IN	B-PP	O
groups	group	NNS	B-NP	O
L	L	NN	I-NP	O
,	,	,	O	O
M	M	NN	B-NP	O
and	and	CC	I-NP	O
H	H	NN	I-NP	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
responses	response	NNS	B-NP	O
in	in	IN	B-PP	O
groups	group	NNS	B-NP	O
M	M	NN	I-NP	O
and	and	CC	I-NP	O
H	H	NN	I-NP	O
being	be	VBG	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
L	L	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	JJR	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Mann	Mann	NNP	B-NP	O
-	-	HYPH	I-NP	O
Whitney	Whitney	NNP	I-NP	O
U	U	NN	I-NP	O
-	-	HYPH	I-NP	O
test	test	NN	I-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
clone	clone	NN	I-NP	O
representing	represent	VBG	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
message	message	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
isolated	isolate	VBN	I-VP	O

This	This	DT	B-NP	O
unusual	unusual	JJ	I-NP	O
behaviour	behaviour	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
amino	amino	JJ	I-NP	I
acid	acid	NN	I-NP	I
-	-	HYPH	B-NP	I
long	long	JJ	I-NP	I
CDR	CDR	NN	I-NP	I
-	-	HYPH	B-NP	I
H1	H1-INSIDE	NN	I-NP	I
and	and	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
value	value	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
design	design	NN	I-NP	O
of	of	IN	B-PP	O
'single	'single	JJ	B-NP	O
domain	domain	NN	I-NP	O
'	'	POS	B-NP	O
antibodies	antibody	NNS	I-NP	O

Bleeding	Bleeding	NN	B-NP	O
was	be	VBD	B-VP	O
successfully	successfully	RB	I-VP	O
prevented	prevent	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
combined	combined	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
incorporating	incorporate	VBG	B-VP	O
IV	IV	CD	B-NP	O
desmopressin	desmopressin	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
antifibrinolytic	antifibrinolytic	JJ	I-NP	O
agent	agent	NN	I-NP	O
(	(	(	O	O
tranexamic	tranexamic	JJ	B-NP	O
acid	acid	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
local	local	JJ	B-NP	O
methods	method	NNS	I-NP	O
(	(	(	O	O
surgical	surgical	JJ	B-NP	O
glue	glue	NN	I-NP	O
and	and	CC	I-NP	O
compression	compression	NN	I-NP	O
techniques	technique	NNS	I-NP	O
)	)	)	O	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
are	be	VBP	B-VP	O
transcribed	transcribe	VBN	I-VP	O
separately	separately	RB	B-ADVP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Systemic	Systemic	JJ	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
increase	increase	VBP	B-VP	O
bone	bone	NN	B-NP	O
mineral	mineral	NN	I-NP	O
density	density	NN	I-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
ossification	ossification	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
longitudinal	longitudinal	JJ	I-NP	O
ligament	ligament	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
after	after	IN	B-PP	O
middle	middle	JJ	B-NP	O
age	age	NN	I-NP	O

FdsR	BEGIN-FdsR-INSIDE	NN	B-NP	B
purified	purify	VBN	B-VP	O
to	to	TO	B-PP	O
homogeneity	homogeneity	NN	B-NP	O
after	after	IN	B-PP	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
fdsR	BEGIN-BEGIN-fds-INSIDER-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
homotetramer	homotetramer	NN	I-NP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
fds	BEGIN-fds-INSIDE	NN	I-NP	B
control	control	NN	I-NP	O
region	region	NN	I-NP	O
located	located	JJ	B-ADJP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
fdsR	BEGIN-BEGIN-fds-INSIDER-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
fdsG	BEGIN-BEGIN-fds-INSIDEG	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I

Surgical	Surgical	JJ	B-NP	O
methods	method	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
rhinophyma	rhinophyma	NN	B-NP	O

The	The	DT	B-NP	O
adeno	adeno	AFX	I-NP	O
-	-	HYPH	I-NP	O
associated	associate	VBN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
AAV	AAV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
Rep1	BEGIN-Rep1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
Rep1	BEGIN-Rep1-INSIDE	NN	I-NP	B
regulatory	regulatory	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
are	be	VBP	B-VP	O
pleiotropic	pleiotropic	JJ	B-NP	O
effectors	effector	NNS	I-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	O
and	and	CC	I-NP	O
cellular	cellular	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
replication	replication	NN	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
transformation	transformation	NN	I-NP	O
by	by	IN	B-PP	O
viral	viral	JJ	B-NP	O
and	and	CC	I-NP	O
cellular	cellular	JJ	I-NP	O
oncogenes	oncogene	NNS	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
of	of	IN	B-PP	O
homologous	homologous	JJ	B-NP	O
and	and	CC	I-NP	O
heterologous	heterologous	JJ	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
Spb1p	BEGIN-Spb1p-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
[	[	(	O	O
(	(	(	O	O
1	1	LS	I-LST	O
)	)	)	O	O
H	H	NN	B-NP	O
]	]	)	O	O
AdoMet	AdoMet	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
methylase	methylase	NN	I-NP	O
,	,	,	O	O
whose	whose	WP$	B-NP	O
possible	possible	JJ	I-NP	O
substrates	substrate	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discussed	discuss	VBN	I-VP	O

Low	Low	JJ	B-NP	O
temperature	temperature	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
impairs	impair	VBZ	B-VP	O
secretory	secretory	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
independently	independently	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
photoperiod	photoperiod	NN	I-NP	O
selected	select	VBN	B-VP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
or	or	CC	O	O
increased	increase	VBN	B-NP	O
caloric	caloric	JJ	I-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
large	large	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
thyroid	thyroid	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
relatively	relatively	RB	B-NP	O
little	little	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
CNS	BEGIN-CNS	NN	B-NP	B
TRH	TRH-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O

Hematopoietic	BEGIN-Hematopoietic	JJ	B-NP	B
progenitor	progenitor	NN	I-NP	I
kinase	kinase	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
HPK1	BEGIN-HPK1-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitogen	BEGIN-mitogen	NN	I-NP	B
-	-	HYPH	B-VP	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase	NN	I-NP	I
kinase	kinase	NN	I-NP	I
kinase	kinase	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
MAP1K	BEGIN-MAP1K-INSIDE	NN	B-NP	B
)	)	)	O	O
family	family	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
activator	activator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	O	I
Jun	Jun	NN	B-NP	I
N	N	NN	I-NP	I
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B
)	)	)	O	O
signaling	signaling	NN	B-NP	O
cascade	cascade	NN	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
outcome	outcome	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
uterine	uterine	JJ	B-NP	O
MMMT	MMMT	NN	I-NP	O
is	be	VBZ	B-VP	O
mainly	mainly	RB	I-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
stage	stage	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	O
component	component	NN	I-NP	O

Increased	Increase	VBN	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
of	of	IN	B-PP	O
aphasics	aphasic	NNS	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
distractor	distractor	NN	I-NP	O
task	task	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
recall	recall	NN	I-NP	O
of	of	IN	B-PP	O
verbal	verbal	JJ	B-NP	O
commands	command	NNS	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
inhibition	inhibition	NN	B-NP	O
occurs	occur	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
NS1	BEGIN-NS1-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
Rev	BEGIN-Rev-INSIDE	NN	I-NP	B
chimera	chimera	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NS1A	BEGIN-BEGIN-NS1-INSIDEA	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
comprising	comprise	VBG	B-VP	O
its	its	PRP$	B-NP	O
entire	entire	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
is	be	VBZ	B-VP	O
deleted	delete	VBN	I-VP	O
,	,	,	O	O
thereby	thereby	RB	B-VP	O
establishing	establish	VBG	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NS1A	BEGIN-BEGIN-NS1-INSIDEA	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
function	function	VB	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
independent	independent	JJ	I-NP	O
effector	effector	NN	I-NP	O
domain	domain	NN	I-NP	O

We	We	PRP	B-NP	O
hypothesized	hypothesize	VBD	B-VP	O
that	that	IN	B-SBAR	O
conjugated	conjugate	VBN	B-NP	O
estrogens	estrogen	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
contain	contain	VBP	B-VP	O
several	several	JJ	B-NP	O
vasoactive	vasoactive	JJ	I-NP	O
estrogenic	estrogenic	JJ	I-NP	O
compounds	compound	NNS	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
favorably	favorably	RB	I-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
vasomotor	vasomotor	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
acetylcholine	acetylcholine	NN	B-NP	O
in	in	IN	B-PP	O
men	man	NNS	B-NP	O

Calcium	Calcium	NN	B-NP	O
bilirubinate	bilirubinate	NN	I-NP	O
crystals	crystal	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
gallbladder	gallbladder	NN	B-NP	O
bile	bile	NN	I-NP	O
or	or	CC	I-NP	O
wall	wall	NN	I-NP	O
scrapings	scraping	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
TPN	TPN	NN	I-NP	O
animals	animal	NNS	I-NP	O
but	but	CC	B-PP	O
in	in	IN	B-PP	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
controls	control	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

Because	Because	IN	B-SBAR	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
myb	myb-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activator	activator	NN	I-NP	O
that	that	WDT	B-NP	O
functions	function	VBZ	B-VP	O
via	via	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
myb	myb-INSIDE	NN	B-NP	I
exerts	exert	VBZ	B-VP	O
its	its	PRP$	B-NP	O
biological	biological	JJ	I-NP	O
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O

Alcohol	Alcohol	NN	B-NP	O
and	and	CC	I-NP	O
stomach	stomach	NN	I-NP	O
diseases	disease	NNS	I-NP	O

Thus	Thus	RB	B-NP	O
integration	BEGIN-integration	NN	I-NP	B
host	host	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
type	BEGIN-type	NN	I-NP	B
1	1	CD	I-NP	I
fimbriae	fimbriae-INSIDE	NN	I-NP	I
phase	phase	NN	I-NP	O
variation	variation	NN	I-NP	O
in	in	IN	B-PP	O
E.	E.	NNP	B-NP	O
coli	coli	NNS	I-NP	O

Multiple	Multiple	JJ	B-NP	O
attempts	attempt	NNS	I-NP	O
aimed	aim	VBN	B-VP	O
at	at	IN	B-PP	O
disruption	disruption	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chromosomal	BEGIN-chromosomal	JJ	I-NP	B
fabG	fabG	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
unsuccessful	unsuccessful	JJ	B-ADJP	O

In	In	IN	B-PP	O
our	our	PRP$	B-NP	O
case	case	NN	I-NP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prostate	prostate	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
PSA	BEGIN-PSA-INSIDE	NN	B-NP	B
immunoreactivity	immunoreactivity	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
mucinous	mucinous	JJ	B-NP	O
glands	gland	NNS	I-NP	O
,	,	,	O	O
sometimes	sometimes	RB	B-ADVP	O
``	``	``	O	O
endocervical	endocervical	JJ	B-NP	O
-	-	HYPH	I-NP	O
like	like	JJ	I-NP	O
''	''	''	O	O
,	,	,	O	O
could	could	MD	B-VP	O
suggest	suggest	VB	I-VP	O
an	an	DT	B-NP	O
origin	origin	NN	I-NP	O
from	from	IN	B-PP	O
embryonic	embryonic	JJ	B-NP	O
mullerian	mullerian	JJ	I-NP	O
remnants	remnant	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prostatic	prostatic	JJ	I-NP	O
utricle	utricle	NN	I-NP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
urogenital	urogenital	JJ	B-NP	O
sinus	sinus	NN	I-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	I-VP	O
and	and	CC	O	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
Fli	Fli	NNP	I-NP	I
-	-	HYPH	I-NP	I
1	1	CD	I-NP	I
protein	protein-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
second	second	JJ	I-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
successfully	successfully	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
prostaglandin	prostaglandin	NN	I-NP	O
F1	F1	NN	I-NP	O
alpha	alpha	NN	I-NP	O
(	(	(	O	O
PGF1	PGF1	NN	B-NP	O
alpha	alpha	NN	I-NP	O
)	)	)	O	O

Salts	Salt	NNS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
four	four	CD	I-NP	O
metal	metal	NN	I-NP	O
ions	ion	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
medium	medium	NN	I-NP	O
to	to	TO	B-VP	O
facilitate	facilitate	VB	I-VP	O
selective	selective	JJ	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
Acinetobacter	Acinetobacter	NN	B-NP	O

DESIGN	DESIGN	NN	B-NP	O
-	-	HYPH	B-ADJP	O
-	-	:	O	O
A	A	DT	B-NP	O
randomised	randomise	VBN	I-NP	O
double	double	JJ	I-NP	O
blind	blind	JJ	I-NP	O
placebo	placebo	NN	I-NP	O
controlled	controlled	JJ	I-NP	O
parallel	parallel	JJ	I-NP	O
arm	arm	NN	I-NP	O
trial	trial	NN	I-NP	O

Base	Base	NN	B-NP	O
substitutions	substitution	NNS	I-NP	O
within	within	IN	B-PP	O
this	this	DT	B-NP	O
NFIL	BEGIN-NFIL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
site	site-INSIDE	NN	I-NP	I
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
virtual	virtual	JJ	B-NP	O
elimination	elimination	NN	I-NP	O
of	of	IN	B-PP	O
LPS	LPS	NN	B-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	O	I
1	1	CD	B-NP	I
beta	beta	SYM	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O

Different	Different	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
variants	variant	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
empty	empty	JJ	I-NP	O
sella	sella	NN	I-NP	O
turcica	turcica	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
are	be	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
,	,	,	O	O
including	include	VBG	B-PP	O
variants	variant	NNS	B-NP	O
resultant	resultant	JJ	B-ADJP	O
from	from	IN	B-PP	O
substitution	substitution	NN	B-NP	O
therapy	therapy	NN	I-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
hypofunction	hypofunction	NN	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
dopamine	dopamine	NN	B-NP	O
agonist	agonist	NN	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
hyperprolactinemic	hyperprolactinemic	JJ	B-NP	O
hypogonadism	hypogonadism	NN	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
of	of	IN	B-PP	O
hypophyseal	hypophyseal	JJ	B-NP	O
adenoma	adenoma	NN	I-NP	O

Repeated	Repeat	VBN	B-NP	O
time	time	NN	I-NP	O
course	course	NN	B-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
patient	patient	NN	I-NP	O
were	be	VBD	B-VP	O
reproducible	reproducible	JJ	B-ADJP	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
absolute	absolute	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
variation	variation	NN	I-NP	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
association	association	NN	B-NP	O
of	of	IN	B-PP	O
TBP	BEGIN-TBP-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
the	the	DT	B-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
,	,	,	O	O
directly	directly	RB	B-ADVP	O
or	or	CC	I-ADVP	O
indirectly	indirectly	RB	I-ADVP	O
,	,	,	O	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
substrate	substrate	NN	I-NP	O
of	of	IN	B-PP	O
Snf1	BEGIN-Snf1-INSIDE	NN	B-NP	B

Site	Site	NN	B-NP	O
-	-	HYPH	B-PP	O
directed	direct	VBN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T1	BEGIN-T1	NN	I-NP	B
endonuclease	endonuclease	NN	I-NP	I
V	V	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
:	:	:	O	O
role	role	NN	B-NP	O
of	of	IN	B-PP	O
lysine	lysine	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

Simulations	Simulation	NNS	B-NP	O
of	of	IN	B-PP	O
velocities	velocity	NNS	B-NP	O
,	,	,	O	O
vorticity	vorticity	NN	B-NP	O
,	,	,	O	O
pressure	pressure	NN	B-NP	O
and	and	CC	O	O
certain	certain	JJ	B-NP	O
stress	stress	NN	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
developed	develop	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
computer	computer	NN	I-NP	O
and	and	CC	O	O
displayed	display	VBN	B-VP	O
for	for	IN	B-PP	O
man	man	NN	B-NP	O
-	-	HYPH	I-NP	O
machine	machine	NN	I-NP	O
interaction	interaction	NN	I-NP	O

Together	Together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
implicate	implicate	VBP	B-VP	O
Fal1p	BEGIN-Fal1p-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1S	BEGIN-1S	NN	I-NP	B
rRNA	rRNA-INSIDE	NN	I-NP	I
maturation	maturation	NN	I-NP	O
pathway	pathway	NN	I-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
in	in	IN	B-PP	O
translation	translation	NN	B-NP	O
initiation	initiation	NN	I-NP	O

TRAF1	BEGIN-TRAF1-INSIDE	NN	B-NP	B
has	have	VBZ	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
both	both	CC	O	O
transcription	transcription	NN	B-NP	O
factor	factor	NN	I-NP	O
nuclear	BEGIN-nuclear	JJ	B-NP	B
factor	factor	NN	I-NP	I
kappaB	kappaB-INSIDE	NN	I-NP	I
(	(	(	O	O
NFkappaB	BEGIN-NFkappaB-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
c	BEGIN-BEGIN-c	NN	I-NP	B
-	-	HYPH	O	I
Jun	Jun-INSIDE	NN	B-NP	I
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
kinase	kinase-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
stress	BEGIN-stress	NN	I-NP	B
-	-	HYPH	O	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
SAPK	BEGIN-SAPK-INSIDE	NN	I-NP	B
)	)	)	O	O
pathway	pathway	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
stimulates	stimulate	VBZ	B-VP	O
transcription	BEGIN-transcription	NN	B-NP	B
factor	factor	NN	I-NP	I
activating	activate	VBG	B-VP	I
protein	protein	NN	B-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
AP1	BEGIN-AP1-INSIDE	NN	B-NP	B
)	)	)	O	O
mainly	mainly	RB	B-ADVP	O
via	via	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
Jun	Jun-INSIDE	NN	I-NP	I
component	component	NN	I-NP	O

Electrophysiology	Electrophysiology	NN	B-NP	O
and	and	CC	I-NP	O
pharmacology	pharmacology	NN	I-NP	O
of	of	IN	B-PP	O
epicardial	epicardial	NN	B-NP	O
,	,	,	O	O
endocardial	endocardial	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
M	M	NN	B-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
compromised	compromise	VBN	B-NP	O
fibrinolytic	fibrinolytic	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
contributing	contribute	VBG	I-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
thrombosis	thrombosis	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
lupus	lupus	NN	I-NP	O
anticoagulant	anticoagulant	NN	I-NP	O

Human	Human	JJ	B-NP	O
psychophysical	psychophysical	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
receptive	receptive	JJ	B-NP	O
field	field	NN	I-NP	O
-	-	HYPH	B-VP	O
like	like	JJ	B-NP	O
properties	property	NNS	I-NP	O
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
II	II	CD	B-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
agonist	agonist	NN	B-NP	O
action	action	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	B-NP	I
HT1	HT1	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
and	and	CC	O	O
antagonist	antagonist	NN	B-NP	O
action	action	NN	I-NP	O
at	at	IN	B-PP	O
1	BEGIN-1	NN	B-NP	B
-	-	HYPH	B-NP	I
HT1	HT1	NN	I-NP	I
receptors	receptor-INSIDE	NNS	I-NP	I
both	both	DT	B-ADVP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
antidepressant	antidepressant	NN	B-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
activity	activity	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
DRL	DRL	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
s	s	NN	I-NP	O
schedule	schedule	NN	I-NP	O

Heliox	Heliox	NN	B-NP	O
improves	improve	VBZ	B-VP	O
pulsus	pulsus	NN	B-NP	O
paradoxus	paradoxus	NN	I-NP	O
and	and	CC	O	O
peak	peak	JJ	B-NP	O
expiratory	expiratory	JJ	I-NP	O
flow	flow	NN	I-NP	O
in	in	IN	B-PP	O
nonintubated	nonintubated	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
asthma	asthma	NN	I-NP	O

Response	Response	NN	B-NP	O
surface	surface	NN	I-NP	O
methodology	methodology	NN	I-NP	O
was	be	VBD	B-VP	O
employed	employ	VBN	I-VP	O
to	to	TO	I-VP	O
describe	describe	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
soman	soman	NN	B-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
incapacitation	incapacitation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ATR	ATR	NN	I-NP	O
/	/	SYM	B-VP	O
DZ	DZ	NN	B-NP	O
or	or	CC	I-NP	O
ATR	ATR	NN	I-NP	O
/	/	SYM	B-NP	O
SCP	SCP	NN	I-NP	O
dosages	dosage	NNS	I-NP	O

Both	Both	CC	O	O
DMP1	BEGIN-DMP1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
DMP1	BEGIN-DMP1-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
closely	closely	RB	I-VP	O
localized	localize	VBN	I-VP	O
on	on	IN	B-PP	O
mouse	mouse	NN	B-NP	O
chromosome	chromosome	NN	I-NP	O
1q1	1q1	NN	I-NP	O
,	,	,	O	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1q1	1q1	NN	I-NP	O

A	A	DT	B-NP	O
kinetic	kinetic	JJ	I-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
1mTc	1mTc	NN	B-NP	O
-	-	HYPH	B-NP	O
DMSA	DMSA	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O

Together	Together	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
up	up	RB	I-NP	O
-	-	HYPH	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cAMP	BEGIN-cAMP	NN	I-NP	B
response	response	NN	I-NP	I
element	element	NN	I-NP	I
modulator	modulator	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
CREM	BEGIN-CREM-INSIDE	NN	B-NP	B
)	)	)	O	O
mRNA	mRNA	NN	B-NP	O
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
levels	level	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
previously	previously	RB	B-ADVP	O
in	in	IN	B-PP	O
CREB	BEGIN-BEGIN-CREB-INSIDE	NN	B-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
mice	mouse	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
up	up	RB	I-NP	O
-	-	HYPH	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
CREB	BEGIN-BEGIN-CREB-INSIDE	NN	B-NP	B
beta	beta-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
also	also	RB	I-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
compensation	compensation	NN	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
CREB	BEGIN-CREB-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
ATF	BEGIN-ATF-INSIDE	NN	I-NP	B
family	family	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
CREB	BEGIN-BEGIN-CREB-INSIDE	NN	B-NP	B
delta	delta-INSIDE	NN	I-NP	I
and	and	CC	O	O
CREB	BEGIN-BEGIN-CREB-INSIDE	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
absent	absent	JJ	B-ADJP	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cAMP	cAMP	NN	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathway	pathway	NN	I-NP	O
on	on	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
subunit	subunit	NN	I-NP	O
of	of	IN	B-PP	O
glucose	BEGIN-glucose	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
phosphatase	phosphatase-INSIDE	NN	I-NP	I
(	(	(	O	O
G1Pase	BEGIN-G1Pase-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
G1Pase	BEGIN-G1Pase-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
chloramphenicol	BEGIN-chloramphenicol	NN	B-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
(	(	(	O	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
)	)	)	O	O
fusion	fusion	NN	B-NP	O
genes	gene	NNS	I-NP	O
were	be	VBD	B-VP	O
transiently	transiently	RB	I-VP	O
transfected	transfecte	VBN	I-VP	O
into	into	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
-	-	HYPH	B-VP	O
derived	derive	VBN	B-NP	O
HepG1	HepG1	NN	I-NP	O
or	or	CC	I-NP	O
kidney	kidney	NN	I-NP	O
-	-	HYPH	O	O
derived	derive	VBN	B-NP	O
LLC	LLC	NN	I-NP	O
-	-	HYPH	B-NP	O
PK	PK	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O

The	The	DT	B-NP	O
structural	structural	JJ	I-NP	O
intestinal	intestinal	JJ	I-NP	O
defects	defect	NNS	I-NP	O
are	be	VBP	B-VP	O
presumed	presume	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
defective	defective	JJ	B-NP	O
collagen	BEGIN-collagen-INSIDE	NN	I-NP	B
synthesis	synthesis	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
hereditary	hereditary	JJ	I-NP	O
connective	connective	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
disorders	disorder	NNS	I-NP	O

Letter	Letter	NNP	B-NP	O
:	:	:	O	O
Dehydrated	Dehydrate	VBN	B-NP	O
test	test	NN	I-NP	O
strip	strip	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
yeasts	yeast	NNS	B-NP	O

Galactorrhoea	Galactorrhoea	NNP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
rare	rare	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
sella	sella	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O

The	The	DT	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
meiotic	meiotic	JJ	I-NP	O
genes	gene	NNS	I-NP	O
to	to	TO	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
middle	middle	JJ	B-NP	O
sporulation	sporulation	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
genes	gene	NNS	I-NP	O
occurs	occur	VBZ	B-VP	O
at	at	IN	B-PP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
that	that	IN	B-NP	O
cells	cell	NNS	B-NP	O
exit	exit	VBP	B-VP	O
from	from	IN	B-PP	O
pachytene	pachytene	NN	B-NP	O
and	and	CC	O	O
form	form	VB	B-VP	O
the	the	DT	B-NP	O
meiosis	meiosis	NN	I-NP	O
I	I	CD	I-NP	O
spindle	spindle	NN	I-NP	O

Mutations	Mutation	NNS	B-NP	O
away	away	RB	B-ADVP	O
from	from	IN	B-PP	O
splice	splice	NN	B-NP	O
site	site	NN	I-NP	O
recognition	recognition	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
might	might	MD	B-VP	O
cis	cis	AFX	O	O
-	-	HYPH	B-NP	O
modulate	modulate	NN	I-NP	O
alternative	alternative	JJ	I-NP	O
splicing	splicing	NN	I-NP	O
of	of	IN	B-PP	O
goat	goat	NN	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
s1	s1	NN	I-NP	I
-	-	HYPH	B-NP	I
casein	casein	NN	I-NP	I
transcripts	transcripts-INSIDE	NN	I-NP	I

These	These	DT	B-NP	O
Tlr	BEGIN-Tlr	JJ	I-NP	B
family	family	NN	I-NP	I
members	members-INSIDE	NN	I-NP	I
,	,	,	O	O
unlike	unlike	IN	B-PP	O
others	other	NNS	B-NP	O
reported	report	VBN	B-VP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
database	database	NN	I-NP	O

Fig1p	BEGIN-BEGIN-Fig1-INSIDEp-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Fig1p	BEGIN-BEGIN-Fig1-INSIDEp-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
act	act	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
as	as	IN	B-PP	O
Fig1	BEGIN-Fig1-INSIDE	NN	B-NP	B
:	:	:	O	O
:	:	:	O	O
beta	BEGIN-beta	NN	B-NP	B
-	-	HYPH	B-NP	I
gal	gal-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Fig1	BEGIN-Fig1-INSIDE	NN	I-NP	B
:	:	:	O	O
:	:	:	O	O
beta	BEGIN-BEGIN-beta	NN	B-NP	B
-	-	HYPH	I-NP	I
gal	gal-INSIDE	NN	I-NP	I
fusion	fusion	NN	I-NP	O
proteins	proteins-INSIDE	NN	I-NP	I
localize	localize	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
periphery	periphery	NN	I-NP	O
of	of	IN	B-PP	O
mating	mating	NN	B-NP	O
cells	cell	NNS	I-NP	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
little	little	JJ	B-NP	O
supportive	supportive	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
ACE	BEGIN-ACE-INSIDE	NN	B-NP	B
inhibitors	inhibitor	NNS	I-NP	O
(	(	(	O	O
captopril	captopril	NN	B-NP	O
or	or	CC	O	O
enalapril	enalapril	NN	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
teratogenic	teratogenic	JJ	B-ADJP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
PVB	PVB	NN	I-NP	O
therapy	therapy	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
cure	cure	VB	I-VP	O
the	the	DT	B-NP	O
cases	case	NNS	I-NP	O
with	with	IN	B-PP	O
choriocarcinoma	choriocarcinoma	NN	B-NP	O
element	element	NN	I-NP	O
or	or	CC	O	O
bulky	bulky	JJ	B-NP	O
metastasis	metastasis	NN	I-NP	O

Evaluation	Evaluation	NN	B-NP	O
of	of	IN	B-PP	O
gamma	BEGIN-gamma	NN	B-NP	B
-	-	HYPH	B-NP	I
glutamyl	glutamyl	NN	I-NP	I
transpeptidase	transpeptidase-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O

The	The	DT	B-NP	O
yjr1c	BEGIN-yjr1c	NN	I-NP	B
delta	delta-INSIDE	NN	I-NP	I
haploid	haploid	JJ	I-NP	O
cells	cell	NNS	I-NP	O
gave	give	VBD	B-VP	O
rise	rise	NN	B-NP	O
to	to	TO	B-PP	O
microcolonies	microcolony	NNS	B-NP	O
comprising	comprise	VBG	B-VP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O

Mean	Mean	JJ	B-NP	O
latency	latency	NN	I-NP	O
periods	period	NNS	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
among	among	IN	B-PP	O
insulators	insulator	NNS	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
among	among	IN	B-PP	O
dock	dock	NN	B-NP	O
workers	worker	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
heterogeneous	heterogeneous	JJ	I-NP	O
group	group	NN	I-NP	O
defined	define	VBN	B-VP	O
as	as	IN	B-PP	O
various	various	JJ	B-ADJP	O
,	,	,	O	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
shipbuilding	shipbuilde	VBG	I-NP	O
industry	industry	NN	I-NP	O
workers	worker	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
shipyard	shipyard	NN	B-NP	O
workers	worker	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
among	among	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
domestic	domestic	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
asbestos	asbestos	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
people	people	NNS	B-NP	O
employed	employ	VBN	B-VP	O
in	in	IN	B-PP	O
maritime	maritime	NN	B-NP	O
trades	trade	NNS	I-NP	O

Influence	Influence	NN	B-NP	O
of	of	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
supplementation	supplementation	NN	I-NP	O
with	with	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
faecium	faecium	NN	I-NP	O
M	M	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
on	on	IN	B-PP	O
broiler	broiler	NN	B-NP	O
body	body	NN	I-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
feed	feed	NN	B-NP	O
conversion	conversion	NN	I-NP	O
,	,	,	O	O
carcass	carcass	NN	B-NP	O
characteristics	characteristic	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
intestinal	intestinal	JJ	B-NP	O
microbial	microbial	JJ	I-NP	O
colonization	colonization	NN	I-NP	O

Two	Two	CD	B-NP	O
plasmids	plasmid	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
P	P	NN	B-NP	O
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
transactivator	transactivator	NN	I-NP	O
,	,	,	O	O
GAL1	BEGIN-GAL1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
NP	BEGIN-NP-INSIDE	NN	B-NP	B
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
herpesvirus	herpesvirus	NN	I-NP	O
transactivator	transactivator	NN	I-NP	O
,	,	,	O	O
VP1	BEGIN-VP1-INSIDE	NN	B-NP	B
,	,	,	O	O
were	be	VBD	B-VP	O
transfected	transfecte	VBN	I-VP	O
in	in	IN	B-PP	O
COS	COS	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
chloramphenicol	BEGIN-chloramphenicol	NN	I-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
(	(	(	O	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
)	)	)	O	O
reporter	reporter	NN	B-NP	O
plasmid	plasmid	NN	I-NP	O
containing	contain	VBG	B-VP	O
GAL1	BEGIN-GAL1-INSIDE	NN	B-NP	B
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O

1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
Nitroindazole	Nitroindazole	NN	I-NP	O
(	(	(	O	O
1NI	1NI	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
selective	selective	JJ	I-NP	O
neuronal	neuronal	JJ	I-NP	O
nitric	BEGIN-nitric	JJ	I-NP	B
oxide	oxide	NN	I-NP	I
synthase	synthase-INSIDE	NN	I-NP	I
(	(	(	O	O
nNOS	BEGIN-nNOS-INSIDE	NN	B-NP	B
)	)	)	O	O
inhibitor.	inhibitor.	NN	B-NP	O
was	be	VBD	B-VP	O
intraperitoneally	intraperitoneally	RB	I-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
guinea	guinea	NN	I-NP	O
pigs	pig	VBZ	B-VP	O
1	1	CD	B-NP	O
minutes	minute	NNS	I-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
local	local	JJ	B-NP	O
anoxia	anoxia	NN	I-NP	O

New	New	JJ	B-NP	O
protein	protein	NN	I-NP	O
-	-	HYPH	O	O
free	free	JJ	B-NP	O
products	product	NNS	I-NP	O
for	for	IN	B-PP	O
diet	diet	NN	B-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O

Impact	Impact	NN	B-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	O
gene	gene	NN	I-NP	O
polymorphisms	polymorphism	NNS	I-NP	O
on	on	IN	B-PP	O
outcomes	outcome	NNS	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
surgery	surgery	NN	I-NP	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	O
protein	protein	NN	I-NP	O
binds	bind	VBZ	B-VP	O
most	most	RBS	B-ADVP	O
strongly	strongly	RB	I-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
the	the	DT	B-NP	O
abl	BEGIN-abl	NN	I-NP	B
proto	proto	AFX	O	I
-	-	HYPH	O	I
oncogene	oncogene-INSIDE	NN	B-NP	I

Adequacy	Adequacy	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Haldane	Haldane	NNP	I-NP	O
transformation	transformation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
computation	computation	NN	I-NP	O
of	of	IN	B-PP	O
exercise	exercise	NN	B-NP	O
V	V	NN	I-NP	O
O1	O1	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O

Covariates	Covariate	NNS	B-NP	O
were	be	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
and	and	CC	O	O
sensory	sensory	JJ	B-NP	O
status	status	NN	I-NP	O

Like	Like	IN	B-PP	O
troponin	BEGIN-troponin	NN	B-NP	B
Cs	Cs-INSIDE	NN	I-NP	I
and	and	CC	O	O
calmodulins	BEGIN-calmodulins-INSIDE	NN	B-NP	B
,	,	,	O	O
PfCPK	BEGIN-PfCPK-INSIDE	NN	B-NP	B
also	also	RB	B-ADVP	O
contains	contain	VBZ	B-VP	O
four	four	CD	B-NP	O
EF	EF	NN	I-NP	O
hand	hand	NN	I-NP	O
calcium	calcium	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
motifs	motif	NNS	B-NP	O

Roller	Roller	NNP	B-NP	O
pumps	pump	VBZ	B-VP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
suction	suction	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
cardiotomy	cardiotomy	NN	I-NP	O
reservoir	reservoir	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O

Akt	BEGIN-Akt-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
antiapoptotic	antiapoptotic	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
farnesyltransferase	farnesyltransferase	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O

LT	BEGIN-LT	JJ	B-NP	B
-	-	HYPH	I-NP	I
beta	beta-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
maximal	maximal	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymic	thymic	JJ	I-NP	O
medulla	medulla	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
splenic	splenic	JJ	B-NP	O
white	white	JJ	I-NP	O
pulp	pulp	NN	I-NP	O

Ultrastructure	Ultrastructure	NN	B-NP	O
and	and	CC	I-NP	O
toxin	toxin	NN	I-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
Cor.	Cor.	NNP	B-NP	O
diphtheriae	diphtheriae	NNP	I-NP	O
PW	PW	NNP	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cultured	culture	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
penicillin	penicillin	NN	B-NP	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
subunits	subunit	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
P	BEGIN-P	NN	I-NP	B
-	-	HYPH	I-NP	I
TEFb	TEFb-INSIDE	NN	I-NP	I
complex	complex	NN	I-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
distinct	distinct	JJ	B-NP	O
roles	role	NNS	I-NP	O
at	at	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
stages	stage	NNS	I-NP	O
to	to	TO	B-VP	O
mediate	mediate	VB	I-VP	O
Tat	BEGIN-Tat-INSIDE	JJ	B-NP	B
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
transcription	transcription	NN	I-NP	O
elongation	elongation	NN	I-NP	O

The	The	DT	B-NP	O
organelles	organelle	NNS	I-NP	O
synthesize	synthesize	VBP	B-VP	O
their	their	PRP$	B-NP	O
own	own	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
Fe	BEGIN-Fe	NN	B-NP	B
/	/	SYM	B-NP	I
S	S	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
initiate	initiate	VBP	B-VP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
extramitochondrial	BEGIN-extramitochondrial	JJ	B-NP	B
Fe	BEGIN-Fe	NN	I-NP	B
/	/	SYM	B-VP	I
S	S	NN	B-NP	I
proteins	proteins-INSIDE-INSIDE	NN	I-NP	I

Ras	BEGIN-Ras-INSIDE	NN	B-NP	B
involvement	involvement	NN	I-NP	O
in	in	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
serotonin	BEGIN-serotonin	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
HT1B	HT1B	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I

Engineering	Engineer	VBG	B-VP	O
temperature	temperature	NN	B-NP	O
-	-	HYPH	I-NP	O
sensitive	sensitive	JJ	I-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I

Orlistat	Orlistat	NNP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
lipase	BEGIN-lipase-INSIDE	NN	I-NP	B
inhibitor	inhibitor	NN	I-NP	O
that	that	WDT	B-NP	O
impairs	impair	VBZ	B-VP	O
fat	fat	JJ	B-NP	O
absorption	absorption	NN	I-NP	O
,	,	,	O	O
thereby	thereby	RB	B-VP	O
reducing	reduce	VBG	I-VP	O
fat	fat	JJ	B-NP	O
uptake	uptake	NN	I-NP	O

We	We	PRP	B-NP	O
identify	identify	VBP	B-VP	O
YY1	BEGIN-YY1-INSIDE	NN	B-NP	B
recognition	recognition	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
VDRE	VDRE	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
osteocalcin	BEGIN-osteocalcin	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
YY1	BEGIN-YY1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
repression	repression	NN	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
-	-	HYPH	B-NP	O
enhanced	enhance	VBN	I-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O

The	The	DT	B-NP	O
nine	nine	CD	I-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
in	in	IN	B-PP	O
random	random	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
with	with	IN	B-PP	O
cimetidine	cimetidine	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
on	on	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
placebo	placebo	NN	B-NP	O
capsules	capsule	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O

ORF1	ORF1	NN	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
periplasmic	BEGIN-periplasmic	JJ	I-NP	B
c	c	NN	I-NP	I
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
cytochrome	cytochrome-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mass	mass	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
Da	Da	NN	I-NP	O
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
seven	seven	CD	B-NP	O
c	c	NN	I-NP	O
-	-	HYPH	B-NP	O
heme	heme	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
motifs	motif	NNS	I-NP	O
but	but	CC	O	O
shows	show	VBZ	B-VP	O
no	no	DT	B-NP	O
sequence	sequence	NN	I-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
occ	BEGIN-occ-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
ORF1	ORF1	NN	I-NP	O

The	The	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
strain	strain	NN	I-NP	O
carries	carry	VBZ	B-VP	O
three	three	CD	B-NP	O
tandem	tandem	JJ	I-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
sequence	sequence	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
duplicated	duplicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
amdI1	BEGIN-amdI1-INSIDE	NN	I-NP	B
mutation	mutation	NN	I-NP	O

The	The	DT	B-NP	O
rat	rat	NN	I-NP	O
anococcygeus	anococcygeus	NN	I-NP	O
muscle	muscle	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
postsynaptic	postsynaptic	JJ	B-NP	O
studies	study	NNS	I-NP	O

The	The	DT	B-NP	O
HPV	HPV	NN	I-NP	O
E1	BEGIN-E1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
E1	BEGIN-E1-INSIDE	NN	I-NP	B
proteins	protein	NNS	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
replication	replication	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
genome	genome	NN	I-NP	O

Multiple	Multiple	JJ	B-NP	O
organ	organ	NN	I-NP	O
failure	failure	NN	I-NP	O
(	(	(	O	O
MOF	MOF	NN	B-NP	O
)	)	)	O	O
following	follow	VBG	B-PP	O
major	major	JJ	B-NP	O
trauma	trauma	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
perfusion	perfusion	NN	B-NP	O
deficits	deficit	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
persistent	persistent	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
focus	focus	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
persistent	persistent	JJ	I-NP	O
focus	focus	NN	I-NP	O
of	of	IN	B-PP	O
dead	dead	JJ	B-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
injured	injure	VBN	B-VP	O
tissue	tissue	NN	B-NP	O

(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
Several	Several	JJ	B-NP	O
ribosomal	ribosomal	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
were	be	VBD	B-VP	O
synthesized	synthesize	VBN	I-VP	O
in	in	IN	B-PP	O
substantial	substantial	JJ	B-NP	O
excess	excess	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
camptothecin	camptothecin	NN	B-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
CEM	CEM	NN	B-NP	O
/	/	SYM	B-NP	O
DOX	DOX	NN	I-NP	O
cells	cell	NNS	I-NP	O
is	be	VBZ	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
different	different	JJ	B-NP	O
mechanism	mechanism	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
topoisomerase	BEGIN-topoisomerase-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
or	or	CC	I-NP	O
P	BEGIN-P	NN	I-NP	B
-	-	HYPH	B-NP	I
glycoprotein	glycoprotein-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
associated	associate	VBN	B-VP	O
multidrug	multidrug	JJ	B-NP	O
resistance	resistance	NN	I-NP	O

The	The	DT	B-NP	O
detection	detection	NN	I-NP	O
limits	limit	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
mixed	mixed	JJ	I-NP	O
eluent	eluent	NN	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
L	L	NN	I-NP	O
,	,	,	O	O
several	several	JJ	B-NP	O
times	time	NNS	I-NP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
obtained	obtain	VBN	B-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
single	single	JJ	B-NP	O
KHPh	KHPh	NN	I-NP	O
eluent	eluent	JJ	B-ADJP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
fabrication	fabrication	NN	I-NP	O
of	of	IN	B-PP	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
molecule	molecule	NN	I-NP	O
transistors	transistor	NNS	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
individual	individual	JJ	B-NP	O
C1	C1	NN	I-NP	O
molecules	molecule	NNS	I-NP	O
connected	connect	VBN	B-VP	O
to	to	TO	B-PP	O
gold	gold	NN	B-NP	O
electrodes	electrode	NNS	I-NP	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
gut	gut	NN	B-NP	O
fermentation	fermentation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
substantial	substantial	JJ	I-NP	O
portion	portion	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
N	N	NN	B-NP	O
is	be	VBZ	B-VP	O
absorbed	absorb	VBN	I-VP	O
as	as	IN	B-PP	O
ammonia	ammonia	NN	B-NP	O
N	N	NN	I-NP	O
(	(	(	O	O
NH1N	NH1N	NN	B-NP	O
)	)	)	O	O

At	At	IN	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
postalfentanil	postalfentanil	NN	I-NP	O
,	,	,	O	O
N1O	N1O	NN	B-NP	O
caused	cause	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
more	more	JJR	I-NP	O
rigidity	rigidity	NN	I-NP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
O1	O1	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

By	By	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
CIS	BEGIN-CIS-INSIDE	NN	B-NP	B
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
response	response	NN	I-NP	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
PMA	PMA	NN	B-NP	O
-	-	HYPH	B-ADJP	O
,	,	,	O	O
PDGF	BEGIN-PDGF-INSIDE	NN	B-NP	B
-	-	HYPH	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
serum	serum	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
GHR	BEGIN-BEGIN-GH-INSIDER-INSIDE	NN	I-NP	B
proteolysis	proteolysis	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
substantial	substantial	JJ	B-NP	O
decreases	decrease	NNS	I-NP	O
in	in	IN	B-PP	O
GH	BEGIN-GH-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
Janus	BEGIN-Janus	NN	B-NP	B
kinase	kinase	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
prevented	prevent	VBN	I-VP	O
by	by	IN	B-PP	O
IC1	IC1	NN	B-NP	O

The	The	DT	B-NP	O
centromeric	centromeric	JJ	I-NP	O
dodeca	dodeca	NN	I-NP	O
-	-	HYPH	O	O
satellite	satellite	NN	B-NP	O
of	of	IN	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
forms	form	NNS	I-NP	O
altered	alter	VBD	B-VP	O
DNA	DNA	NN	B-NP	O
structures	structure	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
its	its	PRP$	B-NP	O
purine	purine	NN	I-NP	O
-	-	HYPH	I-NP	O
rich	rich	JJ	I-NP	O
strand	strand	NN	I-NP	O
(	(	(	O	O
G	G	NN	B-NP	O
-	-	HYPH	B-NP	O
strand	strand	NN	I-NP	O
)	)	)	O	O
forms	form	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
fold	fold	JJ	I-NP	O
-	-	HYPH	I-NP	O
back	back	JJ	I-NP	O
structures	structure	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
complementary	complementary	JJ	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
strand	strand	NN	I-NP	O
remains	remain	VBZ	B-VP	O
unstructured	unstructured	JJ	B-ADJP	O

The	The	DT	B-NP	O
Aspergillus	BEGIN-Aspergillus	JJ	I-NP	B
uvsH	uvsH	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
product	product	NN	I-NP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
yeast	BEGIN-yeast	JJ	B-NP	B
RAD1	RAD1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Neurospora	BEGIN-Neurospora	NN	I-NP	B
UVS	UVS	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
also	also	RB	B-ADVP	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
regulatory	regulatory	JJ	B-NP	O
subunits	subunit	NNS	I-NP	O
modulate	modulate	VBP	B-VP	O
the	the	DT	B-NP	O
PI	BEGIN-PI	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
mediated	mediate	VBN	I-NP	O
signals	signal	NNS	I-NP	O
,	,	,	O	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kinase	kinase	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
through	through	IN	B-PP	O
subcellular	subcellular	JJ	B-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
subunit	subunit	NN	I-NP	O
or	or	CC	I-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
additional	additional	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
molecules	molecule	NNS	I-NP	O

A	A	DT	B-NP	O
continuous	continuous	JJ	I-NP	O
-	-	HYPH	I-NP	O
flow	flow	NN	I-NP	O
BIPAP	BIPAP	NN	I-NP	O
system	system	NN	I-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
flow	flow	NN	I-NP	O
CPAP	CPAP	NN	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
reservoir	reservoir	NN	I-NP	O
bag	bag	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
pneumatically	pneumatically	RB	I-NP	O
controlled	control	VBN	I-NP	O
membrane	membrane	NN	I-NP	O
valve	valve	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expiratory	expiratory	NN	I-NP	O
limb	limb	NN	I-NP	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
sulphur	sulphur	NN	B-NP	O
mustard	mustard	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
androgen	androgen	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
hypo	hypo	AFX	B-NP	O
-	-	HYPH	I-NP	O
responsiveness	responsiveness	NN	I-NP	O
to	to	TO	B-PP	O
GnRH	BEGIN-GnRH-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
five	five	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	I-NP	O
normalization	normalization	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
twelfth	twelfth	JJ	I-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
injury	injury	NN	B-NP	O

The	The	DT	B-NP	O
A1B1	A1B1	NN	I-NP	O
domain	domain	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mass	mass	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
glycosylation	glycosylation	NN	I-NP	O
mass	mass	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
agreement	agreement	NN	I-NP	O
with	with	IN	B-PP	O
seven	seven	CD	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	O	O
linked	link	VBN	B-NP	O
glycosylation	glycosylation	NN	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
average	average	JJ	B-NP	O
mass	mass	NN	I-NP	O
1	1	CD	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
prospectively	prospectively	RB	B-ADVP	O
compared	compare	VBD	B-VP	O
side	side	NN	B-NP	O
effects	effect	NNS	I-NP	O
occurring	occur	VBG	B-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	I-NP	O
OKT1	OKT1	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	O	O
)	)	)	O	O
induction	induction	NN	B-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
OKT1	OKT1	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
)	)	)	O	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
rejection	rejection	NN	I-NP	O

Plasma	BEGIN-Plasma	NN	B-NP	B
prolactin	prolactin-INSIDE	NN	I-NP	I
concentrations	concentration	NNS	I-NP	O
during	during	IN	B-PP	O
incubation	incubation	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-PP	O
ml	ml	NN	B-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
,	,	,	O	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
nestbox	nestbox	NN	B-NP	O
removal	removal	NN	I-NP	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
resting	rest	VBG	B-NP	O
Tl	Tl	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
scintigraphy	scintigraphy	NN	I-NP	O
has	have	VBZ	B-VP	O
limited	limit	VBN	I-VP	O
value	value	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Hurler	Hurler	NNP	B-NP	O
syndrome	syndrome	NN	I-NP	O

Exit	Exit	NN	B-NP	O
from	from	IN	B-PP	O
mitosis	mitosis	NN	B-NP	O
in	in	IN	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
syncytial	syncytial	JJ	I-NP	O
embryos	embryo	NNS	I-NP	O
requires	require	VBZ	B-VP	O
proteolysis	proteolysis	NN	B-NP	O
and	and	CC	I-NP	O
cyclin	BEGIN-cyclin-INSIDE	NN	I-NP	B
degradation	degradation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
localized	localize	VBN	B-NP	O
dephosphorylation	dephosphorylation	NN	I-NP	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
residues	residue	NNS	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
identical	identical	JJ	B-ADJP	O
in	in	IN	B-PP	O
sequence	sequence	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
segment	segment	NN	I-NP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
carboxy	carboxy	NN	I-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
simian	BEGIN-simian	JJ	I-NP	B
foamy	foamy	JJ	I-NP	I
virus	virus	NN	I-NP	I
transcriptional	transcriptional	JJ	I-NP	I
activator	activator	NN	I-NP	I
Taf	Taf-INSIDE	NN	I-NP	I
,	,	,	O	O
can	can	MD	B-VP	O
independently	independently	RB	I-VP	O
enhance	enhance	VB	I-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
activator	activator	NN	I-NP	O
region	region	NN	I-NP	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
buthionine	buthionine	NN	B-NP	O
sulfoximine	sulfoximine	NN	I-NP	O
(	(	(	O	O
BSO	BSO	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
disulfiram	disulfiram	NN	B-NP	O
(	(	(	O	O
DSF	DSF	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
urotoxicity	urotoxicity	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
cyclophosphamide	cyclophosphamide	NN	B-NP	O
(	(	(	O	O
CPA	CPA	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O

METHOD	METHOD	NN	B-NP	O
:	:	:	O	O
Six	Six	CD	B-NP	O
instruments	instrument	NNS	I-NP	O
were	be	VBD	B-VP	O
reviewed	review	VBN	I-VP	O
:	:	:	O	O
the	the	DT	B-NP	O
Berg	Berg	NNP	I-NP	O
Balance	Balance	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
(	(	(	O	O
Berg	Berg	NNP	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
Clinical	Clinical	JJ	I-NP	O
Test	Test	NN	I-NP	O
of	of	IN	B-PP	O
Sensory	Sensory	JJ	B-NP	O
Interaction	Interaction	NN	I-NP	O
and	and	CC	O	O
Balance	Balance	NN	B-NP	O
(	(	(	O	O
CTSIB	CTSIB	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
Functional	Functional	NNP	I-NP	O
Reach	Reach	NNP	I-NP	O
Test	Test	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Tinetti	Tinetti	NNP	I-NP	O
Balance	Balance	NNP	I-NP	O
Test	Test	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Performance	Performance	NN	I-NP	O
-	-	HYPH	B-VP	O
Oriented	Orient	VBN	B-NP	O
Assessment	Assessment	NN	I-NP	O
of	of	IN	B-PP	O
Mobility	Mobility	NN	B-NP	O
Problems	Problem	NNPS	I-NP	O
(	(	(	O	O
Tinetti	Tinetti	NNP	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
Timed	Timed	NNP	I-NP	O
``	``	``	I-NP	O
Up	Up	NNP	I-NP	O
and	and	CC	I-NP	O
Go	Go	NNP	I-NP	O
''	''	''	B-NP	O
Test	Test	NN	I-NP	O
(	(	(	O	O
TU	TU	NN	B-NP	O
&	&	CC	I-NP	O
GT	GT	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Physical	Physical	NNP	I-NP	O
Performance	Performance	NNP	I-NP	O
Test	Test	NNP	I-NP	O
(	(	(	O	O
PPT	PPT	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
side	side	NN	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
percent	percent	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
receiving	receive	VBG	B-VP	O
this	this	DT	B-NP	O
drug	drug	NN	I-NP	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
AGCUS	AGCUS	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
had	have	VBD	B-VP	O
intraepithelial	intraepithelial	JJ	B-NP	O
or	or	CC	I-NP	O
invasive	invasive	JJ	I-NP	O
neoplasms	neoplasm	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
confidence	confidence	NN	I-NP	O
interval	interval	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
including	include	VBG	B-PP	O
1	1	CD	B-NP	O
low	low	JJ	I-NP	O
or	or	CC	I-NP	O
high	high	JJ	I-NP	O
grade	grade	NN	I-NP	O
squamous	squamous	JJ	I-NP	O
intraepithelial	intraepithelial	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
in	in	FW	B-PP	O
situ	situ	FW	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cervix	cervix	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
adenocarcinomas	adenocarcinoma	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cervix	cervix	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
adenocarcinomas	adenocarcinoma	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endometrium	endometrium	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
adenoid	adenoid	JJ	I-NP	O
basal	basal	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cervix	cervix	NN	I-NP	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
``	``	``	I-NP	O
activation	activation	NN	I-NP	O
-	-	HYPH	I-NP	O
defective	defective	JJ	I-NP	O
''	''	''	I-NP	O
mutants	mutant	NNS	I-NP	O
segregated	segregate	VBD	B-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
classes	class	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
those	those	DT	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
dimers	dimer	NNS	B-NP	O
but	but	CC	O	O
that	that	DT	B-NP	O
could	could	MD	B-VP	O
still	still	RB	I-VP	O
form	form	VB	I-VP	O
higher	high	JJR	B-NP	O
order	order	NN	I-NP	O
oligomers	oligomer	NNS	I-NP	O
and	and	CC	O	O
transform	transform	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	LS	B-LST	O
)	)	)	O	O
those	those	DT	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
defective	defective	JJ	B-ADJP	O
for	for	IN	B-PP	O
PDGF	BEGIN-PDGF	NN	B-NP	B
-	-	HYPH	I-NP	I
R	R-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
transformation	transformation	NN	B-NP	O
-	-	HYPH	B-ADJP	O
incompetent	incompetent	JJ	I-ADJP	O

Thus	Thus	RB	B-ADVP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
methods	method	NNS	I-NP	O
to	to	TO	B-VP	O
directly	directly	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
isolated	isolate	VBN	B-NP	O
human	human	JJ	I-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
segments	segment	NNS	I-NP	O
respond	respond	VBP	B-VP	O
to	to	TO	B-PP	O
vasoconstrictor	vasoconstrictor	NN	B-NP	O
agents	agent	NNS	I-NP	O
at	at	IN	B-PP	O
arterial	arterial	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
levels	level	NNS	I-NP	O

Genomic	Genomic	JJ	B-NP	O
Southern	Southern	JJ	I-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
haploid	haploid	JJ	I-NP	O
genome	genome	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
Gs	BEGIN-G	NNS	I-NP	B
alpha	alpha	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Four	Four	CD	B-NP	O
cDNAs	cDNA	NNS	I-NP	O
(	(	(	O	O
Kox1	BEGIN-Kox1-INSIDE	NN	B-NP	B
,	,	,	O	O
Kox1	BEGIN-Kox1-INSIDE	NN	B-NP	B
,	,	,	O	O
Kox1	BEGIN-Kox1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
Kox1	BEGIN-Kox1-INSIDE	NN	B-NP	B
)	)	)	O	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
that	that	WDT	B-NP	O
match	match	VBP	B-VP	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
genomic	genomic	JJ	I-NP	O
clones	clone	NNS	I-NP	O
;	;	:	O	O
these	these	DT	B-NP	O
matches	match	NNS	I-NP	O
were	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
nucleotide	nucleotide	NN	B-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O

The	The	DT	B-NP	O
facilitation	facilitation	NN	I-NP	O
started	start	VBD	B-VP	O
preceding	precede	VBG	I-VP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
electromyographic	electromyographic	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
masseter	masseter	NN	I-NP	O
muscle	muscle	NN	I-NP	O

Reactivation	Reactivation	NN	B-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
virus	virus	NN	I-NP	O
replication	replication	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
rare	rare	JJ	I-NP	O
event	event	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O

SETTING	SETTING	NN	B-NP	O
-	-	HYPH	O	O
-	-	HYPH	B-NP	O
Hospital	Hospital	NN	I-NP	O
laboratories	laboratory	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
United	United	NNP	I-NP	O
States	State	NNPS	I-NP	O
submitting	submit	VBG	B-VP	O
pneumococcal	pneumococcal	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CDC	CDC	NNP	I-NP	O
between	between	IN	B-PP	O
October	October	NNP	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
September	September	NNP	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
orfX	orfX	NN	B-NP	O
and	and	CC	I-NP	O
vfr	BEGIN-vfr-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
controlled	control	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
that	that	WDT	B-NP	O
control	control	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
divergent	divergent	JJ	I-NP	O
ORF	ORF	NN	I-NP	O
(	(	(	O	O
dorf	dorf	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
of	of	IN	B-PP	O
crp	BEGIN-crp-INSIDE	NN	B-NP	B
,	,	,	O	O
we	we	PRP	B-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
vfr	BEGIN-vfr-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
orfX	orfX	NN	I-NP	O
and	and	CC	I-NP	O
crp	BEGIN-crp-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
dorf	dorf	NN	I-NP	O
intergenic	intergenic	JJ	I-NP	O
regions	region	NNS	I-NP	O

Cotransfection	Cotransfection	NN	B-NP	O
with	with	IN	B-PP	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	B-NP	I
EBPbeta	EBPbeta-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
GATA	BEGIN-GATA	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
expression	expression	NN	I-NP	O
vectors	vector	NNS	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
cotransfection	cotransfection	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
C	BEGIN-C	NN	I-NP	B
/	/	SYM	B-VP	I
EBPbeta	EBPbeta-INSIDE	NN	B-NP	I
or	or	CC	I-NP	O
GATA	BEGIN-GATA	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
vectors	vector	NNS	I-NP	O
individually	individually	RB	B-ADVP	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
clones	clone	NNS	I-NP	O
encodes	encode	VBZ	B-VP	O
Xenopus	BEGIN-Xenopus	NN	B-NP	B
N	N	NN	I-NP	I
-	-	HYPH	O	I
ras	ras-INSIDE	NN	B-NP	I

Eighteen	Eighteen	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
epidermoid	epidermoid	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
were	be	VBD	B-VP	O
entered	enter	VBN	I-VP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
phase	phase	NN	I-NP	O
II	II	CD	I-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
N	N	NN	B-NP	O
-	-	HYPH	O	O
Methylformamide	Methylformamide	NN	B-NP	O
(	(	(	O	O
NMF	NMF	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-VP	O
M1	M1	NN	B-NP	O
IV	IV	CD	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
every	every	DT	B-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O

Total	Total	JJ	B-NP	O
body	body	NN	I-NP	O
water	water	NN	I-NP	O
and	and	CC	I-NP	O
distribution	distribution	NN	I-NP	O
space	space	NN	I-NP	O
of	of	IN	B-PP	O
Na1	Na1	NN	B-NP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
body	body	NN	I-NP	O
weight	weight	NN	I-NP	O

Transient	Transient	JJ	B-NP	O
cotransfection	cotransfection	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
cooperative	cooperative	JJ	I-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
IL	IL	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
RelA	BEGIN-RelA-INSIDE	NN	I-NP	B
with	with	IN	B-PP	O
the	the	DT	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
synergistic	synergistic	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O

Sera	Sera	NN	B-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
newborn	newborn	JJ	I-NP	O
infants	infant	NNS	I-NP	O
with	with	IN	B-PP	O
gestational	gestational	JJ	B-NP	O
ages	age	NNS	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
by	by	IN	B-PP	O
radioimmunoassay	radioimmunoassay	NN	B-NP	O
for	for	IN	B-PP	O
IgG	BEGIN-IgG-INSIDE	NN	B-NP	B
antibodies	antibody	NNS	I-NP	O
to	to	TO	B-PP	O
surface	surface	NN	B-NP	O
antigens	antigen	NNS	I-NP	O
of	of	IN	B-PP	O
group	group	NN	B-NP	O
B	B	NN	I-NP	O
streptococci	streptococci	NNS	I-NP	O
(	(	(	O	O
GBS	GBS	NNS	B-NP	O
)	)	)	O	O
types	type	NNS	B-NP	O
Ia	Ia	NN	I-NP	O
,	,	,	O	O
Ib	Ib	NN	B-NP	O
,	,	,	O	O
II	II	CD	B-NP	O
and	and	CC	I-NP	O
III	III	CD	I-NP	O

On	On	IN	B-PP	O
average	average	NN	B-NP	O
,	,	,	O	O
rCMRglc	rCMRglc	NN	B-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
below	below	IN	B-PP	O
control	control	NN	B-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
regions	region	NNS	I-NP	O
studied	study	VBN	B-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
greatest	great	JJS	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
posterior	posterior	JJ	B-NP	O
brain	brain	NN	I-NP	O
regions	region	NNS	I-NP	O
(	(	(	O	O
visual	visual	JJ	B-NP	O
association	association	NN	I-NP	O
cortex	cortex	NN	I-NP	O
,	,	,	O	O
primary	primary	JJ	B-NP	O
visual	visual	JJ	I-NP	O
cortex	cortex	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
parietal	parietal	JJ	B-NP	O
cortex	cortex	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
thalamus	thalamus	NN	B-NP	O

The	The	DT	B-NP	O
NF1	BEGIN-BEGIN-NF1-INSIDE	NN	I-NP	B
family	family-INSIDE	NN	I-NP	I
members	member	NNS	I-NP	O
and	and	CC	O	O
HNF1	BEGIN-HBEGIN-NF1-INSIDE-INSIDE	NN	B-NP	B
interacted	interact	VBD	B-VP	O
with	with	IN	B-PP	O
overlapping	overlap	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
L	L	NN	I-NP	O
-	-	HYPH	O	O
II	II	CD	B-NP	O
element	element	NN	I-NP	O
,	,	,	O	O
wherein	wherein	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
half	half	NN	I-NP	O
-	-	HYPH	I-NP	O
site	site	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
critical	critical	JJ	I-ADJP	O
for	for	IN	B-PP	O
NF1	BEGIN-NF1-INSIDE	NN	B-NP	B
binding	binding	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
site	site	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
important	important	JJ	I-ADJP	O
for	for	IN	B-PP	O
HNF1	BEGIN-HBEGIN-NF1-INSIDE-INSIDE	NN	B-NP	B
binding	binding	NN	I-NP	O

The	The	DT	B-NP	O
shear	shear	NN	I-NP	O
bond	bond	NN	I-NP	O
strength	strength	NN	I-NP	O
recorded	record	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Novabond	Novabond	NNP	I-NP	O
system	system	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
MPa	MPa	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
IR1	IR1	NN	I-NP	O
ORF	ORF	NN	I-NP	O
exhibits	exhibit	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
immediate	BEGIN-immediate	JJ	I-NP	B
-	-	HYPH	I-NP	I
early	early	JJ	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
US1	BEGIN-US1-INSIDE	NN	I-NP	B
(	(	(	O	O
ICP1	BEGIN-ICP1-INSIDE	NN	B-NP	B
)	)	)	O	O
of	of	IN	B-PP	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICP1	BEGIN-ICP1-INSIDE	NN	I-NP	B
homologs	homolog	NNS	I-NP	O
of	of	IN	B-PP	O
varicella	varicella	NN	B-NP	O
-	-	HYPH	O	O
zoster	zoster	NN	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
ORF1	BEGIN-ORF1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
pseudorabies	pseudoraby	NNS	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
RSp1	BEGIN-RSp1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
equine	equine	JJ	B-NP	O
herpesvirus	herpesvirus	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
ORF1	BEGIN-ORF1-INSIDE	NN	B-NP	B
)	)	)	O	O

Psoriasis	Psoriasis	NN	B-NP	O
on	on	IN	B-PP	O
tumor	tumor	NN	B-NP	O

VP1	BEGIN-VP1-INSIDE	NN	B-NP	B
differentially	differentially	RB	B-ADVP	O
regulates	regulate	VBZ	B-VP	O
TRAF1	BEGIN-TRAF1-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O
,	,	,	O	O
disengaging	disengage	VBG	B-VP	O
JNK	BEGIN-JNK-INSIDE	JJ	B-NP	B
activation	activation	NN	I-NP	O
while	while	IN	B-SBAR	O
directing	direct	VBG	B-VP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
effect	effect	NN	B-NP	O
rotavirus	rotavirus	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
responses	response	NNS	I-NP	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
autopsy	autopsy	NN	I-NP	O
findings	finding	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
1	1	CD	I-NP	O
expired	expire	VBN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
Legionella	Legionella	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
successfully	successfully	RB	I-VP	O
treated	treat	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
other	other	JJ	B-NP	O
disease	disease	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
put	put	VBD	B-VP	O
an	an	DT	B-NP	O
end	end	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
a	a	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
eating	eat	VBG	B-VP	O
disorders	disorder	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
lifetime	lifetime	NN	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
irrespective	irrespective	JJ	B-ADJP	O
of	of	IN	B-PP	O
gender	gender	NN	B-NP	O
and	and	CC	I-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
whole	whole	JJ	I-NP	O
sample	sample	NN	I-NP	O
reported	report	VBD	B-VP	O
intentional	intentional	JJ	B-NP	O
insulin	BEGIN-insulin-INSIDE	NN	I-NP	B
undertreatment	undertreatment	NN	I-NP	O
or	or	CC	O	O
omission	omission	NN	B-NP	O

NER	NER	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
host	host	NN	I-NP	O
cell	cell	NN	I-NP	O
re	re	AFX	O	O
-	-	HYPH	O	O
activation	activation	NN	B-NP	O
assay	assay	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
vector	vector	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
luciferase	BEGIN-luciferase	NN	I-NP	B
reporter	reporter	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Also	Also	RB	B-ADVP	O
,	,	,	O	O
like	like	IN	B-PP	O
TUB	BEGIN-TUB-INSIDE	NN	B-NP	B
,	,	,	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
wider	wide	JJR	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	O
expression	expression	NN	I-NP	O
than	than	IN	B-PP	O
either	either	CC	O	O
TULP1	BEGIN-TULP1-INSIDE	NN	B-NP	B
or	or	CC	O	O
TULP1	BEGIN-TULP1-INSIDE	NN	B-NP	B

Accuracy	Accuracy	NN	B-NP	O
and	and	CC	I-NP	O
predictive	predictive	JJ	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
ultrasound	ultrasound	NN	B-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
rejection	rejection	NN	I-NP	O

Moist	Moist	NN	B-NP	O
healing	heal	VBG	B-VP	O
versus	versus	IN	B-PP	O
wet	wet	JJ	B-ADJP	O
-	-	HYPH	O	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
dry	dry	JJ	I-NP	O

Flicker	Flicker	NN	B-NP	O
thresholds	threshold	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
Hz	Hz	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
vertical	vertical	JJ	I-NP	O
-	-	HYPH	I-NP	O
line	line	NN	I-NP	O
target	target	NN	I-NP	O
used	use	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
asynchrony	asynchrony	JJ	I-NP	O
thresholds	threshold	NNS	I-NP	O

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
decreases	decrease	NNS	I-NP	O
or	or	CC	I-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
MAP	MAP	NN	B-NP	O
,	,	,	O	O
RSNA	RSNA	NN	B-NP	O
was	be	VBD	B-VP	O
attenuated	attenuate	VBN	I-VP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
min	min	NN	I-NP	O
of	of	IN	B-PP	O
propofol	propofol	NN	B-NP	O
infusion	infusion	NN	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
control	control	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Ganglia	Ganglia	NNP	B-NP	O
are	be	VBP	B-VP	O
cysts	cyst	NNS	B-NP	O
which	which	WDT	B-NP	O
frequently	frequently	RB	B-ADVP	O
occur	occur	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximity	proximity	NN	I-NP	O
of	of	IN	B-PP	O
joints	joint	NNS	B-NP	O

Fractional	Fractional	JJ	B-NP	O
Ca	Ca	NN	I-NP	O
retention	retention	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
h	h	NN	I-NP	O
postdose	postdose	JJ	I-NP	O
WBR	WBR	NN	I-NP	O
divided	divide	VBN	B-VP	O
by	by	IN	B-PP	O
WBR	WBR	NN	B-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
1	1	CD	I-NP	O

Activity	Activity	NN	B-NP	O
was	be	VBD	B-VP	O
reconstituted	reconstitute	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
by	by	IN	B-PP	O
combining	combine	VBG	B-VP	O
fractions	fraction	NNS	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
enriched	enrich	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
components	component	NNS	I-NP	O

Acute	Acute	JJ	B-NP	O
morphine	morphine	NN	I-NP	O
treatment	treatment	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
locomotor	locomotor	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
mice	mouse	NNS	B-NP	O
withdrawn	withdraw	VBN	B-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
withdrawal	withdrawal	NN	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
controls	control	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
was	be	VBD	B-VP	O
clearly	clearly	RB	B-ADJP	O
larger	large	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
controls	control	NNS	B-NP	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
and	and	CC	I-NP	O
specific	specific	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
binaural	binaural	JJ	B-NP	O
peak	peak	JJ	I-NP	O
amplitude	amplitude	NN	I-NP	O
and	and	CC	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
echo	echo	AFX	I-NP	O
-	-	HYPH	I-NP	O
evoked	evoke	VBN	I-NP	O
middle	middle	JJ	I-NP	O
-	-	HYPH	I-NP	O
latency	latency	NN	I-NP	O
component	component	NN	I-NP	O
Pa	Pa	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

Non	Non	AFX	B-NP	O
-	-	HYPH	I-NP	O
dialyzable	dialyzable	JJ	I-NP	O
transfer	BEGIN-transfer	NN	I-NP	B
factor	factor-INSIDE	NN	I-NP	I

Gene	BEGIN-Gene	NN	B-NP	B
1	1	CD	I-NP	I
of	of	IN	B-PP	I
the	the	DT	B-NP	I
murine	murine	JJ	I-NP	I
coronavirus	coronavirus	NN	I-NP	I
,	,	,	O	I
MHV	MHV	NN	B-NP	I
-	-	HYPH	B-NP	I
A1	A1-INSIDE	NN	I-NP	I
,	,	,	O	O
encodes	encode	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
products	product	NNS	I-NP	O
within	within	IN	B-PP	O
two	two	CD	B-NP	O
overlapping	overlap	VBG	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frames	frame	NNS	I-NP	O
(	(	(	O	O
ORFs	ORF	NNS	B-NP	O
1a	1a	NN	I-NP	O
and	and	CC	O	O
1b	1b	NN	B-NP	O
)	)	)	O	O

Stress	Stress	NN	B-NP	O
thallium	thallium	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
myocardial	myocardial	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
angina	angina	NN	I-NP	O
-	-	HYPH	O	O
free	free	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
clinically	clinically	RB	B-NP	O
silent	silent	JJ	I-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
myocardium	myocardium	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
distinguish	distinguish	VB	I-VP	O
between	between	IN	B-PP	O
scar	scar	NN	B-NP	O
and	and	CC	O	O
reversibly	reversibly	RB	B-NP	O
ischemic	ischemic	JJ	I-NP	O
myocardium	myocardium	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
cause	cause	NN	I-NP	O
for	for	IN	B-PP	O
akinesia	akinesia	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
wall	wall	NN	I-NP	O
segments	segment	NNS	I-NP	O

To	To	TO	B-VP	O
understand	understand	VB	I-VP	O
this	this	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
effect	effect	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
SR	BEGIN-SR	JJ	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
and	and	CC	O	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
SC1	BEGIN-SC1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
shifted	shift	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
in	in	IN	B-PP	O
sky1Delta	BEGIN-sky1Delta-INSIDE	NN	B-NP	B
yeast	yeast	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
this	this	DT	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
obvious	obvious	JJ	B-ADJP	O
with	with	IN	B-PP	O
ASF	BEGIN-ASF-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
SF1	BEGIN-SF1-INSIDE	NN	I-NP	B
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
nuclear	nuclear	JJ	B-NP	O
import	import	NN	I-NP	O
of	of	IN	B-PP	O
SR	BEGIN-SR	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
be	be	VB	I-VP	O
differentially	differentially	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O

GH	BEGIN-GH-INSIDE	NN	B-NP	B
stimulated	stimulate	VBD	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
promoter	promoter	NN	B-NP	O
fragments	fragment	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
ends	end	NNS	I-NP	O
between	between	IN	B-PP	O
nucleotide	nucleotide	NN	B-NP	O
(	(	(	O	O
nt	nt	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
nt	nt	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
fold	fold	RB	B-ADVP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
genomic	genomic	JJ	I-NP	O
fragment	fragment	NN	I-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
coding	cod	VBG	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
MyoD	BEGIN-MyoD-INSIDE	NN	B-NP	B
,	,	,	O	O
distributed	distribute	VBN	B-VP	O
over	over	IN	B-PP	O
three	three	CD	B-NP	O
exons	exon	NNS	I-NP	O
,	,	,	O	O
plus	plus	CC	O	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
noncoding	noncoding	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
noncoding	noncoding	JJ	I-NP	O
sequence	sequence	NN	I-NP	O

These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
KSR	BEGIN-KSR-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
uncoupling	uncouple	VBG	B-VP	O
the	the	DT	B-NP	O
MAP	BEGIN-MAP	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
from	from	IN	B-PP	O
its	its	PRP$	B-NP	O
target	target	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
modulating	modulate	VBG	B-VP	O
the	the	DT	B-NP	O
Ras	BEGIN-Ras-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
MAP	BEGIN-MAP	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O

Since	Since	IN	B-PP	O
1	1	CD	B-NP	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
chlorambucil	chlorambucil	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
initially	initially	RB	B-ADVP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
alternating	alternate	VBG	B-VP	O
fortnights	fortnight	NNS	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
interferon	BEGIN-interferon	NN	B-NP	B
-	-	HYPH	O	I
alpha	alpha	SYM	O	I
1b	1b-INSIDE	NN	B-NP	I
(	(	(	O	O
Schering	Schering	NNP	B-NP	O
-	-	HYPH	O	O
Plough	Plough	NNP	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
x	x	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
U	U	NN	B-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
weekly	weekly	RB	B-ADVP	O
by	by	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
injection	injection	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
compared	compare	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
randomised	randomise	VBN	I-NP	O
trial	trial	NN	I-NP	O
with	with	IN	B-PP	O
chlorambucil	chlorambucil	NN	B-NP	O
alone	alone	RB	B-ADVP	O
in	in	IN	B-PP	O
previously	previously	RB	B-NP	O
untreated	untreated	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
stage	stage	NN	B-NP	O
III	III	CD	I-NP	O
or	or	CC	I-NP	O
IV	IV	CD	I-NP	O
follicular	follicular	JJ	I-NP	O
lymphoma	lymphoma	NN	I-NP	O

Correlation	Correlation	NN	B-NP	O
of	of	IN	B-PP	O
alpha	alpha	NN	B-NP	O
activity	activity	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
frontal	frontal	JJ	I-NP	O
and	and	CC	I-NP	O
occipital	occipital	JJ	I-NP	O
cortex	cortex	NN	I-NP	O

Nonetheless	Nonetheless	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
were	be	VBD	B-VP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
three	three	CD	B-NP	O
short	short	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
terminus	terminus	NN	I-NP	O
,	,	,	O	O
middle	middle	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
C	C	NN	B-NP	O
terminus	terminus	NN	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
phylogenetically	phylogenetically	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
among	among	IN	B-PP	O
all	all	DT	B-NP	O
known	know	VBN	I-NP	O
eubacterial	eubacterial	JJ	I-NP	O
and	and	CC	I-NP	O
chloroplast	chloroplast	NN	I-NP	O
versions	version	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
protein	protein	NN	I-NP	O

All	All	DT	B-NP	O
other	other	JJ	I-NP	O
cysts	cyst	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
unilocular	unilocular	JJ	I-NP	O
,	,	,	I-NP	O
purely	purely	RB	I-NP	O
cystic	cystic	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
homogeneous	homogeneous	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
T1	T1	NN	I-NP	O
relaxation	relaxation	NN	I-NP	O
times	time	NNS	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
lesions	lesion	NNS	I-NP	O
overlapped	overlap	VBD	B-VP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
odontogenic	odontogenic	JJ	B-NP	O
keratocysts	keratocyst	NNS	I-NP	O

Processing	Process	VBG	B-VP	O
MES	MES	NN	B-NP	O
data	datum	NNS	I-NP	O
requires	require	VBZ	B-VP	O
large	large	JJ	B-NP	O
bit	bit	NN	I-NP	O
manipulations	manipulation	NNS	I-NP	O
and	and	CC	O	O
heavy	heavy	JJ	B-NP	O
memory	memory	NN	I-NP	O
storage	storage	NN	I-NP	O
requirements	requirement	NNS	I-NP	O

Recombinant	BEGIN-Recombinant	JJ	B-NP	B
caspases	caspases-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
typically	typically	RB	I-VP	O
produced	produce	VBN	I-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
expression	expression	NN	I-NP	O
systems	system	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
attendant	attendant	JJ	I-NP	O
problems	problem	NNS	I-NP	O
of	of	IN	B-PP	O
solubilization	solubilization	NN	B-NP	O
,	,	,	O	O
re	re	AFX	B-NP	O
-	-	HYPH	I-NP	O
folding	folding	NN	I-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
protease	protease	NN	I-NP	O

Nuclear	Nuclear	JJ	B-NP	O
runoff	runoff	NN	I-NP	O
assays	assay	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
complementation	complementation	NN	B-NP	O
by	by	IN	B-PP	O
HPV1	BEGIN-HPV1	NN	B-NP	B
E1	E1-INSIDE	NN	I-NP	I
restores	restore	VBZ	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E1A	BEGIN-E1A	NN	I-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
stimulate	stimulate	VB	I-VP	O
early	BEGIN-early	JJ	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
deferoxamine	deferoxamine	NN	B-NP	O
B	B	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
behavior	behavior	NN	I-NP	O
in	in	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
loading	loading	NN	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
persons	person	NNS	I-NP	O

Constructs	Construct	NNS	B-NP	O
containing	contain	VBG	B-VP	O
fragments	fragment	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytotactin	BEGIN-cytotactin	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
promoterless	promoterless	JJ	I-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
chloramphenicol	BEGIN-chloramphenicol	NN	B-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
transiently	transiently	RB	I-VP	O
transfected	transfecte	VBN	I-VP	O
into	into	IN	B-PP	O
chicken	chicken	NN	B-NP	O
embryo	embryo	NN	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
to	to	TO	B-VP	O
define	define	VB	I-VP	O
functional	functional	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
sequences	sequence	NNS	I-NP	O

Like	Like	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
erythrocyte	erythrocyte	NN	I-NP	I
P1	P1-INSIDE	NN	I-NP	I
,	,	,	O	O
mouse	BEGIN-mouse	NN	B-NP	B
erythrocyte	erythrocyte	NN	I-NP	I
P1	P1-INSIDE	NN	I-NP	I
contains	contain	VBZ	B-VP	O
regions	region	NNS	B-NP	O
strikingly	strikingly	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
transglutaminase	transglutaminase	NN	I-NP	O
(	(	(	O	O
TGase	TGase	NN	B-NP	O
)	)	)	O	O
proteins	protein	NNS	B-NP	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
too	too	RB	B-ADVP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
lacks	lack	VBZ	B-VP	O
TGase	TGase	NN	B-NP	O
crosslinking	crosslinking	NN	I-NP	O
activity	activity	NN	I-NP	O

The	The	DT	B-NP	O
rate	rate	NN	I-NP	O
for	for	IN	B-PP	O
Arm	Arm	NN	B-NP	O
III	III	CD	I-NP	O
(	(	(	O	O
CAF	CAF	NN	B-NP	O
therapy	therapy	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
little	little	RB	I-NP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
two	two	CD	I-NP	O

The	The	DT	B-NP	O
CHL	BEGIN-CHL	NN	I-NP	B
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
CTF	BEGIN-CTF	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
)	)	)	I-NP	O
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
transmission	transmission	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
in	in	IN	B-PP	O
G1	G1	NN	B-NP	O
/	/	SYM	B-VP	O
M	M	NN	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
putative	putative	JJ	I-NP	O
SL	SL	NN	I-NP	O
structures	structure	NNS	I-NP	O
in	in	IN	B-PP	O
RNA	RNA	NN	B-NP	O
translation	translation	NN	I-NP	O
by	by	IN	B-PP	O
constructing	construct	VBG	B-VP	O
chimeric	BEGIN-chimeric	JJ	B-NP	B
chloramphenicol	chloramphenicol	NN	I-NP	I
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
	BEGIN-	NN	I-NP	B
(	(	(	O	I
CAT	CAT	NN	B-NP	I
)	)	)	O	I
RNAs	RNAs-INSIDE	NN	B-NP	I
,	,	,	O	O
flanked	flank	VBD	B-VP	O
either	either	CC	O	O
by	by	IN	B-PP	O
both	both	CC	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
domains	domain	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
RV	RV	NN	I-NP	O
genome	genome	NN	I-NP	O
or	or	CC	O	O
several	several	JJ	B-NP	O
deletion	deletion	NN	I-NP	O
derivatives	derivative	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O

Mutating	Mutate	VBG	B-VP	O
this	this	DT	B-NP	O
sequence	sequence	NN	I-NP	O
eliminated	eliminate	VBD	B-VP	O
complex	complex	NN	B-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
markedly	markedly	RB	B-VP	O
reduced	reduce	VBD	I-VP	O
basal	basal	JJ	B-NP	O
and	and	CC	I-NP	O
cAMP	cAMP	NN	I-NP	O
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
transfected	transfecte	VBN	B-NP	O
reporter	reporter	NN	I-NP	O
genes	gene	NNS	I-NP	O

The	The	DT	B-NP	O
average	average	JJ	I-NP	O
cumulative	cumulative	JJ	I-NP	O
UVA	UVA	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
J	J	NN	I-NP	O
/	/	SYM	B-NP	O
cm1	cm1	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
J	J	NN	I-NP	O
/	/	SYM	O	O
cm1	cm1	NN	B-NP	O

The	The	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
composite	composite	JJ	I-NP	O
H	BEGIN-H	NN	I-NP	B
-	-	HYPH	B-NP	I
PK	PK-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
Tag	BEGIN-Tag-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
SV	BEGIN-SV	NN	I-NP	B
-	-	HYPH	B-NP	I
PK	PK-INSIDE	NN	I-NP	I
/	/	SYM	I-NP	O
Tag	BEGIN-Tag-INSIDE	NN	I-NP	B
transgenes	transgene	NNS	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
diet	diet	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	BEGIN-endogenous	JJ	I-NP	B
L	L	NN	I-NP	I
-	-	HYPH	B-NP	I
PK	PK	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

For	For	IN	B-PP	O
routine	routine	JJ	B-NP	O
medical	medical	JJ	I-NP	O
applications	application	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sophisticated	sophisticated	JJ	I-NP	O
adjustment	adjustment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CHESS	CHESS	NN	I-NP	O
pulse	pulse	NN	I-NP	O
is	be	VBZ	B-VP	O
needed	need	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
reported	report	VBN	B-VP	O
in	in	IN	B-PP	O
previous	previous	JJ	B-NP	O
methods	method	NNS	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hemF	BEGIN-hemF	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
aerobic	aerobic	JJ	I-NP	O
coproporphyrinogen	BEGIN-coproporphyrinogen	NN	I-NP	B
III	III	CD	I-NP	I
oxidase	oxidase	NN	I-NP	I
from	from	IN	B-PP	I
Escherichia	Escherichia	NNP	B-NP	I
coli	coli-INSIDE	NN	I-NP	I
,	,	,	O	O
by	by	IN	B-PP	O
functional	functional	JJ	B-NP	O
complementation	complementation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Saccharomyces	BEGIN-Saccharomyces	JJ	I-NP	B
cerevisiae	cerevisiae	NN	I-NP	I
HEM1	HEM1	NN	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I

Efficacy	Efficacy	NN	B-NP	O
of	of	IN	B-PP	O
probiotic	probiotic	JJ	B-NP	O
feed	feed	NN	I-NP	O
additives	additive	NNS	I-NP	O
:	:	:	O	O
guidelines	guideline	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
efficiency	efficiency	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
in	in	IN	B-PP	O
dogs	dog	NNS	B-NP	O
,	,	,	O	O
cats	cat	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
horses	horse	NNS	B-NP	O
]	]	)	O	O
Probiotic	Probiotic	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
are	be	VBP	B-VP	O
frequently	frequently	RB	B-ADVP	O
in	in	IN	B-PP	O
use	use	NN	B-NP	O
as	as	IN	B-PP	O
feed	feed	NN	B-NP	O
additives	additive	NNS	I-NP	O
for	for	IN	B-PP	O
farm	farm	NN	B-NP	O
and	and	CC	I-NP	O
pet	pet	NN	I-NP	O
animals	animal	NNS	I-NP	O

We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
different	different	JJ	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
UV	UV	NN	B-NP	O
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
mitogen	BEGIN-mitogen	NN	I-NP	B
-	-	HYPH	B-VP	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
(	(	(	O	I
MAP	MAP	NN	B-NP	I
)	)	)	O	I
kinases	kinases-INSIDE	NN	B-NP	I
(	(	(	O	O
ERK	BEGIN-ERK-INSIDE	NN	B-NP	B
,	,	,	O	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
SAPK	BEGIN-SAPK-INSIDE	NN	I-NP	B
,	,	,	O	O
and	and	CC	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
)	)	)	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
uPA	BEGIN-uPA-INSIDE	NN	I-NP	B
promoter	promoter	NN	I-NP	O
by	by	IN	B-PP	O
UV	UV	NN	B-NP	O

The	The	DT	B-NP	O
largest	large	JJS	I-NP	O
age	age	NN	I-NP	O
adjusted	adjusted	JJ	I-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
men	man	NNS	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
and	and	CC	I-NP	O
normal	normal	JJ	I-NP	O
mood	mood	NN	I-NP	O
were	be	VBD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
AH1	AH1	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
points	point	NNS	I-NP	O
,	,	,	O	O
t	t	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
CAMCOG	CAMCOG	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
points	point	NNS	I-NP	O
,	,	,	O	O
t	t	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Nucleotide	Nucleotide	NN	B-NP	O
sequencing	sequencing	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
base	base	NN	I-NP	O
pair	pair	NN	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
protein	protein	NN	I-NP	O

HrpE	BEGIN-HrpE-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
YscL	BEGIN-YscL-INSIDE	NN	B-NP	B
of	of	IN	B-PP	O
Yersinia	Yersinia	NNP	B-NP	O
spp	spp	NN	I-NP	O

Mean	Mean	JJ	B-NP	O
total	total	JJ	I-NP	O
homocysteine	homocysteine	NN	I-NP	O
(	(	(	O	O
tHcy	tHcy	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
micromol	micromol	NN	I-NP	O
/	/	SYM	B-NP	O
L	L	NN	I-NP	O
and	and	CC	O	O
median	median	JJ	B-NP	O
concentration	concentration	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
micromol	micromol	NN	I-NP	O
/	/	SYM	O	O
L	L	NN	B-NP	O

To	To	TO	B-VP	O
facilitate	facilitate	VB	I-VP	O
the	the	DT	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
E1	E1-INSIDE	NN	I-NP	I
functions	function	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
cDNAs	cDNA	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
two	two	CD	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
small	BEGIN-small	JJ	I-NP	B
Maf	Maf	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I
,	,	,	O	O
MafK	BEGIN-MafK-INSIDE	NN	B-NP	B
and	and	CC	O	O
MafG	BEGIN-MafG-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
immediate	immediate	JJ	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
flanking	flank	VBG	I-NP	O
region	region	NN	I-NP	O
was	be	VBD	B-VP	O
GC	GC	NN	B-NP	O
-	-	HYPH	B-ADJP	O
rich	rich	JJ	I-ADJP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
SP	BEGIN-SP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
like	like-INSIDE	NN	I-NP	I
and	and	CC	O	O
1	1	CD	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
sites	sites-INSIDE	NN	I-NP	I
identified	identify	VBN	B-VP	O
in	in	IN	B-PP	O
close	close	JJ	B-NP	O
proximity	proximity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O

The	The	DT	B-NP	O
ZAG1	BEGIN-ZAG1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
translations	translation	NNS	I-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	O
target	target	NN	I-NP	O
site	site	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
recognized	recognize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
AG	BEGIN-AG	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I

Bone	Bone	NN	B-NP	O
scintigraphy	scintigraphy	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
excellent	excellent	JJ	I-NP	O
screening	screening	NN	I-NP	O
test	test	NN	I-NP	O
for	for	IN	B-PP	O
bone	bone	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
Ga	Ga	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
scintigraphy	scintigraphy	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
tool	tool	NN	I-NP	O
for	for	IN	B-PP	O
detecting	detect	VBG	B-VP	O
inflammatory	inflammatory	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
first	first	JJ	I-NP	O
-	-	HYPH	I-NP	O
person	person	NN	I-NP	O
account	account	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
author	author	NN	I-NP	O
chronicles	chronicle	VBZ	B-VP	O
her	her	PRP$	B-NP	O
experience	experience	NN	I-NP	O
of	of	IN	B-PP	O
being	be	VBG	B-VP	O
mentally	mentally	RB	B-ADJP	O
ill	ill	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
homeless	homeless	JJ	I-ADJP	O
in	in	IN	B-PP	O
New	New	NNP	B-NP	O
York	York	NNP	I-NP	O
and	and	CC	O	O
New	New	NNP	B-NP	O
Jersey	Jersey	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
1s	1	NNS	I-NP	O

Pharmacokinetics	Pharmacokinetic	NNS	B-NP	O
of	of	IN	B-PP	O
skin	skin	NN	B-NP	O
penetration	penetration	NN	I-NP	O

Dmyd	BEGIN-Dmyd-INSIDE	NN	B-NP	B
clone	clone	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
to	to	TO	B-PP	O
MyoD	BEGIN-MyoD-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
helix	helix	NN	I-NP	O
-	-	HYPH	B-NP	O
loop	loop	NN	I-NP	O
-	-	HYPH	I-NP	O
helix	helix	NN	I-NP	O
region	region	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
basic	basic	JJ	I-NP	O
domain	domain	NN	I-NP	O
proposed	propose	VBN	B-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
the	the	DT	B-NP	O
essential	essential	JJ	I-NP	O
recognition	recognition	NN	I-NP	O
code	code	NN	I-NP	O
for	for	IN	B-PP	O
muscle	muscle	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
gene	gene	NN	I-NP	O
activation	activation	NN	I-NP	O

Enterotoxin	Enterotoxin	NN	B-NP	O
production	production	NN	I-NP	O
by	by	IN	B-PP	O
staphylococci	staphylococci	NNS	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
foods	food	NNS	B-NP	O
in	in	IN	B-PP	O
France	France	NNP	B-NP	O

Binding	Bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
were	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
factor	factor	NN	I-NP	O

The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
OKT1	BEGIN-OKT1-INSIDE	NN	B-NP	B
positive	positive	JJ	B-ADJP	O
(	(	(	O	O
helper	helper	NN	B-NP	O
/	/	SYM	O	O
inducer	inducer	NN	B-NP	O
T	T	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
minority	minority	NN	I-NP	O
were	be	VBD	B-VP	O
OKT1	BEGIN-OKT1-INSIDE	NN	B-NP	B
positive	positive	JJ	B-ADJP	O
(	(	(	O	O
suppressor	suppressor	NN	B-NP	O
/	/	SYM	O	O
cytotoxic	cytotoxic	JJ	B-NP	O
T	T	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
)	)	)	O	O

Toxicological	Toxicological	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
Maillard	Maillard	NNP	I-NP	O
reaction	reaction	NN	I-NP	O
products	product	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O

All	All	DT	B-NP	O
relapses	relapse	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
year	year	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
confined	confine	VBN	I-VP	O
to	to	TO	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
PS	PS	NN	B-NP	O
II	II	CD	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
involvement	involvement	NN	B-NP	O

These	These	DT	B-NP	O
patients	patient	NNS	I-NP	O
developed	develop	VBD	B-VP	O
severe	severe	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
including	include	VBG	B-PP	O
glucose	glucose	NN	B-NP	O
intolerance	intolerance	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
impaired	impaired	JJ	B-NP	O
energy	energy	NN	I-NP	O
utilization	utilization	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nerve	nerve	NN	B-NP	O
and	and	CC	I-NP	O
brain	brain	NN	I-NP	O
disorders	disorder	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B

Buserelin	Buserelin	NN	B-NP	O
offers	offer	VBZ	B-VP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
alternative	alternative	JJ	I-NP	O
medical	medical	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
carcinoma	carcinoma	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prostate	prostate	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
apart	apart	RB	B-ADVP	O
from	from	IN	B-PP	O
impotence	impotence	NN	B-NP	O
,	,	,	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
side	side	NN	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
oestrogens	oestrogen	NNS	B-NP	O

BCV	BEGIN-BCV	NN	B-NP	B
mRNAs	mRNA	NNS	I-NP	I
1	1	CD	B-NP	I
and	and	CC	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
a	a	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
strikingly	strikingly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
utilized	utilize	VBN	B-VP	O
by	by	IN	B-PP	O
MHV	MHV	NN	B-NP	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
observation	observation	NN	I-NP	O
,	,	,	O	O
introduction	introduction	NN	B-NP	O
of	of	IN	B-PP	O
Smad	BEGIN-Smad	JJ	B-NP	B
sites	sites-INSIDE	NN	I-NP	I
into	into	IN	B-PP	O
a	a	DT	B-NP	O
TGFbeta	BEGIN-TGFbeta-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
insensitive	insensitive	JJ	I-NP	O
LEF1	BEGIN-LEF1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
TCF	BEGIN-TCF-INSIDE	NN	I-NP	B
target	target	NN	I-NP	O
gene	gene	NN	I-NP	O
confers	confer	VBZ	B-VP	O
cooperative	cooperative	JJ	B-NP	O
TGFbeta	BEGIN-TGFbeta-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
Wnt	BEGIN-Wnt-INSIDE	NN	I-NP	B
responsiveness	responsiveness	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O

Recombinant	Recombinant	JJ	B-NP	O
vaccinia	vaccinia	NN	I-NP	O
viruses	virus	NNS	I-NP	O
that	that	WDT	B-NP	O
express	express	VBP	B-VP	O
the	the	DT	B-NP	O
bacteriophage	BEGIN-bacteriophage	JJ	I-NP	B
T1	T1	NN	I-NP	I
RNA	RNA	NN	I-NP	I
polymerase	polymerase-INSIDE	NN	I-NP	I
(	(	(	O	O
VV	BEGIN-VV	NN	B-NP	B
-	-	HYPH	B-NP	I
T1pol	T1pol-INSIDE	NN	I-NP	I
)	)	)	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
Escherichia	BEGIN-Escherichia	FW	I-NP	B
coli	coli	FW	I-NP	I
lac	lac	NN	I-NP	I
repressor	repressor-INSIDE	NN	I-NP	I
(	(	(	O	O
VV	BEGIN-VV	NN	B-NP	B
-	-	HYPH	B-NP	I
lacI	lacI-INSIDE	NN	I-NP	I
)	)	)	O	O
under	under	IN	B-PP	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
early	BEGIN-early	JJ	I-NP	B
-	-	HYPH	I-NP	I
late	late	JJ	I-NP	I
vaccinia	vaccinia	NN	I-NP	I
promoter	promoter	NN	I-NP	I
P1	P1-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O

Tritiated	Tritiate	VBN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
trihydroxyvitamin	trihydroxyvitamin	NN	I-NP	O
D1	D1	NN	I-NP	O
was	be	VBD	B-VP	O
synthesized	synthesize	VBN	I-VP	O
biologically	biologically	RB	B-ADVP	O
and	and	CC	O	O
used	use	VBN	B-VP	O
as	as	IN	B-PP	O
tracer	tracer	NN	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
the	the	DT	B-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
metabolite	metabolite	NN	I-NP	O
during	during	IN	B-PP	O
isolation	isolation	NN	B-NP	O
from	from	IN	B-PP	O
serum	serum	NN	B-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
examined	examine	VBN	I-VP	O
whether	whether	IN	B-SBAR	O
PTP1B	BEGIN-PTP1B-INSIDE	NN	B-NP	B
effects	effect	NNS	I-NP	O
transformation	transformation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
bcr	BEGIN-bcr-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
abl	BEGIN-abl-INSIDE	NN	B-NP	B

This	This	DT	B-NP	O
study	study	NN	I-NP	O
examines	examine	VBZ	B-VP	O
LEIBNIZ	LEIBNIZ	NN	B-NP	O
'	'	POS	B-NP	O
idea	idea	NN	I-NP	O
of	of	IN	B-PP	O
Veterinary	Veterinary	JJ	B-NP	O
medicine	medicine	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
biographical	biographical	JJ	I-NP	O
context	context	NN	I-NP	O

Internalization	Internalization	NN	B-NP	O
of	of	IN	B-PP	O
prolactin	BEGIN-BEGIN-prolactin-INSIDE	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
prolactin	BEGIN-prolactin-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
transfected	transfecte	VBN	B-NP	O
cells	cell	NNS	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
involve	involve	VB	I-VP	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
conflict	conflict	NN	I-NP	O
drinking	drinking	NN	I-NP	O
test	test	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nonselective	nonselective	JJ	I-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
adrenoceptor	adrenoceptor-INSIDE	NN	I-NP	I
blockers	blocker	NNS	I-NP	O
pindolol	pindolol	NN	I-NP	O
and	and	CC	I-NP	O
cyanopindolol	cyanopindolol	NN	I-NP	O
which	which	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
1	BEGIN-1	NN	B-NP	B
-	-	HYPH	I-NP	I
HT1A	HT1A	NN	I-NP	I
and	and	CC	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
HT1B	HT1B	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
selective	selective	JJ	I-NP	O
beta	BEGIN-beta	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	B-ADJP	I
and	and	CC	O	I
beta	beta	SYM	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
adrenoceptor	adrenoceptor-INSIDE	NN	I-NP	I
antagonists	antagonist	NNS	I-NP	O
betaxolol	betaxolol	NN	I-NP	O
and	and	CC	I-NP	O
ICI	ICI	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
negligible	negligible	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
1	BEGIN-1	NN	B-NP	B
-	-	HYPH	I-NP	I
HT	HT	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I

Rewarding	Reward	VBG	B-VP	O
properties	property	NNS	B-NP	O
of	of	IN	B-PP	O
methylphenidate	methylphenidate	NN	B-NP	O
:	:	:	O	O
sensitization	sensitization	NN	B-NP	O
by	by	IN	B-PP	O
prior	prior	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
and	and	CC	O	O
effects	effect	NNS	B-NP	O
of	of	IN	B-PP	O
dopamine	BEGIN-dopamine	NN	B-NP	B
D1	D1	NN	I-NP	I
-	-	HYPH	B-NP	I
and	and	CC	I-NP	I
D1	D1	NN	I-NP	I
-	-	HYPH	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
antagonists	antagonist	NNS	I-NP	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
mouse	mouse	NN	B-NP	O
microglial	microglial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
macrophages	macrophage	NNS	I-NP	O
,	,	,	O	O
express	express	VBP	B-VP	O
both	both	CC	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
IL	BEGIN-BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Children	Child	NNS	B-NP	O
with	with	IN	B-PP	O
attention	attention	NN	B-NP	O
-	-	HYPH	I-NP	O
deficit	deficit	NN	I-NP	O
/	/	SYM	O	O
hyperactivity	hyperactivity	NN	B-NP	O
disorder	disorder	NN	I-NP	O
(	(	(	O	O
ADHD	ADHD	NN	B-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
all	all	DT	B-NP	O
subtypes	subtype	NNS	I-NP	O
,	,	,	O	O
ages	age	NNS	B-NP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
randomized	randomize	VBN	I-VP	O
to	to	TO	B-PP	O
placebo	placebo	NN	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
immediate	immediate	JJ	B-NP	O
-	-	HYPH	I-NP	O
release	release	NN	I-NP	O
methylphenidate	methylphenidate	NN	I-NP	O
(	(	(	O	O
IR	IR	NN	B-NP	O
MPH	MPH	NN	I-NP	O
)	)	)	O	O
1	1	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
(	(	(	O	O
tid	tid	NN	B-NP	O
;	;	:	O	O
dosed	dose	VBD	B-VP	O
every	every	DT	B-NP	O
1	1	CD	I-NP	O
hours	hour	NNS	I-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
OROS	OROS	NN	B-NP	O
MPH	MPH	NN	I-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
(	(	(	O	O
qd	qd	NN	B-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
blind	blind	JJ	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
day	day	NN	I-NP	O
trial	trial	NN	I-NP	O

Cell	Cell	NN	B-NP	O
sloughing	slough	VBG	B-VP	O
with	with	IN	B-PP	O
proparacaine	proparacaine	NN	B-NP	O

The	The	DT	B-NP	O
possibility	possibility	NN	I-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
this	this	DT	B-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
common	common	JJ	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
problems	problem	NNS	I-NP	O
is	be	VBZ	B-VP	O
indicated	indicate	VBN	I-VP	O

The	The	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
is	be	VBZ	B-VP	O
significantly	significantly	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
HSV	BEGIN-HSV	NN	I-NP	B
1	1	CD	I-NP	I
UL1	BEGIN-UL1-INSIDE	NN	I-NP	I
gene	gene	NN	I-NP	O
product	product-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
as	as	IN	B-PP	O
with	with	IN	B-PP	O
UL1	BEGIN-UL1-INSIDE	NN	B-NP	B
,	,	,	O	O
it	it	PRP	B-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
signal	signal	NN	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
transmembrane	transmembrane	JJ	B-NP	O
domain	domain	NN	I-NP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
membrane	membrane	NN	B-NP	O
-	-	HYPH	B-NP	O
associated	associate	VBN	I-NP	O
proteins	protein	NNS	I-NP	O

Female	Female	NNP	B-NP	O
Wistar	Wistar	NNP	I-NP	O
rats	rat	NNS	I-NP	O
receiving	receive	VBG	B-VP	O
alcohol	alcohol	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
drinking	drinking	NN	B-NP	O
water	water	NN	I-NP	O
during	during	IN	B-PP	O
lactation	lactation	NN	B-NP	O
(	(	(	O	O
N	N	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
controls	control	NNS	I-NP	O
fed	feed	VBN	B-VP	O
ad	ad	NN	B-NP	O
libitum	libitum	NN	I-NP	O
(	(	(	O	O
N	N	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

Suspected	Suspect	VBN	B-NP	O
pelvic	pelvic	JJ	I-NP	O
endometriosis	endometriosis	NN	I-NP	O
was	be	VBD	B-VP	O
prospectively	prospectively	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
T1	T1	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
T1	T1	NN	I-NP	O
-	-	HYPH	O	O
weighted	weight	VBN	B-VP	O
conventional	conventional	JJ	B-NP	O
spin	spin	NN	I-NP	O
-	-	HYPH	B-NP	O
echo	echo	NN	I-NP	O
(	(	(	I-NP	O
CSE	CSE	NN	I-NP	O
)	)	)	I-NP	O
magnetic	magnetic	JJ	I-NP	O
resonance	resonance	NN	I-NP	O
imaging	imaging	NN	I-NP	O
alone	alone	RB	B-ADVP	O
and	and	CC	O	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
T1	T1	NN	B-NP	O
-	-	HYPH	O	O
weighted	weight	VBN	B-NP	O
fat	fat	NN	I-NP	O
-	-	HYPH	B-VP	O
suppressed	suppress	VBN	I-VP	O
(	(	(	O	O
T1FS	T1FS	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
gadolinium	gadolinium	NN	B-NP	O
-	-	HYPH	O	O
enhanced	enhance	VBN	B-VP	O
T1FS	T1FS	NN	B-NP	O
(	(	(	O	O
Gd	Gd	NN	B-NP	O
-	-	HYPH	B-NP	O
T1FS	T1FS	NN	I-NP	O
)	)	)	O	O
spin	spin	NN	B-NP	O
-	-	HYPH	B-NP	O
echo	echo	NN	I-NP	O
techniques	technique	NNS	I-NP	O

Eph	BEGIN-Eph	JJ	B-NP	B
receptors	receptors-INSIDE	NN	I-NP	I
and	and	CC	O	O
their	their	PRP$	B-NP	O
membrane	membrane	NN	I-NP	O
-	-	HYPH	O	O
associated	associate	VBN	B-NP	O
ephrin	BEGIN-ephrin	NN	I-NP	B
ligands	ligands-INSIDE	NN	I-NP	I
regulate	regulate	VBP	B-VP	O
cell	cell	NN	B-NP	O
-	-	HYPH	B-NP	O
cell	cell	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
during	during	IN	B-PP	O
development	development	NN	B-NP	O

A	A	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
factors	factor	NNS	B-NP	O
known	know	VBN	B-VP	O
as	as	IN	B-PP	O
activating	BEGIN-activating	JJ	B-NP	B
transcription	transcription	NN	I-NP	I
factors	factors-INSIDE	NN	I-NP	I
(	(	(	O	O
ATF	BEGIN-ATF-INSIDE	NN	B-NP	B
)	)	)	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
and	and	CC	I-NP	O
related	related	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
found	find	VBN	B-VP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
adenovirus	adenovirus	NN	I-NP	O
promoters	promoter	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
are	be	VBP	B-VP	O
highly	highly	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CREB	BEGIN-CREB	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I

Vk1	BEGIN-Vk1-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
Jk1	BEGIN-Jk1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
Vk1	BEGIN-Vk1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Jk1	BEGIN-Jk1-INSIDE	NN	B-NP	B
rearrangements	rearrangement	NNS	I-NP	O
encoded	encode	VBD	B-VP	O
the	the	DT	B-NP	O
respective	respective	JJ	I-NP	O
L	BEGIN-L	NN	I-NP	B
chain	chain	NN	I-NP	I
V	V	NN	I-NP	I
-	-	HYPH	O	I
regions	regions-INSIDE	NN	B-NP	I

An	An	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
kit	kit	NN	I-NP	I
1	1	CD	I-NP	I
'	'	SYM	I-NP	I
flanking	flanking	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
bacterial	BEGIN-bacterial	JJ	I-NP	B
chloramphenicol	chloramphenicol	NN	I-NP	I
acetyltransferase	acetyltransferase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
assay	assay	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
erythroleukemia	erythroleukemia	NN	I-NP	O
HEL	HEL	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
express	express	VBP	B-VP	O
the	the	DT	B-NP	O
endogenous	endogenous	JJ	I-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
kit	kit	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
from	from	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
kit	kit	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
acetylmethadol	acetylmethadol	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
principal	principal	JJ	I-NP	O
metabolites	metabolite	NNS	I-NP	O
in	in	IN	B-PP	O
biological	biological	JJ	B-NP	O
specimens	specimen	NNS	I-NP	O
by	by	IN	B-PP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
-	-	HYPH	O	O
chemical	chemical	NN	B-NP	O
ionization	ionization	NN	I-NP	O
-	-	HYPH	B-NP	O
multiple	multiple	JJ	I-NP	O
ion	ion	NN	I-NP	O
monitoring	monitor	VBG	B-VP	O
mass	mass	NN	B-NP	O
spectrometry	spectrometry	NN	I-NP	O

Following	Follow	VBG	B-PP	O
immunization	immunization	NN	B-NP	O
of	of	IN	B-PP	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
hybrid	hybrid	NN	B-NP	O
molecules	molecule	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
DNA	DNA	NN	I-NP	O
which	which	WDT	B-NP	O
contained	contain	VBD	B-VP	O
the	the	DT	B-NP	O
transgene	transgene	NN	I-NP	O
recombined	recombine	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	BEGIN-endogenous	JJ	I-NP	B
IgH	IgH	NN	I-NP	I
locus	locus-INSIDE	NN	I-NP	I

(	(	(	O	O
LH	BEGIN-LH-INSIDE	JJ	B-NP	B
P	P	NN	I-NP	O
<	<	JJR	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
LH	BEGIN-LH-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
FSH	BEGIN-FSH-INSIDE	NN	I-NP	B
P	P	NN	I-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
KRAB	BEGIN-KRAB	NN	B-NP	B
domain	domain-INSIDE	NN	I-NP	I
suppresses	suppress	VBZ	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
the	the	DT	B-NP	O
activating	activate	VBG	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
defined	define	VBN	I-NP	O
activating	BEGIN-activating	JJ	I-NP	B
transcription	transcription	NN	I-NP	I
factors	factors-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
KRAB	BEGIN-KRAB	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
specifically	specifically	RB	B-ADVP	O
silences	silence	VBZ	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
promoters	promoter	NNS	B-NP	O
whose	whose	WP$	B-NP	O
initiation	initiation	NN	I-NP	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
cortex	cortex	NN	I-NP	O
,	,	,	O	O
spleen	spleen	NN	B-NP	O
,	,	,	O	O
distal	distal	JJ	B-NP	O
colon	colon	NN	I-NP	O
,	,	,	O	O
ileum	ileum	NN	B-NP	O
,	,	,	O	O
gallbladder	gallbladder	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
stomach	stomach	NN	B-NP	O
body	body	NN	I-NP	O
,	,	,	O	O
regional	regional	JJ	B-NP	O
O1	O1	NN	I-NP	O
delivery	delivery	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
with	with	IN	B-PP	O
hemodilution	hemodilution	NN	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O

None	None	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
probable	probable	JJ	B-NP	O
RA	RA	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
definite	definite	JJ	B-NP	O
RA	RA	NN	I-NP	O
met	meet	VBD	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
criteria	criterion	NNS	I-NP	O

In	In	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
quantitative	quantitative	JJ	I-NP	O
estimates	estimate	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
regional	regional	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
organ	organ	NN	I-NP	O
in	in	IN	B-PP	O
infants	infant	NNS	B-NP	O
and	and	CC	I-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
method	method	NN	I-NP	O
using	use	VBG	B-VP	O
various	various	JJ	B-NP	O
anatomical	anatomical	JJ	I-NP	O
data	datum	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
developed	develop	VBN	I-VP	O

Thus	Thus	RB	B-ADVP	O
the	the	DT	B-NP	O
Hi	Hi	NNP	I-NP	O
-	-	HYPH	I-NP	O
RARE	RARE	NN	I-NP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
RA	RA	NN	B-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
MHC	BEGIN-MHC	NN	B-NP	B
class	class	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
family	family	NN	I-NP	O
genes	gene	NNS	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Considering	Consider	VBG	B-VP	O
an	an	DT	B-NP	O
inulin	inulin	NN	I-NP	O
clearance	clearance	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
m1	m1	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cut	cut	VB	I-NP	O
-	-	HYPH	B-VP	O
off	off	RP	B-PRT	O
value	value	NN	B-NP	O
for	for	IN	B-PP	O
serum	serum	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
mumol	mumol	NN	I-NP	O
/	/	SYM	B-NP	O
liter	liter	NN	I-NP	O
for	for	IN	B-PP	O
men	man	NNS	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
mumol	mumol	NN	I-NP	O
/	/	SYM	B-NP	O
liter	liter	NN	I-NP	O
for	for	IN	B-PP	O
women	woman	NNS	B-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
strongly	strongly	RB	B-VP	O
suggest	suggest	VBP	I-VP	O
that	that	IN	B-SBAR	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
beta	beta	SYM	I-NP	O
origin	origin	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
distant	distant	JJ	I-NP	O
replication	replication	NN	I-NP	O
enhancer	enhancer	NN	I-NP	O
element	element	NN	I-NP	O
requires	require	VBZ	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
target	target	NN	I-NP	O
sequence	sequence	NN	I-NP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
initiator	initiator	NN	B-NP	O
protein	protein	NN	I-NP	O
-	-	HYPH	B-NP	O
mediated	mediate	VBN	I-NP	O
DNA	DNA	NN	I-NP	O
looping	loop	VBG	B-VP	O

Three	Three	CD	B-NP	O
experiments	experiment	NNS	I-NP	O
using	use	VBG	B-VP	O
1	1	CD	B-NP	O
microM	microM	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
(	(	(	O	O
hydroxyamino	hydroxyamino	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
methyl	methyl	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
phenylimidazo	phenylimidazo	NN	I-NP	O
[	[	(	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
b	b	NN	I-NP	O
]	]	)	O	O
pyridine	pyridine	NN	B-NP	O
(	(	(	O	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
OH	OH	NN	I-NP	O
-	-	HYPH	B-NP	O
PhIP	PhIP	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dihydrofolate	BEGIN-dihydrofolate	JJ	I-NP	B
reductase	reductase-INSIDE	NN	I-NP	I
(	(	(	O	O
DHFR	BEGIN-DHFR-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
hemizygous	hemizygous	JJ	I-NP	O
Chinese	Chinese	JJ	I-NP	O
hamster	hamster	NN	I-NP	O
ovary	ovary	NN	I-NP	O
(	(	(	O	O
CHO	CHO	NN	B-NP	O
)	)	)	O	O
cell	cell	NN	B-NP	O
line	line	NN	I-NP	O
(	(	(	O	O
UA1	UA1	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
UL1	BEGIN-BEGIN-UL1-INSIDE	NN	I-NP	B
ORF	ORF-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
shows	show	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
UL1	BEGIN-UL1-INSIDE	NN	B-NP	B
(	(	(	O	O
nuclear	nuclear	JJ	B-NP	O
phosphoprotein	phosphoprotein	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
HSV	HSV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
PRV	PRV	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

Immunogenicity	Immunogenicity	NN	B-NP	O
tested	test	VBN	B-VP	O
in	in	IN	B-PP	O
experiments	experiment	NNS	B-NP	O
on	on	IN	B-PP	O
guinea	guinea	NN	B-NP	O
pigs	pig	NNS	I-NP	O
and	and	CC	I-NP	O
rabbits	rabbit	NNS	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
and	and	CC	O	O
corresponded	correspond	VBN	B-VP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
reference	reference	NN	I-NP	O
STI	STI	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
vaccine	vaccine	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
antisense	antisense	JJ	B-NP	O
mRNA	mRNA	NN	I-NP	O
for	for	IN	B-PP	O
p1CAS	BEGIN-p1CAS-INSIDE	NN	B-NP	B
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
reversion	reversion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transformed	transform	VBN	I-NP	O
phenotype	phenotype	NN	I-NP	O
of	of	IN	B-PP	O
all	all	PDT	B-NP	O
these	these	DT	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

One	One	CD	B-NP	O
hundred	hundred	CD	I-NP	O
cDNA	cDNA	NN	I-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
sequenced	sequence	VBN	I-VP	O
and	and	CC	O	O
1	1	CD	B-NP	O
RTKs	BEGIN-RTKs-INSIDE	NN	I-NP	B
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
1	1	CD	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
RTKs	BEGIN-RTKs-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
1	1	CD	I-NP	O
serine	BEGIN-serine	NN	I-NP	B
/	/	SYM	O	I
threonine	threonine	NN	B-NP	I
kinases	kinases-INSIDE	NN	I-NP	I

Supportive	Supportive	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
xenogenous	xenogenous	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
undergoing	undergo	VBG	B-VP	O
aggressive	aggressive	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
(	(	(	O	O
modified	modify	VBN	B-NP	O
AC	AC	NN	I-NP	O
-	-	HYPH	B-NP	O
protocol	protocol	NN	I-NP	O
)	)	)	O	O
:	:	:	O	O
a	a	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
,	,	,	O	O
randomized	randomize	VBD	B-VP	O
double	double	JJ	B-NP	O
-	-	HYPH	I-NP	O
blind	blind	JJ	I-NP	O
study	study	NN	I-NP	O

The	The	DT	B-NP	O
inactive	inactive	JJ	I-NP	O
X	X	NN	I-NP	O
allele	allele	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
hypermethylated	hypermethylate	VBN	I-VP	O
in	in	IN	B-PP	O
leukocytes	leukocyte	NNS	B-NP	O
,	,	,	O	O
presumably	presumably	RB	B-VP	O
reflecting	reflect	VBG	I-VP	O
early	early	JJ	B-NP	O
X	X	NN	I-NP	O
inactivation	inactivation	NN	I-NP	O
events	event	NNS	I-NP	O
that	that	WDT	B-NP	O
become	become	VBP	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
gene	gene	NN	B-NP	O
dosage	dosage	NN	I-NP	O
in	in	IN	B-PP	O
expressing	express	VBG	B-VP	O
lineages	lineage	NNS	B-NP	O

Development	Development	NN	B-NP	O
of	of	IN	B-PP	O
neural	neural	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
alimentary	alimentary	JJ	B-NP	O
motor	motor	NN	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
vertebrates	vertebrate	NNS	I-NP	O

Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
nitrogen	nitrogen	NN	B-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
heterocyclic	heterocyclic	JJ	B-NP	O
compounds	compound	NNS	I-NP	O

Cell	Cell	NN	B-NP	O
rounding	rounding	NN	I-NP	O
was	be	VBD	B-VP	O
abrogated	abrogate	VBN	I-VP	O
by	by	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
kinase	kinase	NN	B-NP	O
-	-	HYPH	B-NP	O
dead	dead	JJ	I-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
US1	BEGIN-US1	NN	B-NP	B
PK	PK-INSIDE	NN	I-NP	I
or	or	CC	O	O
a	a	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
protein	protein	NN	I-NP	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
acidic	acidic	JJ	I-NP	O
cluster	cluster	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
kinase	kinase	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
domain	domain	NN	I-NP	O

The	The	DT	B-NP	O
psychosocial	psychosocial	JJ	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
people	people	NNS	B-NP	O
using	use	VBG	B-VP	O
self	self	AFX	B-NP	O
-	-	HYPH	I-NP	O
ignition	ignition	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
suicide	suicide	NN	B-NP	O
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
suicide	suicide	NN	B-NP	O
in	in	IN	B-PP	O
general	general	JJ	B-NP	O

The	The	DT	B-NP	O
genes	gene	NNS	I-NP	O
expressed	express	VBN	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
embryonic	embryonic	JJ	I-NP	O
(	(	(	O	O
zeta	BEGIN-zeta-INSIDE	NN	B-NP	B
)	)	)	O	O
or	or	CC	O	O
fetal	fetal	JJ	B-NP	O
and	and	CC	I-NP	O
adult	adult	JJ	I-NP	O
stage	stage	NN	I-NP	O
(	(	(	O	O
alpha	BEGIN-alpha	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
alpha	BEGIN-alpha	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
modified	modify	VBN	I-VP	O
by	by	IN	B-PP	O
point	point	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
which	which	WDT	B-NP	O
affect	affect	VBP	B-VP	O
either	either	CC	O	O
the	the	DT	B-NP	O
processing	processing	NN	I-NP	O
-	-	HYPH	O	O
translation	translation	NN	B-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	O
or	or	CC	O	O
make	make	VB	B-VP	O
the	the	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
chains	chain	NNS	I-NP	O
extremely	extremely	RB	B-ADJP	O
unstable	unstable	JJ	I-ADJP	O

Acoustic	Acoustic	JJ	B-NP	O
-	-	HYPH	I-NP	O
property	property	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oxide	oxide	NN	I-NP	O
superconductor	superconductor	NN	I-NP	O
BaPb1	BaPb1	NN	I-NP	O
-	-	HYPH	B-NP	O
xBixO1	xBixO1	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
sphere	sphere	NN	I-NP	O
-	-	HYPH	B-NP	O
resonance	resonance	NN	I-NP	O
method	method	NN	I-NP	O

The	The	DT	B-NP	O
fusion	fusion	NN	I-NP	O
of	of	IN	B-PP	O
AML1	BEGIN-AML1-INSIDE	NN	B-NP	B
to	to	TO	B-PP	O
MDS1	BEGIN-MDS1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
frame	frame	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
adds	add	VBZ	B-VP	O
1	1	CD	B-NP	O
codons	codon	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
interrupted	interrupted	JJ	I-NP	O
AML1	BEGIN-AML1-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
ends	end	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
barrel	barrel	NN	I-NP	O
are	be	VBP	B-VP	O
capped	cap	VBN	I-VP	O
by	by	IN	B-PP	O
short	short	JJ	B-NP	O
helices	helix	NNS	I-NP	O

Rabbit	BEGIN-Rabbit	NN	B-NP	B
KCC1	KCC1-INSIDE	NN	I-NP	I
(	(	(	O	O
rbKCC1	BEGIN-rbKCC1-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
rat	BEGIN-rat	NN	B-NP	B
KCC1	KCC1-INSIDE	NN	I-NP	I
(	(	(	O	O
rtKCC1	BEGIN-rtKCC1-INSIDE	NN	B-NP	B
)	)	)	O	O
were	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
by	by	IN	B-PP	O
screening	screen	VBG	B-VP	O
rabbit	rabbit	NN	B-NP	O
kidney	kidney	NN	I-NP	O
and	and	CC	O	O
rat	rat	NN	B-NP	O
brain	brain	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
libraries	library	NNS	I-NP	O
using	use	VBG	B-VP	O
homologous	homologous	JJ	B-NP	O
cDNA	cDNA	NN	I-NP	O
probes	probe	NNS	I-NP	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
ZNF1	BEGIN-ZNF1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
ZNF1	BEGIN-ZNF1-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
two	two	CD	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
same	same	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
transactivator	transactivator	NN	B-NP	O
proteins	protein	NNS	I-NP	O

This	This	DT	B-NP	O
model	model	NN	I-NP	O
system	system	NN	I-NP	O
exploits	exploit	VBZ	B-VP	O
the	the	DT	B-NP	O
polyomavirus	polyomavirus	NN	I-NP	O
late	late	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
termination	termination	NN	I-NP	O
and	and	CC	O	O
polyadenylation	polyadenylation	NN	B-NP	O
signals	signal	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
sufficiently	sufficiently	RB	B-ADJP	O
weak	weak	JJ	I-ADJP	O
to	to	TO	B-VP	O
allow	allow	VB	I-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
multigenome	multigenome	JJ	I-NP	O
-	-	HYPH	I-NP	O
length	length	NN	I-NP	O
primary	primary	JJ	I-NP	O
transcripts	transcript	NNS	I-NP	O
with	with	IN	B-PP	O
repeating	repeat	VBG	B-VP	O
introns	intron	NNS	B-NP	O
,	,	,	O	O
exons	exon	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
poly	poly	NN	B-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
)	)	)	O	O
sites	site	NNS	B-NP	O

The	The	DT	B-NP	O
disorders	disorder	NNS	I-NP	O
are	be	VBP	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
consistent	consistent	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
similarly	similarly	RB	B-NP	O
reversible	reversible	JJ	I-NP	O
,	,	,	I-NP	O
electroencephalographic	electroencephalographic	JJ	I-NP	O
changes	change	NNS	I-NP	O

Electronic	Electronic	JJ	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	O	O
optical	optical	JJ	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
B1O1	B1O1	NN	I-NP	O
crystal	crystal	NN	I-NP	O

A	A	DT	B-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
oligomerization	oligomerization	NN	B-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
subunit	subunit	NN	I-NP	O
folding	folding	NN	I-NP	O

The	The	DT	B-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
Repeat	Repeat	NN	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
1	1	CD	I-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
transcribed	transcribe	VBN	I-VP	O
actively	actively	RB	B-ADVP	O
in	in	IN	B-PP	O
sterol	sterol	NN	B-NP	O
-	-	HYPH	B-NP	O
deprived	deprive	VBN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
repressed	repress	VBN	I-VP	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
when	when	WRB	B-ADVP	O
sterols	sterol	NNS	B-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O

Basic	BEGIN-Basic	JJ	B-NP	B
helix	helix	NN	I-NP	I
-	-	HYPH	B-NP	I
loop	loop	NN	I-NP	I
-	-	HYPH	I-NP	I
helix	helix	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
act	act	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
E	E	NN	I-NP	O
-	-	HYPH	B-NP	O
box	box	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
fos	fos	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
influence	influence	VB	I-VP	O
hormone	hormone	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
promoter	promoter	NN	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
Sertoli	Sertoli	NNP	B-NP	O
cells	cell	NNS	I-NP	O

Preventive	Preventive	JJ	B-NP	O
health	health	NN	I-NP	O
counseling	counseling	NN	I-NP	O
tailored	tailor	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
needs	need	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
group	group	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
most	most	RBS	B-ADJP	O
beneficial	beneficial	JJ	I-ADJP	O

Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
reveals	reveal	VBZ	B-VP	O
that	that	IN	B-SBAR	O
cJun	BEGIN-cJun-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
C	BEGIN-C	NN	I-NP	B
/	/	SYM	B-NP	I
EBP	EBP	NN	I-NP	I
family	family	NN	I-NP	I
member	member-INSIDE	NN	I-NP	I
C	BEGIN-C	NN	I-NP	B
/	/	SYM	B-NP	I
EBP	EBP	NN	I-NP	I
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
physiologically	physiologically	RB	B-NP	O
relevant	relevant	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
whose	whose	WP$	B-NP	O
expression	expression	NN	I-NP	O
corresponds	correspond	VBZ	B-VP	O
with	with	IN	B-PP	O
mda	BEGIN-mda	NNP	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O

Recent	Recent	JJ	B-NP	O
developments	development	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
factors	factor	NNS	I-NP	O
:	:	:	O	O
GRF	BEGIN-GRF-INSIDE	NN	B-NP	B
and	and	CC	O	O
somatomedins	BEGIN-somatomedins-INSIDE	NN	B-NP	B

Phenotypic	Phenotypic	JJ	B-NP	O
screening	screening	NN	I-NP	O
of	of	IN	B-PP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
Pmr1	BEGIN-Pmr1-INSIDE	NN	B-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
secretory	secretory	JJ	I-NP	I
pathway	pathway	NN	I-NP	I
Ca1+	Ca1+	NN	I-NP	I
/	/	SYM	B-NP	I
Mn1+	Mn1+	NN	I-NP	I
-	-	HYPH	B-NP	I
ATPase	ATPase-INSIDE	NN	I-NP	I
,	,	,	O	O
reveals	reveal	VBZ	B-VP	O
residues	residue	NNS	B-NP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
ion	ion	NN	B-NP	O
selectivity	selectivity	NN	I-NP	O
and	and	CC	I-NP	O
transport	transport	NN	I-NP	O

IV	IV	CD	B-NP	O

Routine	Routine	NN	B-NP	O
and	and	CC	I-NP	O
default	default	NN	I-NP	O
retrieval	retrieval	NN	I-NP	O
home	home	NN	I-NP	O
visits	visit	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
maximal	maximal	JJ	B-NP	O
drug	drug	NN	I-NP	O
compliance	compliance	NN	I-NP	O

This	This	DT	B-NP	O
review	review	NN	I-NP	O
chronicles	chronicle	VBZ	B-VP	O
the	the	DT	B-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
deliberate	deliberate	JJ	B-NP	O
and	and	CC	I-NP	O
accidental	accidental	JJ	I-NP	O
mass	mass	NN	I-NP	O
poisonings	poisoning	NNS	I-NP	O
that	that	WDT	B-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
World	World	NNP	B-NP	O
Wars	War	NNS	I-NP	O
I	I	CD	I-NP	O
and	and	CC	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
Bhopal	Bhopal	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
historical	historical	JJ	I-NP	O
cases	case	NNS	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
and	and	CC	O	O
including	include	VBG	B-PP	O
modern	modern	JJ	B-NP	O
wars	war	NNS	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
unmodified	unmodified	JJ	I-NP	O
threonine	threonine	NN	I-NP	O
at	at	IN	B-PP	O
position	position	NN	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
G1	BEGIN-G1	NN	B-NP	B
cyclins	cyclins-INSIDE	NN	I-NP	I

These	These	DT	B-NP	O
alterations	alteration	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	O
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
levels	level	NNS	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
subcellular	subcellular	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
four	four	CD	I-NP	O
isoforms	isoform	NNS	I-NP	O

Periarteritis	Periarteritis	NN	B-NP	O
nodosa	nodosa	NN	I-NP	O
with	with	IN	B-PP	O
ruptures	rupture	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
vessels	vessel	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
persistence	persistence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
viruses	virus	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O

SETTING	SETTING	NN	B-NP	O
:	:	:	O	O
Participants	Participant	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Physicians	Physician	NNPS	I-NP	O
'	'	POS	B-NP	O
Health	Health	NNP	I-NP	O
Study	Study	NNP	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
randomized	randomize	VBN	I-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	O	O
beta	beta	SYM	O	O
-	-	HYPH	O	O
carotene	carotene	NN	B-NP	O
among	among	IN	B-PP	O
U.S.	U.S.	NNP	B-NP	O
male	male	JJ	I-NP	O
physicians	physician	NNS	I-NP	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
with	with	IN	B-PP	O
interferon	BEGIN-interferon-INSIDE	NN	B-NP	B
:	:	:	O	O
experience	experience	NN	B-NP	O
in	in	IN	B-PP	O
western	western	JJ	B-NP	O
countries	country	NNS	I-NP	O

Similar	Similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
what	what	WP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
for	for	IN	B-PP	O
P.	P.	NNP	B-NP	O
putida	putida	NNP	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
psrA	BEGIN-psrA-INSIDE	NN	I-NP	B
null	null	JJ	I-NP	O
mutant	mutant	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
aeruginosa	aeruginosa	NNP	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
rpoS	BEGIN-BEGIN-rpoS-INSIDE	NN	B-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
;	;	:	O	O
both	both	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
complemented	complement	VBN	I-VP	O
for	for	IN	B-PP	O
rpoS	BEGIN-BEGIN-rpoS-INSIDE	NN	B-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
psrA	BEGIN-BEGIN-psrA-INSIDE	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
provided	provide	VBN	I-VP	O
in	in	IN	B-PP	O
trans.	trans.	NN	B-NP	O
psrA	BEGIN-BEGIN-psrA-INSIDE	NN	I-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
both	both	DT	B-NP	O
Pseudomonas	Pseudomonas	NNP	I-NP	O
species	specie	NNS	I-NP	O
lost	lose	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
rpoS	BEGIN-rpoS-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
at	at	IN	B-PP	O
stationary	stationary	JJ	B-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
they	they	PRP	B-NP	O
retained	retain	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
quorum	quorum	NN	B-NP	O
-	-	HYPH	O	O
sensing	sense	VBG	B-VP	O
autoinducer	autoinducer	NN	B-NP	O
molecules	molecule	NNS	I-NP	O

The	The	DT	B-NP	O
increments	increment	NNS	I-NP	O
in	in	IN	B-PP	O
median	median	JJ	B-NP	O
plasma	BEGIN-plasma	NN	I-NP	B
secretin	BEGIN-secretin-INSIDE-INSIDE	NN	I-NP	I
concentration	concentration	NN	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
pmol	pmol	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
after	after	IN	B-PP	O
secretin	BEGIN-secretin-INSIDE	NN	B-NP	B
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
fmol	fmol	NN	I-NP	O
x	x	SYM	B-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
min	min	NN	I-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
output	output	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
micromol	micromol	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

The	The	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
stones	stone	NNS	I-NP	O
analysed	analyse	VBN	B-VP	O
by	by	IN	B-PP	O
infrared	infrare	VBN	B-NP	O
spectroscopy	spectroscopy	NN	I-NP	O

Programmed	Program	VBN	B-NP	O
peritoneal	peritoneal	JJ	I-NP	O
lavage	lavage	NN	I-NP	O
in	in	IN	B-PP	O
suppurative	suppurative	JJ	B-NP	O
complications	complication	NNS	I-NP	O
of	of	IN	B-PP	O
perforated	perforated	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O

Vibrio	Vibrio	NNP	B-NP	O
cholerae	cholerae	VBP	B-VP	O
iron	iron	NN	B-NP	O
transport	transport	NN	I-NP	O
:	:	:	O	O
haem	haem	NN	B-NP	O
transport	transport	NN	I-NP	O
genes	gene	NNS	I-NP	O
are	be	VBP	B-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
tonB	BEGIN-tonB-INSIDE	NN	B-NP	B
,	,	,	O	O
exbB	BEGIN-exbB-INSIDE	NN	B-NP	B
,	,	,	O	O
exbD	BEGIN-exbD	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I

Zonography	Zonography	NN	B-NP	O
in	in	IN	B-PP	O
urology	urology	NN	B-NP	O
(	(	(	O	O
author	author	NN	B-NP	O
's	's	POS	B-NP	O
transl	transl	NN	I-NP	O
)	)	)	O	O

Phenazopyridine	Phenazopyridine	NN	B-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
hemolytic	hemolytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
G1PD	BEGIN-G1PD-INSIDE	NN	B-NP	B
deficiency	deficiency	NN	I-NP	O

The	The	DT	B-NP	O
novel	novel	JJ	I-NP	O
gene	gene	NN	I-NP	O
spans	span	NNS	I-NP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
formed	form	VBN	I-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
intervening	intervening	NN	I-NP	O
introns	intron	NNS	I-NP	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
HIF	BEGIN-BEGIN-HIF	NN	I-NP	B
-	-	HYPH	B-NP	I
1alpha	1-INSIDEalpha-INSIDE	NN	I-NP	I
construct	construct	NN	I-NP	O
with	with	IN	B-PP	O
deletions	deletion	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
basic	basic	JJ	I-NP	O
domain	domain	NN	I-NP	O
and	and	CC	I-NP	O
carboxy	carboxy	NN	I-NP	O
terminus	terminus	NN	I-NP	O
blocked	block	VBD	B-VP	O
reporter	reporter	NN	B-NP	O
gene	gene	NN	I-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
HIF	BEGIN-HIF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
hypoxic	hypoxic	JJ	B-NP	O
cells	cell	NNS	I-NP	O

A	A	DT	B-NP	O
preformed	preformed	JJ	I-NP	O
SREBP	BEGIN-SREBP	NN	I-NP	B
-	-	HYPH	B-NP	I
1a	1a	NN	I-NP	I
:	:	:	O	I
[	[	(	O	I
1P	1P	NN	B-NP	I
]	]	)	I-NP	I
DNA	DNA	NN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
bound	bind	VBD	B-VP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-PP	O
membrane	membrane	NN	B-NP	O
-	-	HYPH	O	O
immobilized	immobilize	VBN	B-NP	O
GST	BEGIN-GST-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
CBP	BEGIN-CBP-INSIDE	NN	I-NP	B
fusion	fusion	NN	I-NP	O
proteins	protein	NNS	I-NP	O
that	that	WDT	B-NP	O
contained	contain	VBD	B-VP	O
amino	amino	JJ	B-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
portions	portion	NNS	I-NP	O
of	of	IN	B-PP	O
CBP	BEGIN-CBP-INSIDE	NN	B-NP	B

Extracellular	BEGIN-Extracellular	JJ	B-NP	B
protein	protein	NN	I-NP	I
kinase	kinase	NN	I-NP	I
A	A-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
a	a	DT	B-NP	O
cancer	cancer	NN	I-NP	O
biomarker	biomarker	NN	I-NP	O
:	:	:	O	O
its	its	PRP$	B-NP	O
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
tumor	tumor	NN	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
reversal	reversal	NN	B-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
myristate	myristate	NN	I-NP	O
-	-	HYPH	O	O
lacking	lack	VBG	B-VP	O
Calpha	Calpha	NN	B-NP	O
and	and	CC	I-NP	O
RIIbeta	RIIbeta	NN	I-NP	O
subunit	subunit	NN	I-NP	O
overexpression	overexpression	NN	I-NP	O

By	By	IN	B-PP	O
incorporating	incorporate	VBG	B-VP	O
a	a	DT	B-NP	O
stent	stent	NN	I-NP	O
with	with	IN	B-PP	O
posts	post	NNS	B-NP	O
that	that	WDT	B-NP	O
pivot	pivot	VBP	B-VP	O
about	about	IN	B-PP	O
their	their	PRP$	B-NP	O
base	base	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
expansion	expansion	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
commissures	commissure	NNS	I-NP	O
is	be	VBZ	B-VP	O
realized	realize	VBN	I-VP	O
,	,	,	O	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
the	the	DT	B-NP	O
compressive	compressive	JJ	I-NP	O
commissural	commissural	NN	I-NP	O
stressing	stress	VBG	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
kPa	kPa	NN	I-NP	O

With	With	IN	B-PP	O
rats	rat	NNS	B-NP	O
fed	feed	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Zn	Zn	NN	I-NP	O
-	-	HYPH	B-NP	O
sufficient	sufficient	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	I-NP	O
NaFe1+EDTA	NaFe1+EDTA	NN	I-NP	O
and	and	CC	I-NP	O
Na1EDTA	Na1EDTA	NN	I-NP	O
similarly	similarly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
absorption	absorption	NN	I-NP	O
,	,	,	O	O
urinary	urinary	JJ	B-NP	O
excretion	excretion	NN	I-NP	O
and	and	CC	I-NP	O
retention	retention	NN	I-NP	O
of	of	IN	B-PP	O
Zn	Zn	NN	B-NP	O
but	but	CC	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O

The	The	DT	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
NPH	BEGIN-NPH	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
H1L	BEGIN-H1L-INSIDE	NN	I-NP	B
provides	provide	VBZ	B-VP	O
an	an	DT	B-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
observed	observe	VBN	I-NP	O
restriction	restriction	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
termination	termination	NN	I-NP	O
to	to	TO	B-PP	O
early	early	JJ	B-NP	O
viral	viral	JJ	I-NP	O
genes	gene	NNS	I-NP	O

Other	Other	JJ	B-NP	O
clinicopathological	clinicopathological	JJ	I-NP	O
features	feature	NNS	I-NP	O
have	have	VBP	B-VP	O
no	no	DT	B-NP	O
definite	definite	JJ	I-NP	O
influence	influence	NN	I-NP	O
in	in	IN	B-PP	O
survival	survival	NN	B-NP	O
expectancy	expectancy	NN	I-NP	O

Births	Birth	NNS	B-NP	O
,	,	,	O	O
marriages	marriage	NNS	B-NP	O
,	,	,	O	O
divorces	divorce	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
deaths	death	NNS	B-NP	O
for	for	IN	B-PP	O
July	July	NNP	B-NP	O
1	1	CD	I-NP	O

One	One	CD	B-NP	O
day	day	NN	I-NP	O
postoperatively	postoperatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
mononuclear	mononuclear	JJ	I-NP	O
leukocyte	leukocyte	NN	I-NP	O
beta	BEGIN-beta	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
density	density	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
maximally	maximally	RB	B-ADVP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
enflurane	enflurane	NN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
neurolept	neurolept	JJ	I-NP	O
patients	patient	NNS	I-NP	O

A	A	DT	B-NP	O
direct	direct	JJ	I-NP	O
statistically	statistically	RB	I-NP	O
reliable	reliable	JJ	I-NP	O
correction	correction	NN	I-NP	O
of	of	IN	B-PP	O
decrease	decrease	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enzymes	enzyme	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
established	establish	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
aged	age	VBN	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
in	in	IN	B-PP	O
prosthesis	prosthesis	NN	B-NP	O
of+	of+	IN	B-PP	O
the	the	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
closed	close	VBD	B-VP	O
mitral	mitral	JJ	B-NP	O
commissurotomy	commissurotomy	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
that	that	IN	B-SBAR	O
storage	storage	NN	B-NP	O
time	time	NN	I-NP	O
affected	affect	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
the	the	DT	B-NP	O
biochemical	biochemical	JJ	I-NP	O
changes	change	NNS	I-NP	O
occurring	occur	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
constituents	constituent	NNS	I-NP	O
of	of	IN	B-PP	O
carrots	carrot	NNS	B-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
gamma	gamma	SYM	O	O
-	-	HYPH	O	O
irradiation	irradiation	NN	B-NP	O

Partial	Partial	JJ	B-NP	O
proteolysis	proteolysis	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
surface	surface	NN	I-NP	O
-	-	HYPH	B-VP	O
iodinated	iodinate	VBN	B-NP	O
B	BEGIN-B	NN	I-NP	B
-	-	HYPH	B-NP	I
G	G	NN	I-NP	I
molecules	molecules-INSIDE	NN	I-NP	I
generates	generate	VBZ	B-VP	O
extremely	extremely	RB	B-NP	O
similar	similar	JJ	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
spots	spot	NNS	B-NP	O
,	,	,	O	O
both	both	CC	O	O
within	within	IN	B-PP	O
and	and	CC	I-PP	O
between	between	IN	I-PP	O
haplotypes	haplotype	NNS	B-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
oligonucleotides	oligonucleotide	NNS	B-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
C1T	C1T	NN	I-NP	O
sequence	sequence	NN	I-NP	O
to	to	TO	B-VP	O
confer	confer	VB	I-VP	O
heat	heat	NN	B-NP	O
shock	shock	NN	I-NP	O
inducibility	inducibility	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
and	and	CC	O	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
such	such	JJ	I-NP	O
elements	element	NNS	I-NP	O
produces	produce	VBZ	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
additive	additive	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
induction	induction	NN	B-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
(	(	(	O	O
NAAR	NAAR	NN	B-NP	O
and	and	CC	O	O
PLA	PLA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
no	no	DT	B-NP	O
variation	variation	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
serum	serum	NN	I-NP	O
protease	protease	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

The	The	DT	B-NP	O
KEMAR	KEMAR	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
models	model	NNS	I-NP	O
give	give	VBP	B-VP	O
an	an	DT	B-NP	O
improvement	improvement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
signal	signal	NN	I-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
noise	noise	NN	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
dB	dB	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
diffuse	diffuse	JJ	I-NP	O
sound	sound	NN	I-NP	O
field	field	NN	I-NP	O

Providing	Provide	VBG	B-VP	O
appropriate	appropriate	JJ	B-NP	O
care	care	NN	I-NP	O
to	to	TO	B-PP	O
both	both	DT	B-NP	O
sexes	sex	NNS	I-NP	O

An	An	DT	B-NP	O
X	X	NN	I-NP	O
-	-	HYPH	B-VP	O
linked	link	VBN	B-NP	O
zinc	BEGIN-zinc	NN	I-NP	B
finger	finger	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
mapping	map	VBG	B-VP	O
to	to	TO	B-PP	O
Xq1	Xq1	NN	B-NP	O
-	-	HYPH	I-NP	O
q1	q1	NN	I-NP	O
closely	closely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
ZFX	BEGIN-ZFX-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
ZFY	BEGIN-ZFY-INSIDE	NN	I-NP	B
:	:	:	O	O
possible	possible	JJ	B-NP	O
origins	origin	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
ancestral	ancestral	JJ	I-NP	O
gene	gene	NN	I-NP	O

Mutations	Mutation	NNS	B-NP	O
that	that	WDT	B-NP	O
extend	extend	VBP	B-VP	O
the	the	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endonuclease	endonuclease	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
lambda	BEGIN-lambda	NN	B-NP	B
terminase	terminase-INSIDE	NN	I-NP	I

Promoter	Promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
assayed	assay	VBN	I-VP	O
by	by	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
of	of	IN	B-PP	O
luciferase	BEGIN-luciferase	NN	B-NP	B
reporter	reporter	NN	I-NP	I
constructs	constructs-INSIDE	NN	I-NP	I
containing	contain	VBG	B-VP	O
nested	nested	JJ	B-NP	O
deletions	deletion	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
RPE	RPE	NN	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
ARPE1	ARPE1	NN	B-NP	O
and	and	CC	I-NP	O
D1	D1	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
SK	SK	NN	I-NP	O
-	-	HYPH	B-NP	O
Mel	Mel	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
HeLa	HeLa	NN	B-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
HNF	BEGIN-HNF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
HNF	BEGIN-BEGIN-HNF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
related	relate	VBN	B-NP	O
nuclear	nuclear	JJ	I-NP	O
factors	factors-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
beta	beta	SYM	I-NP	O
A	A	NN	I-NP	O
-	-	HYPH	I-NP	O
A	A	NN	I-NP	O
site	site	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CYP1A1	BEGIN-CYP1A1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
liver	liver	NN	B-NP	O
cells	cell	NNS	I-NP	O

A	A	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
component	component	NN	I-NP	O
to	to	TO	B-PP	O
impotence	impotence	NN	B-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
common	common	JJ	B-ADJP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
neurological	neurological	JJ	B-NP	O
impairment	impairment	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
may	may	MD	B-VP	O
alter	alter	VB	I-VP	O
management	management	NN	B-NP	O

Bandwidth	Bandwidth	NN	B-NP	O
of	of	IN	B-PP	O
auditory	auditory	JJ	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chick	chick	NN	I-NP	O
forebrain	forebrain	NN	I-NP	O
(	(	(	O	O
field	field	NN	B-NP	O
L	L	NN	I-NP	O
/	/	SYM	B-NP	O
Hv	Hv	NN	I-NP	O
complex	complex	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
with	with	IN	B-PP	O
isointensity	isointensity	NN	B-NP	O
tone	tone	NN	I-NP	O
stimuli	stimulus	NNS	I-NP	O

Two	Two	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
Paraquat	Paraquat	NN	B-NP	O
poisoning	poisoning	NN	I-NP	O
of	of	IN	B-PP	O
anticonservative	anticonservative	JJ	B-NP	O
origin	origin	NN	I-NP	O
are	be	VBP	B-VP	O
described	describe	VBN	I-VP	O

The	The	DT	B-NP	O
promoter	promoter	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
methyltransferase	methyltransferase	NN	I-NP	O
gene	gene	NN	I-NP	O
lacks	lack	VBZ	B-VP	O
an	an	DT	B-NP	O
identifiable	identifiable	JJ	I-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
CpG	CpG	NN	I-NP	O
island	island	NN	I-NP	O
which	which	WDT	B-NP	O
begins	begin	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
extends	extend	VBZ	B-VP	O
through	through	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	B-PP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
intron	intron	NN	I-NP	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
preliminary	preliminary	JJ	I-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Phase	Phase	NN	I-NP	O
II	II	CD	I-NP	O
trial	trial	NN	I-NP	O
going	go	VBG	B-VP	O
on	on	RP	B-PRT	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Central	Central	NNP	I-NP	O
Institute	Institute	NNP	I-NP	O
for	for	IN	B-PP	O
Tumors	Tumor	NNPS	B-NP	O
in	in	IN	B-PP	O
Zagreb	Zagreb	NNP	B-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
cis	cis	NN	B-NP	O
-	-	HYPH	I-NP	O
DDP	DDP	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
fluorouracil	fluorouracil	NN	I-NP	O
and	and	CC	I-NP	O
vincristine	vincristine	NN	I-NP	O

Three	Three	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Mirizzi	Mirizzi	NNP	B-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Mirizzi	Mirizzi	NNP	B-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
syndrome	syndrome	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
laparoscopically	laparoscopically	RB	B-ADVP	O

The	The	DT	B-NP	O
pregnancies	pregnancy	NNS	I-NP	O
were	be	VBD	B-VP	O
terminated	terminate	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
gestation	gestation	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

The	The	DT	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
and	and	CC	I-NP	O
immunosuppressants	immunosuppressant	NNS	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
noticeable	noticeable	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
T1	T1	NN	B-NP	O
and	and	CC	I-NP	O
E	BEGIN-E	NN	I-NP	B
-	-	HYPH	O	I
RCF	RCF-INSIDE	NN	B-NP	I

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
competitive	competitive	JJ	B-NP	O
NMDA	BEGIN-NMDA	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
antagonists	antagonist	NNS	I-NP	O
,	,	,	O	O
exemplified	exemplify	VBN	B-VP	O
by	by	IN	B-PP	O
CGP	CGP	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
promising	promising	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
trials	trial	NNS	I-NP	O
in	in	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
disorders	disorder	NNS	I-NP	O

Rapid	Rapid	JJ	B-NP	O
,	,	,	I-NP	O
sensitive	sensitive	JJ	I-NP	O
gas	gas	NN	I-NP	O
chromatographic	chromatographic	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
methoxypsoralen	methoxypsoralen	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
plasma	plasma	NN	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Sixty	Sixty	CD	B-NP	O
-	-	HYPH	I-NP	O
one	one	CD	I-NP	O
percent	percent	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
damage	damage	NN	B-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
onset	onset	NN	B-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
1	1	CD	I-NP	O
yrs	yr	NNS	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
fungus	fungus	JJ	I-NP	O
Neurospora	Neurospora	NNP	I-NP	O
crassa	crassa	NN	I-NP	O
,	,	,	O	O
nit	BEGIN-nit	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
nitrogen	nitrogen	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
unlinked	unlinked	JJ	B-NP	O
structural	structural	JJ	I-NP	O
genes	gene	NNS	I-NP	O
that	that	WDT	B-NP	O
specify	specify	VBP	B-VP	O
nitrogen	nitrogen	NN	B-NP	O
-	-	HYPH	B-NP	O
catabolic	catabolic	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
during	during	IN	B-PP	O
conditions	condition	NNS	B-NP	O
of	of	IN	B-PP	O
nitrogen	nitrogen	NN	B-NP	O
limitation	limitation	NN	I-NP	O

We	We	PRP	B-NP	O
concluded	conclude	VBD	B-VP	O
that	that	IN	B-SBAR	O
HFV	HFV	NN	B-NP	O
can	can	MD	B-VP	O
achieve	achieve	VB	I-VP	O
values	value	NNS	B-NP	O
of	of	IN	B-PP	O
CO1	CO1	NN	B-NP	O
elimination	elimination	NN	I-NP	O
close	close	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
metabolic	metabolic	JJ	I-NP	O
CO1	CO1	NN	I-NP	O
production	production	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
unintubated	unintubated	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
over	over	IN	B-PP	O
short	short	JJ	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O

Tetrazepam	Tetrazepam	NN	B-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
benzodiazepine	benzodiazepine	NN	I-NP	O
which	which	WDT	B-NP	O
dissociates	dissociate	VBZ	B-VP	O
sedation	sedation	NN	B-NP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
benzodiazepine	benzodiazepine	NN	I-NP	O
activities	activity	NNS	I-NP	O

Transcripts	Transcript	NNS	B-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
initiated	initiate	VBN	I-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
,	,	,	O	O
P1	P1	NN	B-NP	O
,	,	,	O	O
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
front	front	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tRNA	BEGIN-tRNA	NN	I-NP	B
(	(	(	O	I
met1	met1	NN	B-NP	I
)	)	)	O	I
gene	gene-INSIDE	NN	B-NP	I
and	and	CC	B-PP	O
from	from	IN	B-PP	O
three	three	CD	B-NP	O
internal	internal	JJ	I-NP	O
promoters	promoter	NNS	I-NP	O
:	:	:	O	O
P1	P1	NN	B-NP	O
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
immediately	immediately	RB	B-ADVP	O
in	in	IN	B-PP	O
front	front	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tRNA	BEGIN-tRNA	NN	I-NP	B
(	(	(	O	I
met1	met1	NN	B-NP	I
)	)	)	O	I
gene	gene-INSIDE	NN	B-NP	I
;	;	:	O	O
PL1	PBEGIN-L1-INSIDE	NN	B-NP	I
is	be	VBZ	B-VP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
L1	BEGIN-L1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
L1	BEGIN-L1-INSIDE	NN	I-NP	B
intergenic	intergenic	JJ	I-NP	O
space	space	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
PL1	PBEGIN-L1-INSIDE	NN	B-NP	I
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
L1	BEGIN-BEGIN-L1-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
sequence	sequence-INSIDE	NN	I-NP	I

Nearly	Nearly	RB	B-NP	O
1	1	CD	I-NP	O
million	million	CD	I-NP	O
American	American	JJ	I-NP	O
men	man	NNS	I-NP	O
age	age	NN	I-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
older	old	JJR	B-ADJP	O
have	have	VBP	B-VP	O
osteoporosis	osteoporosis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
another	another	DT	B-NP	O
1	1	CD	I-NP	O
million	million	CD	I-NP	O
are	be	VBP	B-VP	O
at	at	IN	B-PP	O
risk	risk	NN	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
characterized	characterize	VBN	I-VP	O
1	1	CD	B-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
type	BEGIN-type	JJ	I-NP	B
VII	VII	CD	I-NP	I
collagen	collagen	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
COL1A1	BEGIN-COL1A1-INSIDE	NN	B-NP	B
)	)	)	O	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
anchoring	anchoring	NN	I-NP	O
fibrils	fibril	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
unrelated	unrelated	JJ	I-NP	O
families	family	NNS	I-NP	O
with	with	IN	B-PP	O
recessive	recessive	JJ	B-NP	O
dystrophic	dystrophic	JJ	I-NP	O
epidermolysis	epidermolysis	NN	I-NP	O
bullosa	bullosa	NN	I-NP	O
(	(	(	O	O
RDEB	RDEB	NN	B-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
heterotopic	heterotopic	JJ	B-NP	O
gastric	gastric	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
(	(	(	O	O
pyloric	pyloric	JJ	B-NP	O
gland	gland	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
wall	wall	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
was	be	VBD	B-VP	O
reported	report	VBN	I-VP	O

Ribosome	Ribosome	NN	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
GCN1	BEGIN-GCN1	NN	B-NP	B
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
translational	translational	JJ	I-NP	O
activator	activator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GCN1	BEGIN-GCN1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O

We	We	PRP	B-NP	O
further	further	RB	B-ADVP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
JAK1	BEGIN-JAK1-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
the	the	DT	B-NP	O
GHR	BEGIN-GHR-INSIDE	NN	I-NP	B
cytoplasmic	cytoplasmic	JJ	I-NP	O
domain	domain	NN	I-NP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
lines	line	NNS	I-NP	O
of	of	IN	B-PP	O
investigation	investigation	NN	B-NP	O

These	These	DT	B-NP	O
segments	segment	NNS	I-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
pseudogenes	pseudogene	NNS	B-NP	O

Corresponding	Correspond	VBG	B-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
screen	screen	VB	I-VP	O
a	a	DT	B-NP	O
rat	rat	NN	I-NP	O
liver	liver	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
constructed	construct	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
cloning	cloning	NN	I-NP	O
vector	vector	NN	I-NP	O
,	,	,	O	O
pcDV	pcDV	NN	B-NP	O

A	A	DT	B-NP	O

Extracellular	BEGIN-Extracellular	JJ	B-NP	B
regulated	regulate	VBN	I-NP	I
kinases	kinase	NNS	I-NP	I
(	(	(	O	I
ERK	ERK	NN	B-NP	I
)	)	)	O	I
1	1-INSIDE	NN	B-NP	I
and	and	CC	I-NP	O
ERK1	BEGIN-ERK1-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
authentic	authentic	JJ	B-NP	O
substrates	substrate	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
dual	BEGIN-dual	JJ	I-NP	B
-	-	HYPH	I-NP	I
specificity	specificity	NN	I-NP	I
protein	protein	NN	I-NP	I
-	-	HYPH	B-NP	I
tyrosine	tyrosine	NN	I-NP	I
phosphatase	phosphatase	NN	I-NP	I
VHR	VHR-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
model	model	NN	I-NP	O
therefore	therefore	RB	B-ADVP	O
predicts	predict	VBZ	B-VP	O
that	that	IN	B-SBAR	O
1	1	LS	B-LST	O
)	)	)	O	O
on	on	IN	B-PP	O
-	-	HYPH	B-NP	O
line	line	NN	I-NP	O
calculation	calculation	NN	I-NP	O
of	of	IN	B-PP	O
airway	airway	NN	B-NP	O
dead	dead	JJ	I-NP	O
space	space	NN	I-NP	O
and	and	CC	I-NP	O
end	end	NN	I-NP	O
-	-	HYPH	O	O
expired	expire	VBN	B-NP	O
lung	lung	NN	I-NP	O
volume	volume	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
sine	sine	NN	I-NP	O
-	-	HYPH	B-NP	O
wave	wave	NN	I-NP	O
perturbation	perturbation	NN	I-NP	O
component	component	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
FIO1	FIO1	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
QS	QS	NN	B-NP	O
/	/	SYM	B-NP	O
QT	QT	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
measured	measure	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
resultant	resultant	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
perturbation	perturbation	NN	I-NP	O
sine	sine	NN	I-NP	O
-	-	HYPH	B-NP	O
wave	wave	NN	I-NP	O
amplitudes	amplitude	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expired	expire	VBN	I-NP	O
gas	gas	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
arterial	arterial	JJ	B-NP	O
and	and	CC	I-NP	O
mixed	mixed	JJ	I-NP	O
-	-	HYPH	I-NP	O
venous	venous	JJ	I-NP	O
blood	blood	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
blood	blood	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
partial	partial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
oxyhemoglobin	BEGIN-oxyhemoglobin-INSIDE	NN	I-NP	B
saturation	saturation	NN	I-NP	O
values	value	NNS	I-NP	O

An	An	DT	B-NP	O
anoerxiant	anoerxiant	NN	I-NP	O
,	,	,	O	O
mazindol	mazindol	NN	B-NP	O
suppresses	suppress	VBZ	B-VP	O
food	food	NN	B-NP	O
intake	intake	NN	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
stimulating	stimulate	VBG	B-VP	O
beta	BEGIN-beta	NN	B-NP	B
-	-	HYPH	B-NP	I
adrenergic	adrenergic	JJ	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
,	,	,	O	O
1	1	LS	B-LST	O
)	)	)	O	O
inhibiting	inhibit	VBG	B-VP	O
the	the	DT	B-NP	O
feeding	feeding	NN	I-NP	O
center	center	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
1	1	LS	B-LST	O
)	)	)	O	O
stimulating	stimulate	VBG	B-VP	O
the	the	DT	B-NP	O
satiety	satiety	JJ	I-NP	O
center	center	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hypothalamus	hypothalamus	NN	I-NP	O

When	When	WRB	B-ADVP	O
patients	patient	NNS	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
dark	dark	JJ	B-NP	O
urine	urine	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
shedding	shed	VBG	I-VP	O
HAV	HAV	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
only	only	RB	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
specimens	specimen	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
admitted	admit	VBN	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
week	week	NN	I-NP	O
contained	contain	VBD	B-VP	O
virus	virus	NN	B-NP	O

Positive	Positive	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
radioactive	radioactive	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-PP	O
Guarapari	Guarapari	NN	B-NP	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
doses	dose	NNS	I-NP	O
which	which	WDT	B-NP	O
alone	alone	RB	B-ADVP	O
were	be	VBD	B-VP	O
lacking	lack	VBG	I-VP	O
in	in	IN	B-PP	O
activity	activity	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
B1	B1	NN	I-NP	O
and	and	CC	I-NP	O
B1	B1	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
B1	B1	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
)	)	)	O	O
dose	dose	NN	B-NP	O
-	-	HYPH	B-VP	O
dependently	dependently	RB	I-VP	O
potentiated	potentiate	VBD	I-VP	O
the	the	DT	B-NP	O
antinociceptive	antinociceptive	JJ	I-NP	O
of	of	IN	B-PP	O
diclofenac	diclofenac	NN	B-NP	O

Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
strains	strain	NNS	I-NP	O
carrying	carry	VBG	B-VP	O
recA1	BEGIN-recA1-INSIDE	NN	B-NP	B
(	(	(	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
recA*	BEGIN-recA*	NN	I-NP	B
alleles	alleles-INSIDE	NN	I-NP	I
)	)	)	O	O
exhibit	exhibit	VBP	B-VP	O
dramatic	dramatic	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
SOS	SOS	NN	B-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
spontaneous	spontaneous	JJ	I-NP	O
mutator	mutator	NN	I-NP	O
activity	activity	NN	I-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
contrary	contrary	JJ	I-NP	O
i.v.	i.v.	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
calcitonin	BEGIN-calcitonin-INSIDE	NN	B-NP	B
increased	increase	VBD	B-VP	O
intrapyloric	intrapyloric	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
via	via	IN	B-PP	O
vagal	vagal	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
in	in	IN	B-PP	O
atropinized	atropinize	VBN	B-NP	O
or	or	CC	I-NP	O
gallaminized	gallaminize	VBN	I-NP	O
animals	animal	NNS	I-NP	O

An	An	DT	B-NP	O
hcr1	BEGIN-hcr1-INSIDE	NN	I-NP	B
null	null	JJ	I-NP	O
mutant	mutant	NN	I-NP	O
was	be	VBD	B-VP	O
viable	viable	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
showed	show	VBD	B-VP	O
slight	slight	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
free	free	JJ	B-NP	O
-	-	HYPH	I-NP	O
chlorine	chlorine	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
L	L	NN	I-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
heterotrophic	heterotrophic	JJ	I-NP	O
plate	plate	NN	I-NP	O
numbers	number	NNS	I-NP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
without	without	IN	B-PP	O
free	free	JJ	B-NP	O
chlorine	chlorine	NN	I-NP	O

This	This	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
examines	examine	VBZ	B-VP	O
several	several	JJ	B-NP	O
analytical	analytical	JJ	I-NP	O
and	and	CC	I-NP	O
cost	cost	NN	I-NP	O
parameters	parameter	NNS	I-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
representative	representative	JJ	I-NP	O
assays	assay	NNS	I-NP	O
:	:	:	O	O
IgG	BEGIN-IgG-INSIDE	NN	B-NP	B
,	,	,	O	O
IgA	BEGIN-IgA-INSIDE	NN	B-NP	B
,	,	,	O	O
IgM	BEGIN-IgM-INSIDE	NN	B-NP	B
,	,	,	O	O
phenytoin	phenytoin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
phenobarbital	phenobarbital	NN	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
identified	identify	VBN	I-VP	O
LIT1	BEGIN-LIT1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
paternally	paternally	RB	I-NP	O
expressed	express	VBN	I-NP	O
antisense	antisense	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
KvLQT1	BEGIN-KvLQT1	NN	I-NP	B
locus	locus-INSIDE	NN	I-NP	I
through	through	IN	B-PP	O
a	a	DT	B-NP	O
positional	positional	JJ	I-NP	O
screening	screening	NN	I-NP	O
approach	approach	NN	I-NP	O
using	use	VBG	B-VP	O
human	human	JJ	B-NP	O
monochromosomal	monochromosomal	JJ	I-NP	O
hybrids	hybrid	NNS	I-NP	O

Here	Here	RB	B-NP	O
RFX	BEGIN-RFX-INSIDE	NN	I-NP	B
/	/	SYM	I-NP	O
X1BP	BEGIN-X1BP-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
DNA	DNA	NN	I-NP	O
complexes	complex	NNS	I-NP	O
were	be	VBD	B-VP	O
formed	form	VBN	I-VP	O
on	on	IN	B-PP	O
all	all	DT	B-NP	O
class	class	NN	I-NP	O
II	II	CD	B-NP	O
isotypes	isotype	NNS	I-NP	O
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
X	X	NN	I-NP	O
box	box	NN	I-NP	O
region	region	NN	I-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
either	either	DT	B-NP	O
factor	factor	NN	I-NP	O
individually	individually	RB	B-ADVP	O

Developmental	Developmental	JJ	B-NP	O
slot	slot	NN	I-NP	O
blots	blot	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
mRNAs	mRNA	NNS	B-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
LHM	BEGIN-LHM	NN	I-NP	B
cDNAs	cDNAs-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
transcribed	transcribe	VBN	I-VP	O
from	from	IN	B-PP	O
prophase	prophase	NN	B-NP	O
of	of	IN	B-PP	O
meiosis	meiosis	NN	B-NP	O
I	I	CD	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
uninucleate	uninucleate	JJ	I-NP	O
microspore	microspore	NN	I-NP	O
stage	stage	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
Northern	Northern	NN	B-NP	O
analysis	analysis	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
these	these	DT	B-NP	O
tapetally	tapetally	RB	I-NP	O
expressed	express	VBN	I-NP	O
cDNAs	cDNA	NNS	I-NP	O
to	to	TO	B-VP	O
correspond	correspond	VB	I-VP	O
with	with	IN	B-PP	O
transcripts	transcript	NNS	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O

The	The	DT	B-NP	O
curse	curse	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Pharaohs	Pharaoh	NNS	I-NP	O

The	The	DT	B-NP	O
women	woman	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intermediate	intermediate	JJ	I-NP	O
calcium	calcium	NN	I-NP	O
group	group	NN	I-NP	O
had	have	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
the	the	DT	I-NP	O
same	same	JJ	I-NP	O
mean	mean	JJ	I-NP	O
BMD	BMD	NN	I-NP	O
values	value	NNS	I-NP	O
as	as	IN	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
calcium	calcium	NN	I-NP	O
group	group	NN	I-NP	O

The	The	DT	B-NP	O
enigma	enigma	NN	I-NP	O
of	of	IN	B-PP	O
aging	age	VBG	B-NP	O
bone	bone	NN	I-NP	O
loss	loss	NN	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
After	After	IN	B-PP	O
lavage	lavage	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
arterial	arterial	JJ	B-NP	O
pH	pH	NN	I-NP	O
and	and	CC	I-NP	O
PaO1	PaO1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
PaCO1	PaCO1	NN	B-NP	O
and	and	CC	I-NP	O
PIP	PIP	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
animals	animal	NNS	I-NP	O

In	In	IN	B-PP	O
both	both	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
tyrosine	BEGIN-tyrosine	NN	B-NP	B
phosphorylated	phosphorylate	VBN	B-VP	I
IRS	IRS	NNP	B-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
regulatory	regulatory	JJ	I-NP	I
subunit	subunit-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
PI	BEGIN-PI	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
PI	BEGIN-PI	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	B-NP	I
IRS	IRS	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
immunoprecipitates	immunoprecipitate	NNS	I-NP	O

Twelve	Twelve	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
cognitive	cognitive	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
including	include	VBG	B-PP	O
impairments	impairment	NNS	B-NP	O
in	in	IN	B-PP	O
memory	memory	NN	B-NP	O
,	,	,	O	O
attention	attention	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
affective	affective	JJ	B-NP	O
disturbances	disturbance	NNS	I-NP	O
(	(	(	O	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
irritability	irritability	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
frustration	frustration	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
)	)	)	O	O

These	These	DT	B-NP	O
effects	effect	NNS	I-NP	O
were	be	VBD	B-VP	O
antagonized	antagonize	VBN	I-VP	O
by	by	IN	B-PP	O
prior	prior	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
methoxyphenyl	methoxyphenyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
[	[	(	O	O
-	-	HYPH	O	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
phthalimido	phthalimido	NN	I-NP	O
)	)	)	O	O
butyl	butyl	NN	B-NP	O
]	]	)	O	O
piperazine	piperazine	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
i.p	i.p	NN	B-NP	O
.	.	.	O	O
)	)	)	O	O

Transcription	Transcription	NN	B-NP	O
initiation	initiation	NN	I-NP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
cloned	clone	VBN	I-NP	O
rRNA	rRNA	NN	I-NP	O
gene	gene	NN	I-NP	O
cluster	cluster	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
multi	multi	AFX	I-NP	O
-	-	HYPH	I-NP	O
copy	copy	NN	I-NP	O
plasmid	plasmid	NN	I-NP	O

The	The	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
parvalbumin	parvalbumin	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
polyadenylation	polyadenylation	NN	I-NP	O
signal	signal	NN	I-NP	O
AATAAA	AATAAA	NN	I-NP	O
1	1	CD	B-NP	O
nucleotides	nucleotide	NNS	I-NP	O
upstream	upstream	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
polyadenylation	polyadenylation	NN	I-NP	O
site	site	NN	I-NP	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
dopamine	dopamine	NN	B-NP	O
and	and	CC	B-PP	O
of	of	IN	B-PP	O
dopamine	BEGIN-dopamine	NN	B-NP	B
D1	D1	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
blocker	blocker	NN	I-NP	O
haloperidol	haloperidol	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
carotid	carotid	NN	B-NP	O
chemoreceptors	chemoreceptor	NNS	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
anesthetized	anesthetize	VBN	B-VP	O
,	,	,	O	O
paralyzed	paralyze	VBN	B-VP	O
and	and	CC	O	O
artificially	artificially	RB	B-VP	O
ventilated	ventilate	VBN	I-VP	O
newborn	newborn	JJ	B-NP	O
kittens	kitten	NNS	I-NP	O
aged	age	VBN	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O

DNMT1	BEGIN-DNMT1-INSIDE	NN	B-NP	B
binds	bind	VBZ	B-VP	O
AdoHcy	AdoHcy	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
conformation	conformation	NN	I-NP	O
as	as	IN	B-PP	O
confirmed	confirm	VBN	B-NP	O
m	BEGIN-m	NN	I-NP	B
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
C	C	NN	B-NP	I
MTases	MTases-INSIDE	NN	I-NP	I
and	and	CC	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
DNMT1	BEGIN-DNMT1-INSIDE	NN	B-NP	B
shares	share	NNS	I-NP	O
all	all	DT	B-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
structural	structural	JJ	B-NP	O
features	feature	NNS	I-NP	O
with	with	IN	B-PP	O
m	BEGIN-m	NN	B-NP	B
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
C	C	NN	B-NP	I
MTases	MTases-INSIDE	NN	I-NP	I
,	,	,	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
failed	fail	VBN	I-VP	O
to	to	TO	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
detectable	detectable	JJ	B-NP	O
transmethylase	transmethylase	NN	I-NP	O
activity	activity	NN	I-NP	O

Serum	BEGIN-Serum	NN	B-NP	B
amyloid	amyloid	JJ	I-NP	I
A	A-INSIDE	NN	I-NP	I
(	(	(	O	O
SAA	BEGIN-SAA-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
plasma	plasma	NN	I-NP	O
protein	protein	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
amyloidosis	amyloidosis	NN	B-NP	O
,	,	,	O	O
arthritis	arthritis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
atherosclerosis	atherosclerosis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
abnormal	abnormal	JJ	I-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
nonhepatic	nonhepatic	JJ	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
diseases	disease	NNS	I-NP	O

The	The	DT	B-NP	O
standardized	standardized	JJ	I-NP	O
incidence	incidence	NN	I-NP	O
in	in	IN	B-PP	O
Europeans	European	NNPS	B-NP	O
has	have	VBZ	B-VP	O
risen	rise	VBN	I-VP	O
significantly	significantly	RB	B-ADVP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
year	year	NN	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
year	year	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1s	1	NNS	I-NP	O
(	(	(	O	O
chi	chi	NN	B-NP	O
1	1	CD	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

Physical	Physical	JJ	B-ADJP	O
mapping	map	VBG	B-VP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
centromeric	centromeric	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
MHC	MHC-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
segment	segment	NN	I-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
RING1	BEGIN-RING1-INSIDE	NN	I-NP	B
,	,	,	O	O
HKE1	BEGIN-HKE1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
HKE1	BEGIN-BEGIN-HKE1-INSIDE	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
cells	cell	NNS	I-NP	O
arrest	arrest	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
G1	G1	NN	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
and	and	CC	O	O
grow	grow	VB	B-VP	O
a	a	DT	B-NP	O
projection	projection	NN	I-NP	O
towards	towards	IN	B-PP	O
one	one	CD	B-NP	O
another	another	DT	I-NP	O
forming	form	VBG	B-VP	O
a	a	DT	B-NP	O
shmoo	shmoo	NN	I-NP	O
projection	projection	NN	I-NP	O

Multiple	Multiple	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
thrombi	thrombi	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
protein	BEGIN-protein	NN	B-NP	B
C-INSIDE	C-INBEGIN-S-INSIDEIDE	NN	I-NP	I
and	and	CC	O	O
S	BEGIN-S-INSIDE	NN	B-NP	B
deficiency	deficiency	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
optimum	optimum	JJ	I-NP	O
compressive	compressive	JJ	I-NP	O
strength	strength	NN	I-NP	O
reached	reach	VBD	B-VP	O
values	value	NNS	B-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
CC	CC	NN	B-NP	O
-	-	HYPH	B-NP	O
free	free	JJ	I-NP	O
samples	sample	NNS	I-NP	O

POPULATION	POPULATION	NN	B-NP	O
AND	AND	CC	I-NP	O
METHODS	METHODS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
prospectively	prospectively	RB	B-ADVP	O
(	(	(	O	O
male	male	JJ	B-ADJP	O
:	:	:	O	O
1	1	CD	B-NP	O
;	;	:	O	O
age	age	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
clinical	clinical	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1st	1st	NN	I-NP	O
,	,	,	O	O
1rd	1rd	NN	B-NP	O
and	and	CC	O	O
1th	1th	JJ	B-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
SEKG	SEKG	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1th	1th	JJ	I-NP	O
month	month	NN	I-NP	O
and	and	CC	I-NP	O
recatheterization	recatheterization	NN	I-NP	O
for	for	IN	B-PP	O
angiographic	angiographic	JJ	B-NP	O
control	control	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1th	1th	NN	I-NP	O
month	month	NN	I-NP	O

The	The	DT	B-NP	O
practice	practice	NN	I-NP	O
of	of	IN	B-PP	O
measuring	measuring	NN	B-NP	O
of	of	IN	B-PP	O
AChE	BEGIN-AChE-INSIDE	NN	B-NP	B
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
poisoning	poisoning	NN	I-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	I-VP	O

M.	M.	NNP	B-NP	O
,	,	,	O	O
Adrich	Adrich	NNP	B-NP	O
,	,	,	O	O
Z.	Z.	NNP	B-NP	O
,	,	,	O	O
Fournet	Fournet	NNP	B-NP	O
,	,	,	O	O
B.	B.	NNP	B-NP	O
,	,	,	O	O
Capon	Capon	NNP	B-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
,	,	,	O	O
Bonicel	Bonicel	NNP	B-NP	O
,	,	,	O	O
J	J	NNP	B-NP	O

Confocal	Confocal	JJ	B-NP	O
fluorescent	fluorescent	JJ	I-NP	O
microscopy	microscopy	NN	I-NP	O
analysis	analysis	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
WT	WT	NNP	B-NP	O
,	,	,	O	O
VaI	VaI	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
VaII	VaII	NNP	B-NP	O
all	all	DT	O	O
distribute	distribute	VBP	B-VP	O
equally	equally	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
while	while	IN	B-SBAR	O
,	,	,	O	O
as	as	IN	B-SBAR	O
expected	expect	VBN	B-VP	O
,	,	,	O	O
a	a	DT	B-NP	O
WT	WT	NN	I-NP	O
mutant	mutant	NN	I-NP	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
C	C	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
valine	valine	NN	I-NP	O
residues	residue	NNS	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	O	O

The	The	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
ERCC1	BEGIN-ERCC1-INSIDE	NN	B-NP	B
detectable	detectable	JJ	B-ADJP	O
by	by	IN	B-PP	O
immunoblotting	immunoblotting	NN	B-NP	O
is	be	VBZ	B-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
XP	XP	NN	I-NP	O
-	-	HYPH	B-NP	O
F	F	NN	I-NP	O
extracts	extract	NNS	I-NP	O

Letter	Letter	NNP	B-NP	O
:	:	:	O	O
Ballistocardiography	Ballistocardiography	NN	B-NP	O

Metabolic	Metabolic	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
tetrabenazine	tetrabenazine	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
psychotropic	psychotropic	JJ	I-NP	O
drug	drug	NN	I-NP	O
in	in	IN	B-PP	O
animals	animal	NNS	B-NP	O
and	and	CC	O	O
man	man	NN	B-NP	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
frozen	frozen	JJ	I-NP	O
specimen	specimen	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
sections	section	NNS	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
morphologic	morphologic	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
produced	produce	VBN	I-VP	O

Gene	Gene	NN	B-NP	O
transcripts	transcript	NNS	I-NP	O
are	be	VBP	B-VP	O
detected	detect	VBN	I-VP	O
on	on	IN	B-PP	O
tissues	tissue	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
bovine	bovine	JJ	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
kidney	kidney	NN	B-NP	O
,	,	,	O	O
lung	lung	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
brain	brain	NN	B-NP	O

Plasma	BEGIN-Plasma	NN	B-NP	B
enteroglucagon	enteroglucagon-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
during	during	IN	I-PP	O
three	three	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
meal	meal	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
untreated	untreated	JJ	I-NP	O
adult	adult	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
suspected	suspect	VBN	B-NP	O
coeliac	coeliac	NN	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
all	all	DT	O	O
had	have	VBD	B-VP	O
villous	villous	JJ	B-NP	O
atrophy	atrophy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
intestinal	intestinal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
and	and	CC	I-NP	O
malabsorption	malabsorption	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
nine	nine	CD	B-NP	O
control	control	NN	I-NP	O
subjects	subject	NNS	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
establish	establish	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
heteromeric	heteromeric	JJ	I-NP	O
CCAAT	BEGIN-CCAAT	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
CBF	BEGIN-CBF-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C1	BEGIN-C1	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
(	(	(	O	O
C1F	BEGIN-C1F-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
cells	cell	NNS	I-NP	O

This	This	DT	B-NP	O
growth	growth	NN	I-NP	O
-	-	HYPH	O	O
inhibitory	inhibitory	JJ	B-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
mpk1	BEGIN-mpk1	NN	I-NP	B
delta	delta-INSIDE	NN	I-NP	I
mutation	mutation	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
hyperactivation	hyperactivation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Mpk1	BEGIN-Mpk1-INSIDE	NN	I-NP	B
pathway	pathway	NN	I-NP	O
is	be	VBZ	B-VP	O
toxic	toxic	JJ	B-ADJP	O
to	to	TO	B-PP	O
cells	cell	NNS	B-NP	O

The	The	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
PAX1	PAX1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
generates	generate	VBZ	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
five	five	CD	I-NP	O
different	different	JJ	I-NP	O
alternatively	alternatively	RB	I-NP	O
spliced	splice	VBN	I-NP	O
transcripts	transcript	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
different	different	JJ	B-NP	O
PAX1	BEGIN-PAX1	NN	I-NP	B
isoforms	isoforms-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
somatic	somatic	JJ	I-NP	O
cell	cell	NN	I-NP	O
hybrids	hybrid	NNS	I-NP	O
have	have	VBP	B-VP	O
allowed	allow	VBN	I-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
locate	locate	VB	I-VP	O
the	the	DT	B-NP	O
YAC	YAC	NN	I-NP	O
contig	contig	NN	I-NP	O
telomeric	telomeric	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
D1F1S1	BEGIN-D1F1S1	NN	I-NP	B
locus	locus-INSIDE	NN	I-NP	I
,	,	,	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
frequently	frequently	RB	I-VP	O
deleted	delete	VBN	I-VP	O
in	in	IN	B-PP	O
lung	lung	NN	B-NP	O
carcinomas	carcinoma	NNS	I-NP	O

A	A	DT	B-NP	O
close	close	JJ	I-NP	O
homologue	homologue	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
APK1a	BEGIN-APK1a	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
named	name	VBN	B-VP	O
APK1b	BEGIN-APK1b-INSIDE	NN	B-NP	B
,	,	,	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Arabidopsis	Arabidopsis	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
Chlamydomonas	Chlamydomonas	NN	B-NP	O
reinhardtii	reinhardtii	NN	I-NP	O
zygote	zygote	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
cDNAs	cDNA	NNS	I-NP	O
that	that	WDT	B-NP	O
encode	encode	VBP	B-VP	O
novel	novel	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
containing	contain	VBG	B-VP	O
ankyrin	BEGIN-ankyrin-INSIDE	NN	B-NP	B
repeats	repeat	NNS	I-NP	O
and	and	CC	O	O
WW	WW	NNP	B-NP	O
domains	domain	NNS	I-NP	O

Subsequent	Subsequent	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
MyD1	BEGIN-MyD1-INSIDE	NN	B-NP	B
possesses	possess	VBZ	B-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
modular	modular	JJ	I-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
``	``	``	I-NP	O
death	death	NN	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
''	''	''	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
segments	segment	NNS	I-NP	O
of	of	IN	B-PP	O
TNF	BEGIN-TNF	NN	B-NP	B
receptor	receptor	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Fas	BEGIN-Fas-INSIDE	NN	I-NP	B
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
region	region	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
domains	domain	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Drosophila	BEGIN-Drosophila	NN	I-NP	B
morphogen	morphogen	NN	I-NP	I
Toll	Toll-INSIDE	NN	I-NP	I
and	and	CC	O	O
vertebrate	vertebrate	NN	B-NP	O
interleukin	BEGIN-interleukin	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I

A.	A.	NN	B-NP	O
nidulans	nidulan	NNS	I-NP	O
transformants	transformant	NNS	I-NP	O
secreted	secrete	VBD	B-VP	O
high	high	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
PGI	BEGIN-PGI-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
PGII	BEGIN-PGI-INSIDEI	NN	I-NP	I
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
A.	A.	NN	I-NP	O
niger	niger	NN	I-NP	O
transformants	transformant	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
polygalacturonase	BEGIN-polygalacturonase-INSIDE	NN	I-NP	B
(	(	(	O	O
PGC	BEGIN-PGC-INSIDE	NN	B-NP	B
)	)	)	O	O
was	be	VBD	B-VP	O
produced	produce	VBN	I-VP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
by	by	IN	B-PP	O
A.	A.	NN	B-NP	O
nidulans	nidulan	NNS	I-NP	O
transformed	transform	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
subcloned	subclone	VBN	I-NP	O
pgaC	BEGIN-pgaC	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

Role	Role	NN	B-NP	O
of	of	IN	B-PP	O
zinc	BEGIN-zinc	NN	B-NP	B
-	-	HYPH	B-NP	I
finger	finger	NN	I-NP	I
proteins	protein	NNS	I-NP	I
Sp1	Sp1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
zif1	BEGIN-zif1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
egr	BEGIN-egr	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
in	in	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
synaptobrevin	synaptobrevin	NN	I-NP	I
II	II	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
recovery	recovery	NN	I-NP	O
curve	curve	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
R1	R1	NN	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blink	blink	NN	I-NP	O
reflex	reflex	NN	I-NP	O
diminished	diminish	VBD	B-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
tension	tension	NN	B-NP	O
-	-	HYPH	B-NP	O
type	type	NN	I-NP	O
headache	headache	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
groups	group	NNS	I-NP	O

The	The	DT	B-NP	O
GvpE	BEGIN-GvpE	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
gas	gas	NN	B-NP	O
vesicles	vesicle	NNS	I-NP	O
synthesis	synthesis	NN	I-NP	O
in	in	IN	B-PP	O
halophilic	halophilic	JJ	B-NP	O
archaea	archaea	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activator	activator	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
located	located	JJ	B-ADJP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gvpA	BEGIN-gvpA	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
gas	gas	NN	I-NP	O
vesicle	vesicle	NN	I-NP	O
structural	structural	JJ	I-NP	O
protein	protein	NN	I-NP	O
GvpA	BEGIN-GvpA-INSIDE	NN	I-NP	B

TFIIIB	BEGIN-TFIIIB-INSIDE	NN	B-NP	B
assembles	assemble	VBZ	B-VP	O
autonomously	autonomously	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
U1	U1	NN	I-NP	I
snRNA	snRNA-INSIDE	NN	I-NP	I
(	(	(	O	O
SNR1	BEGIN-SNR1-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
TBP	BEGIN-TBP	NN	I-NP	B
subunit	subunit-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
base	base	NN	B-NP	O
pair	pair	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
bromocriptine	bromocriptine	NN	B-NP	O
and	and	CC	I-NP	O
metoclopramide	metoclopramide	NN	I-NP	O
on	on	IN	B-PP	O
serum	BEGIN-serum	NN	B-NP	B
prolactin	prolactin-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
amyotrophic	amyotrophic	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
sclerosis	sclerosis	NN	I-NP	O

Experience	Experience	NN	B-NP	O
in	in	IN	B-PP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
Romashka	Romashka	NNP	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
laser	laser	NN	I-NP	O
surgical	surgical	JJ	I-NP	O
unit	unit	NN	I-NP	O
in	in	IN	B-PP	O
treating	treat	VBG	B-VP	O
suppurative	suppurative	JJ	B-NP	O
wounds	wound	NNS	I-NP	O

At	At	IN	B-PP	O
a	a	DT	B-NP	O
cutoff	cutoff	NN	I-NP	O
point	point	NN	I-NP	O
for	for	IN	B-PP	O
KISA	KISA	NN	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
participants	participant	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
correctly	correctly	RB	I-VP	O
classified	classify	VBN	I-VP	O

To	To	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
selective	selective	JJ	B-NP	O
thromboxane	thromboxane	NN	I-NP	O
A1	A1	NN	I-NP	O
blockade	blockade	NN	I-NP	O
on	on	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
findings	finding	NNS	I-NP	O
and	and	CC	O	O
platelet	platelet	NN	B-NP	O
reactivity	reactivity	NN	I-NP	O
in	in	IN	B-PP	O
refractory	refractory	JJ	B-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
OKY	OKY	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	NN	I-NP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
p.o.	p.o.	FW	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
another	another	DT	B-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
refractory	refractory	JJ	B-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
therapy	therapy	NN	I-NP	O

The	The	DT	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
recruited	recruit	VBN	B-VP	O
by	by	IN	B-PP	O
ARF1.GTP	BEGIN-ARF1.GTP-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
released	release	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Golgi	Golgi	NNP	I-NP	O
membrane	membrane	NN	I-NP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
M	M	NN	I-NP	O
Tris	Tris	NN	I-NP	O
-	-	HYPH	O	O
HCl	HCl	NN	B-NP	O
(	(	(	O	O
pH	pH	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
or	or	CC	O	O
upon	upon	IN	B-PP	O
reincubation	reincubation	NN	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
degreesC	degreesC	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
AP	BEGIN-AP	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
recruited	recruit	VBN	B-VP	O
with	with	IN	B-PP	O
GTPgammaS	GTPgammaS	NN	B-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
constitutively	constitutively	RB	I-NP	O
active	active	JJ	I-NP	O
point	point	NN	I-NP	O
mutant	mutant	NN	I-NP	O
,	,	,	O	O
ARF1	BEGIN-ARF1	NN	B-NP	B
(	(	(	O	I
Q1L	Q1L	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
,	,	,	O	O
remains	remain	VBZ	B-VP	O
membrane	membrane	NN	B-NP	O
bound	bind	VBN	B-VP	O
after	after	IN	B-PP	O
either	either	DT	B-NP	O
treatment	treatment	NN	I-NP	O

In	In	IN	B-PP	O
K1	K1	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
bicistronic	bicistronic	JJ	I-NP	O
vector	vector	NN	I-NP	O
,	,	,	O	O
selection	selection	NN	B-NP	O
with	with	IN	B-PP	O
colchicine	colchicine	NN	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	B-NP	O
higher	high	JJR	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MDR1	BEGIN-BEGIN-MDR1-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
product	product-INSIDE	NN	I-NP	I
than	than	IN	B-SBAR	O
did	do	VBD	O	O
selection	selection	NN	B-NP	O
with	with	IN	B-PP	O
G1	G1	NN	B-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
stringent	stringent	JJ	I-NP	O
MDR1	BEGIN-MDR1-INSIDE	NN	I-NP	B
selection	selection	NN	I-NP	O
system	system	NN	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
efficient	efficient	JJ	I-ADJP	O
for	for	IN	B-PP	O
obtaining	obtain	VBG	B-VP	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
foreign	foreign	JJ	B-NP	O
genes	gene	NNS	I-NP	O

A	A	DT	B-NP	O
surge	surge	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
ascorbyl	ascorbyl	NN	B-NP	O
radical	radical	NN	I-NP	O
production	production	NN	I-NP	O
,	,	,	O	O
directly	directly	RB	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
oxyradical	oxyradical	JJ	B-NP	O
stress	stress	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
abrupt	abrupt	JJ	I-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
superoxide	BEGIN-superoxide	NN	B-NP	B
dismutase	dismutase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
granuloma	granuloma	NN	I-NP	O
,	,	,	O	O
indicates	indicate	VBZ	B-VP	O
'switching	'switche	VBG	I-VP	O
on	on	RP	B-PRT	O
'	'	''	O	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
free	free	JJ	I-NP	O
radical	radical	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
machinery	machinery	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
granuloma	granuloma	NN	B-NP	O
after	after	IN	B-PP	O
vasectomy	vasectomy	NN	B-NP	O

The	The	DT	B-NP	O
vaccine	vaccine	NN	I-NP	O
was	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
immunogenic	immunogenic	JJ	I-ADJP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
produced	produce	VBD	B-VP	O
anti	BEGIN-anti	AFX	O	B
-	-	HYPH	O	I
HBs	HBs-INSIDE	NN	B-NP	I
(	(	(	O	O
1	1	CD	B-NP	O
mIU	mIU	NN	I-NP	O
/	/	SYM	B-VP	O
ml	ml	NN	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
)	)	)	O	O

Papillomavirus	Papillomavirus	NN	B-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
oncogenes	oncogene	NNS	I-NP	O
downregulate	downregulate	VBP	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
interferon	BEGIN-interferon-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
responsive	responsive	JJ	I-NP	O
genes	gene	NNS	I-NP	O
and	and	CC	O	O
upregulate	upregulate	VBP	B-VP	O
proliferation	proliferation	NN	B-NP	O
-	-	HYPH	B-NP	O
associated	associate	VBN	B-VP	O
and	and	CC	O	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
kappaB	kappaB-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
responsive	responsive	JJ	I-NP	O
genes	gene	NNS	I-NP	O
in	in	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
keratinocytes	keratinocyte	NNS	I-NP	O

A	A	DT	B-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
SMase	BEGIN-SMase-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
sphingomyelin	sphingomyelin	NN	I-NP	O
complex	complex	NN	I-NP	O
structure	structure	NN	I-NP	O
was	be	VBD	B-VP	O
built	build	VBN	I-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
how	how	WRB	B-ADVP	O
the	the	DT	B-NP	O
SMase	BEGIN-SMase-INSIDE	NN	I-NP	B
specifically	specifically	RB	B-VP	O
recognizes	recognize	VBZ	I-VP	O
its	its	PRP$	B-NP	O
substrate	substrate	NN	I-NP	O

MADS	BEGIN-MADS	NN	B-NP	B
-	-	HYPH	I-NP	I
box	box	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
plants	plant	NNS	B-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
diverse	diverse	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
developmental	developmental	JJ	B-NP	O
processes	process	NNS	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-NP	O
meristem	meristem	NN	I-NP	O
and	and	CC	I-NP	O
organ	organ	NN	I-NP	O
identity	identity	NN	I-NP	O
during	during	IN	B-PP	O
floral	floral	JJ	B-NP	O
development	development	NN	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
data	datum	NNS	I-NP	O
set	set	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
sample	sample	NN	I-NP	O
model	model	NN	I-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
to	to	TO	B-VP	O
give	give	VB	I-VP	O
excellent	excellent	JJ	B-NP	O
estimation	estimation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AUC	AUC	NN	I-NP	O
:	:	:	O	O
AUC	AUC	NN	B-NP	O
(	(	(	O	O
mg	mg	NN	B-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
x	x	SYM	I-NP	O
min	min	NN	I-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
x	x	SYM	I-NP	O
C1h	C1h	NN	I-NP	O
+	+	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
MPE	MPE	NN	B-NP	O
%	%	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
RMSE	RMSE	NN	B-NP	O
%	%	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
Pfu	BEGIN-Pfu	NN	B-NP	B
exo	exo	NN	I-NP	I
(	(	(	O	I
-	-	SYM	O	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
at	at	IN	B-PP	O
the	the	DT	B-NP	O
primer	primer	NN	I-NP	O
extension	extension	NN	I-NP	O
step	step	NN	I-NP	O
and	and	CC	I-NP	O
Taq	BEGIN-Taq-INSIDE	NN	I-NP	B
at	at	IN	B-PP	O
the	the	DT	B-NP	O
PCR	PCR	NN	I-NP	O
amplification	amplification	NN	I-NP	O
step	step	NN	I-NP	O
is	be	VBZ	B-VP	O
ideal	ideal	JJ	B-ADJP	O
for	for	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
DNA	DNA	NN	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
damage	damage	NN	I-NP	O
mapping	mapping	NN	I-NP	O
using	use	VBG	B-VP	O
LMPCR	LMPCR	NN	B-NP	O

KU	KU	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
also	also	RB	B-ADVP	O
significantly	significantly	RB	B-VP	O
accelerated	accelerate	VBD	I-VP	O
the	the	DT	B-NP	O
healing	healing	NN	I-NP	O
of	of	IN	B-PP	O
acetic	acetic	JJ	B-NP	O
acid	acid	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
duodenal	duodenal	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
famotidine	famotidine	NN	B-NP	O
and	and	CC	I-NP	O
roxatidine	roxatidine	NN	I-NP	O
acetate	acetate	NN	I-NP	O

Prolongation	Prolongation	NN	B-NP	O
of	of	IN	B-PP	O
prothrombin	BEGIN-prothrombin-INSIDE	NN	B-NP	B
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
depletion	depletion	NN	B-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
K	K	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
coagulation	coagulation	NN	I-NP	O
factors	factor	NNS	I-NP	O
or	or	CC	O	O
manifest	manif	JJS	B-NP	O
fibrinolysis	fibrinolysis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
circulating	circulate	VBG	B-VP	O
fibrinogen	BEGIN-fibrinogen	NN	B-NP	B
fibrinmonomer	fibrinmonomer-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
FDP	FDP	NN	I-NP	O
complexes	complex	NNS	I-NP	O

Clostridium	Clostridium	NNP	B-NP	O
botulinum	botulinum	NNP	I-NP	O
in	in	IN	B-PP	O
marine	marine	JJ	B-NP	O
sediment	sediment	NN	I-NP	O

Upstream	BEGIN-Upstream	JJ	B-NP	B
stimulatory	stimulatory	JJ	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
USF	BEGIN-USF-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
factor	factor	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
basic	basic	JJ	I-NP	O
/	/	SYM	I-NP	O
helix	helix	NN	I-NP	O
-	-	HYPH	B-NP	O
loop	loop	NN	I-NP	O
-	-	HYPH	I-NP	O
helix	helix	NN	I-NP	O
/	/	SYM	O	O
leucin	leucin	NN	B-NP	O
zipper	zipper	NN	I-NP	O
(	(	(	O	O
b	b	NN	B-NP	O
/	/	SYM	B-NP	O
HLH	HLH	NN	I-NP	O
/	/	SYM	I-NP	O
Z	Z	NN	I-NP	O
)	)	)	O	O
motif	motif	NN	B-NP	O
to	to	TO	B-VP	O
homodimerize	homodimerize	VB	I-VP	O
and	and	CC	I-VP	O
recognize	recognize	VB	I-VP	O
specific	specific	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
nuclear	nuclear	JJ	I-NP	O
and	and	CC	I-NP	O
viral	viral	JJ	I-NP	O
genes	gene	NNS	I-NP	O
transcribed	transcribe	VBN	B-VP	O
by	by	IN	B-PP	O
RNA	BEGIN-RNA	NN	B-NP	B
polymerase	polymerase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I

Fusion	Fusion	NN	B-NP	O
of	of	IN	B-PP	O
mouse	BEGIN-mouse	NN	B-NP	B
CD1+	CD1+-INSIDE	NN	I-NP	I
class	BEGIN-class	NN	I-NP	B
I	I	CD	I-NP	I
MHC	MHC-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
restricted	restrict	VBN	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
BW1	BW1	NN	I-NP	O
thymoma	thymoma	NN	I-NP	O
invariably	invariably	RB	B-ADVP	O
yields	yield	VBZ	B-VP	O
CD1	BEGIN-CD1	NN	B-NP	B
-	-	HYPH	I-NP	I
	-INSIDE	NN	I-NP	I
hybridomas	hybridoma	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
RNA	RNA	NN	B-NP	O
transcribed	transcribe	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
CD1	BEGIN-CD1	NN	I-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
(	(	(	O	O
Lyt	BEGIN-Lyt	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
gene	gene	NN	B-NP	O
is	be	VBZ	B-VP	O
undetectable	undetectable	JJ	B-ADJP	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
,	,	,	O	O
alpha1	BEGIN-alpha1	NN	B-NP	B
-	-	HYPH	B-NP	I
PDX	PDX-INSIDE	NN	I-NP	I
prevents	prevent	VBZ	B-VP	O
cleavage	cleavage	NN	B-NP	O
of	of	IN	B-PP	O
BMP	BEGIN-BMP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
an	an	DT	B-NP	O
oocyte	oocyte	NN	I-NP	O
translation	translation	NN	I-NP	O
assay	assay	NN	I-NP	O

Convergence	Convergence	NN	B-NP	O
of	of	IN	B-PP	O
trigeminal	trigeminal	JJ	B-NP	O
input	input	NN	I-NP	O
with	with	IN	B-PP	O
visceral	visceral	JJ	B-NP	O
and	and	CC	I-NP	O
phrenic	phrenic	JJ	I-NP	O
inputs	input	NNS	I-NP	O
on	on	IN	B-PP	O
primate	primate	JJ	B-NP	O
C1	C1	NN	I-NP	O
-	-	HYPH	B-NP	O
C1	C1	NN	I-NP	O
spinothalamic	spinothalamic	JJ	I-NP	O
tract	tract	NN	I-NP	O
neurons	neuron	NNS	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
cloned	clone	VBD	B-VP	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
of	of	IN	B-PP	O
AD1	BEGIN-AD1	NN	B-NP	B
Ag	Ag-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
a	a	DT	B-NP	O
rat	rat	NN	I-NP	O
basophilic	basophilic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
1H1	1H1	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O

Several	Several	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
resembling	resemble	VBG	B-VP	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
for	for	IN	B-PP	O
liver	liver	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	O	O
fat	fat	NN	B-NP	O
body	body	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
upstream	upstream	JJ	B-ADJP	O
and	and	CC	O	O
downstream	downstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O

Root	Root	NN	B-NP	O
surface	surface	NN	I-NP	O
caries	cary	NNS	I-NP	O
incidence	incidence	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
inoculated	inoculate	VBN	B-VP	O
with	with	IN	B-PP	O
A.	A.	NN	B-NP	O
viscosus	viscosus	NN	I-NP	O
and	and	CC	I-NP	O
A.	A.	NN	I-NP	O
viscosus	viscosus	NNP	I-NP	O
plus	plus	CC	O	O
S.	S.	NNP	B-NP	O
sobrinus	sobrinus	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
differ	differ	VB	I-VP	O

METHODS	METHODS	NNS	B-NP	O
AND	AND	CC	I-NP	O
RESULTS	RESULTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
QTd	QTd	NNP	I-NP	O
and	and	CC	I-NP	O
JTd	JTd	NNP	I-NP	O
intervals	interval	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O
with	with	IN	B-PP	O
long	long	JJ	B-NP	O
QT	QT	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
normal	normal	JJ	I-NP	O
age	age	NN	I-NP	O
-	-	HYPH	B-NP	O
matched	match	VBN	I-NP	O
children	child	NNS	I-NP	O

The	The	DT	B-NP	O
prgX	BEGIN-prgX	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
adjacent	adjacent	JJ	B-ADJP	O
to	to	TO	B-PP	O
prgQ	BEGIN-prgQ-INSIDE	NN	B-NP	B
which	which	WDT	B-NP	O
provides	provide	VBZ	B-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
for	for	IN	B-PP	O
prgB	BEGIN-prgB-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O

A	A	DT	B-NP	O
Frank	Frank	NNP	I-NP	O
vectorcardiogram	vectorcardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
before	before	IN	B-PP	O
and	and	CC	O	O
every	every	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
minutes	minute	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
occlusion	occlusion	NN	I-NP	O

The	The	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
Sudeck	Sudeck	NNP	B-NP	O
's	's	POS	B-NP	O
atrophy	atrophy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
limb	limb	NN	I-NP	O
by	by	IN	B-PP	O
sympathetic	sympathetic	JJ	B-NP	O
blockade	blockade	NN	I-NP	O

Frequency	Frequency	NN	B-NP	O
of	of	IN	B-PP	O
recurrence	recurrence	NN	B-NP	O
of	of	IN	B-PP	O
fibroids	fibroid	NNS	B-NP	O
after	after	IN	B-SBAR	O
myomectomy	myomectomy	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
women	woman	NNS	I-NP	O
(	(	(	O	O
median	median	JJ	B-NP	O
age	age	NN	I-NP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
range	range	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
who	who	WP	B-NP	O
underwent	undergo	VBD	B-VP	O
myomectomy	myomectomy	NN	B-NP	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
particular	particular	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
segment	segment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transient	transient	JJ	I-NP	O
contractile	contractile	JJ	I-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
intrinsic	intrinsic	JJ	B-NP	O
tone	tone	NN	I-NP	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
relaxation	relaxation	NN	B-NP	O
to	to	TO	B-PP	O
papaverine	papaverine	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
(	(	(	O	O
-	-	SYM	O	O
1	1	CD	O	O
)	)	)	O	O
M	M	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
of	of	IN	B-PP	O
choice	choice	NN	B-NP	O
for	for	IN	B-PP	O
initial	initial	JJ	B-NP	O
prophylactic	prophylactic	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
among	among	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
pregnant	pregnant	JJ	I-NP	O
women	woman	NNS	I-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
Bacillus	Bacillus	NN	B-NP	O
anthracis	anthracis	NN	I-NP	O
is	be	VBZ	B-VP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O

Spontaneous	Spontaneous	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
spasm	spasm	NN	I-NP	O
during	during	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
angiography	angiography	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
exercise	exercise	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
elevation	elevation	NN	I-NP	O

Nickel	Nickel	NN	B-NP	O
release	release	NN	I-NP	O
from	from	IN	B-PP	O
tools	tool	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Swedish	Swedish	NN	I-NP	O
market	market	NN	I-NP	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
starting	start	VBG	B-VP	O
platelet	platelet	NN	B-NP	O
-	-	HYPH	O	O
associated	associate	VBN	B-NP	O
IgG	BEGIN-IgG-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
or	or	CC	O	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
platelet	platelet	NN	B-NP	O
-	-	HYPH	B-NP	O
associated	associate	VBN	I-NP	O
IgG	BEGIN-IgG-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
with	with	IN	B-PP	O
therapy	therapy	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
increment	increment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O

The	The	DT	B-NP	O
receptor	receptor	NN	I-NP	O
for	for	IN	B-PP	O
CSF	BEGIN-CSF	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	I-NP	I
Fms	Fms-INSIDE	NN	I-NP	I
,	,	,	O	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
osteoclasts	osteoclast	NNS	B-NP	O
,	,	,	O	O
possesses	possess	VBZ	B-VP	O
intrinsic	intrinsic	JJ	B-NP	O
tyrosine	BEGIN-tyrosine	NN	I-NP	B
-	-	HYPH	B-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
signals	signal	NNS	B-NP	O
via	via	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
selected	select	VBN	B-NP	O
proteins	protein	NNS	I-NP	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
rat	rat	NN	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
SAH	SAH	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
assessed	assess	VBD	B-VP	O
BBB	BBB	NN	B-NP	O
changes	change	NNS	I-NP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
[	[	(	O	O
1C	1C	NN	B-NP	O
]	]	)	O	O
-	-	HYPH	O	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
aminoisobutyric	aminoisobutyric	JJ	B-NP	O
acid	acid	NN	I-NP	O
technique	technique	NN	I-NP	O

BAG	BEGIN-BAG	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
prevented	prevent	VBD	B-VP	O
growth	growth	NN	B-NP	O
arrest	arrest	NN	I-NP	O
following	follow	VBG	B-PP	O
UV	UV	NN	B-NP	O
-	-	HYPH	B-NP	O
irradiation	irradiation	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
genotoxic	genotoxic	JJ	I-NP	O
injury	injury	NN	I-NP	O
without	without	IN	B-PP	O
interfering	interfere	VBG	B-VP	O
with	with	IN	B-PP	O
accumulation	accumulation	NN	B-NP	O
of	of	IN	B-PP	O
p1	BEGIN-BEGIN-p1-INSIDE	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
or	or	CC	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
(	(	(	O	O
waf	BEGIN-waf	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
expression	expression	NN	B-NP	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
mean	mean	JJ	B-NP	O
urine	urine	NN	I-NP	O
osmolality	osmolality	NN	I-NP	O
(	(	(	O	O
Uosm	Uosm	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
free	free	JJ	B-NP	O
water	water	NN	I-NP	O
reabsorption	reabsorption	NN	I-NP	O
(	(	(	O	O
TCH1O	TCH1O	NN	B-NP	O
)	)	)	O	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
:	:	:	O	O
[	[	(	O	O
formula	formula	NN	B-NP	O
:	:	:	O	O
see	see	VB	B-VP	O
text	text	NN	B-NP	O
]	]	)	O	O

[	[	(	O	O
(	(	(	O	O
OP	OP	NN	B-NP	O
)	)	)	O	O
1Cu	1Cu	NN	B-NP	O
]	]	)	O	O
+	+	SYM	B-NP	O
also	also	RB	B-ADVP	O
detected	detect	VBN	B-VP	O
protections	protection	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
helix	helix	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
interdomain	interdomain	NN	I-NP	O
hinge	hinge	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
beta	beta	SYM	O	O
-	-	HYPH	O	O
strands	strand	NNS	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

When	When	WRB	B-ADVP	O
O	O	NN	B-NP	O
-	-	HYPH	B-NP	O
1A	1A	NN	I-NP	O
/	/	SYM	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	I-NP	I
myc	myc-INSIDE	NN	I-NP	I
cells	cell	NNS	I-NP	O
underwent	undergo	VBD	B-VP	O
terminal	terminal	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
APprog	BEGIN-APprog	NN	I-NP	B
complexes	complexes-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
lost	lose	VBN	I-VP	O
and	and	CC	O	O
conventional	conventional	JJ	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
became	become	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
astrocytes	astrocyte	NNS	B-NP	O

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
initiator	initiator	NN	I-NP	O
methionine	methionine	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
polyadenylation	polyadenylation	NN	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
contained	contain	VBN	I-VP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
1	1	CD	I-NP	O
basepairs	basepair	NNS	I-NP	O
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
structural	structural	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
homologous	homologous	JJ	I-NP	O
loci	locus	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
KN1	BEGIN-KN1	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
homeobox	homeobox	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hexaploid	hexaploid	JJ	I-NP	O
wheat	wheat	NN	I-NP	O
genome	genome	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
clones	clone	NNS	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
of	of	IN	B-PP	O
young	young	JJ	B-NP	O
spikes	spike	NNS	I-NP	O
of	of	IN	B-PP	O
Japanese	Japanese	JJ	B-NP	O
common	common	JJ	I-NP	O
wheat	wheat	NN	I-NP	O
cultivar	cultivar	NN	I-NP	O
'Norin	'Norin	NN	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	B-NP	O

Treatment	Treatment	NN	B-NP	O
is	be	VBZ	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
antifungal	antifungal	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
nystatin	nystatin	NN	B-NP	O
,	,	,	O	O
amphotericin	amphotericin	NN	B-NP	O
B	B	NN	I-NP	O
and	and	CC	O	O
ketoconazole	ketoconazole	NN	B-NP	O

Controversy	Controversy	NNP	B-NP	O
exists	exist	VBZ	B-VP	O
regarding	regard	VBG	I-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
life	life	NN	I-NP	O
cycle	cycle	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
parasite	parasite	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
species	species	NN	I-NP	O
identity	identity	NN	I-NP	O
of	of	IN	B-PP	O
opossum	opossum	NN	B-NP	O
Sarcocystis	Sarcocystis	NNP	B-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
components	component	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ras	BEGIN-Ras-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Raf	BEGIN-Raf-INSIDE	NN	I-NP	B
/	/	SYM	O	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B
pathway	pathway	NN	I-NP	O
are	be	VBP	B-VP	O
constitutively	constitutively	RB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
lck	BEGIN-lck-INSIDE	NN	I-NP	B
-	-	HYPH	B-VP	O
transformed	transform	VBN	B-NP	O
immature	immature	JJ	I-NP	O
thymoblasts.	thymoblasts.	NN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
(	(	(	O	O
lck	BEGIN-lck-INSIDE	NN	B-NP	B
)	)	)	O	O
utilizes	utilize	VBZ	B-VP	O
Shc	BEGIN-Shc-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Grb1	BEGIN-BEGIN-Grb1-INSIDE	NN	I-NP	B
adaptors	adaptors-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
mediate	mediate	VB	I-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
(	(	(	O	O
ras	BEGIN-ras-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymoblast	thymoblast	NN	I-NP	O
lines	line	NNS	I-NP	O
by	by	IN	B-PP	O
promoting	promote	VBG	B-VP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Shc	BEGIN-BEGIN-Shc-INSIDE	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
and	and	CC	O	O
constitutive	constitutive	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
Shc	BEGIN-Shc-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Grb1	BEGIN-Grb1-INSIDE	NN	I-NP	B

Unfractionated	Unfractionated	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
(	(	(	O	O
UFH	UFH	NN	B-NP	O
)	)	)	O	O
given	give	VBN	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
x	x	SYM	B-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
bolus	bolus	NN	I-NP	O
+	+	SYM	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
x	x	SYM	B-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
h	h	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
infusion	infusion	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
improve	improve	VB	I-VP	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
reperfusion	reperfusion	NN	B-NP	O
or	or	CC	O	O
lower	low	JJR	B-ADJP	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
reocclusion	reocclusion	NN	B-NP	O

The	The	DT	B-NP	O
quantification	quantification	NN	I-NP	O
limit	limit	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
PHT	PHT	NN	B-NP	O
,	,	,	O	O
m	m	NN	B-NP	O
-	-	HYPH	B-NP	O
HPPH	HPPH	NN	I-NP	O
and	and	CC	I-NP	O
p	p	NN	I-NP	O
-	-	HYPH	O	O
HPPH	HPPH	NN	B-NP	O

Plasma	BEGIN-Plasma	NN	B-NP	B
hemopexin	hemopexin-INSIDE	NN	I-NP	I
homeostasis	homeostasis	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
phase	phase	NN	I-NP	O
response	response	NN	I-NP	O

Our	Our	PRP$	B-NP	O
aim	aim	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
whether	whether	IN	B-SBAR	O
,	,	,	O	O
during	during	IN	B-PP	O
PG	PG	NN	B-NP	O
-	-	HYPH	B-NP	O
DS	DS	NN	I-NP	O
administration	administration	NN	I-NP	O
,	,	,	O	O
serum	serum	NN	B-NP	O
lipase	BEGIN-lipase-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O
changes	change	VBZ	B-VP	O
simultaneously	simultaneously	RB	B-ADVP	O
with	with	IN	B-PP	O
serum	serum	NN	B-NP	O
amylase	BEGIN-amylase-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
,	,	,	O	O
if	if	IN	B-SBAR	O
so	so	RB	B-ADVP	O
,	,	,	O	O
what	what	WP	B-NP	O
the	the	DT	B-NP	O
reason	reason	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
detected	detect	VBN	I-NP	O
change	change	NN	I-NP	O

(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
The	The	DT	B-NP	O
chimeric	chimeric	JJ	I-NP	O
gene	gene	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
coding	coding	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
nontranslated	nontranslated	JJ	I-NP	O
leader	leader	NN	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TK	BEGIN-TK	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
portions	portion	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
alpha	BEGIN-alpha	NN	B-NP	B
gene	gene	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
extending	extend	VBG	B-VP	O
largely	largely	RB	B-ADJP	O
upstream	upstream	JJ	I-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
alpha	BEGIN-alpha	NN	B-NP	B
gene	gene	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
regulated	regulate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	B-ADJP	I
and	and	CC	O	I
alpha	alpha	SYM	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
TK	TK-INSIDE	NN	I-NP	I
chimeras	chimera	NNS	I-NP	O

Cytokines	Cytokine	NNS	B-NP	O
and	and	CC	O	O
steroid	steroid	NN	B-NP	O
hormones	hormone	NNS	I-NP	O
use	use	VBP	B-VP	O
different	different	JJ	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
unrelated	unrelated	JJ	B-ADJP	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
northern	northern	JJ	I-NP	O
and	and	CC	O	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
largest	large	JJS	B-ADJP	O
,	,	,	O	O
Q	Q	NNP	B-NP	O
fever	fever	NN	I-NP	O
epidemic	epidemic	JJ	I-NP	O
recorded	record	VBN	B-VP	O
in	in	IN	B-PP	O
Germany	Germany	NNP	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O

Genetic	Genetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
herpes	BEGIN-herpes	NN	B-NP	B
simplex	simplex	NN	I-NP	I
virus	virus	NN	I-NP	I
type	type	NN	I-NP	I
1	1	CD	I-NP	I
glycoprotein	glycoprotein	NN	I-NP	I
K	K-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
virus	virus	NN	I-NP	O
production	production	NN	I-NP	O
and	and	CC	O	O
egress	egress	NN	B-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
EWS	BEGIN-EWS	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
described	describe	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
fused	fuse	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulators	regulator	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
ATF1	BEGIN-ATF1-INSIDE	NN	B-NP	B
,	,	,	O	O
FLI	BEGIN-FLI	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
ERG	BEGIN-ERG-INSIDE	NN	B-NP	B
,	,	,	O	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
human	human	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O

We	We	PRP	B-NP	O
used	use	VBD	B-VP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
resolution	resolution	NN	I-NP	O
ultrasound	ultrasound	VBN	B-VP	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
postprandial	postprandial	JJ	B-NP	O
antral	antral	JJ	I-NP	O
excursion	excursion	NN	I-NP	O
characteristics	characteristic	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O

Multivariable	Multivariable	JJ	B-NP	O
logistic	logistic	JJ	I-NP	O
regression	regression	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
mean	mean	JJ	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
level	level	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
all	all	DT	B-NP	O
independent	independent	JJ	I-NP	O
predictors	predictor	NNS	I-NP	O
of	of	IN	B-PP	O
deep	deep	JJ	B-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O

Fine	Fine	JJ	B-NP	O
tangled	tangled	JJ	I-NP	O
pili	pili	NNS	I-NP	O
expressed	express	VBN	B-VP	O
by	by	IN	B-PP	O
Haemophilus	Haemophilus	NN	B-NP	O
ducreyi	ducreyi	NNS	I-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
pili	pili	NNS	B-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
RRM	RRM	NN	I-NP	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
and	and	CC	O	O
best	best	RB	B-ADVP	O
characterized	characterize	VBN	B-NP	O
RNA	RNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
motifs	motif	NNS	B-NP	O

Torsion	Torsion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
contralateral	contralateral	JJ	I-NP	O
testis	testis	NN	I-NP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
after	after	IN	B-PP	O
orchiopexy	orchiopexy	NN	B-NP	O

Serum	Serum	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
and	and	CC	I-NP	O
specific	BEGIN-specific	JJ	I-NP	B
immunoglobulin	immunoglobulin	NN	I-NP	I
E	E-INSIDE	NN	I-NP	I
(	(	(	O	O
IgE	BEGIN-IgE-INSIDE	NN	B-NP	B
)	)	)	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
radioimmunoassays	radioimmunoassay	NNS	B-NP	O
in	in	IN	B-PP	O
sixty	sixty	CD	B-NP	O
-	-	HYPH	I-NP	O
nine	nine	CD	I-NP	O
allergic	allergic	JJ	I-NP	O
subjects	subject	NNS	I-NP	O

The	The	DT	B-NP	O
largest	large	JJS	I-NP	O
one	one	NN	I-NP	O
probably	probably	RB	B-ADVP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
precursor	precursor	NN	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
PS1	BEGIN-PS1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
E.	E.	NNP	B-NP	O
coli	coli	NNS	I-NP	O

Transcriptional	Transcriptional	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
human	BEGIN-human	JJ	B-NP	B
TBP	TBP-INSIDE	NN	I-NP	I
functions	function	VBZ	B-VP	O
poorly	poorly	RB	B-ADVP	O
at	at	IN	B-PP	O
promoters	promoter	NNS	B-NP	O
recognized	recognize	VBN	B-VP	O
by	by	IN	B-PP	O
RNA	BEGIN-RNA	NN	B-NP	B
polymerases	polymeras	NNS	I-NP	I
I	I	CD	B-NP	I
and	and	CC	O	I
III	III-INSIDE	NN	B-NP	I
and	and	CC	B-PP	O
at	at	IN	B-PP	O
RNA	BEGIN-RNA	NN	B-NP	B
Pol	Pol	NN	I-NP	I
II	II	CD	I-NP	I
promoters	promoters-INSIDE	NN	I-NP	I
lacking	lack	VBG	B-VP	O
a	a	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
TATA	TATA	NN	I-NP	O
element	element	NN	I-NP	O

Elements	Element	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hAT	BEGIN-hAT	NN	I-NP	B
transposon	transposon	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
maize	BEGIN-maize	NN	I-NP	B
activator	activator-INSIDE	NN	I-NP	I
(	(	(	O	O
Ac	BEGIN-Ac-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
discovered	discover	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
eukaryotic	eukaryotic	JJ	B-NP	O
species	specie	NNS	I-NP	O

The	The	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
SRP1sc	BEGIN-BEGIN-SRP-INSIDE1sc-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
SRP1sp	BEGIN-BEGIN-SRP-INSIDE1sp-INSIDE	NN	I-NP	B
provides	provide	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
SRP	BEGIN-SRP-INSIDE	NN	B-NP	B
related	relate	VBN	B-VP	O
proteins	protein	NNS	B-NP	O
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
two	two	CD	B-NP	O
H1	BEGIN-H1	NN	I-NP	B
cDNAs	cDNAs-INSIDE	NN	I-NP	I
(	(	(	O	O
AP	BEGIN-AP-INSIDE	NN	B-NP	B
and	and	CC	O	O
ES	BEGIN-ES-INSIDE	NN	B-NP	B
)	)	)	O	O
that	that	WDT	B-NP	O
contain	contain	VBP	B-VP	O
this	this	DT	B-NP	O
ORF1	ORF1	NN	I-NP	O
and	and	CC	O	O
correspond	correspond	VBP	B-VP	O
to	to	TO	B-PP	O
incomplete	incomplete	JJ	B-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
unique	unique	JJ	I-NP	O
1	BEGIN-1	NN	I-NP	B
kb	kb	NN	I-NP	I
H1	H1	NN	I-NP	I
RNA	RNA-INSIDE	NN	I-NP	I

Urease	BEGIN-Urease-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
,	,	,	O	O
judged	judge	VBN	B-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
ammonia	ammonia	NN	B-NP	O
production	production	NN	I-NP	O
from	from	IN	B-PP	O
urea	urea	NN	B-NP	O
,	,	,	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
measured	measure	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
ng	ng	NN	I-NP	O
per	per	IN	B-PP	O
tube	tube	NN	B-NP	O
(	(	(	O	O
S	S	NN	B-NP	O
/	/	SYM	O	O
N	N	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
Jack	BEGIN-Jack	JJ	B-NP	B
bean	bean	JJ	I-NP	I
meal	meal	NN	I-NP	I
urease	urease-INSIDE	NN	I-NP	I

Radioimmunoassay	Radioimmunoassay	NN	B-NP	O
of	of	IN	B-PP	O
plasma	BEGIN-plasma	NN	B-NP	B
gonadotropins	gonadotropins-INSIDE	NN	I-NP	I
;	;	:	O	O
problems	problem	NNS	B-NP	O
of	of	IN	B-PP	O
specificity	specificity	NN	B-NP	O

Tissue	Tissue	NN	B-NP	O
expansion	expansion	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
successfully	successfully	RB	B-ADVP	O
to	to	TO	B-VP	O
prepare	prepare	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
for	for	IN	B-PP	O
closure	closure	NN	B-NP	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
difficult	difficult	JJ	I-NP	O
clubfoot	clubfoot	NN	I-NP	O
correction	correction	NN	I-NP	O

Legionella	BEGIN-Legionella	NN	B-NP	B
antibodies	antibodies-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
domestic	domestic	JJ	B-NP	O
animals	animal	NNS	I-NP	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
transforming	BEGIN-transforming	JJ	B-NP	B
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	B-NP	I
beta1	beta1-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
mediated	mediate	VBN	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cyclin	BEGIN-cyclin	NN	I-NP	B
A	A	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
we	we	PRP	B-NP	O
mapped	map	VBD	B-VP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ATF	BEGIN-BEGIN-ATF-INSIDE	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I
;	;	:	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
IFN	BEGIN-IFN	NN	B-NP	B
-	-	HYPH	B-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
treatment	treatment	NN	I-NP	O
,	,	,	O	O
functional	functional	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
by	by	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cyclin	BEGIN-cyclin	NN	I-NP	B
A	A	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
persisted	persist	VBD	B-VP	O
despite	despite	IN	B-PP	O
mutation	mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ATF	BEGIN-ATF-INSIDE	NN	I-NP	B
,	,	,	O	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	I-NP	I
Y	Y-INSIDE	NN	I-NP	I
,	,	,	O	O
or	or	CC	O	O
CDE	CDE	NN	B-NP	O
elements	element	NNS	I-NP	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
deterioration	deterioration	NN	I-NP	O
in	in	IN	B-PP	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
interleukin	BEGIN-interleukin	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
GCNF	BEGIN-GCNF-INSIDE	NN	B-NP	B
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
DRO	DRO	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Prm1	BEGIN-Prm1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
DRO	DRO	NN	I-NP	O
sequence	sequence	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Prm1	BEGIN-Prm1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
manner	manner	NN	I-NP	O

The	The	DT	B-NP	O
strategy	strategy	NN	I-NP	O
uses	use	VBZ	B-VP	O
RNA	BEGIN-RNA	NN	B-NP	B
ligase	ligase-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
add	add	VB	I-VP	O
DNA	DNA	NN	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
priming	priming	NN	I-NP	O
sites	site	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
for	for	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
reverse	reverse	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
and	and	CC	O	O
PCR	PCR	NN	B-NP	O
(	(	(	O	O
RNA	BEGIN-RNA	NN	B-NP	B
ligase	ligase-INSIDE	NN	I-NP	I
,	,	,	O	O
reverse	reverse	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
-	-	HYPH	B-NP	O
PCR	PCR	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
RL	RL	NN	B-NP	O
/	/	SYM	O	O
RT	RT	NN	B-NP	O
/	/	SYM	I-NP	O
PCR	PCR	NN	I-NP	O
)	)	)	O	O

From	From	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
squamous	squamous	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anal	anal	JJ	I-NP	O
canal	canal	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
mitomycin	mitomycin	NN	B-NP	O
C	C	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
fluorouracil	fluorouracil	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
FU	FU	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
/	/	SYM	B-NP	O
d	d	NN	I-NP	O
)	)	)	O	O
alone	alone	RB	B-ADVP	O
on	on	IN	B-PP	O
days	day	NNS	B-NP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
radiation	radiation	NN	B-NP	O
therapy	therapy	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
cGy	cGy	NN	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
days	day	NNS	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
choline	choline	NN	B-NP	O
magnesium	magnesium	NN	I-NP	O
trisalicylate	trisalicylate	NN	I-NP	O
on	on	IN	B-PP	O
prostacyclin	prostacyclin	NN	B-NP	O
production	production	NN	I-NP	O
by	by	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
vascular	vascular	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O

The	The	DT	B-NP	O
magnitude	magnitude	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
parameters	parameter	NNS	I-NP	O
increased	increase	VBD	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
exponential	exponential	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
sperm	sperm	NN	I-NP	O
number	number	NN	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
per	per	IN	B-PP	O
ejaculate	ejaculate	NN	B-NP	O

A	A	DT	B-NP	O
sharp	sharp	JJ	I-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
random	random	JJ	I-NP	O
chaotic	chaotic	JJ	I-NP	O
state	state	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
correlated	correlate	VBN	I-NP	O
turbulent	turbulent	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
finite	finite	JJ	B-NP	O
coherence	coherence	NN	I-NP	O
time	time	NN	I-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
Rayleigh	Rayleigh	NNP	I-NP	O
number	number	NN	I-NP	O
becomes	become	VBZ	B-VP	O
larger	large	JJR	B-ADJP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
value	value	NN	I-NP	O
Ra	Ra	NN	I-NP	O
(	(	(	O	O
c	c	NN	B-NP	O
)	)	)	O	O
approximately	approximately	RB	B-ADJP	O
equal	equal	JJ	I-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
HMEC	HMEC	NN	B-NP	O
stably	stably	RB	B-VP	O
transfected	transfecte	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ER	BEGIN-ER	NN	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
deletion	deletion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	I-VP	O
domain	domain	NN	B-NP	O
,	,	,	I-NP	O
E	E	NN	I-NP	O
and	and	CC	I-NP	O
HT	HT	NN	I-NP	O
had	have	VBD	B-VP	O
different	different	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
EBBP	BEGIN-BEGIN-EBBP-INSIDE	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
;	;	:	O	O
EBBP	BEGIN-EBBP-INSIDE	NN	B-NP	B
regulation	regulation	NN	I-NP	O
by	by	IN	B-PP	O
E	E	NN	B-NP	O
was	be	VBD	B-VP	O
dramatically	dramatically	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
HT	HT	NN	B-NP	O
were	be	VBD	B-VP	O
augmented	augment	VBN	I-VP	O

1	1	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
ingestion	ingestion	NN	B-NP	O
of	of	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
both	both	CC	O	O
TX	TX	NN	B-NP	O
and	and	CC	I-NP	O
PGI1	PGI1	NN	I-NP	O
levels	level	NNS	I-NP	O
also	also	RB	B-ADVP	O
significantly	significantly	RB	B-VP	O
decreased	decrease	VBN	I-VP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

When	When	WRB	B-ADVP	O
transfected	transfecte	VBN	B-VP	O
into	into	IN	B-PP	O
HepG1	HepG1	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
lack	lack	VBP	B-VP	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	B-NP	I
EBP	EBP	NN	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
ob	ob	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
only	only	RB	B-ADJP	O
weakly	weakly	RB	I-ADJP	O
active	active	JJ	I-ADJP	O

Desarrollo	Desarrollo	NNP	B-NP	O
de	de	IN	I-NP	O
un	un	NNP	I-NP	O
modelo	modelo	NN	I-NP	O
matematico	matematico	NN	I-NP	O
general	general	JJ	I-NP	O
para	para	JJ	I-NP	O
los	lo	NNS	I-NP	O
procesos	proceso	NNS	I-NP	O
fermentativos	fermentativo	NNS	I-NP	O
,	,	,	O	O
Cinetica	Cinetica	NNP	B-NP	O
de	de	IN	I-NP	O
la	la	NN	I-NP	O
degradacion	degradacion	NN	I-NP	O
anaerobia	anaerobia	NN	I-NP	O
,	,	,	O	O
Ph.D	Ph.D	NN	B-NP	O

NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	I-NP	I
kappaB	kappaB-INSIDE	NN	I-NP	I
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
binding	binding	NN	I-NP	O
and	and	CC	I-NP	O
ICAM	BEGIN-ICAM	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
were	be	VBD	B-VP	O
enhanced	enhance	VBN	I-VP	O
by	by	IN	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1beta	1beta-INSIDE	NN	I-NP	I
and	and	CC	O	O
these	these	DT	B-NP	O
effects	effect	NNS	I-NP	O
were	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
tyrphostin	tyrphostin	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	I-PP	O
by	by	IN	B-PP	O
PD	PD	NN	B-NP	O
1	1	CD	I-NP	O
or	or	CC	O	O
SB	SB	NN	B-NP	O
1	1	CD	I-NP	O

In	In	IN	B-PP	O
murine	murine	JJ	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
FPGS	BEGIN-FPGS-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
controlled	control	VBN	I-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
promoters	promoter	NNS	I-NP	O
that	that	IN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
,	,	,	O	O
vary	vary	VBP	B-VP	O
substantially	substantially	RB	B-ADVP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
efficiency	efficiency	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
assay	assay	NN	I-NP	O

Quantitative	Quantitative	JJ	B-NP	O
measurement	measurement	NN	I-NP	O
of	of	IN	B-PP	O
antigamma	BEGIN-antigamma	NN	B-NP	B
globulin	globulin	NN	I-NP	I
factors	factors-INSIDE	NN	I-NP	I
(	(	(	O	O
rheumatoid	BEGIN-rheumatoid	JJ	B-NP	B
factors	factors-INSIDE	NN	I-NP	I
)	)	)	O	O
using	use	VBG	B-VP	O
laser	laser	NN	B-NP	O
-	-	HYPH	I-NP	O
nephelometry	nephelometry	NN	I-NP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
latex	latex	JJ	I-NP	O
agglutination	agglutination	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Waaler	Waaler	NNP	I-NP	O
-	-	HYPH	I-NP	O
Rose	Rose	NNP	I-NP	O
test	test	NN	I-NP	O

Disruption	Disruption	NN	B-NP	O
of	of	IN	B-PP	O
INP1	BEGIN-INP1-INSIDE	NN	B-NP	B
,	,	,	O	O
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
the	the	DT	B-NP	O
related	relate	VBN	I-NP	O
INP1	BEGIN-INP1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
INP1	BEGIN-BEGIN-INP1-INSIDE	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
alpha	BEGIN-alpha	NN	B-NP	B
-	-	HYPH	B-NP	I
factor	factor-INSIDE	NN	I-NP	I
maturation	maturation	NN	I-NP	O
defects	defect	NNS	I-NP	O
and	and	CC	O	O
exacerbated	exacerbated	JJ	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
-	-	HYPH	B-NP	I
factor	factor-INSIDE	NN	I-NP	I
maturation	maturation	NN	I-NP	O
defects	defect	NNS	I-NP	O
when	when	WRB	B-ADVP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
chc1	BEGIN-chc1	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
complete	complete	JJ	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
odontoglossum	odontoglossum	NN	B-NP	O
ringspot	ringspot	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
Cy	Cy	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
strain	strain	NN	I-NP	O
)	)	)	I-NP	O
genomic	genomic	JJ	I-NP	O
RNA	RNA	NN	I-NP	O

Paradoxically	Paradoxically	RB	B-ADVP	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
soluble	BEGIN-soluble	JJ	B-NP	B
A	A	NN	I-NP	I
beta	beta-INSIDE	NN	I-NP	I
secreted	secrete	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O

When	When	WRB	B-ADVP	O
translated	translate	VBN	B-VP	O
in	in	IN	B-PP	O
-	-	HYPH	B-NP	O
frame	frame	NN	I-NP	O
with	with	IN	B-PP	O
PKC	BEGIN-PKC	NN	B-NP	B
zeta	zeta-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
stop	stop	NN	I-NP	O
codon	codon	NN	I-NP	O
is	be	VBZ	B-VP	O
located	located	JJ	B-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
divergence	divergence	NN	I-NP	O
point	point	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
intervening	intervening	NN	I-NP	O
sequence	sequence	NN	I-NP	O
lacks	lack	VBZ	B-VP	O
an	an	DT	B-NP	O
expected	expect	VBN	I-NP	O
initiating	initiate	VBG	I-NP	O
methionine.	methionine.	NN	I-NP	O
psi	BEGIN-psi	NN	I-NP	B
PKC	BEGIN-PKC	NN	I-NP	B
zeta	zeta-INSIDE-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
non	non	AFX	B-ADJP	O
-	-	HYPH	O	O
functional	functional	JJ	B-ADJP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
since	since	IN	B-PP	O
Western	Western	JJ	B-NP	O
blotting	blotting	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
antibody	antibody	NN	I-NP	O
directed	direct	VBN	B-VP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	O	O
terminus	terminus	NN	B-NP	O
of	of	IN	B-PP	O
PKC	BEGIN-PKC	NN	B-NP	B
zeta	zeta-INSIDE	NN	I-NP	I
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
reveal	reveal	VB	I-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
smaller	small	JJR	B-ADJP	O
than	than	IN	B-PP	O
PKC	BEGIN-PKC	NN	B-NP	B
zeta	zeta-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
synthetic	synthetic	JJ	B-NP	O
psi	BEGIN-BEGIN-psi	JJ	I-NP	B
PKC	BEGIN-PKC	NN	I-NP	B
zeta	zeta-INSIDE-INSIDE	NN	I-NP	I
RNA	RNA-INSIDE	NN	I-NP	I
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
support	support	VB	I-VP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
translation	translation	NN	I-NP	O
system	system	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

Comparative	Comparative	JJ	B-NP	O
ultrafiltration	ultrafiltration	NN	I-NP	O
(	(	(	O	O
UF	UF	NN	B-NP	O
)	)	)	O	O
studies	study	NNS	B-NP	O
with	with	IN	B-PP	O
BiGG	BiGG	NN	B-NP	O
and	and	CC	O	O
standard	standard	JJ	B-NP	O
lactate	lactate	NN	I-NP	O
(	(	(	O	O
La	La	NN	B-NP	O
)	)	)	O	O
solutions	solution	NNS	B-NP	O
in	in	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
net	net	JJ	B-NP	O
UF	UF	NN	I-NP	O
with	with	IN	B-PP	O
La	La	NN	B-NP	O
solution	solution	NN	I-NP	O
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O

The	The	DT	B-NP	O
B.	BEGIN-B.	NNP	I-NP	B
aphidicola	aphidicola	NN	I-NP	I
argS	argS	NN	I-NP	I
-	-	HYPH	B-NP	I
rrn	rrn	NN	I-NP	I
DNA	DNA	NN	I-NP	I
fragments	fragments-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
endosymbionts	endosymbiont	NNS	B-NP	O
from	from	IN	B-PP	O
seven	seven	CD	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
aphids	aphid	NNS	B-NP	O
had	have	VBD	B-VP	O
promoter	promoter	NN	B-NP	O
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
E.	E.	NNP	B-NP	O
coli	coli	NNS	I-NP	O
which	which	WDT	B-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
that	that	DT	O	O
observed	observe	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
comparable	comparable	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
of	of	IN	B-PP	O
E.	BEGIN-E.	FW	B-NP	B
coli	coli	FW	I-NP	I
rrnB	rrnB-INSIDE	NN	I-NP	I

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
These	These	DT	B-NP	O
principally	principally	RB	I-NP	O
structural	structural	JJ	I-NP	O
studies	study	NNS	I-NP	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
thrombus	thrombus	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
self	self	NN	I-NP	O
-	-	HYPH	O	O
sustaining	sustain	VBG	B-VP	O
entity	entity	NN	B-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
significance	significance	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathophysiologic	pathophysiologic	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
aneurysms	aneurysm	NNS	I-NP	O

The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
report	report	VBP	B-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
exeresis	exeresis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pyelonephrictic	pyelonephrictic	JJ	I-NP	O
left	left	JJ	I-NP	O
small	small	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
with	with	IN	B-PP	O
laparoscopic	laparoscopic	JJ	B-NP	O
surgery	surgery	NN	I-NP	O

AMPK	BEGIN-AMPK-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
heterotrimer	heterotrimer	NN	I-NP	O
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
subunit	subunit	NN	I-NP	O
(	(	(	O	O
alpha	alpha	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
regulatory	regulatory	JJ	I-NP	O
subunits	subunit	NNS	I-NP	O
(	(	(	O	O
beta	beta	NN	B-NP	O
and	and	CC	O	O
gamma	gamma	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
genes	gene	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
these	these	DT	B-NP	O
carotenoids	carotenoid	NNS	I-NP	O
in	in	IN	B-PP	O
E.	E.	NNP	B-NP	O
herbicola	herbicola	NN	I-NP	O
Eho1	Eho1	NN	I-NP	O
are	be	VBP	B-VP	O
clustered	cluster	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O

Genetic	Genetic	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
diseases	disease	NNS	I-NP	O

Whereas	Whereas	IN	B-PP	O
mutant	BEGIN-mutant	JJ	B-NP	B
1C1	1C1-INSIDE	NN	I-NP	I
specified	specify	VBD	B-VP	O
a	a	DT	B-NP	O
wild	BEGIN-wild	JJ	I-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
-	-	HYPH	I-NP	I
size	size	NN	I-NP	I
Pol	Pol	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
we	we	PRP	B-NP	O
detected	detect	VBD	B-VP	O
no	no	DT	B-NP	O
full	BEGIN-full	JJ	I-NP	B
-	-	HYPH	I-NP	I
length	length	NN	I-NP	I
Pol	Pol	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
1E1	1E1	NN	B-NP	O
-	-	HYPH	O	O
infected	infect	VBN	B-NP	O
cell	cell	NN	I-NP	O
extracts	extract	NNS	I-NP	O

Incidence	Incidence	NN	B-NP	O
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	O
-	-	HYPH	B-NP	O
thalassemia	thalassemia	NN	I-NP	O
carriers	carrier	NNS	I-NP	O
and	and	CC	O	O
those	those	DT	B-NP	O
deficient	deficient	JJ	B-ADJP	O
in	in	IN	B-PP	O
erythrocyte	BEGIN-erythrocyte	NN	B-NP	B
glucose	glucose	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
phosphate	phosphate	NN	I-NP	I
dehydrogenase	dehydrogenase-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
greater	great	JJR	I-NP	O
Buenos	Buenos	NNP	I-NP	O
Aires	Aires	NNP	I-NP	O
area	area	NN	I-NP	O

Other	Other	JJ	B-NP	O
toxicities	toxicity	NNS	I-NP	O
attributed	attribute	VBN	B-VP	O
to	to	TO	B-PP	O
CPT	CPT	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
included	include	VBD	B-VP	O
dehydration	dehydration	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
asthenia	asthenia	NN	B-NP	O

JCAHO	JCAHO	NN	B-NP	O
moves	move	VBZ	B-VP	O
to	to	TO	I-VP	O
rewrite	rewrite	VB	I-VP	O
many	many	JJ	B-NP	O
rules	rule	NNS	I-NP	O
to	to	TO	B-PP	O
lessen	lessen	JJR	B-NP	O
hospitals	hospital	NNS	I-NP	O
'	'	POS	B-NP	O
regulatory	regulatory	JJ	I-NP	O
burden	burden	NN	I-NP	O

A	A	DT	B-NP	O
phylogenetic	phylogenetic	JJ	I-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
species	specie	NNS	I-NP	O
showed	show	VBD	B-VP	O
minor	minor	JJ	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
apoB	BEGIN-BEGIN-apoB	NN	I-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
apoB	BEGIN-apoB	NN	I-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
1	1	CD	B-NP	O
species	species	NN	I-NP	O
was	be	VBD	B-VP	O
robustly	robustly	RB	I-VP	O
edited	edit	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
was	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	BEGIN-endogenous	JJ	I-NP	B
PDGFbeta	PDGFbeta	NN	I-NP	I
r	r	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

These	These	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
directed	direct	VBD	B-VP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
proteins	protein	NNS	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
virus	BEGIN-virus	NN	I-NP	B
trans	trans	AFX	O	I
-	-	HYPH	O	I
activator	activator	NN	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
EIAV	BEGIN-EIAV	NN	B-NP	B
Tat	Tat-INSIDE	NN	I-NP	I
)	)	)	O	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
ORF	ORF	NN	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
function	function	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
ORF	ORF	NN	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
virus	virus	NN	I-NP	O
envelope	BEGIN-envelope	NN	I-NP	B
glycoprotein	glycoprotein-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
SB1	SB1	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
TNF	BEGIN-TNF-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
or	or	CC	I-NP	O
ceramide	ceramide	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
strongly	strongly	RB	B-ADVP	O
argue	argue	VBP	B-VP	O
against	against	IN	B-PP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
p1	BEGIN-p1	NN	B-NP	B
MAPK	MAPK-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
TNF	BEGIN-TNF-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
-	-	HYPH	I-NP	O
or	or	CC	I-NP	O
ceramide	ceramide	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
apoptosis	apoptosis	NN	I-NP	O

Seven	Seven	CD	B-NP	O
Zebu	Zebu	NN	I-NP	O
cattle	cattle	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	I-VP	O
challenge	challenge	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
cytoskeletal	cytoskeletal	JJ	B-NP	O
rearrangements	rearrangement	NNS	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
set	set	VBD	B-VP	O
up	up	RP	B-PRT	O
a	a	DT	B-NP	O
conjugate	conjugate	NN	I-NP	O
formation	formation	NN	I-NP	O
assay	assay	NN	I-NP	O
using	use	VBG	B-VP	O
Jurkat	Jurkat	NN	B-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
as	as	IN	B-PP	O
effectors	effector	NNS	B-NP	O
and	and	CC	I-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	O	O
sized	size	VBN	B-VP	O
latex	latex	JJ	B-NP	O
beads	bead	NNS	I-NP	O
coated	coat	VBN	B-VP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
antibodies	antibody	NNS	I-NP	O
as	as	IN	B-PP	O
artificial	artificial	JJ	B-NP	O
APCs	APC	NNS	I-NP	O

YACs	YAC	NNS	B-NP	O
,	,	,	O	O
BACs	BAC	NNS	B-NP	O
,	,	,	O	O
cosmids	cosmid	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
STSs	STS	NNS	B-NP	O
are	be	VBP	B-VP	O
defined	define	VBN	I-VP	O
to	to	TO	I-VP	O
aid	aid	VB	I-VP	O
in	in	IN	B-PP	O
further	further	JJ	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O

The	The	DT	B-NP	O
average	average	JJ	I-NP	O
coefficient	coefficient	NN	I-NP	O
of	of	IN	B-PP	O
variation	variation	NN	B-NP	O
between	between	IN	B-PP	O
assays	assay	NNS	B-NP	O
for	for	IN	B-PP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
mass	mass	NN	I-NP	O
spectrometry	spectrometry	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
radioimmunoassay	radioimmunoassay	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
average	average	JJ	I-NP	O
coefficient	coefficient	NN	I-NP	O
of	of	IN	B-PP	O
variation	variation	NN	B-NP	O
within	within	IN	B-PP	O
assays	assay	NNS	B-NP	O
for	for	IN	B-PP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
mass	mass	NN	I-NP	O
spectrometry	spectrometry	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
radioimmunoassay	radioimmunoassay	NN	B-NP	O
1	1	CD	I-NP	O

This	This	DT	B-NP	O
chimera	chimera	NN	I-NP	O
transduced	transduce	VBN	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
signals	signal	NNS	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
and	and	CC	O	O
dramatically	dramatically	RB	B-VP	O
enhanced	enhance	VBD	I-VP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
responses	response	NNS	I-NP	O
(	(	(	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
immunoglobulin	BEGIN-immunoglobulin	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
production	production	NN	I-NP	O
)	)	)	O	O
upon	upon	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
TCR	BEGIN-TCR-INSIDE	NN	I-NP	B
stimulation	stimulation	NN	I-NP	O
or	or	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
antigen	antigen	NN	I-NP	O
challenge	challenge	NN	I-NP	O

Soggy	BEGIN-Soggy-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
spermatocyte	spermatocyte	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
lies	lie	VBZ	B-VP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
and	and	CC	O	O
antipodal	antipodal	JJ	B-ADJP	O
to	to	TO	B-PP	O
TEAD	BEGIN-TEAD	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
expressed	express	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	O
development	development	NN	I-NP	O

We	We	PRP	B-NP	O
previously	previously	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
AKT1	BEGIN-AKT1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
protein	BEGIN-protein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
B	B	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I
,	,	,	O	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
factors	factor	NNS	I-NP	O
via	via	IN	B-PP	O
Ras	BEGIN-Ras-INSIDE	NN	B-NP	B
and	and	CC	O	O
PI	BEGIN-PI	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O

This	This	DT	B-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
PKC	BEGIN-PKC-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
which	which	WDT	B-NP	O
functions	function	VBZ	B-VP	O
independently	independently	RB	B-ADVP	O
from	from	IN	B-PP	O
Lck	BEGIN-Lck-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
MAP	BEGIN-MAP	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
transfection	transfection	NN	B-NP	O
of	of	IN	B-PP	O
Grb1	BEGIN-Grb1	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
induces	induce	VBZ	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
HTC	HTC	NN	B-NP	O
-	-	HYPH	B-NP	O
IR	IR	NN	I-NP	O
and	and	CC	I-NP	O
COS	COS	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O

Small	BEGIN-Small	JJ	B-NP	B
t	t-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
dephosphorylation	dephosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
cAMP	BEGIN-cAMP	NN	B-NP	B
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
PKA	BEGIN-PKA-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	O	O
phosphorylated	phosphorylate	VBN	B-NP	O
CREB	BEGIN-CREB-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
rat	rat	NN	B-NP	O
liver	liver	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O

Physical	Physical	JJ	B-NP	O
map	map	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genome	genome	NN	I-NP	O
of	of	IN	B-PP	O
sonchus	sonchus	RB	B-NP	O
yellow	yellow	JJ	I-NP	O
net	net	JJ	I-NP	O
virus	virus	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
plant	plant	NN	I-NP	O
rhabdovirus	rhabdovirus	NN	I-NP	O
with	with	IN	B-PP	O
six	six	CD	B-NP	O
genes	gene	NNS	I-NP	O
and	and	CC	O	O
conserved	conserve	VBN	B-NP	O
gene	gene	NN	I-NP	O
junction	junction	NN	I-NP	O
sequences	sequence	NNS	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
untested	untested	JJ	I-NP	O
argument	argument	NN	I-NP	O
that	that	IN	B-NP	O
conventional	conventional	JJ	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
adrenoceptor	adrenoceptor-INSIDE	NN	I-NP	I
antagonists	antagonist	NNS	I-NP	O
possess	possess	VBP	B-VP	O
unwanted	unwanted	JJ	B-NP	O
metabolic	metabolic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
counter	counter	VB	I-VP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
potential	potential	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
benefits	benefit	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
easy	easy	JJ	B-ADJP	O
to	to	TO	B-VP	O
establish	establish	VB	I-VP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
thoracic	thoracic	JJ	B-NP	O
MFH	MFH	NN	I-NP	O

An	An	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
intron	intron	NN	I-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
transmembrane	transmembrane	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ORF	ORF	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O

To	To	TO	B-VP	O
assay	assay	VB	I-VP	O
for	for	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
potentially	potentially	RB	I-VP	O
regulate	regulate	VB	I-VP	O
Xenopus	BEGIN-Xenopus	JJ	B-NP	B
proenkephalin	proenkephalin-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
transfected	transfecte	VBD	B-VP	O
constructs	construct	NNS	B-NP	O
that	that	WDT	B-NP	O
contained	contain	VBD	B-VP	O
upstream	upstream	JJ	B-NP	O
genomic	genomic	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CAT	BEGIN-CAT	NN	I-NP	B
reporter	reporter	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
into	into	IN	B-PP	O
various	various	JJ	B-NP	O
eukaryotic	eukaryotic	JJ	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
conceivable	conceivable	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
elevated	elevated	JJ	B-NP	O
insulin	BEGIN-insulin-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
may	may	MD	B-VP	O
cause	cause	VB	I-VP	O
hypertriglyceridaemia	hypertriglyceridaemia	NN	B-NP	O
and	and	CC	O	O
possibly	possibly	RB	B-ADVP	O
other	other	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
of	of	IN	B-PP	O
lipid	lipid	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
sources	source	NNS	I-NP	O
of	of	IN	B-PP	O
commercial	commercial	JJ	B-NP	O
rations	ration	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
humoral	humoral	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
broilers	broiler	NNS	B-NP	O
to	to	TO	B-VP	O
Newcastle	Newcastle	VB	I-VP	O
disease	disease	NN	B-NP	O
vaccination	vaccination	NN	I-NP	O

To	To	TO	B-VP	O
quantify	quantify	VB	I-VP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
coupling	couple	VBG	I-NP	O
patterns	pattern	NNS	I-NP	O
,	,	,	O	O
fresh	fresh	JJ	B-NP	O
cadaveric	cadaveric	JJ	I-NP	O
human	human	JJ	I-NP	O
lumbar	lumbar	NN	I-NP	O
spine	spine	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
(	(	(	O	O
L1	L1	NN	B-NP	O
-	-	HYPH	O	O
S1	S1	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O

Deletion	Deletion	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
were	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
,	,	,	O	O
removing	remove	VBG	B-VP	O
residues	residue	NNS	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
missense	missense	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
dileucine	dileucine	NN	I-NP	O
motif	motif	NN	I-NP	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
measured	measure	VBN	I-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	I-NP	I
galactosidase	galactosidase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pWP	pWP	NN	I-NP	O
-	-	HYPH	B-NP	O
transfected	transfecte	VBN	I-NP	O
cells	cell	NNS	I-NP	O
was	be	VBD	B-VP	O
normalized	normalize	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
pCH1	pCH1	NN	I-NP	O
-	-	HYPH	B-NP	O
transfected	transfecte	VBN	I-NP	O
cells	cell	NNS	I-NP	O
(	(	(	O	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
control	control	NN	I-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
SV1	BEGIN-SV1	NN	I-NP	B
early	early	JJ	I-NP	I
region	region	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
functions	function	VBZ	B-VP	O
constitutively	constitutively	RB	B-ADVP	O
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PLP	BEGIN-PLP	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
information	information	NN	I-NP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
C1	C1	NN	I-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
manner	manner	NN	I-NP	O

Indigenous	Indigenous	JJ	B-NP	O
microbial	microbial	JJ	I-NP	O
flora	flora	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
intestine	intestine	NN	I-NP	O
in	in	IN	B-PP	O
tadpoles	tadpole	NNS	B-NP	O

1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
leukaemia	leukaemia	NN	I-NP	O
,	,	,	O	O
HLA	BEGIN-HLA-INSIDE	NN	B-NP	B
antibodies	antibody	NNS	I-NP	O
and	and	CC	O	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-VP	O
random	random	VB	I-VP	O
donor	donor	NN	B-NP	O
platelet	platelet	NN	I-NP	O
transfusions	transfusion	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	I-NP	O
i.v.	i.v.	JJ	I-NP	O
immunoglobulin	BEGIN-immunoglobulin-INSIDE	NN	I-NP	B

Plasma	BEGIN-Plasma	NN	B-NP	B
renin	renin-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
end	end	NN	B-NP	O
-	-	HYPH	I-NP	O
stage	stage	NN	I-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O

Computer	Computer	NN	B-NP	O
system	system	NN	I-NP	O
trains	train	VBZ	B-VP	O
employees	employee	NNS	B-NP	O
to	to	TO	B-VP	O
meet	meet	VB	I-VP	O
JCAHO	JCAHO	NN	B-NP	O
safety	safety	NN	I-NP	O
ED	ED	NN	I-NP	O
requirements	requirement	NNS	I-NP	O

The	The	DT	B-NP	O
temporal	temporal	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
organ	organ	NN	B-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
lung	lung	NN	B-NP	O
,	,	,	O	O
clotting	clot	VBG	B-VP	O
system	system	NN	B-NP	O
,	,	,	O	O
kidney	kidney	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
liver	liver	NN	B-NP	O

All	All	DT	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
prominent	prominent	JJ	I-NP	O
CpG	CpG	NN	I-NP	O
island	island	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
acting	act	VBG	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
extended	extend	VBN	I-NP	O
,	,	,	I-NP	O
enhancer	enhancer	NN	I-NP	O
-	-	HYPH	I-NP	O
independent	independent	JJ	I-NP	O
promoter	promoter	NN	I-NP	O

One	One	CD	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
check	check	NN	I-NP	O
-	-	HYPH	B-NP	O
point	point	NN	I-NP	O
control	control	NN	I-NP	O
after	after	IN	B-PP	O
DNA	DNA	NN	B-NP	O
damage	damage	NN	I-NP	O

1	1	CD	B-NP	O

IGF	BEGIN-IGF	NN	B-NP	B
-	-	HYPH	I-NP	I
I	I-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CSF	CSF	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O
with	with	IN	B-PP	O
autism	autism	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
females	female	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
males	male	NNS	I-NP	O
;	;	:	O	O
mean	mean	JJ	B-NP	O
age	age	NN	I-NP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
SD	SD	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
sensitive	sensitive	JJ	I-NP	O
radioimmunoassay	radioimmunoassay	NN	I-NP	O
method	method	NN	I-NP	O
and	and	CC	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
levels	level	NNS	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
control	control	NN	I-NP	O
participants	participant	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
females	female	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
males	male	NNS	I-NP	O
;	;	:	O	O
mean	mean	JJ	B-NP	O
age	age	NN	I-NP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
XPR1	BEGIN-XPR1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
Yarrowia	Yarrowia	NNP	B-NP	O
lipolytica	lipolytica	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
an	an	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
alkaline	BEGIN-alkaline	NN	I-NP	B
extracellular	extracellular	JJ	I-NP	I
protease	protease-INSIDE	NN	I-NP	I

Two	Two	CD	B-NP	O
closely	closely	RB	I-NP	O
related	related	JJ	I-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
transcripts	transcript	NNS	B-NP	O
,	,	,	O	O
Sagrp1	BEGIN-Sagrp1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Sagrp1	BEGIN-Sagrp1-INSIDE	NN	I-NP	B
,	,	,	O	O
controlled	control	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
circadian	circadian	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
isolated	isolate	VBN	I-VP	O

In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
autografted	autografte	VBN	B-VP	O
in	in	IN	B-PP	O
CR1	CR1	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
transplant	transplant	NN	I-NP	O
-	-	HYPH	B-VP	O
related	relate	VBN	B-NP	O
mortality	mortality	NN	I-NP	O
(	(	(	O	O
TRM	TRM	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
relapse	relapse	NN	I-NP	O
incidence	incidence	NN	I-NP	O
(	(	(	O	O
RI	RI	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
leukaemia	leukaemia	NN	I-NP	O
-	-	HYPH	O	O
free	free	JJ	B-NP	O
survival	survival	NN	I-NP	O
(	(	(	O	O
LFS	LFS	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
survival	survival	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
H1	BEGIN-H1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
IGF1	BEGIN-IGF1-INSIDE	NN	I-NP	B
lie	lie	VBP	B-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
larger	large	JJR	I-NP	O
imprinted	imprint	VBN	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
H1	BEGIN-H1-INSIDE	NN	B-NP	B
epimutation	epimutation	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
a	a	DT	B-NP	O
persistent	persistent	JJ	I-NP	O
question	question	NN	I-NP	O

Antibiotics	Antibiotic	NNS	B-NP	O
and	and	CC	I-NP	O
CDCA	CDCA	NN	I-NP	O
-	-	HYPH	O	O
mediation	mediation	NN	B-NP	O
are	be	VBP	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O

The	The	DT	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
and	and	CC	I-NP	O
pathogenetic	pathogenetic	JJ	I-NP	O
expediency	expediency	NN	I-NP	O
of	of	IN	B-PP	O
correcting	correct	VBG	B-VP	O
disorders	disorder	NNS	B-NP	O
of	of	IN	B-PP	O
lipid	lipid	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
with	with	IN	B-PP	O
enterosorbents	enterosorbent	NNS	B-NP	O
is	be	VBZ	B-VP	O
substantiated	substantiate	VBN	I-VP	O

Adaptive	Adaptive	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
immersion	immersion	NN	I-NP	O
exposure	exposure	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
body	body	NN	I-NP	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	O
cDNA	cDNA	NN	I-NP	O
was	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
and	and	CC	O	O
sequenced	sequence	VBN	B-VP	O
;	;	:	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
protein	protein	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O
four	four	CD	B-NP	O
peptides	peptide	NNS	I-NP	O
previously	previously	RB	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
micro	micro	AFX	B-NP	O
-	-	HYPH	I-NP	O
sequencing	sequence	VBG	B-VP	O
purified	purify	VBN	B-NP	O
protein	protein	NN	I-NP	O

Octamer	Octamer	NN	B-NP	O
recognition	recognition	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
POU	BEGIN-POU-INSIDE	NN	I-NP	B
domain	domain	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
structural	structural	JJ	I-NP	O
motif	motif	NN	I-NP	O
which	which	WDT	B-NP	O
-	-	HYPH	B-ADVP	O
-	-	HYPH	B-ADVP	O
like	like	IN	B-PP	O
the	the	DT	B-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
and	and	CC	O	O
leucine	leucine	NN	B-NP	O
zipper	zipper	NN	I-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
defines	define	VBZ	B-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
related	related	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
The	The	DT	B-NP	O
Association	Association	NNP	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Study	Study	NNP	I-NP	O
of	of	IN	B-PP	O
Animal	Animal	NNP	B-NP	O
Behaviour	Behaviour	NNP	I-NP	O

Dipetalonema	Dipetalonema	NN	B-NP	O
(	(	(	O	O
Acanthocheilonema	Acanthocheilonema	NN	B-NP	O
)	)	)	O	O
didelphis	didelphis	NN	B-NP	O
sp.	sp.	NN	I-NP	O
n	n	NN	I-NP	O

Forty	Forty	CD	B-NP	O
-	-	HYPH	I-NP	O
five	five	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
-	-	HYPH	I-NP	O
onset	onset	NN	I-NP	O
hyperthyroidism	hyperthyroidism	NN	I-NP	O
(	(	(	O	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
sex	sex	NN	B-NP	O
and	and	CC	I-NP	O
menopause	menopause	NN	I-NP	O
stratified	stratify	VBN	B-VP	O
and	and	CC	O	O
randomly	randomly	RB	B-VP	O
allocated	allocate	VBN	I-VP	O
to	to	TO	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
carbimazole	carbimazole	NN	B-NP	O
(	(	(	O	O
Neotomizol	Neotomizol	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
carbimazole	carbimazole	NN	B-NP	O
plus	plus	CC	O	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
CT	CT	NN	I-NP	O
(	(	(	O	O
Calsynar	Calsynar	JJ	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
/	/	SYM	B-NP	O
week	week	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
carbimazole	carbimazole	NN	B-NP	O
plus	plus	CC	O	O
high	high	JJ	B-NP	O
dose	dose	NN	I-NP	O
CT	CT	NN	I-NP	O
(	(	(	O	O
Calsynar	Calsynar	JJ	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
/	/	SYM	B-NP	O
month	month	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
promyelocytic	BEGIN-promyelocytic	JJ	I-NP	B
leukemia	leukemia	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
and	and	CC	O	O
inhibits	inhibit	VBZ	B-VP	O
its	its	PRP$	B-NP	O
transactivation	transactivation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
epidermal	BEGIN-epidermal	JJ	I-NP	B
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O

CTP	CTP	NN	B-NP	O
,	,	,	I-NP	O
GDP	GDP	NN	I-NP	O
,	,	,	I-NP	O
GTP	GTP	NN	I-NP	O
,	,	,	I-NP	O
ITP	ITP	NN	I-NP	O
)	)	)	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
characterize	characterize	VBP	B-VP	O
TCR	BEGIN-TCR-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
TCR	BEGIN-TCR-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
costimulation	costimulation	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	O
cells	cell	NNS	I-NP	O
expressing	express	VBG	B-VP	O
Lck	BEGIN-Lck-INSIDE	NN	B-NP	B
Src	BEGIN-Src	NN	I-NP	B
homology	homology	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
SH1	BEGIN-SH1-INSIDE	NN	B-NP	B
)	)	)	O	O
mutants	mutant	NNS	B-NP	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
psbH	BEGIN-psbH-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
psbT	BEGIN-psbT-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
transcribed	transcribe	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
psbB	BEGIN-psbB	NN	I-NP	B
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
psbH	BEGIN-BEGIN-psbH-INSIDE	NN	I-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
target	target	NN	I-NP	O
sequence	sequence	NN	I-NP	O
for	for	IN	B-PP	O
Mbb1	BEGIN-Mbb1-INSIDE	NN	B-NP	B
function	function	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
moxalactam	moxalactam	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
reliable	reliable	JJ	I-NP	O
and	and	CC	I-NP	O
useful	useful	JJ	I-NP	O
antibiotic	antibiotic	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
complicated	complicated	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infections	infection	NNS	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
students	student	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
trimethoprim	trimethoprim	NN	B-NP	O
/	/	SYM	O	O
sulphamethoxazole	sulphamethoxazole	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
TMP	TMP	NN	I-NP	O
-	-	HYPH	O	O
SMX	SMX	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
TMP	TMP	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
a	a	DT	B-NP	O
placebo	placebo	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Men	Men	NN	B-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
urethritis	urethritis	NN	B-NP	O
and	and	CC	I-NP	O
women	woman	NNS	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
PID	PID	NN	B-NP	O
both	both	DT	O	O
have	have	VBP	B-VP	O
significantly	significantly	RB	B-NP	O
greater	great	JJR	I-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
mononuclear	mononuclear	JJ	I-NP	O
cell	cell	NN	I-NP	O
proliferative	proliferative	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
DK1	DK1	NN	I-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
C	C	NN	B-NP	O
trachomatis	trachomatis	NN	I-NP	O
than	than	IN	B-PP	O
controls	control	NNS	B-NP	O

The	The	DT	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
Moloney	Moloney	NN	B-NP	O
murine	murine	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
M	M	NN	B-NP	O
-	-	HYPH	B-NP	O
MuLV	MuLV	NN	I-NP	O
)	)	)	O	O
causes	cause	VBZ	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
specific	specific	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
gene	gene	NN	I-NP	O
products	product	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
major	BEGIN-major	JJ	I-NP	B
histocompatibility	histocompatibility	NN	I-NP	I
complex	complex	NN	I-NP	I
(	(	(	O	I
MHC	MHC	NN	B-NP	I
)	)	)	O	I
class	class	NN	B-NP	I
I	I	CD	I-NP	I
antigens	antigens-INSIDE	NN	I-NP	I

Apparent	Apparent	JJ	B-NP	O
Buschke	Buschke	NN	I-NP	O
-	-	HYPH	I-NP	O
Loewenstein	Loewenstein	NN	I-NP	O
tumour	tumour	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
penis	penis	NN	I-NP	O

The	The	DT	B-NP	O
orthologs	ortholog	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Y	BEGIN-Y	NN	I-NP	B
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
and	and	CC	I-NP	O
Y	BEGIN-BEGIN-Y	NN	I-NP	B
(	(	(	O	I
1	1	CD	O	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
subtypes	subtypes-INSIDE	NN	I-NP	I
display	display	VBP	B-VP	O
high	high	JJ	B-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
identities	identity	NNS	I-NP	O
between	between	IN	B-PP	O
pig	pig	NN	B-NP	O
,	,	,	O	O
human	human	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
mouse	mouse	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
Y	BEGIN-Y	NN	I-NP	B
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
,	,	,	O	O
Y	BEGIN-Y	NN	B-NP	B
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
,	,	,	O	O
and	and	CC	O	O
y	BEGIN-y	NN	B-NP	B
(	(	(	B-LST	I
1	1	LS	I-LST	I
)	)	)	O	I
subtypes	subtypes-INSIDE	NN	B-NP	I
display	display	VBP	B-VP	O
lower	low	JJR	B-NP	O
identities	identity	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
NIH	NIH	NN	B-NP	O
1T1	1T1	NN	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1R	1R-INSIDE	NN	I-NP	I
bearing	bear	VBG	B-VP	O
a	a	DT	B-NP	O
deletion	deletion	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
rich	rich	JJ	B-ADJP	O
in	in	IN	B-PP	O
acidic	acidic	JJ	B-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
(	(	(	O	O
the	the	DT	B-NP	O
``	``	``	I-NP	O
acidic	acidic	JJ	I-NP	O
''	''	''	I-NP	O
region	region	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IL	BEGIN-BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1R	1R-INSIDE	NN	I-NP	I
beta	beta	SYM	O	O
-	-	HYPH	O	O
chain	chain-INSIDE	NN	B-NP	I
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
MAP	BEGIN-MAP	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
all	all	DT	I-NP	O
three	three	CD	I-NP	O
nuclear	nuclear	JJ	I-NP	O
proto	proto	AFX	I-NP	O
-	-	HYPH	I-NP	O
oncogenes	oncogene	NNS	I-NP	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytotactin	BEGIN-cytotactin	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
the	the	DT	B-NP	O
homeobox	BEGIN-homeobox	NN	I-NP	B
-	-	HYPH	O	I
containing	contain	VBG	B-VP	I
gene	gene	NN	B-NP	I
Evx	Evx	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
private	private	JJ	I-NP	O
practices	practice	NNS	I-NP	O
accredited	accredit	VBN	B-VP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
participated	participate	VBD	B-VP	O

Enhanced	Enhance	VBN	B-NP	O
phospholipid	phospholipid	NN	I-NP	O
hydrolysis	hydrolysis	NN	I-NP	O
with	with	IN	B-PP	O
free	free	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acid	acid	NN	I-NP	O
and	and	CC	I-NP	O
thromboxane	thromboxane	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
excitatory	excitatory	JJ	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
tissue	tissue	NN	B-NP	O
magnesium	magnesium	NN	I-NP	O
levels	level	NNS	I-NP	O
may	may	MD	B-VP	O
each	each	DT	B-NP	O
serve	serve	VB	B-VP	O
to	to	TO	I-VP	O
worsen	worsen	VB	I-VP	O
secondary	secondary	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
damage	damage	NN	I-NP	O
and	and	CC	O	O
diminish	diminish	VB	B-VP	O
neurologic	neurologic	JJ	B-NP	O
recovery	recovery	NN	I-NP	O
after	after	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
cord	cord	NN	I-NP	O
injury	injury	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
intoxication	intoxication	NN	I-NP	O

This	This	DT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
may	may	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
predict	predict	VB	I-VP	O
the	the	DT	B-NP	O
injury	injury	NN	I-NP	O
severity	severity	NN	I-NP	O
after	after	IN	B-PP	O
trauma	trauma	NN	B-NP	O

With	With	IN	B-PP	O
six	six	CD	B-NP	O
reports	report	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
that	that	WDT	B-NP	O
show	show	VBP	B-VP	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
order	order	NN	I-NP	O
to	to	TO	B-PP	O
melanoma	melanoma	NN	B-NP	O
nodal	nodal	JJ	I-NP	O
metastases	metastasis	NNS	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
SLN	SLN	NN	I-NP	O
histology	histology	NN	I-NP	O
is	be	VBZ	B-VP	O
reflective	reflective	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
histology	histology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nodal	nodal	JJ	I-NP	O
basin	basin	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
more	more	RBR	I-NP	O
conservative	conservative	JJ	I-NP	O
SLN	SLN	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	B-VP	O
adequately	adequately	RB	I-VP	O
stage	stage	VB	I-VP	O
nodally	nodally	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
melanoma	melanoma	NN	B-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
double	double	JJ	I-NP	O
mutant	mutant	NN	I-NP	O
(	(	(	O	O
E1A	E1A	NN	B-NP	O
,	,	,	I-NP	O
D1A	D1A	NN	I-NP	O
)	)	)	O	O
which	which	WDT	B-NP	O
removed	remove	VBD	B-VP	O
negative	negative	JJ	B-NP	O
charges	charge	NNS	I-NP	O
along	along	IN	B-PP	O
one	one	CD	B-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
helix	helix	NN	I-NP	O
had	have	VBD	B-VP	O
negligible	negligible	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
fusion	fusion	NN	B-NP	O
activity	activity	NN	I-NP	O

Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
cells	cell	NNS	I-NP	O
expressing	express	VBG	B-VP	O
a	a	DT	B-NP	O
mutant	BEGIN-mutant	JJ	I-NP	B
glyV	glyV-INSIDE	NN	I-NP	I
(	(	(	O	O
glycine	BEGIN-glycine	NN	B-NP	B
tRNA	tRNA-INSIDE	NN	I-NP	I
)	)	)	O	O
gene	gene	NN	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
UVM	UVM	NN	I-NP	O
-	-	HYPH	B-NP	O
constitutive	constitutive	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
:	:	:	O	O
implications	implication	NNS	B-NP	O
for	for	IN	B-PP	O
mechanisms	mechanism	NNS	B-NP	O
underlying	underlie	VBG	B-VP	O
the	the	DT	B-NP	O
mutA	BEGIN-mutA-INSIDE	NN	I-NP	B
or	or	CC	I-NP	O
mutC	BEGIN-mutC	NN	I-NP	B
mutator	mutator-INSIDE	NN	I-NP	I
effect	effect	NN	I-NP	O

Titres	Titre	NNS	B-NP	O
of	of	IN	B-PP	O
antistreptolysin	BEGIN-antistreptolysin	NN	B-NP	B
O	O-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
mothers	mother	NNS	B-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
affected	affect	VBN	B-VP	O
with	with	IN	B-PP	O
Down	Down	NN	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O

Synthetic	Synthetic	JJ	B-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
furan	furan	NN	B-NP	O
derivatives	derivative	NNS	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
wittig	wittig	NN	I-NP	O
reaction	reaction	NN	I-NP	O

Positive	Positive	JJ	B-NP	O
linear	linear	JJ	I-NP	O
correlations	correlation	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
AUC	AUC	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
elimination	elimination	NN	I-NP	O
t1	t1	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
regressed	regress	VBN	I-VP	O
with	with	IN	B-PP	O
age	age	NN	B-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
social	social	JJ	I-NP	O
learning	learning	NN	I-NP	O
theory	theory	NN	I-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
,	,	,	O	O
developed	develop	VBN	B-VP	O
by	by	IN	B-PP	O
Lewinsohn	Lewinsohn	NNP	B-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O

Intramolecular	Intramolecular	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
MxA	BEGIN-MxA	NN	B-NP	B
monomers	monomers-INSIDE	NN	I-NP	I
,	,	,	O	O
whereas	whereas	IN	O	O
intermolecular	intermolecular	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
may	may	MD	B-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
large	BEGIN-large	JJ	B-NP	B
MxA	MxA	NN	I-NP	I
oligomers	oligomers-INSIDE	NN	I-NP	I

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Het	BEGIN-Het-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
Anabaena	Anabaena	NNP	B-NP	O
sp.	sp.	NN	I-NP	O
strain	strain	NN	I-NP	O
PCC	PCC	NN	I-NP	O
1	1	CD	I-NP	O
implicates	implicate	VBZ	B-VP	O
a	a	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
heterocyst	heterocyst	NN	B-NP	O
spacing	spacing	NN	I-NP	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
lower	low	JJR	I-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
hematoma	hematoma	NN	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O

To	To	TO	B-PP	O
this	this	DT	B-NP	O
end	end	NN	I-NP	O
we	we	PRP	B-NP	O
generated	generate	VBD	B-VP	O
a	a	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
physical	physical	JJ	I-NP	O
map	map	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
region	region	NN	I-NP	O
spanning	span	VBG	B-VP	O
between	between	IN	B-PP	O
sequence	sequence	NN	B-NP	O
-	-	HYPH	O	O
tagged	tag	VBN	B-NP	O
site	site	NN	I-NP	O
markers	marker	NNS	I-NP	O
D1S1	BEGIN-D1S1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
D1S1	BEGIN-D1S1-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
erythromycin	erythromycin	NN	B-NP	O
(	(	(	O	O
E.	E.	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
degrees	degree	NNS	I-NP	O
of	of	IN	B-PP	O
impairment	impairment	NN	B-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
intravenous	intravenous	JJ	I-NP	O
dose	dose	NN	I-NP	O

Lasting	Lasting	JJ	B-NP	O
paraplegia	paraplegia	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
lumbar	lumbar	JJ	B-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O
interneurons	interneuron	NNS	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
direct	direct	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
motor	motor	NN	B-NP	O
neuron	neuron	NN	I-NP	O
loss	loss	NN	I-NP	O

Gold	Gold	NN	B-NP	O
flaxseed	flaxseed	NN	I-NP	O
(	(	(	O	O
whole	whole	JJ	B-NP	O
or	or	CC	O	O
ground	ground	NN	B-NP	O
)	)	)	O	O
fed	feed	VBN	B-VP	O
at	at	IN	B-PP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
1	1	CD	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
menhaden	menhaden	JJ	I-NP	O
oil	oil	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
typical	typical	JJ	I-NP	O
control	control	NN	I-NP	O
layer	layer	NN	I-NP	O
ration	ration	NN	I-NP	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
drugs	drug	NNS	I-NP	O
(	(	(	O	O
combination	combination	NN	B-NP	O
vinblastine	vinblastine	NN	I-NP	O
-	-	HYPH	B-NP	O
CCNU	CCNU	NN	I-NP	O
and	and	CC	O	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
agent	agent	NN	I-NP	O
triazinate	triazinate	NN	I-NP	O
or	or	CC	O	O
dactinomycin	dactinomycin	NN	B-NP	O
)	)	)	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
provide	provide	VB	I-VP	O
any	any	DT	B-NP	O
meaningful	meaningful	JJ	I-NP	O
antitumor	antitumor	JJ	I-NP	O
activity	activity	NN	I-NP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
renal	renal	JJ	I-NP	O
cell	cell	NN	I-NP	O
cancer	cancer	NN	I-NP	O

Some	Some	DT	B-NP	O
CHOP	BEGIN-CHOP-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
C	BEGIN-C	NN	I-NP	B
/	/	SYM	I-NP	I
EBP	EBP-INSIDE	NN	I-NP	I
heterodimers	heterodimer	NNS	I-NP	O
apparently	apparently	RB	B-ADVP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
alternative	alternative	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
thereby	thereby	RB	B-VP	O
regulate	regulate	VBP	I-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
genes	gene	NNS	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
recombinant	BEGIN-recombinant	JJ	I-NP	B
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
YA	Y-INSIDEA	NN	I-NP	I
subunit	subunit-INSIDE	NN	I-NP	I
restores	restore	VBZ	B-VP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	I-NP	I
Y	Y-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
provide	provide	VBP	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
differential	differential	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
receptor	receptor	NN	I-NP	O
gene	gene	NN	I-NP	O
generates	generate	VBZ	B-VP	O
receptor	receptor	NN	B-NP	O
variants	variant	NNS	I-NP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
ligand	ligand	NN	I-NP	O
-	-	HYPH	B-NP	O
binding	bind	VBG	B-VP	O
specificities	specificity	NNS	B-NP	O

Intrathecal	Intrathecal	JJ	B-NP	O
injections	injection	NNS	I-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
volumes	volume	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
adrenoceptor	adrenoceptor-INSIDE	NN	I-NP	I
agonists	agonist	NNS	I-NP	O
,	,	,	O	O
xylazine	xylazine	NN	B-NP	O
and	and	CC	I-NP	O
clonidine	clonidine	NN	I-NP	O
,	,	,	O	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O
of	of	IN	B-PP	O
conscious	conscious	JJ	B-NP	O
unrestrained	unrestrained	JJ	I-NP	O
sheep	sheep	NN	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
analgesia	analgesia	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
forelimbs	forelimb	NNS	I-NP	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
device	device	NN	I-NP	O

The	The	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
ISGF1	BEGIN-ISGF1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
specific	specific	JJ	B-NP	O
elements	element	NNS	I-NP	O
termed	term	VBN	B-NP	O
IFN	BEGIN-BEGIN-IFN-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
stimulatory	stimulatory	JJ	I-NP	O
response	response	NN	I-NP	O
element	element-INSIDE	NN	I-NP	I
(	(	(	O	O
ISRE	BEGIN-ISRE-INSIDE	NN	B-NP	B
)	)	)	O	O
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
IFN	BEGIN-IFN-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
genes	gene	NNS	I-NP	O

Clinical	Clinical	JJ	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
interleukin	BEGIN-interleukin	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Estrogen	Estrogen	NN	B-NP	O
has	have	VBZ	B-VP	O
positive	positive	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
mood	mood	NN	B-NP	O
,	,	,	O	O
sexual	sexual	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
target	target	NN	B-NP	O
end	end	NN	I-NP	O
organs	organ	NNS	I-NP	O
and	and	CC	O	O
cognitive	cognitive	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
Alzheimer	Alzheimer	NNP	B-NP	O
's	's	POS	B-NP	O
Disease	Disease	NN	I-NP	O
by	by	IN	B-PP	O
acting	act	VBG	B-VP	O
to	to	TO	I-VP	O
prevent	prevent	VB	I-VP	O
amyloid	amyloid	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
oxidative	oxidative	JJ	B-NP	O
stress	stress	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
deterioration	deterioration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cholinergic	cholinergic	JJ	I-NP	O
neurotransmitter	neurotransmitter	NN	I-NP	O
system	system	NN	I-NP	O

The	The	DT	B-NP	O
system	system	NN	I-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
microcomputer	microcomputer	NN	I-NP	O
and	and	CC	O	O
six	six	CD	B-NP	O
laboratory	laboratory	NN	I-NP	O
analyzers	analyzer	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
analyzer	analyzer	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
flame	flame	NN	I-NP	O
photometer	photometer	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
plasma	plasma	NN	I-NP	O
osmotic	osmotic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
meter	meter	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
chloride	chloride	NN	I-NP	O
ion	ion	NN	I-NP	O
titrator	titrator	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
analyzer	analyzer	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	I-NP	B
concentration	concentration	NN	I-NP	O
and	and	CC	O	O
saturation	saturation	NN	B-NP	O
meter	meter	NN	I-NP	O

Of	Of	IN	B-PP	O
these	these	DT	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
GIB	GIB	NN	B-NP	O
(	(	(	O	O
Upper	Upper	NN	B-NP	O
GIB	GIB	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
Lower	Low	JJR	B-NP	O
GIB	GIB	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

Hence	Hence	RB	B-ADVP	O
the	the	DT	B-NP	O
GAP1	BEGIN-GAP1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
characteristics	characteristic	NNS	B-NP	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
integral	integral	JJ	B-NP	O
membrane	membrane	NN	I-NP	O
proteins	protein	NNS	I-NP	O
translocating	translocate	VBG	B-VP	O
ligants	ligant	NNS	B-NP	O
across	across	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O

Soluble	Soluble	JJ	B-NP	O
fibrin	BEGIN-fibrin-INSIDE	NN	I-NP	B
monomer	monomer	NN	I-NP	O
complexes	complex	NNS	I-NP	O
in	in	IN	B-PP	O
thromboembolism	thromboembolism	NN	B-NP	O

S1	S1	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

Microenvironments	Microenvironment	NNS	B-NP	O
dominated	dominate	VBN	B-VP	O
by	by	IN	B-PP	O
cyanobacteria	cyanobacteria	NNS	B-NP	O
(	(	(	O	O
BPC	BPC	NN	B-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
pH	pH	NN	I-NP	O
(	(	(	O	O
pH	pH	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
dominated	dominate	VBN	B-VP	O
by	by	IN	B-PP	O
lichen	lichen	NN	B-NP	O
(	(	(	O	O
LTL	LTL	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
pH	pH	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Saturated	Saturate	VBN	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
induce	induce	VBP	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
transcription	transcription	NN	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
unsaturated	unsaturated	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
repress	repress	VBP	B-VP	O
OLE1	BEGIN-OLE1-INSIDE	NN	B-NP	B
transcription	transcription	NN	I-NP	O
as	as	RB	B-NP	O
much	much	JJ	I-NP	O
as	as	IN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	I-NP	O

A	A	DT	B-NP	O
third	third	JJ	I-NP	O
GEF	BEGIN-GEF-INSIDE	NN	I-NP	B
,	,	,	O	O
GRP1	BEGIN-GRP1-INSIDE	NN	B-NP	B
(	(	(	O	O
KIAA1	BEGIN-KIAA1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
activated	activate	VBD	B-VP	O
both	both	CC	O	O
Ras	BEGIN-Ras-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Rap1	BEGIN-Rap1-INSIDE	NN	I-NP	B
and	and	CC	O	O
shared	share	VBD	B-VP	O
significant	significant	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
calcium	calcium	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
diacylglycerol	diacylglycerol	NN	I-NP	O
-	-	HYPH	O	O
activated	activate	VBN	B-NP	O
GEFs	BEGIN-GEF-INSIDE	NNS	I-NP	I
,	,	,	O	O
GRP1	BEGIN-GRP1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
GRP1	BEGIN-GRP1-INSIDE	NN	I-NP	B

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
determined	determine	VBN	I-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
organization	organization	NN	I-NP	O
and	and	CC	I-NP	O
transcription	transcription	NN	I-NP	O
start	start	NN	I-NP	O
points	point	NNS	I-NP	O
(	(	(	O	O
tsp	tsp	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
gene	gene	NN	I-NP	O
(	(	(	O	O
TK	BEGIN-TK-INSIDE	NN	B-NP	B
)	)	)	O	O
encoding	encode	VBG	B-VP	O
thymidine	BEGIN-thymidine	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
gentamycin	gentamycin	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
kidney	kidney	NN	I-NP	O
functional	functional	JJ	I-NP	O
state	state	NN	I-NP	O
in	in	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
pyelonephritis	pyelonephritis	NN	I-NP	O

The	The	DT	B-NP	O
time	time	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
measured	measure	VBN	B-NP	O
facility	facility	NN	I-NP	O
of	of	IN	B-PP	O
outflow	outflow	NN	B-NP	O
or	or	CC	O	O
``	``	``	O	O
washout	washout	NN	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
''	''	''	O	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
result	result	VB	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
gradual	gradual	JJ	I-NP	O
dissolution	dissolution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hyaluronidase	BEGIN-hyaluronidase-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
barriers	barrier	NNS	I-NP	O
to	to	TO	B-PP	O
aqueous	aqueous	JJ	B-NP	O
outflow	outflow	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
canine	canine	NN	I-NP	O
eye	eye	NN	I-NP	O

Melioidosis	Melioidosis	NN	B-NP	O
in	in	IN	B-PP	O
Sika	Sika	NNP	B-NP	O
deer	deer	NNP	I-NP	O
(	(	(	O	O
Cervus	Cervus	NN	B-NP	O
nippon	nippon	NN	I-NP	O
nippon	nippon	NN	I-NP	O
)	)	)	O	O

Many	Many	JJ	B-NP	O
human	human	JJ	I-NP	O
malignant	malignant	JJ	I-NP	O
cells	cell	NNS	I-NP	O
lack	lack	VBP	B-VP	O
methylthioadenosine	BEGIN-methylthioadenosine	NN	B-NP	B
phosphorylase	phosphorylase-INSIDE	NN	I-NP	I
(	(	(	O	O
MTAP	BEGIN-MTAP-INSIDE	NN	B-NP	B
)	)	)	O	O
enzyme	enzyme	NN	B-NP	O
activity	activity	NN	I-NP	O

Nucleocapsid	Nucleocapsid	NN	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	I-NP	O
thermostability	thermostability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
virion	virion	NN	I-NP	O
,	,	,	I-NP	O
nucleocapsid	nucleocapsid	NN	I-NP	O
and	and	CC	I-NP	O
polymerase	polymerase	NN	I-NP	O
complex	complex	NN	I-NP	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
1	1	CD	B-NP	O
separate	separate	JJ	I-NP	O
PAI	BEGIN-PAI	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
inductory	inductory	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
for	for	IN	B-PP	O
PMA	PMA	NN	B-NP	O
and	and	CC	I-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1alpha	1alpha-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
HepG1	HepG1	NN	B-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
involving	involve	VBG	I-NP	O
protein	BEGIN-protein	NN	I-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
may	may	MD	O	O
(	(	(	O	O
partially	partially	RB	B-ADVP	O
)	)	)	O	O
overlap	overlap	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
PMA	PMA	NN	I-NP	O
-	-	HYPH	B-VP	O
activated	activate	VBN	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
mitogen	BEGIN-mitogen	NN	I-NP	B
-	-	HYPH	O	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
pathway	pathway	NN	I-NP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	I-NP	I
Jun	Jun	NN	I-NP	I
homodimer	homodimer-INSIDE	NN	I-NP	I
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PAI	BEGIN-PAI	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
TRE	TRE	NN	I-NP	O

Crude	Crude	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
from	from	IN	B-PP	O
aquatic	aquatic	JJ	B-NP	O
plants	plant	NNS	I-NP	O

Recurrence	Recurrence	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
after	after	IN	B-PP	O
partial	partial	JJ	B-NP	O
excision	excision	NN	I-NP	O
and	and	CC	I-NP	O
drainage	drainage	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
fistula	fistula	NN	B-NP	O
formation	formation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
cyst	cyst	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
duodenum	duodenum	NN	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
by	by	IN	B-PP	O
FES	BEGIN-FES-INSIDE	NN	B-NP	B
affects	affect	VBZ	B-VP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
BCR	BEGIN-BCR-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
partners	partner	NNS	I-NP	O
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
general	general	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
BCR	BEGIN-BCR-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
receptor	receptor	NN	I-NP	O
protein	BEGIN-protein	NN	I-NP	B
-	-	HYPH	B-NP	I
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
regulation	regulation	NN	I-NP	O
and	and	CC	O	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O

Reversal	Reversal	NN	B-NP	O
of	of	IN	B-PP	O
'refractory	'refractory	JJ	B-NP	O
septic	septic	JJ	I-NP	O
shock	shock	NN	I-NP	O
'	'	''	O	O
by	by	IN	B-PP	O
infusion	infusion	NN	B-NP	O
of	of	IN	B-PP	O
amrinone	amrinone	NN	B-NP	O
and	and	CC	I-NP	O
angiotensin	BEGIN-angiotensin	NN	I-NP	B
II	II-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
an	an	DT	B-NP	O
anthracycline	anthracycline	NN	I-NP	O
-	-	HYPH	O	O
treated	treat	VBN	B-VP	O
patient	patient	NN	B-NP	O

Replication	Replication	NN	B-NP	O
regions	region	NNS	I-NP	O
from	from	IN	B-PP	O
plant	plant	NN	B-NP	O
-	-	HYPH	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
Pseudomonas	Pseudomonas	NN	I-NP	O
syringae	syringae	NN	I-NP	O
plasmids	plasmid	NNS	I-NP	O
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
ColE1	ColE1	NN	B-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
replicons	replicon	NNS	I-NP	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
dose	dose	NN	B-NP	O
volume	volume	NN	I-NP	O
histograms	histogram	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
field	field	NN	I-NP	O
plan	plan	NN	I-NP	O
spared	spar	VBD	B-VP	O
relatively	relatively	RB	B-NP	O
more	more	JJR	I-NP	O
heart	heart	NN	I-NP	O
whereas	whereas	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
field	field	NN	I-NP	O
plan	plan	NN	I-NP	O
spared	spar	VBD	B-VP	O
relatively	relatively	RB	B-NP	O
more	more	JJR	I-NP	O
lung	lung	NN	I-NP	O

STUDY	STUDY	NN	B-NP	O
OBJECTIVE	OBJECTIVE	NN	I-NP	O
:	:	:	O	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
gas	gas	NN	B-NP	O
exchange	exchange	NN	I-NP	O
and	and	CC	O	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
performance	performance	NN	I-NP	O
during	during	IN	B-PP	O
maximal	maximal	JJ	B-NP	O
progressive	progressive	JJ	I-NP	O
arm	arm	NN	I-NP	O
crank	crank	NN	I-NP	O
exercise	exercise	NN	I-NP	O

At	At	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
postpartum	postpartum	NN	B-NP	O
,	,	,	O	O
serum	serum	NN	B-NP	O
fT1	fT1	NN	I-NP	O
and	and	CC	I-NP	O
fT1	fT1	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
normal	normal	JJ	I-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
pmol	pmol	NN	I-NP	O
/	/	SYM	B-PP	O
L	L	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
TSH	BEGIN-TSH-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
raised	raise	VBN	I-VP	O
(	(	(	O	O
1	1	CD	B-NP	O
mU	mU	NN	I-NP	O
/	/	SYM	B-NP	O
L	L	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
frequent	frequent	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
was	be	VBD	B-VP	O
GH	BEGIN-GH-INSIDE	JJ	B-NP	B
deficiency	deficiency	NN	I-NP	O
(	(	(	O	O
six	six	CD	B-NP	O
cases	case	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
gonadotropin	BEGIN-gonadotropin-INSIDE	NN	B-NP	B
(	(	(	O	O
four	four	CD	B-NP	O
cases	case	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
cortisol	cortisol	NN	B-NP	O
(	(	(	O	O
four	four	CD	B-NP	O
cases	case	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
TSH	BEGIN-TSH-INSIDE	NN	B-NP	B
(	(	(	O	O
one	one	CD	B-NP	O
case	case	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
four	four	CD	B-NP	O
patients	patient	NNS	I-NP	O
showed	show	VBD	B-VP	O
high	high	JJ	B-NP	O
serum	BEGIN-serum	NN	I-NP	B
PRL	PRL-INSIDE	NN	I-NP	I
values	value	NNS	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
controls	control	NNS	I-NP	O
the	the	DT	B-NP	O
plasma	BEGIN-plasma	NN	I-NP	B
FPA	FPA-INSIDE	NN	I-NP	I
level	level	NN	I-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
+	+	SYM	O	O
/	/	SYM	B-NP	O
-	-	HYPH	B-NP	O
SD	SD	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	O	O
ml	ml	NN	B-NP	O

The	The	DT	B-NP	O
nramp1	BEGIN-nramp1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
comprised	comprise	VBN	I-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
and	and	CC	I-NP	O
spans	span	NNS	I-NP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O

Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
recurrences	recurrence	NNS	B-NP	O
in	in	IN	B-PP	O
gingival	gingival	JJ	B-NP	O
hyperplasia	hyperplasia	NN	I-NP	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
lung	lung	NN	B-NP	O
protective	protective	JJ	I-NP	O
strategy	strategy	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
end	end	NN	I-NP	O
-	-	HYPH	B-NP	O
expiratory	expiratory	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
(	(	(	O	O
PEEP	PEEP	NN	B-NP	O
)	)	)	O	O
slightly	slightly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
Pflex	Pflex	NNP	I-NP	O
(	(	(	O	O
the	the	DT	B-NP	O
airway	airway	NN	I-NP	O
pressure	pressure	NN	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
inflection	inflection	NN	I-NP	O
point	point	NN	I-NP	O
(	(	(	O	O
LIP	LIP	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
-	-	HYPH	O	O
volume	volume	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
-	-	HYPH	B-NP	O
V	V	NN	I-NP	O
)	)	)	O	O
curve	curve	NN	B-NP	O
measured	measure	VBN	B-VP	O
with	with	IN	B-PP	O
ZEEP	ZEEP	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
generally	generally	RB	I-VP	O
recommended	recommend	VBN	I-VP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
constant	constant	JJ	I-NP	O
magnetic	magnetic	JJ	I-NP	O
field	field	NN	I-NP	O
on	on	IN	B-PP	O
different	different	JJ	B-NP	O
models	model	NNS	I-NP	O
of	of	IN	B-PP	O
carcinogenesis	carcinogenesis	NN	B-NP	O

FACS	FACS	NN	B-NP	O
analysis	analysis	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
MCs	MC	NNS	B-NP	O
had	have	VBD	B-VP	O
reached	reach	VBN	I-VP	O
middle	middle	JJ	B-ADJP	O
to	to	TO	B-PP	O
late	late	JJ	B-NP	O
G1	G1	NN	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
progression	progression	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
timepoint	timepoint	NN	I-NP	O

Nuclear	Nuclear	JJ	B-NP	O
export	export	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
in	in	IN	B-PP	O
plants	plant	NNS	B-NP	O
:	:	:	O	O
AtXPO1	BEGIN-AtXPO1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
export	export	NN	I-NP	O
receptor	receptor	NN	I-NP	O
for	for	IN	B-PP	O
leucine	leucine	NN	B-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
export	export	NN	I-NP	O
signals	signal	NNS	I-NP	O
in	in	IN	B-PP	O
Arabidopsis	Arabidopsis	NNP	B-NP	O
thaliana	thaliana	NNP	I-NP	O

Strains	Strain	NNS	B-NP	O
carrying	carry	VBG	B-VP	O
a	a	DT	B-NP	O
snf1	BEGIN-snf1	NN	I-NP	B
mutation	mutation-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
grow	grow	VB	I-VP	O
on	on	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
,	,	,	O	O
galactose	galactose	NN	B-NP	O
,	,	,	O	O
maltose	maltose	NN	B-NP	O
,	,	,	O	O
melibiose	melibiose	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
nonfermentable	nonfermentable	JJ	B-NP	O
carbon	carbon	NN	I-NP	O
sources	source	NNS	I-NP	O
;	;	:	O	O
utilization	utilization	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
carbon	carbon	NN	I-NP	O
sources	source	NNS	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
glucose	glucose	NN	B-NP	O
repression	repression	NN	I-NP	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
beta	BEGIN-beta	NN	B-NP	B
adrenoceptors	adrenoceptors-INSIDE	NN	I-NP	I
blockade	blockade	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
value	value	NN	B-NP	O
in	in	IN	B-PP	O
achieving	achieve	VBG	B-VP	O
continence	continence	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O

The	The	DT	B-NP	O
contractile	contractile	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
oxytocin	BEGIN-oxytocin-INSIDE	NN	B-NP	B
,	,	,	O	O
prostaglandin	prostaglandin	NN	B-NP	O
F1	F1	NN	I-NP	O
alpha	alpha	NN	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
combined	combine	VBN	I-NP	O
use	use	NN	I-NP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	O
pregnant	pregnant	JJ	I-NP	O
myometrium	myometrium	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

Effectively	Effectively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
,	,	,	I-NP	O
housekeeping	housekeeping	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
promoter	promoter	NN	I-NP	O
responds	respond	VBZ	B-VP	O
to	to	TO	B-PP	O
FIXK	BEGIN-FIXK-INSIDE	NN	B-NP	B
and	and	CC	O	O
positively	positively	RB	B-VP	O
regulates	regulate	VBZ	I-VP	O
the	the	DT	B-NP	O
downstream	downstream	JJ	I-NP	O
,	,	,	O	O
sigma	BEGIN-sigma	SYM	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

Km	Km	NN	B-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
uncoupled	uncoupled	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
IIGlc	BEGIN-IIGlc-INSIDE	NN	I-NP	B
for	for	IN	B-PP	O
glucose	glucose	NN	B-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
mM	mM	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
orders	order	NNS	I-NP	O
of	of	IN	B-PP	O
magnitude	magnitude	NN	B-NP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
IIGlc	BEGIN-IIGlc-INSIDE	NN	I-NP	B

Measurement	Measurement	NN	B-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
in	in	IN	B-PP	O
natural	natural	JJ	B-NP	O
rubber	rubber	NN	I-NP	O
latex	latex	NN	I-NP	O

Disruption	Disruption	NN	B-NP	O
of	of	IN	B-PP	O
PML	BEGIN-BEGIN-PML-INSIDE	NN	B-NP	B
subnuclear	subnuclear	JJ	I-NP	O
domains	domains-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
the	the	DT	B-NP	O
acidic	BEGIN-acidic	JJ	I-NP	B
IE1	IE1	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
cytomegalovirus	cytomegalovirus	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
through	through	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
PML	BEGIN-PML-INSIDE	NN	B-NP	B
and	and	CC	O	O
may	may	MD	B-VP	O
modulate	modulate	VB	I-VP	O
a	a	DT	B-NP	O
RING	RING	NN	I-NP	O
finger	finger	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
cryptic	cryptic	JJ	I-NP	O
transactivator	transactivator	NN	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
PML	BEGIN-PML-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
fate	fate	NN	I-NP	O
of	of	IN	B-PP	O
ochratoxin	ochratoxin	NN	B-NP	O
A	A	NN	I-NP	O
during	during	IN	B-PP	O
malting	malting	NN	B-NP	O
and	and	CC	I-NP	O
brewing	brewing	NN	I-NP	O

To	To	TO	B-VP	O
further	further	RB	I-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
PKR	BEGIN-PKR-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
expressed	express	VBD	B-VP	O
the	the	DT	B-NP	O
wild	BEGIN-wild	JJ	I-NP	B
type	type	NN	I-NP	I
human	human	JJ	I-NP	I
PKR	BEGIN-PKR-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	O	O
a	a	DT	B-NP	O
catalytically	catalytically	RB	I-NP	O
inactive	inactive	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
PKR	BEGIN-BEGIN-PKR-INSIDE	NN	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
pre	pre	AFX	I-NP	O
-	-	HYPH	I-NP	O
B	B	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
1Z	1Z	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
experiments	experiment	NNS	I-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
compounds	compound	NNS	I-NP	O
,	,	,	O	O
cocaine	cocaine	NN	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
potent	potent	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O

Atrial	Atrial	JJ	B-NP	O
dissociation	dissociation	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
envisaged	envisage	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
WHOQOL	WHOQOL	NN	I-NP	O
-	-	HYPH	B-NP	O
BREF	BREF	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
most	most	RBS	B-ADJP	O
useful	useful	JJ	I-ADJP	O
in	in	IN	B-PP	O
studies	study	NNS	B-NP	O
that	that	WDT	B-NP	O
require	require	VBP	B-VP	O
a	a	DT	B-NP	O
brief	brief	JJ	I-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
quality	quality	NN	B-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
example	example	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
epidemiological	epidemiological	JJ	I-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
trials	trial	NNS	I-NP	O
where	where	WRB	B-ADVP	O
quality	quality	NN	B-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
interest	interest	NN	B-NP	O

Hepatitis	BEGIN-Hepatitis	NN	B-NP	B
B	B	NN	I-NP	I
immune	immune	JJ	I-NP	I
globulins	globulins-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
HIV	BEGIN-HIV	NN	I-NP	B
antibodies	antibodies-INSIDE	NN	I-NP	I

One	One	CD	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
target	target	NN	I-NP	O
which	which	WDT	B-NP	O
reflects	reflect	VBZ	B-VP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plastids	plastid	NNS	I-NP	O
is	be	VBZ	B-VP	O
protein	BEGIN-protein	JJ	B-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I

A	A	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
located	located	JJ	B-NP	O
over	over	IN	I-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cfl	BEGIN-cfl-INSIDE	NN	I-NP	B
transcriptional	transcriptional	JJ	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
DNase	BEGIN-DNase	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
protection	protection	NN	I-NP	O
assays	assay	NNS	I-NP	O
to	to	TO	B-VP	O
define	define	VB	I-VP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
bases	base	NNS	I-NP	O
bound	bind	VBN	B-VP	O
by	by	IN	B-PP	O
CorR	BEGIN-CorR-INSIDE	NN	B-NP	B

A	A	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
immunological	immunological	JJ	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
stage	stage	NN	I-NP	O
was	be	VBD	B-VP	O
discovered	discover	VBN	I-VP	O
:	:	:	O	O
the	the	DT	B-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1H	1H	NN	I-NP	O
-	-	HYPH	B-NP	O
thymidine	thymidine	NN	I-NP	O
incorporation	incorporation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
1	1	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
remission	remission	NN	B-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
complement	complement	NN	I-NP	O
titre	titre	NN	I-NP	O
reached	reach	VBD	B-VP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
units	unit	NNS	I-NP	O
per	per	IN	B-PP	O
ml	ml	NN	B-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
abortion	abortion	NN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
PAPP	BEGIN-PAPP	NN	B-NP	B
-	-	HYPH	B-NP	I
A	A-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
but	but	CC	O	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
pregnant	pregnant	JJ	I-NP	O
controls	control	NNS	I-NP	O

Maximum	Maximum	JJ	B-NP	O
likelihood	likelihood	NN	I-NP	O
estimation	estimation	NN	I-NP	O
in	in	IN	B-PP	O
covariance	covariance	NN	B-NP	O
structure	structure	NN	I-NP	O
analysis	analysis	NN	I-NP	O
with	with	IN	B-PP	O
truncated	truncate	VBN	B-NP	O
data	datum	NNS	I-NP	O

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
rat	rat	NN	B-NP	O
peptidylglycine	BEGIN-peptidylglycine	NN	I-NP	B
alpha	alpha	SYM	O	I
-	-	HYPH	O	I
amidating	amidate	VBG	B-VP	I
monooxygenase	monooxygenase-INSIDE	NN	B-NP	I
(	(	(	O	O
PAM	BEGIN-PAM-INSIDE	NN	B-NP	B
)	)	)	O	O
contains	contain	VBZ	B-VP	O
1	1	CD	B-NP	O
protein	protein	NN	I-NP	O
-	-	HYPH	O	O
coding	cod	VBG	B-VP	O
exons	exon	NNS	B-NP	O

Whether	Whether	IN	B-SBAR	O
this	this	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
preferential	preferential	JJ	B-NP	O
repair	repair	NN	I-NP	O
has	have	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
repair	repair	NN	B-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
general	general	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
at	at	IN	B-PP	O
present	present	JJ	B-ADJP	O

Pretreatment	Pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
skin	skin	NN	I-NP	O
with	with	IN	B-PP	O
tRA	tRA	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
UV	UV	NN	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Jun	Jun	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
and	and	CC	O	O
,	,	,	O	O
consequently	consequently	RB	B-ADVP	O
,	,	,	O	O
AP	BEGIN-AP	NN	B-NP	B
-	-	HYPH	O	I
1.	1-INSIDE.	NN	B-NP	I
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
Jun	Jun	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
inhibition	inhibition	NN	I-NP	O
occurred	occur	VBD	B-VP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
posttranscriptional	posttranscriptional	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
tRA	tRA	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
inhibit	inhibit	VB	I-VP	O
UV	UV	NN	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Jun	Jun	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I

MUS1	BEGIN-MUS1-INSIDE	NN	B-NP	B
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
helix	BEGIN-helix	JJ	I-NP	B
-	-	HYPH	I-NP	I
hairpin	hairpin	NN	I-NP	I
-	-	HYPH	I-NP	I
helix	helix	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
UV	UV	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
methylation	methylation	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
DNA	DNA	NN	I-NP	O
damage	damage	NN	I-NP	O
in	in	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O

All	All	DT	B-NP	O
possessed	possess	VBD	B-VP	O
cutaneous	cutaneous	JJ	B-NP	O
receptive	receptive	JJ	I-NP	O
fields	field	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
segments	segment	NNS	I-NP	O
of	of	IN	B-PP	O
digits	digit	NNS	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
1	1	CD	B-NP	O

In	In	FW	B-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
strong	strong	JJ	B-NP	O
signals	signal	NNS	I-NP	O
for	for	IN	B-PP	O
Zep	BEGIN-Zep	JJ	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cerebellum	cerebellum	NN	I-NP	O
and	and	CC	O	O
olfactory	olfactory	JJ	B-NP	O
bulb	bulb	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
signals	signal	NNS	I-NP	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hippocampus	hippocampus	NN	I-NP	O
and	and	CC	I-NP	O
cortex	cortex	NN	I-NP	O

A	A	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
sequence	sequence	NN	B-NP	O
fragments	fragment	NNS	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
1	1	CD	B-NP	O
'	'	''	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
chloramphenicol	BEGIN-chloramphenicol	NN	I-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
(	(	(	O	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
)	)	)	O	O
reporter	reporter	NN	B-NP	O
gene	gene	NN	I-NP	O
and	and	CC	O	O
ability	ability	NN	B-NP	O
to	to	TO	B-VP	O
mediate	mediate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
IFN	BEGIN-IFN	NN	B-NP	B
gamma	gamma-INSIDE	NN	I-NP	I
or	or	CC	O	O
LPS	LPS	NN	B-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
following	follow	VBG	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
macrophage	macrophage	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
RAW	RAW	NN	I-NP	O
1	1	CD	I-NP	O

A	A	DT	B-NP	O
GT	GT	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
binding	bind	VBG	B-VP	O
the	the	DT	B-NP	O
transcription	BEGIN-transcription	NN	I-NP	B
factor	factor	NN	I-NP	I
Sp1	Sp1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
crucial	crucial	JJ	B-ADJP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
type	type	NN	I-NP	I
VII	VII	CD	I-NP	I
collagen	collagen	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
COL1A1	BEGIN-COL1A1-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
fibroblasts	fibroblast	NNS	B-NP	O
and	and	CC	I-NP	O
keratinocytes	keratinocyte	NNS	I-NP	O

Using	Use	VBG	B-VP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
genomic	genomic	JJ	I-NP	O
dimethyl	dimethyl	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
and	and	CC	O	O
KMnO1	KMnO1	NN	B-NP	O
footprinting	footprinting	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
differentially	differentially	RB	I-VP	O
protected	protect	VBN	I-VP	O
,	,	,	O	O
depending	depend	VBG	B-VP	O
upon	upon	IN	B-PP	O
which	which	WDT	B-NP	O
holoenzyme	holoenzyme	NN	I-NP	O
is	be	VBZ	B-VP	O
bound	bind	VBN	I-VP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
cDNAs	cDNA	NNS	I-NP	O
belong	belong	VBP	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
GST	BEGIN-GST-INSIDE	NN	I-NP	B
class	class	NN	I-NP	O
hereby	hereby	RB	B-VP	O
designated	designate	VBN	I-VP	O
Kappa	Kappa	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
rat	BEGIN-rat	NN	I-NP	B
GST	BEGIN-GST-INSIDE	NN	I-NP	I
subunit	subunit	NN	I-NP	O
1	1	CD	I-NP	O
gene	gene-INSIDE	NN	I-NP	I
designated	designate	VBN	B-VP	O
rGSTK1	rBEGIN-GST-INSIDEK1	NN	B-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gene	gene	NN	I-NP	O
being	be	VBG	B-VP	O
called	call	VBN	I-VP	O
hGSTK1	hBEGIN-GST-INSIDEK1	NN	B-NP	I

At	At	IN	B-PP	O
onset	onset	NN	B-NP	O
of	of	IN	B-PP	O
first	first	JJ	O	O
post	post	AFX	O	O
-	-	HYPH	O	O
weaning	wean	VBG	B-VP	O
estrus	estrus	NN	B-NP	O
,	,	,	O	O
sows	sow	NNS	B-NP	O
received	receive	VBD	B-VP	O
either	either	CC	O	O
an	an	DT	B-NP	O
intravulval	intravulval	JJ	I-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	O
analogue	analogue	NN	I-NP	O
(	(	(	O	O
PGF	PGF	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
,	,	,	O	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
injected	inject	VBN	I-NP	O
control	control	NN	I-NP	O
(	(	(	O	O
CON	CON	NN	B-NP	O
)	)	)	O	O

Tbx1	BEGIN-Tbx1-INSIDE	NN	B-NP	B
maps	map	VBZ	B-VP	O
to	to	TO	B-PP	O
chromosome	chromosome	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
known	know	VBN	I-NP	O
mutation	mutation	NN	I-NP	O

Before	Before	IN	B-SBAR	O
therapy	therapy	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
,	,	,	O	O
trabecular	trabecular	JJ	B-NP	O
bone	bone	NN	I-NP	O
alterations	alteration	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
observed	observe	VBN	I-VP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
typical	typical	JJ	B-ADJP	O
for	for	IN	B-PP	O
Paget	Paget	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
as	as	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
bulky	bulky	JJ	B-NP	O
trabeculare	trabeculare	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
remodelling	remodelle	VBG	I-VP	O
surfaces	surface	NNS	B-NP	O
and	and	CC	I-NP	O
giant	giant	JJ	I-NP	O
osteoclasts	osteoclast	NNS	I-NP	O

At	At	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
,	,	,	O	O
1	1	CD	B-NP	O
major	major	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
disease	disease	NN	I-NP	O
events	event	NNS	I-NP	O
had	have	VBD	B-VP	O
occurred	occur	VBN	I-VP	O
,	,	,	O	O
1	1	CD	B-NP	O
fatal	fatal	JJ	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
fatal	fatal	JJ	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
additional	additional	JJ	B-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
cell	cell	NN	B-NP	O
lines	line	NNS	I-NP	O
and	and	CC	O	O
whole	whole	JJ	B-NP	O
animals	animal	NNS	I-NP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
understand	understand	VB	I-VP	O
GnRH	BEGIN-GnRH-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
hormones	hormone	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
reproductive	reproductive	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
human	human	JJ	B-NP	O

Total	Total	JJ	B-NP	O
meso	meso	AFX	I-NP	O
-	-	HYPH	I-NP	O
pore	pore	NN	B-NP	O
volume	volume	NN	I-NP	O
and	and	CC	O	O
surface	surface	NN	B-NP	O
area	area	NN	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
cm1	cm1	NN	I-NP	O
g	g	NN	I-NP	O
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
m1	m1	NN	I-NP	O
g	g	NN	I-NP	O
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
accounting	account	VBG	B-VP	O
for	for	IN	B-PP	O
up	up	RB	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
BET	BET	NN	I-NP	O
surface	surface	NN	I-NP	O
area	area	NN	I-NP	O

Contraindications	Contraindication	NNS	B-NP	O
to	to	TO	B-PP	O
adenosine	adenosine	NN	B-NP	O
and	and	CC	I-NP	O
drug	drug	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
are	be	VBP	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
article	article	NN	I-NP	O

The	The	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
odontoblast	odontoblast	NN	I-NP	O
process	process	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
dentin	dentin	NN	I-NP	O

On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
from	from	IN	B-PP	O
glucose	glucose	NN	B-NP	O
,	,	,	O	O
succinate	succinate	NN	B-NP	O
,	,	,	O	O
malate	malate	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
glycerol	glycerol	NN	B-NP	O
medium	medium	NN	I-NP	O
to	to	TO	B-VP	O
citrate	citrate	VB	I-VP	O
medium	medium	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Cit+	Cit+	JJ	I-NP	O
Escherichia	Escherichia	FW	I-NP	O
coli	coli	FW	I-NP	O
strains	strain	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
delay	delay	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
before	before	IN	B-PP	O
growth	growth	NN	B-NP	O

The	The	DT	B-NP	O
index	index	NN	I-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
boy	boy	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
typical	typical	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
OPD	OPD	NN	B-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
bowing	bow	VBG	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	O
bones	bone	NNS	I-NP	O
and	and	CC	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
thorax	thorax	NN	I-NP	O
and	and	CC	O	O
spinal	spinal	JJ	B-NP	O
column	column	NN	I-NP	O

After	After	IN	B-PP	O
enzymatic	enzymatic	JJ	B-NP	O
hydrolysis	hydrolysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
water	water	NN	I-NP	O
soluble	soluble	JJ	I-NP	O
fraction	fraction	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
1	1	CD	B-NP	O
is	be	VBZ	B-VP	O
again	again	RB	B-ADJP	O
extractable	extractable	JJ	I-ADJP	O
by	by	IN	B-PP	O
DCM	DCM	NN	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
1	1	CD	B-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
unchanged	unchanged	JJ	B-NP	O
SC1	SC1	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
therefore	therefore	RB	B-ADVP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
partner	partner	NN	I-NP	O
of	of	IN	B-PP	O
conjugated	conjugate	VBN	B-NP	O
products	product	NNS	I-NP	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
family	family	NN	I-NP	O
display	display	VBP	B-VP	O
strong	strong	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
homologies	homology	NNS	I-NP	O
between	between	IN	B-PP	O
their	their	PRP$	B-NP	O
larger	large	JJR	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
effector	effector	NN	I-NP	O
binding	binding	NN	I-NP	O
/	/	SYM	B-NP	O
oligomerization	oligomerization	NN	I-NP	O
domains	domain	NNS	I-NP	O

Microalbuminuria	Microalbuminuria	NNP	B-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
marker	marker	NN	I-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
disease	disease	NN	I-NP	O

Long	Long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
ambulatory	ambulatory	JJ	I-NP	O
measurement	measurement	NN	I-NP	O
of	of	IN	B-PP	O
transcutaneous	transcutaneous	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
CO1	CO1	NN	I-NP	O
pressure	pressure	NN	I-NP	O
(	(	(	O	O
PCO1	PCO1	NN	B-NP	O
)	)	)	O	O
offers	offer	VBZ	B-VP	O
an	an	DT	B-NP	O
opportunity	opportunity	NN	I-NP	O
to	to	TO	B-VP	O
test	test	VB	I-VP	O
directly	directly	RB	B-ADVP	O
the	the	DT	B-NP	O
co	co	AFX	I-NP	O
-	-	HYPH	I-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
panic	panic	NN	B-NP	O
and	and	CC	I-NP	O
hyperventilation	hyperventilation	NN	I-NP	O
under	under	IN	B-PP	O
natural	natural	JJ	B-NP	O
conditions	condition	NNS	I-NP	O

An	An	DT	B-NP	O
association	association	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
zafirlukast	zafirlukast	NN	B-NP	O
plasma	plasma	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
and	and	CC	I-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
PC1SRaw	PC1SRaw	NN	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

Most	Most	RBS	B-ADVP	O
interestingly	interestingly	RB	I-ADVP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
effector	effector	NN	I-NP	O
plasmid	plasmid	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
ICP1	BEGIN-BEGIN-ICP1-INSIDE	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
had	have	VBD	B-VP	O
little	little	JJ	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
and	and	CC	I-NP	O
marked	marked	JJ	I-NP	O
effects	effect	NNS	I-NP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
when	when	WRB	B-ADVP	O
ICP1	BEGIN-ICP1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
combined	combine	VBN	I-VP	O
with	with	IN	B-PP	O
ICP1	BEGIN-ICP1-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
ICP1	BEGIN-ICP1-INSIDE	NN	I-NP	B
or	or	CC	O	O
both	both	DT	B-NP	O

Water	Water	JJ	B-NP	O
pair	pair	NN	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
-	-	HYPH	I-NP	O
body	body	NN	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
spectroscopic	spectroscopic	JJ	B-NP	O
quality	quality	NN	I-NP	O
from	from	IN	B-PP	O
Ab	Ab	NN	B-NP	O
initio	initio	NN	I-NP	O
calculations	calculation	NNS	I-NP	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
wa	BEGIN-wa	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mutation	mutation-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
vicinity	vicinity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
EGF	BEGIN-EGF	NN	I-NP	B
/	/	SYM	B-NP	I
TGF	TGF	NN	I-NP	I
-	-	HYPH	O	I
alpha	alpha	SYM	O	I
receptor	receptor-INSIDE	NN	B-NP	I
(	(	(	O	O
EGFR	BEGIN-EGFR-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O
on	on	IN	B-PP	O
mouse	mouse	NN	B-NP	O
chromosome	chromosome	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
hypothesized	hypothesize	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
wa	BEGIN-wa	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
phenotype	phenotype-INSIDE	NN	I-NP	I
might	might	MD	B-VP	O
result	result	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
or	or	CC	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
EGFR	BEGIN-EGFR-INSIDE	NN	B-NP	B
,	,	,	O	O
or	or	CC	O	O
both	both	DT	O	O

1	1	LS	B-LST	O
)	)	)	O	O
Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
extracellular	extracellular	JJ	I-NP	O
cysteine	cysteine	NN	I-NP	O
residues	residue	NNS	I-NP	O
of	of	IN	B-PP	O
GFKAR	BEGIN-GFKAR	NN	B-NP	B
beta	beta-INSIDE	NN	I-NP	I
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
conserved	conserve	VBN	I-NP	O
cysteine	cysteine	NN	I-NP	O
residues	residue	NNS	I-NP	O
(	(	(	O	O
C1	C1	NN	B-NP	O
and	and	CC	O	O
C1	C1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
located	located	JJ	B-ADJP	O
between	between	IN	B-PP	O
two	two	CD	B-NP	O
transmembrane	transmembrane	NN	I-NP	O
segments	segment	NNS	I-NP	O
,	,	,	O	O
form	form	VBP	B-VP	O
a	a	DT	B-NP	O
solvent	solvent	NN	I-NP	O
-	-	HYPH	B-NP	O
accessible	accessible	JJ	I-NP	O
disulfide	disulfide	NN	I-NP	O
bond	bond	NN	I-NP	O

R	R	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
wall	wall	NN	I-NP	O
was	be	VBD	B-VP	O
maximum	maximum	JJ	B-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
cmH1O.L	cmH1O.L	NN	I-NP	O
-	-	HYPH	B-NP	O
1.sec	1.sec	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
SE	SE	NN	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
Hz	Hz	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
f	f	NN	I-NP	O
and	and	CC	I-NP	O
VT	VT	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
VT	VT	NN	I-NP	O
effect	effect	NN	I-NP	O
diminished	diminish	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
f	f	NN	I-NP	O

Time	Time	NN	B-NP	O
dependence	dependence	NN	I-NP	O
of	of	IN	B-PP	O
frequency	frequency	NN	B-NP	O
potentiation	potentiation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
guinea	guinea	NN	I-NP	O
-	-	HYPH	O	O
pig	pig	NN	B-NP	O
's	's	POS	B-NP	O
atrium	atrium	NN	I-NP	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Drosophila	BEGIN-Drosophila	NN	I-NP	B
virilis	virilis	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
several	several	JJ	B-NP	O
blocks	block	NNS	I-NP	O
of	of	IN	B-PP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
very	very	RB	B-VP	O
highly	highly	RB	I-VP	O
conserved	conserve	VBN	I-VP	O

The	The	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	O	O
terminal	terminal	JJ	B-NP	O
exon1	exon1	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
homology	homology	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
level	level	NN	I-NP	O
with	with	IN	B-PP	O
NGFI	BEGIN-NGFI	NN	B-NP	B
-	-	HYPH	I-NP	I
B	B-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	O
homologue	homologue	NN	I-NP	O

Although	Although	IN	B-SBAR	O
RAD1	BEGIN-RAD1-INSIDE	NN	B-NP	B
,	,	,	O	O
RAD1	BEGIN-RAD1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
MEC1	BEGIN-MEC1-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
arrest	arrest	NN	I-NP	O
when	when	WRB	B-ADVP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
is	be	VBZ	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
hydroxyurea	hydroxyurea	NN	B-NP	O
(	(	(	O	O
HU	HU	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
they	they	PRP	B-NP	O
do	do	VBP	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
viability	viability	NN	I-NP	O
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	O
cells	cell	NNS	I-NP	O
grown	grow	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
HU	HU	NN	B-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
because	because	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
HU	HU	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
DNA	DNA	NN	I-NP	O
damage	damage	NN	I-NP	O

Single	Single	JJ	B-NP	O
oblique	oblique	NN	I-NP	O
-	-	HYPH	I-NP	O
view	view	NN	I-NP	O
mammography	mammography	NN	I-NP	O
for	for	IN	B-PP	O
periodic	periodic	JJ	B-NP	O
screening	screening	NN	I-NP	O
for	for	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O

Conventional	Conventional	JJ	B-NP	O
toxicological	toxicological	JJ	I-NP	O
considerations	consideration	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
adverse	adverse	JJ	I-NP	O
health	health	NN	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
necessary	necessary	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
coal	coal	NN	B-NP	O
combustion	combustion	NN	I-NP	O
effluents	effluent	NNS	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
greatest	great	JJS	B-ADJP	O
per	per	IN	B-PP	O
unit	unit	NN	B-NP	O
of	of	IN	B-PP	O
coal	coal	NN	B-NP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
areas	area	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
most	most	RBS	B-ADVP	O
heavily	heavily	RB	I-ADVP	O
populated	populated	JJ	B-NP	O
and	and	CC	O	O
have	have	VBP	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
preexisting	preexisting	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gas	gas	NN	I-NP	O
-	-	HYPH	I-NP	O
aerosol	aerosol	NN	I-NP	O
complex	complex	NN	I-NP	O

The	The	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
bloody	bloody	JJ	B-NP	O
method	method	NN	I-NP	O
in	in	IN	B-PP	O
anesthizied	anesthizie	VBN	B-NP	O
animals	animal	NNS	I-NP	O

Nicotinic	BEGIN-Nicotinic	JJ	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
antagonists	antagonist	NNS	I-NP	O
mecamylamine	mecamylamine	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
hexamethonium	hexamethonium	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
nicotine	nicotine	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
work	work	NN	I-NP	O
represents	represent	VBZ	B-VP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
a	a	DT	B-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
measuring	measure	VBG	B-VP	O
relative	relative	JJ	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
in	in	IN	B-PP	O
intestinal	intestinal	JJ	B-NP	O
capillaries	capillary	NNS	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
fluorescein	fluorescein	NN	I-NP	O
(	(	(	O	O
Na	Na	NN	B-NP	O
-	-	HYPH	B-NP	O
F	F	NN	I-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
indicator	indicator	NN	I-NP	O
substance	substance	NN	I-NP	O

The	The	DT	B-NP	O
matrix	matrix	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CBs	CB	NNS	I-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
protein	protein	NN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
coilin	BEGIN-coilin-INSIDE	NN	I-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
colocalized	colocalize	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
U1	BEGIN-U1	NN	I-NP	B
small	small	JJ	I-NP	I
nuclear	nuclear	JJ	I-NP	I
ribonucleoprotein	ribonucleoprotein-INSIDE	NN	I-NP	I
(	(	(	O	O
snRNP	snRNP	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
attached	attach	VBN	I-NP	O
and	and	CC	I-NP	O
embedded	embed	VBN	I-NP	O
B	B	NN	I-NP	O
-	-	HYPH	I-NP	O
snurposomes	snurposome	NNS	B-NP	O
contain	contain	VBP	B-VP	O
splicing	splicing	NN	B-NP	O
snRNPs	snRNP	NNS	I-NP	O

Tritium	Tritium	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
environmental	environmental	JJ	B-NP	O
water	water	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
within	within	IN	B-PP	O
an	an	DT	B-NP	O
accuracy	accuracy	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
method	method	NN	I-NP	O
when	when	WRB	B-ADVP	O
Vi	Vi	NN	B-NP	O
/	/	SYM	I-NP	O
Vf	Vf	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
syndrome	syndrome	NN	B-NP	O
X	X	NN	I-NP	O
,	,	,	O	O
myocardial	myocardial	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
frequently	frequently	RB	B-ADVP	O
develops	develop	VBZ	B-VP	O
during	during	IN	B-PP	O
daily	daily	JJ	B-NP	O
life	life	NN	I-NP	O
;	;	:	O	O
silent	silent	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
oxygen	oxygen	NN	I-NP	O
demand	demand	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
vasodilatory	vasodilatory	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O

Two	Two	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Ewing	Ewing	NNP	B-NP	O
's	's	POS	B-NP	O
sarcoma	sarcoma	NN	I-NP	O
relapsed	relapse	VBD	B-VP	O
(	(	(	O	O
1	1	CD	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
both	both	CC	B-NP	O
local	local	JJ	I-NP	O
and	and	CC	I-NP	O
distant	distant	JJ	I-NP	O
failure	failure	NN	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
again	again	RB	I-VP	O
rendered	render	VBN	B-NP	O
disease	disease	NN	I-NP	O
-	-	HYPH	O	O
free	free	JJ	B-ADJP	O
with	with	IN	B-PP	O
surgery	surgery	NN	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
irradiation	irradiation	NN	I-NP	O
and	and	CC	O	O
further	further	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
subcellular	subcellular	JJ	I-NP	O
location	location	NN	I-NP	O
,	,	,	O	O
domain	domain	NN	B-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
biochemical	biochemical	JJ	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
metaxin	BEGIN-metaxin-INSIDE	NN	B-NP	B
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O

Long	Long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
on	on	IN	B-PP	O
-	-	HYPH	B-NP	O
heart	heart	NN	I-NP	O
-	-	HYPH	O	O
beating	beat	VBG	B-VP	O
donor	donor	NN	B-NP	O
kidney	kidney	NN	I-NP	O
transplantation	transplantation	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
center	center	NN	I-NP	O
experience	experience	NN	I-NP	O

When	When	WRB	B-ADVP	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
point	point	NN	I-NP	O
mutation	mutation	NN	I-NP	O
was	be	VBD	B-VP	O
introduced	introduce	VBN	I-VP	O
to	to	TO	B-PP	O
each	each	DT	B-NP	O
GC	GC	NN	I-NP	O
box	box	NN	I-NP	O
,	,	,	O	O
EBS	BEGIN-EBS-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
GT	GT	NN	B-NP	O
box	box	NN	I-NP	O
in	in	IN	B-PP	O
PFP1a1	BEGIN-PFP1a1-INSIDE	NN	B-NP	B
,	,	,	O	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	I-NP	O
less	less	RBR	I-NP	O
CAT	BEGIN-CAT-INSIDE	JJ	I-NP	B
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
CTLL	CTLL	NN	B-NP	O
-	-	HYPH	B-NP	O
R1	R1	NN	I-NP	O
cells	cell	NNS	I-NP	O

Thirty	Thirty	CD	B-NP	O
-	-	HYPH	I-NP	O
three	three	CD	I-NP	O
percent	percent	NN	I-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
titers	titer	NNS	B-NP	O
(	(	(	O	O
above	above	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	B-NP	O
1	1	CD	I-NP	O
dilution	dilution	NN	I-NP	O
)	)	)	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
uncertainty	uncertainty	NN	B-NP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
how	how	WRB	B-ADVP	O
results	result	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
in	in	IN	B-PP	O
recent	recent	JJ	B-NP	O
experiments	experiment	NNS	I-NP	O
scale	scale	VBP	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
landscape	landscape	NN	B-NP	O
and	and	CC	O	O
regional	regional	JJ	B-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
generalize	generalize	VB	B-VP	O
across	across	IN	B-PP	O
ecosystem	ecosystem	NN	B-NP	O
types	type	NNS	I-NP	O
and	and	CC	I-NP	O
processes	process	NNS	I-NP	O

Chest	Ch	JJS	B-NP	O
X	X	SYM	I-NP	O
-	-	HYPH	I-NP	O
P	P	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
shadow	shadow	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O

Despite	Despite	IN	B-PP	O
these	these	DT	B-NP	O
high	high	JJ	I-NP	O
initial	initial	JJ	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
promoter	promoter	NN	I-NP	O
constructs	construct	NNS	I-NP	O
only	only	RB	B-NP	O
LAT	BEGIN-LAT-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
LTR	LTR	NN	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
remain	remain	VB	I-VP	O
transcriptionally	transcriptionally	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
latent	latent	JJ	I-NP	O
state	state	NN	I-NP	O

Unestablished	Unestablished	JJ	B-NP	O
quail	quail	NN	I-NP	O
myoblasts	myoblast	NNS	I-NP	O
were	be	VBD	B-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
retroviral	retroviral	JJ	I-NP	O
vector	vector	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
oncogenic	oncogenic	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
H	BEGIN-H	NN	B-NP	B
-	-	HYPH	B-NP	I
Ras	Ras-INSIDE	NN	I-NP	I
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
this	this	DT	B-NP	O
oncoprotein	oncoprotein	NN	I-NP	O
interferes	interfere	VBZ	B-VP	O
with	with	IN	B-PP	O
terminal	terminal	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O

Exhaled	Exhaled	JJ	B-NP	O
NO	NO	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
controlled	control	VBN	B-NP	O
-	-	HYPH	I-NP	O
flow	flow	NN	I-NP	O
chemoluminescence	chemoluminescence	NN	I-NP	O
after	after	IN	B-PP	O
adjusting	adjust	VBG	B-VP	O
for	for	IN	B-PP	O
trapped	trap	VBN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	B-PP	O
after	after	IN	B-PP	O
generating	generate	VBG	B-VP	O
pressure	pressure	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
close	close	VB	I-VP	O
the	the	DT	B-NP	O
soft	soft	JJ	I-NP	O
palate	palate	NN	I-NP	O
(	(	(	O	O
Eco	Eco	NNP	B-NP	O
Physics	Physics	NNP	I-NP	O
CLD	CLD	NNP	I-NP	O
1	1	CD	I-NP	O
AM	AM	NNP	I-NP	O
analyzer	analyzer	NN	I-NP	O
)	)	)	O	O

SATB1	BEGIN-SATB1-INSIDE	NN	B-NP	B
interacted	interact	VBD	B-VP	O
with	with	IN	B-PP	O
CDP	BEGIN-CDP-INSIDE	NN	B-NP	B
through	through	IN	B-PP	O
its	its	PRP$	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
by	by	IN	B-PP	O
glutathione	BEGIN-glutathione	NN	B-NP	B
S	S	NN	I-NP	I
-	-	HYPH	O	I
transferase	transferase-INSIDE	NN	B-NP	I
(	(	(	O	O
GST	BEGIN-GST-INSIDE	NN	B-NP	B
)	)	)	O	O
pull	pull	VB	B-VP	O
-	-	HYPH	B-ADJP	O
down	down	RP	B-PRT	O
assays	assay	NNS	B-NP	O

Both	Both	CC	O	O
the	the	DT	B-NP	O
inactive	inactive	JJ	I-NP	O
domain	BEGIN-domain	NN	I-NP	B
II	II	CD	I-NP	I
P1	P1	NN	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
deletion	deletion	NN	I-NP	O
mutant	mutant	NN	I-NP	O
lacking	lack	VBG	B-VP	O
aa	aa	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
were	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
inhibitory	inhibitory	JJ	I-ADJP	O
to	to	TO	B-PP	O
growth	growth	NN	B-NP	O
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
phosphorylate	phosphorylate	VB	I-VP	O
initiation	BEGIN-initiation	NN	B-NP	B
factor	factor	NN	I-NP	I
1	1	CD	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Applying	Apply	VBG	B-VP	O
the	the	DT	B-NP	O
experience	experience	NN	I-NP	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
META	META	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
bond	bond	VB	I-VP	O
a	a	DT	B-NP	O
proprietary	proprietary	JJ	I-NP	O
photocuring	photocure	VBG	I-NP	O
microfilled	microfilled	JJ	I-NP	O
composite	composite	JJ	I-NP	O
material	material	NN	I-NP	O
to	to	TO	B-PP	O
Class	Class	NNP	B-NP	O
V	V	NNP	I-NP	O
cavities	cavity	NNS	I-NP	O
in	in	IN	B-PP	O
freshly	freshly	RB	B-NP	O
extracted	extract	VBN	I-NP	O
human	human	JJ	I-NP	O
teeth	tooth	NNS	I-NP	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intractability	intractability	NN	I-NP	O
,	,	,	O	O
cell	cell	NN	B-NP	O
function	function	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
defense	defense	NN	I-NP	O
against	against	IN	B-PP	O
infection	infection	NN	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O

IV	IV	CD	B-NP	O

A	A	DT	B-NP	O
Premenstrual	Premenstrual	NNP	I-NP	O
Syndrome	Syndrome	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
late	late	JJ	I-NP	O
luteal	luteal	JJ	I-NP	O
phase	phase	NN	I-NP	O
disorder	disorder	NN	I-NP	O
of	of	IN	B-PP	O
DSM	DSM	NN	B-NP	O
-	-	HYPH	B-NP	O
IIIR	IIIR	NN	I-NP	O
criteria	criterion	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
women	woman	NNS	I-NP	O

After	After	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
h	h	NN	I-NP	O
thermal	thermal	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
carrying	carry	VBG	B-VP	O
the	the	DT	B-NP	O
runaway	runaway	JJ	I-NP	O
recombinant	recombinant	JJ	I-NP	O
pBS1	pBS1	NN	I-NP	O
,	,	,	O	O
protein	BEGIN-protein	NN	B-NP	B
B1	B1-INSIDE	NN	I-NP	I
constituted	constitute	VBD	B-VP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
soluble	soluble	JJ	I-NP	O
protein	protein	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
SS	SS	NN	B-NP	O
and	and	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
exercise	exercise	NN	B-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
ST	ST	NN	I-NP	O
-	-	HYPH	I-NP	O
segment	segment	NN	I-NP	O
depression	depression	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
myocardial	myocardial	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
supply	supply	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
myocardial	myocardial	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
demand	demand	NN	I-NP	O
(	(	(	O	O
elevated	elevate	VBN	B-VP	O
double	double	JJ	B-NP	O
products	product	NNS	I-NP	O
)	)	)	O	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
subjects	subject	NNS	B-NP	O
with	with	IN	B-PP	O
SS	SS	NN	B-NP	O
who	who	WP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
exercise	exercise	NN	B-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
ST	ST	NN	I-NP	O
-	-	HYPH	I-NP	O
segment	segment	NN	I-NP	O
depression	depression	NN	I-NP	O

The	The	DT	B-NP	O
highest	high	JJS	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
respirable	respirable	JJ	B-NP	O
mineral	mineral	NN	I-NP	O
fibres	fibre	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
overhaul	overhaul	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
truck	truck	NN	I-NP	O
with	with	IN	B-PP	O
asbestos	asbestos	NN	B-NP	O
insulation	insulation	NN	I-NP	O
;	;	:	O	O
respirable	respirable	JJ	B-NP	O
fibre	fibre	NN	I-NP	O
concentration	concentration	NN	I-NP	O
reached	reach	VBD	B-VP	O
the	the	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
f	f	NN	I-NP	O
/	/	SYM	B-NP	O
cm1	cm1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
total	total	JJ	B-NP	O
dust	dust	NN	I-NP	O
concentration	concentration	NN	I-NP	O
-	-	HYPH	O	O
the	the	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	O	O
m1	m1	NN	B-NP	O

Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
organisation	organisation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
ancestors	ancestor	NNS	I-NP	O

Mechanisms	Mechanism	NNS	B-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
of	of	IN	B-PP	O
local	local	JJ	B-NP	O
anaesthetics	anaesthetic	NNS	I-NP	O

Gastric	Gastric	JJ	B-NP	O
secretory	secretory	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
three	three	CD	B-NP	O
methyl	methyl	NN	I-NP	O
analogs	analog	NNS	I-NP	O
of	of	IN	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	O
E1	E1	NN	I-NP	O
administered	administer	VBN	B-VP	O
intragastrically	intragastrically	RB	B-ADVP	O
to	to	TO	B-VP	O
man	man	VB	I-VP	O

By	By	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
footprint	footprint	NN	B-NP	O
II	II	CD	I-NP	O
at	at	IN	B-PP	O
position	position	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
is	be	VBZ	B-VP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
both	both	CC	O	O
HeLa	HeLa	NN	B-NP	O
and	and	CC	O	O
GH1	GH1	NN	B-NP	O
cell	cell	NN	I-NP	O
extracts	extract	NNS	I-NP	O
and	and	CC	O	O
overlies	overlie	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
base	base	NN	I-NP	O
-	-	HYPH	I-NP	O
pair	pair	NN	I-NP	O
sequence	sequence	NN	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
growth	BEGIN-growth	NN	I-NP	B
hormone	hormone	NN	I-NP	I
gene	gene	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

DNA	DNA	NN	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
UL1	BEGIN-UL1-INSIDE	NN	I-NP	B
to	to	TO	B-PP	O
UL1	BEGIN-BEGIN-UL1-INSIDE	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
laryngotracheitis	laryngotracheitis	NN	I-NP	O
virus	virus	NN	I-NP	O
and	and	CC	O	O
characterization	characterization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
UL1	BEGIN-BEGIN-UL1-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
product	product-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
a	a	DT	B-NP	O
nonglycosylated	nonglycosylated	JJ	I-NP	O
and	and	CC	I-NP	O
nonessential	nonessential	JJ	I-NP	O
virion	virion	NN	I-NP	O
protein	protein	NN	I-NP	O

Unlike	Unlike	IN	B-PP	O
LANA1	BEGIN-LANA1-INSIDE	NN	B-NP	B
,	,	,	O	O
LANA1	BEGIN-LANA1-INSIDE	NN	B-NP	B
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
elicit	elicit	VB	I-VP	O
a	a	DT	B-NP	O
serologic	serologic	JJ	I-NP	O
response	response	NN	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
KS	KS	NN	B-NP	O
,	,	,	O	O
PEL	PEL	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
CD	CD	NNP	B-NP	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O

CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
degradation	degradation	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
Vpu	BEGIN-Vpu-INSIDE	NN	B-NP	B
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	O
chaperone	chaperone	NN	I-NP	O
calnexin	BEGIN-calnexin-INSIDE	NN	I-NP	B
and	and	CC	O	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
intact	intact	JJ	I-NP	O
ubiquitin	BEGIN-ubiquitin-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
conjugating	conjugate	VBG	B-VP	O
system	system	NN	B-NP	O

A	A	DT	B-NP	O
deletion	deletion	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
FAS1	BEGIN-FAS1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
inositol	inositol	NN	I-NP	O
/	/	SYM	B-NP	O
choline	choline	NN	I-NP	O
-	-	HYPH	B-NP	O
responsive	responsive	JJ	I-NP	O
-	-	HYPH	I-NP	O
element	element	NN	I-NP	O
motif	motif	NN	I-NP	O
defined	define	VBD	B-VP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
(	(	(	O	O
nucleotides	nucleotide	NNS	B-NP	O
-	-	SYM	O	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
activation	activation	NN	I-NP	O
potency	potency	NN	I-NP	O

Promoter	Promoter	NN	B-NP	O
constructs	construct	NNS	I-NP	O
containing	contain	VBG	B-VP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PTRE	BEGIN-PTRE	NN	I-NP	B
sequence	sequence-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
selectively	selectively	RB	B-ADVP	O
abolished	abolish	VBD	B-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
either	either	DT	B-NP	O
one	one	CD	I-NP	O
or	or	CC	O	O
both	both	DT	B-NP	O
complexes	complex	NNS	I-NP	O
exerted	exert	VBD	B-VP	O
opposite	opposite	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
trypsin	BEGIN-trypsin	NN	B-NP	B
promoters	promoters-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
A.	A.	NN	B-NP	O
gambiae	gambiae	NN	I-NP	O
and	and	CC	O	O
Aedes	Aede	NNS	B-NP	O
aegypti	aegypti	AFX	B-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

This	This	DT	B-NP	O
preliminary	preliminary	JJ	I-NP	O
study	study	NN	I-NP	O
reports	report	VBZ	B-VP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
HMPAO	HMPAO	NN	B-NP	O
-	-	HYPH	B-NP	O
SPECT	SPECT	NN	I-NP	O
imaging	imaging	NN	I-NP	O
for	for	IN	B-PP	O
assessing	assess	VBG	B-VP	O
regional	regional	JJ	B-NP	O
alterations	alteration	NNS	I-NP	O
in	in	IN	B-PP	O
brain	brain	NN	B-NP	O
function	function	NN	I-NP	O
during	during	IN	B-PP	O
opiate	opiate	NN	B-NP	O
dependence	dependence	NN	I-NP	O
and	and	CC	O	O
withdrawal	withdrawal	NN	B-NP	O

The	The	DT	B-NP	O
revaluation	revaluation	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
compliance	compliance	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
proposed	propose	VBN	I-NP	O
diet	diet	NN	I-NP	O
scheme	scheme	NN	I-NP	O
by	by	IN	B-PP	O
children	child	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
compliance	compliance	NN	I-NP	O
by	by	IN	B-PP	O
their	their	PRP$	B-NP	O
families	family	NNS	I-NP	O

Cytostatic	Cytostatic	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
essential	essential	JJ	I-NP	O
oils	oil	NNS	I-NP	O
against	against	IN	B-PP	O
HEp	HEp	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O

Custom	Custom	NN	B-NP	O
-	-	HYPH	O	O
made	make	VBN	B-NP	O
orthoses	orthos	NNS	I-NP	O
play	play	VBP	B-VP	O
an	an	DT	B-NP	O
invaluable	invaluable	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
achieving	achieve	VBG	B-VP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
goals	goal	NNS	I-NP	O
:	:	:	O	O
improving	improve	VBG	B-VP	O
function	function	NN	B-NP	O
and	and	CC	I-NP	O
pinch	pinch	NN	I-NP	O
,	,	,	O	O
stabilizing	stabilize	VBG	B-VP	O
individual	individual	JJ	B-NP	O
joints	joint	NNS	I-NP	O
,	,	,	O	O
preventing	prevent	VBG	B-VP	O
positional	positional	JJ	B-NP	O
contractures	contracture	NNS	I-NP	O
,	,	,	O	O
protecting	protect	VBG	B-VP	O
joints	joint	NNS	B-NP	O
from	from	IN	B-PP	O
trauma	trauma	NN	B-NP	O
,	,	,	O	O
stretching	stretch	VBG	B-VP	O
the	the	DT	B-NP	O
intrinsic	intrinsic	JJ	I-NP	O
muscles	muscle	NNS	I-NP	O
,	,	,	O	O
correcting	correct	VBG	B-VP	O
joint	joint	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
soft	soft	JJ	I-NP	O
-	-	HYPH	I-NP	O
tissue	tissue	NN	I-NP	O
contractures	contracture	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
controlling	control	VBG	B-VP	O
inflammation	inflammation	NN	B-NP	O

Excess	Excess	JJ	B-NP	O
recombinant	BEGIN-recombinant	JJ	I-NP	B
PTB	PTB-INSIDE	NN	I-NP	I
squelches	squelch	VBZ	B-VP	O
the	the	DT	B-NP	O
splicing	splicing	NN	I-NP	O
switch	switch	NN	I-NP	O
and	and	CC	O	O
reestablishes	reestablish	VBZ	B-VP	O
exon	exon	NN	B-NP	O
skipping	skipping	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
splicing	splicing	NN	I-NP	O
pathway	pathway	NN	I-NP	O

Among	Among	IN	B-PP	O
women	woman	NNS	B-NP	O
,	,	,	O	O
plasma	BEGIN-plasma	NN	B-NP	B
factor	factor	NN	I-NP	I
VII	VII-INSIDE	NN	I-NP	I
:	:	:	O	O
Ag	Ag	NN	B-NP	O
was	be	VBD	B-VP	O
inversely	inversely	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
income	income	NN	B-NP	O

We	We	PRP	B-NP	O
concluded	conclude	VBD	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
feasibility	feasibility	NN	I-NP	O
and	and	CC	I-NP	O
usefulness	usefulness	NN	I-NP	O
of	of	IN	B-PP	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
of	of	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
RCT	RCT	NN	I-NP	O
in	in	IN	B-PP	O
rheumatology	rheumatology	NN	B-NP	O
practice	practice	NN	I-NP	O

K1	K1	NN	B-NP	O
erythroleukemia	erythroleukemia	NN	I-NP	O
cells	cell	NNS	I-NP	O
stably	stably	RB	B-VP	O
transfected	transfecte	VBN	I-VP	O
with	with	IN	B-PP	O
constructs	construct	NNS	B-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
Agamma	Agamma	NN	I-NP	I
-	-	HYPH	B-NP	I
globin	globin	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
enhanced	BEGIN-enhanced	JJ	I-NP	B
green	green	JJ	I-NP	I
fluorescent	fluorescent	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
EGFP	BEGIN-EGFP-INSIDE	NN	B-NP	B
)	)	)	O	O
reporter	reporter	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
or	or	CC	B-PP	O
without	without	IN	B-PP	O
HS1	HS1	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
for	for	IN	B-PP	O
EGFP	BEGIN-EGFP-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
platelet	BEGIN-platelet	NN	B-NP	B
-	-	HYPH	B-VP	I
derived	derive	VBN	B-NP	I
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
(	(	(	O	I
PDGF	PDGF	NN	B-NP	I
)	)	)	O	I
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
various	various	JJ	B-NP	O
other	other	JJ	I-NP	O
growth	growth	NN	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
inhibits	inhibit	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
alpha1D	BEGIN-alpha1D-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	O	O
alpha1A	BEGIN-alpha1A-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
or	or	CC	I-NP	O
alpha1B	BEGIN-alpha1B	NN	I-NP	B
-	-	HYPH	I-NP	I
ARs	ARs-INSIDE	NN	I-NP	I
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
norepinephrine	norepinephrine	NN	I-NP	O
-	-	HYPH	O	O
mediated	mediate	VBN	B-NP	O
SMC	SMC	NN	I-NP	O
growth	growth	NN	I-NP	O

(	(	(	O	O
A	A	DT	B-NP	O
short	short	JJ	I-NP	O
account	account	NN	I-NP	O
of	of	IN	B-PP	O
Karl	Karl	NNP	B-NP	O
Touton	Touton	NNP	I-NP	O
's	's	POS	B-NP	O
life	life	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
included.	included.	VBN	I-VP	O
)	)	)	O	O
After	After	IN	B-PP	O
reviewing	review	VBG	B-VP	O
the	the	DT	B-NP	O
historical	historical	JJ	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
giant	giant	JJ	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
current	current	JJ	B-NP	O
interpretations	interpretation	NNS	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
nature	nature	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
unitarian	unitarian	JJ	I-NP	O
view	view	NN	I-NP	O
of	of	IN	B-PP	O
polykaryons	polykaryon	NNS	B-NP	O
now	now	RB	B-VP	O
favored	favor	VBN	I-VP	O
by	by	IN	B-PP	O
workers	worker	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
field	field	NN	I-NP	O
is	be	VBZ	B-VP	O
extended	extend	VBN	I-VP	O
to	to	TO	I-VP	O
include	include	VB	I-VP	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
``	``	``	I-NP	O
xanthelasmatic	xanthelasmatic	JJ	I-NP	O
giant	giant	JJ	I-NP	O
cell	cell	NN	I-NP	O
''	''	''	O	O
of	of	IN	B-PP	O
Touton	Touton	NNP	B-NP	O
,	,	,	O	O
whose	whose	WP$	B-NP	O
characteristic	characteristic	JJ	I-NP	O
appearance	appearance	NN	I-NP	O
is	be	VBZ	B-VP	O
determined	determine	VBN	I-VP	O
merely	merely	RB	B-ADVP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
demonstrable	demonstrable	JJ	B-NP	O
lipid	lipid	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
previously	previously	RB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
LPS	LPS	NN	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
splenic	splenic	JJ	B-NP	O
B	B	NN	I-NP	O
cells	cell	NNS	I-NP	O
from	from	IN	B-PP	O
athymic	athymic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
steady	steady	JJ	B-NP	O
state	state	NN	I-NP	O
mRNA	mRNA	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
A	BEGIN-A	NN	I-NP	B
alpha	alpha	NN	I-NP	I
class	class	NN	I-NP	I
II	II	CD	I-NP	I
protein	protein-INSIDE	NN	I-NP	I

After	After	IN	B-PP	O
birth	birth	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
higher	high	JJR	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
IgA	BEGIN-IgA-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
IgM	BEGIN-BEGIN-IgM-INSIDE	NN	I-NP	B
anti	anti	AFX	O	O
-	-	HYPH	B-NP	O
M.	M.	NN	I-NP	O
leprae	leprae	NNS	I-NP	O
antibody	antibody-INSIDE	JJ	B-NP	I
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
sera	serum	NNS	B-NP	O
taken	take	VBN	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
birth	birth	NN	B-NP	O
from	from	IN	B-PP	O
babies	baby	NNS	B-NP	O
of	of	IN	B-PP	O
Group	Group	NN	B-NP	O
1	1	CD	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
Group	Group	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
IgA	BEGIN-IgA-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
IgM	BEGIN-IgM-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
sera	serum	NNS	B-NP	O
taken	take	VBN	B-VP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O

Serum	Serum	NN	B-NP	O
estriol	estriol	NN	I-NP	O
levels	level	NNS	I-NP	O
during	during	IN	B-PP	O
beta	BEGIN-beta	NN	B-NP	B
-	-	HYPH	B-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
agonist	agonist	NN	I-NP	O
infusion	infusion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
trimester	trimester	NN	I-NP	O
of	of	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O

These	These	DT	B-NP	O
tiny	tiny	JJ	I-NP	O
premature	premature	JJ	I-NP	O
infants	infant	NNS	I-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
PN	PN	NN	B-NP	O
for	for	IN	B-PP	O
significantly	significantly	RB	B-NP	O
longer	long	JJR	I-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	O	O
longer	long	JJR	O	O
the	the	DT	B-NP	O
infusions	infusion	NNS	I-NP	O
were	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
the	the	DT	B-NP	O
greater	great	JJR	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
cholestasis	cholestasis	NN	B-NP	O
developing	develop	VBG	B-VP	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
sae1	BEGIN-sae1	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
sae1	BEGIN-BEGIN-sae1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
mutations	mutations-INSIDE	NN	I-NP	I
each	each	DT	B-NP	O
confer	confer	VBP	B-VP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
meiotic	meiotic	JJ	B-NP	O
recombination.	recombination.	NN	I-NP	O
sae1	BEGIN-sae1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
produces	produce	VBZ	B-VP	O
recombinants	recombinant	NNS	B-NP	O
but	but	CC	O	O
very	very	RB	B-ADVP	O
slowly	slowly	RB	I-ADVP	O
and	and	CC	O	O
ultimately	ultimately	RB	B-ADVP	O
to	to	TO	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
half	half	PDT	I-NP	O
the	the	DT	I-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
level	level	NN	I-NP	O
;	;	:	O	O
sae1	BEGIN-sae1	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
makes	make	VBZ	B-VP	O
persistent	persistent	JJ	B-NP	O
hyper	hyper	NN	I-NP	O
-	-	HYPH	O	O
resected	resecte	VBN	B-VP	O
meiotic	meiotic	JJ	B-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
strand	strand	NN	I-NP	O
breaks	break	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
severe	severe	JJ	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
recombinants	recombinant	NNS	B-NP	O

Patients	Patient	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mucinous	mucinous	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
group	group	NN	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
CA	BEGIN-CA	NN	I-NP	B
1	1-INSIDE	NN	I-NP	I
cystic	cystic	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
levels	level	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
endometriomas	endometrioma	NNS	B-NP	O
and	and	CC	I-NP	O
dermoids	dermoid	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
&	&	CC	I-NP	O
lt	lt	NN	I-NP	O
;	;	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O

The	The	DT	B-NP	O
brains	brain	NNS	I-NP	O
were	be	VBD	B-VP	O
processed	process	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
tetramethylbenzidine	tetramethylbenzidine	NN	I-NP	O
(	(	(	O	O
TMB	TMB	NN	B-NP	O
)	)	)	O	O
protocol	protocol	NN	B-NP	O
of	of	IN	B-PP	O
Mesulam	Mesulam	NN	B-NP	O
(	(	(	O	O
'1	'1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
studied	study	VBN	B-VP	O
with	with	IN	B-PP	O
darkfield	darkfield	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
WT1	BEGIN-WT1	NN	B-NP	B
target	target	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
stably	stably	RB	B-NP	O
transfected	transfecte	VBN	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

Some	Some	DT	B-NP	O
may	may	MD	B-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
folding	folding	NN	I-NP	O
pathway	pathway	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
chaperonins	BEGIN-chaperonins-INSIDE	NN	B-NP	B

Amniotic	Amniotic	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
ionic	ionic	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
fetal	BEGIN-fetal	JJ	I-NP	B
vasopressin	vasopressin-INSIDE	NN	I-NP	I
infusion	infusion	NN	I-NP	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
bentonite	bentonite	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
compounding	compounding	NN	I-NP	O
of	of	IN	B-PP	O
hydrogels	hydrogel	NNS	B-NP	O

VBP	BEGIN-VBP-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
a1	BEGIN-a1	NN	I-NP	B
/	/	SYM	B-NP	I
EBP	EBP-INSIDE	NN	I-NP	I
could	could	MD	B-VP	O
mediate	mediate	VB	I-VP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
ALV	ALV	NN	B-NP	O
and	and	CC	O	O
RSV	BEGIN-RSV	NN	B-NP	B
LTR	LTR-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
enhanced	enhance	VBN	B-VP	O
transcription	transcription	NN	B-NP	O
in	in	IN	B-PP	O
bursal	bursal	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
many	many	JJ	B-NP	O
other	other	JJ	I-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O

Insulin	BEGIN-Insulin-INSIDE	NN	B-NP	B
therapy	therapy	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
expanded	expand	VBN	I-VP	O
by	by	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
insulin	BEGIN-insulin-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	O	O
new	new	JJ	B-NP	O
modes	mode	NNS	I-NP	O
of	of	IN	B-PP	O
injection	injection	NN	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
pumps	pump	NNS	I-NP	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
HIV	HIV	NN	I-NP	I
gp1	gp1-INSIDE	NN	I-NP	I
and	and	CC	O	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
CD1	CD1-INSIDE	NN	I-NP	I
crosslinking	crosslinking	NN	I-NP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
PI	BEGIN-PI	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	O	I
and	and	CC	O	I
PI	PI	NN	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
CD1	CD1-INSIDE	NN	I-NP	I
precipitates	precipitate	NNS	I-NP	O

The	The	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
organization	organization	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
neural	neural	JJ	I-NP	O
-	-	HYPH	I-NP	O
restricted	restricted	JJ	I-NP	O
family	family	NN	I-NP	O
members	member	NNS	I-NP	O
,	,	,	O	O
Hel	BEGIN-Hel	NN	B-NP	B
-	-	HYPH	O	I
N1	N1-INSIDE	NN	B-NP	I
(	(	(	O	O
ELAVL1	BEGIN-ELAVL1-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
mHuD	BEGIN-mHuD-INSIDE	NN	B-NP	B
(	(	(	O	O
Elavl1	BEGIN-Elavl1-INSIDE	NN	B-NP	B
)	)	)	O	O

Chronic	Chronic	JJ	B-NP	O
active	active	JJ	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
and	and	CC	I-NP	O
pregnancy	pregnancy	NN	I-NP	O

1nd	1nd	CD	B-NP	O
annual	annual	JJ	I-NP	O
meeting	meeting	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
American	American	NNP	I-NP	O
Academy	Academy	NNP	I-NP	O
of	of	IN	B-PP	O
Oral	Oral	NNP	B-NP	O
Pathology	Pathology	NNP	I-NP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
biodistribution	biodistribution	NN	I-NP	O
of	of	IN	B-PP	O
1In	1In	NN	B-NP	O
IgG	BEGIN-IgG-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
1mTc	1mTc	NN	B-NP	O
-	-	HYPH	B-NP	O
HMPAO	HMPAO	NN	I-NP	O
-	-	HYPH	B-NP	O
labeled	label	VBN	I-NP	O
leukocytes	leukocyte	NNS	I-NP	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
assays	assay	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
elements	element	NNS	I-NP	O
identified	identify	VBN	B-VP	O
can	can	MD	B-VP	O
specifically	specifically	RB	I-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Ets	Ets	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
protein	protein-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
BCL	BEGIN-BCL	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
POZ	POZ	NN	I-NP	O
domain	domain	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
POZ	POZ	NN	I-NP	O
domains	domain	NNS	I-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
co	co	AFX	I-NP	O
-	-	HYPH	I-NP	O
repressors	repressor	NNS	I-NP	O
N	BEGIN-N	NN	I-NP	B
-	-	HYPH	B-NP	I
CoR	CoR-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
SMRT	BEGIN-SMRT-INSIDE	NN	I-NP	B

Since	Since	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
often	often	RB	B-ADVP	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
resort	resort	VB	I-VP	O
to	to	TO	B-PP	O
thoracotomy	thoracotomy	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
final	final	JJ	I-NP	O
step	step	NN	I-NP	O
in	in	IN	B-PP	O
making	make	VBG	B-VP	O
such	such	JJ	B-NP	O
a	a	DT	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
sought	seek	VBN	I-VP	O
a	a	DT	B-NP	O
procedure	procedure	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
simpler	simple	JJR	B-ADJP	O
while	while	IN	B-SBAR	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
providing	provide	VBG	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
information	information	NN	I-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
optic	optic	JJ	I-NP	O
tentacle	tentacle	NN	I-NP	O
-	-	HYPH	B-NP	O
gonadal	gonadal	JJ	I-NP	O
axis	axis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
male	male	JJ	I-NP	O
-	-	HYPH	I-NP	O
phase	phase	NN	I-NP	O
ovotestis	ovotestis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
slug	slug	NN	I-NP	O
(	(	(	O	O
Ariolimax	Ariolimax	NN	B-NP	O
californicus	californicus	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O
GF	GF	NN	I-NP	O
-	-	HYPH	B-NP	O
1X	1X	NN	I-NP	O
abolished	abolish	VBD	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
and	and	CC	O	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
CCK	BEGIN-CCK-INSIDE	NN	B-NP	B
by	by	IN	B-PP	O
1	1	CD	B-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
EGF	BEGIN-EGF-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
activated	activate	VBN	B-NP	O
MAPK	BEGIN-MAPK-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O

Four	Four	CD	B-NP	O
multicannulated	multicannulated	JJ	I-NP	O
Holstein	Holstein	NN	I-NP	O
steers	steer	NNS	I-NP	O
(	(	(	O	O
initial	initial	JJ	B-NP	O
BW	BW	NN	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
Latin	Latin	JJ	I-NP	O
square	square	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
on	on	IN	B-PP	O
forage	forage	NN	B-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
site	site	NN	B-NP	O
and	and	CC	O	O
extent	extent	NN	B-NP	O
of	of	IN	B-PP	O
digestion	digestion	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrient	nutrient	NN	B-NP	O
flow	flow	NN	I-NP	O
in	in	IN	B-PP	O
steers	steer	NNS	B-NP	O
consuming	consume	VBG	B-VP	O
dormant	dormant	JJ	B-NP	O
bluestem	bluestem	NN	I-NP	O
-	-	HYPH	O	O
range	range	NN	B-NP	O
forage	forage	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
CP	CP	NN	I-NP	O
)	)	)	O	O

These	These	DT	B-NP	O
morphological	morphological	JJ	I-NP	O
changes	change	NNS	I-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
P1arom	BEGIN-P1arom	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O

This	This	DT	B-NP	O
residue	residue	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
located	located	JJ	B-NP	O
1	1	CD	I-NP	O
rather	rather	RB	I-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
residues	residue	NNS	I-NP	O
NH1	NH1	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
essential	essential	JJ	I-NP	O
glutamate	glutamate	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
undoubtedly	undoubtedly	RB	B-ADVP	O
the	the	DT	B-NP	O
analog	analog	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
aspartate	aspartate	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Asp	Asp	NN	I-NP	O
-	-	HYPH	B-NP	O
Asp	Asp	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
Glu	Glu	NN	I-NP	O
motif	motif	NN	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
family	family	NN	I-NP	O
members	member	NNS	I-NP	O

DNase	BEGIN-DNase	NN	B-NP	B
I	I-INSIDE	NN	I-NP	I
protection	protection	NN	I-NP	O
analysis	analysis	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
oligonucleotide	oligonucleotide	NN	B-NP	O
competition	competition	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
binding	binding	NN	I-NP	O
is	be	VBZ	B-VP	O
sequence	sequence	NN	B-NP	O
specific	specific	JJ	I-NP	O

METHOD	METHOD	NN	B-NP	O
:	:	:	O	O
After	After	IN	B-PP	O
eligibility	eligibility	NN	B-NP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
were	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
allocated	allocate	VBN	I-VP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
groups	group	NNS	I-NP	O
:	:	:	O	O
M	M	NN	B-NP	O
=	=	SYM	B-VP	O
methylprednisolone	methylprednisolone	NN	B-NP	O
1	1	CD	I-NP	O
mg.kg	mg.kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
over	over	IN	I-NP	O
1	1	CD	I-NP	O
hour	hour	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
mg.kg	mg.kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1.h	1.h	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
N	N	NN	B-NP	O
=	=	SYM	B-VP	O
nimodipine	nimodipine	NN	B-NP	O
1	1	CD	I-NP	O
mg.kg	mg.kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1.h	1.h	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
over	over	IN	I-NP	O
1	1	CD	I-NP	O
hours	hour	NNS	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
mg.kg	mg.kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1.h	1.h	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
MN	MN	NN	B-NP	O
or	or	CC	I-NP	O
P	P	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
that	that	IN	B-SBAR	O
EGF	BEGIN-EGF	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
stimulates	stimulate	VBZ	B-VP	O
gastrin	BEGIN-gastrin-INSIDE	NN	B-NP	B
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
GC	GC	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
element	element	NN	I-NP	O
called	call	VBN	B-VP	O
gERE	gERE	NN	B-NP	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
cis	cis	NN	B-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
elements	element	NNS	B-NP	O
controlling	control	VBG	B-VP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
B	BEGIN-B	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
GAP	BEGIN-GAP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
encoding	encode	VBG	B-VP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
flanking	flanking	NN	I-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O

The	The	DT	B-NP	O
traW	BEGIN-traW	JJ	I-NP	B
gene	gene	NN	I-NP	I
of	of	IN	B-PP	I
the	the	DT	B-NP	I
Escherichia	Escherichia	FW	I-NP	I
coli	coli	FW	I-NP	I
K	K	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
sex	sex	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
,	,	,	O	O
F	F	NNP	B-NP	O
,	,	,	O	O
encodes	encode	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
numerous	numerous	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
conjugative	conjugative	JJ	B-NP	O
transfer	transfer	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O

Profilins	BEGIN-Profilin	NNS	B-NP	B
IIa	IIa	NN	I-NP	I
and	and	CC	I-NP	I
IIb	IIb-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
all	all	DT	B-NP	O
mammals	mammal	NNS	I-NP	O
have	have	VBP	B-VP	O
three	three	CD	B-NP	O
profilin	BEGIN-profilin	NN	I-NP	B
isoforms	isoforms-INSIDE	NN	I-NP	I

Results	Result	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prevention	prevention	NN	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
AF	AF	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
equivocal	equivocal	JJ	B-ADJP	O
;	;	:	O	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
defining	define	VBG	B-VP	O
paroxysmal	paroxysmal	JJ	B-NP	O
AF	AF	NN	I-NP	O

Nuclear	Nuclear	JJ	B-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
SNF1	BEGIN-SNF1	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like-INSIDE	NN	I-NP	I
putative	putative	JJ	I-NP	O
helicase	BEGIN-helicase-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
localization	localization	NN	I-NP	O
sequence	sequence	NN	I-NP	O
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
NH1	NH1	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
region	region	NN	I-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
chemokines	chemokine	NNS	I-NP	O
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
that	that	IN	B-NP	O
both	both	DT	B-NP	O
require	require	VBP	B-VP	O
the	the	DT	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I
and	and	CC	O	O
additional	additional	JJ	B-NP	O
regions	region	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
CAAT	BEGIN-CAAT	NN	I-NP	B
/	/	SYM	B-VP	I
enhancer	enhancer	NN	B-NP	I
binding	binding	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	B-NP	I
EBP	EBP-INSIDE	NN	I-NP	I
)	)	)	O	O
element	element	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

Any	Any	DT	B-NP	O
opacity	opacity	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
radiograph	radiograph	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O

Levels	Level	NNS	B-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
were	be	VBD	B-VP	O
substantially	substantially	RB	I-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
adenovirus	adenovirus	NN	B-NP	O
infection	infection	NN	I-NP	O

This	This	DT	B-NP	O
pathway	pathway	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
heterodimer	heterodimer	NN	B-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
proapoptotic	proapoptotic	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
,	,	,	O	O
Bad	BEGIN-Bad-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
toxicity	toxicity	NN	I-NP	O
of	of	IN	B-PP	O
copper	copper	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
collembolan	collembolan	NN	I-NP	O
Folsomia	Folsomia	NNP	I-NP	O
fimetaria	fimetaria	NNP	I-NP	O
L.	L.	NNP	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
soil	soil	NN	B-NP	O
incubated	incubate	VBN	B-VP	O
with	with	IN	B-PP	O
copper	copper	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
for	for	IN	B-PP	O
different	different	JJ	B-NP	O
periods	period	NNS	I-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
introduction	introduction	NN	I-NP	O
of	of	IN	B-PP	O
collembolans	collembolan	NNS	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
aging	aging	NN	B-NP	O
of	of	IN	B-PP	O
contamination	contamination	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
toxicity	toxicity	NN	I-NP	O
of	of	IN	B-PP	O
copper	copper	NN	B-NP	O

Earlier	Earlier	RBR	B-NP	O
published	publish	VBN	I-NP	O
data	datum	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
R1	BEGIN-R1	NN	I-NP	B
alpha	alpha	SYM	O	I
/	/	SYM	O	I
beta	beta	SYM	B-NP	I
regions	regions-INSIDE	NN	B-NP	I
,	,	,	O	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
confirmed	confirm	VBN	I-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
R1	R1	NN	I-NP	O
initiator	initiator	NN	I-NP	O
element	element	NN	I-NP	O
may	may	MD	B-VP	O
function	function	VB	I-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B

We	We	PRP	B-NP	O
sought	seek	VBD	B-VP	O
to	to	TO	I-VP	O
test	test	VB	I-VP	O
whether	whether	IN	B-SBAR	O
a	a	DT	B-NP	O
prolonged	prolonged	JJ	I-NP	O
infusion	infusion	NN	I-NP	O
of	of	IN	B-PP	O
magnesium	magnesium	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
(	(	(	O	O
MgSO	MgSO	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
1	1	CD	B-NP	O
mmol	mmol	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
hours	hour	NNS	I-NP	O
)	)	)	O	O
would	would	MD	B-VP	O
normalize	normalize	VB	I-VP	O
QT	QT	NN	B-NP	O
interval	interval	JJ	I-NP	O
variability	variability	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
compensated	compensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O

Using	Use	VBG	B-VP	O
probes	probe	NNS	B-NP	O
containing	contain	VBG	B-VP	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	B-NP	I
EBP	EBP	NN	I-NP	I
-	-	HYPH	B-PP	I
binding	bind	VBG	B-NP	I
sites	sites-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
the	the	DT	B-NP	O
iNOS	BEGIN-iNOS	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
revealed	reveal	VBD	B-VP	O
further	further	JJ	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
complexes	complex	NNS	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
strongly	strongly	RB	B-ADJP	O
inducible	inducible	JJ	I-ADJP	O
by	by	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
extent	extent	NN	I-NP	O
also	also	RB	B-ADVP	O
by	by	IN	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	O	I
1beta	1beta-INSIDE	NN	B-NP	I

Long	Long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
of	of	IN	B-PP	O
kidney	kidney	NN	B-NP	O
donors	donor	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
longitudinal	longitudinal	JJ	I-NP	O
study	study	NN	I-NP	O

Gore	Gore	NNP	B-NP	O
&	&	CC	I-NP	O
Associates	Associates	NNP	I-NP	O
,	,	,	I-NP	O
Inc.	Inc.	NNP	I-NP	O
)	)	)	O	O
standard	standard	JJ	B-NP	O
wall	wall	NN	I-NP	O
graft	graft	NN	I-NP	O
segments	segment	NNS	I-NP	O
varying	vary	VBG	B-VP	O
in	in	IN	B-PP	O
length	length	NN	B-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
cm	cm	NN	I-NP	O

This	This	DT	B-NP	O
report	report	NN	I-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
and	and	CC	O	O
recombinant	recombinant	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
clone	clone	NN	I-NP	O
encoding	encode	VBG	B-VP	O
HER1	BEGIN-HER1-INSIDE	NN	B-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
fourth	fourth	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
epidermal	epidermal	JJ	I-NP	I
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
EGFR	BEGIN-EGFR-INSIDE	NN	B-NP	B
)	)	)	O	O
family	family	NN	B-NP	O

Precision	Precision	NN	B-NP	O
of	of	IN	B-PP	O
data	datum	NNS	B-NP	O
from	from	IN	B-PP	O
models	model	NNS	B-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
kinetics	kinetic	NNS	I-NP	O
in	in	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O

Cytochrome	BEGIN-Cytochrome	NN	B-NP	B
bd	bd-INSIDE	NN	I-NP	I
biosynthesis	biosynthesis	NN	I-NP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cydC	BEGIN-cydC-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
cydD	BEGIN-cydD	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
encode	encode	VBP	B-VP	O
the	the	DT	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ABC	BEGIN-ABC	JJ	I-NP	B
membrane	membrane	NN	I-NP	I
transporter	transporter-INSIDE	NN	I-NP	I

We	We	PRP	B-NP	O
exposed	expose	VBD	B-VP	O
Dorper	Dorper	NNP	B-NP	O
-	-	HYPH	B-NP	O
cross	cross	JJ	I-NP	O
ewes	ewe	NNS	I-NP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
gestation	gestation	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
hot	hot	JJ	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
relative	relative	JJ	I-NP	O
humidity	humidity	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
cold	cold	JJ	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
relative	relative	JJ	I-NP	O
humidity	humidity	NN	I-NP	O
)	)	)	O	O
environment	environment	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
treadmill	treadmill	VB	I-VP	O
exercise	exercise	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
km	km	NN	I-NP	O
/	/	SYM	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
gradient	gradient	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
measured	measure	VBN	B-NP	O
fetal	fetal	JJ	I-NP	O
lamb	lamb	NN	I-NP	O
and	and	CC	I-NP	O
ewe	ewe	NN	I-NP	O
body	body	NN	I-NP	O
temperatures	temperature	NNS	I-NP	O
using	use	VBG	B-VP	O
previously	previously	RB	B-NP	O
implanted	implant	VBN	I-NP	O
abdominal	abdominal	JJ	I-NP	O
radiotelemeters	radiotelemeter	NNS	I-NP	O

Amino	Amino	AFX	B-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	B-NP	O
polymorphisms	polymorphism	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
beta	beta	SYM	I-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
adrenergic	adrenergic	JJ	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
impart	impart	VBP	B-VP	O
distinct	distinct	JJ	B-NP	O
agonist	agonist	NN	I-NP	O
-	-	HYPH	O	O
promoted	promote	VBN	B-NP	O
regulatory	regulatory	JJ	I-NP	O
properties	property	NNS	I-NP	O

A	A	DT	B-NP	O
brief	brief	JJ	I-NP	O
discussion	discussion	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
among	among	IN	B-PP	O
these	these	DT	B-NP	O
formulas	formula	NNS	I-NP	O
is	be	VBZ	B-VP	O
given	give	VBN	I-VP	O

The	The	DT	B-NP	O
embryology	embryology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vertebral	vertebral	JJ	I-NP	O
column	column	NN	I-NP	O
is	be	VBZ	B-VP	O
reviewed	review	VBN	I-VP	O
briefly	briefly	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
anomaly	anomaly	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C1	C1	NN	I-NP	O
vertebra	vertebra	NN	I-NP	O
is	be	VBZ	B-VP	O
traced	trace	VBN	I-VP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
early	early	JJ	I-NP	O
stages	stage	NNS	I-NP	O
in	in	IN	B-PP	O
development	development	NN	B-NP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mesenchymal	mesenchymal	JJ	I-NP	O
vertebra	vertebra	NN	I-NP	O
or	or	CC	O	O
1	1	CD	B-NP	O
)	)	)	O	O
its	its	PRP$	B-NP	O
induction	induction	NN	I-NP	O
to	to	TO	B-VP	O
cartilage	cartilage	VB	I-VP	O

Visualization	Visualization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
by	by	IN	B-PP	O
phase	phase	NN	B-NP	O
contrast	contrast	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
murine	BEGIN-murine	JJ	B-NP	B
PKCepsilon	PKCepsilon-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
glycerol	glycerol	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	O
cells	cell	NNS	I-NP	O
exhibiting	exhibit	VBG	B-VP	O
very	very	RB	B-NP	O
small	small	JJ	I-NP	O
buds	bud	NNS	I-NP	O

1	1	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
tetracycline	tetracycline	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
epianhydrotetracycline	epianhydrotetracycline	NN	I-NP	O
in	in	IN	B-PP	O
doses	dose	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	O	O
1gamma	1gamma	NN	B-NP	O
per	per	IN	B-PP	O
embryo	embryo	NN	B-NP	O
respectively	respectively	RB	B-ADVP	O

The	The	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
proteins	protein	NNS	I-NP	O
are	be	VBP	B-VP	O
without	without	IN	B-PP	O
effect	effect	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
plasmids	plasmid	NNS	B-NP	O
lacking	lack	VBG	B-VP	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
or	or	CC	O	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
are	be	VBP	B-VP	O
located	located	JJ	B-ADJP	O
further	further	RB	B-ADVP	O
upstream	upstream	RB	B-ADVP	O

The	The	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
PGE1	PGE1	NN	B-NP	O
and	and	CC	I-NP	O
PGF1	PGF1	NN	I-NP	O
alpha	alpha	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
peak	peak	NN	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cycle	cycle	NN	I-NP	O

One	One	CD	B-NP	O
hundred	hundred	CD	I-NP	O
men	man	NNS	I-NP	O
who	who	WP	B-NP	O
received	receive	VBD	B-VP	O
alpha	alpha	SYM	B-NP	O
-	-	HYPH	O	O
tocopherol	tocopherol	NN	B-NP	O
were	be	VBD	B-VP	O
matched	match	VBN	I-VP	O
on	on	IN	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
study	study	NN	B-NP	O
center	center	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
length	length	NN	B-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
between	between	IN	B-PP	O
blood	blood	NN	B-NP	O
draws	draw	NNS	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
men	man	NNS	I-NP	O
who	who	WP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
placebo	placebo	NN	I-NP	O

Serum	BEGIN-Serum	NN	B-NP	B
angiogenin	angiogenin-INSIDE	NN	I-NP	I
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
young	young	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O

Bodily	Bodily	RB	B-NP	O
referents	referent	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
experience	experience	NN	I-NP	O
of	of	IN	B-PP	O
affect	affect	NN	B-NP	O

We	We	PRP	B-NP	O
studied	study	VBD	B-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
histological	histological	JJ	I-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kidneys	kidney	NNS	I-NP	O
including	include	VBG	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infiltrated	infiltrate	VBN	I-NP	O
macrophages	macrophage	NNS	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
hour	hour	NN	I-NP	O
post	post	AFX	B-NP	O
-	-	HYPH	I-NP	O
transplantation	transplantation	NN	I-NP	O
kidney	kidney	NN	I-NP	O
biopsies	biopsy	NNS	I-NP	O
(	(	(	O	O
one	one	CD	B-NP	O
hour	hour	NN	I-NP	O
biopsies	biopsy	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
re	re	AFX	B-NP	O
-	-	HYPH	I-NP	O
biopsies	biopsy	NNS	B-NP	O
on	on	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O

The	The	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
lbc	lbc	NN	I-NP	I
oncogene	oncogene	NN	I-NP	I
product	product-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
guanine	BEGIN-guanine	JJ	I-NP	B
nucleotide	nucleotide	NN	I-NP	I
exchange	exchange	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
specifically	specifically	RB	B-ADVP	O
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
Rho	BEGIN-BEGIN-Rho-INSIDE	NN	I-NP	B
small	small	JJ	I-NP	O
GTP	GTP	NN	I-NP	O
binding	binding	NN	I-NP	O
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
thus	thus	RB	B-ADVP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
biologically	biologically	RB	B-NP	O
active	active	JJ	I-NP	O
,	,	,	I-NP	O
GTP	GTP	NN	I-NP	O
-	-	HYPH	B-ADJP	O
bound	bind	VBN	I-ADJP	O
Rho	BEGIN-Rho-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
mediates	mediate	VBZ	B-VP	O
actin	BEGIN-actin-INSIDE	NN	B-NP	B
cytoskeletal	cytoskeletal	JJ	I-NP	O
reorganization	reorganization	NN	I-NP	O
,	,	,	O	O
gene	gene	NN	B-NP	O
transcription	transcription	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
entry	entry	NN	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
mitotic	mitotic	JJ	I-NP	O
S	S	NN	I-NP	O
phase	phase	NN	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
serum	serum	NN	I-NP	O
vitamin	vitamin	NN	I-NP	O
A	A	NN	I-NP	O
,	,	,	O	O
E	E	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
and	and	CC	O	O
vitamin	vitamin	NN	B-NP	O
E	E	NN	I-NP	O
/	/	SYM	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
ratio	ratio	NN	I-NP	O
between	between	IN	B-PP	O
pregnant	pregnant	JJ	B-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
hemoglobinopathies	BEGIN-hemoglobin-INSIDEopathy	NNS	I-NP	I
,	,	,	O	O
while	while	IN	B-SBAR	O
confounding	confound	VBG	B-VP	O
variables	variable	NNS	B-NP	O
that	that	WDT	B-NP	O
might	might	MD	B-VP	O
affect	affect	VB	I-VP	O
serum	serum	NN	B-NP	O
vitamin	vitamin	NN	I-NP	O
levels	level	NNS	I-NP	O
i.e.	i.e.	FW	B-NP	O
maternal	maternal	JJ	I-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
gravida	gravida	NN	B-NP	O
,	,	,	O	O
BMI	BMI	NN	B-NP	O
,	,	,	O	O
gestational	gestational	JJ	B-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
,	,	,	O	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	B-NP	B
,	,	,	O	O
mean	mean	JJ	B-NP	O
corpuscular	corpuscular	JJ	I-NP	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	I-NP	B
concentration	concentration	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
different	different	JJ	B-ADJP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
SB	SB	NN	B-NP	O
1	1	CD	I-NP	O
sensitive	sensitive	JJ	I-NP	O
p1	BEGIN-p1	NN	I-NP	B
MAP	MAP	NN	I-NP	I
kinases	kinases-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
okadaic	okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
TRE	TRE	NN	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
and	and	CC	I-NP	O
transactivation	transactivation	NN	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
group	group	NN	B-NP	O
II	II	CD	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
peak	peak	JJ	B-NP	O
VO1	VO1	NN	I-NP	O
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
adaptive	adaptive	JJ	I-NP	O
AV	AV	NN	I-NP	O
delay	delay	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
fixed	fix	VBN	B-NP	O
AV	AV	NN	I-NP	O
delay	delay	NN	I-NP	O
programming	programming	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

This	This	DT	B-NP	O
vector	vector	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
applicable	applicable	JJ	B-ADJP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
throughput	throughput	NN	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frames	frame	NNS	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
genome	genome	NN	B-NP	O
sequencing	sequencing	NN	I-NP	O

Each	Each	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
postsurgical	postsurgical	JJ	I-NP	O
maintenance	maintenance	NN	I-NP	O
visits	visit	NNS	I-NP	O

Evidence	Evidence	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Smad1	BEGIN-Smad1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
chick	chick	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
development	development	NN	I-NP	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
response	response	NN	I-NP	O
rate	rate	NN	I-NP	O
including	include	VBG	B-PP	O
CR	CR	NN	B-NP	O
and	and	CC	I-NP	O
PR	PR	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Left	Leave	VBN	B-NP	O
ventricular	ventricular	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
dopamine	dopamine	NN	B-NP	O
in	in	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
-	-	HYPH	I-NP	O
dimensional	dimensional	JJ	I-NP	O
echocardiography	echocardiography	NN	I-NP	O
and	and	CC	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
findings	finding	NNS	B-NP	O
of	of	IN	B-PP	O
thallium	thallium	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
scintigraphy	scintigraphy	NN	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Lateral	Lateral	JJ	B-NP	O
PF	PF	NN	I-NP	O
OA	OA	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
common	common	JJ	I-ADJP	O
than	than	IN	B-PP	O
medial	medial	JJ	B-NP	O
PF	PF	NN	I-NP	O
OA	OA	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
GATA	BEGIN-GATA	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Sp1	BEGIN-Sp1-INSIDE	NN	I-NP	B
synergize	synergize	VBP	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
distance	distance	NN	I-NP	O
in	in	IN	B-PP	O
constructs	construct	NNS	B-NP	O
designed	design	VBN	B-VP	O
to	to	TO	B-VP	O
mimic	mimic	VB	I-VP	O
the	the	DT	B-NP	O
architecture	architecture	NN	I-NP	O
of	of	IN	B-PP	O
globin	BEGIN-globin	NN	B-NP	B
locus	locus	NN	I-NP	I
control	control	NN	I-NP	I
regions	regions-INSIDE	NN	I-NP	I
and	and	CC	O	O
downstream	downstream	JJ	B-NP	O
globin	BEGIN-globin	NN	I-NP	B
promoters	promoters-INSIDE	NN	I-NP	I

After	After	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
C1	C1	NN	I-NP	O
BP	BP	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
Acer	Acer	NN	B-NP	O
stands	stand	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	I-VP	O
fire	fire	VB	I-VP	O
as	as	IN	B-SBAR	O
suggested	suggest	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
strong	strong	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
Betula	Betula	NNP	B-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
delayed	delay	VBN	I-NP	O
expansion	expansion	NN	I-NP	O
of	of	IN	B-PP	O
Pinus	Pinus	NNP	B-NP	O
cembra	cembra	NN	I-NP	O

1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
micromol.	micromol.	NN	I-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	O	O
1.	1.	CD	B-NP	O
min	min	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
changed	change	VBN	I-VP	O
by	by	IN	B-PP	O
training	training	NN	B-NP	O

A	A	DT	B-NP	O
wide	wide	JJ	I-NP	O
conservation	conservation	NN	I-NP	O
of	of	IN	B-PP	O
iscSUA	BEGIN-iscSUA	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
and	and	CC	I-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
NifU	BEGIN-NifU-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
NifS	BEGIN-NifS-INSIDE	NN	I-NP	B
participate	participate	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mobilization	mobilization	NN	I-NP	O
of	of	IN	B-PP	O
iron	iron	NN	B-NP	O
and	and	CC	I-NP	O
sulfur	sulfur	NN	I-NP	O
for	for	IN	B-PP	O
nitrogenase	BEGIN-nitrogenase-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
specific	specific	JJ	B-NP	O
iron	iron	NN	I-NP	O
-	-	HYPH	B-NP	O
sulfur	sulfur	NN	I-NP	O
cluster	cluster	NN	I-NP	O
formation	formation	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
iscSUA	BEGIN-iscSUA	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
could	could	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
general	general	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
or	or	CC	I-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
iron	iron	NN	B-NP	O
-	-	HYPH	B-NP	O
sulfur	sulfur	NN	I-NP	O
clusters	cluster	NNS	I-NP	O

RET	BEGIN-RET-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
PTC	BEGIN-PTC-INSIDE	NN	I-NP	B
oncogenes	oncogene	NNS	I-NP	O
,	,	,	O	O
generated	generate	VBN	B-VP	O
by	by	IN	B-PP	O
chromosomal	chromosomal	JJ	B-NP	O
rearrangements	rearrangement	NNS	I-NP	O
in	in	IN	B-PP	O
papillary	papillary	JJ	B-NP	O
thyroid	thyroid	JJ	I-NP	O
carcinomas	carcinoma	NNS	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
constitutively	constitutively	RB	I-VP	O
activated	activate	VBN	I-VP	O
versions	version	NNS	B-NP	O
of	of	IN	B-PP	O
proto	BEGIN-proto	NN	B-NP	B
-	-	HYPH	B-NP	I
RET	BEGIN-RET-INSIDE-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
receptor	BEGIN-receptor	NN	I-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
TK	BEGIN-TK-INSIDE	NN	B-NP	B
)	)	)	O	O
whose	whose	WP$	B-NP	O
ligand	ligand	NN	I-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
unknown	unknown	JJ	B-ADJP	O

Diclofenac	Diclofenac	NN	B-NP	O
sodium	sodium	NN	I-NP	O
:	:	:	O	O
blood	blood	NN	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
slow	slow	JJ	I-NP	O
-	-	HYPH	I-NP	O
release	release	NN	I-NP	O
form	form	NN	I-NP	O
and	and	CC	I-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
metabolism	metabolism	NN	I-NP	O
of	of	IN	B-PP	O
kallikrein	BEGIN-kallikrein-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
unc	BEGIN-unc	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
sli	BEGIN-sli	JJ	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
rok	BEGIN-rok	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
encode	encode	VBP	B-VP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	O
regulators	regulator	NNS	I-NP	O
of	of	IN	B-PP	O
vulval	vulval	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O

Optimized	Optimize	VBN	B-NP	O
USF	BEGIN-USF-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
MYC	BEGIN-MYC-INSIDE	NN	I-NP	B
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
differ	differ	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nucleotides	nucleotide	NNS	I-NP	O
bordering	border	VBG	B-VP	O
the	the	DT	B-NP	O
hexanucleotide	hexanucleotide	NN	I-NP	O
box	box	NN	I-NP	O
displace	displace	VBP	B-VP	O
the	the	DT	B-NP	O
E	BEGIN-E	NN	I-NP	B
-	-	HYPH	B-NP	I
C1	C1	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
competition	competition	NN	B-NP	O
assays	assay	NNS	I-NP	O
but	but	CC	B-PP	O
with	with	IN	B-PP	O
lesser	less	JJR	B-NP	O
efficiency	efficiency	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
E	BEGIN-E	NN	I-NP	B
-	-	HYPH	B-NP	I
C1	C1	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
itself	itself	PRP	B-NP	O

Fluorescent	Fluorescent	JJ	B-NP	O
in	in	FW	I-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
(	(	(	O	O
FISH	FISH	NN	B-NP	O
)	)	)	O	O
analysis	analysis	NN	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
novel	novel	JJ	I-NP	O
regions	region	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
NFKB1	BEGIN-NFKB1-INSIDE	NN	I-NP	B
rearrangement	rearrangement	NN	I-NP	O
originated	originate	VBN	B-VP	O
from	from	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
1q1	1q1	NN	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
implying	imply	VBG	B-VP	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
t	t	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
q1	q1	NN	B-NP	O
;	;	:	O	O
q1	q1	NN	B-NP	O
)	)	)	O	O
reciprocal	reciprocal	JJ	B-NP	O
chromosomal	chromosomal	JJ	I-NP	O
translocation	translocation	NN	I-NP	O

DESIGN	DESIGN	NN	B-NP	O
:	:	:	O	O
Intradermally	Intradermally	RB	B-NP	O
injected	inject	VBN	I-NP	O
human	human	JJ	I-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
grown	grow	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
mm1	mm1	NN	I-NP	O
in	in	IN	B-PP	O
athymic	athymic	JJ	B-NP	O
nude	nude	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
and	and	CC	O	O
irradiated	irradiate	VBD	B-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
nm	nm	NN	I-NP	O
light	light	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
J	J	NN	I-NP	O
/	/	SYM	B-NP	O
cm1	cm1	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mW	mW	NN	I-NP	O
/	/	SYM	B-NP	O
cm1	cm1	NN	I-NP	O
)	)	)	O	O
1	1	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
intraperitoneal	intraperitoneal	JJ	I-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
SiPc	SiPc	NN	B-NP	O
IV	IV	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
space	space	NN	B-NP	O
radiation	radiation	NN	I-NP	O
are	be	VBP	B-VP	O
partially	partially	RB	I-VP	O
known	know	VBN	I-VP	O
on	on	IN	B-PP	O
astronauts	astronaut	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
much	much	RB	B-VP	O
remains	remain	VBZ	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discovered	discover	VBN	I-VP	O

First	First	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
arm	arm	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GDI	BEGIN-GDI-INSIDE	NN	I-NP	B
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
switch	switch	NN	I-NP	O
I	I	CD	I-NP	O
and	and	CC	I-NP	O
II	II	CD	I-NP	O
domains	domain	NNS	I-NP	O
of	of	IN	B-PP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	B-NP	B
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
GDP	GDP	NN	B-NP	O
dissociation	dissociation	NN	I-NP	O
and	and	CC	O	O
GTP	GTP	NN	B-NP	O
hydrolysis	hydrolysis	NN	I-NP	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
two	two	CD	B-NP	O
regulatory	regulatory	JJ	I-NP	O
regions	region	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
US1	BEGIN-US1-INSIDE	NN	I-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
US1	BEGIN-BEGIN-US1-INSIDE	NN	I-NP	B
transcription	transcription	NN	I-NP	O
units	units-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
the	the	DT	B-NP	O
virus	virus	NN	I-NP	O
-	-	HYPH	B-NP	O
infected	infect	VBN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
translation	translation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
M1	BEGIN-M1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
virus	virus	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
of	of	IN	B-PP	O
neither	neither	CC	O	O
the	the	DT	B-NP	O
nucleoprotein	nucleoprotein	NN	I-NP	O
nor	nor	CC	I-NP	O
NS1	BEGIN-NS1-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
interfered	interfere	VBN	I-VP	O
with	with	IN	B-PP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
NS1	BEGIN-NS1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
translational	translational	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
M1	BEGIN-M1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
M1	M1	NN	I-NP	O
ORF	ORF	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
gene	gene	NN	I-NP	O
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
an	an	DT	B-NP	O
abundant	abundant	JJ	I-NP	O
secreted	secrete	VBN	I-NP	O
protein	protein	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
host	host	NN	B-NP	O
cellular	cellular	JJ	I-NP	O
receptors	receptor	NNS	I-NP	O
or	or	CC	I-NP	O
cytokines	cytokine	NNS	I-NP	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
change	change	NN	B-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
in	in	IN	B-PP	O
parietal	parietal	JJ	B-NP	O
lobe	lobe	NN	I-NP	O
gray	gray	JJ	I-NP	O
-	-	HYPH	I-NP	O
matter	matter	NN	I-NP	O
cytosolic	cytosolic	JJ	I-NP	O
choline	choline	NN	I-NP	O
,	,	,	O	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
choline	choline	NN	B-NP	O
/	/	SYM	B-NP	O
creatine	creatine	NN	I-NP	O
resonance	resonance	NN	I-NP	O
ratios	ratio	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cognitive	cognitive	JJ	B-NP	O
performance	performance	NN	I-NP	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Alzheimer	Alzheimer	NNP	I-NP	O
's	's	POS	B-NP	O
Disease	Disease	NNP	I-NP	O
Assessment	Assessment	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
Cognitive	Cognitive	NNP	I-NP	O
Subscale	Subscale	NNP	I-NP	O

The	The	DT	B-NP	O
protein	protein	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
NF1	BEGIN-NF1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
ezrin	BEGIN-ezrin-INSIDE	NN	B-NP	B
,	,	,	O	O
radixin	BEGIN-radixin-INSIDE	NN	B-NP	B
and	and	CC	O	O
moesin	BEGIN-moesin-INSIDE	NN	B-NP	B
(	(	(	O	O
ERM	BEGIN-ERM-INSIDE	NN	B-NP	B
)	)	)	O	O
proteins	protein	NNS	B-NP	O
that	that	WDT	B-NP	O
link	link	VBP	B-VP	O
membrane	membrane	NN	B-NP	O
proteins	protein	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytoskeleton	cytoskeleton	NN	I-NP	O

1	1	CD	B-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	B-NP	I
ets	ets-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
encoded	encode	VBN	B-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acids	acid	NNS	I-NP	O
located	locate	VBN	B-VP	O
immediately	immediately	RB	B-ADVP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	B-NP	I
myb	myb-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	B-NP	I
ets	ets-INSIDE	NN	I-NP	I
junction	junction	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
P1	BEGIN-P1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
1c	BEGIN-1c	NN	I-NP	B
-	-	HYPH	B-NP	I
ets	ets-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
ets	ets	NN	I-NP	I
proto	proto	AFX	O	I
-	-	HYPH	O	I
oncogene	oncogene-INSIDE	NN	B-NP	I
,	,	,	O	O
nor	nor	CC	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
kDa	kDa	NN	I-NP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
but	but	CC	O	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
P1	BEGIN-P1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
1c	BEGIN-1c	NN	I-NP	B
-	-	HYPH	O	I
ets	ets-INSIDE	NN	B-NP	I

Secretogranin	BEGIN-Secretogranin	NN	B-NP	B
II	II-INSIDE	NN	I-NP	I
(	(	(	O	O
SgII	BEGIN-SgII-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
secretory	secretory	JJ	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
stored	store	VBN	B-VP	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
dense	dense	JJ	I-NP	O
core	core	NN	I-NP	O
vesicles	vesicle	NNS	I-NP	O
of	of	IN	B-PP	O
neuroendocrine	neuroendocrine	JJ	B-NP	O
and	and	CC	I-NP	O
neuronal	neuronal	JJ	I-NP	O
cells	cell	NNS	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Golgi	Golgi	NNP	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
observed	observe	VBN	I-VP	O
when	when	WRB	B-ADVP	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
coexpressed	coexpresse	VBN	I-VP	O
with	with	IN	B-PP	O
NSm	BEGIN-NSm-INSIDE	NN	B-NP	B
,	,	,	O	O
although	although	IN	B-SBAR	O
NSm	BEGIN-NSm-INSIDE	NN	B-NP	B
itself	itself	PRP	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Golgi	Golgi	NNP	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
a	a	DT	B-NP	O
larger	large	JJR	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
substrate	substrate	NN	I-NP	O
carrying	carry	VBG	B-VP	O
the	the	DT	B-NP	O
HD1	BEGIN-HD1	NN	I-NP	B
/	/	SYM	B-NP	I
1C	1C	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
processed	process	VBN	I-VP	O
more	more	RBR	B-ADVP	O
efficiently	efficiently	RB	I-ADVP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
substrate	substrate	NN	I-NP	O
carrying	carry	VBG	B-VP	O
the	the	DT	B-NP	O
POL	BEGIN-POL	NN	I-NP	B
/	/	SYM	B-NP	I
Zn	Zn	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
,	,	,	O	O
cleavage	cleavage	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
substrates	substrate	NNS	I-NP	O
containing	contain	VBG	B-VP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
cleavage	cleavage	NN	I-NP	O
sites	site	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
similar	similar	JJ	B-NP	O
efficiencies	efficiency	NNS	I-NP	O

GBF1	BEGIN-GBF1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
GBF1	BEGIN-BEGIN-GBF1-INSIDE	NN	I-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
light	light	JJ	B-NP	O
and	and	CC	I-NP	O
dark	dark	JJ	I-NP	O
grown	grown	NN	I-NP	O
leaves	leave	VBZ	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
roots	root	NNS	B-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
technique	technique	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
neopharynx	neopharynx	NN	I-NP	O
consists	consist	VBZ	B-VP	O
only	only	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prevertebral	prevertebral	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
flap	flap	NN	I-NP	O
forms	form	VBZ	B-VP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
and	and	CC	I-NP	O
lateral	lateral	JJ	I-NP	O
walls	wall	NNS	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
may	may	MD	B-VP	O
indicate	indicate	VB	I-VP	O
redundancy	redundancy	NN	B-NP	O
between	between	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NGFI	BEGIN-NGFI	NN	I-NP	B
-	-	HYPH	B-NP	I
B	B-INSIDE	NN	I-NP	I
/	/	SYM	I-NP	O
Nurr1	BEGIN-Nurr1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Nor1	BEGIN-Nor1-INSIDE	NN	I-NP	B
subfamily	subfamily	NN	I-NP	O
and	and	CC	O	O
could	could	MD	B-VP	O
explain	explain	VB	I-VP	O
why	why	WRB	B-ADVP	O
no	no	DT	B-NP	O
phenotypic	phenotypic	JJ	I-NP	O
disturbances	disturbance	NNS	I-NP	O
have	have	VBP	B-VP	O
yet	yet	RB	I-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
NGFI	BEGIN-BEGIN-NGFI	NN	I-NP	B
-	-	HYPH	B-NP	I
B	B-INSIDE	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
inactivated	inactivate	VBN	I-VP	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitogen	BEGIN-mitogen	NN	I-NP	B
-	-	HYPH	B-VP	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B
)	)	)	O	O
pathway	pathway	NN	B-NP	O
enhances	enhance	VBZ	B-VP	O
long	long	JJ	B-NP	O
-	-	HYPH	I-NP	O
range	range	NN	I-NP	O
transactivation	transactivation	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
globin	globin	NN	I-NP	I
locus	locus	NN	I-NP	I
control	control	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
(	(	(	O	O
LCR	LCR	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
W	W	NN	B-NP	O

The	The	DT	B-NP	O
gp1	BEGIN-gp1	NN	I-NP	B
peptide	peptide	NN	I-NP	I
(	(	(	O	I
Glu	Glu	NN	B-NP	I
-	-	HYPH	B-NP	I
Leu	Leu	NN	I-NP	I
-	-	HYPH	B-NP	I
Asp	Asp	NN	I-NP	I
-	-	HYPH	B-NP	I
Lys	Lys	NN	I-NP	I
-	-	HYPH	B-NP	I
Trp	Trp	NN	I-NP	I
-	-	HYPH	B-NP	I
Ala	Ala	NN	I-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
Sj	BEGIN-Sj	NN	B-NP	B
GST	GST-INSIDE	NN	I-NP	I
forms	form	VBZ	B-VP	O
a	a	DT	B-NP	O
loop	loop	NN	I-NP	O
stabilized	stabilize	VBN	B-VP	O
by	by	IN	B-PP	O
symmetry	symmetry	NN	B-NP	O
-	-	HYPH	O	O
related	relate	VBN	B-NP	O
GSTs	BEGIN-GSTs-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
GST	BEGIN-GST-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
CBL	BEGIN-CBL-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
LZIP	BEGIN-LZIP-INSIDE	NN	I-NP	B
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
binding	bind	VBG	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
subunit	subunit-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
phosphatidylinositol	BEGIN-phosphatidylinositol	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
mapped	map	VBD	B-VP	O
to	to	TO	B-PP	O
Tyr1	Tyr1	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
YEAM	YEAM	NN	I-NP	O

The	The	DT	B-NP	O
testes	testis	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
specimens	specimen	NNS	I-NP	O
of	of	IN	B-PP	O
Triturus	Triturus	NN	B-NP	O
marmoratus	marmoratus	NN	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
during	during	IN	B-PP	O
each	each	DT	B-NP	O
month	month	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	O	O
processed	process	VBN	B-VP	O
for	for	IN	B-PP	O
electron	electron	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O
and	and	CC	O	O
light	light	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O
demonstration	demonstration	NN	I-NP	O
of	of	IN	B-PP	O
testosterone	testosterone	NN	B-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
ABC	BEGIN-ABC-INSIDE	NN	I-NP	B
(	(	(	O	O
avidin	BEGIN-avidin	NN	B-NP	B
-	-	HYPH	B-NP	I
biotin	biotin	NN	I-NP	I
peroxidase	peroxidase	NN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
)	)	)	O	O
method	method	NN	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
generated	generate	VBN	I-VP	O
transgenic	transgenic	JJ	B-NP	O
fly	fly	JJ	I-NP	O
strains	strain	NNS	I-NP	O
with	with	IN	B-PP	O
mutations	mutation	NNS	B-NP	O
affecting	affect	VBG	B-VP	O
specific	specific	JJ	B-NP	O
TRA	BEGIN-TRA	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
isoforms	isoforms-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
their	their	PRP$	B-NP	O
individual	individual	JJ	I-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
the	the	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
processing	processing	NN	I-NP	O
of	of	IN	B-PP	O
doublesex	BEGIN-doublesex-INSIDE	NN	B-NP	B
,	,	,	O	O
exuperantia	BEGIN-exuperantia-INSIDE	NN	B-NP	B
and	and	CC	O	O
tra	BEGIN-tra	AFX	O	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
pre	pre	AFX	I-NP	I
-	-	HYPH	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I

Few	Few	JJ	B-NP	O
triers	trier	NNS	I-NP	O
or	or	CC	I-NP	O
users	user	NNS	I-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
SLT	SLT	NN	B-NP	O
counseling	counsel	VBG	B-VP	O
from	from	IN	B-PP	O
their	their	PRP$	B-NP	O
dentist	dentist	NN	I-NP	O
despite	despite	IN	B-PP	O
high	high	JJ	B-NP	O
dental	dental	JJ	I-NP	O
utilization	utilization	NN	I-NP	O
rates	rate	NNS	I-NP	O

There	There	EX	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
toxicity	toxicity	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
FU	FU	NN	I-NP	O
instillation	instillation	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
airway	airway	NN	I-NP	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
complained	complain	VBN	I-VP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
hypochondralgia	hypochondralgia	NN	I-NP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
operated	operate	VBN	I-VP	O
for	for	IN	B-PP	O
appendicitis	appendicitis	NN	B-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	O
cells	cell	NNS	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
conflict	conflict	NN	I-NP	O
between	between	IN	B-PP	O
death	death	NN	B-NP	O
and	and	CC	I-NP	O
survival	survival	NN	I-NP	O
signals	signal	NNS	I-NP	O
,	,	,	O	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
death	death	NN	I-NP	O
by	by	IN	B-PP	O
default	default	NN	B-NP	O

Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
testicular	testicular	JJ	B-NP	O
testosterone	testosterone	NN	I-NP	O
and	and	CC	I-NP	O
acid	acid	NN	I-NP	O
and	and	CC	I-NP	O
alkaline	BEGIN-alkaline	NN	I-NP	B
phosphatase	phosphatase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
testis	testis	NN	B-NP	O
and	and	CC	O	O
accessory	accessory	JJ	B-NP	O
sex	sex	NN	I-NP	O
organs	organ	NNS	I-NP	O
after	after	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
varicocele	varicocele	NN	B-NP	O
in	in	IN	B-PP	O
Noble	Noble	NNP	B-NP	O
rats	rat	NNS	I-NP	O

The	The	DT	B-NP	O
reconstituted	reconstitute	VBN	I-NP	O
RNA	BEGIN-RNA	NN	I-NP	B
polymerases	polymerases-INSIDE	NN	I-NP	I
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
alpha	alpha	NN	I-NP	O
subunits	subunit	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
transcription	transcription	NN	B-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
cAMP	BEGIN-cAMP	NN	B-NP	B
-	-	HYPH	B-NP	I
CRP	CRP-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
rrnBP1	BEGIN-rrnBP1	NN	I-NP	B
UP	UP	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I

Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
greater	great	JJR	I-NP	O
omentum	omentum	NN	I-NP	O
of	of	IN	B-PP	O
mice	mouse	NNS	B-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
strains	strain	NNS	I-NP	O
after	after	IN	B-PP	O
intraperitoneal	intraperitoneal	JJ	B-NP	O
immunization	immunization	NN	I-NP	O
with	with	IN	B-PP	O
sheep	sheep	NN	B-NP	O
erythrocytes	erythrocyte	NNS	I-NP	O

In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mL	mL	NN	I-NP	O
of	of	IN	B-PP	O
saline	saline	NN	B-NP	O
lowered	lower	VBD	B-VP	O
DL	DL	NN	B-NP	O
(	(	(	O	O
CO	CO	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	CC	O	O
baseline	baseline	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
D	D	NN	B-NP	O
(	(	(	O	O
M	M	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	CC	O	O
baseline	baseline	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
aldosterone	aldosterone	NN	B-NP	O
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	CC	O	O
baseline	baseline	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
renin	BEGIN-renin-INSIDE	NN	B-NP	B
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	CC	O	O
baseline	baseline	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
hematocrit	hematocrit	NN	B-NP	O
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	CC	O	O
baseline	baseline	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
V	V	NN	I-NP	O
(	(	(	O	O
C	C	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	CC	O	O
baseline	baseline	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
without	without	IN	B-PP	O
changing	change	VBG	B-VP	O
rap	rap	NN	B-NP	O
and	and	CC	I-NP	O
wpp	wpp	NN	I-NP	O

Reversible	Reversible	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
amorphization	amorphization	NN	I-NP	O
in	in	IN	B-PP	O
solid	solid	JJ	B-NP	O
C1	C1	NN	I-NP	O
:	:	:	O	O
Raman	Raman	NN	B-NP	O
and	and	CC	I-NP	O
photoluminescence	photoluminescence	NN	I-NP	O
study	study	NN	I-NP	O

Antibodies	Antibody	NNS	B-NP	O
against	against	IN	B-PP	O
REAP	BEGIN-REAP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
inhibit	inhibit	VBP	B-VP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
RNA	RNA	NN	I-NP	O
editing	editing	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
confirming	confirm	VBG	B-VP	O
its	its	PRP$	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
RNA	RNA	NN	B-NP	O
editing	editing	NN	I-NP	O

The	The	DT	O	O
more	more	RBR	B-ADJP	O
severe	severe	JJ	I-ADJP	O
the	the	DT	B-NP	O
CRF	CRF	NN	I-NP	O
,	,	,	O	O
the	the	DT	O	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
total	total	JJ	B-NP	O
HDL	BEGIN-HDL-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
HDL1	BEGIN-BEGIN-HDL-INSIDE1	NN	I-NP	I
cholesterol	cholesterol-INSIDE	NN	I-NP	I
will	will	MD	B-VP	O
be	be	VB	I-VP	O
low	low	JJ	B-ADJP	O

A	A	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
signal	signal	NN	I-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
NodO	BEGIN-NodO	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I

Mean	Mean	JJ	B-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
percentages	percentage	NNS	I-NP	O
were	be	VBD	B-VP	O
lower	low	JJR	B-NP	O
postpartum	postpartum	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
prepartum	prepartum	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
five	five	CD	I-NP	O
patients	patient	NNS	I-NP	O
studied	study	VBN	B-VP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
proliferative	proliferative	JJ	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mitogens	BEGIN-mitogen	NNS	I-NP	B
phytohemagglutinin	phytohemagglutinin	NN	I-NP	I
and	and	CC	I-NP	I
pokeweed	pokeweed-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
period	period	NN	I-NP	O

Significance	Significance	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
tonus	tonus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
and	and	CC	I-NP	O
arteriosclerotic	arteriosclerotic	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
and	and	CC	I-NP	O
vessels	vessel	NNS	I-NP	O
in	in	IN	B-PP	O
middle	middle	JJ	B-NP	O
-	-	HYPH	I-NP	O
aged	aged	JJ	I-NP	O
and	and	CC	I-NP	O
elderly	elderly	JJ	I-NP	O
persons	person	NNS	I-NP	O
with	with	IN	B-PP	O
fibrillation	fibrillation	NN	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O

The	The	DT	B-NP	O
disease	disease	NN	I-NP	O
processes	process	NNS	I-NP	O
that	that	WDT	B-NP	O
affect	affect	VBP	B-VP	O
transplant	transplant	NN	B-NP	O
patients	patient	NNS	I-NP	O
both	both	CC	B-PP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
transplantation	transplantation	NN	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
seen	see	VBN	I-VP	O
frequently	frequently	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
general	general	JJ	I-NP	O
practice	practice	NN	I-NP	O
of	of	IN	B-PP	O
gastroenterology	gastroenterology	NN	B-NP	O

In	In	IN	B-PP	O
Experiment	Experiment	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
levels	level	NNS	B-NP	O
were	be	VBD	B-VP	O
:	:	:	O	O
amprolium	amprolium	NN	B-NP	O
and	and	CC	I-NP	O
ethopabate	ethopabate	NN	I-NP	O
,	,	,	O	O
.1	.1	NN	B-NP	O
;	;	:	O	O
salinomycin	salinomycin	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
;	;	:	O	O
monensin	monensin	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
lasalocid	lasalocid	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	O	O
kg	kg	NN	B-NP	O

This	This	DT	B-NP	O
duplicated	duplicated	JJ	I-NP	O
genomic	genomic	JJ	I-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
linked	link	VBN	I-VP	O
tightly	tightly	RB	B-ADVP	O
to	to	TO	B-PP	O
D1Z1	BEGIN-D1Z1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
marker	marker	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
polymorphic	polymorphic	JJ	I-NP	O
VNTR	VNTR	NN	I-NP	O
(	(	(	O	O
variable	variable	JJ	B-NP	O
number	number	NN	I-NP	O
tandem	tandem	JJ	I-NP	O
repeat	repeat	NN	I-NP	O
)	)	)	O	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
unusual	unusual	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
reiterated	reiterate	VBD	B-VP	O
sequence	sequence	NN	B-NP	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
generated	generate	VBN	B-VP	O
by	by	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
activators	activator	NNS	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
sum	sum	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
generated	generate	VBN	B-VP	O
by	by	IN	B-PP	O
individual	individual	JJ	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
designated	designate	VBN	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
synergy	synergy	NN	I-NP	O

Aspartame	Aspartame	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
sweetener	sweetener	NN	I-NP	O
commonly	commonly	RB	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
soft	soft	JJ	B-NP	O
drinks	drink	NNS	I-NP	O
and	and	CC	O	O
many	many	JJ	B-NP	O
foods	food	NNS	I-NP	O

Under	Under	IN	B-PP	O
control	control	NN	B-NP	O
conditions	condition	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
micromol	micromol	NN	I-NP	O
/	/	SYM	O	O
kg	kg	NN	B-NP	O
MIB	MIB	NN	I-NP	O
and	and	CC	O	O
VER	VER	NN	B-NP	O
the	the	DT	B-NP	O
maximal	maximal	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
noradrenaline	noradrenaline	NN	B-NP	O
was	be	VBD	B-VP	O
reached	reach	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
micromol	micromol	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
whereas	whereas	IN	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
micromol	micromol	NN	I-NP	O
/	/	SYM	O	O
kg	kg	NN	B-NP	O
MIB	MIB	NN	I-NP	O
and	and	CC	I-NP	O
VER	VER	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
reached	reach	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
micromol	micromol	NN	I-NP	O
/	/	SYM	O	O
kg	kg	NN	B-NP	O

The	The	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
U1	BEGIN-U1	NN	B-NP	B
snRNA	snRNA-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
structural	structural	JJ	I-NP	O
similarity	similarity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	O
strand	strand	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
satellite	satellite	NN	I-NP	O
RNA	RNA	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
ring	ring	NN	I-NP	O
spot	spot	NN	I-NP	O
virus	virus	NN	I-NP	O
[	[	(	O	O
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
sTRSV	sTRSV	NN	B-NP	O
]	]	)	O	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
U1	BEGIN-U1	NN	B-NP	B
snRNA	snRNA-INSIDE	NN	I-NP	I
forms	form	VBZ	B-VP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
center	center	NN	I-NP	O

By	By	IN	B-PP	O
computed	compute	VBN	B-NP	O
homology	homology	NN	I-NP	O
search	search	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
significant	significant	JJ	B-NP	O
similarities	similarity	NNS	I-NP	O
between	between	IN	B-PP	O
US1	BEGIN-US1	NN	B-NP	B
PK	PK-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
p1	BEGIN-p1	NN	I-NP	B
-	-	HYPH	O	I
activated	activate	VBN	B-VP	I
kinase	kinase-INSIDE	NN	B-NP	I
(	(	(	O	O
PAK	BEGIN-PAK-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	I-NP	B
or	or	CC	I-NP	O
Rac	BEGIN-Rac-INSIDE	NN	I-NP	B

Using	Use	VBG	B-VP	O
transgenic	transgenic	JJ	B-NP	O
lines	line	NNS	I-NP	O
a	a	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Hoxa	BEGIN-Hoxa	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
enhancer	enhancer	NN	I-NP	O
-	-	HYPH	O	O
directed	direct	VBN	B-VP	O
expression	expression	NN	B-NP	O
during	during	IN	B-PP	O
embryogenesis	embryogenesis	NN	B-NP	O
was	be	VBD	B-VP	O
performed.	performed.	VBN	I-VP	O
lacZ	BEGIN-lacZ-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
first	first	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
allantois	allantois	NN	I-NP	O
at	at	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
p.c.	p.c.	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
mesoderm	mesoderm	NN	B-NP	O
and	and	CC	I-NP	O
ectoderm	ectoderm	NN	I-NP	O
at	at	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
gestation	gestation	NN	B-NP	O

Its	Its	PRP$	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
strongly	strongly	RB	B-VP	O
potentiates	potentiate	VBZ	I-VP	O
its	its	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
fos	fos	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
through	through	IN	B-PP	O
a	a	DT	B-NP	O
ternary	ternary	JJ	I-NP	O
complex	complex	NN	I-NP	O
assembled	assemble	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
fos	fos	NN	I-NP	I
serum	serum	NN	I-NP	I
response	response	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I

Drosophila	BEGIN-Drosophila	JJ	B-NP	B
melanogaster	melanogaster	NN	I-NP	I
casein	casein	NN	I-NP	I
kinase	kinase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
(	(	(	O	O
DmCKII	BEGIN-DmCKII-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
catalytic	catalytic	JJ	B-NP	O
(	(	(	O	O
alpha	alpha	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
regulatory	regulatory	JJ	B-NP	O
(	(	(	O	O
beta	beta	NN	B-NP	O
)	)	)	O	O
subunits	subunit	NNS	B-NP	O
associated	associate	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
alpha1beta1	alpha1beta1	NN	I-NP	O
heterotetramer	heterotetramer	NN	I-NP	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
DNA	BEGIN-DNA	NN	B-NP	B
topoisomerase	topoisomerase	NN	I-NP	I
II	II	CD	I-NP	I
alpha	alpha	SYM	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
tumor	tumor	NN	I-NP	I
suppressor	suppressor-INSIDE	NN	I-NP	I

These	These	DT	B-NP	O
conditions	condition	NNS	I-NP	O
may	may	MD	B-VP	O
determine	determine	VB	I-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
indoor	indoor	JJ	B-NP	O
pollutants	pollutant	NNS	I-NP	O
(	(	(	O	O
tobacco	tobacco	NN	B-NP	O
smoke	smoke	NN	I-NP	O
,	,	,	O	O
gases	gas	NNS	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
cooling	cool	VBG	B-VP	O
processes	process	NNS	B-NP	O
etc.	etc.	FW	I-NP	O
)	)	)	O	O
and	and	CC	O	O
of	of	IN	B-PP	O
allergens	allergen	NNS	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
mites	mite	NNS	B-NP	O
,	,	,	O	O
domestic	domestic	JJ	B-NP	O
animals	animal	NNS	I-NP	O
and	and	CC	I-NP	O
cockroaches	cockroach	NNS	I-NP	O

Vav	BEGIN-Vav-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Dbl	BEGIN-Dbl-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
oncogene	oncogene	NN	B-NP	O
proteins	protein	NNS	I-NP	O
that	that	WDT	B-NP	O
share	share	VBP	B-VP	O
significant	significant	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
identity	identity	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
approximately	approximately	RB	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
designated	designate	VBN	B-VP	O
the	the	DT	B-NP	O
Dbl	BEGIN-BEGIN-Dbl-INSIDE	NN	I-NP	B
homology	homology	NN	I-NP	O
domain	domain-INSIDE	NN	I-NP	I

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Levels	Level	NNS	B-NP	O
of	of	IN	B-PP	O
sIL	BEGIN-sIL	NN	B-NP	B
-	-	HYPH	B-NP	I
1R	1R-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
simultaneously	simultaneously	RB	B-ADVP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
and	and	CC	O	O
pleural	pleural	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
pleural	pleural	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
causes	cause	NNS	I-NP	O

HCVR	HCVR	NN	B-NP	O
-	-	HYPH	I-NP	O
L	L	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
dVAS	dVAS	NN	B-NP	O
/	/	SYM	B-NP	O
dPCO1	dPCO1	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
/	/	SYM	B-NP	O
Torr	Torr	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
HCVR	HCVR	NN	B-NP	O
-	-	HYPH	O	O
S	S	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Right	Right	RB	B-ADVP	O
-	-	HYPH	I-ADVP	O
sided	sided	JJ	B-NP	O
hemiplegia	hemiplegia	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
duration	duration	NN	I-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
case	case	NN	I-NP	O

Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
excretion	excretion	NN	I-NP	O
of	of	IN	B-PP	O
selenium	selenium	NN	B-NP	O
in	in	IN	B-PP	O
urine	urine	NN	B-NP	O
and	and	CC	I-NP	O
feces	fece	NNS	I-NP	O
and	and	CC	O	O
distribution	distribution	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
organs	organ	NNS	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
radioactivity	radioactivity	NN	B-NP	O
measurement	measurement	NN	I-NP	O

The	The	DT	B-NP	O
LIF	BEGIN-LIF-INSIDE	NN	I-NP	B
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
released	release	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
when	when	WRB	B-ADVP	O
cultured	culture	VBN	B-VP	O
with	with	IN	B-PP	O
optimal	optimal	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
propranolol	propranolol	NN	B-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
confirmed	confirm	VBD	B-VP	O
previous	previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
monkeys	monkey	NNS	B-NP	O
with	with	IN	B-PP	O
total	total	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
striatectomies	striatectomy	NNS	I-NP	O
could	could	MD	B-VP	O
require	require	VB	I-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
execute	execute	VB	I-VP	O
accurate	accurate	JJ	B-NP	O
visually	visually	RB	I-NP	O
guided	guide	VBN	I-NP	O
reaches	reach	NNS	I-NP	O

The	The	DT	B-NP	O
greatest	great	JJS	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
preterm	preterm	JJ	B-NP	O
prelabour	prelabour	JJ	I-NP	O
rupture	rupture	NN	I-NP	O
of	of	IN	B-PP	O
membranes	membrane	NNS	B-NP	O
(	(	(	O	O
PPROM	PPROM	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
preterm	preterm	JJ	B-NP	O
delivery	delivery	NN	I-NP	O

The	The	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
x	x	NN	I-NP	I
1	1	CD	I-NP	I
(	(	(	O	I
1	1	CD	O	I
)	)	)	O	I
base	base	NN	B-NP	I
SUF1+	SUF1+	NN	I-NP	I
transcript	transcript-INSIDE	NN	I-NP	I
contains	contain	VBZ	B-VP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
encode	encode	VB	I-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
Mr	Mr	NN	B-NP	O
protein	protein	NN	I-NP	O

This	This	DT	B-NP	O
regulation	regulation	NN	I-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
several	several	JJ	B-NP	O
kinases	kinase	NNS	I-NP	O
that	that	WDT	B-NP	O
phosphorylate	phosphorylate	VBP	B-VP	O
specific	specific	JJ	B-NP	O
residues	residue	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
functional	functional	JJ	I-NP	O
domains	domain	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
molecule	molecule-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
group	group	NN	B-NP	O
I	I	CD	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	I-NP	O
period	period	NN	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
thallium	thallium	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
scans	scan	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
ECG	ECG	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
;	;	:	O	O
during	during	IN	B-PP	O
angina	angina	NN	B-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
transient	transient	JJ	B-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
M	BEGIN-M	NN	I-NP	B
-	-	HYPH	B-NP	I
MuLV	MuLV	NN	I-NP	I
enhancers	enhancers-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	I-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
M	M	NN	B-NP	O
-	-	HYPH	B-NP	O
MuLV	MuLV	NN	I-NP	O
by	by	IN	B-PP	O
constructing	construct	VBG	B-VP	O
LTRs	LTR	NNS	B-NP	O
containing	contain	VBG	B-VP	O
heterologous	heterologous	JJ	B-NP	O
enhancer	enhancer	NN	I-NP	O
elements	element	NNS	I-NP	O

Acute	Acute	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O

Serum	Serum	NN	B-NP	O
creatinine	BEGIN-creatinine	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
U	U	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
,	,	,	O	O
making	make	VBG	B-VP	O
acute	acute	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
damage	damage	NN	I-NP	O
likely	likely	RB	B-ADJP	O
,	,	,	O	O
probably	probably	RB	B-NP	O
rhabdomyolysis	rhabdomyolysis	NN	I-NP	O

Transcriptional	Transcriptional	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
murine	BEGIN-murine	JJ	I-NP	B
k	k	NN	I-NP	I
-	-	HYPH	B-NP	I
fgf	fgf	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Fetal	Fetal	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
and	and	CC	I-NP	O
sagittal	sagittal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
pH	pH	NN	I-NP	O
,	,	,	O	O
base	base	NN	B-NP	O
excess	excess	NN	I-NP	O
,	,	,	O	O
po1	po1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
hydrogen	hydrogen	NN	B-NP	O
ion	ion	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
and	and	CC	O	O
pco1	pco1	NN	B-NP	O
increased	increase	VBD	B-VP	O
during	during	IN	B-PP	O
asphyxia	asphyxia	NN	B-NP	O
alone	alone	RB	B-ADVP	O
and	and	CC	O	O
asphyxia	asphyxia	NN	B-NP	O
plus	plus	CC	I-NP	O
isoflurane	isoflurane	NN	I-NP	O
-	-	HYPH	O	O
oxygen	oxygen	NN	B-NP	O

To	To	TO	B-VP	O
clarify	clarify	VB	I-VP	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
,	,	,	O	O
both	both	CC	O	O
the	the	DT	B-NP	O
Crk	BEGIN-Crk	NN	I-NP	B
II	II-INSIDE	NN	I-NP	I
and	and	CC	O	O
Crk	BEGIN-BEGIN-Crk	NN	B-NP	B
II	II-INSIDE	JJ	I-NP	I
-	-	HYPH	I-NP	O
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
proteins	protein	NNS	B-NP	O
were	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
and	and	CC	O	O
examined	examine	VBD	B-VP	O
their	their	PRP$	B-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

Growth	BEGIN-Growth	NN	B-NP	B
hormone	hormone-INSIDE	NN	I-NP	I
exerts	exert	VBZ	B-VP	O
its	its	PRP$	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
ovarian	ovarian	JJ	I-NP	O
follicular	follicular	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
directly	directly	RB	B-ADVP	O
or	or	CC	O	O
by	by	IN	B-PP	O
local	local	JJ	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
insulin	BEGIN-insulin	NN	B-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
IGF	BEGIN-IGF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
most	most	JJS	I-NP	O
part	part	NN	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
aerobic	aerobic	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
systems	system	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
so	so	RB	B-ADVP	O
far	far	RB	I-ADVP	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
remodeling	remodeling	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
process	process	NN	I-NP	O
that	that	WDT	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
geometry	geometry	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
vessel	vessel	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
compliant	compliant	JJ	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
(	(	(	O	O
that	that	DT	B-NP	O
is	be	VBZ	B-VP	O
,	,	,	O	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
given	give	VBN	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
transmural	transmural	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
local	local	JJ	I-NP	O
segment	segment	NN	I-NP	O
length	length	NN	I-NP	O
change	change	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
)	)	)	O	O

Although	Although	IN	B-SBAR	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
slightly	slightly	RB	B-ADVP	O
with	with	IN	B-PP	O
PCF	PCF	NN	B-NP	O
,	,	,	O	O
hemodynamic	hemodynamic	JJ	B-NP	O
changes	change	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
PCF	PCF	NN	B-NP	O
were	be	VBD	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
observed	observe	VBN	I-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
PaO1	PaO1	NN	B-NP	O

Swarming	Swarm	VBG	B-VP	O
of	of	IN	B-PP	O
Moraxella	Moraxella	NNP	B-NP	O

Two	Two	CD	B-NP	O
patient	patient	NN	I-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
:	:	:	O	O
Type	Type	NN	B-NP	O
I	I	CD	I-NP	O
-	-	HYPH	B-VP	O
-	-	HYPH	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
ePTFE	ePTFE	NN	I-NP	O
graft	graft	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
-	-	HYPH	O	O
-	-	HYPH	O	O
with	with	IN	B-PP	O
thrombectomy	thrombectomy	NN	B-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
revision	revision	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
placed	place	VBN	I-NP	O
ePTFE	ePTFE	NN	I-NP	O
graft	graft	NN	I-NP	O

No	No	DT	B-NP	O
consensus	consensus	NN	I-NP	O
binding	binding	NN	I-NP	O
sequence	sequence	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
discerned	discern	VBN	I-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
fragments	fragment	NNS	I-NP	O
and	and	CC	O	O
bound	bind	VBN	B-NP	O
factor	factor	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
equilibrium	equilibrium	NN	I-NP	O
with	with	IN	B-PP	O
unbound	unbound	JJ	B-NP	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
cochlear	cochlear	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
1f1	1f1	CD	B-NP	O
-	-	HYPH	I-NP	O
f1	f1	NN	I-NP	O
distortion	distortion	NN	I-NP	O
-	-	HYPH	B-NP	O
product	product	NN	I-NP	O
otoacoustic	otoacoustic	JJ	I-NP	O
emissions	emission	NNS	I-NP	O
(	(	(	O	O
DPOAEs	DPOAE	NNS	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
systematically	systematically	RB	B-ADVP	O
over	over	IN	B-PP	O
time	time	NN	B-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
experiencing	experience	VBG	B-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
paradigm	paradigm	NN	I-NP	O
that	that	WDT	B-NP	O
incorporated	incorporate	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
-	-	HYPH	I-NP	O
frequency	frequency	NN	I-NP	O
tone	tone	NN	I-NP	O

Quasidiatomic	Quasidiatomic	JJ	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
Ly	Ly	NN	B-NP	O
-	-	HYPH	O	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
producing	produce	VBG	B-VP	O
H1	H1	NN	B-NP	O
+	+	SYM	B-VP	O
-	-	HYPH	B-NP	O
Ne	Ne	NN	I-NP	O
collisions	collision	NNS	I-NP	O
at	at	IN	B-PP	O
keV	keV	NN	B-NP	O
energies	energy	NNS	I-NP	O

Detailed	Detailed	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
sequence	sequence	NN	B-NP	O
elements	element	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
DNA	BEGIN-DNA	NN	I-NP	B
and	and	CC	I-NP	I
RNA	RNA	NN	I-NP	I
polymerases	polymerases-INSIDE	NN	I-NP	I

1La	1La	NN	B-NP	O
NQR	NQR	NN	I-NP	O
relaxation	relaxation	NN	I-NP	O
and	and	CC	I-NP	O
microSR	microSR	NN	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
Zn	Zn	NN	B-NP	O
-	-	HYPH	O	O
doping	dope	VBG	B-VP	O
effects	effect	NNS	B-NP	O
in	in	IN	B-PP	O
La1CuO1	La1CuO1	NN	B-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
myc	myc	NN	I-NP	I
-	-	HYPH	I-NP	I
null	null-INSIDE	NN	I-NP	I
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O

Our	Our	PRP$	B-NP	O
study	study	NN	I-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
NaCl	NaCl	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
social	social	JJ	B-NP	O
isolation	isolation	NN	I-NP	O
stress	stress	NN	I-NP	O
would	would	MD	B-VP	O
increase	increase	VB	I-VP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
(	(	(	O	O
SBP	SBP	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
endogenous	endogenous	JJ	B-NP	O
sodium	sodium	NN	I-NP	O
pump	pump	NN	I-NP	O
ligands	ligand	NNS	I-NP	O
(	(	(	O	O
SPL	SPL	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
ouabainlike	ouabainlike	IN	B-PP	O
compound	compound	NN	B-NP	O
(	(	(	O	O
OLC	OLC	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
marinobufagenin	marinobufagenin	NN	B-NP	O
(	(	(	O	O
MBG	MBG	NN	B-NP	O
)	)	)	O	O

Percentage	Percentage	NN	B-NP	O
incremental	incremental	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
OHB	OHB	NN	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
metoclopramide	metoclopramide	NN	B-NP	O
were	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
meq	meq	NN	I-NP	O
sodium	sodium	NN	I-NP	O
intake	intake	NN	I-NP	O
than	than	IN	B-PP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
meq	meq	NN	I-NP	O
sodium	sodium	NN	I-NP	O
intake	intake	NN	I-NP	O

An	An	DT	B-NP	O
additional	additional	JJ	I-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
D1	BEGIN-D1	NN	B-NP	B
receptors	receptors-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
giving	give	VBG	B-VP	O
SKF1	SKF1	NN	B-NP	O
1	1	CD	I-NP	O
min	min	NN	I-NP	O
later	later	RB	B-ADVP	O
produced	produce	VBD	B-VP	O
an	an	DT	B-NP	O
almost	almost	RB	I-NP	O
continuous	continuous	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
jaw	jaw	NN	B-NP	O
openings	opening	NNS	I-NP	O
but	but	CC	O	O
less	less	JJR	B-NP	O
closure	closure	NN	I-NP	O
movements	movement	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
position	position	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
openings	opening	NNS	I-NP	O
were	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
tongue	tongue	NN	I-NP	O
protrusions	protrusion	NNS	I-NP	O

PURPOSE	PURPOSE	NN	B-NP	O
:	:	:	O	O
Second	Second	JJ	B-NP	O
malignant	malignant	JJ	I-NP	O
neoplasms	neoplasm	NNS	I-NP	O
(	(	(	O	O
SMNs	SMN	NNS	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
rare	rare	JJ	I-NP	O
occurrence	occurrence	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
successful	successful	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
childhood	childhood	NN	B-NP	O
cancer	cancer	NN	I-NP	O

A	A	DT	B-NP	O
p1	BEGIN-BEGIN-p1-INSIDE	NN	I-NP	B
cDNA	cDNA-INSIDE	NN	I-NP	I
deletion	deletion	NN	I-NP	O
mutant	mutant	NN	I-NP	O
(	(	(	O	O
delta	delta	SYM	B-NP	O
pro	pro	JJ	I-NP	O
AE	AE	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
lacks	lack	VBZ	B-VP	O
this	this	DT	B-NP	O
entire	entire	JJ	I-NP	O
proline	proline	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
domain	domain	NN	I-NP	O
(	(	(	O	O
deleted	delete	VBN	B-VP	O
for	for	IN	B-PP	O
amino	amino	NN	B-NP	O
acids	acid	NNS	I-NP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
was	be	VBD	B-VP	O
created	create	VBN	I-VP	O
and	and	CC	O	O
characterized	characterize	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
functions	function	NNS	I-NP	O

Mutations	Mutation	NNS	B-NP	O
in	in	IN	B-PP	O
nifR1	BEGIN-nifR1-INSIDE	NN	B-NP	B
(	(	(	O	O
ntrC	BEGIN-ntrC-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
nifR1	BEGIN-nifR1-INSIDE	NN	B-NP	B
(	(	(	O	O
rpoN	BEGIN-rpoN-INSIDE	NN	B-NP	B
,	,	,	O	O
encoding	encode	VBG	B-VP	O
sigma1	BEGIN-sigma1-INSIDE	NN	B-NP	B
)	)	)	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
xdh	BEGIN-xdh	JJ	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O

Candidate	Candidate	NN	B-NP	O
factors	factor	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-SBAR	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
induction	induction	NN	I-NP	O
parameters	parameter	NNS	I-NP	O
in	in	IN	B-PP	O
CV	CV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
reproduced	reproduce	VBN	I-VP	O
by	by	IN	B-PP	O
varying	vary	VBG	B-VP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
coactivators	coactivator	NNS	B-NP	O
[	[	(	O	O
transcriptional	BEGIN-transcriptional	JJ	B-NP	B
intermediary	intermediary	JJ	I-NP	I
factor	factor	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
TIF1	BEGIN-TIF1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
steroid	BEGIN-steroid	NN	B-NP	B
receptor	receptor	NN	I-NP	I
coactivator	coactivator	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
SRC	BEGIN-SRC	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
amplified	BEGIN-amplified	JJ	B-ADJP	B
in	in	IN	B-PP	I
breast	breast	NN	B-NP	I
cancer	cancer	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
AIB1	BEGIN-AIB1-INSIDE	NN	B-NP	B
)	)	)	O	O
]	]	)	O	O
,	,	,	O	O
comodulator	comodulator	NN	B-NP	O
[	[	(	O	O
CREB	BEGIN-CREB	NN	B-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
CBP	BEGIN-CBP-INSIDE	NN	B-NP	B
)	)	)	O	O
]	]	)	O	O
,	,	,	O	O
or	or	CC	O	O
corepressor	corepressor	NN	B-NP	O
[	[	(	I-NP	O
silencing	BEGIN-silencing	NN	I-NP	B
mediator	mediator	NN	I-NP	I
for	for	IN	B-PP	I
retinoid	retinoid	NN	B-NP	I
and	and	CC	I-NP	I
thyroid	thyroid	NN	I-NP	I
-	-	HYPH	O	I
hormone	hormone	NN	B-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
(	(	(	O	O
SMRT	BEGIN-SMRT-INSIDE	NN	B-NP	B
)	)	)	O	O
]	]	)	O	O
without	without	IN	B-PP	O
concomitant	concomitant	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
GR	BEGIN-GR-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
pyridostigmine	pyridostigmine	NN	I-NP	O
inhibited	inhibit	VBD	B-VP	O
AChE	BEGIN-AChE-INSIDE	NN	B-NP	B
recovered	recover	VBD	B-VP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
mumol	mumol	NN	I-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
kg	kg	NN	I-NP	O
oxime	oxime	NN	I-NP	O
groups	group	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
experiment	experiment	NN	I-NP	O

We	We	PRP	B-NP	O
compared	compare	VBD	B-VP	O
retrospectively	retrospectively	RB	B-ADVP	O
the	the	DT	B-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
granulocyte	BEGIN-granulocyte	NN	B-NP	B
colony	colony	NN	I-NP	I
stimulating	stimulate	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
(	(	(	O	O
G	BEGIN-G	NN	B-NP	B
-	-	HYPH	B-NP	I
CSF	CSF-INSIDE	NN	I-NP	I
)	)	)	O	O
alone	alone	RB	B-ADVP	O
with	with	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
plus	plus	CC	I-NP	O
G	BEGIN-G	NN	I-NP	B
-	-	HYPH	O	I
CSF	CSF-INSIDE	NN	B-NP	I
in	in	IN	B-PP	O
mobilizing	mobilize	VBG	B-VP	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
positive	positive	JJ	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O

An	An	DT	B-NP	O
additional	additional	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
Gy	Gy	NN	I-NP	O
was	be	VBD	B-VP	O
delivered	deliver	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
original	original	JJ	B-NP	O
involvement	involvement	NN	I-NP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
implant	implant	NN	I-NP	O
when	when	WRB	B-ADVP	O
feasible	feasible	JJ	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
induces	induce	VBZ	B-VP	O
Ret	BEGIN-Ret-INSIDE	NN	B-NP	B
phosphorylation	phosphorylation	NN	I-NP	O
that	that	WDT	B-NP	O
leads	lead	VBZ	B-VP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
-	-	HYPH	O	O
promoting	promote	VBG	B-VP	O
effects	effect	NNS	B-NP	O

Adenovirus	Adenovirus	NN	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
hepatoma	hepatoma	NN	B-NP	O
cells	cell	NNS	I-NP	O
inhibited	inhibit	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phosphoenolpyruvate	BEGIN-phosphoenolpyruvate	JJ	I-NP	B
carboxykinase	carboxykinase-INSIDE	NN	I-NP	I
(	(	(	O	O
GTP	GTP	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
EC	BEGIN-EC	NN	B-NP	B
1.1	1.1-INSIDE	NN	I-NP	I
)	)	)	O	O
(	(	(	O	O
PEPCK	BEGIN-PEPCK-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O
and	and	CC	O	O
virtually	virtually	RB	B-NP	O
eliminated	eliminate	VBN	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
chimeric	chimeric	JJ	I-NP	O
gene	gene	NN	I-NP	O
which	which	WDT	B-NP	O
contained	contain	VBD	B-VP	O
the	the	DT	B-NP	O
PEPCK	BEGIN-BEGIN-PEPCK-INSIDE	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
structural	structural	JJ	I-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
chloramphenicol	BEGIN-chloramphenicol	NN	B-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
(	(	(	O	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
)	)	)	O	O

Circulating	Circulate	VBG	B-VP	O
immune	immune	JJ	B-NP	O
complexes	complex	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
phagocytosis	phagocytosis	NN	B-NP	O
and	and	CC	I-NP	O
immunofluorescence	immunofluorescence	NN	I-NP	O

LCCH1	BEGIN-LCCH1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Rdl	BEGIN-Rdl	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
known	know	VBN	I-NP	O
GABA	BEGIN-GABA	NN	I-NP	B
receptor	receptor	NN	I-NP	I
subunit	subunit	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
D.	D.	NNP	B-NP	O
melanogaster	melanogaster	NNP	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
LCCH1	BEGIN-LCCH1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
LCCH1	BEGIN-LCCH1-INSIDE	NN	I-NP	B
were	be	VBD	B-VP	O
novel	novel	JJ	B-NP	O
D.	D.	NNP	I-NP	O
melanogaster	melanogaster	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
that	that	WDT	B-NP	O
exhibited	exhibit	VBD	B-VP	O
structural	structural	JJ	B-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ligand	BEGIN-ligand	NN	I-NP	B
-	-	HYPH	B-VP	I
gated	gate	VBN	B-NP	I
chloride	chloride	NN	I-NP	I
channel	channel	NN	I-NP	I
gene	gene	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
cleavage	cleavage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RRKR	RRKR	NN	I-NP	O
motif	motif	NN	I-NP	O
of	of	IN	B-PP	O
MT	BEGIN-MT	NN	B-NP	B
-	-	HYPH	B-NP	I
MMP1	MMP1-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
Golgi	BEGIN-Golgi	NN	B-NP	B
-	-	HYPH	O	I
associated	associate	VBN	B-NP	I
furin	furin-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
analogous	analogous	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
activation	activation	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
observed	observe	VBN	B-VP	O
with	with	IN	B-PP	O
stromelysin	BEGIN-stromelysin	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Lifestyle	Lifestyle	NN	B-NP	O
characteristics	characteristic	NNS	I-NP	O
were	be	VBD	B-VP	O
ascertained	ascertain	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
self	self	NN	I-NP	O
-	-	HYPH	O	O
administered	administer	VBN	B-VP	O
questionnaire	questionnaire	NN	B-NP	O

The	The	DT	B-NP	O
oxalate	BEGIN-oxalate	JJ	I-NP	B
oxidase	oxidase-INSIDE	NN	I-NP	I
method	method	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	NN	I-NP	O
and	and	CC	I-NP	O
reference	reference	NN	I-NP	O
interval	interval	NN	I-NP	O
for	for	IN	B-PP	O
oxalate	oxalate	NN	B-NP	O
excretion	excretion	NN	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
comparable	comparable	JJ	B-ADJP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
by	by	IN	B-PP	O
isotope	isotope	NN	B-NP	O
dilution	dilution	NN	I-NP	O
,	,	,	O	O
gas	gas	NN	B-NP	O
-	-	HYPH	B-ADJP	O
chromatographic	chromatographic	JJ	B-NP	O
,	,	,	I-NP	O
colorimetric	colorimetric	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
other	other	JJ	B-NP	O
enzymic	enzymic	JJ	I-NP	O
procedures	procedure	NNS	I-NP	O

Normal	Normal	JJ	B-NP	O
replication	replication	NN	I-NP	O
of	of	IN	B-PP	O
DNA	BEGIN-DNA	JJ	B-NP	B
A	A-INSIDE	NN	I-NP	I
still	still	RB	B-ADVP	O
carrying	carry	VBG	B-VP	O
the	the	DT	B-NP	O
AC1	BEGIN-AC1	NN	I-NP	B
ORF	ORF-INSIDE	NN	I-NP	I
mutation	mutation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
extracts	extract	NNS	B-NP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
plants	plant	NNS	I-NP	O

Kohtz	Kohtz	NNP	B-NP	O
,	,	,	O	O
J	J	NNP	B-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
and	and	CC	I-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
EEC	EEC	NN	B-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
fibrinogen	BEGIN-fibrinogen	NN	I-NP	B
gamma	gamma	NN	I-NP	I
chain	chain	NN	I-NP	I
region	region	NN	I-NP	I
Gly1	Gly1	NN	I-NP	I
-	-	HYPH	B-NP	I
Val1	Val1-INSIDE	NN	I-NP	I
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
recognition	recognition	NN	I-NP	O
sequence	sequence	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
leukocyte	leukocyte	NN	I-NP	O
integrin	integrin	NN	I-NP	O
CD1b	BEGIN-BEGIN-CD1-INSIDEb-INSIDE	NN	I-NP	B
/	/	SYM	B-VP	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
audiologic	audiologic	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
of	of	IN	B-PP	O
vestibular	vestibular	JJ	B-NP	O
schwannoma	schwannoma	NN	I-NP	O
(	(	(	O	O
VS	VS	NN	B-NP	O
)	)	)	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
neurofibromatosis	neurofibromatosis	NN	B-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
NF1	NF1	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
characterized	characterize	VBN	I-VP	O

Siglec	BEGIN-Siglec	JJ	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
predicted	predict	VBN	I-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
three	three	CD	B-NP	O
extracellular	extracellular	JJ	I-NP	O
immunoglobulin	BEGIN-immunoglobulin	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
domains	domains-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
comprise	comprise	VBP	B-VP	O
an	an	DT	B-NP	O
N	BEGIN-N	NN	I-NP	B
-	-	HYPH	O	I
terminal	terminal	JJ	B-NP	I
V	V	NN	I-NP	I
-	-	HYPH	O	I
set	set	VBN	B-VP	I
domain	domain-INSIDE	NN	B-NP	I
and	and	CC	O	O
two	two	CD	B-NP	O
C1	BEGIN-C1	NN	I-NP	B
-	-	HYPH	O	I
set	set	VBN	B-VP	I
domains	domains-INSIDE	NN	B-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
transmembrane	transmembrane	JJ	I-NP	O
region	region	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
tail	tail	NN	I-NP	O
containing	contain	VBG	B-VP	O
two	two	CD	B-NP	O
putative	putative	JJ	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
-	-	HYPH	B-VP	O
based	base	VBN	B-NP	O
signaling	signaling	NN	I-NP	O
motifs	motif	NNS	I-NP	O

Development	Development	NN	B-NP	O
of	of	IN	B-PP	O
P	P	NN	B-NP	O
carinii	carinii	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
Kaposi	Kaposi	NNP	B-NP	O
's	's	POS	B-NP	O
sarcoma	sarcoma	NN	I-NP	O
,	,	,	O	O
B	B	NN	B-NP	O
subtype	subtype	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
X	X	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
L	L	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
mm1	mm1	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
fewer	few	JJR	B-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
cells	cell	NNS	I-NP	O
at	at	IN	B-PP	O
study	study	NN	B-NP	O
entry	entry	NN	I-NP	O

Dermatophagoides	Dermatophagoide	NNS	B-NP	O
farinae	farinae	VBP	B-VP	O
-	-	HYPH	B-NP	O
sensitized	sensitize	VBN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
in	in	IN	B-PP	O
asthmatic	asthmatic	JJ	B-NP	O
children	child	NNS	I-NP	O
as	as	IN	B-SBAR	O
evaluated	evaluate	VBN	B-VP	O
by	by	IN	B-PP	O
interleukin	BEGIN-interleukin	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
production	production	NN	B-NP	O
and	and	CC	I-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
responsiveness	responsiveness	NN	I-NP	O

Adenocarcinoma	Adenocarcinoma	NN	B-NP	O
and	and	CC	O	O
large	large	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
worse	worse	JJR	I-NP	O
prognosis	prognosis	NN	I-NP	O
than	than	IN	B-PP	O
squamous	squamous	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T1N1	T1N1	NN	I-NP	O
and	and	CC	I-NP	O
T1N1	T1N1	NN	I-NP	O
subsets	subset	NNS	I-NP	O

The	The	DT	B-NP	O
DNA	DNA	NN	I-NP	O
element	element	NN	I-NP	O
through	through	IN	B-PP	O
which	which	WDT	B-NP	O
EBNA	BEGIN-EBNA	NN	B-VP	B
-	-	HYPH	O	I
1C	1C-INSIDE	NN	B-NP	I
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
LMP	BEGIN-LMP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
includes	include	VBZ	B-VP	O
a	a	DT	B-NP	O
Spi	BEGIN-Spi	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
Spi	BEGIN-Spi	NN	I-NP	B
-	-	HYPH	B-NP	I
B	B-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
previously	previously	RB	B-VP	O
characterized	characterize	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
EBNA	BEGIN-EBNA	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
response	response	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
PCR	PCR	NN	B-NP	O
strategies	strategy	NNS	I-NP	O
and	and	CC	O	O
expression	expression	NN	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
define	define	VBP	B-VP	O
the	the	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
FUT1b	BEGIN-FUT1b	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

Cord	Cord	NN	B-NP	O
formation	formation	NN	I-NP	O
in	in	IN	B-PP	O
BACTEC	BACTEC	NN	B-NP	O
1H1	1H1	NN	I-NP	O
medium	medium	NN	I-NP	O
for	for	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
,	,	,	I-NP	O
presumptive	presumptive	JJ	I-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
Mycobacterium	Mycobacterium	NN	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
complex	complex	NN	I-NP	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NMDA	BEGIN-NMDA	NN	I-NP	B
-	-	HYPH	O	I
receptor	receptor-INSIDE	NN	B-NP	I
antagonist	antagonist	NN	I-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
/	/	SYM	O	O
-	-	SYM	O	O
)	)	)	O	O
-	-	HYPH	B-NP	O
CPP	CPP	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
conditioned	condition	VBN	I-NP	O
-	-	HYPH	I-NP	O
reflex	reflex	NN	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
operant	operant	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
electrical	electrical	JJ	I-NP	O
self	self	NN	I-NP	O
-	-	HYPH	B-NP	O
stimulation	stimulation	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O

Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
H1	H1	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1R	1R-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
mediated	mediate	VBN	B-NP	O
immediate	immediate	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
events	event	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
Jak1	BEGIN-Jak1-INSIDE	NN	B-NP	B
,	,	,	O	O
Jak1	BEGIN-Jak1-INSIDE	NN	B-NP	B
,	,	,	O	O
insulin	BEGIN-insulin	NN	B-NP	B
receptor	receptor	NN	I-NP	I
substrate	substrate	NN	I-NP	I
(	(	(	O	I
IRS	IRS	NN	B-NP	I
)	)	)	O	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
IRS	BEGIN-IRS	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
or	or	CC	O	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
Stat1	BEGIN-Stat1-INSIDE	NN	B-NP	B

(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

Vasodilation	Vasodilation	NN	B-NP	O
in	in	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
established	establish	VBN	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
principal	principal	NN	I-NP	O

The	The	DT	B-NP	O
translational	translational	JJ	I-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
UL1	BEGIN-UL1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
infected	BEGIN-infected	JJ	B-ADJP	B
-	-	HYPH	B-NP	I
cell	cell	NN	I-NP	I
protein	protein	NN	I-NP	I
1c	1c	NN	I-NP	I
,	,	,	O	I
d	d-INSIDE	NN	B-NP	I
(	(	(	O	O
ICP1c	BEGIN-ICP1c	NN	B-NP	B
,	,	,	O	I
d	d-INSIDE	NN	B-NP	I
)	)	)	O	O
(	(	(	O	O
F	F	NN	B-NP	O

Our	Our	PRP$	B-NP	O
experience	experience	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
T1	T1	NN	B-NP	O
weighting	weighting	NN	I-NP	O
is	be	VBZ	B-VP	O
adequate	adequate	JJ	B-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
choice	choice	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
recognition	recognition	NN	I-NP	O
of	of	IN	B-PP	O
necrosis	necrosis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lunate	lunate	NN	I-NP	O

Minor	Minor	JJ	B-NP	O
changes	change	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
transmembrane	transmembrane	NN	I-NP	O
domains	domain	NNS	I-NP	O
(	(	(	O	O
TMs	TM	NNS	B-NP	O
)	)	)	O	O
sometimes	sometimes	RB	B-ADVP	O
produced	produce	VBD	B-VP	O
major	major	JJ	B-NP	O
effects	effect	NNS	I-NP	O
and	and	CC	O	O
more	more	RBR	B-NP	O
drastic	drastic	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
TMs	TM	NNS	I-NP	O
ablated	ablate	VBD	B-VP	O
surface	surface	NN	B-NP	O
expression	expression	NN	I-NP	O
entirely	entirely	RB	B-ADVP	O

Molecular	Molecular	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mannitol	mannitol	NN	I-NP	O
operon	operon	NN	I-NP	O
of	of	IN	B-PP	O
Clostridium	Clostridium	NN	B-NP	O
acetobutylicum	acetobutylicum	NN	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
phosphotransferase	phosphotransferase	NN	I-NP	O
system	system	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
PTS	PTS	NN	I-NP	O
-	-	HYPH	O	O
modulated	modulate	VBN	B-VP	O
regulator	regulator	NN	B-NP	O

Mammalian	Mammalian	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
ends	end	NNS	I-NP	O
contain	contain	VBP	B-VP	O
long	long	JJ	B-NP	O
arrays	array	NNS	I-NP	O
of	of	IN	B-PP	O
TTAGGG	TTAGGG	NN	B-NP	O
repeats	repeat	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
complexed	complexe	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
telomere	telomere	NN	I-NP	O
specific	specific	JJ	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
TTAGGG	BEGIN-TTAGGG	NN	I-NP	B
repeat	repeat	NN	I-NP	I
binding	binding	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
,	,	,	O	O
TRF1	BEGIN-TRF1-INSIDE	NN	B-NP	B

HPV	HPV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
MARs	MAR	NNS	I-NP	O
are	be	VBP	B-VP	O
context	context	JJ	B-NP	O
dependent	dependent	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
enhancers	enhancer	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
activated	activate	VBN	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
HPV	HPV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
oncogenes	oncogene	NNS	I-NP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
chromosomal	chromosomal	JJ	B-NP	O
integration	integration	NN	I-NP	O
may	may	MD	B-VP	O
positively	positively	RB	I-VP	O
select	select	VB	I-VP	O
tumorigenic	tumorigenic	JJ	B-NP	O
cells	cell	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
multistep	multistep	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
cancer	cancer	NN	I-NP	O

Vancomycin	Vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
tetracycline	tetracycline	NN	I-NP	O
eliminated	eliminate	VBD	B-VP	O
toxin	toxin	NN	B-NP	O
in	in	IN	B-PP	O
stools	stool	NNS	B-NP	O
and	and	CC	O	O
delayed	delay	VBN	B-VP	O
death	death	NN	B-NP	O

This	This	DT	B-NP	O
combination	combination	NN	I-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
pathognomonic	pathognomonic	JJ	B-ADJP	O
for	for	IN	B-PP	O
factitious	factitious	JJ	B-NP	O
hyperinsulinism	hyperinsulinism	NN	I-NP	O

The	The	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
naloxone	naloxone	NN	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dose	dose	NN	B-NP	O
-	-	HYPH	O	O
related	relate	VBN	B-VP	O
,	,	,	O	O
statistically	statistically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
hr	hr	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
genomic	genomic	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
KCNQ1	BEGIN-KCNQ1-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
spanning	span	VBG	B-VP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
on	on	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
1p1	1p1	NN	I-NP	O

A	A	DT	B-NP	O
comparison	comparison	NN	I-NP	O
between	between	IN	B-PP	O
attenuation	attenuation	NN	B-NP	O
-	-	HYPH	O	O
corrected	correct	VBN	B-VP	O
and	and	CC	O	O
-	-	HYPH	O	O
uncorrected	uncorrected	JJ	B-NP	O
transmission	transmission	NN	I-NP	O
-	-	HYPH	B-NP	O
emission	emission	NN	I-NP	O
SPECT	SPECT	NN	I-NP	O
images	image	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
Tl	Tl	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
CAD	CAD	NN	B-NP	O
patients	patient	NNS	I-NP	O

Reconstruction	Reconstruction	NN	B-NP	O
time	time	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
matrix	matrix	NN	I-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
/	/	SYM	B-NP	O
transaxial	transaxial	JJ	I-NP	O
slice	slice	NNS	I-NP	O

The	The	DT	B-NP	O
hyperpigmentation	hyperpigmentation	NN	I-NP	O
is	be	VBZ	B-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
numerous	numerous	JJ	B-NP	O
single	single	JJ	I-NP	O
melanosomes	melanosome	NNS	I-NP	O
and	and	CC	I-NP	O
polymelanosomes	polymelanosome	NNS	I-NP	O
in	in	IN	B-PP	O
keratinocytes	keratinocyte	NNS	B-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
epidermis	epidermis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
dermal	dermal	JJ	B-NP	O
Factor	BEGIN-Factor	NN	I-NP	B
XIIIa	XIIIa-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
positive	positive	JJ	I-NP	O
dendrocytes	dendrocyte	NNS	I-NP	O

The	The	DT	B-NP	O
immediate	immediate	JJ	I-NP	O
and	and	CC	I-NP	O
remote	remote	JJ	I-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
adenocarcinomas	adenocarcinoma	NNS	I-NP	O

Six	Six	CD	B-NP	O
patients	patient	NNS	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
electrophysiologic	electrophysiologic	JJ	I-NP	O
study	study	NN	I-NP	O

In	In	IN	B-PP	O
agreement	agreement	NN	B-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
archaea	archaea	NN	B-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
lack	lack	VB	I-VP	O
eIF1	BEGIN-eIF1-INSIDE	NN	B-NP	B
,	,	,	O	O
eIF1B	BEGIN-eIF1-INSIDEB	NN	B-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
lysine	lysine	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
binding	binding	NN	I-NP	O
domain	domain	NN	I-NP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
eIF1beta	BEGIN-BEGIN-eIF1-INSIDEbeta	NN	I-NP	I
homolog	homolog-INSIDE	NN	I-NP	I

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
MCMI	MCMI	NN	I-NP	O
-	-	HYPH	I-NP	O
III	III	CD	I-NP	O
group	group	NN	I-NP	O
profile	profile	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
in	in	IN	B-PP	O
magnitude	magnitude	NN	B-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
MCMI	MCMI	NN	I-NP	O
-	-	HYPH	I-NP	O
II	II	CD	I-NP	O

Spen	BEGIN-Spen-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
only	only	RB	I-NP	O
known	known	JJ	I-NP	O
homeotic	BEGIN-homeotic	JJ	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
RNP	RNP	NN	B-NP	O
binding	binding	NN	I-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
splicing	splicing	NN	B-NP	O
,	,	,	O	O
transport	transport	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
steps	step	NNS	I-NP	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diversification	diversification	NN	I-NP	O
of	of	IN	B-PP	O
segmental	segmental	JJ	B-NP	O
morphology	morphology	NN	I-NP	O

The	The	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
universal	universal	JJ	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
of	of	IN	B-PP	O
external	external	JJ	B-NP	O
factors	factor	NNS	I-NP	O
upon	upon	IN	B-PP	O
the	the	DT	B-NP	O
living	live	VBG	I-NP	O
tissue	tissue	NN	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
DEL	DEL	NN	I-NP	O
-	-	HYPH	B-NP	O
reaction	reaction	NN	I-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O

The	The	DT	B-NP	O
impairment	impairment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
secretion	secretion	NN	I-NP	O
was	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
'	'	POS	B-NP	O
age	age	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
GH	BEGIN-GH-INSIDE	NN	I-NP	B
secretory	secretory	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MMSE	MMSE	NN	I-NP	O
score	score	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
cloned	clone	VBD	B-VP	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	O
-	-	HYPH	I-NP	O
length	length	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	O
PAX1	BEGIN-PAX1-INSIDE	NN	I-NP	B
by	by	IN	B-PP	O
RACE	RACE	NN	B-NP	O
(	(	(	O	O
rapid	rapid	JJ	B-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	O
ends	end	NNS	I-NP	O
)	)	)	O	O
using	use	VBG	B-VP	O
RNA	RNA	NN	B-NP	O
from	from	IN	B-PP	O
MIN1	MIN1	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
mouse	mouse	NN	I-NP	O
insulinoma	insulinoma	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O

Sixteen	Sixteen	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
encountered	encounter	VBD	B-VP	O
rejection	rejection	NN	B-NP	O
while	while	IN	B-SBAR	O
weaning	wean	VBG	B-VP	O
at	at	IN	B-PP	O
median	median	JJ	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
(	(	(	O	O
range	range	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
start	start	NN	I-NP	O
of	of	IN	B-PP	O
weaning	weaning	NN	B-NP	O

Earlier	Earlier	RBR	B-NP	O
nonoptical	nonoptical	JJ	I-NP	O
methods	method	NNS	I-NP	O
probably	probably	RB	B-ADVP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
include	include	VB	I-VP	O
the	the	DT	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
film	film	NN	I-NP	O
that	that	WDT	B-NP	O
contained	contain	VBD	B-VP	O
mucus	mucus	NN	B-NP	O

Antibodies	Antibody	NNS	B-NP	O
specific	specific	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Jun	BEGIN-Jun-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
Fos	BEGIN-Fos	NN	I-NP	B
family	family	NN	I-NP	I
of	of	IN	B-PP	I
transcription	transcription	NN	B-NP	I
factors	factors-INSIDE	NN	I-NP	I
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
gel	gel	NN	B-NP	O
retardation	retardation	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
Jun	BEGIN-BEGIN-Jun-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
factor	factor-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
H1	BEGIN-H1	NN	I-NP	B
specific	specific	JJ	I-NP	I
complex	complex-INSIDE	NN	I-NP	I

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Results	Result	NNS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	B-NP	O
male	male	JJ	I-NP	O
and	and	CC	I-NP	O
female	female	JJ	I-NP	O
soldiers	soldier	NNS	I-NP	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
chlamydia	chlamydia	NN	B-NP	O
infections	infection	NNS	I-NP	O
have	have	VBP	B-VP	O
relatively	relatively	RB	B-NP	O
high	high	JJ	I-NP	O
risks	risk	NNS	I-NP	O
of	of	IN	B-PP	O
reinfection	reinfection	NN	B-NP	O
through	through	IN	B-PP	O
their	their	PRP$	B-NP	O
1s	1	NNS	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
point	point	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Abd	BEGIN-Abd	JJ	I-NP	B
-	-	HYPH	I-NP	I
B	B	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
trans	tran	NNS	B-NP	O
suppress	suppress	VBP	B-VP	O
the	the	DT	B-NP	O
Fab	BEGIN-Fab	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
phenotype	phenotype-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
pairing	pairing	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
represent	represent	VBP	I-VP	O
a	a	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
transvection	transvection	NN	B-NP	O

The	The	DT	B-NP	O
glucose	glucose	NN	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
pyruvate	BEGIN-pyruvate	JJ	I-NP	B
kinase	kinase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
reversibly	reversibly	RB	I-VP	O
antagonized	antagonize	VBN	I-VP	O
by	by	IN	B-PP	O
agents	agent	NNS	B-NP	O
increasing	increase	VBG	B-VP	O
intracellular	intracellular	JJ	B-NP	O
cAMP	cAMP	NN	I-NP	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
spindle	spindle	NN	I-NP	O
checkpoint	checkpoint	NN	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
mph1	BEGIN-mph1-INSIDE	NN	B-NP	B
(	(	(	O	O
Mps1p	BEGIN-Mps1p	NN	B-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
pombe	pombe	NN	I-NP	I
homolog	homolog-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fission	fission	NN	I-NP	O
yeast	yeast	NN	I-NP	O
Schizosaccharomyces	Schizosaccharomyces	FW	B-NP	O
pombe	pombe	FW	I-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
checkpoint	checkpoint	NN	B-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-VP	O
spindle	spindle	VB	I-VP	O
defects.	defects.	NN	B-NP	O
mph1	BEGIN-mph1-INSIDE	NN	I-NP	B
functions	function	VBZ	B-VP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
mad1	BEGIN-mad1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spindle	spindle	NN	I-NP	O
checkpoint	checkpoint	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
measurements	measurement	NNS	B-NP	O
of	of	IN	B-PP	O
shielded	shielded	JJ	B-NP	O
and	and	CC	I-NP	O
unshielded	unshielded	JJ	I-NP	O
syringes	syrinx	NNS	I-NP	O
containing	contain	VBG	B-VP	O
1mTc	1mTc	NN	B-NP	O
-	-	HYPH	B-NP	O
labelled	label	VBN	I-NP	O
radiopharmaceuticals	radiopharmaceutical	NNS	I-NP	O
were	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O

Combination	Combination	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
in	in	IN	B-PP	O
advanced	advance	VBN	B-NP	O
ovarian	ovarian	JJ	I-NP	O
cancer	cancer	NN	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
untreated	untreated	JJ	I-NP	O
patients	patient	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
bulk	bulk	NN	B-NP	O
reduction	reduction	NN	I-NP	O
at	at	IN	B-PP	O
initial	initial	JJ	B-NP	O
laparotomy	laparotomy	NN	I-NP	O

Vertebrate	Vertebrate	JJ	B-NP	O
U1	BEGIN-U1	NN	I-NP	B
small	small	JJ	I-NP	I
nuclear	nuclear	JJ	I-NP	I
RNA	RNA-INSIDE	NN	I-NP	I
(	(	(	O	O
snRNA	snRNA	NN	B-NP	O
)	)	)	O	O
loci	locus	NNS	B-NP	O
exemplify	exemplify	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
polymerase	BEGIN-polymerase	NN	B-NP	B
III	III-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
transcribed	transcribe	VBN	I-NP	O
genes	gene	NNS	I-NP	O
that	that	WDT	B-NP	O
lack	lack	VBP	B-VP	O
an	an	DT	B-NP	O
intragenic	intragenic	JJ	I-NP	O
control	control	NN	I-NP	O
region	region	NN	I-NP	O
(	(	(	O	O
ICR	ICR	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
well	well	RB	I-NP	O
-	-	HYPH	I-NP	O
trained	train	VBN	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
once	once	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
respiration	respiration	NN	I-NP	O
chamber	chamber	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
protocol	protocol	NN	I-NP	O

PtdIns	BEGIN-PtdIn	NNS	B-NP	B
(	(	(	O	I
1	1	CD	B-NP	I
,	,	,	I-NP	I
1	1	CD	I-NP	I
)	)	)	O	I
P1	P1-INSIDE	NN	B-NP	I
synthesis	synthesis	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
only	only	RB	I-VP	O
moderately	moderately	RB	I-VP	O
affected	affect	VBN	I-VP	O
even	even	RB	B-ADVP	O
in	in	IN	B-PP	O
fab1Delta	BEGIN-fab1Delta	NN	B-NP	B
mutants	mutants-INSIDE	NN	I-NP	I

Protein	Protein	NN	B-NP	O
sequencing	sequencing	NN	I-NP	O
,	,	,	O	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
immunoblot	immunoblot	NN	B-NP	O
analyses	analysis	NNS	I-NP	O
identify	identify	VBP	B-VP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
p1	BEGIN-BEGIN-p1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
1	1-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hepatocyte	BEGIN-hepatocyte	NN	I-NP	B
nuclear	nuclear	JJ	I-NP	I
factor	factor	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
HNF1	BEGIN-HNF1-INSIDE	NN	B-NP	B
[	[	(	O	O
forkhead	BEGIN-forkhead-INSIDE	NN	B-NP	B
]	]	)	O	O
)	)	)	O	O
family	family	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors.	factors.	NN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
belongs	belong	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
subfamily	subfamily	NN	I-NP	O
of	of	IN	B-PP	O
HNF1	BEGIN-BEGIN-HNF1-INSIDE	NN	B-NP	B
beta	beta	NN	I-NP	O
proteins	proteins-INSIDE	NN	I-NP	I
,	,	,	O	O
while	while	IN	B-SBAR	O
p1	BEGIN-BEGIN-p1-INSIDE	NN	B-NP	B
/	/	SYM	O	O
1	1-INSIDE	NN	B-NP	I
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
includes	include	VBZ	B-VP	O
HNF1	BEGIN-BEGIN-HNF1-INSIDE	NN	B-NP	B
gamma	gamma-INSIDE	NN	I-NP	I

Molecular	Molecular	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
inactivation	inactivation	NN	B-NP	O
of	of	IN	B-PP	O
H	BEGIN-H	NN	B-NP	B
-	-	HYPH	B-NP	I
1L	1L-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
nearly	nearly	RB	B-NP	O
every	every	DT	I-NP	O
null	null	JJ	I-NP	O
clone	clone	NN	I-NP	O
resulted	result	VBD	B-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
deletion	deletion	NN	I-NP	O
or	or	CC	I-NP	O
rearrangement	rearrangement	NN	I-NP	O
of	of	IN	B-PP	O
1	BEGIN-1	NN	B-NP	B
'	'	SYM	O	I
-	-	HYPH	O	I
flanking	flanking	NN	B-NP	I
and	and	CC	I-NP	I
1	1	CD	I-NP	I
'	'	SYM	I-NP	I
-	-	HYPH	I-NP	I
coding	cod	VBG	B-VP	I
H	BEGIN-H	NN	B-NP	B
-	-	HYPH	I-NP	I
1L	1L-INSIDE	NN	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
,	,	,	O	O
with	with	IN	B-PP	O
breakpoints	breakpoint	NNS	B-NP	O
consistently	consistently	RB	B-VP	O
mapping	map	VBG	I-VP	O
to	to	TO	B-PP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
GC	GC	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
region	region	NN	I-NP	O
between	between	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
middle	middle	NN	I-NP	O
of	of	IN	B-PP	O
intron	intron	NN	B-NP	O
1	1	CD	I-NP	O

CBD	CBD	NN	B-NP	O
exploration	exploration	NN	I-NP	O
was	be	VBD	B-VP	O
avoided	avoid	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
POC	POC	NN	I-NP	O

These	These	DT	B-NP	O
mutations	mutation	NNS	I-NP	O
prevent	prevent	VBP	B-VP	O
FKBP1	BEGIN-FKBP1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
rapamycin	rapamycin	NN	I-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
TOR1	BEGIN-TOR1-INSIDE	NN	B-NP	B
,	,	,	O	O
as	as	IN	B-SBAR	O
assayed	assay	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
hybrid	hybrid	NN	I-NP	O
system	system	NN	I-NP	O

The	The	DT	B-NP	O
psbA	BEGIN-psbA	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
D1	BEGIN-D1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
photosystem	BEGIN-photosystem	NN	B-NP	B
II	II-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
synthesized	synthesize	VBN	I-VP	O
at	at	IN	B-PP	O
very	very	RB	B-NP	O
high	high	JJ	I-NP	O
rates	rate	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
light	light	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
replace	replace	VB	I-VP	O
photodamaged	photodamaged	JJ	B-NP	O
protein	protein	NN	I-NP	O

The	The	DT	B-NP	O
TCR	BEGIN-TCR	NN	I-NP	B
beta	beta	NN	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
active	active	JJ	B-ADJP	O
on	on	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
minimal	BEGIN-minimal	JJ	I-NP	B
simian	simian	JJ	I-NP	I
virus	virus	NN	I-NP	I
1	1	CD	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
and	and	CC	O	O
a	a	DT	B-NP	O
TCR	BEGIN-TCR	NN	I-NP	B
beta	beta	NN	I-NP	I
variable	variable	JJ	I-NP	I
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
both	both	CC	O	O
TCR	BEGIN-TCR	NN	B-NP	B
alpha	alpha	NN	I-NP	I
/	/	SYM	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
+	+	SYM	B-NP	O
and	and	CC	O	O
TCR	BEGIN-TCR	NN	B-NP	B
gamma	gamma	NN	I-NP	I
/	/	SYM	B-NP	I
delta	delta-INSIDE	NN	I-NP	I
+	+	SYM	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O

Fibrosis	Fibrosis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	O
myocardium	myocardium	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
five	five	CD	B-NP	O
cases	case	NNS	I-NP	O

Symptoms	Symptom	NNS	B-NP	O
,	,	,	O	O
skin	skin	NN	B-NP	O
-	-	HYPH	I-NP	O
prick	prick	NN	I-NP	O
tests	test	NNS	I-NP	O
(	(	(	O	O
SPT	SPT	NN	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
environmental	environmental	JJ	B-NP	O
allergens	allergen	NNS	I-NP	O
and	and	CC	O	O
Pt	Pt	NN	B-NP	O
salt	salt	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
serum	BEGIN-serum	NN	I-NP	B
IgE	IgE-INSIDE	NN	I-NP	I
,	,	,	O	O
lung	lung	NN	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
bronchial	bronchial	JJ	B-NP	O
hyperresponsiveness	hyperresponsiveness	NN	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
standard	standard	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
T1R	BEGIN-T1R-INSIDE	NN	B-NP	B
can	can	MD	B-VP	O
repress	repress	VB	I-VP	O
or	or	CC	I-VP	O
activate	activate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
while	while	IN	B-SBAR	O
tethered	tether	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LBD	LBD	NN	I-NP	O
of	of	IN	B-PP	O
GAL1	BEGIN-GAL1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
RXR	BEGIN-RXR-INSIDE	NN	I-NP	B
and	and	CC	O	O
that	that	IN	B-SBAR	O
heterodimerization	heterodimerization	NN	B-NP	O
can	can	MD	B-VP	O
occur	occur	VB	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
without	without	IN	B-PP	O
stabilization	stabilization	NN	B-NP	O
by	by	IN	B-PP	O
hormone	hormone	NN	B-NP	O
response	response	NN	I-NP	O
elements	element	NNS	I-NP	O

During	During	IN	B-PP	O
1	1	CD	B-NP	O
O1	O1	NN	I-NP	O
ventilation	ventilation	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
(	(	(	O	O
PVR	PVR	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
dilator	dilator	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
both	both	CC	O	O
ACh	ACh	NN	B-NP	O
and	and	CC	I-NP	O
SNP	SNP	NN	I-NP	O
were	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
in	in	IN	B-PP	O
1D	1D	NN	B-NP	O
lungs	lung	NNS	I-NP	O

HGF	BEGIN-HGF-INSIDE	NN	B-NP	B
treatment	treatment	NN	I-NP	O
increased	increase	VBD	B-VP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
A	A-INSIDE	NN	I-NP	I
,	,	,	O	O
cyclin	BEGIN-cyclin	NN	B-NP	B
G1	G1-INSIDE	NN	I-NP	I
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
factor	factor	NN	I-NP	O
(	(	(	O	O
NFkappaB	BEGIN-NFkappaB-INSIDE	NN	B-NP	B
)	)	)	O	O
protein	protein	NN	B-NP	O
expression	expression	NN	I-NP	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
adult	adult	JJ	B-NP	O
animals	animal	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
suprabasal	suprabasal	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
dnRXR	BEGIN-dnRXR	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
significantly	significantly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
topically	topically	RB	B-NP	O
applied	apply	VBN	I-NP	O
tRA	tRA	NN	I-NP	O
to	to	TO	B-VP	O
stimulate	stimulate	VB	I-VP	O
proliferation	proliferation	NN	B-NP	O
of	of	IN	B-PP	O
undifferentiated	undifferentiated	JJ	B-NP	O
keratinocytes	keratinocyte	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
layer	layer	NN	I-NP	O
of	of	IN	B-PP	O
epidermis	epidermis	NN	B-NP	O

A	A	DT	B-NP	O
third	third	JJ	I-NP	O
-	-	HYPH	I-NP	O
order	order	NN	I-NP	O
polynominal	polynominal	JJ	I-NP	O
fit	fit	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
parameter	parameter	NN	I-NP	O
Q*	Q*	NN	I-NP	O
and	and	CC	O	O
MTT	MTT	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
T	T	NN	B-NP	O
and	and	CC	I-NP	O
SImax	SImax	NN	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
correlation	correlation	NN	I-NP	O

This	This	DT	B-NP	O
article	article	NN	I-NP	O
focuses	focus	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
general	general	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
ARV	ARV	NN	B-NP	O
agents	agent	NNS	I-NP	O

Although	Although	IN	B-SBAR	O
FKH1	BEGIN-FKH1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
redundant	redundant	JJ	B-ADJP	O
with	with	IN	B-PP	O
FKH1	BEGIN-FKH1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
controlling	control	VBG	B-VP	O
pseudohyphal	pseudohyphal	JJ	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
genes	gene	NNS	I-NP	O
have	have	VBP	B-VP	O
different	different	JJ	B-NP	O
functions	function	NNS	I-NP	O
in	in	IN	B-PP	O
silencing	silencing	NN	B-NP	O
HMRa	BEGIN-HMRa-INSIDE	NN	I-NP	B

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
extensive	extensive	JJ	I-NP	O
homology	homology	NN	I-NP	O
in	in	IN	B-PP	O
sequence	sequence	NN	B-NP	O
among	among	IN	B-PP	O
light	light	JJ	B-NP	O
chains	chain	NNS	I-NP	O
of	of	IN	B-PP	O
IgM	BEGIN-IgM	NN	B-NP	B
kappa	kappa	NN	I-NP	I
autoantibodies	autoantibodies-INSIDE	NN	I-NP	I
and	and	CC	O	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
particular	particular	JJ	I-NP	O
V	BEGIN-V	NN	I-NP	B
kappa	kappa	NN	I-NP	I
germ	germ	NN	I-NP	I
line	line	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
kappa	BEGIN-kappa	NN	B-NP	B
IIIb	IIIb-INSIDE	NN	I-NP	I
,	,	,	O	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
phylogenetic	phylogenetic	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
certain	certain	JJ	B-NP	O
self	self	NN	I-NP	O
antigens	antigen	NNS	I-NP	O
or	or	CC	B-PP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
selection	selection	NN	I-NP	O
process	process	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
these	these	DT	B-NP	O
autoimmune	autoimmune	JJ	I-NP	O
responses	response	NNS	I-NP	O
are	be	VBP	B-VP	O
regulated	regulate	VBN	I-VP	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
long	long	JJ	B-NP	O
term	term	NN	I-NP	O
intravenous	intravenous	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
naftidrofuryl	naftidrofuryl	NN	B-NP	O
(	(	(	O	O
Dusodril	Dusodril	NNP	B-NP	O
-	-	HYPH	O	O
Lipha	Lipha	NNP	B-NP	O
Arzn	Arzn	NNP	I-NP	O
)	)	)	O	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
continuous	continuous	JJ	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
hour	hour	NN	I-NP	O
infusion	infusion	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
1	1	CD	B-NP	O
NaCl	NaCl	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
arterial	arterial	JJ	I-NP	O
occlusive	occlusive	JJ	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
PAOD	PAOD	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
condition	condition	NN	I-NP	O
with	with	IN	B-PP	O
special	special	JJ	B-NP	O
attention	attention	NN	I-NP	O
paid	pay	VBN	B-VP	O
to	to	TO	B-PP	O
transcutaneous	transcutaneous	JJ	B-NP	O
partial	partial	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
pressure	pressure	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
(	(	(	O	O
tcPO1	tcPO1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
rheographic	rheographic	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O

We	We	PRP	B-NP	O
concluded	conclude	VBD	B-VP	O
that	that	IN	B-SBAR	O
RXR	BEGIN-RXR	NN	B-NP	B
-	-	HYPH	B-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
induced	induce	VBD	B-VP	O
terminal	terminal	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
in	in	IN	B-PP	O
SCC	SCC	NN	B-NP	O
lines	line	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
suppressor	suppressor	NN	I-NP	O
function	function	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
appropriate	appropriate	JJ	B-NP	O
recognition	recognition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pivotal	pivotal	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
BP	BP	NN	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
forestalling	forestall	VBG	B-NP	O
pressure	pressure	NN	I-NP	O
-	-	HYPH	O	O
related	relate	VBN	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
complications	complication	NNS	I-NP	O
,	,	,	O	O
even	even	RB	B-ADVP	O
among	among	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
risk	risk	NN	I-NP	O
persons	person	NNS	I-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O

RNA	RNA	NN	B-NP	O
determinants	determinant	NNS	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
L1	BEGIN-L1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
mediated	mediate	VBN	I-NP	O
attenuation	attenuation	NN	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
S1	BEGIN-S1	NN	I-NP	B
r	r	NN	I-NP	I
-	-	HYPH	B-NP	I
protein	protein	NN	I-NP	I
operon	operon	NN	I-NP	I
of	of	IN	B-PP	I
Escherichia	Escherichia	NN	B-NP	I
coli	coli-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
psh1	BEGIN-psh1	NN	I-NP	B
(	(	(	O	I
+	+	SYM	O	I
)	)	)	O	I
gene	gene-INSIDE	NN	B-NP	I
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
shares	share	VBZ	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
structural	structural	JJ	B-NP	O
and	and	CC	I-NP	O
functional	functional	JJ	I-NP	O
similarity	similarity	NN	I-NP	O
with	with	IN	B-PP	O
Shr1p	BEGIN-Shr1p-INSIDE	NN	B-NP	B

A	A	DT	B-NP	O
very	very	RB	I-NP	O
large	large	JJ	I-NP	O
PC	PC	NN	I-NP	O
LAN	LAN	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
hospital	hospital	NN	I-NP	O
information	information	NN	I-NP	O
system	system	NN	I-NP	O

A	A	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
mixing	mixing	NN	I-NP	O
device	device	NN	I-NP	O
for	for	IN	B-PP	O
quasielastic	quasielastic	JJ	B-NP	O
light	light	JJ	I-NP	O
scattering	scattering	NN	I-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
reacting	react	VBG	B-VP	O
systems	system	NNS	B-NP	O

After	After	IN	B-PP	O
institution	institution	NN	B-NP	O
of	of	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
treatment	treatment	NN	I-NP	O
,	,	,	O	O
diabetic	diabetic	JJ	B-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
as	as	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
by	by	IN	B-PP	O
decreasing	decrease	VBG	B-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
HbA1	BEGIN-HbA1-INSIDE	NN	B-NP	B

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
tested	test	VBN	I-VP	O
yet	yet	RB	B-ADVP	O
,	,	,	O	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
glaucoma	glaucoma	NN	B-NP	O
damage	damage	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
better	well	RBR	B-ADJP	O
quantified	quantify	VBN	I-ADJP	O
using	use	VBG	B-VP	O
reference	reference	NN	B-NP	O
plane	plane	NN	I-NP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
1	1	CD	I-NP	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
identity	identity	NN	I-NP	O
we	we	PRP	B-NP	O
designated	designate	VBD	B-VP	O
GAPC1	BEGIN-GAPC1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
GAPC1	BEGIN-GAPC1-INSIDE	NN	I-NP	B
as	as	IN	B-PP	O
group	group	NN	B-NP	O
I	I	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
identical	identical	JJ	I-NP	O
)	)	)	O	O
and	and	CC	O	O
GAPC1	BEGIN-GAPC1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
GAPC1	BEGIN-GAPC1-INSIDE	NN	I-NP	B
as	as	IN	B-PP	O
group	group	NN	B-NP	O
II	II	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
identical	identical	JJ	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
analogy	analogy	NN	B-NP	O
to	to	TO	B-PP	O
human	BEGIN-human	JJ	B-NP	B
CD1	CD1-INSIDE	NN	I-NP	I
,	,	,	O	O
mCD1	BEGIN-mCD1	NN	B-NP	B
transcript	transcript-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
are	be	VBP	B-VP	O
strongly	strongly	RB	B-ADVP	O
but	but	CC	I-ADVP	O
transiently	transiently	RB	I-ADVP	O
up	up	RB	B-ADVP	O
-	-	HYPH	B-NP	O
regulated	regulate	VBN	B-VP	O
during	during	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
line	line	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
CD1	BEGIN-CD1	NN	I-NP	B
-	-	HYPH	B-NP	I
CD1	CD1	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
pair	pair	NN	I-NP	O
early	early	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O

Both	Both	DT	B-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
individual	individual	JJ	I-NP	O
eye	eye	NN	I-NP	O
by	by	IN	B-PP	O
applying	apply	VBG	B-VP	O
the	the	DT	B-NP	O
dye	dye	NN	I-NP	O
first	first	RB	B-ADVP	O
by	by	IN	B-PP	O
iontophoresis	iontophoresis	NN	B-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
by	by	IN	B-PP	O
intravitreal	intravitreal	JJ	B-NP	O
injection	injection	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
allows	allow	VBZ	B-VP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
fluorescein	fluorescein	NN	B-NP	O
glucuronide	glucuronide	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
fluorophotometric	fluorophotometric	JJ	I-NP	O
measurements	measurement	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
excluded	exclude	VBN	I-VP	O

Phase	Phase	NN	B-NP	O
I	I	CD	I-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
methotrexate	methotrexate	NN	B-NP	O
and	and	CC	I-NP	O
mitomycin	mitomycin	NN	I-NP	O
C	C	NN	I-NP	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
animals	animal	NNS	I-NP	O
were	be	VBD	B-VP	O
infected	infect	VBN	I-VP	O
by	by	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
O1	O1	NN	I-NP	O
:	:	:	O	O
K1	K1	NN	B-NP	O
:	:	:	O	O
H1	H1	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
hematogenic	hematogenic	JJ	I-NP	O
route	route	NN	I-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
clone	clone	NN	I-NP	O
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
produced	produce	VBD	B-VP	O
cAMP	BEGIN-cAMP	NN	B-NP	B
PDEase	PDEase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
identical	identical	JJ	B-ADJP	O
in	in	IN	B-PP	O
properties	property	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Drosophila	Drosophila	FW	I-NP	O
enzyme	enzyme	NN	I-NP	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
dnc	BEGIN-dnc	NN	I-NP	B
mutation	mutation-INSIDE	NN	I-NP	I

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
by	by	IN	B-PP	O
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
and	and	CC	O	O
cofactors	cofactor	NNS	B-NP	O
,	,	,	O	O
vIRF	BEGIN-vIRF	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
modulate	modulate	VB	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
genes	gene	NNS	I-NP	O
and	and	CC	O	O
potentially	potentially	RB	B-VP	O
deregulate	deregulate	VBP	I-VP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
system	system	NN	I-NP	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pontomesencephalic	pontomesencephalic	JJ	I-NP	O
parabrachial	parabrachial	JJ	I-NP	O
region	region	NN	I-NP	O
(	(	(	O	O
PBR	PBR	NN	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
microinjection	microinjection	NN	B-NP	O
of	of	IN	B-PP	O
cholinergic	cholinergic	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
or	or	CC	O	O
electricity	electricity	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cat	cat	NN	I-NP	O
produces	produce	VBZ	B-VP	O
potent	potent	JJ	B-NP	O
pain	pain	NN	I-NP	O
suppression	suppression	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
antagonized	antagonize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
opiate	opiate	NN	I-NP	O
antagonist	antagonist	NN	I-NP	O
,	,	,	O	O
naloxone	naloxone	NN	B-NP	O

AIMS	AIMS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
static	static	JJ	B-NP	O
and	and	CC	I-NP	O
dynamic	dynamic	JJ	I-NP	O
bone	bone	NN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
rickets	ricket	NNS	B-NP	O

The	The	DT	B-NP	O
homeodomain	BEGIN-homeodomain	NN	I-NP	B
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
CDP	BEGIN-CDP-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
cut	BEGIN-cut-INSIDE	NN	I-NP	B
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
histone	BEGIN-histone	NN	B-NP	B
H1	H1	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
packaged	package	VBN	B-VP	O
into	into	IN	B-PP	O
nucleosomes	nucleosome	NNS	B-NP	O

K.	K.	NNP	B-NP	O
,	,	,	O	O
Weiss	Weiss	NNP	B-NP	O
,	,	,	O	O
M	M	NNP	B-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
IF	IF	NN	B-NP	O
-	-	HYPH	I-NP	O
laser	laser	NN	I-NP	O
therapy	therapy	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
certain	certain	JJ	I-NP	O
antioxidative	antioxidative	JJ	I-NP	O
effect	effect	NN	I-NP	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
SOD	BEGIN-SOD-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
RA	RA	NN	B-NP	O
patients	patient	NNS	I-NP	O
'	'	POS	B-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
reducing	reduce	VBG	B-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
highly	highly	RB	B-NP	O
reactive	reactive	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
and	and	CC	I-NP	O
nitrogen	nitrogen	NN	I-NP	O
forms	form	NNS	I-NP	O

During	During	IN	B-PP	O
hexamethylene	hexamethylene	NN	B-NP	O
bisactamide	bisactamide	NN	I-NP	O
(	(	(	O	O
HMBA	HMBA	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
murine	murine	JJ	B-NP	O
erythroleukemia	erythroleukemia	NN	I-NP	O
(	(	(	O	O
MEL	MEL	NN	B-NP	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
erythroid	erythroid	JJ	B-NP	O
genes	gene	NNS	I-NP	O
are	be	VBP	B-VP	O
transcriptionally	transcriptionally	RB	I-VP	O
activated	activate	VBN	I-VP	O
while	while	IN	B-SBAR	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
myb	myb-INSIDE	NN	I-NP	I
and	and	CC	O	O
several	several	JJ	B-NP	O
other	other	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
proto	proto	AFX	I-NP	O
-	-	HYPH	I-NP	O
oncogenes	oncogene	NNS	I-NP	O
are	be	VBP	B-VP	O
down	down	RB	B-ADVP	O
-	-	HYPH	B-NP	O
regulated	regulate	VBN	B-VP	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
report	report	VBP	B-VP	O
identification	identification	NN	B-NP	O
and	and	CC	O	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activities	activity	NNS	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
three	three	CD	B-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	B-VP	O
acting	act	VBG	B-NP	O
sites	site	NNS	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rDNA	rDNA	NN	I-NP	O
enhancer	enhancer	NN	I-NP	O
designated	designate	VBN	B-VP	O
the	the	DT	B-NP	O
modulator	modulator	NN	I-NP	O
region	region	NN	I-NP	O

Background	Background	NN	B-NP	O
reduction	reduction	NN	I-NP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
agents	agent	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
prominent	prominent	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
DTIn1	DTIn1	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
1mTc	1mTc	NN	B-NP	O
-	-	HYPH	I-NP	O
DTPA	DTPA	NN	I-NP	O
biodistribution	biodistribution	NN	I-NP	O

Influence	Influence	NN	B-NP	O
of	of	IN	B-PP	O
copper	copper	NN	B-NP	O
addition	addition	NN	I-NP	O

In	In	IN	B-PP	O
human	human	JJ	B-NP	O
WI1	WI1	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
E1B	BEGIN-E1B	NN	I-NP	B
1K	1K	NN	I-NP	I
gene	gene	NN	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
viruses	virus	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
substantial	substantial	JJ	I-NP	O
growth	growth	NN	I-NP	O
advantage	advantage	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
virus	virus	NN	I-NP	O
,	,	,	O	O
yielding	yield	VBG	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
fold	fold	RB	B-ADVP	O
-	-	HYPH	B-NP	O
higher	high	JJR	I-NP	O
titers	titer	NNS	I-NP	O

The	The	DT	B-NP	O
cooperation	cooperation	NN	I-NP	O
between	between	IN	B-PP	O
health	health	NN	B-NP	O
and	and	CC	I-NP	O
hospital	hospital	NN	I-NP	O
services	service	NNS	I-NP	O

The	The	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
extracellular	BEGIN-extracellular	JJ	I-NP	B
MEP1	MEP1-INSIDE	NN	I-NP	I
,	,	,	O	O
TKVAS	BEGIN-TKVAS-INSIDE	NN	B-NP	B
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
at	at	IN	B-PP	O
aa	aa	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
ORF	ORF	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
element	element	NN	B-NP	O
II	II	CD	I-NP	O
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
structure	structure	NN	I-NP	O
near	near	IN	B-PP	O
element	element	NN	B-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
-	-	HYPH	I-NP	O
range	range	NN	I-NP	O
interaction	interaction	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
promote	promote	VB	I-VP	O
translation	translation	NN	B-NP	O

(	(	(	O	O
We	We	PRP	B-NP	O
observed	observe	VBD	B-VP	O
a	a	DT	B-NP	O
ferritin	BEGIN-ferritin-INSIDE	NN	I-NP	B
value	value	NN	I-NP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
L	L	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
patient.	patient.	NN	I-NP	O
)	)	)	O	O
Results	Result	NNS	B-NP	O
with	with	IN	B-PP	O
all	all	PDT	B-NP	O
these	these	DT	I-NP	O
kits	kit	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
inter	inter	AFX	I-VP	O
-	-	HYPH	B-NP	O
compare	compare	NN	I-NP	O
well	well	RB	B-ADVP	O
for	for	IN	B-PP	O
ferritin	BEGIN-ferritin-INSIDE	NN	B-NP	B
concentrations	concentration	NNS	I-NP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
L	L	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
finding	finding	NN	I-NP	O
that	that	WDT	B-NP	O
casts	cast	VBZ	B-VP	O
further	further	JJ	B-NP	O
doubt	doubt	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
controversial	controversial	JJ	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
serum	BEGIN-serum	NN	B-NP	B
ferritin	BEGIN-ferritin-INSIDE-INSIDE	NN	I-NP	I
measurement	measurement	NN	I-NP	O
in	in	IN	B-PP	O
cases	case	NNS	B-NP	O
of	of	IN	B-PP	O
iron	iron	NN	B-NP	O
overload	overload	NN	I-NP	O

Most	Most	JJS	B-NP	O
other	other	JJ	I-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
Leporipoxviruses	Leporipoxvirus	NNS	I-NP	O
are	be	VBP	B-VP	O
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
telomeres	telomere	NNS	I-NP	O

The	The	DT	B-NP	O
Tat	BEGIN-Tat	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
coded	cod	VBN	B-VP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HIV	HIV	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
activator	activator	NN	I-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	O
terminal	terminal	JJ	I-NP	O
repeat	repeat	NN	I-NP	O
(	(	(	O	O
LTR	LTR	NN	B-NP	O
)	)	)	O	O

A	A	DT	B-NP	O

This	This	DT	B-NP	O
case	case	NN	I-NP	O
report	report	NN	I-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
periodontosis	periodontosis	NN	B-NP	O

Upstream	Upstream	JJ	B-NP	O
tissue	BEGIN-tissue	NN	I-NP	B
inhibitor	inhibitor	NN	I-NP	I
of	of	IN	B-PP	I
metalloproteinases	metalloproteinas	NNS	B-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
(	(	(	O	I
TIMP	TIMP	NN	B-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
)	)	)	O	I
element	element	NN	B-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
and	and	CC	I-NP	O
essential	essential	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
motif	motif	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
TIMP	TIMP	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
directly	directly	RB	B-ADVP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
protein	protein	NN	I-NP	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
U1	BEGIN-U1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
methylation	methylation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
G1	G1	NN	I-NP	O
residue	residue	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
1S	1S	NN	I-NP	I
rRNA	rRNA-INSIDE	NN	I-NP	I

Also	Also	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
placebo	placebo	NN	I-NP	O
nondepressed	nondepressed	JJ	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
better	good	JJR	I-NP	O
treatment	treatment	NN	I-NP	O
outcome	outcome	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
placebo	placebo	NN	I-NP	O
depressed	depress	VBD	B-VP	O
patients	patient	NNS	B-NP	O

Animals	Animal	NNS	B-NP	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
six	six	CD	B-NP	O
equal	equal	JJ	I-NP	O
groups	group	NNS	I-NP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
no	no	DT	B-NP	O
oral	oral	JJ	I-NP	O
drug	drug	NN	I-NP	O
(	(	(	O	O
water	water	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
no	no	DT	B-NP	O
hemodilution	hemodilution	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
IV	IV	CD	I-NP	O
drug	drug	NN	I-NP	O
(	(	(	O	O
saline	saline	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
oral	oral	JJ	B-NP	O
water	water	NN	I-NP	O
,	,	,	O	O
hemodilution	hemodilution	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
saline	saline	NN	I-NP	O
;	;	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
oral	oral	JJ	B-NP	O
water	water	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hemodilution	hemodilution	NN	I-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
propranolol	propranolol	NN	I-NP	O
;	;	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
oral	oral	JJ	B-NP	O
water	water	NN	I-NP	O
,	,	,	O	O
hemodilution	hemodilution	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
propranolol	propranolol	NN	I-NP	O
;	;	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
oral	oral	JJ	B-NP	O
propranolol	propranolol	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hemodilution	hemodilution	NN	I-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
saline	saline	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
oral	oral	JJ	B-NP	O
propranolol	propranolol	NN	I-NP	O
,	,	,	O	O
hemodilution	hemodilution	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
saline	saline	NN	I-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
1	1	CD	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserved	JJ	I-NP	O
regions	region	NNS	I-NP	O
to	to	TO	B-VP	O
vertebrate	BEGIN-vertebrate	VB	I-VP	B
Hsp1	Hsp1-INSIDE	NN	B-NP	I
exclusively	exclusively	RB	B-ADVP	O
and	and	CC	O	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
conserved	conserve	VBN	B-VP	O
among	among	IN	B-PP	O
but	but	CC	O	O
differing	differ	VBG	B-VP	O
between	between	IN	B-PP	O
Hsp1	BEGIN-Hsp1	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
and	and	CC	O	O
Hsp1	BEGIN-Hsp1	NN	B-NP	B
beta	beta	NN	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I

Four	Four	CD	B-NP	O
newborns	newborn	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
group	group	NN	I-NP	O
became	become	VBD	B-VP	O
HBsAg	BEGIN-HBsAg-INSIDE	NN	B-NP	B
carriers	carrier	NNS	I-NP	O

It	It	PRP	B-NP	O
tends	tend	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
higher	high	JJR	B-ADJP	O
between	between	IN	B-PP	O
frazioni	frazioni	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
community	community	NN	I-NP	O
than	than	IN	B-PP	O
between	between	IN	B-PP	O
communities	community	NNS	B-NP	O

In	In	IN	B-PP	O
previous	previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
import	import	NN	I-NP	O
of	of	IN	B-PP	O
SREBP	BEGIN-SREBP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
occurs	occur	VBZ	B-VP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
direct	direct	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
importin	BEGIN-importin	NN	B-NP	B
beta	beta-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
the	the	DT	B-NP	O
HLH	HLH	NN	I-NP	O
-	-	HYPH	O	O
Zip	Zip	NN	B-NP	O
domain	domain	NN	I-NP	O

The	The	DT	B-NP	O
destruction	destruction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mesometrium	mesometrium	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
lengthen	lengthen	VB	I-VP	O
the	the	DT	B-NP	O
oestrous	oestrous	JJ	I-NP	O
cycle	cycle	NN	I-NP	O

Ftz	BEGIN-Ftz-INSIDE	NN	B-NP	B
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
influences	influence	VBZ	B-VP	O
Ftz	BEGIN-Ftz-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
F1	BEGIN-F1-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
AF	AF	NN	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
domain	domain	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
manner	manner	NN	I-NP	O
that	that	WDT	B-NP	O
mimics	mimic	VBZ	B-VP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
coactivator	coactivator	NN	I-NP	O

Type	Type	NN	B-NP	O
C	C	NN	I-NP	O
units	unit	NNS	I-NP	O
summate	summate	VBP	B-VP	O
the	the	DT	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
tone	tone	NN	I-NP	O
stimulus	stimulus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
show	show	VBP	B-VP	O
little	little	JJ	B-NP	O
or	or	CC	I-NP	O
no	no	DT	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
influences	influence	NNS	I-NP	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
ulcerative	ulcerative	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
,	,	,	O	O
circulating	circulate	VBG	B-VP	O
concentrations	concentration	NNS	B-NP	O
of	of	IN	B-PP	O
NOX	NOX	NN	B-NP	O
are	be	VBP	B-VP	O
increased	increase	VBN	I-VP	O
at	at	IN	B-PP	O
presentation	presentation	NN	B-NP	O
and	and	CC	O	O
fall	fall	VBP	B-VP	O
promptly	promptly	RB	B-ADVP	O
during	during	IN	B-PP	O
parenteral	parenteral	JJ	B-NP	O
steroid	steroid	NN	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
irrespective	irrespective	JJ	B-ADJP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
outcome	outcome	NN	I-NP	O

A	A	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
for	for	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
microfibril	microfibril	NN	I-NP	I
-	-	HYPH	B-VP	I
associated	associate	VBN	B-NP	I
glycoprotein	glycoprotein	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
MAGP	BEGIN-MAGP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
screen	screen	VB	I-VP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	O
leukocyte	leukocyte	NN	I-NP	O
genomic	genomic	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
library	library	NN	I-NP	O
in	in	IN	B-PP	O
EMBL	EMBL	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
vector	vector	NN	I-NP	O

Screening	Screening	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	O
foetal	foetal	JJ	I-NP	O
brain	brain	NN	I-NP	O
genomic	genomic	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
library	library	NN	I-NP	O
allowed	allow	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
isolate	isolate	VB	I-VP	O
an	an	DT	B-NP	O
EcoRI	BEGIN-EcoRI-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
EcoRI	BEGIN-EcoRI-INSIDE	NN	I-NP	B
fragment	fragment	NN	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
flanking	flank	VBG	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
flanking	flank	VBG	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha1C1	BEGIN-alpha1C1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

Using	Use	VBG	B-VP	O
gel	gel	NN	B-NP	O
retardation	retardation	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
four	four	CD	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
for	for	IN	B-PP	O
Rap1p	BEGIN-Rap1p-INSIDE	NN	B-NP	B
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RAP1	BEGIN-RAP1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

They	They	PRP	B-NP	O
are	be	VBP	B-VP	O
transduced	transduce	VBN	I-VP	O
through	through	IN	B-PP	O
TM	TM	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
portion	portion	NN	I-NP	O
(	(	(	O	O
cytoloops	cytoloop	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
tail	tail	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
,	,	,	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
signaling	signal	VBG	I-NP	O
molecules	molecule	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
G	BEGIN-G	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I

Sgs	BEGIN-Sg	NNS	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
eight	eight	CD	I-NP	O
known	know	VBN	I-NP	O
genes	gene	NNS	I-NP	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
larval	larval	JJ	B-NP	O
secretion	secretion	NN	I-NP	O
proteins	protein	NNS	I-NP	O
in	in	IN	B-PP	O
Drosophila	Drosophila	NNP	B-NP	O
melanogaster	melanogaster	NN	I-NP	O

Unlike	Unlike	IN	B-PP	O
CSK	BEGIN-CSK-INSIDE	NN	B-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
HYL	BEGIN-HYL-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
unique	unique	JJ	B-ADJP	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
ALYDY	ALYDY	NN	I-NP	O
motif	motif	NN	I-NP	O
was	be	VBD	B-VP	O
absent	absent	JJ	B-ADJP	O

This	This	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
is	be	VBZ	B-VP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
known	know	VBN	I-NP	O
E1s	BEGIN-E1s-INSIDE	NN	I-NP	B
,	,	,	O	O
including	include	VBG	B-PP	O
E1	BEGIN-E1	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
/	/	SYM	B-VP	O
UBR1	BEGIN-UBR1-INSIDE	NN	B-NP	B
,	,	,	O	O
E1	BEGIN-E1	NN	B-NP	B
beta	beta-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
E1	BEGIN-E1	NN	B-NP	B
-	-	HYPH	O	I
AP	AP-INSIDE	NN	B-NP	I

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Although	Although	IN	B-SBAR	O
low	low	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
vIRF	BEGIN-vIRF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mRNAs	mRNAs-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HHV	HHV	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
positive	positive	JJ	I-NP	O
BCBL	BCBL	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
tumor	tumor	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
tetradecanoylphorbol	tetradecanoylphorbol	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
TPA	TPA	NN	B-NP	O
)	)	)	O	O
treatment	treatment	NN	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
stimulate	stimulate	VB	I-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
vIRF	BEGIN-vIRF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
lytic	lytic	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
genes	gene	NNS	I-NP	O

Primary	Primary	JJ	B-NP	O
TJRs	TJR	NNS	I-NP	O
were	be	VBD	B-VP	O
clinically	clinically	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
degree	degree	NN	B-NP	O
of	of	IN	B-PP	O
osteoarthrosis	osteoarthrosis	NN	B-NP	O

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
relatively	relatively	RB	I-NP	O
small	small	JJ	I-NP	O
deletion	deletion	NN	I-NP	O
affects	affect	VBZ	B-VP	O
a	a	DT	B-NP	O
segment	segment	NN	I-NP	O
containing	contain	VBG	B-VP	O
1	BEGIN-1	NN	B-NP	B
'	'	POS	B-NP	I
VH	VH	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
important	important	JJ	B-NP	O
regulatory	regulatory	JJ	I-NP	O
functions	function	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ali	ali	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O

Apoptosis	Apoptosis	NN	B-NP	O
triggered	trigger	VBD	B-VP	O
through	through	IN	B-PP	O
Fas	BEGIN-Fas-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
F	BEGIN-F	NN	I-NP	B
/	/	SYM	B-NP	I
F	F-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
coexpression	coexpression	NN	B-NP	O
of	of	IN	B-PP	O
CrmA	BEGIN-CrmA-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
Bcl	BEGIN-Bcl	NN	B-NP	B
-	-	HYPH	O	I
xL	xL-INSIDE	NN	B-NP	I

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
Helios	BEGIN-Helios-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
earliest	early	JJS	I-NP	O
hematopoietic	hematopoietic	JJ	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
embryo	embryo	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	O
stem	stem	NN	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adult	adult	JJ	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	B-ADJP	O
restricted	restricted	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
lineage	lineage	NN	I-NP	O

It	It	PRP	B-NP	O
produced	produce	VBD	B-VP	O
extrapyramidal	extrapyramidal	JJ	B-NP	O
disturbances	disturbance	NNS	I-NP	O
in	in	IN	B-PP	O
nearly	nearly	RB	B-NP	O
every	every	DT	I-NP	O
subject	subject	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
being	be	VBG	I-NP	O
akathisia	akathisia	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
severe	severe	JJ	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
individual	individual	NN	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
acute	acute	JJ	B-NP	O
dystonia	dystonia	NN	I-NP	O

Electron	Electron	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O
of	of	IN	B-PP	O
pH	pH	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
treated	treat	VBN	B-NP	O
TMV	TMV	NN	I-NP	O
particles	particle	NNS	I-NP	O
incubated	incubate	VBN	B-VP	O
in	in	IN	B-PP	O
SPN	BEGIN-SPN-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
wheatgerm	wheatgerm	NN	I-NP	O
extract	extract	NN	I-NP	O
or	or	CC	O	O
rabbit	rabbit	NN	B-NP	O
reticulocyte	reticulocyte	NN	I-NP	O
lysate	lysate	NN	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
virions	virion	NNS	B-NP	O
complexed	complexe	VBN	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
ribosome	ribosome	NN	I-NP	O
and	and	CC	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
bound	bind	VBN	I-NP	O
ribosomes	ribosome	NNS	I-NP	O
,	,	,	O	O
confirming	confirm	VBG	B-VP	O
that	that	IN	B-SBAR	O
omega	omega	SYM	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
uncoated	uncoated	JJ	B-ADJP	O

The	The	DT	B-NP	O
absorbance	absorbance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
eluent	eluent	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
nm	nm	NN	I-NP	O

As	As	IN	B-SBAR	O
anticipated	anticipate	VBN	B-VP	O
,	,	,	O	O
both	both	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
SAPKbeta	BEGIN-SAPKbeta-INSIDE	NN	I-NP	B
activation	activation	NN	I-NP	O
and	and	CC	O	O
Bcl	BEGIN-Bcl	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
phosphorylation	phosphorylation	NN	I-NP	O
are	be	VBP	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
co	co	AFX	B-NP	O
-	-	HYPH	I-NP	O
transfection	transfection	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
MAP	BEGIN-MAP	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
specific	specific	JJ	I-NP	O
phosphatase	phosphatase	NN	I-NP	O
MKP1	BEGIN-MKP1-INSIDE	NN	I-NP	B
/	/	SYM	B-VP	O
PYST1	BEGIN-PYST1-INSIDE	NN	B-NP	B

All	All	DT	B-NP	O
patients	patient	NNS	I-NP	O
studied	study	VBN	B-VP	O
were	be	VBD	B-VP	O
pregnant	pregnant	JJ	B-NP	O
women	woman	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
delivered	deliver	VBN	I-NP	O
children	child	NNS	I-NP	O

PRP1	BEGIN-PRP1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
related	related	JJ	B-ADJP	O
,	,	,	O	O
both	both	CC	B-PP	O
in	in	IN	I-PP	O
structure	structure	NN	B-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RCC1	BEGIN-RCC1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
mammals	mammal	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
PIM1	BEGIN-PIM1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
Schizosaccharomyces	Schizosaccharomyces	FW	B-ADVP	O
pombe	pombe	FW	I-ADVP	O
,	,	,	O	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
regulate	regulate	VB	I-VP	O
entry	entry	NN	B-NP	O
into	into	IN	B-PP	O
mitosis	mitosis	NN	B-NP	O
and	and	CC	I-NP	O
chromosome	chromosome	NN	I-NP	O
condensation	condensation	NN	I-NP	O

Using	Use	VBG	B-VP	O
this	this	DT	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
probe	probe	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kilobase	kilobase	NN	I-NP	O
HindIII	BEGIN-HindIII-INSIDE	NN	I-NP	B
fragment	fragment	NN	I-NP	O
of	of	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
subjected	subject	VBN	B-VP	O
to	to	TO	B-PP	O
Sanger	Sanger	NNP	B-NP	O
dideoxy	dideoxy	NN	I-NP	O
DNA	DNA	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O

The	The	DT	B-NP	O
Rep	BEGIN-Rep	JJ	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
adeno	adeno	AFX	B-NP	O
-	-	HYPH	I-NP	O
associated	associate	VBN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
AAV	AAV	NN	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
Rep	BEGIN-Rep	JJ	B-NP	B
recognition	recognition	NN	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
(	(	(	O	O
RRSs	BEGIN-RRSs-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AAV	AAV	NN	I-NP	O
inverted	invert	VBD	B-VP	O
terminal	terminal	JJ	B-NP	O
repeats	repeat	NNS	I-NP	O
(	(	(	O	O
ITRs	ITR	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
AAV	BEGIN-AAV	NN	I-NP	B
p1	p1	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
preferred	preferred	JJ	I-NP	O
AAV	AAV	NN	I-NP	O
integration	integration	NN	I-NP	O
site	site	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
called	call	VBN	B-VP	O
AAVS1	AAVS1	NN	B-NP	O

The	The	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
tachycardia	tachycardia	NN	B-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
noteworthy	noteworthy	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
under	under	IN	B-PP	O
more	more	RBR	B-NP	O
physiological	physiological	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
mimicking	mimic	VBG	B-VP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
GDP	GDP	NN	I-NP	O
/	/	SYM	B-NP	O
GTP	GTP	NN	I-NP	O
ratio	ratio	NN	I-NP	O
,	,	,	O	O
Raf	BEGIN-Raf-INSIDE	NN	B-NP	B
enhances	enhance	VBZ	B-VP	O
the	the	DT	B-NP	O
GEF	BEGIN-GEF-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
stimulated	stimulate	VBN	I-NP	O
GDP	GDP	NN	I-NP	O
/	/	SYM	I-NP	O
GTP	GTP	NN	I-NP	O
exchange	exchange	NN	I-NP	O
on	on	IN	B-PP	O
Ha	BEGIN-Ha	NN	B-NP	B
-	-	HYPH	O	I
Ras	Ras-INSIDE	NN	B-NP	I
,	,	,	O	O
in	in	IN	B-PP	O
agreement	agreement	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
sequestration	sequestration	NN	I-NP	O
of	of	IN	B-PP	O
Ras.GTP	BEGIN-Ras.GTP-INSIDE	NN	B-NP	B
by	by	IN	B-PP	O
Raf	BEGIN-Raf-INSIDE	NN	B-NP	B

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
HNF	BEGIN-HNF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
steroid	BEGIN-steroid	NN	I-NP	B
hormone	hormone	NN	I-NP	I
receptor	receptor	NN	I-NP	I
superfamily	superfamily-INSIDE	NN	I-NP	I
,	,	,	O	O
binds	bind	VBZ	B-VP	O
the	the	DT	B-NP	O
AF	BEGIN-AF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
site	site-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
the	the	DT	B-NP	O
apoB	BEGIN-apoB	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
and	and	CC	B-PP	O
through	through	IN	B-NP	O
it	it	PRP	B-NP	O
activates	activate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
assays	assay	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
liver	liver	NN	B-NP	O
and	and	CC	O	O
non	non	AFX	O	O
-	-	HYPH	B-NP	O
liver	liver	NN	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
,	,	,	O	O
HepG1	HepG1	NN	B-NP	O
and	and	CC	I-NP	O
HeLa	HeLa	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

In	In	IN	B-PP	O
Cos	Cos	NNP	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
oCRF1var	BEGIN-BEGIN-oCRF-INSIDE1var-INSIDE	NN	B-NP	B
,	,	,	O	O
cAMP	cAMP	NN	B-NP	O
accumulation	accumulation	NN	I-NP	O
was	be	VBD	B-VP	O
only	only	RB	I-VP	O
observed	observe	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
oCRF	BEGIN-oCRF-INSIDE	NN	B-NP	B
utilized	utilize	VBN	B-VP	O
(	(	(	O	O
1	1	CD	B-NP	O
nM	nM	NN	I-NP	O
)	)	)	O	O

Usefulness	Usefulness	NN	B-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
1	1	CD	B-NP	O
trials	trial	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
different	different	JJ	I-NP	O
regimens	regimen	NNS	I-NP	O
of	of	IN	B-PP	O
droperidol	droperidol	NN	B-NP	O

The	The	DT	B-NP	O
local	local	JJ	I-NP	O
median	median	JJ	I-NP	O
scores	score	NNS	I-NP	O
(	(	(	O	O
ranges	range	NNS	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
-	-	HYPH	B-NP	O
AMT	AMT	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
CMMS	CMMS	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
SBT	SBT	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
WL	WL	NN	B-NP	O
-	-	HYPH	I-NP	O
i	i	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
WL	WL	NN	B-NP	O
-	-	HYPH	I-NP	O
d	d	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
WL	WL	NN	B-NP	O
-	-	HYPH	I-NP	O
r	r	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
ST	ST	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
BNT	BNT	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
CPT	CPT	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
BDT	BDT	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
OAT	OAT	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MBP	BEGIN-MBP	NN	I-NP	B
-	-	HYPH	I-NP	I
A	A	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
arrangement	arrangement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
highly	highly	RB	I-NP	O
homologous	BEGIN-homologous	JJ	I-NP	B
pulmonary	pulmonary	JJ	I-NP	I
surfactant	surfactant	JJ	I-NP	I
apoprotein	apoprotein-INSIDE	NN	I-NP	I
,	,	,	O	O
although	although	IN	B-SBAR	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intron	intron	NN	I-NP	O
positions	position	NNS	I-NP	O
is	be	VBZ	B-VP	O
shifted	shift	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O

Plasma	BEGIN-Plasma	NN	B-NP	B
renin	renin-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
essential	essential	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O

In	In	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
cytokine	cytokine	NN	B-NP	O
-	-	HYPH	B-NP	O
or	or	CC	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-VP	O
up	up	RB	B-ADVP	O
-	-	HYPH	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
Fas	BEGIN-Fas-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
RTC	RTC	NN	B-NP	O
apoptosis	apoptosis	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Reg1	BEGIN-Reg1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
Glc1	BEGIN-Glc1-INSIDE	NN	I-NP	B
phosphatase	phosphatase	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
machinery	machinery	NN	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
returning	return	VBG	B-VP	O
Snf1	BEGIN-Snf1	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
basal	basal	JJ	I-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
reestablishing	reestablish	VBG	B-VP	O
glucose	glucose	NN	B-NP	O
repression	repression	NN	I-NP	O

To	To	TO	B-VP	O
explore	explore	VB	I-VP	O
further	further	RBR	B-ADVP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
domain	domain	NN	I-NP	O
in	in	IN	B-PP	O
determining	determine	VBG	B-VP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
CDC1	BEGIN-CDC1-INSIDE	NN	B-NP	B
,	,	,	O	O
we	we	PRP	B-NP	O
constructed	construct	VBD	B-VP	O
and	and	CC	O	O
characterized	characterize	VBD	B-VP	O
genes	gene	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
chimeric	BEGIN-chimeric	JJ	B-NP	B
E1s	BEGIN-E1-INSIDEs-INSIDE	NN	I-NP	I
incorporating	incorporate	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O
from	from	IN	B-PP	O
CDC1	BEGIN-CDC1-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
related	related	JJ	I-NP	O
but	but	CC	I-NP	O
functionally	functionally	RB	I-NP	O
distinct	distinct	JJ	I-NP	O
E1	BEGIN-E1-INSIDE	NN	I-NP	B
RAD1	BEGIN-RAD1-INSIDE	NN	I-NP	B
(	(	(	O	O
UBC1	BEGIN-UBC1-INSIDE	NN	B-NP	B
)	)	)	O	O

In	In	IN	B-PP	O
F1	F1	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
prototype	prototype	NN	I-NP	O
of	of	IN	B-PP	O
embryonal	embryonal	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
cells	cell	NNS	I-NP	O
expressing	express	VBG	B-VP	O
hst	BEGIN-hst-INSIDE	NN	B-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
hst	BEGIN-BEGIN-hst-INSIDE	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
positively	positively	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
downstream	downstream	JJ	I-NP	O
octamer	octamer	NN	I-NP	O
motif	motif	NN	I-NP	O
that	that	WDT	B-NP	O
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
enhancer	enhancer	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
rubella	BEGIN-rubella	NN	B-NP	B
IgM	IgM	NN	I-NP	I
antibody	antibody-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
never	never	RB	I-VP	O
detected	detect	VBN	I-VP	O
after	after	IN	B-PP	O
immunization	immunization	NN	B-NP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
HAI	HAI	NN	B-NP	O
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
and	and	CC	I-NP	O
LA	LA	NN	I-NP	O
-	-	HYPH	O	O
positive	positive	JJ	B-ADJP	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O

Since	Since	IN	B-SBAR	O
simian	BEGIN-simian	JJ	B-NP	B
virus	virus	NN	I-NP	I
1	1	CD	I-NP	I
(	(	(	O	I
SV1	SV1	NN	B-NP	I
)	)	)	O	I
large	large	JJ	B-NP	I
T	T	NN	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
and	and	CC	O	O
human	BEGIN-human	JJ	B-NP	B
papillomavirus	papillomavirus	NN	I-NP	I
type	type	NN	I-NP	I
1	1	CD	I-NP	I
(	(	(	O	I
HPV1	HPV1	NN	B-NP	I
)	)	)	O	I
E1	E1	NN	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
bind	bind	VBP	B-VP	O
host	host	NN	B-NP	O
regulatory	regulatory	JJ	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
these	these	DT	B-NP	O
viral	viral	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
can	can	MD	B-VP	O
complement	complement	VB	I-VP	O
E1A	BEGIN-E1A	NN	B-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
defective	defective	JJ	B-ADJP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
gene	gene	NN	I-NP	O
activation	activation	NN	I-NP	O

Only	Only	RB	B-NP	O
viable	viable	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
induced	induce	VBD	B-VP	O
purulent	purulent	JJ	B-NP	O
otitis	otitis	NN	I-NP	O
media	medium	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
culture	culture	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cases	case	NNS	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O

Results	Result	NNS	B-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
hobbies	hobby	NNS	B-NP	O
/	/	SYM	B-VP	O
leisure	leisure	NN	B-NP	O
activities	activity	NNS	I-NP	O
,	,	,	O	O
mobility	mobility	NN	B-NP	O
,	,	,	O	O
transport	transport	NN	B-NP	O
,	,	,	O	O
social	social	JJ	B-NP	O
relationships	relationship	NNS	I-NP	O
,	,	,	O	O
working	work	VBG	B-VP	O
capacity	capacity	NN	B-NP	O
,	,	,	O	O
energy	energy	NN	B-NP	O
and	and	CC	O	O
doing	do	VBG	B-VP	O
things	thing	NNS	B-NP	O
slower	slow	JJR	B-ADJP	O
were	be	VBD	B-VP	O
aspects	aspect	NNS	B-NP	O
relevant	relevant	JJ	B-ADJP	O
to	to	TO	B-PP	O
IPF	IPF	NN	B-NP	O
patients	patient	NNS	I-NP	O
'	'	POS	B-NP	O
QOL	QOL	NN	I-NP	O

Residues	Residue	NNS	B-NP	O
that	that	WDT	B-NP	O
affect	affect	VBP	B-VP	O
PLCbeta	BEGIN-BEGIN-PLC-INSIDEbeta-INSIDE	NN	B-NP	B
and	and	CC	O	O
adenylyl	BEGIN-BEGIN-adenylyl	JJ	B-NP	B
cyclase	cyclase-INSIDE	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
opposite	opposite	JJ	B-NP	O
sides	side	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
tunnel	tunnel	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
PLC	BEGIN-PLC-INSIDE	NN	B-NP	B
and	and	CC	O	O
adenylyl	BEGIN-adenylyl	JJ	B-NP	B
cyclase	cyclase-INSIDE	NN	I-NP	I
,	,	,	O	O
like	like	IN	B-PP	O
the	the	DT	B-NP	O
alpha	alpha	NN	I-NP	O
subunit	subunit	NN	I-NP	O
,	,	,	O	O
make	make	VBP	B-VP	O
many	many	JJ	B-NP	O
contacts	contact	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
top	top	NN	I-NP	O
surface	surface	NN	I-NP	O

One	One	CD	B-NP	O
new	new	JJ	I-NP	O
ORF	ORF	NN	I-NP	O
,	,	,	O	O
YBR1	BEGIN-YBR1-INSIDE	NN	B-NP	B
,	,	,	O	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
,	,	,	O	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O

The	The	DT	B-NP	O
law	law	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
chiropractor	chiropractor	NN	I-NP	O

A	A	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
sequence	sequence	NN	I-NP	O
in	in	IN	B-PP	O
clone	clone	NN	B-NP	O
hMIWC1	hMIWC1	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
an	an	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
upstream	upstream	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
initiation	initiation	NN	I-NP	O
site	site	NN	I-NP	O

Rectal	Rectal	JJ	B-NP	O
temperatures	temperature	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
walk	walk	NN	I-NP	O
were	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
.1	.1	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
native	native	JJ	B-NP	O
Simmental	Simmental	JJ	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
.1	.1	NN	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
Bos	Bos	NNP	B-NP	O
indicus	indicus	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
.1	.1	NN	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
)	)	)	O	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
pre1	BEGIN-pre1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mutation	mutation-INSIDE	NN	I-NP	I
strengthened	strengthen	VBD	B-VP	O
phenotypes	phenotype	NNS	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
other	other	JJ	B-NP	O
1	BEGIN-1	NN	I-NP	B
S	S	NN	I-NP	I
proteasomal	proteasomal	JJ	I-NP	I
mutations	mutations-INSIDE	NN	I-NP	I
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
peptidylglutamyl	peptidylglutamyl	NN	I-NP	O
peptide	peptide	NN	I-NP	O
-	-	HYPH	B-NP	O
hydrolyzing	hydrolyzing	NN	I-NP	O
activity	activity	NN	I-NP	O
has	have	VBZ	B-VP	O
to	to	TO	I-VP	O
fulfill	fulfill	VB	I-VP	O
some	some	DT	B-NP	O
rescue	rescue	NN	I-NP	O
functions	function	NNS	I-NP	O

A	A	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	O
protein	protein	NN	I-NP	O
called	call	VBN	B-VP	O
RFX	BEGIN-RFX-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
X	X-INSIDE	NN	I-NP	I
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
X	X	NN	I-NP	O
box	box	NN	I-NP	O
(	(	(	O	O
or	or	CC	O	O
X1	X1	NN	B-NP	O
box	box	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoters	promoter	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
major	BEGIN-major	JJ	B-NP	B
histocompatibility	histocompatibility	NN	I-NP	I
(	(	(	O	I
MHC	MHC	NN	B-NP	I
)	)	)	O	I
class	class	NN	B-NP	I
II	II	CD	I-NP	I
genes	genes-INSIDE	NN	I-NP	I

This	This	DT	B-NP	O
result	result	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
protein	protein	NN	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
E1s	BEGIN-E1s-INSIDE	NN	B-NP	B
can	can	MD	B-VP	O
be	be	VB	I-VP	O
altered	alter	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
extensions	extension	NNS	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
providing	provide	VBG	B-VP	O
a	a	DT	B-NP	O
way	way	NN	I-NP	O
to	to	TO	B-VP	O
modify	modify	VB	I-VP	O
the	the	DT	B-NP	O
selectivity	selectivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ubiquitin	BEGIN-ubiquitin-INSIDE	NN	I-NP	B
system	system	NN	I-NP	O

This	This	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
and	and	CC	O	O
differential	differential	JJ	B-NP	O
processing	processing	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
inrpk1	BEGIN-inrpk1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
some	some	DT	B-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
SD	SD	NN	B-NP	O
photoperiodic	photoperiodic	JJ	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
flowering	flowering	NN	I-NP	O
in	in	IN	B-PP	O
morning	morning	NN	B-NP	O
glory	glory	NN	I-NP	O

Co	Co	AFX	B-NP	O
-	-	HYPH	I-NP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
gag	BEGIN-gag-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
TRalpha	BEGIN-TRalpha-INSIDE	NN	I-NP	B
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O
in	in	IN	B-PP	O
AEV	AEV	NN	B-NP	O
-	-	HYPH	B-NP	O
transformed	transform	VBN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
ligand	ligand	NN	B-NP	O
derepresses	derepresse	VBZ	B-VP	O
CAII	BEGIN-CAII-INSIDE	NN	B-NP	B
transcription	transcription	NN	I-NP	O

A	A	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
fragment	fragment	NN	I-NP	O
(	(	(	O	O
bp	bp	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
through	through	IN	B-PP	O
+1	+1	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD1	BEGIN-CD1	NN	I-NP	B
promoter	promoter	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
subcloned	subclone	VBN	I-VP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
pGEM	pGEM	NN	I-NP	O
-	-	HYPH	I-NP	O
chloramphenicol	BEGIN-chloramphenicol	NN	I-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
vector	vector	NN	I-NP	O
and	and	CC	B-PP	O
after	after	IN	B-PP	O
transfection	transfection	NN	B-NP	O
into	into	IN	B-PP	O
B	B	NN	B-NP	O
and	and	CC	O	O
T	T	NN	B-NP	O
cells	cell	NNS	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	CC	O	O
B	B	NN	B-NP	O
and	and	CC	O	O
T	T	NN	B-NP	O
cells	cell	NNS	B-NP	O

This	This	DT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
varicocele	varicocele	FW	B-NP	O
per	per	FW	I-NP	O
se	se	FW	I-NP	O
could	could	MD	B-VP	O
affect	affect	VB	I-VP	O
DHT	DHT	NN	B-NP	O
seminal	seminal	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
levels	level	NNS	I-NP	O

Five	Five	CD	B-NP	O
RNA	RNA	NN	I-NP	O
transcripts	transcript	NNS	I-NP	O
of	of	IN	B-PP	O
about	about	RB	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
kilobases	kilobas	NNS	I-NP	O
were	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genome	genome	NN	I-NP	O
of	of	IN	B-PP	O
insect	insect	NN	B-NP	O
iridescent	iridescent	JJ	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
Chilo	Chilo	NNP	B-NP	O
iridescent	iridescent	JJ	I-NP	O
virus	virus	NN	I-NP	O
;	;	:	O	O
CIV	CIV	NN	B-NP	O
)	)	)	O	O
between	between	IN	B-PP	O
genome	genome	NN	B-NP	O
coordinates	coordinate	VBZ	B-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
EcoRI	BEGIN-EcoRI	NN	I-NP	B
DNA	DNA	NN	I-NP	I
fragment	fragment	NN	I-NP	I
F	F-INSIDE	NN	I-NP	I

Cutting	Cut	VBG	B-VP	O
the	the	DT	B-NP	O
intraorbital	intraorbital	JJ	I-NP	O
nerves	nerve	NNS	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
temporary	temporary	JJ	I-NP	O
retrieval	retrieval	JJ	I-NP	O
impairment	impairment	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
indistinguishable	indistinguishable	JJ	B-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
intramystacial	intramystacial	JJ	B-NP	O
lidocaine	lidocaine	NN	I-NP	O
injection	injection	NN	I-NP	O

The	The	DT	B-NP	O
comparisons	comparison	NNS	I-NP	O
of	of	IN	B-PP	O
swimming	swimming	NN	B-NP	O
performance	performance	NN	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
treatments	treatment	NNS	B-NP	O
with	with	IN	B-PP	O
deltamethrin	deltamethrin	NN	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
locomotory	locomotory	JJ	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
rainbow	rainbow	NN	B-NP	O
trout	trout	NNS	I-NP	O
which	which	WDT	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
strong	strong	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
(	(	(	O	O
e.g	e.g	NN	B-NP	O

Increased	Increase	VBN	B-NP	O
trabecular	trabecular	JJ	I-NP	O
spacing	spacing	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
it	it	PRP	B-NP	O
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
osteoporosis	osteoporosis	NN	B-NP	O
,	,	,	O	O
reduces	reduce	VBZ	B-VP	O
the	the	DT	B-NP	O
spatial	spatial	JJ	I-NP	O
field	field	NN	I-NP	O
inhomogeneity	inhomogeneity	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
prolongs	prolong	VBZ	I-VP	O
T1*	T1*	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
both	both	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Decidual	BEGIN-Decidual	JJ	B-NP	B
/	/	SYM	I-NP	I
trophoblast	trophoblast	NN	I-NP	I
prolactin	prolactin	NN	I-NP	I
-	-	HYPH	B-NP	I
related	relate	VBN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
:	:	:	O	O
characterization	characterization	NN	B-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	B-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
cognitive	cognitive	JJ	I-NP	O
performance	performance	NN	I-NP	O
of	of	IN	B-PP	O
elderly	elderly	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
trained	train	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
extent	extent	NN	I-NP	O

The	The	DT	B-NP	O
map	map	NN	I-NP	O
is	be	VBZ	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
CEPH	CEPH	NN	I-NP	O
reference	reference	NN	I-NP	O
pedigrees	pedigree	NNS	I-NP	O
and	and	CC	O	O
includes	include	VBZ	B-VP	O
over	over	IN	B-NP	O
1	1	CD	I-NP	O
new	new	JJ	I-NP	O
genotypes	genotype	NNS	I-NP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
previously	previously	RB	I-NP	O
reported	report	VBN	I-NP	O
data	datum	NNS	I-NP	O
plus	plus	CC	O	O
1	1	CD	B-NP	O
allele	allele	NN	I-NP	O
systems	system	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
published	publish	VBN	I-NP	O
CEPH	CEPH	NN	I-NP	O
version	version	NN	I-NP	O
1	1	CD	I-NP	O
database	database	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
using	use	VBG	I-VP	O
the	the	DT	B-NP	O
program	program	NN	I-NP	O
package	package	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-	-	HYPH	O	O
MAP	MAP	NN	B-NP	O

RMR	RMR	NN	B-NP	O
was	be	VBD	B-VP	O
positively	positively	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
TEF	TEF	NN	B-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
net	net	JJ	B-NP	O
TEF	TEF	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
luteal	luteal	JJ	I-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
follicular	follicular	JJ	I-NP	O
phase	phase	NN	I-NP	O

1	1	CD	B-NP	O
varix	varix	NN	I-NP	O
ligations	ligation	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
during	during	IN	B-PP	O
1	1	CD	B-NP	O
separate	separate	JJ	I-NP	O
EVL	EVL	NN	I-NP	O
sessions	session	NNS	I-NP	O

Nine	Nine	CD	B-NP	O
individuals	individual	NNS	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
dosage	dosage	NN	I-NP	O
were	be	VBD	B-VP	O
randomized	randomize	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
further	further	JJ	I-NP	O
month	month	NN	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
or	or	CC	I-NP	O
high	high	JJ	I-NP	O
dosage	dosage	NN	I-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
which	which	WDT	B-NP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
dosage	dosage	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
partial	partial	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
dosage	dosage	NN	I-NP	O
manifested	manifest	VBD	B-VP	O
response	response	NN	B-NP	O

A	A	DT	B-NP	O
factor	factor	NN	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
wounded	wound	VBN	B-NP	O
potato	potato	NN	I-NP	O
tubers	tuber	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-PP	O
nucleotides	nucleotide	NNS	B-NP	O
located	locate	VBN	B-VP	O
between	between	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
contains	contain	VBZ	B-VP	O
important	important	JJ	B-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	B-NP	O
regulatory	regulatory	JJ	I-NP	O
elements	element	NNS	I-NP	O

Two	Two	CD	B-NP	O
genes	gene	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
encoding	encode	VBG	B-VP	O
mouse	BEGIN-mouse	NN	B-NP	B
ribosomal	ribosomal	JJ	I-NP	I
protein	protein	NN	I-NP	I
S1	S1-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
,	,	,	O	O
sequenced	sequence	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
analyzed	analyze	VBN	B-VP	O

Bile	Bile	NN	B-NP	O
reflux	reflux	NN	I-NP	O
demonstrated	demonstrate	VBN	B-VP	O
by	by	IN	B-PP	O
1m	1m	NN	B-NP	O
Tc	Tc	NN	I-NP	O
disofenin	disofenin	NN	I-NP	O

The	The	DT	B-NP	O
mode	mode	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
is	be	VBZ	B-VP	O
often	often	RB	I-VP	O
suggested	suggest	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
slopes	slope	NNS	I-NP	O
of	of	IN	B-PP	O
concentration	concentration	NN	B-NP	O
-	-	HYPH	B-NP	O
effect	effect	NN	I-NP	O
curves	curve	NNS	I-NP	O

Two	Two	CD	B-NP	O
full	full	JJ	I-NP	O
-	-	HYPH	I-NP	O
length	length	NN	I-NP	O
clones	clone	NNS	I-NP	O
(	(	(	O	O
pBCH1	pBCH1	NN	B-NP	O
and	and	CC	O	O
pBCH1	pBCH1	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O

In	In	IN	B-PP	O
dehydrated	dehydrate	VBN	B-NP	O
animals	animal	NNS	I-NP	O
at	at	IN	B-PP	O
Ta	Ta	NNP	B-NP	O
1	1	CD	I-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
,	,	,	I-NP	O
Tb	Tb	NN	I-NP	O
and	and	CC	I-NP	O
EWL	EWL	NN	I-NP	O
were	be	VBD	B-VP	O
both	both	DT	O	O
significantly	significantly	RB	O	O
altered	alter	VBN	O	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
normally	normally	RB	I-NP	O
hydrated	hydrate	VBN	I-NP	O
state	state	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
degree	degree	NN	I-NP	O
C	C	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
W	W	NN	I-NP	O
.	.	SYM	I-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
respectively	respectively	RB	B-ADVP	O

The	The	DT	B-NP	O
optimum	optimum	JJ	I-NP	O
cooling	cooling	NN	I-NP	O
rate	rate	NN	I-NP	O
from	from	IN	B-PP	O
RT	RT	NN	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
maximum	maximum	JJ	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
spermatozoa	spermatozoa	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
degree	degree	NN	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
when	when	WRB	B-ADVP	O
cooled	cool	VBN	B-VP	O
from	from	IN	B-PP	O
RT	RT	NN	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
frozen	freeze	VBN	I-VP	O
-	-	HYPH	B-NP	O
thawed	thaw	VBN	B-VP	O
in	in	IN	B-PP	O
liquid	liquid	JJ	B-NP	O
nitrogen	nitrogen	NN	I-NP	O
(	(	(	O	O
LN1	LN1	NN	B-NP	O
)	)	)	O	O

Replacement	Replacement	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
valine	valine	NN	I-NP	O
(	(	(	O	O
V1	V1	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ETS	BEGIN-ETS-INSIDE	NN	I-NP	B
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
SAP1a	BEGIN-SAP1a-INSIDE	NN	B-NP	B
by	by	IN	B-PP	O
aspartic	aspartic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
as	as	IN	B-SBAR	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Ets	Ets	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
Elk	BEGIN-Elk	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
Net	BEGIN-Net-INSIDE	NN	B-NP	B
)	)	)	O	O
enhanced	enhance	VBD	B-VP	O
ternary	ternary	JJ	B-NP	O
complex	complex	NN	I-NP	O
formation	formation	NN	I-NP	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	I-NP	O

Methylprednisolone	Methylprednisolone	NN	B-NP	O
and	and	CC	I-NP	O
U	U	NN	I-NP	O
-	-	HYPH	B-NP	O
1F	1F	NN	I-NP	O
were	be	VBD	B-VP	O
equally	equally	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
at	at	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
neurological	neurological	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
U	U	NN	B-NP	O
-	-	HYPH	I-NP	O
1F	1F	NN	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
less	less	RBR	I-ADJP	O
effective	effective	JJ	I-ADJP	O
than	than	IN	B-PP	O
U	U	NN	B-NP	O
-	-	HYPH	B-NP	O
1F	1F	NN	I-NP	O
and	and	CC	I-NP	O
methylprednisolone	methylprednisolone	NN	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
better	good	JJR	I-ADJP	O
than	than	IN	B-PP	O
vehicle	vehicle	NN	B-NP	O
in	in	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
neurological	neurological	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O

Comparison	Comparison	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
Ricketts	Ricketts	NNP	I-NP	O
and	and	CC	I-NP	O
Bimler	Bimler	NNP	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
technics	technic	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
cases	case	NNS	B-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
division	division	NN	B-NP	O
I	I	CD	I-NP	O
mmalocclusion	mmalocclusion	NN	I-NP	O

Sample	Sample	JJ	B-NP	O
size	size	NN	I-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
measurements	measurement	NNS	I-NP	O
in	in	IN	B-PP	O
continuous	continuous	JJ	B-NP	O
data	datum	NNS	I-NP	O

Transfection	Transfection	NN	B-NP	O
assays	assay	NNS	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
from	from	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
ALDH1	BEGIN-ALDH1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
especially	especially	RB	B-ADVP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	I-NP	I
Y	Y-INSIDE	NN	I-NP	I
/	/	SYM	I-NP	O
CP1	BEGIN-CP1-INSIDE	NN	I-NP	B
binding	binding	NN	I-NP	O
site	site	NN	I-NP	O
from	from	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
CCAAT	CCAAT	NN	B-NP	O
box	box	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
five	five	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
evaluable	evaluable	JJ	I-NP	O
patients	patient	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
allogeneic	allogeneic	JJ	B-NP	O
sibling	sibling	NN	I-NP	O
BM	BM	NN	I-NP	O
or	or	CC	I-NP	O
PBSC	PBSC	NNS	I-NP	O
transplantation	transplantation	NN	I-NP	O
for	for	IN	B-PP	O
MM	MM	NN	B-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
who	who	WP	B-NP	O
met	meet	VBD	B-VP	O
the	the	DT	B-NP	O
criteria	criterion	NNS	I-NP	O
for	for	IN	B-PP	O
adjuvant	adjuvant	JJ	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
-	-	HYPH	B-NP	I
IFN	IFN-INSIDE	NN	I-NP	I
therapy	therapy	NN	I-NP	O

Both	Both	CC	O	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
'	'	``	I-NP	O
untranslated	untranslated	JJ	I-NP	O
regions	region	NNS	I-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
significant	significant	JJ	B-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
sequence	sequence	NN	I-NP	O
identity	identity	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Plasma	Plasma	NNP	B-NP	O
Pi	Pi	NNP	I-NP	O
,	,	,	O	O
tibia	tibia	NN	B-NP	O
breaking	breaking	NN	I-NP	O
strength	strength	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
percentage	percentage	NN	B-NP	O
of	of	IN	B-PP	O
tibia	tibia	NN	B-NP	O
ash	ash	NN	I-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
raising	raise	VBG	B-VP	O
dietary	dietary	JJ	B-NP	O
Pav	Pav	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
.1	.1	NN	B-NP	O
A1	A1	NN	I-NP	O
with	with	IN	B-PP	O
either	either	CC	O	O
level	level	NN	B-NP	O
of	of	IN	B-PP	O
Ca	Ca	NN	B-NP	O

A	A	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
region	region	NN	I-NP	O
which	which	WDT	B-NP	O
stimulates	stimulate	VBZ	B-VP	O
origin	origin	NN	B-NP	O
function	function	NN	I-NP	O
mapped	map	VBD	B-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
Abf1p	BEGIN-Abf1p-INSIDE	NN	B-NP	B

Hepatocyte	BEGIN-Hepatocyte	NN	B-NP	B
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
HGF	BEGIN-HGF-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
cytokine	cytokine	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
growth	growth	NN	I-NP	O
and	and	CC	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
summarise	summarise	VB	I-VP	O
quantitatively	quantitatively	RB	B-ADVP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
biological	biological	JJ	B-NP	O
markers	marker	NNS	I-NP	O
of	of	IN	B-PP	O
risk	risk	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
predict	predict	VB	I-VP	O
how	how	WRB	B-ADVP	O
these	these	DT	B-NP	O
changes	change	NNS	I-NP	O
would	would	MD	B-VP	O
lower	lower	VB	I-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O

(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
EMBO	EMBO	NN	B-NP	O
J	J	NN	I-NP	O

Tissue	Tissue	NN	B-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
gene	gene	NN	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
eukaryotic	eukaryotic	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
extent	extent	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
manner	manner	NN	I-NP	O

Teratospermia	Teratospermia	NN	B-NP	O
is	be	VBZ	B-VP	O
therefore	therefore	RB	B-ADVP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
evaluating	evaluate	VBG	B-VP	O
fertilization	fertilization	NN	B-NP	O
capacity	capacity	NN	I-NP	O

Genomic	Genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
trout	BEGIN-trout	JJ	I-NP	B
L1	L1	NN	I-NP	I
locus	locus-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
cluster	cluster	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
organization	organization	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
trout	BEGIN-trout	JJ	I-NP	B
L1	L1	NN	I-NP	I
locus	locus-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
IgL	BEGIN-IgL	NN	I-NP	B
locus	locus-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
teleost	teleost	NN	I-NP	O
fish	fish	NNS	I-NP	O

Genetic	Genetic	JJ	B-NP	O
polymorphisms	polymorphism	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
flanking	flank	VBG	I-NP	O
region	region	NN	I-NP	O
change	change	NN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
cytochrome	cytochrome	NN	I-NP	I
P1IIE1	P1IIE1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

As	As	IN	B-SBAR	O
exogenously	exogenously	RB	B-NP	O
expressed	express	VBN	I-NP	O
PKR	BEGIN-PKR-INSIDE	NN	I-NP	B
can	can	MD	B-VP	O
form	form	VB	I-VP	O
heterodimers	heterodimer	NNS	B-NP	O
with	with	IN	B-PP	O
endogenous	BEGIN-endogenous	JJ	B-NP	B
PKR	BEGIN-PKR-INSIDE-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
mutant	mutant	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
PKR	BEGIN-PKR-INSIDE	NN	B-NP	B
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
taken	take	VBN	I-VP	O
with	with	IN	B-PP	O
caution	caution	NN	B-NP	O

Basal	Basal	JJ	B-NP	O
JNK	BEGIN-JNK	NN	I-NP	B
MAPK	MAPK	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
specifically	specifically	RB	I-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
deltaEGFR	BEGIN-deltaEGFR-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	I-NP	I
kDa	kDa	NN	I-NP	I
JNK1	JNK1	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
deltaEGFR	BEGIN-deltaEGFR-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
cells	cell	NNS	B-NP	O

Isolation	Isolation	NN	B-NP	O
and	and	CC	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
Drosophila	BEGIN-Drosophila	NN	B-NP	B
melanogaster	melanogaster	NN	I-NP	I
ferritin	ferritin-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
-	-	HYPH	B-NP	O
molecular	molecular	JJ	I-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
one	one	CD	B-NP	O
subunit	subunit	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
localization	localization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
chromosome	chromosome	NN	I-NP	O

The	The	DT	B-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
copy	copy	NN	I-NP	O
U1	BEGIN-U1	NN	I-NP	B
sequence	sequence-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
strand	strand	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
nucleolin	BEGIN-nucleolin	NN	I-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I

Maximum	Maximum	JJ	B-NP	O
baroreceptor	baroreceptor	NN	I-NP	O
activity	activity	NN	I-NP	O
measured	measure	VBN	B-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
slope	slope	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pressure	pressure	NN	I-NP	O
-	-	HYPH	B-NP	O
activity	activity	NN	I-NP	O
curve	curve	NN	I-NP	O
were	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
rabbits	rabbit	NNS	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	IN	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
spikes	spike	NNS	I-NP	O
per	per	IN	B-PP	O
second	second	JJ	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
spikes	spike	NNS	I-NP	O
per	per	IN	B-PP	O
second	second	NN	B-NP	O
per	per	IN	B-PP	O
mm	mm	NN	B-NP	O
Hg	Hg	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
.1	.1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
effective	effective	JJ	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
superoxide	BEGIN-superoxide	NN	B-NP	B
dismutase	dismutase-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
erythrocytes	erythrocyte	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
late	late	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
influenza	influenza	NN	I-NP	O
infection	infection	NN	I-NP	O

EMT	BEGIN-EMT-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
localized	localized	JJ	B-ADJP	O
to	to	TO	B-PP	O
chromosome	chromosome	NN	B-NP	O
1q1	1q1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
growth	growth	NN	I-NP	O
factors	factor	NNS	I-NP	O
and	and	CC	I-NP	O
receptors	receptor	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
early	early	JJ	B-NP	O
activation	activation	NN	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
those	those	DT	B-NP	O
involved	involve	VBN	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hematopoietic	hematopoietic	JJ	I-NP	O
system	system	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
neither	neither	CC	O	O
SF	BEGIN-SF	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
nor	nor	CC	I-NP	O
NGF	BEGIN-NGF	NN	I-NP	B
-	-	HYPH	I-NP	I
IB	IB-INSIDE	NN	I-NP	I
alone	alone	RB	B-ADVP	O
,	,	,	O	O
binding	binding	NN	B-NP	O
as	as	IN	B-PP	O
monomers	monomer	NNS	B-NP	O
,	,	,	O	O
increases	increase	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O

Both	Both	CC	O	O
purH	BEGIN-purH-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
purD	BEGIN-purD	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
constitute	constitute	VBP	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
operon	operon	NN	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
coregulated	coregulate	VBN	I-VP	O
in	in	IN	B-PP	O
expression	expression	NN	B-NP	O
by	by	IN	B-PP	O
purines	purine	NNS	B-NP	O
as	as	IN	B-SBAR	O
other	other	JJ	B-NP	O
purine	BEGIN-purine	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O

Fluorescence	Fluorescence	NN	B-NP	O
in	in	FW	B-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
and	and	CC	O	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
retrotransposon	retrotransposon	NN	B-NP	O
families	family	NNS	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
all	all	DT	B-NP	O
sugar	sugar	NN	I-NP	O
beet	beet	NN	I-NP	O
chromosomes	chromosome	NNS	I-NP	O
and	and	CC	O	O
largely	largely	RB	B-VP	O
excluded	exclude	VBN	I-VP	O
from	from	IN	B-PP	O
chromosomal	chromosomal	JJ	B-NP	O
regions	region	NNS	I-NP	O
harbouring	harbour	VBG	B-VP	O
the	the	DT	B-NP	O
1S	BEGIN-1S-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
1S	BEGIN-1S-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
1S	BEGIN-1S-INSIDE	NN	I-NP	B
rRNA	rRNA	NN	I-NP	O
genes	gene	NNS	I-NP	O

Application	Application	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
method	method	NN	I-NP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
microseismicity	microseismicity	NN	I-NP	O
record	record	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
systematic	systematic	JJ	B-NP	O
spatial	spatial	JJ	I-NP	O
and	and	CC	I-NP	O
temporal	temporal	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
slip	slip	JJ	I-NP	O
rate	rate	NN	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
synchronous	synchronous	JJ	B-ADJP	O
with	with	IN	B-PP	O
earthquake	earthquake	NN	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
independent	independent	JJ	I-NP	O
measures	measure	NNS	I-NP	O
of	of	IN	B-PP	O
fault	fault	NN	B-NP	O
-	-	HYPH	B-NP	O
zone	zone	NN	I-NP	O
slip	slip	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
(	(	(	O	O
RF1	RF1	NN	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
being	be	VBG	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
,	,	,	O	O
SP1	BEGIN-SP1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
TATA	TATA	NN	B-NP	O
box	box	NN	I-NP	O
motifs	motif	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
immunodeficiency	immunodeficiency	NN	I-NP	I
virus	virus	NN	I-NP	I
LTR	LTR-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
all	all	DT	O	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
HHV	BEGIN-HHV	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
encoded	encode	VBN	I-NP	I
transactivator	transactivator-INSIDE	NN	I-NP	I

Two	Two	CD	B-NP	O
conserved	conserve	VBN	I-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	I-NP	O
W1RKRRY1	W1RKRRY1	NN	I-NP	O
and	and	CC	I-NP	O
P1KKIKP1	P1KKIKP1	NN	I-NP	O
,	,	,	O	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
addressing	addressing	NN	I-NP	O
signals	signal	NNS	I-NP	O

All	All	DT	B-NP	O
testosterone	testosterone	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
raised	raise	VBD	B-VP	O
plasma	plasma	NN	B-NP	O
testosterone	testosterone	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
above	above	IN	B-PP	O
control	control	NN	B-NP	O
and	and	CC	I-NP	O
pretreatment	pretreatment	NN	I-NP	O
levels	level	NNS	I-NP	O
(	(	(	O	O
testosterone	testosterone	NN	B-NP	O
and	and	CC	O	O
synovex	synovex	NN	B-NP	O
+	+	SYM	B-NP	O
testosterone	testosterone	NN	I-NP	O
>	>	SYM	I-NP	O
synovex	synovex	NN	I-NP	O
>	>	SYM	B-NP	O
control	control	NN	I-NP	O
;	;	:	O	O
all	all	DT	B-NP	O
P	P	NN	I-NP	O
<	<	JJR	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
educational	educational	JJ	I-NP	O
program	program	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
significant	significant	JJ	I-NP	O
factor	factor	NN	I-NP	O
that	that	WDT	B-NP	O
influenced	influence	VBD	B-VP	O
the	the	DT	B-NP	O
change	change	NN	I-NP	O
of	of	IN	B-PP	O
concern	concern	NN	B-NP	O
trajectories	trajectory	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
/	/	SYM	O	O
non	non	AFX	O	O
-	-	HYPH	B-NP	O
recurrent	recurrent	JJ	I-NP	O
factor	factor	NN	I-NP	O
influenced	influence	VBD	B-VP	O
the	the	DT	B-NP	O
change	change	NN	I-NP	O
of	of	IN	B-PP	O
concern	concern	NN	B-NP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
pamphlet	pamphlet	NN	B-NP	O
group	group	NN	I-NP	O

Biol	Biol	NNP	B-NP	O

Snails	Snail	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
or	or	CC	I-NP	O
five	five	CD	I-NP	O
miracidia	miracidia	NNS	I-NP	O
produced	produce	VBD	B-VP	O
more	more	JJR	B-NP	O
metacercariae	metacercariae	NNS	I-NP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
miracidium	miracidium	NN	I-NP	O

Evidence	Evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
AT1A	BEGIN-AT1A	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
activates	activate	VBZ	B-VP	O
transcription	BEGIN-transcription	NN	B-NP	B
factor	factor	NN	I-NP	I
-	-	HYPH	B-NP	I
Stat1	Stat1-INSIDE	NN	I-NP	I
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
related	relate	VBN	I-NP	O
protein	protein	NN	I-NP	O

Two	Two	CD	B-NP	O
estimates	estimate	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fractal	fractal	JJ	I-NP	O
exponent	exponent	NN	I-NP	O
are	be	VBP	B-VP	O
considered	consider	VBN	I-VP	O
which	which	WDT	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
suffer	suffer	VB	I-VP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
limit	limit	NN	I-NP	O
:	:	:	O	O
one	one	CD	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Allan	Allan	NNP	I-NP	O
variance	variance	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
developed	develop	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
one	one	CD	B-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
periodogram	periodogram	NN	I-NP	O

The	The	DT	B-NP	O
full	full	JJ	I-NP	O
-	-	HYPH	I-NP	O
length	length	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
was	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
and	and	CC	I-VP	O
sequenced	sequence	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
inferred	inferred	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
encode	encode	VB	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
we	we	PRP	B-NP	O
named	name	VBD	B-VP	O
cystatin	BEGIN-cystatin	NN	B-NP	B
M	M-INSIDE	NN	I-NP	I
,	,	,	O	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
human	BEGIN-human	JJ	B-NP	B
family	family	NN	I-NP	I
1	1	CD	I-NP	I
cystatins	cystatins-INSIDE	NN	I-NP	I
and	and	CC	O	O
similar	similar	JJ	B-NP	O
overall	overall	JJ	I-NP	O
structure	structure	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
oxyR	BEGIN-oxyR	NN	B-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
locked	lock	VBN	I-VP	O
on	on	IN	B-PP	O
for	for	IN	B-PP	O
Ag1	BEGIN-Ag1-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
dam	BEGIN-dam	NN	B-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
locked	lock	VBN	I-VP	O
off	off	RP	B-PRT	O
for	for	IN	B-PP	O
Ag1	BEGIN-Ag1-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O

GH	BEGIN-GH-INSIDE	NN	B-NP	B
induced	induce	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Western	Western	JJ	B-NP	O
blotting	blotting	NN	I-NP	O
with	with	IN	B-PP	O
STAT	BEGIN-STAT	NN	B-NP	B
-	-	HYPH	B-NP	I
specific	specific	JJ	I-NP	I
antibodies	antibodies-INSIDE	NN	I-NP	I
revealed	reveal	VBD	B-VP	O
STAT1	BEGIN-STAT1-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
(	(	(	O	O
phosphorylation	phosphorylation	NN	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
GH	BEGIN-GH-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
team	team	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	I-NP	O
conditioning	conditioning	NN	I-NP	O
of	of	IN	B-PP	O
athletes	athlete	NNS	B-NP	O
for	for	IN	B-PP	O
sports	sport	NNS	B-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	O
statement	statement	NN	I-NP	O

Experimental	Experimental	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
of	of	IN	B-PP	O
poults	poult	NNS	B-NP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
strains	strain	NNS	I-NP	O
representing	represent	VBG	B-VP	O
the	the	DT	B-NP	O
rarely	rarely	RB	I-NP	O
reported	report	VBN	I-NP	O
capsular	capsular	JJ	I-NP	O
group	group	NN	I-NP	O
B	B	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
both	both	DT	B-NP	O
were	be	VBD	B-VP	O
virulent	virulent	JJ	B-ADJP	O

A	A	DT	B-NP	O
drop	drop	NN	I-NP	O
of	of	IN	B-PP	O
methylprednisolone	methylprednisolone	NN	B-NP	O
acetate	acetate	NN	I-NP	O
or	or	CC	O	O
vehicle	vehicle	NN	B-NP	O
constituent	constituent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
dissected	dissect	VBN	I-NP	O
plantar	plantar	NN	I-NP	O
nerve	nerve	NN	I-NP	O
proximal	proximal	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
stimulating	stimulate	VBG	I-NP	O
electrodes	electrode	NNS	I-NP	O
after	after	IN	B-PP	O
recording	record	VBG	B-VP	O
control	control	NN	B-NP	O
responses	response	NNS	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
-	-	HYPH	I-NP	O
fibre	fibre	NN	I-NP	O
volley	volley	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sciatic	sciatic	JJ	I-NP	O
nerve	nerve	NN	I-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
fibre	fibre	NN	I-NP	O
evoked	evoke	VBD	B-VP	O
reflex	reflex	NN	B-NP	O
discharge	discharge	NN	I-NP	O
in	in	IN	B-PP	O
flexor	flexor	NN	B-NP	O
motoneurons	motoneuron	NNS	I-NP	O
)	)	)	O	O

Case	Case	NN	B-NP	O
of	of	IN	B-PP	O
nephrotic	nephrotic	JJ	B-NP	O
syndrome	syndrome	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
gold	gold	NN	B-NP	O
preparations	preparation	NNS	I-NP	O

Pax	BEGIN-Pax	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
constructs	construct	NNS	I-NP	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
activation	activation	NN	I-NP	O
domain	domain	NN	I-NP	O
repressed	repress	VBD	B-VP	O
betaB1	BEGIN-betaB1	NN	B-NP	B
-	-	HYPH	B-NP	I
crystallin	crystallin	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
as	as	RB	B-ADVP	O
effectively	effectively	RB	I-ADVP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	O
-	-	HYPH	I-NP	O
length	length	NN	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
PD	BEGIN-PD-INSIDE	NN	I-NP	B
alone	alone	RB	B-ADVP	O
or	or	CC	O	O
Pax	BEGIN-BEGIN-Pax	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
1a	1a	NN	B-NP	O
)	)	)	O	O
	-INSIDE	NN	B-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
splice	splice	NN	I-NP	O
variant	variant	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
altered	altered	JJ	I-NP	O
PD	BEGIN-PD-INSIDE	NN	I-NP	B
affecting	affect	VBG	B-VP	O
its	its	PRP$	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
specificity	specificity	NN	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
important	important	JJ	B-ADJP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
treating	treat	VBG	B-VP	O
diabetic	diabetic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
not	not	RB	O	O
to	to	TO	B-VP	O
assume	assume	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
itself	itself	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
cases	case	NNS	I-NP	O

A	A	DT	B-NP	O
retrospective	retrospective	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
clozapine	clozapine	NN	B-NP	O
and	and	CC	O	O
electroencephalographic	electroencephalographic	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
in	in	IN	B-PP	O
schizophrenic	schizophrenic	JJ	B-NP	O
patients	patient	NNS	I-NP	O

While	While	IN	B-SBAR	O
working	work	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
toxicity	toxicity	NN	I-NP	O
of	of	IN	B-PP	O
war	war	NN	B-NP	O
gases.	gases.	NN	I-NP	O
he	he	PRP	B-NP	O
formulated	formulate	VBD	B-VP	O
'Haber	'Haber	NNP	B-NP	O
's	's	POS	B-NP	O
rule	rule	NN	I-NP	O
'	'	''	O	O
,	,	,	O	O
also	also	RB	B-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
C	C	NN	B-NP	O
x	x	SYM	B-VP	O
T=	T=	NN	B-NP	O
constant	constant	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
the	the	DT	B-NP	O
toxicity	toxicity	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
inhalant	inhalant	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
conferred	confer	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
in	in	IN	B-PP	O
Drosophila	Drosophila	NNP	B-NP	O
by	by	IN	B-PP	O
three	three	CD	B-NP	O
closely	closely	RB	I-NP	O
related	related	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
even	even	RB	B-NP	O
subtle	subtle	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
changes	change	NNS	I-NP	O
within	within	IN	B-PP	O
an	an	DT	B-NP	O
E	E	NN	I-NP	O
box	box	NN	I-NP	O
or	or	CC	O	O
flanking	flanking	NN	B-NP	O
bases	base	NNS	I-NP	O
have	have	VBP	B-VP	O
dramatic	dramatic	JJ	B-NP	O
consequences	consequence	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
repertoire	repertoire	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
bind	bind	VB	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

The	The	DT	B-NP	O
Sensititre	Sensititre	NNP	I-NP	O
MIC	MIC	NN	I-NP	O
panels	panel	NNS	I-NP	O
containing	contain	VBG	B-VP	O
meropenem	meropenem	NN	B-NP	O
offer	offer	VBP	B-VP	O
a	a	DT	B-NP	O
convenient	convenient	JJ	I-NP	O
and	and	CC	I-NP	O
valid	valid	JJ	I-NP	O
alternative	alternative	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
NCCLS	NCCLS	NN	I-NP	O
reference	reference	NN	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
testing	testing	NN	I-NP	O
of	of	IN	B-PP	O
potential	potential	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
recovered	recover	VBN	I-VP	O
from	from	IN	B-PP	O
mixed	mix	VBN	B-NP	O
infections	infection	NNS	I-NP	O

Two	Two	CD	B-NP	O
putative	putative	JJ	I-NP	O
ATP	ATP	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
domains	domain	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
one	one	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
argA	BEGIN-argA	NN	I-NP	B
-	-	HYPH	B-VP	I
encoded	encode	VBN	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
carboxy	carboxy	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
half	half	NN	I-NP	O

Previously	Previously	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
identified	identify	VBD	B-VP	O
two	two	CD	B-NP	O
human	BEGIN-human	JJ	I-NP	B
SMC	SMC	NN	I-NP	I
family	family	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
,	,	,	O	O
hCAP	BEGIN-hCAP	NN	B-NP	B
-	-	HYPH	B-NP	I
C	C-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
hCAP	BEGIN-hCAP	NN	I-NP	B
-	-	HYPH	O	I
E	E-INSIDE	NN	B-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
form	form	VBP	B-VP	O
a	a	DT	B-NP	O
heterodimeric	heterodimeric	JJ	I-NP	O
complex	complex	NN	I-NP	O
(	(	(	O	O
hCAP	BEGIN-hCAP	NN	B-NP	B
-	-	HYPH	B-NP	I
C	C-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
hCAP	BEGIN-hCAP	NN	I-NP	B
-	-	HYPH	B-NP	I
E	E-INSIDE	NN	I-NP	I
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
major	major	JJ	I-NP	O
postoperative	postoperative	JJ	I-NP	O
complications	complication	NNS	I-NP	O
and	and	CC	O	O
at	at	IN	B-PP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
operation	operation	NN	B-NP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
satisfactory	satisfactory	JJ	B-ADJP	O

The	The	DT	B-NP	O
interleukin	BEGIN-interleukin	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
receptor	receptor	NN	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
(	(	(	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1R	1R	NN	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
)	)	)	I-NP	O
chain	chain	NN	I-NP	O
gene	gene	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	BEGIN-immunoglobulin	NN	I-NP	B
(	(	(	O	I
Ig	Ig	NN	B-NP	I
)	)	)	O	I
kappa	kappa-INSIDE	NN	B-NP	I
(	(	(	O	O
kappa	kappa	NN	B-NP	O
)	)	)	O	O
enhancer	enhancer	NN	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B	NN	I-NP	I
binding	binding	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I

(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
J	J	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
)	)	)	O	O
intron	intron	NN	B-NP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
atX	BEGIN-atX	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
predicted	predict	VBN	I-VP	O
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
canonical	canonical	JJ	I-NP	O
GT	GT	NN	I-NP	O
and	and	CC	I-NP	O
AG	AG	NN	I-NP	O
dinucleotides	dinucleotide	NNS	I-NP	O
at	at	IN	B-PP	O
its	its	PRP$	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
splicing	splicing	NN	I-NP	O
junctions	junction	NNS	I-NP	O

Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
reaction	reaction	NN	I-NP	O
of	of	IN	B-PP	O
cytochrome	BEGIN-cytochrome	NN	B-NP	B
c	c-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
corticosteroids	corticosteroid	NNS	B-NP	O

In	In	IN	B-PP	O
accordance	accordance	NN	B-NP	O
with	with	IN	B-PP	O
Ann	Ann	NNP	B-NP	O
Arbor	Arbor	NNP	I-NP	O
classification	classification	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
1	1	CD	B-NP	O
CS	CS	NN	I-NP	O
IA	IA	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
CS	CS	NN	I-NP	O
IB	IB	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
CS	CS	NN	I-NP	O
IIA	IIA	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
CS	CS	NN	I-NP	O
IIB	IIB	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
summarized	summarize	VBN	I-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PDE	BEGIN-BEGIN-PDE-INSIDE	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
by	by	IN	B-PP	O
immunoblot	immunoblot	NN	B-NP	O
analysis	analysis	NN	I-NP	O
using	use	VBG	B-VP	O
two	two	CD	B-NP	O
specific	specific	JJ	I-NP	O
cAMP	BEGIN-cAMP	NN	I-NP	B
-	-	HYPH	I-NP	I
PDE	BEGIN-PDE-INSIDE	NN	I-NP	I
polyclonal	polyclonal	JJ	I-NP	O
antibodies	antibodies-INSIDE	NN	I-NP	I
and	and	CC	B-PP	O
by	by	IN	B-PP	O
measuring	measure	VBG	B-VP	O
the	the	DT	B-NP	O
PDE	BEGIN-PDE-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O

HL	BEGIN-HL-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
hypothesized	hypothesize	VBN	I-VP	O
to	to	TO	B-VP	O
directly	directly	RB	I-VP	O
couple	couple	VB	I-VP	O
HDL	BEGIN-HDL-INSIDE	NN	B-NP	B
lipid	lipid	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
to	to	TO	B-PP	O
tissue	tissue	NN	B-NP	O
/	/	SYM	B-NP	O
cellular	cellular	JJ	I-NP	O
lipid	lipid	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O

The	The	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
ABP	BEGIN-ABP-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
DAO	BEGIN-DAO-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kilobase	kilobase	NN	I-NP	O
messenger	messenger	NN	I-NP	O
RNA	RNA	NN	I-NP	O
is	be	VBZ	B-VP	O
transcribed	transcribe	VBN	I-VP	O
from	from	IN	B-PP	O
two	two	CD	B-NP	O
close	close	JJ	I-NP	O
origins	origin	NNS	I-NP	O
identifying	identify	VBG	B-VP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
promoter	promoter	NN	I-NP	O

Rottlerin	Rottlerin	NN	B-NP	O
also	also	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
MAP	BEGIN-MAP	NN	B-NP	B
kinase	kinase	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
MEK	BEGIN-MEK-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
activated	activate	VBN	B-NP	O
Raf	BEGIN-Raf-INSIDE	NN	I-NP	B
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
upon	upon	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Raf	BEGIN-Raf-INSIDE-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
or	or	CC	O	O
ERK	BEGIN-ERK-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
activated	activate	VBN	B-NP	O
MEK	BEGIN-MEK-INSIDE	NN	I-NP	B

Especially	Especially	RB	B-SBAR	O
if	if	IN	I-SBAR	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
dimensions	dimension	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
is	be	VBZ	B-VP	O
large	large	JJ	B-ADJP	O
,	,	,	O	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
said	say	VBN	I-VP	O
that	that	IN	B-SBAR	O
BPN	BPN	NN	B-NP	O
is	be	VBZ	B-VP	O
better	good	JJR	B-ADJP	O
than	than	IN	B-PP	O
k	k	NN	B-NP	O
-	-	HYPH	B-NP	O
NN	NN	NN	I-NP	O
in	in	IN	B-PP	O
classification	classification	NN	B-NP	O
ability	ability	NN	I-NP	O

Several	Several	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
,	,	,	O	O
clone	clone	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
reported	report	VBN	I-VP	O
and	and	CC	O	O
characterized	characterize	VBN	B-VP	O
here	here	RB	B-ADVP	O

Immunoprecipitation	Immunoprecipitation	NN	B-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
lysates	lysate	NNS	I-NP	O
with	with	IN	B-PP	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
phosphotyrosine	phosphotyrosine-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
immunoblotting	immunoblotting	NN	I-NP	O
showed	show	VBD	B-VP	O
phosphorylated	phosphorylated	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitogenic	mitogenic	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
proteins	protein	NNS	I-NP	O
Shc	BEGIN-Shc-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
MAPK	BEGIN-MAPK-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
(	(	(	O	O
neu	BEGIN-neu-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Ras	BEGIN-Ras-INSIDE	NN	I-NP	B
to	to	TO	B-VP	O
MAPK	BEGIN-MAPK-INSIDE	VB	I-VP	B
mitogenic	mitogenic	JJ	B-NP	O
pathway	pathway	NN	I-NP	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O

The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
upstream	upstream	RB	I-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
was	be	VBD	B-VP	O
G	G	G	B-ADJP	O
+	+	+	B-NP	O
C	C	NN	I-NP	O
rich	rich	JJ	B-ADJP	O
(	(	(	O	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
contained	contain	VBD	B-VP	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	O
CCAAT	CCAAT	NN	I-NP	O
sequence	sequence	NN	I-NP	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O

The	The	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
pathological	pathological	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
in	in	IN	B-PP	O
thymus	thymus	NN	B-NP	O
,	,	,	O	O
spleen	spleen	NN	B-NP	O
,	,	,	O	O
lymph	lymph	NN	B-NP	O
nodes	node	NNS	I-NP	O
and	and	CC	O	O
bone	bone	NN	B-NP	O
-	-	HYPH	O	O
marrow	marrow	NN	B-NP	O
is	be	VBZ	B-VP	O
frequently	frequently	RB	I-VP	O
observed	observe	VBN	I-VP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
After	After	IN	B-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
platelet	platelet	NN	B-NP	O
count	count	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
microliter	microliter	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
maximal	maximal	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	B-NP	O
microliter	microliter	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
adjacent	adjacent	JJ	B-NP	O
matrix	matrix	NN	I-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
fibrocartilage	fibrocartilage	NN	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
chondrocytes	chondrocyte	NNS	B-NP	O

Radiation	Radiation	NN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
irradiated	irradiate	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
condition	condition	NN	I-NP	O
of	of	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
opioid	opioid	JJ	I-NP	O
antagonist	antagonist	NN	I-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
animals	animal	NNS	B-NP	O
1	1	CD	I-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
termination	termination	NN	B-NP	O
of	of	IN	B-PP	O
single	single	JJ	B-NP	O
or	or	CC	I-NP	O
multiple	multiple	JJ	I-NP	O
exposures	exposure	NNS	I-NP	O
to	to	TO	B-VP	O
restraint	restraint	VB	I-VP	O
,	,	,	O	O
NALT	NALT	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
basal	basal	JJ	B-NP	O
plasma	BEGIN-plasma	NN	I-NP	B
LH	LH-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
attenuated	attenuate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chronically	chronically	RB	I-NP	O
stressed	stress	VBN	I-NP	O
rats	rat	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
animals	animal	NNS	B-NP	O
subjected	subject	VBN	B-VP	O
to	to	TO	B-VP	O
stress	stress	VB	I-VP	O
only	only	RB	B-ADVP	O
once	once	RB	I-ADVP	O
or	or	CC	I-ADVP	O
not	not	RB	I-ADVP	O
at	at	IN	B-PP	O
all.	all.	NN	B-NP	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-NP	O
1	1	CD	I-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
CBP	BEGIN-CBP-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
stimulated	stimulate	VBD	B-VP	O
both	both	CC	O	O
TGF	BEGIN-TGF	NN	B-NP	B
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
Smad	BEGIN-Smad-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
transcription	transcription	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Smad1	BEGIN-Smad-INSIDE1	NN	I-NP	I
/	/	SYM	B-NP	O
DPC1	BEGIN-DPC1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
fashion	fashion	NN	I-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
factor	BEGIN-factor	NN	I-NP	B
IX	IX	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
C	C	NN	I-NP	O
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
>	>	SYM	I-NP	O
T	T	NN	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
codon	codon	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
propeptide	propeptide	NN	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
substitution	substitution	NN	I-NP	O
of	of	IN	B-PP	O
alanine	alanine	NN	B-NP	O
by	by	IN	B-PP	O
valine	valine	NN	B-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
restricted	restricted	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
gonadotropin	BEGIN-gonadotropin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
TSH	BEGIN-TSH	NN	I-NP	B
receptors	receptors-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
gonads	gonad	NNS	B-NP	O
and	and	CC	O	O
thyroid	thyroid	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
LGR1	BEGIN-LGR1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
diverse	diverse	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
including	include	VBG	B-PP	O
ovary	ovary	NN	B-NP	O
,	,	,	O	O
testis	testis	NN	B-NP	O
,	,	,	O	O
adrenal	adrenal	JJ	B-NP	O
,	,	,	I-NP	O
placenta	placenta	NN	I-NP	O
,	,	,	O	O
thymus	thymus	NN	B-NP	O
,	,	,	O	O
spinal	spinal	JJ	B-NP	O
cord	cord	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
thyroid	thyroid	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
LGR1	BEGIN-LGR1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
muscle	muscle	NN	B-NP	O
,	,	,	O	O
placenta	placenta	NN	B-NP	O
,	,	,	O	O
spinal	spinal	JJ	B-NP	O
cord	cord	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
brain	brain	NN	B-NP	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
purified	purify	VBN	B-NP	O
recombinant	recombinant	JJ	I-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
sis	sis-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
PDGF	BEGIN-PDGF-INSIDE	NN	I-NP	B
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
this	this	DT	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
which	which	WDT	B-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
termed	term	VBN	I-VP	O
SIF	BEGIN-SIF-INSIDE	NN	B-NP	B
,	,	,	O	O
for	for	IN	B-PP	O
sis	BEGIN-sis	NN	B-NP	B
-	-	HYPH	B-NP	I
inducible	inducible	JJ	I-NP	I
factor	factor-INSIDE	NN	I-NP	I

Antinuclear	Antinuclear	JJ	B-NP	O
antibodies	antibody	NNS	I-NP	O
,	,	,	O	O
rheumatoid	BEGIN-rheumatoid	JJ	B-NP	B
factor	factor-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
C	BEGIN-C	NN	I-NP	B
-	-	HYPH	B-NP	I
reactive	reactive	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
women	woman	NNS	I-NP	O
using	use	VBG	B-VP	O
oral	oral	JJ	B-NP	O
contraceptives	contraceptive	NNS	I-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
AChE	BEGIN-AChE-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
tends	tend	VBZ	B-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
in	in	IN	B-PP	O
individuals	individual	NNS	B-NP	O
sampled	sample	VBN	B-VP	O
in	in	IN	B-PP	O
tanks	tank	NNS	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
salinity	salinity	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
per	per	IN	B-PP	O
thousand	thousand	CD	B-NP	O
as	as	IN	B-SBAR	O
temperature	temperature	NN	B-NP	O
increases	increase	NNS	I-NP	O

The	The	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
donor	donor	NN	B-NP	O
status	status	NN	I-NP	O
for	for	IN	B-PP	O
antibody	antibody	NN	B-NP	O
to	to	TO	B-PP	O
hepatitis	BEGIN-hepatitis	NN	B-NP	B
B	B	NN	I-NP	I
core	core	NN	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
A	A	NN	I-NP	O
,	,	,	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
B	B	NN	I-NP	O
posttransfusion	posttransfusion	NN	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
recipient	recipient	NN	I-NP	O
was	be	VBD	B-VP	O
prospectively	prospectively	RB	I-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
open	open	JJ	B-NP	O
-	-	HYPH	I-NP	O
heart	heart	NN	I-NP	O
surgery	surgery	NN	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
surgery	surgery	NN	B-NP	O

Both	Both	CC	O	O
control	control	NN	B-NP	O
and	and	CC	I-NP	O
Mn	Mn	NN	I-NP	O
-	-	HYPH	O	O
exposed	expose	VBN	B-NP	O
quail	quail	NN	I-NP	O
accumulated	accumulate	VBD	B-VP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
times	time	NNS	I-NP	O
more	more	JJR	I-NP	O
Mn	Mn	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
livers	liver	NNS	I-NP	O
than	than	IN	B-PP	O
similarly	similarly	RB	B-NP	O
treated	treat	VBN	I-NP	O
rodents	rodent	NNS	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
mutant	BEGIN-mutant	JJ	B-NP	B
PS1	BEGIN-PS1-INSIDE-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
cause	cause	VB	I-VP	O
disease	disease	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
reduction	reduction	NN	B-NP	O
in	in	IN	B-PP	O
PS1	BEGIN-PS1-INSIDE	NN	B-NP	B
function	function	NN	I-NP	O

In	In	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
phosphorus	phosphorus	NN	B-NP	O
limitation	limitation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
fungus	fungus	NN	I-NP	O
Neurospora	Neurospora	NNP	I-NP	O
crassa	crassa	NN	I-NP	O
synthesizes	synthesize	VBZ	B-VP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	O
that	that	WDT	B-NP	O
function	function	VBP	B-VP	O
to	to	TO	I-VP	O
bring	bring	VB	I-VP	O
more	more	JJR	B-NP	O
phosphate	phosphate	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O

IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
urine	urine	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
pyelonephritis	pyelonephritis	NN	B-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
children	child	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
pretreatment	pretreatment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
competitive	competitive	JJ	I-NP	O
NMDA	NMDA	NN	I-NP	O
antagonist	antagonist	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
MK	MK	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
behavioral	behavioral	JJ	I-NP	O
alterations	alteration	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
restraint	restraint	NN	I-NP	O
stress	stress	NN	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O

Radiation	Radiation	NN	B-NP	O
was	be	VBD	B-VP	O
delivered	deliver	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
mJ	mJ	NN	I-NP	O
pulse	pulse	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
microseconds	microsecond	NNS	I-NP	O
duration	duration	NN	I-NP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
articulated	articulate	VBN	I-NP	O
zirconium	zirconium	NN	I-NP	O
fluoride	fluoride	NN	I-NP	O
optical	optical	JJ	I-NP	O
fibre	fibre	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
microns	micron	NNS	I-NP	O
quartz	quartz	NN	I-NP	O
-	-	HYPH	B-NP	O
fibre	fibre	NN	I-NP	O
tip	tip	NN	I-NP	O

MsEPV	MsEPV	NN	B-NP	O
genes	gene	NNS	I-NP	O
with	with	IN	B-PP	O
putative	putative	JJ	B-NP	O
functions	function	NNS	I-NP	O
in	in	IN	B-PP	O
prevention	prevention	NN	B-NP	O
and	and	CC	I-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
damage	damage	NN	I-NP	O
include	include	VBP	B-VP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
base	base	NN	I-NP	O
excision	excision	NN	I-NP	O
repair	repair	NN	I-NP	O
pathway	pathway	NN	I-NP	O
(	(	(	O	O
uracil	BEGIN-uracil	NN	B-NP	B
DNA	DNA	NN	I-NP	I
glycosylase	glycosylase-INSIDE	NN	I-NP	I
,	,	,	O	O
AP	BEGIN-AP	NN	B-NP	B
endonuclease	endonuclease-INSIDE	NN	I-NP	I
,	,	,	O	O
DNA	BEGIN-DNA	NN	B-NP	B
polymerase	polymerase	NN	I-NP	I
beta	beta-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
NAD+	BEGIN-NAD+	JJ	I-NP	B
-	-	HYPH	I-NP	I
dependent	dependent	JJ	I-NP	I
DNA	DNA	NN	I-NP	I
ligase	ligase-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
photoreactivation	photoreactivation	NN	I-NP	O
repair	repair	NN	I-NP	O
pathway	pathway	NN	I-NP	O
(	(	(	O	O
cyclobutane	BEGIN-cyclobutane	NN	B-NP	B
pyrimidine	pyrimidine	NN	I-NP	I
dimer	dimer	NN	I-NP	I
photolyase	photolyase-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
LINE	BEGIN-LINE	NN	I-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
reverse	reverse	JJ	I-NP	I
transcriptase	transcriptase-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
mutT	BEGIN-mutT	NN	I-NP	B
homologue	homologue-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
olfactory	olfactory	JJ	I-NP	O
cilia	cilia	NN	I-NP	O
certain	certain	JJ	I-NP	O
odorants	odorant	NNS	I-NP	O
elicit	elicit	VBP	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
and	and	CC	I-NP	O
transient	transient	JJ	I-NP	O
cAMP	cAMP	NN	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
terminated	terminate	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
concerted	concerted	JJ	I-NP	O
process	process	NN	I-NP	O
which	which	WDT	B-NP	O
requires	require	VBZ	B-VP	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
protein	protein	NN	I-NP	O
kinases	kinase	NNS	I-NP	O
,	,	,	O	O
protein	BEGIN-protein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
A	A-INSIDE	NN	I-NP	I
(	(	(	O	O
PKA	BEGIN-PKA-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
receptor	BEGIN-receptor	NN	I-NP	B
-	-	HYPH	B-NP	I
specific	specific	JJ	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
GRK1	BEGIN-GRK1-INSIDE	NN	B-NP	B
)	)	)	O	O
(	(	(	O	O
Schleicher	Schleicher	NNP	B-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
,	,	,	O	O
Boekhoff	Boekhoff	NNP	B-NP	O
,	,	,	O	O
I	I	PRP	B-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
corroborate	corroborate	VBP	B-VP	O
the	the	DT	B-NP	O
proposed	proposed	JJ	I-NP	O
physiological	physiological	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
CCoAOMT	BEGIN-CCoAOMT-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
elicited	elicit	VBN	B-NP	O
plant	plant	NN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
shed	shed	VB	I-VP	O
new	new	JJ	B-NP	O
light	light	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
sequential	sequential	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
trans	trans	AFX	B-NP	O
-	-	HYPH	I-NP	O
active	active	JJ	I-NP	O
factors	factor	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
phenylpropanoid	phenylpropanoid	JJ	B-NP	O
genes	gene	NNS	I-NP	O

Two	Two	CD	B-NP	O
hundred	hundred	CD	I-NP	O
and	and	CC	I-NP	O
eighty	eighty	CD	I-NP	O
-	-	HYPH	O	O
three	three	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
females	female	NNS	I-NP	O
(	(	(	O	O
median	median	JJ	B-NP	O
age	age	NN	I-NP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
range	range	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
males	male	NNS	I-NP	O
(	(	(	O	O
median	median	JJ	B-NP	O
age	age	NN	I-NP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
range	range	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O

Pneumatic	Pneumatic	JJ	B-NP	O
dilation	dilation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
esophageal	esophageal	JJ	I-NP	O
sphincter	sphincter	NN	I-NP	O
was	be	VBD	B-VP	O
accomplished	accomplish	VBN	I-VP	O
by	by	IN	B-PP	O
endoscopic	endoscopic	JJ	B-NP	O
visualization	visualization	NN	I-NP	O
and	and	CC	I-NP	O
positioning	positioning	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
polyurethane	polyurethane	NN	I-NP	O
dilator	dilator	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
F	F	NN	I-NP	O
diameter	diameter	NN	I-NP	O
)	)	)	O	O
without	without	IN	B-PP	O
fluoroscopy	fluoroscopy	NN	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
consecutive	consecutive	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
achalasia	achalasia	NN	I-NP	O

The	The	DT	B-NP	O
organotins	organotin	NNS	I-NP	O

A	A	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
mutations	mutation	NNS	B-NP	O
were	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
E1	BEGIN-E1-INSIDE	NN	I-NP	B
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
which	which	WDT	B-NP	O
delete	delete	VBP	B-VP	O
various	various	JJ	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
and	and	CC	I-NP	O
transactivation	transactivation	NN	I-NP	O
domains	domain	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
internal	internal	JJ	I-NP	O
hinge	hinge	NN	I-NP	O
region	region	NN	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
chromatic	chromatic	JJ	B-NP	O
processing	processing	NN	I-NP	O
in	in	IN	B-PP	O
areas	area	NNS	B-NP	O
V1	V1	NN	I-NP	O
and	and	CC	I-NP	O
V1	V1	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
after	after	IN	B-SBAR	O
V1	V1	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
behavioural	behavioural	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
areas	area	NNS	I-NP	O
are	be	VBP	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
basic	basic	JJ	I-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
colour	colour	NN	B-NP	O
perception	perception	NN	I-NP	O

The	The	DT	B-NP	O
Cryotherapy	Cryotherapy	NN	I-NP	O
for	for	IN	B-PP	O
Retinopathy	Retinopathy	NNP	B-NP	O
of	of	IN	B-PP	O
Prematurity	Prematurity	NNP	B-NP	O
Study	Study	NNP	I-NP	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
number	number	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
halved	halve	VBN	I-VP	O
with	with	IN	B-PP	O
treatment	treatment	NN	B-NP	O

The	The	DT	B-NP	O
non	BEGIN-non	NN	I-NP	B
-	-	HYPH	O	I
major	major	JJ	B-NP	I
histocompatibility	histocompatibility	NN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
(	(	(	O	O
MHC	BEGIN-MHC-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	O	O
encoded	encode	VBN	B-NP	O
CD1	BEGIN-CD1	NN	I-NP	B
family	family-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
emerged	emerge	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
antigen	antigen	NN	I-NP	O
-	-	HYPH	O	O
presenting	present	VBG	B-VP	O
system	system	NN	B-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
either	either	CC	O	O
MHC	BEGIN-BEGIN-MHC-INSIDE	NN	B-NP	B
class	class	NN	I-NP	O
I	I	CD	B-NP	O
or	or	CC	O	O
class	class	NN	B-NP	O
II	II	CD	I-NP	O
molecules	molecules-INSIDE	NN	I-NP	I

Nitroglycerin	Nitroglycerin	NN	B-NP	O
(	(	(	O	O
glyceryl	glyceryl	NN	B-NP	O
trinitrate	trinitrate	NN	I-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
monoamine	BEGIN-monoamine	NN	I-NP	B
oxidase	oxidase-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O

Doxazosin	Doxazosin	NNP	B-NP	O
produced	produce	VBD	B-VP	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
mean	mean	JJ	I-NP	O
and	and	CC	I-NP	O
maximum	maximum	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
flow	flow	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	I-NP	O
s	s	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	I-NP	O
s	s	NN	I-NP	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	I-NP	O
s	s	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	I-NP	O
s	s	NN	I-NP	O
on	on	IN	B-PP	O
placebo	placebo	NN	B-NP	O

We	We	PRP	B-NP	O
determined	determine	VBD	B-VP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gypsy	BEGIN-gypsy	JJ	I-NP	B
element	element-INSIDE	NN	I-NP	I
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
forked	BEGIN-forked	JJ	I-NP	B
locus	locus-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
melanogaster	melanogaster	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
f1	f1	NN	I-NP	O
allele	allele	NN	I-NP	O

Cloning	Cloning	NN	B-NP	O
and	and	CC	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
that	that	IN	B-SBAR	O
BUR1	BEGIN-BUR1-INSIDE	NN	B-NP	B
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
homolog	homolog	NN	I-NP	O
of	of	IN	B-PP	O
DRAP1	BEGIN-DRAP1-INSIDE	NN	B-NP	B
(	(	(	O	O
also	also	RB	B-ADVP	O
called	call	VBN	B-VP	O
NC1alpha	BEGIN-NC1alpha-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	O
repressor	repressor	NN	I-NP	O
of	of	IN	B-PP	O
basal	basal	JJ	B-NP	O
transcription	transcription	NN	I-NP	O

The	The	DT	B-NP	O
ATF	BEGIN-ATF-INSIDE	NN	I-NP	B
/	/	SYM	B-VP	O
CRE	CRE	NN	B-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
CD1	BEGIN-CD1	NN	B-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
forskolin	forskolin	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
activator	activator	NN	I-NP	O
of	of	IN	B-PP	O
adenylate	BEGIN-adenylate	NN	B-NP	B
cyclase	cyclase-INSIDE	NN	I-NP	I

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
point	point	VBP	B-VP	O
towards	towards	IN	B-PP	O
post	post	AFX	B-NP	O
-	-	HYPH	I-NP	O
translational	translational	JJ	B-NP	O
steric	steric	JJ	I-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
allosteric	allosteric	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
EKLF	BEGIN-EKLF-INSIDE	NN	B-NP	B
function	function	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
not	not	RB	B-CONJP	O
just	just	RB	I-CONJP	O
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
ability	ability	NN	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
that	that	WDT	B-NP	O
fully	fully	RB	B-ADVP	O
establish	establish	VBP	B-VP	O
the	the	DT	B-NP	O
correct	correct	JJ	I-NP	O
stereospecific	stereospecific	JJ	I-NP	O
array	array	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
efficient	efficient	JJ	B-NP	O
switching	switching	NN	I-NP	O
of	of	IN	B-PP	O
beta	BEGIN-beta	NN	B-NP	B
-	-	HYPH	B-NP	I
globin	globin-INSIDE	NN	I-NP	I
transcription	transcription	NN	I-NP	O
during	during	IN	B-PP	O
development	development	NN	B-NP	O

They	They	PRP	B-NP	O
are	be	VBP	B-VP	O
growth	growth	NN	B-NP	O
-	-	HYPH	O	O
inhibited	inhibit	VBN	B-VP	O
by	by	IN	B-PP	O
TGF	BEGIN-TGF	NN	B-NP	B
-	-	HYPH	O	I
beta1	beta1-INSIDE	NN	B-NP	I

Chronic	Chronic	JJ	B-NP	O
active	active	JJ	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
and	and	CC	I-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O

Colonization	Colonization	NN	B-NP	O
increased	increase	VBD	B-VP	O
with	with	IN	B-PP	O
level	level	NN	B-NP	O
of	of	IN	B-PP	O
care	care	NN	B-NP	O
:	:	:	O	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
in	in	IN	B-PP	O
independent	independent	JJ	B-NP	O
residents	resident	NNS	I-NP	O
of	of	IN	B-PP	O
apartments	apartment	NNS	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
ward	ward	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

Interaction	Interaction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	B-NP	I
rel	rel	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
an	an	DT	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B	NN	I-NP	I
DNA	DNA	NN	I-NP	I
binding	binding	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I

CVO1	CVO1	NN	B-NP	O
saturation	saturation	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
reliable	reliable	JJ	I-NP	O
and	and	CC	I-NP	O
sensitive	sensitive	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
detecting	detect	VBG	B-VP	O
blood	blood	NN	B-NP	O
loss	loss	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Saccharomyces	BEGIN-Saccharomyces	FW	I-NP	B
cerevisiae	cerevisiae	FW	I-NP	I
actin	actin	NN	I-NP	I
intron	intron-INSIDE	NN	I-NP	I
a	a	DT	B-NP	O
silent	silent	JJ	I-NP	O
branch	branch	NN	I-NP	O
point	point	NN	I-NP	O
-	-	HYPH	B-VP	O
like	like	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
(	(	(	O	O
UACUAAG	UACUAAG	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
located	located	JJ	B-NP	O
1	1	CD	I-NP	O
nt	nt	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
canonical	canonical	JJ	I-NP	O
sequence	sequence	NN	I-NP	O

The	The	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
inositol	inositol	NN	B-NP	O
phosphates	phosphate	NNS	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
N	BEGIN-N	NN	B-NP	B
(	(	(	O	I
epi	epi	NN	B-NP	I
)	)	)	O	I
alpha	alpha	NN	B-NP	I
qQ1L	qQ1L-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
carbachol	carbachol	NN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
M1	BEGIN-M1	NN	I-NP	B
muscarinic	muscarinic	JJ	I-NP	I
acetylcholine	acetylcholine	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I

To	To	TO	B-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
circulating	circulate	VBG	B-VP	O
polymorphonuclear	polymorphonuclear	JJ	B-NP	O
neutrophils	neutrophil	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	O
granulocyte	BEGIN-granulocyte	NN	I-NP	B
-	-	HYPH	O	I
macrophage	macrophage	NN	B-NP	I
colony	colony	NN	I-NP	I
-	-	HYPH	O	I
stimulating	stimulate	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
(	(	(	O	O
GM	BEGIN-GM	NN	B-NP	B
-	-	HYPH	B-NP	I
CSF	CSF-INSIDE	NN	I-NP	I
)	)	)	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
protein	protein	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
bodyweight	bodyweight	NN	I-NP	O
s.c.	s.c.	NN	I-NP	O
/	/	SYM	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O

PrRP	BEGIN-PrRP-INSIDE	NN	B-NP	B
rapidly	rapidly	RB	B-VP	O
and	and	CC	I-VP	O
transiently	transiently	RB	I-VP	O
activated	activate	VBN	I-VP	O
extracellular	BEGIN-extracellular	JJ	B-NP	B
signal	signal	NN	I-NP	I
-	-	HYPH	B-NP	I
regulated	regulate	VBN	I-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
ERK	BEGIN-ERK-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
PEG	PEG	NN	B-NP	O
influenced	influence	VBN	B-VP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
drug	drug	NN	I-NP	O
availability	availability	NN	I-NP	O
considerably	considerably	RB	B-ADVP	O
,	,	,	O	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
both	both	CC	O	O
drug	drug	NN	B-NP	O
solubility	solubility	NN	I-NP	O
and	and	CC	O	O
dissolution	dissolution	NN	B-NP	O
rate	rate	NN	I-NP	O

Reversible	Reversible	JJ	B-NP	O
topology	topology	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
bifunctional	bifunctional	JJ	I-NP	O
transmembrane	transmembrane	JJ	I-NP	O
protein	protein	NN	I-NP	O
depends	depend	VBZ	B-VP	O
upon	upon	IN	B-PP	O
the	the	DT	B-NP	O
charge	charge	NN	I-NP	O
balance	balance	NN	I-NP	O
around	around	IN	B-PP	O
its	its	PRP$	B-NP	O
transmembrane	transmembrane	JJ	I-NP	O
domain	domain	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
documented	document	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
that	that	IN	B-SBAR	O
glucocorticoid	glucocorticoid	NN	B-NP	O
hormones	hormone	NNS	I-NP	O
modulate	modulate	VBP	B-VP	O
the	the	DT	B-NP	O
posttranslational	posttranslational	JJ	I-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
surface	surface	NN	I-NP	O
mouse	mouse	NN	I-NP	O
mammary	mammary	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
MMTV	MMTV	NN	B-NP	O
)	)	)	O	O
glycoproteins	glycoprotein	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
-	-	HYPH	I-NP	O
infected	infected	JJ	I-NP	O
M1	M1	NN	I-NP	O
rat	rat	NN	I-NP	O
HTC	HTC	NN	I-NP	O
hepatoma	hepatoma	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O

Contrast	Contrast	NN	B-NP	O
radiography	radiography	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
especially	especially	RB	I-NP	O
inaccurate	inaccurate	JJ	I-NP	O
method	method	NN	I-NP	O
to	to	TO	B-VP	O
document	document	VB	I-VP	O
PUD	PUD	NN	B-NP	O
in	in	IN	B-PP	O
CF	CF	NN	B-NP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
duodenal	duodenal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
typically	typically	RB	B-ADVP	O
appears	appear	VBZ	B-VP	O
nodular	nodular	JJ	B-NP	O
and	and	CC	I-NP	O
distorted	distorted	JJ	I-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
definition	definition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
folds	fold	NNS	I-NP	O

Spodoptera	Spodoptera	NN	B-NP	O
frugiperda	frugiperda	NN	I-NP	O
(	(	(	O	O
Sf1	Sf1	NN	B-NP	O
)	)	)	I-NP	O
cells	cell	NNS	I-NP	O
have	have	VBP	B-VP	O
proved	prove	VBN	I-VP	O
a	a	DT	B-NP	O
suitable	suitable	JJ	I-NP	O
cell	cell	NN	I-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
this	this	DT	B-NP	O
association	association	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
recombinant	BEGIN-recombinant	JJ	B-NP	B
CR1	CR1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
another	another	DT	B-NP	O
lepidopteran	lepidopteran	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
Trichoplusia	Trichoplusia	NN	B-NP	O
niTN	niTN	NN	I-NP	O
-	-	HYPH	B-NP	O
1B1	1B1	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
High	High	JJ	B-NP	O
-	-	HYPH	I-NP	O
Five	Five	CD	I-NP	O
)	)	)	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
allows	allow	VBZ	B-VP	O
the	the	DT	B-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
functional	BEGIN-functional	JJ	B-NP	B
recombinant	BEGIN-recombinant	JJ	I-NP	B
CR1	CR1-INSIDE-INSIDE	NN	I-NP	I

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
standard	standard	JJ	I-NP	O
scoring	scoring	NN	I-NP	O
,	,	,	O	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
full	full	JJ	B-NP	O
scale	scale	NN	I-NP	O
IQ	IQ	NN	I-NP	O
<	<	SYM	B-VP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Wechsler	Wechsler	NNP	I-NP	O
Preschool	Preschool	NNP	I-NP	O
and	and	CC	O	O
Primary	Primary	NNP	B-NP	O
Scale	Scale	NNP	I-NP	O
of	of	IN	B-PP	O
Intelligence	Intelligence	NNP	B-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
were	be	VBD	B-VP	O
poorly	poorly	RB	I-VP	O
identified	identify	VBN	I-VP	O
(	(	(	O	O
sensitivity	sensitivity	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
composite	composite	JJ	I-NP	O
S	S	NN	I-NP	O
-	-	HYPH	B-NP	O
B	B	NN	I-NP	O
IV	IV	CD	I-NP	O
score	score	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
1	1	CD	I-NP	O

The	The	DT	B-NP	O
relation	relation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
density	density	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
calcium	calcium	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
phosphorus	phosphorus	NN	I-NP	O
and	and	CC	O	O
alkaline	BEGIN-alkaline	NN	B-NP	B
phosphatase	phosphatase-INSIDE	NN	I-NP	I
(	(	(	O	O
AKP	BEGIN-AKP-INSIDE	NN	B-NP	B
)	)	)	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
metabolism	metabolism	NN	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O

To	To	TO	B-VP	O
clarify	clarify	VB	I-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GTP	BEGIN-GTP	NN	I-NP	B
cyclohydrolase	cyclohydrolase	NN	I-NP	I
I	I	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
and	and	CC	O	O
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
multiple	multiple	JJ	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
clones	clone	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
and	and	CC	I-NP	O
mouse	mouse	NN	I-NP	O
GTP	BEGIN-GTP	NN	I-NP	B
cyclohydrolase	cyclohydrolase	NN	I-NP	I
I	I	CD	B-NP	I
genes	gene-INSIDE	NNS	I-NP	I

Perception	Perception	NN	B-NP	O
of	of	IN	B-PP	O
sweetness	sweetness	NN	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
accurately	accurately	RB	I-VP	O
meter	meter	VB	I-VP	O
the	the	DT	B-NP	O
metabolizable	metabolizable	JJ	I-NP	O
energy	energy	NN	I-NP	O
or	or	CC	O	O
nutritive	nutritive	JJ	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
food	food	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
termination	termination	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
specific	specific	JJ	I-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
not	not	RB	O	O
merely	merely	RB	B-ADVP	O
a	a	DT	B-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
stability	stability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
EC	EC	NNP	I-NP	O

All	All	DT	B-NP	O
sows	sow	NNS	I-NP	O
nursed	nurse	VBD	B-VP	O
nine	nine	CD	B-NP	O
pigs	pig	NNS	I-NP	O

When	When	WRB	B-ADVP	O
labeled	label	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
described	describe	VBN	I-NP	O
method	method	NN	I-NP	O
,	,	,	O	O
1mTc	1mTc	NN	B-NP	O
on	on	IN	B-PP	O
DTPA	DTPA	NN	B-NP	O
coupled	couple	VBN	I-NP	O
antibodies	antibody	NNS	I-NP	O
shows	show	VBZ	B-VP	O
instability	instability	NN	B-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
but	but	CC	O	O
superior	superior	JJ	B-NP	O
stability	stability	NN	I-NP	O
than	than	IN	B-PP	O
1mTc	1mTc	NN	B-NP	O
on	on	IN	B-PP	O
antibodies	antibody	NNS	B-NP	O
without	without	IN	B-PP	O
the	the	DT	B-NP	O
attached	attach	VBN	I-NP	O
DTPA	DTPA	NN	I-NP	O

The	The	DT	B-NP	O
crystal	crystal	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
Phe	BEGIN-Phe	NN	I-NP	B
-	-	HYPH	B-NP	I
tRNAPhe	tRNAPhe	NN	I-NP	I
ternary	ternary	JJ	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
Thermus	Thermus	NN	B-NP	O
aquaticus	aquaticus	NN	I-NP	O
EF	BEGIN-EF	NN	I-NP	B
-	-	HYPH	B-NP	I
Tu	Tu-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
GDPNP	GDPNP	NN	I-NP	O
(	(	(	O	O
Phe	BEGIN-Phe	NN	B-NP	B
-	-	HYPH	B-NP	I
TC	TC-INSIDE	NN	I-NP	I
)	)	)	O	O
has	have	VBZ	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
determined	determine	VBN	I-VP	O
as	as	IN	B-PP	O
one	one	CD	B-NP	O
representative	representative	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
general	general	JJ	I-NP	O
yet	yet	CC	O	O
highly	highly	RB	B-VP	O
discriminating	discriminate	VBG	I-VP	O
complex	complex	NN	B-NP	O
formation	formation	NN	I-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
GCN1	BEGIN-GCN1-INSIDE	NN	B-NP	B
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
activation	activation	NN	I-NP	O
domains	domain	NNS	I-NP	O
of	of	IN	B-PP	O
similar	similar	JJ	B-NP	O
potency	potency	NN	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
function	function	VB	I-VP	O
independently	independently	RB	B-ADVP	O
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
level	level	NN	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
genes	gene	NNS	I-NP	O
HIS1	BEGIN-HIS1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
HIS1	BEGIN-HIS1-INSIDE	NN	I-NP	B

U.S.A	U.S.A	NN	B-NP	O

Human	BEGIN-Human	JJ	B-NP	B
plastin	plastin	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I

Role	Role	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CCAAT	BEGIN-CCAAT	NN	I-NP	B
/	/	SYM	B-VP	I
enhancer	enhancer	NN	B-NP	I
binding	binding	NN	I-NP	I
protein	protein	NN	I-NP	I
-	-	HYPH	B-VP	I
alpha	alpha	SYM	B-NP	I
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
p1waf1	BEGIN-p1waf1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
cip1	BEGIN-cip1-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
growth	growth	NN	B-NP	O
-	-	HYPH	O	O
arrested	arrest	VBN	B-NP	O
rat	rat	NN	I-NP	O
hepatoma	hepatoma	NN	I-NP	O
cells	cell	NNS	I-NP	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
p1RB1	BEGIN-p1RB1	NN	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
but	but	CC	O	O
intact	intact	JJ	B-ADJP	O
in	in	IN	B-PP	O
E1a	BEGIN-E1a-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
large	BEGIN-large	JJ	I-NP	B
T	T	NN	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
properties	property	NNS	I-NP	O
,	,	,	O	O
represses	repress	VBZ	B-VP	O
EIIaE	BEGIN-EIIaE-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
fold	fold	RB	B-NP	O
greater	great	JJR	I-NP	O
efficiency	efficiency	NN	I-NP	O
than	than	IN	B-PP	O
wild	BEGIN-wild	JJ	B-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
p1RB1	p1RB1-INSIDE	NN	I-NP	I

For	For	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
stimuli	stimulus	NNS	I-NP	O
,	,	,	O	O
P1	P1	NN	B-NP	O
amplitude	amplitude	NN	I-NP	O
and	and	CC	I-NP	O
latency	latency	NN	I-NP	O
were	be	VBD	B-VP	O
negatively	negatively	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
and	and	CC	O	O
most	most	RBS	B-VP	O
tightly	tightly	RB	I-VP	O
coupled	couple	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
frontal	frontal	JJ	I-NP	O
-	-	HYPH	I-NP	O
central	central	JJ	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
medial	medial	JJ	I-NP	O
/	/	SYM	I-NP	O
lateral	lateral	JJ	I-NP	O
recording	record	VBG	I-NP	O
sites	site	NNS	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
characterized	characterize	VBN	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
cDNA	cDNA	NN	I-NP	O
,	,	,	O	O
1k	1k	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
potentially	potentially	RB	B-VP	O
encoding	encode	VBG	I-VP	O
a	a	DT	B-NP	O
tobacco	BEGIN-tobacco	NN	I-NP	B
1	1	CD	I-NP	I
kDa	kDa	NN	I-NP	I
chloroplast	chloroplast	NN	I-NP	I
RNP	RNP	NN	I-NP	I
(	(	(	O	I
cp1	cp1	NN	B-NP	I
)	)	)	O	I
homologue	homologue-INSIDE	NN	B-NP	I

Though	Though	IN	B-SBAR	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
established	establish	VBN	I-VP	O
that	that	IN	B-SBAR	O
skinfold	skinfold	JJ	B-NP	O
anthropometry	anthropometry	NN	I-NP	O
has	have	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
limitations	limitation	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
deriving	derive	VBG	B-VP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
fat	fat	NN	I-NP	O
(	(	(	O	O
TBF	TBF	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
problem	problem	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
more	more	JJR	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
assumptions	assumption	NNS	I-NP	O
implicit	implicit	VBP	B-VP	O
in	in	IN	B-PP	O
densitometry	densitometry	NN	B-NP	O
has	have	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
addressed	address	VBN	I-VP	O

Gene	BEGIN-Gene	NN	B-NP	B
GPR	GPR	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
localized	localize	VBN	I-VP	O
by	by	IN	B-PP	O
radiation	radiation	NN	B-NP	O
hybrid	hybrid	NN	I-NP	O
mapping	map	VBG	B-VP	O
to	to	TO	B-PP	O
chromosome	chromosome	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
cR	cR	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
WI	WI	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
marker	marker	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
proximal	proximal	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hereditary	BEGIN-hereditary	JJ	I-NP	B
sensory	sensory	JJ	I-NP	I
neuropathy	neuropathy	NN	I-NP	I
type	type	NN	I-NP	I
1	1	CD	I-NP	I
locus	locus-INSIDE	NN	I-NP	I

A	A	DT	B-NP	O
)	)	)	O	O
During	During	IN	B-PP	O
O1	O1	NN	B-NP	O
-	-	HYPH	O	O
ischemia	ischemia	NN	B-NP	O
both	both	CC	O	O
extracellular	extracellular	JJ	B-NP	O
[	[	(	O	O
K+	K+	NN	B-NP	O
]	]	)	O	O
and	and	CC	O	O
change	change	NN	B-NP	O
of	of	IN	B-PP	O
pH	pH	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subepicardium	subepicardium	NN	I-NP	O
are	be	VBP	B-VP	O
significantly	significantly	RB	B-ADJP	O
less	less	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
midmyocardium	midmyocardium	NN	I-NP	O

Some	Some	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
responses	response	NNS	I-NP	O
are	be	VBP	B-VP	O
regulated	regulate	VBN	I-VP	O
via	via	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
activator	BEGIN-activator	NN	B-NP	B
protein	protein	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
AP	BEGIN-AP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
(	(	(	O	O
CBF	BEGIN-CBF	NN	B-NP	B
-	-	HYPH	B-NP	I
A	A-INSIDE	NN	I-NP	I
)	)	)	O	O
encoding	encode	VBG	B-VP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
(	(	(	O	O
aa	aa	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	I-NP	I
galactosidase	galactosidase	NN	I-NP	I
fusion	fusion	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
bacterially	bacterially	RB	B-VP	O
produced	produce	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
,	,	,	O	O
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	O
fragments	fragment	NNS	I-NP	O
containing	contain	VBG	B-VP	O
several	several	JJ	B-NP	O
CArG	CArG	NN	I-NP	O
boxes	box	NNS	I-NP	O

Alveoli	Alveoli	AFX	B-NP	O
-	-	HYPH	I-NP	O
capillary	capillary	JJ	B-NP	O
diffusion	diffusion	NN	I-NP	O

The	The	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	I-NP	O
other	other	JJ	I-NP	O
Chi1	BEGIN-Chi1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Chi1	BEGIN-Chi1-INSIDE	NN	I-NP	B
chimeric	chimeric	JJ	I-NP	O
promoters	promoter	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
E	BEGIN-E	NN	I-NP	B
-	-	HYPH	O	I
region	region-INSIDE	NN	B-NP	I
contains	contain	VBZ	B-VP	O
cis	cis	NN	B-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O
which	which	WDT	B-NP	O
activate	activate	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
in	in	IN	B-PP	O
aleurone	aleurone	NN	B-NP	O
and	and	CC	I-NP	O
silence	silence	NN	I-NP	O
transcription	transcription	NN	I-NP	O
in	in	IN	B-PP	O
leaves	leaf	NNS	B-NP	O

Interobserver	Interobserver	NN	B-NP	O
agreement	agreement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Nottingham	Nottingham	NNP	I-NP	O
histologic	histologic	JJ	I-NP	O
grading	grading	NN	I-NP	O
scheme	scheme	NN	I-NP	O
for	for	IN	B-PP	O
infiltrating	infiltrate	VBG	B-VP	O
duct	duct	NN	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
breast	breast	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
determination	determination	NN	I-NP	O
and	and	CC	I-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	O
FbDP	BEGIN-FbDP-INSIDE	NN	I-NP	B
alone	alone	RB	B-ADVP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
thrombolytic	thrombolytic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transmembrane	transmembrane	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
HN	BEGIN-HN-INSIDE	NN	B-NP	B
on	on	IN	B-PP	O
fusion	fusion	NN	B-NP	O
-	-	HYPH	O	O
promoting	promote	VBG	B-VP	O
activity	activity	NN	B-NP	O
,	,	,	O	O
mutant	BEGIN-mutant	JJ	B-NP	B
HN	BEGIN-HN-INSIDE	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
biological	biological	JJ	I-NP	O
activities	activity	NNS	I-NP	O
examined	examine	VBN	B-VP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
transgene	transgene	NN	B-NP	O
expression	expression	NN	I-NP	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
and	and	CC	I-NP	O
mouse	BEGIN-mouse	JJ	I-NP	B
Rb	BEGIN-Rb-INSIDE	NN	I-NP	I
promoters	promoters-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
tissues	tissue	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
Rb	BEGIN-Rb-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
normally	normally	RB	I-VP	O
expressed	express	VBN	I-VP	O
during	during	IN	B-PP	O
embryogenesis	embryogenesis	NN	B-NP	O

The	The	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
is	be	VBZ	B-VP	O
predicted	predict	VBN	I-VP	O
to	to	TO	I-VP	O
encode	encode	VB	I-VP	O
a	a	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Y	BEGIN-Y	NN	I-NP	B
-	-	HYPH	B-NP	I
box	box	NN	I-NP	I
(	(	(	O	I
inverted	invert	VBN	B-NP	I
CCAAT	CCAAT	NN	I-NP	I
)	)	)	O	I
family	family	NN	B-NP	I
of	of	IN	B-PP	I
DNA	DNA	NN	B-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
transcription	transcription	NN	B-NP	I
factors	factors-INSIDE	NN	I-NP	I

RAP	BEGIN-RAP-INSIDE	NN	B-NP	B
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
target	target	NN	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
RIP	BEGIN-RIP-INSIDE	NN	B-NP	B
and	and	CC	O	O
inhibitory	inhibitory	JJ	B-NP	O
AIPs	BEGIN-AIPs-INSIDE	NN	I-NP	B
as	as	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
molecules	molecule	NNS	I-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
and	and	CC	I-VP	O
suppress	suppress	VB	I-VP	O
S.	S.	NNP	B-NP	O
aureus	aureus	NN	I-NP	O
infections	infection	NNS	I-NP	O

First	First	RB	B-ADVP	O
,	,	,	O	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IFNgamma	BEGIN-IFNgamma	NN	I-NP	B
-	-	HYPH	O	I
activated	activate	VBN	B-VP	I
sequence	sequence-INSIDE	NN	B-NP	I
(	(	(	O	O
GAS	BEGIN-GAS-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
either	either	CC	O	O
multimerized	multimerized	JJ	B-ADJP	O
or	or	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	O	I
kb	kb	NN	B-NP	I
IRF	BEGIN-IRF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
a	a	DT	B-NP	O
PRL	BEGIN-PRL-INSIDE	NN	I-NP	B
response	response	NN	I-NP	O
,	,	,	O	O
showing	show	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
IRF	BEGIN-IRF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
GAS	BEGIN-GAS-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
of	of	IN	B-PP	O
PRL	BEGIN-PRL-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
both	both	CC	O	O
RAR	BEGIN-RAR-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
RXR	BEGIN-RXR-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
specific	specific	JJ	B-NP	O
ligands	ligand	NNS	I-NP	O
increase	increase	VBP	B-VP	O
CaSki	CaSki	NNP	B-NP	O
number	number	NN	I-NP	O
by	by	IN	B-PP	O
>	>	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O

Tight	Tight	NN	B-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
band	band	NN	B-NP	O
structure	structure	NN	I-NP	O
calculations	calculation	NNS	I-NP	O
for	for	IN	B-PP	O
beta	beta	SYM	O	O
-	-	HYPH	O	O
MNX	MNX	NN	B-NP	O
(	(	(	O	O
M	M	NN	B-NP	O
=	=	SYM	B-VP	O
Zr	Zr	NN	B-NP	O
,	,	,	O	O
X	X	NN	B-NP	O
=	=	SYM	B-VP	O
Cl	Cl	NN	B-NP	O
,	,	,	O	O
Br	Br	NNP	B-NP	O
;	;	:	O	O
M	M	NN	B-NP	O
=	=	SYM	B-VP	O
Hf	Hf	NN	B-NP	O
,	,	,	O	O
X	X	NN	B-NP	O
=	=	SYM	B-VP	O
Cl	Cl	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
ZrCl	ZrCl	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Y	Y	NN	B-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
C	C	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
Br	Br	NNP	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
reported	report	VBN	I-VP	O

The	The	DT	B-NP	O
same	same	JJ	I-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
sequence	sequence	NN	B-NP	O
homology	homology	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
F.	F.	NNP	I-NP	O
diplosiphon	diplosiphon	NN	I-NP	O
PC	BEGIN-PC	NN	I-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
and	and	CC	O	O
PC	BEGIN-PC	NN	B-NP	B
beta	beta	NN	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
(	(	(	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
at	at	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
and	and	CC	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
similar	similar	JJ	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
for	for	IN	B-PP	O
interspecies	interspecy	NNS	B-NP	O
comparisons	comparison	NNS	I-NP	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
Id1	BEGIN-Id1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
Sertoli	Sertoli	NNP	B-NP	O
cells	cell	NNS	I-NP	O
is	be	VBZ	B-VP	O
only	only	RB	B-ADJP	O
detectable	detectable	JJ	I-ADJP	O
after	after	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
FSH	BEGIN-FSH-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
cAMP	cAMP	NN	I-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
between	between	IN	B-PP	O
Sxl	BEGIN-Sxl-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Snf	BEGIN-Snf-INSIDE	NN	I-NP	B
,	,	,	O	O
we	we	PRP	B-NP	O
present	present	VBP	B-VP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
Sxl	BEGIN-Sxl-INSIDE	NN	B-NP	B
splicing	splicing	NN	I-NP	O
regulation	regulation	NN	I-NP	O

It	It	PRP	B-NP	O
thus	thus	RB	B-ADVP	O
seems	seem	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
genistein	genistein	NN	B-NP	O
affects	affect	VBZ	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
downstream	downstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
signals	signal	NNS	I-NP	O

LiF	LiF	NN	B-NP	O
thermoluminescence	thermoluminescence	NN	I-NP	O
dosimeters	dosimeter	NNS	I-NP	O
(	(	(	O	O
TLD	TLD	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
chip	chip	NN	B-NP	O
form	form	NN	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
onto	onto	IN	B-NP	O
1	1	CD	I-NP	O
eyelid	eyelid	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
thyroid	thyroid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
clothes	clothe	NNS	I-NP	O
covering	cover	VBG	B-VP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
breasts	breast	NNS	B-NP	O
and	and	CC	I-NP	O
ovaries	ovary	NNS	I-NP	O
of	of	IN	B-PP	O
female	female	JJ	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
testicles	testicle	NNS	I-NP	O
of	of	IN	B-PP	O
male	male	JJ	B-NP	O
patients	patient	NNS	I-NP	O

Several	Several	JJ	B-NP	O
positive	positive	JJ	I-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
encoded	encode	VBD	B-VP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
RNA	BEGIN-RNA	NN	I-NP	B
helicase	helicase-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
DEAD	BEGIN-DEAD	NN	I-NP	B
box	box	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
designated	designate	VBN	B-VP	O
DDX1	BEGIN-DDX1-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
related	related	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
suppressor	suppressor	NN	I-NP	O
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
also	also	RB	B-ADVP	O
effects	effect	NNS	B-NP	O
this	this	DT	B-NP	O
function.	function.	NN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
increase	increase	VBP	B-VP	O
substantially	substantially	RB	B-ADVP	O
as	as	IN	B-SBAR	O
cells	cell	NNS	B-NP	O
progress	progress	VBP	B-VP	O
through	through	IN	B-PP	O
S	S	NN	B-NP	O
phase.	phase.	NN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
E1F	BEGIN-E1F-INSIDE	NN	B-NP	B
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
primarily	primarily	RB	B-ADVP	O
in	in	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
cells	cell	NNS	I-NP	O
coincident	coincident	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
p1	BEGIN-BEGIN-p1-INSIDE	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
observations	observation	NNS	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
cTnC	BEGIN-cTnC	NN	I-NP	B
1'Ile	1'Ile	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
composite	composite	JJ	I-NP	O
enhancer	enhancer	NN	I-NP	O
that	that	WDT	B-NP	O
functions	function	VBZ	B-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
combined	combined	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
of	of	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
five	five	CD	I-NP	O
regulatory	regulatory	JJ	I-NP	O
elements	element	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
cognate	cognate	JJ	I-NP	O
binding	binding	NN	I-NP	O
factors	factor	NNS	I-NP	O
:	:	:	O	O
three	three	CD	B-NP	O
or	or	CC	I-NP	O
four	four	CD	I-NP	O
E	E	NN	I-NP	O
-	-	HYPH	I-NP	O
boxes	box	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
MEF	BEGIN-MEF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
site	site-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
MEF	BEGIN-MEF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
site	site-INSIDE	NN	I-NP	I

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
secreted	secrete	VBN	I-NP	O
,	,	,	I-NP	O
truncated	truncate	VBN	I-NP	O
receptor	receptor	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	O	I
kb	kb	NN	B-NP	I
c	c	NN	I-NP	I
-	-	HYPH	B-NP	I
erbB	erbB	NN	I-NP	I
transcript	transcript-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
TGF	BEGIN-TGF	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
and	and	CC	O	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
growth	growth	NN	I-NP	O
-	-	HYPH	I-NP	O
regulatory	regulatory	JJ	I-NP	O
function	function	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
paper	paper	NN	I-NP	O
we	we	PRP	B-NP	O
review	review	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
on	on	IN	B-PP	O
smoking	smoking	NN	B-NP	O
and	and	CC	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
among	among	IN	B-PP	O
Latinos	Latino	NNS	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
findings	finding	NNS	B-NP	O
from	from	IN	B-PP	O
several	several	JJ	B-NP	O
unpublished	unpublished	JJ	I-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
technical	technical	JJ	B-NP	O
reports	report	NNS	I-NP	O

Although	Although	IN	B-SBAR	O
several	several	JJ	B-NP	O
large	large	JJ	I-NP	O
waterborne	waterborne	NN	I-NP	O
outbreaks	outbreak	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
decade	decade	NN	I-NP	O
,	,	,	O	O
most	most	JJS	B-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
small	small	JJ	B-NP	O
communities	community	NNS	I-NP	O

Many	Many	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
thiazide	thiazide	NN	B-NP	O
diuretics	diuretic	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
doses	dose	NNS	I-NP	O

Uptake	Uptake	NN	B-NP	O
of	of	IN	B-PP	O
colicins	BEGIN-colicins-INSIDE	NN	B-NP	B
required	require	VBD	B-VP	O
different	different	JJ	B-NP	O
domains	domain	NNS	I-NP	O
in	in	IN	B-PP	O
TonB	BEGIN-TonB-INSIDE	NN	B-NP	B
,	,	,	O	O
for	for	IN	B-PP	O
colicin	BEGIN-colicin	NN	B-NP	B
B	B	NN	I-NP	I
and	and	CC	O	I
M	M-INSIDE	NN	B-NP	I
around	around	IN	B-PP	O
residue	residue	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
for	for	IN	B-PP	O
colicin	BEGIN-colicin	NN	B-NP	B
Ia	Ia-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
domain	domain	NN	I-NP	O
closer	closer	RBR	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
end	end	NN	I-NP	O

A	A	DT	B-NP	O
phase	phase	NN	I-NP	O
II	II	CD	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
interferon	BEGIN-interferon	NN	B-NP	B
-	-	HYPH	B-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
,	,	,	O	O
interleukin	BEGIN-interleukin	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
fluorouracil	fluorouracil	NN	I-NP	O
in	in	IN	B-PP	O
advanced	advance	VBN	B-NP	O
renal	renal	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
:	:	:	O	O
clinical	clinical	JJ	B-NP	O
data	datum	NNS	I-NP	O
and	and	CC	O	O
laboratory	laboratory	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
protease	protease	NN	B-NP	O
activation	activation	NN	I-NP	O

Three	Three	CD	B-NP	O
putative	putative	JJ	I-NP	O
ORFs	ORF	NNS	I-NP	O
have	have	VBP	B-VP	O
significant	significant	JJ	B-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
:	:	:	O	O
L1	BEGIN-L1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
very	very	RB	I-NP	O
large	large	JJ	I-NP	O
'seripauperins'	BEGIN-'seripauperins'-INSIDE	NN	I-NP	B
family	family	NN	I-NP	O
,	,	,	O	O
comprising	comprise	VBG	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
yeast	yeast	NN	I-NP	O
members	member	NNS	I-NP	O
;	;	:	O	O
L1	BEGIN-L1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
ABC	BEGIN-ABC	NNP	I-NP	B
transporter	transporter-INSIDE	NN	I-NP	I
highly	highly	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
cadmium	cadmium	NN	I-NP	O
resistance	resistance	NN	I-NP	O
protein	protein	NN	I-NP	O
Ycf1p	BEGIN-Ycf1p-INSIDE	NN	I-NP	B
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
multidrug	multidrug	JJ	I-NP	I
resistance	resistance	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
hMRP1	BEGIN-hMRP1-INSIDE	NN	I-NP	B
;	;	:	O	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
L1	BEGIN-L1-INSIDE	NN	B-NP	B
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
sequence	sequence	NN	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
fruit	fruit	NN	I-NP	O
fly	fly	NN	I-NP	O
abdominal	abdominal	JJ	I-NP	O
segment	segment	NN	I-NP	O
formation	formation	NN	I-NP	O
protein	protein	NN	I-NP	O
Pumilio	BEGIN-Pumilio-INSIDE	NN	I-NP	B

Previously	Previously	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
reported	report	VBD	B-VP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kD	kD	NN	I-NP	O
protein	protein	NN	I-NP	O
that	that	WDT	B-NP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
zyxin	BEGIN-zyxin-INSIDE	NN	B-NP	B
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
(	(	(	O	O
Sadler	Sadler	NNP	B-NP	O
et	et	FW	I-NP	O
al.	al.	FW	I-NP	O
,	,	,	O	O
1	1	LS	B-LST	O
)	)	)	O	O

Most	Most	RBS	B-ADVP	O
significantly	significantly	RB	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
cyclin	BEGIN-cyclin	NN	I-NP	B
E	E-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
Cdk1	BEGIN-Cdk1-INSIDE	NN	I-NP	B
complex	complex	NN	I-NP	O
is	be	VBZ	B-VP	O
maximally	maximally	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
G1	G1	NN	I-NP	O
/	/	SYM	B-NP	O
S	S	NN	I-NP	O
transition	transition	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
decreases	decrease	VBZ	B-VP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
it	it	PRP	B-NP	O
takes	take	VBZ	B-VP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
to	to	TO	B-PP	O
complete	complete	JJ	B-NP	O
G1	G1	NN	I-NP	O
and	and	CC	I-NP	O
enter	enter	NN	I-NP	O
S	S	NN	I-NP	O
phase	phase	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
FRS1	BEGIN-FRS1-INSIDE	NN	B-NP	B
forms	form	VBZ	B-VP	O
a	a	DT	B-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
N	BEGIN-N	NN	I-NP	B
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
SH1	SH1	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
tyrosine	tyrosine	NN	I-NP	I
phosphatase	phosphatase	NN	I-NP	I
Shp1	Shp1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
FGF	BEGIN-FGF-INSIDE	NN	B-NP	B
stimulation	stimulation	NN	I-NP	O

In	In	IN	B-PP	O
static	static	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
body	body	NN	B-NP	O
sway	sway	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
force	force	NN	I-NP	O
platform	platform	NN	I-NP	O
with	with	IN	B-PP	O
eyes	eye	NNS	B-NP	O
open	open	JJ	B-ADJP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
eyes	eye	NNS	B-NP	O
closed	close	VBD	B-VP	O

Antiserum	Antiserum	NN	B-NP	O
raised	raise	VBN	B-VP	O
against	against	IN	B-PP	O
rat	BEGIN-rat	NN	B-NP	B
liver	liver	NN	I-NP	I
S1	BEGIN-S1	NN	I-NP	B
kinase	kinase-INSIDE-INSIDE	NN	I-NP	I
specifically	specifically	RB	B-ADVP	O
immunoprecipitates	immunoprecipitate	VBZ	B-VP	O
the	the	DT	B-NP	O
purified	purify	VBN	I-NP	O
1P	1P	NN	I-NP	O
-	-	HYPH	B-VP	O
labeled	label	VBN	B-NP	O
H1	H1	NN	I-NP	O
hepatoma	hepatoma	NN	I-NP	O
insulin	insulin	NN	I-NP	O
-	-	HYPH	B-VP	O
stimulated	stimulate	VBN	B-NP	O
S1	BEGIN-S1	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I

In	In	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
SHIP	BEGIN-SHIP-INSIDE	NN	B-NP	B
catalyzes	catalyze	VBZ	B-VP	O
the	the	DT	B-NP	O
conversion	conversion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phosphoinositide	BEGIN-phosphoinositide	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
PI1K	BEGIN-PI1K-INSIDE	NN	B-NP	B
)	)	)	O	O
product	product	NN	B-NP	O
phosphatidylinositol	phosphatidylinositol	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
trisphosphate	trisphosphate	NN	I-NP	O
(	(	(	O	O
PIP1	PIP1	NN	B-NP	O
)	)	)	O	O
into	into	IN	B-PP	O
phosphatidylinositol	phosphatidylinositol	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bisphosphate	bisphosphate	NN	I-NP	O

A	A	DT	B-NP	O
species	species	NN	I-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	O
sequences	sequence	NNS	I-NP	O
and	and	CC	O	O
isolation	isolation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
clone	clone	NN	I-NP	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intensity	intensity	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
evoked	evoke	VBN	B-VP	O
by	by	IN	B-PP	O
heat	heat	NN	B-NP	O
is	be	VBZ	B-VP	O
relatively	relatively	RB	B-ADJP	O
exhaustive	exhaustive	JJ	I-ADJP	O
:	:	:	O	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
local	local	JJ	I-NP	O
,	,	,	I-NP	O
stimulus	stimulus	NN	I-NP	O
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
or	or	CC	I-NP	O
general	general	JJ	I-NP	O
factors	factor	NNS	I-NP	O
upon	upon	IN	B-PP	O
threshold	threshold	NN	B-NP	O
values	value	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
studied	study	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
has	have	VBZ	B-VP	O
the	the	DT	B-NP	O
relation	relation	NN	I-NP	O
between	between	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
stimulus	stimulus	NN	I-NP	O
intensities	intensity	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
they	they	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
cross	cross	AFX	I-NP	O
-	-	HYPH	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
quinolone	quinolone	NN	B-NP	O
,	,	,	O	O
josamycin	josamycin	NN	B-NP	O
and	and	CC	O	O
tylosin	tylosin	NN	B-NP	O

A	A	DT	B-NP	O
search	search	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
for	for	IN	B-PP	O
suppressors	suppressor	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inositol	inositol	NN	I-NP	O
auxotrophic	auxotrophic	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ino1	BEGIN-ino1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	O

Diabetic	Diabetic	JJ	B-NP	O
osteopathy	osteopathy	NN	I-NP	O

A	A	DT	B-NP	O
simple	simple	JJ	I-NP	O
technique	technique	NN	I-NP	O
for	for	IN	B-PP	O
obtaining	obtain	VBG	B-VP	O
ultra	ultra	AFX	B-NP	O
-	-	HYPH	I-NP	O
thin	thin	JJ	I-NP	O
sections	section	NNS	I-NP	O
of	of	IN	B-PP	O
coccidian	coccidian	JJ	B-NP	O
oocysts	oocyst	NNS	I-NP	O
is	be	VBZ	B-VP	O
reported	report	VBN	I-VP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
,	,	,	O	O
taken	take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
CRF	BEGIN-CRF-INSIDE	NN	B-NP	B
produces	produce	VBZ	B-VP	O
its	its	PRP$	B-NP	O
behavioral	behavioral	JJ	I-NP	O
activating	activate	VBG	I-NP	O
and	and	CC	I-NP	O
anxiogenic	anxiogenic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
LC	LC	NN	B-NP	O
noradrenergic	noradrenergic	JJ	I-NP	O
neurons	neuron	NNS	I-NP	O

Moyamoya	Moyamoya	NNP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
intriguing	intriguing	JJ	I-NP	O
and	and	CC	I-NP	O
controversial	controversial	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O

An	An	DT	B-NP	O
ethnic	ethnic	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
central	central	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
(	(	(	O	O
CNS	CNS	NN	B-NP	O
)	)	)	O	O
tumors	tumor	NNS	B-NP	O
seen	see	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Armed	Armed	NNP	I-NP	O
Forces	Forces	NNP	I-NP	O
Institute	Institute	NNP	I-NP	O
of	of	IN	B-PP	O
Pathology	Pathology	NNP	B-NP	O
(	(	(	O	O
AFIP	AFIP	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Washington	Washington	NNP	B-NP	O
,	,	,	O	O
DC	DC	NNP	B-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O

SN	SN	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
rebound	rebound	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
courses	course	NNS	I-NP	O
at	at	IN	B-PP	O
about	about	RB	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
hour	hour	NN	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
i.v.	i.v.	JJ	I-NP	O
infusion	infusion	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
enterohepatic	enterohepatic	JJ	B-NP	O
recycling	recycling	NN	I-NP	O

Kondo	Kondo	NN	B-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
Cu	Cu	NN	B-NP	O
(	(	(	O	O
Fe	Fe	NN	B-NP	O
)	)	)	O	O
films	film	NNS	B-NP	O

The	The	DT	B-NP	O
S1	BEGIN-S1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
repair	repair	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
efficiently	efficiently	RB	B-VP	O
processing	process	VBG	I-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
oxoguanine	oxoguanine	NN	I-NP	O
residues	residue	NNS	I-NP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
via	via	IN	B-PP	O
an	an	DT	B-NP	O
N	BEGIN-N	NN	I-NP	B
-	-	HYPH	I-NP	I
glycosylase	glycosylase-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
apurinic	BEGIN-apurinic	JJ	I-NP	B
-	-	HYPH	I-NP	I
apyrimidinic	apyrimidinic	JJ	I-NP	I
(	(	(	O	I
AP	AP	NN	B-NP	I
)	)	)	O	I
lyase	lyase-INSIDE	NN	B-NP	I
activity	activity	NN	I-NP	O

The	The	DT	B-NP	O
orf1	orf1	NN	I-NP	O
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
with	with	IN	B-PP	O
characteristics	characteristic	NNS	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Tat	BEGIN-Tat-INSIDE	NN	I-NP	B
(	(	(	O	O
transactivator	BEGIN-transactivator-INSIDE	NN	B-NP	B
)	)	)	O	O
proteins	protein	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ungulate	ungulate	JJ	I-NP	O
lentiviruses	lentivirus	NNS	I-NP	O

This	This	DT	B-NP	O
paper	paper	NN	I-NP	O
describes	describe	VBZ	B-VP	O
a	a	DT	B-NP	O
longitudinal	longitudinal	JJ	I-NP	O
study	study	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
clinical	clinical	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
and	and	CC	O	O
aspartate	BEGIN-aspartate	NN	B-NP	B
aminotransferase	aminotransferase-INSIDE	NN	I-NP	I
(	(	(	O	O
AST	BEGIN-AST-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
gingival	gingival	JJ	B-NP	O
crevicular	crevicular	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
(	(	(	O	O
GCF	GCF	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
bimonthly	bimonthly	RB	B-ADVP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
period	period	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
sites	site	NNS	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
treated	treat	VBN	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
patients	patient	NNS	I-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
unlike	unlike	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
for	for	IN	B-PP	O
sos1	BEGIN-sos1-INSIDE	NN	B-NP	B
,	,	,	O	O
sos1	BEGIN-BEGIN-sos1-INSIDE	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
dispensable	dispensable	JJ	B-ADJP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
mouse	mouse	NN	I-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
growth	growth	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
fertility	fertility	NN	B-NP	O

This	This	DT	B-NP	O
finding	finding	NN	I-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
importance	importance	NN	B-NP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
completes	complete	VBZ	B-VP	O
an	an	DT	B-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
central	central	JJ	B-NP	O
near	near	JJ	I-NP	O
-	-	HYPH	I-NP	O
location	location	NN	I-NP	O
errors	error	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
partial	partial	JJ	I-NP	O
-	-	HYPH	I-NP	O
report	report	NN	I-NP	O
bar	bar	NN	I-NP	O
-	-	HYPH	I-NP	O
probe	probe	NN	I-NP	O
task	task	NN	I-NP	O

Patients	Patient	NNS	B-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
either	either	CC	B-NP	O
1	1	CD	I-NP	O
million	million	CD	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
procaine	procaine	NN	B-NP	O
penicillin	penicillin	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
probenecid	probenecid	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
of	of	IN	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
probenecid	probenecid	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
of	of	IN	B-PP	O
tetracycline	tetracycline	NN	B-NP	O
given	give	VBN	B-VP	O
over	over	IN	B-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Lactococcus	BEGIN-Lactococcus	NN	I-NP	B
lactis	lactis	NN	I-NP	I
Ll.LtrB	Ll.LtrB	NN	I-NP	I
group	group	NN	I-NP	I
II	II	CD	I-NP	I
intron	intron	NN	I-NP	I
endonuclease	endonuclease-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
DNA	DNA	NN	I-NP	O
target	target	NN	I-NP	O
site	site	NN	I-NP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
footprinting	footprinting	NN	I-NP	O
and	and	CC	I-NP	O
modification	modification	NN	I-NP	O
-	-	HYPH	B-NP	O
interference	interference	NN	I-NP	O
approaches	approach	NNS	I-NP	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
JEA1	JEA1	NN	B-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
interleukin	BEGIN-interleukin	NN	B-NP	B
(	(	(	O	I
IL	IL	NN	B-NP	I
)	)	)	O	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
induces	induce	VBZ	B-VP	O
CBLB	BEGIN-CBLB-INSIDE	NN	B-NP	B
phosphorylation	phosphorylation	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O

Plasmid	Plasmid	NN	B-NP	O
pNK1	pNK1	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
sequence	sequence	NN	I-NP	O
covering	cover	VBG	B-VP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
nitrilase	BEGIN-nitrilase-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lac	BEGIN-lac	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
directed	direct	VBN	B-NP	O
overproduction	overproduction	NN	I-NP	O
of	of	IN	B-PP	O
enzymatically	BEGIN-enzymatically	RB	B-NP	B
active	active	JJ	I-NP	I
nitrilase	BEGIN-nitrilase-INSIDE-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
isopropyl	isopropyl	NN	B-NP	O
beta	beta	SYM	B-NP	O
-	-	HYPH	B-NP	O
D	D	NN	I-NP	O
-	-	HYPH	B-NP	O
thiogalactopyranoside	thiogalactopyranoside	NN	I-NP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O

Penicillamine	Penicillamine	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
myasthenia	myasthenia	NN	I-NP	O
gravis	gravis	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
antibodies	antibody	NNS	B-NP	O
to	to	TO	B-PP	O
acetylcholine	BEGIN-acetylcholine	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I

UV	UV	NN	B-NP	O
cross	cross	AFX	O	O
-	-	HYPH	O	O
linking	link	VBG	B-VP	O
and	and	CC	O	O
Southwestern	Southwestern	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
KTP1	BEGIN-KTP1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
protein	protein	NN	B-NP	O
clearly	clearly	RB	B-ADJP	O
distinct	distinct	JJ	I-ADJP	O
from	from	IN	B-PP	O
AP1	BEGIN-AP1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
protein	protein	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
keratinocyte	keratinocyte	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
BPAG1	BEGIN-BPAG1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
frozen	freeze	VBN	B-NP	O
sections	section	NNS	I-NP	O
the	the	DT	B-NP	O
spots	spot	NNS	I-NP	O
appear	appear	VBP	B-VP	O
as	as	IN	B-PP	O
blue	blue	JJ	B-NP	O
labelled	labelled	JJ	I-NP	O
neurones	neurone	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
light	light	JJ	I-NP	O
microscope	microscope	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
brilliant	brilliant	JJ	I-NP	O
red	red	JJ	I-NP	O
neurones	neurone	NNS	I-NP	O
surrounded	surround	VBN	B-VP	O
by	by	IN	B-PP	O
reddish	reddish	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fluorescence	fluorescence	NN	I-NP	O
microscope	microscope	NN	I-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Elevation	Elevation	NN	B-NP	O
of	of	IN	B-PP	O
TBARS	TBARS	NN	B-NP	O
and	and	CC	I-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
GSH	GSH	NN	B-NP	O
show	show	VBP	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
oxidative	oxidative	JJ	B-NP	O
stress	stress	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
PFD	PFD	NN	I-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
hemodiafilter	hemodiafilter	NN	B-NP	O
SG1	SG1	NN	I-NP	O

Like	Like	IN	B-PP	O
the	the	DT	B-NP	O
DMA	BEGIN-DMA-INSIDE	NN	I-NP	B
,	,	,	O	O
but	but	CC	O	O
unlike	unlike	IN	B-PP	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
mammalian	BEGIN-mammalian	JJ	I-NP	B
class	class	NN	I-NP	I
II	II	CD	I-NP	I
A	A	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
zebrafish	zebrafish	NN	I-NP	O
gene	gene	NN	I-NP	O
codes	cod	VBZ	B-VP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
cysteine	cysteine	NN	I-NP	O
residues	residue	NNS	I-NP	O
which	which	WDT	B-NP	O
might	might	MD	B-VP	O
potentially	potentially	RB	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
disulfide	disulfide	NN	I-NP	O
bond	bond	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
alpha	alpha	SYM	I-NP	O
1	1	CD	I-NP	O
domain	domain	NN	I-NP	O

For	For	IN	B-PP	O
any	any	DT	B-NP	O
given	give	VBN	I-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
stressed	stressed	JJ	I-NP	O
plantaris	plantaris	NN	I-NP	O
tendons	tendon	NNS	I-NP	O
were	be	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
fatigue	fatigue	JJ	I-NP	O
quality	quality	NN	I-NP	O
than	than	IN	B-PP	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
stressed	stressed	JJ	I-NP	O
extensor	extensor	NN	I-NP	O
tendons	tendon	NNS	I-NP	O

A	A	DT	B-NP	O
mutated	BEGIN-mutated	JJ	I-NP	B
ABF1	BEGIN-ABF1-INSIDE	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
displays	display	VBZ	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
low	low	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
ABF1	BEGIN-ABF1-INSIDE	NN	B-NP	B
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
functionally	functionally	RB	I-VP	O
replace	replace	VB	I-VP	O
the	the	DT	B-NP	O
ILV1	BEGIN-ILV1-INSIDE	NN	I-NP	B
REB1	BEGIN-REB1	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
interest	interest	NN	B-NP	O
that	that	IN	B-NP	O
,	,	,	O	O
aside	aside	RB	B-ADVP	O
from	from	IN	B-PP	O
starvation	starvation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
nutrition	nutrition	NN	I-NP	O
catastrophes	catastrophe	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
scurvy	scurvy	NN	B-NP	O
(	(	(	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
)	)	)	O	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
fresh	fresh	JJ	B-NP	O
vegetables	vegetable	NNS	I-NP	O
and	and	CC	O	O
fruit	fruit	NN	B-NP	O
and	and	CC	I-NP	O
beriberi	beriberi	NNS	I-NP	O
(	(	(	O	O
vitamin	vitamin	NN	B-NP	O
B1	B1	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
consumption	consumption	NN	B-NP	O
of	of	IN	B-PP	O
polished	polish	VBN	B-NP	O
rice	rice	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
forgotten	forget	VBN	I-VP	O
and	and	CC	O	O
only	only	RB	B-ADVP	O
of	of	IN	B-PP	O
interest	interest	NN	B-NP	O
as	as	IN	B-PP	O
history	history	NN	B-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DREB1A	BEGIN-DREB1A	NN	I-NP	B
cDNA	cDNA-INSIDE	NN	I-NP	I
induced	induce	VBD	B-VP	O
weak	weak	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
genes	gene	NNS	I-NP	O
under	under	IN	B-PP	O
unstressed	unstressed	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
and	and	CC	O	O
caused	cause	VBD	B-VP	O
growth	growth	NN	B-NP	O
retardation	retardation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transgenic	transgenic	JJ	I-NP	O
plants	plant	NNS	I-NP	O

In	In	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	I-NP	I
Src	Src-INSIDE	NN	I-NP	I
phosphorylated	phosphorylate	VBN	I-NP	O
FAK	BEGIN-BEGIN-FAK-INSIDE	NN	I-NP	B
Tyr	Tyr	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
glutathione	BEGIN-glutathione	NN	I-NP	B
S	S	NN	I-NP	I
-	-	HYPH	B-NP	I
transferase	transferase-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
FAK	BEGIN-FAK-INSIDE	NN	B-NP	B
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
domain	domain	NN	I-NP	O
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
FAK	BEGIN-FAK-INSIDE	NN	B-NP	B
did	do	VBD	B-VP	O
not	not	RB	O	O

The	The	DT	B-NP	O
aetiology	aetiology	NN	I-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
impotence	impotence	NN	I-NP	O
is	be	VBZ	B-VP	O
well	well	RB	B-ADVP	O
-	-	HYPH	B-ADJP	O
documented	document	VBN	B-VP	O
;	;	:	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
on	on	IN	B-PP	O
female	female	JJ	B-NP	O
sexuality	sexuality	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
so	so	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O

The	The	DT	B-NP	O
percentage	percentage	NN	I-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
types	type	NNS	B-NP	O
of	of	IN	B-PP	O
fixation	fixation	NN	B-NP	O
disparity	disparity	NN	I-NP	O
curves	curve	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
some	some	DT	B-NP	O
previous	previous	JJ	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
Type	Type	NN	B-NP	O
I	I	CD	I-NP	O
curve	curve	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
Type	Type	NN	B-NP	O
III	III	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
curves	curve	NNS	B-NP	O

1	1	LS	B-LST	O
)	)	)	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
PPARalpha	BEGIN-PPARalpha	NN	I-NP	B
-	-	HYPH	O	I
interacting	interact	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I

Reading	Read	VBG	B-VP	O
disability	disability	NN	B-NP	O
in	in	IN	B-PP	O
twins	twin	NNS	B-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
termini	terminus	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
produced	produce	VBD	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
puf	BEGIN-puf	JJ	I-NP	B
operon	operon	NN	I-NP	I
of	of	IN	B-PP	I
R.	R.	NNP	B-NP	I
sphaeroides	sphaeroides-INSIDE	NN	I-NP	I
PUF	BEGIN-PUF	NN	I-NP	B
delta	delta	SYM	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
three	three	CD	B-NP	O
transcripts	transcript	NNS	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
kilobases	kilobas	NNS	I-NP	O
)	)	)	O	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
puf	puf	NN	I-NP	O
-	-	HYPH	B-NP	O
intercistronic	intercistronic	JJ	I-NP	O
terminator	terminator	NN	I-NP	O
structure	structure	NN	I-NP	O
were	be	VBD	B-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
puf	BEGIN-puf	JJ	I-NP	B
transcripts	transcripts-INSIDE	NN	I-NP	I
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
wild	wild	JJ	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
R.	R.	NN	I-NP	O
sphaeroides	sphaeroide	NNS	I-NP	O
1.1	1.1	CD	B-NP	O
(	(	(	O	O
four	four	CD	B-NP	O
transcripts	transcript	NNS	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
kilobases	kilobas	NNS	I-NP	O
)	)	)	O	O
showing	show	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
begin	begin	VB	B-VP	O
and	and	CC	I-VP	O
end	end	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
sites	site	NNS	I-NP	O

The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
loss	loss	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
injection	injection	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
units	unit	NNS	I-NP	O
(	(	(	O	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
units	unit	NNS	I-NP	O
)	)	)	O	O

Several	Several	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drugs	drug	NNS	I-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
MAC	MAC	NN	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
drug	drug	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
cytochrome	BEGIN-cytochrome	NN	I-NP	B
P1	P1-INSIDE	NN	I-NP	I
(	(	(	O	O
CYP	BEGIN-CYP-INSIDE	NN	B-NP	B
)	)	)	O	O
enzyme	enzyme	NN	B-NP	O
system	system	NN	I-NP	O

Therapy	Therapy	NN	B-NP	O
and	and	CC	I-NP	O
prevention	prevention	NN	I-NP	O
of	of	IN	B-PP	O
irreversible	irreversible	JJ	B-NP	O
shock	shock	NN	I-NP	O
with	with	IN	B-PP	O
pharmacological	pharmacological	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
corticosteroids	corticosteroid	NNS	I-NP	O

Suppression	Suppression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cka1	BEGIN-cka1	NN	I-NP	B
delta	delta	SYM	B-NP	I
cka1	BEGIN-cka1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
phenotype	phenotype	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
by	by	IN	B-PP	O
interaction	interaction	NN	B-NP	O
of	of	IN	B-PP	O
CKB1	BEGIN-CKB1-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
the	the	DT	B-NP	O
defective	defective	JJ	I-NP	O
,	,	,	I-NP	O
cka1	BEGIN-cka1	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
encoded	encode	VBN	I-VP	O
,	,	,	O	O
catalytic	catalytic	JJ	B-NP	O
subunit	subunit	NN	I-NP	O

Historically	Historically	RB	B-ADVP	O
,	,	,	O	O
Cyps	BEGIN-Cyps-INSIDE	NN	B-NP	B
were	be	VBD	B-VP	O
first	first	RB	I-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
the	the	DT	B-NP	O
immunosuppressive	immunosuppressive	JJ	I-NP	O
agent	agent	NN	I-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
CsA	CsA	NN	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
;	;	:	O	O
they	they	PRP	B-NP	O
later	later	RB	B-ADVP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
peptidyl	BEGIN-peptidyl	JJ	B-NP	B
-	-	HYPH	I-NP	I
prolyl	prolyl	NN	I-NP	I
cis	cis	NN	I-NP	I
-	-	HYPH	B-NP	I
trans	trans	JJ	I-NP	I
isomerase	isomerase-INSIDE	NN	I-NP	I
(	(	(	O	O
PPIase	BEGIN-PPIase-INSIDE	NN	B-NP	B
)	)	)	O	O
activity	activity	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
catalyzes	catalyze	VBZ	B-VP	O
the	the	DT	B-NP	O
folding	folding	NN	I-NP	O
of	of	IN	B-PP	O
oligopeptides	oligopeptide	NNS	B-NP	O
at	at	IN	B-PP	O
proline	proline	NN	B-NP	O
-	-	HYPH	O	O
peptide	peptide	NN	B-NP	O
bonds	bond	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
protein	protein	NN	B-NP	O
folding	folding	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Reduced	Reduce	VBN	B-NP	O
glutathione	glutathione	NN	I-NP	O
in	in	IN	B-PP	O
whole	whole	JJ	B-NP	O
blood	blood	NN	I-NP	O
decreases	decrease	VBZ	B-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
Se	Se	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
Se	Se	NN	I-NP	O
area	area	NN	I-NP	O

Promoter	Promoter	NN	B-NP	O
elements	element	NNS	I-NP	O
and	and	CC	O	O
transcriptional	transcriptional	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
acetylcholinesterase	acetylcholinesterase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

To	To	TO	B-PP	O
our	our	PRP$	B-NP	O
knowledge	knowledge	NN	I-NP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
EAT	EAT	NNS	B-NP	O
treated	treat	VBN	B-VP	O
by	by	IN	B-PP	O
catheter	catheter	NN	B-NP	O
ablation	ablation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ectopic	ectopic	JJ	I-NP	O
focus	focus	NN	I-NP	O
are	be	VBP	B-VP	O
reported	report	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
success	success	NN	I-NP	O
rate	rate	NN	I-NP	O
superior	superior	JJ	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O

The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
report	report	VBP	B-VP	O
two	two	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
orbital	orbital	JJ	B-NP	O
cavernous	cavernous	JJ	I-NP	O
hemangioma	hemangioma	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
by	by	IN	B-PP	O
Tc	Tc	NN	B-NP	O
-	-	HYPH	I-NP	O
1m	1m	NN	I-NP	O
RBC	RBC	NN	I-NP	O
SPECT	SPECT	NN	I-NP	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
]	]	)	O	O

Arterial	Arterial	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
using	use	VBG	B-VP	O
intraarterial	intraarterial	JJ	B-NP	O
pulse	pulse	NN	I-NP	O
contour	contour	NN	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
Windkessel	Windkessel	NNP	I-NP	O
model	model	NN	I-NP	O
were	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
systolic	systolic	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
(	(	(	O	O
>	>	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
/	/	SYM	B-VP	O
<	<	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
measurements	measurement	NNS	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
essential	essential	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
(	(	(	O	O
diastolic	diastolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
[	[	(	O	O
BP	BP	NN	B-NP	O
]	]	)	O	O
>	>	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
normotensive	normotensive	JJ	I-NP	O
control	control	NN	I-NP	O
subjects	subject	NNS	I-NP	O

The	The	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
CSF	BEGIN-CSF	NN	B-NP	B
somatostatin	somatostatin-INSIDE	NN	I-NP	I
and	and	CC	O	O
peripheral	peripheral	JJ	B-NP	O
thyroid	thyroid	NN	I-NP	O
hormones	hormone	NNS	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
affectively	affectively	RB	I-NP	O
ill	ill	JJ	I-NP	O
patients	patient	NNS	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
during	during	IN	I-PP	O
carbamazepine	carbamazepine	NN	B-NP	O
treatment	treatment	NN	I-NP	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
CREM	BEGIN-CREM-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
ICER	BEGIN-ICER-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Rad1B	BEGIN-BEGIN-Rad1B-INSIDE	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
spermatogenesis	spermatogenesis	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
determined	determine	VBD	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	B-NP	B
,	,	,	O	O
Rad1B	BEGIN-Rad1B-INSIDE	NN	B-NP	B
,	,	,	O	O
CREM	BEGIN-CREM-INSIDE	NN	B-NP	B
/	/	SYM	B-VP	O
ICER	BEGIN-ICER-INSIDE	NN	B-NP	B
isoforms	isoform	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Skp1	BEGIN-Skp1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
Cullin	BEGIN-Cullin-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
F	F	NN	I-NP	O
-	-	HYPH	I-NP	O
box	box	NN	I-NP	O
ubiquitin	BEGIN-ubiquitin-INSIDE	NN	I-NP	B
protein	protein	NN	I-NP	O
ligase	ligase	NN	I-NP	O
subunits	subunit	NNS	I-NP	O
Cul	BEGIN-Cul	JJ	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Cul	BEGIN-Cul	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
during	during	IN	B-PP	O
murine	murine	JJ	B-NP	O
testicular	testicular	JJ	I-NP	O
development	development	NN	I-NP	O

Since	Since	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
1s	1	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
hypothesis	hypothesis	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O

Kettin	BEGIN-Kettin-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
modular	modular	JJ	I-NP	O
protein	protein	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
thin	thin	JJ	B-NP	O
filaments	filament	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Z	Z	NN	I-NP	O
-	-	HYPH	B-NP	O
disc	disc	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
insect	insect	NN	B-NP	O
muscles	muscle	NNS	I-NP	O

To	To	TO	B-VP	O
probe	probe	VB	I-VP	O
the	the	DT	B-NP	O
inter	inter	AFX	I-NP	O
-	-	HYPH	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
virion	virion	NN	I-NP	O
-	-	HYPH	O	O
anchoring	anchor	VBG	B-VP	O
function	function	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
oligomerization	oligomerization	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
constructed	construct	VBD	B-VP	O
two	two	CD	B-NP	O
serotype	serotype	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
T1	T1	NN	B-NP	O
)	)	)	O	O
sigma	BEGIN-sigma	NN	B-NP	B
1	1-INSIDE	NN	I-NP	I
deletion	deletion	NN	I-NP	O
mutants	mutant	NNS	I-NP	O
in	in	IN	B-PP	O
SV1	SV1	NN	B-NP	O
expression	expression	NN	I-NP	O
vectors	vector	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
hydrophobic	hydrophobic	JJ	I-NP	O
tail	tail	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
hinge	hinge	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
lacking	lack	VBG	B-VP	O
an	an	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	O
region	region	NN	I-NP	O
which	which	WDT	B-NP	O
constituted	constitute	VBD	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
coiled	coil	VBN	I-NP	O
-	-	HYPH	I-NP	O
coil	coil	NN	I-NP	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
description	description	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
integron	integron	NN	I-NP	O
located	located	JJ	B-ADJP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
composite	composite	JJ	I-NP	O
transposon	transposon	NN	I-NP	O

By	By	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
detection	detection	NN	I-NP	O
and	and	CC	I-NP	O
correction	correction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
causes	cause	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
therapeutic	therapeutic	JJ	B-NP	O
efficacy	efficacy	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
achieved	achieve	VBN	I-VP	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
Single	Single	JJ	B-NP	O
white	white	JJ	I-NP	O
flash	flash	NN	I-NP	O
ERG	ERG	NN	I-NP	O
,	,	,	O	O
photopic	photopic	JJ	B-NP	O
ERG	ERG	NN	I-NP	O
,	,	,	O	O
scotopic	scotopic	JJ	B-NP	O
ERG	ERG	NN	I-NP	O
and	and	CC	I-NP	O
flicker	flicker	NN	I-NP	O
ERG	ERG	NN	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
unilateral	unilateral	JJ	B-NP	O
CRVO	CRVO	NN	I-NP	O

RESULT	RESULT	NN	B-NP	O
(	(	(	O	O
S	S	NN	B-NP	O
)	)	)	O	O
:	:	:	O	O
A	A	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
couples	couple	NNS	I-NP	O
with	with	IN	B-PP	O
nafarelin	nafarelin	NN	B-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
couples	couple	NNS	I-NP	O
with	with	IN	B-PP	O
buserelin	buserelin	NN	B-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
IVF	IVF	NN	I-NP	O
protocol	protocol	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
couples	couple	NNS	I-NP	O
with	with	IN	B-PP	O
nafarelin	nafarelin	NN	B-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
couples	couple	NNS	I-NP	O
with	with	IN	B-PP	O
buserelin	buserelin	NN	B-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
IVF	IVF	NN	I-NP	O
protocol	protocol	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
couples	couple	NNS	I-NP	O
with	with	IN	B-PP	O
nafarelin	nafarelin	NN	B-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
couples	couple	NNS	I-NP	O
with	with	IN	B-PP	O
buserelin	buserelin	NN	B-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
ICSI	ICSI	NN	I-NP	O
protocol	protocol	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
couples	couple	NNS	I-NP	O
with	with	IN	B-PP	O
nafarelin	nafarelin	NN	B-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
couples	couple	NNS	I-NP	O
with	with	IN	B-PP	O
buserelin	buserelin	NN	B-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
ICSI	ICSI	NN	I-NP	O
protocol	protocol	NN	I-NP	O

Mutations	Mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
galactosidase	galactosidase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lysosomal	lysosomal	JJ	I-NP	O
storage	storage	NN	I-NP	O
disorders	disorder	NNS	I-NP	O
GM1	GM1	NN	I-NP	O
-	-	HYPH	B-NP	O
gangliosidosis	gangliosidosis	NN	I-NP	O
and	and	CC	I-NP	O
Morquio	Morquio	NN	I-NP	O
B	B	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O

Angiographic	Angiographic	JJ	B-NP	O
follow	follow	VB	B-VP	O
-	-	HYPH	B-ADJP	O
up	up	RP	B-PRT	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
primary	primary	JJ	I-NP	O
success	success	NN	I-NP	O
of	of	IN	B-PP	O
angioplasty	angioplasty	JJ	B-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
only	only	RB	I-VP	O
loosely	loosely	RB	I-VP	O
associated	associate	VBN	I-VP	O
,	,	,	O	O
or	or	CC	O	O
not	not	RB	B-VP	O
associated	associate	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
viral	viral	JJ	B-NP	O
particles.	particles.	NN	I-NP	O
gp1	BEGIN-gp1-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
generated	generate	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
alternatively	alternatively	RB	I-NP	O
spliced	splice	VBN	I-NP	O
Env	BEGIN-Env	NN	I-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
splice	splice	NN	I-NP	O
donor	donor	NN	I-NP	O
and	and	CC	I-NP	O
splice	splice	NN	I-NP	O
acceptor	acceptor	NN	I-NP	O
pair	pair	NN	I-NP	O
localized	localize	VBN	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
env	BEGIN-env	NN	I-NP	B
open	open	JJ	I-NP	I
reading	reading	NN	I-NP	I
frame	frame	NN	I-NP	I
(	(	(	O	I
ORF	ORF	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
normally	normally	RB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
Bell	BEGIN-Bell-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Bet	BEGIN-Bet	NN	I-NP	B
transcripts	transcripts-INSIDE	NN	I-NP	I
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
internal	internal	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
env	BEGIN-env	NNP	I-NP	B
ORF.	ORF-INSIDE.	NNP	I-NP	I
gp1	BEGIN-gp1-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Env	BEGIN-Env	NN	I-NP	B
precursor	precursor-INSIDE	NN	I-NP	I
gp1	BEGIN-gp1-INSIDE	NN	I-NP	B

They	They	PRP	B-NP	O
are	be	VBP	B-VP	O
both	both	DT	O	O
insensitive	insensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
serine	BEGIN-serine	NN	B-NP	B
and	and	CC	I-NP	I
aspartyl	aspartyl	NN	I-NP	I
proteinases	proteinases-INSIDE	NN	I-NP	I
but	but	CC	O	O
are	be	VBP	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
sulfhydryl	sulfhydryl	NN	B-NP	O
reagents	reagent	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
mM	mM	NN	I-NP	O
ZnCl1	ZnCl1	NN	I-NP	O

The	The	DT	B-NP	O
Brassica	BEGIN-Brassica	NNP	I-NP	B
BTH1	BTH1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
correspond	correspond	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Arabidopsis	BEGIN-Arabidopsis	NN	I-NP	B
TH	TH	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Electron	Electron	NN	B-NP	O
microscopic	microscopic	JJ	I-NP	O
visualization	visualization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
general	general	JJ	I-NP	O
population	population	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
genes	gene	NNS	I-NP	O
in	in	IN	B-PP	O
flies	fly	NNS	B-NP	O
overexpressing	overexpresse	VBG	B-VP	O
hnRNP	BEGIN-hnRNP	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
also	also	RB	B-ADVP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
great	great	JJ	I-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
seemed	seem	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
cotranscriptional	cotranscriptional	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
processing	processing	NN	I-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
rare	rare	JJ	B-NP	O
exon	exon	NN	I-NP	O
-	-	HYPH	O	O
skipping	skip	VBG	B-VP	O
events	event	NNS	B-NP	O

ESR	ESR	NN	B-NP	O
spectra	spectrum	NNS	I-NP	O
of	of	IN	B-PP	O
Er1+	Er1+	NN	B-NP	O
in	in	IN	B-PP	O
SmB1	SmB1	NN	B-NP	O
single	single	JJ	I-NP	O
crystals	crystal	NNS	I-NP	O
:	:	:	O	O
Dynamic	Dynamic	JJ	B-NP	O
Jahn	Jahn	NNP	I-NP	O
-	-	HYPH	I-NP	O
Teller	Teller	NNP	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
mixed	mix	VBN	I-NP	O
-	-	HYPH	I-NP	O
valence	valence	NN	I-NP	O
compound	compound	NN	I-NP	O

T.	T.	NN	B-NP	O
infestans	infestan	NNS	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
delpontei	delpontei	NNP	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
rubrovaria	rubrovaria	NNP	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
sordida	sordida	NNP	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
guasayana	guasayana	NNP	I-NP	O
and	and	CC	O	O
T.	T.	NNP	B-NP	O
vitticeps	vitticep	NNS	I-NP	O
from	from	IN	B-PP	O
infestans	infestan	NNS	B-NP	O
subgroup	subgroup	NN	I-NP	O
and	and	CC	I-NP	O
T.	T.	NN	I-NP	O
pallidipennis	pallidipennis	NN	I-NP	O
from	from	IN	B-PP	O
rubrofasciata	rubrofasciata	NNS	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
were	be	VBD	B-VP	O
directly	directly	RB	I-VP	O
introduced	introduce	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
parental	parental	JJ	I-NP	O
PV	PV	NN	I-NP	O
/	/	SYM	B-NP	O
CBV1	CBV1	NN	I-NP	O
-	-	HYPH	B-NP	O
1A	1A	NN	I-NP	O
genome	genome	NN	I-NP	O
,	,	,	O	O
chimeric	chimeric	JJ	B-NP	O
viruses	virus	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
-	-	HYPH	I-NP	O
plaque	plaque	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
PV	PV	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
growth	growth	NN	I-NP	O
pattern	pattern	NN	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
upon	upon	IN	B-PP	O
transfection	transfection	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
observation	observation	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
point	point	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
alone	alone	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
drastic	drastic	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PV	PV	NN	I-NP	O
/	/	SYM	B-NP	O
CBV1	CBV1	NN	I-NP	O
chimeric	chimeric	JJ	I-NP	O
virus	virus	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
feline	feline	NN	I-NP	O
L	BEGIN-L	NN	I-NP	B
/	/	SYM	B-NP	I
B	B	NN	I-NP	I
/	/	SYM	B-NP	I
K	K	NN	I-NP	I
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
ALP	ALP-INSIDE	NN	I-NP	I
expressed	express	VBN	B-VP	O
on	on	IN	B-PP	O
cell	cell	NN	B-NP	O
surfaces	surface	NNS	I-NP	O
via	via	IN	B-PP	O
phosphatidylinositol	phosphatidylinositol	NN	B-NP	O
-	-	HYPH	B-NP	O
glycan	glycan	NN	I-NP	O
linkage	linkage	NN	I-NP	O

Clinical	Clinical	JJ	B-NP	O
experience	experience	NN	I-NP	O
gained	gain	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
combined	combined	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
1Cf	1Cf	NN	B-NP	O
brachytherapy	brachytherapy	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
staff	staff	NN	I-NP	O
-	-	HYPH	O	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Research	Research	NNP	I-NP	O
Institute	Institute	NNP	I-NP	O
of	of	IN	B-PP	O
Medical	Medical	NNP	B-NP	O
Radiology	Radiology	NNP	I-NP	O
,	,	,	O	O
USSR	USSR	NNP	B-NP	O
AMS	AMS	NNP	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
generalized	generalize	VBN	I-VP	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
VBP	BEGIN-VBP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
solely	solely	RB	I-VP	O
expressed	express	VBN	I-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
located	locate	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
localize	localize	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
endogenous	BEGIN-endogenous	JJ	B-NP	B
Cdk1	Cdk1-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
dominant	BEGIN-dominant	JJ	B-NP	B
negative	negative	JJ	I-NP	I
Cdk1	Cdk1-INSIDE	NN	I-NP	I
attenuated	attenuate	VBD	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
Thr1	Thr1	NN	B-NP	O
,	,	,	I-NP	O
Thr1	Thr1	NN	I-NP	O
and	and	CC	I-NP	O
Thr1	Thr1	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
upon	upon	IN	B-PP	O
Ser1	Ser1	NN	B-NP	O
modification	modification	NN	I-NP	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
excessive	excessive	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
after	after	IN	B-PP	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
was	be	VBD	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
algorithm	algorithm	NN	I-NP	O
using	use	VBG	B-VP	O
point	point	NN	B-NP	O
-	-	HYPH	B-ADJP	O
of	of	IN	B-PP	O
-	-	HYPH	B-NP	O
care	care	NN	I-NP	O
testing	testing	NN	I-NP	O
with	with	IN	B-PP	O
whole	whole	JJ	B-NP	O
blood	BEGIN-blood	NN	I-NP	B
prothrombin	prothrombin-INSIDE	NN	I-NP	I
time	time	NN	I-NP	O
,	,	,	O	O
activated	activate	VBN	B-VP	O
partial	partial	JJ	B-NP	O
thromboplastin	BEGIN-thromboplastin-INSIDE	NN	I-NP	B
time	time	NN	I-NP	O
,	,	,	O	O
heparinase	BEGIN-heparinase-INSIDE	NN	B-NP	B
activated	activate	VBD	B-VP	O
clotting	clotting	NN	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
platelet	platelet	NN	B-NP	O
count	count	NN	I-NP	O

Endocarditis	Endocarditis	NN	B-NP	O
remains	remain	VBZ	B-VP	O
a	a	DT	B-NP	O
life	life	NN	I-NP	O
-	-	HYPH	O	O
threatening	threaten	VBG	B-VP	O
disease	disease	NN	B-NP	O
with	with	IN	B-PP	O
substantial	substantial	JJ	B-NP	O
morbidity	morbidity	NN	I-NP	O
and	and	CC	I-NP	O
mortality	mortality	NN	I-NP	O

Association	Association	NN	B-NP	O
between	between	IN	B-PP	O
diaphragm	diaphragm	NN	B-NP	O
use	use	NN	I-NP	O
and	and	CC	O	O
asymptomatic	asymptomatic	JJ	B-NP	O
bacteriuria	bacteriuria	NNS	I-NP	O

The	The	DT	B-NP	O
high	high	JJ	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
septal	septal	JJ	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
tetralogy	tetralogy	NN	B-NP	O
of	of	IN	B-PP	O
Fallot	Fallot	NN	B-NP	O
is	be	VBZ	B-VP	O
cited	cite	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
analogy	analogy	NN	I-NP	O
because	because	IN	B-SBAR	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
high	high	JJ	B-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
compliance	compliance	NN	I-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
from	from	IN	B-PP	O
birth	birth	NN	B-NP	O

Experience	Experience	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Kenya	Kenya	NNP	I-NP	O
district	district	NN	I-NP	O
hospital	hospital	NN	I-NP	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
initial	initial	JJ	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
plasma	plasma	NN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
prognosis	prognosis	NN	B-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
larger	large	JJR	B-NP	O
cDNA	cDNA	NN	I-NP	O
clones	clone	NNS	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
isoforms	isoform	NNS	I-NP	O
of	of	IN	B-PP	O
RIP1	BEGIN-RIP1-INSIDE	NN	B-NP	B
that	that	WDT	B-NP	O
differ	differ	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
and	and	CC	O	O
B	B	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
hinge	hinge	NN	B-NP	O
(	(	(	O	O
D	D	NN	B-NP	O
)	)	)	O	O
domains	domain	NNS	B-NP	O

A	A	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
clone	clone	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chicken	BEGIN-chicken	JJ	I-NP	B
osteopontin	osteopontin	NN	I-NP	I
-	-	HYPH	O	I
encoding	encode	VBG	B-VP	I
gene	gene-INSIDE	NN	B-NP	I
(	(	(	O	O
opn	BEGIN-opn-INSIDE	NN	B-NP	B
)	)	)	O	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
organized	organize	VBN	I-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
an	an	DT	B-NP	O
untranslated	untranslated	JJ	I-NP	O
1	1	CD	I-NP	O
'	'	''	I-NP	O
exon	exon	NN	I-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
signal	signal	NN	I-NP	O
peptide	peptide	NN	I-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
recognition	recognition	NN	I-NP	O
sequence	sequence	NN	I-NP	O
for	for	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
by	by	IN	B-PP	O
casein	BEGIN-casein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
;	;	:	O	O
a	a	DT	B-NP	O
domain	domain	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
O	O	NN	I-NP	O
-	-	HYPH	B-NP	O
linkage	linkage	NN	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
glycosylation	glycosylation	NN	B-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
casein	BEGIN-BEGIN-casein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
phosphorylation	phosphorylation	NN	I-NP	O
site	site-INSIDE	NN	I-NP	I
;	;	:	O	O
an	an	DT	B-NP	O
exon	exon	NN	I-NP	O
containing	contain	VBG	B-VP	O
three	three	CD	B-NP	O
functional	functional	JJ	I-NP	O
regions	region	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
poly	poly	NN	I-NP	O
-	-	HYPH	B-NP	O
Asp	Asp	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
seven	seven	CD	B-NP	O
consecutive	consecutive	JJ	I-NP	O
Asp	Asp	NN	I-NP	O
residues	residue	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
RGD	BEGIN-RGD	NN	I-NP	B
integrin	integrin	NN	I-NP	I
recognition	recognition	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I
and	and	CC	O	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
linkage	linkage	NN	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
glycosylation	glycosylation	NN	B-NP	O
;	;	:	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
exon	exon	NN	I-NP	O
which	which	WDT	B-NP	O
also	also	RB	B-ADVP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
linkage	linkage	NN	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
glycosylation	glycosylation	NN	B-NP	O

The	The	DT	B-NP	O
entire	entire	JJ	I-NP	O
coding	cod	VBG	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ovine	BEGIN-ovine	JJ	I-NP	B
endometrial	endometrial	JJ	I-NP	I
oxytocin	oxytocin	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
OTR	BEGIN-OTR-INSIDE	NN	B-NP	B
)	)	)	O	O
cDNA	cDNA	NN	B-NP	O
was	be	VBD	B-VP	O
generated	generate	VBN	I-VP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
,	,	,	O	O
subcloned	subclone	VBN	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
SV1	BEGIN-SV1	NN	I-NP	B
major	major	JJ	I-NP	I
late	late	JJ	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
vector	vector	NN	I-NP	O
pSVLJ	pSVLJ	NN	I-NP	O
and	and	CC	O	O
transiently	transiently	RB	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
Cos	Cos	NNP	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O

Critical	Critical	JJ	B-NP	O
review	review	NN	I-NP	O
of	of	IN	B-PP	O
tests	test	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
HBs	BEGIN-HB	NNS	I-NP	B
antigen	antigen-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
blood	blood	NN	I-NP	O

Diff	Diff	NNP	B-NP	O
-	-	HYPH	I-NP	O
Quik	Quik	NNP	I-NP	O
stain	stain	NN	I-NP	O
for	for	IN	B-PP	O
Tzanck	Tzanck	NN	B-NP	O
smears	smear	NNS	I-NP	O

Disease	Disease	NN	B-NP	O
-	-	HYPH	O	O
free	free	JJ	B-NP	O
interval	interval	NN	I-NP	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
in	in	IN	B-PP	O
node	node	NN	B-NP	O
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
Lx	Lx	NN	I-NP	O
patients	patient	NNS	I-NP	O
for	for	IN	B-PP	O
both	both	CC	O	O
T1	T1	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
T1	T1	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
)	)	)	I-NP	O
presentations	presentation	NNS	I-NP	O

Deletion	Deletion	NN	B-NP	O
analysis	analysis	NN	I-NP	O
defines	define	VBZ	B-VP	O
distinct	distinct	JJ	B-NP	O
functional	functional	JJ	I-NP	O
domains	domain	NNS	I-NP	O
for	for	IN	B-PP	O
protein	protein	NN	B-NP	O
-	-	HYPH	O	O
protein	protein	NN	B-NP	O
and	and	CC	O	O
nucleic	nucleic	JJ	B-NP	O
acid	acid	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ORF1	BEGIN-ORF1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	O
LINE	BEGIN-LINE	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Allergen	Allergen	NN	B-NP	O
-	-	HYPH	I-NP	O
stimulated	stimulate	VBN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
PGD1	PGD1	NN	B-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
after	after	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
;	;	:	O	O
likewise	likewise	RB	B-ADVP	O
,	,	,	O	O
allergen	allergen	NN	B-NP	O
-	-	HYPH	B-VP	O
stimulated	stimulate	VBN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
HETE	HETE	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
LTE1	LTE1	NN	B-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
and	and	CC	O	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
HETE	HETE	NN	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
versus	versus	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O

To	To	TO	B-VP	O
confirm	confirm	VB	I-VP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
HPLC	HPLC	NN	I-NP	O
-	-	HYPH	B-NP	O
ESI	ESI	NN	I-NP	O
-	-	HYPH	I-NP	O
MS	MS	NN	I-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
fractions	fraction	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glycosides	glycoside	NNS	I-NP	O
from	from	IN	B-PP	O
four	four	CD	B-NP	O
berries	berry	NNS	I-NP	O
were	be	VBD	B-VP	O
separated	separate	VBN	I-VP	O
,	,	,	O	O
hydrolyzed	hydrolyze	VBN	B-VP	O
,	,	,	O	O
silylated	silylate	VBN	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
using	use	VBG	B-VP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
-	-	HYPH	O	O
mass	mass	NN	B-NP	O
spectrometry	spectrometry	NN	I-NP	O

Usefulness	Usefulness	NN	B-NP	O
of	of	IN	B-PP	O
computerized	computerized	JJ	B-NP	O
tomography	tomography	NN	I-NP	O
in	in	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
patients	patient	NNS	I-NP	O

Prevalence	Prevalence	NN	B-NP	O
of	of	IN	B-PP	O
use	use	NN	B-NP	O
,	,	,	O	O
claims	claim	NNS	B-NP	O
volume	volume	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
expenditures	expenditure	NNS	B-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
for	for	IN	B-PP	O
cisapride	cisapride	NN	B-NP	O
,	,	,	O	O
proton	proton	NN	B-NP	O
pump	pump	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
histamine	BEGIN-histamine	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
antagonists	antagonist	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
prokinetic	prokinetic	JJ	I-NP	O
agent	agent	NN	I-NP	O
metoclopramide	metoclopramide	NN	I-NP	O
during	during	IN	B-PP	O
these	these	DT	B-NP	O
periods	period	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
quasiparticle	quasiparticle	NN	I-NP	O
scattering	scattering	NN	I-NP	O
rate	rate	NN	I-NP	O
tau	tau	SYM	O	O
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
such	such	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
Planck	Planck	NNP	B-NP	O
's	's	POS	B-NP	O
over	over	IN	B-PP	O
1pi	1pi	NN	B-NP	O
/	/	SYM	B-VP	O
tau	tau	SYM	B-NP	O
approximately	approximately	RB	B-NP	O
1t	1t	CD	I-NP	O
(	(	(	O	O
perpendicular	perpendicular	JJ	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
implying	imply	VBG	B-VP	O
that	that	IN	B-SBAR	O
kappa	kappa	NN	B-NP	O
-	-	HYPH	O	O
(	(	(	O	O
BEDT	BEDT	NN	B-NP	O
-	-	HYPH	B-NP	O
TTF	TTF	NN	I-NP	O
)	)	)	O	O
1Cu	1Cu	NN	B-NP	O
(	(	(	O	O
NCS	NCS	NN	B-NP	O
)	)	)	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
meets	meet	VBZ	B-VP	O
the	the	DT	B-NP	O
criterion	criterion	NN	I-NP	O
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
interlayer	interlayer	NN	B-NP	O
incoherence	incoherence	NN	I-NP	O

The	The	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
significant	significant	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
and	and	CC	I-NP	I
prokaryotic	prokaryotic	JJ	I-NP	I
RNA	RNA	NN	I-NP	I
polymerase	polymerase	NN	I-NP	I
subunits	subunits-INSIDE	NN	I-NP	I
involved	involve	VBN	B-VP	O
with	with	IN	B-PP	O
subunit	subunit	NN	B-NP	O
assembly	assembly	NN	I-NP	O

In	In	IN	B-PP	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
nine	nine	CD	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
dyskinesia	dyskinesia	NN	B-NP	O
score	score	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
concomitant	concomitant	JJ	I-NP	O
worsening	worsening	NN	I-NP	O
of	of	IN	B-PP	O
parkinsonian	parkinsonian	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
seven	seven	CD	I-NP	O
,	,	,	O	O
full	full	JJ	B-NP	O
parkinsonian	parkinsonian	JJ	I-NP	O
akinesia	akinesia	NN	I-NP	O
followed	follow	VBD	B-VP	O
THDL	THDL	NN	B-NP	O
administration	administration	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
analogous	analogous	JJ	I-NP	O
myristoylated	myristoylate	VBN	I-NP	O
peptide	peptide	NN	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
Yes	Yes-INSIDE	NN	B-NP	I
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
activity	activity	NN	I-NP	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leukocyte	BEGIN-leukocyte	NN	I-NP	B
EL	BEGIN-EL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
regulated	regulate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
manner	manner	NN	I-NP	O
as	as	IN	B-PP	O
L	BEGIN-L	NN	B-NP	B
-	-	HYPH	B-NP	I
selectin	selectin-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
EL	BEGIN-EL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
recognized	recognize	VBN	B-VP	O
anti	BEGIN-anti	AFX	O	B
-	-	HYPH	B-NP	I
L	BEGIN-L	NN	I-NP	B
-	-	HYPH	I-NP	I
selectin	selectin-INSIDE	NN	I-NP	I
mAb	mAb-INSIDE	NN	I-NP	I
affinity	affinity	NN	I-NP	O
-	-	HYPH	B-VP	O
purified	purify	VBN	B-NP	O
antigen	antigen	NN	I-NP	O
in	in	IN	B-PP	O
SDS	SDS	NN	B-NP	O
/	/	SYM	B-NP	O
PAGE	PAGE	NN	I-NP	O
Western	Western	NN	I-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O

A	A	DT	B-NP	O
proposed	propose	VBN	I-NP	O
method	method	NN	I-NP	O

The	The	DT	B-NP	O
two	two	CD	I-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
separated	separate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
linker	linker	NN	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
whose	whose	WP$	B-NP	O
length	length	NN	I-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
xenopus	xenopus	NN	B-NP	O
,	,	,	O	O
chicken	chicken	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
mamalian	BEGIN-mamalian	JJ	B-NP	B
Crk	Crk	NN	I-NP	I
II	II	CD	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I

A	A	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
mitomycin	mitomycin	NN	I-NP	O
C	C	NN	I-NP	O
derivative	derivative	NN	I-NP	O
,	,	,	O	O
KW	KW	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	O	O
(	(	(	O	O
p	p	NN	B-NP	O
-	-	HYPH	B-NP	O
hydroxyphenyl	hydroxyphenyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
mitomycin	mitomycin	NN	I-NP	O
C	C	NN	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
active	active	JJ	B-NP	O
TB	TB	NN	I-NP	O
,	,	,	O	O
cytokines	cytokine	NNS	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
were	be	VBD	B-VP	O
IFN	BEGIN-IFN	NN	B-NP	B
-	-	HYPH	B-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
,	,	,	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
cotransfection	cotransfection	NN	I-NP	O
studies	study	NNS	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
CRP	BEGIN-CRP	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
+1	+1	CD	I-NP	O
)	)	)	O	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
luciferase	BEGIN-BEGIN-luciferase-INSIDE	NN	I-NP	B
reporter	reporter-INSIDE	NN	I-NP	I
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
luciferase	BEGIN-luciferase-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
C	BEGIN-C	NN	B-NP	B
/	/	SYM	O	I
EBPbeta	EBPbeta-INSIDE	NN	B-NP	I
overexpression	overexpression	NN	I-NP	O
caused	cause	VBD	B-VP	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
;	;	:	O	O
simultaneous	simultaneous	JJ	B-NP	O
overexpression	overexpression	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
increased	increase	VBD	B-VP	O
luciferase	BEGIN-luciferase-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	I-NP	O

Complexities	Complexity	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
-	-	HYPH	B-NP	O
pathogen	pathogen	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
during	during	IN	B-PP	O
actual	actual	JJ	B-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
Gram	Gram	NN	B-NP	O
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
may	may	MD	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
difficulties	difficulty	NNS	I-NP	O
in	in	IN	B-PP	O
demonstrating	demonstrate	VBG	B-VP	O
this	this	DT	B-NP	O
phenomena	phenomenon	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

PKCI	BEGIN-PKCI	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIT	BEGIN-HIT	NN	I-NP	B
family	family-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
,	,	,	O	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
sequence	sequence	NN	B-NP	O
identity	identity	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
broad	broad	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
organisms	organism	NNS	B-NP	O
including	include	VBG	B-PP	O
mycoplasma	mycoplasma	NN	B-NP	O
,	,	,	O	O
plants	plant	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
humans	human	NNS	B-NP	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
/	/	SYM	O	O
mm1	mm1	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
;	;	:	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
.1	.1	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
twelve	twelve	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
inmates	inmate	NNS	I-NP	O
who	who	WP	B-NP	O
developed	develop	VBD	B-VP	O
AIDS	AIDS	NNP	B-NP	O
had	have	VBD	B-VP	O
counts	count	NNS	B-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
/	/	SYM	O	O
mm1	mm1	NN	B-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
only	only	RB	B-NP	O
six	six	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
controls	control	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
.1	.1	NN	B-NP	O
)	)	)	O	O

Hpr1	BEGIN-Hpr1-INSIDE	NN	B-NP	B
forms	form	NNS	I-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
Tho1	BEGIN-Tho1-INSIDE	NN	B-NP	B
,	,	,	O	O
Mft1	BEGIN-Mft1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
Thp1	BEGIN-Thp1-INSIDE	NN	B-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
THO	BEGIN-THO	NN	I-NP	B
complex	complex-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
controls	control	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
elongation	elongation	NN	I-NP	O
and	and	CC	O	O
genome	genome	NN	B-NP	O
stability	stability	NN	I-NP	O
in	in	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
objective	objective	JJ	B-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
ripening	ripening	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	O
E1	E1	NN	I-NP	O
and	and	CC	O	O
prelabor	prelabor	NN	B-NP	O
contractility	contractility	NN	I-NP	O

Insulin	BEGIN-Insulin-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
secreting	secrete	VBG	B-VP	O
islet	islet	NN	B-NP	O
-	-	HYPH	I-NP	O
cell	cell	NN	I-NP	O
tumours	tumour	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pancreas	pancreas	NN	I-NP	O

Suprapubic	Suprapubic	JJ	B-NP	O
and	and	CC	I-NP	O
intravesical	intravesical	JJ	I-NP	O
methods	method	NNS	I-NP	O

Previous	Previous	JJ	B-NP	O
work	work	NN	I-NP	O
established	establish	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
TAL1	BEGIN-TAL1	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
phosphorylated	phosphorylate	VBN	I-VP	O
exclusively	exclusively	RB	B-ADVP	O
on	on	IN	B-PP	O
serine	serine	NN	B-NP	O
and	and	CC	O	O
identified	identify	VBD	B-VP	O
Ser1	Ser1	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
substrate	substrate	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
mitogen	BEGIN-mitogen	NN	I-NP	B
-	-	HYPH	B-VP	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
ERK	BEGIN-ERK	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
ALAD	BEGIN-ALAD-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
and	and	CC	I-NP	O
EP	EP	NN	I-NP	O
as	as	IN	B-PP	O
cumulative	cumulative	JJ	B-NP	O
lead	lead	NN	I-NP	O
exposure	exposure	NN	I-NP	O
indicators	indicator	NNS	I-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O

Immunofluorescence	Immunofluorescence	NN	B-NP	O
obtained	obtain	VBN	B-VP	O
using	use	VBG	B-VP	O
antibodies	antibody	NNS	B-NP	O
against	against	IN	B-PP	O
alphaI	BEGIN-alphaI	NN	B-NP	B
SigmaI	SigmaI	NN	I-NP	I
/	/	SYM	B-NP	I
++betaI	++betaI	NN	I-NP	I
SigmaI	SigmaI	NN	I-NP	I
spectrin	spectrin-INSIDE	NN	I-NP	I
and	and	CC	O	O
Abl	BEGIN-Abl	NN	B-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
but	but	CC	B-PP	O
not	not	RB	O	O
against	against	IN	B-PP	O
alphaII	BEGIN-alphaII	NN	B-NP	B
/	/	SYM	B-NP	I
betaII	betaII	NN	I-NP	I
spectrin	spectrin-INSIDE	NN	I-NP	I
colocalized	colocalize	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
overexpressed	overexpresse	VBN	I-NP	O
green	BEGIN-green	JJ	I-NP	B
fluorescent	fluorescent	JJ	I-NP	I
protein	protein-INSIDE	JJ	I-NP	I
-	-	HYPH	I-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
showed	show	VBD	B-VP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
Stroop	Stroop	NNP	I-NP	O
task	task	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
measure	measure	NN	I-NP	O
of	of	IN	B-PP	O
implicit	implicit	JJ	B-NP	O
processing	processing	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
stimuli	stimulus	NNS	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
light	light	NN	I-NP	O
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
CPRF	BEGIN-BEGIN-CPRF-INSIDE	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
insensitive	insensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
post	post	AFX	I-NP	O
-	-	HYPH	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
controls	control	VBZ	B-VP	O
CPRF	BEGIN-CPRF-INSIDE	NN	B-NP	B
accumulation	accumulation	NN	I-NP	O

1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
,	,	,	O	O
in	in	IN	B-PP	O
RCC	RCC	NN	B-NP	O
samples	sample	NNS	I-NP	O
with	with	IN	B-PP	O
VHL	BEGIN-VHL-INSIDE	NN	B-NP	B
methylation	methylation	NN	I-NP	O
or	or	CC	I-NP	O
mutation	mutation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
1p1	1p1	NN	B-NP	O
-	-	HYPH	B-NP	O
p1	p1	NN	I-NP	O
LOH	LOH	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
differ	differ	VB	I-VP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
sp1	sp1	NN	B-NP	O
-	-	HYPH	B-NP	O
p1	p1	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
vs	v	NNS	I-NP	O

One	One	CD	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
chronic	chronic	JJ	B-NP	O
dysphoria	dysphoria	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
encephalopatia	encephalopatia	NN	I-NP	O
toxica	toxica	NN	I-NP	O

A	A	DT	B-NP	O
single	single	JJ	I-NP	O
clone	clone	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
conserved	conserve	VBN	I-VP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
near	near	JJ	B-NP	O
-	-	HYPH	I-NP	O
perfect	perfect	JJ	I-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
eight	eight	CD	B-NP	O
human	human	JJ	I-NP	O
/	/	SYM	I-NP	O
rodent	rodent	NN	I-NP	O
expressed	express	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
tags	tag	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
template	template	NN	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
rapid	rapid	JJ	I-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	O
ends	end	NNS	I-NP	O
and	and	CC	O	O
SPICE	SPICE	NN	B-NP	O
(	(	(	O	O
system	system	NN	B-NP	O
for	for	IN	B-PP	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	O
ends	end	NNS	I-NP	O
)	)	)	O	O
reactions	reaction	NNS	B-NP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
,	,	,	O	O
LGL1	BEGIN-LGL1-INSIDE	NN	B-NP	B
(	(	(	O	O
Genbank	BEGIN-Genbank	NN	B-NP	B
,	,	,	O	I
AF	AF	NN	B-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
(	(	(	O	O
lgl1	BEGIN-lgl1-INSIDE	NN	B-NP	B
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
dimethyl	dimethyl	NN	B-NP	O
sulfoxide	sulfoxide	NN	I-NP	O
on	on	IN	B-PP	O
cooling	cool	VBG	B-VP	O
rates	rate	NNS	B-NP	O
of	of	IN	B-PP	O
unrestrained	unrestrained	JJ	B-NP	O
rats	rat	NNS	I-NP	O

The	The	DT	B-NP	O
GIS	GIS	NN	I-NP	O
software	software	NN	I-NP	O
program	program	NN	I-NP	O
,	,	,	O	O
ArcView	ArcView	NNP	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
spatial	spatial	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	I-NP	O
distance	distance	NN	I-NP	O
calculations.	calculations.	NN	I-NP	O
chi1	chi1	NN	I-NP	O
Tests	Test	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
characteristics	characteristic	NNS	I-NP	O
between	between	IN	B-PP	O
intersection	intersection	NN	B-NP	O
and	and	CC	I-NP	O
midblock	midblock	NN	I-NP	O
collisions	collision	NNS	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HU	BEGIN-HU	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
invertasome	invertasome	NN	B-NP	O
assembly	assembly	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
enhancer	enhancer	NN	I-NP	O
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
variable	variable	JJ	B-NP	O
positions	position	NNS	I-NP	O
close	close	RB	B-ADJP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
recombination	recombination	NN	I-NP	O
sites	site	NNS	I-NP	O

We	We	PRP	B-NP	O
compared	compare	VBD	B-VP	O
these	these	DT	B-NP	O
responses	response	NNS	I-NP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
hatchling	hatchling	NN	I-NP	O
and	and	CC	O	O
eight	eight	CD	B-NP	O
adult	adult	JJ	I-NP	O
Chrysemys	Chrysemys	NNP	I-NP	O
picta	picta	NN	I-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
Ohio	Ohio	NNP	I-NP	O
population	population	NN	I-NP	O

The	The	DT	B-NP	O
likelihood	likelihood	NN	I-NP	O
of	of	IN	B-PP	O
death	death	NN	B-NP	O
was	be	VBD	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
times	time	NNS	I-NP	O
higher	high	JJR	I-ADJP	O
among	among	IN	B-PP	O
patients	patient	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ERA	ERA	NN	I-NP	O
-	-	HYPH	I-NP	O
II	II	CD	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
mortality	mortality	NN	B-NP	O
risk	risk	NN	I-NP	O
ratio	ratio	NN	I-NP	O
1	1	CD	I-NP	O
[	[	(	O	O
1	1	CD	B-NP	O
CI	CI	NN	I-NP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
]	]	)	O	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

Pros	Pro	NNS	B-NP	O
and	and	CC	I-NP	O
cons	con	NNS	I-NP	O
of	of	IN	B-PP	O
selective	selective	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
cyclooxygenase	BEGIN-BEGIN-cyclooxygenase-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
1	1-INSIDE	NN	I-NP	I
versus	versus	IN	B-PP	O
dual	dual	JJ	B-NP	O
lipoxygenase	BEGIN-lipoxygenase-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
cyclooxygenase	BEGIN-cyclooxygenase-INSIDE	NN	I-NP	B
inhibition	inhibition	NN	I-NP	O
:	:	:	O	O
is	be	VBZ	B-VP	O
two	two	CD	B-NP	O
better	good	JJR	B-ADJP	O
than	than	IN	B-PP	O
one	one	CD	B-NP	O

INTERNET	INTERNET	NN	B-NP	O
is	be	VBZ	B-VP	O
literally	literally	RB	B-ADVP	O
a	a	DT	B-NP	O
world	world	NN	I-NP	O
of	of	IN	B-PP	O
data	datum	NNS	B-NP	O
,	,	,	O	O
dialogue	dialogue	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
discourse	discourse	VB	B-VP	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
topic	topic	JJ	I-NP	O
imaginable	imaginable	JJ	I-NP	O
,	,	,	I-NP	O
right	right	JJ	I-NP	O
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
fingertips	fingertip	NNS	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anticodon	anticodon	NN	I-NP	O
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
psi	psi	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
also	also	RB	B-ADVP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
suppressor	suppressor	NN	I-NP	O
efficiency	efficiency	NN	I-NP	O
displayed	display	VBN	B-VP	O
by	by	IN	B-PP	O
cytoplasmic	BEGIN-cytoplasmic	JJ	B-NP	B
tRNA	tRNA	NN	I-NP	I
(	(	(	O	I
Tyr	Tyr	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I

We	We	PRP	B-NP	O
established	establish	VBD	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
unstimulated	unstimulated	JJ	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Src	BEGIN-Src	NN	I-NP	B
homology	homology	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
SH1	BEGIN-SH1-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
SH1	BEGIN-BEGIN-SH1-INSIDE	NN	B-NP	B
domain	domain	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
protein	protein-INSIDE	JJ	B-NP	I
Grb1	BEGIN-Grb1-INSIDE	NN	I-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
subunit	subunit	NN	I-NP	O
of	of	IN	B-PP	O
phosphatidylinositol	BEGIN-phosphatidylinositol	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
associate	associate	VBP	B-VP	O
constitutively	constitutively	RB	B-ADVP	O
with	with	IN	B-PP	O
Cbl	BEGIN-Cbl-INSIDE	NN	B-NP	B
via	via	IN	B-PP	O
their	their	PRP$	B-NP	O
SH1	BEGIN-BEGIN-SH1-INSIDE	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
Fc	BEGIN-Fc	NN	B-NP	B
epsilon	epsilon	NN	I-NP	I
R1	R1-INSIDE	NN	I-NP	I
cross	cross	AFX	O	O
-	-	HYPH	B-VP	O
linking	link	VBG	I-VP	O
activates	activate	VBZ	B-VP	O
PI	BEGIN-PI	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
construct	construct	NN	I-NP	O
(	(	(	O	O
pBLCAT	pBLBEGIN-CAT-INSIDE	NN	B-NP	I
-	-	HYPH	B-NP	O
ENDOA	BEGIN-ENDOA-INSIDE	NN	I-NP	B
)	)	)	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
1AQS1	1AQS1	NN	B-NP	O
cells	cell	NNS	I-NP	O

Indirect	Indirect	JJ	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
maximal	maximal	JJ	B-NP	O
O1	O1	NN	I-NP	O
consumption	consumption	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O

The	The	DT	B-NP	O
two	two	CD	I-NP	O
complexes	complex	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
activation	activation	NN	I-NP	O
kinetics	kinetic	NNS	I-NP	O
upon	upon	IN	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
stimulation	stimulation	NN	I-NP	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
ventricular	ventricular	JJ	I-NP	O
ectopic	ectopic	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
detected	detect	VBN	B-VP	O
by	by	IN	B-PP	O
either	either	DT	B-NP	O
or	or	CC	O	O
both	both	DT	B-NP	O
methods	method	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
common	common	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
percent	percent	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
percent	percent	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
eating	eat	VBG	B-VP	O
dark	dark	JJ	B-NP	O
-	-	HYPH	I-NP	O
meat	meat	NN	I-NP	O
fish	fish	NN	I-NP	O
was	be	VBD	B-VP	O
positively	positively	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
serum	serum	NN	B-NP	O
eicosapentaenoic	eicosapentaenoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
and	and	CC	O	O
docosahexaenoic	docosahexaenoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
omega1	omega1	NN	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
inversely	inversely	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
serum	serum	NN	B-NP	O
stearic	stearic	JJ	I-NP	O
acid	acid	NN	I-NP	O
and	and	CC	O	O
linoleic	linoleic	JJ	B-NP	O
acid	acid	NN	I-NP	O

These	These	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	B-NP	I
oxoguanine	oxoguanine	NN	I-NP	I
DNA	DNA	NN	I-NP	I
glycosylases	glycosylases-INSIDE	NN	I-NP	I
,	,	,	O	O
hOgg1	BEGIN-hOgg1-INSIDE	NN	B-NP	B
(	(	(	O	O
human	human	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
mOgg1	BEGIN-mOgg1-INSIDE	NN	B-NP	B
(	(	(	O	O
murine	murine	JJ	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
are	be	VBP	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
yeast	BEGIN-yeast	NN	B-NP	B
Ogg1	Ogg1-INSIDE	NN	I-NP	I

HDE	BEGIN-HDE-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
exclusively	exclusively	RB	I-VP	O
targeted	target	VBN	I-VP	O
to	to	TO	B-PP	O
and	and	CC	O	O
imported	import	VBN	B-VP	O
into	into	IN	B-PP	O
peroxisomes	peroxisome	NNS	B-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
heterologous	heterologous	JJ	I-NP	O
expression	expression	NN	I-NP	O
systems	system	NNS	I-NP	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
ICSBP	BEGIN-ICSBP-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
PU.1	BEGIN-PU.1-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
critical	critical	JJ	B-NP	O
elements	element	NNS	I-NP	O
for	for	IN	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O

Model	Model	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
on	on	IN	B-PP	O
pheasants	pheasant	NNS	B-NP	O
using	use	VBG	B-VP	O
single	single	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
insecticide	insecticide	NN	I-NP	O
(	(	(	O	O
Lindane	Lindane	NN	B-NP	O
)	)	)	O	O
the	the	DT	B-NP	O
herbicide	herbicide	NN	I-NP	O
(	(	(	O	O
Terbutryn	Terbutryn	NN	B-NP	O
)	)	)	O	O
a	a	DT	B-NP	O
mineral	mineral	NN	I-NP	O
fertilizer	fertilizer	NN	I-NP	O
(	(	(	O	O
calcium	calcium	NN	B-NP	O
ammonium	ammonium	NN	I-NP	O
nitrate	nitrate	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
fungicide	fungicide	NN	I-NP	O
(	(	(	O	O
HCB	HCB	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
main	main	JJ	I-NP	O
side	side	NN	I-NP	O
-	-	HYPH	I-NP	O
effects	effect	NNS	I-NP	O
were	be	VBD	B-VP	O
myelosuppression	myelosuppression	NN	B-NP	O
,	,	,	I-NP	O
mucositis	mucositis	NN	I-NP	O
and	and	CC	I-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
all	all	DT	B-NP	O
common	common	JJ	I-NP	O
and	and	CC	I-NP	O
often	often	RB	I-NP	O
severe	severe	JJ	I-NP	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
support	support	NN	I-NP	O
system	system	NN	I-NP	O
uses	use	VBZ	B-VP	O
the	the	DT	B-NP	O
network	network	NN	I-NP	O
at	at	IN	B-PP	O
its	its	PRP$	B-NP	O
core	core	NN	I-NP	O
and	and	CC	O	O
helps	help	VBZ	B-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
in	in	IN	B-PP	O
reaching	reach	VBG	B-VP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
in	in	IN	B-PP	O
finding	find	VBG	B-VP	O
the	the	DT	B-NP	O
optimal	optimal	JJ	I-NP	O
way	way	NN	I-NP	O
to	to	TO	B-VP	O
reach	reach	VB	I-VP	O
that	that	IN	B-SBAR	O
diagnosis	diagnosis	NN	B-NP	O

Metapsychiatry	Metapsychiatry	NNP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
term	term	NN	I-NP	O
born	bear	VBN	B-VP	O
of	of	IN	B-PP	O
necessity	necessity	NN	B-NP	O
to	to	TO	B-VP	O
designate	designate	VB	I-VP	O
the	the	DT	B-NP	O
important	important	JJ	I-NP	O
but	but	CC	I-NP	O
hitherto	hitherto	RB	I-NP	O
unclassified	unclassified	JJ	I-NP	O
interface	interface	NN	I-NP	O
between	between	IN	B-PP	O
psychiatry	psychiatry	NN	B-NP	O
and	and	CC	I-NP	O
mysticism	mysticism	NN	I-NP	O

Repression	Repression	NN	B-NP	O
was	be	VBD	B-VP	O
strictly	strictly	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
upstream	upstream	JJ	B-NP	O
Oshox1	BEGIN-Oshox1-INSIDE	NN	I-NP	B
binding	binding	NN	I-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
constructs	construct	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
Oshox1	BEGIN-Oshox1-INSIDE	NN	B-NP	B
,	,	,	O	O
preceding	precede	VBG	B-VP	O
the	the	DT	B-NP	O
homeodomain	BEGIN-homeodomain-INSIDE	NN	I-NP	B

Experimental	Experimental	JJ	B-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
plasma	BEGIN-plasma	NN	B-NP	B
ACTH	ACTH-INSIDE	NN	I-NP	I
radioimmunoassay	radioimmunoassay	NN	I-NP	O
kit	kit	NN	I-NP	O
without	without	IN	B-PP	O
extraction	extraction	NN	B-NP	O
process	process	NN	I-NP	O

Defects	Defect	NNS	B-NP	O
in	in	IN	B-PP	O
RT1	BEGIN-RT1-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
coincide	coincide	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
in	in	IN	B-PP	O
animal	animal	NN	B-NP	O
models	model	NNS	I-NP	O
for	for	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
autoimmune	autoimmune	JJ	I-NP	O
diseases	disease	NNS	I-NP	O

By	By	IN	B-PP	O
cloning	clone	VBG	B-VP	O
genes	gene	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
benzene	benzene	NN	B-NP	O
-	-	HYPH	B-NP	O
degradative	degradative	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
strain	strain	NN	B-NP	O
JS1	JS1	NN	I-NP	O
also	also	RB	B-ADVP	O
carries	carry	VBZ	B-VP	O
genes	gene	NNS	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
toluene	BEGIN-toluene	NN	I-NP	B
/	/	SYM	B-NP	I
benzene	benzene	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
monooxygenase	monooxygenase-INSIDE	NN	I-NP	I

Thus	Thus	RB	B-NP	O
G1	BEGIN-G1-INSIDE	NN	I-NP	B
targets	target	VBZ	B-VP	O
the	the	DT	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	I-NP	I
fos	fos	NN	I-NP	I
promoter	promoter	NN	I-NP	I
CArG	CArG	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
via	via	IN	B-PP	O
Rho	BEGIN-Rho	JJ	B-NP	B
A	A-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Rho	BEGIN-Rho	JJ	B-NP	B
A	A-INSIDE	NN	I-NP	I
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
trophic	trophic	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
G1	BEGIN-G1-INSIDE	NN	B-NP	B

By	By	IN	B-PP	O
contrast	contrast	NN	B-NP	O
with	with	IN	B-PP	O
ama	BEGIN-ama	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
rpc	BEGIN-rpc	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
deleted	delete	VBN	I-VP	O
by	by	IN	B-PP	O
mDf1	mDf1	NN	B-NP	O
or	or	CC	O	O
larger	large	JJR	B-NP	O
deficiencies	deficiency	NNS	I-NP	O
examined	examine	VBN	B-VP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
are	be	VBP	B-VP	O
no	no	RB	B-ADJP	O
closer	close	JJR	I-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteriophage	BEGIN-bacteriophage	NN	I-NP	B
T1	T1	NN	I-NP	I
DNA	DNA	NN	I-NP	I
terminase	terminase	NN	I-NP	I
genes	gene	NNS	I-NP	I
1	1	CD	B-NP	I
and	and	CC	O	I
1	1-INSIDE	NN	B-NP	I
yields	yield	VBZ	B-VP	O
multiple	multiple	JJ	B-NP	O
proteins	protein	NNS	I-NP	O

Rat	BEGIN-Rat	NN	B-NP	B
p1	p1	NN	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
discovered	discover	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
its	its	PRP$	B-NP	O
strong	strong	JJ	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
pancreas	pancreas	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O

Dual	Dual	JJ	B-NP	O
signal	signal	NN	I-NP	O
peptides	peptide	NNS	I-NP	O
mediate	mediate	VBP	B-VP	O
the	the	DT	B-NP	O
signal	BEGIN-signal	JJ	I-NP	B
recognition	recognition	NN	I-NP	I
particle	particle-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
Sec	BEGIN-Sec-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
independent	independent	JJ	I-NP	O
insertion	insertion	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
thylakoid	thylakoid	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
polyprotein	polyprotein	NN	I-NP	O
,	,	,	O	O
PsbY	BEGIN-PsbY-INSIDE	NN	B-NP	B

Sequence	Sequence	NN	B-NP	O
divergence	divergence	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
reduced	reduce	VBN	I-NP	O
transformation	transformation	NN	I-NP	O
frequencies	frequency	NNS	I-NP	O
by	by	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	I-NP	O

During	During	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
CS	CS	NN	I-NP	O
-	-	HYPH	I-NP	O
alone	alone	JJ	I-NP	O
trials	trial	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
responses	response	NNS	I-NP	O
of	of	IN	B-PP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
MK	MK	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
injected	inject	VBN	I-NP	O
mice	mouse	NNS	I-NP	O
were	be	VBD	B-VP	O
extinguished	extinguish	VBN	I-VP	O
as	as	RB	B-ADVP	O
easily	easily	RB	I-ADVP	O
as	as	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
saline	saline	NN	B-NP	O
-	-	HYPH	B-NP	O
injected	inject	VBN	I-NP	O
mice	mouse	NNS	I-NP	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
respective	respective	JJ	I-NP	O
time	time	NN	I-NP	O
control	control	NN	I-NP	O
groups	group	NNS	I-NP	O
(	(	(	O	O
C1	C1	NN	B-NP	O
,	,	,	O	O
C1	C1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
C1	C1	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
injected	inject	VBN	I-VP	O
with	with	IN	B-PP	O
saline	saline	NN	B-NP	O
solution	solution	NN	I-NP	O

Next	Next	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
ERM	BEGIN-ERM-INSIDE	NN	I-NP	B
interaction	interaction	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
reexamined	reexamine	VBD	B-VP	O
the	the	DT	B-NP	O
immunoprecipitated	immunoprecipitate	VBN	I-NP	O
CD1	BEGIN-CD1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
ERM	BEGIN-ERM-INSIDE	NN	I-NP	B
complex	complex	NN	I-NP	O
from	from	IN	B-PP	O
BHK	BHK	NN	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
contains	contain	VBZ	B-VP	O
Rho	BEGIN-Rho	JJ	B-NP	B
-	-	HYPH	I-NP	I
GDP	GDP	NN	I-NP	I
dissociation	dissociation	NN	I-NP	I
inhibitor	inhibitor-INSIDE	NN	I-NP	I
(	(	(	O	O
GDI	BEGIN-GDI-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
Rho	BEGIN-Rho	NN	B-NP	B
GTPase	GTPase-INSIDE	NN	I-NP	I

Ten	Ten	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
aged	age	VBN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
terminal	terminal	JJ	I-NP	O
jejunostomy	jejunostomy	NN	I-NP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
meter	meter	NN	I-NP	O
of	of	IN	B-PP	O
jejunum	jejunum	NN	B-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
by	by	IN	B-PP	O
infusion	infusion	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
elemental	elemental	JJ	I-NP	O
diet	diet	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
(	(	(	O	O
IEDDSB	IEDDSB	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
illuminator	illuminator	NN	I-NP	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
grain	grain	NN	I-NP	O
-	-	HYPH	B-NP	O
of	of	IN	B-PP	O
-	-	HYPH	B-NP	O
wheat	wheat	NN	I-NP	O
light	light	NN	I-NP	O
bulb	bulb	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
adjustable	adjustable	JJ	I-NP	O
bulb	bulb	NN	I-NP	O
holder	holder	NN	I-NP	O
fashioned	fashion	VBN	B-VP	O
from	from	IN	B-PP	O
bent	bent	JJ	B-NP	O
paper	paper	NN	I-NP	O
clips	clip	NNS	I-NP	O

The	The	DT	B-NP	O
goals	goal	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
experiments	experiment	NNS	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
lactational	lactational	JJ	B-NP	O
anestrus	anestrus	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
prolonged	prolong	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
h	h	NN	I-NP	O
fast	fast	RB	B-ADVP	O
at	at	IN	B-PP	O
days	day	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
postpartum	postpartum	NN	I-NP	O
(	(	(	O	O
pp	pp	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
,	,	,	O	O
if	if	IN	B-SBAR	O
so	so	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
effect	effect	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
reversed	reverse	VBN	I-VP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Ob	BEGIN-Ob	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
leptin	BEGIN-leptin-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	O
1C	1C	NN	I-NP	O
]	]	)	I-NP	O
NG	NG	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dosed	dose	VBN	I-NP	O
animals	animal	NNS	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
necrotising	necrotise	VBG	B-VP	O
fasciitis	fasciitis	NN	B-NP	O
the	the	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
PO1	PO1	NN	I-NP	O
rose	rise	VBD	B-VP	O
about	about	RB	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-VP	O
fold	fold	RB	B-ADVP	O
whereas	whereas	IN	B-PP	O
the	the	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
PCO1	PCO1	NN	I-NP	O
increased	increase	VBD	B-VP	O
only	only	RB	B-ADVP	O
slightly	slightly	RB	I-ADVP	O
during	during	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
absolute	absolute	JJ	I-NP	O
atmospheres	atmosphere	NNS	I-NP	O
(	(	(	O	O
ATA	ATA	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O

Coronary	Coronary	JJ	B-NP	O
arteriographies	arteriography	NNS	I-NP	O
and	and	CC	I-NP	O
ventriculographies	ventriculography	NNS	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
consecutive	consecutive	JJ	I-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
January	January	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
October	October	NNP	I-NP	O
,	,	,	O	O
1	1	LS	B-LST	O
)	)	)	O	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
are	be	VBP	B-VP	O
reviewed	review	VBN	I-VP	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
processing	processing	NN	B-NP	O
time	time	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
intensity	intensity	NN	B-NP	O
is	be	VBZ	B-VP	O
modified	modify	VBN	I-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
retina	retina	NN	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
at	at	IN	B-PP	O
later	late	JJR	B-NP	O
processing	processing	NN	I-NP	O
sites	site	NNS	I-NP	O

Lag	Lag	NN	B-NP	O
phases	phase	NNS	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
hours	hour	NNS	I-NP	O
+	+	SYM	O	O
/	/	SYM	B-NP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
hours	hour	NNS	I-NP	O
+	+	SYM	O	O
/	/	SYM	B-NP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
hours	hour	NNS	I-NP	O
+	+	SYM	O	O
/	/	SYM	B-NP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
hours	hour	NNS	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
for	for	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
LDL	BEGIN-LDL-INSIDE	NN	I-NP	B
oxidation	oxidation	NN	I-NP	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
Ogg1	BEGIN-Ogg1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
eukaryotic	eukaryotic	JJ	I-NP	O
DNA	BEGIN-DNA	NN	I-NP	B
glycosylase	glycosylase-INSIDE	NN	I-NP	I
/	/	SYM	B-VP	O
AP	BEGIN-AP	NN	B-NP	B
lyase	lyase-INSIDE	NN	I-NP	I

Being	Be	VBG	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
GK	BEGIN-GK	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
regulations	regulation	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
,	,	,	O	O
IPF1	BEGIN-IPF1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
STF	BEGIN-STF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
PDX	BEGIN-PDX	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
maintaining	maintain	VBG	B-VP	O
normal	normal	JJ	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
cell	cell	NN	I-NP	O
functions	function	NNS	I-NP	O

MATERIAL	MATERIAL	NN	B-NP	O
AND	AND	CC	I-NP	O
METHODS	METHODS	NNS	I-NP	O
:	:	:	O	O

Salt	Salt	NN	B-NP	O
wars	war	NNS	I-NP	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
synthetic	synthetic	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
substrates	substrate	NNS	B-NP	O
for	for	IN	B-PP	O
PR	BEGIN-PR-INSIDE	NN	B-NP	B

As	As	IN	B-PP	O
an	an	DT	B-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
structure	structure	NN	B-NP	O
-	-	HYPH	B-NP	O
function	function	NN	I-NP	O
relationships	relationship	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PRP1	BEGIN-PRP1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
fifty	fifty	CD	I-NP	O
new	new	JJ	I-NP	O
alleles	allele	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PRP1	BEGIN-PRP1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
through	through	IN	B-PP	O
random	random	NN	B-NP	O
and	and	CC	I-NP	O
site	site	NN	I-NP	O
-	-	HYPH	O	O
directed	direct	VBN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
the	the	DT	B-NP	O
phenotypes	phenotype	NNS	I-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O

Brainstem	Brainstem	NN	B-NP	O
auditory	auditory	JJ	I-NP	O
evoked	evoked	JJ	I-NP	O
potential	potential	JJ	I-NP	O
responses	response	NNS	I-NP	O
(	(	(	O	O
BAEPs	BAEP	NNS	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
from	from	IN	B-PP	O
CZ	CZ	NN	B-NP	O
-	-	HYPH	B-NP	O
A1	A1	NN	I-NP	O
and	and	CC	I-NP	O
CZ	CZ	NN	I-NP	O
-	-	HYPH	B-NP	O
A1	A1	NN	I-NP	O
scalp	scalp	NN	I-NP	O
regions	region	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
hypertensive	hypertensive	JJ	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
normotensive	normotensive	JJ	I-NP	O
subjects	subject	NNS	I-NP	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
Gly1Arg	Gly1Arg	NN	I-NP	O
substitution	substitution	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
UM	UM	NN	B-NP	O
:	:	:	O	O
JG1	JG1	NN	B-NP	O
is	be	VBZ	B-VP	O
non	non	AFX	B-ADJP	O
-	-	HYPH	O	O
conservative	conservative	JJ	B-ADJP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
possible	possible	JJ	B-ADJP	O
to	to	TO	B-VP	O
distinguish	distinguish	VB	I-VP	O
whether	whether	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
mutation	mutation	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
polymorphism	polymorphism	NN	I-NP	O

Two	Two	CD	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
Ras	BEGIN-Ras-INSIDE	NN	I-NP	B
GTPase	BEGIN-GTPase	NN	I-NP	B
-	-	HYPH	O	I
activating	activate	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
bind	bind	VBP	B-VP	O
synergistically	synergistically	RB	B-ADVP	O
to	to	TO	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylated	phosphorylated	JJ	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
Rho	Rho	NN	I-NP	O
GTPase	BEGIN-GTPase	NN	I-NP	B
-	-	HYPH	O	I
activating	activate	VBG	B-VP	I
protein.	protein-INSIDE.	JJ	B-NP	I
p1	BEGIN-p1-INSIDE	NN	I-NP	B
GTPase	BEGIN-GTPase	NN	I-NP	B
-	-	HYPH	O	I
activating	activate	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
GAP	BEGIN-GAP-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
Ras	BEGIN-Ras-INSIDE	NN	B-NP	B
that	that	WDT	B-NP	O
functions	function	VBZ	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
relay	relay	NN	I-NP	O
point	point	NN	I-NP	O
in	in	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
that	that	WDT	B-NP	O
control	control	VBP	B-VP	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O

Phosphorylation	Phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ras	BEGIN-ras-INSIDE	NN	I-NP	B
GTPase	BEGIN-GTPase	NN	I-NP	B
-	-	HYPH	O	I
activating	activate	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
GAP	BEGIN-GAP-INSIDE	NN	B-NP	B
)	)	)	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
p1c	BEGIN-p1c	NN	I-NP	B
-	-	HYPH	O	I
fes	BEGIN-fes-INSIDE-INSIDE	NN	B-NP	I
protein	BEGIN-protein	NN	I-NP	B
-	-	HYPH	B-NP	I
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
GAP	BEGIN-GAP-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
fes	BEGIN-fes-INSIDE	NN	I-NP	B
complexes	complex	NNS	I-NP	O
via	via	IN	B-PP	O
an	an	DT	B-NP	O
SH1	BEGIN-SH1-INSIDE	NN	I-NP	B
domain	domain	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O

This	This	DT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
shift	shift	NN	I-NP	O
of	of	IN	B-PP	O
C1	C1	NN	B-NP	O
/	/	SYM	B-NP	O
C1	C1	NN	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
collagen	BEGIN-collagen-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
pronounced	pronounced	JJ	I-ADJP	O
(	(	(	O	O
maximal	maximal	JJ	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
C1	C1	NN	B-NP	O
/	/	SYM	B-NP	O
C1	C1	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
ADP	ADP	NN	B-NP	O
(	(	(	O	O
maximal	maximal	JJ	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
C1	C1	NN	B-NP	O
/	/	SYM	B-NP	O
C1	C1	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
permeability	permeability	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
normal	normal	JJ	I-NP	O
human	human	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
after	after	IN	B-PP	O
instillation	instillation	NN	B-NP	O
of	of	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
percent	percent	NN	I-NP	O
v	v	NN	I-NP	O
/	/	SYM	B-NP	O
v	v	NN	I-NP	O
)	)	)	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
domain	domain	NN	B-NP	O
deletion	deletion	NN	I-NP	O
mutants	mutant	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
strong	strong	JJ	B-NP	O
synergy	synergy	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
RRM	RRM	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
degenerate	degenerate	JJ	I-NP	O
RRM	RRM	NN	I-NP	O
repeat	repeat	NN	I-NP	O
in	in	IN	B-PP	O
binding	binding	NN	B-NP	O
to	to	TO	B-PP	O
RNA	RNA	NN	B-NP	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
eIF1E	BEGIN-eIF1E-INSIDE	NN	B-NP	B
transforms	transform	VBZ	B-VP	O
cells	cell	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
eIF1E	BEGIN-eIF1E-INSIDE	NN	B-NP	B
arrest	arrest	NN	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
G	G	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
cdc1	BEGIN-cdc1	NN	B-NP	B
mutants	mutants-INSIDE	NN	I-NP	I

ZF1	BEGIN-ZF1-INSIDE	NN	B-NP	B
specifically	specifically	RB	B-ADVP	O
binds	bind	VBZ	B-VP	O
the	the	DT	B-NP	O
ME1a1	ME1a1	NN	I-NP	O
element	element	NN	I-NP	O
with	with	IN	B-PP	O
higher	high	JJR	B-NP	O
affinity	affinity	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
ME1a1	ME1a1	NN	I-NP	O
element	element	NN	I-NP	O

The	The	DT	B-NP	O
unusual	unusual	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
TRAC	BEGIN-TRAC-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
relationship	relationship	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
any	any	DT	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
enigmatic	enigmatic	JJ	I-NP	O
Ku	BEGIN-Ku	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O

Structure	Structure	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
connective	connective	JJ	I-NP	O
stroma	stroma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
epididymis	epididymis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
zebu	zebu	NN	I-NP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
regions	region	NNS	B-NP	O
of	of	IN	B-PP	O
fibronectin	BEGIN-fibronectin-INSIDE	NN	B-NP	B
besides	besides	IN	B-PP	O
the	the	DT	B-NP	O
arginine	arginine	NN	I-NP	O
-	-	HYPH	B-NP	O
glycine	glycine	NN	I-NP	O
-	-	HYPH	B-NP	O
aspartic	aspartic	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
adhesive	adhesive	JJ	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
domain	domain	NN	B-NP	O
using	use	VBG	B-VP	O
site	site	NN	B-NP	O
-	-	HYPH	O	O
directed	direct	VBN	B-VP	O
mutagenesis	mutagenesis	NN	B-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
multiple	multiple	JJ	B-NP	O
genetic	genetic	JJ	I-NP	O
recombination	recombination	NN	I-NP	O
among	among	IN	B-PP	O
bacteriophages	bacteriophage	NNS	B-NP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
immunities	immunity	NNS	I-NP	O
took	take	VBD	B-VP	O
place	place	NN	B-NP	O
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
the	the	DT	B-NP	O
prophage	prophage	NN	I-NP	O
VT1	VT1	NN	I-NP	O
-	-	HYPH	O	O
Sakai	Sakai	NNP	B-NP	O

Transient	Transient	JJ	B-NP	O
-	-	HYPH	I-NP	O
expression	expression	NN	I-NP	O
assay	assay	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
subclones	subclone	NNS	B-NP	O
of	of	IN	B-PP	O
pPstI	pPstI	NN	B-NP	O
-	-	HYPH	B-NP	O
G	G	NN	I-NP	O
localized	localize	VBD	B-VP	O
the	the	DT	B-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
active	active	JJ	I-NP	O
factor	factor	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	B-NP	I
kilobase	kilobase	NN	I-NP	I
XbaI	XbaI	NN	I-NP	I
fragment	fragment-INSIDE	NN	I-NP	I

We	We	PRP	B-NP	O
used	use	VBD	B-VP	O
an	an	DT	B-NP	O
immobilized	immobilize	VBN	I-NP	O
template	template	NN	I-NP	O
-	-	HYPH	O	O
based	base	VBN	B-NP	O
assay	assay	NN	I-NP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
transcription	transcription	NN	B-NP	O
termination	termination	NN	I-NP	O
by	by	IN	B-PP	O
VA1	BEGIN-VA1-INSIDE	NN	B-NP	B
,	,	,	O	O
1SL	BEGIN-1SL-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
Alu	BEGIN-BEGIN-Alu-INSIDE	NN	B-NP	B
class	class	NN	I-NP	O
III	III-INSIDE	NN	I-NP	I
templates	template	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
transcript	transcript	NN	B-NP	O
release	release	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pol	BEGIN-pol	NN	I-NP	B
III	III-INSIDE	NN	I-NP	I
terminator	terminator	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
processing	processing	NN	B-NP	O
of	of	IN	B-PP	O
B1	BEGIN-B1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
Alu	BEGIN-Alu-INSIDE	NN	I-NP	B
transcripts	transcript	NNS	I-NP	O

Concentrations	Concentration	NNS	B-NP	O
of	of	IN	B-PP	O
platelet	platelet	NN	B-NP	O
nitrite	nitrite	NN	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
nitrate	nitrate	NN	I-NP	O
/	/	SYM	B-NP	O
nitrite	nitrite	NN	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
using	use	VBG	B-VP	O
simple	simple	JJ	B-NP	O
and	and	CC	I-NP	O
sensitive	sensitive	JJ	I-NP	O
nitrate	nitrate	NN	I-NP	O
/	/	SYM	B-NP	O
nitrite	nitrite	NN	I-NP	O
fluorometric	fluorometric	JJ	I-NP	O
assay	assay	NN	I-NP	O
techniques	technique	NNS	I-NP	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
GTP	GTP	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
,	,	,	I-NP	O
brefeldin	brefeldin	NN	I-NP	O
A	A	NN	I-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
determined	determine	VBN	I-VP	O
here	here	RB	B-ADVP	O
the	the	DT	B-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
binding	binding	NN	I-NP	O
reaction	reaction	NN	I-NP	O

By	By	IN	B-PP	O
using	use	VBG	B-VP	O
methanol	methanol	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
M	M	NN	I-NP	O
borate	borate	JJ	I-NP	O
buffer	buffer	NN	I-NP	O
of	of	IN	B-PP	O
pH	pH	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
cate	BEGIN-cate	JJ	B-NP	B
-	-	HYPH	I-NP	I
chol	chol	NN	I-NP	I
-	-	HYPH	B-NP	I
O	O	NN	I-NP	I
-	-	HYPH	I-NP	I
methyltransferase	methyltransferase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
assayed	assay	VBN	I-VP	O

Replacement	Replacement	NN	B-NP	O
of	of	IN	B-PP	O
Val1	Val1	NN	B-NP	O
-	-	HYPH	B-NP	O
Leu1	Leu1	NN	I-NP	O
with	with	IN	B-PP	O
Ala	Ala	NN	B-NP	O
-	-	HYPH	B-NP	O
Ala	Ala	NN	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
dimeric	BEGIN-dimeric	JJ	I-NP	B
RII	RII	NN	I-NP	I
beta	beta	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
AKAP1	BEGIN-AKAP1-INSIDE	NN	B-NP	B
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
as	as	IN	B-SBAR	O
avidly	avidly	RB	B-ADVP	O
as	as	IN	B-PP	O
wild	BEGIN-wild	JJ	B-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
RII	RII	NN	I-NP	I
beta	beta-INSIDE	NN	I-NP	I

Plasmodium	Plasmodium	NN	B-NP	O
vivax	vivax	NN	I-NP	O
malaria	malaria	NN	I-NP	O

Postcontrast	Postcontrast	NN	B-NP	O
images	image	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
acquired	acquire	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sagittal	sagittal	JJ	I-NP	O
(	(	(	O	O
six	six	CD	B-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
coronal	coronal	JJ	B-ADJP	O
(	(	(	O	O
three	three	CD	B-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
planes	plane	NNS	B-NP	O

Conservation	Conservation	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
motif	motif	NN	I-NP	O
from	from	IN	B-PP	O
yeast	yeast	NN	B-NP	O
to	to	TO	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
human	human	JJ	B-NP	O
implies	imply	VBZ	B-VP	O
functional	functional	JJ	B-NP	O
importance	importance	NN	I-NP	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
death	death	NN	I-NP	O
assays	assay	NNS	I-NP	O
with	with	IN	B-PP	O
transient	transient	JJ	B-NP	O
overexpression	overexpression	NN	I-NP	O
of	of	IN	B-PP	O
deletion	deletion	NN	B-NP	O
constructs	construct	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
isoforms	isoform	NNS	I-NP	O
using	use	VBG	B-VP	O
beta	BEGIN-beta	NN	B-NP	B
-	-	HYPH	B-NP	I
galactosidase	galactosidase-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
a	a	DT	B-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
in	in	IN	B-PP	O
MCF1	MCF1	NN	B-NP	O
cells	cell	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
binding	binding	NN	I-NP	O
domain	domain	NN	I-NP	O
may	may	MD	B-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
killing	killing	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
DEFCAP	BEGIN-DEFCAP-INSIDE	NN	B-NP	B
;	;	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
LRR	BEGIN-LRR-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
CARD	BEGIN-CARD-INSIDE	NN	I-NP	B
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
constitutively	constitutively	RB	I-NP	O
active	active	JJ	I-NP	O
inducer	inducer	NN	I-NP	O
of	of	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
;	;	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
killing	killing	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
LRR	BEGIN-LRR-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
CARD	BEGIN-CARD-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
inhibitable	inhibitable	JJ	B-ADJP	O
by	by	IN	B-PP	O
benzyloxycarbonyl	benzyloxycarbonyl	NN	B-NP	O
-	-	HYPH	B-NP	O
Val	Val	NN	I-NP	O
-	-	HYPH	B-NP	O
Ala	Ala	NN	I-NP	O
-	-	HYPH	O	O
Asp	Asp	NN	B-NP	O
(	(	(	O	O
OMe	OMe	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
fluoromethyl	fluoromethyl	NN	I-NP	O
ketone	ketone	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
by	by	IN	B-PP	O
Asp	Asp	NN	B-NP	O
-	-	HYPH	B-NP	O
Glu	Glu	NN	I-NP	O
-	-	HYPH	B-NP	O
Val	Val	NN	I-NP	O
-	-	HYPH	O	O
Asp	Asp	NN	B-NP	O
(	(	(	O	O
OMe	OMe	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
fluoromethyl	fluoromethyl	NN	I-NP	O
ketone	ketone	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
1	1	LS	B-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
CARD	BEGIN-CARD-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
killing	kill	VBG	B-VP	O
activity	activity	NN	B-NP	O
of	of	IN	B-PP	O
DEFCAP	BEGIN-DEFCAP-INSIDE	NN	B-NP	B

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
provide	provide	VBP	B-VP	O
direct	direct	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
meiotic	meiotic	JJ	I-NP	O
defect	defect	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
either	either	CC	B-NP	O
unregulated	unregulated	JJ	I-NP	O
cAPK	BEGIN-cAPK-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O
or	or	CC	O	O
unregulated	unregulated	JJ	B-NP	O
ran1+	BEGIN-ran1+	JJ	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mei1+	BEGIN-mei1+	JJ	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
meiotic	meiotic	JJ	B-NP	O
initiation	initiation	NN	I-NP	O

Sailer	Sailer	NNP	B-NP	O
,	,	,	O	O
K	K	NNP	B-NP	O

The	The	DT	B-NP	O
terminal	terminal	JJ	I-NP	O
a	a	DT	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
herpes	herpes	NN	I-NP	O
simplex	simplex	NN	I-NP	O
virus	virus	NN	I-NP	O
genome	genome	NN	I-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
located	locate	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
repeat	repeat	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
L	L	NN	I-NP	O
component	component	NN	I-NP	O

The	The	DT	B-NP	O
Caenorhabditis	BEGIN-Caenorhabditis	NN	I-NP	B
elegans	elegan	VBZ	B-VP	I
NK	NK	NN	B-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
class	class	NN	I-NP	I
homeoprotein	homeoprotein	NN	I-NP	I
CEH	CEH	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
combinatorial	combinatorial	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
pharyngeal	pharyngeal	JJ	B-NP	O
muscle	muscle	NN	I-NP	O

As	As	IN	B-SBAR	O
tat	BEGIN-tat-INSIDE	NN	B-NP	B
itself	itself	PRP	B-NP	O
dramatically	dramatically	RB	B-ADVP	O
increases	increase	VBZ	B-VP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
too	too	RB	B-ADVP	O
is	be	VBZ	B-VP	O
presumably	presumably	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
latent	latent	JJ	I-NP	O
state	sBEGIN-tat-INSIDEe	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
mitogenic	mitogenic	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O

The	The	DT	B-NP	O
CBS	BEGIN-CBS	NNP	I-NP	B
-	-	HYPH	I-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
to	to	TO	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
1p1	1p1	NN	I-NP	O
between	between	IN	B-PP	O
markers	marker	NNS	B-NP	O
WI	BEGIN-WI	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
WI	BEGIN-WI	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
tightly	tightly	RB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
STRP	STRP	NN	I-NP	O
markers	marker	NNS	I-NP	O
of	of	IN	B-PP	O
D1S1	BEGIN-D1S1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
D1S1	BEGIN-D1S1-INSIDE	NN	I-NP	B

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
described	describe	VBN	I-VP	O
the	the	DT	B-NP	O
partial	partial	JJ	I-NP	O
purification	purification	NN	I-NP	O
of	of	IN	B-PP	O
Ap1A	BEGIN-Ap1A	NN	B-NP	B
hydrolase	hydrolase-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
S.	S.	FW	B-NP	O
pombe	pombe	FW	I-NP	O
[	[	(	O	O
Robinson	Robinson	NNP	B-NP	O
,	,	,	O	O
de	de	NNP	B-NP	O
la	la	NNP	I-NP	O
Pena	Pena	NNP	I-NP	O
and	and	CC	O	O
Barnes	Barnes	NNP	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
Biochim	Biochim	NNP	B-NP	O

Both	Both	DT	B-NP	O
flavoproteins	flavoprotein	NNS	I-NP	O
are	be	VBP	B-VP	O
active	active	JJ	B-ADJP	O
as	as	IN	B-PP	O
AhpC	BEGIN-AhpC	NN	B-NP	B
reductases	reductases-INSIDE	NN	I-NP	I
and	and	CC	O	O
mediate	mediate	VBP	B-VP	O
electron	electron	NN	B-NP	O
transfer	transfer	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
NADH	NADH	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
hydrogen	hydrogen	NN	B-NP	O
peroxide	peroxide	NN	I-NP	O
and	and	CC	O	O
cumene	cumene	NN	B-NP	O
hydroperoxide	hydroperoxide	NN	I-NP	O

Together	Together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
YTS1	BEGIN-YTS1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
bifunctional	bifunctional	JJ	I-NP	O
protein	protein	NN	I-NP	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	CC	O	O
splicing	splicing	NN	B-NP	O
and	and	CC	O	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
operon	operon	NN	I-NP	O
,	,	,	O	O
orf1	orf1	NN	B-NP	O
-	-	HYPH	B-NP	O
tolQRA	BEGIN-tolQRA-INSIDE	NN	I-NP	B
,	,	,	O	O
is	be	VBZ	B-VP	O
iron	iron	NN	B-NP	O
regulated	regulate	VBN	B-VP	O
throughout	throughout	IN	B-PP	O
growth	growth	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
iron	iron	NN	B-NP	O
-	-	HYPH	O	O
regulated	regulate	VBN	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
tolB	BEGIN-tolB-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
oprL	BEGIN-oprL	NN	I-NP	B
fusions	fusions-INSIDE	NN	I-NP	I
occurs	occur	VBZ	B-VP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
late	late	JJ	B-NP	O
log	log	NN	I-NP	O
phase	phase	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
STK1	BEGIN-STK1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
homologue	homologue	NN	I-NP	I
of	of	IN	B-PP	I
MO1	MO1-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
IFI1	IFI1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
interferon	BEGIN-interferon-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
human	human	JJ	B-NP	O
genes	gene	NNS	I-NP	O
closely	closely	RB	B-VP	O
linked	link	VBN	I-VP	O
on	on	IN	B-PP	O
syntenic	syntenic	JJ	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
1	1	CD	I-NP	O

Late	Late	RB	B-ADVP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
urotuberculosis	urotuberculosis	NN	B-NP	O

Blood	Blood	NN	B-NP	O
samples	sample	NNS	I-NP	O
for	for	IN	B-PP	O
determination	determination	NN	B-NP	O
of	of	IN	B-PP	O
fibrinolytic	fibrinolytic	JJ	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	I-NP	O
factor	BEGIN-factor	NN	I-NP	B
VIII	VIII-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
before	before	RB	B-ADVP	O
and	and	CC	O	O
immediately	immediately	RB	B-ADVP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
compression	compression	NN	B-NP	O
and	and	CC	I-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
stocking	stocking	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Exon	Exon	NN	B-NP	O
A1a	A1a	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
untranslated	untranslated	JJ	I-NP	O
region	region	NN	I-NP	O

Methylation	Methylation	NN	B-NP	O
interference	interference	NN	I-NP	O
analysis	analysis	NN	I-NP	O
established	establish	VBN	B-VP	O
at	at	IN	B-PP	O
single	single	JJ	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
resolution	resolution	NN	I-NP	O
that	that	WDT	B-NP	O
purified	purify	VBD	B-VP	O
recombinant	recombinant	JJ	B-NP	O
Fos	BEGIN-Fos-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
Jun	BEGIN-Jun	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
bind	bind	VBP	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
manner	manner	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
sites	sites-INSIDE	NN	I-NP	I
within	within	IN	B-PP	O
the	the	DT	B-NP	O
VDRE	VDRE	NN	I-NP	O
and	and	CC	I-NP	O
OC	BEGIN-OC	NN	I-NP	B
box	box-INSIDE	NN	I-NP	I

Also	Also	RB	B-ADVP	O
,	,	,	O	O
PTx	BEGIN-PTx-INSIDE	NN	B-NP	B
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
shear	shear	NN	B-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B

Cardiovascular	Cardiovascular	JJ	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
prizidilol	prizidilol	NN	I-NP	O
hydrochloride	hydrochloride	NN	I-NP	O
(	(	(	O	O
SK	SK	NN	B-NP	O
&	&	CC	I-NP	O
F	F	NN	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
;	;	:	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
agent	agent	NN	I-NP	O

The	The	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
p1	p1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
spans	span	NNS	I-NP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
exons	exon	NNS	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
encode	encode	VBP	B-VP	O
the	the	DT	B-NP	O
p1	BEGIN-p1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I

Partial	Partial	JJ	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CCAAT	CCAAT	NN	I-NP	O
box	box	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hLGFBP	BEGIN-hLGFBP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
:	:	:	O	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
negatively	negatively	RB	B-ADVP	O
acting	act	VBG	B-VP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
in	in	IN	B-PP	O
decidualized	decidualize	VBN	B-NP	O
human	human	JJ	I-NP	O
endometrial	endometrial	JJ	I-NP	O
stromal	stromal	JJ	I-NP	O
cells	cell	NNS	I-NP	O

Footprints	Footprint	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
HPV	BEGIN-HPV	NN	I-NP	B
1	1	CD	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I
show	show	NN	I-NP	O
five	five	CD	B-NP	O
protected	protect	VBN	I-NP	O
regions	region	NNS	I-NP	O
with	with	IN	B-PP	O
homologies	homology	NNS	B-NP	O
to	to	TO	B-PP	O
NF1	BEGIN-NF1-INSIDE	NN	B-NP	B
,	,	,	I-NP	O
AP1	BEGIN-AP1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
EFII	BEGIN-EFII	NN	I-NP	B
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
binding	binding	NN	I-NP	I
motifs	motifs-INSIDE	NN	I-NP	I

These	These	DT	B-NP	O
cDNAs	cDNA	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
derived	derive	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
''	''	''	O	O
-	-	HYPH	B-NP	O
untranslated	untranslated	JJ	I-NP	O
region	region	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
''	''	''	O	O
-	-	HYPH	B-NP	O
UTR	UTR	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
methyl	BEGIN-methyl	NN	I-NP	B
-	-	HYPH	B-NP	I
CpG	CpG	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein	NN	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
MeCP1	BEGIN-MeCP1-INSIDE	NN	B-NP	B
)	)	)	O	O

A	A	DT	B-NP	O
simple	simple	JJ	I-NP	O
algorithm	algorithm	NN	I-NP	O
fitting	fit	VBG	B-VP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
moving	move	VBG	I-NP	O
1Ir	1Ir	NN	I-NP	O
source	source	NN	I-NP	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O

Univariate	Univariate	JJ	B-NP	O
and	and	CC	I-NP	O
multivariate	multivariate	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
calculate	calculate	VB	I-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
survival	survival	NN	I-NP	O
probabilities	probability	NNS	I-NP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
variables	variable	NNS	I-NP	O
:	:	:	O	O
age	age	NN	B-NP	O
(	(	(	O	O
<	<	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
sex	sex	NN	B-NP	O
,	,	,	O	O
depth	depth	NN	B-NP	O
of	of	IN	B-PP	O
invasion	invasion	NN	B-NP	O
(	(	(	O	O
mucosal	mucosal	JJ	B-ADJP	O
,	,	,	O	O
submucosal	submucosal	JJ	B-ADJP	O
)	)	)	O	O
tumor	tumor	NN	B-NP	O
location	location	NN	I-NP	O
(	(	(	O	O
upper	upper	JJ	B-NP	O
,	,	,	I-NP	O
middle	middle	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
third	third	JJ	I-NP	O
)	)	)	O	O
,	,	,	O	O
gross	gross	JJ	B-NP	O
appearance	appearance	NN	I-NP	O
(	(	(	O	O
type	type	NN	B-NP	O
I	I	CD	I-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
and	and	CC	O	O
type	type	NN	B-NP	O
III	III	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
size	size	NN	B-NP	O
(	(	(	O	O
<	<	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
cm	cm	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
presence	presence	NN	B-NP	O
or	or	CC	O	O
absence	absence	NN	B-NP	O
of	of	IN	B-PP	O
lymph	lymph	NN	B-NP	O
node	node	NN	I-NP	O
metastasis	metastasis	NN	I-NP	O
,	,	,	O	O
histological	histological	JJ	B-NP	O
type	type	NN	I-NP	O
(	(	(	O	O
intestinal	intestinal	JJ	B-ADJP	O
,	,	,	O	O
diffuse	diffuse	JJ	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
extent	extent	NN	B-NP	O
of	of	IN	B-PP	O
lymphadenectomy	lymphadenectomy	NN	B-NP	O
(	(	(	O	O
limited	limit	VBN	B-VP	O
or	or	CC	I-VP	O
extended	extend	VBN	I-VP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
type	type	NN	B-NP	O
of	of	IN	B-PP	O
gastrectomy	gastrectomy	NN	B-NP	O
(	(	(	O	O
total	total	JJ	B-NP	O
or	or	CC	I-NP	O
distal	distal	JJ	I-NP	O
subtotal	subtotal	JJ	I-NP	O
)	)	)	O	O

Preventing	Prevent	VBG	B-VP	O
the	the	DT	B-NP	O
heterosexual	heterosexual	JJ	I-NP	O
spread	spread	NN	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
into	into	IN	B-PP	O
this	this	DT	B-NP	O
vulnerable	vulnerable	JJ	I-NP	O
population	population	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
formidable	formidable	JJ	I-NP	O
public	public	JJ	I-NP	O
health	health	NN	I-NP	O
challenge	challenge	NN	I-NP	O

Carotid	Carotid	JJ	B-NP	O
body	body	NN	I-NP	O
chemoreceptor	chemoreceptor	NN	I-NP	O
activity	activity	NN	I-NP	O
as	as	IN	B-SBAR	O
recorded	record	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
petrosal	petrosal	NN	I-NP	O
ganglion	ganglion	NN	I-NP	O
in	in	IN	B-PP	O
cats	cat	NNS	B-NP	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
decision	decision	NN	I-NP	O
in	in	IN	B-PP	O
management	management	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
consider	consider	VB	I-VP	O
cardioversion	cardioversion	NN	B-NP	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
achieved	achieve	VBN	I-VP	O
in	in	IN	B-PP	O
suitable	suitable	JJ	B-NP	O
cases	case	NNS	I-NP	O
electrically	electrically	RB	B-ADVP	O
,	,	,	O	O
or	or	CC	O	O
pharmacologically	pharmacologically	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
class	class	NN	I-NP	O
Ic	Ic	NN	I-NP	O
antiarrhythmic	antiarrhythmic	JJ	I-NP	O
drug	drug	NN	I-NP	O
like	like	IN	B-PP	O
flecainide	flecainide	NN	B-NP	O
or	or	CC	I-NP	O
propafenone	propafenone	NN	I-NP	O

Several	Several	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
corticotropin	BEGIN-corticotropin	NN	I-NP	B
-	-	HYPH	O	I
releasing	release	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
test	test	NN	I-NP	O
(	(	(	O	O
CRF	BEGIN-CRF-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
aetiological	aetiological	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
Cushing	Cushing	NN	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
:	:	:	O	O
in	in	IN	B-PP	O
Cushing	Cushing	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
opposed	oppose	VBN	B-VP	O
to	to	TO	B-PP	O
ectopic	ectopic	JJ	B-NP	O
ACTH	BEGIN-ACTH-INSIDE	NN	I-NP	B
secretion	secretion	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
hypothalamus	hypothalamus	NN	I-NP	O
-	-	HYPH	B-NP	O
pituitary	pituitary	JJ	I-NP	O
-	-	HYPH	O	O
adrenal	adrenal	JJ	O	O
(	(	(	O	O
HPA	HPA	JJ	B-ADJP	O
)	)	)	O	O
axis	axis	NN	B-NP	O
can	can	MD	B-VP	O
still	still	RB	I-VP	O
be	be	VB	I-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
CRF	BEGIN-CRF-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	I-NP	I
kappaB	kappaB-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
Rel	BEGIN-Rel-INSIDE	NN	I-NP	B
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
participate	participate	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
immune	immune	JJ	B-NP	O
system	system	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
genes	gene	NNS	I-NP	O
and	and	CC	O	O
viral	BEGIN-viral	JJ	B-NP	B
early	early	JJ	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
immunodeficiency	immunodeficiency	NN	I-NP	I
virus	virus	NN	I-NP	I
type	type	NN	I-NP	I
1	1	CD	I-NP	I
long	long	JJ	I-NP	I
terminal	terminal	JJ	I-NP	I
repeat	repeat-INSIDE	NN	I-NP	I

These	These	DT	B-NP	O
three	three	CD	I-NP	O
chromosomes	chromosome	NNS	I-NP	O
share	share	VBP	B-VP	O
the	the	DT	B-NP	O
transferrin	BEGIN-transferrin	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
TF	BEGIN-TF-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
myosin	BEGIN-myosin	NN	I-NP	B
light	light	NN	I-NP	I
polypeptide	polypeptide	NN	I-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
MYL1	BEGIN-MYL1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
acylpeptide	BEGIN-acylpeptide	NN	I-NP	B
hydrolase	hydrolase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
APEH	BEGIN-APEH-INSIDE	NN	B-NP	B
)	)	)	O	O

The	The	DT	B-NP	O
preference	preference	NN	I-NP	O
for	for	IN	B-PP	O
third	third	JJ	B-NP	O
base	base	NN	I-NP	O
codon	codon	NN	I-NP	O
in	in	IN	B-PP	O
Y	Y	NN	B-NP	O
position	position	NN	I-NP	O
prolines	proline	NNS	I-NP	O
is	be	VBZ	B-VP	O
U	U	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
1	1	CD	I-NP	I
(	(	(	O	I
VI	VI	CD	O	I
)	)	)	O	I
collagen	collagen-INSIDE	NN	B-NP	I
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
fibrillar	fibrillar	JJ	I-NP	I
collagen	collagen	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I

BK	BEGIN-BK-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
translocation	translocation	NN	I-NP	O
and	and	CC	I-NP	O
overexpression	overexpression	NN	I-NP	O
of	of	IN	B-PP	O
PKC	BEGIN-PKC	NN	B-NP	B
isoforms	isoforms-INSIDE	NN	I-NP	I
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
coexpression	coexpression	NN	B-NP	O
of	of	IN	B-PP	O
inactive	inactive	JJ	B-NP	O
or	or	CC	I-NP	O
constitutively	constitutively	RB	I-NP	O
active	active	JJ	I-NP	O
mutants	mutant	NNS	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
PKC	BEGIN-PKC	NN	I-NP	B
isozymes	isozymes-INSIDE	NN	I-NP	I
provided	provide	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
diacylglycerol	diacylglycerol	NN	I-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
PKCs	BEGIN-PKC	NNS	I-NP	B
alpha	alpha	NN	I-NP	I
and	and	CC	O	I
epsilon	epsilon-INSIDE	NN	B-NP	I
in	in	IN	B-PP	O
BK	BEGIN-BK-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O
toward	toward	IN	B-PP	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
decrease	decrease	NN	B-NP	O
of	of	IN	B-PP	O
PRA	PRA	NN	B-NP	O
after	after	IN	B-PP	O
REM	REM	NN	B-NP	O
onset	onset	NN	I-NP	O
closely	closely	RB	B-ADVP	O
approximates	approximate	VBZ	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
estimations	estimation	NNS	I-NP	O
of	of	IN	B-PP	O
PRA	PRA	NN	B-NP	O
half	half	NN	I-NP	O
-	-	HYPH	I-NP	O
life	life	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
REM	REM	NN	B-NP	O
onset	onset	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
virtual	virtual	JJ	I-NP	O
cessation	cessation	NN	I-NP	O
in	in	IN	B-PP	O
renin	BEGIN-renin-INSIDE	NN	B-NP	B
production	production	NN	I-NP	O

The	The	DT	B-NP	O
second	second	JJ	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
)	)	)	O	O
group	group	NN	B-NP	O
was	be	VBD	B-VP	O
represented	represent	VBN	I-VP	O
by	by	IN	B-PP	O
cases	case	NNS	B-NP	O
diagnosed	diagnose	VBN	B-VP	O
as	as	IN	B-PP	O
HSIL	HSIL	NN	B-NP	O
by	by	IN	B-PP	O
cytology	cytology	NN	B-NP	O

Clinical	Clinical	JJ	B-NP	O
trial	trial	NN	I-NP	O
endpoints	endpoint	NNS	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
magnitude	magnitude	NN	B-NP	O
of	of	IN	B-PP	O
reduction	reduction	NN	B-NP	O
in	in	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
RNA	RNA	NN	I-NP	O
levels	level	NNS	I-NP	O
provide	provide	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
complement	complement	NN	I-NP	O
to	to	TO	B-PP	O
endpoints	endpoint	NNS	B-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
percentage	percentage	NN	B-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
achieving	achieve	VBG	B-VP	O
complete	complete	JJ	B-NP	O
virologic	virologic	JJ	I-NP	O
suppression	suppression	NN	I-NP	O

The	The	DT	B-NP	O
psi	BEGIN-psi	NNP	I-NP	B
zeta	BEGIN-BEGIN-zeta-INSIDE	NN	I-NP	I
gene	gene-INSIDE-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
nonsense	nonsense	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
identical	identical	JJ	B-NP	O
promoter	promoter	NN	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
RNA	RNA	NN	B-NP	O
processing	processing	NN	I-NP	O
sites	site	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
zeta	BEGIN-BEGIN-zeta-INSIDE	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
raising	raise	VBG	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-NP	O
both	both	CC	B-NP	O
psi	BEGIN-psi	JJ	I-NP	B
zeta	BEGIN-zeta-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
zeta	BEGIN-zeta-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
transcriptionally	transcriptionally	RB	B-ADJP	O
active	active	JJ	I-ADJP	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cor1b	BEGIN-cor1b-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
strongly	strongly	RB	B-ADJP	O
impaired	impaired	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
barley	barley	NN	I-NP	O
albino	albino	NN	I-NP	O
mutant	mutant	NN	I-NP	O
an	an	DT	B-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
plastidial	plastidial	JJ	I-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O

Pulse	Pulse	NN	B-NP	O
monitors	monitor	NNS	I-NP	O
in	in	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
dental	dental	JJ	I-NP	O
anaesthesia	anaesthesia	NN	I-NP	O

Synthesis	Synthesis	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
thiazolyl	thiazolyl	NN	I-NP	O
)	)	)	O	O
alkanebenzimidazoles	alkanebenzimidazole	VBZ	B-VP	O
-	-	HYPH	O	O
-	-	HYPH	B-NP	O
potential	potential	JJ	I-NP	O
anthelmintics	anthelmintic	NNS	I-NP	O

Wild	Wild	JJ	B-NP	O
type	type	NN	I-NP	O
MEKK1	BEGIN-MEKK1-INSIDE	NN	I-NP	B
enhances	enhance	VBZ	B-VP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
dominant	dominant	JJ	B-NP	O
negative	negative	JJ	I-NP	O
MEKK1	BEGIN-MEKK1-INSIDE	NN	I-NP	B
,	,	,	O	O
MEK1	BEGIN-MEK1-INSIDE	NN	B-NP	B
,	,	,	O	O
MEK1	BEGIN-MEK1-INSIDE	NN	B-NP	B
,	,	,	O	O
MEK1	BEGIN-MEK1-INSIDE	NN	B-NP	B
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
RK	BEGIN-RK-INSIDE	NN	I-NP	B
,	,	,	O	O
and	and	CC	O	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
Jun	Jun-INSIDE	NN	B-NP	I

Tax	BEGIN-Tax-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
Tax	BEGIN-BEGIN-Tax-INSIDE	NN	I-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
abrogate	abrogate	VB	I-VP	O
the	the	DT	B-NP	O
G1	G1	NN	I-NP	O
arrest	arrest	NN	I-NP	O
and	and	CC	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
effect	effect	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
correlate	correlate	VB	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
altered	altered	JJ	I-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	BEGIN-nuclear	JJ	B-NP	B
p1	BEGIN-p1-INSIDE-INSIDE	NN	I-NP	I
or	or	CC	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
disruption	disruption	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-BEGIN-p1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
DNA	DNA	NN	I-NP	O
complexes	complexes-INSIDE	NN	I-NP	I

Chronic	Chronic	JJ	B-NP	O
,	,	,	I-NP	O
recurrent	recurrent	JJ	I-NP	O
multifocal	multifocal	JJ	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O

Our	Our	PRP$	B-NP	O
current	current	JJ	I-NP	O
study	study	NN	I-NP	O
aims	aim	VBZ	B-VP	O
at	at	IN	B-PP	O
clarifying	clarify	VBG	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
myristoylation	myristoylation	NN	B-NP	O
in	in	IN	B-PP	O
caveolar	caveolar	JJ	B-NP	O
targeting	targeting	NN	I-NP	O
using	use	VBG	B-VP	O
well	well	RB	B-ADVP	O
-	-	HYPH	B-NP	O
characterized	characterize	VBN	I-NP	O
acylation	acylation	NN	I-NP	O
mutants	mutant	NNS	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
model	model	NN	I-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
namely	namely	RB	B-NP	O
Gi1	BEGIN-Gi1	NN	I-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	O	I
Src	Src-INSIDE	NN	B-NP	I

Single	Single	JJ	B-NP	O
substitutions	substitution	NNS	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
phenylalanine	phenylalanine	NN	I-NP	O
residues	residue	NNS	I-NP	O
(	(	(	O	O
Phe	Phe	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Phe	Phe	NN	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
,	,	,	O	O
Phe	Phe	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
alanine	alanine	NN	B-NP	O
and	and	CC	I-NP	O
substitution	substitution	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
histidine	histidine	NN	I-NP	O
(	(	(	O	O
His	His	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
glutamine	glutamine	NN	B-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
located	located	JJ	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
sites	site	NNS	B-NP	O
RNP	BEGIN-RNP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
RNP	BEGIN-RNP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
abolished	abolish	VBD	B-VP	O
the	the	DT	B-NP	O
nucleic	nucleic	JJ	I-NP	O
acid	acid	NN	I-NP	O
-	-	HYPH	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
CspB	BEGIN-CspB-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
heterozygous	heterozygous	JJ	B-NP	O
positions	position	NNS	I-NP	O
essentially	essentially	RB	B-ADVP	O
facilitates	facilitate	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
one	one	CD	I-NP	O
hand	hand	NN	I-NP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
alleles	allele	NNS	I-NP	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
extract	extract	NN	I-NP	O
of	of	IN	B-PP	O
medicinal	medicinal	JJ	B-NP	O
plants	plant	NNS	I-NP	O
containing	contain	VBG	B-VP	O
curcumin	curcumin	NN	B-NP	O
is	be	VBZ	B-VP	O
traditionally	traditionally	RB	I-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
contraction	contraction	NN	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gall	gall	NN	I-NP	O
-	-	HYPH	O	O
bladder	bladder	NN	B-NP	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	NN	I-NP	O
between	between	IN	B-PP	O
IclR	BEGIN-IclR-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
operator	operator	NN	I-NP	O
/	/	SYM	B-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
impaired	impair	VBN	I-VP	O
by	by	IN	B-PP	O
phosphoenol	phosphoenol	NN	B-NP	O
pyruvate	pyruvate	NN	I-NP	O
but	but	CC	O	O
insensitive	insensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
acetate	acetate	NN	B-NP	O
,	,	,	O	O
acetyl	acetyl	NN	B-NP	O
-	-	HYPH	O	O
CoA	CoA	NN	B-NP	O
,	,	,	O	O
pyruvate	pyruvate	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oxaloacetate	oxaloacetate	NN	B-NP	O

Immunoprecipitation	Immunoprecipitation	NN	B-NP	O
of	of	IN	B-PP	O
spinophilin	BEGIN-spinophilin-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
neurabin	BEGIN-neurabin-INSIDE	NN	I-NP	B
from	from	IN	B-PP	O
crude	crude	JJ	B-NP	O
brain	brain	NN	I-NP	O
extracts	extract	NNS	I-NP	O
selectively	selectively	RB	B-ADVP	O
coprecipitated	coprecipitate	VBD	B-VP	O
PP1gamma	BEGIN-PP1gamma	NN	B-NP	B
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
over	over	IN	B-PP	O
PP1beta	BEGIN-PP1beta-INSIDE	NN	B-NP	B

Most	Most	RBS	B-ADJP	O
important	important	JJ	I-ADJP	O
,	,	,	O	O
after	after	IN	B-PP	O
all	all	DT	B-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
ionization	ionization	NN	I-NP	O
technique	technique	NN	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
stage	stage	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
five	five	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
survival	survival	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
T1N1	T1N1	NN	B-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
T1N1	T1N1	NN	B-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	O	O
T1N1	T1N1	NN	B-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O

The	The	DT	B-NP	O
encoded	encode	VBN	I-NP	O
Arabidopsis	BEGIN-Arabidopsis	NN	I-NP	B
U1	U1	NN	I-NP	I
snRNAs	snRNAs-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
be	be	VB	I-VP	O
folded	fold	VBN	I-VP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
structure	structure	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
U1	BEGIN-U1	NN	B-NP	B
RNAs	RNAs-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
lower	low	JJR	B-NP	O
eukaryotes	eukaryote	NNS	I-NP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
from	from	IN	B-PP	O
metazoa	metazoa	NN	B-NP	O

Cytokinetics	Cytokinetic	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Krebs	Kreb	NNS	I-NP	O
1	1	CD	I-NP	O
carcinoma	carcinoma	NN	I-NP	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
two	two	CD	B-NP	O
WT1	BEGIN-WT1	NN	I-NP	B
splice	splice	NN	I-NP	I
variants	variants-INSIDE	NN	I-NP	I
lacking	lack	VBG	B-VP	O
or	or	CC	I-VP	O
including	include	VBG	I-VP	O
a	a	DT	B-NP	O
three	three	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
KTS	KTS	NN	B-NP	O
)	)	)	O	O
insertion	insertion	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
and	and	CC	I-NP	O
fourth	fourth	JJ	I-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
could	could	MD	B-VP	O
repress	repress	VB	I-VP	O
the	the	DT	B-NP	O
IR	BEGIN-IR	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

These	These	DT	B-NP	O
back	back	JJ	I-NP	O
mutations	mutation	NNS	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
modest	modest	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
kinase	kinase	NN	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
tumorigenic	tumorigenic	JJ	B-NP	O
potential	potential	NN	I-NP	O
in	in	IN	B-PP	O
chickens	chicken	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
unexpected	unexpected	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
transforming	transform	VBG	B-VP	O
activity	activity	NN	B-NP	O
in	in	IN	B-PP	O
rat	rat	NN	B-NP	O
cells	cell	NNS	I-NP	O

Extragonadal	Extragonadal	JJ	B-NP	O
endodermal	endodermal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
are	be	VBP	B-VP	O
very	very	RB	B-ADJP	O
rare	rare	JJ	I-ADJP	O

Plasma	Plasma	NN	B-NP	O
NE	NE	NN	I-NP	O
and	and	CC	I-NP	O
E	E	NN	I-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
values	value	NNS	I-NP	O
after	after	IN	B-SBAR	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
young	young	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
vs	v	NNS	I-NP	O

Utility	Utility	NN	B-NP	O
of	of	IN	B-PP	O
thallium	thallium	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
scintigraphy	scintigraphy	NN	I-NP	O
in	in	IN	B-PP	O
detecting	detect	VBG	B-VP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
in	in	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O

E.	E.	NN	B-NP	O
granulosus	granulosus	NN	I-NP	O
infection	infection	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
confirmed	confirm	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
by	by	IN	B-PP	O
finding	find	VBG	B-VP	O
parasite	parasite	NN	B-NP	O
protoscoleces	protoscolece	NNS	I-NP	O
or	or	CC	I-NP	O
hooks	hook	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
nine	nine	CD	B-NP	O
cases	case	NNS	I-NP	O
by	by	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antigen	antigen	NN	I-NP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
E.	BEGIN-E.	JJ	B-NP	B
granulosus	granulosus	NN	I-NP	I
,	,	,	O	I
antigen	antigen	NN	B-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
Ag1	BEGIN-Ag1-INSIDE	NN	B-NP	B
)	)	)	O	O

Transcription	Transcription	NN	B-NP	O
of	of	IN	B-PP	O
FN	BEGIN-FN	NN	B-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
chloramphenicol	BEGIN-chloramphenicol	NN	I-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
fusion	fusion	NN	I-NP	O
genes	gene	NNS	I-NP	O
carrying	carry	VBG	B-VP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
substitution	substitution	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
G	G	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
both	both	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
substitution	substitution	NN	I-NP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
G	G	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
reduction	reduction	NN	B-NP	O
of	of	IN	B-PP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
downstream	downstream	JJ	I-NP	O
GC	GC	NN	I-NP	O
box	box	NN	I-NP	O
(	(	(	O	O
GCd	GCd	NN	B-NP	O
)	)	)	O	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
primary	primary	JJ	I-NP	O
role	role	NN	I-NP	O

Teboroxime	Teboroxime	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
boronic	boronic	JJ	I-NP	O
acid	acid	NN	I-NP	O
adduct	adduct	NN	I-NP	O
of	of	IN	B-PP	O
technetium	technetium	NN	B-NP	O
dioxime	dioxime	NN	I-NP	O
(	(	(	O	O
BATO	BATO	NN	B-NP	O
)	)	)	O	O
compound	compound	NN	B-NP	O
that	that	WDT	B-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
favorable	favorable	JJ	B-NP	O
characteristics	characteristic	NNS	I-NP	O
in	in	IN	B-PP	O
preliminary	preliminary	JJ	B-NP	O
studies	study	NNS	I-NP	O

We	We	PRP	B-NP	O
tested	test	VBD	B-VP	O
several	several	JJ	B-NP	O
growth	growth	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
genes	gene	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
repressed	repress	VBN	I-VP	O
in	in	IN	B-PP	O
senescent	senescent	JJ	B-NP	O
cells	cell	NNS	I-NP	O
for	for	IN	B-PP	O
ability	ability	NN	B-NP	O
to	to	TO	B-VP	O
restore	restore	VB	I-VP	O
activity	activity	NN	B-NP	O
to	to	TO	B-PP	O
T	BEGIN-T	NN	B-NP	B
[	[	(	O	I
K1	K1	NN	B-NP	I
]	]	)	O	I
	-INSIDE	NN	B-NP	I

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
our	our	PRP$	B-NP	O
conclusion	conclusion	NN	I-NP	O
that	that	IN	B-SBAR	O
Sonoclot	Sonoclot	NN	B-NP	O
coagulation	coagulation	NN	I-NP	O
analysis	analysis	NN	I-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
time	time	NN	I-NP	O
in	in	IN	B-PP	O
whom	whom	WP	B-NP	O
platelet	platelet	NN	B-NP	O
count	count	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
coagulation	coagulation	NN	I-NP	O
factors	factor	NNS	I-NP	O
are	be	VBP	B-VP	O
normal	normal	JJ	B-ADJP	O

The	The	DT	B-NP	O
single	single	JJ	I-NP	O
copy	copy	NN	I-NP	O
flotillin	BEGIN-flotillin	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
1p1	1p1	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MHC	BEGIN-MHC	NN	I-NP	B
class	class	NN	I-NP	I
I	I	CD	I-NP	I
region	region-INSIDE	NN	I-NP	I
and	and	CC	O	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
exons	exon	NNS	I-NP	O
over	over	IN	B-PP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O

Low	Low	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
glucose	glucose	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
or	or	CC	O	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
sufficiently	sufficiently	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
to	to	TO	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
observed	observe	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
concomitant	concomitant	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
diverse	diverse	JJ	I-NP	O
diseases	disease	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
DPX	DPX	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
observed	observe	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
associated	associate	VBN	I-NP	O
condition	condition	NN	I-NP	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
castor	castor	NN	B-NP	O
oil	oil	NN	I-NP	O
,	,	,	O	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
PGI1	PGI1	NN	B-NP	O
and	and	CC	I-NP	O
indomethacin	indomethacin	NN	I-NP	O
on	on	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
functions	function	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
TNF	BEGIN-TNF-INSIDE	NN	B-NP	B
,	,	,	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
the	the	DT	B-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
Tenon	Tenon	NNP	I-NP	O
's	's	POS	B-NP	O
capsule	capsule	NN	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
in	in	IN	B-PP	O
tissue	tissue	NN	B-NP	O
culture	culture	NN	I-NP	O

Previous	Previous	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
motif	motif	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lactose	BEGIN-lactose	JJ	I-NP	B
permease	permease-INSIDE	NN	I-NP	I
(	(	(	O	O
A	A	NN	B-NP	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
RVW	RVW	NNP	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
IVS	IVS	NN	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
RV	RV	NN	I-NP	O
high	high	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
load	load	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LV	LV	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
IVS	IVS	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
LV	LV	NN	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
EF	EF	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
abnormal	abnormal	JJ	B-NP	O
two	two	CD	I-NP	O
chamber	chamber	NN	I-NP	O
inflow	inflow	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PS	PS	NNP	I-NP	O
group	group	NN	I-NP	O
before	before	IN	B-PP	O
BV	BV	NN	B-NP	O

Several	Several	JJ	B-NP	O
reports	report	NNS	I-NP	O
assert	assert	VBP	B-VP	O
that	that	IN	B-SBAR	O
prolactin	BEGIN-prolactin-INSIDE	NN	B-NP	B
affects	affect	VBZ	B-VP	O
the	the	DT	B-NP	O
delta	delta	SYM	I-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
delta	delta	SYM	B-NP	O
1	1	CD	I-NP	O
pathways	pathway	NNS	I-NP	O
through	through	IN	B-PP	O
its	its	PRP$	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
1beta	BEGIN-1beta	NN	B-NP	B
-	-	HYPH	B-NP	I
hydroxysteroid	hydroxysteroid	NN	I-NP	I
dehydrogenase	dehydrogenase-INSIDE	NN	I-NP	I
(	(	(	O	O
1beta	BEGIN-1beta	NN	B-NP	B
-	-	HYPH	B-NP	I
OHSD	OHSD-INSIDE	NN	I-NP	I
)	)	)	O	O

Acidosis	Acidosis	NN	B-NP	O
provoked	provoke	VBN	B-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
CO1	CO1	NN	I-NP	O
irreversibly	irreversibly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
BDRT	BDRT	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
the	the	DT	B-NP	O
TRT	TRT	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
changed	change	VBN	I-VP	O

In	In	IN	B-PP	O
each	each	DT	B-NP	O
study	study	NN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
I	I	PRP	B-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

A	A	DT	B-NP	O
decrease	decrease	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
and	and	CC	I-NP	O
LDL	BEGIN-LDL	NN	I-NP	B
-	-	HYPH	O	I
cholesterol	cholesterol-INSIDE	NN	B-NP	I

Sequencing	Sequencing	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
fragment	fragment	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
MRP1	BEGIN-MRP1-INSIDE	NN	I-NP	B
coding	coding	NN	I-NP	O
region	region	NN	I-NP	O
specifies	specify	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
basic	basic	JJ	I-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
calculated	calculate	VBN	I-NP	O
Mr	Mr	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O

Low	Low	JJ	B-NP	O
serum	BEGIN-serum	NN	I-NP	B
C1	C1-INSIDE	NN	I-NP	I
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
1	1	CD	I-NP	O
children	child	NNS	I-NP	O
at	at	IN	B-PP	O
some	some	DT	B-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
illness	illness	NN	I-NP	O

In	In	IN	B-PP	O
spite	spite	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
real	real	JJ	I-NP	O
pathology	pathology	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
indian	indian	JJ	I-NP	O
population	population	NN	I-NP	O
of	of	IN	B-PP	O
Colombie	Colombie	NNP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
known	know	VBN	B-VP	O

During	During	IN	B-PP	O
chordotonal	chordotonal	JJ	B-NP	O
organ	organ	NN	I-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
enhancer	enhancer	NN	I-NP	O
directs	direct	VBZ	B-VP	O
expression	expression	NN	B-NP	O
in	in	IN	B-PP	O
proneural	proneural	JJ	B-NP	O
clusters	cluster	NNS	I-NP	O
;	;	:	O	O
whereas	whereas	IN	B-PP	O
successive	successive	JJ	B-NP	O
modular	modular	JJ	I-NP	O
enhancers	enhancer	NNS	I-NP	O
located	locate	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
region	region	NN	I-NP	O
drive	drive	NN	I-NP	O
tissue	tissue	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
chordotonal	chordotonal	JJ	B-NP	O
organ	organ	NN	I-NP	O
precursors	precursor	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
embryo	embryo	NN	I-NP	O
and	and	CC	I-NP	O
larval	larval	NN	I-NP	O
leg	leg	NN	I-NP	O
,	,	,	O	O
wing	wing	NN	B-NP	O
and	and	CC	O	O
antennal	antennal	JJ	B-NP	O
imaginal	imaginal	JJ	I-NP	O
discs	disc	NNS	I-NP	O

Is	Be	VBZ	O	O
conventional	conventional	JJ	B-NP	O
sperm	sperm	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
use	use	NN	I-NP	O
?	?	.	O	O
The	The	DT	B-NP	O
computerised	computerised	JJ	I-NP	O
records	record	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
couples	couple	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
prognostic	prognostic	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
semen	seman	NNS	B-NP	O
volume	volume	NN	I-NP	O
,	,	,	O	O
motility	motility	NN	B-NP	O
,	,	,	O	O
density	density	NN	B-NP	O
and	and	CC	O	O
morphology	morphology	NN	B-NP	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
guaiphenesin	guaiphenesin	NN	B-NP	O
on	on	IN	B-PP	O
absorption	absorption	NN	B-NP	O
and	and	CC	I-NP	O
bioavailability	bioavailability	NN	I-NP	O
of	of	IN	B-PP	O
paracetamol	paracetamol	NN	B-NP	O
from	from	IN	B-PP	O
composite	composite	JJ	B-NP	O
analgesic	analgesic	JJ	I-NP	O
preparations	preparation	NNS	I-NP	O

Detailed	Detailed	JJ	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
excretion	excretion	NN	I-NP	O
of	of	IN	B-PP	O
purines	purine	NNS	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Lesch	Lesch	NNP	I-NP	O
-	-	HYPH	I-NP	O
Nyhan	Nyhan	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
subject	subject	NN	I-NP	O

Antisense	Antisense	JJ	B-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
complementary	complementary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
PKC	BEGIN-PKC	NN	B-NP	B
-	-	HYPH	B-NP	I
zeta	zeta	NN	I-NP	I
mRNA	mRNA	NN	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
significantly	significantly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
collagen	BEGIN-collagen-INSIDE	NN	I-NP	B
lattice	lattice	NN	I-NP	O
-	-	HYPH	B-NP	O
stimulated	stimulate	VBN	I-NP	O
alpha1	alpha1	NN	I-NP	O
and	and	CC	I-NP	O
MMP	BEGIN-MMP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
ERK	BEGIN-ERK-INSIDE	NN	B-NP	B
phosphorylation	phosphorylation	NN	I-NP	O
was	be	VBD	B-VP	O
substantially	substantially	RB	I-VP	O
prolonged	prolong	VBN	I-VP	O
in	in	IN	B-PP	O
LC	LC	NN	B-NP	O
/	/	SYM	B-NP	O
BRY	BRY	NN	I-NP	O
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
cells	cell	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
BRY	BRY	NN	B-NP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
pretreatment	pretreatment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highly	highly	RB	I-NP	O
specific	specific	JJ	I-NP	O
MEK	BEGIN-MEK-INSIDE	NN	I-NP	B
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
PD1	PD1	NN	B-NP	O
,	,	,	O	O
U1	U1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
SL1	SL1	NN	B-NP	O
,	,	,	O	O
opposed	oppose	VBD	B-VP	O
ERK	BEGIN-ERK-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
while	while	IN	B-SBAR	O
protecting	protect	VBG	B-VP	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
LC	LC	NN	B-NP	O
/	/	SYM	B-NP	O
BRY	BRY	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
lethality	lethality	NN	I-NP	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
valid	valid	JJ	I-NP	O
method	method	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
AXB	AXB	NN	I-NP	O
bearing	bear	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cephalometric	cephalometric	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
concordance	concordance	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
coligation	coligation	NN	B-NP	O
of	of	IN	B-PP	O
Fc	BEGIN-Fc	NN	B-NP	B
gamma	gamma	NN	I-NP	I
RIIB1	RIIB1-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
B	BEGIN-B	NN	B-NP	B
cell	cell	NN	I-NP	I
Ag	Ag	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
(	(	(	O	O
BCR	BEGIN-BCR-INSIDE	NN	B-NP	B
)	)	)	O	O
inhibits	inhibit	VBZ	B-VP	O
BCR	BEGIN-BCR-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
mediated	mediate	VBN	B-NP	O
signaling	signaling	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
involve	involve	VB	I-VP	O
recruitment	recruitment	NN	B-NP	O
of	of	IN	B-PP	O
phosphatases	BEGIN-phosphatas	NNS	B-NP	B
SHP	BEGIN-SHP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE-INSIDE	NN	I-NP	I
,	,	,	O	O
SHP	BEGIN-SHP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
containing	contain	VBG	B-VP	I
inositol	inositol	NN	B-NP	I
1'phosphatase	1'phosphatase-INSIDE	NN	I-NP	I
(	(	(	O	O
SHIP	BEGIN-SHIP-INSIDE	NN	B-NP	B
)	)	)	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
phosphorylated	phosphorylate	VBN	I-NP	O
Fc	BEGIN-BEGIN-Fc	NN	I-NP	B
gamma	gamma	NN	I-NP	I
RIIB1	RIIB1-INSIDE	NN	I-NP	I
immunoreceptor	immunoreceptor	NN	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
-	-	HYPH	O	O
based	base	VBN	B-VP	O
inhibitory	inhibitory	JJ	B-NP	O
motif	motif-INSIDE	NN	I-NP	I

At	At	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
phase	phase	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
ms	ms	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
VMN	VMN	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
ms	ms	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
LN	LN	NN	I-NP	O
)	)	)	O	O
the	the	DT	B-NP	O
hypothalamic	hypothalamic	JJ	I-NP	O
-	-	HYPH	I-NP	O
cortical	cortical	JJ	I-NP	O
responses	response	NNS	I-NP	O
completely	completely	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
VC	VC	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
light	light	NN	I-NP	O
stimulus	stimulus	NN	I-NP	O

The	The	DT	B-NP	O
slope	slope	NN	I-NP	O
of	of	IN	B-PP	O
QD	QD	NNP	B-NP	O
versus	versus	IN	B-PP	O
QEMF	QEMF	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
four	four	CD	I-NP	O
tubes	tube	NNS	I-NP	O
was	be	VBD	B-VP	O
near	near	IN	B-PP	O
unity	unity	NN	B-NP	O

The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
residue	residue	NN	I-NP	I
NrfF	NrfF	NN	I-NP	I
polypeptide	polypeptide	NN	I-NP	I
,	,	,	O	I
M	M	NN	B-NP	I
(	(	(	O	I
r	r	NN	B-NP	I
)	)	)	O	I
1	1	CD	B-NP	I
,	,	,	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
is	be	VBZ	B-VP	O
strikingly	strikingly	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CcI1	BEGIN-CcI1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
R.	R.	NNP	B-NP	O
capsulatus	capsulatus	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
haem	haem	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
motif	motif	NN	I-NP	O
,	,	,	O	O
RCPQCQNQN.	RCPQCQNQN.	NN	B-NP	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-NP	O
1	1	CD	I-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

When	When	WRB	B-ADVP	O
cotransfected	cotransfecte	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
HIV	BEGIN-HIV	NN	I-NP	B
LTR	LTR-INSIDE	NN	I-NP	I
CAT	BEGIN-CAT-INSIDE	NN	I-NP	B
into	into	IN	B-PP	O
CV	CV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
both	both	CC	O	O
the	the	DT	B-NP	O
pCD1	BEGIN-pCD1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
pGD1	BEGIN-pGD1-INSIDE	NN	I-NP	B
clones	clone	NNS	I-NP	O
trans	trans	AFX	O	O
-	-	HYPH	O	O
activated	activate	VBN	B-VP	O
the	the	DT	B-NP	O
HIV	BEGIN-HIV	NN	I-NP	B
LTR	LTR-INSIDE	NN	I-NP	I

From	From	IN	B-PP	O
this	this	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
aa	aa	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
ATPK1	BEGIN-ATPK1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
subfamily	subfamily	NN	I-NP	O
of	of	IN	B-PP	O
Ser	BEGIN-Ser	NN	B-NP	B
/	/	SYM	B-NP	I
Thr	Thr	NN	I-NP	I
PKs	PKs-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
plants	plant	NNS	B-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
probable	probable	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
change	change	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
mechanical	mechanical	JJ	B-NP	O
effects	effect	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
injecting	inject	VBG	B-VP	O
a	a	DT	B-NP	O
hypertonic	hypertonic	JJ	I-NP	O
solution	solution	NN	I-NP	O
of	of	IN	B-PP	O
MT	MT	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	O	O
dog	dog	NN	B-NP	O

Both	Both	DT	B-NP	O
viruses	virus	NNS	I-NP	O
express	express	VBP	B-VP	O
the	the	DT	B-NP	O
mil	BEGIN-mil-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
raf	BEGIN-raf-INSIDE	NN	I-NP	B
oncogene	oncogene	NN	I-NP	O
product	product	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
gag	BEGIN-gag	NN	I-NP	B
-	-	HYPH	B-NP	I
fusion	fusion-INSIDE	NN	I-NP	I
polyprotein	polyprotein	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
myc	BEGIN-myc-INSIDE	NN	I-NP	B
oncogene	oncogene	NN	I-NP	O
of	of	IN	B-PP	O
MH1	MH1	NN	B-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
subgenomic	subgenomic	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
the	the	DT	B-NP	O
aldosterone	aldosterone	NN	I-NP	O
stimulating	stimulating	NN	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
sodium	sodium	NN	I-NP	O
diet	diet	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
and	and	CC	I-NP	O
prolonged	prolonged	JJ	I-NP	O
vomiting	vomiting	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
synthetic	synthetic	JJ	B-NP	O
ACTH	BEGIN-ACTH-INSIDE	NN	I-NP	B
(	(	(	O	O
1	1	CD	B-NP	O
children	child	NNS	I-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
our	our	PRP$	B-NP	O
modified	modify	VBN	I-NP	O
method	method	NN	I-NP	O

Transmural	Transmural	JJ	B-NP	O
metabolic	metabolic	JJ	I-NP	O
heterogeneity	heterogeneity	NN	I-NP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
work	work	NN	I-NP	O
states	state	NNS	I-NP	O

A	A	DT	B-NP	O
flow	flow	NN	I-NP	O
probe	probe	NN	I-NP	O
for	for	IN	B-PP	O
direct	direct	JJ	B-NP	O
measurement	measurement	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
flow	flow	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
was	be	VBD	B-VP	O
devised	devise	VBN	I-VP	O

The	The	DT	B-NP	O
adoption	adoption	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
twisted	twisted	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
importin	BEGIN-importin	NN	B-NP	B
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
interaction	interaction	NN	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
transport	transport	NN	I-NP	O

Liver	Liver	NN	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
HCV	HCV	NN	B-NP	O
infection	infection	NN	I-NP	O
after	after	IN	B-PP	O
transplantation	transplantation	NN	B-NP	O
of	of	IN	B-PP	O
organs	organ	NNS	B-NP	O
from	from	IN	B-PP	O
hepatitis	BEGIN-hepatitis	NNP	B-NP	B
C	C	NNP	I-NP	I
antibody	antibody-INSIDE	JJ	I-NP	I
positive	positive	JJ	I-NP	O
donors	donor	NNS	I-NP	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
RPG	BEGIN-RPG	NN	I-NP	B
-	-	HYPH	I-NP	I
boxes	boxes-INSIDE	NN	I-NP	I
mediate	mediate	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
L1	BEGIN-L1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
S1	BEGIN-S1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
two	two	CD	B-NP	O
experimental	experimental	JJ	I-NP	O
strategies	strategy	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
:	:	:	O	O
cloning	cloning	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
respective	respective	JJ	I-NP	O
genes	gene	NNS	I-NP	O
on	on	IN	B-PP	O
multicopy	multicopy	JJ	B-NP	O
vectors	vector	NNS	I-NP	O
and	and	CC	O	O
construction	construction	NN	B-NP	O
of	of	IN	B-PP	O
fusion	fusion	NN	B-NP	O
genes	gene	NNS	I-NP	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
sequences	sequence	NNS	B-NP	O
within	within	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
bind	bind	VBP	B-VP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Sp1	BEGIN-Sp1	NN	I-NP	B
family	family	NN	I-NP	I
of	of	IN	B-PP	I
transcription	transcription	NN	B-NP	I
factors	factors-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	O
to	to	TO	B-PP	O
HRES	BEGIN-HRES	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
peptides	peptide	NNS	I-NP	I
pep1	pep1	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
and	and	CC	I-NP	I
pep1	pep1	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
normal	normal	JJ	I-NP	O
blood	blood	NN	I-NP	O
donors	donor	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
immunological	immunological	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O

SCOF	BEGIN-SCOF	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
localized	localize	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
bind	bind	VB	I-VP	O
directly	directly	RB	B-ADVP	O
to	to	TO	B-PP	O
either	either	CC	O	O
C	C	NN	B-NP	O
-	-	HYPH	B-NP	O
repeat	repeat	NN	I-NP	O
/	/	SYM	O	O
dehydration	dehydration	NN	B-NP	O
(	(	(	O	O
CRT	CRT	NN	B-NP	O
/	/	SYM	B-NP	O
DRE	DRE	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
ABA	ABA	NN	B-NP	O
responsive	responsive	JJ	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
ABRE	ABRE	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
cis	cis	NN	B-NP	O
-	-	HYPH	B-NP	O
acting	act	VBG	I-NP	O
DNA	DNA	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
elements	element	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
COR	BEGIN-COR	NN	B-NP	B
gene	gene	NN	I-NP	I
promoters	promoters-INSIDE	NN	I-NP	I

To	To	TO	B-PP	O
date	date	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mammalian	mammalian	JJ	I-NP	O
GRKs	BEGIN-GRKs-INSIDE	NN	I-NP	B
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
molecular	molecular	JJ	B-NP	O
cloning	cloning	NN	I-NP	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
report	report	VB	I-VP	O
a	a	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
fulminant	fulminant	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
quadriparesis	quadriparesis	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
vincristine	vincristine	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
Mb	Mb	NN	I-NP	O
region	region	NN	I-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
cosmids	cosmid	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
overlap	overlap	NN	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
cosmids	cosmid	NNS	I-NP	O
assigned	assign	VBN	B-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
bins	bin	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
contigs	contig	NNS	I-NP	O

Homodimers	Homodimer	NNS	B-NP	O
of	of	IN	B-PP	O
RIP1	BEGIN-RIP1-INSIDE	NN	B-NP	B
(	(	(	O	O
replication	BEGIN-replication	NN	B-NP	B
initiation	initiation	NN	I-NP	I
-	-	HYPH	B-NP	I
region	region	NN	I-NP	I
protein	protein	NN	I-NP	I
1	1	CD	I-NP	I
kDA	kDA-INSIDE	NN	I-NP	I
)	)	)	O	O
purified	purify	VBN	B-VP	O
from	from	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extract	extract	NN	I-NP	O
bind	bind	VBP	B-VP	O
two	two	CD	B-NP	O
ATT	ATT	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
oribeta	oribeta	NN	B-NP	O
and	and	CC	O	O
foster	foster	VB	B-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
twisted	twisted	JJ	I-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
DNA	DNA	NN	I-NP	O
loop	loop	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
on	on	IN	B-PP	O
glucose	glucose	NN	B-NP	O
,	,	,	O	O
reducing	reduce	VBG	B-VP	O
sugars	sugar	NNS	B-NP	O
and	and	CC	O	O
plasma	BEGIN-plasma	NN	B-NP	B
insulin	insulin-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
of	of	IN	B-PP	O
milk	milk	NN	B-NP	O
-	-	HYPH	B-NP	O
fed	feed	VBN	I-NP	O
calves	calf	NNS	I-NP	O

Principal	Principal	JJ	B-NP	O
component	component	NN	I-NP	O
analysis	analysis	NN	I-NP	O
using	use	VBG	B-VP	O
psychosocial	psychosocial	JJ	B-NP	O
factors	factor	NNS	I-NP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
showed	show	VBD	B-VP	O
two	two	CD	B-NP	O
psychosocial	psychosocial	JJ	I-NP	O
structures	structure	NNS	I-NP	O
,	,	,	O	O
i.e.	i.e.	FW	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
principal	principal	NN	I-NP	O
(	(	(	O	O
high	high	JJ	B-NP	O
SOC	SOC	NN	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
lifestyle	lifestyle	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
low	low	JJ	B-NP	O
stress	stress	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
1th	1th	JJ	I-NP	O
principal	principal	JJ	I-NP	O
components	component	NNS	I-NP	O
(	(	(	O	O
high	high	JJ	B-NP	O
supernatural	supernatural	JJ	I-NP	O
HLC	HLC	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
high	high	JJ	B-NP	O
PHLC	PHLC	NN	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
acoustical	acoustical	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
the	the	DT	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
response	response	NN	B-NP	O
latency	latency	NN	I-NP	O
,	,	,	O	O
discharge	discharge	NN	B-NP	O
pattern	pattern	NN	I-NP	O
,	,	,	O	O
frequency	frequency	NN	B-NP	O
tuning	tuning	NN	I-NP	O
,	,	,	O	O
binaural	binaural	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
habituation	habituation	NN	B-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
to	to	TO	B-VP	O
allow	allow	VB	I-VP	O
an	an	DT	B-NP	O
appraisal	appraisal	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MGB	MGB	NN	I-NP	O
by	by	IN	B-PP	O
electrophysiological	electrophysiological	JJ	B-NP	O
means	mean	NNS	I-NP	O

These	These	DT	B-NP	O
two	two	CD	I-NP	O
enhancer	enhancer	NN	I-NP	O
elements	element	NNS	I-NP	O
also	also	RB	B-ADVP	O
enhanced	enhance	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
when	when	WRB	B-ADVP	O
fused	fuse	VBN	B-VP	O
separately	separately	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chicken	BEGIN-chicken	JJ	I-NP	B
vimentin	vimentin	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Availability	Availability	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
less	less	RBR	I-NP	O
palatable	palatable	JJ	I-NP	O
diet	diet	NN	I-NP	O
(	(	(	O	O
chow	chow	NN	B-NP	O
)	)	)	O	O
following	follow	VBG	B-PP	O
presentation	presentation	NN	B-NP	O
of	of	IN	B-PP	O
palatable	palatable	JJ	B-NP	O
diets	diet	NNS	I-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
diminished	diminish	VBN	B-NP	O
caloric	caloric	JJ	I-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
body	body	NN	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
and	and	CC	O	O
hyperinsulinemia	hyperinsulinemia	NN	B-NP	O

Residues	Residue	NNS	B-NP	O
of	of	IN	B-PP	O
Stauffer	Stauffer	NNP	B-NP	O
R	R	NNP	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
analogue	analogue	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
tissues	tissue	NNS	I-NP	O
of	of	IN	B-PP	O
cattle	cattle	NNS	B-NP	O
fed	feed	VBN	B-NP	O
R	R	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diet	diet	NN	I-NP	O

Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
neuroleptanalgesia	neuroleptanalgesia	NN	I-NP	O
in	in	IN	B-PP	O
odonto	odonto	AFX	B-NP	O
-	-	HYPH	I-NP	O
stomatology	stomatology	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1	NN	B-NP	B
Ras	Ras-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
GTPase	BEGIN-GTPase	NN	I-NP	B
-	-	HYPH	O	I
activating	activate	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
GAP	BEGIN-GAP-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
GAP	BEGIN-GAP-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
associated	associate	VBN	B-VP	O
p1	p1	NN	B-NP	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
Respiratory	Respiratory	NN	B-NP	O
-	-	HYPH	O	O
related	relate	VBN	B-VP	O
electromyographic	electromyographic	JJ	B-ADJP	O
(	(	(	O	O
EMG	EMG	NN	B-NP	O
)	)	)	O	O
activity	activity	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
superior	superior	JJ	I-NP	O
pharyngeal	pharyngeal	JJ	I-NP	O
constrictor	constrictor	NN	I-NP	O
(	(	(	O	O
SPC	SPC	NN	B-NP	O
)	)	)	O	O
muscle	muscle	NN	B-NP	O
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
forced	force	VBN	B-NP	O
breathing	breathing	NN	I-NP	O

Glutathione	BEGIN-Glutathione	NN	B-NP	B
reductase	reductase-INSIDE	NN	I-NP	I
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
liver	liver	NN	B-NP	O
,	,	,	O	O
kidney	kidney	NN	B-NP	O
,	,	,	O	O
lung	lung	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
brain	brain	NN	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
diet	diet	NN	B-NP	O

LIP	LIP	NN	B-NP	O
and	and	CC	I-NP	O
DIP	DIP	NN	I-NP	O
are	be	VBP	B-VP	O
less	less	RBR	B-NP	O
common	common	JJ	I-NP	O
IIPs	IIP	NNS	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
ground	ground	NN	B-NP	O
-	-	HYPH	I-NP	O
glass	glass	NN	I-NP	O
attenuation	attenuation	NN	I-NP	O

Healthy	Healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
received	receive	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	JJ	I-NP	O
regimens	regimen	NNS	I-NP	O
,	,	,	O	O
dosed	dose	VBN	B-VP	O
to	to	TO	B-PP	O
steady	steady	JJ	B-NP	O
state	state	NN	I-NP	O
:	:	:	O	O
trovafloxacin	trovafloxacin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
;	;	:	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
;	;	:	O	O
trovafloxacin	trovafloxacin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
plus	plus	CC	O	O
cefepime	cefepime	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
plus	plus	CC	O	O
cefepime	cefepime	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
/	/	SYM	O	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
from	from	IN	B-PP	O
HepG1	HepG1	NN	B-NP	O
cells	cell	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
transcription	transcription	NN	B-NP	O
is	be	VBZ	B-VP	O
initiated	initiate	VBN	I-VP	O
1	1	CD	B-NP	O
bases	base	NNS	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
-	-	HYPH	B-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
polyadenylation	polyadenylation	NN	I-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
located	located	JJ	B-NP	O
1	1	CD	I-NP	O
bases	base	NNS	I-NP	O
downstream	downstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stop	stop	NN	I-NP	O
codon	codon	NN	I-NP	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
possible	possible	JJ	B-NP	O
roles	role	NNS	I-NP	O
for	for	IN	B-PP	O
HCP	BEGIN-HCP-INSIDE	NN	B-NP	B
during	during	IN	B-PP	O
late	late	JJ	B-NP	O
erythroid	erythroid	JJ	I-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
effects	effect	NNS	B-NP	O
of	of	IN	B-PP	O
manipulating	manipulate	VBG	B-VP	O
HCP	BEGIN-HCP-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
or	or	CC	O	O
recruitment	recruitment	NN	B-NP	O
on	on	IN	B-PP	O
EPO	BEGIN-EPO-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
hemoglobinization	hemoglobinization	NN	I-NP	O
in	in	IN	B-PP	O
erythroleukemic	erythroleukemic	JJ	B-NP	O
SKT1	SKT1	NN	I-NP	O
cells	cell	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
investigated	investigate	VBN	I-VP	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
bHLH	BEGIN-bHLH	JJ	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
MC1T1	MC1T1	NN	B-NP	O
-	-	HYPH	B-NP	O
E1	E1	NN	I-NP	O
osteoblasts	osteoblast	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
undergo	undergo	VBP	B-VP	O
a	a	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
osteocalcin	BEGIN-osteocalcin	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
stable	stable	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
osteocalcin	BEGIN-osteocalcin	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
luciferase	BEGIN-luciferase-INSIDE	NN	I-NP	B
chimeric	chimeric	JJ	I-NP	O
gene	gene	NN	I-NP	O
(	(	(	O	O
p1OC	BEGIN-p1OC	NN	B-NP	B
-	-	HYPH	B-NP	I
luc	luc-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
assessed	assess	VBD	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
E	E	NN	B-NP	O
-	-	HYPH	B-NP	O
box	box	NN	I-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
elements	element	NNS	B-NP	O
in	in	IN	B-PP	O
osteocalcin	BEGIN-osteocalcin	NN	B-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
assays	assay	NNS	I-NP	O

Genetic	Genetic	JJ	B-NP	O
linkage	linkage	NN	I-NP	O
mapping	mapping	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CYP1A1	BEGIN-CYP1A1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
side	side	NN	I-NP	O
-	-	HYPH	B-NP	O
chain	chain	NN	I-NP	O
cleavage	cleavage	NN	I-NP	O
P1scc	BEGIN-P1scc-INSIDE	NN	I-NP	B
close	close	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CYP1A1	BEGIN-CYP1A1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
D1S1	BEGIN-D1S1-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chromosome	chromosome	NN	I-NP	O
1q1	1q1	NN	I-NP	O
-	-	HYPH	B-NP	O
q1	q1	NN	I-NP	O
region	region	NN	I-NP	O

Expression	Expression	NN	B-NP	O
,	,	,	O	O
characterization	characterization	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
genomic	genomic	JJ	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
carp	BEGIN-carp	JJ	B-NP	B
JAK1	JAK1	NN	I-NP	I
kinase	kinase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Jornvall	Jornvall	NNP	B-NP	O
,	,	,	O	O
B	B	NNP	B-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O

Three	Three	CD	B-NP	O
modern	modern	JJ	I-NP	O
hematology	hematology	NN	I-NP	O
analyzers	analyzer	NNS	I-NP	O
(	(	(	O	O
Abbott	Abbott	NN	B-NP	O
Cell	Cell	NN	I-NP	O
-	-	HYPH	O	O
Dyn	Dyn	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Coulter	Coulter	NNP	B-NP	O
STKS	STKS	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Sysmex	Sysmex	NNP	B-NP	O
NE	NE	NNP	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
throughput	throughput	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
part	part	NN	I-NP	O
differential	differential	JJ	I-NP	O
capability	capability	NN	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
protocol	protocol	NN	I-NP	O
designed	design	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
quality	quality	NN	I-NP	O
team	team	NN	I-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	O
E1	E1	NN	I-NP	O
on	on	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
atherosclerosis	atherosclerosis	NN	I-NP	O

The	The	DT	B-NP	O
tro	BEGIN-tro	NNP	I-NP	B
operon	operon-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
flanked	flank	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
Holliday	BEGIN-Holliday	NNP	I-NP	B
structure	structure	NN	I-NP	I
DNA	DNA	NN	I-NP	I
helicase	helicase-INSIDE	NN	I-NP	I
homolog	homolog	NN	I-NP	O
(	(	(	O	O
upstream	upstream	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
ORFs	ORF	NNS	I-NP	O
representing	represent	VBG	B-VP	O
a	a	DT	B-NP	O
purine	BEGIN-purine	JJ	I-NP	B
nucleoside	nucleoside	NN	I-NP	I
phosphorylase	phosphorylase-INSIDE	NN	I-NP	I
homolog	homolog	NN	I-NP	O
and	and	CC	I-NP	O
tpp1	BEGIN-tpp1-INSIDE	NN	I-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
membrane	membrane	NN	I-NP	O
lipoprotein	lipoprotein	NN	I-NP	O
(	(	(	O	O
downstream	downstream	JJ	B-ADJP	O
)	)	)	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
genomes	genome	NNS	I-NP	O
of	of	IN	B-PP	O
EC	EC	NN	B-NP	O
cells	cell	NNS	I-NP	O
permit	permit	VBP	B-VP	O
M	BEGIN-M	NN	B-NP	B
-	-	HYPH	B-NP	I
MuLVneo	MuLVneo	NN	I-NP	I
delta	delta	SYM	B-VP	I
Enh	Enh-INSIDE	NN	B-NP	I
proviral	proviral	JJ	I-NP	O
expression	expression	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
developing	develop	VBG	I-VP	O
a	a	DT	B-NP	O
digital	digital	JJ	I-NP	O
fluoroscopic	fluoroscopic	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
system	system	NN	I-NP	O
to	to	TO	B-VP	O
replace	replace	VB	I-VP	O
the	the	DT	B-NP	O
portal	portal	JJ	I-NP	O
films	film	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
currently	currently	RB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
verify	verify	VB	I-VP	O
patient	patient	NN	B-NP	O
positioning	positioning	NN	I-NP	O
during	during	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
treatments	treatment	NNS	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
utilized	utilize	VBN	I-VP	O
transient	transient	JJ	B-NP	O
transfections	transfection	NNS	I-NP	O
,	,	,	O	O
mutation	mutation	NN	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
electromobility	electromobility	NN	B-NP	O
gel	gel	NN	I-NP	O
-	-	HYPH	B-NP	O
shifts	shift	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
immunoblot	immunoblot	NN	B-NP	O
analysis	analysis	NN	I-NP	O
to	to	TO	B-VP	O
test	test	VB	I-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CTalpha	BEGIN-CTalpha	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
controlled	control	VBN	I-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
acting	act	VBG	B-VP	O
nuclear	nuclear	JJ	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
,	,	,	O	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B

Determinants	Determinant	NNS	B-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
ischaemia	ischaemia	NN	I-NP	O
and	and	CC	I-NP	O
revascularisation	revascularisation	NN	I-NP	O
procedures	procedure	NNS	I-NP	O
after	after	IN	B-PP	O
thrombolysis	thrombolysis	NN	B-NP	O
with	with	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	O
tissue	BEGIN-tissue	NN	I-NP	B
plasminogen	plasminogen	NN	I-NP	I
activator	activator-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
occlusion	occlusion	NN	I-NP	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
PAK1	BEGIN-PAK1-INSIDE	NN	B-NP	B
,	,	,	O	O
HPK1	BEGIN-HPK1-INSIDE	NN	B-NP	B
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
contain	contain	VB	I-VP	O
the	the	DT	B-NP	O
small	BEGIN-small	JJ	I-NP	B
GTPase	GTPase-INSIDE	NN	I-NP	I
Rac1	BEGIN-Rac1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
domain	domain	NN	B-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
either	either	CC	O	O
Rac1	BEGIN-Rac1-INSIDE	NN	B-NP	B
or	or	CC	O	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	B-NP	B
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
HPK1.	BEGIN-HPK1-INSIDE.	NN	B-NP	I
activation	activation	NN	I-NP	O
is	be	VBZ	B-VP	O
Rac1	BEGIN-Rac1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
Cdc1	BEGIN-Cdc1-INSIDE	NN	I-NP	B
-	-	HYPH	B-VP	O
independent	independent	JJ	B-ADJP	O

Transformations	Transformation	NNS	B-NP	O
with	with	IN	B-PP	O
circular	circular	JJ	B-NP	O
plasmids	plasmid	NNS	I-NP	O
yielded	yield	VBD	B-VP	O
slowly	slowly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
irregularly	irregularly	RB	I-ADVP	O
growing	grow	VBG	B-NP	O
geneticin	geneticin	NN	I-NP	O
-	-	HYPH	B-NP	O
resistant	resistant	JJ	I-NP	O
mycelia	mycelia	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
nuclei	nucleus	NNS	B-NP	O
contained	contain	VBD	B-VP	O
plasmid	plasmid	NN	B-NP	O
sequences	sequence	NNS	I-NP	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
combined	combine	VBN	I-NP	O
pharmacokinetic	pharmacokinetic	JJ	I-NP	O
-	-	HYPH	I-NP	O
pharmacodynamic	pharmacodynamic	JJ	I-NP	O
model	model	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
impact	impact	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
factors	factor	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
effective	effective	JJ	I-NP	O
bioavailability	bioavailability	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
estimation	estimation	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
intravenous	intravenous	JJ	I-NP	O
-	-	HYPH	I-NP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
oral	oral	JJ	I-NP	O
dose	dose	NN	I-NP	O
ratio	ratio	NN	I-NP	O
required	require	VBN	B-VP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
area	area	NN	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
time	time	NN	I-NP	O
curve	curve	NN	I-NP	O
after	after	IN	B-SBAR	O
acute	acute	JJ	B-NP	O
administration	administration	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
explored	explore	VBN	I-VP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
anesthetized	anesthetize	VBN	B-NP	O
,	,	,	I-NP	O
paralyzed	paralyzed	JJ	I-NP	O
cats	cat	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
visual	visual	JJ	I-NP	O
evoked	evoke	VBN	I-NP	O
potential	potential	NN	I-NP	O
(	(	(	O	O
VEP	VEP	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
on	on	IN	B-PP	O
magnitude	magnitude	NN	B-NP	O
of	of	IN	B-PP	O
delta	delta	NN	B-NP	O
C	C	NN	I-NP	O
at	at	IN	B-PP	O
each	each	DT	B-NP	O
pattern	pattern	NN	I-NP	O
transition	transition	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
starting	start	VBG	I-NP	O
or	or	CC	I-VP	O
ending	end	VBG	I-VP	O
contrast	contrast	NN	B-NP	O
level	level	NN	I-NP	O

Plasmid	Plasmid	NN	B-NP	O
pSP1E1E1	pSP1BEGIN-E1-INSIDEBEGIN-E1-INSIDE	NN	I-NP	I
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
reading	reading	NN	I-NP	O
frames	frame	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
E1	BEGIN-E1-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
proteins	protein	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
coupled	couple	VBN	I-NP	O
transcription	transcription	NN	I-NP	O
/	/	SYM	O	O
rabbit	rabbit	NN	B-NP	O
reticulocyte	reticulocyte	NN	I-NP	O
translation	translation	NN	I-NP	O
system	system	NN	I-NP	O

A	A	DT	B-NP	O
1m	1m	NN	I-NP	O
Tc	Tc	NN	I-NP	O
bone	bone	NN	I-NP	O
scan	scan	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
focal	focal	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
uptake	uptake	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mass	mass	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
calcaneus	calcaneus	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
FOP	BEGIN-FOP-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
FGFR1	BEGIN-FGFR1-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
expressing	express	VBG	I-NP	O
cells	cell	NNS	I-NP	O
show	show	VBP	B-VP	O
constitutive	constitutive	JJ	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
positive	positive	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
translation	translation	NN	B-NP	O
p1S1	BEGIN-p1S1	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
;	;	:	O	O
this	this	DT	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
is	be	VBZ	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
PI1	BEGIN-PI1	NN	B-NP	B
-	-	HYPH	B-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
mTOR	BEGIN-mTOR-INSIDE	NN	I-NP	B
(	(	(	O	O
mammalian	BEGIN-mammalian	JJ	B-NP	B
target	target	NN	I-NP	I
of	of	IN	B-PP	I
rapamycin	rapamycin-INSIDE	NN	B-NP	I
)	)	)	O	O
inhibitors	inhibitor	NNS	B-NP	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
test	test	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
predicted	predict	VBD	B-VP	O
that	that	IN	B-SBAR	O
mice	mouse	NNS	B-NP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
altered	alter	VBN	I-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
I	I	CD	I-NP	O
gene	gene	NN	I-NP	O
products	product	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
beta1	BEGIN-beta1	NN	I-NP	B
-	-	HYPH	B-NP	I
microglobulin	microglobulin-INSIDE	NN	I-NP	I
knockout	knockout	NN	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
	BEGIN-	NN	B-NP	B
[	[	(	O	I
beta1m	beta1m	NN	B-NP	I
(	(	(	O	I
-	-	SYM	B-NP	I
/	/	SYM	O	I
-	-	SYM	O	I
)	)	)	O	I
]	]	)	O	I
	-INSIDE	NN	B-NP	I
,	,	,	O	O
would	would	MD	B-VP	O
develop	develop	VB	I-VP	O
Fe	Fe	NNP	B-NP	O
overload	overload	.	O	O

The	The	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
endo	endo	AFX	B-NP	O
-	-	HYPH	I-NP	O
adduct	adduct	NN	I-NP	O
[	[	(	O	O
1aS	1aS	NN	B-NP	O
,	,	,	O	O
1S	1S	NN	B-NP	O
,	,	,	O	O
1R	1R	NN	B-NP	O
,	,	,	O	O
1aR	1aR	NN	B-NP	O
,	,	,	O	O
SS	SS	NN	B-NP	O
]	]	)	O	O
-	-	HYPH	B-NP	O
1d	1d	NN	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
cycloaddition	cycloaddition	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
substituted	substitute	VBN	I-NP	O
C	C	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
C	C	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
double	double	JJ	B-NP	O
bond	bond	NN	I-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
chemo	chemo	AFX	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
diastereoselective	diastereoselective	JJ	I-NP	O
way	way	NN	I-NP	O
from	from	IN	B-PP	O
quinone	quinone	NN	B-NP	O
1d	1d	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
ZnBr	ZnBr	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

Mad1	BEGIN-Mad1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Mad1	BEGIN-Mad1-INSIDE	NN	I-NP	B
:	:	:	O	O
novel	novel	JJ	B-NP	O
Max	BEGIN-Max-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
interacting	interact	VBG	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
repressors	repressor	NNS	I-NP	O
that	that	WDT	B-NP	O
suppress	suppress	VBP	B-VP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
myc	myc-INSIDE	NN	I-NP	I
dependent	dependent	JJ	I-NP	O
transformation	transformation	NN	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
during	during	IN	B-PP	O
neural	neural	JJ	B-NP	O
and	and	CC	I-NP	O
epidermal	epidermal	JJ	I-NP	O
differentiation	differentiation	NN	I-NP	O

Maximal	Maximal	JJ	B-NP	O
Expiratory	Expiratory	JJ	I-NP	O
Flow	Flow	NN	I-NP	O
Rates	Rate	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Peak	Peak	NNP	B-NP	O
Expiratory	Expiratory	NNP	I-NP	O
Flow	Flow	NNP	I-NP	O
Rate	Rate	NNP	I-NP	O
(	(	(	O	O
PEFR	PEFR	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
rates	rate	NNS	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
forced	forced	JJ	B-NP	O
vital	vital	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
(	(	(	O	O
V	V	NN	B-NP	O
max	max	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
V	V	NN	B-NP	O
max	max	NN	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
V	V	CD	I-NP	O
max	max	NN	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
forced	force	VBN	B-VP	O
expiratory	expiratory	JJ	B-NP	O
flow	flow	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	JJ	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
forced	force	VBN	B-NP	O
vital	vital	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
(	(	(	O	O
FEF	FEF	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
smoking	smoking	NN	I-NP	O
adults	adult	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
males	male	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
females	female	NNS	I-NP	O
)	)	)	O	O
aged	age	VBN	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
living	live	VBG	B-VP	O
in	in	IN	B-PP	O
Madras	Madras	NNP	B-NP	O

This	This	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
includes	include	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
three	three	CD	I-NP	O
zinc	zinc	NN	I-NP	O
fingers	finger	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TFIIIA	BEGIN-TFIIIA	NN	I-NP	B
DNA	DNA	NN	I-NP	I
binding	binding	NN	I-NP	I
domain	domain-INSIDE	NN	I-NP	I

Transcription	Transcription	NN	B-NP	O
of	of	IN	B-PP	O
eukaryotic	eukaryotic	JJ	B-NP	O
tRNA	tRNA	NN	I-NP	O
genes	gene	NNS	I-NP	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
A	A	NN	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	O
-	-	HYPH	I-NP	O
Box	Box	NN	I-NP	O
internal	internal	JJ	I-NP	O
control	control	NN	I-NP	O
regions	region	NNS	I-NP	O
(	(	(	O	O
ICRs	ICR	NNS	B-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
modulatory	modulatory	JJ	I-NP	O
region	region	NN	I-NP	O

This	This	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Na1	Na1	NN	B-NP	O
citrate	citrate	NN	I-NP	O
produced	produce	VBD	B-VP	O
no	no	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
hypocalcaemia	hypocalcaemia	NN	B-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
subjects	subject	NNS	I-NP	O
,	,	,	O	O
even	even	RB	B-SBAR	O
though	though	IN	I-SBAR	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
acid	acid	NN	B-NP	O
-	-	HYPH	B-NP	O
citrate	citrate	NN	I-NP	O
-	-	HYPH	O	O
dextrose	dextrose	NN	B-NP	O
,	,	,	O	O
NIH	NIH	NN	B-NP	O
formula	formula	NN	I-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
ACD	ACD	NN	B-NP	O
-	-	HYPH	B-NP	O
A	A	NN	I-NP	O
)	)	)	O	O
under	under	IN	B-PP	O
identical	identical	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
reduce	reduce	VB	I-VP	O
significantly	significantly	RB	B-NP	O
the	the	DT	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
concomitantly	concomitantly	RB	B-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
or	or	CC	I-NP	O
reactions	reaction	NNS	I-NP	O
occurring	occur	VBG	B-VP	O
in	in	IN	B-PP	O
donors	donor	NNS	B-NP	O

Cough	Cough	JJ	B-NP	O
-	-	HYPH	I-NP	O
CPR	CPR	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
deep	deep	JJ	I-NP	O
rhythmic	rhythmic	JJ	I-NP	O
forceful	forceful	JJ	I-NP	O
cough	cough	NN	I-NP	O
repeated	repeat	VBN	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
resuscitative	resuscitative	JJ	I-NP	O
technique	technique	NN	I-NP	O
during	during	IN	B-PP	O
emergencies	emergency	NNS	B-NP	O
occurring	occur	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
laboratory	laboratory	NN	I-NP	O

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
Neisseria	BEGIN-Neisseria	NN	I-NP	B
lactamica	lactamica	NN	I-NP	I
III	III	CD	I-NP	I
DNA	DNA	NN	I-NP	I
methyltransferase	methyltransferase-INSIDE	NN	I-NP	I
(	(	(	O	O
M.NlaIII	BEGIN-M.NlaIII-INSIDE	NN	B-NP	B
)	)	)	O	O
which	which	WDT	B-NP	O
recognizes	recognize	VBZ	B-VP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
CATG	CATG	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
cloned	clone	VBN	I-VP	O
and	and	CC	O	O
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O

A	A	DT	B-NP	O
multivariant	multivariant	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
pituitary	pituitary	JJ	B-NP	O
adenoma	adenoma	NN	I-NP	O
,	,	,	O	O
obtainment	obtainment	NN	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
logistic	logistic	JJ	I-NP	O
regression	regression	NN	I-NP	O
equations	equation	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
auxiliary	auxiliary	JJ	I-NP	O
support	support	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
tumors	tumor	NNS	I-NP	O

Increased	Increase	VBN	B-NP	O
TRE	TRE	NN	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
transactivation	transactivation	NN	I-NP	O
correlating	correlate	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
inability	inability	NN	I-NP	O
of	of	IN	B-PP	O
SB	SB	NN	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	O	I
1	1	CD	B-NP	I
proteins	proteins-INSIDE	NN	I-NP	I

APL	APL	NN	B-NP	O
patients	patient	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
,	,	,	I-NP	O
yet	yet	RB	I-NP	O
variable	variable	JJ	I-NP	O
,	,	,	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
JEM	BEGIN-JEM	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
mRNA	mRNA-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O

The	The	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
clones	clone	NNS	I-NP	O
encode	encode	VBP	B-VP	O
a	a	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bHLH	bHLH	JJ	I-NP	O
(	(	(	O	O
basic	basic	JJ	B-NP	O
-	-	HYPH	I-NP	O
helix	helix	NN	I-NP	O
-	-	HYPH	B-NP	O
loop	loop	NN	I-NP	O
-	-	HYPH	I-NP	O
helix	helix	NN	I-NP	O
)	)	)	O	O
domain	domain	NN	B-NP	O
,	,	,	O	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
PAS	BEGIN-PAS-INSIDE	NN	I-NP	B
(	(	(	O	O
Per	BEGIN-Per-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
Arnt	BEGIN-Arnt-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
Sim	BEGIN-Sim-INSIDE	NN	I-NP	B
)	)	)	O	O
domain	domain	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
half	half	NN	I-NP	O
region	region	NN	I-NP	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
an	an	DT	B-NP	O
apical	apical	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
protein	protein	NN	I-NP	O
that	that	WDT	B-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
amiloride	amiloride	NN	I-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
epithelial	epithelial	JJ	I-NP	O
sodium	sodium	NN	I-NP	O
channel	channel	NN	I-NP	O

Nedocromil	Nedocromil	NN	B-NP	O
sodium	sodium	NN	I-NP	O
shifted	shift	VBD	B-VP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
allergic	allergic	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
EAR	EAR	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
mean	mean	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
later	later	RB	I-NP	O
allergic	allergic	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
LAR	LAR	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
+1	+1	CD	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

Values	Value	NNS	B-NP	O
of	of	IN	B-PP	O
K1	K1	NN	B-NP	O
and	and	CC	I-NP	O
Vd	Vd	NN	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	O
tissue	tissue	NN	I-NP	O

The	The	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
PTB	BEGIN-PTB-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
antagonistic	antagonistic	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
U1AF	BEGIN-U1AF-INSIDE	NN	B-NP	B
to	to	TO	B-PP	O
the	the	DT	B-NP	O
enhancer	enhancer	NN	I-NP	O
-	-	HYPH	B-NP	O
located	located	JJ	I-NP	O
pyrimidine	pyrimidine	NN	I-NP	O
tract	tract	NN	I-NP	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
separate	separate	VBP	B-VP	O
these	these	DT	B-NP	O
factors	factor	NNS	I-NP	O
into	into	IN	B-PP	O
four	four	CD	B-NP	O
regulatory	regulatory	JJ	I-NP	O
classes	class	NNS	I-NP	O
:	:	:	O	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
constitutive	constitutive	JJ	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Oct	BEGIN-Oct	JJ	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
probably	probably	RB	B-ADVP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
,	,	,	O	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
stages	stage	NNS	I-NP	O
;	;	:	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
inducible	inducible	JJ	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	I-NP	I
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
and	and	CC	O	O
complexes	complex	NNS	B-NP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
CD1	BEGIN-CD1	NN	I-NP	B
response	response	NN	I-NP	I
element	element-INSIDE	NN	I-NP	I
,	,	,	O	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
thymocytes	thymocyte	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
those	those	DT	B-NP	O
cells	cell	NNS	I-NP	O
(	(	(	O	O
CD1+	BEGIN-CD1+-INSIDE	NN	B-NP	B
CD1+	BEGIN-CD1+-INSIDE	NN	I-NP	B
TcRlow	BEGIN-TcRlow-INSIDE	NN	I-NP	B
)	)	)	O	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
undergo	undergo	VB	I-VP	O
selection	selection	NN	B-NP	O
;	;	:	O	O
(	(	(	B-LST	O
iii	iii	LS	I-LST	O
)	)	)	O	O
inducible	inducible	JJ	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
AT	AT-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
mature	mature	JJ	B-NP	O
(	(	(	O	O
CD1+	BEGIN-CD1+-INSIDE	NN	B-NP	B
CD1	BEGIN-CD1	NN	I-NP	B
-	-	HYPH	B-NP	I
	-INSIDE	NN	I-NP	I
TcRhigh	BEGIN-TcRhigh-INSIDE	NN	I-NP	B
)	)	)	O	O
and	and	CC	O	O
immature	immature	JJ	B-NP	O
(	(	(	O	O
CD1	BEGIN-CD1	NN	B-NP	B
-	-	HYPH	O	I
	-INSIDE	NN	B-NP	I
CD1	BEGIN-CD1	NN	I-NP	B
-	-	HYPH	B-NP	I
	-INSIDE	NN	I-NP	I
TcR	BEGIN-TcR	NN	I-NP	B
-	-	HYPH	B-NP	I
	-INSIDE	NN	I-NP	I
)	)	)	O	O
thymocytes	thymocyte	NNS	B-NP	O
alike	alike	RB	B-ADVP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
transitional	transitional	JJ	I-NP	O
stages	stage	NNS	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
(	(	(	O	O
CD1+	BEGIN-CD1+-INSIDE	NN	B-NP	B
CD1+	BEGIN-CD1+-INSIDE	NN	I-NP	B
TcRlow	BEGIN-TcRlow-INSIDE	NN	I-NP	B
)	)	)	O	O
are	be	VBP	B-VP	O
subject	subject	JJ	B-ADJP	O
to	to	TO	B-PP	O
selection	selection	NN	B-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
iv	iv	LS	I-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
factor	factor	NN	I-NP	O
containing	contain	VBG	B-VP	O
CREB	BEGIN-CREB-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
stages	stage	NNS	I-NP	O
by	by	IN	B-PP	O
culture	culture	NN	B-NP	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
specific	specific	JJ	B-NP	O
induction	induction	NN	I-NP	O

Similar	Similar	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
patterns	pattern	NNS	I-NP	O
are	be	VBP	B-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fusion	fusion	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
caufliflower	BEGIN-caufliflower	NNP	I-NP	B
mosaic	mosaic	JJ	I-NP	I
virus	virus	NN	I-NP	I
1S	1S	NN	I-NP	I
RNA	RNA	NN	I-NP	I
promotor	promotor-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
GUS	BEGIN-GUS	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
rapidly	rapidly	RB	B-ADVP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
case	case	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
either	either	CC	O	O
the	the	DT	B-NP	O
DQ	BEGIN-DQ	NN	I-NP	B
alpha	alpha	SYM	B-VP	I
-	-	HYPH	B-NP	I
or	or	CC	O	I
DQ	DQ	NN	B-NP	I
beta	beta	SYM	B-NP	I
-	-	HYPH	B-NP	I
chain	chain-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
exchanged	exchange	VBN	I-VP	O
,	,	,	O	O
major	major	JJ	B-NP	O
alterations	alteration	NNS	I-NP	O
or	or	CC	I-NP	O
reversals	reversal	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
interaction	interaction	NN	B-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

Two	Two	CD	B-NP	O
methods	method	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
routine	routine	JJ	I-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
hemoglobin	BEGIN-hemoglobin-INSIDE	NN	I-NP	B
oxygen	oxygen	NN	I-NP	O
affinity	affinity	NN	I-NP	O
are	be	VBP	B-VP	O
described	describe	VBN	I-VP	O

The	The	DT	B-NP	O
cause	cause	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
plasma	BEGIN-plasma	NN	B-NP	B
ANP	ANP-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
phase	phase	NN	I-NP	O
remains	remain	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
survival	survival	NN	B-NP	O
of	of	IN	B-PP	O
adjuvant	adjuvant	JJ	B-NP	O
treatments	treatment	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
pre	pre	AFX	B-NP	O
-	-	HYPH	I-NP	O
or	or	CC	O	O
postoperative	postoperative	JJ	B-NP	O
systemic	systemic	JJ	I-NP	O
or	or	CC	I-NP	O
postoperative	postoperative	JJ	I-NP	O
intra	intra	AFX	I-NP	O
-	-	HYPH	I-NP	O
arterial	arterial	JJ	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
currently	currently	RB	B-ADVP	O
under	under	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O

Malformations	Malformation	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
regenerating	regenerate	VBG	I-NP	O
optic	optic	JJ	I-NP	O
tectum	tectum	NN	I-NP	O
of	of	IN	B-PP	O
larvae	larva	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Egyptian	Egyptian	JJ	I-NP	O
toad	toad	NN	I-NP	O
,	,	,	O	O
Bufo	Bufo	NNP	B-NP	O
regularis	regulari	VBZ	B-VP	O
Reuss	Reuss	NNP	B-NP	O

Immunological	Immunological	JJ	B-NP	O
studies	study	NNS	I-NP	O
also	also	RB	B-ADVP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
any	any	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
natural	natural	JJ	B-NP	O
killer	killer	NN	I-NP	O
(	(	(	O	O
NK	NK	NN	B-NP	O
)	)	)	O	O
cell	cell	NN	B-NP	O
activity	activity	NN	I-NP	O
after	after	IN	B-PP	O
IFN	BEGIN-IFN	NN	B-NP	B
-	-	HYPH	B-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
infusion	infusion	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
systemic	systemic	JJ	B-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ototoxic	ototoxic	JJ	I-NP	O
drug	drug	NN	I-NP	O
amikacin	amikacin	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
total	total	JJ	B-NP	O
cochlear	cochlear	JJ	I-NP	O
haircell	haircell	NN	I-NP	O
loss	loss	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chinchilla	chinchilla	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
create	create	VB	I-VP	O
an	an	DT	B-NP	O
animal	animal	NN	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
profound	profound	JJ	B-NP	O
deafness	deafness	NN	I-NP	O

BACKGROUND	BACKGROUND	NN	B-NP	O
-	-	HYPH	O	O
-	-	SYM	O	O
Platelet	BEGIN-Platelet	NN	B-NP	B
activating	activate	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
(	(	(	O	O
PAF	BEGIN-PAF-INSIDE	NN	B-NP	B
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
airway	airway	NN	B-NP	O
hyperresponsiveness	hyperresponsiveness	NN	I-NP	O
in	in	IN	B-PP	O
asthma	asthma	NN	B-NP	O

To	To	TO	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
nurse	nurse	NN	I-NP	O

Chronic	Chronic	JJ	B-NP	O
granulocytic	granulocytic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O

Charcot	Charcot	NN	B-NP	O
joints	joint	NNS	I-NP	O

Recombinant	BEGIN-Recombinant	JJ	B-NP	B
apoA	apoA	NN	I-NP	I
-	-	HYPH	O	I
I	I	PRP	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
recovered	recover	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
soluble	soluble	JJ	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
cell	cell	NN	I-NP	O
pellet	pellet	NN	I-NP	O
was	be	VBD	B-VP	O
purified	purify	VBN	I-VP	O
to	to	TO	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
homogeneity	homogeneity	NN	I-NP	O
by	by	IN	B-PP	O
reversed	reverse	VBN	B-NP	O
-	-	HYPH	I-NP	O
phase	phase	NN	I-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
performance	performance	NN	I-NP	O
liquid	liquid	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O

Kaposi	Kaposi	NNP	B-NP	O
's	's	POS	B-NP	O
sarcoma	sarcoma	NN	I-NP	O
-	-	HYPH	O	O
associated	associate	VBN	B-NP	O
herpesvirus	herpesvirus	NN	I-NP	O
/	/	SYM	B-NP	O
human	human	JJ	B-NP	O
herpesvirus	herpesvirus	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
ORF1	BEGIN-ORF1-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
activation	activation	NN	I-NP	O
domain	domain	NN	I-NP	O
which	which	WDT	B-NP	O
activates	activate	VBZ	B-VP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
target	target	NN	I-NP	O
sequence	sequence	NN	I-NP	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
flanking	flanking	NN	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
J	J	NN	I-NP	I
kappa	kappa	NN	I-NP	I
elements	elements-INSIDE	NN	I-NP	I
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
putative	putative	JJ	I-NP	O
recombination	recombination	NN	I-NP	O
target	target	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
,	,	,	O	O
shows	show	VBZ	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
differences	difference	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
variation	variation	NN	I-NP	O
in	in	IN	B-PP	O
recombinational	recombinational	JJ	B-NP	O
efficiency	efficiency	NN	I-NP	O
,	,	,	O	O
so	so	IN	O	O
we	we	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	O
heptamer	heptamer	NN	I-NP	O
and	and	CC	I-NP	O
nonamer	nonamer	NN	I-NP	O
signals	signal	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
a	a	DT	B-NP	O
recombination	recombination	NN	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
probability	probability	NN	I-NP	O
that	that	IN	B-SBAR	O
that	that	DT	B-NP	O
site	site	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
depends	depend	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
other	other	JJ	B-NP	O
determinants	determinant	NNS	I-NP	O

Further	Further	JJ	B-NP	O
interventions	intervention	NNS	I-NP	O
were	be	VBD	B-VP	O
:	:	:	O	O
nephrectomy	nephrectomy	NN	B-NP	O
(	(	(	O	O
1x	1x	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
resection	resection	NN	B-NP	O
and	and	CC	I-NP	O
ligation	ligation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
vena	vena	NN	I-NP	O
cava	cava	NN	I-NP	O
(	(	(	O	O
1x	1x	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
resection	resection	NN	B-NP	O
and	and	CC	I-NP	O
replacement	replacement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
renal	renal	JJ	I-NP	O
vein	vein	NN	I-NP	O
(	(	(	O	O
1x	1x	NN	B-NP	O
)	)	)	O	O

Herein	Herein	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
CRE	CRE	NN	B-NP	O
-	-	HYPH	B-NP	O
decoy	decoy	NN	I-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
treatment	treatment	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
p1	BEGIN-BEGIN-p1-INSIDE	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
level	level	NN	I-NP	O
in	in	IN	B-PP	O
MCF	MCF	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
human	human	JJ	I-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
cells	cell	NNS	I-NP	O
that	that	WDT	B-NP	O
express	express	VBP	B-VP	O
wild	wild	JJ	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B

Competition	Competition	NN	B-NP	O
and	and	CC	I-NP	O
methylation	methylation	NN	I-NP	O
interference	interference	NN	I-NP	O
assays	assay	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
novel	novel	JJ	I-NP	O
factor	factor	NN	I-NP	O
was	be	VBD	B-VP	O
limited	limit	VBN	I-VP	O
to	to	TO	B-PP	O
nucleotides	nucleotide	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kappa	BEGIN-kappa	NN	I-NP	B
B	B	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
introduced	introduce	VBN	I-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
tRNA	tRNA	NN	I-NP	I
(	(	(	O	I
Trp	Trp	NN	B-NP	I
)	)	)	O	I
gene	gene-INSIDE	NN	B-NP	I
and	and	CC	O	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
tRNA	tRNA	NN	I-NP	O
acts	act	VBZ	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
efficient	efficient	JJ	I-NP	O
amber	amber	NN	I-NP	O
suppressor	suppressor	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Both	Both	DT	B-NP	O
proteins	protein	NNS	I-NP	O
share	share	VBP	B-VP	O
sequence	sequence	NN	B-NP	O
similarity	similarity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
myelin	BEGIN-myelin	NN	I-NP	B
-	-	HYPH	B-VP	I
associated	associate	VBN	B-NP	I
glycoprotein	glycoprotein-INSIDE	NN	I-NP	I
,	,	,	O	O
an	an	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
molecule	molecule	NN	I-NP	O
of	of	IN	B-PP	O
oligodendrocytes	oligodendrocyte	NNS	B-NP	O
and	and	CC	O	O
Schwann	Schwann	NNP	B-NP	O
cells	cell	NNS	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
myelination	myelination	NN	B-NP	O
,	,	,	O	O
raising	raise	VBG	B-VP	O
the	the	DT	B-NP	O
important	important	JJ	I-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
whether	whether	IN	B-SBAR	O
myelin	BEGIN-myelin	NN	B-NP	B
-	-	HYPH	B-NP	I
associated	associate	VBN	I-NP	I
glycoprotein	glycoprotein-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
sialic	BEGIN-sialic	JJ	I-NP	B
acid	acid	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
1	1	CD	I-NP	O
'	'	''	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
ends	end	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcript	transcript	NN	I-NP	O
are	be	VBP	B-VP	O
in	in	IN	B-PP	O
very	very	RB	B-NP	O
good	good	JJ	I-NP	O
agreement	agreement	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
determined	determine	VBN	I-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LEU1	BEGIN-LEU1-INSIDE	NN	I-NP	B
message	message	NN	I-NP	O

These	These	DT	B-NP	O
clones	clone	NNS	I-NP	O
contain	contain	VBP	B-VP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
exon	exon	NN	I-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
D1	D1-INSIDE	NN	I-NP	I
except	except	IN	B-PP	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O

By	By	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
FFA	FFA	NN	B-NP	O
levels	level	NNS	I-NP	O
from	from	IN	B-PP	O
shams	sham	NNS	B-NP	O

The	The	DT	B-NP	O
clr1	BEGIN-clr1	NN	I-NP	B
locus	locus-INSIDE	NN	I-NP	I
regulates	regulate	VBZ	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cryptic	BEGIN-cryptic	JJ	I-NP	B
mating	mating	NN	I-NP	I
-	-	HYPH	B-NP	I
type	type	NN	I-NP	I
loci	locus	NNS	I-NP	I
of	of	IN	B-PP	I
fission	fission	NN	B-NP	I
yeast	yeast-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
odds	odd	NNS	I-NP	O
of	of	IN	B-PP	O
atopy	atopy	NN	B-NP	O
(	(	(	O	O
defined	define	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
test	test	NN	I-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antigens	antigen	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
1	1	CD	B-ADJP	O
times	time	NNS	I-ADJP	O
higher	high	JJR	I-ADJP	O
(	(	(	O	O
odds	odd	NNS	B-NP	O
ratio	ratio	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
confidence	confidence	NN	I-NP	O
interval	interval	NN	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
uninfected	uninfected	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
taking	take	VBG	B-VP	O
into	into	IN	B-PP	O
account	account	NN	B-NP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
gender	gender	NN	B-NP	O
and	and	CC	I-NP	O
age	age	NN	I-NP	O

In	In	IN	B-PP	O
mouse	mouse	NN	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
affinity	affinity	NN	I-NP	O
binding	binding	NN	I-NP	O
sites	site	NNS	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
dissociation	dissociation	NN	I-NP	O
constant	constant	NN	I-NP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
nM	nM	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
mapped	map	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
ETS	BEGIN-ETS-INSIDE	NN	I-NP	B
upstream	upstream	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
pre	pre	AFX	I-NP	O
-	-	HYPH	I-NP	O
rRNA	rRNA	NN	I-NP	O
processing	processing	NN	I-NP	O
site	site	NN	I-NP	O

As	As	IN	B-SBAR	O
much	much	JJ	B-NP	O
thrombin	BEGIN-thrombin-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
formed	form	VBN	I-VP	O
during	during	IN	B-PP	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
(	(	(	O	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
prothrombin	BEGIN-proBEGIN-thrombin-INSIDE	NN	I-NP	B
activation	activation	NN	I-NP	O
fragment	fragment	NN	I-NP	O
F1	F1	NN	I-NP	O
+	+	SYM	B-NP	O
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
thrombin	BEGIN-thrombin-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
antithrombin	antiBEGIN-thrombin-INSIDE	JJ	I-NP	I
complexes	complex	NNS	I-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
showing	show	VBG	B-VP	O
that	that	IN	B-SBAR	O
factor	BEGIN-factor	NN	B-NP	B
XII	XII-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
not	not	RB	O	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
thrombin	BEGIN-thrombin-INSIDE	NN	B-NP	B
generation	generation	NN	I-NP	O

This	This	DT	B-NP	O
article	article	NN	I-NP	O
reviews	review	VBZ	B-VP	O
current	current	JJ	B-NP	O
concepts	concept	NNS	I-NP	O
of	of	IN	B-PP	O
pathophysiology	pathophysiology	NN	B-NP	O
and	and	CC	O	O
summarises	summarise	VBZ	B-VP	O
clinical	clinical	JJ	B-NP	O
features	feature	NNS	I-NP	O
,	,	,	O	O
natural	natural	JJ	B-NP	O
history	history	NN	I-NP	O
and	and	CC	O	O
available	available	JJ	B-NP	O
treatments	treatment	NNS	I-NP	O

Pendulin	BEGIN-Pendulin-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
Drosophila	Drosophila	NNP	I-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
localization	localization	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
cell	cell	NN	I-NP	O
proliferation	proliferation	NN	I-NP	O

The	The	DT	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
active	active	JJ	I-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
located	locate	VBN	I-VP	O
within	within	IN	B-PP	O
residues	residue	NNS	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

The	The	DT	B-NP	O
central	central	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sarcomere	sarcomere	JJ	I-NP	O
,	,	,	I-NP	O
coincident	coincident	JJ	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
M	M	NN	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
selectively	selectively	RB	I-VP	O
labeled	label	VBN	I-VP	O
with	with	IN	B-PP	O
antibodies	antibody	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
short	short	JJ	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
form	form	NN	I-NP	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
antibody	antibody	NN	B-NP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
two	two	CD	I-NP	O
determinants	determinant	NNS	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
when	when	WRB	B-ADVP	O
ZAP	BEGIN-ZAP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
or	or	CC	O	O
the	the	DT	B-NP	O
SH1	BEGIN-SH1	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
zeta	zeta	NN	I-NP	O
chain	chain	NN	I-NP	O
or	or	CC	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
1pY	BEGIN-1pY	NN	I-NP	B
-	-	HYPH	O	I
ITAM	ITAM-INSIDE	NN	B-NP	I

Interleukin	BEGIN-Interleukin	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
noradrenaline	noradrenaline	NN	I-NP	O
release	release	NN	I-NP	O

A	A	DT	B-NP	O
representative	representative	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
undergoing	undergo	VBG	B-VP	O
open	open	JJ	B-NP	O
radical	radical	NN	I-NP	O
nephrectomy	nephrectomy	NN	I-NP	O
for	for	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
T1	T1	NN	I-NP	O
,	,	,	O	O
T1	T1	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
identified	identify	VBN	I-VP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
KCTG	KCTG	NN	B-NP	O
can	can	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
improved	improve	VBN	B-NP	O
monitoring	monitoring	NN	I-NP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
risk	risk	NN	I-NP	O
pregnancies	pregnancy	NNS	I-NP	O

These	These	DT	B-NP	O
extrachromosomal	extrachromosomal	JJ	I-NP	O
copies	copy	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
isolated	isolate	VBN	I-VP	O
as	as	IN	B-PP	O
covalently	covalently	RB	B-NP	O
closed	close	VBN	I-NP	O
molecules	molecule	NNS	I-NP	O
with	with	IN	B-PP	O
lengths	length	NNS	B-NP	O
around	around	IN	B-PP	O
1mu	1mu	NN	B-NP	O

Significant	Significant	JJ	B-NP	O
reductions	reduction	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
vertical	vertical	JJ	B-NP	O
GRFs	GRF	NNS	I-NP	O
per	per	IN	B-PP	O
newton	newton	NN	B-NP	O
of	of	IN	B-PP	O
body	body	NN	B-NP	O
weight	weight	NN	I-NP	O
exerted	exert	VBD	B-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
stance	stance	NN	B-NP	O
phase	phase	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
anteroposterior	anteroposterior	JJ	B-NP	O
GRFs	GRF	NNS	I-NP	O
exerted	exert	VBN	B-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
stance	stance	NN	B-NP	O
phase	phase	NN	I-NP	O
when	when	WRB	B-ADVP	O
ambulation	ambulation	NN	B-NP	O
was	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
and	and	CC	I-PP	O
without	without	IN	I-PP	O
the	the	DT	B-NP	O
orthotic	orthotic	JJ	I-NP	O
device	device	NN	I-NP	O

Similar	Similar	JJ	B-NP	O
immunological	immunological	JJ	I-NP	O
disturbances	disturbance	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
SCI	SCI	NN	B-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
PC1	PC1	NN	I-NP	O
subgroup	subgroup	NN	I-NP	O
,	,	,	O	O
i.e.	i.e.	FW	B-NP	O
patients	patient	NNS	I-NP	O
examined	examine	VBN	B-VP	O
later	later	RB	B-ADVP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
injury	injury	NN	B-NP	O

Trimethylcolchicinic	Trimethylcolchicinic	JJ	B-NP	O
acid	acid	NN	I-NP	O
methyl	methyl	NN	I-NP	O
ether	ether	NN	I-NP	O
d	d	NN	I-NP	O
-	-	HYPH	O	O
tartrate	tartrate	NN	B-NP	O
(	(	(	O	O
TMCA	TMCA	NN	B-NP	O
;	;	:	O	O
NSC	NSC	NNP	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
lymphomas	lymphoma	NNS	I-NP	O

After	After	IN	B-PP	O
multivariate	multivariate	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
TWA	TWA	NNP	B-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
age	age	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
LV	LV	NN	B-NP	O
function	function	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
occurred	occur	VBD	B-VP	O
more	more	RBR	B-ADVP	O
often	often	RB	I-ADVP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
after	after	IN	B-PP	O
nonanterior	nonanterior	JJ	B-NP	O
MI	MI	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
rats	rat	NNS	B-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
Cd	Cd	NN	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
excretion	excretion	NN	I-NP	O
of	of	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
parathyroid	BEGIN-parathyroid	JJ	B-NP	B
hormone	hormone-INSIDE	NN	I-NP	I
(	(	(	O	O
PTH	BEGIN-PTH-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
parathyroidectomy	parathyroidectomy	NN	B-NP	O
(	(	(	O	O
PTX	PTX	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
1	1	CD	O	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
hydroxycholecalciferol	hydroxycholecalciferol	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
alpha	alpha	SYM	O	O
-	-	HYPH	B-NP	O
OH	OH	NN	I-NP	O
-	-	HYPH	I-NP	O
D1	D1	NN	I-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
almost	almost	RB	B-NP	O
the	the	DT	I-NP	O
same	same	JJ	I-NP	O
patterns	pattern	NNS	I-NP	O
as	as	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
rats	rat	NNS	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
cAMP	cAMP	NN	I-NP	O
to	to	TO	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
PTH	BEGIN-PTH-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
continuous	continuous	JJ	B-NP	O
oral	oral	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
Cd	Cd	NN	B-NP	O

Receptor	BEGIN-Receptor	NN	B-NP	B
-	-	HYPH	I-NP	I
type	type	NN	I-NP	I
serine	serine	NN	I-NP	I
/	/	SYM	B-VP	I
threonine	threonine	NN	B-NP	I
kinases	kinases-INSIDE	NN	I-NP	I
(	(	(	O	O
RSKs	BEGIN-RSKs-INSIDE	NN	B-NP	B
)	)	)	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
organized	organize	VBN	I-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
classes	class	NNS	I-NP	O
known	know	VBN	B-VP	O
as	as	IN	B-PP	O
types	type	NNS	B-NP	O
I	I	CD	B-NP	O
and	and	CC	I-NP	O
II	II	CD	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
sequence	sequence	NN	B-NP	O
similarity	similarity	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
1	1	CD	I-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
coagulase	BEGIN-coagulase-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
Staphylococci	Staphylococci	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NN	B-NP	O
epidermidis	epidermidis	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
Staphylococcus	Staphylococcus	FW	B-ADVP	O
aureus	aureus	FW	I-ADVP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
Corynebacterium	Corynebacterium	NN	B-NP	O
species	specie	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
others	other	NNS	B-NP	O
(	(	(	O	O
seven	seven	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O

This	This	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
corresponded	correspond	VBD	B-VP	O
to	to	TO	B-PP	O
FGF	BEGIN-FGF	NN	B-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
FGF	BEGIN-FGF	NN	B-NP	B
-	-	HYPH	O	I
BP	BP-INSIDE	NN	B-NP	I
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
secreted	secrete	VBN	I-NP	O
protein	protein	NN	I-NP	O
previously	previously	RB	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
acidic	acidic	JJ	B-NP	O
and	and	CC	I-NP	O
basic	BEGIN-basic	JJ	I-NP	B
FGF	FGF-INSIDE	NN	I-NP	I
and	and	CC	O	O
to	to	TO	B-VP	O
modulate	modulate	VB	I-VP	O
their	their	PRP$	B-NP	O
activities	activity	NNS	I-NP	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
-	-	HYPH	O	O
shift	shift	NN	B-NP	O
assays	assay	NNS	I-NP	O
using	use	VBG	B-VP	O
oligonucleotides	oligonucleotide	NNS	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
sites	site	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
complexes	complex	NNS	I-NP	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
P	BEGIN-P	NN	I-NP	B
transcript	transcript-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
phage	phage	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
G	G	NN	I-NP	O
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
orientation	orientation	NN	B-NP	O
,	,	,	O	O
full	full	JJ	B-NP	O
termination	termination	NN	I-NP	O
activity	activity	NN	I-NP	O
required	require	VBD	B-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
stem	stem	NN	I-NP	O
-	-	HYPH	B-NP	O
loop	loop	NN	I-NP	O
structure	structure	NN	I-NP	O
and	and	CC	O	O
upstream	upstream	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O

One	One	CD	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
injection	injection	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
injected	inject	VBN	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
skeleton	skeleton	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
kidneys	kidney	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
organs	organ	NNS	I-NP	O

Of	Of	IN	B-PP	O
these	these	DT	B-NP	O
four	four	CD	I-NP	O
PP1C	BEGIN-PP1C	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PP1Cbeta	BEGIN-PP1Cbeta	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tissue	tissue	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
and	and	CC	I-NP	O
development	development	NN	I-NP	O
-	-	HYPH	O	O
dependent	dependent	JJ	O	O

Combined	Combine	VBN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
with	with	IN	B-PP	O
VM	VM	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
BCNU	BCNU	NN	B-NP	O
for	for	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
malignant	malignant	JJ	I-NP	O
gliomas	glioma	NNS	I-NP	O
after	after	IN	B-PP	O
operation	operation	NN	B-NP	O
and	and	CC	I-NP	O
irradiation	irradiation	NN	I-NP	O

Administration	Administration	NN	B-NP	O
of	of	IN	B-PP	O
FR	FR	NN	B-NP	O
1	1	CD	I-NP	O
reduced	reduce	VBD	B-VP	O
aortic	aortic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
in	in	IN	B-PP	O
anesthetized	anesthetize	VBN	B-NP	O
dogs	dog	NNS	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ameroid	ameroid	NN	I-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O

Alternative	Alternative	JJ	B-NP	O
immune	BEGIN-immune	JJ	I-NP	B
globulin	globulin-INSIDE	NN	I-NP	I
preparation	preparation	NN	I-NP	O
when	when	WRB	B-ADVP	O
standard	standard	JJ	B-NP	O
immune	BEGIN-immune	JJ	I-NP	B
serum	serum	NN	I-NP	I
globulin	globulin-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
not	not	RB	O	O
available	available	JJ	B-ADJP	O

Two	Two	CD	B-NP	O
sibs	sib	NNS	I-NP	O
with	with	IN	B-PP	O
identical	identical	JJ	B-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
short	short	JJ	B-NP	O
-	-	HYPH	I-NP	O
limbed	limbed	JJ	I-NP	O
dwarfism	dwarfism	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
skull	skull	NN	I-NP	O
and	and	CC	I-NP	O
face	face	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
intelligence	intelligence	NN	I-NP	O
are	be	VBP	B-VP	O
described	describe	VBN	I-VP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
sugar	sugar	NN	I-NP	O
intake	intake	NN	I-NP	O
on	on	IN	B-PP	O
some	some	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
and	and	CC	I-NP	O
regulatory	regulatory	JJ	I-NP	O
indicators	indicator	NNS	I-NP	O
in	in	IN	B-PP	O
young	young	JJ	B-NP	O
men	man	NNS	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
group	group	NN	I-NP	O
the	the	DT	B-NP	O
untreated	untreated	JJ	I-NP	O
fellow	fellow	NN	I-NP	O
eye	eye	NN	I-NP	O
was	be	VBD	B-VP	O
microscopically	microscopically	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
(	(	(	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
treated	treat	VBN	I-NP	O
eye	eye	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
alter	alter	VB	I-VP	O
the	the	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
uronic	uronic	JJ	B-NP	O
acid	acid	NN	I-NP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
parts	part	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sclera	sclera	NN	I-NP	O

Amplification	Amplification	NN	B-NP	O
of	of	IN	B-PP	O
1q1	1q1	CD	B-NP	O
-	-	HYPH	I-NP	O
q1	q1	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
MXR	BEGIN-MXR	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
independently	independently	RB	B-NP	O
derived	derive	VBN	I-NP	O
mitoxantrone	mitoxantrone	NN	I-NP	O
-	-	HYPH	I-NP	O
resistant	resistant	JJ	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
putative	putative	JJ	B-NP	O
constitutively	constitutively	RB	I-NP	O
active	active	JJ	I-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
DdMEK1	BEGIN-DdMEK1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
a	a	DT	B-NP	O
ddmek1	BEGIN-ddmek1-INSIDE	NN	I-NP	B
null	null	JJ	I-NP	O
background	background	NN	I-NP	O
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
partially	partially	RB	B-ADVP	O
,	,	,	O	O
of	of	IN	B-PP	O
complementing	complement	VBG	B-VP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
aggregate	aggregate	JJ	I-NP	O
size	size	NN	I-NP	O
defect	defect	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
guanylyl	BEGIN-guanylyl	NN	B-NP	B
cyclase	cyclase-INSIDE	NN	I-NP	I

Quantitative	Quantitative	JJ	B-NP	O
Tl	Tl	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
analysis	analysis	NN	I-NP	O
after	after	IN	B-SBAR	O
stress	stress	NN	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
shown	show	VBN	I-VP	O
viable	viable	JJ	B-NP	O
myocardium	myocardium	NN	I-NP	O
in	in	IN	B-PP	O
most	most	JJS	B-ADJP	O
mild	mild	JJ	I-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
to	to	TO	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
uptake	uptake	NN	I-NP	O
)	)	)	I-NP	O
irreversible	irreversible	JJ	I-NP	O
Tl	Tl	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
defects	defect	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
ADAR1	BEGIN-ADAR1-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
related	related	JJ	I-NP	O
deaminase	BEGIN-deaminase	NN	I-NP	B
ADAR1	BEGIN-ADAR1-INSIDE-INSIDE	NN	I-NP	I
showed	show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
examined	examine	VBN	B-VP	O
,	,	,	O	O
including	include	VBG	B-PP	O
cortex	cortex	NN	B-NP	O
,	,	,	O	O
hippocampus	hippocampus	NN	B-NP	O
,	,	,	O	O
olfactory	olfactory	JJ	B-NP	O
bulb	bulb	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
striatum	striatum	NN	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	I-NP	I
HT1CR	HT1CR	NN	I-NP	I
pre	pre	AFX	O	I
-	-	HYPH	O	I
mRNA	mRNA-INSIDE	NN	B-NP	I
was	be	VBD	B-VP	O
extensively	extensively	RB	I-VP	O
edited	edit	VBN	I-VP	O

Psychophysical	Psychophysical	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
is	be	VBZ	B-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
systems	system	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
vision	vision	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
fast	fast	NN	I-NP	O
,	,	,	O	O
sign	sign	NN	B-NP	O
-	-	HYPH	I-NP	O
invariant	invariant	JJ	I-NP	O
system	system	NN	I-NP	O
concerned	concern	VBN	B-VP	O
with	with	IN	B-PP	O
extracting	extract	VBG	B-NP	O
contours	contour	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
slower	slow	JJR	I-NP	O
,	,	,	I-NP	O
sign	sign	NN	I-NP	O
-	-	HYPH	I-NP	O
sensitive	sensitive	JJ	I-NP	O
system	system	NN	I-NP	O
concerned	concern	VBN	B-VP	O
with	with	IN	B-PP	O
assigning	assign	VBG	B-VP	O
surface	surface	NN	B-NP	O
color	color	NN	I-NP	O

Five	Five	CD	B-NP	O
girls	girl	NNS	I-NP	O
with	with	IN	B-PP	O
Turner	Turner	NNP	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
aged	age	VBN	B-VP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
showed	show	VBD	B-VP	O
LH	BEGIN-LH-INSIDE	NN	B-NP	B
values	value	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
or	or	CC	O	O
slightly	slightly	RB	B-ADVP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
and	and	CC	O	O
pathologically	pathologically	RB	B-NP	O
high	high	JJ	I-NP	O
values	value	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
IU	IU	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
FSH	BEGIN-FSH-INSIDE	NN	B-NP	B

Thirty	Thirty	CD	B-NP	O
-	-	HYPH	I-NP	O
seven	seven	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
temporal	temporal	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
epilepsy	epilepsy	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
interictally	interictally	RB	B-ADVP	O
with	with	IN	B-PP	O
[	[	(	B-NP	O
1F	1F	NN	I-NP	O
]	]	)	I-NP	O
fluorodeoxyglucose	fluorodeoxyglucose	NN	I-NP	O
-	-	HYPH	B-NP	O
PET	PET	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
conditions	condition	NNS	I-NP	O
:	:	:	O	O
resting	rest	VBG	B-VP	O
,	,	,	O	O
during	during	IN	B-PP	O
emotional	emotional	JJ	B-NP	O
speech	speech	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
while	while	IN	B-SBAR	O
performing	perform	VBG	B-VP	O
a	a	DT	B-NP	O
visual	visual	JJ	I-NP	O
recognition	recognition	NN	I-NP	O
task	task	NN	I-NP	O

The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
Vac1p	BEGIN-Vac1p-INSIDE	NN	B-NP	B
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
putative	putative	JJ	I-NP	O
zinc	zinc	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
RING	RING	NN	B-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
motif	motif	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
coiled	coil	VBN	I-NP	O
-	-	HYPH	I-NP	O
coil	coil	NN	I-NP	O
motif	motif	NN	I-NP	O

Serum	Serum	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
hormones	hormone	NNS	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
classified	classify	VBN	B-VP	O
as	as	IN	B-PP	O
C	C	NN	B-NP	O
were	be	VBD	B-VP	O
characteristically	characteristically	RB	B-ADVP	O
and	and	CC	O	O
inclined	incline	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypergonadotropic	hypergonadotropic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
hypoestrogenic	hypoestrogenic	JJ	I-ADJP	O

Kinase	Kinase	NN	B-NP	O
renaturation	renaturation	NN	I-NP	O
tests	test	NNS	I-NP	O
designed	design	VBN	B-VP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
reactivated	reactivate	VBN	B-NP	O
protein	protein	NN	I-NP	O
kinases	kinase	NNS	I-NP	O
after	after	IN	B-PP	O
electrophoresis	electrophoresis	NN	B-NP	O
in	in	IN	B-PP	O
sodium	sodium	NN	B-NP	O
dodecyl	dodecyl	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
-	-	HYPH	B-NP	O
polyacrylamide	polyacrylamide	NN	I-NP	O
gels	gel	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
kinase	kinase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
washed	wash	VBN	I-NP	O
immunoprecipitate	immunoprecipitate	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
liver	liver	NN	B-NP	O
cytosol	cytosol	NN	I-NP	O
using	use	VBG	B-VP	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
AHR	AHR	NN	B-NP	I
antibody	antibody-INSIDE	NN	I-NP	I
(	(	(	O	O
IgG	BEGIN-IgG-INSIDE	NN	B-NP	B
)	)	)	O	O
and	and	CC	O	O
protein	protein	NN	B-NP	O
A	A	NN	I-NP	O
/	/	SYM	B-NP	O
G	G	NN	I-NP	O
/	/	SYM	B-NP	O
agarose	agarose	NN	B-NP	O
beads	bead	NNS	I-NP	O
but	but	CC	O	O
not	not	RB	O	O
when	when	WRB	B-ADVP	O
a	a	DT	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
IgG	BEGIN-IgG-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
AHR	AHR	NN	I-NP	I
antibody	antibody-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
partially	partially	RB	B-ADJP	O
responsible	responsible	JJ	I-ADJP	O
for	for	IN	B-PP	O
both	both	CC	O	O
protection	protection	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
destructive	destructive	JJ	I-NP	O
consequences	consequence	NNS	I-NP	O
of	of	IN	B-PP	O
chlamydial	chlamydial	JJ	B-NP	O
infection	infection	NN	I-NP	O

Activated	Activate	VBN	B-NP	O
FGFR1	BEGIN-FGFR1-INSIDE	NN	I-NP	B
predominantly	predominantly	RB	B-ADVP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
GRB1.Sos	BEGIN-GRB1.Sos-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
complex	complex	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
identified	identify	VBN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
protein	protein	NN	I-NP	O
and	and	CC	O	O
designated	designate	VBN	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
1K	1K	NN	I-NP	I
-	-	HYPH	O	I
H	H-INSIDE	NN	B-NP	I

We	We	PRP	B-NP	O
generated	generate	VBD	B-VP	O
``	``	``	B-NP	O
signature	signature	NN	I-NP	O
''	''	''	I-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
CDR1s	BEGIN-CDR1s-INSIDE	NN	I-NP	B
and	and	CC	O	O
probed	probe	VBD	B-VP	O
PCR	PCR	NN	B-NP	O
amplified	amplify	VBN	I-NP	O
V	BEGIN-V	NN	I-NP	B
kappa	kappa	NN	I-NP	I
products	products-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
the	the	DT	B-NP	O
synovium	synovium	NN	I-NP	O
and	and	CC	I-NP	O
PBLs	PBL	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
patient	patient	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
from	from	IN	B-PP	O
PBLs	PBL	NNS	B-NP	O
and	and	CC	O	O
spleen	spleen	NN	B-NP	O
of	of	IN	B-PP	O
individuals	individual	NNS	B-NP	O
without	without	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
disease	disease	NN	I-NP	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
predicted	predict	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Stroop	Stroop	NNP	I-NP	O
task	task	NN	I-NP	O
would	would	MD	B-VP	O
trigger	trigger	VB	I-VP	O
greater	great	JJR	B-NP	O
consumption	consumption	NN	I-NP	O
of	of	IN	B-PP	O
ice	ice	NN	B-NP	O
cream	cream	NN	I-NP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
fearful	fearful	JJ	I-NP	O
film	film	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
effect	effect	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
pronounced	pronounced	JJ	I-ADJP	O
for	for	IN	B-PP	O
binge	binge	NN	B-NP	O
-	-	HYPH	I-NP	O
eaters	eater	NNS	I-NP	O
than	than	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
binge	binge	NN	I-NP	O
-	-	HYPH	I-NP	O
eaters	eater	NNS	I-NP	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
PLM	PLM	NN	B-NP	O
show	show	VBP	B-VP	O
excessive	excessive	JJ	B-NP	O
daytime	daytime	NN	I-NP	O
sleepiness	sleepiness	NN	I-NP	O
or	or	CC	O	O
insomnia	insomnia	NN	B-NP	O

Plasma	BEGIN-Plasma	NN	B-NP	B
colony	colony	NN	I-NP	I
-	-	HYPH	O	I
stimulating	stimulate	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
significance	significance	NN	I-NP	O

Structure	Structure	NN	B-NP	O
and	and	CC	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
KGD1	BEGIN-KGD1-INSIDE	NN	B-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
structural	structural	JJ	I-NP	O
gene	gene	NN	I-NP	O
for	for	IN	B-PP	O
yeast	BEGIN-yeast	JJ	B-NP	B
dihydrolipoyl	dihydrolipoyl	NN	I-NP	I
transsuccinylase	transsuccinylase-INSIDE	NN	I-NP	I

We	We	PRP	B-NP	O
identified	identify	VBD	B-VP	O
two	two	CD	B-NP	O
potential	potential	JJ	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
sites	site	NNS	I-NP	O
at	at	IN	B-PP	O
serine1	serine1	NN	B-NP	O
and	and	CC	I-NP	O
serine1	serine1	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
Myf	BEGIN-Myf	JJ	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O

Exposure	Exposure	NN	B-NP	O
of	of	IN	B-PP	O
raft	raft	NN	B-NP	O
cultures	culture	NNS	I-NP	O
to	to	TO	B-PP	O
activators	activator	NNS	B-NP	O
of	of	IN	B-PP	O
protein	BEGIN-protein	NN	B-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
phorbol	phorbol	NN	B-NP	O
esters	ester	NNS	I-NP	O
,	,	,	O	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
further	further	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
late	BEGIN-late	JJ	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
virion	virion	NN	B-NP	O
assembly	assembly	NN	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
T	BEGIN-T	NN	I-NP	B
cell	cell	NN	I-NP	I
antigen	antigen	NN	I-NP	I
receptor	receptor	NN	I-NP	I
zeta	zeta	NN	I-NP	I
-	-	HYPH	B-NP	I
chain	chain	NN	I-NP	I
-	-	HYPH	O	I
associated	associate	VBN	B-NP	I
ZAP	ZAP	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
T	BEGIN-T	NN	I-NP	B
cell	cell	NN	I-NP	I
antigen	antigen	NN	I-NP	I
receptor	receptor	NN	I-NP	I
zeta	zeta	NN	I-NP	I
-	-	HYPH	B-NP	I
chain	chain	NN	I-NP	I
immunoreceptor	immunoreceptor	NN	I-NP	I
tyrosine	tyrosine	NN	I-NP	I
-	-	HYPH	B-VP	I
based	base	VBN	B-NP	I
activation	activation	NN	I-NP	I
motifs	motifs-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	O
recruitment	recruitment	NN	I-NP	O
of	of	IN	B-PP	O
SOS	BEGIN-SOS-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
Vav	BEGIN-Vav-INSIDE	NN	I-NP	B

Above	Above	IN	B-PP	O
this	this	DT	B-NP	O
transition	transition	NN	I-NP	O
temperature	temperature	NN	I-NP	O
the	the	DT	B-NP	O
calcium	calcium	NN	I-NP	O
antagonist	antagonist	NN	I-NP	O
lowers	lower	NNS	I-NP	O
fm	fm	NN	I-NP	O
more	more	RBR	B-ADVP	O
pronouncedly	pronouncedly	RB	I-ADVP	O
than	than	IN	B-PP	O
below	below	IN	B-NP	O

Behavioral	Behavioral	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
benzodiazepine	benzodiazepine	NN	B-NP	O
ligands	ligand	NNS	I-NP	O
in	in	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
,	,	,	I-NP	O
diazepam	diazepam	NN	I-NP	O
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
and	and	CC	I-NP	O
diazepam	diazepam	NN	I-NP	O
-	-	HYPH	B-NP	O
withdrawn	withdraw	VBN	I-NP	O
baboons	baboon	NNS	I-NP	O

Gastrointestinal	Gastrointestinal	JJ	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
indium	indium	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
labelled	label	VBN	I-NP	O
granulocytes	granulocyte	NNS	I-NP	O
in	in	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O

TNF	BEGIN-TNF	NN	B-NP	B
-	-	HYPH	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
stimulated	stimulate	VBD	B-VP	O
these	these	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
transcription	transcription	NN	B-NP	O
and	and	CC	I-NP	O
stabilization	stabilization	NN	I-NP	O
of	of	IN	B-PP	O
RNA	RNA	NN	B-NP	O
for	for	IN	B-PP	O
amphiregulin	BEGIN-amphiregulin-INSIDE	NN	B-NP	B
,	,	,	O	O
an	an	DT	B-NP	O
EGF	BEGIN-EGF	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
ligand	ligand	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
amphiregulin	BEGIN-amphiregulin-INSIDE	NN	B-NP	B
directly	directly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
HPV	HPV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
E1	BEGIN-E1-INSIDE	NN	I-NP	B
/	/	SYM	O	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
cyclin	BEGIN-cyclin	NN	I-NP	B
A	A	NN	I-NP	I
RNAs	RNAs-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
JNK	BEGIN-JNK-INSIDE	NN	I-NP	B
/	/	SYM	B-VP	O
SAPK	BEGIN-SAPK-INSIDE	NN	B-NP	B
activator	activator	NN	I-NP	O
mixed	BEGIN-mixed	JJ	I-NP	B
lineage	lineage	NN	I-NP	I
kinase	kinase	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
MLK1	BEGIN-MLK1-INSIDE	NN	B-NP	B
)	)	)	O	O
transforms	transform	VBZ	B-VP	O
NIH	NIH	NN	B-NP	O
1T1	1T1	NN	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
MEK	BEGIN-MEK-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
fashion	fashion	NN	I-NP	O

Biochemical	Biochemical	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
norepinephrine	norepinephrine	NN	B-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
significantly	significantly	RB	B-ADVP	O
in	in	IN	B-PP	O
cortex	cortex	NN	B-NP	O
-	-	HYPH	B-NP	O
hippocampus	hippocampus	NN	I-NP	O
and	and	CC	O	O
olfactory	olfactory	JJ	B-NP	O
bulb	bulb	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
other	other	JJ	B-NP	O
regions	region	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
dopamine	dopamine	NN	B-NP	O
and	and	CC	I-NP	O
serotonin	serotonin	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
altered	alter	VBN	I-VP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
brain	brain	NN	I-NP	O
region	region	NN	I-NP	O
examined	examine	VBN	B-VP	O

A	A	DT	B-NP	O
mouth	mouth	JJ	I-NP	O
asymmetry	asymmetry	NN	I-NP	O
study	study	NN	I-NP	O

Control	Control	NN	B-NP	O
oligomers	oligomer	NNS	I-NP	O
of	of	IN	B-PP	O
scrambled	scramble	VBN	B-NP	O
sequence	sequence	NN	I-NP	O
but	but	CC	O	O
identical	identical	JJ	B-NP	O
base	base	NN	I-NP	O
composition	composition	NN	I-NP	O
were	be	VBD	B-VP	O
ineffective	ineffective	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
TFO	TFO	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
recombination	recombination	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
LTK	LTK	NN	I-NP	O
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
cell	cell	NN	B-NP	O
line	line	NN	I-NP	O
carrying	carry	VBG	B-VP	O
an	an	DT	B-NP	O
otherwise	otherwise	RB	I-NP	O
identical	identical	JJ	I-NP	O
dual	dual	JJ	I-NP	O
TK	BEGIN-TK	NN	I-NP	B
gene	gene	NN	I-NP	I
construct	construct-INSIDE	NN	I-NP	I
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
polypurine	polypurine	NN	I-NP	O
target	target	NN	I-NP	O
site	site	NN	I-NP	O

Transformation	Transformation	NN	B-NP	O
of	of	IN	B-PP	O
chicken	chicken	NN	B-NP	O
embryo	embryo	NN	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
(	(	(	O	O
CEF	CEF	NN	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Gag	BEGIN-Gag-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
Crk	BEGIN-Crk-INSIDE	NN	I-NP	B
fusion	fusion	NN	I-NP	O
protein	protein	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
elevation	elevation	NN	I-NP	O
of	of	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
on	on	IN	B-PP	O
specific	specific	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
with	with	IN	B-PP	O
molecular	molecular	JJ	B-NP	O
weights	weight	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
an	an	DT	B-NP	O
event	event	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
cell	cell	NN	B-NP	O
transformation	transformation	NN	I-NP	O

Tilisolol	Tilisolol	NN	B-NP	O
and	and	CC	I-NP	O
carboxymethylcellulose	carboxymethylcellulose	NN	I-NP	O
sodium	sodium	NN	I-NP	O
salt	salt	NN	I-NP	O
(	(	(	O	O
CMC	CMC	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
model	model	NN	I-NP	O
ophthalmic	ophthalmic	JJ	I-NP	O
drug	drug	NN	I-NP	O
and	and	CC	O	O
viscous	viscous	JJ	B-NP	O
polymer	polymer	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

OAT	OAT	NN	B-NP	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
safer	safe	JJR	B-ADJP	O
in	in	IN	B-PP	O
recent	recent	JJ	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
if	if	IN	B-SBAR	O
monitored	monitor	VBN	B-VP	O
in	in	IN	B-PP	O
special	special	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
clinics	clinic	NNS	I-NP	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
in	in	IN	B-PP	O
pair	pair	NN	B-NP	O
-	-	HYPH	O	O
fed	feed	VBN	B-VP	O
non	non	AFX	O	O
-	-	HYPH	O	O
treated	treat	VBN	B-NP	O
animals	animal	NNS	I-NP	O
(	(	(	O	O
Control	Control	NNP	B-NP	O
Group	Group	NNP	I-NP	O
)	)	)	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
are	be	VBP	B-VP	O
in	in	IN	B-PP	O
line	line	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
E1F	BEGIN-E1F-INSIDE	NN	B-NP	B
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
growth	growth	NN	I-NP	O
-	-	HYPH	O	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
regulated	regulated	JJ	I-NP	O
tethering	tethering	NN	I-NP	O
factor	factor	NN	I-NP	O
between	between	IN	B-PP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B
and	and	CC	O	O
the	the	DT	B-NP	O
basic	basic	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
machinery	machinery	NN	I-NP	O

Fetal	Fetal	JJ	B-NP	O
transplants	transplant	NNS	I-NP	O
rescue	rescue	VBP	B-VP	O
axial	axial	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
representations	representation	NNS	I-NP	O
in	in	IN	B-PP	O
M1	M1	NN	B-NP	O
cortex	cortex	NN	I-NP	O
of	of	IN	B-PP	O
neonatally	neonatally	RB	B-NP	O
transected	transecte	VBN	I-NP	O
rats	rat	NNS	I-NP	O
that	that	WDT	B-NP	O
develop	develop	VBP	B-VP	O
weight	weight	NN	B-NP	O
support	support	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
encourage	encourage	VB	I-VP	O
good	good	JJ	B-NP	O
contact	contact	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
farmers	farmer	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
inseminating	inseminate	VBG	I-NP	O
personnel	personnel	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
beneficial	beneficial	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
herdsmen	herdsman	NNS	B-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
cows	cow	NNS	B-NP	O
are	be	VBP	B-VP	O
inseminated	inseminate	VBN	I-VP	O

Solution	Solution	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Boltzmann	Boltzmann	NNP	I-NP	O
equation	equation	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
random	random	JJ	I-NP	O
magnetic	magnetic	JJ	I-NP	O
field	field	NN	I-NP	O

These	These	DT	B-NP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
undefined	BEGIN-undefined	JJ	B-NP	B
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
UD1	BEGIN-UD1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
UD1	BEGIN-UD1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
UD1	BEGIN-UD1-INSIDE	NN	B-NP	B
,	,	,	O	O
each	each	DT	B-NP	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
proteins	protein	NNS	B-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
ken	BEGIN-ken	JJ	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
Kruppel	BEGIN-Kruppel	NNP	I-NP	B
-	-	HYPH	I-NP	I
like	like	JJ	I-NP	I
putative	putative	JJ	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
fly	fly	JJ	I-NP	O
homologues	homologue	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mammalian	BEGIN-mammalian	JJ	I-NP	B
mitochondrial	mitochondrial	JJ	I-NP	I
trifunctional	trifunctional	JJ	I-NP	I
enzyme	enzyme-INSIDE	NN	I-NP	I
(	(	(	O	O
thiolase	BEGIN-thiolase-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
TAR	BEGIN-TAR	NN	I-NP	B
DNA	DNA	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-NP	I
protein	protein	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
TBPH	BEGIN-TBPH-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
nonvertebrate	nonvertebrate	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transmembrane	BEGIN-transmembrane	NN	I-NP	B
1	1	CD	I-NP	I
superfamily	superfamily-INSIDE	NN	I-NP	I
(	(	(	O	O
TM1SF	BEGIN-TM1SF-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
homeodomain	BEGIN-homeodomain	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
binding	bind	VBG	I-NP	O
protein	protein	NN	I-NP	O
(	(	(	O	O
PNBP	PNBP	NN	B-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
maleless	BEGIN-maleless-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
Copia	BEGIN-Copia	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
element	element-INSIDE	NN	I-NP	I

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
area	area	NN	B-NP	O
correction	correction	NN	I-NP	O
be	be	VB	B-VP	O
attempted	attempt	VBN	I-VP	O
in	in	IN	B-PP	O
bioequivalence	bioequivalence	NN	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
drugs	drug	NNS	B-NP	O
where	where	WRB	B-ADVP	O
high	high	JJ	B-NP	O
intrasubject	intrasubject	JJ	I-NP	O
variability	variability	NN	I-NP	O
in	in	IN	B-PP	O
clearance	clearance	NN	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
or	or	CC	I-VP	O
suspected	suspect	VBN	I-VP	O

A	A	DT	B-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
determining	determine	VBG	B-VP	O
the	the	DT	B-NP	O
toxicity	toxicity	NN	I-NP	O
of	of	IN	B-PP	O
neutralizers	neutralizer	NNS	B-NP	O
for	for	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
agents	agent	NNS	I-NP	O
to	to	TO	B-PP	O
A.	A.	NN	B-NP	O
castellanii	castellanii	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
use	use	VBP	B-VP	O
a	a	DT	B-NP	O
tnaC	BEGIN-tnaC-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
UGA	UGA	NN	I-NP	O
-	-	HYPH	I-NP	O
'lacZ	BEGIN-'lacZ-INSIDE	NN	I-NP	B
construct	construct	NN	I-NP	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
tnaC	BEGIN-tnaC-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
tnaA	BEGIN-tnaA-INSIDE	NN	I-NP	B
spacer	spacer	NN	I-NP	O
region	region	NN	I-NP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
TnaC	BEGIN-TnaC-INSIDE	NN	B-NP	B
synthesis	synthesis	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
behavior	behavior	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ribosome	ribosome	NN	I-NP	O
that	that	WDT	B-NP	O
translates	translate	VBZ	B-VP	O
tnaC	BEGIN-tnaC-INSIDE	NN	B-NP	B

Unlike	Unlike	IN	B-PP	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
,	,	,	O	O
ERK	BEGIN-ERK-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
mapped	map	VBN	I-VP	O
to	to	TO	B-PP	O
specific	specific	JJ	B-NP	O
reovirus	reovirus	NN	I-NP	O
gene	gene	NN	I-NP	O
segments	segment	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
ERK	BEGIN-ERK-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
and	and	CC	O	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O
are	be	VBP	B-VP	O
triggered	trigger	VBN	I-VP	O
by	by	IN	B-PP	O
different	different	JJ	B-NP	O
events	event	NNS	I-NP	O
during	during	IN	B-PP	O
virus	virus	NN	B-NP	O
-	-	HYPH	B-NP	O
host	host	NN	I-NP	O
cell	cell	NN	I-NP	O
interaction	interaction	NN	I-NP	O

Promoter	Promoter	NN	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
alpha	alpha	NN	I-NP	I
1A	1A	NN	I-NP	I
adrenergic	adrenergic	JJ	I-NP	I
receptor	receptor	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
deletion	deletion	NN	B-NP	O
and	and	CC	I-NP	O
substitution	substitution	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MER1	BEGIN-MER1	NN	I-NP	B
1	1	CD	I-NP	I
'	'	''	I-NP	I
exon	exon-INSIDE	NN	I-NP	I
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
unusually	unusually	RB	I-NP	O
large	large	JJ	I-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
exon	exon	NN	I-NP	O
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
splicing	splicing	NN	B-NP	O
regulation	regulation	NN	I-NP	O

Schottky	Schottky	JJ	B-NP	O
-	-	HYPH	I-NP	O
barrier	barrier	NN	I-NP	O
heights	height	NNS	I-NP	O
of	of	IN	B-PP	O
Ti	Ti	NN	B-NP	O
and	and	CC	I-NP	O
TiSi1	TiSi1	NN	I-NP	O
on	on	IN	B-PP	O
n	n	NN	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
and	and	CC	I-NP	O
p	p	NN	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
Si	Si	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
BLMC	BLMC	NN	I-NP	O
uptake	uptake	NN	I-NP	O
was	be	VBD	B-VP	O
directly	directly	RB	B-ADJP	O
proportional	proportional	JJ	I-ADJP	O
to	to	TO	B-PP	O
Ki	BEGIN-Ki	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
MIB	BEGIN-MIB	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
and	and	CC	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
mitoses	mitos	NNS	B-NP	O
in	in	IN	B-PP	O
tumor	tumor	NN	B-NP	O
tissue	tissue	NN	I-NP	O

The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
Ig	Ig	NN	I-NP	I
heavy	heavy	JJ	I-NP	I
chain	chain	NN	I-NP	I
(	(	(	O	I
IgH	IgH	NN	B-NP	I
)	)	)	O	I
constant	constant	JJ	O	I
(	(	(	O	I
C	C	NN	B-NP	I
)	)	)	O	I
region	region	NN	B-NP	I
locus	locus-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
cloned	clone	VBN	I-VP	O
and	and	CC	O	O
mapped	map	VBN	B-VP	O

On	On	IN	B-PP	O
guanidine	guanidine	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
botulism	botulism	NN	B-NP	O

Excellent	Excellent	JJ	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
where	where	WRB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
a	a	DT	B-NP	O
varicose	varicose	NN	I-NP	O
complex	complex	NN	I-NP	O
was	be	VBD	B-VP	O
involved	involve	VBN	I-VP	O

By	By	IN	B-PP	O
differential	differential	JJ	B-NP	O
screening	screening	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Xenopus	Xenopus	NN	I-NP	O
laevis	laevis	NN	I-NP	O
egg	egg	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
which	which	WDT	B-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
maternal	maternal	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O
specifically	specifically	RB	B-VP	O
deadenylated	deadenylate	VBN	I-VP	O
after	after	IN	B-PP	O
fertilisation	fertilisation	NN	B-NP	O

Most	Most	JJS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
elements	element	NNS	I-NP	O
are	be	VBP	B-VP	O
adjacent	adjacent	JJ	B-ADJP	O
to	to	TO	B-PP	O
type	type	NN	B-NP	O
X	X	NN	I-NP	O
telomeric	telomeric	JJ	I-NP	O
repeats	repeat	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
regions	region	NNS	B-NP	O
flanking	flank	VBG	B-VP	O
four	four	CD	B-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
characterized	characterize	VBN	I-NP	O
S.	S.	NNP	I-NP	O
paradoxus	paradoxus	NN	I-NP	O
insertions	insertion	NNS	I-NP	O
carry	carry	VBP	B-VP	O
autonomously	autonomously	RB	I-VP	O
replicating	replicate	VBG	I-VP	O
sequences	sequence	NNS	B-NP	O

Mutational	Mutational	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
effector	effector	NN	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GTP	BEGIN-GTP	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
Ypt1	Ypt1	NN	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
yeast	yeast	NN	B-NP	O
suggests	suggest	VBZ	B-VP	O
specific	specific	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
GAP	BEGIN-GAP-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O

We	We	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
described	describe	VBD	B-VP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
nontoxic	nontoxic	JJ	B-NP	O
PAP	BEGIN-PAP	NN	I-NP	B
mutants	mutants-INSIDE	NN	I-NP	I
,	,	,	O	O
NT1	NT1	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
point	point	NN	I-NP	O
mutation	mutation	NN	I-NP	O
(	(	(	O	O
E1V	E1V	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
site	site	NN	I-NP	O
that	that	WDT	B-NP	O
abolishes	abolish	VBZ	B-VP	O
enzymatic	enzymatic	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NT1	NT1	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
nonsense	nonsense	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
that	that	WDT	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
1	1	CD	I-NP	O
aa	aa	NN	I-NP	O
(	(	(	O	O
W1Stop	W1Stop	NN	B-NP	O
)	)	)	O	O

This	This	DT	B-NP	O
ligand	ligand	NN	I-NP	O
-	-	HYPH	B-NP	O
independent	independent	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
can	can	MD	B-VP	O
function	function	VB	I-VP	O
through	through	IN	B-PP	O
another	another	DT	B-NP	O
androgen	androgen	NN	I-NP	O
-	-	HYPH	B-VP	O
regulated	regulate	VBN	B-NP	O
promoter	promoter	NN	I-NP	O
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
mammary	mammary	JJ	I-NP	I
tumor	tumor	NN	I-NP	I
virus	virus	NN	I-NP	I
MMTV	MMTV	NN	I-NP	I
-	-	HYPH	B-NP	I
CAT	CAT	NN	I-NP	I
reporter	reporter-INSIDE	NN	I-NP	I

From	From	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
results	result	NNS	I-NP	O
a	a	DT	B-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
hormone	hormone	NN	B-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
AR	BEGIN-AR-INSIDE	NN	I-NP	B
activation	activation	NN	I-NP	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
requires	require	VBZ	B-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
,	,	,	I-NP	O
direct	direct	JJ	I-NP	O
or	or	CC	I-NP	O
indirect	indirect	JJ	I-NP	O
intramolecular	intramolecular	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
TAD	TAD	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
LBD	LBD	NN	I-NP	O

All	All	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
peritonitis	peritonitis	NN	B-NP	O
-	-	HYPH	B-ADJP	O
free	free	JJ	B-NP	O
at	at	IN	I-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
before	before	IN	B-PP	O
each	each	DT	B-NP	O
PET	PET	NN	I-NP	O

After	After	IN	B-PP	O
control	control	NN	B-NP	O
for	for	IN	B-PP	O
body	body	NN	B-NP	O
mass	mass	NN	I-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
trait	trait	NN	B-NP	O
anxiety	anxiety	NN	I-NP	O
and	and	CC	I-NP	O
anger	anger	NN	I-NP	O
-	-	HYPH	B-ADJP	O
in	in	IN	B-PP	O
remained	remain	VBN	B-NP	O
independent	independent	JJ	I-NP	O
predictors	predictor	NNS	I-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
women	woman	NNS	I-NP	O

Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	I-NP	O
oral	oral	JJ	I-NP	O
contraceptives	contraceptive	NNS	I-NP	O
:	:	:	O	O
cervical	cervical	JJ	B-NP	O
mucus	mucus	NN	I-NP	O
and	and	CC	O	O
plasma	plasma	NN	B-NP	O
hormone	hormone	NN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
circulating	circulate	VBG	B-VP	O
D	D	NN	B-NP	O
-	-	HYPH	B-NP	O
norgestrel	norgestrel	NN	I-NP	O
and	and	CC	I-NP	O
1alpha	1alpha	NN	I-NP	O
ethynyl	ethynyl	NN	I-NP	O
-	-	HYPH	B-NP	O
estradiol	estradiol	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O

The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
vav	BEGIN-vav	NN	I-NP	B
oncogene	oncogene	NN	I-NP	I
protein	protein	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
exhibits	exhibit	VBZ	B-VP	O
several	several	JJ	B-NP	O
motifs	motif	NNS	I-NP	O
reminiscent	reminiscent	JJ	B-ADJP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
factors	factor	NNS	I-NP	O

The	The	DT	B-NP	O
platelet	BEGIN-platelet	JJ	I-NP	B
membrane	membrane	NN	I-NP	I
glycoprotein	glycoprotein	NN	I-NP	I
IIb	IIb	NN	I-NP	I
/	/	SYM	B-NP	I
IIIa	IIIa	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O
abciximab	abciximab	NN	I-NP	O
is	be	VBZ	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
undergoing	undergo	VBG	B-VP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
risk	risk	NN	I-NP	O
percutaneous	percutaneous	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
interventions	intervention	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
third	third	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
interventions	intervention	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
United	United	NNP	I-NP	O
States	State	NNPS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
growing	grow	VBG	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
procedures	procedure	NNS	B-NP	O
in	in	IN	B-PP	O
Europe	Europe	NNP	B-NP	O

The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
times	time	NNS	I-NP	O
to	to	TO	B-PP	O
LNR	LNR	NN	B-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
(	(	(	O	O
range	range	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
(	(	(	O	O
range	range	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
)	)	)	O	O
respectively	respectively	RB	B-ADVP	O

Ultraviolet	Ultraviolet	NN	B-NP	O
crosslinking	crosslinking	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
using	use	VBG	B-VP	O
element	element	NN	B-NP	O
B	B	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
proteins	protein	NNS	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O

The	The	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
densely	densely	RB	I-VP	O
ciliated	ciliate	VBN	I-VP	O
,	,	,	O	O
each	each	DT	B-NP	O
cilium	cilium	NN	I-NP	O
showing	show	VBG	B-VP	O
a	a	DT	B-NP	O
typical	typical	JJ	I-NP	O
1+1	1+1	CD	I-NP	O
fibrilar	fibrilar	JJ	I-NP	O
pattern	pattern	NN	I-NP	O

Searching	Search	VBG	B-VP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
data	data	NN	I-NP	O
base	base	NN	I-NP	O
of	of	IN	B-PP	O
expressed	express	VBN	B-NP	O
sequence	sequence	NN	I-NP	O
tags	tag	NNS	I-NP	O
(	(	(	O	O
EST	EST	NN	B-NP	O
)	)	)	O	O
revealed	reveal	VBD	B-VP	O
novel	novel	JJ	B-NP	O
partial	partial	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
,	,	,	O	O
but	but	CC	O	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
,	,	,	O	O
the	the	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
known	know	VBN	I-NP	O
PEF	BEGIN-PEF	NN	I-NP	B
proteins	proteins-INSIDE	NN	I-NP	I

HBO	HBO	NNP	B-NP	O
had	have	VBD	B-VP	O
marked	mark	VBN	I-VP	O
effects	effect	NNS	B-NP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
enzymes	enzyme	NNS	I-NP	O
:	:	:	O	O
lung	BEGIN-lung	JJ	B-NP	B
SOD	SOD-INSIDE	NN	I-NP	I
increased	increase	VBD	B-VP	O
(	(	(	O	O
guinea	guinea	NN	B-NP	O
pigs	pig	NNS	I-NP	O
1	1	CD	B-NP	O
,	,	,	O	O
rats	rat	NNS	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
GSHPx	BEGIN-GSHPx-INSIDE	NN	I-NP	B
activities	activity	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
in	in	IN	B-PP	O
brain	brain	NN	B-NP	O
and	and	CC	I-NP	O
lung	lung	NN	I-NP	O

RXRalpha	BEGIN-RXRalpha-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
RARalpha	BEGIN-RARalpha-INSIDE	NN	I-NP	B
heterodimers	heterodimer	NNS	I-NP	O
and	and	CC	I-NP	O
HNF	BEGIN-HNF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
homodimers	homodimers-INSIDE	NN	I-NP	I
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
DR	DR	NN	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
motifs	motif	NNS	I-NP	O
on	on	IN	B-PP	O
elements	element	NNS	B-NP	O
B	B	NN	B-NP	O
and	and	CC	O	O
I1	I1	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Adenomas	Adenoma	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
:	:	:	O	O
Vater	Vater	NNP	B-NP	O
's	's	POS	B-NP	O
papilla	papilla	NN	I-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
duodenum	duodenum	NN	B-NP	O
-	-	SYM	B-VP	O
-	-	SYM	B-NP	O
nine	nine	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
gastric	gastric	JJ	B-NP	O
antrum	antrum	NN	I-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
seven	seven	CD	B-NP	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
direct	direct	JJ	I-NP	O
hemagglutination	hemagglutination	NN	I-NP	O
test	test	NN	I-NP	O
(	(	(	O	O
HI	HI	NN	B-NP	O
-	-	HYPH	B-NP	O
GONAVIS	GONAVIS	NN	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
LH	BEGIN-LH-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
radioimmuno	radioimmuno	AFX	O	O
-	-	HYPH	O	O
assay	assay	NN	B-NP	O
of	of	IN	B-PP	O
LH	BEGIN-LH-INSIDE	NN	B-NP	B

Sucrose	Sucrose	NN	B-NP	O
produced	produce	VBN	B-VP	O
in	in	IN	B-PP	O
source	source	NN	B-NP	O
leaves	leaf	NNS	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
carbon	carbon	NN	I-NP	O
source	source	NN	I-NP	O
for	for	IN	B-PP	O
developing	develop	VBG	B-VP	O
sink	sink	NN	B-NP	O
tissues	tissue	NNS	I-NP	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
higher	high	JJR	I-NP	O
plants	plant	NNS	I-NP	O

Accumulation	Accumulation	NN	B-NP	O
of	of	IN	B-PP	O
amines	amine	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
perfused	perfuse	VBN	I-NP	O
rabbit	rabbit	NN	I-NP	O
lung	lung	NN	I-NP	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
M.	M.	NN	B-NP	O
malmoense	malmoense	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
environment	environment	NN	I-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infection	infection	NN	I-NP	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
pharmacology	pharmacology	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
dihydro	dihydro	AFX	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
methyl	methyl	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
piperidylidene	piperidylidene	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
anthrol	anthrol	NN	I-NP	O
(	(	(	O	O
WA	WA	NNP	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
histamine	histamine	NN	I-NP	O
and	and	CC	I-NP	O
serotonin	serotonin	NN	I-NP	O
antagonist	antagonist	NN	I-NP	O

This	This	DT	B-NP	O
incompatibility	incompatibility	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
requires	require	VBZ	B-VP	O
the	the	DT	B-NP	O
global	global	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
repressor	repressor	NN	I-NP	O
,	,	,	O	O
KorB	BEGIN-KorB-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
incC	BEGIN-incC-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
mediated	mediate	VBN	I-NP	O
incompatibility	incompatibility	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
KorB	BEGIN-BEGIN-KorB-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
site	site	NN	B-NP	O
(	(	(	O	O
O	O	NN	B-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
)	)	)	O	O
)	)	)	O	O
	-INSIDE	NN	B-NP	I

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
structural	structural	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
PsaL	BEGIN-PsaL-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
PsaI	BEGIN-PsaI-INSIDE	NN	I-NP	B
may	may	MD	B-VP	O
stabilize	stabilize	VB	I-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
PsaL	BEGIN-PsaL-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
the	the	DT	B-NP	O
photosystem	BEGIN-photosystem	NN	I-NP	B
I	I	CD	I-NP	I
core	core-INSIDE	NN	I-NP	I

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TorR	BEGIN-TorR	NN	I-NP	B
regulator	regulator-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
cis	cis	NN	B-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
direct	direct	JJ	B-NP	O
repeats	repeat	NNS	I-NP	O
activates	activate	VBZ	B-VP	O
tor	BEGIN-tor	NN	B-NP	B
operon	operon-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O

Histological	Histological	JJ	B-NP	O
and	and	CC	I-NP	O
immunophenotypic	immunophenotypic	JJ	I-NP	O
studies	study	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
1	1	CD	B-NP	O
large	large	JJ	I-NP	O
cell	cell	NN	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
two	two	CD	B-NP	O
small	small	JJ	I-NP	O
noncleaved	noncleaved	JJ	I-NP	O
cell	cell	NN	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
-	-	HYPH	I-NP	O
cell	cell	NN	I-NP	O
phenotype	phenotype	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
five	five	CD	B-NP	O
low	low	JJ	I-NP	O
grade	grade	NN	I-NP	O
B	B	NN	I-NP	O
-	-	HYPH	B-NP	O
cell	cell	NN	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O
(	(	(	O	O
two	two	CD	B-NP	O
small	small	JJ	I-NP	O
lymphocytic	lymphocytic	JJ	I-NP	O
and	and	CC	I-NP	O
three	three	CD	I-NP	O
follicular	follicular	JJ	I-NP	O
mixed	mixed	JJ	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
android	android	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
(	(	(	O	O
four	four	CD	B-NP	O
men	man	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
women	woman	NNS	I-NP	O
)	)	)	O	O
aged	age	VBN	B-ADJP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
body	body	NN	I-NP	O
mass	mass	NN	I-NP	O
index	index	NN	I-NP	O
(	(	(	O	O
BMI	BMI	NN	B-NP	O
)	)	)	O	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
kg	kg	NN	I-NP	O
/	/	SYM	B-NP	O
m1	m1	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
-	-	HYPH	I-NP	O
gluteal	gluteal	JJ	I-NP	O
ratio	ratio	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O

A	A	DT	B-NP	O
mean	mean	JJ	I-NP	O
value	value	NN	I-NP	O
for	for	IN	B-PP	O
HbA1	BEGIN-HbA1-INSIDE	NN	B-NP	B
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
retinopathy	retinopathy	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
value	value	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diminished	diminish	VBN	I-NP	O
risk	risk	NN	I-NP	O

An	An	DT	B-NP	O
emended	emend	VBN	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
Tylocephalum	Tylocephalum	NN	B-NP	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
excluding	exclude	VBG	B-PP	O
this	this	DT	B-NP	O
feature	feature	NN	I-NP	O
,	,	,	O	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
distribution	distribution	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
testes	testis	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
preovarian	preovarian	JJ	I-NP	O
field	field	NN	I-NP	O
and	and	CC	O	O
circummedullary	circummedullary	JJ	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
vitelline	vitelline	NN	B-NP	O
follicles	follicle	NNS	I-NP	O

Role	Role	NN	B-NP	O
of	of	IN	B-PP	O
double	BEGIN-double	JJ	B-NP	B
-	-	HYPH	I-NP	I
stranded	stranded	JJ	I-NP	I
RNA	RNA	NN	I-NP	I
-	-	HYPH	I-NP	I
dependent	dependent	JJ	I-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
mediating	mediate	VBG	B-VP	O
hypersensitivity	hypersensitivity	NN	B-NP	O
of	of	IN	B-PP	O
Fanconi	Fanconi	NNP	B-NP	O
anemia	anemia	NN	I-NP	O
complementation	complementation	NN	I-NP	O
group	group	NN	I-NP	O
C	C	NN	I-NP	O
cells	cell	NNS	I-NP	O
to	to	TO	B-PP	O
interferon	BEGIN-interferon	NN	B-NP	B
gamma	gamma-INSIDE	NN	I-NP	I
,	,	,	O	O
tumor	BEGIN-tumor	NN	B-NP	B
necrosis	necrosis	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	B-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
double	double	JJ	B-NP	O
-	-	HYPH	I-NP	O
stranded	stranded	JJ	I-NP	O
RNA	RNA	NN	I-NP	O

Different	Different	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
reoxygenation	reoxygenation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
electrical	electrical	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
muscle	muscle	NN	I-NP	O

Similar	Similar	JJ	B-NP	O
observations	observation	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
when	when	WRB	B-ADVP	O
these	these	DT	B-NP	O
mutated	mutate	VBN	I-NP	O
versions	version	NNS	I-NP	O
of	of	IN	B-PP	O
site	site	NN	B-NP	O
A	A	NN	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
transient	transient	JJ	B-NP	O
cotransfection	cotransfection	NN	I-NP	O
assays	assay	NNS	I-NP	O
in	in	IN	B-PP	O
CV1	CV1	NN	B-NP	O
cells	cell	NNS	I-NP	O

YLL1c	BEGIN-YLL1c-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
gene	gene	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
measured	measure	VBN	I-VP	O
percentage	percentage	NN	B-NP	O
O1	O1	NN	I-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
adult	adult	JJ	I-NP	O
Sprague	Sprague	NNP	I-NP	O
-	-	HYPH	I-NP	O
Dawley	Dawley	NNP	I-NP	O
rats	rat	NNS	I-NP	O
exposed	expose	VBN	B-VP	O
,	,	,	O	O
nose	nose	NN	B-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
1	1	CD	B-NP	O
ppm	ppm	NN	I-NP	O
O1	O1	NN	I-NP	O

Threefold	Threefold	JJ	B-NP	O
risks	risk	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
for	for	IN	B-PP	O
men	man	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
intensity	intensity	NN	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
probability	probability	NN	I-NP	O
of	of	IN	B-PP	O
EMF	EMF	NN	B-NP	O
exposure	exposure	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
heavy	heavy	JJ	B-NP	O
EMF	EMF	NN	I-NP	O
exposure	exposure	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
experience	experience	VB	I-VP	O
increased	increase	VBN	B-NP	O
risk	risk	NN	I-NP	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
cells	cell	NNS	B-NP	O
cotransfected	cotransfecte	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
UF	BEGIN-UF	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
luciferase	BEGIN-luciferase-INSIDE	NN	I-NP	B
(	(	(	O	O
-	-	HYPH	B-NP	O
1UF	BEGIN-1UF-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
Luc	BEGIN-Luc-INSIDE	NN	I-NP	B
)	)	)	I-NP	O
reporter	reporter	NN	I-NP	O
gene	gene	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
BTEB	BEGIN-BTEB-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
vector	vector	NN	I-NP	O
had	have	VBD	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
fold	fold	RB	B-NP	O
higher	high	JJR	I-NP	O
Luc	BEGIN-Luc-INSIDE	NN	I-NP	B
activity	activity	NN	I-NP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
cotransfected	cotransfecte	VBN	B-VP	O
with	with	IN	B-PP	O
reporter	reporter	NN	B-NP	O
gene	gene	NN	I-NP	O
and	and	CC	I-NP	O
pcDNA	pcDNA	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

Early	Early	JJ	B-NP	O
complement	complement	NN	I-NP	O
components	component	NNS	I-NP	O
,	,	,	O	O
C1q	BEGIN-BEGIN-C1-INSIDEq-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
C1	BEGIN-C1-INSIDE	NN	I-NP	B
,	,	,	O	O
and	and	CC	O	O
IgA	BEGIN-IgA-INSIDE	NN	B-NP	B
secretory	secretory	JJ	I-NP	O
piece	piece	NN	I-NP	O
were	be	VBD	B-VP	O
absent	absent	JJ	B-ADJP	O

Although	Although	IN	B-SBAR	O
IRS	BEGIN-BEGIN-IRS	JJ	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
-	-	HYPH	B-NP	O
1	1-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
overall	overall	JJ	B-NP	O
structure	structure	NN	I-NP	O
,	,	,	B-NP	O
IRS	BEGIN-IRS	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
shorter	short	JJR	I-NP	O
and	and	CC	O	O
differs	differ	VBZ	B-VP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
sites	site	NNS	B-NP	O
of	of	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
SIV	SIV	NN	B-NP	O
and	and	CC	I-NP	O
HIV	BEGIN-HIV	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
nef	nef-INSIDE	NN	I-NP	I
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
HIV	BEGIN-HIV	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
nef	nef-INSIDE	NN	I-NP	I
,	,	,	O	O
with	with	IN	B-PP	O
TCRzeta	BEGIN-TCRzeta-INSIDE	NN	B-NP	B

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
retrospectively	retrospectively	RB	B-ADVP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
underwent	undergo	VBD	B-VP	O
both	both	CC	I-VP	O
gated	gate	VBD	I-VP	O
fluorine	fluorine	NN	B-NP	O
1	1	CD	I-NP	O
deoxyglucose	deoxyglucose	NN	I-NP	O
(	(	(	O	O
FDG	FDG	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
PET	PET	NN	I-NP	O
and	and	CC	I-NP	O
equilibrium	equilibrium	NN	I-NP	O
radionuclide	radionuclide	NN	I-NP	O
angiography	angiography	NN	I-NP	O
(	(	(	O	O
ERNA	ERNA	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
spatial	spatial	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
unusual	unusual	JJ	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
indicate	indicate	VB	I-VP	O
a	a	DT	B-NP	O
particular	particular	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
DTEF	BEGIN-DTEF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
gene	gene	NN	I-NP	O
regulation	regulation	NN	I-NP	O

Rac1	BEGIN-Rac1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Rho	BEGIN-Rho	JJ	I-NP	B
family	family-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
GTPases	BEGIN-GTPases-INSIDE	NN	B-NP	B
,	,	,	O	O
is	be	VBZ	B-VP	O
highly	highly	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NADPH	BEGIN-NADPH	NN	I-NP	B
-	-	HYPH	B-NP	I
oxidase	oxidase	NN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
yeast	BEGIN-yeast	JJ	I-NP	B
mitochondrial	mitochondrial	JJ	I-NP	I
Hsp1	Hsp1-INSIDE	NN	I-NP	I
,	,	,	O	O
Ssc1p	BEGIN-Ssc1p-INSIDE	NN	B-NP	B
,	,	,	O	O
functions	function	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
chaperone	chaperone	NN	I-NP	O
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
partner	partner	NN	I-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
Mdj1p	BEGIN-Mdj1p-INSIDE	NN	B-NP	B
(	(	(	O	O
DnaJ	BEGIN-DnaJ	NN	B-NP	B
homologue	homologue-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
Yge1p	BEGIN-Yge1p-INSIDE	NN	B-NP	B
(	(	(	O	O
GrpE	BEGIN-GrpE	NN	B-NP	B
homologue	homologue-INSIDE	NN	I-NP	I
)	)	)	O	O

The	The	DT	B-NP	O
best	good	JJS	I-NP	O
sequences	sequence	NNS	I-NP	O
for	for	IN	B-PP	O
pelvic	pelvic	JJ	B-NP	O
study	study	NN	I-NP	O
are	be	VBP	B-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
experience	experience	NN	I-NP	O
,	,	,	I-NP	O
IR	IR	NN	I-NP	O
or	or	CC	I-NP	O
short	short	JJ	I-NP	O
TR	TR	NN	I-NP	O
spin	spin	NN	I-NP	O
-	-	HYPH	B-NP	O
echo	echo	NN	I-NP	O
for	for	IN	B-PP	O
T1	T1	NN	B-NP	O
-	-	HYPH	B-NP	O
weighted	weight	VBN	I-NP	O
images	image	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
spin	spin	NN	B-NP	O
-	-	HYPH	O	O
echo	echo	NN	B-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
TR	TR	NN	I-NP	O
for	for	IN	B-PP	O
T1	T1	NN	B-NP	O
images	image	NNS	I-NP	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
HSCR	BEGIN-HSCR-INSIDE	NN	B-NP	B
mutations	mutation	NNS	I-NP	O
impair	impair	VBP	B-VP	O
the	the	DT	B-NP	O
fixation	fixation	NN	I-NP	O
of	of	IN	B-PP	O
Shc	BEGIN-Shc-INSIDE	NN	B-NP	B
to	to	TO	B-PP	O
RET	BEGIN-RET-INSIDE	NN	B-NP	B
and	and	CC	O	O
consequently	consequently	RB	B-VP	O
prevent	prevent	VB	I-VP	O
its	its	PRP$	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
describe	describe	VBP	B-VP	O
a	a	DT	B-NP	O
HepG1	BEGIN-HepG1	NN	I-NP	B
cell	cell	NN	I-NP	I
casein	casein	NN	I-NP	I
kinase	kinase	NN	I-NP	I
II	II	CD	I-NP	I
beta	beta	SYM	I-NP	I
subunit	subunit	NN	I-NP	I
cDNA	cDNA-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
bases	base	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
untranslated	untranslated	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
bases	base	NNS	I-NP	O
of	of	IN	B-PP	O
open	open	JJ	B-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
bases	base	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
untranslated	untranslated	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
polyadenylation	polyadenylation	NN	I-NP	O
consensus	consensus	NN	I-NP	O
signal	signal	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
poly	poly	NN	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
)	)	)	O	O
stretches	stretch	NNS	B-NP	O

Platelet	BEGIN-Platelet	JJ	B-NP	B
factor	factor	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O

Serum	Serum	NN	B-NP	O
pituitary	pituitary	JJ	I-NP	O
and	and	CC	I-NP	O
steroid	steroid	JJ	I-NP	O
hormone	hormone	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adult	adult	JJ	I-NP	O
male	male	NN	I-NP	O
:	:	:	O	O
one	one	CD	B-NP	O
value	value	NN	I-NP	O
is	be	VBZ	B-VP	O
as	as	RB	B-ADJP	O
good	good	JJ	I-ADJP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O

Blood	Blood	NN	B-NP	O
ammonia	ammonia	NN	I-NP	O
concentration	concentration	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
males	male	NNS	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
VO1	VO1	NN	B-NP	O
peak	peak	NN	I-NP	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
crystal	crystal	JJ	I-NP	O
structure	structure	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
A	A	NN	I-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
fragment	fragment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
integrase	BEGIN-integrase	NN	I-NP	B
of	of	IN	B-PP	I
Rous	Rous	NNP	B-NP	I
sarcoma	sarcoma	NN	I-NP	I
virus	virus	NN	I-NP	I
(	(	(	O	I
residues	residue	NNS	B-NP	I
1	1	CD	O	I
-	-	HYPH	O	I
1	1	CD	O	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
containing	contain	VBG	B-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
catalytic	catalytic	JJ	I-NP	O
domain	domain	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
modulatory	modulatory	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
domain	domain	NN	B-NP	O
(	(	(	O	O
C	C	NN	B-NP	O
domain	domain	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
kidney	kidney	NN	B-NP	O
length	length	NN	I-NP	O
was	be	VBD	B-VP	O
considerably	considerably	RB	B-ADJP	O
prolonged	prolonged	JJ	I-ADJP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
effect	effect	NN	I-NP	O

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
microalbuminuria	microalbuminuria	NN	B-NP	O
,	,	,	O	O
defined	define	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
UAER	UAER	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
min	min	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
overnight	overnight	JJ	I-NP	O
urine	urine	NN	I-NP	O
sample	sample	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
C.I.	C.I.	NN	I-NP	O
interval	interval	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
noticed	notice	VBN	I-VP	O
in	in	IN	B-PP	O
nonpregnant	nonpregnant	JJ	B-ADJP	O
than	than	IN	B-SBAR	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
pregnant	pregnant	JJ	B-NP	O
rats	rat	NNS	I-NP	O

Despite	Despite	IN	B-PP	O
their	their	PRP$	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
sequence	sequence	NN	B-NP	O
similarity	similarity	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
five	five	CD	I-NP	O
RFC	BEGIN-RFC	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
in	in	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O

Rev	Rev	NNP	B-NP	O

The	The	DT	B-NP	O
strongly	strongly	RB	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
p1	BEGIN-p1	NN	I-NP	B
subunit	subunit-INSIDE	NN	I-NP	I
showed	show	VBD	B-VP	O
only	only	RB	B-ADVP	O
very	very	RB	B-ADJP	O
weak	weak	JJ	I-ADJP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
any	any	DT	B-NP	O
,	,	,	O	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O

Stability	Stability	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
I	I	NN	I-NP	O
-	-	HYPH	B-NP	O
labeled	label	VBN	I-NP	O
insulin	BEGIN-insulin-INSIDE	NN	I-NP	B
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
radioimmunoassay	radioimmunoassay	NN	B-NP	O
of	of	IN	B-PP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B

Influence	Influence	NN	B-NP	O
of	of	IN	B-PP	O
long	long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
zimelidine	zimelidine	NN	I-NP	O
treatment	treatment	NN	I-NP	O
on	on	IN	B-PP	O
LSD	LSD	NN	B-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
behavioural	behavioural	JJ	I-NP	O
effects	effect	NNS	I-NP	O

Using	Use	VBG	B-VP	O
mammalian	mammalian	JJ	B-NP	O
expression	expression	NN	I-NP	O
vectors	vector	NNS	I-NP	O
(	(	(	O	O
pRSV	pRSV	NN	B-NP	O
-	-	HYPH	I-NP	O
neo	neo	NN	I-NP	O
and	and	CC	I-NP	O
pSV1	pSV1	NN	I-NP	O
-	-	HYPH	B-NP	O
neo	neo	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
antisense	antisense	JJ	B-NP	O
constructs	construct	NNS	I-NP	O
for	for	IN	B-PP	O
perforin	BEGIN-perforin-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
granzyme	BEGIN-granzyme	NN	I-NP	B
B	B-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
independently	independently	RB	I-VP	O
electroporated	electroporate	VBN	I-VP	O
into	into	IN	B-PP	O
YT	YT	NN	B-NP	O
-	-	HYPH	B-NP	O
INDY	INDY	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
MHC	BEGIN-MHC-INSIDE	NN	I-NP	B
-	-	HYPH	B-VP	O
restricted	restrict	VBN	I-VP	O
,	,	,	O	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
independent	independent	JJ	I-NP	O
,	,	,	I-NP	O
cytotoxic	cytotoxic	JJ	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O

When	When	WRB	B-ADVP	O
targeted	target	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
GAL1	BEGIN-GAL1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
fusing	fuse	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Gal1p	BEGIN-Gal1p	NN	I-NP	B
DNA	DNA	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-NP	I
domain	domain-INSIDE	NN	I-NP	I
,	,	,	O	O
Sko1p	BEGIN-Sko1p-INSIDE	NN	B-NP	B
acts	act	VBZ	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
Ssn1	BEGIN-Ssn1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Tup1p	BEGIN-Tup1p-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
repressor	repressor	NN	I-NP	O
regulated	regulate	VBN	B-VP	O
by	by	IN	B-PP	O
osmotic	osmotic	JJ	B-NP	O
stress	stress	NN	I-NP	O

Like	Like	IN	B-PP	O
Rev	BEGIN-Rev-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
Erb	BEGIN-Erb-INSIDE	NN	I-NP	B
,	,	,	O	O
BD1	BEGIN-BD1-INSIDE	NN	B-NP	B
binds	bind	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
monomer	monomer	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
which	which	WDT	B-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
A	A	NN	I-NP	O
/	/	SYM	I-NP	O
T	T	NN	I-NP	O
-	-	HYPH	I-NP	O
rich	rich	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	O
hexameric	hexameric	JJ	I-NP	O
half	half	NN	I-NP	O
-	-	HYPH	I-NP	O
site	site	NN	I-NP	O
specified	specify	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
P	P	NN	I-NP	O
box	box	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
domain	domain	NN	B-NP	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Allergic	Allergic	JJ	B-NP	O
rhinoconjunctivitis	rhinoconjunctivitis	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
people	people	NNS	B-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
socioeconomic	socioeconomic	JJ	I-NP	O
strata	stratum	NNS	I-NP	O

INTERVENTIONS	INTERVENTIONS	NNS	B-NP	O
:	:	:	O	O
Postoperative	Postoperative	JJ	B-VP	O
follow	follow	VB	I-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
serial	serial	JJ	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
biochemical	biochemical	JJ	I-NP	O
markers	marker	NNS	I-NP	O
(	(	(	O	O
CK	BEGIN-CK-INSIDE	NN	B-NP	B
,	,	,	O	O
CK	BEGIN-BEGIN-CK-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
MB	MB-INSIDE	NN	I-NP	I
,	,	,	O	O
cTnI	BEGIN-cTnI-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
ECGs	ECG	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
echocardiography	echocardiography	NN	B-NP	O

The	The	DT	B-NP	O
striking	striking	JJ	I-NP	O
similarity	similarity	NN	I-NP	O
in	in	IN	B-PP	O
preference	preference	NN	B-NP	O
for	for	IN	B-PP	O
mismatched	mismatched	JJ	B-NP	O
and	and	CC	I-NP	O
weakly	weakly	RB	I-NP	O
paired	pair	VBN	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O
for	for	IN	B-PP	O
binding	binding	NN	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
excision	excision	NN	B-NP	O
suggests	suggest	VBZ	B-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
binding	binding	NN	B-NP	O
and	and	CC	I-NP	O
cleavage	cleavage	NN	I-NP	O
reactions	reaction	NNS	I-NP	O

New	New	JJ	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
importance	importance	NN	B-NP	O
for	for	IN	B-PP	O
optimization	optimization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
]	]	)	I-NP	O
Complications	Complication	NNS	I-NP	O
after	after	IN	B-PP	O
major	major	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
factors	factor	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
stress	stress	NN	I-NP	O
response	response	NN	I-NP	O
with	with	IN	B-PP	O
endocrine	endocrine	NN	B-NP	O
-	-	HYPH	B-NP	O
metabolic	metabolic	JJ	I-NP	O
and	and	CC	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
changes	change	NNS	I-NP	O

Immunoblotting	Immunoblotting	NN	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
the	the	DT	B-NP	O
(	(	(	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
peptide	peptide	NN	I-NP	O
and	and	CC	O	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
peptide	peptide	NN	I-NP	O
are	be	VBP	B-VP	O
recognized	recognize	VBN	I-VP	O
by	by	IN	B-PP	O
1J1	BEGIN-1J1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	O
antibody	antibody	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
raised	raise	VBN	I-VP	O
against	against	IN	B-PP	O
perlecan	BEGIN-perlecan	NN	B-NP	B
-	-	HYPH	O	I
(	(	(	O	I
1	1	CD	B-NP	I
-	-	HYPH	I-NP	I
1	1	CD	I-NP	I
)	)	)	O	I
-	-	HYPH	B-NP	I
peptide	peptide-INSIDE	NN	I-NP	I
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O

Tumor	BEGIN-Tumor	NN	B-NP	B
necrosis	necrosis	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
enzyme	enzyme	NN	B-NP	O
-	-	HYPH	O	O
linked	link	VBN	B-VP	O
immunoabsorbent	immunoabsorbent	JJ	B-NP	O
assay	assay	NN	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
samples	sample	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hyperthermic	hyperthermic	JJ	I-NP	O
isolated	isolate	VBN	I-NP	O
limb	limb	NN	I-NP	O
perfusion	perfusion	NN	I-NP	O
circuit	circuit	NN	I-NP	O
and	and	CC	O	O
systemic	systemic	JJ	B-NP	O
circulation	circulation	NN	I-NP	O

Serum	BEGIN-Serum	NN	B-NP	B
alpha	alpha	SYM	O	I
-	-	HYPH	O	I
amylase	amylase-INSIDE	NN	B-NP	I
,	,	,	O	O
trypsin	BEGIN-trypsin-INSIDE	NN	B-NP	B
,	,	,	O	O
trypsin	BEGIN-BEGIN-trypsin-INSIDE	NN	B-NP	B
inhibitor	inhibitor-INSIDE	NN	I-NP	I
,	,	,	O	O
lipase	BEGIN-lipase-INSIDE	NN	B-NP	B
and	and	CC	O	O
total	total	JJ	B-NP	O
protease	protease	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
as	as	IN	B-PP	O
indicator	indicator	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
efficacy	efficacy	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
fluorouracil	fluorouracil	NN	I-NP	O
electro	electro	AFX	O	O
-	-	HYPH	O	O
cumulation	cumulation	NN	B-NP	O

The	The	DT	B-NP	O
possible	possible	JJ	I-NP	O
equivalency	equivalency	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
form	form	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Multiple	Multiple	NNP	I-NP	O
Affect	Affect	NNP	I-NP	O
Adjective	Adjective	NNP	I-NP	O
Check	Check	NNP	I-NP	O
List	List	NNP	I-NP	O
-	-	HYPH	I-NP	O
Revised	Revised	NNP	I-NP	O
(	(	(	O	O
MAACL	MAACL	NN	B-NP	O
-	-	HYPH	B-NP	O
R	R	NN	I-NP	O
;	;	:	O	O
Zuckerman	Zuckerman	NNP	B-NP	O
&	&	CC	I-NP	O
Lubin	Lubin	NNP	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
correlating	correlate	VBG	B-VP	O
both	both	DT	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MAACL	MAACL	NN	I-NP	O
-	-	HYPH	B-NP	O
R	R	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
State	State	NNP	I-NP	O
Trait	Trait	NNP	I-NP	O
Personality	Personality	NNP	I-NP	O
Inventory	Inventory	NNP	I-NP	O
(	(	(	O	O
Spielberger	Spielberger	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
the	the	DT	B-NP	O
Affect	Affect	NNP	I-NP	O
Balance	Balance	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
(	(	(	O	O
Bradburn	Bradburn	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Sensation	Sensation	NNP	I-NP	O
Seeking	Seeking	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
(	(	(	O	O
Zuckerman	Zuckerman	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
platelet	BEGIN-platelet	NN	B-NP	B
factor	factor	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
and	and	CC	I-NP	O
high	high	JJ	I-NP	O
risk	risk	NN	I-NP	O
newborns	newborn	NNS	I-NP	O

Studies	Study	NNS	B-NP	O
of	of	IN	B-PP	O
HS1	BEGIN-HS1	NN	B-NP	B
-	-	HYPH	B-NP	I
gamma	gamma	SYM	I-NP	I
gene	gene	NN	I-NP	I
reporter	reporter	NN	I-NP	I
constructs	constructs-INSIDE	NN	I-NP	I
carrying	carry	VBG	B-VP	O
CACCC	CACCC	NN	B-NP	O
box	box	NN	I-NP	O
deletions	deletion	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
CACCC	CACCC	NN	I-NP	O
box	box	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gamma	gamma	NN	I-NP	O
gene	gene	NN	I-NP	O
promoter	promoter	NN	I-NP	O
mediates	mediate	VBZ	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gamma	gamma	NN	I-NP	O
gene	gene	NN	I-NP	O
by	by	IN	B-PP	O
FKLF	BEGIN-FKLF-INSIDE	NN	B-NP	B

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
mrp1	BEGIN-mrp1	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
mutations	mutation	NNS	I-NP	O
affecting	affect	VBG	B-VP	O
another	another	DT	B-NP	O
mitochondrial	mitochondrial	JJ	I-NP	O
ribosomal	ribosomal	JJ	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
defective	defective	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O

Erdheim	Erdheim	NNP	B-NP	O
-	-	HYPH	I-NP	O
Chester	Chester	NNP	I-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
lipoidosis	lipoidosis	NN	I-NP	O
or	or	CC	O	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spectrum	spectrum	NN	I-NP	O
of	of	IN	B-PP	O
histiocytosis	histiocytosis	NN	B-NP	O
?	?	.	O	O
Erdheim	Erdheim	NNP	B-NP	O
-	-	HYPH	B-NP	O
Chester	Chester	NNP	I-NP	O
disease	disease	NN	I-NP	O
has	have	VBZ	B-VP	O
always	always	RB	I-VP	O
been	be	VBN	I-VP	O
considered	consider	VBN	I-VP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
lipoidosis	lipoidosis	NN	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
radiographic	radiographic	JJ	I-NP	O
criteria	criterion	NNS	I-NP	O

The	The	DT	B-NP	O
ossification	ossification	NN	I-NP	O
was	be	VBD	B-VP	O
located	locate	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
C1	C1	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
activating	activate	VBG	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
1	1-INSIDE	NN	I-NP	I
,	,	,	O	O
a	a	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activator	activator	NN	I-NP	O
that	that	WDT	B-NP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
domains	domain	NNS	I-NP	O
of	of	IN	B-PP	O
cAMP	BEGIN-cAMP	NN	B-NP	B
-	-	HYPH	O	I
responsive	responsive	JJ	B-NP	I
element	element	NN	I-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
CREB	BEGIN-CREB-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	B-NP	O
binding	bind	VBG	B-VP	O
protein	protein	NN	B-NP	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cystic	cystic	JJ	I-NP	O
liver	liver	NN	I-NP	O
-	-	HYPH	B-NP	O
lesions	lesion	NNS	I-NP	O
excludes	exclude	VBZ	B-VP	O
a	a	DT	B-NP	O
curative	curative	JJ	I-NP	O
operative	operative	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
refuses	refuse	VBZ	B-VP	O
surgery	surgery	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
indication	indication	NN	I-NP	O
for	for	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
with	with	IN	B-PP	O
mebendazole	mebendazole	NN	B-NP	O
is	be	VBZ	B-VP	O
given	give	VBN	I-VP	O

The	The	DT	B-NP	O
Ixodes	Ixodes	NNP	I-NP	O
fauna	fauna	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Michourin	Michourin	NNP	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
pastures	pasture	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
were	be	VBD	B-VP	O
grazed	graze	VBN	I-VP	O
only	only	RB	B-ADVP	O
by	by	IN	B-PP	O
sheep	sheep	NNS	B-NP	O
,	,	,	O	O
shows	show	VBZ	B-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
trends	trend	NNS	I-NP	O
:	:	:	O	O
H.	H.	NN	B-NP	O
punctata	punctata	NN	I-NP	O
and	and	CC	O	O
R.	R.	NNP	B-NP	O
turanicus	turanicus	NN	I-NP	O
ticks	tick	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
preferably	preferably	RB	I-VP	O
parasitising	parasitise	VBG	I-VP	O
in	in	IN	B-PP	O
sheep	sheep	NNS	B-NP	O
,	,	,	O	O
increase	increase	VB	B-VP	O
their	their	PRP$	B-NP	O
relative	relative	JJ	I-NP	O
share	share	NN	I-NP	O

The	The	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
residues	residue	NNS	B-NP	O
outside	outside	IN	B-PP	O
the	the	DT	B-NP	O
Ras	BEGIN-BEGIN-Ras-INSIDE	NN	I-NP	B
binding	binding	NN	I-NP	O
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
Raf	BEGIN-Raf-INSIDE	NN	B-NP	B
(	(	(	O	O
RafRBD	BEGIN-Raf-INSIDERBD	NN	B-NP	I
)	)	)	O	O
to	to	TO	B-PP	O
Ras	BEGIN-Ras-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
Raf	BEGIN-Raf-INSIDE	NN	I-NP	B
interaction	interaction	NN	I-NP	O
and	and	CC	I-NP	O
Ras	BEGIN-Ras-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
Raf	BEGIN-Raf-INSIDE	NN	I-NP	B
activation	activation	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
unresolved	unresolved	JJ	B-ADJP	O

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
electrical	electrical	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NTS	NTS	NNS	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
undergoing	undergo	VBG	B-VP	O
such	such	JJ	B-NP	O
surgical	surgical	JJ	I-NP	O
preparation	preparation	NN	I-NP	O
to	to	TO	B-VP	O
observe	observe	VB	I-VP	O
the	the	DT	B-NP	O
pressor	pressor	NN	I-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
increase	increase	VB	B-VP	O
in	in	IN	B-PP	O
pVP	pVP	NN	B-NP	O
,	,	,	O	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
approach	approach	NN	I-NP	O
for	for	IN	B-PP	O
screening	screen	VBG	B-VP	O
the	the	DT	B-NP	O
neurosecretory	neurosecretory	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
neural	neural	JJ	I-NP	O
integration	integration	NN	I-NP	O
to	to	TO	B-VP	O
release	release	VB	I-VP	O
vasopressin	BEGIN-vasopressin-INSIDE	NN	B-NP	B

CONCLUSION	CONCLUSION	NN	B-NP	O
/	/	SYM	I-NP	O
INTERPRETATION	INTERPRETATION	NN	I-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
hip	hip	NN	B-NP	O
fracture	fracture	NN	I-NP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
younger	young	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
with	with	IN	B-PP	O
Type	Type	NN	B-NP	O
I	I	CD	B-NP	O
diabetes	diabete	NNS	I-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
of	of	IN	B-PP	O
long	long	JJ	B-NP	O
duration	duration	NN	I-NP	O

Mean	Mean	NN	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
excretion	excretion	NN	I-NP	O
values	value	NNS	I-NP	O
confirmed	confirm	VBD	B-VP	O
this	this	DT	B-NP	O
observation	observation	NN	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
investigate	investigate	VBP	B-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
TPA	TPA	NN	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
FGF	BEGIN-FGF	NN	B-NP	B
-	-	HYPH	B-NP	I
BP	BP-INSIDE	NN	I-NP	I
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
ME	ME	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
SCC	SCC	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O

They	They	PRP	B-NP	O
represent	represent	VBP	B-VP	O
a	a	DT	B-NP	O
physiologically	physiologically	RB	I-NP	O
more	more	RBR	I-NP	O
meaningful	meaningful	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
arithmetic	arithmetic	JJ	I-NP	O
mean	mean	NN	I-NP	O
with	with	IN	B-PP	O
standard	standard	JJ	B-NP	O
deviation	deviation	NN	I-NP	O

The	The	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
gas	gas	NN	B-NP	O
composition	composition	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
air	air	NN	I-NP	O
cell	cell	NN	I-NP	O
on	on	IN	B-PP	O
pipping	pipping	NN	B-NP	O
and	and	CC	I-NP	O
liver	liver	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
embryonic	embryonic	JJ	B-NP	O
chicks	chick	NNS	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
FosB	BEGIN-BEGIN-FosB-INSIDE	NN	B-NP	B
-	-	HYPH	I-NP	O
L	L-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
FosB	BEGIN-BEGIN-FosB-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
S	S-INSIDE	NN	I-NP	I
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
differ	differ	VB	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
regulatory	regulatory	JJ	I-NP	O
properties	property	NNS	I-NP	O
:	:	:	O	O
Trans	Trans	AFX	O	O
-	-	HYPH	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1x	1x	NN	I-NP	O
TRE	BEGIN-TRE	NN	I-NP	B
-	-	HYPH	B-NP	I
CAT	CAT-INSIDE	NN	I-NP	I
reporter	reporter	NN	I-NP	O
construct	construct	NN	I-NP	O
in	in	IN	B-PP	O
HeLa	HeLa	NN	B-NP	O
and	and	CC	I-NP	O
NIH	NIH	NN	I-NP	O
-	-	HYPH	B-NP	O
1T1	1T1	NN	I-NP	O
cells	cell	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
with	with	IN	B-PP	O
both	both	DT	B-NP	O
FosB	BEGIN-FosB-INSIDE	JJ	I-NP	B
forms	form	NNS	I-NP	O

Numerous	Numerous	JJ	B-NP	O
genes	gene	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
family	family	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
animals	animal	NNS	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
largest	large	JJS	I-NP	O
number	number	NN	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
vertebrates	vertebrate	NNS	B-NP	O

Mineralized	Mineralize	VBN	B-NP	O
bone	bone	NN	I-NP	O
nodule	nodule	NN	I-NP	O
formation	formation	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
cell	cell	NN	B-NP	O
populations	population	NNS	I-NP	O
from	from	IN	B-PP	O
young	young	JJ	B-NP	O
adult	adult	JJ	I-NP	O
rabbit	rabbit	NN	I-NP	O
alveolar	alveolar	JJ	I-NP	O
bone	bone	NN	I-NP	O

Soluble	Soluble	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
FGF	BEGIN-FGF-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
treated	treat	VBN	B-VP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
quiescent	quiescent	JJ	B-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
exhibited	exhibit	VBD	B-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-ADVP	O
fold	fold	RB	B-NP	O
higher	high	JJR	I-NP	O
kinase	kinase	NN	I-NP	O
activity	activity	NN	I-NP	O
towards	towards	IN	B-PP	O
S1	BEGIN-S1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
exogenously	exogenously	RB	B-NP	O
added	add	VBN	I-NP	O
rat	BEGIN-rat	NN	I-NP	B
liver	liver	NN	I-NP	I
1S	1S	NN	I-NP	I
ribosomes	ribosomes-INSIDE	NN	I-NP	I
and	and	CC	O	O
a	a	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
,	,	,	O	O
RRLSSLRA	RRLSSLRA	NN	B-NP	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
pulmonary	pulmonary	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
HTLV	HTLV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
carriers	carrier	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
careful	careful	JJ	B-ADJP	O
in	in	IN	B-PP	O
determining	determine	VBG	B-VP	O
whether	whether	IN	B-SBAR	O
such	such	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
involvements	involvement	NNS	I-NP	O
are	be	VBP	B-VP	O
etiologically	etiologically	RB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
HTLV	HTLV	NN	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
infection	infection	NN	I-NP	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
their	their	PRP$	B-NP	O
thoracolumbar	thoracolumbar	JJ	I-NP	O
blood	blood	NN	I-NP	O
supply	supply	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
anterior	anterior	JJ	I-NP	O
radiculospinal	radiculospinal	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
,	,	,	O	O
or	or	CC	O	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
,	,	,	O	O
T1	T1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
and	and	CC	I-NP	O
higher	high	JJR	I-NP	O
one	one	CD	I-NP	O
between	between	IN	B-PP	O
T1	T1	NN	B-NP	O
and	and	CC	I-NP	O
T1	T1	NN	I-NP	O

Cross	Cross	AFX	B-NP	O
-	-	HYPH	I-NP	O
species	species	NN	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
promoter	BEGIN-promoter	JJ	I-NP	B
region	region	NN	I-NP	I
of	of	IN	B-PP	I
the	the	DT	B-NP	I
cystic	cystic	JJ	I-NP	I
fibrosis	fibrosis	NN	I-NP	I
transmembrane	transmembrane	JJ	I-NP	I
conductance	conductance	NN	I-NP	I
regulator	regulator	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
reveals	reveal	VBZ	B-VP	O
multiple	multiple	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
regulation	regulation	NN	B-NP	O

The	The	DT	B-NP	O
leader	leader	NN	I-NP	O
peptide	peptide	NN	I-NP	O
was	be	VBD	B-VP	O
hypothesized	hypothesize	VBN	I-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
ribosome	ribosome	NN	B-NP	O
release	release	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
tnaC	BEGIN-tnaC	NN	I-NP	B
stop	stop	NN	I-NP	I
codon	codon-INSIDE	NN	I-NP	I
,	,	,	O	O
thereby	thereby	RB	B-VP	O
blocking	block	VBG	I-VP	O
Rho	BEGIN-Rho-INSIDE	NN	B-NP	B
's	's	POS	B-NP	O
access	access	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transcript	transcript	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
murine	BEGIN-murine	JJ	I-NP	B
FLT1	BEGIN-FLT1-INSIDE	NN	I-NP	I
cDNA	cDNA-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
codes	cod	VBZ	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
variant	variant	JJ	I-NP	O
isoform	isoform	NN	I-NP	O
of	of	IN	B-PP	O
FLT1	BEGIN-FLT1-INSIDE	NN	B-NP	B
,	,	,	O	O
devoid	devoid	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fifth	fifth	JJ	I-NP	O
Ig	BEGIN-Ig	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
,	,	,	O	O
by	by	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
prototypic	prototypic	JJ	I-NP	O
form	form	NN	I-NP	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
MDS	MDS	NN	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
PLAC	PLAC	NN	I-NP	O

Plasma	BEGIN-Plasma	NN	B-NP	B
beta	beta	SYM	O	I
-	-	HYPH	O	I
thromboglobulin	thromboglobulin-INSIDE	NN	B-NP	I
(	(	(	O	O
beta	BEGIN-beta	NN	B-NP	B
-	-	HYPH	B-NP	I
TG	TG-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
platelet	platelet	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
marker	marker	NN	I-NP	O
of	of	IN	B-PP	O
intravascular	intravascular	JJ	B-NP	O
platelet	platelet	NN	I-NP	O
degranulation	degranulation	NN	I-NP	O

The	The	DT	B-NP	O
Synechococcus	BEGIN-Synechococcus	NN	I-NP	B
gene	gene	NN	I-NP	I
rps1	rps1-INSIDE	NN	I-NP	I
encoding	encode	VBG	B-VP	O
S1	BEGIN-S1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
located	located	JJ	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
downstream	downstream	RB	B-ADVP	O
from	from	IN	B-PP	O
psbB	BEGIN-psbB-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
photosystem	BEGIN-photosystem	NN	I-NP	B
II	II	CD	I-NP	I
P1	P1	NN	I-NP	I
chlorophyll	chlorophyll	NN	I-NP	I
a	a	DT	B-NP	I
apoprotein	apoprotein-INSIDE	NN	I-NP	I

Additions	Addition	NNS	B-NP	O
of	of	IN	B-PP	O
NH1+	NH1+	NN	B-NP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
not	not	RB	O	O
stimulatory	stimulatory	JJ	B-ADJP	O
,	,	,	O	O
whereas	whereas	IN	O	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
-	-	SYM	O	O
1	1	CD	O	O
)	)	)	O	O
levels	level	NNS	B-NP	O
,	,	,	O	O
Ke	Ke	NNP	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
for	for	IN	B-PP	O
NO1	NO1	NN	B-NP	O
-	-	HYPH	O	O
enriched	enrich	VBN	B-VP	O
medium	medium	NN	B-NP	O

Pretreatment	Pretreatment	NN	B-NP	O
with	with	IN	B-PP	O
lipid	lipid	NN	B-NP	O
X	X	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
survival	survival	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
infected	infected	JJ	B-NP	O
and	and	CC	I-NP	O
visibly	visibly	RB	I-NP	O
ill	ill	JJ	I-NP	O
animals	animal	NNS	I-NP	O
that	that	WDT	B-NP	O
received	receive	VBD	B-VP	O
lipid	lipid	NN	B-NP	O
X	X	NN	I-NP	O
and	and	CC	O	O
ticarcillin	ticarcillin	NN	B-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
thigh	thigh	JJ	B-NP	O
inoculation	inoculation	NN	I-NP	O
survived	survive	VBD	B-VP	O
versus	versus	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
control	control	NN	B-NP	O
animals	animal	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
ticarcillin	ticarcillin	NN	B-NP	O
alone	alone	RB	B-ADVP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

Between	Between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
data	datum	NNS	B-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
large	large	JJ	I-NP	O
sites	site	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
fold	fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
antidepressant	antidepressant	NN	B-NP	O
(	(	(	O	O
ATD	ATD	NN	B-NP	O
)	)	)	O	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
U.S.	U.S.	NNP	B-NP	O
youths	youth	NNS	I-NP	O
aged	age	VBN	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O

1	1	CD	B-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Analysis	Analysis	NN	B-NP	O
by	by	IN	B-PP	O
Pearson	Pearson	NNP	B-NP	O
's	's	POS	B-NP	O
correlation	correlation	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
higher	high	JJR	B-NP	O
scores	score	NNS	I-NP	O
of	of	IN	B-PP	O
SSMS	SSMS	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
drum	drum	NN	I-NP	O
rotation	rotation	NN	I-NP	O
generated	generate	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
a	a	LS	B-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
rating	rating	NN	I-NP	O
of	of	IN	B-PP	O
over	over	AFX	B-NP	O
-	-	HYPH	I-NP	O
all	all	DT	B-NP	O
sickness	sickness	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
b	b	LS	B-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
spectral	spectral	JJ	B-NP	O
power	power	NN	I-NP	O
of	of	IN	B-PP	O
EGG	EGG	NN	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
cycles	cycle	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
(	(	(	O	O
cpm	cpm	NN	B-NP	O
)	)	)	O	O
between	between	IN	B-PP	O
drum	drum	NN	B-NP	O
rotation	rotation	NN	I-NP	O
and	and	CC	I-NP	O
baseline	baseline	NN	I-NP	O
periods	period	NNS	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
c	c	LS	B-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
net	net	JJ	I-NP	O
percent	percent	NN	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
spectral	spectral	JJ	B-NP	O
power	power	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
EEG	EEG	NN	I-NP	O
frequency	frequency	NN	I-NP	O
band	band	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
Hz	Hz	NN	I-NP	O
between	between	IN	B-PP	O
drum	drum	NN	B-NP	O
rotation	rotation	NN	I-NP	O
and	and	CC	O	O
baseline	baseline	NN	B-NP	O
periods	period	NNS	I-NP	O
on	on	IN	B-PP	O
C1	C1	NN	B-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
C1	C1	NN	B-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
d	d	LS	B-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
spectral	spectral	JJ	B-NP	O
power	power	NN	I-NP	O
of	of	IN	B-PP	O
EEG	EEG	NN	B-NP	O
frequency	frequency	NN	I-NP	O
band	band	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
Hz	Hz	NN	I-NP	O
between	between	IN	B-PP	O
drum	drum	NN	B-NP	O
rotation	rotation	NN	I-NP	O
and	and	CC	O	O
baseline	baseline	NN	B-NP	O
periods	period	NNS	I-NP	O
on	on	IN	B-PP	O
C1	C1	NN	B-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
and	and	CC	O	O
e	e	LS	B-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
net	net	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
skin	skin	NN	B-NP	O
conductance	conductance	NN	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
to	to	TO	B-PP	O
drum	drum	NN	B-NP	O
rotation	rotation	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O

After	After	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
monoamine	BEGIN-monoamine	NN	B-NP	B
oxidase	oxidase-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
pargyline	pargyline	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg.	kg.	NN	I-NP	O
i.v.	i.v.	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
tyramine	tyramine	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
)	)	)	O	O
injected	inject	VBN	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	O
artery	artery	NN	I-NP	O
were	be	VBD	B-VP	O
potentiated	potentiate	VBN	I-VP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
FPFD	FPFD	NN	B-NP	O
1	1	CD	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
Gcn1	BEGIN-Gcn1-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
histone	BEGIN-histone	NN	I-NP	B
H1	H1	NN	I-NP	I
acetylase	acetylase-INSIDE	NN	I-NP	I
,	,	,	O	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
meiosis	meiosis	NN	B-NP	O
via	via	IN	B-PP	O
effects	effect	NNS	B-NP	O
on	on	IN	B-PP	O
IME1	BEGIN-IME1-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
(	(	(	O	O
propofol	propofol	NN	B-NP	O
1	1	CD	I-NP	O
microg	microg	NN	I-NP	O
mL	mL	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
thiopental	thiopental	JJ	B-NP	O
1	1	CD	I-NP	O
microg	microg	NN	I-NP	O
mL	mL	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
marked	marked	JJ	B-NP	O
relaxation	relaxation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
(	(	(	O	O
propofol	propofol	NN	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
thiopental	thiopental	JJ	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
further	far	JJR	B-NP	O
support	support	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
biological	biological	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
IL1RA	BEGIN-IL1RA-INSIDE	NN	I-NP	B
oligonucleotide	oligonucleotide	NN	I-NP	O
from	from	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
proved	prove	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
sufficient	sufficient	JJ	B-ADJP	O
in	in	IN	B-PP	O
either	either	CC	O	O
orientation	orientation	NN	B-NP	O
to	to	TO	B-VP	O
confer	confer	VB	I-VP	O
PMA	PMA	NN	B-NP	O
inducibility	inducibility	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mitogen	mitogen	NN	I-NP	O
-	-	HYPH	B-NP	O
insensitive	insensitive	JJ	I-NP	O
thymidine	BEGIN-thymidine	NN	I-NP	B
kinase	kinase	NN	I-NP	I
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
and	and	CC	I-NP	O
subdomains	subdomain	NNS	I-NP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
,	,	,	O	O
hormone	hormone	NN	B-NP	O
binding	binding	NN	I-NP	O
,	,	,	O	O
dimerization	dimerization	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
transactivation	transactivation	NN	B-NP	O
are	be	VBP	B-VP	O
mostly	mostly	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
among	among	IN	B-PP	O
all	all	DT	B-NP	O
VDR	BEGIN-VDR-INSIDE	NN	I-NP	B
species	specie	NNS	I-NP	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
(	(	(	O	O
nt	nt	NN	B-NP	O
)	)	)	O	O
sequence	sequence	NN	B-NP	O
and	and	CC	O	O
genomic	genomic	JJ	B-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
ipiB	BEGIN-ipiB-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
ipiO	BEGIN-ipiO-INSIDE	NN	I-NP	B

Specifically	Specifically	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
base	base	NN	I-NP	O
pair	pair	NN	I-NP	O
region	region	NN	I-NP	O
mediates	mediate	VBZ	B-VP	O
the	the	DT	B-NP	O
up	up	RB	I-NP	O
-	-	HYPH	I-NP	O
regulatory	regulatory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
TGF	BEGIN-TGF	NN	B-NP	B
-	-	HYPH	I-NP	I
beta	beta-INSIDE	NN	B-NP	I
on	on	IN	B-PP	O
COL1A1	BEGIN-COL1A1	NN	B-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
and	and	CC	O	O
allows	allow	VBZ	B-VP	O
antagonistic	antagonistic	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
TNF	BEGIN-TNF	NN	B-NP	B
-	-	HYPH	B-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
the	the	DT	B-NP	O
TGF	BEGIN-TGF	NN	I-NP	B
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
effect	effect	NN	I-NP	O

The	The	DT	B-NP	O
phosphatidylglycerol	BEGIN-phosphatidylglycerol	NN	I-NP	B
/	/	SYM	B-VP	I
phosphatidylinositol	phosphatidylinositol	NN	B-NP	I
transfer	transfer	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
PG	BEGIN-PG	NN	B-NP	B
/	/	SYM	B-NP	I
PI	PI	NN	I-NP	I
-	-	HYPH	B-NP	I
TP	TP-INSIDE	NN	I-NP	I
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
and	and	CC	I-NP	O
original	original	JJ	I-NP	O
phospholipid	BEGIN-phospholipid	NN	I-NP	B
transfer	transfer	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
PLTP	BEGIN-PLTP-INSIDE	NN	B-NP	B
)	)	)	O	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Deuteromycete	Deuteromycete	NNP	I-NP	O
,	,	,	I-NP	O
Aspergillus	Aspergillus	NNP	I-NP	O
oryzae	oryzae	NNS	I-NP	O

A	A	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	B-NP	I
nucleotide	nucleotide	NN	I-NP	I
-	-	HYPH	B-NP	I
long	long	JJ	I-NP	I
EcoRI	EcoRI	NN	I-NP	I
fragment	fragment-INSIDE	NN	I-NP	I
from	from	IN	B-PP	O
the	the	DT	B-NP	O
genome	genome	NN	I-NP	O
of	of	IN	B-PP	O
Thermotoga	Thermotoga	NNP	B-NP	O
maritima	maritima	NNP	I-NP	O
,	,	,	O	O
identified	identify	VBN	B-VP	O
by	by	IN	B-PP	O
cross	cross	AFX	B-NP	O
-	-	HYPH	I-NP	O
hybridization	hybridization	NN	I-NP	O
to	to	TO	B-PP	O
L1	BEGIN-L1-INSIDE	NN	B-NP	B
,	,	,	O	O
L1	BEGIN-L1-INSIDE	NN	B-NP	B
,	,	,	O	O
L1	BEGIN-L1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
L1	BEGIN-BEGIN-L1-INSIDE	NN	B-NP	B
ribosomal	ribosomal	JJ	I-NP	O
protein	protein	NN	I-NP	O
gene	gene	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
from	from	IN	B-PP	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli-INSIDE	NN	I-NP	I
,	,	,	O	O
was	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
and	and	CC	O	O
sequenced	sequence	VBN	B-VP	O

Endotoxemia	Endotoxemia	NN	B-NP	O
and	and	CC	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intensive	intensive	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O

Several	Several	JJ	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
mm	mm	NN	I-NP	O
slides	slide	NNS	I-NP	O
of	of	IN	B-PP	O
dystrophin	BEGIN-dystrophin-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
,	,	,	O	O
laminin	BEGIN-laminin-INSIDE	NN	B-NP	B
-	-	HYPH	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
concanavalin	BEGIN-concanavalin	NN	B-NP	B
A	A-INSIDE	NN	I-NP	I
(	(	(	O	O
ConA	BEGIN-ConA-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	O	O
stained	stain	VBN	B-NP	O
muscle	muscle	NN	I-NP	O
sections	section	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
calculate	calculate	VB	I-VP	O
myofiber	myofiber	NN	B-NP	O
cross	cross	AFX	O	O
-	-	HYPH	O	O
sectional	sectional	JJ	B-NP	O
areas	area	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
different	different	JJ	B-NP	O
techniques	technique	NNS	I-NP	O
and	and	CC	I-NP	O
settings	setting	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
image	image	NN	I-NP	O
capture	capture	NN	I-NP	O
system	system	NN	I-NP	O

Indeed	Indeed	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
oral	oral	JJ	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mu	BEGIN-mu	NN	I-NP	B
-	-	HYPH	B-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
agonist	agonist	NN	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antinociceptive	antinociceptive	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
tramadol	tramadol	NN	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
minor	minor	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
analgesic	analgesic	JJ	I-NP	O
effect	effect	NN	I-NP	O
being	be	VBG	B-VP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
nonopioid	nonopioid	JJ	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
parent	parent	NN	I-NP	O
compound	compound	NN	I-NP	O

The	The	DT	B-NP	O
mRNA	mRNA	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
protein	protein	NN	I-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	O
-	-	HYPH	I-NP	O
ALL	ALL	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
Jurkat	Jurkat	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
designated	designate	VBN	I-VP	O
HUG1	BEGIN-HUG1-INSIDE	NN	B-NP	B
,	,	,	O	O
for	for	IN	B-PP	O
HOX1	BEGIN-HOX1	NN	B-NP	B
Upstream	Upstream	NN	I-NP	I
Gene	Gene-INSIDE	NN	I-NP	I

In	In	IN	B-PP	O
solution	solution	NN	B-NP	O
,	,	,	O	O
[	[	(	O	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
I	I	PRP	B-NP	O
]	]	)	O	O
-	-	HYPH	O	O
labeled	label	VBN	B-NP	O
ankyrin	BEGIN-ankyrin-INSIDE	NN	I-NP	B
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
by	by	IN	B-PP	O
ND	ND	NN	B-NP	O
-	-	HYPH	B-NP	O
PAGE1	PAGE1	NN	I-NP	O
to	to	TO	B-VP	O
enhance	enhance	VB	I-VP	O
the	the	DT	B-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
spectrin	BEGIN-spectrin-INSIDE	NN	B-NP	B
self	self	AFX	O	O
-	-	HYPH	O	O
association	association	NN	B-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
fold	fold	RB	B-ADVP	O

The	The	DT	B-NP	O
MEF	BEGIN-MEF	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activators	activator	NNS	I-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
types	type	NNS	I-NP	O

Jet	Jet	NN	B-NP	O
lag	lag	NN	I-NP	O
and	and	CC	O	O
melatonin	melatonin	NN	B-NP	O

Manual	Manual	JJ	B-NP	O
sample	sample	NN	I-NP	O
clean	clean	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
procedures	procedure	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
internal	internal	JJ	I-NP	O
standard	standard	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
needed	need	VBN	I-VP	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	O	O
retinal	retinal	JJ	B-NP	O
complications	complication	NNS	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
N	BEGIN-N	NN	I-NP	B
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
RNAP	RNAP	NN	I-NP	I
mutant	mutant-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
capacity	capacity	NN	I-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
stranded	stranded	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
forms	form	NNS	I-NP	O
halted	halt	VBD	B-VP	O
complexes	complex	NNS	B-NP	O
with	with	IN	B-PP	O
much	much	RB	B-NP	O
lower	low	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
stability	stability	NN	B-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
WT	WT	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
these	these	DT	B-NP	O
complexes	complex	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
stabilized	stabilize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NT	NT	NN	I-NP	O
strand	strand	NN	I-NP	O

The	The	DT	B-NP	O
densities	density	NNS	I-NP	O
ranged	range	VBD	B-VP	O
between	between	IN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
neurites	neurite	NNS	I-NP	O
/	/	SYM	B-NP	O
mm1	mm1	NN	I-NP	O
skin	skin	NN	I-NP	O
surface	surface	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
overlap	overlap	NN	I-NP	O
between	between	IN	B-PP	O
subjects	subject	NNS	B-NP	O
and	and	CC	B-PP	O
without	without	IN	B-PP	O
PHN	PHN	NN	B-NP	O
was	be	VBD	B-VP	O
small	small	JJ	B-ADJP	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
proto	BEGIN-proto	AFX	I-NP	B
-	-	HYPH	I-NP	I
oncogene	oncogene	NN	I-NP	I
c	c	NN	I-NP	I
-	-	HYPH	O	I
jun	jun-INSIDE	NN	B-NP	I
represses	repress	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
CG	CG	NN	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
CG	BEGIN-CG	NN	I-NP	B
beta	beta	SYM	B-NP	I
promoters.	promoters-INSIDE.	NN	B-NP	I
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
Jun	Jun-INSIDE	NN	I-NP	I
repressed	repress	VBD	B-VP	O
the	the	DT	B-NP	O
CG	BEGIN-CG	NN	I-NP	B
alpha	alpha	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
through	through	IN	B-PP	O
a	a	DT	B-NP	O
canonical	canonical	JJ	I-NP	O
cAMP	cAMP	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
CRE	CRE	NN	B-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	O	I
Jun	Jun-INSIDE	NN	B-NP	I
and	and	CC	O	O
other	other	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
B	BEGIN-B	NN	I-NP	B
-	-	HYPH	B-NP	I
Zip	Zip	NN	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
mouse	mouse	NN	I-NP	O
lactoferrin	BEGIN-lactoferrin-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
promoter	promoter	NN	I-NP	O
was	be	VBD	B-VP	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
endometrium	endometrium	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
RL	RL	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
rat	rat	NN	B-NP	O
glioma	glioma	NN	I-NP	O
C1	C1	NN	I-NP	O
cells	cell	NNS	I-NP	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
report	report	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
PH	BEGIN-PH	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
an	an	DT	B-NP	O
IRS	BEGIN-IRS	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
can	can	MD	B-VP	O
function	function	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
manner	manner	NN	I-NP	O
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
insulin	BEGIN-insulin-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O

Is	Be	VBZ	O	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
Crohn	Crohn	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
an	an	DT	B-NP	O
environmental	environmental	JJ	I-NP	O
factor	factor	NN	I-NP	O
for	for	IN	B-PP	O
developing	develop	VBG	B-VP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
power	power	NN	I-NP	O
laser	laser	NN	I-NP	O
irradiation	irradiation	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
promotion	promotion	NN	B-NP	O
of	of	IN	B-PP	O
vascularization	vascularization	NN	B-NP	O
and	and	CC	I-NP	O
take	take	NN	I-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	O
transplants	transplant	NNS	I-NP	O

In	In	IN	B-PP	O
experiment	experiment	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
subjects	subject	NNS	B-NP	O
were	be	VBD	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
discriminate	discriminate	VB	I-VP	O
male	male	JJ	B-ADJP	O
from	from	IN	B-PP	O
female	female	JJ	B-NP	O
faces	face	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
hemispheric	hemispheric	JJ	I-NP	O
asymmetries	asymmetry	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O

1	1	CD	B-NP	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
albino	albino	NN	I-NP	O
,	,	,	O	O
both	both	CC	O	O
the	the	DT	B-NP	O
ST1	ST1	NN	I-NP	O
and	and	CC	I-NP	O
ST1	ST1	NN	I-NP	O
spatial	spatial	JJ	I-NP	O
responses	response	NNS	I-NP	O
peak	peak	VBP	B-VP	O
at	at	IN	B-PP	O
around	around	IN	B-NP	O
1	1	CD	I-NP	O
cycles	cycle	NNS	I-NP	O
deg	deg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
both	both	DT	B-NP	O
curves	curve	NNS	I-NP	O
are	be	VBP	B-VP	O
displaced	displace	VBN	I-VP	O
considerably	considerably	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
spatial	spatial	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
ST1	ST1	NN	I-NP	O
spatial	spatial	JJ	I-NP	O
response	response	NN	I-NP	O

The	The	DT	B-NP	O
scores	score	NNS	I-NP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
three	three	CD	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
corresponded	correspond	VBD	B-VP	O
to	to	TO	B-PP	O
recognizable	recognizable	JJ	B-NP	O
dimensions	dimension	NNS	I-NP	O
of	of	IN	B-PP	O
depressive	depressive	JJ	B-NP	O
illness	illness	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
then	then	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
rCBF	rCBF	NN	B-NP	O

The	The	DT	B-NP	O
etiology	etiology	NN	I-NP	O
was	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O

Depending	Depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
body	body	NN	I-NP	O
position	position	NN	I-NP	O
telemetrically	telemetrically	RB	B-ADVP	O
measured	measure	VBD	B-VP	O
CSF	CSF	NN	B-NP	O
-	-	HYPH	B-NP	O
pressures	pressure	NNS	I-NP	O
varied	vary	VBD	B-VP	O
between	between	IN	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
cmH1O	cmH1O	NN	I-NP	O
in	in	IN	B-PP	O
erect	erect	JJ	B-ADJP	O
and	and	CC	O	O
1	1	CD	B-NP	O
cmH1O	cmH1O	NN	I-NP	O
in	in	IN	B-PP	O
supine	supine	NN	B-NP	O
position	position	NN	I-NP	O

Patients	Patient	NNS	B-NP	O
received	receive	VBD	B-VP	O
either	either	CC	O	O
sodium	sodium	NN	B-NP	O
cephalothin	cephalothin	NN	I-NP	O
or	or	CC	I-NP	O
placebo	placebo	NN	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
additional	additional	JJ	I-NP	O
doses	dose	NNS	I-NP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
NMDA	BEGIN-NMDA	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
blockade	blockade	NN	I-NP	O
may	may	MD	B-VP	O
ameliorate	ameliorate	VB	I-VP	O
the	the	DT	B-NP	O
dyskinetic	dyskinetic	JJ	I-NP	O
complications	complication	NNS	I-NP	O
of	of	IN	B-PP	O
long	long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
levodopa	levodopa	NN	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
diminishing	diminish	VBG	B-VP	O
the	the	DT	B-NP	O
beneficial	beneficial	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
parkinsonian	parkinsonian	JJ	B-NP	O
signs	sign	NNS	I-NP	O

Before	Before	IN	B-PP	O
flecainide	flecainide	NN	B-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
easily	easily	RB	B-NP	O
inducible	inducible	JJ	I-NP	O
VT	VT	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
morphologically	morphologically	RB	B-ADJP	O
identical	identical	JJ	I-ADJP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
spontaneously	spontaneously	RB	I-NP	O
occurring	occur	VBG	I-NP	O
arrhythmia	arrhythmia	NN	I-NP	O

In	In	IN	B-PP	O
cells	cell	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	O
vaccinia	vaccinia	NN	I-NP	O
virus	virus	NN	I-NP	O
expressing	express	VBG	B-VP	O
HCV	HCV	NN	B-NP	O
structural	structural	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
(	(	(	O	O
core	BEGIN-core-INSIDE	NN	B-NP	B
,	,	,	O	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
,	,	,	O	O
and	and	CC	O	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
DDX1	BEGIN-DDX1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
core	BEGIN-core-INSIDE	NN	I-NP	B
colocalized	colocalize	VBD	B-VP	O
in	in	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
spots	spot	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
perinuclear	perinuclear	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
PC1	PC1	NN	B-NP	O
cell	cell	NN	I-NP	O
clones	clone	NNS	I-NP	O
which	which	WDT	B-NP	O
expressed	express	VBD	B-VP	O
p1rsu	BEGIN-p1rsu	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
at	at	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
level	level	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
regulatable	regulatable	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O

Differential	Differential	JJ	B-NP	O
decay	decay	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
polycistronic	polycistronic	JJ	I-NP	O
Escherichia	Escherichia	FW	I-NP	O
coli	coli	FW	I-NP	O
transcript	transcript	NN	I-NP	O
is	be	VBZ	B-VP	O
initiated	initiate	VBN	I-VP	O
by	by	IN	B-PP	O
RNaseE	BEGIN-RNaseE-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
endonucleolytic	endonucleolytic	JJ	I-NP	O
processing	processing	NN	I-NP	O

An	An	DT	B-NP	O
incorrect	incorrect	JJ	I-NP	O
response	response	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
trial	trial	NN	I-NP	O
enhanced	enhance	VBD	B-VP	O
the	the	DT	B-NP	O
accuracy	accuracy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
trial	trial	NN	I-NP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
visual	visual	JJ	I-NP	O
field	field	NN	I-NP	O
(	(	(	O	O
LVF	LVF	NN	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
SEC1	BEGIN-SEC1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
predicts	predict	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
sequence	sequence	NN	I-NP	O
identity	identity	NN	I-NP	O
to	to	TO	B-PP	O
mammalian	mammalian	JJ	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
'	'	''	O	I
-	-	HYPH	B-NP	I
COP	COP-INSIDE	NN	I-NP	I

Column	Column	NN	B-NP	O
chromatographic	chromatographic	JJ	I-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
polymyxin	polymyxin	NN	B-NP	O
B	B	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O

Subgroup	Subgroup	NN	B-NP	O
analysis	analysis	NN	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
benefit	benefit	NN	I-NP	O
for	for	IN	B-PP	O
etoposide	etoposide	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
monocytic	monocytic	JJ	B-NP	O
or	or	CC	I-NP	O
myelomonocytic	myelomonocytic	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
diagnostic	diagnostic	JJ	I-NP	O
subgroup	subgroup	NN	I-NP	O

Monosulfates	Monosulfate	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-VP	O
oxygenated	oxygenate	VBN	B-NP	O
ketonic	ketonic	JJ	I-NP	O
C1	C1	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
in	in	IN	B-PP	O
adult	adult	JJ	B-NP	O
human	human	JJ	I-NP	O
urine	urine	NN	I-NP	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
cancers	cancer	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
colon	colon	NN	I-NP	O

Pretoria	Pretoria	NNP	B-NP	O
Pasteurisation	Pasteurisation	NNP	I-NP	O
is	be	VBZ	B-VP	O
feasible	feasible	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
reliable	reliable	JJ	I-ADJP	O
under	under	IN	B-PP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
conditions	condition	NNS	B-NP	O

Computer	Computer	NN	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
protein	protein	NN	I-NP	I
P1	P1	NN	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
binding	binding	NN	I-NP	O
domain	domain	NN	I-NP	O
displays	display	VBZ	B-VP	O
high	high	JJ	B-NP	O
homology	homology	NN	I-NP	O
(	(	(	O	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
identity	identity	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
similarity	similarity	NN	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
animal	animal	NN	I-NP	O
virus	virus	NN	I-NP	O
proteins	protein	NNS	I-NP	O
which	which	WDT	B-NP	O
possess	possess	VBP	B-VP	O
RNA	RNA	NN	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
vaccinia	BEGIN-vaccinia	NN	B-NP	B
virus	virus	NN	I-NP	I
E1L	E1L-INSIDE	NN	I-NP	I
;	;	:	O	O
rotavirus	BEGIN-rotavirus	NN	B-NP	B
VP1	VP1-INSIDE	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
proteins	protein	NNS	I-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
function	function	NN	I-NP	O
(	(	(	O	O
murine	BEGIN-murine	JJ	B-NP	B
TIK	TIK-INSIDE	NN	I-NP	I
;	;	:	O	O
rotavirus	BEGIN-rotavirus	NN	B-NP	B
NS1	NS1-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
likely	likely	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
binding	binding	NN	I-NP	O
proteins	protein	NNS	I-NP	O

C	BEGIN-C	NN	B-NP	B
/	/	SYM	O	I
EBP	EBP	NN	B-NP	I
delta	delta-INSIDE	NN	I-NP	I
(	(	(	O	O
NFIL	BEGIN-NFBEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
beta	beta-INSIDE	NN	I-NP	I
)	)	)	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
complexes	complex	NNS	B-NP	O
utilizing	utilize	VBG	B-VP	O
extracts	extract	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
nonproducing	nonproducing	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O

Noise	Noise	NN	B-NP	O
in	in	IN	B-PP	O
STM	STM	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
atoms	atom	NNS	B-NP	O
moving	move	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tunneling	tunneling	NN	I-NP	O
space	space	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
mutations	mutation	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
element	element	NN	I-NP	O
that	that	WDT	B-NP	O
disrupted	disrupt	VBD	B-VP	O
a	a	DT	B-NP	O
GC	GC	NN	I-NP	O
box	box	NN	I-NP	O
located	located	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
inverse	inverse	JJ	I-NP	O
strand	strand	NN	I-NP	O
eliminated	eliminate	VBD	B-VP	O
PMA	PMA	NN	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
in	in	IN	B-PP	O
gel	gel	NN	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
eliminated	eliminate	VBD	B-VP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
Sp1	BEGIN-Sp1-INSIDE	NN	B-NP	B

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	O
casein	BEGIN-casein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
II	II-INSIDE	NN	I-NP	I
(	(	(	O	O
CKII	BEGIN-CKII-INSIDE	NN	B-NP	B
)	)	)	O	O
site	site	NN	B-NP	O
and	and	CC	O	O
,	,	,	O	O
using	use	VBG	B-VP	O
purified	purify	VBN	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
and	and	CC	I-NP	O
mutant	mutant	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
CKII	BEGIN-BEGIN-CKII-INSIDE	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
complex	complex	NN	I-NP	O
-	-	HYPH	O	O
forming	form	VBG	B-VP	O
region	region	NN	B-NP	O

Down	Down	RB	B-ADVP	O
-	-	HYPH	O	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
Id1	BEGIN-Id1	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
mitogenesis	mitogenesis	NN	B-NP	O
and	and	CC	O	O
occurred	occur	VBD	B-VP	O
when	when	WRB	B-ADVP	O
quiescent	quiescent	JJ	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
growth	growth	NN	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
activate	activate	VBP	B-VP	O
G	BEGIN-G	NN	B-NP	B
protein	protein	NN	I-NP	I
-	-	HYPH	B-NP	I
coupled	couple	VBN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
receptor	BEGIN-receptor	NN	I-NP	B
protein	protein	NN	I-NP	I
tyrosine	tyrosine	NN	I-NP	I
kinases	kinases-INSIDE	NN	I-NP	I
but	but	CC	B-PP	O
not	not	RB	B-PP	O
with	with	IN	I-PP	O
a	a	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
mitogenic	mitogenic	JJ	I-NP	O
cAMP	cAMP	NN	I-NP	O
analog	analog	NN	I-NP	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
adaptive	adaptive	JJ	B-NP	O
processes	process	NNS	I-NP	O
following	follow	VBG	B-PP	O
spinal	spinal	JJ	B-NP	O
cord	cord	NN	I-NP	O
injury	injury	NN	I-NP	O
,	,	,	O	O
unstructured	unstructured	JJ	B-NP	O
audiotaped	audiotaped	JJ	I-NP	O
interviews	interview	NNS	I-NP	O
were	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
almost	almost	RB	I-NP	O
daily	daily	JJ	I-NP	O
basis	basis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
divorced	divorce	VBN	B-VP	O
male	male	JJ	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
comprehensive	comprehensive	JJ	I-NP	O
inpatient	inpatient	NN	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O

Cloning	Cloning	NN	B-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
flanking	flanking	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
ATP	ATP	NN	I-NP	I
-	-	HYPH	B-NP	I
citrate	citrate	NN	I-NP	I
lyase	lyase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
broad	broad	JJ	I-NP	O
range	range	NN	I-NP	O
protein	BEGIN-protein	NN	I-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O
genistein	genistein	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
phosphatidylinositol	BEGIN-phosphatidylinositol	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
inhibitors	inhibitor	NNS	I-NP	O
wortmannin	wortmannin	NN	I-NP	O
and	and	CC	O	O
LY	LY	NN	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
morpholinyl	morpholinyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
phenyl	phenyl	NN	I-NP	O
-	-	HYPH	B-NP	O
1H	1H	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
benzopyran	benzopyran	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
one	one	CD	I-NP	O
)	)	)	O	O
also	also	RB	B-ADVP	O
blocked	block	VBD	B-VP	O
adenosine	BEGIN-adenosine	NN	B-NP	B
A1	A1	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
/	/	SYM	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
MAPK	MAPK	NN	I-NP	O

Defective	Defective	JJ	B-NP	O
concanavalin	BEGIN-concanavalin	NN	I-NP	B
A	A-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
suppression	suppression	NN	I-NP	O
in	in	IN	B-PP	O
bancroftian	bancroftian	JJ	B-NP	O
filariasis	filariasis	NN	I-NP	O

Rising	Rise	VBG	B-NP	O
antibody	antibody	NN	I-NP	O
titres	titre	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
astrovirus	astrovirus	NN	I-NP	O
particles	particle	NNS	I-NP	O
were	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
child	child	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
IgM	BEGIN-IgM-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
serum	serum	NN	I-NP	O

Demonstration	Demonstration	NN	B-NP	O
of	of	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
fetal	fetal	JJ	B-NP	O
liver	liver	NN	I-NP	O
erythropoiesis	erythropoiesis	NN	I-NP	O
using	use	VBG	B-VP	O
echo	echo	AFX	B-NP	O
-	-	HYPH	I-NP	O
planar	planar	JJ	I-NP	O
magnetic	magnetic	JJ	I-NP	O
resonance	resonance	NN	I-NP	O
imaging	imaging	NN	I-NP	O

Conversely	Conversely	RB	B-ADVP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
bioavailability	bioavailability	NN	B-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Reference	Reference	NN	I-NP	O
patch	patch	NN	I-NP	O
the	the	DT	B-NP	O
release	release	NN	I-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
fast	fast	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
E1	E1	NN	I-NP	O
peak	peak	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
Cmax	Cmax	NN	I-NP	O
in	in	IN	B-PP	O
average	average	NN	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O

Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
radiation	radiation	NN	B-NP	O
nephropathy	nephropathy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O

Reaction	Reaction	NN	B-NP	O
of	of	IN	B-PP	O
aromatic	aromatic	JJ	B-NP	O
/	/	SYM	I-NP	O
heterocyclic	heterocyclic	JJ	I-NP	O
sulfonamides	sulfonamide	NNS	I-NP	O
possessing	possess	VBG	B-VP	O
free	free	JJ	B-NP	O
amino	amino	NN	I-NP	O
,	,	,	O	O
imino	imino	NN	B-NP	O
or	or	CC	O	O
hydrazino	hydrazino	NN	B-NP	O
moieties	moiety	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
chloro	chloro	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
chloromethylcoumarin	chloromethylcoumarin	NN	I-NP	O
afforded	afford	VBD	B-VP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
N	N	NN	B-NP	O
-	-	HYPH	O	O
[	[	(	O	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
chloro	chloro	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
coumarinyl	coumarinyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
methyl	methyl	NN	I-NP	O
]	]	)	O	O
-	-	HYPH	B-NP	O
derivatives	derivative	NNS	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
effective	effective	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
carbonic	BEGIN-carbonic	JJ	I-NP	B
anhydrase	anhydrase-INSIDE	NN	I-NP	I
(	(	(	O	O
CA	BEGIN-CA-INSIDE	NN	B-NP	B
)	)	)	O	O
isozymes	isozyme	NNS	B-NP	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
also	also	RB	B-ADVP	O
emphasizes	emphasize	VBZ	B-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
of	of	IN	B-PP	O
establishing	establish	VBG	B-VP	O
dose	dose	NN	B-NP	O
-	-	HYPH	B-NP	O
response	response	NN	I-NP	O
curves	curve	NNS	I-NP	O
to	to	TO	B-VP	O
correctly	correctly	RB	I-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
steroid	BEGIN-steroid	NN	B-NP	B
hormone	hormone	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O

(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
described	describe	VBN	B-VP	O
optic	optic	JJ	B-NP	O
nerve	nerve	NN	I-NP	O
degenerations	degeneration	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Alzheimer	Alzheimer	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
Sadun	Sadun	NNP	B-NP	O
published	publish	VBD	B-VP	O
a	a	DT	B-NP	O
dropout	dropout	NN	I-NP	O
of	of	IN	B-PP	O
retinal	retinal	JJ	B-NP	O
ganglion	ganglion	NN	I-NP	O
cells	cell	NNS	I-NP	O
that	that	WDT	B-NP	O
range	range	VBP	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
interactions	interaction	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
consequently	consequently	RB	B-ADVP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
,	,	,	O	O
governing	govern	VBG	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
CTF	BEGIN-CTF-INSIDE	NN	B-NP	B
are	be	VBP	B-VP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
mediating	mediate	VBG	I-NP	O
DNA	DNA	NN	I-NP	O
replication	replication	NN	I-NP	O

These	These	DT	B-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
called	call	VBN	B-VP	O
variant	BEGIN-variant	JJ	B-NP	B
surface	surface	NN	I-NP	I
glycoproteins	glycoproteins-INSIDE	NN	I-NP	I
(	(	(	O	O
VSGs	BEGIN-VSGs-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
locus	locus	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
VSG	BEGIN-VSG	NN	I-NP	B
gene	gene	NN	I-NP	I
expression	expression	NN	I-NP	I
site	site	NN	I-NP	I
(	(	(	O	I
ES	ES	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
temporal	temporal	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
immunoreactive	BEGIN-immunoreactive	JJ	B-NP	B
atrial	atrial	JJ	I-NP	I
natriuretic	natriuretic	JJ	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
iANF	BEGIN-iANF-INSIDE	NN	B-NP	B
)	)	)	O	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
conscious	conscious	JJ	I-NP	O
dogs	dog	NNS	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
arteriovenous	arteriovenous	JJ	I-NP	O
(	(	(	O	O
AV	AV	NN	B-NP	O
)	)	)	O	O
fistula	fistula	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
output	output	NN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O

In	In	FW	B-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
of	of	IN	B-PP	O
whole	whole	JJ	B-NP	O
-	-	HYPH	I-NP	O
mount	mount	NN	I-NP	O
mouse	mouse	NN	I-NP	O
embryos	embryo	NNS	I-NP	O
with	with	IN	B-PP	O
Mex1	BEGIN-BEGIN-Mex1-INSIDE	NN	B-NP	B
antisense	antisense	JJ	I-NP	O
RNA	RNA-INSIDE	NN	I-NP	I
provide	provide	VBP	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
exclusion	exclusion	NN	I-NP	O
of	of	IN	B-PP	O
Mex1	BEGIN-Mex1-INSIDE	NN	B-NP	B
during	during	IN	B-PP	O
embryonic	embryonic	JJ	B-NP	O
development	development	NN	I-NP	O

Karyo	Karyo	NNP	B-NP	O
-	-	:	O	O
and	and	CC	O	O
cytometric	cytometric	JJ	B-NP	O
investigations	investigation	NNS	I-NP	O
of	of	IN	B-PP	O
cortical	cortical	JJ	B-NP	O
layer	layer	NN	I-NP	O
V	V	NN	I-NP	O
pyramidal	pyramidal	JJ	I-NP	O
neurons	neuron	NNS	I-NP	O
of	of	IN	B-PP	O
albino	albino	NN	B-NP	O
rat	rat	NN	I-NP	O
after	after	IN	B-PP	O
three	three	CD	B-NP	O
various	various	JJ	I-NP	O
fixations	fixation	NNS	I-NP	O

The	The	DT	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
apo	BEGIN-apo	JJ	I-NP	B
B	B	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE-INSIDE	NN	B-NP	I
has	have	VBZ	B-VP	O
provided	provide	VBN	I-VP	O
new	new	JJ	B-NP	O
insights	insight	NNS	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	I-NP	O
physicochemical	physicochemical	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
apo	BEGIN-apo	NN	B-NP	B
B	B	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
will	will	MD	B-VP	O
facilitate	facilitate	VB	I-VP	O
studies	study	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
factors	factor	NNS	I-NP	O
modulating	modulate	VBG	B-VP	O
apo	BEGIN-apo	JJ	B-NP	B
B	B	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
biosynthesis	biosynthesis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
apo	BEGIN-BEGIN-apo	JJ	I-NP	B
B	B	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
dyslipoproteinemias	dyslipoproteinemia	NNS	B-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
green	green	JJ	I-NP	O
unicellular	unicellular	JJ	I-NP	O
alga	alga	NN	I-NP	O
Chlamydomonas	Chlamydomonas	NN	I-NP	O
eugametos	eugameto	NNS	I-NP	O
,	,	,	O	O
cellular	cellular	JJ	B-NP	O
division	division	NN	I-NP	O
is	be	VBZ	B-VP	O
readily	readily	RB	I-VP	O
synchronized	synchronize	VBN	I-VP	O
by	by	IN	B-PP	O
light	light	NN	B-NP	O
/	/	SYM	B-NP	O
dark	dark	JJ	I-NP	O
cycles	cycle	NNS	I-NP	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
linked	link	VBN	B-VP	O
Plk	BEGIN-Plk-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
and	and	CC	I-NP	O
tissues	tissue	NNS	I-NP	O

A	A	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
month	month	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
boy	boy	NN	I-NP	O
with	with	IN	B-PP	O
Sandifer	Sandifer	NNP	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O

A	A	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
chloramphenicol	BEGIN-chloramphenicol	NN	B-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
four	four	CD	B-NP	O
tandem	tandem	JJ	I-NP	O
repeats	repeat	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SNE	BEGIN-SNE-INSIDE	NN	I-NP	B
could	could	MD	B-VP	O
be	be	VB	I-VP	O
induced	induce	VBN	I-VP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
(	(	(	O	O
and	and	CC	O	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
fold	fold	RB	B-ADVP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
after	after	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
TPA	TPA	NN	B-NP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
-	-	HYPH	O	O
transfected	transfecte	VBN	B-NP	O
U	U	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
stimulation	stimulation	NN	I-NP	O
appeared	appear	VBD	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
true	true	JJ	I-NP	O
protein	BEGIN-protein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
event	event	NN	I-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
a	a	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
response	response	NN	I-NP	O

A	A	DT	B-NP	O
silica	silica	NN	I-NP	O
-	-	HYPH	B-VP	O
based	base	VBN	I-VP	O
,	,	,	O	O
fluoride	fluoride	NN	B-NP	O
-	-	HYPH	O	O
free	free	JJ	B-NP	O
placebo	placebo	NN	I-NP	O
containing	contain	VBG	B-VP	O
NaTPP	NaTPP	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
NaF	NaF	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
silica	silica	NN	B-NP	O
-	-	HYPH	O	O
based	base	VBN	B-NP	O
USP	USP	NN	I-NP	O
reference	reference	NN	I-NP	O
standard	standard	JJ	I-NP	O
toothpaste	toothpaste	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
negative	negative	JJ	B-NP	O
and	and	CC	I-NP	O
positive	positive	JJ	I-NP	O
control	control	NN	I-NP	O
toothpastes	toothpaste	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

Molecular	Molecular	JJ	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
-	-	HYPH	B-NP	I
globin	globin	NN	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
CP1	BEGIN-CP1-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
tries	try	VBZ	B-VP	O
to	to	TO	I-VP	O
associate	associate	VB	I-VP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
hot	hot	JJ	B-NP	O
ischaemia	ischaemia	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
agony	agony	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
corpse	corpse	NN	I-NP	O
donor	donor	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
those	those	DT	B-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
sympathetic	sympathetic	JJ	B-NP	O
efference	efference	NN	I-NP	O
during	during	IN	B-PP	O
removal	removal	NN	B-NP	O

The	The	DT	B-NP	O
cost	cost	NN	I-NP	O
and	and	CC	I-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
nurse	nurse	NN	B-NP	O
education	education	NN	I-NP	O
-	-	HYPH	B-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O

Between	Between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
children	child	NNS	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
myeloid	myeloid	JJ	I-NP	O
leukaemia	leukaemia	NN	I-NP	O
(	(	(	O	O
AML	AML	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Research	Research	NNP	I-NP	O
Council	Council	NNP	I-NP	O
Acute	Acute	NNP	I-NP	O
Myeloid	Myeloid	NNP	I-NP	O
Leukaemia	Leukaemia	NNP	I-NP	O
Trial	Trial	NNP	I-NP	O
(	(	(	O	O
MRC	MRC	NN	B-NP	O
AML1	AML1	NN	I-NP	O
)	)	)	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
hybrid	hybrid	NN	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
RING	RING	NN	I-NP	O
finger	finger	NN	I-NP	O
(	(	(	O	O
C1HC1	C1HC1	NN	B-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
)	)	)	O	O
protein	protein	NN	B-NP	O
,	,	,	O	O
TIF1	BEGIN-TIF1	NN	B-NP	B
beta	beta-INSIDE	NN	I-NP	I
(	(	(	O	O
also	also	RB	B-ADVP	O
named	name	VBN	B-VP	O
KAP	BEGIN-KAP	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
that	that	WDT	B-NP	O
specifically	specifically	RB	B-ADVP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
KRAB	BEGIN-KRAB	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
factor	factor	NN	I-NP	O
KOX1	BEGIN-KOX1-INSIDE	NN	I-NP	B
/	/	SYM	O	O
ZNF1	BEGIN-ZNF1-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
isoforms	isoform	NNS	B-NP	O
beta	beta	SYM	B-NP	O
to	to	TO	B-PP	O
epsilon	epsilon	NN	B-NP	O
contain	contain	VBP	B-VP	O
a	a	DT	B-NP	O
PEST	PEST	NN	I-NP	O
region	region	NN	I-NP	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
induce	induce	VB	I-VP	O
rapid	rapid	JJ	B-NP	O
intracellular	intracellular	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
isoforms	isoform	NNS	B-NP	O
beta	beta	SYM	B-NP	O
and	and	CC	O	O
delta	delta	SYM	B-NP	O

Their	Their	PRP$	B-NP	O
central	central	JJ	I-NP	O
projections	projection	NNS	I-NP	O
were	be	VBD	B-VP	O
indistinguishable	indistinguishable	JJ	B-ADJP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
axons	axon	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
trigeminal	trigeminal	JJ	I-NP	O
subnuclei	subnuclei	NNS	I-NP	O

Typicality	Typicality	NN	B-NP	O
is	be	VBZ	B-VP	O
probably	probably	RB	B-ADVP	O
a	a	DT	B-NP	O
better	good	JJR	I-NP	O
representation	representation	NN	I-NP	O
of	of	IN	B-PP	O
Alexander	Alexander	NNP	B-NP	O
,	,	,	O	O
Dunbar	Dunbar	NNP	B-NP	O
and	and	CC	O	O
others	other	NNS	B-NP	O
'	'	POS	B-NP	O
conclusions	conclusion	NNS	I-NP	O
than	than	IN	B-PP	O
specificity	specificity	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
always	always	RB	B-ADVP	O
too	too	RB	B-NP	O
absolute	absolute	JJ	I-NP	O
a	a	DT	I-NP	O
term	term	NN	I-NP	O

We	We	PRP	B-NP	O
then	then	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
yeast	yeast	NN	I-NP	O
artificial	artificial	JJ	I-NP	O
chromosome	chromosome	NN	I-NP	O
(	(	(	O	O
YAC	YAC	NN	B-NP	O
)	)	)	O	O
contig	contig	NN	B-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
TAK1	BEGIN-TAK1-INSIDE	NN	B-NP	B
,	,	,	O	O
TGF	BEGIN-TGF	NN	B-NP	B
-	-	HYPH	O	I
beta	beta-INSIDE	NN	B-NP	I
also	also	RB	B-ADVP	O
stimulated	stimulate	VBD	B-VP	O
JNK	BEGIN-JNK-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
BSI	BSI	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
recommendations	recommendation	NNS	B-NP	O
for	for	IN	B-PP	O
testing	test	VBG	B-VP	O
restorative	restorative	JJ	B-NP	O
materials	material	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
report	report	NN	I-NP	O

Sixteen	Sixteen	CD	B-NP	O
patients	patient	NNS	I-NP	O
on	on	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
dialysis	dialysis	NN	B-NP	O
with	with	IN	B-PP	O
either	either	CC	O	O
cuprophane	cuprophane	NN	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
or	or	CC	O	O
polymethylmethacrylate	polymethylmethacrylate	NN	B-NP	O
(	(	(	O	O
PMMA	PMMA	NN	B-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
membranes	membrane	NNS	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
opposite	opposite	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
week	week	NN	I-NP	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
ET	BEGIN-ET-INSIDE	NN	I-NP	B
levels	level	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
and	and	CC	I-NP	O
peripheral	peripheral	JJ	I-NP	O
sampling	sampling	NN	I-NP	O
sites	site	NNS	I-NP	O
(	(	(	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
atrium	atrium	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
artery	artery	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vein	vein	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
fmol	fmol	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
:	:	:	O	O
N.S.	N.S.	NNP	B-NP	O
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
among	among	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
uncomplicated	uncomplicated	JJ	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
fmol	fmol	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
fmol	fmol	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O

Oxalates	Oxalate	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
digestive	digestive	JJ	I-NP	O
tract	tract	NN	I-NP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MCV	BEGIN-MCV	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
RPO1	RPO1-INSIDE	NN	I-NP	I
revealed	reveal	VBD	B-VP	O
high	high	JJ	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
homologies	homology	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
polypeptides	polypeptide	NNS	I-NP	O
of	of	IN	B-PP	O
vaccinia	vaccinia	NN	B-NP	O
and	and	CC	I-NP	O
variola	variola	NN	I-NP	O
virus	virus	NN	I-NP	O

This	This	DT	B-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
functional	functional	JJ	B-ADJP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
retargeting	retargeting	NN	B-NP	O
of	of	IN	B-PP	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
p1	BEGIN-p1-INSIDE	NN	I-NP	B
from	from	IN	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O

Point	Point	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
of	of	IN	B-PP	O
Stat1	BEGIN-Stat1-INSIDE	NN	B-NP	B
within	within	IN	B-PP	O
the	the	DT	B-NP	O
interacting	interact	VBG	I-NP	O
domains	domain	NNS	I-NP	O
blocked	block	VBD	B-VP	O
both	both	CC	O	O
physical	physical	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
Stat1	BEGIN-Stat1-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Jun	Jun-INSIDE	NN	I-NP	I
and	and	CC	O	O
their	their	PRP$	B-NP	O
cooperation	cooperation	NN	I-NP	O
in	in	IN	B-PP	O
IL	BEGIN-IL	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
transcription	transcription	NN	I-NP	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
alpha	BEGIN-alpha	NN	I-NP	B
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
-	-	HYPH	B-NP	I
macroglobulin	macroglobulin	NN	I-NP	I
enhancer	enhancer-INSIDE	NN	I-NP	I

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
masked	mask	VBN	B-NP	O
toxins	toxin	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
exotoxin	exotoxin	NN	I-NP	O
complex	complex	NN	I-NP	O
of	of	IN	B-PP	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
pyogenes	pyogene	NNS	I-NP	O
und	und	VBP	B-VP	O
Cl.	Cl.	NNP	B-NP	O
perfringens	perfringen	NNS	I-NP	O
;	;	:	O	O
significance	significance	NN	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
existence	existence	NN	I-NP	O
for	for	IN	B-PP	O
clarifying	clarifying	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
masking	masking	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O

Correlation	Correlation	NN	B-NP	O
coefficients	coefficient	NNS	I-NP	O
between	between	IN	B-PP	O
SF	SF	NN	B-NP	O
thickness	thickness	NN	I-NP	O
and	and	CC	O	O
NIR	NIR	NN	B-NP	O
optical	optical	JJ	I-NP	O
density	density	NN	I-NP	O
readings	reading	NNS	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
nm	nm	NN	I-NP	O
(	(	(	O	O
OD1	OD1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
nm	nm	NN	I-NP	O
(	(	(	O	O
OD1	OD1	NN	B-NP	O
)	)	)	O	O
wavelengths	wavelength	NNS	B-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
subscapula	subscapula	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
biceps	bicep	NNS	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
OD1	OD1	NN	B-NP	O
and	and	CC	I-NP	O
r	r	NN	I-NP	O
=	=	SYM	B-VP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
axilla	axilla	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
biceps	bicep	NNS	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
OD1	OD1	NN	B-NP	O

Transfer	Transfer	NN	B-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
care	care	NN	I-NP	O
to	to	TO	B-PP	O
natives	native	NNS	B-NP	O
holds	hold	VBZ	B-VP	O
much	much	JJ	B-NP	O
promise	promise	NN	I-NP	O
,	,	,	O	O
lecturers	lecturer	NNS	B-NP	O
say	say	VBP	B-VP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
babies	baby	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
gestational	gestational	JJ	B-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
haptoglobin	BEGIN-haptoglobin-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
infants	infant	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
levels	level	NNS	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
dl	dl	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O

The	The	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
picture	picture	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
light	light	NN	I-NP	O
and	and	CC	I-NP	O
electron	electron	NN	I-NP	O
microscopic	microscopic	JJ	I-NP	O
appearance	appearance	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
histochemical	histochemical	JJ	I-NP	O
findings	finding	NNS	I-NP	O
are	be	VBP	B-VP	O
described	describe	VBN	I-VP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
fibroma	fibroma	NN	B-NP	O
of	of	IN	B-PP	O
tendon	tendon	NN	B-NP	O
sheath	sheath	NN	I-NP	O

We	We	PRP	B-NP	O
hypothesize	hypothesize	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
acidic	acidic	JJ	I-NP	O
activators	activator	NNS	I-NP	O
to	to	TO	B-VP	O
specifically	specifically	RB	I-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
initiation	initiation	NN	I-NP	O
complex	complex	NN	I-NP	O
likely	likely	RB	B-ADVP	O
underlies	underlie	VBZ	B-VP	O
the	the	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
functional	functional	JJ	I-NP	O
synergy	synergy	NN	I-NP	O
exhibited	exhibit	VBN	B-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
activation	activation	NN	B-NP	O
domains	domain	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

High	High	JJ	B-NP	O
and	and	CC	I-NP	O
pathological	pathological	JJ	I-NP	O
PAI	BEGIN-PAI	NN	I-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
the	the	DT	B-NP	O
VO	VO	NNP	I-NP	O
test	test	NN	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
defective	defective	JJ	I-NP	O
fibrinolytic	fibrinolytic	JJ	I-NP	O
potential	potential	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
PAI	BEGIN-PAI	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	B-NP	I
on	on	IN	B-PP	O
plasminogen	BEGIN-plasminogen-INSIDE	NN	B-NP	B
activation	activation	NN	I-NP	O

S.	S.	FW	B-NP	O
aureus	aureus	FW	I-NP	O
leakage	leakage	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
totally	totally	RB	I-NP	O
submerged	submerged	JJ	I-NP	O
test	test	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
samples	sample	NNS	I-NP	O
incubated	incubate	VBN	B-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
no	no	DT	B-NP	O
leakage	leakage	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
specimens	specimen	NNS	B-NP	O
incubated	incubate	VBN	B-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
weeks	week	NNS	I-NP	O

MAPKK	BEGIN-BEGIN-MAPK-INSIDEK	NN	B-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
MEKK	BEGIN-BEGIN-MEK-INSIDEK-INSIDE	NN	I-NP	B
phosphorylates	phosphorylate	VBZ	B-VP	O
and	and	CC	I-VP	O
activates	activate	VBZ	I-VP	O
its	its	PRP$	B-NP	O
downstream	downstream	JJ	I-NP	O
protein	protein	NN	I-NP	O
kinase	kinase	NN	I-NP	O
,	,	,	O	O
MAPK	BEGIN-BEGIN-MAPK-INSIDE	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
MEK	BEGIN-MEK-INSIDE	NN	I-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
activates	activate	VBZ	B-VP	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
Prompt	Prompt	NNP	I-NP	O
and	and	CC	I-NP	O
Praise	Praise	NNP	I-NP	O
condition	condition	NN	I-NP	O
was	be	VBD	B-VP	O
superior	superior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
two	two	CD	I-NP	O
conditions	condition	NNS	I-NP	O
in	in	IN	B-PP	O
encouraging	encouraging	JJ	B-NP	O
participation	participation	NN	I-NP	O
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
interest	interest	NN	I-NP	O
recreational	recreational	JJ	I-NP	O
activities	activity	NNS	I-NP	O

The	The	DT	B-NP	O
author	author	NN	I-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
technique	technique	NN	I-NP	O
in	in	IN	B-PP	O
detail	detail	NN	B-NP	O
and	and	CC	O	O
presents	present	VBZ	B-VP	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
men	man	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
women	woman	NNS	I-NP	O
)	)	)	O	O
examined	examine	VBN	B-VP	O
for	for	IN	B-PP	O
suspected	suspect	VBN	B-NP	O
ileostomy	ileostomy	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
Crohn	Crohn	NNP	I-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
or	or	CC	O	O
ileal	ileal	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
remote	remote	VB	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
stoma	stoma	NN	I-NP	O

Biochemical	Biochemical	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
a	a	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
non	BEGIN-non	NN	I-NP	B
-	-	HYPH	O	I
P	P	NN	B-NP	I
element	element	NN	I-NP	I
-	-	HYPH	B-VP	I
encoded	encode	VBN	B-NP	I
DNA	DNA	NN	I-NP	I
binding	binding	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
,	,	,	O	O
termed	term	VBN	B-VP	O
the	the	DT	B-NP	O
inverted	BEGIN-inverted	JJ	I-NP	B
repeat	repeat	NN	I-NP	I
binding	binding	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
IRBP	BEGIN-IRBP-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
that	that	WDT	B-NP	O
specifically	specifically	RB	B-ADVP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
outer	outer	JJ	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
terminal	terminal	JJ	I-NP	O
inverted	inverted	JJ	I-NP	O
repeats	repeat	NNS	I-NP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
eIF1	BEGIN-eIF1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
eIF1beta	BEGIN-eIF1-INSIDEbeta	NN	I-NP	I
interaction	interaction	NN	I-NP	O
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
eIF1	BEGIN-eIF1-INSIDE	NN	B-NP	B
function	function	NN	I-NP	O
in	in	IN	B-PP	O
eukaryotic	eukaryotic	JJ	B-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
delayed	delay	VBN	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prostaglandin	BEGIN-prostaglandin	NN	I-NP	B
G	G	NN	I-NP	I
/	/	SYM	B-VP	I
H	H	NN	B-NP	I
synthase	synthase	NN	I-NP	I
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
promoter	promoter	NN	I-NP	O
in	in	IN	B-PP	O
bovine	bovine	JJ	B-NP	O
granulosa	granulosa	NN	I-NP	O
cells	cell	NNS	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
down	down	RB	B-ADVP	O
-	-	HYPH	O	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
truncated	truncate	VBN	B-NP	O
upstream	BEGIN-upstream	JJ	I-NP	B
stimulatory	stimulatory	JJ	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

Nb1	Nb1	NN	B-NP	O
-	-	HYPH	I-NP	O
1C	1C	NN	I-NP	O
cells	cell	NNS	I-NP	O
expressed	express	VBD	B-VP	O
three	three	CD	B-NP	O
PNR	BEGIN-PNR	NN	I-NP	B
-	-	HYPH	O	I
related	relate	VBN	B-NP	I
mRNA	mRNA	NN	I-NP	I
transcripts	transcripts-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O

E1A	BEGIN-E1A-INSIDE	NN	B-NP	B
+	+	SYM	I-NP	O
cHa	BEGIN-cHa	NN	I-NP	B
-	-	HYPH	I-NP	I
ras	ras-INSIDE	NN	I-NP	I
transformed	transform	VBN	I-NP	O
rat	rat	NN	I-NP	O
embryo	embryo	NN	I-NP	O
fibroblast	fibroblast	NN	I-NP	O
cells	cell	NNS	I-NP	O
are	be	VBP	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
and	and	CC	I-NP	O
constitutive	constitutive	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
AP	BEGIN-AP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
dimers	dimers-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
significantly	significantly	RB	B-NP	O
altered	alter	VBN	I-NP	O
composition	composition	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
Southern	Southern	JJ	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
to	to	TO	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
that	that	IN	B-SBAR	O
TSG1	BEGIN-TSG1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
copy	copy	NN	I-NP	O
gene	gene	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
and	and	CC	I-NP	O
murine	murine	JJ	I-NP	O
species	specie	NNS	I-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
Latanoprost	Latanoprost	RB	B-VP	O
administered	administer	VBN	I-VP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
IOP	IOP	NN	B-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
unoprostone	unoprostone	NN	B-NP	O
administered	administer	VBN	B-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
POAG	POAG	NN	B-NP	O
and	and	CC	O	O
OH	OH	NN	B-NP	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
UV	UV	NN	B-NP	O
must	must	MD	B-VP	O
therefore	therefore	RB	I-VP	O
involve	involve	VB	I-VP	O
additional	additional	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
processes	process	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
those	those	DT	B-NP	O
triggered	trigger	VBN	B-VP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
damage	damage	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
generation	generation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
response	response	NN	I-NP	O

One	One	CD	B-NP	O
promoter	promoter	NN	I-NP	O
,	,	,	O	O
p1P1	BEGIN-p1P1-INSIDE	NN	B-NP	B
,	,	,	O	O
is	be	VBZ	B-VP	O
located	located	JJ	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
noncoding	noncoding	JJ	I-NP	O
first	first	JJ	I-NP	O
exon	exon	NN	I-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
,	,	,	I-NP	O
stronger	strong	JJR	I-NP	O
promoter	promoter	NN	I-NP	O
,	,	,	O	O
p1P1	BEGIN-p1P1-INSIDE	NN	B-NP	B
,	,	,	O	O
maps	map	VBZ	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
intron	intron	NN	I-NP	O

Hydropathy	Hydropathy	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
deduced	deduce	VBN	B-NP	O
A1	A1	NN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
four	four	CD	B-NP	O
putative	putative	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
-	-	HYPH	O	O
spanning	span	VBG	B-VP	O
alpha	alpha	SYM	B-NP	O
-	-	HYPH	B-VP	O
helices	helix	NNS	B-NP	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
includes	include	VBZ	B-VP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
treated	treat	VBN	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
age	age	NN	I-NP	O
range	range	NN	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
required	require	VBD	B-VP	O
1	1	CD	B-NP	O
generators	generator	NNS	I-NP	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
little	little	JJ	B-NP	O
similarity	similarity	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
upstream	upstream	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
CAP	CAP	NN	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Spec1	BEGIN-Spec1	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
except	except	IN	B-PP	O
the	the	DT	B-NP	O
TATA	TATA	NN	I-NP	O
consensus	consensus	NN	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
repeating	repeating	NN	I-NP	O
trinucleotide	trinucleotide	NN	I-NP	O
,	,	,	O	O
AAC	AAC	NN	B-NP	O

Radiological	Radiological	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
UGI	UGI	NN	B-NP	O
series	series	NN	I-NP	O
and	and	CC	O	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
useful	useful	JJ	B-ADJP	O
to	to	TO	B-VP	O
arrive	arrive	VB	I-VP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
accurate	accurate	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O

A	A	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
acquired	acquire	VBN	B-NP	O
immune	immune	JJ	I-NP	O
deficiency	deficiency	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
before	before	IN	B-PP	O
1	1	CD	B-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
promoters	promoter	NNS	I-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
immediate	BEGIN-immediate	JJ	I-NP	B
early	early	JJ	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
including	include	VBG	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
fos	fos-INSIDE	NN	I-NP	I
,	,	,	O	O
CArG	CArG	NN	B-NP	O
DNA	DNA	NN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
elements	element	NNS	I-NP	O
mediate	mediate	VBP	B-VP	O
basal	basal	JJ	B-NP	O
constituitive	constituitive	JJ	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
rapid	rapid	JJ	B-NP	O
and	and	CC	I-NP	O
transient	transient	JJ	I-NP	O
serum	serum	NN	I-NP	O
induction	induction	NN	I-NP	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
optimal	optimal	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gD	BEGIN-gD	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
ICP1	BEGIN-ICP1-INSIDE	NN	B-NP	B
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
and	and	CC	O	O
cellular	cellular	JJ	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
recognize	recognize	VBP	B-VP	O
specific	specific	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
elements	element	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O

Strains	Strain	NNS	B-NP	O
lacking	lack	VBG	B-VP	O
a	a	DT	B-NP	O
functional	BEGIN-functional	JJ	I-NP	B
RPL1A	RPL1A	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
grow	grow	NN	I-NP	O
as	as	RB	B-ADVP	O
rapidly	rapidly	RB	I-ADVP	O
as	as	IN	B-PP	O
wild	wild	JJ	B-NP	O
type	type	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
those	those	DT	B-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
null	null	JJ	I-NP	O
allele	allele	NN	I-NP	O
of	of	IN	B-PP	O
RPL1B	BEGIN-RPL1B-INSIDE	NN	B-NP	B
grow	grow	VBP	B-VP	O
more	more	RBR	B-ADVP	O
slowly	slowly	RB	I-ADVP	O
than	than	IN	B-PP	O
wild	wild	JJ	B-NP	O
type	type	NN	I-NP	O

Maduromycosis	Maduromycosis	NNP	B-NP	O
in	in	IN	B-PP	O
Italy	Italy	NNP	B-NP	O

Cetn1	BEGIN-Cetn1-INSIDE	NN	B-NP	B
possesses	possess	VBZ	B-VP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
expressed	express	VBN	I-NP	O
retroposon	retroposon	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
lacks	lack	VBZ	B-VP	O
introns	intron	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
interrupted	interrupt	VBN	I-VP	O
by	by	IN	B-PP	O
stop	stop	NN	B-NP	O
codons	codon	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
coding	coding	NN	I-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
flanked	flank	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
pair	pair	NN	I-NP	O
of	of	IN	B-PP	O
direct	direct	JJ	B-NP	O
repeats	repeat	NNS	I-NP	O

Substitutions	Substitution	NNS	B-NP	O
of	of	IN	B-PP	O
Asp1	Asp1	NN	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
dominant	dominant	JJ	B-NP	O
lethality	lethality	NN	I-NP	O

The	The	DT	B-NP	O
Sty1	BEGIN-Sty1	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
stress	stress	NN	I-NP	O
conditions	condition	NNS	I-NP	O
including	include	VBG	B-PP	O
osmotic	osmotic	JJ	B-NP	O
and	and	CC	I-NP	O
oxidative	oxidative	JJ	I-NP	O
stress	stress	NN	I-NP	O
and	and	CC	I-NP	O
heat	heat	NN	I-NP	O
shock	shock	NN	I-NP	O

Acute	Acute	JJ	B-NP	O
toxicity	toxicity	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
first	first	JJ	B-NP	O
instar	instar	NN	I-NP	O
Toxorhynchites	Toxorhynchite	NNS	I-NP	O
splendens	splenden	VBZ	B-VP	O
to	to	TO	B-PP	O
commonly	commonly	RB	B-NP	O
used	use	VBN	I-NP	O
mosquito	mosquito	NN	I-NP	O
adulticides	adulticide	NNS	I-NP	O
:	:	:	O	O
malathion	malathion	NN	B-NP	O
,	,	,	O	O
naled	nale	VBD	B-VP	O
and	and	CC	O	O
resmethrin	resmethrin	NN	B-NP	O

We	We	PRP	B-NP	O
prospectively	prospectively	RB	B-ADVP	O
studied	study	VBD	B-VP	O
serum	BEGIN-serum	NN	B-NP	B
prolactin	prolactin-INSIDE	NN	I-NP	I
(	(	(	O	O
PRL	BEGIN-PRL-INSIDE	NN	B-NP	B
)	)	)	O	O
elevation	elevation	NN	B-NP	O
after	after	IN	B-PP	O
different	different	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
documented	document	VBN	B-NP	O
seizures	seizure	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O

To	To	TO	B-VP	O
further	further	RB	I-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
residues	residue	NNS	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
the	the	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
viruses	virus	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
neutralized	neutralize	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
soluble	soluble	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
MHV	BEGIN-MHV	NN	B-NP	B
receptor	receptor	NN	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
,	,	,	O	O
since	since	IN	B-SBAR	O
such	such	JJ	B-NP	O
mutants	mutant	NNS	I-NP	O
were	be	VBD	B-VP	O
expected	expect	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
amino	amino	JJ	B-NP	O
acids	acid	NNS	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
receptor	receptor	NN	B-NP	O
-	-	HYPH	O	O
binding	binding	NN	B-NP	O
activity	activity	NN	I-NP	O

When	When	WRB	B-ADVP	O
lipid	lipid	NN	B-NP	O
X	X	NN	I-NP	O
was	be	VBD	B-VP	O
combined	combine	VBN	I-VP	O
with	with	IN	B-PP	O
ticarcillin	ticarcillin	NN	B-NP	O
,	,	,	O	O
survival	survival	NN	B-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
both	both	CC	O	O
significant	significant	JJ	B-NP	O
and	and	CC	I-NP	O
prolonged	prolonged	JJ	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
stress	stress	NN	I-NP	O
responses	response	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
pronounced	pronounced	JJ	I-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
recover	recover	VB	I-VP	O
from	from	IN	B-PP	O
them	them	PRP	B-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
impaired	impair	VBN	I-VP	O
in	in	IN	B-PP	O
exposed	expose	VBN	B-NP	O
fish	fish	NNS	I-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
unexposed	unexposed	JJ	B-NP	O
fish	fish	NNS	I-NP	O

Focal	Focal	JJ	B-NP	O
glomerulosclerosis	glomerulosclerosis	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
nephrotic	nephrotic	JJ	B-NP	O
syndrome	syndrome	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
horse	horse	NN	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
activated	activate	VBD	B-VP	O
Ral	BEGIN-Ral	JJ	B-NP	B
-	-	HYPH	I-NP	I
GDS	GDS	NN	I-NP	I
-	-	HYPH	I-NP	I
like	like-INSIDE	NN	I-NP	I
factor	factor	NN	I-NP	O
and	and	CC	O	O
Raf	BEGIN-Raf-INSIDE	NN	B-NP	B
stimulate	stimulate	VBP	B-VP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
D	D	NN	I-NP	I
(	(	(	O	I
1	1	CD	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
transcription	transcription	NN	I-NP	O
and	and	CC	O	O
E1F	BEGIN-E1F-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
and	and	CC	O	O
act	act	VBP	B-VP	O
in	in	IN	B-PP	O
synergy	synergy	NN	B-NP	O
with	with	IN	B-PP	O
PI	BEGIN-PI	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I

Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
polyinosinic	polyinosinic	JJ	B-NP	O
-	-	HYPH	I-NP	O
polycytidylic	polycytidylic	JJ	I-NP	O
acid	acid	NN	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
Cre	BEGIN-Cre-INSIDE	NN	B-NP	B
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
complete	complete	JJ	B-NP	O
disruption	disruption	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Arnt	BEGIN-Arnt	JJ	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
ARNT	BEGIN-ARNT	JJ	B-NP	B
messenger	messenger	NN	I-NP	I
RNA	RNA-INSIDE	NN	I-NP	I
(	(	(	O	O
mRNA	mRNA	NN	B-NP	O
)	)	)	O	O
expression	expression	NN	B-NP	O
in	in	IN	B-PP	O
liver	liver	NN	B-NP	O

Twelve	Twelve	CD	B-NP	O
patients	patient	NNS	I-NP	O
of	of	IN	B-PP	O
leprosy	leprosy	NN	B-NP	O
with	with	IN	B-PP	O
arthritis	arthritis	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
without	without	IN	B-PP	O
arthritis	arthritis	NN	B-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
for	for	IN	B-PP	O
immunological	immunological	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
like	like	IN	B-PP	O
immunoglobulins	BEGIN-immunoglobulins-INSIDE	NN	B-NP	B
(	(	(	O	O
IgG	BEGIN-IgG-INSIDE	NN	B-NP	B
,	,	,	O	O
IgM	BEGIN-IgM-INSIDE	NN	B-NP	B
,	,	,	O	O
IgA	BEGIN-IgA-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
C	BEGIN-C	NN	B-NP	B
-	-	HYPH	B-NP	I
reactive	reactive	JJ	I-NP	I
proteins	proteins-INSIDE	NN	I-NP	I
and	and	CC	O	O
rheumatoid	BEGIN-rheumatoid	JJ	B-NP	B
factor	factor-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
biological	biological	JJ	I-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
rat	rat	NN	B-NP	O
surfactant	BEGIN-surfactant	JJ	I-NP	B
protein	protein	NN	I-NP	I
A	A-INSIDE	NN	I-NP	I
(	(	(	O	O
SP	BEGIN-SP	NN	B-NP	B
-	-	HYPH	B-NP	I
A	A-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
an	an	DT	B-NP	O
oligomer	oligomer	NN	I-NP	O
composed	compose	VBN	B-VP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
subunits	subunit	NNS	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
intact	intact	JJ	B-NP	O
disulfide	disulfide	NN	I-NP	O
bonds	bond	NNS	I-NP	O

DIC	DIC	NN	B-NP	O
and	and	CC	I-NP	O
low	low	JJ	I-NP	O
grade	grade	NN	I-NP	O
fibrinolysis	fibrinolysis	NN	I-NP	O
may	may	MD	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
coagulation	coagulation	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O

All	All	DT	B-NP	O
depressive	depressive	JJ	I-NP	O
groups	group	NNS	I-NP	O
showed	show	VBD	B-VP	O
improved	improved	JJ	B-NP	O
error	error	NN	I-NP	O
measures	measure	NNS	I-NP	O
post	post	AFX	O	O
-	-	HYPH	O	O
treatment	treatment	NN	B-NP	O

Plasmid	Plasmid	NN	B-NP	O
subclones	subclone	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hr1a	BEGIN-hr1a-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
AcMNPV	AcMNPV	NN	B-NP	O
HindIII	BEGIN-HindIII-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
N	N	NN	I-NP	O
fragment	fragment	NN	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
replicate	replicate	VB	I-VP	O
in	in	IN	B-PP	O
virus	virus	NN	B-NP	O
-	-	HYPH	O	O
infected	infect	VBN	B-VP	O
(	(	(	O	O
Spodoptera	Spodoptera	NN	B-NP	O
frugiperda	frugiperda	NN	I-NP	O
)	)	)	O	O
Sf1	Sf1	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
stimulate	stimulate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
when	when	WRB	B-ADVP	O
linked	link	VBN	B-VP	O
in	in	IN	B-PP	O
cis	cis	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
1K	BEGIN-1K	NN	I-NP	B
gene	gene	NN	I-NP	I
promoter	promoter	NN	I-NP	I
-	-	HYPH	B-NP	I
beta	beta	SYM	I-NP	I
-	-	HYPH	I-NP	I
glucuronidase	glucuronidase	NN	I-NP	I
fusion	fusion-INSIDE	NN	I-NP	I
and	and	CC	O	O
cotransfected	cotransfecte	VBN	B-VP	O
into	into	IN	B-PP	O
cells	cell	NNS	B-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	O
(	(	(	O	O
ple	ple	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
trans	trans	AFX	I-NP	O
-	-	HYPH	I-NP	O
acting	act	VBG	I-NP	O
factor	factor	NN	I-NP	O
IE	BEGIN-IE	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

This	This	DT	B-NP	O
new	new	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
,	,	,	O	O
TOR	BEGIN-TOR-INSIDE	NN	B-NP	B
(	(	(	O	O
thymus	BEGIN-thymus	NN	B-NP	B
orphan	orphan	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
closely	closely	RB	I-ADJP	O
related	related	JJ	I-ADJP	O
in	in	IN	B-PP	O
both	both	CC	O	O
its	its	PRP$	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	I-VP	O
domain	domain	NN	B-NP	O
and	and	CC	I-NP	O
ligand	ligand	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-PP	O
ROR	BEGIN-ROR	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
/	/	SYM	B-VP	O
RZR	BEGIN-RZR	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
and	and	CC	O	O
clusters	cluster	NNS	B-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
receptors	receptor	NNS	I-NP	O
and	and	CC	O	O
RZR	BEGIN-RZR	NN	B-NP	B
beta	beta-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
a	a	DT	B-NP	O
phylogenetic	phylogenetic	JJ	I-NP	O
tree	tree	NN	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
both	both	CC	O	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ligand	ligand	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
domain	domain	NN	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
receptors	receptor	NNS	I-NP	O
are	be	VBP	B-VP	O
compared	compare	VBN	I-VP	O

Immunofluorescence	Immunofluorescence	NN	B-NP	O
tests	test	NNS	I-NP	O
for	for	IN	B-PP	O
Borrelia	BEGIN-Borrelia	FW	B-NP	B
burgdorferi	burgdorferi	FW	I-NP	I
serum	serum	NN	I-NP	I
antibodies	antibodies-INSIDE	NN	I-NP	I
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
G	G	NN	B-NP	O
-	-	HYPH	B-NP	O
penicillin	penicillin	NN	I-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
ineffective	ineffective	JJ	B-ADJP	O

Laser	Laser	NN	B-NP	O
soldering	solder	VBG	B-VP	O
with	with	IN	B-PP	O
exogenous	exogenous	JJ	B-NP	O
fibrinogen	BEGIN-fibrinogen-INSIDE	NN	I-NP	B
is	be	VBZ	B-VP	O
feasible	feasible	JJ	B-ADJP	O
without	without	IN	B-PP	O
topical	topical	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
additional	additional	JJ	B-NP	O
clotting	clotting	NN	I-NP	O
agents	agent	NNS	I-NP	O
,	,	,	O	O
significantly	significantly	RB	B-VP	O
improves	improve	VBZ	I-VP	O
the	the	DT	B-NP	O
bursting	burst	VBG	I-NP	O
strength	strength	NN	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
laser	laser	NN	I-NP	O
welded	weld	VBD	B-VP	O
anastomoses	anastomosis	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
result	result	VB	I-VP	O
from	from	IN	B-PP	O
urokinase	BEGIN-urokinase-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
resistant	resistant	JJ	I-NP	O
fibrinogen	BEGIN-fibrinogen-INSIDE	NN	I-NP	B
cross	cross	AFX	O	O
-	-	HYPH	O	O
linking	link	VBG	B-VP	O

Raman	Raman	NNP	B-NP	O
scattering	scatter	VBG	B-VP	O
from	from	IN	B-PP	O
VO1	VO1	NN	B-NP	O
single	single	JJ	I-NP	O
crystals	crystal	NNS	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
surface	surface	NN	B-NP	O
oxidation	oxidation	NN	I-NP	O

Left	Leave	VBN	B-NP	O
ventricular	ventricular	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
requires	require	VBZ	B-VP	O
two	two	CD	B-NP	O
SP	SP	NN	I-NP	O
/	/	SYM	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
results	result	NNS	I-NP	O
in	in	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
p.	p.	NN	I-NP	O
cent	cent	NN	I-NP	O

Overexpression	Overexpression	NN	B-NP	O
of	of	IN	B-PP	O
wild	wild	JJ	B-NP	O
type	type	NN	I-NP	O
and	and	CC	I-NP	O
SeCys	SeCys	NN	I-NP	O
/	/	SYM	B-NP	O
Cys	Cys	NN	I-NP	O
mutant	mutant	NN	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
thioredoxin	thioredoxin	NN	I-NP	I
reductase	reductase-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
selenocysteine	selenocysteine	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
activity	activity	NN	I-NP	O

1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
foreign	foreign	JJ	B-NP	O
protein	protein	NN	I-NP	O
production	production	NN	I-NP	O

A	A	DT	B-NP	O
rare	rare	JJ	I-NP	O
tRNA	BEGIN-tRNA	NN	I-NP	B
-	-	HYPH	O	I
Arg	Arg	NN	B-NP	I
(	(	(	O	I
CCU	CCU	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
that	that	WDT	B-NP	O
regulates	regulate	VBZ	B-VP	O
Ty1	BEGIN-BEGIN-Ty1-INSIDE	NN	B-NP	B
element	element-INSIDE	NN	I-NP	I
ribosomal	ribosomal	JJ	I-NP	O
frameshifting	frameshifting	NN	I-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
Ty1	BEGIN-Ty1-INSIDE	NN	B-NP	B
retrotransposition	retrotransposition	NN	I-NP	O
in	in	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
putative	putative	JJ	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
for	for	IN	B-PP	O
SH1	BEGIN-SH1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
SH1	BEGIN-BEGIN-SH1-INSIDE	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
molecule	molecule	NN	I-NP	O

The	The	DT	B-NP	O
technique	technique	NN	I-NP	O
used	use	VBN	B-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
system	system	NN	I-NP	O
involves	involve	VBZ	B-VP	O
a	a	DT	B-NP	O
transient	transient	JJ	I-NP	O
,	,	,	O	O
externally	externally	RB	B-VP	O
applied	apply	VBD	I-VP	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
breathing	breathing	NN	B-NP	O

Copyright	Copyright	NN	B-NP	O
1	1	CD	I-NP	O
Academic	Academic	NNP	I-NP	O
Press	Press	NNP	I-NP	O

Vorozole	Vorozole	NN	B-NP	O
(	(	(	O	O
Rivizor	Rivizor	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
and	and	CC	I-NP	O
stereospecific	stereospecific	JJ	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
aromatase	BEGIN-aromatase-INSIDE	NN	B-NP	B
having	have	VBG	B-VP	O
shown	show	VBN	I-VP	O
promising	promising	JJ	B-NP	O
endocrine	endocrine	JJ	I-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
phase	phase	NN	B-NP	O
I	I	CD	I-NP	O
studies	study	NNS	I-NP	O

Mapping	Map	VBG	B-VP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
termini	terminus	NNS	I-NP	O
of	of	IN	B-PP	O
TED	BEGIN-TED	JJ	B-NP	B
RNAs	RNAs-INSIDE	NN	I-NP	I
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
LTRs	LTR	NNS	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
retroviral	retroviral	JJ	I-NP	O
U1	U1	NN	I-NP	O
-	-	HYPH	B-NP	O
R	R	NN	I-NP	O
-	-	HYPH	B-NP	O
U1	U1	NN	I-NP	O
structural	structural	JJ	I-NP	O
organization	organization	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
directing	direct	VBG	B-VP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
transcripts	transcript	NNS	B-NP	O
that	that	WDT	B-NP	O
represent	represent	VBP	B-VP	O
potential	potential	JJ	B-NP	O
substrates	substrate	NNS	I-NP	O
for	for	IN	B-PP	O
reverse	reverse	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
and	and	CC	O	O
intermediates	intermediate	NNS	B-NP	O
in	in	IN	B-PP	O
transposition	transposition	NN	B-NP	O

A	A	DT	B-NP	O
Meis1	BEGIN-Meis1	NN	I-NP	B
cDNA	cDNA-INSIDE	NN	I-NP	I
clone	clone	NN	I-NP	O
that	that	WDT	B-NP	O
encoded	encode	VBD	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
homeobox	BEGIN-homeobox	NN	I-NP	B
gene	gene	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O

Cellular	Cellular	JJ	B-NP	O
lysates	lysate	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
for	for	IN	B-PP	O
luciferase	BEGIN-luciferase-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	B-NP	I
galactosidase	galactosidase-INSIDE	NN	I-NP	I
activities	activity	NNS	I-NP	O

The	The	DT	B-NP	O
protein	protein	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
SHAQKYF	SHAQKYF	NN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
signature	signature	NN	I-NP	O
motif	motif	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
myb	BEGIN-myb	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
repeat	repeat-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
recently	recently	RB	B-NP	O
identified	identify	VBN	I-NP	O
plant	BEGIN-plant	NN	I-NP	B
myb	myb	NN	I-NP	I
-	-	HYPH	B-NP	I
related	relate	VBN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
thus	thus	RB	B-ADVP	O
defining	define	VBG	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
plant	plant	NN	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
proteins	protein	NNS	B-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
sphincter	sphincter	NN	B-NP	O
length	length	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
with	with	IN	B-PP	O
age	age	NN	B-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
mm.	mm.	NN	I-NP	O
,	,	,	O	O
maximal	maximal	JJ	B-NP	O
urethral	urethral	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
cm.	cm.	NN	I-NP	O
water	water	NN	I-NP	O
and	and	CC	O	O
maximal	maximal	JJ	B-NP	O
urethral	urethral	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
during	during	IN	B-PP	O
voluntary	voluntary	JJ	B-NP	O
contraction	contraction	NN	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
cm.	cm.	NN	I-NP	O
water	water	NN	I-NP	O

The	The	DT	B-NP	O
DF1	BEGIN-DF1-INSIDE	NN	I-NP	B
/	/	SYM	I-NP	O
MUC1	BEGIN-MUC1-INSIDE	NN	I-NP	B
gene	gene	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
high	BEGIN-high	JJ	I-NP	B
molecular	molecular	JJ	I-NP	I
weight	weight	NN	I-NP	I
mucin	mucin	NN	I-NP	I
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
glycoprotein	glycoprotein-INSIDE	NN	I-NP	I
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
overexpressed	overexpresse	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
level	level	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancers	cancer	NNS	I-NP	O

A	A	DT	B-NP	O
cephalothoracophagus	cephalothoracophagus	NN	I-NP	O
disymmetros	disymmetros	NN	I-NP	O
buffalo	buffalo	NN	I-NP	O
calf	calf	NN	I-NP	O

In	In	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
performance	performance	NN	I-NP	O
test	test	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
submaximal	submaximal	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
(	(	(	O	O
VO1	VO1	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
[	[	(	O	O
bpm	bpm	NN	B-NP	O
]	]	)	O	O
)	)	)	O	O
was	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
another	another	DT	B-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
physical	physical	JJ	B-NP	O
performance	performance	NN	I-NP	O
capacity	capacity	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
from	from	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
ventilatory	ventilatory	JJ	I-NP	O
threshold	threshold	NN	I-NP	O

Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
KP	KP	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
preparation	preparation	NN	I-NP	O
usually	usually	RB	B-ADVP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
partial	partial	JJ	B-NP	O
regression	regression	NN	I-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
reappearance	reappearance	NN	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
picture	picture	NN	I-NP	O
and	and	CC	O	O
biochemical	biochemical	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O

Electromobility	Electromobility	NN	B-NP	O
shift	shift	NN	I-NP	O
analysis	analysis	NN	I-NP	O
using	use	VBG	B-VP	O
oligonucleotides	oligonucleotide	NNS	B-NP	O
encompassing	encompass	VBG	B-VP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
,	,	,	I-NP	O
distal	distal	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
BED	BED	VBN	B-VP	O
/	/	SYM	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
regions	region	NNS	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
selective	selective	JJ	B-NP	O
transactivation	transactivation	NN	I-NP	O
after	after	IN	B-PP	O
CD1	BEGIN-CD1-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O
of	of	IN	B-PP	O
LPMC	LPMC	NN	B-NP	O

Four	Four	CD	B-NP	O
families	family	NNS	I-NP	O
of	of	IN	B-PP	O
homing	BEGIN-homing	JJ	B-NP	B
endonucleases	endonucleases-INSIDE	NN	I-NP	I
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
LAGLIDADG	BEGIN-LAGLIDADG-INSIDE	NN	I-NP	B
,	,	,	O	O
the	the	DT	B-NP	O
His	BEGIN-His	NN	I-NP	B
-	-	HYPH	B-NP	I
Cys	Cys	NN	I-NP	I
box	box-INSIDE	NN	I-NP	I
,	,	,	O	O
the	the	DT	B-NP	O
GIY	BEGIN-GIY	NN	I-NP	B
-	-	HYPH	B-NP	I
YIG	YIG-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
H	BEGIN-H	NN	I-NP	B
-	-	HYPH	B-NP	I
N	N	NN	I-NP	I
-	-	HYPH	I-NP	I
H	H	NN	I-NP	I
endonucleases	endonucleases-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
aluminum	aluminum	NN	B-NP	O
hydroxide	hydroxide	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
fecal	fecal	JJ	B-NP	O
fluoride	fluoride	NN	I-NP	O
excretion	excretion	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
net	net	JJ	B-NP	O
absorption	absorption	NN	I-NP	O
of	of	IN	B-PP	O
fluoride	fluoride	NN	B-NP	O
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intake	intake	JJ	I-NP	O
fluoride	fluoride	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
,	,	,	O	O
phosphorus	phosphorus	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
magnesium	magnesium	NN	B-NP	O

Administration	Administration	NN	B-NP	O
of	of	IN	B-PP	O
SnCl1	SnCl1	NN	B-NP	O
and	and	CC	O	O
ZnSO1	ZnSO1	NN	B-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
V	V	NN	I-NP	O
)	)	)	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
ALA	BEGIN-ALA	NN	B-NP	B
-	-	HYPH	B-NP	I
D	D-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
CP	CP	NN	B-NP	O
-	-	HYPH	O	O
U	U	NN	B-NP	O

Coexistence	Coexistence	NN	B-NP	O
of	of	IN	B-PP	O
Turner	Turner	NNP	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	I-NP	O
schizophrenia	schizophrenia	NN	I-NP	O

A	A	DT	B-NP	O
selectable	selectable	JJ	I-NP	O
marker	marker	NN	I-NP	O
for	for	IN	B-PP	O
transformation	transformation	NN	B-NP	O
was	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
by	by	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
fusion	fusion	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Ustilago	BEGIN-Ustilago	JJ	I-NP	B
maydis	maydis	NN	I-NP	I
heat	heat	NN	I-NP	I
shock	shock	NN	I-NP	I
gene	gene	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hygromycin	BEGIN-hygromycin	NN	I-NP	B
B	B	NN	I-NP	I
phosphotransferase	phosphotransferase	NN	I-NP	I
gene	gene	NN	I-NP	I
of	of	IN	B-PP	I
Escherichia	Escherichia	NN	B-NP	I
coli	coli-INSIDE	NN	I-NP	I

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
FACT	BEGIN-FACT-INSIDE	NN	B-NP	B
specifically	specifically	RB	B-ADVP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
nucleosomes	nucleosome	NNS	B-NP	O
and	and	CC	O	O
histone	histone	NN	B-NP	O
H1A	BEGIN-H1A-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
H1B	BEGIN-H1B-INSIDE	NN	I-NP	B
dimers	dimer	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
work	work	VB	I-VP	O
by	by	IN	B-PP	O
promoting	promote	VBG	B-VP	O
nucleosome	nucleosome	NN	B-NP	O
disassembly	disassembly	NN	I-NP	O
upon	upon	IN	B-PP	O
transcription	transcription	NN	B-NP	O

All	All	DT	B-NP	O
exon	exon	NN	I-NP	O
/	/	SYM	I-NP	O
intron	intron	NN	I-NP	O
splice	splice	NN	I-NP	O
junctions	junction	NNS	I-NP	O
follow	follow	VBP	B-VP	O
the	the	DT	B-NP	O
GT	GT	NN	I-NP	O
/	/	SYM	B-VP	O
AG	AG	NN	B-NP	O
rule	rule	NN	I-NP	O

Acetoacetate	BEGIN-Acetoacetate	NN	B-NP	B
decarboxylase	decarboxylase-INSIDE	NN	I-NP	I
(	(	(	O	O
ADC	BEGIN-ADC-INSIDE	NN	B-NP	B
)	)	)	O	O
(	(	(	O	O
EC1.1	BEGIN-EC1.1-INSIDE	NN	B-NP	B
)	)	)	O	O
of	of	IN	B-PP	O
Clostridium	Clostridium	NN	B-NP	O
acetobutylicum	acetobutylicum	NN	I-NP	O
DSM	DSM	NN	I-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
purified	purify	VBN	I-VP	O
to	to	TO	B-PP	O
homogeneity	homogeneity	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
first	first	JJ	I-NP	O
1	1	CD	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
tandem	tandem	JJ	B-NP	O
alpha	alpha	SYM	I-NP	O
-	-	HYPH	I-NP	O
helices	helix	NNS	B-NP	O
located	locate	VBN	B-VP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminus	terminus	NN	I-NP	O
of	of	IN	B-PP	O
PC	BEGIN-PC	NN	B-NP	B
-	-	HYPH	B-NP	I
TP	TP-INSIDE	NN	I-NP	I
facilitate	facilitate	VBP	B-VP	O
membrane	membrane	NN	B-NP	O
binding	binding	NN	I-NP	O
and	and	CC	I-NP	O
extraction	extraction	NN	I-NP	O
of	of	IN	B-PP	O
phosphatidylcholines	phosphatidylcholine	NNS	B-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
Tax	BEGIN-Tax-INSIDE	NN	B-NP	B
activates	activate	VBZ	B-VP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
conjunction	conjunction	NN	B-NP	O
with	with	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ATF	BEGIN-ATF-INSIDE	NN	I-NP	B
/	/	SYM	B-VP	O
CREB	BEGIN-CREB-INSIDE	NN	B-NP	B
family	family	NN	I-NP	O

Repression	Repression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
herpes	BEGIN-herpes	NN	I-NP	B
simplex	simplex	NN	I-NP	I
virus	virus	NN	I-NP	I
1	1	CD	I-NP	I
alpha	alpha	SYM	I-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
(	(	(	O	O
ICP1	BEGIN-ICP1-INSIDE	NN	B-NP	B
)	)	)	O	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
genome	genome	NN	I-NP	O
is	be	VBZ	B-VP	O
conditioned	condition	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
distance	distance	NN	I-NP	O
and	and	CC	I-NP	O
stereoaxial	stereoaxial	JJ	I-NP	O
alignment	alignment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ICP1	BEGIN-BEGIN-ICP1-INSIDE	NN	I-NP	B
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
site	site-INSIDE	NN	I-NP	I
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
TATA	TATA	NN	I-NP	O
box	box	NN	I-NP	O

We	We	PRP	B-NP	O
studied	study	VBD	B-VP	O
1	1	CD	B-NP	O
dogs	dog	NNS	I-NP	O
,	,	,	O	O
anaesthetised	anaesthetise	VBN	B-VP	O
and	and	CC	O	O
spontaneously	spontaneously	RB	B-ADVP	O
breathing	breathing	NN	B-NP	O
both	both	CC	O	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	B-PP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
inhalation	inhalation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
gas	gas	NN	I-NP	O
mixture	mixture	NN	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
CO1	CO1	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
O1	O1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
N1	N1	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
histamine	histamine	NN	B-NP	O
,	,	,	O	O
serotonin	serotonin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
acidaemia	acidaemia	NN	B-NP	O
in	in	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
hypercapnia	hypercapnia	NN	B-NP	O

Disaster	Disaster	NN	B-NP	O
medicine	medicine	NN	I-NP	O

In	In	IN	B-PP	O
both	both	CC	O	O
liver	liver	NN	B-NP	O
and	and	CC	O	O
pancreatic	pancreatic	JJ	B-NP	O
islet	islet	NN	I-NP	O
,	,	,	O	O
glucokinase	BEGIN-glucokinase-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
subject	subject	JJ	B-ADJP	O
to	to	TO	B-PP	O
inhibition	inhibition	NN	B-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
protein	protein	NN	I-NP	O
(	(	(	O	O
GCKR	BEGIN-GCKR-INSIDE	NN	B-NP	B
)	)	)	O	O

At	At	IN	B-PP	O
promoters	promoter	NNS	B-NP	O
that	that	WDT	B-NP	O
initiate	initiate	VBP	B-VP	O
with	with	IN	B-PP	O
+1	+1	NN	B-NP	O
GGG	GGG	NN	I-NP	O
,	,	,	O	O
T1	BEGIN-T1	NN	B-NP	B
RNAP	RNAP-INSIDE	NN	I-NP	I
synthesizes	synthesize	VBZ	B-VP	O
a	a	DT	B-NP	O
ladder	ladder	NN	I-NP	O
of	of	IN	B-PP	O
poly	poly	NN	B-NP	O
(	(	(	O	O
G	G	NN	B-NP	O
)	)	)	O	O
products	product	NNS	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
slippage	slippage	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcript	transcript	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
C	C	JJ	I-NP	O
residues	residue	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
template	template	NN	I-NP	O
strand	strand	NN	I-NP	O
from	from	IN	B-PP	O
+1	+1	CD	B-NP	O
to	to	TO	B-PP	O
+1	+1	CD	B-NP	O

Transcription	Transcription	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
EcoRI	BEGIN-EcoRI	NN	I-NP	B
D	D	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
baculovirus	baculovirus	NN	I-NP	O
Autographa	Autographa	NN	I-NP	O
californica	californica	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
polyhedrosis	polyhedrosis	NN	I-NP	O
virus	virus	NN	I-NP	O
identifies	identify	VBZ	B-VP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kilobase	kilobase	NN	I-NP	O
RNA	RNA	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
essential	essential	JJ	I-NP	O
p1	BEGIN-p1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

Vectorcardiography	Vectorcardiography	NN	B-NP	O
in	in	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
electrocardiographic	electrocardiographic	JJ	I-NP	O
RS	RS	NN	I-NP	O
segment	segment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
V1	V1	NN	I-NP	O
lead	lead	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
second	second	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
paper	paper	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
microphthalmia	microphthalmia	NN	B-NP	O
in	in	IN	B-PP	O
sheep	sheep	NNS	B-NP	O
reported	report	VBN	B-VP	O
by	by	IN	B-PP	O
Wagenaar	Wagenaar	NNP	B-NP	O
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O
in	in	IN	B-PP	O
greater	great	JJR	B-NP	O
detail	detail	NN	I-NP	O

Both	Both	CC	O	O
the	the	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
and	and	CC	I-NP	O
venous	venous	JJ	I-NP	O
thrombi	thrombi	NN	I-NP	O
were	be	VBD	B-VP	O
clearly	clearly	RB	B-ADJP	O
discernible	discernible	JJ	I-ADJP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
injection	injection	NN	B-NP	O
of	of	IN	B-PP	O
1Tcm	1Tcm	NN	B-NP	O
-	-	HYPH	B-NP	O
SZ	SZ	NN	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O

First	First	JJ	B-NP	O
aid	aid	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
blend	blend	NN	I-NP	O
of	of	IN	B-PP	O
Metanil	Metanil	NNP	B-NP	O
yellow	yellow	NN	I-NP	O
and	and	CC	O	O
Orange	Orange	NN	B-NP	O
II	II	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
:	:	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
D1	D1	NN	I-NP	O
1.value	1.value	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O

A	A	DT	B-NP	O
novel	novel	JJ	I-NP	O
protein	BEGIN-protein	NN	I-NP	B
kinase	kinase	NN	I-NP	I
C	C-INSIDE	NN	I-NP	I
(	(	(	O	O
PKC	BEGIN-PKC-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	O	O
interacting	interact	VBG	B-VP	O
protein	protein	NN	B-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
hybrid	hybrid	NN	I-NP	O
screening	screening	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
PKC	BEGIN-BEGIN-PKC-INSIDE	NN	B-NP	B
beta	beta	NN	I-NP	O
I	I-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
a	a	DT	B-NP	O
bait	bait	NN	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
activating	activate	VBG	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
mutation	mutation	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
creating	create	VBG	B-VP	O
an	an	DT	B-NP	O
exonic	exonic	JJ	I-NP	O
splicing	splicing	NN	I-NP	O
enhancer	enhancer	NN	I-NP	O
(	(	(	O	O
ESE	ESE	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
disrupting	disrupt	VBG	B-VP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
secondary	secondary	JJ	I-NP	O
structure	structure	NN	I-NP	O

The	The	DT	B-NP	O
architecture	architecture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hRap1	BEGIN-hRap1-INSIDE	NN	I-NP	B
Myb	BEGIN-Myb	NN	I-NP	B
domain	domain-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
close	close	JJ	I-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Myb	BEGIN-Myb	NN	I-NP	B
domains	domain-INSIDE	NNS	I-NP	I
from	from	IN	B-PP	O
TRF1	BEGIN-TRF1-INSIDE	NN	B-NP	B
,	,	,	I-NP	O
scRap1p	BEGIN-scRap1p-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	O	I
Myb	Myb-INSIDE	NN	B-NP	I

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
tragically	tragically	RB	I-VP	O
highlighted	highlight	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
death	death	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
dental	dental	JJ	I-NP	O
nurse	nurse	NN	I-NP	O
after	after	IN	B-PP	O
taking	take	VBG	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
tablet	tablet	NN	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
nitrite	nitrite	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
posttranslational	posttranslational	JJ	I-NP	O
modification	modification	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gar1	BEGIN-gar1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
1S	BEGIN-1S	NN	B-NP	B
rRNA	rRNA-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
BRSV	BEGIN-BRSV	NN	I-NP	B
L	L	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
nt	nt	NN	I-NP	O
in	in	IN	B-PP	O
length	length	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
derived	derive	VBN	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
has	have	VBZ	B-VP	O
1	1	CD	B-NP	O
aa	aa	NN	I-NP	O

BRAP1	BEGIN-BRAP1-INSIDE	NN	B-NP	B
also	also	RB	B-ADVP	O
shares	share	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hypothetical	hypothetical	JJ	I-NP	O
protein	protein	NN	I-NP	O
from	from	IN	B-PP	O
yeast	yeast	NN	B-NP	O
Saccharomyces	Saccharomyces	FW	B-ADVP	O
cerevisiae	cerevisiae	FW	I-ADVP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
zinc	zinc	NN	I-NP	O
finger	finger	NN	I-NP	O
region	region	NN	I-NP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	I-VP	O
determined	determine	VBN	I-VP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
another	another	DT	B-NP	O
operon	operon	NN	I-NP	O
,	,	,	O	O
cpeCD	BEGIN-cpeCD-INSIDE	NN	B-NP	B
,	,	,	O	O
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
linker	linker	NN	I-NP	O
proteins	protein	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
phycoerythrin	BEGIN-phycoerythrin	NN	B-NP	B
hexamers	hexamers-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
phycobilisome	BEGIN-phycobilisome-INSIDE	NN	I-NP	B

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
study	study	NN	I-NP	O
aimed	aim	VBN	B-VP	O
at	at	IN	B-PP	O
identifying	identify	VBG	B-VP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
or	or	CC	O	O
genes	gene	NNS	B-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
growth	growth	NN	I-NP	O
-	-	HYPH	B-NP	O
arrest	arrest	NN	I-NP	O
response	response	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
chromosome	chromosome	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

A	A	DT	B-NP	O
novel	novel	JJ	I-NP	O
Cdc1Hs	BEGIN-Cdc1H	NNS	I-NP	B
mutant	mutant-INSIDE	NN	I-NP	I
induces	induce	VBZ	B-VP	O
cellular	cellular	JJ	B-NP	O
transformation	transformation	NN	I-NP	O

We	We	PRP	B-NP	O
identified	identify	VBD	B-VP	O
Tyr	Tyr	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
Leu	Leu	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
U1	BEGIN-U1	NN	I-NP	B
1K	1K	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
to	to	TO	B-VP	O
be	be	VB	I-VP	O
cross	cross	AFX	O	O
-	-	HYPH	O	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
G	G	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
U	U	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
stem	stem	NN	B-NP	O
-	-	HYPH	O	O
loop	loop	NN	B-NP	O
I	I	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
scallop	scallop	NN	I-NP	O
extract	extract	NN	I-NP	O
potentiated	potentiate	VBD	B-VP	O
phototactic	phototactic	JJ	B-NP	O
suppression	suppression	NN	I-NP	O

Magnetic	Magnetic	JJ	B-NP	O
field	field	NN	I-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
central	central	JJ	B-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
function	function	NN	I-NP	O

Only	Only	RB	B-NP	O
Staphylococcus	Staphylococcus	NN	I-NP	O
xylosus	xylosus	NN	I-NP	O
SX1	SX1	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
strain	strain	NN	I-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
adherence	adherence	NN	I-NP	O
activity	activity	NN	I-NP	O

Macrophages	Macrophage	NNS	B-NP	O
:	:	:	O	O
modulators	modulator	NNS	B-NP	O
of	of	IN	B-PP	O
immunity	immunity	NN	B-NP	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
Die	Die	NNP	I-NP	O
Deutsche	Deutsche	NNP	I-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Dialyse	Dialyse	NNP	I-NP	O
Studie	Studie	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
randomized	randomize	VBN	I-NP	O
placebo	placebo	NN	I-NP	O
-	-	HYPH	B-VP	O
controlled	control	VBN	B-NP	O
trial	trial	NN	I-NP	O
that	that	WDT	B-NP	O
tests	test	VBZ	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-NP	O
atorvastatin	atorvastatin	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
hydroxymethyl	BEGIN-hydroxymethyl	NN	I-NP	B
-	-	HYPH	I-NP	I
glutaryl	glutaryl	NN	I-NP	I
coenzyme	coenzyme	NN	I-NP	I
A	A	NN	I-NP	I
reductase	reductase-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
decreases	decrease	VBZ	B-VP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
cardiovascular	cardiovascular	JJ	B-NP	O
mortality	mortality	NN	I-NP	O
and	and	CC	B-PP	O
of	of	IN	B-PP	O
nonfatal	nonfatal	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
who	who	WP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
more	more	JJR	I-NP	O
than	than	IN	I-NP	O
two	two	CD	I-NP	O
years	year	NNS	I-NP	O

An	An	DT	B-NP	O
OD	OD	NN	I-NP	O
1	1	CD	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
,	,	,	I-NP	O
reliable	reliable	JJ	I-NP	O
indicator	indicator	NN	I-NP	O
of	of	IN	B-PP	O
fetal	fetal	JJ	B-NP	O
lung	lung	NN	I-NP	O
maturity	maturity	NN	I-NP	O

This	This	DT	B-NP	O
high	high	JJ	I-NP	O
dose	dose	NN	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
FU	FU	NN	I-NP	O
+	+	SYM	I-NP	O
Act	Act	NN	I-NP	O
-	-	HYPH	B-NP	O
D	D	NN	I-NP	O
protocol	protocol	NN	I-NP	O
was	be	VBD	B-VP	O
effective	effective	JJ	B-ADJP	O
for	for	IN	B-PP	O
drug	drug	NN	B-NP	O
resistant	resistant	JJ	I-NP	O
cases	case	NNS	I-NP	O
with	with	IN	B-PP	O
MEA	MEA	NN	B-NP	O
protocol	protocol	NN	I-NP	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
GCN1	BEGIN-GCN1	NN	B-NP	B
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
stimulated	stimulate	VBN	I-VP	O
posttranslationally	posttranslationally	RB	B-ADVP	O
in	in	IN	B-PP	O
amino	amino	NN	B-NP	O
acid	acid	NN	I-NP	O
-	-	HYPH	B-NP	O
starved	starve	VBN	I-NP	O
cells	cell	NNS	I-NP	O

CSEn	BEGIN-CSEn-INSIDE	NN	B-NP	B
stimulated	stimulate	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
promoters	promoter	NNS	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
hCS	BEGIN-hCS-INSIDE	NN	I-NP	B
,	,	,	O	O
human	BEGIN-human	JJ	B-NP	B
growth	growth	NN	I-NP	I
hormone	hormone-INSIDE	NN	I-NP	I
,	,	,	O	O
thymidine	BEGIN-thymidine	NN	B-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
Rous	BEGIN-Rous	JJ	B-NP	B
sarcoma	sarcoma	NN	I-NP	I
virus	virus	NN	I-NP	I
promoters	promoters-INSIDE	NN	I-NP	I
,	,	,	O	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
choriocarcinoma	choriocarcinoma	NN	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
(	(	(	O	O
BeWo	BeWo	NN	B-NP	O
and	and	CC	I-NP	O
JEG	JEG	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
HeLa	HeLa	NN	B-NP	O
cells	cell	NNS	I-NP	O
or	or	CC	O	O
rat	rat	NN	B-NP	O
somatolactotrophes	somatolactotrophe	NNS	I-NP	O
(	(	(	O	O
GC	GC	NNS	B-NP	O
)	)	)	O	O

HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
Spain	Spain	NNP	B-NP	O

Reversal	Reversal	NN	B-NP	O
of	of	IN	B-PP	O
mefloquine	mefloquine	NN	B-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
rodent	rodent	NN	B-NP	O
Plasmodium	Plasmodium	NN	I-NP	O

Airborne	Airborne	JJ	B-NP	O
rabies	raby	NNS	I-NP	O
encephalitis	encephalitis	NN	I-NP	O
:	:	:	O	O
demonstration	demonstration	NN	B-NP	O
of	of	IN	B-PP	O
rabies	raby	NNS	B-NP	O
virus	virus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
central	central	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O

No	No	DT	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
mouse	BEGIN-mouse	JJ	I-NP	B
Fli	Fli	NNP	I-NP	I
-	-	HYPH	I-NP	I
1	1	CD	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
CAT	BEGIN-CAT-INSIDE	NN	I-NP	B
constructs	construct	NNS	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
bp	bp	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
flanking	flanking	NN	I-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
exon	exon	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
intron	intron	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
retroviral	retroviral	JJ	B-NP	O
LTR	LTR	NN	I-NP	O
sequence	sequence	NN	I-NP	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
FRAP	BEGIN-FRAP-INSIDE	NN	I-NP	B
Ser1	Ser1	NN	I-NP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
Ala	Ala	NN	I-NP	O
mutant	mutant	NN	I-NP	O
displays	display	VBZ	B-VP	O
similar	similar	JJ	B-NP	O
binding	binding	NN	I-NP	O
affinity	affinity	NN	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
mutations	mutation	NNS	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
mimics	mimic	NNS	B-NP	O
of	of	IN	B-PP	O
phosphoserine	phosphoserine	NN	B-NP	O
,	,	,	O	O
abolish	abolish	JJ	B-NP	O
binding	binding	NN	I-NP	O
,	,	,	O	O
presumably	presumably	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
either	either	CC	O	O
unfavorable	unfavorable	JJ	B-NP	O
steric	steric	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
or	or	CC	O	O
induced	induce	VBN	B-NP	O
conformational	conformational	JJ	I-NP	O
changes	change	NNS	I-NP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
ribosomal	ribosomal	JJ	B-NP	O
frameshifting	frameshifting	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
PVM	PVM	NN	I-NP	O
signal	signal	NN	I-NP	O
is	be	VBZ	B-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
one	one	CD	I-NP	O
described	describe	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
'simultaneous	'simultaneous	JJ	I-NP	O
slippage	slippage	NN	I-NP	O
'	'	''	I-NP	O
model	model	NN	I-NP	O
in	in	IN	B-PP	O
that	that	IN	B-NP	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
string	string	NN	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
adenosine	adenosine	NN	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O
represents	represent	VBZ	B-VP	O
the	the	DT	B-NP	O
slippery	slippery	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
P	P	NN	I-NP	O
-	-	HYPH	O	O
site	site	NN	B-NP	O
slippage	slippage	NN	I-NP	O

The	The	DT	B-NP	O
fru	BEGIN-fru	JJ	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
has	have	VBZ	B-VP	O
seven	seven	CD	B-NP	O
exons	exon	NNS	I-NP	O
spanning	span	VBG	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
encoding	encode	VBG	B-VP	O
two	two	CD	B-NP	O
transcripts	transcript	NNS	I-NP	O
with	with	IN	B-PP	O
ORFs	ORF	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O

This	This	DT	B-NP	O
sequence	sequence	NN	I-NP	O
can	can	MD	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
proteins	protein	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
fibroblast	fibroblast	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
extract	extract	NN	I-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
binding	bind	VBG	I-VP	O
characteristics	characteristic	NNS	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
Ets	BEGIN-Ets	NN	I-NP	B
family	family	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
and	and	CC	O	O
a	a	DT	B-NP	O
serum	BEGIN-serum	NN	I-NP	B
response	response	NN	I-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
protein	protein-INSIDE	NN	I-NP	I

Response	Response	NN	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
single	single	JJ	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
accessory	accessory	JJ	I-NP	O
optic	optic	JJ	I-NP	O
system	system	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dark	dark	NN	I-NP	O
-	-	HYPH	O	O
reared	rear	VBN	B-VP	O
cat	cat	NN	B-NP	O

Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
tetracycline	tetracycline	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
glycogen	glycogen	NN	I-NP	O
-	-	HYPH	O	O
producing	produce	VBG	B-VP	O
function	function	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
and	and	CC	I-NP	O
intestinal	intestinal	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
in	in	IN	B-PP	O
white	white	JJ	B-NP	O
mice	mouse	NNS	I-NP	O

Significantly	Significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
and	and	CC	O	O
catalase	BEGIN-catalase-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
vegetarians	vegetarian	NNS	B-NP	O
(	(	(	O	O
C	C	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
mumol	mumol	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
;	;	:	O	O
CAT	CAT	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
U	U	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
for	for	IN	B-PP	O
males	male	NNS	B-NP	O
and	and	CC	I-NP	O
females	female	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
nonvegetarians	nonvegetarian	NNS	B-NP	O
(	(	(	O	O
C	C	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
mumol	mumol	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
;	;	:	O	O
CAT	CAT	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
U	U	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
only	only	RB	B-NP	O
plasma	BEGIN-plasma	NN	I-NP	B
fibrinogen	fibrinogen-INSIDE	NN	I-NP	I
concentrations	concentration	NNS	I-NP	O
showed	show	VBD	B-VP	O
statistically	statistically	RB	B-NP	O
significant	significant	JJ	I-NP	O
positive	positive	JJ	I-NP	O
associations	association	NNS	I-NP	O
with	with	IN	B-PP	O
IMT	IMT	NN	B-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O

METHODS	METHODS	NNS	B-NP	O

Presently	Presently	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
made	make	VBD	B-VP	O
chain	chain	NN	B-NP	O
pair	pair	NN	I-NP	O
switch	switch	NN	I-NP	O
,	,	,	O	O
chimeric	chimeric	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
site	site	NN	B-NP	O
mutant	BEGIN-mutant	JJ	I-NP	B
gamma	gamma	NN	I-NP	I
delta	delta	NN	I-NP	I
TCRs	TCRs-INSIDE	NN	I-NP	I
and	and	CC	O	O
transfected	transfecte	VBN	B-VP	O
them	them	PRP	B-NP	O
into	into	IN	B-PP	O
TCR	TCR	NN	B-NP	O
-	-	HYPH	B-NP	O
mutant	mutant	JJ	I-NP	O
Jurkat	Jurkat	NN	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
changing	change	VBG	B-VP	O
the	the	DT	B-NP	O
TCR	BEGIN-TCR	NN	I-NP	B
gamma	gamma	NN	I-NP	I
junctional	junctional	JJ	I-NP	I
region	region	NN	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
on	on	IN	B-PP	O
reactivity	reactivity	NN	B-NP	O
to	to	TO	B-PP	O
prenyl	BEGIN-prenyl	NN	B-NP	B
pyrophosphate	pyrophosphate	NN	I-NP	I
Ags	Ags-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
dynamics	dynamic	NNS	I-NP	O
simulations	simulation	NNS	I-NP	O
provide	provide	VBP	B-VP	O
insight	insight	NN	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
conformational	conformational	JJ	I-NP	O
flexibility	flexibility	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
analogs	analog	NNS	I-NP	O

Modified	Modified	NNP	B-NP	O
Grocott	Grocott	NNP	I-NP	O
's	's	POS	B-NP	O
methenamine	methenamine	NN	I-NP	O
silver	silver	NN	I-NP	O
nitrate	nitrate	NN	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
quick	quick	JJ	B-NP	O
staining	staining	NN	I-NP	O
of	of	IN	B-PP	O
Pneumocystis	Pneumocystis	NNP	B-NP	O
carinii	carinii	NNS	I-NP	O

The	The	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
aromatase	BEGIN-aromatase-INSIDE-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
complex	complex	JJ	B-ADJP	O
in	in	IN	B-PP	O
that	that	DT	B-NP	O
several	several	JJ	I-NP	O
promoters	promoter	NNS	I-NP	O
drive	drive	VBP	B-VP	O
aromatase	BEGIN-aromatase-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
tissue	tissue	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
manner	manner	NN	I-NP	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
Mist1	BEGIN-Mist1-INSIDE	NN	B-NP	B
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
E	E	NN	B-NP	O
-	-	HYPH	I-NP	O
boxes	box	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
Mist1	BEGIN-BEGIN-Mist1-INSIDE	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
lacks	lack	VBZ	B-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
activation	activation	NN	I-NP	O
domain	domain	NN	I-NP	O

Selective	Selective	JJ	B-NP	O
upper	upper	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
sympathectomy	sympathectomy	NN	I-NP	O
increased	increase	VBD	B-VP	O
basal	basal	JJ	B-NP	O
acid	acid	NN	I-NP	O
output	output	NN	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
effect	effect	NN	B-NP	O
on	on	IN	B-PP	O
stimulated	stimulate	VBN	B-NP	O
acid	acid	NN	I-NP	O
output	output	NN	I-NP	O
,	,	,	O	O
serum	BEGIN-serum	NN	B-NP	B
gastrin	gastrin-INSIDE	NN	I-NP	I
concentration	concentration	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
gastric	BEGIN-gastric	JJ	B-NP	B
mucosal	mucosal	JJ	I-NP	I
histidine	histidine	NN	I-NP	I
decarboxylase	decarboxylase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O

To	To	TO	B-VP	O
isolate	isolate	VB	I-VP	O
genes	gene	NNS	B-NP	O
that	that	WDT	B-NP	O
contain	contain	VBP	B-VP	O
zinc	zinc	NN	B-NP	O
finger	finger	NN	I-NP	O
motifs	motif	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	O
brain	brain	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
was	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
complementary	complementary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
``	``	``	I-NP	O
linker	linker	NN	I-NP	O
''	''	''	I-NP	O
sequence	sequence	NN	I-NP	O
between	between	IN	B-PP	O
adjacent	adjacent	JJ	B-NP	O
zinc	zinc	NN	I-NP	O
fingers	finger	NNS	I-NP	O

Transforming	BEGIN-Transforming	JJ	B-NP	B
growth	growth	NN	I-NP	I
factor	factor	NN	I-NP	I
beta	beta-INSIDE	NN	I-NP	I
activates	activate	VBZ	B-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
inhibitor	inhibitor	NN	I-NP	O
p1INK1B	BEGIN-p1INK1B-INSIDE	NN	I-NP	B
through	through	IN	B-PP	O
an	an	DT	B-NP	O
Sp1	BEGIN-Sp1	NN	I-NP	B
consensus	consensus	NN	I-NP	I
site	site-INSIDE	NN	I-NP	I

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
FAS	BEGIN-FAS	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
factor	factor	NN	B-NP	I
1	1-INSIDE	NN	I-NP	I
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
inositol	inositol	NN	I-NP	O
/	/	SYM	B-NP	O
choline	choline	NN	I-NP	O
-	-	HYPH	B-NP	O
responsive	responsive	JJ	I-NP	O
-	-	HYPH	I-NP	O
element	element	NN	I-NP	O
motif	motif	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
motif	motif	NN	I-NP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
FAS	BEGIN-FAS	JJ	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
could	could	MD	B-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O

Kluyveromyces	Kluyveromyce	NNS	B-NP	O
lactis	lactis	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
budding	bud	VBG	I-NP	O
yeast	yeast	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
grow	grow	VB	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
wider	wide	JJR	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
substrates	substrate	NNS	B-NP	O
and	and	CC	O	O
shows	show	VBZ	B-VP	O
less	less	JJR	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
glucose	glucose	NN	B-NP	O
repression	repression	NN	I-NP	O
than	than	IN	B-SBAR	O
does	do	VBZ	O	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O

Sociological	Sociological	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O

Like	Like	IN	B-PP	O
other	other	JJ	B-NP	O
known	know	VBN	I-NP	O
GCD	BEGIN-GCD	NN	I-NP	B
genes	genes-INSIDE	NN	I-NP	I
,	,	,	I-NP	O
GCD1	BEGIN-GCD1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
GCD1	BEGIN-GCD1-INSIDE	NN	I-NP	B
are	be	VBP	B-VP	O
therefore	therefore	RB	B-ADVP	O
probably	probably	RB	B-ADVP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
general	general	JJ	B-NP	O
translation	translation	NN	I-NP	O
initiation	initiation	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
GCN1	BEGIN-GCN1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
translational	translational	JJ	I-NP	O
control	control	NN	I-NP	O

Sorting	Sort	VBG	B-VP	O
information	information	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
chloroplastic	chloroplastic	JJ	I-NP	O
inner	inner	JJ	I-NP	O
envelope	envelope	NN	I-NP	O
is	be	VBZ	B-VP	O
contained	contain	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
NH1	NH1	NN	I-NP	O
-	-	HYPH	B-NP	O
proximal	proximal	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
mature	BEGIN-mature	JJ	B-NP	B
IEP1	IEP1-INSIDE	NN	I-NP	I
(	(	(	O	O
1N	BEGIN-1N-INSIDE	NN	B-NP	B
)	)	)	O	O

Both	Both	DT	B-NP	O
algorithms	algorithm	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
implemented	implement	VBN	I-VP	O
and	and	CC	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
data	datum	NNS	B-NP	O
simulated	simulate	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
scanner	scanner	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
axial	axial	JJ	I-NP	O
aperture	aperture	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
to	to	TO	B-PP	O
data	datum	NNS	B-NP	O
acquired	acquire	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
ECAT	ECAT	NN	I-NP	O
HR	HR	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ECAT	ECAT	NN	I-NP	O
HR+	HR+	JJ	I-NP	O
scanners	scanner	NNS	I-NP	O

BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
Murine	BEGIN-Murine	JJ	B-NP	B
Nramp	Nramp-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
macrophage	macrophage	NN	I-NP	O
resistance	resistance	NN	I-NP	O
gene	gene	NN	I-NP	O
Ity	BEGIN-Ity-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Lsh	BEGIN-Lsh-INSIDE	NN	I-NP	B
/	/	SYM	O	O
Bcg	BEGIN-Bcg-INSIDE	NN	B-NP	B

Serum	Serum	NN	B-NP	O
zinc	zinc	NN	I-NP	O
and	and	CC	O	O
copper	copper	NN	B-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
urine	urine	NN	B-NP	O
copper	copper	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
men	man	NNS	B-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
or	or	CC	O	O
urinary	urinary	JJ	B-NP	O
zinc	zinc	NN	I-NP	O
and	and	CC	I-NP	O
copper	copper	NN	I-NP	O
levels	level	NNS	I-NP	O
with	with	IN	B-PP	O
age	age	NN	B-NP	O

Pregnancy	Pregnancy	NN	B-NP	O
was	be	VBD	B-VP	O
ensued	ensue	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
in	in	IN	B-PP	O
group	group	NN	B-NP	O
I	I	CD	I-NP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
response	response	NN	I-NP	O
rate	rate	NN	I-NP	O
with	with	IN	B-PP	O
either	either	CC	O	O
HBA	HBA	NN	B-NP	O
+	+	SYM	O	O
VVIR	VVIR	NN	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
or	or	CC	O	O
atrioventricular	atrioventricular	JJ	B-NP	O
modifying	modify	VBG	I-NP	O
drugs	drug	NNS	I-NP	O
+	+	SYM	O	O
VVI	VVI	NN	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
will	will	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
exercise	exercise	NN	B-NP	O
duration	duration	NN	I-NP	O
and	and	CC	O	O
quality	quality	NN	B-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O

Western	Western	JJ	B-NP	O
immunoblot	immunoblot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
detected	detect	VBD	B-VP	O
p1gag	BEGIN-BEGIN-p1-INSIDEBEGIN-gag-INSIDE-INSIDE	NN	B-NP	B
and	and	CC	O	O
its	its	PRP$	B-NP	O
cleavage	cleavage	NN	I-NP	O
products	product	NNS	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
p1	BEGIN-p1-INSIDE	NN	I-NP	B
in	in	IN	B-PP	O
purified	purify	VBN	B-NP	O
particles	particle	NNS	I-NP	O
derived	derive	VBN	B-VP	O
by	by	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
gag	BEGIN-gag-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
gag	BEGIN-gag-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
pol	BEGIN-pol-INSIDE	NN	I-NP	B
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

These	These	DT	B-NP	O
three	three	CD	I-NP	O
phases	phase	NNS	I-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
association	association	NN	I-NP	O
with	with	IN	B-PP	O
chromatin	chromatin	NN	B-NP	O
may	may	MD	B-VP	O
facilitate	facilitate	VB	I-VP	O
the	the	DT	B-NP	O
diverse	diverse	JJ	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
E	E-INSIDE	NN	I-NP	I
-	-	HYPH	O	O
-	-	HYPH	O	O
Cdk1	BEGIN-Cdk1-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
initiating	initiate	VBG	B-VP	O
replication	replication	NN	B-NP	O
,	,	,	O	O
blocking	block	VBG	B-VP	O
rereplication	rereplication	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
allowing	allow	VBG	B-VP	O
resetting	reset	VBG	B-NP	O
of	of	IN	B-PP	O
origins	origin	NNS	B-NP	O
after	after	IN	B-PP	O
mitosis	mitosis	NN	B-NP	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
renin	BEGIN-renin-INSIDE	NN	B-NP	B
secretion	secretion	NN	I-NP	O
is	be	VBZ	B-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
endothelin	BEGIN-endothelin-INSIDE	NN	B-NP	B
,	,	,	O	O
a	a	DT	B-NP	O
recently	recently	RB	I-NP	O
discovered	discover	VBN	I-NP	O
peptide	peptide	NN	I-NP	O
with	with	IN	B-PP	O
strong	strong	JJ	B-NP	O
vasoconstrictive	vasoconstrictive	JJ	I-NP	O
properties	property	NNS	I-NP	O
and	and	CC	O	O
stimulating	stimulate	VBG	B-VP	O
effects	effect	NNS	B-NP	O
on	on	IN	B-PP	O
renin	BEGIN-renin-INSIDE	NN	B-NP	B
secretion	secretion	NN	I-NP	O

A	A	DT	B-NP	O
higher	high	JJR	I-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
cerebral	cerebral	JJ	B-NP	O
malaria	malaria	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
with	with	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
cerebral	cerebral	JJ	I-NP	O
malaria	malaria	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
controls	control	NNS	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
)	)	)	O	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
either	either	CC	O	O
serum	BEGIN-serum	NN	B-NP	B
ferritin	ferritin-INSIDE	NN	I-NP	I
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
and	and	CC	I-NP	O
inflammation	inflammation	NN	I-NP	O
or	or	CC	I-NP	O
sTfR	BEGIN-sTfR-INSIDE	NN	I-NP	B
>	>	SYM	B-NP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-PP	O
l	l	NN	B-NP	O
or	or	CC	O	O
both	both	DT	B-NP	O

Patients	Patient	NNS	B-NP	O
received	receive	VBD	B-VP	O
BPB	BPB	NN	B-NP	O
using	use	VBG	B-VP	O
bupivacaine	bupivacaine	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
with	with	IN	B-PP	O
adrenaline	adrenaline	NN	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
either	either	CC	B-PP	O
with	with	IN	I-PP	O
or	or	CC	B-PP	O
without	without	IN	B-PP	O
hyaluronidase	BEGIN-hyaluronidase-INSIDE	NN	B-NP	B
1	1	CD	I-NP	O
iu	iu	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
per	per	IN	B-PP	O
1	1	CD	B-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
height	height	NN	I-NP	O

The	The	DT	B-NP	O
rifampicin	rifampicin	NN	I-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
uvsW	BEGIN-uvsW-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
repressed	repress	VBN	I-NP	O
replication	replication	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
involves	involve	VBZ	B-VP	O
either	either	CC	O	O
tertiary	tertiary	JJ	B-NP	O
initiation	initiation	NN	I-NP	O
or	or	CC	O	O
some	some	DT	B-NP	O
novel	novel	JJ	I-NP	O
mode	mode	NN	I-NP	O
of	of	IN	B-PP	O
initiation	initiation	NN	B-NP	O

Association	Association	NN	B-NP	O
between	between	IN	B-PP	O
hyperhomocysteinemia	hyperhomocysteinemia	NN	B-NP	O
and	and	CC	O	O
ischemic	ischemic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
Sri	Sri	NNP	B-NP	O
Lankans	Lankans	NNP	I-NP	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
proteolipids	proteolipid	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vacuolar	BEGIN-vacuolar	JJ	I-NP	B
H+	H+	NN	I-NP	I
-	-	HYPH	B-NP	I
ATPases	ATPases-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
evolved	evolve	VBN	I-VP	O
in	in	IN	B-PP	O
parallel	parallel	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
eubacterial	eubacterial	JJ	I-NP	O
proteolipid	proteolipid	NN	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
ancestral	ancestral	JJ	I-NP	O
gene	gene	NN	I-NP	O
that	that	WDT	B-NP	O
underwent	undergo	VBD	B-VP	O
gene	gene	NN	B-NP	O
duplication	duplication	NN	I-NP	O

Coexpression	Coexpression	NN	B-NP	O
of	of	IN	B-PP	O
c	BEGIN-c	NN	B-NP	B
-	-	HYPH	B-NP	I
Rel	Rel-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
ATF	BEGIN-ATF	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
CREB1	BEGIN-CREB1-INSIDE	NN	B-NP	B
,	,	,	O	O
or	or	CC	O	O
ATF	BEGIN-ATF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	I-NP	O
CREB1	BEGIN-CREB1-INSIDE	NN	I-NP	B
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
synergistic	synergistic	JJ	B-NP	O
transactivation	transactivation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
CD1RE	BEGIN-CD1RE	NN	I-NP	B
-	-	HYPH	B-NP	I
TRE	TRE	NN	I-NP	I
reporter	reporter-INSIDE	NN	I-NP	I
plasmid	plasmid	NN	I-NP	O
in	in	IN	B-PP	O
quiescent	quiescent	JJ	B-NP	O
Jurkat	Jurkat	NN	I-NP	O
T	T	NN	I-NP	O
-	-	HYPH	I-NP	O
cells	cell	NNS	I-NP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cDNA	BEGIN-cDNA	NN	I-NP	B
encoding	encoding	NN	I-NP	I
CNN	CNN-INSIDE	NN	I-NP	I
predicts	predict	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
structural	structural	JJ	I-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
leucine	leucine	NN	I-NP	O
zipper	zipper	NN	I-NP	O
motifs	motif	NNS	I-NP	O
and	and	CC	O	O
several	several	JJ	B-NP	O
coiled	coil	VBN	I-NP	O
-	-	HYPH	I-NP	O
coil	coil	NN	I-NP	O
domains	domain	NNS	I-NP	O
exhibiting	exhibit	VBG	B-VP	O
limited	limited	JJ	B-NP	O
homology	homology	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
rod	rod	NN	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
myosin	BEGIN-myosin-INSIDE	NN	B-NP	B

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
weight	weight	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
food	food	NN	B-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
brain	brain	NN	B-NP	O
MOPEG	MOPEG	NN	I-NP	O
-	-	HYPH	B-NP	O
SO1	SO1	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
cyanamide	cyanamide	NN	B-NP	O
reflect	reflect	VBP	B-VP	O
possible	possible	JJ	B-NP	O
anorectic	anorectic	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O

The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
mineral	mineral	NN	B-NP	O
oil	oil	NN	I-NP	O
lipidosis	lipidosis	NN	I-NP	O
in	in	IN	B-PP	O
lymph	lymph	NN	B-NP	O
nodes	node	NNS	I-NP	O
with	with	IN	B-PP	O
reaction	reaction	NN	B-NP	O
to	to	TO	B-VP	O
radiopaque	radiopaque	VB	I-VP	O
oils	oil	NNS	B-NP	O
and	and	CC	O	O
Whipple	Whipple	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O

The	The	DT	B-NP	O
serum	serum	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
and	and	CC	I-NP	O
prolactin	BEGIN-prolactin-INSIDE	NN	I-NP	B
after	after	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
instillation	instillation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
suspension	suspension	NN	I-NP	O
of	of	IN	B-PP	O
vaginal	vaginal	JJ	B-NP	O
exudate	exudate	NN	I-NP	O
showed	show	VBD	B-VP	O
lower	low	JJR	B-NP	O
values	value	NNS	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
control	control	NN	B-NP	O
conditions	condition	NNS	I-NP	O
(	(	(	O	O
nasal	nasal	JJ	B-NP	O
instillation	instillation	NN	I-NP	O
of	of	IN	B-PP	O
saline	saline	NN	B-NP	O
)	)	)	O	O

This	This	DT	B-NP	O
enhancer	enhancer	NN	I-NP	O
element	element	NN	I-NP	O
functioned	function	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
position	position	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
orientation	orientation	NN	I-NP	O
-	-	HYPH	O	O
independent	independent	JJ	B-NP	O
manner	manner	NN	I-NP	O
both	both	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Pax	BEGIN-Pax	NN	I-NP	B
-	-	HYPH	B-NP	I
QNR	QNR	NN	I-NP	I
P1	P1	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
and	and	CC	O	O
the	the	DT	B-NP	O
heterologous	BEGIN-heterologous	JJ	I-NP	B
thymidine	thymidine	NN	I-NP	I
kinase	kinase	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
when	when	WRB	B-ADVP	O
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
stimulate	stimulate	VB	I-VP	O
the	the	DT	B-NP	O
collection	collection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
information	information	NN	I-NP	O
at	at	IN	B-PP	O
antenatal	antenatal	JJ	B-NP	O
or	or	CC	I-NP	O
postnatal	postnatal	JJ	I-NP	O
visits	visit	NNS	I-NP	O
,	,	,	O	O
nonetheless	nonetheless	RB	B-ADVP	O
provide	provide	VBP	B-VP	O
an	an	DT	B-NP	O
accurate	accurate	JJ	I-NP	O
description	description	NN	I-NP	O
of	of	IN	B-PP	O
under	under	IN	B-PP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
mortality	mortality	NN	I-NP	O
trends	trend	NNS	I-NP	O
and	and	CC	I-NP	O
differences	difference	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
periods	period	NNS	I-NP	O
examined	examine	VBN	B-VP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
before	before	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	O	O
before	before	IN	B-PP	O
1	1	CD	B-NP	O

The	The	DT	B-NP	O
BHV	BEGIN-BHV	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
UL1	BEGIN-UL1-INSIDE-INSIDE	NN	I-NP	I
,	,	,	O	O
UL1	BEGIN-UL1-INSIDE	NN	B-NP	B
,	,	,	O	O
UL1	BEGIN-UL1-INSIDE	NN	B-NP	B
and	and	CC	O	O
UL1	BEGIN-BEGIN-UL1-INSIDE	NN	B-NP	B
transcripts	transcripts-INSIDE	NN	I-NP	I
all	all	DT	O	O
terminated	terminate	VBN	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
polyadenylation	polyadenylation	NN	I-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
varied	vary	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
relative	relative	JJ	I-NP	O
abundance	abundance	NN	I-NP	O

A	A	DT	B-NP	O

Ligand	Ligand	NN	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
multi	multi	AFX	B-NP	O
-	-	HYPH	I-NP	O
chain	chain	NN	I-NP	O
antigen	antigen	NN	I-NP	O
receptors	receptor	NNS	I-NP	O
and	and	CC	O	O
hematopoietin	BEGIN-hematopoietin-INSIDE	NN	B-NP	B
/	/	SYM	O	O
cytokine	cytokine	NN	B-NP	O
receptors	receptor	NNS	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
protein	BEGIN-protein	NN	B-NP	B
tyrosine	tyrosine	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
PTK	BEGIN-PTK-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
signalling	signalling	NN	I-NP	O
molecules	molecule	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
phosphatidylinositol	BEGIN-phosphatidylinositol	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
PI	BEGIN-PI	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
)	)	)	O	O

Post	Post	AFX	B-NP	O
-	-	HYPH	I-NP	O
CPB	CPB	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
index	index	NN	I-NP	O
was	be	VBD	B-VP	O
superior	superior	JJ	B-ADJP	O
in	in	IN	B-PP	O
group	group	NN	B-NP	O
B	B	NN	I-NP	O
(	(	(	O	O
1+	1+	SYM	B-NP	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
vs	v	NNS	I-NP	O

The	The	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
genes	gene	NNS	I-NP	O
cnrYXH	BEGIN-cnrYXH-INSIDE	NN	I-NP	B
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
cloned	clone	VBN	I-VP	O
,	,	,	O	O
overexpressed	overexpresse	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
purified	purify	VBN	B-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O

Cognitive	Cognitive	JJ	B-NP	O
measures	measure	NNS	I-NP	O
of	of	IN	B-PP	O
attention	attention	NN	B-NP	O
included	include	VBD	B-VP	O
the	the	DT	B-NP	O
Stroop	Stroop	NNP	I-NP	O
and	and	CC	I-NP	O
Controlled	Controlled	NNP	I-NP	O
Oral	Oral	NNP	I-NP	O
Word	Word	NNP	I-NP	O
Association	Association	NNP	I-NP	O
Test	Test	NNP	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
letters	letter	NNS	I-NP	O
``	``	``	O	O
C	C	NN	B-NP	O
,	,	,	O	O
''	''	''	O	O
``	``	``	O	O
F	F	NNP	B-NP	O
,	,	,	O	O
''	''	''	O	O
and	and	CC	O	O
``	``	``	O	O
L	L	NNP	B-NP	O
''	''	''	O	O
(	(	(	O	O
COWAT	COWAT	NN	B-NP	O
,	,	,	O	O
CFL	CFL	NNP	B-NP	O
version	version	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
objectives	objective	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
quantify	quantify	VB	I-VP	O
the	the	DT	B-NP	O
comparative	comparative	JJ	I-NP	O
structural	structural	JJ	I-NP	O
static	static	JJ	I-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pointe	pointe	NN	I-NP	O
shoe	shoe	NN	I-NP	O
toe	toe	NN	I-NP	O
box	box	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
preferred	preferred	JJ	I-NP	O
shoe	shoe	NN	I-NP	O
characteristics	characteristic	NNS	I-NP	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
survey	survey	NN	I-NP	O
of	of	IN	B-PP	O
local	local	JJ	B-NP	O
dancers	dancer	NNS	I-NP	O

When	When	WRB	B-ADVP	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
herpes	herpes	NN	I-NP	O
simplex	simplex	NN	I-NP	O
thymidine	BEGIN-thymidine	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
minimal	minimal	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
fragment	fragment	NN	I-NP	O
acts	act	VBZ	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
enhancing	enhance	VBG	I-NP	O
element	element	NN	I-NP	O
in	in	IN	B-PP	O
Rcho	Rcho	NNP	B-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
GC	GC	NN	B-NP	O
cells	cell	NNS	I-NP	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
old	old	JJ	I-NP	O
-	-	HYPH	I-NP	O
male	male	JJ	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bronchogenic	bronchogenic	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
esophagus	esophagus	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
misdiagnosed	misdiagnose	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
malignant	malignant	JJ	I-NP	O
esophageal	esophageal	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
preoperative	preoperative	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
markers	marker	NNS	I-NP	O
CA	BEGIN-BEGIN-CA	NN	I-NP	B
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
CA	BEGIN-CA	NN	I-NP	B
1	1-INSIDE	NN	I-NP	I

Oscillatory	Oscillatory	JJ	B-NP	O
flow	flow	NN	I-NP	O
is	be	VBZ	B-VP	O
reestablished	reestablish	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
model	model	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
capillary	capillary	NN	I-NP	O
-	-	HYPH	B-NP	O
cerebrospinal	cerebrospinal	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
and	and	CC	I-NP	O
capillary	capillary	NN	I-NP	O
-	-	HYPH	B-NP	O
venous	venous	JJ	I-NP	O
interfaces	interface	NNS	I-NP	O

This	This	DT	B-NP	O
substrate	substrate	NN	I-NP	O
was	be	VBD	B-VP	O
cleaved	cleave	VBN	I-VP	O
efficiently	efficiently	RB	B-ADVP	O
in	in	IN	B-PP	O
trans	tran	NNS	B-NP	O
by	by	IN	B-PP	O
protease	BEGIN-protease	NN	B-NP	B
1C	1C-INSIDE	NN	I-NP	I
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
another	another	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	O
vaccinia	vaccinia	NN	I-NP	O
virus	virus	NN	I-NP	O
expressing	express	VBG	B-VP	O
a	a	DT	B-NP	O
1C	BEGIN-1C	NN	I-NP	B
precursor	precursor	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I

Human	BEGIN-Human	JJ	B-NP	B
and	and	CC	I-NP	I
murine	murine	JJ	I-NP	I
cytotoxic	cytotoxic	JJ	I-NP	I
T	T	NN	I-NP	I
lymphocyte	lymphocyte	NN	I-NP	I
serine	serine	NN	I-NP	I
proteases	proteases-INSIDE	NN	I-NP	I
:	:	:	O	O
subsite	subsite	NN	B-NP	O
mapping	mapping	NN	I-NP	O
with	with	IN	B-PP	O
peptide	peptide	NN	B-NP	O
thioester	thioester	NN	I-NP	O
substrates	substrate	NNS	I-NP	O
and	and	CC	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
enzyme	enzyme	NN	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
cytolysis	cytolysis	NN	B-NP	O
by	by	IN	B-PP	O
isocoumarins	isocoumarin	NNS	B-NP	O

The	The	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
Fc	Fc	NN	I-NP	I
gamma	gamma	NN	I-NP	I
receptor	receptor	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
Fc	BEGIN-Fc	NN	I-NP	B
gamma	gamma	NN	I-NP	I
RIIA	RIIA-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
platelets	platelet	NNS	B-NP	O
,	,	,	O	O
neutrophils	neutrophil	NNS	B-NP	O
,	,	,	O	O
monocytes	monocyte	NNS	B-NP	O
and	and	CC	O	O
macrophages	macrophage	NNS	B-NP	O

Like	Like	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
envelope	envelope	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
intranuclear	intranuclear	JJ	I-NP	O
double	double	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
lamellae	lamella	NNS	I-NP	O
enclosed	enclose	VBD	B-VP	O
a	a	DT	B-NP	O
defined	define	VBN	I-NP	O
cisterna	cisterna	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
interrupted	interrupt	VBN	I-VP	O
by	by	IN	B-PP	O
pores	pore	NNS	B-NP	O
but	but	CC	O	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
envelope	envelope	NN	I-NP	O
pores	pore	NNS	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
lacked	lack	VBD	B-VP	O
NPCs	NPC	NNS	B-NP	O

Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
stress	stress	NN	I-NP	I
response	response	NN	I-NP	I
gene	gene	NN	I-NP	I
GADD1	GADD1-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
:	:	:	O	O
role	role	NN	B-NP	O
of	of	IN	B-PP	O
ETS1	BEGIN-ETS1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
FLI	BEGIN-FLI	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene	NN	I-NP	I
products	products-INSIDE	NN	I-NP	I

On	On	IN	B-PP	O
days	day	NNS	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
postinoculation	postinoculation	NN	I-NP	O
(	(	(	O	O
PI	PI	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
all	all	DT	B-NP	O
birds	bird	NNS	I-NP	O
received	receive	VBD	B-VP	O
sheep	sheep	NN	B-NP	O
erythrocytes	erythrocyte	NNS	I-NP	O
intravenously	intravenously	RB	B-ADVP	O

The	The	DT	B-NP	O
higher	high	JJR	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
calories	calorie	NNS	B-NP	O
was	be	VBD	B-VP	O
attained	attain	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
intake	intake	NN	I-NP	O
of	of	IN	B-PP	O
carbohydrates	carbohydrate	NNS	B-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
more	more	RBR	B-NP	O
slowly	slowly	RB	I-NP	O
digested	digest	VBN	I-NP	O
starchy	starchy	JJ	I-NP	O
foods	food	NNS	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
positive	positive	JJ	B-NP	O
health	health	NN	I-NP	O
benefits	benefit	NNS	I-NP	O

Each	Each	DT	B-NP	O
receptor	receptor	NN	I-NP	O
must	must	MD	B-VP	O
therefore	therefore	RB	I-VP	O
engage	engage	VB	I-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
available	available	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
elements	element	NNS	I-NP	O
-	-	SYM	O	O
-	-	HYPH	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
partly	partly	RB	B-ADVP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
selection	selection	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
with	with	IN	B-PP	O
src	BEGIN-src	NN	B-NP	B
-	-	HYPH	O	I
homology	homology	NN	B-NP	I
1	1	CD	I-NP	I
domains	domains-INSIDE	NN	I-NP	I
(	(	(	O	O
SH1	BEGIN-SH1	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I
)	)	)	O	O

Hence	Hence	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
perhaps	perhaps	RB	B-ADVP	O
not	not	RB	O	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
spinal	spinal	JJ	B-NP	O
puncture	puncture	NN	I-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
purpose	purpose	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
CSF	CSF	NN	I-NP	O
/	/	SYM	B-VP	O
serum	serum	NN	B-NP	O
ratio	ratio	NN	I-NP	O

NSAIDS	NSAIDS	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
microcirculation	microcirculation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O

Highly	Highly	RB	B-NP	O
significant	significant	JJ	I-NP	O
similarities	similarity	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
P1	BEGIN-P1-INSIDE	NN	B-NP	B
and	and	CC	O	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
GENA	BEGIN-GENA-INSIDE	NN	B-NP	B
[	[	(	O	O
the	the	DT	B-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
another	another	DT	B-NP	O
unidentified	unidentified	JJ	I-NP	O
gene	gene	NN	I-NP	O
(	(	(	O	O
geneA	BEGIN-geneA-INSIDE	NN	B-NP	B
)	)	)	O	O
located	located	JJ	B-ADJP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aceEF	BEGIN-aceEF-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
lpd	BEGIN-lpd-INSIDE	NN	I-NP	B
operon	operon	NN	I-NP	O
]	]	)	O	O
,	,	,	O	O
and	and	CC	O	O
GNTR	BEGIN-GNTR-INSIDE	NN	B-NP	B
(	(	(	O	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
repressor	repressor	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gluconate	BEGIN-gluconate	JJ	I-NP	B
operon	operon-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
Bacillus	Bacillus	NNP	B-NP	O
subtilis	subtili	NNS	I-NP	O
)	)	)	O	O

Promoting	Promote	VBG	B-VP	O
fat	fat	JJ	B-NP	O
utilisation	utilisation	NN	I-NP	O
by	by	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
the	the	DT	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
-	-	HYPH	B-NP	O
fat	fat	JJ	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TPN	TPN	NN	I-NP	O
reduces	reduce	VBZ	B-VP	O
free	free	JJ	B-NP	O
radical	radical	NN	I-NP	O
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
extent	extent	NN	I-NP	O
as	as	IN	B-PP	O
fat	fat	NN	B-NP	O
exclusion	exclusion	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
postulated	postulate	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
peptidoglycan	peptidoglycan	NN	I-NP	O
layer	layer	NN	I-NP	O
was	be	VBD	B-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
antimetabolites	antimetabolite	NNS	I-NP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
morphological	morphological	JJ	I-NP	O
effects	effect	NNS	I-NP	O
were	be	VBD	B-VP	O
strikingly	strikingly	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
E.	E.	NNP	B-NP	O
cloacae	cloaca	NNS	I-NP	O
with	with	IN	B-PP	O
disodium	disodium	NN	B-NP	O
edetate	edetate	NN	I-NP	O
plus	plus	CC	O	O
lysozyme	BEGIN-lysozyme-INSIDE	NN	B-NP	B

The	The	DT	B-NP	O
selective	selective	JJ	I-NP	O
1	BEGIN-1	NN	I-NP	B
-	-	HYPH	B-NP	I
HT1	HT1	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
blocker	blocker	NN	I-NP	O
ketanserin	ketanserin	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
reduce	reduce	VB	I-VP	O
maximal	maximal	JJ	B-NP	O
urethral	urethral	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
females	female	NNS	I-NP	O
by	by	IN	B-PP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
without	without	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Of	Of	IN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
chemistry	chemistry	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
submitted	submit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
participating	participate	VBG	I-NP	O
laboratories	laboratory	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
collection	collection	NN	I-NP	O
period	period	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
rejected	reject	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
testing	testing	NN	B-NP	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
VDR	BEGIN-VDR-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
VDREs	BEGIN-VDR-INSIDEE	NNS	B-NP	I
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
fully	fully	RB	I-VP	O
activate	activate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
in	in	IN	B-PP	O
intact	intact	JJ	B-NP	O
yeast	yeast	NN	I-NP	O
cells	cell	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
retinoid	BEGIN-retinoid	JJ	I-NP	B
X	X	NN	I-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
(	(	(	O	O
RXR	BEGIN-RXR-INSIDE	NN	B-NP	B
)	)	)	O	O

The	The	DT	B-NP	O
newly	newly	RB	I-NP	O
identified	identify	VBN	I-NP	O
repressor	repressor	NN	I-NP	O
element	element	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
rare	rare	JJ	I-NP	O
example	example	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
naturally	naturally	RB	I-NP	O
occurring	occur	VBG	I-NP	O
perfect	perfect	JJ	B-NP	O
palindromic	palindromic	JJ	I-NP	O
binding	binding	NN	I-NP	O
motif	motif	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	SYM	I-NP	I
B	B-INSIDE	NN	I-NP	I
/	/	SYM	I-NP	O
Rel	BEGIN-Rel-INSIDE	NN	I-NP	B
family	family	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
factors	factor	NNS	I-NP	O

UV	UV	NN	B-NP	O
-	-	HYPH	O	O
cross	cross	AFX	O	O
-	-	HYPH	B-PP	O
linking	link	VBG	B-NP	O
studies	study	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
complexes	complex	NNS	I-NP	O
represent	represent	VBP	B-VP	O
one	one	CD	B-NP	O
and	and	CC	I-NP	O
two	two	CD	I-NP	O
molecules	molecule	NNS	I-NP	O
of	of	IN	B-PP	O
ADR1	BEGIN-ADR1-INSIDE	NN	B-NP	B
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
conservation	conservation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
residues	residue	NNS	I-NP	O
most	most	RBS	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
to	to	TO	B-PP	O
mutations	mutation	NNS	B-NP	O
(	(	(	O	O
Y1	Y1	NN	B-NP	O
and	and	CC	O	O
Y1	Y1	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
TM1	TM1	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
homologous	homologous	JJ	I-NP	O
TM1	TM1	NN	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
mammalian	BEGIN-mammalian	JJ	I-NP	B
P	P	NN	I-NP	I
-	-	HYPH	B-NP	I
gps	gps-INSIDE	NN	I-NP	I
and	and	CC	O	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
ABC	BEGIN-ABC	NN	I-NP	B
transporters	transporters-INSIDE	NN	I-NP	I
,	,	,	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
residues	residue	NNS	I-NP	O
and	and	CC	I-NP	O
domains	domain	NNS	I-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
structural	structural	JJ	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
mechanistic	mechanistic	JJ	B-NP	O
aspects	aspect	NNS	I-NP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O

SF1	BEGIN-SF1-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
mBBP	BEGIN-mBBP-INSIDE	NN	I-NP	B
utilizes	utilize	VBZ	B-VP	O
a	a	DT	B-NP	O
	BEGIN-	NN	I-NP	B
''	''	''	O	I
maxi	maxi	AFX	B-NP	I
-	-	HYPH	B-NP	I
K	K	NN	I-NP	I
homology	homology	NN	I-NP	I
''	''	''	I-NP	I
	-INSIDE	NN	I-NP	I
(	(	(	O	O
maxi	BEGIN-maxi	NN	B-NP	B
-	-	HYPH	B-NP	I
KH	KH-INSIDE	NN	I-NP	I
)	)	)	O	O
domain	domain	NN	B-NP	O
for	for	IN	B-PP	O
recognition	recognition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
stranded	stranded	JJ	I-NP	O
BPS	BPS	NN	I-NP	O
and	and	CC	O	O
requires	require	VBZ	B-VP	O
a	a	DT	B-NP	O
cooperative	cooperative	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
splicing	splicing	NN	B-NP	O
factor	factor	NN	I-NP	O
U1AF1	BEGIN-U1AF1-INSIDE	NN	I-NP	B
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	O
polypyrimidine	polypyrimidine	NN	I-NP	O
tract	tract	NN	I-NP	O
(	(	(	O	O
PPT	PPT	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
affinity	affinity	NN	I-NP	O
binding	binding	NN	I-NP	O

The	The	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PacC	BEGIN-BEGIN-PacC-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
decamers	decamers-INSIDE	NN	I-NP	I
to	to	TO	B-PP	O
external	external	JJ	B-NP	O
pH	pH	NN	I-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pH	pH	NN	I-NP	O
-	-	HYPH	B-VP	O
regulated	regulate	VBN	B-NP	O
activator	activator	NN	I-NP	O
YlRim1p	BEGIN-YlRim1p-INSIDE	NN	I-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
A.	A.	NN	I-NP	O
nidulans	nidulan	VBZ	B-VP	O
PacC	BEGIN-PacC-INSIDE	NN	B-NP	B
regulator	regulator	NN	I-NP	O

Spongiosa	Spongiosa	NN	B-NP	O
regeneration	regeneration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
millipore	millipore	NN	I-NP	O
chamber	chamber	NN	I-NP	O

MTX	MTX	NN	B-NP	O
therapy	therapy	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
Ga	Ga	NNP	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
liver	liver	NN	B-NP	O
,	,	,	O	O
tumor	tumor	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
muscle	muscle	NN	B-NP	O

Each	Each	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
materials	material	NNS	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
different	different	JJ	I-NP	O
placement	placement	NN	I-NP	O
techniques	technique	NNS	I-NP	O
(	(	(	O	O
Bulk	Bulk	NN	B-NP	O
pack	pack	NN	I-NP	O
,	,	,	O	O
Horizontal	Horizontal	JJ	B-NP	O
layering	layering	NN	I-NP	O
and	and	CC	O	O
Vertical	Vertical	JJ	B-NP	O
layering	layering	NN	I-NP	O
)	)	)	O	O
into	into	IN	B-PP	O
class	class	NN	B-NP	O
II	II	CD	I-NP	O
cavities	cavity	NNS	I-NP	O
in	in	IN	B-PP	O
extracted	extract	VBN	B-NP	O
human	human	JJ	I-NP	O
molars	molar	NNS	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
EFT1	BEGIN-EFT1-INSIDE	NN	B-NP	B
were	be	VBD	B-VP	O
localized	localized	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
start	start	NN	I-NP	O
ATG	ATG	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
stop	stop	NN	I-NP	O
codon	codon	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
VPS1	BEGIN-VPS1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
that	that	WDT	B-NP	O
terminates	terminate	VBZ	B-VP	O
1	1	CD	B-NP	O
nt	nt	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
strand	strand	NN	I-NP	O

No	No	DT	B-NP	O
transactivation	transactivation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ovalbumin	BEGIN-ovalbumin	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
(	(	(	O	O
pLovTATA	BEGIN-pLovTATA-INSIDE	NN	B-NP	B
)	)	)	O	O
template	template	NN	B-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O

Removal	Removal	NN	B-NP	O
of	of	IN	B-PP	O
cyclin	BEGIN-cyclin	NN	B-NP	B
-	-	HYPH	B-NP	I
dependant	dependant	JJ	I-NP	I
kinases	kinases-INSIDE	NN	I-NP	I
(	(	(	O	O
cdks	BEGIN-cdks-INSIDE	NN	B-NP	B
)	)	)	O	O
or	or	CC	O	O
cdk1	BEGIN-cdk1-INSIDE	NN	B-NP	B
from	from	IN	B-PP	O
these	these	DT	B-NP	O
extracts	extract	NNS	I-NP	O
using	use	VBG	B-VP	O
affinity	affinity	NN	B-NP	O
matrices	matrix	NNS	I-NP	O
severely	severely	RB	B-ADVP	O
inhibits	inhibit	VBZ	B-VP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
,	,	,	O	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
A	BEGIN-A	NN	B-NP	B
(	(	(	O	I
1A	1A	NN	B-NP	I
)	)	)	O	I
-	-	HYPH	B-NP	I
R	R-INSIDE	NN	I-NP	I
or	or	CC	I-NP	O
PKA	BEGIN-PKA-INSIDE	NN	I-NP	B
enhanced	enhance	VBD	B-VP	O
nuclear	BEGIN-nuclear	JJ	B-NP	B
aPKC	aPKC-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O

Foreign	Foreign	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
inserts	insert	NNS	I-NP	O
contained	contain	VBN	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
fowlpox	fowlpox	NN	I-NP	O
virus	virus	NN	I-NP	O
sequence	sequence	NN	I-NP	O
were	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
genome	genome	NN	I-NP	O
by	by	IN	B-PP	O
homologous	homologous	JJ	B-NP	O
recombination	recombination	NN	I-NP	O
occurring	occur	VBG	B-VP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fowlpox	fowlpox	NN	I-NP	O
virus	virus	NN	I-NP	O
temperature	temperature	NN	I-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
mutant	mutant	NN	I-NP	O
and	and	CC	O	O
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
both	both	CC	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
viral	viral	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
and	and	CC	I-NP	O
plasmid	plasmid	NN	I-NP	O
DNA	DNA	NN	I-NP	O

JCAHO	JCAHO	NN	B-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
ORYX	ORYX	NN	B-NP	O
data	datum	NNS	I-NP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
sentinel	sentinel	NN	B-NP	O
events	event	NNS	I-NP	O

Comparisons	Comparison	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
benazepril	benazepril	NN	B-NP	O
and	and	CC	I-NP	O
hydrochlorothiazide	hydrochlorothiazide	NN	I-NP	O
alone	alone	RB	B-ADVP	O
and	and	CC	O	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
benazepril	benazepril	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
is	be	VBZ	B-VP	O
as	as	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
as	as	IN	B-PP	O
or	or	CC	O	O
more	more	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
lowering	lower	VBG	B-VP	O
diastolic	diastolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
than	than	IN	B-PP	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
benazepril	benazepril	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
and	and	CC	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
possibly	possibly	RB	I-NP	O
synergistic	synergistic	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O

Carcinoma	BEGIN-Carcinoma	NN	B-NP	B
-	-	HYPH	B-PP	I
related	relate	VBN	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
production	production	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
played	play	VBN	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
observed	observe	VBN	I-NP	O
renal	renal	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
study	study	NN	I-NP	O
population	population	NN	I-NP	O
included	include	VBD	B-VP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
syndromes	syndrome	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
acute	acute	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
pectoris	pectoris	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
angina	angina	NN	I-NP	O
pectoris	pectoris	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
control	control	NN	I-NP	O
subjects	subject	NNS	I-NP	O

Single	Single	JJ	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
substitutions	substitution	NNS	I-NP	O
were	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
result	result	VB	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mutations	mutation	NNS	I-NP	O
pdr1	BEGIN-pdr1	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
M1I	M1I	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
pdr1	BEGIN-pdr1	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
F1S	F1S	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
pdr1	BEGIN-pdr1	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
K1Q	K1Q	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
pdr1	BEGIN-pdr1	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
P1A	P1A	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
pdr1	BEGIN-pdr1	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
(	(	(	O	O
L1	L1	NN	B-NP	O
W	W	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
intragenic	intragenic	JJ	I-NP	O
suppressor	suppressor	NN	I-NP	O
mutant	mutant	JJ	I-NP	O
pdr1	BEGIN-pdr1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
deleted	delete	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
L1	L1	NN	B-NP	O
and	and	CC	O	O
A1	A1	NN	B-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
statistical	statistical	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Ca	Ca	NN	I-NP	O
/	/	SYM	B-NP	O
P	P	NN	I-NP	O
ratio	ratio	NN	I-NP	O
,	,	,	O	O
carbon	carbon	NN	B-NP	O
concentration	concentration	NN	I-NP	O
and	and	CC	O	O
surface	surface	NN	B-NP	O
energy	energy	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
heat	heat	NN	I-NP	O
treatments	treatment	NNS	I-NP	O

These	These	DT	B-NP	O
motions	motion	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	O	O
terminal	terminal	JJ	B-NP	O
tails	tail	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
segment	segment	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
which	which	WDT	B-NP	O
forms	form	VBZ	B-VP	O
the	the	DT	B-NP	O
turn	turn	NN	I-NP	O
between	between	IN	B-PP	O
beta	beta	SYM	B-NP	O
-	-	HYPH	I-NP	O
strands	strand	NNS	I-NP	O
S1	S1	NN	I-NP	O
and	and	CC	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
residues	residue	NNS	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
located	locate	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
loop	loop	NN	I-NP	O
preceding	precede	VBG	B-VP	O
strand	strand	NN	B-NP	O
S1	S1	NN	I-NP	O

Enterobius	Enterobius	NNP	B-NP	O
vermicularis	vermicularis	NNP	I-NP	O
eggs	egg	NNS	I-NP	O
were	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
during	during	IN	B-PP	O
microscopic	microscopic	JJ	B-NP	O
examination	examination	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
smear	smear	NN	I-NP	O
taken	take	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
fornix	fornix	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vagina	vagina	NN	I-NP	O

Differentiation	Differentiation	NN	B-NP	O
of	of	IN	B-PP	O
porcine	porcine	JJ	B-NP	O
mycoplasma	mycoplasma	NN	I-NP	O
strains	strain	NNS	I-NP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
paper	paper	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
test	test	NN	I-NP	O

D.	D.	NNP	B-NP	O
,	,	,	O	O
Hughes	Hughes	NNP	B-NP	O
,	,	,	O	O
F	F	NNP	B-NP	O

We	We	PRP	B-NP	O
further	further	RB	B-ADVP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
repression	repression	NN	I-NP	O
of	of	IN	B-PP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
fold	fold	RB	B-ADVP	O
)	)	)	O	O
by	by	IN	B-PP	O
E1	BEGIN-E1	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
(	(	(	O	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
RSRS	RSRS	NN	I-NP	O
)	)	)	O	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
E1	BEGIN-E1	NN	I-NP	B
reporter	reporter	NN	I-NP	I
construct	construct-INSIDE	NN	I-NP	I
,	,	,	O	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
hexameric	hexameric	JJ	I-NP	O
E	E	NN	I-NP	O
-	-	HYPH	I-NP	O
box	box	NN	I-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
AEBP1	BEGIN-AEBP1	NN	B-NP	B
cDNA	cDNA-INSIDE	NN	I-NP	I
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
containing	contain	VBG	B-VP	O
three	three	CD	B-NP	O
Gli	BEGIN-Gli-INSIDE	NN	I-NP	B
-	-	HYPH	I-NP	O
Kruppel	BEGIN-Kruppel-INSIDE	NN	I-NP	B
(	(	(	O	O
Cys1	Cys1	NN	B-NP	O
-	-	HYPH	B-NP	O
His1	His1	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
type	type	NN	I-NP	O
zinc	zinc	NN	I-NP	O
fingers	finger	NNS	I-NP	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
haemagglutination	BEGIN-haemagglutination	NN	B-NP	B
inhibiting	inhibiting	NN	I-NP	I
(	(	(	O	I
HI	HI	NN	B-NP	I
)	)	)	O	I
antibodies	antibodies-INSIDE	NN	B-NP	I
to	to	TO	B-PP	O
JE	JE	NN	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
JEV	JEV	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
West	West	NNP	B-NP	O
Nile	Nile	NNP	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
WNV	WNV	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
dengue	dengue	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
DEN	DEN	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
HI	HI	NN	B-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
IgM	BEGIN-IgM	NN	B-NP	B
antibody	antibody-INSIDE	NN	I-NP	I
capture	capture	NN	I-NP	O
ELISA	ELISA	NN	I-NP	O
(	(	(	O	O
MAC	MAC	NN	B-NP	O
ELISA	ELISA	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
recent	recent	JJ	B-NP	O
infections	infection	NNS	I-NP	O
with	with	IN	B-PP	O
JE	JE	NN	B-NP	O
virus	virus	NN	I-NP	O

To	To	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
hormonal	hormonal	JJ	I-NP	O
effects	effect	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
studied	study	VBN	I-VP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PFK	BEGIN-PFK	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
transfection	transfection	NN	B-NP	O
experiments	experiment	NNS	I-NP	O

Tryptophan	Tryptophan	NN	B-NP	O
induction	induction	NN	I-NP	O
prevents	prevent	VBZ	B-VP	O
Rho	BEGIN-Rho-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
termination	termination	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
leader	leader	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
operon	operon	NN	I-NP	O

An	An	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
Raf	BEGIN-Raf	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
assay	assay	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
detect	detect	VB	I-VP	O
LPS	LPS	NN	B-NP	O
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
Raf	BEGIN-Raf	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
RAW	RAW	NN	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
RAW	RAW	NN	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
Raf	BEGIN-Raf	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
not	not	RB	O	O
an	an	DT	B-NP	O
activating	activate	VBG	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LPS	LPS	NN	I-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
regulating	regulate	VBG	B-VP	O
MAPK	BEGIN-MAPK-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
or	or	CC	O	O
sIL	BEGIN-sIL	NN	B-NP	B
-	-	HYPH	B-NP	I
1Ra	1Ra	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O

Subjects	Subject	NNS	B-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
male	male	JJ	I-NP	O
and	and	CC	I-NP	O
female	female	JJ	I-NP	O
employees	employee	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Xerox	Xerox	NNP	I-NP	O
Corporation	Corporation	NNP	I-NP	O
joining	join	VBG	B-VP	O
a	a	DT	B-NP	O
newly	newly	RB	I-NP	O
developed	develop	VBN	I-NP	O
health	health	NN	I-NP	O
fitness	fitness	NN	I-NP	O
program	program	NN	I-NP	O

The	The	DT	B-NP	O
LT	BEGIN-LT	NN	I-NP	B
-	-	HYPH	O	I
beta	beta	SYM	B-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
organs	organ	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
its	its	PRP$	B-NP	O
inducible	inducible	JJ	I-NP	O
regulation	regulation	NN	I-NP	O

Dose	Dose	NN	B-NP	O
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
pharmacokinetics	pharmacokinetic	NNS	I-NP	O
:	:	:	O	O
emphasis	emphasis	NN	B-NP	O
on	on	IN	B-PP	O
phase	phase	NN	B-NP	O
I	I	CD	I-NP	O
metabolism	metabolism	NN	I-NP	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
fractured	fractured	JJ	B-NP	O
zonas	zona	NNS	I-NP	O

Our	Our	PRP$	B-NP	O
Northern	Northern	JJ	I-NP	O
and	and	CC	I-NP	O
Southern	Southern	JJ	I-NP	O
blot	blot	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
of	of	IN	B-PP	O
meningiomas	meningioma	NNS	B-NP	O
clearly	clearly	RB	B-ADVP	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
CLH	BEGIN-CLH	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
tumor	tumor	NN	I-NP	O
suppressor	suppressor	NN	I-NP	O

The	The	DT	B-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
dose	dose	NN	I-NP	O
AHLG	BEGIN-AHLG-INSIDE	NN	I-NP	B
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
stress	stress	NN	I-NP	O
/	/	SYM	B-NP	O
BHV	BHV	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
model	model	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
calves	calf	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
difference	difference	NN	I-NP	O
observed	observe	VBN	B-VP	O
between	between	IN	B-PP	O
treatment	treatment	NN	B-NP	O
groups	group	NNS	I-NP	O

Cytomegalovirus	Cytomegalovirus	NN	B-NP	O
infection	infection	NN	I-NP	O
-	-	HYPH	B-VP	O
-	-	HYPH	B-NP	O
modern	modern	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O

Genomic	Genomic	JJ	B-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
multidrug	multidrug	JJ	I-NP	I
resistance	resistance	NN	I-NP	I
(	(	(	O	I
MDR1	MDR1	NN	B-NP	I
)	)	)	O	I
gene	gene-INSIDE	NN	B-NP	I
and	and	CC	I-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
P	BEGIN-P	NN	B-NP	B
-	-	HYPH	O	I
glycoproteins	glycoproteins-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
pepI	BEGIN-pepI	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
overexpressed	overexpresse	VBN	I-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O

Deep	Deep	NN	B-NP	O
bite	bite	NN	I-NP	O
CL	CL	NN	I-NP	O
II	II	NNP	I-NP	O
Div	Div	NNP	I-NP	O

Negative	Negative	JJ	B-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
alpha1	BEGIN-alpha1	NN	B-NP	B
(	(	(	O	I
I	I	NN	B-NP	I
)	)	)	O	I
procollagen	procollagen	NN	B-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
skin	skin	NN	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	O
:	:	:	O	O
transcriptional	transcriptional	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
by	by	IN	B-PP	O
interferon	BEGIN-interferon	NN	B-NP	B
-	-	HYPH	O	I
gamma	gamma-INSIDE	NN	B-NP	I

Yet	Yet	RB	B-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
IFN	BEGIN-IFN	NN	I-NP	B
-	-	HYPH	O	I
gamma	gamma-INSIDE	NN	B-NP	I
production	production	NN	I-NP	O
are	be	VBP	B-VP	O
independently	independently	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
by	by	IN	B-PP	O
their	their	PRP$	B-NP	O
differential	differential	JJ	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
certain	certain	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
subsets	subset	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
elements	element	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
genes	gene	NNS	I-NP	O
must	must	MD	B-VP	O
differ	differ	VB	I-VP	O

In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
FGFR1	BEGIN-FGFR1-INSIDE	NN	B-NP	B
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
utilizes	utilize	VBZ	B-VP	O
two	two	CD	B-NP	O
GRB1	BEGIN-BEGIN-GRB1-INSIDE	NN	I-NP	B
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
complexes	complexes-INSIDE	NN	B-NP	I
;	;	:	O	O
Shc.GRB1.Sos	BEGIN-Shc-INSIDE.BEGIN-GRB1-INSIDE.BEGIN-Sos-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
1K	BEGIN-1K	NN	I-NP	B
-	-	HYPH	B-NP	I
H.pp1.GRB1.Sos	H-INSIDE.BEGIN-pp1-INSIDE.BEGIN-GRB1-INSIDE.BEGIN-Sos-INSIDE	NN	I-NP	I
;	;	:	O	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
complexes	complex	NNS	I-NP	O
may	may	MD	B-VP	O
alternatively	alternatively	RB	I-VP	O
link	link	VB	I-VP	O
FGFG1	BEGIN-FGFG1-INSIDE	NN	B-NP	B
to	to	TO	B-PP	O
mitogen	BEGIN-mitogen	NN	B-NP	B
-	-	HYPH	O	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I

Resistance	Resistance	NN	B-NP	O
to	to	TO	B-PP	O
Mup	Mup	NN	B-NP	O
was	be	VBD	B-VP	O
classified	classify	VBN	I-VP	O
as	as	IN	B-PP	O
low	low	JJ	O	O
(	(	(	O	O
minimal	minimal	JJ	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
[	[	(	O	O
MIC	MIC	NN	B-NP	O
]	]	)	O	O
>	>	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
microg	microg	NN	I-NP	O
/	/	SYM	B-NP	O
mL	mL	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
high	high	JJ	B-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
>	>	SYM	B-VP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
microg	microg	NN	I-NP	O
/	/	SYM	B-NP	O
mL	mL	NN	I-NP	O
)	)	)	O	O
degree	degree	NN	B-NP	O

STUDY	STUDY	NN	B-NP	O
DESIGN	DESIGN	NN	I-NP	O
:	:	:	O	O
Retrospective	Retrospective	JJ	B-NP	O
review	review	NN	I-NP	O

One	One	CD	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
hour	hour	NN	I-NP	O
cycle	cycle	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
hour	hour	NN	I-NP	O
cycle	cycle	NN	I-NP	O

1	1	LS	B-LST	O
The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
piretanide	piretanide	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
diuretic	diuretic	JJ	I-NP	O
agent	agent	NN	I-NP	O
chemically	chemically	RB	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
frusemide	frusemide	NN	B-NP	O
and	and	CC	I-NP	O
bumetanide	bumetanide	NN	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
twelve	twelve	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
(	(	(	O	O
creatinine	creatinine	NN	B-NP	O
clearance	clearance	NN	I-NP	O
below	below	IN	B-PP	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
)	)	)	O	O

S1	BEGIN-S1	NN	B-NP	B
nuclease	nuclease-INSIDE	NN	I-NP	I
protection	protection	NN	I-NP	O
mapping	mapping	NN	I-NP	O
and	and	CC	O	O
primer	primer	NN	B-NP	O
extension	extension	NN	I-NP	O
analysis	analysis	NN	I-NP	O
allowed	allow	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
propose	propose	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
A	A	NN	I-NP	O
residue	residue	NN	I-NP	O
located	located	JJ	I-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
initiation	initiation	NN	I-NP	O
codon	codon	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
initiation	initiation	NN	I-NP	O

Various	Various	JJ	B-NP	O
stimuli	stimulus	NNS	I-NP	O
inactivate	inactivate	VBP	B-VP	O
IkappaB	BEGIN-IkappaB	NN	B-NP	B
alpha	alpha-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
triggering	trigger	VBG	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
residues	residue	NNS	I-NP	O
Ser1	Ser1	NN	I-NP	O
and	and	CC	O	O
Ser1	Ser1	NN	B-NP	O

A	A	DT	B-NP	O
mouse	mouse	NN	I-NP	O
brain	brain	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
in	in	IN	B-PP	O
lambdagt1	lambdagt1	NN	B-NP	O
was	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
association	association	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
positive	positive	JJ	I-NP	O
clones	clone	NNS	I-NP	O
encoding	encode	VBG	B-VP	O
tyrosine	BEGIN-tyrosine	NN	B-NP	B
phosphatase	phosphatase-INSIDE	NN	I-NP	I
SH	BEGIN-SH	NN	I-NP	B
-	-	HYPH	B-NP	I
PTP1	PTP1-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O

Intensive	Intensive	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O

Adjusting	Adjust	VBG	B-VP	O
a	a	DT	B-NP	O
steady	steady	JJ	I-NP	O
-	-	HYPH	I-NP	O
state	state	NN	I-NP	O
warfarin	warfarin	NN	I-NP	O
dose	dose	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
measured	measure	VBN	I-NP	O
INR	INR	NN	I-NP	O
values	value	NNS	I-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
factors	factor	NNS	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
INR	INR	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
slightly	slightly	RB	B-ADVP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
range	range	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
most	most	JJS	B-NP	O
changes	change	NNS	I-NP	O
should	should	MD	B-VP	O
alter	alter	VB	I-VP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
weekly	weekly	JJ	I-NP	O
dose	dose	NN	I-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O

Successful	Successful	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
multifocal	multifocal	JJ	I-NP	O
leukoencephalopathy	leukoencephalopathy	NN	I-NP	O
after	after	IN	B-PP	O
combination	combination	NN	B-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
cidofovir	cidofovir	NN	B-NP	O
and	and	CC	I-NP	O
cytosine	cytosine	NN	I-NP	O
arabinoside	arabinoside	NN	I-NP	O

The	The	DT	B-NP	O
DFGF	BEGIN-DFGF	NN	I-NP	B
-	-	HYPH	I-NP	I
R	R	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
may	may	MD	B-VP	O
thus	thus	RB	I-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
receiving	receive	VBG	B-VP	O
spatial	spatial	JJ	B-NP	O
cues	cue	NNS	I-NP	O
that	that	WDT	B-NP	O
guide	guide	VBP	B-VP	O
tracheal	tracheal	JJ	B-NP	O
cell	cell	NN	I-NP	O
outgrowth	outgrowth	NN	I-NP	O

FTF	FTF	NN	B-NP	O
(	(	(	O	O
Joint	Joint	NNP	B-NP	O
Council	Council	NNP	I-NP	O
of	of	IN	B-PP	O
Civil	Civil	NNP	B-NP	O
Servants	Servant	NNPS	I-NP	O
and	and	CC	I-NP	O
Functionaries	Functionary	NNPS	I-NP	O
)	)	)	O	O
:	:	:	O	O
clarification	clarification	NN	B-NP	O
about	about	IN	B-PP	O
membership	membership	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
organizations	organization	NNS	I-NP	O

The	The	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
binding	binding	NN	B-NP	O
(	(	(	O	O
Kdapp	Kdapp	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
incorporation	incorporation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
extension	extension	NN	B-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
oxo	oxo	NN	I-NP	O
-	-	HYPH	I-NP	O
dGTP	dGTP	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
dNTP	dNTP	NN	I-NP	O
incorporation	incorporation	NN	I-NP	O
at	at	IN	B-PP	O
template	template	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
oxo	oxo	NN	I-NP	O
-	-	HYPH	I-NP	O
G	G	NN	I-NP	O
adducts	adduct	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
polymerase	polymerase	NN	B-NP	O
fidelity	fidelity	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
depend	depend	VB	I-VP	O
solely	solely	RB	B-ADVP	O
upon	upon	IN	B-PP	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
geometry	geometry	NN	I-NP	O
of	of	IN	B-PP	O
Watson	Watson	NNP	B-NP	O
-	-	HYPH	I-NP	O
Crick	Crick	NNP	I-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
and	and	CC	O	O
reflects	reflect	VBZ	B-VP	O
the	the	DT	B-NP	O
asymmetry	asymmetry	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
active	active	JJ	I-NP	O
site	site	NN	I-NP	O

Retroviral	Retroviral	JJ	B-NP	O
vector	vector	NN	I-NP	O
producer	producer	NN	I-NP	O
cell	cell	NN	I-NP	O
populations	population	NNS	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
chLTR	BEGIN-chLTR-INSIDE	NN	I-NP	B
vector	vector	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
all	all	DT	B-NP	O
were	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
yielding	yield	VBG	B-VP	O
high	high	JJ	B-NP	O
vector	vector	NN	I-NP	O
titers	titer	NNS	I-NP	O
(	(	(	O	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
1	1	CD	O	O
)	)	)	O	O
G1R	BEGIN-G1R-INSIDE	NN	B-NP	B
cfu	cfu	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
on	on	IN	B-PP	O
NIH	NIH	NN	B-NP	O
-	-	HYPH	B-NP	O
1T1	1T1	NN	I-NP	O
)	)	)	O	O

None	None	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
developed	develop	VBD	B-VP	O
clinical	clinical	JJ	B-NP	O
events	event	NNS	I-NP	O
before	before	IN	B-PP	O
disappearance	disappearance	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phospholipid	phospholipid	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
of	of	IN	B-PP	O
coagulation	coagulation	NN	B-NP	O

A	A	DT	B-NP	O
high	high	JJ	I-NP	O
titer	titer	NN	I-NP	O
of	of	IN	B-PP	O
anti	BEGIN-anti	AFX	B-NP	B
-	-	HYPH	I-NP	I
HBc	HBc-INSIDE	NN	I-NP	I
,	,	,	O	O
thus	thus	RB	B-ADVP	O
suggested	suggest	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
indicator	indicator	NN	I-NP	O
of	of	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
virus	virus	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
rarely	rarely	RB	B-ADVP	O
in	in	IN	B-PP	O
seronegative	seronegative	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
,	,	,	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
alcoholic	alcoholic	JJ	B-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
alcoholic	alcoholic	JJ	B-NP	O
liver	liver	NN	I-NP	O
diseases	disease	NNS	I-NP	O

Using	Use	VBG	B-VP	O
beta	BEGIN-beta	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
AR	AR-INSIDE	NN	I-NP	I
-	-	HYPH	I-NP	O
luciferase	BEGIN-luciferase-INSIDE	NN	I-NP	B
reporter	reporter	NN	I-NP	O
recombinants	recombinant	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
determined	determine	VBN	I-VP	O
that	that	IN	B-SBAR	O
important	important	JJ	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
AR	AR-INSIDE	JJ	I-NP	I
genetic	genetic	JJ	I-NP	O
elements	element	NNS	I-NP	O
controlling	control	VBG	B-VP	O
expression	expression	NN	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
C1	C1	NN	I-NP	O
glioma	glioma	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
are	be	VBP	B-VP	O
contained	contain	VBN	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
translational	translational	JJ	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
well	well	RB	I-VP	O
known	know	VBN	I-VP	O
that	that	IN	B-SBAR	O
giant	giant	JJ	B-NP	O
cell	cell	NN	I-NP	O
arteritis	arteritis	NN	I-NP	O
can	can	MD	B-VP	O
cause	cause	VB	I-VP	O
fatal	fatal	JJ	B-NP	O
complications	complication	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
rupture	rupture	NN	B-NP	O
of	of	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
aneurysms	aneurysm	NNS	I-NP	O
or	or	CC	O	O
cerebral	cerebral	JJ	B-NP	O
and	and	CC	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarctions	infarction	NNS	I-NP	O

Temporal	Temporal	JJ	B-NP	O
recruitment	recruitment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mSin1A	BEGIN-mSin1A-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
histone	BEGIN-histone	NN	I-NP	B
deacetylase	deacetylase-INSIDE	NN	I-NP	I
corepressor	corepressor	NN	I-NP	O
complex	complex	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ETS	BEGIN-ETS	JJ	I-NP	B
domain	domain	NN	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
Elk	BEGIN-Elk	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

By	By	IN	B-PP	O
screening	screen	VBG	B-VP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	O
testis	testis	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
probe	probe	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
mouse	BEGIN-mouse	NN	I-NP	B
PEA1	PEA1-INSIDE	NN	I-NP	I
ETS	BEGIN-ETS-INSIDE	NN	I-NP	B
domain	domain	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
clone	clone	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
AA	AA	NN	I-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
HAP1	BEGIN-HAP1	NN	I-NP	B
/	/	SYM	B-NP	I
1	1	CD	I-NP	I
/	/	SYM	I-NP	I
1	1	CD	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor	NN	I-NP	I
complex	complex-INSIDE	NN	I-NP	I
and	and	CC	B-PP	O
by	by	IN	B-PP	O
SNF1	BEGIN-SNF1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
SSN1	BEGIN-SSN1-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
is	be	VBZ	B-VP	O
predicted	predict	VBN	I-VP	O
to	to	TO	I-VP	O
encode	encode	VB	I-VP	O
an	an	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
protein	protein	NN	I-NP	O
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
C1H1	C1H1	NN	I-NP	O
zinc	zinc	NN	I-NP	O
fingers	finger	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
localization	localization	NN	I-NP	O
sequence	sequence	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
domains	domain	NNS	I-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
H	BEGIN-H	NN	B-NP	B
-	-	HYPH	O	I
1RIIBP	1RIIBP-INSIDE	NN	B-NP	I
(	(	(	O	O
i	i	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
superfamily	superfamily	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	BEGIN-nuclear	JJ	B-NP	B
hormone	hormone	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
and	and	CC	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
may	may	MD	B-VP	O
regulate	regulate	VB	I-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
MHC	BEGIN-MHC	NN	B-NP	B
class	class	NN	I-NP	I
I	I	CD	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
genes	gene	NNS	B-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
ERE	ERE	NN	I-NP	O
and	and	CC	I-NP	O
related	related	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O

Relaxant	Relaxant	JJ	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	O
E1	E1	NN	I-NP	O
(	(	(	O	O
PGE1	PGE1	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
papaverine	papaverine	NN	B-NP	O
(	(	(	O	O
PAP	PAP	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
strips	strip	NNS	B-NP	O
of	of	IN	B-PP	O
corpus	corpus	NN	B-NP	O
cavernosum	cavernosum	NN	I-NP	O
smooth	smooth	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
taken	take	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
men	man	NNS	B-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
from	from	IN	B-PP	O
arteriogenically	arteriogenically	RB	B-NP	O
impotent	impotent	JJ	I-NP	O
men	man	NNS	I-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
additionally	additionally	RB	B-NP	O
diabetic	diabetic	JJ	I-NP	O
impotent	impotent	JJ	I-NP	O
men	man	NNS	I-NP	O
(	(	(	O	O
C	C	NN	B-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
venous	venous	JJ	B-NP	O
leakage	leakage	NN	I-NP	O

The	The	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
central	BEGIN-central	JJ	B-NP	B
dopamine	dopamine	NN	I-NP	I
receptors	receptors-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
growth	BEGIN-growth	NN	I-NP	B
hormone	hormone-INSIDE	NN	I-NP	I
response	response	NN	I-NP	O
to	to	TO	B-PP	O
apomorphine	apomorphine	NN	B-NP	O
application	application	NN	I-NP	O

Pathogenesis	Pathogenesis	NN	B-NP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O

The	The	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
TCRB	BEGIN-TCRB-INSIDE	NN	B-NP	B
rearrangement	rearrangement	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
has	have	VBZ	B-VP	O
implications	implication	NNS	B-NP	O
for	for	IN	B-PP	O
PCR	PCR	NN	B-NP	O
-	-	HYPH	B-NP	O
based	base	VBN	I-NP	O
clonality	clonality	NN	I-NP	O
assessment	assessment	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
PCR	PCR	NN	B-NP	O
-	-	HYPH	O	O
based	base	VBN	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
residual	residual	JJ	I-NP	O
disease	disease	NN	I-NP	O
via	via	IN	B-PP	O
TCRB	BEGIN-BEGIN-TCRB-INSIDE	NN	B-NP	B
gene	gene-INSIDE	NN	I-NP	I
analysis	analysis	NN	I-NP	O

In	In	IN	B-PP	O
many	many	JJ	B-NP	O
other	other	JJ	I-NP	O
contractile	contractile	JJ	I-NP	O
protein	protein	NN	I-NP	O
gene	gene	NN	I-NP	O
families	family	NNS	I-NP	O
,	,	,	O	O
genes	gene	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
cardiac	cardiac	JJ	B-NP	O
isoforms	isoform	NNS	I-NP	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
early	early	RB	B-ADVP	O
in	in	IN	B-PP	O
skeletal	skeletal	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
later	later	RB	I-VP	O
repressed	repress	VBN	I-VP	O

The	The	DT	B-NP	O
NH1	NH1	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
fragments	fragment	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
susceptibility	susceptibility	NN	B-NP	O
to	to	TO	B-PP	O
modification	modification	NN	B-NP	O
with	with	IN	B-PP	O
Nalpha	Nalpha	NN	B-NP	O
-	-	HYPH	B-NP	O
(	(	(	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
maleimidylpropionyl	maleimidylpropionyl	NN	I-NP	O
)	)	)	O	O
biocytin	biocytin	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
attaches	attach	VBZ	B-VP	O
a	a	DT	B-NP	O
biotin	biotin	NN	I-NP	O
group	group	NN	I-NP	O
to	to	TO	B-PP	O
cysteine	cysteine	NN	B-NP	O
sulfhydryls	sulfhydryl	NNS	I-NP	O

Directional	Directional	JJ	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
smectic	smectic	JJ	I-NP	O
-	-	HYPH	I-NP	O
A	A	NN	I-NP	O
-	-	HYPH	I-NP	O
smectic	smectic	JJ	I-NP	O
-	-	HYPH	I-NP	O
B	B	NN	I-NP	O
interface	interface	NN	I-NP	O
lying	lie	VBG	B-VP	O
along	along	IN	B-PP	O
a	a	DT	B-NP	O
forbidden	forbidden	JJ	I-NP	O
orientation	orientation	NN	I-NP	O

METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
performed	perform	VBD	B-VP	O
nasal	nasal	JJ	B-NP	O
mupirocin	mupirocin	NN	I-NP	O
treatment	treatment	NN	I-NP	O
on	on	IN	B-PP	O
1	1	CD	B-NP	O
infants	infant	NNS	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
MRSA	MRSA	NN	B-NP	O
-	-	HYPH	O	O
positive	positive	JJ	B-ADJP	O
either	either	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nose	nose	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
pharynx	pharynx	NN	I-NP	O
and	and	CC	O	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
mupirocin	mupirocin	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
eradication	eradication	NN	I-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O

TOM1	BEGIN-TOM1-INSIDE	NN	B-NP	B
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hect	BEGIN-hect-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
domain	domain	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
ubiquitin	BEGIN-ubiquitin	NN	I-NP	B
-	-	HYPH	B-NP	I
protein	protein	NN	I-NP	I
ligase	ligase-INSIDE	NN	I-NP	I
family	family	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
growth	growth	NN	B-NP	O
at	at	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
temperatures	temperature	NNS	I-NP	O

Purified	Purify	VBN	B-NP	O
preparations	preparation	NNS	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
AGT	AGT	NN	I-NP	O
mutants	mutant	NNS	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
approximately	approximately	RB	I-NP	O
similar	similar	JJ	I-NP	O
degree	degree	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
fold	fold	RB	B-ADVP	O
)	)	)	O	O
of	of	IN	B-PP	O
reduction	reduction	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
reaction	reaction	NN	B-NP	O
with	with	IN	B-PP	O
O1	O1	NN	B-NP	O
-	-	HYPH	O	O
benzylguanine	benzylguanine	NN	B-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
m1	BEGIN-m1	NN	B-NP	B
receptors	receptors-INSIDE	NN	I-NP	I
couple	couple	NN	I-NP	O
to	to	TO	B-PP	O
both	both	CC	O	O
G	BEGIN-G	NN	B-NP	B
alpha	alpha	NN	I-NP	I
i1	i1-INSIDE	NN	I-NP	I
and	and	CC	O	O
G	BEGIN-G	NN	B-NP	B
alpha	alpha	NN	I-NP	I
i1	i1-INSIDE	NN	I-NP	I
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
integral	integral	JJ	B-ADJP	O
to	to	TO	B-PP	O
both	both	CC	O	O
positive	positive	JJ	B-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
PLC	BEGIN-PLC-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
desensitization	desensitization	NN	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
signaling	signaling	NN	I-NP	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
case	case	NN	I-NP	O
report	report	NN	I-NP	O
of	of	IN	B-PP	O
NIHF	NIHF	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
fetal	fetal	JJ	B-NP	O
Kasabach	Kasabach	NNP	I-NP	O
-	-	HYPH	I-NP	O
Merritt	Merritt	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
prenatally	prenatally	RB	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
by	by	IN	B-PP	O
sonography	sonography	NN	B-NP	O
,	,	,	O	O
computerized	computerize	VBN	B-VP	O
tomography	tomography	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
percutaneous	percutaneous	JJ	B-NP	O
umbilical	umbilical	JJ	I-NP	O
blood	blood	NN	I-NP	O
sampling	sampling	NN	I-NP	O

The	The	DT	B-NP	O
cholesterol	BEGIN-cholesterol	NN	I-NP	B
1alpha	1alpha	NN	I-NP	I
-	-	HYPH	O	I
hydroxylase	hydroxylase	NN	B-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
CYP1A	BEGIN-CYP1A-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
transcriptionally	transcriptionally	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
factors	factor	NNS	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
hormones	hormone	NNS	B-NP	O
,	,	,	O	O
bile	bile	NN	B-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diurnal	diurnal	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O

Restriction	Restriction	NN	B-NP	O
mapping	mapping	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
recombinant	recombinant	JJ	I-NP	O
plasmids	plasmid	NNS	I-NP	O
shared	share	VBD	B-VP	O
an	an	DT	B-NP	O
EcoRI	BEGIN-EcoRI	NN	I-NP	B
fragment	fragment-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kb	kb	NN	I-NP	O

Two	Two	CD	B-NP	O
mutants	mutant	NNS	I-NP	O
,	,	,	O	O
mapping	map	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
HindIII	BEGIN-HindIII	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I
(	(	(	O	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pSC1	BEGIN-pSC1	NN	I-NP	B
tetA	tetA	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
,	,	,	O	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
:	:	:	O	O
MA1	MA1	NN	B-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
deletion	deletion	NN	I-NP	O
between	between	IN	B-PP	O
positions	position	NNS	B-NP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
B1	B1	NN	B-NP	O
bears	bear	VBZ	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
insertion	insertion	NN	I-NP	O
C	C	NN	I-NP	O
(	(	(	O	O
TA	TA	NN	B-NP	O
)	)	)	O	O
1	1	CD	B-NP	O
G	G	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
HindIII	BEGIN-HindIII	NN	I-NP	B
site	site-INSIDE	NN	I-NP	I

Meq	BEGIN-Meq-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
Jun	Jun-INSIDE	NN	I-NP	I
heterodimers	heterodimer	NNS	I-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
AP1	BEGIN-AP1	NN	I-NP	B
-	-	HYPH	B-NP	I
like	like	JJ	I-NP	I
sequence	sequence-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
the	the	DT	B-NP	O
meq	BEGIN-meq	NN	I-NP	B
promoter	promoter	NN	I-NP	I
region	region-INSIDE	NN	I-NP	I
with	with	IN	B-PP	O
an	an	DT	B-NP	O
affinity	affinity	NN	I-NP	O
much	much	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Meq	BEGIN-Meq-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
Meq	BEGIN-Meq-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
Jun	Jun-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
c	BEGIN-c	NN	I-NP	B
-	-	HYPH	B-NP	I
Jun	Jun-INSIDE	NN	I-NP	I
homodimers	homodimer	NNS	I-NP	O

Infra	Infra	AFX	B-NP	O
-	-	HYPH	I-NP	O
red	red	JJ	I-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
of	of	IN	B-PP	O
tissues	tissue	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
cm	cm	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
region	region	NN	I-NP	O

Although	Although	IN	B-SBAR	O
no	no	DT	B-NP	O
detectable	detectable	JJ	I-NP	O
phenotypes	phenotype	NNS	I-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
disruption	disruption	NN	I-NP	O
allele	allele	NN	I-NP	O
of	of	IN	B-PP	O
ABP1	BEGIN-ABP1-INSIDE	NN	B-NP	B
,	,	,	O	O
mutations	mutation	NNS	B-NP	O
that	that	WDT	B-NP	O
create	create	VBP	B-VP	O
a	a	DT	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
protein	protein	NN	I-NP	O
have	have	VBP	B-VP	O
now	now	RB	I-VP	O
been	be	VBN	I-VP	O
isolated	isolate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
identified	identify	VBN	I-NP	O
gene	BEGIN-gene	JJ	I-NP	B
SAC1	SAC1-INSIDE	NN	I-NP	I
and	and	CC	O	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
new	new	JJ	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
SLA1	BEGIN-SLA1-INSIDE	NN	B-NP	B
and	and	CC	O	O
SLA1	BEGIN-SLA1-INSIDE	NN	B-NP	B

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
bioreactive	bioreactive	JJ	B-NP	O
and	and	CC	I-NP	O
immunoreactive	immunoreactive	JJ	I-NP	O
gastrin	BEGIN-gastrin-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
claustrocortical	claustrocortical	JJ	I-NP	O
connection	connection	NN	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
cats	cat	NNS	I-NP	O
with	with	IN	B-PP	O
selective	selective	JJ	B-NP	O
injections	injection	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
HRP	HRP	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
subdivisions	subdivision	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
auditory	auditory	JJ	I-NP	O
cortex.	cortex.	NN	I-NP	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-NP	O
1	1	CD	I-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
report	report	VBP	B-VP	O
a	a	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
painful	painful	JJ	I-NP	O
wrist	wrist	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
Manieux	Manieux	NN	I-NP	O
muscle	muscle	NN	I-NP	O
''	''	''	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dorsal	dorsal	JJ	I-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hand	hand	NN	I-NP	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
total	total	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
p1	BEGIN-p1	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
levels	level	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
p1	BEGIN-p1	NN	B-NP	B
mRNA	mRNA-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
observed	observe	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
Cdk	BEGIN-Cdk-INSIDE	JJ	B-NP	B
regulatory	regulatory	JJ	I-NP	O
kinases	kinase	NNS	I-NP	O
and	and	CC	I-NP	O
phosphatases	phosphatas	NNS	I-NP	O
occur	occur	VBP	B-VP	O

This	This	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
unrearranged	BEGIN-unrearranged	JJ	B-NP	B
V	BEGIN-V	NN	I-NP	B
kappa	kappa-INSIDE	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
transcriptionally	transcriptionally	RB	B-ADJP	O
silent	silent	JJ	I-ADJP	O
,	,	,	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
structural	structural	JJ	B-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
V	BEGIN-V	NN	I-NP	B
kappa	kappa-INSIDE	NN	I-NP	I
and	and	CC	O	O
C	BEGIN-C	NN	B-NP	B
kappa	kappa	NN	I-NP	I
loci	loci-INSIDE	NN	I-NP	I
contribute	contribute	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
efficiency	efficiency	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
rearranged	BEGIN-rearranged	JJ	I-NP	B
V	BEGIN-V	NN	I-NP	B
kappa	kappa-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
C	C	NN	I-NP	O
kappa	kappa	NN	I-NP	O
gene	gene-INSIDE	NN	I-NP	I

Level	Level	NN	B-NP	O
II	II	CD	I-NP	O
mosaicism	mosaicism	NN	I-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
of	of	IN	B-PP	O
CVS	CVS	NN	B-NP	O
mesenchyme	mesenchyme	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
of	of	IN	B-PP	O
amniotic	amniotic	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
general	general	JJ	B-ADJP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
perceived	perceive	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
sufficient	sufficient	JJ	B-NP	O
concern	concern	NN	I-NP	O
to	to	TO	B-VP	O
warrant	warrant	VB	I-VP	O
cytogenetic	cytogenetic	JJ	B-NP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
studies	study	NNS	B-NP	O

Measures	Measure	NNS	B-NP	O
of	of	IN	B-PP	O
sedation	sedation	NN	B-NP	O
,	,	,	O	O
BIS	BIS	NN	B-NP	O
,	,	,	O	O
deltaBIS	deltaBIS	NN	B-NP	O
(	(	(	O	O
absolute	absolute	JJ	B-NP	O
change	change	NN	I-NP	O
of	of	IN	B-PP	O
BIS	BIS	NN	B-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
painful	painful	JJ	I-NP	O
stimulus	stimulus	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
memory	memory	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
drug	drug	NN	B-NP	O
concentration	concentration	NN	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
at	at	IN	B-PP	O
each	each	DT	B-NP	O
target	target	NN	I-NP	O
drug	drug	NN	I-NP	O
concentration	concentration	NN	I-NP	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
three	three	CD	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
problems	problem	NNS	B-NP	O
:	:	:	O	O
problems	problem	NNS	B-NP	O
arising	arise	VBG	B-VP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
enters	enter	VBZ	B-VP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
(	(	(	O	O
solubilization	solubilization	NN	B-NP	O
,	,	,	O	O
stabilization	stabilization	NN	B-NP	O
and	and	CC	O	O
improved	improve	VBN	B-NP	O
acceptability	acceptability	NN	I-NP	O
)	)	)	O	O
;	;	:	O	O
problems	problem	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
penetration	penetration	NN	I-NP	O
and	and	CC	I-NP	O
fate	fate	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
(	(	(	O	O
absorption	absorption	NN	B-NP	O
,	,	,	O	O
barrier	barrier	NN	B-NP	O
crossing	crossing	NN	I-NP	O
,	,	,	O	O
duration	duration	NN	B-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
problems	problem	NNS	B-NP	O
relating	relate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
target	target	NN	I-NP	O
(	(	(	O	O
selective	selective	JJ	B-NP	O
local	local	JJ	I-NP	O
delivery	delivery	NN	I-NP	O
)	)	)	O	O

The	The	DT	B-NP	O
structure	structure	NN	I-NP	O
elucidation	elucidation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
iridoid	iridoid	JJ	I-NP	O
compounds	compound	NNS	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
in	in	IN	B-PP	O
detail	detail	NN	B-NP	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
trinucleotide	trinucleotide	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	O	O
tandem	tandem	JJ	B-NP	O
repeat	repeat	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
transcripts	transcript	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
density	density	NN	I-NP	O
filter	filter	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O

CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Urbanisation	Urbanisation	NN	B-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
risk	risk	NN	I-NP	O
behaviours	behaviour	VBZ	B-VP	O

The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
emphasize	emphasize	VBP	B-VP	O
absence	absence	NN	B-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
vagal	vagal	JJ	B-NP	O
involvement	involvement	NN	I-NP	O
,	,	,	O	O
importance	importance	NN	B-NP	O
for	for	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O
of	of	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
extirpation	extirpation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mildness	mildness	NN	B-NP	O
of	of	IN	B-PP	O
post	post	NN	B-NP	O
operative	operative	JJ	I-NP	O
course	course	NN	I-NP	O

Growth	Growth	NN	B-NP	O
factors	factor	NNS	I-NP	O
promote	promote	VBP	B-VP	O
cell	cell	NN	B-NP	O
survival	survival	NN	I-NP	O
through	through	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
Bad	BEGIN-Bad-INSIDE	NN	B-NP	B
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
dissociation	dissociation	NN	I-NP	O
from	from	IN	B-PP	O
Bcl	BEGIN-Bcl	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Bcl	BEGIN-Bcl	NN	I-NP	B
-	-	HYPH	O	I
x	x	SYM	B-NP	I
(	(	(	O	I
L	L	NN	B-NP	I
)	)	)	O	I
	-INSIDE	NN	B-NP	I
and	and	CC	O	O
its	its	PRP$	B-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
1	BEGIN-1	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
1tau	1tau-INSIDE	NN	I-NP	I

Both	Both	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Federal	Federal	NNP	I-NP	O
Republic	Republic	NNP	I-NP	O
of	of	IN	B-PP	O
Germany	Germany	NNP	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
neighbouring	neighbouring	NN	I-NP	O
countries	country	VBZ	B-VP	O
the	the	DT	B-NP	O
epizootic	epizootic	JJ	I-NP	O
situation	situation	NN	I-NP	O
of	of	IN	B-PP	O
Aujeszky	Aujeszky	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
unsatisfactory	unsatisfactory	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
areas	area	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
pig	pig	NN	I-NP	O
density	density	NN	I-NP	O

The	The	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
1mTc	1mTc	NN	B-NP	O
-	-	HYPH	B-NP	O
IgG	BEGIN-IgG-INSIDE	NN	I-NP	B
scintigraphy	scintigraphy	NN	I-NP	O
ranged	range	VBD	B-VP	O
between	between	IN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O

Acad	Acad	NNP	B-NP	O

Aggravation	Aggravation	NN	B-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
-	-	HYPH	I-NP	O
blood	blood	NN	I-NP	O
cytopenia	cytopenia	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
hypocellularity	hypocellularity	NN	B-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
-	-	HYPH	B-NP	O
marrow	marrow	NN	I-NP	O
aspirates	aspirate	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	I-NP	O
Ara	Ara	NN	I-NP	O
C	C	NN	I-NP	O
exerts	exert	VBZ	B-VP	O
its	its	PRP$	B-NP	O
main	main	JJ	I-NP	O
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
leukaemic	leukaemic	JJ	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
by	by	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
in	in	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
cells	cell	NNS	I-NP	O

Those	Those	DT	B-NP	O
participating	participate	VBG	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
investigation	investigation	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
centers	center	NNS	I-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
computer	computer	NN	B-NP	O
disks	disk	NNS	I-NP	O
containing	contain	VBG	B-VP	O
1	1	CD	B-NP	O
1mTc	1mTc	NN	I-NP	O
-	-	HYPH	B-NP	O
DMSA	DMSA	NN	I-NP	O
studies	study	NNS	I-NP	O

Probiotics	Probiotic	NNS	B-NP	O
,	,	,	O	O
prebiotics	prebiotic	NNS	B-NP	O
,	,	,	O	O
vaccination	vaccination	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
acidification	acidification	NN	B-NP	O
of	of	IN	B-PP	O
drinking	drinking	NN	B-NP	O
water	water	NN	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
as	as	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
Salmonella	Salmonella	NNP	B-NP	O

Mutation	Mutation	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
threonine	threonine	NN	I-NP	O
to	to	TO	B-PP	O
isoleucine	isoleucine	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
observable	observable	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
either	either	CC	B-NP	O
nuclear	nuclear	JJ	I-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
or	or	CC	I-NP	O
DNA	DNA	NN	I-NP	O
replication	replication	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intact	intact	JJ	I-NP	O
viral	viral	JJ	I-NP	O
genome	genome	NN	I-NP	O

The	The	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
monoamine	BEGIN-monoamine	NN	B-NP	B
oxidase	oxidase-INSIDE	NN	I-NP	I
(	(	(	O	O
MAO	BEGIN-MAO-INSIDE	NN	B-NP	B
)	)	)	O	O
by	by	IN	B-PP	O
tranylcypromine	tranylcypromine	NN	B-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
given	give	VBN	B-VP	O
increasing	increase	VBG	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
week	week	NN	I-NP	O
period	period	NN	I-NP	O

Myocardial	Myocardial	JJ	B-NP	O
technetium	technetium	NN	I-NP	O
-	-	HYPH	B-NP	O
1m	1m	NN	I-NP	O
-	-	HYPH	I-NP	O
teboroxime	teboroxime	NN	I-NP	O
uptake	uptake	NN	I-NP	O
during	during	IN	B-PP	O
adenosine	adenosine	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
hyperemia	hyperemia	NN	I-NP	O
in	in	IN	B-PP	O
dogs	dog	NNS	B-NP	O
with	with	IN	B-PP	O
either	either	CC	B-NP	O
a	a	DT	I-NP	O
critical	critical	JJ	I-NP	O
or	or	CC	I-NP	O
mild	mild	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
:	:	:	O	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
thallium	thallium	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
regional	regional	JJ	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O

Both	Both	CC	O	O
atracurium	atracurium	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
mumol	mumol	NN	I-NP	O
litre	litre	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
laudanosine	laudanosine	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
mumol	mumol	NN	I-NP	O
litre	litre	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
enhanced	enhance	VBD	B-VP	O
the	the	DT	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
1H	1H	NN	B-NP	O
-	-	HYPH	B-NP	O
NA	NA	NN	I-NP	O
evoked	evoke	VBN	B-VP	O
by	by	IN	B-PP	O
field	field	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
Hz	Hz	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
stimuli	stimulus	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
resting	rest	VBG	B-NP	O
release	release	NN	I-NP	O

The	The	DT	B-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
xanthomegnin	xanthomegnin	NN	B-NP	O
added	add	VBN	B-VP	O
to	to	TO	B-PP	O
corn	corn	NN	B-NP	O
samples	sample	NNS	I-NP	O
at	at	IN	B-PP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	B-NP	O
-	-	SYM	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
averaged	average	VBD	B-VP	O
1	1	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
coefficient	coefficient	NN	I-NP	O
of	of	IN	B-PP	O
variation	variation	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
LAC1	BEGIN-LAC1-INSIDE	NN	B-NP	B
contacts	contact	VBZ	B-VP	O
positions	position	NNS	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
plus	plus	CC	I-NP	O
and	and	CC	I-NP	O
minus	minus	NN	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
UAS	UAS	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
separated	separate	VBN	I-VP	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
one	one	CD	I-NP	O
turn	turn	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
helix	helix	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
twists	twist	NNS	B-NP	O
part	part	NN	I-NP	O
way	way	NN	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
protecting	protect	VBG	B-VP	O
the	the	DT	B-NP	O
broad	broad	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
minor	minor	JJ	I-NP	O
groove	groove	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
-	-	HYPH	I-NP	O
groove	groove	NN	I-NP	O
contacts	contact	NNS	I-NP	O

Istanbul	Istanbul	NNP	B-NP	O
,	,	,	O	O
Turkey	Turkey	NNP	B-NP	O

After	After	IN	B-PP	O
Northern	Northern	JJ	B-NP	O
blot	blot	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
Cx1	BEGIN-Cx1	NN	I-NP	B
transcripts	transcript	NNS	I-NP	I
of	of	IN	B-PP	I
1	1	CD	B-NP	I
and	and	CC	I-NP	I
1	1	CD	I-NP	I
kb	kb-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
total	total	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
keratinocyte	keratinocyte	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
HaCaT	HaCaT	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
transcripts	transcript	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
kb	kb	NN	I-NP	O
in	in	IN	B-PP	O
total	total	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
of	of	IN	B-PP	O
E1	BEGIN-E1-INSIDE	NN	B-NP	B
/	/	SYM	B-NP	O
E1	BEGIN-E1-INSIDE	NN	I-NP	B
transfected	transfecte	VBN	B-VP	O
human	human	JJ	B-NP	O
keratinocytes	keratinocyte	NNS	I-NP	O
(	(	(	O	O
HEK	HEK	NN	B-NP	O
cells	cell	NNS	I-NP	O
)	)	)	O	O

While	While	IN	B-SBAR	O
differential	differential	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
transcripts	transcript	NNS	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
controlling	control	VBG	B-VP	O
LT1	BEGIN-LT1-INSIDE	NN	B-NP	B
/	/	SYM	I-NP	O
LT1	BEGIN-LT1-INSIDE	NN	I-NP	B
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O

SYC1	BEGIN-SYC1-INSIDE	NN	B-NP	B
(	(	(	O	O
suppressor	BEGIN-suppressor	NN	B-NP	B
of	of	IN	B-PP	I
yeast	yeast	NN	B-NP	I
cbf1	BEGIN-cbf1	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE-INSIDE	NN	I-NP	I
)	)	)	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
multicopy	multicopy	JJ	I-NP	O
suppressor	suppressor	NN	I-NP	O
of	of	IN	B-PP	O
cbf1	BEGIN-cbf1	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
was	be	VBD	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
RRN1	BEGIN-RRN1-INSIDE	NN	B-NP	B
,	,	,	O	O
an	an	DT	B-NP	O
RNA	BEGIN-RNA	NN	I-NP	B
polymerase	polymerase	NN	I-NP	I
I	I	CD	I-NP	I
transcription	transcription	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I

Developmental	Developmental	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
malate	BEGIN-malate	JJ	I-NP	B
synthase	synthase	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
transgenic	transgenic	JJ	B-NP	O
plants	plant	NNS	I-NP	O

All	All	DT	B-NP	O
three	three	CD	I-NP	O
SSV	SSV	NN	I-NP	O
-	-	HYPH	I-NP	O
transformed	transform	VBN	I-NP	O
cells	cell	NNS	I-NP	O
secreted	secrete	VBD	B-VP	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	B-NP	I
sis	sis	NN	I-NP	I
gene	gene	NN	I-NP	I
product	product-INSIDE	NN	I-NP	I
(	(	(	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
)	)	)	O	O
.	.	.	O	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
was	be	VBD	B-VP	O
secreted	secrete	VBN	I-VP	O
but	but	CC	O	O
remained	remain	VBD	B-VP	O
tightly	tightly	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
identified	identify	VBD	B-VP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
kbp	kbp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
coding	cod	VBG	I-NP	O
exon	exon	NN	I-NP	O
of	of	IN	B-PP	O
human	BEGIN-human	JJ	B-NP	B
aFGF	aFGF-INSIDE	NN	I-NP	I
,	,	,	O	O
whose	whose	WP$	B-NP	O
sequence	sequence	NN	I-NP	O
is	be	VBZ	B-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
the	the	DT	I-NP	O
primate	primate	NN	I-NP	O
and	and	CC	I-NP	O
rodent	rodent	NN	I-NP	O
genomes	genome	NNS	I-NP	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
respect	respect	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
COX	BEGIN-COX	NN	B-NP	B
genes	genes-INSIDE	NN	I-NP	I
resemble	resemble	VBP	B-VP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
house	house	NN	I-NP	O
-	-	HYPH	O	O
keeping	keep	VBG	B-VP	O
genes	gene	NNS	B-NP	O

The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
FlaB1	BEGIN-FlaB1	NN	I-NP	B
polypeptide	polypeptide-INSIDE	NN	I-NP	I
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
T.	BEGIN-T.	FW	B-NP	B
pallidum	pallidum	FW	I-NP	I
FlaB1	FlaB1-INSIDE	NN	I-NP	I
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
identity	identity	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
level	level	NN	I-NP	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
CCTalpha	BEGIN-CCTalpha-INSIDE	NN	B-NP	B
can	can	MD	B-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
lipids	lipid	NNS	B-NP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
independent	independent	JJ	I-NP	O
domains	domain	NNS	I-NP	O
:	:	:	O	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
amphipathic	amphipathic	JJ	I-NP	O
alpha	alpha	SYM	I-NP	O
-	-	HYPH	I-NP	O
helical	helical	JJ	I-NP	O
repeats	repeat	NNS	I-NP	O
that	that	WDT	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
both	both	CC	B-NP	O
neutral	neutral	JJ	I-NP	O
and	and	CC	I-NP	O
anionic	anionic	JJ	I-NP	O
lipid	lipid	NN	I-NP	O
mixtures	mixture	NNS	I-NP	O
and	and	CC	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
1	1	CD	I-NP	O
residues	residue	NNS	I-NP	O
that	that	WDT	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
anionic	anionic	JJ	B-NP	O
lipids	lipid	NNS	I-NP	O

Ion	Ion	NN	B-NP	O
-	-	HYPH	I-NP	O
Bernstein	Bernstein	NN	I-NP	O
-	-	HYPH	I-NP	O
wave	wave	NN	I-NP	O
heating	heating	NN	I-NP	O
and	and	CC	O	O
improved	improve	VBN	B-NP	O
confinement	confinement	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Alcator	Alcator	NNP	I-NP	O
C	C	NNP	I-NP	O
tokamak	tokamak	NN	I-NP	O

Of	Of	IN	B-PP	O
1	1	CD	B-NP	O
serum	serum	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
sows	sow	NNS	B-NP	O
received	receive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Tennessee	Tennessee	NNP	I-NP	O
State	State	NNP	I-NP	O
Diagnostic	Diagnostic	NNP	I-NP	O
Laboratory	Laboratory	NNP	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
Toxoplasma	BEGIN-Toxoplasma	NN	B-NP	B
gondii	gondii	NN	I-NP	I
antibody	antibody-INSIDE	NN	I-NP	I

Morphometry	Morphometry	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intestine	intestine	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pig	pig	NN	I-NP	O

The	The	DT	B-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
indomethacin	indomethacin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
thrice	thrice	NN	I-NP	O
daily	daily	JJ	B-ADJP	O

Human	BEGIN-Human	JJ	B-NP	B
parvovirus	parvovirus	NN	I-NP	I
B1	B1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
viral	BEGIN-viral	JJ	I-NP	B
p1	p1	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
(	(	(	O	O
B1p1	BEGIN-B1p1-INSIDE	NN	B-NP	B
)	)	)	O	O
is	be	VBZ	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
primary	primary	JJ	B-NP	O
human	human	JJ	I-NP	O
hematopoietic	hematopoietic	JJ	I-NP	O
cells	cell	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
erythroid	erythroid	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O

To	To	TO	B-VP	O
further	further	RB	I-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
tTG	BEGIN-tTG-INSIDE	NN	B-NP	B
in	in	IN	B-PP	O
liver	liver	NN	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
initiated	initiate	VBD	B-VP	O
investigations	investigation	NNS	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	O
mediator	mediator	NN	I-NP	O
,	,	,	O	O
tumor	BEGIN-tumor	NN	B-NP	B
necrosis	necrosis	NN	I-NP	I
factor	factor	NN	I-NP	I
(	(	(	O	I
TNF	TNF	NN	B-NP	I
)	)	)	O	I
-	-	HYPH	O	I
alpha	alpha-INSIDE	NN	B-NP	I
,	,	,	O	O
on	on	IN	B-PP	O
tTG	BEGIN-tTG-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
cultured	culture	VBN	B-NP	O
liver	liver	NN	I-NP	O
cells	cell	NNS	I-NP	O

The	The	DT	B-NP	O
atopic	atopic	JJ	I-NP	O
disposition	disposition	NN	I-NP	O
,	,	,	O	O
indicated	indicate	VBN	B-VP	O
by	by	IN	B-PP	O
positive	positive	JJ	B-NP	O
skin	skin	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
and	and	CC	O	O
IgE	BEGIN-IgE-INSIDE	NN	B-NP	B
antibody	antibody	NN	I-NP	O
titers	titer	NNS	I-NP	O
etc.	etc.	FW	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
bronchial	bronchial	JJ	I-NP	O
reactivity	reactivity	NN	I-NP	O
to	to	TO	B-PP	O
inhaled	inhale	VBN	B-NP	O
acetylcholine	acetylcholine	NN	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
three	three	CD	I-NP	O
groups	group	NNS	I-NP	O
:	:	:	O	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
1	1	CD	B-NP	O
young	young	JJ	I-NP	O
adults	adult	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
childhood	childhood	NN	B-NP	O
asthma	asthma	NN	I-NP	O
who	who	WP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
symptom	symptom	JJ	B-ADJP	O
-	-	HYPH	O	O
free	free	JJ	B-ADJP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
yr	yr	NN	I-NP	O
;	;	:	O	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
1	1	CD	B-NP	O
current	current	JJ	I-NP	O
asthmatics	asthmatic	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
1	1	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
young	young	JJ	I-NP	O
adults	adult	NNS	I-NP	O

Continuous	Continuous	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
sampling	sampling	NN	I-NP	O
method	method	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
microsphere	microsphere	NN	I-NP	O
model	model	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
rCBF	rCBF	NN	I-NP	O
measurement	measurement	NN	I-NP	O

Members	Member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
steroid	BEGIN-steroid	NN	I-NP	B
/	/	SYM	B-NP	I
hormone	hormone	NN	I-NP	I
nuclear	nuclear	JJ	I-NP	I
receptor	receptor	NN	I-NP	I
superfamily	superfamily-INSIDE	NN	I-NP	I
regulate	regulate	VBP	B-VP	O
target	target	NN	B-NP	O
gene	gene	NN	I-NP	O
transcription	transcription	NN	I-NP	O
via	via	IN	B-PP	O
recognition	recognition	NN	B-NP	O
and	and	CC	I-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
,	,	,	O	O
called	call	VBN	B-VP	O
hormone	hormone	NN	B-NP	O
response	response	NN	I-NP	O
elements	element	NNS	I-NP	O
(	(	(	O	O
HREs	HRE	NNS	B-NP	O
)	)	)	O	O

Thomas	Thomas	NNP	B-NP	O
,	,	,	O	O
S.S	S.S	NNP	B-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
w	w	VBP	B-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
Loa	Loa	NN	I-NP	O
microfilaremia	microfilaremia	NN	I-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
milder	mild	JJR	B-NP	O
neurologic	neurologic	JJ	I-NP	O
manifestations	manifestation	NNS	I-NP	O
causing	cause	VBG	B-VP	O
functional	functional	JJ	B-NP	O
impairment	impairment	NN	I-NP	O
lasting	last	VBG	B-VP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
demographics	demographic	NNS	I-NP	O
(	(	(	O	O
means	mean	VBZ	B-VP	O
+	+	SYM	B-NP	O
/	/	SYM	O	O
-	-	HYPH	O	O
standard	standard	JJ	B-NP	O
deviations	deviation	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
age	age	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
;	;	:	O	O
sex	sex	NN	B-NP	O
,	,	,	O	O
nine	nine	CD	B-NP	O
males	male	NNS	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
females	female	NNS	I-NP	O
;	;	:	O	O
APACHE	APACHE	NN	B-NP	O
II	II	CD	I-NP	O
score	score	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
diagnosis	diagnosis	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
binocular	binocular	JJ	B-NP	O
pregeniculate	pregeniculate	JJ	I-NP	O
visual	visual	JJ	I-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
balanced	balanced	JJ	B-NP	O
binocular	binocular	JJ	I-NP	O
pregeniculate	pregeniculate	JJ	I-NP	O
loss	loss	NN	I-NP	O
without	without	IN	B-PP	O
RAPD	RAPD	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
monocular	monocular	JJ	B-NP	O
pregeniculate	pregeniculate	JJ	I-NP	O
visual	visual	JJ	I-NP	O
loss	loss	NN	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
larger	large	JJR	I-NP	O
pupils	pupil	NNS	I-NP	O
than	than	IN	B-PP	O
age	age	NN	B-NP	O
-	-	HYPH	B-NP	O
matched	match	VBN	I-NP	O
controls	control	NNS	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
corticotropin	BEGIN-corticotropin	NN	B-NP	B
releasing	release	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
(	(	(	O	O
CRF	BEGIN-CRF-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
injected	inject	VBN	B-VP	O
centrally	centrally	RB	B-ADVP	O
produces	produce	VBZ	B-VP	O
a	a	DT	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
punished	punish	VBN	O	O
and	and	CC	O	O
non	non	AFX	O	O
-	-	HYPH	O	O
punished	punish	VBN	B-VP	O
responding	respond	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
conflict	conflict	NN	I-NP	O
test	test	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
hypothesized	hypothesize	VBN	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
mediating	mediate	VBG	B-VP	O
behavioral	behavioral	JJ	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-VP	O
stress	stress	VB	I-VP	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
replicative	replicative	JJ	B-NP	O
intermediates	intermediate	NNS	I-NP	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
plasmid	plasmid	NN	B-NP	O
YRp1	YRp1	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
chromosomal	chromosomal	JJ	I-NP	O
replicator	replicator	NN	I-NP	O
ARS1	ARS1	NN	I-NP	O
,	,	,	O	O
initiates	initiate	VBZ	B-VP	O
bidirectional	bidirectional	JJ	B-NP	O
replication	replication	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
region	region	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
autonomous	autonomous	JJ	B-NP	O
replication	replication	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

Tag	BEGIN-Tag-INSIDE	NN	B-NP	B
expression	expression	NN	I-NP	O
induced	induce	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
mammary	mammary	JJ	B-NP	O
epithelial	epithelial	JJ	I-NP	O
cells	cell	NNS	I-NP	O
during	during	IN	B-PP	O
late	late	JJ	B-NP	O
pregnancy	pregnancy	NN	I-NP	O

Concentrations	Concentration	NNS	B-NP	O
of	of	IN	B-PP	O
Co	Co	NNP	B-NP	O
,	,	,	I-NP	O
Cu	Cu	NNP	I-NP	O
,	,	,	I-NP	O
Fe	Fe	NNP	I-NP	O
,	,	,	I-NP	O
Hg	Hg	NNP	I-NP	O
,	,	,	I-NP	O
Mn	Mn	NNP	I-NP	O
,	,	,	I-NP	O
Sb	Sb	NN	I-NP	O
,	,	,	I-NP	O
Se	Se	NN	I-NP	O
and	and	CC	I-NP	O
Zn	Zn	NN	I-NP	O
in	in	IN	B-PP	O
IAEA	IAEA	NN	B-NP	O
milk	milk	NN	I-NP	O
(	(	(	O	O
dry	dry	JJ	B-ADJP	O
)	)	)	O	O
standard	standard	JJ	B-NP	O
A	A	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
were	be	VBD	B-VP	O
re	re	AFX	B-ADJP	O
-	-	HYPH	B-NP	O
evaluated	evaluate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
help	help	NN	I-NP	O
of	of	IN	B-PP	O
instrumental	instrumental	JJ	B-NP	O
and	and	CC	I-NP	O
radiochemical	radiochemical	JJ	I-NP	O
neutron	neutron	NN	I-NP	O
activation	activation	NN	I-NP	O
analysis	analysis	NN	I-NP	O
(	(	(	O	O
NAA	NAA	NN	B-NP	O
)	)	)	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
are	be	VBP	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
processing	processing	NN	B-NP	O
of	of	IN	B-PP	O
U1	BEGIN-U1-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
snR1	BEGIN-snR1	NN	I-NP	B
snoRNAs	snoRNAs-INSIDE	NN	I-NP	I
and	and	CC	O	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
compensate	compensate	VBP	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
canonical	canonical	JJ	I-NP	O
terminal	terminal	JJ	I-NP	O
stem	stem	NN	I-NP	O

In	In	IN	B-PP	O
serum	serum	NN	B-NP	O
-	-	HYPH	B-NP	O
starved	starve	VBN	I-NP	O
NIH	NIH	NN	I-NP	O
1T1	1T1	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
v	BEGIN-v	NN	B-NP	B
-	-	HYPH	B-NP	I
raf	raf-INSIDE	NN	I-NP	I
increased	increase	VBD	B-VP	O
mdr1	BEGIN-mdr1	NN	B-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
v	BEGIN-v	NN	I-NP	B
-	-	HYPH	O	I
raf	raf-INSIDE	NN	B-NP	I
frame	frame	NN	I-NP	O
-	-	HYPH	O	O
shift	shift	NN	B-NP	O
control	control	NN	I-NP	O

An	An	DT	B-NP	O
insertion	insertion	NN	I-NP	O
sequence	sequence	NN	I-NP	O
element	element	NN	I-NP	O
(	(	(	O	O
IS1	IS1	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nimC	BEGIN-nimC	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

Two	Two	CD	B-NP	O
genes	gene	NNS	I-NP	O
(	(	(	O	O
ptsI	BEGIN-ptsI-INSIDE	NN	B-NP	B
and	and	CC	O	O
ptsA	BEGIN-ptsA-INSIDE	NN	B-NP	B
)	)	)	O	O
that	that	WDT	B-NP	O
encode	encode	VBP	B-VP	O
homologues	homologue	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
energy	energy	NN	I-NP	O
coupling	coupling	NN	I-NP	O
Enzyme	BEGIN-Enzyme	NN	I-NP	B
I	I-INSIDE	NN	I-NP	I
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phosphoenolpyruvate	BEGIN-phosphoenolpyruvate	NN	I-NP	B
-	-	HYPH	O	I
dependent	dependent	JJ	B-NP	I
sugar	sugar	NN	I-NP	I
-	-	HYPH	O	I
transporting	transport	VBG	B-VP	I
phosphotransferase	phosphotransferase-INSIDE	NN	B-NP	I
system	system	NN	I-NP	O
(	(	(	O	O
PTS	PTS	NN	B-NP	O
)	)	)	O	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Escherichia	Escherichia	FW	I-NP	O
coli	coli	FW	I-NP	O
chromosome	chromosome	NN	I-NP	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
beta	BEGIN-beta	NN	I-NP	B
-	-	HYPH	O	I
MyHC	MyHC	NN	B-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
start	start	NN	I-NP	O
site	site	NN	I-NP	O
)	)	)	O	O
directed	direct	VBD	B-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activity	activity	NN	I-NP	O
only	only	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
stably	stably	RB	B-VP	O
integrated	integrate	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
when	when	WRB	B-ADVP	O
expressed	express	VBN	B-VP	O
extrachromosomally	extrachromosomally	RB	B-ADVP	O
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
assays	assay	NNS	I-NP	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
cDNAs	cDNA	NNS	I-NP	O
of	of	IN	B-PP	O
HMG	BEGIN-HMG	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
HMG	BEGIN-HMG	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
do	do	VBP	B-VP	O
not	not	RB	O	O
cross	cross	AFX	O	O
-	-	HYPH	O	O
hybridize	hybridize	NN	B-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
have	have	VBP	B-VP	O
several	several	JJ	B-NP	O
similar	similar	JJ	I-NP	O
structural	structural	JJ	I-NP	O
features	feature	NNS	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
open	open	JJ	I-NP	O
reading	reading	NN	I-NP	O
frame	frame	NN	I-NP	O
comprises	comprise	VBZ	B-VP	O
only	only	RB	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
untranslated	untranslated	JJ	I-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
extremely	extremely	RB	B-ADJP	O
GC	GC	NN	I-ADJP	O
rich	rich	JJ	I-ADJP	O
whereas	whereas	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
untranslated	untranslated	JJ	I-NP	O
region	region	NN	I-NP	O
is	be	VBZ	B-VP	O
unusually	unusually	RB	B-ADJP	O
long	long	JJ	I-ADJP	O
and	and	CC	O	O
AT	AT	NN	B-VP	O
rich	rich	JJ	B-ADJP	O

A	A	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
pheromone	pheromone	NN	I-NP	O
induction	induction	NN	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
delineated	delineate	VBN	B-VP	O
as	as	IN	B-PP	O
residues	residue	NNS	B-NP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
Ste1p	BEGIN-Ste1p-INSIDE	NN	B-NP	B
,	,	,	O	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
pheromone	pheromone	NN	I-NP	O
mitogen	BEGIN-mitogen	NN	I-NP	B
-	-	HYPH	B-VP	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
(	(	(	O	I
MAP	MAP	NN	B-NP	I
)	)	)	O	I
kinase	kinase-INSIDE	NN	B-NP	I
pathway	pathway	NN	I-NP	O
for	for	IN	B-PP	O
induction	induction	NN	B-NP	O
activity	activity	NN	I-NP	O

The	The	DT	B-NP	O
IFNAR	BEGIN-IFNAR	NN	I-NP	B
chain	chain-INSIDE	NN	I-NP	I
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
both	both	CC	O	O
IFN	BEGIN-IFN	NN	B-NP	B
-	-	HYPH	B-NP	I
alpha	alpha	SYM	I-NP	I
1	1-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
IFN	BEGIN-IFN	NN	I-NP	B
-	-	HYPH	O	I
beta	beta-INSIDE	NN	B-NP	I
,	,	,	O	O
as	as	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
by	by	IN	B-PP	O
cross	cross	AFX	B-NP	O
-	-	HYPH	I-NP	O
linking	link	VBG	B-VP	O

To	To	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
thrombus	thrombus	NN	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
determined	determine	VBD	B-VP	O
the	the	DT	B-NP	O
accretion	accretion	NN	I-NP	O
of	of	IN	B-PP	O
1I	1I	NN	B-NP	O
-	-	HYPH	O	O
labeled	label	VBN	B-NP	O
fibrinogen	BEGIN-fibrinogen-INSIDE	NN	I-NP	B
onto	onto	IN	B-PP	O
autologous	autologous	JJ	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
radioactive	radioactive	JJ	I-NP	O
thrombi	thrombi	NN	I-NP	O
preformed	preforme	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
veins	vein	NNS	I-NP	O
of	of	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
two	two	CD	I-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
fluoxetine	fluoxetine	NN	B-NP	O
adjunct	adjunct	NN	I-NP	O
produced	produce	VBD	B-VP	O
benefits	benefit	NNS	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
additional	additional	JJ	I-NP	O
side	side	NN	I-NP	O
effects	effect	NNS	I-NP	O

This	This	DT	B-NP	O
radiolabeled	radiolabele	VBD	B-VP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
amplicon	amplicon	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
hybridization	hybridization	NN	I-NP	O
probe	probe	NN	I-NP	O
to	to	TO	B-VP	O
screen	screen	VB	I-VP	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
library	library	NN	I-NP	O
constructed	construct	VBN	B-VP	O
from	from	IN	B-PP	O
poly	poly	NN	B-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
RNA	RNA	NN	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
induced	induce	VBN	B-NP	O
Taxus	Taxus	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
which	which	WDT	B-NP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
-	-	HYPH	I-NP	O
length	length	NN	I-NP	O
transacetylase	transacetylase	NN	I-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
TAM	BEGIN-TAM	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
reverted	revert	VBD	B-VP	O
the	the	DT	B-NP	O
morphology	morphology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AdoMetDC	BEGIN-AdoMetDC	NN	I-NP	B
-	-	HYPH	B-NP	I
antisense	antisense	JJ	I-NP	I
expressors	expressors-INSIDE	NN	I-NP	I

For	For	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
wk	wk	NN	I-NP	O
for	for	IN	B-PP	O
RIR	RIR	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
for	for	IN	B-PP	O
WL	WL	NN	B-NP	O
males	male	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
wk	wk	NN	I-NP	O
for	for	IN	B-PP	O
RIR	RIR	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
for	for	IN	B-PP	O
WL	WL	NN	B-NP	O
females	female	NNS	I-NP	O

TFEC	BEGIN-BEGIN-TFEC-INSIDE	NN	B-NP	B
RNA	RNA-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
of	of	IN	B-PP	O
adult	adult	JJ	B-NP	O
rats	rat	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
TFEC	BEGIN-TFEC-INSIDE	NN	B-NP	B
and	and	CC	I-NP	O
TFE1	BEGIN-TFE1	NN	I-NP	B
RNAs	RNAs-INSIDE	NN	I-NP	I
vary	vary	VBP	B-VP	O
considerably	considerably	RB	B-ADVP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
different	different	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Three	Three	CD	B-NP	O
patients	patient	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
PPI	PPI	NN	B-NP	O
medication	medication	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
histamine	histamine	NN	I-NP	O
(	(	(	O	O
H1	H1	NN	B-NP	O
)	)	)	O	O
blockers	blocker	NNS	B-NP	O

VLA	BEGIN-VLA	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
integrin	integrin-INSIDE	NN	I-NP	I
cross	cross	AFX	O	O
-	-	HYPH	O	O
linking	link	VBG	B-VP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	O
monocytic	monocytic	JJ	I-NP	O
THP	THP	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
cells	cell	NNS	I-NP	O
induces	induce	VBZ	B-VP	O
tissue	tissue	NN	B-NP	O
factor	factor	NN	I-NP	O
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
involving	involve	VBG	B-VP	O
mitogen	BEGIN-mitogen	NN	B-NP	B
-	-	HYPH	O	I
activated	activate	VBN	B-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I

Diethyldithiocarbamate	Diethyldithiocarbamate	NN	B-NP	O
and	and	CC	I-NP	O
amphetamine	amphetamine	NN	I-NP	O
stereotype	stereotype	NN	I-NP	O
behavior	behavior	NN	I-NP	O

This	This	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
unrearranged	BEGIN-unrearranged	JJ	B-NP	B
V	BEGIN-V	NN	I-NP	B
kappa	kappa-INSIDE	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I
are	be	VBP	B-VP	O
transcriptionally	transcriptionally	RB	B-ADJP	O
silent	silent	JJ	I-ADJP	O
,	,	,	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
structural	structural	JJ	B-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
V	BEGIN-V	NN	I-NP	B
kappa	kappa-INSIDE	NN	I-NP	I
and	and	CC	O	O
C	BEGIN-BEGIN-C	NN	B-NP	B
kappa	kappa-INSIDE	NN	I-NP	I
loci	loci-INSIDE	NN	I-NP	I
contribute	contribute	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
efficiency	efficiency	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
rearranged	rearrange	VBN	I-NP	O
V	BEGIN-V	NN	I-NP	B
kappa	kappa-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
C	BEGIN-C	NN	I-NP	B
kappa	kappa-INSIDE	NN	I-NP	I
gene	gene	NN	I-NP	O

Oct	BEGIN-Oct	JJ	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
ubiquitously	ubiquitously	RB	I-NP	O
expressed	express	VBN	I-NP	O
regulatory	regulatory	JJ	I-NP	O
gene	gene	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
POU	BEGIN-POU	NN	I-NP	B
domain	domain	NN	I-NP	I
family	family-INSIDE	NN	I-NP	I

Both	Both	CC	O	O
RNA1	BEGIN-RNA1-INSIDE	NN	B-NP	B
and	and	CC	O	O
RNA1	BEGIN-BEGIN-RNA1-INSIDE	NN	B-NP	B
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
genes	genes-INSIDE	NN	I-NP	I
,	,	,	O	O
when	when	WRB	B-ADVP	O
cloned	clone	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
multicopy	multicopy	JJ	I-NP	O
plasmid	plasmid	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
suppress	suppress	VB	I-VP	O
the	the	DT	B-NP	O
temperature	temperature	NN	I-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
of	of	IN	B-PP	O
strains	strain	NNS	B-NP	O
bearing	bear	VBG	B-VP	O
either	either	CC	O	O
the	the	DT	B-NP	O
rna1	BEGIN-rna1-INSIDE	NN	I-NP	B
or	or	CC	O	O
the	the	DT	B-NP	O
rna1	BEGIN-BEGIN-rna1-INSIDE	NN	I-NP	B
mutation	mutation-INSIDE	NN	I-NP	I
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
encoded	encode	VBN	I-NP	O
proteins	protein	NNS	I-NP	O
could	could	MD	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O

Recent	Recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
concentrated	concentrate	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
methods	method	NNS	I-NP	O
of	of	IN	B-PP	O
preparation	preparation	NN	B-NP	O
of	of	IN	B-PP	O
coffee	coffee	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
vary	vary	VBP	B-VP	O
from	from	IN	B-PP	O
country	country	NN	B-NP	O
to	to	TO	B-PP	O
country	country	NN	B-NP	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
GCN1	BEGIN-GCN1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
for	for	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
eIF	BEGIN-eIF	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
by	by	IN	B-PP	O
GCN1	BEGIN-GCN1-INSIDE	NN	B-NP	B
,	,	,	O	O
cell	cell	NN	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
gcn1	BEGIN-gcn1	NN	B-NP	B
delta	delta-INSIDE	NN	I-NP	I
strains	strain	NNS	I-NP	O
contained	contain	VBD	B-VP	O
wild	wild	JJ	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
GCN1	BEGIN-GCN1-INSIDE	NN	B-NP	B
eIF	BEGIN-eIF	NN	I-NP	B
-	-	HYPH	O	I
1	1	CD	B-NP	I
alpha	alpha-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
kinase	kinase	NN	I-NP	O
activity	activity	NN	I-NP	O

Seven	Seven	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
syndromic	syndromic	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O

Experimental	Experimental	JJ	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
analogous	analogous	JJ	B-ADJP	O
to	to	TO	B-PP	O
hydramnios	hydramnio	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
fetus	fetus	NN	I-NP	O

The	The	DT	B-NP	O
phP1	BEGIN-phP1-INSIDE	NN	I-NP	B
mutation	mutation	NN	I-NP	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
P	BEGIN-P	NN	I-NP	B
element	element-INSIDE	NN	I-NP	I
into	into	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
transcribed	transcribe	VBN	I-NP	O
nontranslated	nontranslated	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
polyhomeotic	BEGIN-polyhomeotic	JJ	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

By	By	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
clonidine	clonidine	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
elicited	elicit	VBD	B-VP	O
an	an	DT	B-NP	O
immediate	immediate	JJ	I-NP	O
and	and	CC	I-NP	O
prolonged	prolonged	JJ	I-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
when	when	WRB	B-ADVP	O
given	give	VBN	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
vertebral	vertebral	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
intravenously	intravenously	RB	B-ADVP	O

Forty	Forty	CD	B-NP	O
-	-	HYPH	I-NP	O
eight	eight	CD	I-NP	O
pregnant	pregnant	JJ	I-NP	O
adult	adult	JJ	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
fetal	fetal	JJ	I-NP	O
guinea	guinea	NN	I-NP	O
pigs	pig	NNS	I-NP	O
were	be	VBD	B-VP	O
sacrificed	sacrifice	VBN	I-VP	O
at	at	IN	B-PP	O
intervals	interval	NNS	B-NP	O
throughout	throughout	IN	B-PP	O
gestation	gestation	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
carcasses	carcass	NNS	I-NP	O
analyzed	analyze	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
parameters	parameter	NNS	I-NP	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
chimeric	BEGIN-chimeric	JJ	I-NP	B
bZIP	bZIP	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
oncogenic	oncogenic	JJ	B-NP	O
transformation	transformation	NN	I-NP	O
,	,	,	O	O
its	its	PRP$	B-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
directed	direct	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
compartments	compartment	NNS	I-NP	O
of	of	IN	B-PP	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O

The	The	DT	B-NP	O
MALDI	MALDI	NN	I-NP	O
-	-	HYPH	I-NP	O
TOF	TOF	NN	I-NP	O
experiment	experiment	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
proved	prove	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
superior	superior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
GC	GC	NN	I-NP	O
experiment	experiment	NN	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
unsaturated	unsaturated	JJ	B-NP	O
acids	acid	NNS	I-NP	O

The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
serum	serum	NN	I-NP	O
CDT	CDT	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
SD	SD	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
U	U	NN	B-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
(	(	(	O	O
SD	SD	NN	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
U	U	NN	B-NP	O
/	/	SYM	O	O
l	l	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

In	In	IN	B-PP	O
female	female	JJ	B-NP	O
toads	toad	NNS	I-NP	O
,	,	,	O	O
Bufo	Bufo	NNP	B-NP	O
bufo	bufo	NN	I-NP	O
,	,	,	O	O
feeding	feed	VBG	B-VP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
rates	rate	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
uncorrected	uncorrected	JJ	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
n	n	NN	B-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
metabolism	metabolism	NN	B-NP	O
and	and	CC	I-NP	O
growth	growth	NN	I-NP	O
were	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
as	as	IN	B-PP	O
kJ	kJ	NN	B-NP	O
kJ	kJ	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
vRel	BEGIN-vRel-INSIDE	NN	B-NP	B
lacks	lack	VBZ	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
gene	gene	NN	I-NP	O
activation	activation	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
a	a	DT	B-NP	O
LexA	BEGIN-LexA	NN	I-NP	B
fusion	fusion	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
containing	contain	VBG	B-VP	O
C	BEGIN-C	NN	B-NP	B
-	-	HYPH	B-NP	I
terminal	terminal	JJ	I-NP	I
vRel	BEGIN-vRel-INSIDE	NN	I-NP	I
sequences	sequences-INSIDE	NN	I-NP	I
alone	alone	RB	B-ADVP	O
only	only	RB	B-ADVP	O
weakly	weakly	RB	I-ADVP	O
activated	activate	VBD	B-VP	O
transcription	transcription	NN	B-NP	O

Our	Our	PRP$	B-NP	O
study	study	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
adhesion	adhesion	NN	B-NP	O
receptor	receptor	NN	I-NP	O
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
signaling	signaling	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
potentially	potentially	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
production	production	NN	B-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	O
and	and	CC	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
proto	proto	AFX	B-NP	O
-	-	HYPH	I-NP	O
oncogenes	oncogene	NNS	I-NP	O
,	,	,	O	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
controlled	control	VBN	I-VP	O
through	through	IN	B-PP	O
1	1	CD	B-NP	O
'	'	SYM	I-NP	O
AU	AU	NN	I-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
elements	element	NNS	I-NP	O

Assessment	Assessment	NN	B-NP	O
of	of	IN	B-PP	O
ammonia	ammonia	NN	B-NP	O
and	and	CC	I-NP	O
urea	urea	NN	I-NP	O
blood	blood	NN	I-NP	O
content	content	NN	I-NP	O
in	in	IN	B-PP	O
metabolic	metabolic	JJ	B-NP	O
acid	acid	NN	I-NP	O
-	-	HYPH	B-NP	O
base	base	NN	I-NP	O
disorders	disorder	NNS	I-NP	O
in	in	IN	B-PP	O
white	white	JJ	B-NP	O
rats	rat	NNS	I-NP	O

1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
EGF	BEGIN-EGF	NN	B-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
but	but	CC	B-NP	O
not	not	RB	I-NP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
(	(	(	O	O
neu	BEGIN-neu-INSIDE	NN	B-NP	B
)	)	)	O	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
occur	occur	VBP	B-VP	O
following	follow	VBG	B-PP	O
Gi	BEGIN-Gi	NN	B-NP	B
-	-	HYPH	O	I
coupled	couple	VBN	B-NP	I
receptor	receptor-INSIDE	NN	I-NP	I
stimulation	stimulation	NN	I-NP	O

So	So	IN	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
sometimes	sometimes	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
convenient	convenient	JJ	I-ADJP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
the	the	DT	B-NP	O
back	back	JJ	I-NP	O
Radon	Radon	NNP	I-NP	O
transform	transform	NN	I-NP	O
R	R	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
to	to	TO	B-VP	O
correct	correct	VB	I-VP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
taking	take	VBG	B-VP	O
into	into	IN	B-PP	O
account	account	NN	B-NP	O
attenuation	attenuation	NN	I-NP	O

Immune	Immune	JJ	B-NP	O
and	and	CC	I-NP	O
clinical	clinical	JJ	I-NP	O
impact	impact	NN	I-NP	O
of	of	IN	B-PP	O
Lactobacillus	Lactobacillus	NN	B-NP	O
acidophilus	acidophilus	NN	I-NP	O
on	on	IN	B-PP	O
asthma	asthma	NN	B-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
RXR	BEGIN-RXR-INSIDE	NN	B-NP	B
-	-	HYPH	O	O
TR	BEGIN-TR-INSIDE	NN	B-NP	B
heterodimers	heterodimer	NNS	I-NP	O
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
basal	basal	JJ	B-NP	O
transactivation	transactivation	NN	I-NP	O
and	and	CC	I-NP	O
T1	T1	NN	I-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
negatively	negatively	RB	B-NP	O
regulated	regulate	VBN	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
RXRs	BEGIN-RXR-INSIDE	NNS	B-NP	I
increase	increase	VBP	B-VP	O
the	the	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
TRs	BEGIN-TR-INSIDE	NNS	I-NP	I
on	on	IN	B-PP	O
specific	specific	JJ	B-NP	O
negative	negative	JJ	I-NP	O
TREs	BEGIN-TR-INSIDEE	NNS	I-NP	I

Injections	Injection	NNS	B-NP	O
of	of	IN	B-PP	O
PD	PD	NN	B-NP	O
solutions	solution	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
glucose	glucose	NN	B-NP	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
ingestion	ingestion	NN	I-NP	O
of	of	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
ingestion	ingestion	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	B-NP	O
active	active	JJ	I-NP	O
elements	element	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
enhancer	enhancer	NN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	BEGIN-rat	NN	I-NP	B
PRL	PRL	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
deletional	deletional	JJ	B-NP	O
and	and	CC	I-NP	O
mutational	mutational	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
region	region	NN	I-NP	O
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
GH1	GH1	NN	B-NP	O
pituitary	pituitary	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
cells	cell	NNS	I-NP	O

While	While	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
growing	grow	VBG	I-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
perception	perception	NN	B-NP	O
and	and	CC	I-NP	O
imagery	imagery	NN	I-NP	O
share	share	VBP	B-VP	O
common	common	JJ	B-NP	O
neural	neural	JJ	I-NP	O
substrates	substrate	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
D.F.	D.F.	NNP	B-NP	O
shows	show	VBZ	B-VP	O
intact	intact	JJ	B-NP	O
visual	visual	JJ	I-NP	O
imagery	imagery	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
face	face	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
massive	massive	JJ	I-NP	O
perceptual	perceptual	JJ	I-NP	O
deficit	deficit	NN	I-NP	O
in	in	IN	B-PP	O
form	form	NN	B-NP	O
vision	vision	NN	I-NP	O
challenges	challenge	VBZ	B-VP	O
recent	recent	JJ	B-NP	O
suggestions	suggestion	NNS	I-NP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
psychological	psychological	JJ	I-NP	O
processes	process	NNS	I-NP	O
share	share	VBP	B-VP	O
common	common	JJ	B-NP	O
input	input	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
vision	vision	NN	I-NP	O

Site	Site	NN	B-NP	O
-	-	HYPH	B-PP	O
directed	direct	VBN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
cysteine	cysteine	NN	I-NP	O
residue	residue	NN	I-NP	O
(	(	(	O	O
tom1C1A	BEGIN-tom1C1A-INSIDE	NN	B-NP	B
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hect	BEGIN-hect	JJ	I-NP	B
-	-	HYPH	I-NP	I
domain	domain-INSIDE	NN	I-NP	I
,	,	,	O	O
supposed	suppose	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
thioester	thioester	NN	B-NP	O
-	-	HYPH	I-NP	O
bond	bond	NN	I-NP	O
formation	formation	NN	I-NP	O
with	with	IN	B-PP	O
ubiquitin	BEGIN-ubiquitin-INSIDE	NN	B-NP	B
,	,	,	O	O
abolished	abolish	VBD	B-VP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
function	function	NN	I-NP	O

The	The	DT	B-NP	O
Seldinger	Seldinger	NN	I-NP	O
technique	technique	NN	I-NP	O
for	for	IN	B-PP	O
difficult	difficult	JJ	B-NP	O
transurethral	transurethral	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
gentle	gentle	JJ	I-NP	O
alternative	alternative	NN	I-NP	O
to	to	TO	B-PP	O
suprapubic	suprapubic	JJ	B-NP	O
puncture	puncture	NN	I-NP	O
(	(	(	O	O
Br	Br	NNP	B-NP	O
J	J	NNP	I-NP	O
Surg	Surg	NNP	I-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Gingival	Gingival	JJ	B-NP	O
retraction	retraction	NN	I-NP	O
for	for	IN	B-PP	O
class	class	NN	B-NP	O
V	V	CD	I-NP	O
restorations	restoration	NNS	I-NP	O

The	The	DT	B-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
MSK1	BEGIN-MSK1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
yeast	BEGIN-yeast	JJ	B-NP	B
cytoplasmic	cytoplasmic	JJ	I-NP	I
lysyl	lysyl	NN	I-NP	I
-	-	HYPH	B-NP	I
tRNA	tRNA	NN	I-NP	I
synthetase	synthetase-INSIDE	NN	I-NP	I
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
herC	BEGIN-herC	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
to	to	TO	B-VP	O
code	code	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Escherichia	Escherichia	FW	I-NP	O
coli	coli	FW	I-NP	O
enzyme	enzyme	NN	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
(	(	(	O	O
dok	BEGIN-dok-INSIDE	NN	B-NP	B
)	)	)	O	O
,	,	,	O	O
DOKL	BEGIN-DOKL-INSIDE	NN	B-NP	B
lacks	lack	VBZ	B-VP	O
YxxP	YxxP	NN	B-NP	O
motifs	motif	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
terminus	terminus	NN	I-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
Ras	BEGIN-Ras	NN	B-NP	B
GTPase	GTPase	NN	I-NP	I
-	-	HYPH	O	I
activating	activate	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
(	(	(	O	O
RasGAP	BEGIN-RasGAP-INSIDE	NN	B-NP	B
)	)	)	O	O
upon	upon	IN	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
chloroquine	chloroquine	NN	B-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
from	from	IN	B-PP	O
seven	seven	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
oral	oral	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
was	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
by	by	IN	B-PP	O
chromatographic	chromatographic	JJ	B-NP	O
and	and	CC	I-NP	O
spectroscopic	spectroscopic	JJ	I-NP	O
methods	method	NNS	I-NP	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
binding	binding	NN	I-NP	O
studies	study	NNS	I-NP	O
previously	previously	RB	B-ADVP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
NF	BEGIN-NF	NN	B-NP	B
-	-	HYPH	B-NP	I
kappa	kappa	NN	I-NP	I
B	B-INSIDE	NN	I-NP	I
p1	BEGIN-p1-INSIDE	NN	I-NP	B
homodimer	homodimer	NN	I-NP	O
binds	bind	VBZ	B-VP	O
the	the	DT	B-NP	O
switch	BEGIN-switch	JJ	I-NP	B
nuclear	nuclear	JJ	I-NP	I
B	B	NN	I-NP	I
-	-	HYPH	O	I
site	site	NN	B-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
SNIP	BEGIN-SNIP-INSIDE	NN	B-NP	B
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
S	BEGIN-S	NN	I-NP	B
gamma	gamma	NN	I-NP	I
1	1	CD	I-NP	I
tandem	tandem	NN	I-NP	I
repeat	repeat-INSIDE	NN	I-NP	I

If	If	IN	B-SBAR	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
myocardial	myocardial	JJ	B-NP	O
stunning	stunning	NN	I-NP	O
is	be	VBZ	B-VP	O
severe	severe	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
involves	involve	VBZ	B-VP	O
large	large	JJ	B-NP	O
parts	part	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LV	LV	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
impairs	impair	VBZ	I-VP	O
global	global	JJ	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
reversed	reverse	VBN	I-VP	O
with	with	IN	B-PP	O
inotropic	inotropic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
and	and	CC	I-NP	O
procedures	procedure	NNS	I-NP	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
interfering	interfere	VBG	B-VP	O
with	with	IN	B-PP	O
MEKK	BEGIN-MEKK-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
lies	lie	VBZ	B-VP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
JNK1	BEGIN-JNK1-INSIDE	NN	B-NP	B
,	,	,	O	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
negative	negative	JJ	I-NP	O
expression	expression	NN	I-NP	O
vector	vector	NN	I-NP	O
reduced	reduce	VBD	B-VP	O
MMP	BEGIN-MMP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
range	range	NN	I-NP	O
which	which	WDT	B-NP	O
repressed	repress	VBD	B-VP	O
the	the	DT	B-NP	O
AP	BEGIN-AP	NN	I-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
thymidine	BEGIN-thymidine	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
CAT	BEGIN-CAT-INSIDE	NN	I-NP	B
reporter	reporter	NN	I-NP	O
construct	construct	NN	I-NP	O

The	The	DT	B-NP	O
1	BEGIN-1	NN	I-NP	B
kb	kb	NN	I-NP	I
EcoRI	EcoRI	NN	I-NP	I
fragment	fragment	NN	I-NP	I
of	of	IN	B-PP	I
AfMNPV	AfMNPV-INSIDE	NN	B-NP	I
was	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
polyhedrin	BEGIN-polyhedrin-INSIDE	NN	I-NP	B
coding	coding	NN	I-NP	O
region	region	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
flanking	flanking	NN	I-NP	O
regions	region	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O

Joint	Joint	NN	B-NP	O
ultrasonography	ultrasonography	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
thickening	thickening	NN	B-NP	O
of	of	IN	B-PP	O
synoviae	synoviae	NNS	B-NP	O
and	and	CC	I-NP	O
tendons	tendon	NNS	I-NP	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
invasive	invasive	JJ	I-NP	O
diagnostic	diagnostic	JJ	I-NP	O
tool	tool	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
beta	BEGIN-beta	NN	B-NP	B
1	1	CD	I-NP	I
-	-	HYPH	I-NP	I
M	M-INSIDE	NN	I-NP	I
amyloidosis	amyloidosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
results	result	NNS	B-NP	O
depend	depend	VBP	B-VP	O
on	on	IN	B-PP	O
observer	observer	NN	B-NP	O
experience	experience	NN	I-NP	O

Sequence	Sequence	NN	B-NP	O
analyses	analysis	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
partial	partial	JJ	I-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
cDNA	cDNA	NN	I-NP	O
that	that	WDT	B-NP	O
encoded	encode	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
polypeptide	polypeptide	NN	I-NP	O

Estimating	Estimate	VBG	B-VP	O
the	the	DT	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
costs	cost	NNS	I-NP	O
of	of	IN	B-PP	O
smokers	smoker	NNS	B-NP	O

Although	Although	IN	B-SBAR	O
paclitaxel	paclitaxel	NN	B-NP	O
alone	alone	RB	B-ADVP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
MAPK	MAPK	NN	I-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
subsequent	subsequent	JJ	B-ADJP	O
(	(	(	O	O
but	but	CC	O	O
not	not	RB	O	O
prior	prior	JJ	B-ADJP	O
)	)	)	O	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
PD1	PD1	NN	B-NP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
p1	BEGIN-p1-INSIDE	NN	B-NP	B
MAPK	MAPK	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O

The	The	DT	B-NP	O
cyclin	BEGIN-cyclin	NN	I-NP	B
-	-	HYPH	B-NP	I
dependent	dependent	JJ	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
Cdk1	BEGIN-Cdk1-INSIDE	NN	I-NP	B
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
cyclins	BEGIN-cyclins	NNP	B-NP	B
A	A	NNP	I-NP	I
,	,	,	O	I
D	D	NNP	B-NP	I
,	,	,	O	I
and	and	CC	O	I
E	E-INSIDE	NN	B-NP	I
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
G1	G1	NN	I-NP	O
to	to	TO	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
transition	transition	NN	I-NP	O
in	in	IN	B-PP	O
mammals	mammal	NNS	B-NP	O

Sequences	Sequence	NNS	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
UAS1	UAS1	NN	I-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ENO1	BEGIN-ENO1	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
bound	bind	VBD	B-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
protein	protein	NN	I-NP	O
which	which	WDT	B-NP	O
corresponded	correspond	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ABFI	BEGIN-ABFI-INSIDE	NN	I-NP	B
(	(	(	O	O
autonomously	BEGIN-autonomously	RB	B-VP	B
replicating	replicate	VBG	I-VP	I
sequence	sequence	NN	B-NP	I
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
factor	factor-INSIDE	NN	B-NP	I
)	)	)	O	O
protein	protein	NN	B-NP	O

Videoanalysis	Videoanalysis	NN	B-NP	O
confirms	confirm	VBZ	B-VP	O
the	the	DT	B-NP	O
ballistic	ballistic	JJ	I-NP	O
character	character	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
reaching	reaching	NN	I-NP	O
movement	movement	NN	I-NP	O

Toward	Toward	IN	B-PP	O
this	this	DT	B-NP	O
end	end	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
two	two	CD	B-NP	O
cultured	culture	VBN	I-NP	O
colon	colon	NN	I-NP	O
cancer	cancer	NN	I-NP	O
cell	cell	NN	I-NP	O
lines	line	NNS	I-NP	O
;	;	:	O	O
one	one	CD	B-NP	O
(	(	(	O	O
RKO	RKO	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
transcriptionally	transcriptionally	RB	I-NP	O
activated	activate	VBN	I-NP	O
u	BEGIN-u	NN	I-NP	B
-	-	HYPH	I-NP	I
PAR	PAR	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
(	(	(	O	O
GEO	GEO	NN	B-NP	O
)	)	)	O	O
overexpresses	overexpresse	VBZ	B-VP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
only	only	RB	B-ADVP	O
after	after	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
treatment	treatment	NN	I-NP	O

Early	Early	JJ	B-NP	O
detection	detection	NN	I-NP	O
and	and	CC	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
hepatoangiosarcoma	hepatoangiosarcoma	NN	B-NP	O
among	among	IN	B-PP	O
vinyl	vinyl	NN	B-NP	O
chloride	chloride	NN	I-NP	O
workers	worker	NNS	I-NP	O

Many	Many	JJ	B-NP	O
retroviruses	retrovirus	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
and	and	CC	I-NP	O
simian	simian	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
viruses	virus	NNS	I-NP	O
,	,	,	O	O
contain	contain	VBP	B-VP	O
a	a	DT	B-NP	O
leucine	leucine	NN	I-NP	O
zipper	zipper	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
repeat	repeat	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
external	external	JJ	I-NP	O
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transmembrane	transmembrane	NN	I-NP	O
(	(	(	O	O
TM	TM	NN	B-NP	O
)	)	)	O	O
glycoprotein	glycoprotein	NN	B-NP	O

Conversion	Conversion	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
NF	BEGIN-NF	NN	I-NP	B
-	-	HYPH	I-NP	I
kappaB	kappaB-INSIDE	NN	I-NP	I
into	into	IN	B-PP	O
a	a	DT	B-NP	O
GABP	BEGIN-GABP-INSIDE	NN	I-NP	B
binding	binding	NN	I-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
occurred	occur	VBN	I-VP	O
also	also	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
worldwide	worldwide	JJ	I-NP	O
spread	spread	NN	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
we	we	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
LTR	LTR	NN	I-NP	O
modification	modification	NN	I-NP	O
in	in	IN	B-PP	O
subtype	subtype	NN	B-NP	O
E	E	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
from	from	IN	B-PP	O
Thailand	Thailand	NNP	B-NP	O

Bedbug	Bedbug	NN	B-NP	O
(	(	(	O	O
Cimex	Cimex	NN	B-NP	O
lectularius	lectularius	NN	I-NP	O
)	)	)	O	O
samples	sample	NNS	B-NP	O
adult	adult	JJ	B-ADJP	O
and	and	CC	O	O
nymphs	nymph	NNS	B-NP	O
either	either	CC	O	O
engorged	engorge	VBN	B-VP	O
or	or	CC	O	O
starved	starve	VBN	B-VP	O
from	from	IN	B-PP	O
Central	Central	NNP	B-NP	O
Security	Security	NNP	I-NP	O
Forces	Forces	NNP	I-NP	O
sleeping	sleep	VBG	I-NP	O
wards	ward	NNS	I-NP	O
,	,	,	O	O
laboratory	laboratory	NN	B-NP	O
animal	animal	NN	I-NP	O
house	house	NN	I-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
laboratory	laboratory	NN	B-NP	O
reared	rear	VBD	B-VP	O
colonies	colony	NNS	B-NP	O
were	be	VBD	B-VP	O
ground	ground	NN	B-NP	O
and	and	CC	O	O
subjected	subject	VBN	B-VP	O
to	to	TO	B-PP	O
ELISA	ELISA	NN	B-NP	O
test	test	NN	I-NP	O
of	of	IN	B-PP	O
hepatitis	BEGIN-hepatitis	NN	B-NP	B
B	B	NN	I-NP	I
surface	surface	NN	I-NP	I
antigen	antigen-INSIDE	NN	I-NP	I
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
serum	serum	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
recruits	recruit	NNS	I-NP	O
slept	sleep	VBD	B-VP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
wards	ward	NNS	I-NP	O

Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
attained	attain	VBD	B-VP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
serum	serum	NN	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
half	half	NN	I-NP	O
-	-	HYPH	I-NP	O
life	life	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O

As	As	IN	B-SBAR	O
usual	usual	JJ	B-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
``	``	``	O	O
time	time	NN	B-NP	O
''	''	''	O	O
of	of	IN	B-PP	O
cephalin	cephalin	NN	B-NP	O
are	be	VBP	B-VP	O
slightly	slightly	RB	B-ADJP	O
sensible	sensible	JJ	I-ADJP	O
to	to	TO	B-PP	O
LMW	LMW	NN	B-NP	O
-	-	HYPH	I-NP	O
Hep	Hep	NN	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
anti	anti	AFX	I-NP	O
-	-	HYPH	I-NP	O
Xa	Xa	NN	B-NP	O
activity	activity	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O

Although	Although	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
IL1R	BEGIN-IL1R	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
identity	identity	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
copies	copy	NNS	I-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
contains	contain	VBZ	B-VP	O
sequences	sequence	NNS	B-NP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
flanking	flanking	NN	I-NP	O
region	region	NN	I-NP	O
or	or	CC	O	O
exon	exon	NN	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL1R	BEGIN-IL1R	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
ORFs	ORF	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
inactivated	inactivate	VBN	I-VP	O
by	by	IN	B-PP	O
various	various	JJ	B-NP	O
point	point	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
and	and	CC	I-NP	O
deletions	deletion	NNS	I-NP	O

In	In	IN	B-PP	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
male	male	JJ	I-NP	O
homosexual	homosexual	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
hemophiliac	hemophiliac	NN	I-NP	O
,	,	,	O	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
AIDS	AIDS	NN	B-NP	O
-	-	HYPH	O	O
related	relate	VBN	B-VP	O
complex	complex	NN	B-NP	O

Choline	BEGIN-Choline	NN	B-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
immunohistochemistry	immunohistochemistry	NN	I-NP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
retrograde	retrograde	JJ	I-NP	O
transport	transport	NN	I-NP	O
of	of	IN	B-PP	O
horseradish	BEGIN-horseradish	JJ	B-NP	B
peroxidase	peroxidase-INSIDE	NN	I-NP	I
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
reticular	reticular	JJ	I-NP	O
and	and	CC	I-NP	O
mediodorsal	mediodorsal	JJ	I-NP	O
thalamic	thalamic	JJ	I-NP	O
nuclei	nucleus	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cat	cat	NN	I-NP	O
receive	receive	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
input	input	NN	I-NP	O
from	from	IN	B-PP	O
cholinergic	cholinergic	JJ	B-ADJP	O
and	and	CC	O	O
non	non	AFX	O	O
-	-	HYPH	O	O
cholinergic	cholinergic	JJ	B-NP	O
neurons	neuron	NNS	I-NP	O
of	of	IN	B-PP	O
substantia	substantia	NN	B-NP	O
innominata	innominata	NNS	I-NP	O
and	and	CC	O	O
adjacent	adjacent	JJ	B-NP	O
structures	structure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
forebrain	forebrain	NN	I-NP	O

Mortality	Mortality	NN	B-NP	O
among	among	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
CAVB	CAVB	NN	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
high	high	JJ	B-ADJP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
declined	decline	VBN	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
decade	decade	NN	I-NP	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
fatty	fatty	JJ	B-NP	O
acids	acid	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
medium	medium	NN	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
SPS1	BEGIN-SPS1-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
directly	directly	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
Pip1p	BEGIN-Pip1p-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
Oaf1p	BEGIN-Oaf1p-INSIDE	NN	I-NP	B
and	and	CC	I-NP	O
Adr1p	BEGIN-Adr1p-INSIDE	NN	I-NP	B

The	The	DT	B-NP	O
purified	purify	VBN	I-NP	O
RAG1	BEGIN-BEGIN-RAG1-INSIDE	NN	I-NP	B
protein	protein-INSIDE	NN	I-NP	I
overexpressed	overexpresse	VBN	B-VP	O
in	in	IN	B-PP	O
E.coli	E.coli	NNP	B-NP	O
exhibited	exhibit	VBD	B-VP	O
the	the	DT	B-NP	O
expected	expect	VBN	I-NP	O
cleavage	cleavage	NN	I-NP	O
activity	activity	NN	I-NP	O
when	when	WRB	B-ADVP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
RAG1	BEGIN-RAG1-INSIDE	NN	B-NP	B
purified	purify	VBN	B-VP	O
from	from	IN	B-PP	O
transfected	transfecte	VBN	B-NP	O
1T	1T	NN	I-NP	O
cells	cell	NNS	I-NP	O

Serum	Serum	NN	B-NP	O
triglycerides	triglyceride	NNS	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
from	from	IN	B-PP	O
birth	birth	NN	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
months	month	NNS	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O

These	These	DT	B-NP	O
mutant	BEGIN-mutant	JJ	I-NP	B
rps1	rps1-INSIDE	NN	I-NP	I
leaders	leader	NNS	I-NP	O
were	be	VBD	B-VP	O
ligated	ligate	VBN	I-VP	O
into	into	IN	B-PP	O
an	an	DT	B-NP	O
aadA	aadA	NN	I-NP	O
expression	expression	NN	I-NP	O
cassette	cassette	NN	I-NP	O
and	and	CC	O	O
transformed	transform	VBN	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
chloroplast	chloroplast	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
reinhardtii	reinhardtii	NNP	I-NP	O
and	and	CC	B-PP	O
into	into	IN	B-PP	O
E.	E.	NNP	B-NP	O
coli	coli	NNS	I-NP	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
medication	medication	NN	B-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
minor	minor	JJ	B-NP	O
importance	importance	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
flight	flight	NN	B-NP	O
phobia	phobia	NN	I-NP	O

We	We	PRP	B-NP	O
previously	previously	RB	B-ADVP	O
described	describe	VBD	B-VP	O
the	the	DT	B-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MT1	BEGIN-MT1	NN	I-NP	B
antigen	antigen-INSIDE	NN	I-NP	I
during	during	IN	B-PP	O
urodele	urodele	NN	B-NP	O
limb	limb	NN	I-NP	O
regeneration	regeneration	NN	I-NP	O
and	and	CC	O	O
characterized	characterize	VBD	B-VP	O
the	the	DT	B-NP	O
MT1	BEGIN-MT1	NN	I-NP	B
antigen	antigen-INSIDE	NN	I-NP	I
as	as	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
chondroitin	chondroitin	NN	I-NP	O
-	-	HYPH	B-VP	O
sulfated	sulfate	VBN	B-NP	O
glycoprotein	glycoprotein	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
core	core	NN	I-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
kDa	kDa	NN	I-NP	O

Southern	Southern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
following	follow	VBG	B-PP	O
reverse	reverse	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
and	and	CC	I-NP	O
PCR	PCR	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
B1R	BEGIN-B1R-INSIDE	NN	B-NP	B
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
mouse	mouse	NN	I-NP	O
tissues	tissue	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
wide	wide	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
B1R	BEGIN-B1R-INSIDE	NN	B-NP	B
activity	activity	NN	I-NP	O
as	as	IN	B-SBAR	O
deduced	deduce	VBN	B-VP	O
from	from	IN	B-PP	O
pharmacological	pharmacological	JJ	B-NP	O
studies	study	NNS	I-NP	O

The	The	DT	B-NP	O
dynamics	dynamic	NNS	I-NP	O
of	of	IN	B-PP	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
interaction	interaction	NN	I-NP	O
and	and	CC	I-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
retention	retention	NN	I-NP	O
during	during	IN	B-PP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
CPB	CPB	NN	I-NP	O
was	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
with	with	IN	B-PP	O
autologous	autologous	JJ	B-NP	O
In	In	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
labeled	label	VBN	I-NP	O
neutrophils	neutrophil	NNS	I-NP	O
(	(	(	O	O
INN	INN	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
Yorkshire	Yorkshire	NN	I-NP	O
pigs	pig	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
sham	sham	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
CPB	CPB	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
CPB	CPB	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
CPB	CPB	NN	I-NP	O
with	with	IN	B-PP	O
heparinized	heparinize	VBN	B-NP	O
circuit	circuit	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
)	)	)	O	O
;	;	:	O	O
anesthetized	anesthetize	VBN	B-NP	O
pigs	pig	NNS	I-NP	O
were	be	VBD	B-VP	O
injected	inject	VBN	I-VP	O
with	with	IN	B-PP	O
INN	INN	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
microCi	microCi	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
1	1	CD	B-NP	O
min	min	NN	I-NP	O
before	before	IN	B-PP	O
CPB	CPB	NN	B-NP	O
and	and	CC	O	O
heparinized	heparinize	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
CPB	CPB	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
roller	roller	NN	I-NP	O
pump	pump	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
hollow	hollow	JJ	I-NP	O
fiber	fiber	NN	I-NP	O
OX	OX	NN	I-NP	O
(	(	(	O	O
Bentley	Bentley	NNP	B-NP	O
CM	CM	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
m1	m1	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
AF	AF	NN	B-NP	O
(	(	(	O	O
Bentley	Bentley	NNP	B-NP	O
AF	AF	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
m1	m1	NN	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
l	l	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
element	element	NN	I-NP	O
is	be	VBZ	B-VP	O
negated	negate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
viral	BEGIN-viral	JJ	I-NP	B
IE1	IE1	NN	I-NP	I
protein	protein-INSIDE	NN	I-NP	I
(	(	(	O	O
L	L	NN	B-NP	O

Cloning	Cloning	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GATA	BEGIN-GATA	NN	I-NP	B
-	-	HYPH	O	I
binding	bind	VBG	B-VP	I
protein	protein-INSIDE	NN	B-NP	I
that	that	WDT	B-NP	O
regulates	regulate	VBZ	B-VP	O
endothelin	BEGIN-endothelin	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1	CD	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	O
cells	cell	NNS	I-NP	O

John	John	NNP	B-NP	O
's	's	POS	B-NP	O
wort	wort	NN	I-NP	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
SF	BEGIN-SF-INSIDE	NN	I-NP	B
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
GM	BEGIN-GM	NN	B-NP	B
-	-	HYPH	B-NP	I
CSF	CBEGIN-SF-INSIDE-INSIDE	NN	I-NP	I
or	or	CC	I-NP	O
IL	BEGIN-IL	NN	I-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
,	,	,	O	O
induced	induce	VBD	B-VP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
phospholipase	BEGIN-phospholipase	NN	B-NP	B
C	C	NN	I-NP	I
-	-	HYPH	B-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
(	(	(	O	O
PLC	BEGIN-PLC	NN	B-NP	B
-	-	HYPH	B-NP	I
gamma	gamma-INSIDE	NN	I-NP	I
)	)	)	O	O

Using	Use	VBG	B-VP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
-	-	HYPH	B-NP	O
trap	trap	NN	I-NP	O
assay	assay	NN	I-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
candidate	candidate	NN	B-NP	O
proteins	protein	NNS	I-NP	O
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LAR	BEGIN-LAR	NN	I-NP	B
transmembrane	transmembrane	JJ	I-NP	I
protein	protein	NN	I-NP	I
tyrosine	tyrosine	NN	I-NP	I
phosphatase	phosphatase-INSIDE	NN	I-NP	I
(	(	(	O	O
PT	BEGIN-PT	NN	B-NP	B
-	-	HYPH	B-NP	I
Pase	Pase-INSIDE	NN	I-NP	I
)	)	)	O	O
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
protein	protein	NN	I-NP	O
termed	term	VBN	B-VP	O
Trio	BEGIN-Trio-INSIDE	NN	B-NP	B
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
three	three	CD	B-NP	O
enzyme	enzyme	NN	I-NP	O
domains	domain	NNS	I-NP	O
:	:	:	O	O
two	two	CD	B-NP	O
functional	functional	JJ	I-NP	O
GEF	BEGIN-GEF	NN	I-NP	B
domains	domains-INSIDE	NN	I-NP	I
and	and	CC	O	O
a	a	DT	B-NP	O
protein	BEGIN-protein	NN	I-NP	B
serine	serine	NN	I-NP	I
/	/	SYM	B-VP	I
threonine	threonine	NN	B-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
(	(	(	O	O
PSK	BEGIN-PSK-INSIDE	NN	B-NP	B
)	)	)	O	O
domain	domain	NN	B-NP	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
C1	BEGIN-C1-INSIDE	NN	I-NP	B
domain	domain	NN	I-NP	O
of	of	IN	B-PP	O
Nedd1	BEGIN-Nedd1-INSIDE	NN	B-NP	B
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
elucidated	elucidate	VBN	I-VP	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
FIV	BEGIN-FIV	NN	B-NP	B
LTR	LTR	NN	I-NP	I
promoter	promoter-INSIDE	NN	I-NP	I
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
progressively	progressively	RB	B-VP	O
deleting	delete	VBG	I-VP	O
these	these	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
factor	factor	NN	I-NP	O
binding	binding	NN	I-NP	O
sites	site	NNS	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
by	by	IN	B-PP	O
linking	link	VBG	B-VP	O
LTR	LTR	NN	B-NP	O
deletion	deletion	NN	I-NP	O
mutants	mutant	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
chloramphenicol	BEGIN-chloramphenicol	NN	I-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
(	(	(	O	O
CAT	BEGIN-CAT-INSIDE	NN	B-NP	B
)	)	)	O	O
gene	gene	NN	B-NP	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
have	have	VBP	B-VP	O
important	important	JJ	B-NP	O
implications	implication	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
latency	latency	NN	I-NP	O
and	and	CC	I-NP	O
reactivation	reactivation	NN	I-NP	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
Nck	BEGIN-Nck	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
recognizing	recognize	VBG	B-VP	O
several	several	JJ	B-NP	O
key	key	JJ	I-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
growth	BEGIN-growth	NN	B-NP	B
factor	factor	NN	I-NP	I
receptor	receptor	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
signaling	signaling	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
including	include	VBG	B-PP	O
EGF	BEGIN-EGF	NN	B-NP	B
receptors	receptors-INSIDE	NN	I-NP	I
,	,	,	O	O
PDGF	BEGIN-PDGF	NN	B-NP	B
receptor	receptor	NN	I-NP	I
-	-	HYPH	B-NP	I
beta	beta-INSIDE	NN	I-NP	I
,	,	,	O	O
and	and	CC	O	O
IRS	BEGIN-IRS	NN	B-NP	B
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I

The	The	DT	B-NP	O
average	average	JJ	I-NP	O
mean	mean	JJ	I-NP	O
difference	difference	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
intermediate	intermediate	JJ	I-NP	O
calcium	calcium	NN	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
femoral	femoral	JJ	I-NP	O
neck	neck	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
lumbar	lumbar	JJ	I-NP	O
spine	spine	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
BMDs	BMD	NNS	I-NP	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
kits	kit	NNS	B-NP	O
has	have	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
precision	precision	NN	I-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
,	,	,	O	O
showing	show	VBG	B-VP	O
that	that	IN	B-SBAR	O
more	more	JJR	B-NP	O
robust	robust	JJ	I-NP	O
methods	method	NNS	I-NP	O
are	be	VBP	B-VP	O
now	now	RB	I-VP	O
employed	employ	VBN	I-VP	O

The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
contained	contain	VBD	B-VP	O
all	all	DT	B-NP	O
consensus	consensus	NN	I-NP	O
regions	region	NNS	I-NP	O
for	for	IN	B-PP	O
S	BEGIN-S	NN	B-NP	B
-	-	HYPH	I-NP	I
adenosyl	adenosyl	NN	I-NP	I
methionine	methionine	NN	I-NP	I
methyltransferases	BEGIN-methyltransferase-INSIDEs-INSIDE	NN	I-NP	I
and	and	CC	O	O
presented	present	VBD	B-VP	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
Saccharomyces	BEGIN-Saccharomyces	FW	B-NP	B
cerevisiae	cerevisiae	FW	I-NP	I
DHHB	DHHB	NN	I-NP	I
-	-	HYPH	B-NP	I
methyltransferase	BEGIN-methyltransferase-INSIDE-INSIDE	NN	I-NP	I
and	and	CC	O	O
1	1	CD	B-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
(	(	(	O	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O
and	and	CC	O	O
Salmonella	Salmonella	NNP	B-NP	O
typhimurium	typhimurium	NNP	I-NP	O
)	)	)	O	O
methyltransferase	BEGIN-methyltransferase-INSIDE	NN	B-NP	B
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
UBIG	BEGIN-UBIG	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
its	its	PRP$	B-NP	O
transcription	transcription	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
kilobases	kilobas	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
flanking	flanking	NN	I-NP	O
sequence	sequence	NN	I-NP	O
were	be	VBD	B-VP	O
fused	fuse	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
luciferase	BEGIN-luciferase	NN	I-NP	B
reporter	reporter	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I

A	A	DT	B-NP	O
selective	selective	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
induction	induction	NN	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
cells	cell	NNS	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
Gal1	BEGIN-Gal1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
estrogen	BEGIN-estrogen	NN	I-NP	B
receptor	receptor-INSIDE	NN	I-NP	I
fusion	fusion	NN	I-NP	O
proteins	protein	NNS	I-NP	O

PATIENT	PATIENT	NN	B-NP	O
(	(	(	O	O
S	S	NN	B-NP	O
)	)	)	O	O
:	:	:	O	O
Two	Two	CD	B-NP	O
hundred	hundred	CD	I-NP	O
thirty	thirty	CD	I-NP	O
-	-	HYPH	O	O
eight	eight	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
RPLs	RPL	NNS	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
IVF	IVF	NN	I-NP	O
-	-	HYPH	B-NP	O
ET	ET	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
nonpregnant	nonpregnant	JJ	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
pregnant	pregnant	JJ	I-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
women	woman	NNS	I-NP	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
oxalate	oxalate	NN	B-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
products	product	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
exposed	expose	VBN	I-NP	O
dentine	dentine	NN	I-NP	O
surface	surface	NN	I-NP	O
:	:	:	O	O
an	an	DT	B-NP	O
SEM	SEM	NN	I-NP	O
investigation	investigation	NN	I-NP	O

The	The	DT	B-NP	O
cyanobacterial	BEGIN-cyanobacterial	JJ	I-NP	B
phycobilisome	phycobilisome-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
protein	protein	NN	I-NP	O
complex	complex	NN	I-NP	O
located	located	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
photosynthetic	photosynthetic	JJ	I-NP	O
membrane	membrane	NN	I-NP	O

Up	Up	IN	B-PP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
in	in	IN	B-PP	O
literature	literature	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
cases	case	NNS	I-NP	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
country	country	NN	I-NP	O

Lamivudine	Lamivudine	NN	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
infection	infection	NN	I-NP	O
following	follow	VBG	B-PP	O
peripheral	peripheral	JJ	B-NP	O
blood	blood	NN	I-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
transplantation	transplantation	NN	I-NP	O

Disorganization	Disorganization	NN	B-NP	O
scores	score	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
zone	zone	NN	I-NP	O
and	and	CC	O	O
trabecular	trabecular	JJ	B-NP	O
bone	bone	NN	I-NP	O
were	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
approaching	approach	VBG	B-VP	O
normal	normal	JJ	B-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
for	for	IN	B-PP	O
turkey	turkey	NN	B-NP	O
poults	poult	NNS	I-NP	O
fed	feed	VBN	B-VP	O
on	on	IN	B-PP	O
diets	diet	NNS	B-NP	O
with	with	IN	B-PP	O
phytase	BEGIN-phytase-INSIDE	NN	B-NP	B
supplementation	supplementation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
tibial	tibial	JJ	B-NP	O
abnormality	abnormality	NN	I-NP	O
scores	score	NNS	I-NP	O
were	be	VBD	B-VP	O
linearly	linearly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
nP	nP	NN	B-NP	O
levels	level	NNS	I-NP	O
increased	increase	VBD	B-VP	O
(	(	(	O	O
zero	zero	CD	B-NP	O
score	score	NN	I-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
normal	normal	JJ	B-ADJP	O
)	)	)	O	O

The	The	DT	B-NP	O
collicular	collicular	JJ	I-NP	O
labels	label	NNS	I-NP	O
found	find	VBN	B-VP	O
after	after	IN	B-PP	O
injections	injection	NNS	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
MST	MST	NN	I-NP	O
area	area	NN	I-NP	O
exhibited	exhibit	VBD	B-VP	O
their	their	PRP$	B-NP	O
distribution	distribution	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
deep	deep	JJ	I-NP	O
SC	SC	NN	I-NP	O
subdivision	subdivision	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
they	they	PRP	B-NP	O
spared	spar	VBD	B-VP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
superficial	superficial	JJ	I-NP	O
layers	layer	NNS	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
deep	deep	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SO	SO	NN	I-NP	O

Modern	Modern	JJ	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
shock	shock	NN	B-NP	O
-	-	HYPH	B-NP	O
treatment	treatment	NN	I-NP	O
in	in	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
burns	burn	NNS	I-NP	O
(	(	(	O	O
author	author	NN	B-NP	O
's	's	POS	B-NP	O
transl	transl	NN	I-NP	O
)	)	)	O	O

UVB	UVB	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
tumor	BEGIN-tumor	NN	B-NP	B
necrosis	necrosis	NN	I-NP	I
factor	factor	NN	I-NP	I
(	(	(	O	I
TNF	TNF	NN	B-NP	I
)	)	)	O	I
receptor	receptor	NN	B-NP	I
1	1-INSIDE	NN	I-NP	I
/	/	SYM	B-VP	O
TNF	BEGIN-TNF	NN	B-NP	B
receptor	receptor	NN	I-NP	I
-	-	HYPH	O	I
associated	associate	VBN	B-NP	I
factor	factor	NN	I-NP	I
-	-	HYPH	O	I
1	1-INSIDE	NN	B-NP	I
mediates	mediate	VBZ	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
Rel	BEGIN-Rel	NN	B-NP	B
proteins	proteins-INSIDE	NN	I-NP	I

Mapping	Mapping	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
in	in	IN	B-PP	O
KAP	BEGIN-KAP	NN	B-NP	B
-	-	HYPH	B-NP	I
1	1-INSIDE	NN	I-NP	I
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
HP1	BEGIN-HP1-INSIDE	NN	B-NP	B
interaction	interaction	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
substitutions	substitution	NNS	I-NP	O
which	which	WDT	B-NP	O
abolish	abolish	VBP	B-VP	O
HP1	BEGIN-HP1-INSIDE	NN	B-NP	B
binding	binding	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
reduce	reduce	VBP	B-VP	O
KAP	BEGIN-KAP	NN	B-NP	B
-	-	HYPH	I-NP	I
1	1-INSIDE	NN	I-NP	I
mediated	mediate	VBN	I-NP	O
repression	repression	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
spleen	spleen	NN	B-NP	O
removal	removal	NN	I-NP	O
after	after	IN	B-PP	O
adjustment	adjustment	NN	B-NP	O
for	for	IN	B-PP	O
risk	risk	NN	B-NP	O
factors	factor	NNS	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
determined	determine	VBN	I-VP	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Smad1	BEGIN-Smad1-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Smad1	BEGIN-Smad1-INSIDE	NN	I-NP	B
complex	complex	NN	I-NP	O
has	have	VBZ	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
separable	separable	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
functions	function	NNS	I-NP	O
:	:	:	O	O
it	it	PRP	B-NP	O
forms	form	VBZ	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
,	,	,	I-NP	O
yet	yet	RB	I-NP	O
transient	transient	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
complex	complex	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
potentiates	potentiate	VBZ	B-VP	O
AP1	BEGIN-AP1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O

However	However	RB	B-ADVP	O
,	,	,	O	O
one	one	CD	B-NP	O
activity	activity	NN	I-NP	O
binds	bind	VBZ	B-VP	O
preferentially	preferentially	RB	B-ADVP	O
to	to	TO	B-PP	O
G+C	G+C	NN	B-NP	O
-	-	HYPH	B-NP	O
rich	rich	JJ	I-NP	O
promoters	promoter	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
another	another	DT	B-NP	O
activity	activity	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
preferentially	preferentially	RB	B-ADVP	O
to	to	TO	B-PP	O
only	only	RB	B-NP	O
two	two	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
promoters	promoter	NNS	I-NP	O
tested	test	VBN	B-VP	O

The	The	DT	B-NP	O
donors	donor	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
ABO	ABO	NN	B-NP	O
-	-	HYPH	O	O
incompatible	incompatible	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
pairs	pair	NNS	I-NP	O
the	the	DT	B-NP	O
ABO	ABO	NN	I-NP	O
incompatibility	incompatibility	NN	I-NP	O
was	be	VBD	B-VP	O
major	major	JJ	B-ADJP	O

In	In	IN	B-PP	O
treatments	treatment	NNS	B-NP	O
R1	R1	NN	I-NP	O
and	and	CC	I-NP	O
R1	R1	NN	I-NP	O
,	,	,	O	O
feed	feed	NN	B-NP	O
quality	quality	NN	I-NP	O
was	be	VBD	B-VP	O
restricted	restrict	VBN	I-VP	O
by	by	IN	B-PP	O
withholding	withhold	VBG	B-VP	O
concentrates	concentrate	NNS	B-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
mo	mo	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O

The	The	DT	B-NP	O
major	major	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Xenopus	BEGIN-Xenopus	NNP	I-NP	B
laevis	laevis	NN	I-NP	I
1S	1S	NN	I-NP	I
RNA	RNA	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
transcribed	transcribe	VBN	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
and	and	CC	O	O
forms	form	VBZ	B-VP	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
initiation	initiation	NN	I-NP	O
factor	factor	NN	I-NP	O
TFIIIA	BEGIN-TFIIIA-INSIDE	NN	I-NP	B

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
truncation	truncation	NN	I-NP	O
of	of	IN	B-PP	O
as	as	RB	B-NP	O
little	little	JJ	I-NP	O
as	as	IN	I-NP	O
1	1	CD	I-NP	O
Nurr1	BEGIN-Nurr1-INSIDE	NN	I-NP	B
COOH	COOH	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
diminished	diminish	VBD	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
B1A	BEGIN-B1A-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
thymidine	BEGIN-thymidine	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
-	-	HYPH	B-NP	O
chloramphenicol	BEGIN-chloramphenicol	NN	I-NP	B
acetyltransferase	acetyltransferase-INSIDE	NN	I-NP	I
reporter	reporter	NN	I-NP	O

Small	Small	JJ	B-NP	O
cell	cell	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
:	:	:	O	O
contribution	contribution	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
solution	solution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
problem	problem	NN	I-NP	O
of	of	IN	B-PP	O
differential	differential	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
with	with	IN	B-PP	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
and	and	CC	I-NP	O
electron	electron	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O

Four	Four	CD	B-NP	O
experiments	experiment	NNS	I-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cholinergic	cholinergic	JJ	I-NP	O
projections	projection	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
septum	septum	NN	I-NP	O
and	and	CC	O	O
vertical	vertical	JJ	B-NP	O
limb	limb	NN	I-NP	O
nucleus	nucleus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
diagonal	diagonal	JJ	I-NP	O
band	band	NN	I-NP	O
of	of	IN	B-PP	O
Broca	Broca	NNP	B-NP	O
(	(	(	O	O
VDB	VDB	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
acquisition	acquisition	NN	B-NP	O
and	and	CC	I-NP	O
performance	performance	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
conditional	conditional	JJ	I-NP	O
visual	visual	JJ	I-NP	O
discrimination	discrimination	NN	I-NP	O

Deletion	Deletion	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
consensus	consensus	NN	I-NP	O
element	element	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
spo1	BEGIN-spo1	NN	I-NP	B
promoter	promoter-INSIDE	NN	I-NP	I
abolished	abolish	VBD	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
spo1+	BEGIN-spo1+-INSIDE	NN	B-NP	B
and	and	CC	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sporulation	sporulation	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O

This	This	DT	B-NP	O
region	region	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
contain	contain	VB	I-VP	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	O
estrogen	estrogen	NN	I-NP	O
response	response	NN	I-NP	O
element	element	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ER	BEGIN-ER-INSIDE	NN	B-NP	B
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
observed	observe	VBN	I-VP	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
that	that	IN	B-SBAR	O
analgesic	analgesic	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
morphine	morphine	NN	B-NP	O
accelerate	accelerate	VBP	B-VP	O
mortality	mortality	NN	B-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
hemorrhage	hemorrhage	NN	B-NP	O
(	(	(	O	O
Feuerstein	Feuerstein	NN	B-NP	O
and	and	CC	O	O
Siren	Siren	NN	B-NP	O
:	:	:	O	O
Circ	Circ	NN	B-NP	O
Shock	Shock	NN	I-NP	O
1	1	CD	I-NP	O
:	:	SYM	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
)	)	)	O	O

Microsporum	Microsporum	NNP	B-NP	O
persicolor	persicolor	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
easily	easily	RB	I-NP	O
misinterpreted	misinterpret	VBN	I-NP	O
dermatophyt	dermatophyt	NN	I-NP	O

When	When	WRB	B-ADVP	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
intermittent	intermittent	JJ	B-NP	O
schedules	schedule	NNS	I-NP	O
of	of	IN	B-PP	O
punishment	punishment	NN	B-NP	O
(	(	(	O	O
fixed	fix	VBN	B-VP	O
-	-	HYPH	B-NP	O
interval	interval	NN	I-NP	O
[	[	(	I-NP	O
FI	FI	NN	I-NP	O
]	]	)	I-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
or	or	CC	O	O
FI	FI	CD	B-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
SIB	SIB	NN	B-NP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
but	but	CC	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
participants	participant	NNS	I-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
levels	level	NNS	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
observed	observe	VBN	B-VP	O
during	during	IN	B-PP	O
baseline	baseline	NN	B-NP	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
1a	BEGIN-1a-INSIDE	NN	B-NP	B
,	,	,	O	O
which	which	WDT	B-NP	O
also	also	RB	B-ADVP	O
interacts	interact	VBZ	B-VP	O
independently	independently	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	O
and	and	CC	O	O
viral	viral	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
organizer	organizer	NN	I-NP	O
of	of	IN	B-PP	O
RNA	RNA	NN	B-NP	O
replication	replication	NN	I-NP	O
complex	complex	NN	I-NP	O
assembly	assembly	NN	I-NP	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
examine	examine	VBP	B-VP	O
the	the	DT	B-NP	O
population	population	NN	I-NP	O
of	of	IN	B-PP	O
gammaS	BEGIN-gammaS	NN	B-NP	B
transcripts	transcripts-INSIDE	NN	I-NP	I
in	in	IN	B-PP	O
adult	adult	JJ	B-NP	O
human	human	JJ	I-NP	O
lens	lens	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
CRYGS	CRYGS	NN	I-NP	I
genes	genes-INSIDE	NN	I-NP	I

PKK	BEGIN-PKK-INSIDE	NN	B-NP	B
exists	exist	VBZ	B-VP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
discernible	discernible	JJ	I-NP	O
forms	form	NNS	I-NP	O
at	at	IN	B-PP	O
steady	steady	JJ	B-NP	O
state	state	NN	I-NP	O
:	:	:	O	O
an	an	DT	B-NP	O
underphosphorylated	underphosphorylated	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kDa	kDa	NN	I-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
soluble	soluble	JJ	I-NP	O
,	,	,	I-NP	O
cytosolic	cytosolic	JJ	I-NP	O
,	,	,	I-NP	O
phosphorylated	phosphorylated	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kDa	kDa	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
phosphorylated	phosphorylate	VBN	I-NP	O
,	,	,	I-NP	O
detergent	detergent	NN	I-NP	O
-	-	HYPH	I-NP	O
insoluble	insoluble	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
kDa	kDa	NN	I-NP	O

The	The	DT	B-NP	O
lamina	lamina	NN	I-NP	O
densa	densa	NN	I-NP	O
was	be	VBD	B-VP	O
always	always	RB	I-VP	O
interrupted	interrupt	VBN	I-VP	O
by	by	IN	B-PP	O
numerous	numerous	JJ	B-NP	O
small	small	JJ	I-NP	O
gaps	gap	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
areas	area	NNS	I-NP	O
the	the	DT	B-NP	O
basement	basement	NN	I-NP	O
membrane	membrane	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
distance	distance	NN	I-NP	O

The	The	DT	B-NP	O
human	BEGIN-human	JJ	I-NP	B
CA1	CA1	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
located	located	JJ	B-ADJP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
secretor	BEGIN-secretor	NN	I-NP	B
type	type	NN	I-NP	I
alpha	alpha	NN	I-NP	I
(	(	(	O	I
1	1	CD	B-NP	I
,	,	,	I-NP	I
1	1	CD	I-NP	I
)	)	)	O	I
-	-	HYPH	B-NP	I
fucosyltransferase	fucosyltransferase	NN	I-NP	I
gene	gene	NN	I-NP	I
cluster	cluster-INSIDE	NN	I-NP	I
(	(	(	O	O
FUT1	BEGIN-FUT1-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
FUT1	BEGIN-FUT1-INSIDE	NN	I-NP	B
-	-	HYPH	B-NP	O
FUT1P	BEGIN-FUT1-INSIDEP	NN	I-NP	I
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
D	BEGIN-D	NN	I-NP	B
-	-	HYPH	B-NP	I
site	site	NN	I-NP	I
binding	binding	NN	I-NP	I
protein	protein	NN	I-NP	I
gene	gene-INSIDE	NN	I-NP	I
(	(	(	O	O
DBP	BEGIN-DBP-INSIDE	NN	B-NP	B
)	)	)	O	O
on	on	IN	B-PP	O
chromosome	chromosome	NN	B-NP	O
1q1	1q1	NN	I-NP	O

A	A	DT	B-NP	O
score	score	NN	I-NP	O
(	(	(	O	O
APACHE	APACHE	NN	B-NP	O
II	II	CD	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
FAK	BEGIN-FAK-INSIDE	NN	I-NP	B
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
facilitating	facilitate	VBG	B-VP	O
epidermal	BEGIN-epidermal	JJ	B-NP	B
growth	growth	NN	I-NP	I
factor	factor-INSIDE	NN	I-NP	I
(	(	(	O	O
EGF	BEGIN-EGF-INSIDE	NN	B-NP	B
)	)	)	O	O
-	-	HYPH	O	O
stimulated	stimulate	VBN	B-NP	O
human	human	JJ	I-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
(	(	(	O	O
A1	A1	NN	B-NP	O
)	)	)	O	O
cell	cell	NN	B-NP	O
motility	motility	NN	I-NP	O
,	,	,	O	O
antisense	antisense	JJ	B-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
FAK	BEGIN-BEGIN-FAK-INSIDE	NN	B-NP	B
protein	protein-INSIDE	NN	I-NP	I
expression	expression	NN	I-NP	O
>	>	SYM	B-NP	O
1	1	CD	I-NP	O

Evaluation	Evaluation	NN	B-NP	O
of	of	IN	B-PP	O
materials	material	NNS	B-NP	O
and	and	CC	I-NP	O
technics	technic	NNS	I-NP	O
in	in	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
using	use	VBG	B-VP	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
Indium	Indium	NN	I-NP	O

Functional	Functional	JJ	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
properly	properly	RB	I-NP	O
folded	fold	VBN	I-NP	O
surface	surface	NN	I-NP	O
loop	loop	NN	I-NP	O
covering	cover	VBG	B-VP	O
the	the	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
center	center	NN	I-NP	O

Hypoxia	Hypoxia	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
impulse	impulse	NN	I-NP	O
initiation	initiation	NN	I-NP	O
in	in	IN	B-PP	O
SA	SA	NN	B-NP	O
nodal	nodal	JJ	I-NP	O
fibers	fiber	NNS	I-NP	O
by	by	IN	B-PP	O
decreasing	decrease	VBG	B-VP	O
the	the	DT	B-NP	O
slope	slope	NN	I-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
depolarization	depolarization	NN	I-NP	O

Radiative	Radiative	JJ	B-NP	O
corrections	correction	NNS	I-NP	O
to	to	TO	B-PP	O
pi	pi	NN	B-NP	O
l1	l1	NN	I-NP	O
decays	decay	VBZ	B-VP	O

The	The	DT	B-NP	O
availability	availability	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
commercial	commercial	JJ	I-NP	O
program	program	NN	I-NP	O
(	(	(	O	O
PCNONLIN	PCNONLIN	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
carry	carry	VB	I-VP	O
out	out	RP	B-PRT	O
matrix	matrix	NN	B-NP	O
handling	handling	NN	I-NP	O
calculations	calculation	NNS	I-NP	O

The	The	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
TPAR1	BEGIN-TPAR1	NN	B-NP	B
mRNAs	mRNAs-INSIDE	NN	I-NP	I
were	be	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
down	down	RB	I-ADVP	O
-	-	HYPH	B-NP	O
regulated	regulate	VBN	B-VP	O
in	in	IN	B-PP	O
regenerating	regenerate	VBG	B-VP	O
rat	rat	NN	B-NP	O
liver	liver	NN	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
adult	adult	JJ	I-NP	O
liver	liver	NN	I-NP	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
tetralogy	tetralogy	NN	B-NP	O
of	of	IN	B-PP	O
Fallot	Fallot	NN	B-NP	O
with	with	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
electrophysiologic	electrophysiologic	JJ	B-NP	O
study	study	NN	I-NP	O
is	be	VBZ	B-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
reproducing	reproduce	VBG	B-VP	O
clinical	clinical	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
VT	VT	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
selecting	select	VBG	B-VP	O
effective	effective	JJ	B-NP	O
antiarrhythmic	antiarrhythmic	JJ	I-NP	O
medication	medication	NN	I-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
premature	premature	JJ	I-NP	O
complexes	complex	NNS	I-NP	O
alone	alone	RB	B-ADVP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
inducible	inducible	JJ	B-NP	O
sustained	sustained	JJ	I-NP	O
VT	VT	NN	I-NP	O
during	during	IN	B-PP	O
electrophysiologic	electrophysiologic	JJ	B-NP	O
study	study	NN	I-NP	O
;	;	:	O	O
prognosis	prognosis	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
improved	improve	VBN	I-VP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
that	that	WDT	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
prevention	prevention	NN	B-NP	O
of	of	IN	B-PP	O
VT	VT	NN	B-NP	O
induction	induction	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
VT	VT	NN	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
drug	drug	NN	B-NP	O
treatment	treatment	NN	I-NP	O

Hip	Hip	NN	B-NP	O
fracture	fracture	NN	I-NP	O
mortality	mortality	NN	I-NP	O
and	and	CC	O	O
prospective	prospective	JJ	B-NP	O
payment	payment	NN	I-NP	O
system	system	NN	I-NP	O

Primary	Primary	JJ	B-NP	O
care	care	NN	I-NP	O
programs	program	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
indigent	indigent	NN	I-NP	O

In	In	IN	B-PP	O
human	human	JJ	B-NP	O
myxoid	myxoid	JJ	I-NP	O
liposarcoma	liposarcoma	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
chromosomal	chromosomal	JJ	I-NP	O
rearrangement	rearrangement	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
fusion	fusion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
-	-	HYPH	B-VP	O
arresting	arrest	VBG	B-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
damage	damage	NN	I-NP	O
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
CHOP	BEGIN-CHOP-INSIDE	NN	I-NP	B
(	(	(	O	O
GADD1	BEGIN-GADD1-INSIDE	NN	B-NP	B
)	)	)	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
peptide	peptide	NN	I-NP	O
fragment	fragment	NN	I-NP	O
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
TLS	BEGIN-TLS	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I

Categorisation	Categorisation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
substructures	substructure	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
sections	section	NNS	I-NP	O
allows	allow	VBZ	B-VP	O
them	them	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
analysed	analyse	VBN	I-VP	O
and	and	CC	O	O
displayed	display	VBN	B-VP	O
separately	separately	RB	B-ADVP	O

Authors	Author	NNS	B-NP	O
present	present	VBP	B-VP	O
the	the	DT	B-NP	O
anatomical	anatomical	JJ	I-NP	O
variations	variation	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
mesenteric	mesenteric	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
branches	branch	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
human	human	JJ	I-NP	O
fetus	fetus	NN	I-NP	O

This	This	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
VIP	BEGIN-VIP-INSIDE	NN	B-NP	B
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
PRL	BEGIN-PRL	NN	I-NP	B
gene	gene-INSIDE	NN	I-NP	I
regulation	regulation	NN	I-NP	O

The	The	DT	B-NP	O
only	only	JJ	I-NP	O
quantities	quantity	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
between	between	IN	B-PP	O
appendicitis	appendicitis	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
appendix	appendix	NN	I-NP	O
were	be	VBD	B-VP	O
sex	sex	NN	B-NP	O
,	,	,	O	O
duration	duration	NN	B-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
,	,	,	O	O
anorexia	anorexia	NN	B-NP	O
and	and	CC	O	O
vomiting	vomiting	NN	B-NP	O

Signaling	Signaling	NN	B-NP	O
through	through	IN	B-PP	O
mitogen	BEGIN-mitogen	NN	B-NP	B
-	-	HYPH	B-NP	I
activated	activate	VBN	I-NP	I
protein	protein	NN	I-NP	I
kinase	kinase-INSIDE	NN	I-NP	I
and	and	CC	I-NP	O
Rac	BEGIN-Rac-INSIDE	NN	I-NP	B
/	/	SYM	B-NP	O
Rho	BEGIN-Rho-INSIDE	NN	B-NP	B
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
duplicate	duplicate	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
activated	activate	VBN	B-NP	O
Ras	BEGIN-Ras-INSIDE	NN	I-NP	B
on	on	IN	B-PP	O
skeletal	skeletal	JJ	B-NP	O
myogenesis	myogenesis	NN	I-NP	O

The	The	DT	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
,	,	,	O	O
even	even	RB	B-SBAR	O
if	if	IN	I-SBAR	O
they	they	PRP	B-NP	O
need	need	VBP	B-VP	O
long	long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
parenteral	parenteral	JJ	I-NP	O
nutrition	nutrition	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
good	good	JJ	B-ADJP	O

Unlike	Unlike	IN	B-PP	O
these	these	DT	B-NP	O
contaminant	contaminant	NN	I-NP	O
-	-	HYPH	B-NP	O
responsive	responsive	JJ	I-NP	O
T	T	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
those	those	DT	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
truly	truly	RB	B-ADJP	O
specific	specific	JJ	I-ADJP	O
for	for	IN	B-PP	O
natural	natural	JJ	B-NP	O
AChR	BEGIN-AChR	NN	I-NP	B
epitopes	epitopes-INSIDE	NN	I-NP	I
appear	appear	VBP	B-VP	O
less	less	RBR	B-ADJP	O
heterogeneous	heterogeneous	JJ	I-ADJP	O
and	and	CC	O	O
therefore	therefore	RB	B-ADJP	O
more	more	JJR	B-NP	O
suitable	suitable	JJ	I-NP	O
targets	target	NNS	I-NP	O
for	for	IN	B-PP	O
selective	selective	JJ	B-NP	O
immunotherapy	immunotherapy	NN	I-NP	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
initial	initial	JJ	I-NP	O
experience	experience	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
short	short	JJ	B-ADJP	O
-	-	HYPH	O	O
to	to	TO	B-PP	O
middle	middle	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
efficiency	efficiency	NN	I-NP	O
and	and	CC	O	O
safety	safety	NN	B-NP	O
when	when	WRB	B-ADVP	O
using	use	VBG	B-VP	O
GKS	GKS	NN	B-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
MTLE	MTLE	NN	B-NP	O

A	A	DT	B-NP	O
Brassica	Brassica	NNP	I-NP	O
cDNA	cDNA	NN	I-NP	O
clone	clone	NN	I-NP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
bifunctional	bifunctional	JJ	I-NP	O
hydroxymethylpyrimidine	BEGIN-hydroxymethylpyrimidine	NN	I-NP	B
kinase	kinase-INSIDE	NN	I-NP	I
/	/	SYM	B-NP	O
thiamin	BEGIN-thiamin	NN	I-NP	B
-	-	HYPH	B-NP	I
phosphate	phosphate	NN	I-NP	I
pyrophosphorylase	pyrophosphorylase-INSIDE	NN	I-NP	I
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
thiamin	thiamin	NN	B-NP	O
biosynthesis	biosynthesis	NN	I-NP	O

The	The	DT	B-NP	O
aims	aim	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
examine	examine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
EORTC	EORTC	NN	I-NP	O
(	(	(	O	O
European	European	JJ	B-NP	O
Organisation	Organisation	NNP	I-NP	O
for	for	IN	B-PP	O
Research	Research	NNP	B-NP	O
and	and	CC	O	O
Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
Cancer	Cancer	NN	B-NP	O
)	)	)	O	O
QLQ	QLQ	NN	B-NP	O
-	-	HYPH	B-NP	O
C1	C1	NN	I-NP	O
core	core	NN	I-NP	O
questionnaire	questionnaire	NN	I-NP	O
alone	alone	RB	B-ADVP	O
could	could	MD	B-VP	O
distinguish	distinguish	VB	I-VP	O
between	between	IN	B-PP	O
two	two	CD	B-NP	O
clinically	clinically	RB	I-NP	O
different	different	JJ	I-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
design	design	VB	I-VP	O
a	a	DT	B-NP	O
module	module	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
included	include	VBD	B-VP	O
relevant	relevant	JJ	B-NP	O
patient	patient	NN	I-NP	O
-	-	HYPH	O	O
defined	define	VBN	B-VP	O
gastric	gastric	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
variables	variable	NNS	I-NP	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
work	work	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
hearing	hearing	NN	B-NP	O
thresholds	threshold	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
hearing	hear	VBG	B-VP	O
impairment	impairment	NN	B-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
hereditary	hereditary	JJ	B-NP	O
motor	motor	NN	I-NP	O
and	and	CC	O	O
sensory	sensory	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
(	(	(	O	O
HMSN	HMSN	NN	B-NP	O
I	I	CD	I-NP	O
)	)	)	O	O

Causal	Causal	JJ	B-NP	O
modeling	modeling	NN	I-NP	O
combines	combine	NNS	I-NP	O
theory	theory	NN	I-NP	O
and	and	CC	I-NP	O
research	research	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
interpretation	interpretation	NN	I-NP	O
of	of	IN	B-PP	O
data	datum	NNS	B-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proposed	propose	VBN	I-NP	O
theory	theory	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
offers	offer	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
advancing	advance	VBG	B-VP	O
the	the	DT	B-NP	O
science	science	NN	I-NP	O
while	while	IN	B-SBAR	O
maintaining	maintain	VBG	B-VP	O
the	the	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
practice	practice	NN	I-NP	O

